Psyllid ID: psy12305
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | 2.2.26 [Sep-21-2011] | |||||||
| Q00537 | 523 | Cyclin-dependent kinase 1 | yes | N/A | 0.614 | 0.606 | 0.662 | 1e-122 | |
| Q8K0D0 | 523 | Cyclin-dependent kinase 1 | yes | N/A | 0.614 | 0.606 | 0.662 | 1e-122 | |
| Q00536 | 496 | Cyclin-dependent kinase 1 | no | N/A | 0.563 | 0.586 | 0.71 | 1e-120 | |
| Q04735 | 496 | Cyclin-dependent kinase 1 | no | N/A | 0.563 | 0.586 | 0.7 | 1e-119 | |
| O35831 | 523 | Cyclin-dependent kinase 1 | yes | N/A | 0.571 | 0.564 | 0.694 | 1e-119 | |
| O35832 | 451 | Cyclin-dependent kinase 1 | no | N/A | 0.612 | 0.700 | 0.640 | 1e-116 | |
| Q63686 | 496 | Cyclin-dependent kinase 1 | no | N/A | 0.563 | 0.586 | 0.683 | 1e-116 | |
| Q5RD01 | 472 | Cyclin-dependent kinase 1 | no | N/A | 0.612 | 0.669 | 0.643 | 1e-115 | |
| Q04899 | 451 | Cyclin-dependent kinase 1 | no | N/A | 0.612 | 0.700 | 0.640 | 1e-114 | |
| Q07002 | 472 | Cyclin-dependent kinase 1 | no | N/A | 0.612 | 0.669 | 0.634 | 1e-114 |
| >sp|Q00537|CDK17_HUMAN Cyclin-dependent kinase 17 OS=Homo sapiens GN=CDK17 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 439 bits (1129), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/332 (66%), Positives = 267/332 (80%), Gaps = 15/332 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 200 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 259
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 260 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 319
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 320 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 379
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 380 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGISSNEEFK-NYNFPKYKPQPLINH 438
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+SA AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 439 AP-RLDSEGIELITKFLQYESKKRVSAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 497
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P F + G +RRQSML
Sbjct: 498 QKDPG------FRNSSYPETGHGKNRRQSMLF 523
|
May play a role in terminally differentiated neurons. Has a Ser/Thr-phosphorylating activity for histone H1. Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q8K0D0|CDK17_MOUSE Cyclin-dependent kinase 17 OS=Mus musculus GN=Cdk17 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 437 bits (1124), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/332 (66%), Positives = 266/332 (80%), Gaps = 15/332 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 200 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 259
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 260 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 319
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 320 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 379
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 380 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGVSSNDEFK-NYNFPKYKPQPLINH 438
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+ A AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 439 AP-RLDSEGIELITKFLQYESKKRVPAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 497
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P F + G +RRQSML
Sbjct: 498 QKDPG------FRNSSYPETGHGKNRRQSMLF 523
|
May play a role in terminally differentiated neurons. Has a Ser/Thr-phosphorylating activity for histone H1. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q00536|CDK16_HUMAN Cyclin-dependent kinase 16 OS=Homo sapiens GN=CDK16 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1113), Expect = e-120, Method: Compositional matrix adjust.
Identities = 213/300 (71%), Positives = 255/300 (85%), Gaps = 9/300 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 173 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 232
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC NI++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNL
Sbjct: 233 EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 292
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+YST IDM GVGCIF
Sbjct: 293 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 352
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
+EM++GRPLFPGST+E++L I ILG P +E + S EF T YP LL
Sbjct: 353 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK-TYNYPKYRAEALLSH 411
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L ++ + RISA +AM+HP+F SLG ++H+L DT SIF+L I+L
Sbjct: 412 AP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 470
|
May play a role in signal transduction cascades in terminally differentiated cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q04735|CDK16_MOUSE Cyclin-dependent kinase 16 OS=Mus musculus GN=Cdk16 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1102), Expect = e-119, Method: Compositional matrix adjust.
Identities = 210/300 (70%), Positives = 254/300 (84%), Gaps = 9/300 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 173 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 232
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC N+++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNL
Sbjct: 233 EKSLTLVFEYLDKDLKQYLDDCGNVINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 292
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+YST IDM GVGCIF
Sbjct: 293 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 352
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
+EM++GRPLFPGST+E++L I ILG P +E + S EF T YP LL
Sbjct: 353 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFR-TYNYPKYRAEALLSH 411
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L ++ + RISA +A +HP+F SLG ++H+L DT SIF+L ++L
Sbjct: 412 AP-RLDSDGADLLTKLLQFEGRNRISAEDARKHPFFLSLGERIHKLPDTTSIFALKEVQL 470
|
May play a role in signal transduction cascades in terminally differentiated cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|O35831|CDK17_RAT Cyclin-dependent kinase 17 OS=Rattus norvegicus GN=Cdk17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 428 bits (1101), Expect = e-119, Method: Compositional matrix adjust.
Identities = 211/304 (69%), Positives = 255/304 (83%), Gaps = 9/304 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 200 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 259
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC +I+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 260 DKSLTLVFEYLDKDLKQYMDDCGSIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 319
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 320 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 379
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 380 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGVSSNDEFK-NYNFPKYKPQPLINH 438
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R A AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 439 AP-RLDSEGIELITKFLQYESKKRAPAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 497
Query: 485 TSNP 488
+P
Sbjct: 498 QKDP 501
|
May play a role in terminally differentiated neurons. Has a Ser/Thr-phosphorylating activity for histone H1. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|O35832|CKD18_RAT Cyclin-dependent kinase 18 OS=Rattus norvegicus GN=Cdk18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-116, Method: Compositional matrix adjust.
Identities = 212/331 (64%), Positives = 264/331 (79%), Gaps = 15/331 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHD+IHT
Sbjct: 129 EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDLIHT 188
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
++ LTLVFEYL+ DLK+Y+D C N+++M+NVK+F+FQLLRGLAYCH R+ILHRDLKPQNL
Sbjct: 189 DRSLTLVFEYLDSDLKQYLDHCGNLMNMHNVKIFMFQLLRGLAYCHRRKILHRDLKPQNL 248
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCI
Sbjct: 249 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 308
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM++G+PLFPGST+++EL LI +LG P +E + S EF P Y + L
Sbjct: 309 YEMATGKPLFPGSTVKEELHLIFRLLGTPTEESWPGVTSISEFRAYNFPRYLPQPLLS-H 367
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++D++ ++L+ L+Y++K R+SA A+ HPYF SLG +VH+L DT SIFSL I+L
Sbjct: 368 AP-RLDTEGINLLTSLLLYESKSRMSAEAALSHPYFQSLGERVHQLDDTASIFSLKEIQL 426
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSML 515
+P + G + G SRRQS+
Sbjct: 427 QKDPG------YRGLAFQHPGRGKSRRQSIF 451
|
May play a role in signal transduction cascades in terminally differentiated cells. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q63686|CDK16_RAT Cyclin-dependent kinase 16 OS=Rattus norvegicus GN=Cdk16 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 420 bits (1080), Expect = e-116, Method: Compositional matrix adjust.
Identities = 205/300 (68%), Positives = 254/300 (84%), Gaps = 9/300 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 173 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 232
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC N+++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNL
Sbjct: 233 EKSLTLVFEYLDKDLKQYLDDCGNVINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 292
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLA AKS+PTKT+SNEVVTLWYRPPD+LLGST+YS IDM GVGCIF
Sbjct: 293 LINERGELKLADFGLAYAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSGQIDMWGVGCIF 352
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCI--TPVYPSESKLQLL 424
+EM++GRPLFPGST+E++L I ILG P ++ + S EF P Y +E+ L+
Sbjct: 353 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEDTWPGILSNEEFRTYNYPKYRAEALLR-H 411
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP +++ D DL+ K L ++ + RISA +AM+HP+F SLG ++H+L DT SIF+L ++L
Sbjct: 412 AP-RLECDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEVQL 470
|
May play a role in signal transduction cascades in terminally differentiated cells. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q5RD01|CDK18_PONAB Cyclin-dependent kinase 18 OS=Pongo abelii GN=CDK18 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 213/331 (64%), Positives = 263/331 (79%), Gaps = 15/331 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL+ L+HANIVTLHD+IHT
Sbjct: 150 EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDLIHT 209
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
++ LTLVFEYL+ DLK+Y+D C N++SM+NVK+F+FQLLRGLAYCH R+ILHRDLKPQNL
Sbjct: 210 DRSLTLVFEYLDSDLKQYLDHCGNLMSMHNVKIFMFQLLRGLAYCHHRKILHRDLKPQNL 269
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCI
Sbjct: 270 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIH 329
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL----EFCITPVYPSESKLQLL-- 424
+EM++GRPLFPGST+++EL LI +LG P +E + EF T +P L+
Sbjct: 330 YEMATGRPLFPGSTVKEELHLIFRLLGTPTEETWPGVTAFSEFR-TYSFPRYLPQPLISH 388
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++D+D + L+ L+Y++K R+SA A+ HPYF SLG +VH+L DT SIFSL I+L
Sbjct: 389 AP-RLDTDGIQLLSSLLLYESKSRMSAEAALSHPYFRSLGERVHQLEDTASIFSLKEIQL 447
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSML 515
+P + G ++ G +RRQS+
Sbjct: 448 QKDPG------YRGLAFQQPGRGKNRRQSIF 472
|
May play a role in signal transduction cascades in terminally differentiated cells. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q04899|CDK18_MOUSE Cyclin-dependent kinase 18 OS=Mus musculus GN=Cdk18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1063), Expect = e-114, Method: Compositional matrix adjust.
Identities = 212/331 (64%), Positives = 264/331 (79%), Gaps = 15/331 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHD+IHT
Sbjct: 129 EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDLIHT 188
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
++ LTLVFEYL+ DLK+Y+D C N+++M+NVK+F+FQLLRGLAYCH R+ILHRDLKPQNL
Sbjct: 189 DRSLTLVFEYLDSDLKQYLDHCGNLMNMHNVKIFMFQLLRGLAYCHHRKILHRDLKPQNL 248
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCI
Sbjct: 249 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 308
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM++G+PLFPGST+++EL LI +LG P +E + S EF P Y + L
Sbjct: 309 YEMATGKPLFPGSTVKEELHLIFRLLGTPTEESWPGVTSISEFRAYNFPRYLPQPLLS-H 367
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++D++ ++L+ L+Y++K R+SA A+ HPYF SLG +VH+L DT SIFSL I+L
Sbjct: 368 AP-RLDTEGINLLSSLLLYESKSRMSAEAALNHPYFQSLGDRVHQLHDTASIFSLKEIQL 426
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSML 515
+P + G + G SRRQS+
Sbjct: 427 QKDPG------YRGLAFQHPGRGKSRRQSIF 451
|
May play a role in signal transduction cascades in terminally differentiated cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q07002|CDK18_HUMAN Cyclin-dependent kinase 18 OS=Homo sapiens GN=CDK18 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 411 bits (1056), Expect = e-114, Method: Compositional matrix adjust.
Identities = 210/331 (63%), Positives = 260/331 (78%), Gaps = 15/331 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL+ L+HANIVTLHD+IHT
Sbjct: 150 EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDLIHT 209
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
++ LTLVFEYL+ DLK+Y+D C N++SM+NVK+F+FQLLRGLAYCH R+ILHRDLKPQNL
Sbjct: 210 DRSLTLVFEYLDSDLKQYLDHCGNLMSMHNVKIFMFQLLRGLAYCHHRKILHRDLKPQNL 269
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCI
Sbjct: 270 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIH 329
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDELK------SKLEFCITPVYPSESKLQLL 424
+EM++GRPLFPGST+++EL LI +LG P +E S+ P Y + +
Sbjct: 330 YEMATGRPLFPGSTVKEELHLIFRLLGTPTEETWPGVTAFSEFRTYSFPCYLPQPLIN-H 388
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++D+D + L+ L+Y++K R+SA A+ H YF SLG +VH+L DT SIFSL I+L
Sbjct: 389 AP-RLDTDGIHLLSSLLLYESKSRMSAEAALSHSYFRSLGERVHQLEDTASIFSLKEIQL 447
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSML 515
+P + G ++ G +RRQS+
Sbjct: 448 QKDPG------YRGLAFQQPGRGKNRRQSIF 472
|
May play a role in signal transduction cascades in terminally differentiated cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | ||||||
| 47213605 | 492 | unnamed protein product [Tetraodon nigro | 0.864 | 0.906 | 0.573 | 1e-154 | |
| 321465852 | 433 | hypothetical protein DAPPUDRAFT_54893 [D | 0.598 | 0.713 | 0.698 | 1e-126 | |
| 443723893 | 552 | hypothetical protein CAPTEDRAFT_175804 [ | 0.620 | 0.579 | 0.692 | 1e-123 | |
| 410899679 | 527 | PREDICTED: cyclin-dependent kinase 17-li | 0.612 | 0.599 | 0.681 | 1e-122 | |
| 348513009 | 618 | PREDICTED: cyclin-dependent kinase 17-li | 0.618 | 0.516 | 0.660 | 1e-122 | |
| 348521492 | 527 | PREDICTED: cyclin-dependent kinase 17-li | 0.614 | 0.601 | 0.689 | 1e-121 | |
| 432866322 | 580 | PREDICTED: cyclin-dependent kinase 17-li | 0.608 | 0.541 | 0.677 | 1e-121 | |
| 344266506 | 523 | PREDICTED: cyclin-dependent kinase 17 [L | 0.614 | 0.606 | 0.665 | 1e-121 | |
| 291236637 | 469 | PREDICTED: cyclin-dependent kinase 17-li | 0.612 | 0.673 | 0.663 | 1e-120 | |
| 402887308 | 468 | PREDICTED: cyclin-dependent kinase 17 [P | 0.614 | 0.677 | 0.662 | 1e-120 |
| >gi|47213605|emb|CAG07271.1| unnamed protein product [Tetraodon nigroviridis] | Back alignment and taxonomy information |
|---|
Score = 550 bits (1418), Expect = e-154, Method: Compositional matrix adjust.
Identities = 298/520 (57%), Positives = 372/520 (71%), Gaps = 74/520 (14%)
Query: 6 VVHENPKIGSEEELEE-VQDNLSKPVEVVKVRQRPKR-SSEDINKRLSLPADLHLPESFL 63
+VHE+ K+ S+ E + D + PV KVR R K+ S+EDINKRLSLPAD+ LP+ +L
Sbjct: 2 IVHEDVKMSSDGESDPPSSDGVQSPV---KVRLRNKKISTEDINKRLSLPADIRLPDGYL 58
Query: 64 AKTNII-----DAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNL 118
K N+I + P++R R SLSEIGFG++E+Y KLDKLG+GTYATV+KG+S+LTDNL
Sbjct: 59 EKFNVIGPSLFEQPISRRLHRVSLSEIGFGKLETYIKLDKLGEGTYATVYKGRSKLTDNL 118
Query: 119 VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRY 178
VALKEI+LEHEEGAPCTAIREVS+ + +E + F LE +K
Sbjct: 119 VALKEIRLEHEEGAPCTAIREVSVF--------------VQSE----IGFGKLETYIK-- 158
Query: 179 MDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR 238
+D +GTYATV+KG+S+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+
Sbjct: 159 LDKLG--------EGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK 210
Query: 239 HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS 298
HANIVTLHDIIHT+K LTLVFEYL+KDLK+Y+DDC N+++++NVKLFLFQLLRGL+YCH
Sbjct: 211 HANIVTLHDIIHTQKSLTLVFEYLDKDLKQYLDDCGNLINVHNVKLFLFQLLRGLSYCHR 270
Query: 299 RRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY 358
R++LHRDLKPQNLLINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+Y
Sbjct: 271 RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 330
Query: 359 STSIDM----------------------------GVGCIFHEMSSGRPLFPGSTIEDELR 390
ST IDM GVGCIF+EM +GRPLFPGST+E+EL
Sbjct: 331 STHIDMWSVGPRKRPPLLPRTAPPSSSPSVSAPRGVGCIFYEMVTGRPLFPGSTVEEELH 390
Query: 391 LICSILGPPPDE----LKSKLEFCITPVYPS--ESKLQLLAPEQMDSDALDLVQKFLMYD 444
I +LG P + + S EF + YP +L P ++ S+ +DL+ KFL ++
Sbjct: 391 FIFKLLGTPTERTWPGISSNDEF-VAYNYPQYRADRLSNHTP-RLSSEGVDLLSKFLQFE 448
Query: 445 AKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
K+RISA +M H YF +LG + L DT SIFSLP I+L
Sbjct: 449 GKKRISAEESMTHCYFGNLGKRAMALPDTTSIFSLPEIQL 488
|
Source: Tetraodon nigroviridis Species: Tetraodon nigroviridis Genus: Tetraodon Family: Tetraodontidae Order: Tetraodontiformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|321465852|gb|EFX76851.1| hypothetical protein DAPPUDRAFT_54893 [Daphnia pulex] | Back alignment and taxonomy information |
|---|
Score = 457 bits (1175), Expect = e-126, Method: Compositional matrix adjust.
Identities = 236/338 (69%), Positives = 271/338 (80%), Gaps = 29/338 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKSRLTDNLVALKEI+LEHEEGAPCTAIREVSLL++LRHANIVTLHDI+HT
Sbjct: 112 EGTYATVYKGKSRLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLRHANIVTLHDIVHT 171
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYLEKDLK+YMDDC +ILSMNNVK+FLFQLLRGLAYCH RRILHRDLKPQNL
Sbjct: 172 EKSLTLVFEYLEKDLKQYMDDCGSILSMNNVKIFLFQLLRGLAYCHRRRILHRDLKPQNL 231
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LIN++GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCIF
Sbjct: 232 LINDKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIF 291
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE-----------LKSKLEFCITPVYPSES 419
EM+SGRPLFPGST+ED+L+LI S+LG P +E L + + C +
Sbjct: 292 FEMASGRPLFPGSTVEDQLQLIFSLLGTPTEETWPGIHGNEDFLSYRFDHC------APQ 345
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSL 479
L AP ++D D LDL+ KFL Y+AK+RISA +AMRHPYF SLG VH++ D SIF+
Sbjct: 346 SLIHRAP-RLDGDGLDLLNKFLSYEAKKRISAQDAMRHPYFRSLGSMVHKIPDVASIFTC 404
Query: 480 PHIKLTSNPTDGGLLPF-YGQKSEKRWTGLSRRQSMLL 516
I+LT +P G P +G S+ +RRQSMLL
Sbjct: 405 QGIQLTRDP---GYRPSNHGNHSK------TRRQSMLL 433
|
Source: Daphnia pulex Species: Daphnia pulex Genus: Daphnia Family: Daphniidae Order: Diplostraca Class: Branchiopoda Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|443723893|gb|ELU12112.1| hypothetical protein CAPTEDRAFT_175804 [Capitella teleta] | Back alignment and taxonomy information |
|---|
Score = 448 bits (1152), Expect = e-123, Method: Compositional matrix adjust.
Identities = 230/332 (69%), Positives = 259/332 (78%), Gaps = 12/332 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKGKSRLTDNLVALKEI+LEHEEGAPCTAIREVSLLREL+HANIVTLHDIIHT
Sbjct: 226 EGTYATVFKGKSRLTDNLVALKEIRLEHEEGAPCTAIREVSLLRELKHANIVTLHDIIHT 285
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYLEKDLK+YMDDC NI+SM NVKLFL+QLLRGL YCH RR+LHRDLKPQNL
Sbjct: 286 EKSLTLVFEYLEKDLKQYMDDCGNIMSMTNVKLFLYQLLRGLQYCHKRRVLHRDLKPQNL 345
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCIF
Sbjct: 346 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDVLLGSTEYSTQIDMWGVGCIF 405
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE------LKSKLEFCITPVYPSESKLQLL 424
EM+ GRPLFPGST+E+EL LI LG P + + F P + +E L
Sbjct: 406 FEMACGRPLFPGSTVEEELHLIFKTLGTPTEASWPGVTINEDFRFYKQPFHAAEPLLN-H 464
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD L+L+ FL YD ++RISA ++MRH YF LG +H+L D SIF+LP I L
Sbjct: 465 AP-RLDSDGLNLLSHFLQYDVRRRISALDSMRHKYFLPLGLAIHKLPDATSIFTLPGISL 523
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P GL S + G RRQSML
Sbjct: 524 HRDP---GLRSSAVGASGRHKQGKQRRQSMLF 552
|
Source: Capitella teleta Species: Capitella teleta Genus: Capitella Family: Capitellidae Order: Capitellida Class: Polychaeta Phylum: Annelida Superkingdom: Eukaryota |
| >gi|410899679|ref|XP_003963324.1| PREDICTED: cyclin-dependent kinase 17-like [Takifugu rubripes] | Back alignment and taxonomy information |
|---|
Score = 446 bits (1146), Expect = e-122, Method: Compositional matrix adjust.
Identities = 227/333 (68%), Positives = 268/333 (80%), Gaps = 17/333 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 204 EGTYATVFKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 263
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+KCLTLVFEYLEKDLK+YMDDC NI+S++NVK+FLFQLLRGLAYCH R++LHRDLKPQNL
Sbjct: 264 DKCLTLVFEYLEKDLKQYMDDCGNIMSVHNVKIFLFQLLRGLAYCHRRKVLHRDLKPQNL 323
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEY TSIDM GVGCIF
Sbjct: 324 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYFTSIDMWGVGCIF 383
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM +GRPLFPGST+EDEL LI ILG P +E + + EF P Y +E L
Sbjct: 384 YEMITGRPLFPGSTVEDELHLIFRILGTPTEESWPGITTSEEFKTYNFPQYQAEP-LVSH 442
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++D+D LDL+ L ++AK+R+SA +A+RH YF S G QV L+DT SIFS+ I+L
Sbjct: 443 AP-RIDNDGLDLLSMLLQFEAKKRVSAEDALRHSYFRSFGDQVQTLADTASIFSVKGIQL 501
Query: 485 TSNP-TDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P + P Q G +RRQS+L
Sbjct: 502 QKDPGKKSSMFPESAQ-------GKNRRQSVLF 527
|
Source: Takifugu rubripes Species: Takifugu rubripes Genus: Takifugu Family: Tetraodontidae Order: Tetraodontiformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|348513009|ref|XP_003444035.1| PREDICTED: cyclin-dependent kinase 17-like [Oreochromis niloticus] | Back alignment and taxonomy information |
|---|
Score = 445 bits (1145), Expect = e-122, Method: Compositional matrix adjust.
Identities = 218/330 (66%), Positives = 266/330 (80%), Gaps = 11/330 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 295 EGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 354
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NILSM NVK+FLFQ+LRGLAYCH R++LHRDLKPQNL
Sbjct: 355 DKSLTLVFEYLDKDLKQYMDDCGNILSMQNVKIFLFQILRGLAYCHRRKVLHRDLKPQNL 414
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LIN+RGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 415 LINDRGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 474
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLLAP 426
+EM++GRPLFPGST+EDEL LI +LG P ++ + S EF + +++ +
Sbjct: 475 YEMAAGRPLFPGSTVEDELHLIFRLLGTPTEDSWPGISSIDEFKSYKFHKYKAQSLINHA 534
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKLTS 486
++D+D +DL+ FL Y++K+RISA AMR PYF SLGP+VH L +T SIF+L ++L
Sbjct: 535 PRLDNDGIDLLMSFLKYESKKRISADEAMRQPYFRSLGPRVHTLPETVSIFTLKEVQLQR 594
Query: 487 NPTDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P + + G SRRQSML
Sbjct: 595 DPG------YRNSSYPESGNGKSRRQSMLF 618
|
Source: Oreochromis niloticus Species: Oreochromis niloticus Genus: Oreochromis Family: Cichlidae Order: Perciformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|348521492|ref|XP_003448260.1| PREDICTED: cyclin-dependent kinase 17-like [Oreochromis niloticus] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1138), Expect = e-121, Method: Compositional matrix adjust.
Identities = 229/332 (68%), Positives = 269/332 (81%), Gaps = 15/332 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 204 EGTYATVFKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 263
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+KCLTLVFEYLEKDLK+YMDDC +I+S++NVK+FLFQLLRGLAYCH R++LHRDLKPQNL
Sbjct: 264 DKCLTLVFEYLEKDLKQYMDDCGSIMSVHNVKIFLFQLLRGLAYCHRRKVLHRDLKPQNL 323
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCIF
Sbjct: 324 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIF 383
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM +GRPLFPGST+EDEL LI ILG P +E + + EF P Y +E L
Sbjct: 384 YEMITGRPLFPGSTVEDELHLIFRILGTPTEETWPGITTSEEFKTYNFPRYHAEP-LVNH 442
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L ++AK+RI A +A+RH YF LG QV L+DT SIFS+ I+L
Sbjct: 443 AP-RIDSDGHDLLSKLLQFEAKKRILAEDALRHAYFKCLGEQVQTLADTASIFSVKGIQL 501
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P G Y + S+ G SRRQS+L
Sbjct: 502 QKDP--GKRSSVYPESSQ----GKSRRQSVLF 527
|
Source: Oreochromis niloticus Species: Oreochromis niloticus Genus: Oreochromis Family: Cichlidae Order: Perciformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|432866322|ref|XP_004070794.1| PREDICTED: cyclin-dependent kinase 17-like [Oryzias latipes] | Back alignment and taxonomy information |
|---|
Score = 442 bits (1137), Expect = e-121, Method: Compositional matrix adjust.
Identities = 227/335 (67%), Positives = 271/335 (80%), Gaps = 21/335 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 257 EGTYATVFKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 316
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+KCLTLVFEYLEKDLK+YMDDC NI+S+NNVK+FL+QLLRGLAYCH R++LHRDLKPQNL
Sbjct: 317 DKCLTLVFEYLEKDLKQYMDDCGNIMSVNNVKIFLYQLLRGLAYCHRRKVLHRDLKPQNL 376
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LI+E+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCIF
Sbjct: 377 LISEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIF 436
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM +GRPLFPGST+EDEL LI +LG P ++ + + EF P+Y +E L
Sbjct: 437 YEMITGRPLFPGSTVEDELHLIFRVLGTPTEKTWPGMPTSEEFKTYNFPLYRAEP-LVNH 495
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L +DAK+R+SA +A++H YF SLG QV L DT SIFS+ I+L
Sbjct: 496 AP-RIDSDGHDLLSKLLQFDAKKRVSAEDALKHSYFRSLGEQVQTLPDTASIFSVKGIQL 554
Query: 485 TSNPTDGGLLPFYGQKSE---KRWTGLSRRQSMLL 516
+P G++S + G SRRQS+L
Sbjct: 555 QKDP---------GKRSSVHPESTQGKSRRQSVLF 580
|
Source: Oryzias latipes Species: Oryzias latipes Genus: Oryzias Family: Adrianichthyidae Order: Beloniformes Class: Actinopterygii Phylum: Chordata Superkingdom: Eukaryota |
| >gi|344266506|ref|XP_003405321.1| PREDICTED: cyclin-dependent kinase 17 [Loxodonta africana] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/332 (66%), Positives = 268/332 (80%), Gaps = 15/332 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 200 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 259
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 260 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 319
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 320 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 379
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 380 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGVSSNDEFK-NYNFPKYKPQPLINH 438
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+SA AM+H YF SLGP++H LS++ SIFSL I+L
Sbjct: 439 AP-RLDSEGIELITKFLQYESKKRVSAEEAMKHVYFRSLGPRIHALSESVSIFSLKEIQL 497
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P F + G +RRQSML
Sbjct: 498 QKDPG------FRNSSYPETGHGKNRRQSMLF 523
|
Source: Loxodonta africana Species: Loxodonta africana Genus: Loxodonta Family: Elephantidae Order: Proboscidea Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
| >gi|291236637|ref|XP_002738242.1| PREDICTED: cyclin-dependent kinase 17-like [Saccoglossus kowalevskii] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1131), Expect = e-120, Method: Compositional matrix adjust.
Identities = 221/333 (66%), Positives = 259/333 (77%), Gaps = 17/333 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKGKS+LTD+LVALKEI+LEHEEGAPCTAIREVSLL+EL+HANIVTLHDIIHT
Sbjct: 146 EGTYATVFKGKSKLTDSLVALKEIRLEHEEGAPCTAIREVSLLKELKHANIVTLHDIIHT 205
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
LTLVFEYLEKDLK+YMDDC NI+SMNNV LFL+QLLRGLAYCH R+LHRDLKPQNL
Sbjct: 206 PNALTLVFEYLEKDLKQYMDDCGNIMSMNNVMLFLYQLLRGLAYCHKSRVLHRDLKPQNL 265
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCIF
Sbjct: 266 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTHIDMWGVGCIF 325
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF------CITPVYPSESKLQLL 424
+EM++GRPLFPGST+EDEL LI +LG P ++ + F P Y E +
Sbjct: 326 YEMAAGRPLFPGSTVEDELHLIWKLLGTPTEDTWPGISFNDEFQSYSFPYYDPEPLIN-- 383
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
++D D +DL++K L ++ RISA +AM+HP+F LG ++HE+SD QSIF L I+L
Sbjct: 384 HSPRIDPDGIDLLKKLLQFEGINRISARDAMKHPFFKCLGTRIHEISDVQSIFVLNEIEL 443
Query: 485 TSNPT-DGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P + P G +G RRQSML
Sbjct: 444 NKDPGYRSSIFPHSG-------SGRGRRQSMLF 469
|
Source: Saccoglossus kowalevskii Species: Saccoglossus kowalevskii Genus: Saccoglossus Family: Harrimaniidae Order: Class: Enteropneusta Phylum: Hemichordata Superkingdom: Eukaryota |
| >gi|402887308|ref|XP_003907038.1| PREDICTED: cyclin-dependent kinase 17 [Papio anubis] | Back alignment and taxonomy information |
|---|
Score = 439 bits (1130), Expect = e-120, Method: Compositional matrix adjust.
Identities = 220/332 (66%), Positives = 267/332 (80%), Gaps = 15/332 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 145 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 204
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 205 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 264
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 265 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 324
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 325 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGISSNEEFK-NYNFPKYKPQPLINH 383
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+SA AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 384 AP-RLDSEGIELITKFLQYESKKRVSAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 442
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSMLL 516
+P F + G +RRQSML
Sbjct: 443 QKDPG------FRNSSYPETGHGKNRRQSMLF 468
|
Source: Papio anubis Species: Papio anubis Genus: Papio Family: Cercopithecidae Order: Primates Class: Mammalia Phylum: Chordata Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 516 | ||||||
| UNIPROTKB|Q00537 | 523 | CDK17 "Cyclin-dependent kinase | 0.612 | 0.604 | 0.667 | 2.9e-112 | |
| MGI|MGI:97517 | 523 | Cdk17 "cyclin-dependent kinase | 0.612 | 0.604 | 0.667 | 7.6e-112 | |
| UNIPROTKB|F5H6Z0 | 470 | CDK17 "Cyclin-dependent kinase | 0.571 | 0.627 | 0.697 | 3.3e-111 | |
| UNIPROTKB|F1P1K1 | 526 | CDK17 "Uncharacterized protein | 0.612 | 0.600 | 0.664 | 5.3e-111 | |
| UNIPROTKB|I3LDK7 | 533 | CDK17 "Uncharacterized protein | 0.571 | 0.553 | 0.697 | 5.3e-111 | |
| UNIPROTKB|F1MN42 | 526 | CDK17 "Uncharacterized protein | 0.571 | 0.560 | 0.697 | 5.3e-111 | |
| UNIPROTKB|J3KQP7 | 502 | CDK16 "PCTAIRE protein kinase | 0.563 | 0.579 | 0.706 | 1.8e-110 | |
| UNIPROTKB|Q00536 | 496 | CDK16 "Cyclin-dependent kinase | 0.563 | 0.586 | 0.706 | 1.8e-110 | |
| UNIPROTKB|E2RDF8 | 570 | CDK16 "Uncharacterized protein | 0.563 | 0.510 | 0.703 | 2.3e-110 | |
| UNIPROTKB|K7GKS2 | 496 | CDK16 "Uncharacterized protein | 0.563 | 0.586 | 0.703 | 2.3e-110 |
| UNIPROTKB|Q00537 CDK17 "Cyclin-dependent kinase 17" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1108 (395.1 bits), Expect = 2.9e-112, P = 2.9e-112
Identities = 221/331 (66%), Positives = 268/331 (80%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 200 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 259
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 260 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 319
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 320 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 379
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 380 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGISSNEEFK-NYNFPKYKPQPLINH 438
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+SA AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 439 AP-RLDSEGIELITKFLQYESKKRVSAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 497
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSML 515
+P G F + G +RRQSML
Sbjct: 498 QKDP--G----FRNSSYPETGHGKNRRQSML 522
|
|
| MGI|MGI:97517 Cdk17 "cyclin-dependent kinase 17" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 7.6e-112, P = 7.6e-112
Identities = 221/331 (66%), Positives = 267/331 (80%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 200 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 259
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 260 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 319
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 320 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 379
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 380 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGVSSNDEFK-NYNFPKYKPQPLINH 438
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+ A AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 439 AP-RLDSEGIELITKFLQYESKKRVPAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 497
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSML 515
+P G F + G +RRQSML
Sbjct: 498 QKDP--G----FRNSSYPETGHGKNRRQSML 522
|
|
| UNIPROTKB|F5H6Z0 CDK17 "Cyclin-dependent kinase 17" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
Identities = 212/304 (69%), Positives = 257/304 (84%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 147 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 206
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 207 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 266
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 267 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 326
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 327 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGISSNEEFK-NYNFPKYKPQPLINH 385
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+SA AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 386 AP-RLDSEGIELITKFLQYESKKRVSAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 444
Query: 485 TSNP 488
+P
Sbjct: 445 QKDP 448
|
|
| UNIPROTKB|F1P1K1 CDK17 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
Identities = 220/331 (66%), Positives = 267/331 (80%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 203 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 262
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 263 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 322
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 323 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 382
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 383 FEMASGRPLFPGSTVEDELHLIFRLLGTPCQETWPGISSSDEFR-NYNFPKYKPQPLINH 441
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++D++ ++L+ KFL Y++K+RISA AM+H YF SLG ++H L ++ SIFSL I+L
Sbjct: 442 AP-RLDTEGIELIAKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESVSIFSLKEIQL 500
Query: 485 TSNPTDGGLLPFYGQKSEKRWTGLSRRQSML 515
+P G F + G +RRQSML
Sbjct: 501 QKDP--G----FRNSTYPETGHGKNRRQSML 525
|
|
| UNIPROTKB|I3LDK7 CDK17 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
Identities = 212/304 (69%), Positives = 257/304 (84%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 209 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 268
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 269 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 328
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 329 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 388
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 389 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQETWPGVSSNDEFK-NYNFPKYKPQPLINH 447
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+SA AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 448 AP-RLDSEGIELITKFLQYESKKRVSAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 506
Query: 485 TSNP 488
+P
Sbjct: 507 QKDP 510
|
|
| UNIPROTKB|F1MN42 CDK17 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1096 (390.9 bits), Expect = 5.3e-111, P = 5.3e-111
Identities = 212/304 (69%), Positives = 257/304 (84%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 203 EGTYATVYKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 262
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVKLFL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 263 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKLFLYQILRGLAYCHRRKVLHRDLKPQNL 322
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 323 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 382
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P E + S EF +P L+
Sbjct: 383 FEMASGRPLFPGSTVEDELHLIFRLLGTPSQENWPGVSSNDEFK-NYNFPKYKPQPLINH 441
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DS+ ++L+ KFL Y++K+R+SA AM+H YF SLGP++H L ++ SIFSL I+L
Sbjct: 442 AP-RLDSEGIELITKFLQYESKKRVSAEEAMKHVYFRSLGPRIHALPESVSIFSLKEIQL 500
Query: 485 TSNP 488
+P
Sbjct: 501 QKDP 504
|
|
| UNIPROTKB|J3KQP7 CDK16 "PCTAIRE protein kinase 1, isoform CRA_b" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
Identities = 212/300 (70%), Positives = 256/300 (85%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 179 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 238
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC NI++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNL
Sbjct: 239 EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 298
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+YST IDM GVGCIF
Sbjct: 299 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 358
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM++GRPLFPGST+E++L I ILG P +E + S EF P Y +E+ L
Sbjct: 359 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH- 417
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L ++ + RISA +AM+HP+F SLG ++H+L DT SIF+L I+L
Sbjct: 418 AP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 476
|
|
| UNIPROTKB|Q00536 CDK16 "Cyclin-dependent kinase 16" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
Identities = 212/300 (70%), Positives = 256/300 (85%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 173 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 232
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC NI++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNL
Sbjct: 233 EKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 292
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+YST IDM GVGCIF
Sbjct: 293 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 352
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM++GRPLFPGST+E++L I ILG P +E + S EF P Y +E+ L
Sbjct: 353 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH- 411
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L ++ + RISA +AM+HP+F SLG ++H+L DT SIF+L I+L
Sbjct: 412 AP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 470
|
|
| UNIPROTKB|E2RDF8 CDK16 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
Identities = 211/300 (70%), Positives = 256/300 (85%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 247 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 306
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC N+++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNL
Sbjct: 307 EKSLTLVFEYLDKDLKQYLDDCGNVINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 366
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+YST IDM GVGCIF
Sbjct: 367 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 426
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM++GRPLFPGST+E++L I ILG P +E + S EF P Y +E+ L
Sbjct: 427 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH- 485
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L ++ + RISA +AM+HP+F SLG ++H+L DT SIF+L I+L
Sbjct: 486 AP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 544
|
|
| UNIPROTKB|K7GKS2 CDK16 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
Identities = 211/300 (70%), Positives = 256/300 (85%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 173 EGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 232
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC N+++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNL
Sbjct: 233 EKSLTLVFEYLDKDLKQYLDDCGNVINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 292
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+YST IDM GVGCIF
Sbjct: 293 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 352
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYPSESKLQLL 424
+EM++GRPLFPGST+E++L I ILG P +E + S EF P Y +E+ L
Sbjct: 353 YEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH- 411
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
AP ++DSD DL+ K L ++ + RISA +AM+HP+F SLG ++H+L DT SIF+L I+L
Sbjct: 412 AP-RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQL 470
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q27032 | CDC2H_THEPA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5107 | 0.5193 | 0.8993 | yes | N/A |
| Q26671 | CDC2H_THEAN | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5070 | 0.5155 | 0.8926 | yes | N/A |
| Q751E8 | PHO85_ASHGO | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5070 | 0.5193 | 0.8903 | yes | N/A |
| P61075 | CDC2H_PLAF7 | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5232 | 0.5096 | 0.9131 | yes | N/A |
| P24100 | CDKA1_ARATH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5122 | 0.5193 | 0.9115 | yes | N/A |
| Q6C7U8 | PHO85_YARLI | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5555 | 0.5135 | 0.9013 | yes | N/A |
| Q8K0D0 | CDK17_MOUSE | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6626 | 0.6143 | 0.6061 | yes | N/A |
| Q92241 | PHO85_KLULA | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5248 | 0.5193 | 0.8815 | yes | N/A |
| O74456 | PEF1_SCHPO | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5342 | 0.5174 | 0.9270 | yes | N/A |
| Q00537 | CDK17_HUMAN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6626 | 0.6143 | 0.6061 | yes | N/A |
| P29619 | CDKA2_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5392 | 0.5232 | 0.9246 | yes | N/A |
| P34117 | CDK5_DICDI | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5633 | 0.5213 | 0.9212 | yes | N/A |
| Q6BRY2 | PHO85_DEBHA | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5257 | 0.5426 | 0.8484 | yes | N/A |
| P17157 | PHO85_YEAST | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5281 | 0.5155 | 0.8721 | yes | N/A |
| Q6FKD4 | PHO85_CANGA | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5228 | 0.5174 | 0.8841 | yes | N/A |
| O35831 | CDK17_RAT | 2, ., 7, ., 1, 1, ., 2, 2 | 0.6940 | 0.5717 | 0.5640 | yes | N/A |
| O96821 | CDC2H_PLAKH | 2, ., 7, ., 1, 1, ., 2, 3 | 0.5161 | 0.5096 | 0.9131 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.22 | 0.914 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 516 | |||
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-165 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-150 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-148 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-142 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-134 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-125 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-119 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-114 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-103 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-103 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-102 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-101 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-101 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-100 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-98 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-97 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-89 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-86 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-85 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-82 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-78 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-77 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-77 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-74 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-73 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-72 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-72 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-70 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-69 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-67 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-66 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-66 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 9e-66 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-65 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-65 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-61 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-61 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-59 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-58 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-58 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-58 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-57 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-56 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-55 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-54 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-53 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-52 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-50 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-50 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-48 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-48 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-48 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-46 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-44 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-44 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-43 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-42 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-42 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-41 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-40 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-40 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-39 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-38 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-38 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-37 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-35 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-34 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-34 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 8e-32 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-31 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-31 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-31 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-30 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-29 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-29 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-25 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-24 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-24 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-23 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 8e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-21 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-20 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-20 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-19 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-18 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-18 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-17 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-16 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-15 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-15 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-15 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-15 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-15 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 8e-15 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-14 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-13 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-13 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-13 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-13 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-13 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-13 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 9e-13 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-12 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-10 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-10 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-10 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-10 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-10 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-09 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 6e-09 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-07 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-07 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 7e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-06 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-06 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-06 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 9e-06 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-05 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 5e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-04 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-04 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.001 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 0.002 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 0.002 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.002 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.002 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.002 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.003 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 0.004 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 0.004 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 0.004 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 0.004 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 0.004 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.004 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 468 bits (1207), Expect = e-165
Identities = 192/276 (69%), Positives = 223/276 (80%), Gaps = 8/276 (2%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G+YATV+KG+S+LT LVALKEI+LEHEEGAP TAIRE SLL++L+HANIVTLHDIIHT+
Sbjct: 16 GSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK 75
Query: 253 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
K LTLVFEYL+ DLK+YMDDC LSM+NV+LFLFQLLRGLAYCH RR+LHRDLKPQNLL
Sbjct: 76 KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLL 135
Query: 313 INERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFH 371
I+ERGELKLADFGLARAKSVP+KT+SNEVVTLWYRPPDVLLGSTEYSTS+DM GVGCIF+
Sbjct: 136 ISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFY 195
Query: 372 EMSSGRPLFPGST-IEDELRLICSILGPPPDE----LKSKLEFCI--TPVYPSESKLQLL 424
EM++GRPLFPGST +ED+L I +LG P +E + S EF P YP +
Sbjct: 196 EMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHA 255
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+L KFL Y+ K+RISAA AM+HPYF
Sbjct: 256 PRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 432 bits (1111), Expect = e-150
Identities = 209/295 (70%), Positives = 252/295 (85%), Gaps = 9/295 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDI+HT
Sbjct: 16 EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT 75
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFEYL+KDLK+YMDDC NI+SM+NVK+FL+Q+LRGLAYCH R++LHRDLKPQNL
Sbjct: 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGS+EYST IDM GVGCIF
Sbjct: 136 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF 195
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL-- 424
EM+SGRPLFPGST+EDEL LI +LG P +E + S EF +P L+
Sbjct: 196 FEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF-KNYNFPKYKPQPLINH 254
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSL 479
AP ++D++ ++L+ KFL Y++K+RISA AM+H YF SLG ++H L ++ SIFSL
Sbjct: 255 AP-RLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESISIFSL 308
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 425 bits (1094), Expect = e-148
Identities = 202/288 (70%), Positives = 243/288 (84%), Gaps = 9/288 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG+S+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHT
Sbjct: 16 EGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT 75
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
EK LTLVFEYL+KDLK+Y+DDC N ++M+NVKLFLFQLLRGL YCH R++LHRDLKPQNL
Sbjct: 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINERGELKLADFGLARAKS+PTKT+SNEVVTLWYRPPD+LLGST+YST IDM GVGCIF
Sbjct: 136 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF 195
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPS--ESKLQLL 424
+EMS+GRPLFPGST+E++L I ILG P +E + S EF + YP L
Sbjct: 196 YEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF-KSYNYPKYRADCLHNH 254
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
AP ++DSD +L+ K L ++ ++RISA AM+HPYF+ LG ++H+L D
Sbjct: 255 AP-RLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLPD 301
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 411 bits (1057), Expect = e-142
Identities = 194/276 (70%), Positives = 236/276 (85%), Gaps = 9/276 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL+ L+HANIVTLHDIIHT
Sbjct: 15 EGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT 74
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
E+CLTLVFEYL+ DLK+Y+D+C N++SM+NVK+F+FQLLRGL+YCH R+ILHRDLKPQNL
Sbjct: 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL 134
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LINE+GELKLADFGLARAKSVPTKT+SNEVVTLWYRPPDVLLGSTEYST IDM GVGCI
Sbjct: 135 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCIL 194
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEF--CITPVYPSESKLQLL 424
+EM++GRP+FPGST+++EL LI +LG P +E + S EF + P Y ++ L
Sbjct: 195 YEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQP-LINH 253
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
AP ++D+D +DL+ L+Y+ K RISA A+RH YF
Sbjct: 254 AP-RLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 391 bits (1006), Expect = e-134
Identities = 146/277 (52%), Positives = 194/277 (70%), Gaps = 13/277 (4%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V+K + + T +VALK+I+L++E EG P TA+RE+SLL+EL+H NIV L D+IHT
Sbjct: 10 GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT 69
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
E+ L LVFEY + DLK+Y+D LS N +K ++QLLRGLAYCHS RILHRDLKPQN+
Sbjct: 70 ERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI 129
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LIN G LKLADFGLARA +P +T+++EVVTLWYR P++LLGS YST++D+ VGCIF
Sbjct: 130 LINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIF 189
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE-------LKSKLEFCITPVYPSESKLQL 423
EM +G+PLFPG + D+L I ILG P +E L P +P + ++
Sbjct: 190 AEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP--TFPKFPPKDLEKV 247
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
L +D + +DL+ K L Y+ +RISA A++HPYF
Sbjct: 248 LPR--LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 367 bits (943), Expect = e-125
Identities = 161/277 (58%), Positives = 200/277 (72%), Gaps = 10/277 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+GTYATV+KG++R T +VALKEI L+ EEG P TAIRE+SL++EL+H NIV LHD+IHT
Sbjct: 10 EGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT 69
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E L LVFEY++KDLK+YMD L N VK F +QLL+G+A+CH R+LHRDLKPQ
Sbjct: 70 ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ 129
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
NLLIN+RGELKLADFGLARA +P TFSNEVVTLWYR PDVLLGS YSTSID+ VGC
Sbjct: 130 NLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGC 189
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL----EFCIT-PVYPSESKLQL 423
I EM +GRPLFPG+ ED+L I I+G P + + E+ T P YP + LQ
Sbjct: 190 IMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQ-DLQQ 248
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
L P D +DL+ + L + + RISA +A++HP+F
Sbjct: 249 LFP-HADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 352 bits (905), Expect = e-119
Identities = 150/276 (54%), Positives = 205/276 (74%), Gaps = 8/276 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY TVFK K+R T +VALK ++L+ + EG P +A+RE+ LL+EL+H NIV L+D++H
Sbjct: 10 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH 69
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
++K LTLVFEY ++DLK+Y D C+ + VK F+FQLL+GLA+CHS +LHRDLKPQN
Sbjct: 70 SDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQN 129
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
LLIN+ GELKLADFGLARA +P + +S EVVTLWYRPPDVL G+ YSTSIDM GCI
Sbjct: 130 LLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 189
Query: 370 FHEMS-SGRPLFPGSTIEDELRLICSILGPPPDEL---KSKL-EFCITPVYPSESKLQLL 424
F E++ +GRPLFPG+ ++D+L+ I +LG P +E SKL ++ P+YP+ + L +
Sbjct: 190 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNV 249
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P +++S DL+Q L+ + QRISA A++HPYF
Sbjct: 250 VP-KLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 338 bits (868), Expect = e-114
Identities = 146/276 (52%), Positives = 194/276 (70%), Gaps = 10/276 (3%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V+K + +LT +VALK+I+LE E EG P TAIRE+SLL+EL H NIV L D++H+
Sbjct: 10 GTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS 69
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
E L LVFE+L+ DLK+YMD L +K +L+QLL+G+AYCHS R+LHRDLKPQN
Sbjct: 70 ENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN 129
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
LLI+ G LKLADFGLARA VP +T+++EVVTLWYR P++LLGS +YST +D+ +GCI
Sbjct: 130 LLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI 189
Query: 370 FHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL----KSKLEFCIT-PVYPSESKLQLL 424
F EM + RPLFPG + D+L I LG P +++ S ++ T P + + L +
Sbjct: 190 FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQD-LSKV 248
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P +D D LDL+ K L+YD +RISA A++HPYF
Sbjct: 249 VPN-LDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 311 bits (799), Expect = e-103
Identities = 143/282 (50%), Positives = 195/282 (69%), Gaps = 11/282 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY V+K + R+T+ +ALK+I+LE E EG P TAIRE+SLL+E++H NIV L D++H
Sbjct: 12 EGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH 71
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNIL-SMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+EK L LVFEYL+ DLK++MD + + +K +L+Q+LRG+AYCHS R+LHRDLKPQ
Sbjct: 72 SEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQ 131
Query: 310 NLLINER-GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
NLLI+ R LKLADFGLARA +P +TF++EVVTLWYR P++LLGS YST +D+ VG
Sbjct: 132 NLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVG 191
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT-PVYPSESKLQ 422
CIF EM + +PLFPG + DEL I ILG P +E + S ++ P +P + L
Sbjct: 192 CIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKD-LA 250
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464
+ P ++ +DL+ K L D +RI+A A+ H YF LG
Sbjct: 251 TVVP-TLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291
|
Length = 294 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = e-103
Identities = 140/280 (50%), Positives = 191/280 (68%), Gaps = 16/280 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY V+K +++LT +VALK+I+L+ E EG P TAIRE+SLL+EL H NIV L D+IH
Sbjct: 10 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 69
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
TE L LVFE+L +DLK++MD + + + +K +LFQLL+GLA+CHS R+LHRDLKPQ
Sbjct: 70 TENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 129
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
NLLIN G +KLADFGLARA VP +T+++EVVTLWYR P++LLG YST++D+ +GC
Sbjct: 130 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 189
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL--------KSKLEFCITPVYPSESK 420
IF EM + R LFPG + D+L I LG P + + K F P + +
Sbjct: 190 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF---PKWARQDF 246
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+++ P +D D DL+ + L YD +RISA A+ HP+F
Sbjct: 247 SKVVPP--LDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 309 bits (793), Expect = e-102
Identities = 156/284 (54%), Positives = 194/284 (68%), Gaps = 22/284 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+YATV+KG SR+ LVALK I ++ EEG P TAIRE SLL+ L+HANIV LHDIIHT
Sbjct: 15 EGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT 74
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
++ LT VFEY+ DL +YM L NV+LF+FQLLRGLAY H + ILHRDLKPQNL
Sbjct: 75 KETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LI+ GELKLADFGLARAKS+P++T+S+EVVTLWYRPPDVLLG+T+YS+++D+ G GCIF
Sbjct: 135 LISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIF 194
Query: 371 HEMSSGRPLFPG-STIEDELRLICSILGPPPDEL---KSKLEFCITPVYPSESKLQLLAP 426
EM G+P FPG S + ++L I ++LG P ++ SKL P Y E L
Sbjct: 195 IEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL-----PNYKPE--WFLPCK 247
Query: 427 EQMDSD----------ALDLVQKFLMYDAKQRISAANAMRHPYF 460
Q A DL + LM K RISA +A+ HPYF
Sbjct: 248 PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 306 bits (786), Expect = e-101
Identities = 122/278 (43%), Positives = 173/278 (62%), Gaps = 10/278 (3%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V+K +++ T LVALK+I++E+E EG P TAIRE+ LL++LRH NIV L +I+ +
Sbjct: 10 GTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS 69
Query: 252 EKCLT--LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ + +VFEY++ DL +D + + +K ++ QLL GL Y HS ILHRD+K
Sbjct: 70 KGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGS 129
Query: 310 NLLINERGELKLADFGLARA-KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
N+LIN G LKLADFGLAR + ++N V+TLWYRPP++LLG+T Y +DM VG
Sbjct: 130 NILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVG 189
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC-----ITPVYPSESKLQ 422
CI E+ G+P+F GST ++L I + G P DE + + P P + +L+
Sbjct: 190 CILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLR 249
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+D ALDL+ K L D K+RISA A++H YF
Sbjct: 250 EFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 305 bits (783), Expect = e-101
Identities = 135/276 (48%), Positives = 191/276 (69%), Gaps = 7/276 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY V+KG+++ T +VA+K+I+LE E EG P TAIRE+SLL+EL+H NIV L D++
Sbjct: 10 EGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM 69
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNN--VKLFLFQLLRGLAYCHSRRILHRDLKP 308
E L L+FE+L DLK+Y+D M+ VK +L+Q+L+G+ +CHSRR+LHRDLKP
Sbjct: 70 QESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKP 129
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
QNLLI+ +G +KLADFGLARA +P + +++EVVTLWYR P+VLLGS YST +D+ +G
Sbjct: 130 QNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG 189
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC--ITPVYPSESKLQLLA 425
IF EM++ +PLF G + D+L I ILG P +++ + +P K L +
Sbjct: 190 TIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRS 249
Query: 426 P-EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ +D D LDL++K L+YD +RISA A+ HPYF
Sbjct: 250 AVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 303 bits (777), Expect = e-100
Identities = 166/289 (57%), Positives = 201/289 (69%), Gaps = 8/289 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+YATV+KGKS++ LVALK I+L+ EEG P TAIRE SLL+ L+HANIV LHDIIHT
Sbjct: 15 EGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT 74
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
++ LTLVFEY+ DL +YMD L NVKLFLFQLLRGL+Y H R ILHRDLKPQNL
Sbjct: 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL 134
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LI++ GELKLADFGLARAKSVP+ T+SNEVVTLWYRPPDVLLGSTEYST +DM GVGCIF
Sbjct: 135 LISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIF 194
Query: 371 HEMSSGRPLFPG-STIEDELRLICSILGPPPDELKSKLEFC--ITP----VYPSESKLQL 423
EM G FPG I+D+L I +LG P ++ + P +Y ++ Q
Sbjct: 195 VEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQA 254
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
+ A DL K L K R+SA A+ H YF+ L P++ EL+D
Sbjct: 255 WNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPRLWELTD 303
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 299 bits (768), Expect = 1e-98
Identities = 119/283 (42%), Positives = 169/283 (59%), Gaps = 17/283 (6%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC----TAIREVSLLRELRHANIVTLHDI 248
GTYA V+K + + T +VA+K+IKL + A TA+RE+ LL+EL+H NI+ L D+
Sbjct: 11 GTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDV 70
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+ + LVFE++E DL++ + D S +L+ ++K ++ LRGL Y HS ILHRDLKP
Sbjct: 71 FGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKP 130
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
NLLI G LKLADFGLAR+ P + +++VVT WYR P++L G+ Y +DM VG
Sbjct: 131 NNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVG 190
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE-------LKSKLEFCITPVYPSESK 420
CIF E+ P PG + D+L I LG P +E L +EF P P
Sbjct: 191 CIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTP---- 246
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
L+ + P DALDL+Q+ L + +RI+A A+ HPYF++
Sbjct: 247 LKQIFP-AASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 295 bits (757), Expect = 3e-97
Identities = 129/275 (46%), Positives = 171/275 (62%), Gaps = 8/275 (2%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKL-EHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V+K + +LT +VA+K+IKL EG P TA+RE+ LL+EL H NI+ L D+
Sbjct: 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH 69
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+ L LVFE+++ DL + + D L + +K +L+QLL+GLA+CHS ILHRDLKP+NL
Sbjct: 70 KGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LIN G LKLADFGLAR+ P + +++ VVT WYR P++LLG YST +D+ VGCIF
Sbjct: 130 LINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF 189
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK-----LQLLA 425
E+ S RPLFPG + D+L I LG P E+ K S K L L
Sbjct: 190 AELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF 249
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P ALDL+ + L YD +RI+A A+ HPYF
Sbjct: 250 PN-ASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 274 bits (704), Expect = 4e-89
Identities = 120/278 (43%), Positives = 173/278 (62%), Gaps = 10/278 (3%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDII-- 249
GTY V++ + + T +VALK++K+E E EG P T++RE+++L +L+H NIVT+ +++
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVG 75
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ +V EY+E DLK M+ + VK + QLL G+A+ H ILHRDLK
Sbjct: 76 SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS 135
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
NLL+N RG LK+ DFGLAR P K ++ VVTLWYR P++LLG+ EYST+IDM VGC
Sbjct: 136 NLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGC 195
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE---LKSKLEFC--ITPVYPSESKLQL 423
IF E+ + +PLFPG + D+L I +LG P ++ S+L T ++L+
Sbjct: 196 IFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRK 255
Query: 424 LAPEQMDSDA-LDLVQKFLMYDAKQRISAANAMRHPYF 460
P SD DL+ + L YD +RISA +A++HPYF
Sbjct: 256 KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 1e-86
Identities = 132/290 (45%), Positives = 186/290 (64%), Gaps = 25/290 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELRHAN-IVTLHDII 249
+GTY V+K + + T LVALK+ +LE EEG P TA+RE+SLL+ L + IV L D+
Sbjct: 11 EGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVE 70
Query: 250 HTEK-----CLTLVFEYLEKDLKRYMDD----CSNILSMNNVKLFLFQLLRGLAYCHSRR 300
H E+ L LVFEYL+ DLK++MD L +K F++QLL+G+A+CH
Sbjct: 71 HVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG 130
Query: 301 ILHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
++HRDLKPQNLL++ ++G LK+AD GL RA S+P K++++E+VTLWYR P+VLLGST YS
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYS 190
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE-------LKSKLEFCI 411
T +D+ VGCIF EMS +PLFPG + +L I +LG P ++ L+ EF
Sbjct: 191 TPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF-- 248
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
P + + + + + + LDL+QK L YD +RISA A+ HPYF+
Sbjct: 249 -PQWKPQDLSRAV--PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 265 bits (680), Expect = 1e-85
Identities = 117/292 (40%), Positives = 171/292 (58%), Gaps = 36/292 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELR---HANIVTLHD 247
+G Y TV+K + T VALK++++ EEG P + +RE++LL++L H NIV L D
Sbjct: 9 EGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLD 68
Query: 248 IIHT-----EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRI 301
+ H E LTLVFE++++DL Y+ C L +K + QLLRG+ + HS RI
Sbjct: 69 VCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRI 128
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNE------VVTLWYRPPDVLLGS 355
+HRDLKPQN+L+ G++K+ADFGLAR +S E VVTLWYR P+VLL S
Sbjct: 129 VHRDLKPQNILVTSDGQVKIADFGLAR-------IYSFEMALTSVVVTLWYRAPEVLLQS 181
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE------LKSKLE 408
+ Y+T +DM VGCIF E+ RPLF G++ D+L I ++G P +E +
Sbjct: 182 S-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS 240
Query: 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
F +S + ++ + LDL++K L ++ +RISA A++HPYF
Sbjct: 241 FPSYTPRSFKSFVP-----EICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 256 bits (656), Expect = 2e-82
Identities = 93/271 (34%), Positives = 147/271 (54%), Gaps = 27/271 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G++ V+ + + T LVA+K IK + + +RE+ +L++L+H NIV L+D+
Sbjct: 9 EGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFED 68
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
E L LV EY E DL + LS + + +L Q+L L Y HS+ I+HRDLKP+N
Sbjct: 69 EDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPEN 127
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
+L++E G +KLADFGLAR P + + V T Y P+VLLG Y ++D+ +G I
Sbjct: 128 ILLDEDGHVKLADFGLARQLD-PGEKLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVI 185
Query: 370 FHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQM 429
+E+ +G+P FPG + L L I P P + +
Sbjct: 186 LYELLTGKPPFPGD--DQLLELFKKIGKPKPPFPPPEWDI-------------------- 223
Query: 430 DSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+A DL++K L+ D ++R++A A++HP+F
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 2e-78
Identities = 116/288 (40%), Positives = 170/288 (59%), Gaps = 32/288 (11%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V++ + + +VALK++++++E +G P +++RE++LL LRH NIV L +++
Sbjct: 18 GTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVV-V 76
Query: 252 EKCLT---LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
K L LV EY E+DL +D+ S + VK + QLLRGL Y H I+HRDLK
Sbjct: 77 GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKV 136
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
NLL+ ++G LK+ADFGLAR +P K + +VVTLWYR P++LLG T Y+T+IDM VG
Sbjct: 137 SNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVG 196
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA-- 425
CI E+ + +PL PG + ++L LI +LG P + ++P S L L+
Sbjct: 197 CILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNES-----------IWPGFSDLPLVGKF 245
Query: 426 --PEQ----------MDSDA-LDLVQKFLMYDAKQRISAANAMRHPYF 460
P+Q S+A L L+ LMYD K+R +A A+ YF
Sbjct: 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 243 bits (623), Expect = 2e-77
Identities = 102/272 (37%), Positives = 145/272 (53%), Gaps = 23/272 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
G++ TV+K K + T +VA+K +K E TA RE+ +LR L H NIV L D
Sbjct: 9 SGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFE 68
Query: 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ L LV EY E DL Y+ LS + K Q+LRGL Y HS I+HRDLKP+
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPE 127
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
N+L++E G +K+ADFGLA+ + + + V T WY P+VLLG Y +D+ +G
Sbjct: 128 NILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGV 187
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
I +E+ +G+P F G I D+L+LI ILGPP + S
Sbjct: 188 ILYELLTGKPPFSGENILDQLQLIRRILGPPLEF----------DEPKWSSG-------- 229
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+A DL++K L D +R +A ++HP+F
Sbjct: 230 -SEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 7e-77
Identities = 111/281 (39%), Positives = 159/281 (56%), Gaps = 15/281 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G + VFK K R T VALK++ L E G P A+RE+ L+ +H +V L D+
Sbjct: 10 EGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP 69
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
LV EY+ DL + D L VK ++ LL+G+AY H+ I+HRDLKP N
Sbjct: 70 HGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPAN 129
Query: 311 LLINERGELKLADFGLARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
LLI+ G LK+ADFGLAR S + +S++V T WYR P++L G+ +Y +D+ VGC
Sbjct: 130 LLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGC 189
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP----VYPSESKLQLL 424
IF E+ +G PLFPG ++L ++ LG P ++ P + ESK L
Sbjct: 190 IFAELLNGSPLFPGENDIEQLAIVFRTLGTP--NEETWPGLTSLPDYNKITFPESKPIPL 247
Query: 425 APEQM----DSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
E++ +ALDL++ L+YD +R+SAA A+RHPYF
Sbjct: 248 --EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 4e-74
Identities = 110/311 (35%), Positives = 160/311 (51%), Gaps = 28/311 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA---IREVSLLRELRHANIVTLHDI 248
G Y V + T VA+K K+ + A +RE+ LLR LRH NI+ L DI
Sbjct: 10 SGAYGVVCSAVDKRTGRKVAIK--KISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 249 I-----HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+ + +V E +E DL + + L+ ++++ FL+Q+LRGL Y HS ++H
Sbjct: 68 LRPPSPEDFNDVYIVTELMETDLHKVIK-SPQPLTDDHIQYFLYQILRGLKYLHSANVIH 126
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSN---EVVTLWYRPPDVLLGSTEYST 360
RDLKP N+L+N +LK+ DFGLAR VVT WYR P++LL S+ Y+
Sbjct: 127 RDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTK 186
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY---- 415
+ID+ VGCIF E+ + +PLFPG D+L LI +LG P +E L+F +
Sbjct: 187 AIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED---LKFITSEKARNYL 243
Query: 416 ---PSESKLQL--LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHEL 470
P + K L L P +A+DL++K L++D K+RI+A A+ HPY L E
Sbjct: 244 KSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEP 302
Query: 471 SDTQSIFSLPH 481
Sbjct: 303 VAKPPFDFDFF 313
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 8e-73
Identities = 107/278 (38%), Positives = 160/278 (57%), Gaps = 11/278 (3%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G Y V K +++ T +VA+K+ K + E TA+REV +LR+LRH NIV L +
Sbjct: 12 GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR 71
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+ L LVFEY+E+ L ++ L + V+ +++QLL+ +AYCHS I+HRD+KP+N+
Sbjct: 72 KGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131
Query: 312 LINERGELKLADFGLARA-KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
L++E G LKL DFG ARA ++ P ++ V T WYR P++L+G T Y +D+ +GCI
Sbjct: 132 LVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCI 191
Query: 370 FHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE-------FCITPVYPSESKLQ 422
E+ G PLFPG + D+L LI LGP P + ES L+
Sbjct: 192 MAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPES-LE 250
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P ++ S ALD ++ L D K+R++ ++HPYF
Sbjct: 251 RRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 2e-72
Identities = 107/312 (34%), Positives = 172/312 (55%), Gaps = 35/312 (11%)
Query: 181 DCSNILSMNNVK----GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLR 235
CS + + GT+ V+K + T +VALK+I + +E +G P TA+RE+ +L+
Sbjct: 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK 62
Query: 236 ELRHANIVTLHDII--------HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLF 287
+L+H N+V L D+ + +V Y++ DL +++ S L+ + +K ++
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR-----------AKSVPTKT 336
QLL G+ Y H ILHRD+K N+LI+ +G LK+ADFGLAR T+
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 337 FSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395
++N VVT WYRPP++LLG Y+T++D+ G+GC+F EM + RP+ G + D+L LI +
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242
Query: 396 LGPPPDE---LKSKLEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR 448
G P +E L C YP + + ++ + LDL+ K L D +R
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF---GKLGPEGLDLLSKLLSLDPYKR 299
Query: 449 ISAANAMRHPYF 460
++A++A+ HPYF
Sbjct: 300 LTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 4e-72
Identities = 110/279 (39%), Positives = 168/279 (60%), Gaps = 16/279 (5%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHT 251
GT+ +V+ +++ T LVA+K++K + C +REV LR+L H NIV L ++
Sbjct: 10 GTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE 69
Query: 252 EKCLTLVFEYLEKDL-KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
L VFEY+E +L + D S + ++ ++Q+L+GLA+ H HRDLKP+N
Sbjct: 70 NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPEN 129
Query: 311 LLINERGELKLADFGLAR-AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
LL++ +K+ADFGLAR +S P +++ V T WYR P++LL ST YS+ +D+ +GC
Sbjct: 130 LLVSGPEVVKIADFGLAREIRSRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGC 187
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPP-----PD--ELKSKLEFCITPVYPSESKL 421
I E+ + RPLFPGS+ D+L ICS+LG P P+ +L SKL F P + L
Sbjct: 188 IMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAP--TSL 245
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
L P +A+DL++ L +D K+R +A+ A++HPYF
Sbjct: 246 HQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 3e-70
Identities = 109/308 (35%), Positives = 163/308 (52%), Gaps = 42/308 (13%)
Query: 193 GTYATVFKGKS--RLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
GTY V+K K A+K+ K E G +A RE++LLREL+H N+V+L ++
Sbjct: 11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEV 70
Query: 249 I--HTEKCLTLVFEYLEKDL----KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
H +K + L+F+Y E DL K + + + VK L+Q+L G+ Y HS +L
Sbjct: 71 FLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVL 130
Query: 303 HRDLKPQNLLI----NERGELKLADFGLARAKSVPTKTFSNE---VVTLWYRPPDVLLGS 355
HRDLKP N+L+ ERG +K+ D GLAR + P K ++ VVT+WYR P++LLG+
Sbjct: 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIE---------DELRLICSILGPPPDE--- 402
Y+ +ID+ +GCIF E+ + P+F G + D+L I +LG P ++
Sbjct: 191 RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWP 250
Query: 403 -LKS--------KLEFCITPVYPSESK-LQLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452
+K K T S +K ++ DS DL++K L YD +RI+A
Sbjct: 251 DIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP--DSQGFDLLRKLLEYDPTKRITAE 308
Query: 453 NAMRHPYF 460
A+ HPYF
Sbjct: 309 EALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 224 bits (572), Expect = 3e-69
Identities = 117/301 (38%), Positives = 167/301 (55%), Gaps = 44/301 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GT+ VFK + + T +VALK++ +E+E EG P TA+RE+ +L+ L+H N+V L +I
Sbjct: 22 QGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 81
Query: 251 TEKCLT--------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
T+ LVFE+ E DL + + + +++ +K + LL GL Y H +IL
Sbjct: 82 TKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKIL 141
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKT----FSNEVVTLWYRPPDVLLGSTEY 358
HRD+K N+LI + G LKLADFGLARA S+ + ++N VVTLWYRPP++LLG +Y
Sbjct: 142 HRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDY 201
Query: 359 STSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP-VYP 416
IDM G GCI EM + P+ G+T + +L LI + G ITP V+P
Sbjct: 202 GPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS------------ITPEVWP 249
Query: 417 SESKLQL-----------------LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
KL+L L P D ALDL+ K L+ D +RI A A+ H +
Sbjct: 250 GVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309
Query: 460 F 460
F
Sbjct: 310 F 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 8e-67
Identities = 117/287 (40%), Positives = 165/287 (57%), Gaps = 21/287 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELR-HANIVTLHDI 248
KG Y V+K R T +VALK+I + A T RE+ L+EL H NIV L ++
Sbjct: 17 KGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT-FREIMFLQELGDHPNIVKLLNV 75
Query: 249 IHTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
I E K + LVFEY+E DL + +NIL + + ++QLL+ L Y HS ++HRDL
Sbjct: 76 IKAENDKDIYLVFEYMETDLHAVIR--ANILEDVHKRYIMYQLLKALKYIHSGNVIHRDL 133
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNE-----VVTLWYRPPDVLLGSTEYSTS 361
KP N+L+N +KLADFGLAR+ S + N V T WYR P++LLGST Y+
Sbjct: 134 KPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKG 193
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYP 416
+DM VGCI EM G+PLFPG++ ++L I ++GPP E +KS + P
Sbjct: 194 VDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLP 253
Query: 417 SESK--LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
S + L L P + DALDL++K L+++ +R++A A+ HPY
Sbjct: 254 SRPRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 5e-66
Identities = 110/287 (38%), Positives = 168/287 (58%), Gaps = 21/287 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY V+K + + T LVALK+++L++E EG P TAIRE+ +LR+L H NIV L +I+
Sbjct: 17 EGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIV- 75
Query: 251 TEK-----------CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR 299
T+K LVFEY++ DL ++ S +++K F+ QLL GL YCH +
Sbjct: 76 TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK 135
Query: 300 RILHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTFSNEVVTLWYRPPDVLLGSTEY 358
LHRD+K N+L+N +G++KLADFGLAR S ++ ++N+V+TLWYRPP++LLG Y
Sbjct: 136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195
Query: 359 STSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP-----PDELKSKLEFCIT 412
+ID+ GCI E+ + +P+F + +L LI + G P PD +K +
Sbjct: 196 GPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMK 255
Query: 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P +L+ + + ALDL+ L D +R +A A+ P+
Sbjct: 256 PKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 214 bits (547), Expect = 7e-66
Identities = 79/106 (74%), Positives = 96/106 (90%)
Query: 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL 146
FG++E+Y KLDKLG+G+YATV+KG+S+LT LVALKEI+LEHEEGAP TAIRE SLL++L
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL 60
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
+HANIVTLHDIIHT+K LTLVFEYL+ DLK+YMDDC LSM+NV+
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVR 106
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 9e-66
Identities = 117/299 (39%), Positives = 169/299 (56%), Gaps = 29/299 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
+G Y V K+ T+ VA+K+I ++ A T +RE+ LLR L H N++ + DI+
Sbjct: 15 RGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKDIM 73
Query: 250 ---HTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
H E + +V+E ++ DL + + S LS ++ + FL+QLLRGL Y HS +LHR
Sbjct: 74 PPPHREAFNDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHR 132
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
DLKP NLL+N +LK+ DFGLAR S + VVT WYR P++LL +EY+T+ID+
Sbjct: 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDV 192
Query: 365 -GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT----------P 413
VGCIF E+ +PLFPG +L+LI +LG P +E L F P
Sbjct: 193 WSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE---DLGFIRNEKARRYIRSLP 249
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
P +S L P + A+DL++K L++D +RI+ A+ HPY SL H+ SD
Sbjct: 250 YTPRQS-FARLFP-HANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL----HDPSD 302
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 1e-65
Identities = 107/305 (35%), Positives = 156/305 (51%), Gaps = 39/305 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-------------EEGAPCTAIREVSLLRELR 238
+GTY V K LT +VA+K++K+ G T +RE+ ++ E++
Sbjct: 19 EGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK 78
Query: 239 HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCH 297
H NI+ L D+ + LV + + DLK+ +D I L+ + VK L Q+L GL H
Sbjct: 79 HENIMGLVDVYVEGDFINLVMDIMASDLKKVVD--RKIRLTESQVKCILLQILNGLNVLH 136
Query: 298 SRRILHRDLKPQNLLINERGELKLADFGLARA--------------KSVPTKTFSNEVVT 343
+HRDL P N+ IN +G K+ADFGLAR + +++VVT
Sbjct: 137 KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVT 196
Query: 344 LWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP--- 399
LWYR P++L+G+ +Y ++DM VGCIF E+ +G+PLFPG D+L I +LG P
Sbjct: 197 LWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNED 256
Query: 400 --PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
P K L TP P + K DA+DL+Q L + +RISA A++H
Sbjct: 257 NWPQAKKLPLYTEFTPRKPKDLKTIF---PNASDDAIDLLQSLLKLNPLERISAKEALKH 313
Query: 458 PYFNS 462
YF S
Sbjct: 314 EYFKS 318
|
Length = 335 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 212 bits (543), Expect = 9e-65
Identities = 105/287 (36%), Positives = 156/287 (54%), Gaps = 24/287 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA---IREVSLLRELRHANIVTLHDII 249
G Y V + VA+K K+ H P A +RE+ +LR +H NI+ + DI+
Sbjct: 16 GAYGVVCSAIDTRSGKKVAIK--KIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDIL 73
Query: 250 HTE----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
K + +V + +E DL + L+ +++ FL+QLLRGL Y HS ++HRD
Sbjct: 74 RPPGADFKDVYVVMDLMESDLHHIIH-SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRD 132
Query: 306 LKPQNLLINERGELKLADFGLARA---KSVPTKTFSNE-VVTLWYRPPDVLLGSTEYSTS 361
LKP NLL+NE EL++ DFG+AR K F E V T WYR P++LL EY+T+
Sbjct: 133 LKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTA 192
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL-----KSKLEFCITPVY 415
IDM VGCIF EM R LFPG +L+LI S+LG P +E+ ++ I
Sbjct: 193 IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQN-L 251
Query: 416 PSESKLQL--LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P + + + P + +ALDL+ + L +D ++RI+ A++HP+
Sbjct: 252 PRKQPVPWSKIFP-KASPEALDLLSQMLQFDPEERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 202 bits (514), Expect = 4e-61
Identities = 112/281 (39%), Positives = 168/281 (59%), Gaps = 16/281 (5%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELR---HANIVTLHDI 248
G Y TV+K + + + VALK ++++ +E+G P + +REV+LL+ L H NIV L D+
Sbjct: 11 GAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDV 70
Query: 249 IHT-----EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRIL 302
T E +TLVFE++++DL+ Y+D L +K + Q LRGL + H+ I+
Sbjct: 71 CATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIV 130
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
HRDLKP+N+L+ G++KLADFGLAR S + VVTLWYR P+VLL ST Y+T +
Sbjct: 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQM-ALTPVVVTLWYRAPEVLLQST-YATPV 188
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILG-PPPDELKSKLEFCITPVYP-SES 419
DM VGCIF EM +PLF G++ D+L I ++G PP D+ + P
Sbjct: 189 DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPR 248
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+Q + PE ++ L+ + L ++ +RISA A++HP+F
Sbjct: 249 PVQSVVPE-IEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 6e-61
Identities = 100/277 (36%), Positives = 152/277 (54%), Gaps = 13/277 (4%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHT 251
GT++ V K +SR T A+K +K + +RE+ LR L H NI+ L +++
Sbjct: 10 GTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD 69
Query: 252 EK--CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
K L LVFE ++ +L + L VK +++QLL+ L + H I HRD+KP+
Sbjct: 70 RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPE 129
Query: 310 NLLINERGELKLADFGLARAKSVPTKT-FSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
N+LI + LKLADFG R + +K ++ + T WYR P+ LL Y +D+ VG
Sbjct: 130 NILIKD-DILKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVG 186
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE--FCITPVYPSE--SKLQL 423
C+F E+ S PLFPG+ D++ I +LG P E+ K + +PS+ + L+
Sbjct: 187 CVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRK 246
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
L P ++ LDL++K L YD +RI+A A+RHPYF
Sbjct: 247 LLP-NASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 199 bits (507), Expect = 2e-59
Identities = 106/284 (37%), Positives = 152/284 (53%), Gaps = 22/284 (7%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G Y V + T VA+K+I EH+ T +RE+ +LR +H NI+ + DII
Sbjct: 16 GAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDIIRP 74
Query: 252 E-----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ +V E +E DL + + + LS ++++ FL+Q+LRGL Y HS +LHRDL
Sbjct: 75 PSFESFNDVYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDL 132
Query: 307 KPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
KP NLL+N +LK+ DFGLAR + T + V T WYR P+++L S Y+ +ID
Sbjct: 133 KPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAID 192
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE-------LKSKLEFCITPVY 415
+ VGCI EM S RPLFPG +L LI +LG P E L+++ P
Sbjct: 193 IWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFK 252
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P +L D ALDL+ K L ++ +RI+ A+ HPY
Sbjct: 253 PKVPWNKLFP--NADPKALDLLDKMLTFNPHKRITVEEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-58
Identities = 100/292 (34%), Positives = 148/292 (50%), Gaps = 40/292 (13%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKL----EHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G Y V T VA+K KL + A T RE+ LL+ + H N++ L D+
Sbjct: 26 GAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKRT-YRELRLLKHMDHENVIGLLDV 82
Query: 249 IHTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
L LV + DL + LS ++++ ++Q+LRGL Y HS I+
Sbjct: 83 FTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGII 140
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
HRDLKP N+ +NE ELK+ DFGLAR + V T WYR P+++L Y+ ++
Sbjct: 141 HRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTV 197
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK- 420
D+ VGCI E+ +G+ LFPGS D+L+ I +++G P +EL K+ SES
Sbjct: 198 DIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS--------SESAR 249
Query: 421 --LQLLAPEQ----------MDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+Q L + A+DL++K L+ D +RI+AA A+ HPY
Sbjct: 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 8e-58
Identities = 86/107 (80%), Positives = 103/107 (96%)
Query: 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE 145
GFG++E+Y KLDKLG+GTYATV+KG+S+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++
Sbjct: 1 GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKD 60
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
L+HANIVTLHDIIHTEK LTLVFEYL+KDLK+Y+DDC N ++M+NVK
Sbjct: 61 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK 107
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 9e-58
Identities = 87/116 (75%), Positives = 107/116 (92%)
Query: 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE 145
GFG++E+Y KL+KLG+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL++
Sbjct: 1 GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKD 60
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKG 201
L+HANIVTLHDI+HT+K LTLVFEYL+KDLK+YMDDC NI+SM+NVK + +G
Sbjct: 61 LKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRG 116
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 192 bits (488), Expect = 2e-57
Identities = 84/106 (79%), Positives = 102/106 (96%)
Query: 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL 146
FG++E+Y KLDKLG+GTYATVFKG+S+LT+NLVALKEI+LEHEEGAPCTAIREVSLL+ L
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
+HANIVTLHDIIHTE+CLTLVFEYL+ DLK+Y+D+C N++SM+NVK
Sbjct: 61 KHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVK 106
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 190 bits (484), Expect = 5e-56
Identities = 112/300 (37%), Positives = 160/300 (53%), Gaps = 25/300 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDII- 249
KG+Y V T VA+K+I E + T I RE+ LLR LRH +IV + I+
Sbjct: 10 KGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIML 69
Query: 250 ----HTEKCLTLVFEYLEKDLKRYM---DDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
K + +VFE +E DL + + DD L+ + + FL+QLLR L Y H+ +
Sbjct: 70 PPSRREFKDIYVVFELMESDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTANVF 125
Query: 303 HRDLKPQNLLINERGELKLADFGLARA--KSVPTKTF-SNEVVTLWYRPPDVLLGS--TE 357
HRDLKP+N+L N +LK+ DFGLAR PT F ++ V T WYR P+ L GS ++
Sbjct: 126 HRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGSFFSK 184
Query: 358 YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYP 416
Y+ +ID+ +GCIF E+ +G+PLFPG + +L LI +LG P E S++ Y
Sbjct: 185 YTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYL 244
Query: 417 SESKLQLLAP-----EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELS 471
S + + P D AL L+++ L +D K R +A A+ PYF L E S
Sbjct: 245 SSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPS 304
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 2e-55
Identities = 100/285 (35%), Positives = 165/285 (57%), Gaps = 25/285 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCT--AIREVSLLRELRHANIVTLHDII 249
+G+Y V K K + T +VA+K+ LE E+ A+RE+ +L++LRH N+V L ++
Sbjct: 11 EGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF 69
Query: 250 HTEKCLTLVFEYLEK----DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+K L LVFE+++ DL++Y N L + V+ +LFQ+LRG+ +CHS I+HRD
Sbjct: 70 RRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRD 125
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
+KP+N+L+++ G +KL DFG AR + P + +++ V T WYR P++L+G T+Y ++D+
Sbjct: 126 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIW 185
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE--FCITPVYPSESKLQ 422
VGC+ EM +G PLFPG + D+L I LG L + + F P++ +
Sbjct: 186 AVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG----NLIPRHQEIFQKNPLFAGMRLPE 241
Query: 423 LLAPEQMD-------SDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ E ++ LDL ++ L D R S++ + H +F
Sbjct: 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 184 bits (467), Expect = 4e-54
Identities = 117/287 (40%), Positives = 167/287 (58%), Gaps = 25/287 (8%)
Query: 192 KGTYATVFKGKS-RLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELR---HANIVTLH 246
+G Y VFK + + VALK ++++ EEG P + IREV++LR L H N+V L
Sbjct: 11 EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 70
Query: 247 DIIHT-----EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRR 300
D+ E LTLVFE++++DL Y+D + +K +FQLLRGL + HS R
Sbjct: 71 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR 130
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
++HRDLKPQN+L+ G++KLADFGLAR S ++ VVTLWYR P+VLL S+ Y+T
Sbjct: 131 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEVLLQSS-YAT 188
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP-----PDELK-SKLEFCITP 413
+D+ VGCIF EM +PLF GS+ D+L I ++G P P ++ + F
Sbjct: 189 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 248
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P E + +D DL+ K L ++ +RISA +A+ HPYF
Sbjct: 249 AQPIEK----FVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-53
Identities = 69/187 (36%), Positives = 102/187 (54%), Gaps = 3/187 (1%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + TV+ + + T VA+K IK E +RE+ +L++L H NIV L+ +
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED 62
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
E L LV EY E LK + + LS + + L Q+L GL Y HS I+HRDLKP+N
Sbjct: 63 ENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPEN 122
Query: 311 LLINER-GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
+L++ G++KLADFGL++ + V T Y P+VLLG YS D+ +G
Sbjct: 123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGV 182
Query: 369 IFHEMSS 375
I +E+
Sbjct: 183 ILYELPE 189
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 4e-52
Identities = 95/282 (33%), Positives = 161/282 (57%), Gaps = 21/282 (7%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCT---AIREVSLLRELRHANIVTLHDII 249
G+Y VFK ++R T +VA+K+ +E E+ P A+RE+ +L++L+H N+V L ++
Sbjct: 12 GSYGVVFKCRNRETGQIVAIKKF-VESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVF 69
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
++ L LVFEY + + ++ + + +K ++Q L+ + +CH +HRD+KP+
Sbjct: 70 RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPE 129
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
N+LI ++G++KL DFG AR + P +++ V T WYR P++L+G T+Y +D+ +GC
Sbjct: 130 NILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGC 189
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILG---PPPDELKSKLEF----CI---TPVYPSE 418
+F E+ +G+PL+PG + D+L LI LG P ++ S +F I P E
Sbjct: 190 VFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLE 249
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
SK + S AL ++ L D +R+S + HPYF
Sbjct: 250 SKF-----PNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-50
Identities = 104/278 (37%), Positives = 152/278 (54%), Gaps = 19/278 (6%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA---IREVSLLRELRHANIVTLHDI- 248
G + V + +LT VA+K K+ P A RE+ LL+ LRH NI++L DI
Sbjct: 21 GAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIF 78
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
I + + V E L DL R + S L ++ FL+Q+LRGL Y HS ++HRDLKP
Sbjct: 79 ISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKP 136
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
N+LINE +LK+ DFGLAR + + V T +YR P+++L +Y +D+ G
Sbjct: 137 SNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG 193
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL------KSKLEFCITPVYPSESKL 421
CIF EM G+PLFPG ++ +I +LG PPD++ ++ L F +
Sbjct: 194 CIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPF 253
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
D A+DL++K L++D ++RISAA A+ HPY
Sbjct: 254 SEKFK-NADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 9e-50
Identities = 93/248 (37%), Positives = 144/248 (58%), Gaps = 18/248 (7%)
Query: 227 AIREVSLLRELRHANIVTLHDIIHTEKC-----LTLVFEYLEKDLKRYMDDCSN-ILSMN 280
RE+ +L +H N+++ DI+ + +V E ++ DL + + S LS +
Sbjct: 46 VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKII--VSPQPLSSD 103
Query: 281 NVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTFSN 339
+VK+FL+Q+LRGL Y HS ILHRD+KP NLL+N LK+ DFGLAR + +K +
Sbjct: 104 HVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ 163
Query: 340 EVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398
EVVT +YR P++L+GS Y++++D+ VGCIF E+ R LF + +L LI +LG
Sbjct: 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGT 223
Query: 399 PP-DELKSKLEFCITPVY------PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451
P + ++S E + PS L L+ Q +A+ L+ + L++D +RISA
Sbjct: 224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLS-SQATHEAVHLLCRMLVFDPDKRISA 282
Query: 452 ANAMRHPY 459
A+A+ HPY
Sbjct: 283 ADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-48
Identities = 98/306 (32%), Positives = 146/306 (47%), Gaps = 37/306 (12%)
Query: 192 KGTYATV--FKGKSRLTDNLVALKEIKLEHEEGAPCT-AIREVSLLRELR-HANIVTLHD 247
+G Y V + + VA+K+I + A+RE+ LLR R H NI L+D
Sbjct: 10 QGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYD 69
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMD----DCSNI------LSMNNVKLFLFQLLRGLAYCH 297
+ +VF +L Y + D I L+ + + F++Q+L GL Y H
Sbjct: 70 -------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIH 122
Query: 298 SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT----FSNEVVTLWYRPPDVLL 353
S +LHRDLKP NLL+N ELK+ DFGLAR S + V T WYR P+++L
Sbjct: 123 SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML 182
Query: 354 GSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK------ 406
Y+ +ID+ VGCI E+ +P+F G D+L I +LG P +E S+
Sbjct: 183 SFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKA 242
Query: 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
+ + + + + P + ALDL++K L +D +RIS A+ HPY
Sbjct: 243 QNYIRSLPNIPKKPFESIFPNA-NPLALDLLEKLLAFDPTKRISVEEALEHPYLA----I 297
Query: 467 VHELSD 472
H+ D
Sbjct: 298 WHDPDD 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 4e-48
Identities = 98/293 (33%), Positives = 149/293 (50%), Gaps = 30/293 (10%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G+ VF D VA+K+I L + A+RE+ ++R L H NIV +++++
Sbjct: 16 GSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK-HALREIKIIRRLDHDNIVKVYEVLGPS 74
Query: 253 --------------KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS 298
+ +V EY+E DL ++ LS + +LF++QLLRGL Y HS
Sbjct: 75 GSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHS 132
Query: 299 RRILHRDLKPQNLLIN-ERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLG 354
+LHRDLKP N+ IN E LK+ DFGLAR S +VT WYR P +LL
Sbjct: 133 ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192
Query: 355 STEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP 413
Y+ +IDM GCIF EM +G+PLF G+ ++++LI + P E + P
Sbjct: 193 PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV-PVVREEDRNELLNVIP 251
Query: 414 VYPSES------KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ L+ L P ++ +ALD +++ L ++ R++A A+ HPY
Sbjct: 252 SFVRNDGGEPRRPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAEEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 5e-48
Identities = 99/281 (35%), Positives = 153/281 (54%), Gaps = 16/281 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G Y V K + + T +VA+K+ K E E T +RE+ +LR L+ NIV L +
Sbjct: 11 EGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR 70
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
L LVFEY+EK++ +++ N + V+ +++QL++ + +CH I+HRD+KP+N
Sbjct: 71 RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPEN 130
Query: 311 LLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
LLI+ LKL DFG AR S + ++ V T WYR P++LLG+ Y ++DM VGC
Sbjct: 131 LLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGC 189
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGP-PPDELKSKLEFCITP-----VYPSESKLQ 422
I E+S G+PLFPG + D+L I +LGP P +++K F P +P+ + Q
Sbjct: 190 ILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL---FYSNPRFHGLRFPAVNHPQ 246
Query: 423 LLAPEQ---MDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
L + LDL++ L + R + HP F
Sbjct: 247 SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 8e-46
Identities = 104/294 (35%), Positives = 154/294 (52%), Gaps = 24/294 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALKEI-KLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G Y TV R T VA+K++ + E A RE+ LL+ ++H N++ L D+
Sbjct: 26 GAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTP 85
Query: 252 EKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ L LV ++ DL + M LS + ++ ++Q+L+GL Y H+ I+HRD
Sbjct: 86 DLSLDRFHDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRD 143
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
LKP NL +NE ELK+ DFGLAR + VVT WYR P+V+L Y+ ++D+
Sbjct: 144 LKPGNLAVNEDCELKILDFGLARQTD---SEMTGYVVTRWYRAPEVILNWMHYTQTVDIW 200
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY----PSESK 420
VGCI EM +G+PLF G D+L I + G P E KL+ Y P K
Sbjct: 201 SVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRK 260
Query: 421 --LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
+ L P + A+++++K L+ DA+ RI+AA A+ HPYF H+ D
Sbjct: 261 KDFRSLLP-NANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF----HDPED 309
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 107/308 (34%), Positives = 158/308 (51%), Gaps = 23/308 (7%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G Y +V + T VA+K++ + E A RE++LL+ ++H N++ L D+ +
Sbjct: 26 GAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS 85
Query: 252 EKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
LV Y++ DL++ M + LS + V+ ++Q+L GL Y HS I+HRD
Sbjct: 86 AVSGDEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD 142
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
LKP NL +NE ELK+ DFGLAR + VVT WYR P+V+L Y+ ++D+
Sbjct: 143 LKPGNLAVNEDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILNWMHYNQTVDIW 199
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE-------FCITPVYPS 417
VGCI EM +G+ LF G D+L I + G P E KLE P YP
Sbjct: 200 SVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPR 259
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIF 477
+ L P+ A+DL++K L D +R++A A+ HPYF+S E
Sbjct: 260 KD-FSTLFPKASP-QAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDD 317
Query: 478 SLPHIKLT 485
SL + KL+
Sbjct: 318 SLENEKLS 325
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 3e-44
Identities = 67/127 (52%), Positives = 91/127 (71%), Gaps = 2/127 (1%)
Query: 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 151
++ +L+KLG+GTYATV+KG++R T +VALKEI L+ EEG P TAIRE+SL++EL+H NI
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 152 VTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSN--ILSMNNVKGTYATVFKGKSRLTDNL 209
V LHD+IHTE L LVFEY++KDLK+YMD L N VK + KG + +N
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120
Query: 210 VALKEIK 216
V +++K
Sbjct: 121 VLHRDLK 127
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 3e-43
Identities = 93/261 (35%), Positives = 144/261 (55%), Gaps = 31/261 (11%)
Query: 229 REVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNV 282
RE+ LL+ ++H N++ L D+ + L LV + DL + C L+ ++V
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQK-LTDDHV 122
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV 342
+ ++Q+LRGL Y HS I+HRDLKP NL +NE ELK+ DFGLAR + V
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVA 179
Query: 343 TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401
T WYR P+++L Y+ ++D+ VGCI E+ +GR LFPG+ D+L+LI ++G P
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239
Query: 402 ELKSKLEFCITPVYPSESKLQLLA--PEQMDSD--------ALDLVQKFLMYDAKQRISA 451
EL K+ + + +Q L P+ ++ A+DL++K L+ D+ +RI+A
Sbjct: 240 ELLKKI-----SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 294
Query: 452 ANAMRHPYFNSLGPQVHELSD 472
A A+ H YF Q H+ D
Sbjct: 295 AQALAHAYF----AQYHDPDD 311
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 56/101 (55%), Positives = 76/101 (75%), Gaps = 1/101 (0%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANI 151
Y KL+KLG+GTY V+K + + T +VALK+I+L++E EG P TA+RE+SLL+EL+H NI
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 152 VTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
V L D+IHTE+ L LVFEY + DLK+Y+D LS N +K
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIK 101
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 77/280 (27%), Positives = 135/280 (48%), Gaps = 40/280 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTL--HDI 248
+G++ +V+ + T L+A+K ++L + A+ RE+ +L L+H NIV +
Sbjct: 10 RGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSER 69
Query: 249 IHTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+ L + EY L LK++ L ++ + Q+L GLAY HS I+H
Sbjct: 70 DEEKNTLNIFLEYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNGIVH 124
Query: 304 RDLKPQNLLINERGELKLADFGLAR-AKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTS 361
RD+K N+L++ G +KLADFG A+ + T + V T ++ P+V+ G EY +
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG-EEYGRA 183
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
D+ +GC EM++G+P P S + + + + I S
Sbjct: 184 ADIWSLGCTVIEMATGKP--PWSELGNPMAALYKIGS-------------------SGEP 222
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
++ PE + +A D ++K L D K+R +A ++HP+
Sbjct: 223 PEI--PEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 106/310 (34%), Positives = 165/310 (53%), Gaps = 44/310 (14%)
Query: 192 KGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
+GTY V+K K + D ALK+I+ G +A RE++LLREL+H N+++L +
Sbjct: 11 RGTYGHVYKAKRKDGKDDRDYALKQIE---GTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 250 --HTEKCLTLVFEYLEKDL----KRYMDDCSNI----LSMNNVKLFLFQLLRGLAYCHSR 299
H ++ + L+F+Y E DL K + +N L VK L+Q+L G+ Y H+
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 300 RILHRDLKPQNLLI----NERGELKLADFGLARAKSVPTKTFSN---EVVTLWYRPPDVL 352
+LHRDLKP N+L+ ERG +K+AD G AR + P K ++ VVT WYR P++L
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLF---------PGSTIEDELRLICSILGPPPD- 401
LG+ Y+ +ID+ +GCIF E+ + P+F D+L I +++G P D
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADK 247
Query: 402 ---ELKSKLEFCI------TPVYPSESKLQLLAPEQM--DSDALDLVQKFLMYDAKQRIS 450
++K E Y + S ++ + ++ DS A L+QK L D +RI+
Sbjct: 248 DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 307
Query: 451 AANAMRHPYF 460
+ AM+ PYF
Sbjct: 308 SEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 8e-41
Identities = 80/279 (28%), Positives = 126/279 (45%), Gaps = 41/279 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG++ V + + T L A+K +K + + + E ++L + H IV LH
Sbjct: 3 KGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF 62
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
TE+ L LV EY +L ++ S + + +++ L Y HS I++RDLKP
Sbjct: 63 QTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKP 121
Query: 309 QNLLINERGELKLADFGLARAKSVP---TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
+N+L++ G +KL DFGLA+ S T TF T Y P+VLLG Y ++D
Sbjct: 122 ENILLDADGHIKLTDFGLAKELSSEGSRTNTF---CGTPEYLAPEVLLG-KGYGKAVDWW 177
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
+G + +EM +G+P F ++ I LK L F
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKI----------LKDPLRF--------------- 212
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANA---MRHPYF 460
PE + +A DL+ L D +R+ + A HP+F
Sbjct: 213 -PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 3e-40
Identities = 105/312 (33%), Positives = 165/312 (52%), Gaps = 48/312 (15%)
Query: 192 KGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
+GTY V+K K + + ALK+I+ G +A RE++LLREL+H N++ L +
Sbjct: 11 RGTYGHVYKAKRKDGKDEKEYALKQIE---GTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 250 --HTEKCLTLVFEYLEKDL----KRYMDDCSNILSM----NNVKLFLFQLLRGLAYCHSR 299
H+++ + L+F+Y E DL K + +N M + VK L+Q+L G+ Y H+
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 300 RILHRDLKPQNLLI----NERGELKLADFGLARAKSVPTKTFSN---EVVTLWYRPPDVL 352
+LHRDLKP N+L+ ERG +K+AD G AR + P K ++ VVT WYR P++L
Sbjct: 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELL 187
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLF---------PGSTIEDELRLICSILGPPPDE 402
LG+ Y+ +ID+ +GCIF E+ + P+F D+L I S++G P D
Sbjct: 188 LGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPAD- 246
Query: 403 LKSKLEFCITPVYPSESK------------LQLLAPEQM--DSDALDLVQKFLMYDAKQR 448
K + P YP+ K ++ + ++ DS L+QK L D +R
Sbjct: 247 -KDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKR 305
Query: 449 ISAANAMRHPYF 460
I++ A++ PYF
Sbjct: 306 ITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 9e-40
Identities = 91/258 (35%), Positives = 141/258 (54%), Gaps = 25/258 (9%)
Query: 229 REVSLLRELRHANIVTLHDIIHTEKCLTLVFE-YLEKDLKRYMDDCSNI-----LSMNNV 282
RE+ LL+ ++H N++ L D+ + E YL +L D +NI LS +V
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMG--ADLNNIVKCQKLSDEHV 120
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV 342
+ ++QLLRGL Y HS I+HRDLKP N+ +NE EL++ DFGLAR + V
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD---DEMTGYVA 177
Query: 343 TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401
T WYR P+++L Y+ ++D+ VGCI E+ G+ LFPG+ D+L+ I ++G P
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSP 237
Query: 402 ELKSKLE-------FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA 454
E+ K+ P P + ++ + A+DL++K L+ D+ +RISA+ A
Sbjct: 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIF--RGANPLAIDLLEKMLVLDSDKRISASEA 295
Query: 455 MRHPYFNSLGPQVHELSD 472
+ HPYF+ Q H+ D
Sbjct: 296 LAHPYFS----QYHDPED 309
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 145 bits (365), Expect = 8e-39
Identities = 91/330 (27%), Positives = 144/330 (43%), Gaps = 32/330 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHA-NIVTLHDI 248
+G++ V+ + R VALK + KLE + +RE+ +L L H NIV L+D
Sbjct: 10 EGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66
Query: 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNN--VKLFLFQLLRGLAYCHSRRILHRD 305
E L LV EY++ L+ + ++ L Q+L L Y HS+ I+HRD
Sbjct: 67 FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRD 126
Query: 306 LKPQNLLINERG-ELKLADFGLARA------KSVPTKTFSNEVVTLWYRPPDVLLGSTE- 357
+KP+N+L++ G +KL DFGLA+ S S V T Y P+VLLG +
Sbjct: 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLA 186
Query: 358 -YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
S+S D+ +G +E+ +G P F G + + TP
Sbjct: 187 YASSSSDIWSLGITLYELLTGLPPFEGEKNSS-----------ATSQTLKIILELPTPSL 235
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQS 475
S PE + A DL++K L D K R+S+++ + H L + +LSD
Sbjct: 236 ASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
Query: 476 IFSLPHIKLTSNPTDGGLLPFYGQKSEKRW 505
++L+ P+ L+ +
Sbjct: 294 PDDSAPLRLSLPPSLEALISSLNSLAISGS 323
|
Length = 384 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 92/287 (32%), Positives = 156/287 (54%), Gaps = 22/287 (7%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G++ V++ T VA+K++ + P RE+ +++ L H NI+ L D +TE
Sbjct: 77 GSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYYYTE 131
Query: 253 KC--------LTLVFEYLEKDLKRYMDDCS---NILSMNNVKLFLFQLLRGLAYCHSRRI 301
L +V E++ + + +YM + + L + VKL+ +QL R LAY HS+ I
Sbjct: 132 CFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFI 191
Query: 302 LHRDLKPQNLLINERGE-LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
HRDLKPQNLLI+ LKL DFG A+ ++ S + + +YR P+++LG+T Y+T
Sbjct: 192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-YICSRFYRAPELMLGATNYTT 250
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
ID+ +GCI EM G P+F G + D+L I +LG P ++ ++ + +
Sbjct: 251 HIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDV 310
Query: 420 K---LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
K L+ + P+ DA++ + +FL Y+ +R++ A+ P+F+ L
Sbjct: 311 KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357
|
Length = 440 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 9e-38
Identities = 90/263 (34%), Positives = 133/263 (50%), Gaps = 37/263 (14%)
Query: 227 AIREVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSNI---L 277
A RE+ L++ + H NI+ L ++ +K L LV E ++ +L C I L
Sbjct: 62 AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANL------CQVIQMDL 115
Query: 278 SMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF 337
+ L+Q+L G+ + HS I+HRDLKP N+++ LK+ DFGLAR
Sbjct: 116 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MM 174
Query: 338 SNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
+ VVT +YR P+V+LG Y ++D+ VGCI EM G LFPG+ D+ I L
Sbjct: 175 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233
Query: 397 GPPPDELKSKLEFCIT------PVYPSESKLQLLAPEQM------------DSDALDLVQ 438
G P DE S+L+ + P Y S + L P+ + S A DL+
Sbjct: 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYS-FEELFPDVLFPPDSESHNKLKASQARDLLS 292
Query: 439 KFLMYDAKQRISAANAMRHPYFN 461
K L+ D ++RIS +A++HPY N
Sbjct: 293 KMLVIDPEKRISVDDALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-37
Identities = 52/94 (55%), Positives = 70/94 (74%), Gaps = 1/94 (1%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANI 151
Y K++K+G+GTY V+K + +LT +VALK+I+LE E EG P TAIRE+SLL+EL H NI
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 152 VTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNI 185
V L D++H+E L LVFE+L+ DLK+YMD
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLT 94
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-37
Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 36/277 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
KG++ V+ + + L LKEI L + E A+ EV +L++L H NI+ ++
Sbjct: 10 KGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE 69
Query: 251 TEKCLTLVFEYLE-KDLKRYMDDCSNI---LSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ L +V EY + DL + + + + QL L Y HSR+ILHRD+
Sbjct: 70 EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDI 129
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM- 364
KPQN+ + G +KL DFG+++ S T + VV T +Y P++ Y+ D+
Sbjct: 130 KPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIW 187
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPSESKLQL 423
+GC+ +E+ + + F G + + L IL G P I Y SE L+
Sbjct: 188 SLGCVLYELCTLKHPFEGENLLE---LALKILKGQYPP---------IPSQYSSE--LR- 232
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+LV L D ++R S A ++ P+
Sbjct: 233 -----------NLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 69/130 (53%), Positives = 92/130 (70%)
Query: 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL 146
FG+ +SY KL+KLG+G+YATV+KGKS++ LVALK I+L+ EEG P TAIRE SLL+ L
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL 60
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLT 206
+HANIV LHDIIHT++ LTLVFEY+ DL +YMD L NVK + +G S +
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 207 DNLVALKEIK 216
+ +++K
Sbjct: 121 QRYILHRDLK 130
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-34
Identities = 53/102 (51%), Positives = 77/102 (75%), Gaps = 1/102 (0%)
Query: 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHAN 150
Y KL+K+G+GTY TVFK K+R T +VALK ++L+ + EG P +A+RE+ LL+EL+H N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
IV L+D++H++K LTLVFEY ++DLK+Y D C+ + VK
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK 102
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 51/96 (53%), Positives = 75/96 (78%), Gaps = 1/96 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
++ Y K++K+G+GTY V+K + R+T+ +ALK+I+LE E EG P TAIRE+SLL+E++H
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSN 184
NIV L D++H+EK L LVFEYL+ DLK++MD +
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPD 96
|
Length = 294 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 7e-34
Identities = 58/93 (62%), Positives = 71/93 (76%)
Query: 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL 146
FG SY L+KLG+G+YATV+KG SR+ LVALK I ++ EEG P TAIRE SLL+ L
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL 60
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179
+HANIV LHDIIHT++ LT VFEY+ DL +YM
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYM 93
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 74/272 (27%), Positives = 126/272 (46%), Gaps = 32/272 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG + V+K + + T VA+K IKLE + I E+ +L++ +H NIV +
Sbjct: 10 KGGFGEVYKARHKRTGKEVAIKVIKLE-SKEKKEKIINEIQILKKCKHPNIVKYYGSYLK 68
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ L +V E+ LK + + L+ + + +LL+GL Y HS I+HRD+K N
Sbjct: 69 KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAAN 128
Query: 311 LLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
+L+ GE+KL DFGL+ + + T V T ++ P+V+ G Y D+ +G
Sbjct: 129 ILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVING-KPYDYKADIWSLG 184
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
E++ G+P + L I + GPP L PE
Sbjct: 185 ITAIELAEGKPPYSELPPMKALFKI-ATNGPPG----------------------LRNPE 221
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
+ + D ++K L + ++R +A ++HP+
Sbjct: 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-33
Identities = 52/103 (50%), Positives = 77/103 (74%), Gaps = 2/103 (1%)
Query: 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHAN 150
++ K++K+G+GTY V+K +++LT +VALK+I+L+ E EG P TAIRE+SLL+EL H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVK 192
IV L D+IHTE L LVFE+L +DLK++MD + + + +K
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK 103
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 40/277 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G + V+KG + T + VA+K+I LE +E A + ++E+ LL+ L+H NIV I
Sbjct: 10 RGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE 69
Query: 251 TEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
T L ++ EY L + +K++ + V ++++Q+L+GLAY H + ++HRD
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRD 124
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM 364
+K N+L + G +KLADFG+A K VV T ++ P+V+ S ST+ D+
Sbjct: 125 IKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMS-GASTASDI 182
Query: 365 -GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
+GC E+ +G P + L I PP
Sbjct: 183 WSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPL----------------------- 219
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
PE + + D + + D R +A ++HP+
Sbjct: 220 --PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 74/256 (28%), Positives = 114/256 (44%), Gaps = 28/256 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
KG++ TV K + + ++ KEI + + EV++LREL+H NIV +D I
Sbjct: 10 KGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRII 69
Query: 251 --TEKCLTLVFEYLEK-DLKRYMDDCSNILSM---NNVKLFLFQLLRGLAYCHSR----- 299
+ + L +V EY E DL + + C + L QLL L CH+R
Sbjct: 70 DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN 129
Query: 300 RILHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGST 356
+LHRDLKP N+ ++ +KL DFGLA+ S KT+ V T +Y P+ L +
Sbjct: 130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY---VGTPYYMSPEQLNHMS 186
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP-----PDELKSKLEFC 410
Y D+ +GC+ +E+ + P F I EL ++
Sbjct: 187 -YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSM 245
Query: 411 ITPVYPSE--SKLQLL 424
+ V P + S +LL
Sbjct: 246 LN-VDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-32
Identities = 72/280 (25%), Positives = 133/280 (47%), Gaps = 40/280 (14%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDI-IH 250
GT+ V+ + T L+A+KEI+++ + I E+ +L L+H N+V + + +H
Sbjct: 11 GTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH 70
Query: 251 TEKCLTLVFEYLEK----DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
EK + + EY +L + IL + ++++ QLL GLAY HS I+HRD+
Sbjct: 71 REK-VYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 307 KPQNLLINERGELKLADFG----LARAKSVPTKTFSNEVVTLWYRPPDVLLGST--EYST 360
KP N+ ++ G +KL DFG L + + + T Y P+V+ G +
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
+ D+ +GC+ EM++G+ P S +++E +++ + P P
Sbjct: 186 AADIWSLGCVVLEMATGKR--PWSELDNEFQIM------------FHVGAGHKPPIP--- 228
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
Q+ + D + + L D K+R +A+ ++HP+
Sbjct: 229 -----DSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 48/89 (53%), Positives = 69/89 (77%), Gaps = 1/89 (1%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANI 151
Y K++K+G+GTY V+KG+++ T +VA+K+I+LE E EG P TAIRE+SLL+EL+H NI
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 152 VTLHDIIHTEKCLTLVFEYLEKDLKRYMD 180
V L D++ E L L+FE+L DLK+Y+D
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLD 90
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-31
Identities = 81/292 (27%), Positives = 134/292 (45%), Gaps = 51/292 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE--HEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG Y VF K + T ++ A+K IK + + E +L + + +V L+
Sbjct: 3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSM------NNVKLFLFQLLRGLAYCHSRRILH 303
+K L LV EYL D +++L + ++++ +++ L Y HS I+H
Sbjct: 63 QGKKNLYLVMEYLPGG------DLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 304 RDLKPQNLLINERGELKLADFGLA------RAKSVPTKTFSNEVV--TLWYRPPDVLLGS 355
RDLKP N+LI+ G LKL DFGL+ R ++ ++ + T Y P+V+LG
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
+S ++D +GCI +E G P F G T E+ + I K+E+ P
Sbjct: 177 G-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL----------NGKIEW---PE 222
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA---MRHPYFNSL 463
S +A+DL+ K L+ D ++R+ A + HP+F +
Sbjct: 223 DVEVSD-----------EAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 89/261 (34%), Positives = 131/261 (50%), Gaps = 34/261 (13%)
Query: 227 AIREVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSNI---L 277
A RE+ L++ + H NI+ L ++ +K L +V E ++ +L C I L
Sbjct: 70 AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL------CQVIQMEL 123
Query: 278 SMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF 337
+ L+Q+L G+ + HS I+HRDLKP N+++ LK+ DFGLAR +
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMM 182
Query: 338 SNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
+ VVT +YR P+V+LG Y ++D+ VGCI EM G LFPG+ D+ + L
Sbjct: 183 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQL 241
Query: 397 GPPPDELKSKLEFCI------TPVYPSESKLQL----LAPEQMD------SDALDLVQKF 440
G P E KL+ + P Y S +L L P + S A DL+ K
Sbjct: 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 301
Query: 441 LMYDAKQRISAANAMRHPYFN 461
L+ DA +RIS A++HPY N
Sbjct: 302 LVIDASKRISVDEALQHPYIN 322
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 43/104 (41%), Positives = 68/104 (65%), Gaps = 4/104 (3%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC----TAIREVSLLRELRH 148
Y K KLG+GTYA V+K + + T +VA+K+IKL + A TA+RE+ LL+EL+H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
NI+ L D+ + + LVFE++E DL++ + D S +L+ ++K
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK 105
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-30
Identities = 85/258 (32%), Positives = 132/258 (51%), Gaps = 32/258 (12%)
Query: 227 AIREVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKR--YMDDCSNILS 278
A RE+ LL+ + H NI++L ++ +K L LV E ++ +L + +M+ L
Sbjct: 67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----LD 121
Query: 279 MNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFS 338
+ L+Q+L G+ + HS I+HRDLKP N+++ LK+ DFGLAR +
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT-NFMMT 180
Query: 339 NEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397
VVT +YR P+V+LG Y ++D+ VGCI E+ G +F G+ D+ + LG
Sbjct: 181 PYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239
Query: 398 PPPDELKSKLEFCI------TPVYPSESKLQLLA----PEQMDSDAL------DLVQKFL 441
P E ++L+ + P YP S +L P + + D L DL+ K L
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299
Query: 442 MYDAKQRISAANAMRHPY 459
+ D +RIS A+RHPY
Sbjct: 300 VIDPDKRISVDEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 1e-30
Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 57/297 (19%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIRE-VSLLRELRHANIVTLHDII 249
G+++TV K + T+ A+K + +E E L R H I+ L+
Sbjct: 12 GSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E+ L V EY +L +Y+ + L + + ++L L Y HS+ I+HRDLKP
Sbjct: 72 QDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRFYAAEILLALEYLHSKGIIHRDLKP 130
Query: 309 QNLLINERGELKLADFGLARAKS--------------------VPTKTFSNEVVTLWYRP 348
+N+L+++ +K+ DFG A+ + F++ V T Y
Sbjct: 131 ENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVS 190
Query: 349 PDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407
P+ LL S D+ +GCI ++M +G+P F GS E IL
Sbjct: 191 PE-LLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQKIL----------- 235
Query: 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA----MRHPYF 460
KL+ P DA DL++K L+ D + R+ HP+F
Sbjct: 236 ------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 3e-30
Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 42/278 (15%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI----REVSLLRELRHANIVTLHDI 248
G++ +V++G + + A+KE+ L + A+ +E++LL +L+H NIV
Sbjct: 11 GSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGT 70
Query: 249 IHTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
E L + E L K LK+Y ++L+ Q+L GL Y H R +H
Sbjct: 71 EREEDNLYIFLELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRNTVH 125
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSI 362
RD+K N+L++ G +KLADFG+ AK V +F+ + ++ P+V+ Y +
Sbjct: 126 RDIKGANILVDTNGVVKLADFGM--AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D+ +GC EM++G+P + S+LE SK
Sbjct: 184 DIWSLGCTVLEMATGKPPW------------------------SQLEGVAAVFKIGRSKE 219
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P+ + +A D + K L D R +AA + HP+
Sbjct: 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 48/282 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G V+K R T VA+K+++L + I E+ ++++ +H NIV +D
Sbjct: 29 EGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPNIVDYYDSYLV 86
Query: 252 EKCLTLVFEYLEKDLKRYMDDCS--NILSMNNVKL-------FLFQLLRGLAYCHSRRIL 302
L +V EY MD S +I++ N V++ ++L+GL Y HS+ ++
Sbjct: 87 GDELWVVMEY--------MDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI 138
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
HRD+K N+L+++ G +KLADFG A + ++ V T ++ P+V+ +Y +
Sbjct: 139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRK-DYGPKV 197
Query: 363 D---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
D +G+ CI EM+ G P + L LI + G PP
Sbjct: 198 DIWSLGIMCI--EMAEGEPPYLREPPLRALFLI-TTKGIPP------------------- 235
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
L PE+ + D + K L+ D ++R SA ++HP+
Sbjct: 236 ---LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 85/265 (32%), Positives = 130/265 (49%), Gaps = 42/265 (15%)
Query: 227 AIREVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSNI---L 277
A RE+ L++ + H NI++L ++ +K L LV E ++ +L C I L
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL------CQVIQMEL 116
Query: 278 SMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF 337
+ L+Q+L G+ + HS I+HRDLKP N+++ LK+ DFGLAR +
Sbjct: 117 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMM 175
Query: 338 SNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
+ VVT +YR P+V+LG Y ++D+ VGCI EM + LFPG D+ + L
Sbjct: 176 TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 397 GPPPDELKSKLEFCI--------------------TPVYPSESKLQLLAPEQMDSDALDL 436
G P E KL+ + ++P++S+ L Q A DL
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQ----ARDL 290
Query: 437 VQKFLMYDAKQRISAANAMRHPYFN 461
+ K L+ D +RIS A++HPY N
Sbjct: 291 LSKMLVIDPAKRISVDEALQHPYIN 315
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 44/101 (43%), Positives = 65/101 (64%), Gaps = 1/101 (0%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKL-EHEEGAPCTAIREVSLLRELRHANI 151
Y KL K+G+GTY V+K + +LT +VA+K+IKL EG P TA+RE+ LL+EL H NI
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 152 VTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
+ L D+ + L LVFE+++ DL + + D L + +K
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK 101
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 78/278 (28%), Positives = 127/278 (45%), Gaps = 42/278 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+ V+K + + T + ALK+I ++ +E +RE+ LR +V + +
Sbjct: 11 QGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK 70
Query: 252 EKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRD 305
E +++V EY L LK+ + + Q+L+GL Y H+ R I+HRD
Sbjct: 71 EGEISIVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRD 125
Query: 306 LKPQNLLINERGELKLADFGLARAKS---VPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
+KP NLLIN +GE+K+ADFG+++ TF V T+ Y P+ + G + YS +
Sbjct: 126 IKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPERIQGES-YSYAA 181
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPSESK 420
D+ +G E + G+ F L+ +I GPPP
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS------------------- 222
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
L E+ + D + L D K+R SAA ++HP
Sbjct: 223 ---LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHP 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 80/276 (28%), Positives = 130/276 (47%), Gaps = 41/276 (14%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G+Y +V+K + T +VA+K + +E I+E+S+L++ IV +
Sbjct: 14 GSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPYIVKYYGSYFKN 70
Query: 253 KCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
L +V EY D+ M + L+ + L+Q L+GL Y HS + +HRD+K
Sbjct: 71 TDLWIVMEYCGAGSVSDI---MKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKA 127
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSID---M 364
N+L+NE G+ KLADFG++ + T N V+ T ++ P+V+ Y+ D +
Sbjct: 128 GNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSL 185
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
G+ I EM+ G+P P S I +R I I PP L
Sbjct: 186 GITAI--EMAEGKP--PYSDIH-PMRAIFMIPNKPPPTLSD------------------- 221
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
PE+ + D V+K L+ D ++R SA ++HP+
Sbjct: 222 -PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 48/143 (33%), Positives = 78/143 (54%), Gaps = 5/143 (3%)
Query: 192 KGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V+KGK VA+K +K + E +RE ++R+L H N+V L
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLG 68
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ E+ L +V EY+E DL Y+ LS++++ F Q+ RG+ Y S+ +HRDL
Sbjct: 69 VCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDL 128
Query: 307 KPQNLLINERGELKLADFGLARA 329
+N L+ E +K++DFGL+R
Sbjct: 129 AARNCLVGENLVVKISDFGLSRD 151
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKL----EHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG ++ V+K L +VALK++++ + + C ++E+ LL++L H N++
Sbjct: 12 KGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC--LKEIDLLKQLDHPNVIKYLA 69
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCHSRRILH 303
L +V E + DL R + ++ + + QL L + HS+RI+H
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMH 129
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RD+KP N+ I G +KL D GL R S T + V T +Y P+ + Y+ D
Sbjct: 130 RDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSD 188
Query: 364 M-GVGCIFHEMSSGRPLFPGS 383
+ +GC+ +EM++ + F G
Sbjct: 189 IWSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 4e-25
Identities = 47/144 (32%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 192 KGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V+KG + VA+K +K + E +RE ++R+L H NIV L
Sbjct: 9 EGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLG 68
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ E+ L +V EY+ DL Y+ LS++++ F Q+ RG+ Y S+ +HRD
Sbjct: 69 VCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRD 128
Query: 306 LKPQNLLINERGELKLADFGLARA 329
L +N L+ E +K++DFGL+R
Sbjct: 129 LAARNCLVGENLVVKISDFGLSRD 152
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 67/221 (30%), Positives = 108/221 (48%), Gaps = 23/221 (10%)
Query: 192 KGTYATVFKGKSRLTDN-LVALKEIKL------EHEEGAPCTAIREVSLLRELRHANIVT 244
KG+Y +V+K K RL+DN ALKE+ L E E+ A+ E+ +L + H NI++
Sbjct: 10 KGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKERED-----AVNEIRILASVNHPNIIS 63
Query: 245 LHDIIHTEKCLTLVFEYLE-KDLKRYM---DDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
+ L +V EY DL + + ++ + QLLRGL H ++
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYS 359
ILHRDLK N+L+ +K+ D G+++ V K + + T Y P+V G YS
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISK---VLKKNMAKTQIGTPHYMAPEVWKG-RPYS 179
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399
D+ +GC+ +EM++ P F +++D + PP
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 81/283 (28%), Positives = 127/283 (44%), Gaps = 48/283 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLRELRHANIVTLHDIIH 250
GTY V+K + T LVA+K IKLE G I+ E+S+L+E RH NIV
Sbjct: 13 SGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 251 TEKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
L +V EY +D+ + LS + + L+GLAY H +HRD+
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGP---LSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNE---VVTLWYRPPDVLLGSTE--YSTS 361
K N+L+ E G++KLADFG++ + T T + + T ++ P+V + Y
Sbjct: 128 KGANILLTEDGDVKLADFGVS---AQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGK 184
Query: 362 ID---MGVGCIFHEMSSGRPLFPGSTIEDELR--LICSILGPPPDELKSKLEFCITPVYP 416
D +G+ I E++ +P P + +R + S PP +LK K
Sbjct: 185 CDIWALGITAI--ELAELQP--PMFDL-HPMRALFLISKSNFPPPKLKDK---------- 229
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
E+ D ++K L D K+R +A ++HP+
Sbjct: 230 ----------EKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 74/278 (26%), Positives = 126/278 (45%), Gaps = 38/278 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI-KLEH-EEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V + R T + A+K + K + E+G+ + E +L+EL H +V L
Sbjct: 10 KGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF 69
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E+ + LV + L DL RY S VK ++ +++ L Y HS+ I+HRD+KP
Sbjct: 70 QDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM-GV 366
N+L++E+G + + DF +A V T + T Y P+VL YS ++D +
Sbjct: 129 DNILLDEQGHVHITDFNIAT--KVTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSL 185
Query: 367 GCIFHEMSSGRPLFPG--STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
G +E G+ + G TI D++R + + + +
Sbjct: 186 GVTAYECLRGKRPYRGHSRTIRDQIRAK---------QETADVLY--------------- 221
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAA--NAMRHPYF 460
P ++A+D + K L D ++R+ + HPYF
Sbjct: 222 -PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 48/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA-----NIVTLH 246
KG + +V+ K R T + A+K +K + + V R + + L+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLK--KSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNI------LSMNNVKLFLFQLLRGLAYCHSRR 300
++ L LV EYL DC+++ L + K ++ +++ G+ H R
Sbjct: 64 YSFQSKDYLYLVMEYLNGG------DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
I+HRD+KP+NLLI++ G LKL DFGL+R K T Y P+ +LG +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG----TPDYLAPETILGVGDDKM 173
Query: 361 SIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
S +GC+ E G P F T + I S P+E+K EFC
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVK---EFC---------- 220
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISA---ANAMRHPYFNSL 463
+PE A+DL+ + L D +R+ A HP+F S+
Sbjct: 221 ----SPE-----AVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 47/149 (31%), Positives = 81/149 (54%), Gaps = 12/149 (8%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G + V+KGK + D VA+K +K + E ++E ++++L H N+V L +
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGV 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDC--------SNILSMNNVKLFLFQLLRGLAYCHSR 299
E+ L LV EY+E DL Y+ + LS+ ++ F Q+ +G+ Y S+
Sbjct: 65 CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK 124
Query: 300 RILHRDLKPQNLLINERGELKLADFGLAR 328
+ +HRDL +N L+ E +K++DFGL+R
Sbjct: 125 KFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 48/97 (49%), Positives = 67/97 (69%), Gaps = 7/97 (7%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELRHA 149
++Y KL+K+G+GTY V+K + + T LVALK+ +LE EEG P TA+RE+SLL+ L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 150 N-IVTLHDIIHTEK-----CLTLVFEYLEKDLKRYMD 180
IV L D+ H E+ L LVFEYL+ DLK++MD
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD 97
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 2e-23
Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 42/284 (14%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G + V+K + + T A K I++E EE + E+ +L E +H NIV L++ E
Sbjct: 16 GAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAYFYE 74
Query: 253 KCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
L ++ E+ + L M + L+ ++ Q+L L + HS +++HRDLK N+
Sbjct: 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNI 134
Query: 312 LINERGELKLADFGL-ARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSID----- 363
L+ G++KLADFG+ A+ KS K TF + T ++ P+V+ T D
Sbjct: 135 LLTLDGDVKLADFGVSAKNKSTLQKRDTF---IGTPYWMAPEVVACETFKDNPYDYKADI 191
Query: 364 --MGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPSESK 420
+G+ I E++ P P + + +R++ IL PP
Sbjct: 192 WSLGITLI--ELAQMEP--PHHEL-NPMRVLLKILKSEPP-------------------- 226
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464
L P + S D ++ L+ D R +AA ++HP+ +
Sbjct: 227 -TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 6e-23
Identities = 42/144 (29%), Positives = 74/144 (51%), Gaps = 5/144 (3%)
Query: 192 KGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V+KG T+ VA+K +K E + E S++++L H NIV L
Sbjct: 9 EGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLG 68
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ + L +V EY+ DL ++ L++ ++ Q+ +G+ Y S+ +HRDL
Sbjct: 69 VCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDL 128
Query: 307 KPQNLLINERGELKLADFGLARAK 330
+N L+ E +K++DFGL+R
Sbjct: 129 AARNCLVTENLVVKISDFGLSRDI 152
|
Length = 258 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 1e-22
Identities = 76/285 (26%), Positives = 130/285 (45%), Gaps = 48/285 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKE------IKLEHEEGAPCTAIREVSLLRELRHANIVTL 245
GT+ V + R++++ ALK I+L+ E+ E +L+E+ H I+ L
Sbjct: 11 TGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH----NEKRVLKEVSHPFIIRL 66
Query: 246 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
H ++ L ++ EY+ +L Y+ + S S + + +++ L Y HS+ I++R
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYR 125
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
DLKP+N+L+++ G +KL DFG A+ T T T Y P+V + S ++ ++D
Sbjct: 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG---TPEYLAPEV-IQSKGHNKAVDW 181
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
+G + +EM G P F I L KLEF
Sbjct: 182 WALGILIYEMLVGYPPFFDDNPFGIYEKI----------LAGKLEF-------------- 217
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P +D A DL++K L+ D +R+ A + H +F S+
Sbjct: 218 --PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 73/282 (25%), Positives = 135/282 (47%), Gaps = 41/282 (14%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC-------TAI-REVSLLRELRHANIVT 244
G++ +V+ G + + L+A+K+++L + A+ RE++LL+EL+H NIV
Sbjct: 11 GSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQ 70
Query: 245 LHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
L + EY+ + + V+ F+ Q+L+GL Y H+R I+HR
Sbjct: 71 YLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHR 130
Query: 305 DLKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVV---TLWYRPPDVLLGSTEY 358
D+K N+L++ +G +K++DFG+++ A S+ TKT ++++ P+V + T Y
Sbjct: 131 DIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV-VKQTSY 189
Query: 359 STSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417
+ D+ +GC+ EM +G+ FP T + I P
Sbjct: 190 TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEI----------------- 232
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P + S+A+D ++K D +R +AA ++HP+
Sbjct: 233 --------PSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 69/282 (24%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKL----EHEEGAPCTAIR-EVSLLRELRHANIVTLHD 247
G +++ ++ + T L+A+K++ E+ A+R E+ L+ L H +I+ +
Sbjct: 11 GAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG 70
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L E++ ++ + + QLLRGL+Y H +I+HRD+K
Sbjct: 71 ATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVK 130
Query: 308 PQNLLINERGE-LKLADFGLA---RAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSI 362
NLLI+ G+ L++ADFG A AK F +++ T+ + P+VL G +Y S
Sbjct: 131 GANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSC 189
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSI---LGPPPDELKSKLEFCITPVYPSE 418
D+ VGC+ EM++ +P + + L LI I P
Sbjct: 190 DVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPS------------------ 231
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
PE + D+ + L + R + ++HP F
Sbjct: 232 ------IPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-22
Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 50/296 (16%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G TV+K R T L ALK I HE+ RE+ +LR++ H N+V HD+
Sbjct: 85 GAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN 144
Query: 253 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFL----FQLLRGLAYCHSRRILHRDLKP 308
+ ++ E+ MD S + + FL Q+L G+AY H R I+HRD+KP
Sbjct: 145 GEIQVLLEF--------MDGGSLEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKP 196
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPP-----DVLLGSTE-YSTSI 362
NLLIN +K+ADFG++R + ++ V T+ Y P D+ G+ + Y+ I
Sbjct: 197 SNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDI 256
Query: 363 -DMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
+GV + E GR F D L+C+I P E
Sbjct: 257 WSLGVSIL--EFYLGRFPFGVGRQGDWASLMCAICMSQPPE------------------- 295
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF-------NSLGPQVHEL 470
AP + + L + +R SA ++HP+ GP +H+L
Sbjct: 296 ---APATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQL 348
|
Length = 353 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 42/132 (31%), Positives = 80/132 (60%), Gaps = 5/132 (3%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
+ + KL+++G+GTY V++ + + +VALK++++++E +G P +++RE++LL LRH
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH 65
Query: 149 ANIVTLHDIIHTEKCLT---LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRL 205
NIV L +++ K L LV EY E+DL +D+ S + VK + +G L
Sbjct: 66 PNIVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 206 TDNLVALKEIKL 217
+N + +++K+
Sbjct: 125 HENFIIHRDLKV 136
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 76/280 (27%), Positives = 127/280 (45%), Gaps = 34/280 (12%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
G + V K + + ALK +K H E G E +L E H IV L+
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK 63
Query: 251 TEKCLTLVFEY-LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+K + ++ EY L +L + D + + ++ ++ Y H+R I++RDLKP+
Sbjct: 64 DKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPE 122
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
NLL++ G +KL DFG A+ KT++ T Y P+++L Y S+D +G
Sbjct: 123 NLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKG-YDFSVDYWSLGI 180
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ +E+ +GRP F G ED + + IL + KLEF P
Sbjct: 181 LLYELLTGRPPF-GEDDEDPMEIYNDIL-----KGNGKLEF----------------PNY 218
Query: 429 MDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
+D A DL+++ L + ++R+ + +H +FN
Sbjct: 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 40/100 (40%), Positives = 62/100 (62%), Gaps = 9/100 (9%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELR---H 148
Y +L ++G+G Y TV+K + T VALK++++ EEG P + +RE++LL++L H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 149 ANIVTLHDIIHT-----EKCLTLVFEYLEKDLKRYMDDCS 183
NIV L D+ H E LTLVFE++++DL Y+ C
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCP 100
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 9e-21
Identities = 78/288 (27%), Positives = 122/288 (42%), Gaps = 47/288 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKL------EHEEGAPCT--AIR-EVSLLRELRHANI 242
KGTY V+ + T ++A+K+++L H+ A+R E+ L++L H NI
Sbjct: 11 KGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI 70
Query: 243 VTLHDIIHTEKCLTLVFEYLEKD-----LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH 297
V TE+ L++ EY+ L+ Y V+ F Q+L GLAY H
Sbjct: 71 VQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR-----FEEQLVRFFTEQVLEGLAYLH 125
Query: 298 SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV---TLWYRPPDVLLG 354
S+ ILHRDLK NLL++ G K++DFG+++ N + W P +
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 355 STEYSTSIDM-GVGCIFHEMSSG-RPLFPGSTIEDELRLICSILGPP-PDELKSKLEFCI 411
S YS +D+ +GC+ EM +G RP I +L PP P ++ L
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS--- 242
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
ALD + + R +A ++HP+
Sbjct: 243 -------------------PVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 9e-21
Identities = 80/281 (28%), Positives = 125/281 (44%), Gaps = 50/281 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKL------EHEEGAPCTAIREVSLLRELRHANIVTL 245
KG++ VFK + + A+K+I L E EE AI E +L +L + I+
Sbjct: 10 KGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREE-----AIDEARVLAKLDSSYIIRY 64
Query: 246 HDIIHTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
++ + L +V EY L K LK L + V F Q+L GLA+ HS++
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYS 359
ILHRD+K NL ++ +K+ D G+A+ S F+N +V T +Y P+ L Y+
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPE-LCEDKPYN 179
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
D+ +G + +E +G+ F ++ LI I I V+P
Sbjct: 180 EKSDVWALGVVLYECCTGKHPF---DANNQGALILKI---------------IRGVFPPV 221
Query: 419 SKLQLLAPEQMDSDAL-DLVQKFLMYDAKQRISAANAMRHP 458
S QM S L L+ + L D +QR +R+P
Sbjct: 222 S--------QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-20
Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 56/285 (19%)
Query: 193 GTYATVFKGKSRLTDNLVALKE------IKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
G++ V + + + ALK +KL+ E + E +L+ +RH +V L+
Sbjct: 12 GSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE----HVLNEKRILQSIRHPFLVNLY 67
Query: 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ L LV EY+ +L ++ + + Q++ L Y HS I++RD
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLRKSGR-FPEPVARFYAAQVVLALEYLHSLDIVYRD 126
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLW----YRPPDVLLGSTEYSTS 361
LKP+NLL++ G +K+ DFG AK V +T+ TL Y P+++L S Y +
Sbjct: 127 LKPENLLLDSDGYIKITDFGF--AKRVKGRTY-----TLCGTPEYLAPEIIL-SKGYGKA 178
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
+D +G + +EM +G P F I K+ F
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE----------GKVRF----------- 217
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYF 460
P DA DL++ L D +R+ + HP+F
Sbjct: 218 -----PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 79/282 (28%), Positives = 123/282 (43%), Gaps = 43/282 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G V K R T ++A+K I+LE E +RE+ +L + IV + +
Sbjct: 11 AGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN 70
Query: 252 EKCLTLVFEY-----LEKDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHS-RRILHR 304
+++ EY L+K LK IL K+ +L+GL Y H +I+HR
Sbjct: 71 NGDISICMEYMDGGSLDKILKEVQGRIPERILG----KIA-VAVLKGLTYLHEKHKIIHR 125
Query: 305 DLKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
D+KP N+L+N RG++KL DFG++ S+ KTF V T Y P+ + G+ YS
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSGQLVNSL-AKTF---VGTSSYMAPERIQGND-YSVKS 180
Query: 363 DM-GVGCIFHEMSSGR-PL-FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
D+ +G E+++GR P + L+ I+ PP P PS
Sbjct: 181 DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------------PRLPS-- 226
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
+ D D V L+ D ++R S + HP+
Sbjct: 227 -------GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 60/228 (26%), Positives = 112/228 (49%), Gaps = 5/228 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G++ + +D A+KEI+L A + +E LL +++H NIV +
Sbjct: 10 EGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA 69
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLF-QLLRGLAYCHSRRILHRDLKPQ 309
+ L +V EY + DL + + L + L F Q+ G+ + H +R+LHRD+K +
Sbjct: 70 DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSK 129
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
N+ + + G++KL DFG AR + P V T +Y PP++ + Y+ D+ +GC
Sbjct: 130 NIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEI-WENMPYNNKSDIWSLGC 188
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICS-ILGPPPDELKSKLEFCITPVY 415
I +E+ + + F ++ ++ + +C P P +L I ++
Sbjct: 189 ILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMF 236
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 79/280 (28%), Positives = 124/280 (44%), Gaps = 35/280 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL----RHANIVTLHD 247
+G Y VF K + T +VALK +K +R V R++ + +V L
Sbjct: 11 QGGYGQVFLAKKKDTGEIVALKRMKKSLLFKL--NEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
++ L L EY+ R + + +LS ++ + ++ ++ + H +HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM-G 365
P+N LI+ G +KL DFGL++ T++N VV + Y P+VL G Y ++D
Sbjct: 129 PENFLIDASGHIKLTDFGLSKG----IVTYANSVVGSPDYMAPEVLRG-KGYDFTVDYWS 183
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425
+GC+ +E G P F GST + LK E PVY
Sbjct: 184 LGCMLYEFLCGFPPFSGSTPNETWE-----------NLKYWKETLQRPVYDD-------- 224
Query: 426 PEQMDSD-ALDLVQKFLMYDAKQRI-SAANAMRHPYFNSL 463
P SD A DL+ K + D +R S + HP+F +
Sbjct: 225 PRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPFFKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 70/285 (24%), Positives = 123/285 (43%), Gaps = 44/285 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + TD L A+K +K + ++ CT + L +H + LH
Sbjct: 5 KGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSC 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T+ L V EY+ DL ++ + + +++ GL + H R I++RDLK
Sbjct: 65 FQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFLHERGIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARA---KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
N+L++ G +K+ADFG+ + V T TF T Y P++L Y ++D
Sbjct: 124 LDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG---TPDYIAPEILSY-QPYGPAVDW 179
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
+G + +EM +G+ F G +DE L SIL Y
Sbjct: 180 WALGVLLYEMLAGQSPFEG---DDEDELFQSILEDE-------------VRY-------- 215
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISA-----ANAMRHPYFNSL 463
P + +A +++ FL + ++R+ + HP+F +
Sbjct: 216 --PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 38/106 (35%), Positives = 68/106 (64%), Gaps = 3/106 (2%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
++ Y KL+++ +GTY V++ + + T +VALK++K+E E EG P T++RE+++L +L+H
Sbjct: 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH 63
Query: 149 ANIVTLHDII--HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
NIVT+ +++ + +V EY+E DLK M+ + VK
Sbjct: 64 PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK 109
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-20
Identities = 64/238 (26%), Positives = 112/238 (47%), Gaps = 18/238 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
+G ++ V++ L VALK++++ + A I+E+ LL++L H N++ +
Sbjct: 12 RGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 71
Query: 250 HTEKCLTLVFEYLEK-DLK---RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ L +V E + DL ++ ++ V + QL L + HSRR++HRD
Sbjct: 72 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRD 131
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG 365
+KP N+ I G +KL D GL R S T + V T +Y P+ + + S
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILG----PP------PDELKSKLEFCITP 413
+GC+ +EM++ + F G + L +C + PP +EL+ + CI P
Sbjct: 192 LGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINP 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 8e-20
Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 39/240 (16%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE----KD-LKRYMDDCSNILSMNNVKL 284
E+ LL+ L+H IV + + ++ L++ EY+ KD LK Y L+ +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-----GALTETVTRK 108
Query: 285 FLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA-RAKSVPTK-TFSNEVV 342
+ Q+L G+ Y HS I+HRD+K N+L + G +KL DFG + R +++ + T V
Sbjct: 109 YTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 343 -TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400
T ++ P+V+ G Y D+ VGC EM + +P P + E + I I P
Sbjct: 169 GTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKP--PWAEFE-AMAAIFKIATQPT 224
Query: 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P PS + DA + +++ + +AK+R SA +RH +
Sbjct: 225 -----------NPQLPSH----------VSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-20
Identities = 57/191 (29%), Positives = 94/191 (49%), Gaps = 5/191 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA---NIVTLHDI 248
+G Y V++GK T +VALK I L+ + REV+LL +LR + NI +
Sbjct: 11 RGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGS 70
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
L ++ EY E R + I + + + + ++L L Y H ++HRD+K
Sbjct: 71 YLKGPRLWIIMEYAEGGSVRTLMKAGPI-AEKYISVIIREVLVALKYIHKVGVIHRDIKA 129
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
N+L+ G +KL DFG+A + + S V T ++ P+V+ Y T D+ +G
Sbjct: 130 ANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLG 189
Query: 368 CIFHEMSSGRP 378
+EM++G P
Sbjct: 190 ITIYEMATGNP 200
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 70/312 (22%), Positives = 121/312 (38%), Gaps = 75/312 (24%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR--EVSLLRELR----HAN---I 242
+G + V+ + + T + A+K ++ I+ +++ +R R A+ I
Sbjct: 11 RGAFGEVWLVRDKDTGQVYAMKVLR-------KSDMIKRNQIAHVRAERDILADADSPWI 63
Query: 243 VTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
V L+ E+ L LV EY+ DL + ++ + ++ +L+ L H
Sbjct: 64 VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 302 LHRDLKPQNLLINERGELKLADFGLA-----------------------------RAKSV 332
+HRD+KP N+LI+ G +KLADFGL R
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 333 PTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRL 391
++ V T Y P+VL G T Y D +G I +EM G P F T
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT------- 234
Query: 392 ICSILGPPPDELKSKL-EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS 450
E +K+ + + +P + + +A+DL+ + L D + R+
Sbjct: 235 --------LQETYNKIINWKESLRFPPDPPVS--------PEAIDLICRLLC-DPEDRLG 277
Query: 451 AA-NAMRHPYFN 461
+ HP+F
Sbjct: 278 SFEEIKSHPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 80/277 (28%), Positives = 117/277 (42%), Gaps = 36/277 (12%)
Query: 192 KGTYATVF---KGKSRLTDNLVALKEIKL-EHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG++ TV+ K+ + L LKEI + E A +E LL +L H IV H
Sbjct: 10 KGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHA 69
Query: 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCHSRRILH 303
++ EY E +DL +++ + LS N V + QLL G+ Y H RRILH
Sbjct: 70 SFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILH 129
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RDLK +N+ + + LK+ DFG++R + T +Y P+ L S S
Sbjct: 130 RDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDI 188
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPSESKLQ 422
+GCI +EM F G L ++ I+ GP P
Sbjct: 189 WSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPTPS--------------------- 224
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
PE ++Q L D R SAA +R+P+
Sbjct: 225 --LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-19
Identities = 64/233 (27%), Positives = 110/233 (47%), Gaps = 19/233 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
+G ++ V++ L VALK++++ + A ++E+ LL++L H N++ D
Sbjct: 12 RGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF 71
Query: 250 HTEKCLTLVFEYLEK-DLK---RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ L +V E + DL +Y ++ V + QL + + HSRR++HRD
Sbjct: 72 IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRD 131
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG 365
+KP N+ I G +KL D GL R S T + V T +Y P+ + + S
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
+GC+ +EM++ + F G D++ L L K+E C P P+E
Sbjct: 192 LGCLLYEMAALQSPFYG----DKMNLF---------SLCQKIEQCDYPPLPTE 231
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 67/241 (27%), Positives = 109/241 (45%), Gaps = 41/241 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLREL-RHANIVTLH--- 246
+GTY V+K + + T LVA+K + + +E I+ E ++LR+ H NI T +
Sbjct: 16 EGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 247 ---DIIHTEKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR 299
+ + L LV E DL + + L + L + LRGLAY H
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN 132
Query: 300 RILHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGST 356
+++HRD+K QN+L+ + E+KL DFG++ + TF + T ++ P+V+
Sbjct: 133 KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF---IGTPYWMAPEVIACDE 189
Query: 357 EYSTSIDM-------GVGCIFHEMSSGRPLF----PGSTIEDELRLICSILGPPPDELKS 405
+ S D G+ I E++ G+P P +R + I PP LKS
Sbjct: 190 QPDASYDARSDVWSLGITAI--ELADGKPPLCDMHP-------MRALFKIPRNPPPTLKS 240
Query: 406 K 406
Sbjct: 241 P 241
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 40/98 (40%), Positives = 63/98 (64%), Gaps = 13/98 (13%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
++ + + ++G+GTY V+K + + T LVALK+++L++E EG P TAIRE+ +LR+L H
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 149 ANIVTLHDIIHTEK-----------CLTLVFEYLEKDL 175
NIV L +I+ T+K LVFEY++ DL
Sbjct: 66 RNIVNLKEIV-TDKQDALDFKKDKGAFYLVFEYMDHDL 102
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 56/199 (28%), Positives = 104/199 (52%), Gaps = 7/199 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G + V + + LV +K+I +E + A E +L+ L H NI+ ++
Sbjct: 10 RGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL 69
Query: 251 TEKCLTLVFEYLEK-DLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+K L +V EY L Y+ C+++L + + F Q+L L + H++ ILHRDLK
Sbjct: 70 EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKT 129
Query: 309 QNLLINERGE-LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
QN+L+++ +K+ DFG+++ S +K ++ V T Y P+ L Y+ D+ +
Sbjct: 130 QNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPE-LCEGKPYNQKSDIWAL 187
Query: 367 GCIFHEMSSGRPLFPGSTI 385
GC+ +E++S + F + +
Sbjct: 188 GCVLYELASLKRAFEAANL 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 57/207 (27%), Positives = 103/207 (49%), Gaps = 6/207 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLRELRHANIVTLHDIIH 250
+G++ ++ K++ +KEI L A + EV LL +++H NIVT
Sbjct: 10 EGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ 69
Query: 251 TEKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
L +V EY + +KR + S + + + Q+ GL + H R+ILHRD+K
Sbjct: 70 ENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKS 129
Query: 309 QNLLINERGEL-KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
QN+ +++ G + KL DFG+AR + + V T +Y P++ + Y+ D+ +
Sbjct: 130 QNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEI-CQNRPYNNKTDIWSL 188
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLIC 393
GC+ +E+ + + F G+ + + IC
Sbjct: 189 GCVLYELCTLKHPFEGNNLHQLVLKIC 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 42/140 (30%), Positives = 78/140 (55%), Gaps = 9/140 (6%)
Query: 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLR 144
G ++ Y L KLG+GT+ V+K + T +VALK+I + +E +G P TA+RE+ +L+
Sbjct: 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILK 62
Query: 145 ELRHANIVTLHDII--------HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYA 196
+L+H N+V L D+ + +V Y++ DL +++ S L+ + +K
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 197 TVFKGKSRLTDNLVALKEIK 216
+ +G + L +N + ++IK
Sbjct: 123 QLLEGINYLHENHILHRDIK 142
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 1/95 (1%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 158
LG+G + TV+ + + T VA+K IK E +RE+ +L++L H NIV L+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 159 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVK 192
E L LV EY E LK + + LS + +
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL 95
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 6/89 (6%)
Query: 93 YFKLDKLGQGTYATVFKGKS--RLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRH 148
Y +G+GTY V+K K A+K+ K E G +A RE++LLREL+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 149 ANIVTLHDII--HTEKCLTLVFEYLEKDL 175
N+V+L ++ H +K + L+F+Y E DL
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDL 90
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 68/284 (23%), Positives = 113/284 (39%), Gaps = 42/284 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G A V+ + VA+K I LE + + +EV + + H N+V +
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70
Query: 252 EKCLTLVFEYLEK----DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
L LV YL D+ + L + L ++L+GL Y HS +HRD+K
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIK 129
Query: 308 PQNLLINERGELKLADFGLARAKSVPT-------KTFSNEVVTLWYRPPDVLLGSTEYST 360
N+L+ E G +K+ADFG++ + + KTF V T + P+V+ Y
Sbjct: 130 AGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF---VGTPCWMAPEVMEQVHGYDF 186
Query: 361 SIDM---GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP-VYP 416
D+ G+ I E+++G P S L+ ++ PP LE Y
Sbjct: 187 KADIWSFGITAI--ELATGAA--PYSKYPPMKVLMLTLQNDPPS-----LETGADYKKYS 237
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ ++ L D +R +A ++H +F
Sbjct: 238 KSFR--------------KMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 73/280 (26%), Positives = 117/280 (41%), Gaps = 49/280 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH-DIIH 250
KG++ V+K + T+ +VA+K I LE E +E+ L + R I + +
Sbjct: 11 KGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK 70
Query: 251 TEKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
K L ++ EY DL + L + L ++L GL Y H +HRD+
Sbjct: 71 GSK-LWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEGKIHRDI 124
Query: 307 KPQNLLINERGELKLADFGLA---RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
K N+L++E G++KLADFG++ + TF V T ++ P+V+ S Y D
Sbjct: 125 KAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF---VGTPFWMAPEVIKQS-GYDEKAD 180
Query: 364 ---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
+G+ I E++ G P P S + +R++ I P L
Sbjct: 181 IWSLGITAI--ELAKGEP--PLSDL-HPMRVLFLIPKNNPPSL----------------- 218
Query: 421 LQLLAPEQMDSDAL-DLVQKFLMYDAKQRISAANAMRHPY 459
S D V L D K+R SA ++H +
Sbjct: 219 -----EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 46/279 (16%)
Query: 192 KGTY--ATVFKGKSRLTDNLVALKEIKL-EHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG + AT+++ D+LV KE+ L E A+ E+ +L L+H NI+ ++
Sbjct: 10 KGAFGEATLYRRTE--DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 249 IHTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+ L + EY L + R + V +LFQ++ ++Y H ILH
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV--TLWYRPPDVLLGSTEYSTS 361
RD+K N+ + + G +KL DFG+ +K + ++ E V T +Y P++ G +Y+
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGI--SKILGSEYSMAETVVGTPYYMSPELCQG-VKYNFK 181
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCI-TPVYPSES 419
D+ +GC+ +E+ + + F + P L K+ TPV
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATN---------------PLNLVVKIVQGNYTPV----- 221
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
S+ + LV L D ++R +A + P
Sbjct: 222 ------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 41/102 (40%), Positives = 53/102 (51%), Gaps = 3/102 (2%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANI 151
Y L KLG G++ TV+K K + T +VA+K +K E TA RE+ +LR L H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 152 VTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVK 192
V L D + L LV EY E DL Y+ LS + K
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAK 101
|
Length = 260 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 71/271 (26%), Positives = 116/271 (42%), Gaps = 41/271 (15%)
Query: 222 GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNN 281
G T + E LL+ + H +++ + D + + +V + DL Y+ S L ++
Sbjct: 99 GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158
Query: 282 VKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEV 341
+ Q+L GL Y H++RI+HRD+K +N+ IN+ ++ + D G A+ V F
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA 217
Query: 342 VTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDE------------ 388
T+ P+V L +Y++ D+ G + EM + +P + ED
Sbjct: 218 GTVETNAPEV-LARDKYNSKADIWSAGIVLFEMLA----YPSTIFEDPPSTPEEYVKSCH 272
Query: 389 --LRLICSILGPPPDEL----KSKL-----EFCIT-----PVYPSESKLQLLAPEQMDSD 432
L I S L P+E S+L E+ YP ++ L P D
Sbjct: 273 SHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNL--PI----D 326
Query: 433 ALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
LV K L +DA R SA + +P F L
Sbjct: 327 GEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 71/283 (25%), Positives = 124/283 (43%), Gaps = 30/283 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G+YA V + + T+ + A+K +K E +E + + H +V LH
Sbjct: 5 RGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
TE L V EY+ DL +M L + + + ++ L Y H R I++RDLK
Sbjct: 65 FQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
N+L++ G +KL D+G+ + P T S T Y P++L G +Y S+D +
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWAL 182
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + EM +GR F I+G + ++ ++ + Q+ P
Sbjct: 183 GVLMFEMMAGRSPF-------------DIVGSSDNPDQNTEDYLFQVILEK----QIRIP 225
Query: 427 EQMDSDALDLVQKFLMYDAKQRISA------ANAMRHPYFNSL 463
+ A +++ FL D K+R+ A+ HP+F ++
Sbjct: 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 70/275 (25%), Positives = 124/275 (45%), Gaps = 34/275 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ VF + + T+ A+K +K + ++ CT + + L H + L+
Sbjct: 5 KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T++ L V EYL DL ++ C + + +++ GL + HS+ I++RDLK
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHIQSCHK-FDLPRATFYAAEIICGLQFLHSKGIVYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
N+L++ G +K+ADFG+ + + T Y P++LLG +Y+TS+D
Sbjct: 124 LDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSF 182
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM G+ F G DE L SI P P
Sbjct: 183 GVLLYEMLIGQSPFHG---HDEEELFQSIRMDNP-----------------------CYP 216
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMR-HPYF 460
+ +A D++ K + + ++R+ +R HP+F
Sbjct: 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 70/285 (24%), Positives = 121/285 (42%), Gaps = 39/285 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALK----EIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KGT+ V + + + A+K E+ + +E A + E +L+ RH + +L
Sbjct: 5 KGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVA--HTLTESRVLKNTRHPFLTSLKY 62
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T+ L V EY+ + + S + + + +++ L Y HS +I++RDLK
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLK 122
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
+NL++++ G +K+ DFGL + T T Y P+V L +Y ++D G+
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGL 181
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM GR F E LI L ++F P
Sbjct: 182 GVVMYEMMCGRLPFYNQDHEKLFELI----------LMEDIKF----------------P 215
Query: 427 EQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQ 466
+ +DA L+ L+ D +R+ A MRH +F + Q
Sbjct: 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 80/332 (24%), Positives = 137/332 (41%), Gaps = 53/332 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + T+ A+K +K + ++ CT + L H + L
Sbjct: 5 KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCT 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T++ L V EYL DL ++ + + +++ GL + H + I++RDLK
Sbjct: 65 FQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
N+L+++ G +K+ADFG+ + S T Y P++L G +Y+ S+D
Sbjct: 124 LDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSF 182
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM G+ F G EDE L SIL P + P
Sbjct: 183 GVLLYEMLIGQSPFHG---EDEDELFDSILND-------------RPHF----------P 216
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMR-HPYFNSLG--------------PQVHELS 471
+ +A D + K D +R+ +R HP+F + P+V S
Sbjct: 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPS 276
Query: 472 DTQSI---FSLPHIKLTSNPTDGGLLPFYGQK 500
D + F+ ++L+ P D LL Q+
Sbjct: 277 DASNFDREFTNEKVRLS--PVDKKLLASMDQE 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 71/293 (24%), Positives = 118/293 (40%), Gaps = 45/293 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG Y +V+K R T +A+KEI+LE +E I E+ +L + IV +
Sbjct: 11 KGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSM--NNVKLFLFQLLRGLAYCHSR-RILHRDLK 307
E + + EY++ L + + + ++ + +++GL + I+HRD+K
Sbjct: 71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK 130
Query: 308 PQNLLINERGELKLADFGLA--RAKSVPTKTFSNEVVTLWYRPPDVLLGST-----EYST 360
P N+L+N G++KL DFG++ S+ KT + Y P+ + Y+
Sbjct: 131 PTNVLVNGNGQVKLCDFGVSGNLVASL-AKT---NIGCQSYMAPERIKSGGPNQNPTYTV 186
Query: 361 SIDM-GVGCIFHEMSSGRPLFP---GSTIEDELRLICSILGPPPDELKSKLEFCITPVYP 416
D+ +G EM+ GR +P + I +L I G PP
Sbjct: 187 QSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT--------------- 229
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL-GPQVH 468
P DA D V K L +R + A + HP+ V
Sbjct: 230 --------LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 49/216 (22%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
KGTY V+ + T +A+KEI P E++L L+H NIV
Sbjct: 18 KGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV------- 68
Query: 251 TEKCLTLVFEYLEKDL-----KRYMDDC-----SNIL---------SMNNVKLFLFQLLR 291
+YL D K +M+ S +L + + + Q+L
Sbjct: 69 ---------QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 292 GLAYCHSRRILHRDLKPQNLLINE-RGELKLADFG----LARAKSVPTKTFSNEVVTLWY 346
GL Y H +I+HRD+K N+L+N G +K++DFG LA T+TF+ TL Y
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-TETFTG---TLQY 175
Query: 347 RPPDVL-LGSTEYSTSIDM-GVGCIFHEMSSGRPLF 380
P+V+ G Y D+ +GC EM++G+P F
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 193 GTYATVFK-GKSRLTDNLVALKEIKLEHEEGAPCTA---------IREVSLLRE-LRHAN 241
G + V+K K NL+ALKEI + + + EV++++E LRH N
Sbjct: 11 GAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN 70
Query: 242 IVTLHDIIHTEKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH 297
IV + L +V + +E + + + + + Q++ L Y H
Sbjct: 71 IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH 130
Query: 298 -SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST 356
+RI+HRDL P N+++ E ++ + DFGLA+ K P ++ V T+ Y P++ + +
Sbjct: 131 KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGTILYSCPEI-VKNE 188
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLF 380
Y D+ GCI ++M + +P F
Sbjct: 189 PYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 17/195 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALKEI----KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G++ V+ + T+ +VA+K++ K +E+ I+EV L++L+H N +
Sbjct: 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ--DIIKEVKFLQQLKHPNTIEYKGC 89
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E LV EY ++ L + L+GLAY HS ++HRD+K
Sbjct: 90 YLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKA 149
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE--YSTSID--- 363
N+L+ E G++KLADFG A +KS P +F V T ++ P+V+L E Y +D
Sbjct: 150 GNILLTEPGQVKLADFGSA-SKSSPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWS 205
Query: 364 MGVGCIFHEMSSGRP 378
+G+ CI E++ +P
Sbjct: 206 LGITCI--ELAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 24/274 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G + V+K K++ T L A K I+ + EE + E+ +L H IV L + +
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPYIVKLLGAFYWD 81
Query: 253 KCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
L ++ E+ + M + L+ +++ Q+L L Y HS +I+HRDLK N+
Sbjct: 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDMGVGCIF 370
L+ G++KLADFG++ AK+V T + + T ++ P+V++ T T D
Sbjct: 142 LLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI-- 198
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS-KLEFCITPVYPSESKLQLLAPEQM 429
S G L + IE PP EL ++ I P L P +
Sbjct: 199 --WSLGITLIEMAQIE-----------PPHHELNPMRVLLKIAKSEPP----TLSQPSKW 241
Query: 430 DSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ D ++ L + R SAA + HP+ +S+
Sbjct: 242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 13/216 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKL------EHEEGAPCTAIREVSLLRELRHANIVTL 245
+G++ KS+ +KEI + E EE + +EV++L ++H NIV
Sbjct: 10 EGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREE-----SRKEVAVLSNMKHPNIVQY 64
Query: 246 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNIL-SMNNVKLFLFQLLRGLAYCHSRRILH 303
+ L +V +Y E DL + ++ +L + + + Q+ L + H R+ILH
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RD+K QN+ + + G +KL DFG+AR + + + T +Y P++ + S
Sbjct: 125 RDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDI 184
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399
+GC+ +EM + + F +++ + I PP
Sbjct: 185 WALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 70/281 (24%), Positives = 116/281 (41%), Gaps = 37/281 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALK----EIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG++ V K + A+K + L+ +E A R V LL+ ++H +V LH
Sbjct: 5 KGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVGLHY 63
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L V +Y+ + + + ++ L Y HS I++RDLK
Sbjct: 64 SFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG-V 366
P+N+L++ +G + L DFGL + +KT S T Y P+VL Y ++D +
Sbjct: 124 PENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR-KQPYDRTVDWWCL 182
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM G P F D + +IL P L+L
Sbjct: 183 GAVLYEMLYGLPPFYS---RDTAEMYDNILNKP---------------------LRL--K 216
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMR----HPYFNSL 463
+ A L++ L D +R+ A + H +F+S+
Sbjct: 217 PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 73/289 (25%), Positives = 124/289 (42%), Gaps = 55/289 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-------EVSLLRELRHANIVT 244
KG Y TV+ G + L+A+K+++L+ A + EV LL+ L+H NIV
Sbjct: 10 KGAYGTVYCGLTN-QGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 245 LHDIIHTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR 299
+ +++ E+ + L R+ + + Q+L G+AY H+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK-----YTKQILDGVAYLHNN 121
Query: 300 RILHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTL----WYRPPDVLL 353
++HRD+K N+++ G +KL DFG AR A T SN + ++ ++ P+V+
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 354 GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSI---LGPPPDELKSKLEFC 410
S S +GC EM++G+P P +++ D L + I G P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKP--PLASM-DRLAAMFYIGAHRGLMPR--------- 229
Query: 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P+ + A+D V L D +R SA +RH +
Sbjct: 230 --------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-15
Identities = 86/331 (25%), Positives = 139/331 (41%), Gaps = 60/331 (18%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHD--II 249
G + VF K + T K I +E + EV+++REL+H NIV D +
Sbjct: 24 GRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNI---LSMNNVKLFLFQLLRGLAYCHS------- 298
+ L ++ E+ + DL R + C + + + + QLL LAYCH+
Sbjct: 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNG 143
Query: 299 RRILHRDLKPQNLL-----------------INERGELKLADFGLARAKSVPTKTFSNEV 341
R+LHRDLKPQN+ +N R K+ DFGL++ + + S V
Sbjct: 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSC-V 202
Query: 342 VTLWYRPPDVLLGSTE-YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399
T +Y P++LL T+ Y DM +GCI +E+ SG+ F + +L
Sbjct: 203 GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQL---------- 252
Query: 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
ELK + P+ +L + L++ L AK+R SA + +
Sbjct: 253 ISELKRGPDL---PIKGKSKELNI------------LIKNLLNLSAKERPSALQCLGYQI 297
Query: 460 FNSLGPQVHELSDTQSIFSLPHIKLT-SNPT 489
++GP V + + P + NP+
Sbjct: 298 IKNVGPPVGAAGGGAGVAAAPGAVVARRNPS 328
|
Length = 1021 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 3/160 (1%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLRELRHANIVTLHDIIHT 251
GTY V+K ++ T L A+K IKLE G + I+ E+ +++E +H NIV +
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+ L + EY + + + LS + + L+GLAY HS+ +HRD+K N+
Sbjct: 78 REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI 137
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDV 351
L+ + G++KLADFG+A + + + T ++ P+V
Sbjct: 138 LLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 49/245 (20%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-----KDLKRYMDDCSNILSMNNVKL 284
E ++L ++H IV L T L L+ EYL L+R I +
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER-----EGIFMEDTACF 104
Query: 285 FLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEV 341
+L ++ L + H + I++RDLKP+N+L++ +G +KL DFGL + + T TF
Sbjct: 105 YLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCG-- 162
Query: 342 VTLWYRPPDVLLGSTEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400
T+ Y P++L+ S + ++D +G + ++M +G P F T E+ + I I
Sbjct: 163 -TIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPF---TAENRKKTIDKI----- 212
Query: 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAM 455
LK KL P Y L PE A DL++K L + R+ AA
Sbjct: 213 --LKGKL---NLPPY--------LTPE-----ARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254
Query: 456 RHPYF 460
HP+F
Sbjct: 255 SHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 74/286 (25%), Positives = 123/286 (43%), Gaps = 51/286 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREV-SLLRE---------LRHAN 241
+G + V + + T L A+K +K A EV SL+ E RH
Sbjct: 9 RGHFGKVLLAEYKKTGELYAIKALKKGD-----IIARDEVESLMCEKRIFETANSERHPF 63
Query: 242 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
+V L TE + V EY DL ++ ++ S + ++ GL Y H +
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK 121
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
I++RDLK NLL++ G +K+ADFGL + S T + P+VL T Y+
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE-TSYTR 180
Query: 361 SID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
++D G+G + +EM G FPG +DE + SI+ DE Y
Sbjct: 181 AVDWWGLGVLIYEMLVGESPFPG---DDEEEVFDSIVN---DE----------VRY---- 220
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYF 460
P + +A+ ++++ L + ++R+ A + + P+F
Sbjct: 221 ------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKE-----IKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
KG + V + R T + A K+ IK E A+ E +L ++ +V+L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEA---MALNEKQILEKVNSRFVVSLA 66
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHR 304
T+ L LV + DLK ++ + N + ++ GL H RI++R
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYR 126
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
DLKP+N+L+++ G ++++D GLA + +T V T+ Y P+V + + Y+ S D
Sbjct: 127 DLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEV-VKNERYTFSPDW 184
Query: 365 -GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
G+GC+ +EM G+ F + K K E V + +
Sbjct: 185 WGLGCLIYEMIEGKSPFRQR------------------KEKVKREEVERRVKEDQEEYS- 225
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
E+ A + ++ L D R+ A HP+F +
Sbjct: 226 ---EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 68/269 (25%), Positives = 115/269 (42%), Gaps = 22/269 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G + V+K +++ T L A K I + EE + E+ +L H NIV L D + E
Sbjct: 16 GAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYE 74
Query: 253 KCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
L ++ E+ + M + L+ +++ Q L L Y H +I+HRDLK N+
Sbjct: 75 NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFH 371
L G++KLADFG++ + + + + T ++ P+V++ T D
Sbjct: 135 LFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV--- 191
Query: 372 EMSSGRPLFPGSTIEDELRLICSILGPPPDELKS-KLEFCITPVYPSESKLQLLAPEQMD 430
S G L + IE PP EL ++ I P L P +
Sbjct: 192 -WSLGITLIEMAQIE-----------PPHHELNPMRVLLKIAKSEPP----TLAQPSRWS 235
Query: 431 SDALDLVQKFLMYDAKQRISAANAMRHPY 459
S+ D ++K L + R + ++HP+
Sbjct: 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 47/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE----HEEGAPCTAIREVSLLRELRHANIVTLHD 247
KGT+ V + + T A+K +K E +E A + E +L+ RH + L
Sbjct: 5 KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVA--HTLTESRVLQNTRHPFLTALKY 62
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
T L V EY +L ++ + S + + + +++ L Y HS +++RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 307 KPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
K +NL++++ G +K+ DFGL + + KTF T Y P+V L +Y ++D
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG---TPEYLAPEV-LEDNDYGRAVD 177
Query: 364 -MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
G+G + +EM GR F E LI L ++ F
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELI----------LMEEIRF------------- 214
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P + +A L+ L D KQR+ A M H +F S+
Sbjct: 215 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 45/141 (31%), Positives = 73/141 (51%), Gaps = 6/141 (4%)
Query: 193 GTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + +V KG + VA+K +K EH +RE S++ +L H IV L +
Sbjct: 6 GNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVC 65
Query: 250 HTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E L LV E L +Y+ I ++++K Q+ G+AY S+ +HRDL
Sbjct: 66 KGEP-LMLVMELAPLGPLLKYLKKRREI-PVSDLKELAHQVAMGMAYLESKHFVHRDLAA 123
Query: 309 QNLLINERGELKLADFGLARA 329
+N+L+ R + K++DFG++RA
Sbjct: 124 RNVLLVNRHQAKISDFGMSRA 144
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 62/198 (31%), Positives = 97/198 (48%), Gaps = 18/198 (9%)
Query: 193 GTYATVFKGKSRLTDNLVALKEI----KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G++ V+ + T+ +VA+K++ K +E+ I+EV L++LRH N +
Sbjct: 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ--DIIKEVRFLQQLRHPNTIEYKGC 83
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E LV EY ++ L + L+GLAY HS +HRD+K
Sbjct: 84 YLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKA 143
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE--YSTSID--- 363
N+L+ E G +KLADFG A S P +F V T ++ P+V+L E Y +D
Sbjct: 144 GNILLTEPGTVKLADFGSASLVS-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWS 199
Query: 364 MGVGCIFHEMSSGR-PLF 380
+G+ CI E++ + PLF
Sbjct: 200 LGITCI--ELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 6e-15
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 16/216 (7%)
Query: 206 TDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIHTEKCLTL-VFEYL 262
T + VA+K ++ + E A RE +L L H NIV L D L VFEY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 263 EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG---EL 319
R + L + Q+L LA H++ I+HRDLKPQN+++++ G
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 320 KLADFGL------ARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDMGVGCIFHE 372
K+ DFG+ R V T T + EV+ T Y P+ L G S G IF E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 373 MSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408
+G+ + G+++ + ++ L P L +
Sbjct: 182 CLTGQRVVQGASVAE---ILYQQLSPVDVSLPPWIA 214
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 60/240 (25%), Positives = 110/240 (45%), Gaps = 17/240 (7%)
Query: 184 NILSMNNV-KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 242
I+ ++ + +G +V K + + T + ALK I + +RE+ + + + I
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 243 VTLHDIIHTEK--CLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAY 295
V + E + + EY L+ K+ + + + +L+GL+Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK-VKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTFSNEVVTLWYRPPDVLLG 354
HSR+I+HRD+KP N+L+ +G++KL DFG++ + TF+ T +Y P+ + G
Sbjct: 121 LHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMAPERIQG 177
Query: 355 STEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIED--ELRLICSILGPPPDELKSKLEFCI 411
YS + D+ +G E++ R FP + L+ I+ P ELK + I
Sbjct: 178 KP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGI 236
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 7e-15
Identities = 50/175 (28%), Positives = 81/175 (46%), Gaps = 8/175 (4%)
Query: 206 TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE--KCLTLVFEYLE 263
T VA+K +K E +E+ +LR L H NIV I + + L+ E+L
Sbjct: 32 TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 264 K-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322
LK Y+ N +++ + Q+ +G+ Y SR+ +HRDL +N+L+ ++K+
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 151
Query: 323 DFGLARA----KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEM 373
DFGL +A K T + WY P+ L+ S Y S G +E+
Sbjct: 152 DFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 55/199 (27%), Positives = 89/199 (44%), Gaps = 13/199 (6%)
Query: 192 KGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V + + VA+K + EE RE+ +LR L H NIV
Sbjct: 14 EGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKG 73
Query: 248 IIH--TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ + L L+ EYL L+ Y+ + +++ + LF Q+ +G+ Y S+R +HR
Sbjct: 74 VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHR 133
Query: 305 DLKPQNLLINERGELKLADFGLARA----KSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
DL +N+L+ +K++DFGLA+ K E WY P+ L S S
Sbjct: 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRTSKFSSA 192
Query: 361 SIDMGVGCIFHEM-SSGRP 378
S G +E+ + G P
Sbjct: 193 SDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 18/216 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G VFK + + ++A K I LE + IRE+ +L E IV + +++
Sbjct: 16 GNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75
Query: 253 KCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDL 306
+++ E+ L++ LK+ IL ++ + ++GL Y + +I+HRD+
Sbjct: 76 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV-----IKGLTYLREKHKIMHRDV 130
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM- 364
KP N+L+N RGE+KL DFG++ + +N V T Y P+ L G T YS D+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQG-THYSVQSDIW 186
Query: 365 GVGCIFHEMSSGR-PLFPGSTIEDELRLICSILGPP 399
+G EM+ GR P+ P E EL C + G P
Sbjct: 187 SMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDP 222
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 8e-15
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 39/281 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG++ V + + R T + ALK I+ H + E ++L ++ IV L
Sbjct: 3 KGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF 62
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ + L LV ++ + ++ + + +LL L H +++RDLKP+
Sbjct: 63 QSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPE 122
Query: 310 NLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MG 365
N+L++ +G + L DFGL + T TF T Y P++LLG Y+ ++D
Sbjct: 123 NILLDYQGHIALCDFGLCKLNMKDDDKTNTFCG---TPEYLAPELLLGHG-YTKAVDWWT 178
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425
+G + +EM +G P F + + R I L+ L F
Sbjct: 179 LGVLLYEMLTGLPPFYDENVNEMYRKI----------LQEPLRF---------------- 212
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAM---RHPYFNSL 463
P+ D DA DL+ L D +R+ A HP+F+ L
Sbjct: 213 PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 39/285 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALK----EIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KGT+ V + + T A+K E+ + +E A + E +L+ RH + L
Sbjct: 5 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA--HTVTESRVLQNTRHPFLTALKY 62
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L V EY + + + + + +++ L Y HSR +++RD+K
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIK 122
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
+NL++++ G +K+ DFGL + T T Y P+V L +Y ++D G+
Sbjct: 123 LENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWWGL 181
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM GR F E LI L ++ F P
Sbjct: 182 GVVMYEMMCGRLPFYNQDHERLFELI----------LMEEIRF----------------P 215
Query: 427 EQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQ 466
+ +A L+ L D KQR+ A M H +F S+ Q
Sbjct: 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 1e-14
Identities = 31/83 (37%), Positives = 49/83 (59%), Gaps = 1/83 (1%)
Query: 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 156
+LG GT+ +V+ +++ T LVA+K++K + C +REV LR+L H NIV L +
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 157 IIHTEKCLTLVFEYLEKDLKRYM 179
+ L VFEY+E +L + M
Sbjct: 66 VFRENDELYFVFEYMEGNLYQLM 88
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 34/122 (27%), Positives = 62/122 (50%), Gaps = 3/122 (2%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKD--LK 267
VA+K +K + ++E +++ L H N++ L+ ++ T L +V E L
Sbjct: 26 VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLD 84
Query: 268 RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327
R D ++ + + Q+ G+ Y S+R +HRDL +N+L+ ++K+ DFGL
Sbjct: 85 RLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
Query: 328 RA 329
RA
Sbjct: 145 RA 146
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 14/217 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG++ VFKG T +VA+K I LE E +E+++L + + +
Sbjct: 14 KGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73
Query: 252 EKCLTLVFEYL----EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
L ++ EYL DL R + + L ++L+GL Y HS + +HRD+K
Sbjct: 74 GTKLWIIMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDMGV 366
N+L++E+G++KLADFG+A + T+ N V T ++ P+V+ S S + +
Sbjct: 129 AANVLLSEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 187
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403
G E++ G P P S + +R++ I P L
Sbjct: 188 GITAIELAKGEP--PNSDMH-PMRVLFLIPKNNPPTL 221
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 67/276 (24%), Positives = 117/276 (42%), Gaps = 29/276 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G TV+ T VA+K++ L+ + I E+ ++RE +H NIV D
Sbjct: 29 QGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI-INEILVMRENKHPNIVNYLDSYLV 87
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
L +V EYL L + + + + + L+ L + HS +++HRD+K N
Sbjct: 88 GDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDN 145
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
+L+ G +KL DFG + S V T ++ P+V+ Y +D+ +G +
Sbjct: 146 ILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIM 204
Query: 370 FHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQM 429
EM G P + E+ LR + I + +L PE++
Sbjct: 205 AIEMVEGEPPYLN---ENPLRALYLI--------------------ATNGTPELQNPEKL 241
Query: 430 DSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ D + + L D ++R SA ++HP+ P
Sbjct: 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 74/284 (26%), Positives = 121/284 (42%), Gaps = 38/284 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V + + T + A K++ K + A+ E +L ++ IV+L
Sbjct: 3 KGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF 62
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T+ L LV + DLK ++ + + Q++ GL + H RRI++RDLK
Sbjct: 63 ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
P+N+L+++ G ++++D GLA K T Y P+VL G Y S+D +
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKI-KGRAGTPGYMAPEVLQGE-VYDFSVDWFAL 180
Query: 367 GCIFHEMSSGRPLFP--GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
GC +EM +GR F +E E ELK + +
Sbjct: 181 GCTLYEMIAGRSPFRQRKEKVEKE-------------ELKRR-------TLEMAVEY--- 217
Query: 425 APEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P++ +A DL + L D ++R+ SA HP F L
Sbjct: 218 -PDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 77/293 (26%), Positives = 124/293 (42%), Gaps = 72/293 (24%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIK---------LEHEEGAPCTAIREVSLLRELRHANIV 243
G++ V K + T A+K +K ++H +E S+L EL H IV
Sbjct: 29 GSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-------VAQEKSILMELSHPFIV 81
Query: 244 TLHDIIHTEKCLTLVFEYLE--------KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAY 295
+ E + + E++ + R+ +D + K + +L+ Y
Sbjct: 82 NMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA--------KFYHAELVLAFEY 133
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS 355
HS+ I++RDLKP+NLL++ +G +K+ DFG AK VP +TF+ T Y P+V + S
Sbjct: 134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGF--AKKVPDRTFT-LCGTPEYLAPEV-IQS 189
Query: 356 TEYSTSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412
+ ++D MGV + +E +G P F T R+ IL
Sbjct: 190 KGHGKAVDWWTMGV--LLYEFIAGYPPFFDDT---PFRIYEKIL---------------- 228
Query: 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-----ANAMRHPYF 460
+L+ P D A DLV+ L D +R+ A+ HPYF
Sbjct: 229 -----AGRLKF--PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 56/188 (29%), Positives = 94/188 (50%), Gaps = 3/188 (1%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG++ VFKG T +VA+K I LE E +E+++L + + +
Sbjct: 14 KGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 73
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+ L ++ EYL + + L + L ++L+GL Y HS + +HRD+K N+
Sbjct: 74 DTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDMGVGCIF 370
L++E GE+KLADFG+A + T+ N V T ++ P+V+ S S + +G
Sbjct: 133 LLSEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITA 191
Query: 371 HEMSSGRP 378
E++ G P
Sbjct: 192 IELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 40/125 (32%), Positives = 61/125 (48%), Gaps = 1/125 (0%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANI 151
Y L ++G+G + VFK K R T VALK++ L E G P A+RE+ L+ +H +
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 152 VTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVA 211
V L D+ LV EY+ DL + D L VK + KG + + N +
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIM 121
Query: 212 LKEIK 216
+++K
Sbjct: 122 HRDLK 126
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 64/243 (26%), Positives = 106/243 (43%), Gaps = 46/243 (18%)
Query: 230 EVSLLRELRHANIVTLHDII--HTEKCLTLVFEYL-----EKDLKRYMDDCSNILSMNNV 282
E+ LL+ L+H IV + + EK LT+ EY+ + LK Y L+ +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-----GALTESVT 108
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV 342
+ + Q+L G++Y HS I+HRD+K N+L + G +KL DFG +K + T S +
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG--ASKRLQTICMSGTGI 166
Query: 343 -----TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
T ++ P+V+ G Y D+ +GC EM + +
Sbjct: 167 RSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEK------------------- 206
Query: 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456
PP E ++ P+ +L P + A D + + +A+ R SA +R
Sbjct: 207 -PPWAEYEAMAAIFKIATQPTNPQL----PSHISEHARDFLGCIFV-EARHRPSAEELLR 260
Query: 457 HPY 459
HP+
Sbjct: 261 HPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 7/194 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG++ V K + + A+K ++ L+ +E A R V LL+ L+H +V LH
Sbjct: 5 KGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVGLHY 63
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T + L V +Y+ + + + ++ + Y HS I++RDLK
Sbjct: 64 SFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG-V 366
P+N+L++ +G + L DFGL + P +T S T Y P+V L Y ++D +
Sbjct: 124 PENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV-LRKEPYDRTVDWWCL 182
Query: 367 GCIFHEMSSGRPLF 380
G + +EM G P F
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 65/251 (25%), Positives = 105/251 (41%), Gaps = 63/251 (25%)
Query: 242 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILS------MNNVKLFLFQLLRGLAY 295
+V++ T++ L +V EY+E DC+ +L ++ +++ + + L Y
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGG------DCATLLKNIGALPVDMARMYFAETVLALEY 116
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLARAK-------------SVPTKTFSNEVV 342
H+ I+HRDLKP NLLI G +KL DFGL++ T+ F ++ V
Sbjct: 117 LHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV 176
Query: 343 --TLWYRPPDVLLGSTEYSTSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICS--I 395
T Y P+V+L Y +D MG+ I +E G F G T E+ + S I
Sbjct: 177 CGTPEYIAPEVIL-RQGYGKPVDWWAMGI--ILYEFLVGCVPFFGDTPEELFGQVISDDI 233
Query: 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI---SAA 452
P D E + +DA DL+ + L + +R+ A
Sbjct: 234 EWPEGD-------------------------EALPADAQDLISRLLRQNPLERLGTGGAF 268
Query: 453 NAMRHPYFNSL 463
+H +F L
Sbjct: 269 EVKQHRFFLGL 279
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 2e-14
Identities = 56/193 (29%), Positives = 94/193 (48%), Gaps = 13/193 (6%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAP--CTAIREVSLLRELRHANIVTLHDIIH 250
G++ V+ + T+ +VA+K++ ++ I+EV L+ ++H N +
Sbjct: 36 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
E LV EY ++ L + L+GLAY HS ++HRD+K N
Sbjct: 96 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGN 155
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE--YSTSID---MG 365
+L+ E G++KLADFG A S P +F V T ++ P+V+L E Y +D +G
Sbjct: 156 ILLTEPGQVKLADFGSASIAS-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 211
Query: 366 VGCIFHEMSSGRP 378
+ CI E++ +P
Sbjct: 212 ITCI--ELAERKP 222
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 10/210 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK---LEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + TD L A+K +K + ++ CT + + L + + LH
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC 69
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L V EY+ DL ++ + V + ++ GL + HS+ I++RDLK
Sbjct: 70 FQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHSKGIIYRDLK 128
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
N++++ G +K+ADFG+ + KT T Y P+++ Y S+D
Sbjct: 129 LDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA-YQPYGKSVDWWAF 187
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
G + +EM +G+P F G EDE L SI+
Sbjct: 188 GVLLYEMLAGQPPFDG---EDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 31/273 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIH 250
KG+Y V + R +K++ L + A +E LL +L+H NIV +
Sbjct: 10 KGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE 69
Query: 251 TEKC-LTLVFEYLEK-DL-KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
E L +V + E DL + + +L N V + Q+ L Y H + ILHRDLK
Sbjct: 70 GEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLK 129
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
QN+ + +K+ D G+AR S + T +Y P+ L + Y+ D+ +
Sbjct: 130 TQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWAL 188
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
GC +EM++ + F +D L+ I+ E KL + P
Sbjct: 189 GCCVYEMATLKHAF---NAKDMNSLVYRII---------------------EGKLPPM-P 223
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
+ + +L+ L ++R S + +R PY
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 1/91 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHA 149
Y L +G+G Y V K +++ T +VA+K+ K + E TA+REV +LR+LRH
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMD 180
NIV L + + L LVFEY+E+ L ++
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLE 91
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 75/287 (26%), Positives = 117/287 (40%), Gaps = 43/287 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH----AN---IVT 244
+G + V + + T ++ A+K +K + A VS E R +N I
Sbjct: 11 RGHFGEVQVVREKATGDIYAMKVMK-----KSVLLAQETVSFFEEERDILSISNSPWIPQ 65
Query: 245 LHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
L + L LV EY DL ++ + + + +L +L+ + H +H
Sbjct: 66 LQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH 125
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLL-----GSTE 357
RD+KP+N+LI+ G +KLADFG A + S V T Y P+VL G
Sbjct: 126 RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGT 185
Query: 358 YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYP 416
Y D +G I +EM GR F T I + + L+F P
Sbjct: 186 YGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN--------FQRFLKF------P 231
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ K+ SD LDL+Q L+ K+R+ HP+F+ +
Sbjct: 232 EDPKVS--------SDFLDLIQS-LLCGQKERLGYEGLCCHPFFSKI 269
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 75/265 (28%), Positives = 124/265 (46%), Gaps = 47/265 (17%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDII-- 249
GTY V+KG+ T L A+K + + +E E+++L++ H NI T +
Sbjct: 27 GTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKL--EINMLKKYSHHRNIATYYGAFIK 84
Query: 250 -----HTEKCLTLVFEY--------LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYC 296
H ++ L LV E+ L K+ K N L + + ++LRGLA+
Sbjct: 85 KSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTK------GNALKEDWIAYICREILRGLAHL 137
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL--- 353
H+ +++HRD+K QN+L+ E E+KL DFG++ + + T ++ P+V+
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 197
Query: 354 ---GSTEYSTSI-DMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK--- 406
+ +Y + I +G+ I EM+ G P P + +R + I PP +LKSK
Sbjct: 198 NPDATYDYRSDIWSLGITAI--EMAEGAP--PLCDMH-PMRALFLIPRNPPPKLKSKKWS 252
Query: 407 ------LEFCITPVYPSE-SKLQLL 424
+E C+ Y S S QLL
Sbjct: 253 KKFIDFIEGCLVKNYLSRPSTEQLL 277
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 82/290 (28%), Positives = 132/290 (45%), Gaps = 43/290 (14%)
Query: 198 VFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 257
V K R + ++A K I LE + IRE+ +L E IV + +++ +++
Sbjct: 17 VTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISI 76
Query: 258 VFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR-ILHRDLKPQNL 311
E+ L++ LK+ NIL ++ + LRGL Y + I+HRD+KP N+
Sbjct: 77 CMEHMDGGSLDQVLKKAGRIPENILGKISIAV-----LRGLTYLREKHKIMHRDVKPSNI 131
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSID---MGVG 367
L+N RGE+KL DFG++ + +N V T Y P+ L G T Y+ D +G+
Sbjct: 132 LVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLS 187
Query: 368 CIFHEMSSGR-PLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK-----L 421
+ EM+ GR P+ P E E ++ G P E ++K +P +S
Sbjct: 188 LV--EMAIGRYPIPPPDAKELE-----AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIF 240
Query: 422 QLLA------PEQMDSDAL-----DLVQKFLMYDAKQRISAANAMRHPYF 460
+LL P ++ S A D V K L + K+R +HP+
Sbjct: 241 ELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + TD L A+K +K + ++ CT + + L + + + LH
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC 69
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L V EY+ DL ++ V + ++ GL + H R I++RDLK
Sbjct: 70 FQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV-FYAAEISVGLFFLHRRGIIYRDLK 128
Query: 308 PQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
N++++ G +K+ADFG+ + V T+TF T Y P++ + Y S+D
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCG---TPDYIAPEI-IAYQPYGKSVDW 184
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
G + +EM +G+P F G EDE L SI+
Sbjct: 185 WAYGVLLYEMLAGQPPFDG---EDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-14
Identities = 66/278 (23%), Positives = 126/278 (45%), Gaps = 34/278 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + A+K +K + ++ CT + + L + + L+
Sbjct: 5 KGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCT 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T++ L V E+L DL ++ D + + +++ GL + HS+ I++RDLK
Sbjct: 65 FQTKEHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
N++++ G +K+ADFG+ + S T Y P++L G +Y+ S+D
Sbjct: 124 LDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG-LKYTFSVDWWSF 182
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM G+ F G +DE L SI +++ TP Y P
Sbjct: 183 GVLLYEMLIGQSPFHG---DDEDELFESI----------RVD---TPHY----------P 216
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMR-HPYFNSL 463
+ ++ D+++K D +R+ +R HP+F ++
Sbjct: 217 RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 21/157 (13%)
Query: 193 GTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
G + V+KG+ RL+ VA+K +K E +E L+ +L+H NIV L
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLG 75
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYM---------------DDCSNILSMNNVKLFLFQLLR 291
+ E+ ++FEYL DL ++ + + L ++ Q+
Sbjct: 76 VCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAA 135
Query: 292 GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
G+ Y S +HRDL +N L+ E +K++DFGL+R
Sbjct: 136 GMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + V++G + VA+K +K L+ ++ +EV L+ LRH ++++L +
Sbjct: 17 GYFGEVWEGLWK-NRVRVAIKILKSDDLLKQQDFQ-----KEVQALKRLRHKHLISLFAV 70
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ + ++ E +EK L ++ +L + ++ Q+ G+AY + +HRDL
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDL 130
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-G 365
+N+L+ E K+ADFGLAR S++ + + P+ +ST D+
Sbjct: 131 AARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEA-ASHGTFSTKSDVWS 189
Query: 366 VGCIFHEMSS-GRPLFPGSTIEDELRLI 392
G + +EM + G+ +PG + I
Sbjct: 190 FGILLYEMFTYGQVPYPGMNNHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 16/213 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + TD L A+K +K + ++ CT + + L + + LH
Sbjct: 10 KGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSC 69
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L V EY+ DL + + V + ++ GL + HS+ I++RDLK
Sbjct: 70 FQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAV-FYAAEIAIGLFFLHSKGIIYRDLK 128
Query: 308 PQNLLINERGELKLADFGLARAK---SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
N++++ G +K+ADFG+ + V TKTF T Y P++ + Y S+D
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG---TPDYIAPEI-IAYQPYGKSVDW 184
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
G + +EM +G+ F G EDE L SI+
Sbjct: 185 WAFGVLLYEMLAGQAPFEG---EDEDELFQSIM 214
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 13/193 (6%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAP--CTAIREVSLLRELRHANIVTLHDIIH 250
G++ V+ + +VA+K++ ++ I+EV L++LRH N +
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
E LV EY ++ L + L+GLAY HS ++HRD+K N
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE--YSTSID---MG 365
+L++E G +KL DFG A + P F V T ++ P+V+L E Y +D +G
Sbjct: 146 ILLSEPGLVKLGDFGSASIMA-PANXF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLG 201
Query: 366 VGCIFHEMSSGRP 378
+ CI E++ +P
Sbjct: 202 ITCI--ELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 8e-14
Identities = 44/132 (33%), Positives = 72/132 (54%), Gaps = 7/132 (5%)
Query: 206 TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLE 263
T +VA+K +K E + +E+++L+ L H NIV K L L+ EY+
Sbjct: 32 TGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 264 -KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322
L+ Y+ + L++ + LF Q+ G+AY HS+ +HRDL +N+L++ +K+
Sbjct: 92 LGSLRDYLP--KHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIG 149
Query: 323 DFGLARAKSVPT 334
DFGL AK+VP
Sbjct: 150 DFGL--AKAVPE 159
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 9e-14
Identities = 71/247 (28%), Positives = 113/247 (45%), Gaps = 47/247 (19%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL-----KRYMDDCSNILSMNNVK 283
E +L E+ H IV LH TE L L+ ++L DL K M + +VK
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM------FTEEDVK 101
Query: 284 LFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTFSNEVV 342
+L +L L + HS I++RDLKP+N+L++E G +KL DFGL++ + K +S
Sbjct: 102 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF-CG 160
Query: 343 TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401
T+ Y P+V + ++ S D G + EM +G F G ++ + +I
Sbjct: 161 TVEYMAPEV-VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI--------- 210
Query: 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA-----NAMR 456
LK+KL Q L+PE A L++ + R+ A R
Sbjct: 211 -LKAKL-----------GMPQFLSPE-----AQSLLRALFKRNPANRLGAGPDGVEEIKR 253
Query: 457 HPYFNSL 463
HP+F+++
Sbjct: 254 HPFFSTI 260
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 9e-14
Identities = 69/277 (24%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G TVF T VA+K+I L+ + I E+ +++EL++ NIV D
Sbjct: 29 QGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI-INEILVMKELKNPNIVNFLDSFLV 87
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLF--QLLRGLAYCHSRRILHRDLKPQ 309
L +V EYL + D M+ ++ + L+ L + H+ +++HRD+K
Sbjct: 88 GDELFVVMEYLAGG---SLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSD 144
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
N+L+ G +KL DFG + S V T ++ P+V+ Y +D+ +G
Sbjct: 145 NVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGI 203
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ EM G P + E+ LR + I EL++ PE+
Sbjct: 204 MAIEMVEGEPPYLN---ENPLRALYLIATNGTPELQN--------------------PEK 240
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ D + + L D ++R SA ++HP+ P
Sbjct: 241 LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 63/243 (25%), Positives = 108/243 (44%), Gaps = 46/243 (18%)
Query: 230 EVSLLRELRHANIVTLHDII--HTEKCLTLVFEYL-----EKDLKRYMDDCSNILSMNNV 282
E+ LL+ LRH IV + + EK L++ EY+ + LK Y L+ N
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-----GALTENVT 108
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV 342
+ + Q+L+G++Y HS I+HRD+K N+L + G +KL DFG +K + T S +
Sbjct: 109 RRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG--ASKRIQTICMSGTGI 166
Query: 343 -----TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396
T ++ P+V+ G Y D+ V C EM + +
Sbjct: 167 KSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEK------------------- 206
Query: 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456
PP E ++ P++ L P+ + D +++ + + K+R +A +R
Sbjct: 207 -PPWAEYEAMAAIFKIATQPTKPML----PDGVSDACRDFLKQ-IFVEEKRRPTAEFLLR 260
Query: 457 HPY 459
HP+
Sbjct: 261 HPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 53/202 (26%), Positives = 93/202 (46%), Gaps = 6/202 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + TD + A+K +K + ++ CT + L +H + LH
Sbjct: 5 KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCC 64
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
T+ L V EY+ + S + + ++ L + H +++RDLK
Sbjct: 65 FQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKL 124
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGVG 367
N+L++ G KLADFG+ + + T + T Y P++ L EY S+D +G
Sbjct: 125 DNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI-LQELEYGPSVDWWALG 183
Query: 368 CIFHEMSSGRPLFPGSTIEDEL 389
+ +EM +G+P F ED+L
Sbjct: 184 VLMYEMMAGQPPFEADN-EDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 44/137 (32%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELR---H 148
Y + ++G G Y TV+K + + + VALK ++++ +E+G P + +REV+LL+ L H
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61
Query: 149 ANIVTLHDIIHT-----EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKGTYATVFKGK 202
NIV L D+ T E +TLVFE++++DL+ Y+D L +K +G
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 203 SRLTDNLVALKEIKLEH 219
L N + +++K E+
Sbjct: 122 DFLHANCIVHRDLKPEN 138
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 16/193 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G TV+K LT ++A+K I L+ + E+ +L + I+ + E
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE 71
Query: 253 KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+++ E+++ L Y ++L V + ++GL Y S +ILHRD+KP N+
Sbjct: 72 NRISICTEFMDGGSLDVYRKIPEHVLGRIAVAV-----VKGLTYLWSLKILHRDVKPSNM 126
Query: 312 LINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
L+N RG++KL DFG++ S+ KT+ V T Y P+ + G +Y D+ +G
Sbjct: 127 LVNTRGQVKLCDFGVSTQLVNSI-AKTY---VGTNAYMAPERISGE-QYGIHSDVWSLGI 181
Query: 369 IFHEMSSGRPLFP 381
F E++ GR FP
Sbjct: 182 SFMELALGR--FP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 53/194 (27%), Positives = 89/194 (45%), Gaps = 7/194 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG++ V + + + A+K ++ L+ +E + R V LL+ ++H +V LH
Sbjct: 5 KGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGLHF 63
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L V +Y+ Y + + ++ L Y HS I++RDLK
Sbjct: 64 SFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG-V 366
P+N+L++ +G + L DFGL + T S T Y P+V L Y ++D +
Sbjct: 124 PENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV-LHKQPYDRTVDWWCL 182
Query: 367 GCIFHEMSSGRPLF 380
G + +EM G P F
Sbjct: 183 GAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 34/236 (14%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQ 288
EV ++R+ +H N+V ++ + L ++ E+L+ D S L+ +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG--ALTDIVSQTRLNEEQIATVCES 125
Query: 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWY 346
+L+ L Y HS+ ++HRD+K ++L+ G +KL+DFG +K VP + + V T ++
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLVGTPYW 183
Query: 347 RPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGR-PLFPGSTIEDELRLICSILGPPPDELK 404
P+V + T Y T +D+ +G + EM G P F S ++ RL S PPP K
Sbjct: 184 MAPEV-ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PPP---K 236
Query: 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
K I+PV D +++ L + ++R +A + HP+
Sbjct: 237 LKNAHKISPVLR------------------DFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 9/140 (6%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGA--PCTAIREVSLLRELRHANIVTLHDIIH 250
G + V+ G T VA+K +K G P ++E ++++LRH +V L+ +
Sbjct: 17 GQFGEVWMGTWNGTTK-VAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 251 TEKCLTLVFEYLEK-DLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E+ + +V EY+ K L ++ L + + Q+ G+AY SR +HRDL
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAA 131
Query: 309 QNLLINERGELKLADFGLAR 328
+N+L+ E K+ADFGLAR
Sbjct: 132 RNILVGENLVCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 84/312 (26%), Positives = 128/312 (41%), Gaps = 69/312 (22%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI-KLEHEEGAPCTAIR-EVSLLRELRHANIVTLHDII 249
KG VF + + T L ALK + K E + + E +L L H + TL+
Sbjct: 11 KGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF 70
Query: 250 HTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
TE L LV +Y L + L+R C LS + + ++L L Y H I++R
Sbjct: 71 QTETYLCLVMDYCPGGELFRLLQRQPGKC---LSEEVARFYAAEVLLALEYLHLLGIVYR 127
Query: 305 DLKPQNLLINERGELKLADFGLA----------------------------RAKSVPTKT 336
DLKP+N+L++E G + L+DF L+ S
Sbjct: 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSF 187
Query: 337 FSNEVV-TLWYRPPDVLLGSTEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICS 394
SN V T Y P+V+ G + +++D +G + +EM G F GS ++ I
Sbjct: 188 RSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNI-- 244
Query: 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI----S 450
LK ++ F P P S S A DL++K L+ D +R+
Sbjct: 245 --------LKKEVTF---PGSPPVS-----------SSARDLIRKLLVKDPSKRLGSKRG 282
Query: 451 AANAMRHPYFNS 462
AA +HP+F
Sbjct: 283 AAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 32/283 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G+YA V + + D + A+K +K E +E + + + +V LH
Sbjct: 5 RGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSC 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L LV EY+ DL +M L + + + ++ L + H R I++RDLK
Sbjct: 65 FQTTSRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
N+L++ G +KL D+G+ + P T S T Y P++L G EY S+D +
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWAL 182
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + EM +GR F I+ PD F + P + P
Sbjct: 183 GVLMFEMMAGRSPF-------------DIITDNPDMNTEDYLFQVILEKP------IRIP 223
Query: 427 EQMDSDALDLVQKFLMYDAKQRISA------ANAMRHPYFNSL 463
+ A +++ FL D K+R+ ++ H +F S+
Sbjct: 224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 57/194 (29%), Positives = 94/194 (48%), Gaps = 15/194 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG++ V+KG T +VA+K I LE E +E+++L + I +
Sbjct: 14 KGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK 73
Query: 252 EKCLTLVFEYL----EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
L ++ EYL DL + L + L ++L+GL Y HS R +HRD+K
Sbjct: 74 GTKLWIIMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV--TLWYRPPDVLLGSTEYSTSI-DM 364
N+L++E+G++KLADFG+A + T+ N V W P + + ++ I +
Sbjct: 129 AANVLLSEQGDVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 365 GVGCIFHEMSSGRP 378
G+ I E++ G P
Sbjct: 188 GITAI--ELAKGEP 199
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
KG + V G R VA+K +K ++ A + E S++ LRH N+V L ++
Sbjct: 16 KGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 251 TEKCLTLVFEYLEK----DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
L +V EY+ K D R ++++ F + G+ Y + +HRDL
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128
Query: 307 KPQNLLINERGELKLADFGLARAKSV 332
+N+L++E K++DFGLA+ S
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAKEASQ 154
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 4e-13
Identities = 69/305 (22%), Positives = 125/305 (40%), Gaps = 59/305 (19%)
Query: 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREV- 231
+L +++ +C + + + G + V K + T L K IK ++ AI E
Sbjct: 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKN-----FNAI-EPM 60
Query: 232 --SLLRELRHANIVTLHDIIHTEKCLTLV---------FEYLEKDLKRYMDDCSNILSMN 280
L+++ + N + L+ + T K L+ F+ L+K+ K LS
Sbjct: 61 VHQLMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK---------LSEA 109
Query: 281 NVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTFSN 339
VK + QL+ L H I+H D+K +N+L + + + L D+GL + P S
Sbjct: 110 EVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----SC 165
Query: 340 EVVTLWYRPPDVLLGSTEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398
TL Y P+ + G Y S D VG + +E+ +G+ F ++EL
Sbjct: 166 YDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDE-DEELD-------- 215
Query: 399 PPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA-MRH 457
+ L + + + + + +A D VQ L Y+ R++ N ++H
Sbjct: 216 -LESLLKRQQKKLPF------------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262
Query: 458 PYFNS 462
P+
Sbjct: 263 PFLKI 267
|
Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 7/194 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G+YA V + + T + A+K IK E +E + H +V LH
Sbjct: 5 RGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSC 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
TE L V E++ DL +M L + + + ++ L + H R I++RDLK
Sbjct: 65 FQTESRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
N+L++ G +KL D+G+ + P T S T Y P++L G +Y S+D +
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWAL 182
Query: 367 GCIFHEMSSGRPLF 380
G + EM +GR F
Sbjct: 183 GVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 69/283 (24%), Positives = 120/283 (42%), Gaps = 39/283 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + + + L A+K +K + ++ CT + L H + L+
Sbjct: 5 KGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCC 64
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T L V E++ DL ++ + + ++ L + H + I++RDLK
Sbjct: 65 FQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAEITSALMFLHDKGIIYRDLK 123
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
N+L++ G KLADFG+ + KT S T Y P++ L Y S+D +
Sbjct: 124 LDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI-LQEMLYGPSVDWWAM 182
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM G F ED+ L +IL DE+ VYP+
Sbjct: 183 GVLLYEMLCGHAPFEAEN-EDD--LFEAILN---DEV----------VYPT--------- 217
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAAN------AMRHPYFNSL 463
+ DA+D+++ F+ + R+ + +RHP+F L
Sbjct: 218 -WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 1/159 (0%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
GTY V+K ++ T L A+K IKLE E +E+ ++++ +H+NIV
Sbjct: 20 GTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-QEIIMMKDCKHSNIVAYFGSYLRR 78
Query: 253 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
L + E+ + + + LS + + + L+GL Y HS+ +HRD+K N+L
Sbjct: 79 DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANIL 138
Query: 313 INERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDV 351
+ + G +KLADFG++ + + + T ++ P+V
Sbjct: 139 LTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 64/277 (23%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+ V + + LVA+K++ L ++ EV ++R+ +H N+V +++
Sbjct: 30 EGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELL-FNEVVIMRDYQHENVVEMYNSYLV 88
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMN--NVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
L +V E+LE + D MN + +L+ L+ H++ ++HRD+K
Sbjct: 89 GDELWVVMEFLEGGA---LTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
++L+ G +KL+DFG S + V T ++ P+ L+ Y +D+ +G
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWSLGI 204
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ EM G P + +++I D L KL+ L ++P
Sbjct: 205 MVIEMVDGEPPYFNEPPLKAMKMI-------RDNLPPKLK-----------NLHKVSPSL 246
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ + L+ D QR +AA ++HP+ GP
Sbjct: 247 K-----GFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 72/282 (25%), Positives = 120/282 (42%), Gaps = 34/282 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALK--EIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V + R T + A K E K + A+ E +L ++ +V L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY 69
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T+ L LV + DLK ++ + N + ++L GL H ++RDLK
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK 129
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
P+N+L+++ G ++++D GLA K ++ V T+ Y P+V L + Y+ S D G+
Sbjct: 130 PENILLDDYGHIRISDLGLA-VKIPEGESIRGRVGTVGYMAPEV-LNNQRYTLSPDYWGL 187
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
GC+ +EM G+ F G + K K E V +E
Sbjct: 188 GCLIYEMIEGQSPFRGR------------------KEKVKREEVDRRVLETEEVYS---- 225
Query: 427 EQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
+ +A + + L D KQR+ A RHP+F ++
Sbjct: 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 5e-13
Identities = 55/194 (28%), Positives = 96/194 (49%), Gaps = 7/194 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V + + T + A K++ K ++ A+ E +L ++ IV L
Sbjct: 3 KGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF 62
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
++ L LV + DLK ++ + L M V + Q+ G+ + HS I++RD+K
Sbjct: 63 ESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMK 122
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGV 366
P+N+L++++G +L+D GLA + KT + T Y P++L YS +D +
Sbjct: 123 PENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAM 180
Query: 367 GCIFHEMSSGRPLF 380
GC +EM +GR F
Sbjct: 181 GCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALK----EIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG++ V K +L A+K +I L +E A R V LL+ ++H +V LH
Sbjct: 5 KGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVGLHY 63
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T + L V +++ + + + ++ L Y HS I++RDLK
Sbjct: 64 SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLK 123
Query: 308 PQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
P+N+L++ +G + L DFGL + A+S T TF T Y P+V+ Y ++D
Sbjct: 124 PENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG---TPEYLAPEVIR-KQPYDNTVDW 179
Query: 365 G-VGCIFHEMSSGRPLF 380
+G + +EM G P F
Sbjct: 180 WCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 7e-13
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 31/277 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G TV+ T VA+K++ L+ + I E+ ++RE ++ NIV D
Sbjct: 29 QGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELI-INEILVMRENKNPNIVNYLDSYLV 87
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMN--NVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
L +V EYL + D M+ + + L+ L + HS +++HRD+K
Sbjct: 88 GDELWVVMEYLAGG---SLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSD 144
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
N+L+ G +KL DFG + S V T ++ P+V+ Y +D+ +G
Sbjct: 145 NILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGI 203
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ EM G P + E+ LR + I EL++ PE+
Sbjct: 204 MAIEMVEGEPPYLN---ENPLRALYLIATNGTPELQN--------------------PER 240
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ + D + + L D +R SA ++HP+ P
Sbjct: 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 67/286 (23%), Positives = 125/286 (43%), Gaps = 37/286 (12%)
Query: 192 KGTYATVF---KGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVT 244
G Y VF K L A+K +K ++ + A T L R +VT
Sbjct: 10 TGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVT 69
Query: 245 LHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
LH T+ L L+ +Y+ +L ++ + + + V++++ +++ L + H I++
Sbjct: 70 LHYAFQTDTKLHLILDYVNGGELFTHLYQREH-FTESEVRVYIAEIVLALDHLHQLGIIY 128
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTE-YSTS 361
RD+K +N+L++ G + L DFGL++ + + T+ Y P+V+ G + + +
Sbjct: 129 RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKA 188
Query: 362 ID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
+D +G + E+ +G F T++ E I S+ P +P
Sbjct: 189 VDWWSLGVLTFELLTGASPF---TVDGEQNSQSEI---------SRRILKSKPPFPKT-- 234
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA---MRHPYFNSL 463
M ++A D +QK L D K+R+ A A HP+F +
Sbjct: 235 --------MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 9/195 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V + R T + A K++ K + A+ E +L ++ +V+L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY 69
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T+ L LV + DLK ++ + N + +L GL RI++RDLK
Sbjct: 70 ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK 129
Query: 308 PQNLLINERGELKLADFGLARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSID-MG 365
P+N+L+++RG ++++D GL A +P +T V T+ Y P+V + + +Y+ S D G
Sbjct: 130 PENILLDDRGHIRISDLGL--AVQIPEGETVRGRVGTVGYMAPEV-INNEKYTFSPDWWG 186
Query: 366 VGCIFHEMSSGRPLF 380
+GC+ +EM G+ F
Sbjct: 187 LGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 65/219 (29%), Positives = 107/219 (48%), Gaps = 29/219 (13%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G V K + + + ++A K I LE + IRE+ +L E IV + +++
Sbjct: 16 GNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75
Query: 253 KCLTLVFEYLE--------KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILH 303
+++ E+++ K+ KR ++ +S+ +LRGLAY + +I+H
Sbjct: 76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--------AVLRGLAYLREKHQIMH 127
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSI 362
RD+KP N+L+N RGE+KL DFG++ + +N V T Y P+ L G T YS
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQG-THYSVQS 183
Query: 363 DM-GVGCIFHEMSSGR-PLFPGSTIEDELRLICSILGPP 399
D+ +G E++ GR P+ P E E +I G P
Sbjct: 184 DIWSMGLSLVELAIGRYPIPPPDAKELE-----AIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 65/277 (23%), Positives = 119/277 (42%), Gaps = 31/277 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+ V + T VA+K++ L ++ EV ++R+ +H NIV ++
Sbjct: 29 EGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELL-FNEVVIMRDYQHPNIVEMYSSYLV 87
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMN--NVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
L +V E+LE + D MN + +L+ L++ H++ ++HRD+K
Sbjct: 88 GDELWVVMEFLEGGA---LTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSD 144
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
++L+ G +KL+DFG S + V T ++ P+V+ Y T +D+ +G
Sbjct: 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGI 203
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ EM G P + E L+ + I P +LK+ +
Sbjct: 204 MVIEMVDGEPPYFN---EPPLQAMKRIRDNLPPKLKN--------------------LHK 240
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ + + L+ D QR +AA + HP+ GP
Sbjct: 241 VSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 82/350 (23%), Positives = 134/350 (38%), Gaps = 58/350 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE----HEEGAPCTAIREVSLLRELRHANIVTLHD 247
KGT+ V K + T A+K +K E +E A + E +L+ RH + L
Sbjct: 5 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA--HTLTENRVLQNSRHPFLTALKY 62
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR-ILHRDL 306
T L V EY + + S + + + +++ L Y HS + +++RDL
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDL 122
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MG 365
K +NL++++ G +K+ DFGL + T T Y P+V L +Y ++D G
Sbjct: 123 KLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV-LEDNDYGRAVDWWG 181
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425
+G + +EM GR F E LI L ++ F
Sbjct: 182 LGVVMYEMMCGRLPFYNQDHEKLFELI----------LMEEIRF---------------- 215
Query: 426 PEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL--------------GPQ 466
P + +A L+ L D KQR+ A M+H +F + PQ
Sbjct: 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQ 275
Query: 467 VHELSDTQSI---FSLPHIKLTSNPTDGGLLPFYGQKSEKRWTGLSRRQS 513
V +DT+ F+ I +T P + + + S S
Sbjct: 276 VTSETDTRYFDEEFTAQMITITP-PDQDDSMETVDNERRPHFPQFSYSAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 71/257 (27%), Positives = 103/257 (40%), Gaps = 22/257 (8%)
Query: 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLF 285
+++ E LLR L H ++ L D+ LV DL Y+ L + V
Sbjct: 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAV 265
Query: 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA--RAKSVPTKTFSNEVVT 343
QLL + Y H I+HRD+K +N+L+N ++ L DFG A S T T
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325
Query: 344 LWYRPPDVLLGSTEYSTSIDMGVG--CIFHEMSSGRPLFPGSTIEDELR----LICSILG 397
+ P+VL G Y+ S+D+ IF LF S DE R I I+
Sbjct: 326 VDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASR-GDERRPYDAQILRIIR 383
Query: 398 PP---PDELKSKLEFCITPVY---------PSESKLQLLAPEQMDSDALDLVQKFLMYDA 445
DE + Y P+ ++ ++D D LV + L +D
Sbjct: 384 QAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDG 443
Query: 446 KQRISAANAMRHPYFNS 462
+R SAA +R P F S
Sbjct: 444 ARRPSAAELLRLPLFQS 460
|
Length = 461 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 26/218 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHAN--IVTL 245
KGT+ V++ + + T + A+K + + +E A R + L+R L + IV L
Sbjct: 3 KGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNI-LVRTLLDESPFIVGL 61
Query: 246 HDIIHTEKCLTLVFEY---------LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYC 296
T+ L LV +Y L+K+ + S + K ++ +L+ L +
Sbjct: 62 KFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---------FSEDRAKFYIAELVLALEHL 112
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST 356
H I++RDLKP+N+L++ G + L DFGL++A KT + T Y P+VLL
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLIC 393
Y+ +D +G + EM G F + R I
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIA 210
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 63/255 (24%), Positives = 108/255 (42%), Gaps = 26/255 (10%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQL 289
E +LR + H +I+ L K L+ + DL Y+ NI ++ ++ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNI-AICDILAIERSV 191
Query: 290 LRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV----TLW 345
LR + Y H RI+HRD+K +N+ IN G++ L DFG A P +N+ T+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG---AACFPVDINANKYYGWAGTIA 248
Query: 346 YRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGR-PLFPGSTI------EDELRLICSILG 397
P+ LL Y ++D+ G + EM++ LF + + +++LI G
Sbjct: 249 TNAPE-LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG 307
Query: 398 PPPDELKSKLEFCITPVYPSESKLQLLAP---------EQMDSDALDLVQKFLMYDAKQR 448
P+E + + +Y +K P ++ D L+ K L +DA R
Sbjct: 308 THPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHR 367
Query: 449 ISAANAMRHPYFNSL 463
SA + F +
Sbjct: 368 PSAEALLDFAAFQDI 382
|
Length = 391 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 3/103 (2%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANI 151
Y L K+G+GT++ V K +SR T A+K +K + +RE+ LR L H NI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 152 VTLHDIIHTEK--CLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
+ L +++ K L LVFE ++ +L + L VK
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVK 103
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 40/140 (28%), Positives = 73/140 (52%), Gaps = 8/140 (5%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIHT 251
G Y V++G + VA+K +K E+ ++E ++++E++H N+V L +
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLF--QLLRGLAYCHSRRILHRDLKP 308
E ++ E++ +L Y+ +C N +N V L Q+ + Y + +HRDL
Sbjct: 74 EPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 309 QNLLINERGELKLADFGLAR 328
+N L+ E +K+ADFGL+R
Sbjct: 133 RNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 67/279 (24%), Positives = 123/279 (44%), Gaps = 35/279 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+ V + T VA+K++ L ++ EV ++R+ H N+V +++
Sbjct: 32 EGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELL-FNEVVIMRDYHHENVVDMYNSYLV 90
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMN--NVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
L +V E+LE + D MN + +LR L+Y H++ ++HRD+K
Sbjct: 91 GDELWVVMEFLEGGA---LTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147
Query: 310 NLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
++L+ G +KL+DFG +K VP + + V T ++ P+V + Y T +D+ +
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKR--KSLVGTPYWMAPEV-ISRLPYGTEVDIWSL 204
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + EM G P + PP + ++ + P K+
Sbjct: 205 GIMVIEMIDGEPPY---------------FNEPPLQAMRRIRDNLPPRVKDSHKVS---- 245
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ LDL+ L+ + QR +A ++HP+ GP
Sbjct: 246 -SVLRGFLDLM---LVREPSQRATAQELLQHPFLKLAGP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 67/278 (24%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G TV+ T VA++++ L+ + I E+ ++RE ++ NIV D
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELI-INEILVMRENKNPNIVNYLDSYLV 88
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMN--NVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
L +V EYL + D M+ + + L+ L + HS +++HRD+K
Sbjct: 89 GDELWVVMEYLAGG---SLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSD 145
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM-GVG 367
N+L+ G +KL DFG A+ P ++ + +V T ++ P+V+ Y +D+ +G
Sbjct: 146 NILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLG 203
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ EM G P + E+ LR + I EL++ PE
Sbjct: 204 IMAIEMIEGEPPYLN---ENPLRALYLIATNGTPELQN--------------------PE 240
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
++ + D + + L D ++R SA ++H + P
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 52/287 (18%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
G +V K K T ++A K + + + +RE+ ++ E R IV+ + E
Sbjct: 16 GNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75
Query: 253 KCLTLVFEYLEKD-----LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDL 306
+ + E+++ K+ IL V ++ GL Y ++ RI+HRD+
Sbjct: 76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAV-----AVVEGLTYLYNVHRIMHRDI 130
Query: 307 KPQNLLINERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
KP N+L+N RG++KL DFG++ S+ TF V T Y P+ + G +Y+ D
Sbjct: 131 KPSNILVNSRGQIKLCDFGVSGELINSI-ADTF---VGTSTYMSPERIQGG-KYTVKSDV 185
Query: 364 --MGVGCIFHEMSSGRPLFPGSTIEDE--------LRLICSILGPPPDELKSKLEFCITP 413
+G+ I E++ G+ F S I+D+ L L+ I+ PP P
Sbjct: 186 WSLGISII--ELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------------P 231
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
PS D D V L+ D +R + P F
Sbjct: 232 RLPS---------SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 38/121 (31%), Positives = 65/121 (53%), Gaps = 2/121 (1%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKR 268
VA+K K ++E ++R+ H +IV L +I TE + +V E +L+
Sbjct: 37 VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRS 95
Query: 269 YMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
Y+ L + ++ L+ +QL LAY S+R +HRD+ +N+L++ +KL DFGL+R
Sbjct: 96 YLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
Query: 329 A 329
Sbjct: 156 Y 156
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 19/232 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALK-----EIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G + V+ + T + A+K IK++ E +SL+ IV +
Sbjct: 4 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMT 63
Query: 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
HT L + + + Y + S ++ + +++ GL + H+R +++RDL
Sbjct: 64 YAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDL 123
Query: 307 KPQNLLINERGELKLADFGLA--RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
KP N+L++E G ++++D GLA +K P + V T Y P+VL T Y +S D
Sbjct: 124 KPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKGTAYDSSADW 179
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDEL---RLICSILGPPPD----ELKSKLE 408
+GC+ ++ G F +D+ R+ ++ PD ELKS LE
Sbjct: 180 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 6e-12
Identities = 34/85 (40%), Positives = 56/85 (65%), Gaps = 5/85 (5%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCT---AIREVSLLRELR 147
E Y KL K+G+G+Y VFK ++R T +VA+K+ +E E+ P A+RE+ +L++L+
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDD-PVIKKIALREIRMLKQLK 58
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLE 172
H N+V L ++ ++ L LVFEY +
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCD 83
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 6e-12
Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 50/285 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR----EVSLLRELRHANIVTLHD 247
+G + V+ T +A+K+++ + E + E+ LL+ L H IV +
Sbjct: 12 QGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYG 71
Query: 248 IIH--TEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
+ E+ L++ E+ ++ LK Y L+ N + + Q+L G++Y HS
Sbjct: 72 CLRDPMERTLSIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM 126
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-----TLWYRPPDVLLGS 355
I+HRD+K N+L + G +KL DFG +K + T S + T ++ P+V+ G
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFG--ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
Y D+ VGC EM + + PP E ++
Sbjct: 185 G-YGRKADIWSVGCTVVEMLTEK--------------------PPWAEFEAMAAIFKIAT 223
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P+ L P + D +++ + +AK R SA +RH +
Sbjct: 224 QPTNPVL----PPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG + V + R T L A K++ +L+ +G A+ E +L ++ IV+L
Sbjct: 3 KGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYE-GAMVEKRILAKVHSRFIVSLAYA 61
Query: 249 IHTEKCLTLVFEYLEKDLKRY----MDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
T+ L LV + RY +D+ + + Q++ GL + H RRI++R
Sbjct: 62 FQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYR 121
Query: 305 DLKPQNLLINERGELKLADFGLA---RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
DLKP+N+L++ G ++++D GLA + TK ++ T + P++L G EY S
Sbjct: 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG---TPGFMAPELLQGE-EYDFS 177
Query: 362 ID-MGVGCIFHEMSSGRPLF 380
+D +G +EM + R F
Sbjct: 178 VDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 193 GTYATVFKGKSR--LTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
G + VF G+ +N LVA+K +K A RE LL +H NIV +
Sbjct: 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYG 75
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYM---DDCSNILSMNNVK---LFLFQLLR-------GL 293
+ +VFEY+E DL +++ + L + L L QLL+ G+
Sbjct: 76 VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGM 135
Query: 294 AYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
Y S+ +HRDL +N L+ +K+ DFG++R
Sbjct: 136 VYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 75/286 (26%), Positives = 123/286 (43%), Gaps = 46/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIH 250
KGTY V+K ++ +L A+K + + A E ++L+ L H N+V + + +
Sbjct: 32 KGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA--EYNILQSLPNHPNVVKFYGMFY 89
Query: 251 -TEKC----LTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
+K L LV E +L + + C L + L+ L GL + H+ RI
Sbjct: 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRI 149
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYST 360
+HRD+K N+L+ G +KL DFG++ A+ T+ N V T ++ P+V+ +Y
Sbjct: 150 IHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDY 208
Query: 361 SID-------MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP 413
S D +G+ I E+ G P P D K F I P
Sbjct: 209 SYDARCDVWSLGITAI--ELGDGDP-------------------PLFDMHPVKTLFKI-P 246
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P + LL PE+ + + L+ D + R S + + HP+
Sbjct: 247 RNPPPT---LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 13/155 (8%)
Query: 193 GTYATVFKGKSRL---TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + VF+G ++ + VA+K +K + E + E S++ + H NI+ L ++
Sbjct: 16 GEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV 75
Query: 250 HTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLA----YCHSRRILHR 304
K ++ EY+E L +Y+ D S L +LRG+A Y +HR
Sbjct: 76 TKFKPAMIITEYMENGALDKYLRDHDGEFS----SYQLVGMLRGIAAGMKYLSDMNYVHR 131
Query: 305 DLKPQNLLINERGELKLADFGLARA-KSVPTKTFS 338
DL +N+L+N E K++DFGL+R + P T++
Sbjct: 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 70/287 (24%), Positives = 119/287 (41%), Gaps = 52/287 (18%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDII-- 249
GTY V+KG+ T L A+K + + +E +E+++L++ H NI T +
Sbjct: 17 GTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIK--QEINMLKKYSHHRNIATYYGAFIK 74
Query: 250 ----HTEKCLTLVFEY--------LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH 297
+ L LV E+ L K+ K N L + ++LRGL++ H
Sbjct: 75 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK------GNTLKEEWIAYICREILRGLSHLH 128
Query: 298 SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE 357
+++HRD+K QN+L+ E E+KL DFG++ + + T ++ P+V+
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDEN 188
Query: 358 YSTSIDM-----GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412
+ D +G EM+ G P P + +R + I P LKSK
Sbjct: 189 PDATYDFKSDLWSLGITAIEMAEGAP--PLCDMH-PMRALFLIPRNPAPRLKSK------ 239
Query: 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
K Q ++ L+ + QR + M+HP+
Sbjct: 240 ---KWSKKFQ------------SFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 1e-11
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 25/182 (13%)
Query: 207 DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KD 265
+VA+K +K E RE +L+ E H NIV L + K + L+FEY+ D
Sbjct: 35 FTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGD 94
Query: 266 LKRYMDDCS----NILSMNNVKLFLF-----------------QLLRGLAYCHSRRILHR 304
L ++ S LS + Q+ G+AY R+ +HR
Sbjct: 95 LNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHR 154
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
DL +N L+ E +K+ADFGL+R K N+ + + + PP+ + Y+T
Sbjct: 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF-YNRYTTES 213
Query: 363 DM 364
D+
Sbjct: 214 DV 215
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 8/139 (5%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIH 250
G + V GK R + VA+K I+ EGA I E ++ +L H N+V L+ +
Sbjct: 15 GQFGVVHLGKWRGKID-VAIKMIR----EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 251 TEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
++ + +V EY+ L Y+ + L + + + Y S +HRDL +
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAAR 129
Query: 310 NLLINERGELKLADFGLAR 328
N L+ E +K++DFGLAR
Sbjct: 130 NCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 42/134 (31%), Positives = 72/134 (53%), Gaps = 11/134 (8%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCT--AIREVSLLRELRH 148
E Y L +G+G+Y V K K + T +VA+K+ LE E+ A+RE+ +L++LRH
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKF-LESEDDKMVKKIAMREIRMLKQLRH 59
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEK----DLKRYMDDCSNILSMNNVKGTYATVFKGKSR 204
N+V L ++ +K L LVFE+++ DL++Y N L + V+ + +G
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEF 115
Query: 205 LTDNLVALKEIKLE 218
+ + ++IK E
Sbjct: 116 CHSHNIIHRDIKPE 129
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 43/137 (31%), Positives = 72/137 (52%), Gaps = 11/137 (8%)
Query: 91 ESYFKLDKLGQGTYATVFKGKS-RLTDNLVALKEIKLE-HEEGAPCTAIREVSLLREL-- 146
+ Y + ++G+G Y VFK + + VALK ++++ EEG P + IREV++LR L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 147 -RHANIVTLHDIIHT-----EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKGTYATVF 199
H N+V L D+ E LTLVFE++++DL Y+D + +K +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 200 KGKSRLTDNLVALKEIK 216
+G L + V +++K
Sbjct: 121 RGLDFLHSHRVVHRDLK 137
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 22/255 (8%)
Query: 229 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQ 288
RE+ +L+ + H I+ L + + +V + DL Y+D L + +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRR 193
Query: 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA--RAKSVPTKTFSNEVVTLWY 346
LL LAY H R I+HRD+K +N+ ++E L DFG A T TL
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 347 RPPDVLLGSTEYSTSIDM-GVGCIFHEMS-SGRPLF----PGSTIEDELRLICSILGPPP 400
P+ LL Y D+ G + EMS LF S+ +LR I + P
Sbjct: 254 NSPE-LLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS--SQLRSIIRCMQVHP 310
Query: 401 DEL---------KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451
E K ++ I + P + ++ M D L+ K L +D + R SA
Sbjct: 311 LEFPQNGSTNLCKHFKQYAI-VLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA 369
Query: 452 ANAMRHPYFNSLGPQ 466
+ + P F
Sbjct: 370 QDILSLPLFTKEPIN 384
|
Length = 392 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-11
Identities = 38/123 (30%), Positives = 73/123 (59%), Gaps = 9/123 (7%)
Query: 210 VALKEIKLEHEEGA--PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 266
VA+K +K +G+ P + E +L+++L+H +V L+ ++ T++ + ++ EY+E L
Sbjct: 33 VAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYMENGSL 87
Query: 267 KRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325
++ I L++N + Q+ G+A+ + +HRDL+ N+L++E K+ADFG
Sbjct: 88 VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFG 147
Query: 326 LAR 328
LAR
Sbjct: 148 LAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 57/264 (21%), Positives = 106/264 (40%), Gaps = 31/264 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + VF G+ R + VA+K + ++E +L++ H NIV L +
Sbjct: 5 RGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 64
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
++ + +V E ++ D ++ L + + + G+ Y S+ +HRDL +N
Sbjct: 65 KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARN 124
Query: 311 LLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
L+ E+ LK++DFG++R V T + + + + P+ L YS+ D+ G
Sbjct: 125 CLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEA-LNYGRYSSESDVWSFG 183
Query: 368 CIFHE-MSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
+ E S G + + + I E ++L P
Sbjct: 184 ILLWEAFSLGAVPYANLSNQQTREAI-------------------------EQGVRLPCP 218
Query: 427 EQMDSDALDLVQKFLMYDAKQRIS 450
E L+++ YD QR S
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 58/244 (23%), Positives = 112/244 (45%), Gaps = 33/244 (13%)
Query: 230 EVSLLRELRHAN-IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLF 287
E +L +R + +VTLH T+ L L+ +Y+ +L ++ V+++
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER-FKEQEVQIYSG 112
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTFSNEVVTLWY 346
+++ L + H I++RD+K +N+L++ G + L DFGL++ + + T+ Y
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
Query: 347 RPPDVLL-GSTEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404
PD++ G + ++D +G + +E+ +G F ++ I + LK
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI------LK 226
Query: 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPY 459
S+ P YP E M + A D++Q+ LM D K+R+ A +HP+
Sbjct: 227 SE------PPYPQE----------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
Query: 460 FNSL 463
F +
Sbjct: 271 FQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 8e-11
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V +G+ T VA+K IK + A + E +++ +L H N+V L +I
Sbjct: 16 EGEFGAVLQGE--YTGQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI-L 69
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQL--LRGLAYCHSRRILHRDLKP 308
L +V E + K +L ++ L ++ ++L F L G+ Y S++++HRDL
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAA 128
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGC 368
+N+L++E G K++DFGLAR S N + + + P+ L S S G
Sbjct: 129 RNILVSEDGVAKVSDFGLARVGS---MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGV 185
Query: 369 IFHEM-SSGRPLFPGSTIED 387
+ E+ S GR +P ++++
Sbjct: 186 LLWEVFSYGRAPYPKMSLKE 205
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 8e-11
Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALK--EIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V + R T + A K E K + A+ E +L ++ +V+L
Sbjct: 10 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY 69
Query: 250 HTEKCLTLVFEYLEK-DLK---RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
T+ L LV + DLK +M + + ++ GL H RI++RD
Sbjct: 70 ETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
LKP+N+L+++ G ++++D GL A VP +T V T+ Y P+V + + Y+ S D
Sbjct: 128 LKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRVGTVGYMAPEV-VKNERYTFSPDW 184
Query: 364 MGVGCIFHEMSSGRPLF 380
+GC+ +EM +G+ F
Sbjct: 185 WALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 9e-11
Identities = 36/138 (26%), Positives = 67/138 (48%), Gaps = 2/138 (1%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG + V+KG + + VA+K + ++E +L++ H NIV L +
Sbjct: 5 KGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ 63
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
++ + +V E + L ++ N L++ + G+ Y S+ +HRDL +N
Sbjct: 64 KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARN 123
Query: 311 LLINERGELKLADFGLAR 328
L+ E LK++DFG++R
Sbjct: 124 CLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 8/139 (5%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIH 250
G + V+ G L VA+K I+ EGA I E ++ +L H +V L+ +
Sbjct: 15 GQFGLVWLG-YWLEKRKVAIKTIR----EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 251 TEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ LVFE++E L Y+ S + + G+AY S ++HRDL +
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAAR 129
Query: 310 NLLINERGELKLADFGLAR 328
N L+ E +K++DFG+ R
Sbjct: 130 NCLVGENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 2e-10
Identities = 23/79 (29%), Positives = 42/79 (53%), Gaps = 1/79 (1%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANI 151
Y + ++G+G++ V+ + + L LKEI L + E A+ EV +L++L H NI
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61
Query: 152 VTLHDIIHTEKCLTLVFEY 170
+ ++ + L +V EY
Sbjct: 62 IKYYESFEEKGKLCIVMEY 80
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 42/236 (17%)
Query: 193 GTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V +G+ +L + VA+K +K + E + E S++ + H NI+ L ++
Sbjct: 15 GEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCS--NILSMNNVKLFLFQL---LRGLA----YCHSRR 300
T+ ++ + +M++ + + L N+ + + QL LRG+A Y
Sbjct: 75 -TKSRPVMI-------ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN 126
Query: 301 ILHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTFS--NEVVTLWYRPPDVLLG 354
+HRDL +N+L+N K++DFGL+R S PT T S ++ W P +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY- 185
Query: 355 STEYSTSIDM-GVGCIFHE-MSSG-RPLFPGS------TIEDELRLICSILGPPPD 401
+++++ D+ G + E MS G RP + S IE + R L PP D
Sbjct: 186 -RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR-----LPPPMD 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 46/290 (15%)
Query: 193 GTYATVF---KGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHAN-IVT 244
G Y VF K T L A+K ++ ++ + T E ++L +R + +VT
Sbjct: 11 GAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRT-ERNVLEHVRQSPFLVT 69
Query: 245 LHDIIHTEKCLTLVFEYL---EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
LH TE L L+ +Y+ E Y D S + V+ + +++ L + H I
Sbjct: 70 LHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLGI 126
Query: 302 LHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
++RD+K +N+L++ G + L DFGL++ +T+S T+ Y P+++ G +
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSF-CGTIEYMAPEIIRGKGGHG 185
Query: 360 TSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
++D +G + E+ +G F T+E E E+ ++ C P +PS
Sbjct: 186 KAVDWWSLGILIFELLTGASPF---TLEGERN--------TQSEVSRRILKC-DPPFPS- 232
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA-----NAMRHPYFNSL 463
+ PE A DL+ K L D K+R+ A HP+F L
Sbjct: 233 ----FIGPE-----AQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 31/228 (13%)
Query: 242 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
IV + HT L+ + + + Y + S ++ + +++ GL + H+R +
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
++RDLKP N+L++E G ++++D GLA S K V T Y P+VL Y +S
Sbjct: 119 VYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSS 176
Query: 362 ID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
D +GC+ ++ G F +D+ + ++ + P
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------------DRMTLTMAVELPDSFS 223
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
+L L++ L D +R+ A HP+F SL
Sbjct: 224 PEL----------RSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 22/158 (13%)
Query: 193 GTYATVFKGKSRLTDNL-----VALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246
G + V K ++ DN VA+K +K + E + E+ +++ + +H NI+ L
Sbjct: 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 82
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRY-------MDDCSNI--------LSMNNVKLFLFQLL 290
+ E L +V EY +L+ + + S L+ ++ F +Q+
Sbjct: 83 GVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVA 142
Query: 291 RGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
RG+ + S++ +HRDL +N+L+ E +K+ADFGLAR
Sbjct: 143 RGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 37/130 (28%), Positives = 61/130 (46%), Gaps = 17/130 (13%)
Query: 91 ESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEH-------------EEGAPCTA 136
E Y + LG+GTY V K LT +VA+K++K+ G T
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 137 IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKGTY 195
+RE+ ++ E++H NI+ L D+ + LV + + DLK+ +D I L+ + VK
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD--RKIRLTESQVKCIL 125
Query: 196 ATVFKGKSRL 205
+ G + L
Sbjct: 126 LQILNGLNVL 135
|
Length = 335 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 24/78 (30%), Positives = 42/78 (53%), Gaps = 1/78 (1%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 154
L+K+G+G + V+K + + T VA+K IKLE + I E+ +L++ +H NIV
Sbjct: 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLE-SKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 155 HDIIHTEKCLTLVFEYLE 172
+ + L +V E+
Sbjct: 63 YGSYLKKDELWIVMEFCS 80
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V+ G T VA+K +K +P ++E ++++LRH +V L+ ++ +
Sbjct: 16 QGCFGEVWMGTWNGTTR-VAIKTLK--PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-S 71
Query: 252 EKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E+ + +V EY+ K L + L + + Q+ G+AY +HRDL+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 131
Query: 310 NLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVG 367
N+L+ E K+ADFGLAR + T + W P L G + + G
Sbjct: 132 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV-WSFG 190
Query: 368 CIFHEMSS-GRPLFPG 382
+ E+++ GR +PG
Sbjct: 191 ILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 22/182 (12%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIH 250
G + V GK R + VA+K IK EG+ I E ++ +L H +V L+ +
Sbjct: 15 GQFGVVKYGKWRGQYD-VAIKMIK----EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 251 TEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
++ + +V EY+ L Y+ + + + + G+AY S++ +HRDL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAAR 129
Query: 310 NLLINERGELKLADFGLAR-------AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
N L++++G +K++DFGL+R SV +K + + PP+VLL S ++S+
Sbjct: 130 NCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK------FPVRWSPPEVLLYS-KFSSKS 182
Query: 363 DM 364
D+
Sbjct: 183 DV 184
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-10
Identities = 43/136 (31%), Positives = 70/136 (51%), Gaps = 17/136 (12%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
VA+K +K + I E+ L++ + +H NI+ L + E L ++ EY K +L+
Sbjct: 47 VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106
Query: 268 RY--------MDDCSNI-------LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
+ D +I LS ++ +Q+ RG+ Y SRR +HRDL +N+L
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166
Query: 313 INERGELKLADFGLAR 328
+ E +K+ADFGLAR
Sbjct: 167 VTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 19/155 (12%)
Query: 239 HAN---IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV-----KLFLFQLL 290
HAN IV LH +K L +V EY+ D N++S ++ + + +++
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGG------DLVNLMSNYDIPEKWARFYTAEVV 152
Query: 291 RGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTFSNEVVTLWYRPP 349
L HS +HRD+KP N+L+++ G LKLADFG + + V T Y P
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212
Query: 350 DVLL---GSTEYSTSIDM-GVGCIFHEMSSGRPLF 380
+VL G Y D VG +EM G F
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 32/100 (32%), Positives = 49/100 (49%), Gaps = 5/100 (5%)
Query: 94 FKLDKLGQGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
KLG+G + V+KGK VA+K +K + E +RE ++R+L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSM 188
N+V L + E+ L +V EY+E DL Y+ LS+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSL 101
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 206 TDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYL 262
T +VA+K KL+H RE+ +L+ L+H NIV + ++ + L LV EYL
Sbjct: 32 TGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYL 89
Query: 263 -EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321
L+ Y+ L + L+ Q+ +G+ Y S+R +HRDL +N+L+ +K+
Sbjct: 90 PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKI 149
Query: 322 ADFGLARA----KSVPTKTFSNEVVTLWYRP 348
DFGL + K E WY P
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAP 180
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 5e-10
Identities = 71/320 (22%), Positives = 123/320 (38%), Gaps = 82/320 (25%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V + + T ++ A+K+++ LE E+ A A R++ L E + +V L+
Sbjct: 11 RGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI--LAEADNPWVVKLYY 68
Query: 248 IIHTEKCLTLVFEYLEKD-----LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
E L L+ EYL L + + + + ++ + + + H +
Sbjct: 69 SFQDENYLYLIMEYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 303 HRDLKPQNLLINERGELKLADFGL---------------------ARAKSVPTKTF-SNE 340
HRD+KP NLL++ +G +KL+DFGL + +K S
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 341 VVTLW----------------YRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGS 383
W Y P+V L T Y+ D +G I +EM G P F
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMY 443
++ R I + K L+F P E L +A DL+++
Sbjct: 243 NPQETYRKIIN--------WKETLQF------PDEVPLS--------PEAKDLIKRLCC- 279
Query: 444 DAKQRISAANA---MRHPYF 460
+A++R+ HP+F
Sbjct: 280 EAERRLGNNGVNEIKSHPFF 299
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 39/94 (41%), Positives = 52/94 (55%), Gaps = 7/94 (7%)
Query: 88 GRIESYFK-LDKLGQGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLR 144
I ++ L KLG+G Y V+K R T +VALK+I + A T RE+ L+
Sbjct: 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT-FREIMFLQ 61
Query: 145 ELR-HANIVTLHDIIHTE--KCLTLVFEYLEKDL 175
EL H NIV L ++I E K + LVFEY+E DL
Sbjct: 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDL 95
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 7e-10
Identities = 30/87 (34%), Positives = 48/87 (55%), Gaps = 4/87 (4%)
Query: 97 DKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 153
KLG+G + V+KGK + D VA+K +K + E ++E ++++L H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRYM 179
L + E+ L LV EY+E DL Y+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYL 87
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 7e-10
Identities = 43/174 (24%), Positives = 81/174 (46%), Gaps = 19/174 (10%)
Query: 228 IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLF 285
+ E ++++ L+H +V LH ++ T++ + ++ E++ K L D + + + F
Sbjct: 49 LAEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 107
Query: 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTL- 344
Q+ G+A+ R +HRDL+ N+L++ K+ADFGLAR NE
Sbjct: 108 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE------DNEYTARE 161
Query: 345 -------WYRPPDVLLGSTEYSTSIDMGVGCIFHEM-SSGRPLFPGSTIEDELR 390
W P + GS + + G + E+ + GR +PG + + +R
Sbjct: 162 GAKFPIKWTAPEAINFGSFTIKSDV-WSFGILLMEIVTYGRIPYPGMSNPEVIR 214
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 7e-10
Identities = 59/195 (30%), Positives = 95/195 (48%), Gaps = 14/195 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG + V G R N VA+K IK + A + E S++ +LRH+N+V L +I
Sbjct: 16 KGEFGDVMLGDYR--GNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 252 EK-CLTLVFEYLEK-DLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
EK L +V EY+ K L Y+ ++L + + F + + Y + +HRDL
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAA 130
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
+N+L++E K++DFGL + S T ++ W P L ++ST D+ G
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDT--GKLPVKWTAPE--ALREKKFSTKSDVWSFG 186
Query: 368 CIFHEMSS-GRPLFP 381
+ E+ S GR +P
Sbjct: 187 ILLWEIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 42/136 (30%), Positives = 71/136 (52%), Gaps = 17/136 (12%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
VA+K +K + E I E+ +++ + +H NI+ L + L ++ EY K +L+
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 268 RY--------MDDCSN-------ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
Y M+ C N LS ++ +Q+ RG+ Y S++ +HRDL +N+L
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172
Query: 313 INERGELKLADFGLAR 328
+ E +K+ADFGLAR
Sbjct: 173 VTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 32/81 (39%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLRELRHA 149
E Y + ++G GTY V+K + T LVA+K IKL E G I+ E+S+L+E RH
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL--EPGDDFEIIQQEISMLKECRHP 60
Query: 150 NIVTLHDIIHTEKCLTLVFEY 170
NIV L +V EY
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEY 81
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 52/198 (26%), Positives = 90/198 (45%), Gaps = 8/198 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG + VFKG + VA+K K + + + E +L++ H NIV L +
Sbjct: 5 KGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ 63
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + +V E + D ++ + L + F G+AY S+ +HRDL +N
Sbjct: 64 RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARN 123
Query: 311 LLINERGELKLADFGLARAKS--VPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
L+ E LK++DFG++R + + + + ++ W P + G YS+ D+ G
Sbjct: 124 CLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYG--RYSSESDVWSYG 181
Query: 368 CIFHE-MSSGRPLFPGST 384
+ E S G +PG T
Sbjct: 182 ILLWETFSLGVCPYPGMT 199
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 11/183 (6%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY-----LEK 264
V K + L E A A E+ L H IV D ++ L L+ EY L K
Sbjct: 96 VVAKFVMLNDERQA-AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNK 154
Query: 265 DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324
+K+ + + V L +Q++ L HSR+++HRDLK N+ + G +KL DF
Sbjct: 155 QIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF 213
Query: 325 GLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFP 381
G ++ + SV S+ T +Y P+ L YS DM +G I +E+ + F
Sbjct: 214 GFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRPFK 272
Query: 382 GST 384
G +
Sbjct: 273 GPS 275
|
Length = 478 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 34/131 (25%), Positives = 66/131 (50%), Gaps = 11/131 (8%)
Query: 209 LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
LVA+K ++ + + A ++E+ ++ L+ NI+ L + T L ++ EY+E DL
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 268 RYM----------DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317
+++ +S + + Q+ G+ Y S +HRDL +N L+ +
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 318 ELKLADFGLAR 328
+K+ADFG++R
Sbjct: 168 TIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 28/109 (25%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY-------MDDCSNILSMNN 281
E S+++E ++V L ++ T + +V E + K DLK Y ++ +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118
Query: 282 VKLFLF--QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
K ++ G+AY +++ +HRDL +N ++ E +K+ DFG+ R
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)
Query: 195 YATVFKGKSRLTD----NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+ ++KG L LVA+K +K + +E SL+ EL H NIV L ++
Sbjct: 18 FGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT 77
Query: 251 TEKCLTLVFEYLEK-DLKRYM-------------DDCSNILSMNNVKLFL---FQLLRGL 293
E+ + ++FEYL + DL ++ D+ + S + FL Q+ G+
Sbjct: 78 QEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGM 137
Query: 294 AYCHSRRILHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDV 351
Y S +H+DL +N+LI E+ +K++D GL+R + + ++ + + PP+
Sbjct: 138 EYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEA 197
Query: 352 LLGSTEYSTSIDM-GVGCIFHEMSS 375
++ ++S+ D+ G + E+ S
Sbjct: 198 IM-YGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 32/103 (31%), Positives = 58/103 (56%), Gaps = 2/103 (1%)
Query: 228 IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLF 285
+ E +L++ L+H +V L+ ++ E+ + ++ EY+ K L D + + + F
Sbjct: 49 LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF 108
Query: 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
Q+ G+AY + +HRDL+ N+L++E K+ADFGLAR
Sbjct: 109 SAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 18/147 (12%)
Query: 193 GTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V +G+ +L VA+K +K + + E S++ + H NI+ L ++
Sbjct: 15 GEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV 74
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQL---LRGLA----YCHSRRI 301
+ + ++ EY+E L ++ L N+ K + QL LRG+A Y
Sbjct: 75 TKSRPVMIITEYMENGSLDKF-------LRENDGKFTVGQLVGMLRGIASGMKYLSEMNY 127
Query: 302 LHRDLKPQNLLINERGELKLADFGLAR 328
+HRDL +N+L+N K++DFGL+R
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 67/286 (23%), Positives = 120/286 (41%), Gaps = 46/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIH 250
KGTY VFK ++ + A+K + H+ A E ++L+ L H N+V + + +
Sbjct: 28 KGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA--EYNILKALSDHPNVVKFYGMYY 85
Query: 251 TEKC-----LTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
+ L LV E DL + + + L + L GL + H +
Sbjct: 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKT 145
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYST 360
+HRD+K N+L+ G +KL DFG++ A+ T+ N V T ++ P+V+ + +
Sbjct: 146 IHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDS 204
Query: 361 SID-------MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP 413
+ D +G+ I E+ G P P + + L PPP
Sbjct: 205 TYDARCDVWSLGITAI--ELGDGDP--PLADLHPMRALFKIPRNPPP------------- 247
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
L PE ++ D ++K L D ++R + ++ ++H +
Sbjct: 248 --------TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 64/248 (25%), Positives = 106/248 (42%), Gaps = 52/248 (20%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEY---------LEKDLKRYMDDCSNILSMN 280
E +L + H V L+ E L LV E+ L ++ KR+ +D +
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQ 139
Query: 281 NVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNE 340
V +F Y S I++RDLKP+NLL+++ G +K+ DFG AK V T+T++
Sbjct: 140 IVLIF--------EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF--AKVVDTRTYT-L 188
Query: 341 VVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400
T Y P++LL + +G +E+ G P F +E LI +
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF----YANEPLLIYQKI---- 240
Query: 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAM 455
L+ + F P+ +D++ L++K L +D +R A N
Sbjct: 241 --LEGIIYF----------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK 282
Query: 456 RHPYFNSL 463
HP+F ++
Sbjct: 283 EHPWFGNI 290
|
Length = 340 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 37/122 (30%), Positives = 62/122 (50%), Gaps = 1/122 (0%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVSLLRELRHANIVTLHDI 157
+G+G Y V K + + T +VA+K+ K E E T +RE+ +LR L+ NIV L +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 158 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217
L LVFEY+EK++ +++ N + V+ + K N + ++IK
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKP 128
Query: 218 EH 219
E+
Sbjct: 129 EN 130
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 29/90 (32%), Positives = 44/90 (48%), Gaps = 5/90 (5%)
Query: 94 FKLDKLGQGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
KLG+G + V+KG + VA+K +K + E +RE ++R+L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
NIV L + E+ L +V EY+ DL Y
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDY 91
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 37/133 (27%), Positives = 72/133 (54%), Gaps = 4/133 (3%)
Query: 198 VFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 257
V+K + + D VA+K +K E+E+ +RE ++ +L + IV + + E L L
Sbjct: 15 VYKMRKKQID--VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LML 71
Query: 258 VFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER 316
V E L +++ + ++++NV + Q+ G+ Y + +HRDL +N+L+ +
Sbjct: 72 VMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQ 131
Query: 317 GELKLADFGLARA 329
K++DFGL++A
Sbjct: 132 HYAKISDFGLSKA 144
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 36/133 (27%), Positives = 71/133 (53%), Gaps = 12/133 (9%)
Query: 208 NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 266
LVA+K ++ + + A ++E+ ++ L++ NI+ L + ++ L ++ EY+E DL
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 267 KRYMDD---------CSNI--LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE 315
+++ +NI +S+ N+ Q+ G+ Y S +HRDL +N L+
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGN 164
Query: 316 RGELKLADFGLAR 328
+K+ADFG++R
Sbjct: 165 HYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 44/166 (26%), Positives = 83/166 (50%), Gaps = 35/166 (21%)
Query: 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR----EVSLLRELRHANIVTLH 246
VK T A KG++ T VA+K +K E A + +R E +LL+++ H +++ L+
Sbjct: 17 VKAT-AFRLKGRAGYTT--VAVKMLK----ENASSSELRDLLSEFNLLKQVNHPHVIKLY 69
Query: 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNI-----------------------LSMNNV 282
+ L L+ EY + L+ ++ + + L+M ++
Sbjct: 70 GACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDL 129
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
F +Q+ RG+ Y +++HRDL +N+L+ E ++K++DFGL+R
Sbjct: 130 ISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 50/204 (24%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
VA+K +K + E + E+ +++ + +H NI+ L + L ++ EY K +L+
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 268 RYMD-----------DCSNI----LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
Y+ D + + ++ ++ +Q+ RG+ Y S++ +HRDL +N+L
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169
Query: 313 INERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIF 370
+ E +K+ADFGLAR + K +N + + + P+ L S G +
Sbjct: 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 229
Query: 371 HEMSS--GRPLFPGSTIEDELRLI 392
E+ + G P +PG +E+ +L+
Sbjct: 230 WEIFTLGGSP-YPGIPVEELFKLL 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 66/280 (23%), Positives = 102/280 (36%), Gaps = 80/280 (28%)
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL---------------- 326
+ ++ +L + H +HRD+KP N+LI+ G +KL DFGL
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG 163
Query: 327 -------------------ARAKSVPTKTFSNE--------VVTLWYRPPDVLLGSTEYS 359
R K + + V T Y P+VLL T Y+
Sbjct: 164 DHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL-RTGYT 222
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGST-IEDELRLICSILGPPPDELKSKLEFCITPVYPS 417
D VG I +EM G+P F T E +L++I ++ L PS
Sbjct: 223 QLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVI---------NWETTLHI------PS 267
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI---SAANAMRHPYFNSLGPQVHELSDTQ 474
++KL +A DL+ + L A+ R+ A HP+F + + +
Sbjct: 268 QAKLS--------REASDLILR-LCCGAEDRLGKNGADEIKAHPFFKGI-----DFASLI 313
Query: 475 SIFSLPHIKLTSNPTDGGLLPFYGQKSEKRWTGLSRRQSM 514
P+I ++PTD F EK + S S
Sbjct: 314 RRQKAPYIPKITHPTDTS--NFDPVDPEKLRSDDSGESSP 351
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 16/146 (10%)
Query: 193 GTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V G+ +L + VA+K +K + E + E S++ + H NI+ L ++
Sbjct: 15 GEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV 74
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQL---LRGLA----YCHSRRIL 302
K + +V EY+E L ++ + + QL LRG+A Y +
Sbjct: 75 TKSKPVMIVTEYMENG------SLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYV 128
Query: 303 HRDLKPQNLLINERGELKLADFGLAR 328
HRDL +N+L+N K++DFGL+R
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 6e-09
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 5/99 (5%)
Query: 95 KLDKLGQGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
KLG+G + V+KG T+ VA+K +K E + E S++++L H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSM 188
IV L + + L +V EY+ DL ++ L++
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTL 101
|
Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 6e-09
Identities = 30/103 (29%), Positives = 56/103 (54%), Gaps = 2/103 (1%)
Query: 228 IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM-DDCSNILSMNNVKLF 285
+ E ++++LRH ++ L+ + E+ + +V E ++ L Y+ L + +
Sbjct: 49 LAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDM 108
Query: 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
Q+ G+AY ++ +HRDL +N+L+ E K+ADFGLAR
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 57.1 bits (136), Expect = 8e-09
Identities = 52/216 (24%), Positives = 85/216 (39%), Gaps = 22/216 (10%)
Query: 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHA 149
SY L KLG+G++ V+ + R VALK + KLE + +RE+ +L L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 150 -NIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNN--VKGTYATVFKGKSRL 205
NIV L+D E L LV EY++ L+ + ++ A + L
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 206 TDNLVALKEIK-----LEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF- 259
+ ++IK L+ + + L + L + + + T +
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLI--DFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 260 --EYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGL 293
E L Y S+I S+ L++LL GL
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGIT---LYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 8/140 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G + V GK R VA+K I EGA I E ++ +L H +V L+ +
Sbjct: 14 SGQFGVVHLGKWRAQIK-VAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 250 HTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+K L +V E++E L Y+ LS + + + G+ Y +HRDL
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAA 128
Query: 309 QNLLINERGELKLADFGLAR 328
+N L++ G +K++DFG+ R
Sbjct: 129 RNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 29/103 (28%), Positives = 64/103 (62%), Gaps = 2/103 (1%)
Query: 228 IREVSLLRELRHANIVTLHDI-IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLF 285
++E ++++ H N+++L I + +E +V Y++ DL+ ++ ++ ++ ++ F
Sbjct: 44 LKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGF 103
Query: 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
Q+ +G+ Y S++ +HRDL +N +++E +K+ADFGLAR
Sbjct: 104 GLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 32/82 (39%), Positives = 51/82 (62%), Gaps = 7/82 (8%)
Query: 98 KLGQGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
K+G+GTY V+K K + D ALK+I+ G +A RE++LLREL+H N+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIE---GTGISMSACREIALLRELKHPNVISLQ 64
Query: 156 DII--HTEKCLTLVFEYLEKDL 175
+ H ++ + L+F+Y E DL
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDL 86
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 2/80 (2%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
Y L+K+G+G V+K R T VA+K+++L + I E+ ++++ +H NIV
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN--KELIINEILIMKDCKHPNIV 78
Query: 153 TLHDIIHTEKCLTLVFEYLE 172
+D L +V EY++
Sbjct: 79 DYYDSYLVGDELWVVMEYMD 98
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 21/58 (36%), Positives = 39/58 (67%)
Query: 271 DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
D +L++ ++ + FQ+ +G+ + SR+ +HRDL +N+L++E +K+ DFGLAR
Sbjct: 170 DLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 16/135 (11%)
Query: 209 LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
LVA+K +K E E A RE LL L+H +IV + + + L +VFEY+ DL
Sbjct: 37 LVAVKALK-EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 268 RYM--------------DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI 313
R++ D L++ + Q+ G+ Y S +HRDL +N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 314 NERGELKLADFGLAR 328
+ +K+ DFG++R
Sbjct: 156 GQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 34/141 (24%), Positives = 72/141 (51%), Gaps = 6/141 (4%)
Query: 193 GTYATVFKGKSR-LTDNL---VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + TV+KG + + VA+K ++ E A + E ++ + H ++V L I
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGI 77
Query: 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ + + L+ + + L Y+ + + + + + Q+ +G++Y +R++HRDL
Sbjct: 78 CLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLA 136
Query: 308 PQNLLINERGELKLADFGLAR 328
+N+L+ +K+ DFGLA+
Sbjct: 137 ARNVLVKTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 41/139 (29%), Positives = 71/139 (51%), Gaps = 6/139 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V+ G VA+K +K +P + + E ++++LRH +V L+ ++ +
Sbjct: 16 NGQFGEVWMGTWNGNTK-VAVKTLK--PGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-S 71
Query: 252 EKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E+ + +V EY+ K L D L + N+ Q+ G+AY +HRDL+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSA 131
Query: 310 NLLINERGELKLADFGLAR 328
N+L+ + K+ADFGLAR
Sbjct: 132 NILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 61/311 (19%), Positives = 111/311 (35%), Gaps = 50/311 (16%)
Query: 196 ATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIHTEKC 254
V K + T+ LVA+K+I L+ + +E+ R+L+H NI+ +
Sbjct: 14 MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73
Query: 255 LTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
L +V + +DL + L + L +L L Y HS+ +HR +K +
Sbjct: 74 LYVVSPLMAYGSCEDLLK--THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASH 131
Query: 311 LLINERGELKLADFGLA--------RAKSVPTKTFSNEVVTLWYRPPDVL----LGSTEY 358
+L++ G++ L+ + R + V S+ W P+VL G E
Sbjct: 132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL-SPEVLQQNLQGYNEK 190
Query: 359 STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
S +G+ E+++G P + L+ + G P L + E
Sbjct: 191 SDIYSVGITAC--ELANG--HVPFKDMPATQMLLEKVRGTVPCLLD------KSTYPLYE 240
Query: 419 SKLQLLAPEQMDSDALD----------------LVQKFLMYDAKQRISAANAMRHPYFNS 462
+ + D V+ L D + R SA+ + H +F
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK- 299
Query: 463 LGPQVHELSDT 473
Q + +
Sbjct: 300 ---QCKRRNTS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 24/248 (9%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLE-HEEGAPCTAIREVSLLRELRHANIVTLH-DIIH 250
G TV K A+K + +E E A EV L +IV H D
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102
Query: 251 TEK-------CLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSR 299
+ + LV +Y DL++ + + + L Q+L + + HS+
Sbjct: 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK 162
Query: 300 RILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEV-----VTLWYRPPDVLLG 354
++HRD+K N+L+ G +KL DFG ++ + T S++V T +Y P++
Sbjct: 163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYA---ATVSDDVGRTFCGTPYYVAPEIWR- 218
Query: 355 STEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDEL-RLICSILGPPPDELKSKLEFCIT 412
YS DM +G + +E+ + + F G +E+ + + + P P + +++ +T
Sbjct: 219 RKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVT 278
Query: 413 PVYPSESK 420
+ S+ K
Sbjct: 279 ALLSSDPK 286
|
Length = 496 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
VA+K +K + + + E+ +++ + +H NI+ L + L ++ EY K +L+
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 268 RYM------------DDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
Y+ D C L+ ++ +Q+ RG+ Y S++ +HRDL +N+L
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166
Query: 313 INERGELKLADFGLARAK---SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCI 369
+ E +K+ADFGLAR KT + + W P+ L S G +
Sbjct: 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWM-APEALFDRVYTHQSDVWSFGVL 225
Query: 370 FHEM-SSGRPLFPGSTIEDELRLI 392
E+ + G +PG +E+ +L+
Sbjct: 226 LWEIFTLGGSPYPGIPVEELFKLL 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 61/264 (23%), Positives = 114/264 (43%), Gaps = 48/264 (18%)
Query: 242 IVTLHDIIHTEKCLTLVFEY-LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
I TLH E L LV +Y + DL + + L + + ++ +++ + H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 301 ILHRDLKPQNLLINERGELKLADFG-LARAKSVPTKTFSNEVVTLWYRPPDVLL----GS 355
+HRD+KP N+L++ G ++LADFG + T S V T Y P++L G
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 356 TEYSTSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412
+Y D +GV C++ + P + S +E +++ + + +F
Sbjct: 183 GKYGPECDWWSLGV-CMYEMLYGETPFYAESLVETYGKIM---------NHEERFQF--- 229
Query: 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM----RHPYFNSLGPQVH 468
PS + +A DL+Q+ + +++R N + +H +F +
Sbjct: 230 ---PSHIT-------DVSEEAKDLIQRLIC--SRERRLGQNGIEDFKKHAFFEGI----- 272
Query: 469 ELSDTQSIFSL--PHIKLTSNPTD 490
D ++I +L P+I S+P+D
Sbjct: 273 ---DWENIRNLEAPYIPDVSSPSD 293
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 67/278 (24%), Positives = 115/278 (41%), Gaps = 72/278 (25%)
Query: 192 KGTYATVFKGKSRLTDNL--VALKEIKLEHEEGAPCTA------IREVSLLRELRHANIV 243
+G + +V +G+ D++ VA+K +K+ A CT + E ++E H N++
Sbjct: 9 EGEFGSVMEGQLNQDDSILKVAVKTMKI-----AICTRSEMEDFLSEAVCMKEFDHPNVM 63
Query: 244 TLHDIIHTEKCL-----------TLVFEYLEK-DLKRYM-----DDCSNILSMNNVKLFL 286
L + CL ++ +++ DL ++ DC L + F+
Sbjct: 64 RLIGV-----CLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 287 FQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA------------RAKSVPT 334
+ G+ Y S+ +HRDL +N ++NE + +ADFGL+ R +P
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 335 KTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSS-GRPLFPG---STIEDEL 389
K + E L Y+T D+ G E+++ G+ +PG S I D L
Sbjct: 179 KWIAIES-----------LADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
Query: 390 RLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
R + L PPD C+ +Y S LL P+
Sbjct: 228 RQ-GNRLKQPPD--------CLDGLYSLMSSCWLLNPK 256
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 38/139 (27%), Positives = 68/139 (48%), Gaps = 19/139 (13%)
Query: 209 LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
LVA+K ++ + + A ++EV +L L+ NI+ L + E L ++ EY+E DL
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 268 RYM------------------DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+++ C +S +++ Q+ G+ Y S +HRDL +
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 310 NLLINERGELKLADFGLAR 328
N L+ E +K+ADFG++R
Sbjct: 168 NCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 31/82 (37%), Positives = 51/82 (62%), Gaps = 7/82 (8%)
Query: 98 KLGQGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
K+G+GTY V+K K + + ALK+I+ G +A RE++LLREL+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIE---GTGISMSACREIALLRELKHPNVIALQ 64
Query: 156 DII--HTEKCLTLVFEYLEKDL 175
+ H+++ + L+F+Y E DL
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDL 86
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 81/328 (24%), Positives = 135/328 (41%), Gaps = 62/328 (18%)
Query: 197 TVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLRELRHANIVTLHDIIHTEKCL 255
+V+ + T LV ++ LE+ A++ EV L RH NI+T + T L
Sbjct: 15 SVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74
Query: 256 TLVFEYL-----EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
++ ++ LK Y + + + N+ LF LRGL Y H +HR++K +
Sbjct: 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNI---LFGALRGLNYLHQNGYIHRNIKASH 131
Query: 311 LLINERGELKLADFGLA----------RAKSV-PTKTFSNEVVTLWYRPPDVLLGSTEYS 359
+LI+ G + L+ GL+ +AK V FS V+ W P + Y+
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLP-WLSPELLRQDLYGYN 188
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELR---LICSILGPPPDEL------------ 403
D+ VG E+++GR F +D LR L+ + GPP L
Sbjct: 189 VKSDIYSVGITACELATGRVPF-----QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243
Query: 404 ------------KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451
+S + +T SE +L+ + + +LV+ L D ++R SA
Sbjct: 244 KNSQSGVDSGIGESVVAAGMTQTMTSE-RLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA 302
Query: 452 ANAMRHPYFNSLGPQVHELSDTQSIFSL 479
++ + H +F + Q SI SL
Sbjct: 303 SSLLSHAFFKQVKEQTQG-----SILSL 325
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 37/132 (28%), Positives = 65/132 (49%), Gaps = 11/132 (8%)
Query: 208 NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 266
LVA+K ++ + + A ++EV +L L NI L + + L ++ EY+E DL
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 267 KRYM--------DDCSNI--LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER 316
+++ N LS + + Q+ G+ Y S +HRDL +N L+ +
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN 166
Query: 317 GELKLADFGLAR 328
+K+ADFG++R
Sbjct: 167 YTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 22/52 (42%), Positives = 37/52 (71%)
Query: 277 LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
L+M ++ + FQ+ RG+ + SR+ +HRDL +N+L++E +K+ DFGLAR
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 2e-07
Identities = 38/133 (28%), Positives = 66/133 (49%), Gaps = 14/133 (10%)
Query: 209 LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267
LVA+K +K + + A RE LL L+H +IV + + L +VFEY++ DL
Sbjct: 37 LVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95
Query: 268 RYM------------DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE 315
+++ + L+ + + Q+ G+ Y S+ +HRDL +N L+ E
Sbjct: 96 KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155
Query: 316 RGELKLADFGLAR 328
+K+ DFG++R
Sbjct: 156 NLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 6/139 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V+ G T VA+K +K P ++E ++++LRH +V L+ ++ +
Sbjct: 16 QGCFGEVWMGTWNGTTK-VAIKTLK--PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-S 71
Query: 252 EKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E+ + +V E++ K L + L + + Q+ G+AY +HRDL+
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA 131
Query: 310 NLLINERGELKLADFGLAR 328
N+L+ + K+ADFGLAR
Sbjct: 132 NILVGDNLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 9/110 (8%)
Query: 228 IREVSLLRELRHANIVT-LHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNI-------LS 278
++E LL L H NI+ LH I + +++ Y+ +LK ++ C LS
Sbjct: 56 LQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 279 MNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
+ Q+ G++Y H R ++H+D+ +N +I+E ++K+ D L+R
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 41/187 (21%), Positives = 84/187 (44%), Gaps = 16/187 (8%)
Query: 192 KGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G + VF K++ + LV +K ++ +E RE+ + R+L H N+V L
Sbjct: 15 RGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLL 74
Query: 247 DIIHTEKCLTLVFEYLE-KDLKRYM--------DDCSNILSMNNVKLFLFQLLRGLAYCH 297
+ + ++ EY + DLK+++ LS Q+ G+ +
Sbjct: 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 298 SRRILHRDLKPQNLLINERGELKLADFGLARAK-SVPTKTFSNEVVTLWYRPPDVLLGST 356
+ R +HRDL +N L++ + E+K++ L++ + N ++ L + P+ +
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQ-ED 193
Query: 357 EYSTSID 363
++ST D
Sbjct: 194 DFSTKSD 200
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 19/42 (45%), Positives = 31/42 (73%), Gaps = 1/42 (2%)
Query: 287 FQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFGLA 327
+++ L Y HS+ ++HRD+KP N+LIN G++KL DFG++
Sbjct: 110 VSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 96 LDKLGQGTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
L++LG+G + V+KG+ RL+ VA+K +K E +E L+ +L+H N
Sbjct: 10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPN 69
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179
IV L + E+ ++FEYL DL ++
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFL 99
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI-KLEHEEGAPCTAIREV-SLLRELRHANIVTLHDII 249
+G + V K + D + A+K + K E + A RE +L + I TLH
Sbjct: 11 RGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF 70
Query: 250 HTEKCLTLVFEY-LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E L LV +Y + DL + + L + + +L +++ + H +HRD+KP
Sbjct: 71 QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKP 130
Query: 309 QNLLINERGELKLADFG-LARAKSVPTKTFSNEVVTLWYRPPDVLL----GSTEYSTSID 363
N+L++ G ++LADFG + T S V T Y P++L G +Y D
Sbjct: 131 DNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190
Query: 364 ---MGVGCIFHEMSSGRPLFPGSTIE 386
+GV C++ + P + S +E
Sbjct: 191 WWSLGV-CMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 21/76 (27%), Positives = 40/76 (52%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 154
++ LGQG+ V+K + + T + ALK+I ++ +E +RE+ LR +V
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKC 64
Query: 155 HDIIHTEKCLTLVFEY 170
+ + E +++V EY
Sbjct: 65 YGAFYKEGEISIVLEY 80
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 23/93 (24%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKL----EHEEGAPCTAIREVSLLRE 145
+ ++ K+G+G ++ V+K L +VALK++++ + + C ++E+ LL++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC--LKEIDLLKQ 58
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKR 177
L H N++ L +V E + DL R
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSR 91
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 11/89 (12%)
Query: 242 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV-----KLFLFQLLRGLAYC 296
+V L +K L +V EY+ D N++S +V K + +++ L
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGG------DLVNLMSNYDVPEKWAKFYTAEVVLALDAI 158
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFG 325
HS ++HRD+KP N+L+++ G LKLADFG
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 34/96 (35%), Positives = 49/96 (51%), Gaps = 14/96 (14%)
Query: 242 IVTLHDIIHTEKCLTLVFEYL-EKDLKR------YMDDCSNILSMNNVKLFLFQLLRGLA 294
IV L+ + + + LV EYL D+K Y D+ + ++ V L L
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVAL-------ALD 118
Query: 295 YCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330
Y H I+HRDLKP N+LI+ G +KL DFGL++
Sbjct: 119 YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 58/226 (25%), Positives = 92/226 (40%), Gaps = 54/226 (23%)
Query: 286 LFQLLRGLAYCHSR-RILHRDLKPQNLLINERGE-----------------LKLADFG-- 325
+FQ L Y H+ ++H DLKP+N+L+ E + +++ D G
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILM-ETSDTVVDPVTNRALPPDPCRVRICDLGGC 295
Query: 326 ----LARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDM-GVGCIFHEMSSGRPL 379
+R V T+ YR P+V+LG YST DM +GCI +E+ +G+ L
Sbjct: 296 CDERHSRTAIVSTRH---------YRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLL 344
Query: 380 FPGSTIEDELRLICSILGPPPDELKSK---------------LEFCITPVYPSESKLQLL 424
+ + L L+ LG P E + L C P + +
Sbjct: 345 YDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARP 404
Query: 425 APEQMDSDAL-DLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHE 469
E + D L DL+ L YD ++R++A HPY P+ +
Sbjct: 405 VREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPECRQ 450
|
Length = 467 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 39/151 (25%), Positives = 72/151 (47%), Gaps = 5/151 (3%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCS----NILSMNNVKLF 285
E+ L L H NI+ + +I+ +E ++ + + DL +M D + + + +
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272
Query: 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFS-NEVVTL 344
+ QLL + Y H ++++HRD+K +N+ +N G++ L DFG A + F V T+
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332
Query: 345 WYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS 375
P++L G + G I +M S
Sbjct: 333 ATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 21/52 (40%), Positives = 37/52 (71%)
Query: 277 LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
L++ ++ + FQ+ RG+ + SR+ +HRDL +N+L++E +K+ DFGLAR
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 71/315 (22%), Positives = 125/315 (39%), Gaps = 69/315 (21%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V + + T ++ A+K ++ LE E+ A A R++ L E A +V +
Sbjct: 11 RGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI--LVEADGAWVVKMFY 68
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
++ L L+ E+L + + LS + ++ + + + H +HRD+K
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128
Query: 308 PQNLLINERGELKLADFGLARA--KSVPTKTFSN-------------------------- 339
P NLL++ +G +KL+DFGL K+ T+ + N
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188
Query: 340 -------EVVTLWYRPPDVLLGSTEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRL 391
V T Y P+V + T Y+ D +G I +EM G P F T
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSET------- 240
Query: 392 ICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451
P + + + + T V+P E + A DL+ +F D++ RI +
Sbjct: 241 -------PQETYRKVMNWKETLVFPPEVPIS--------EKAKDLILRFCT-DSENRIGS 284
Query: 452 ANAMR---HPYFNSL 463
HP+F +
Sbjct: 285 NGVEEIKSHPFFEGV 299
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 29/91 (31%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVSLLRELRHANI 151
Y L +G+G Y V + T VA+K+I EH+ T +RE+ +LR +H NI
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENI 65
Query: 152 VTLHDIIHTE-----KCLTLVFEYLEKDLKR 177
+ + DII + +V E +E DL +
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETDLYK 96
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 23/75 (30%), Positives = 40/75 (53%), Gaps = 3/75 (4%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
L+KLG+G+Y +V+K + T +VA+K + + E I+E+S+L++ IV +
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPV---EEDLQEIIKEISILKQCDSPYIVKYY 64
Query: 156 DIIHTEKCLTLVFEY 170
L +V EY
Sbjct: 65 GSYFKNTDLWIVMEY 79
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 25/78 (32%), Positives = 41/78 (52%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 154
LD+LG+G Y +V+K R T +A+KEI+LE +E I E+ +L + IV
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 155 HDIIHTEKCLTLVFEYLE 172
+ E + + EY++
Sbjct: 65 YGAFFIEGAVYMCMEYMD 82
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 40/141 (28%), Positives = 75/141 (53%), Gaps = 6/141 (4%)
Query: 193 GTYATVFKG--KSRLTDNLVALKEIKLEHEEGA-PCTAIREVSLLRELRHANIVTLHDII 249
G + TV KG K + ++ VA+K +K ++ + A +RE +++++L + IV + I
Sbjct: 6 GNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC 65
Query: 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E LV E E L +++ ++ N +L + Q+ G+ Y +HRDL
Sbjct: 66 EAES-WMLVMELAELGPLNKFLQKNKHVTEKNITEL-VHQVSMGMKYLEETNFVHRDLAA 123
Query: 309 QNLLINERGELKLADFGLARA 329
+N+L+ + K++DFGL++A
Sbjct: 124 RNVLLVTQHYAKISDFGLSKA 144
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 20/101 (19%)
Query: 292 GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK------------SVPTKTFSN 339
+ Y HS+ +LHRDLKP N+L+ GE+ + D+G A K +S+
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 340 EVV------TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEM 373
+ T Y P+ LLG S S D+ +G I ++M
Sbjct: 185 MTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQM 224
|
Length = 932 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 61/262 (23%), Positives = 109/262 (41%), Gaps = 44/262 (16%)
Query: 242 IVTLHDIIHTEKCLTLVFEY-LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
I LH E L LV +Y + DL + + L + + +L +++ + H
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 301 ILHRDLKPQNLLINERGELKLADFG-LARAKSVPTKTFSNEVVTLWYRPPDVLL----GS 355
+HRD+KP N+L+++ G ++LADFG R + T + V T Y P++L G
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 356 TEYSTSID-MGVGCIFHEMSSGR-PLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP 413
Y D +G +EM G P + S +E +++ K +F
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM---------NHKEHFQF---- 229
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI---SAANAMRHPYFNSLGPQVHEL 470
P + + +A DL+++ L+ + R+ + HP+F +
Sbjct: 230 --PPDV-------TDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGI------- 272
Query: 471 SDTQSIFSL--PHIKLTSNPTD 490
D +I + P++ S+PTD
Sbjct: 273 -DWDNIRNSTAPYVPEVSSPTD 293
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 99 LGQGTYATVFKGKSR--LTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 153
LG+G + VF G+ +N LVA+K +K A RE LL +H NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRYM 179
+ + +VFEY+E DL +++
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFL 99
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 210 VALKEIKLEHEEGAPCTAIREVSLLR-ELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLK 267
VA+K +K + EG + +++R L+H NIV L ++ E+ L+++F Y DL
Sbjct: 38 VAIKTLK-DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 268 RYM------------DDCSNILSMNNVKLFLF---QLLRGLAYCHSRRILHRDLKPQNLL 312
++ DD + S F+ Q+ G+ + S ++H+DL +N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 313 INERGELKLADFGLARAKSVPT--KTFSNEVVTL-WYRPPDVLLGSTEYSTSIDMGVGCI 369
+ ++ +K++D GL R K N ++ + W P ++ G + I G +
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI-WSYGVV 215
Query: 370 FHEM-SSGRPLFPGSTIEDELRLICS--ILGPPPDE 402
E+ S G + G + +D + +I + +L P PD+
Sbjct: 216 LWEVFSYGLQPYCGYSNQDVIEMIRNRQVL-PCPDD 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 22/49 (44%), Positives = 33/49 (67%)
Query: 279 MNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327
+N +K + Q+L GL H I+HRD+KP+NLL+ G++K+ DFG A
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 31/106 (29%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 232 SLLRELR-------HANIVTLHDIIHTEKCLTLVFEY-LEKDLKRYMDDCSN-ILSMNNV 282
+L+ EL+ H NIV L + ++ EY DL ++ L++ ++
Sbjct: 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL 143
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
F +Q+ +G+A+ S+ +HRDL +N+L+ +K+ DFGLAR
Sbjct: 144 LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 16/116 (13%)
Query: 229 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD---------------D 272
RE LL L+H +IV + + L +VFEY++ DL +++
Sbjct: 56 REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115
Query: 273 CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
L ++ + Q+ G+ Y S+ +HRDL +N L+ +K+ DFG++R
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 22/58 (37%), Positives = 37/58 (63%)
Query: 271 DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
DD S L+ ++ F +Q+ RG+ + S+ +HRDL +N+L+ + +K+ DFGLAR
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 3/83 (3%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA--- 149
Y +L+ +G+G Y V++GK T +VALK I L+ + REV+LL +LR +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 150 NIVTLHDIIHTEKCLTLVFEYLE 172
NI + L ++ EY E
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAE 85
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 44/155 (28%), Positives = 69/155 (44%), Gaps = 17/155 (10%)
Query: 242 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV-----KLFLFQLLRGLAYC 296
+V L ++ L +V EY+ D N++S +V + + +++ L
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGG------DLVNLMSNYDVPEKWARFYTAEVVLALDAI 158
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLL-- 353
HS +HRD+KP N+L+++ G LKLADFG + + V T Y P+VL
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 354 -GSTEYSTSID-MGVGCIFHEMSSG-RPLFPGSTI 385
G Y D VG +EM G P + S +
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 20/149 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLREL----RHAN---IV 243
+G + TV K + + ++A+K I+ +E +E LL +L R ++ IV
Sbjct: 14 RGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-------KEQKRLLMDLDVVMRSSDCPYIV 66
Query: 244 TLHDIIHTEK----CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR 299
+ + E C+ L+ L+K K + +++ + ++ L Y
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE 126
Query: 300 -RILHRDLKPQNLLINERGELKLADFGLA 327
+I+HRD+KP N+L++ G +KL DFG++
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANI 151
Y + +G+G+Y V T VA+K+I E + T I RE+ LLR LRH +I
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 152 VTLHDII-----HTEKCLTLVFEYLEKDL 175
V + I+ K + +VFE +E DL
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELMESDL 90
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 23/78 (29%), Positives = 44/78 (56%), Gaps = 3/78 (3%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVT 153
+ +K+G GT+ V+ + T L+A+KEI+++ + I E+ +L L+H N+V
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 154 LHDI-IHTEKCLTLVFEY 170
+ + +H EK + + EY
Sbjct: 64 YYGVEVHREK-VYIFMEY 80
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-06
Identities = 60/259 (23%), Positives = 96/259 (37%), Gaps = 80/259 (30%)
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA--------------- 327
+ ++ +L + H +HRD+KP N+LI+ G +KL DFGL
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG 163
Query: 328 -------------------------------RAKSVPTKTFSNEVV-TLWYRPPDVLLGS 355
RA + ++ +V T Y P+VLL
Sbjct: 164 SHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-R 222
Query: 356 TEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
Y+ D VG I EM G+P F L P P E + K V
Sbjct: 223 KGYTQLCDWWSVGVILFEMLVGQPPF---------------LAPTPTETQLK-------V 260
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI---SAANAMRHPYFNSLGPQVHELS 471
E+ L + ++ +A+DL+ K L A++R+ A + HP+F+ + + S
Sbjct: 261 INWENTLHIPPQVKLSPEAVDLITK-LCCSAEERLGRNGADDIKAHPFFSEV-----DFS 314
Query: 472 DTQSIFSLPHIKLTSNPTD 490
P++ S+P D
Sbjct: 315 SDIRTQPAPYVPKISHPMD 333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 35/124 (28%), Positives = 59/124 (47%), Gaps = 8/124 (6%)
Query: 50 LSLPADLHLPESFLAKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFK 109
L++P L P S + ++ A + S +SLSE+ ++G G TV+K
Sbjct: 41 LAVPLPLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVN--------RIGSGAGGTVYK 92
Query: 110 GKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169
R T L ALK I HE+ RE+ +LR++ H N+V HD+ + ++ E
Sbjct: 93 VIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152
Query: 170 YLEK 173
+++
Sbjct: 153 FMDG 156
|
Length = 353 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 23/72 (31%), Positives = 38/72 (52%)
Query: 274 SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVP 333
++ LS + F + RG+ Y ++ +HRDL +N+L+ E K+ADFGL+R + V
Sbjct: 118 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 177
Query: 334 TKTFSNEVVTLW 345
K + W
Sbjct: 178 VKKTMGRLPVRW 189
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 9/94 (9%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA---IREVSLLRELR 147
Y ++ +G G Y V + VA+K K+ H P A +RE+ +LR +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK--KIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 148 HANIVTLHDIIHTE----KCLTLVFEYLEKDLKR 177
H NI+ + DI+ K + +V + +E DL
Sbjct: 63 HDNIIAIRDILRPPGADFKDVYVVMDLMESDLHH 96
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (112), Expect = 9e-06
Identities = 24/84 (28%), Positives = 41/84 (48%), Gaps = 3/84 (3%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHD 156
LG+G++ V + + T L A+K +K + + + E ++L + H IV LH
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 157 IIHTEKCLTLVFEYLEK-DLKRYM 179
TE+ L LV EY +L ++
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL 84
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 26/89 (29%), Positives = 44/89 (49%), Gaps = 9/89 (10%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI----REVSLLRELRHANIVTL 154
LG G++ +V++G + + A+KE+ L + A+ +E++LL +L+H NIV
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 155 HDIIHTEKCLTLVFEY-----LEKDLKRY 178
E L + E L K LK+Y
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKY 96
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 30/82 (36%), Positives = 45/82 (54%), Gaps = 13/82 (15%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-LVALKEIKL------EHEEGAPCTAIREVSLLRELRH 148
L KLG+G+Y +V+K K RL+DN ALKE+ L E E+ A+ E+ +L + H
Sbjct: 5 LKKLGKGSYGSVYKVK-RLSDNQFYALKEVDLGSMSQKERED-----AVNEIRILASVNH 58
Query: 149 ANIVTLHDIIHTEKCLTLVFEY 170
NI++ + L +V EY
Sbjct: 59 PNIISYKEAFLDGNKLCIVMEY 80
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 23/72 (31%), Positives = 38/72 (52%), Gaps = 1/72 (1%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 158
LG G + V+K + + T A K I++E EE + E+ +L E +H NIV L++
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPNIVGLYEAY 71
Query: 159 HTEKCLTLVFEY 170
E L ++ E+
Sbjct: 72 FYENKLWILIEF 83
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 34/146 (23%), Positives = 60/146 (41%), Gaps = 7/146 (4%)
Query: 192 KGTYATVFKGK--SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V G+ ++ V +KE++ ++EV REL H N++
Sbjct: 5 NGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQC 64
Query: 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQL----LRGLAYCHSRRILHR 304
LV E+ DLK Y+ +++ K L ++ GL + H +H
Sbjct: 65 IESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHS 124
Query: 305 DLKPQNLLINERGELKLADFGLARAK 330
DL +N + +K+ D+GLA +
Sbjct: 125 DLALRNCQLTADLSVKIGDYGLALEQ 150
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 54/245 (22%), Positives = 97/245 (39%), Gaps = 30/245 (12%)
Query: 192 KGTYATVFKGKSRLTDNL-----VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
G + V++G R D VA+K + E + E ++ + H NIV L
Sbjct: 16 HGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLI 75
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSN------ILSMNNVKLFLFQLLRGLAYCHSR 299
+ ++ E + DLK ++ + L+M ++ + +G Y
Sbjct: 76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135
Query: 300 RILHRDLKPQNLLINERGE---LKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLG 354
+HRD+ +N L+ +G K+ADFG+AR ++ + ++ + + PP+ L
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD 195
Query: 355 S--TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS--ILGPPPDELKSKLEFC 410
T + GV + S G +PG T ++ + + L PP C
Sbjct: 196 GIFTSKTDVWSFGVLL-WEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKG--------C 246
Query: 411 ITPVY 415
PVY
Sbjct: 247 PGPVY 251
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 44/175 (25%), Positives = 82/175 (46%), Gaps = 31/175 (17%)
Query: 170 YLEKDLKRYMDDCSNILSMNNV-KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI 228
YL D ++Y D +++ ++ + GT V+K + + T +++A+K++ T
Sbjct: 2 YLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM--------RRTGN 53
Query: 229 REVSLLRELRHANIVTL-HDIIHTEKCL-TLVFEY------------LEKDLKR-YMDDC 273
+E R L ++V HD + KC + + L+K LKR
Sbjct: 54 KE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIP 112
Query: 274 SNILSMNNVKLFLFQLLRGLAYCHSRR-ILHRDLKPQNLLINERGELKLADFGLA 327
+IL V +++ L Y + ++HRD+KP N+L++ G +KL DFG++
Sbjct: 113 EDILGKMTV-----AIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 12/144 (8%)
Query: 193 GTYATVFKGKSRLTDNLVALK-EIKLEHEEGAPCTAIR---EVSLLRELRHANIVTLHDI 248
G + TV+KG V + IK+ +E P + E ++ + H ++V L +
Sbjct: 18 GAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGV 77
Query: 249 I--HTEKCLTLVFEY--LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
T + +T + + L + + D+ + L +N + Q+ +G+ Y RR++HR
Sbjct: 78 CLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLN----WCVQIAKGMMYLEERRLVHR 133
Query: 305 DLKPQNLLINERGELKLADFGLAR 328
DL +N+L+ +K+ DFGLAR
Sbjct: 134 DLAARNVLVKSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 30/160 (18%)
Query: 192 KGTYATVFKGKSRLTDNL---VALKEIKL------EHEEGAPCTAIREVSLLRELRHANI 242
+G + +V +G+ D VA+K +KL E EE + E + +++ H N+
Sbjct: 9 EGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-----FLSEAACMKDFDHPNV 63
Query: 243 VTLHDIIHTEKCL------TLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLR---- 291
+ L + L ++ +++ DL ++ + L KL L LL+
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFL--LYSRLGGLPEKLPLQTLLKFMVD 121
Query: 292 ---GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
G+ Y +R +HRDL +N ++ E + +ADFGL++
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 63/268 (23%), Positives = 111/268 (41%), Gaps = 52/268 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V + + T ++ A+K ++ LE E+ A R++ L E +V +
Sbjct: 11 RGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI--LVEADSLWVVKMFY 68
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L L+ E+L + + L+ + ++ + + + H +HRD+K
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128
Query: 308 PQNLLINERGELKLADFGLARA--------------KSVPTK-TFSN------------- 339
P NLL++ +G +KL+DFGL S+P+ TF N
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188
Query: 340 -------EVVTLWYRPPDVLLGSTEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRL 391
V T Y P+V + T Y+ D +G I +EM G P F T ++ +
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKK 247
Query: 392 IC----SILGPP--PDELKSK---LEFC 410
+ +++ PP P K+K L FC
Sbjct: 248 VMNWKETLIFPPEVPISEKAKDLILRFC 275
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 26/79 (32%), Positives = 40/79 (50%), Gaps = 1/79 (1%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
Y + +K+GQG TV+ T VA+K++ L+ + I E+ ++RE +H NIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI-INEILVMRENKHPNIV 79
Query: 153 TLHDIIHTEKCLTLVFEYL 171
D L +V EYL
Sbjct: 80 NYLDSYLVGDELWVVMEYL 98
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 46/229 (20%)
Query: 241 NIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR 299
N+V LH I +E + LV ++ E L ++ NI VK + +++ L H
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPE-ECVKRWAAEMVVALDALHRE 104
Query: 300 RILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
I+ RDL P N+L+++RG ++L F R V + E V Y P+V G +E +
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEV-EDSCDGEAVENMYCAPEV-GGISEET 160
Query: 360 TSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS- 417
+ D +G I E+ +G+ L +PS
Sbjct: 161 EACDWWSLGAILFELLTGKTL--------------------------------VECHPSG 188
Query: 418 -ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA-----MRHPYF 460
+ L PE + +A L+Q+ L ++ +R+ A A HP+F
Sbjct: 189 INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 22/55 (40%), Positives = 34/55 (61%)
Query: 274 SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
S LS ++ F +Q+ G+ + S+ +HRDL +N+LI E +K+ DFGLAR
Sbjct: 233 SPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR 287
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 24/83 (28%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 261 YLEKDLK-RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGEL 319
Y+++D+ +++ L ++ F +Q+ +G+++ S+ +HRDL +N+L+
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT 253
Query: 320 KLADFGLARAKSVPTKTFSNEVV 342
K+ DFGLAR + SN VV
Sbjct: 254 KICDFGLAR----DIRNDSNYVV 272
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 22/157 (14%)
Query: 192 KGTYATVFKGKSRLTDNL--------VALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243
G + V++G TD L VA+K ++ + ++E L+ H NIV
Sbjct: 5 SGAFGEVYEGT--ATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 244 TLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC------SNILSMNNVKLFLFQLLRGLAYC 296
L + + ++ E +E DL Y+ D +L++ + + +G Y
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 297 HSRRILHRDLKPQNLLINERGE-----LKLADFGLAR 328
+HRDL +N L++E+G +K+ DFGLAR
Sbjct: 123 EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 33/95 (34%), Positives = 45/95 (47%), Gaps = 6/95 (6%)
Query: 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA---IREVSLL 143
F Y L +G G + V + +LT VA+K K+ P A RE+ LL
Sbjct: 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLL 63
Query: 144 RELRHANIVTLHDI-IHTEKCLTLVFEYLEKDLKR 177
+ LRH NI++L DI I + + V E L DL R
Sbjct: 64 KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHR 98
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 23/70 (32%), Positives = 38/70 (54%), Gaps = 17/70 (24%)
Query: 259 FEYLEKDLKR-YMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317
++ +D+ R YM +C +L++ V H +HRD+KP N+LI+ G
Sbjct: 95 YDTFSEDVTRFYMAEC--VLAIEAV--------------HKLGFIHRDIKPDNILIDRGG 138
Query: 318 ELKLADFGLA 327
+KL+DFGL+
Sbjct: 139 HIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 66/262 (25%), Positives = 100/262 (38%), Gaps = 86/262 (32%)
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA--------------- 327
+ ++ +L + H +HRD+KP N+LI+ G +KL DFGL
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG 163
Query: 328 ---RAKSVPTKTFSNE--------------------------------VVTLWYRPPDVL 352
R S+ FSNE V T Y P+VL
Sbjct: 164 DHVRQDSM---DFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220
Query: 353 LGSTEYSTSID-MGVGCIFHEMSSGRPLFPGST-IEDELRLICSILGPPPDELKSKLEFC 410
L T Y+ D VG I +EM G+P F T +E ++++I ++ L
Sbjct: 221 L-RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI---------NWQTSLHI- 269
Query: 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLM--YDAKQRISAANAMRHPYFNSLGPQVH 468
P ++K L+PE A DL+ K D + A HP+F ++
Sbjct: 270 -----PPQAK---LSPE-----ASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTI----- 311
Query: 469 ELSDTQSIFSLPHIKLTSNPTD 490
+ S S P+I ++PTD
Sbjct: 312 DFSSDLRQQSAPYIPKITHPTD 333
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 5e-05
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 15/103 (14%)
Query: 229 REVSLLRELRHANIVT--LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLF 285
E LL E R A + T ++D+ EK T+V EY+ KDLK ++ ++
Sbjct: 385 AEARLLSEARRAGVPTPVIYDVDPEEK--TIVMEYIGGKDLKDVLEGNPELVRK------ 436
Query: 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
+ +A H I+H DL N ++ + L L DFGL +
Sbjct: 437 ---VGEIVAKLHKAGIVHGDLTTSNFIVRD-DRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 8/84 (9%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHD 156
+G+G Y V K+ T+ VA+K+I ++ A T +RE+ LLR L H N++ + D
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 157 II---HTE--KCLTLVFEYLEKDL 175
I+ H E + +V+E ++ DL
Sbjct: 72 IMPPPHREAFNDVYIVYELMDTDL 95
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 9e-05
Identities = 36/153 (23%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 192 KGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTA-IREVSLLRELRHANI----- 242
KG + +V + + + D VA+K +K + + +RE + ++E H N+
Sbjct: 9 KGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIG 68
Query: 243 VTLHDIIHTEKCLTLVFEYLEK--DLKRYM-----DDCSNILSMNNVKLFLFQLLRGLAY 295
V+L + +V K DL ++ + L + + F+ + G+ Y
Sbjct: 69 VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEY 128
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
S+ +HRDL +N ++NE + +ADFGL++
Sbjct: 129 LSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 30/114 (26%), Positives = 50/114 (43%), Gaps = 17/114 (14%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
Y L LG G+ VF D VA+K+I L + A+RE+ ++R L H NIV
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK-HALREIKIIRRLDHDNIV 65
Query: 153 TLHDIIHTE--------------KCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
+++++ + +V EY+E DL ++ LS + +
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHAR 117
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 23/79 (29%), Positives = 38/79 (48%), Gaps = 1/79 (1%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLRELRHANI 151
Y + K+G+G++ ++ K++ +KEI L A + EV LL +++H NI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 152 VTLHDIIHTEKCLTLVFEY 170
VT L +V EY
Sbjct: 62 VTFFASFQENGRLFIVMEY 80
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 17/50 (34%), Positives = 30/50 (60%)
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF 337
Q+ +G++Y R++HRDL +N+L+ +K+ DFGLAR + +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEY 166
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 7/65 (10%)
Query: 288 QLLR-------GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNE 340
QLL G+ Y ++ +HRDL +N+L+ E K+ADFGL+R + V K
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 172
Query: 341 VVTLW 345
+ W
Sbjct: 173 LPVRW 177
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 17/52 (32%), Positives = 33/52 (63%)
Query: 277 LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
L ++++ F Q+ +G+ + S+ +HRD+ +N+L+ + K+ DFGLAR
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR 260
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 30/111 (27%), Positives = 45/111 (40%), Gaps = 13/111 (11%)
Query: 79 RQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKL----EHEEGAPC 134
RQ L++ + + Y L +G G Y V T VA+K KL + A
Sbjct: 3 RQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK--KLSRPFQSAIHAKR 60
Query: 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYM 179
T RE+ LL+ + H N++ L D+ L LV + DL +
Sbjct: 61 T-YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIV 110
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 24/86 (27%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKL------EHEEGAPCTAIREVSLLREL 146
Y K+ K+G+G++ KS+ +KEI + E EE + +EV++L +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREE-----SRKEVAVLSNM 56
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLE 172
+H NIV + L +V +Y E
Sbjct: 57 KHPNIVQYQESFEENGNLYIVMDYCE 82
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 6/91 (6%)
Query: 99 LGQGTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 153
+GQG + VF+ + +VA+K +K E RE +L+ E H NIV
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 154 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS 183
L + K + L+FEY+ DL ++ S
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRS 103
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 19/53 (35%), Positives = 31/53 (58%)
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNE 340
Q+ +G+ Y RR++HRDL +N+L+ +K+ DFGLA+ K + E
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAE 169
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 21/72 (29%), Positives = 37/72 (51%)
Query: 274 SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVP 333
++ L+ + F + G+ Y ++ +HRDL +N+L+ E K+ADFGL+R + V
Sbjct: 113 ASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY 172
Query: 334 TKTFSNEVVTLW 345
K + W
Sbjct: 173 VKKTMGRLPVRW 184
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 31/152 (20%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 192 KGTYATVFKGKSRLT-----DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G++ V++G ++ + VA+K + + E S+++E ++V L
Sbjct: 16 QGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 75
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYM------DDCSNILSMNNVKLFL---FQLLRGLAYC 296
++ + ++ E + + DLK Y+ + + + + ++K + ++ G+AY
Sbjct: 76 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL 135
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLAR 328
++ + +HRDL +N ++ E +K+ DFG+ R
Sbjct: 136 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 19/41 (46%), Positives = 26/41 (63%), Gaps = 1/41 (2%)
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFGLA 327
Q+L L HS I+HRD+KPQN++ +E G K+ D G A
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 22/78 (28%), Positives = 38/78 (48%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
Y L +G+G++ + +D A+KEI+L A + +E LL +++H NIV
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 153 TLHDIIHTEKCLTLVFEY 170
+ + L +V EY
Sbjct: 62 AFKESFEADGHLYIVMEY 79
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 22/65 (33%), Positives = 38/65 (58%), Gaps = 6/65 (9%)
Query: 94 FKLDKL-GQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLREL-RHAN 150
F+L ++ G+GTY V+K + + T LVA+K + + +E I+ E ++LR+ H N
Sbjct: 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE---EEIKEEYNILRKYSNHPN 64
Query: 151 IVTLH 155
I T +
Sbjct: 65 IATFY 69
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 5e-04
Identities = 25/89 (28%), Positives = 40/89 (44%), Gaps = 5/89 (5%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 154
L +LG G V K R T ++A+K I+LE E +RE+ +L + IV
Sbjct: 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 155 HDIIHTEKCLTLVFEY-----LEKDLKRY 178
+ + +++ EY L+K LK
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEV 93
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 22/81 (27%), Positives = 42/81 (51%), Gaps = 8/81 (9%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC-------TAI-REVSLLRELRHAN 150
+G G++ +V+ G + + L+A+K+++L + A+ RE++LL+EL+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 151 IVTLHDIIHTEKCLTLVFEYL 171
IV L + EY+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYV 88
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 18/62 (29%), Positives = 32/62 (51%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + L+ +G+G++ V+K + T+ +VA+K I LE E +E+ L + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60
Query: 151 IV 152
I
Sbjct: 61 IT 62
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 3/81 (3%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHA 149
Y + ++G GTY V+K ++ T L A+K IKL E G + I +E+ +++E +H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL--EPGDDFSLIQQEIFMVKECKHC 66
Query: 150 NIVTLHDIIHTEKCLTLVFEY 170
NIV + + L + EY
Sbjct: 67 NIVAYFGSYLSREKLWICMEY 87
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 23/81 (28%), Positives = 41/81 (50%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + KL+++G+G++ VFKG T +VA+K I LE E +E+++L +
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 151 IVTLHDIIHTEKCLTLVFEYL 171
+ + L ++ EYL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYL 84
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 0.001
Identities = 27/81 (33%), Positives = 42/81 (51%), Gaps = 1/81 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ Y + +K+GQG TVF T VA+K+I L+ + I E+ +++EL++ N
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELI-INEILVMKELKNPN 77
Query: 151 IVTLHDIIHTEKCLTLVFEYL 171
IV D L +V EYL
Sbjct: 78 IVNFLDSFLVGDELFVVMEYL 98
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 21/62 (33%), Positives = 37/62 (59%), Gaps = 1/62 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + + ++G GTY V+K ++ T L A+K IKLE E +E+ ++++ +H+N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-QEIIMMKDCKHSN 67
Query: 151 IV 152
IV
Sbjct: 68 IV 69
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 36/146 (24%), Positives = 59/146 (40%), Gaps = 7/146 (4%)
Query: 192 KGTYATVFKGK--SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V G+ S T V +KE+++ + E R L+H+N++
Sbjct: 5 NGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQC 64
Query: 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFL----FQLLRGLAYCHSRRILHR 304
LV E+ DLK Y+ C M L ++ GL + H +H
Sbjct: 65 TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHS 124
Query: 305 DLKPQNLLINERGELKLADFGLARAK 330
DL +N L+ +K+ D+GL+ K
Sbjct: 125 DLALRNCLLTADLTVKIGDYGLSHNK 150
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 23/85 (27%), Positives = 45/85 (52%), Gaps = 3/85 (3%)
Query: 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLH 155
K+G+G ++ V++ L VALK++++ + A I+E+ LL++L H N++ +
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRYM 179
+ L +V E + DL R +
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMI 93
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 20/59 (33%), Positives = 29/59 (49%), Gaps = 3/59 (5%)
Query: 99 LGQGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 154
LG G + +V KG + VA+K +K EH +RE S++ +L H IV L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL 61
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 24/81 (29%), Positives = 42/81 (51%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + KL+K+G+G++ VFKG T +VA+K I LE E +E+++L +
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 151 IVTLHDIIHTEKCLTLVFEYL 171
+ + + L ++ EYL
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYL 84
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 28/113 (24%), Positives = 52/113 (46%), Gaps = 4/113 (3%)
Query: 99 LGQGTYATVFKGKSRL---TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
+G G + VF+G ++ + VA+K +K + E + E S++ + H NI+ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 156 DIIHTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKGTYATVFKGKSRLTD 207
++ K ++ EY+E L +Y+ D S + G + G L+D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 27/89 (30%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTD----NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 151
+++LG+ + ++KG L LVA+K +K + +E SL+ EL H NI
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 152 VTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179
V L ++ E+ + ++FEYL + DL ++
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFL 98
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 47/183 (25%), Positives = 72/183 (39%), Gaps = 20/183 (10%)
Query: 230 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQ 288
E L + H+NIV L +I + +V EY+ L ++ L + L
Sbjct: 56 EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPG 115
Query: 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG-LARAKSVPT-KTFSNEVVTLWY 346
L G+ Y +H+ L +L+N K++ F L KS T S + LW
Sbjct: 116 LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 347 RPPDVLLGSTEYSTSIDM-GVGCIFHE-MSSG-RPLFPGS------TIEDELRLICSILG 397
P + +S++ D+ G + E MS G RP + S +ED RL
Sbjct: 176 APEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------ 227
Query: 398 PPP 400
P P
Sbjct: 228 PAP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 7/88 (7%)
Query: 98 KLGQGTYATVFKGK-SRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+LG+G + VF + L LVA+K +K E E A RE LL L+H +IV
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTVLQHQHIV 70
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRYM 179
+ + + L +VFEY+ DL R++
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFL 98
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 34/132 (25%), Positives = 58/132 (43%), Gaps = 19/132 (14%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKL------EHEEGAPCTAIREVSLLRELRHA 149
L+K+G+G++ VFK + + A+K+I L E EE AI E +L +L +
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREE-----AIDEARVLAKLDSS 59
Query: 150 NIVTLHDIIHTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSR 204
I+ ++ + L +V EY L K LK L + V + + G +
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAH 116
Query: 205 LTDNLVALKEIK 216
L + ++IK
Sbjct: 117 LHSKKILHRDIK 128
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 21/83 (25%), Positives = 37/83 (44%), Gaps = 10/83 (12%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKE------IKLEHEEGAPCTAIREVSLLRELRHA 149
+ LG G++ V + + + ALK +KL+ E + E +L+ +RH
Sbjct: 6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE----HVLNEKRILQSIRHP 61
Query: 150 NIVTLHDIIHTEKCLTLVFEYLE 172
+V L+ + L LV EY+
Sbjct: 62 FLVNLYGSFQDDSNLYLVMEYVP 84
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 19/55 (34%), Positives = 27/55 (49%), Gaps = 3/55 (5%)
Query: 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIV 152
LG+GTY V+ + T +A+KEI P E++L L+H NIV
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV 68
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.004
Identities = 24/78 (30%), Positives = 41/78 (52%), Gaps = 7/78 (8%)
Query: 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGA--PCTAIREVSLLRELRHANIVTLH 155
KLG G + V+ G T VA+K +K G P ++E ++++LRH +V L+
Sbjct: 13 KLGAGQFGEVWMGTWNGTTK-VAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 156 DIIHTEKCLTLVFEYLEK 173
+ E+ + +V EY+ K
Sbjct: 68 AVCSEEEPIYIVTEYMSK 85
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.5 bits (90), Expect = 0.004
Identities = 23/80 (28%), Positives = 38/80 (47%), Gaps = 6/80 (7%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVT 153
+G+G + V G R VA+K +K ++ A + E S++ LRH N+V
Sbjct: 10 LGATIGKGEFGDVMLGDYR--GQKVAVKCLK---DDSTAAQAFLAEASVMTTLRHPNLVQ 64
Query: 154 LHDIIHTEKCLTLVFEYLEK 173
L ++ L +V EY+ K
Sbjct: 65 LLGVVLQGNPLYIVTEYMAK 84
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 23/87 (26%), Positives = 46/87 (52%), Gaps = 5/87 (5%)
Query: 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHD 156
KLG G Y V++G + VA+K +K E+ ++E ++++E++H N+V L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 157 IIHTEKCLTLVFEYLEK-DLKRYMDDC 182
+ E ++ E++ +L Y+ +C
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLREC 96
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 37/149 (24%), Positives = 66/149 (44%), Gaps = 15/149 (10%)
Query: 179 MDDCSNILSMNNV--KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE 236
++D + L NV +G +KGKS +KEI E++ + +
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-----DVNSIPSSEIADMGK 739
Query: 237 LRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAY 295
L+H NIV L + +EK L+ EY+E K+L + LS + + + L +
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL----RNLSWERRRKIAIGIAKALRF 795
Query: 296 CH---SRRILHRDLKPQNLLINERGELKL 321
H S ++ +L P+ ++I+ + E L
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| KOG0660|consensus | 359 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0667|consensus | 586 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0033|consensus | 355 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0580|consensus | 281 | 100.0 | ||
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0599|consensus | 411 | 100.0 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| KOG4236|consensus | 888 | 100.0 | ||
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1290|consensus | 590 | 100.0 | ||
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0665|consensus | 369 | 100.0 | ||
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0664|consensus | 449 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG4257|consensus | 974 | 100.0 | ||
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278|consensus | 1157 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG1167|consensus | 418 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1152|consensus | 772 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG2052|consensus | 513 | 99.98 | ||
| KOG3653|consensus | 534 | 99.98 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1024|consensus | 563 | 99.97 | ||
| KOG1345|consensus | 378 | 99.96 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0603|consensus | 612 | 99.95 | ||
| KOG0590|consensus | 601 | 99.94 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1164|consensus | 322 | 99.93 | ||
| KOG1163|consensus | 341 | 99.93 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0606|consensus | 1205 | 99.92 | ||
| KOG1165|consensus | 449 | 99.92 | ||
| KOG1033|consensus | 516 | 99.92 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG4158|consensus | 598 | 99.89 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1240|consensus | 1431 | 99.86 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| KOG0195|consensus | 448 | 99.83 | ||
| KOG1166|consensus | 974 | 99.8 | ||
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1023|consensus | 484 | 99.74 | ||
| KOG0590|consensus | 601 | 99.73 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG0601|consensus | 524 | 99.72 | ||
| KOG0606|consensus | 1205 | 99.69 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0601|consensus | 524 | 99.58 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| KOG1266|consensus | 458 | 99.52 | ||
| KOG1243|consensus | 690 | 99.39 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG0576|consensus | 829 | 99.3 | ||
| KOG3741|consensus | 655 | 99.21 | ||
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.12 | |
| KOG1094|consensus | 807 | 99.12 | ||
| KOG1095|consensus | 1025 | 99.11 | ||
| KOG3087|consensus | 229 | 99.06 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.04 | |
| KOG4278|consensus | 1157 | 98.99 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| KOG2137|consensus | 700 | 98.97 | ||
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 98.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 98.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 98.96 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 98.88 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 98.84 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 98.81 | |
| KOG1290|consensus | 590 | 98.79 | ||
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 98.78 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 98.76 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 98.75 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 98.75 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 98.74 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 98.74 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 98.7 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 98.69 | |
| KOG0607|consensus | 463 | 98.68 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.5 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 98.47 | |
| KOG0663|consensus | 419 | 98.45 | ||
| KOG1235|consensus | 538 | 98.43 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.37 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| KOG0584|consensus | 632 | 98.32 | ||
| KOG1026|consensus | 774 | 98.3 | ||
| KOG0200|consensus | 609 | 98.29 | ||
| KOG4250|consensus | 732 | 98.29 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 98.2 | |
| KOG0661|consensus | 538 | 98.19 | ||
| KOG0658|consensus | 364 | 98.13 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.07 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 98.02 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.99 | |
| KOG1035|consensus | 1351 | 97.98 | ||
| KOG0595|consensus | 429 | 97.9 | ||
| KOG0660|consensus | 359 | 97.9 | ||
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.85 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 97.85 |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-63 Score=461.41 Aligned_cols=282 Identities=34% Similarity=0.634 Sum_probs=244.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.|+.+.++|+|+||+||||+++.||+.||||++.-..++.
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~--------------------------------------- 42 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP--------------------------------------- 42 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH---------------------------------------
Confidence 57999999999999999999999999999999875332211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....-++|||++|++|+|+|+|.|+++|.
T Consensus 43 ---------------------------------------------------~VkKIAlREIrmLKqLkH~NLVnLiEVFr 71 (396)
T KOG0593|consen 43 ---------------------------------------------------VVKKIALREIRMLKQLKHENLVNLIEVFR 71 (396)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhcccchHHHHHHHHH
Confidence 11224567777777777777788888888
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
....++||||||+.++++.+......++.+.++.+++|++.|+.|||+++||||||||+||||+.+|.+||||||+|+..
T Consensus 72 rkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L 151 (396)
T KOG0593|consen 72 RKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTL 151 (396)
T ss_pred hcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhh
Confidence 88899999999999999999998888999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc-
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE- 408 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~- 408 (516)
..+...++..+.|.||+|||.+.|. .|..+.|+||+||++.||++|.+.|+|.++.|++..|...+|..+..-.....
T Consensus 152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence 8888889999999999999999994 56677788999999999999999999999999999999999998776543221
Q ss_pred ---c--ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 409 ---F--CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 409 ---~--~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
| ...|.....+.++..+| .++.-+.||+.+||..||++|++.+|+|.||||.++
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 1 13444444456666666 678899999999999999999999999999999754
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-60 Score=439.67 Aligned_cols=282 Identities=44% Similarity=0.760 Sum_probs=242.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|..+++||+|+||+||||++..||+.||||+|+......
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd--------------------------------------- 42 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD--------------------------------------- 42 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc---------------------------------------
Confidence 57999999999999999999999999999999998764321
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+....++|||..|+.++|+||+.++|+|.
T Consensus 43 ---------------------------------------------------Gi~~talREIK~Lqel~h~nIi~LiD~F~ 71 (318)
T KOG0659|consen 43 ---------------------------------------------------GINRTALREIKLLQELKHPNIIELIDVFP 71 (318)
T ss_pred ---------------------------------------------------CccHHHHHHHHHHHHccCcchhhhhhhcc
Confidence 12225566777777777777777777777
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
....+.||+||++.+|...+++....++..+++.|+.++++||+|||++.|+||||||.|+||+.+|.+||+|||+|+..
T Consensus 72 ~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f 151 (318)
T KOG0659|consen 72 HKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFF 151 (318)
T ss_pred CCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence 77889999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred CCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc-
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE- 408 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~- 408 (516)
..+.......+.|.||+|||++.|... ....|+||+|||+.||+-|.+.|+|.++.+++..|+..+|+|.++.|..+.
T Consensus 152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS 231 (318)
T ss_pred CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence 877777777789999999999998754 456677899999999999999999999999999999999999998886543
Q ss_pred ---cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 409 ---FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 409 ---~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
+.....++. ......+| ..+.++.||+.+||.+||.+|+||.|+|+||||++..
T Consensus 232 lpdY~~~~~~P~-~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 232 LPDYVKIQQFPK-PPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred cccHHHHhcCCC-Cccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 222222222 23333566 6778889999999999999999999999999999754
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-59 Score=464.78 Aligned_cols=287 Identities=39% Similarity=0.710 Sum_probs=236.6
Q ss_pred cccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccce
Q psy12305 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 162 (516)
Q Consensus 84 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 162 (516)
.....+.+.|+.+++||+|+||.||||++..||+.||+|++..+.. .+...
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~---------------------------- 161 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPI---------------------------- 161 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchH----------------------------
Confidence 3444577889999999999999999999999999999999987653 33333
Q ss_pred eeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccce
Q psy12305 163 CLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 242 (516)
Q Consensus 163 ~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 242 (516)
...|||.||++|+||||
T Consensus 162 ---------------------------------------------------------------t~~REI~ILr~l~HpNI 178 (560)
T KOG0600|consen 162 ---------------------------------------------------------------TAIREIKILRRLDHPNI 178 (560)
T ss_pred ---------------------------------------------------------------HHHHHHHHHHhcCCCcc
Confidence 44455555555556666
Q ss_pred eeEeeeEeeC--ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEE
Q psy12305 243 VTLHDIIHTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELK 320 (516)
Q Consensus 243 v~l~~~~~~~--~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vk 320 (516)
++|.+..... ..+|||||||+.||.-++...+-.|++.+++.|++||+.||+|||++||+|||||.+|||||.+|.+|
T Consensus 179 ikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LK 258 (560)
T KOG0600|consen 179 IKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLK 258 (560)
T ss_pred cceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEE
Confidence 6666655554 57999999999999999988777899999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCCCC-ccccCCcccccccchhhccCCCCCC-ceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 321 LADFGLARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYS-TSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 321 L~DFGla~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~-~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
|+|||||+...... ..+++.+.|+||+|||+++|...|+ ..|+||+||||.||++|+++|+|.+..++++.|++++|.
T Consensus 259 iaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGS 338 (560)
T KOG0600|consen 259 IADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGS 338 (560)
T ss_pred eccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCC
Confidence 99999999765443 3578889999999999999976554 557789999999999999999999999999999999999
Q ss_pred CChhhhhhc--ccc--cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 399 PPDELKSKL--EFC--ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 399 ~p~~~~~~~--~~~--~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
|.++.|... ... ..+..+-...+...+ ...++.+.+|+..||..||++|.||.++|+|+||..
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~-~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLRETF-KDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHHHHh-ccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 999998732 211 111111112222222 267899999999999999999999999999999943
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-59 Score=441.61 Aligned_cols=284 Identities=39% Similarity=0.693 Sum_probs=239.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|+++++|++|+||.||+|+|+.|++.||+|+++-+.. .+.....+|||.+|.+++|||||.+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~v------------ 140 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEV------------ 140 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeee------------
Confidence 467899999999999999999999999999999999976543 4444455555555555555555554
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
-
T Consensus 141 -------------------------------------------------------------------------------k 141 (419)
T KOG0663|consen 141 -------------------------------------------------------------------------------K 141 (419)
T ss_pred -------------------------------------------------------------------------------E
Confidence 4
Q ss_pred eeEee--CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 247 DIIHT--EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 247 ~~~~~--~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++... -+.+|||||||+.||...+..-..++.+.+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+||
T Consensus 142 EVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDF 221 (419)
T KOG0663|consen 142 EVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADF 221 (419)
T ss_pred EEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEeccc
Confidence 43332 2458999999999999999988888999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
|+||.+..+...++..+.|.||+|||+++|...| ++.|.||+|||+.||+++++.|+|.+..+++.+|+..+|+|.+..
T Consensus 222 GLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~i 301 (419)
T KOG0663|consen 222 GLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAI 301 (419)
T ss_pred chhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcccc
Confidence 9999999998889999999999999999987655 555678999999999999999999999999999999999999998
Q ss_pred hhhcc------cccCCCCCCchhhhhcCCCC-CCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 404 KSKLE------FCITPVYPSESKLQLLAPEQ-MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 404 ~~~~~------~~~~~~~~~~~~~~~~~p~~-~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
|.... ...++..+- ..++..++.. +++...||+.++|.+||.+|.||+|+|+|+||...
T Consensus 302 wpg~~~lp~~k~~~f~~~py-n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPY-NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred CCCccccchhhccccCCCCc-hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 85322 112222222 3444445543 77999999999999999999999999999999874
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-58 Score=446.35 Aligned_cols=299 Identities=50% Similarity=0.800 Sum_probs=243.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCC-eeecccccccceeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHAN-IVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv 167 (516)
...|+.+++||+|+||+||+|+++.+|+.||+|++..... ++.+..++||+.+|++|+|+| ||+|++++..+..
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~---- 85 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN---- 85 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc----
Confidence 5679999999999999999999999999999999987654 455555555555555555555 5555444332220
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
T Consensus 86 -------------------------------------------------------------------------------- 85 (323)
T KOG0594|consen 86 -------------------------------------------------------------------------------- 85 (323)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCS---NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+.....+++||||++.+|..++.... ..++...++.+++||+.||+|||+++|+||||||+||||+.+|.+||+||
T Consensus 86 -~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 86 -HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred -ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeecc
Confidence 01112689999999999999999877 46888999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
|+|+....+...++..++|.||+|||+++|. .|.+..|+||+|||++||+++++.|+|.+..+++..|+..+|+|.++.
T Consensus 165 GlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 165 GLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred chHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 9999998888889999999999999999998 556677889999999999999999999999999999999999999888
Q ss_pred hhhcc----cc-cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcccCCCCC
Q psy12305 404 KSKLE----FC-ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQ 474 (516)
Q Consensus 404 ~~~~~----~~-~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~~~~~~ 474 (516)
|.... +. .++.......+....| ..++++.||+.+||++||.+|+||+.+|.||||..............
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~-~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~~~~~~~~ 319 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILP-KLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKSSQLLLQA 319 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhcc-ccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccchhhhhccc
Confidence 75432 22 2222222233333333 45579999999999999999999999999999998876655554443
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=446.72 Aligned_cols=278 Identities=27% Similarity=0.409 Sum_probs=241.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++++.||+|+||+||.++.+.|++.||+|++++..--.
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~------------------------------------ 65 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVE------------------------------------ 65 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhh------------------------------------
Confidence 45678999999999999999999999999999999997642110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.........|..||..++||+||+++.
T Consensus 66 -----------------------------------------------------~~e~~~~~~Er~IL~~v~hPFiv~l~y 92 (357)
T KOG0598|consen 66 -----------------------------------------------------KKEVRHTKAERNILSKIKHPFIVKLIY 92 (357)
T ss_pred -----------------------------------------------------hhhHHHHHHHHHHHHhCCCCcEeeeEE
Confidence 012235678999999999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.|++...+|||+||+.| .|...+.+ .+.+++..++.|+.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+
T Consensus 93 sFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 93 SFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred ecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999999999996 77777765 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+..........+.|||+.|||||++.+.+++...|+|||||++|||++|.+||.+.+.......|...-
T Consensus 172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---------- 241 (357)
T KOG0598|consen 172 CKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---------- 241 (357)
T ss_pred chhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc----------
Confidence 9976656666677899999999999999999999998999999999999999999999888888875421
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC----CHHHHHcCCCCCCCCCCcccCCCCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI----SAANAMRHPYFNSLGPQVHELSDTQSIFSLP 480 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~----ta~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~ 480 (516)
....|..++.+++|||.++|+.||++|. .++++.+||||..++|.........++|...
T Consensus 242 ---------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~ 304 (357)
T KOG0598|consen 242 ---------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPN 304 (357)
T ss_pred ---------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecC
Confidence 1223445899999999999999999996 6889999999999998877777777666543
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=456.56 Aligned_cols=280 Identities=38% Similarity=0.675 Sum_probs=238.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.++++||.|+||.||+|+.+.+|..||||++++......++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~---------------------------------- 53 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC---------------------------------- 53 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH----------------------------------
Confidence 4578999999999999999999999999999999987654333222
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~ 247 (516)
.-+||+..|++|+ |||||+|.+
T Consensus 54 ---------------------------------------------------------~nLREvksL~kln~hpniikL~E 76 (538)
T KOG0661|consen 54 ---------------------------------------------------------MNLREVKSLRKLNPHPNIIKLKE 76 (538)
T ss_pred ---------------------------------------------------------HHHHHHHHHHhcCCCCcchhhHH
Confidence 3456666666666 777777777
Q ss_pred eEeeCc-eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEK-CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~-~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+.+ ++|+|||||+.+|.+.++++++.+++..++.|+.||++||+|+|++|+.|||+||+|||+..+..+||+|||+
T Consensus 77 vi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGL 156 (538)
T KOG0661|consen 77 VIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGL 156 (538)
T ss_pred HhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccc
Confidence 776666 8999999999999999999999999999999999999999999999999999999999999889999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
||... ....++..+.|.||+|||+++...+| .+.|+||+|||++|+++-++.|+|.+..|++.+|++++|+|..+.|.
T Consensus 157 ARev~-SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 157 AREVR-SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccccc-cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 99765 45567788999999999999876655 55677899999999999999999999999999999999999877663
Q ss_pred h-------cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 K-------LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~-------~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
. +.+ .+|.... ..+....|. .+.++.+||.+||.|||++||||+|+|+||||+.-
T Consensus 236 eg~~La~~mnf-~~P~~~~-~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~ 297 (538)
T KOG0661|consen 236 EGYNLASAMNF-RFPQVKP-SPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG 297 (538)
T ss_pred hHHHHHHHhcc-CCCcCCC-CChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence 2 222 2233332 345555664 89999999999999999999999999999999754
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-58 Score=447.56 Aligned_cols=266 Identities=28% Similarity=0.405 Sum_probs=219.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-+.|.+.+.||+|+||.|-+|..+.||+.||||++++.......
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s------------------------------------ 214 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCS------------------------------------ 214 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhccccc------------------------------------
Confidence 35599999999999999999999999999999999765322210
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
..........+|+++|++|+|||||+++++|
T Consensus 215 -------------------------------------------------~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 215 -------------------------------------------------RAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred -------------------------------------------------ccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 0001112457899999999999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC---CCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER---GELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkL~DFG 325 (516)
+..+..||||||++ |+|.+.+..+ +.+.+...+.+++|++.||.|||++||+||||||+|||++.+ ..+||+|||
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999 5899988875 458999999999999999999999999999999999999877 679999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCC---CceeeehHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHhcCCCCh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY---STSIDMGVGCIFHEMSSGRPLFPGSTIED-ELRLICSILGPPPD 401 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~---~~~d~~SlGvil~elltG~~pF~~~~~~~-~~~~i~~~~~~~p~ 401 (516)
+|+... ......+.||||.|.|||++.+.... .+.|+||+||+||-+|+|.+||.+..... ...+|.+..-.
T Consensus 325 lAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~--- 400 (475)
T KOG0615|consen 325 LAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA--- 400 (475)
T ss_pred hhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc---
Confidence 999876 45566788999999999999775433 35699999999999999999998765443 44445332110
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
+.......++++++|||.+||..||++|||++|+|+||||+...
T Consensus 401 -------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 401 -------------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred -------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 01111237899999999999999999999999999999998653
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=459.88 Aligned_cols=255 Identities=27% Similarity=0.415 Sum_probs=231.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|...+.||+|||++||++++..+|..||+|++.+....+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k--------------------------------------- 58 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKK--------------------------------------- 58 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcC---------------------------------------
Confidence 46999999999999999999999999999999997643211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
........+||+|+++|+|||||+++++|+
T Consensus 59 --------------------------------------------------~~~reKv~~EIeIHr~L~HpnIV~f~~~FE 88 (592)
T KOG0575|consen 59 --------------------------------------------------PKQREKVLNEIEIHRSLKHPNIVQFYHFFE 88 (592)
T ss_pred --------------------------------------------------cchHHHHHHHHHHHHhcCCCcEEeeeeEee
Confidence 122346778999999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+.+++|||+|+|. ++|..+++ ..+.++|.+|+.|++||+.||.|||+++|+|||||..|+|++.+.+|||+|||||..
T Consensus 89 Ds~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~ 167 (592)
T KOG0575|consen 89 DSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ 167 (592)
T ss_pred cCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeee
Confidence 9999999999999 56776666 567899999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
...+.....+.||||.|.|||++....++..+|+||+||+||.||+|+|||...+..+.+..|..
T Consensus 168 le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--------------- 232 (592)
T KOG0575|consen 168 LEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--------------- 232 (592)
T ss_pred ecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh---------------
Confidence 88777777888999999999999999999999999999999999999999999999999988843
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
-...+|..++.+++|||.+||+.||.+|||++++|.|+||+
T Consensus 233 -----------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 233 -----------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFK 273 (592)
T ss_pred -----------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhh
Confidence 33456679999999999999999999999999999999993
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-56 Score=445.07 Aligned_cols=272 Identities=29% Similarity=0.420 Sum_probs=237.4
Q ss_pred cccccccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccc
Q psy12305 80 QSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 159 (516)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 159 (516)
+...+.+....++|...+.||+|+|++||+|+++.+++.||||++.+.. +++|
T Consensus 62 ~~~~~~~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~-------Iike-------------------- 114 (604)
T KOG0592|consen 62 QPARQEEKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRY-------IIKE-------------------- 114 (604)
T ss_pred CcchhhccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHH-------HHhh--------------------
Confidence 3334445678899999999999999999999999999999999987642 2222
Q ss_pred cceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-c
Q psy12305 160 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-R 238 (516)
Q Consensus 160 ~~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~ 238 (516)
| ....+.+|-.+|.+| .
T Consensus 115 -----------------------------------------------------~---------KvkYV~~Ek~~l~~L~~ 132 (604)
T KOG0592|consen 115 -----------------------------------------------------K---------KVKYVTREKEALTQLSG 132 (604)
T ss_pred -----------------------------------------------------c---------ccchhhHHHHHHHHhhC
Confidence 0 011345788888888 8
Q ss_pred ccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC
Q psy12305 239 HANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317 (516)
Q Consensus 239 HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 317 (516)
||.|++|+..|+++..+|+|+||++ |+|++++.+.+ .+++..++.|+.||+.||+|||++|||||||||+|||++.+|
T Consensus 133 hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 133 HPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred CCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC
Confidence 9999999999999999999999999 79999999864 599999999999999999999999999999999999999999
Q ss_pred CEEEeeeccccccCCCC-----------cc--ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 318 ELKLADFGLARAKSVPT-----------KT--FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~-----------~~--~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
++||+|||.|+.+.... .. ...++||..|.+||++..+..+..+|+|+||||||.|+.|.+||.+.+
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 99999999998754211 11 245899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..-.+++|.. +...+|++.++++.|||.++|..||.+|+|++||.+||||.++.
T Consensus 292 eyliFqkI~~--------------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 292 EYLIFQKIQA--------------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred HHHHHHHHHH--------------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 9988888855 34456678899999999999999999999999999999999998
Q ss_pred CCc
Q psy12305 465 PQV 467 (516)
Q Consensus 465 ~~~ 467 (516)
|..
T Consensus 346 w~n 348 (604)
T KOG0592|consen 346 WEN 348 (604)
T ss_pred hhh
Confidence 765
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-56 Score=389.85 Aligned_cols=283 Identities=51% Similarity=0.939 Sum_probs=251.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|...++||+|+||+||||+++.+++.||+|+++.+...
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd---------------------------------------- 41 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD---------------------------------------- 41 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC----------------------------------------
Confidence 3577889999999999999999999999999999876432
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
++.+..+++||.+|+.++|.|||+++++.+
T Consensus 42 --------------------------------------------------egvpssalreicllkelkhknivrl~dvlh 71 (292)
T KOG0662|consen 42 --------------------------------------------------EGVPSSALREICLLKELKHKNIVRLHDVLH 71 (292)
T ss_pred --------------------------------------------------CCCcHHHHHHHHHHHHhhhcceeehhhhhc
Confidence 223335666666777777777777777777
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.++.+.+|+|||+.+|..+....++.++.+.++.++.|+++||.|||+++++||||||+|+||+.+|.+||+|||+|+..
T Consensus 72 sdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglaraf 151 (292)
T KOG0662|consen 72 SDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAF 151 (292)
T ss_pred cCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhc
Confidence 78889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCce-eeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh--
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS-IDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK-- 406 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~-d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~-- 406 (516)
..+...++..+.|.||++|.++.|...|+.+ |.||.|||+.|+.. |++.|+|.+..+++.+|+..+|+|.++-|..
T Consensus 152 gipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred CCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence 9999899999999999999999987766555 56799999999997 8999999999999999999999999988754
Q ss_pred --cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 --LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 --~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.++...|.|+....+....| .++...+||++++|.-+|.+|++|+++|+||||....
T Consensus 232 ~lpdyk~yp~ypattswsqivp-~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVP-KLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred cCCCCcccCCccccchHHHHhh-hhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 45677888988888877777 7888999999999999999999999999999998754
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-56 Score=426.70 Aligned_cols=286 Identities=37% Similarity=0.642 Sum_probs=233.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
..|..++.||+|+||.|.+|.++.+|+.||||+|...-. ....++..||+++|+.++|+||+.+++++..+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~------- 94 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPS------- 94 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccc-------
Confidence 457778999999999999999999999999999974322 333446666666666666666666665543311
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.
T Consensus 95 -------------------------------------------------------------------------------~ 95 (359)
T KOG0660|consen 95 -------------------------------------------------------------------------------R 95 (359)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
..-+.+|+|+|+|+.||.+.++.. ..+++..++.+++||+.||.|+|+.+|+||||||.|+|++.+..+||+|||+||.
T Consensus 96 ~~f~DvYiV~elMetDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 96 DKFNDVYLVFELMETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred cccceeEEehhHHhhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence 112458999999999999988864 3499999999999999999999999999999999999999999999999999998
Q ss_pred cCC--CCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 330 KSV--PTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 330 ~~~--~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
... .....+..+.|.||+|||+++... |+...|+||+||||.||++|++.|+|.+..+++..|...+|+|+++....
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~ 254 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK 254 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence 753 233446778899999999987654 45566779999999999999999999999999999999999999887654
Q ss_pred cc------cc-cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 407 LE------FC-ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 407 ~~------~~-~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.. +. ..|..+. ..+...+| +.++.+.||+.+||.+||.+|+|++|+|+||||.....
T Consensus 255 i~s~~ar~yi~slp~~p~-~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 255 IRSEKARPYIKSLPQIPK-QPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred hccHHHHHHHHhCCCCCC-CCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 43 21 2344443 55666677 89999999999999999999999999999999987643
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=410.67 Aligned_cols=283 Identities=24% Similarity=0.380 Sum_probs=243.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++++.||.|+||+|.+++++.+|.+||+|++.+.. +--|++.
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~-----------vVklKQv--------------------- 88 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQK-----------VVKLKQV--------------------- 88 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHH-----------HHHHHHH---------------------
Confidence 45678999999999999999999999999999999987642 1111111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
....+|..+|+.+.||+++++++
T Consensus 89 ---------------------------------------------------------eH~~nEk~vL~~v~~PFlv~l~~ 111 (355)
T KOG0616|consen 89 ---------------------------------------------------------EHTHNEKRVLKAVSHPFLVKLYG 111 (355)
T ss_pred ---------------------------------------------------------HHHhhHHHHHhhccCceeEEEEE
Confidence 13457899999999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.|.+..++||||||.+| .|..++++.+ ++++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+
T Consensus 112 t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGF 190 (355)
T KOG0616|consen 112 TFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGF 190 (355)
T ss_pred eeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccc
Confidence 99999999999999995 7888887754 599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+..... ..+.||||.|+|||++...++....|+|||||++|||+.|.+||...+....+.+|++
T Consensus 191 AK~v~~r---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~------------ 255 (355)
T KOG0616|consen 191 AKRVSGR---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE------------ 255 (355)
T ss_pred eEEecCc---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh------------
Confidence 9876533 3456999999999999999888888888999999999999999999999988888865
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcccCCCCCCCCCCCc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHELSDTQSIFSLPH 481 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~ 481 (516)
....+|...+++++|||.++|+.|-.+|. ..+++..||||+++.|........+.++..|.
T Consensus 256 --------------~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~ 321 (355)
T KOG0616|consen 256 --------------GKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPN 321 (355)
T ss_pred --------------CcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCcc
Confidence 23456778999999999999999999995 56899999999999988877777777776655
Q ss_pred ccccCCCC
Q psy12305 482 IKLTSNPT 489 (516)
Q Consensus 482 ~~~~~~~~ 489 (516)
+..+.+..
T Consensus 322 ~~~~gdts 329 (355)
T KOG0616|consen 322 IHGPGDTS 329 (355)
T ss_pred ccCCcccc
Confidence 55444433
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-55 Score=423.40 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=219.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++.+.++.||+|..|+||||+|+.|++.+|+|.|.......
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~------------------------------------- 119 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPA------------------------------------- 119 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHH-------------------------------------
Confidence 3457889999999999999999999999999999985433221
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...++.+|+++++.++||+||++|+.
T Consensus 120 ------------------------------------------------------~~~Qi~rEl~il~~~~spyIV~~yga 145 (364)
T KOG0581|consen 120 ------------------------------------------------------LQKQILRELEILRSCQSPYIVGFYGA 145 (364)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhhCCCCCeeeEeEE
Confidence 12367788888888899999999999
Q ss_pred EeeCc-eeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 249 IHTEK-CLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 249 ~~~~~-~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
|..+. .++|+||||+| +|...+... +++++.....++.+|++||.|||+ ++||||||||+|||++..|.|||||||
T Consensus 146 F~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFG 224 (364)
T KOG0581|consen 146 FYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFG 224 (364)
T ss_pred EEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEecccc
Confidence 99988 49999999995 666666554 679999999999999999999995 999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHhcCCCChhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS--TIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~--~~~~~~~~i~~~~~~~p~~~ 403 (516)
.++..... ...+++||..|||||.+.+..|+.++|+||||++++|+++|+.||+.. ...+.+..+..+...||+.
T Consensus 225 VS~~lvnS--~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~- 301 (364)
T KOG0581|consen 225 VSGILVNS--IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR- 301 (364)
T ss_pred ccHHhhhh--hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC-
Confidence 99887644 557789999999999999999999999999999999999999999874 2233344444444333321
Q ss_pred hhhcccccCCCCCCchhhhhcCCCC-CCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQ-MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.|.. .|+++++||..||++||.+|+|+.|+++|||++....
T Consensus 302 ---------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 302 ---------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred ---------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 2334 8999999999999999999999999999999986543
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-54 Score=420.42 Aligned_cols=263 Identities=28% Similarity=0.451 Sum_probs=225.2
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+...+++|....+||.|+||+||+|+++.++..||||.|.+.....
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~---------------------------------- 50 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNK---------------------------------- 50 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCH----------------------------------
Confidence 4467789999999999999999999999999999999986643110
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.....+..|+.+|+.++|||||.+
T Consensus 51 --------------------------------------------------------k~~e~L~~Ei~iLkel~H~nIV~l 74 (429)
T KOG0595|consen 51 --------------------------------------------------------KLVELLLSEIKILKELKHPNIVRL 74 (429)
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHhcCCcceeeE
Confidence 011245678888999999999999
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC------CC
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER------GE 318 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~------~~ 318 (516)
++++.+++++|||||||+ |||..|+...+ .+++..++.++.||+.||++||+++||||||||+||||+.. -.
T Consensus 75 ~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 75 LDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred EEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCce
Confidence 999999999999999999 69999998865 69999999999999999999999999999999999999875 35
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
+||+|||+|+.+. +.....+.|||+.|||||++....|+.++|.||+|+++|+|++|++||...+..+.+..+....
T Consensus 154 LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~-- 230 (429)
T KOG0595|consen 154 LKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGN-- 230 (429)
T ss_pred EEecccchhhhCC-chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccc--
Confidence 8999999999887 4445567899999999999988899999999999999999999999999999888877654321
Q ss_pred CChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 399 PPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 399 ~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
......+..++....+|+..+|+.+|.+|.+..+-+.|+++..-
T Consensus 231 ---------------------~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 231 ---------------------EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ---------------------cccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 11222334667778899999999999999999999999998754
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=417.50 Aligned_cols=285 Identities=34% Similarity=0.587 Sum_probs=230.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|+-.+.+|.|+||.||+|....+++.||||++..+..-. -+|+.+|++++|||||+|.-+|.....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~~-------- 91 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSSTE-------- 91 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecCC--------
Confidence 3899999999999999999999999999999987654322 367777777777777766555433210
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.+
T Consensus 92 ------------------------------------------------------------------------------~d 93 (364)
T KOG0658|consen 92 ------------------------------------------------------------------------------SD 93 (364)
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 01
Q ss_pred CceeeEeeehhhchHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCEEEeeeccc
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GELKLADFGLA 327 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~DFGla 327 (516)
+-++.+||||++.+|.+.++.. +..++.-.++-+.+||++||.|||+.||+||||||+|||+|.+ |.+||||||.|
T Consensus 94 ~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 94 EVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 2256799999999999988853 5679999999999999999999999999999999999999977 89999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+........ ....+|..|+|||.+.|...| .+-|+||.||++.||+-|++.|+|++..+++..|.+++|+|+.+-...
T Consensus 174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 987644443 556779999999999987655 556779999999999999999999999999999999999999887654
Q ss_pred cccc----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCccc
Q psy12305 407 LEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 407 ~~~~----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~ 469 (516)
+... ..|........+ ......++++.||+.++|+++|.+|.++.|+|.||||+.+......
T Consensus 253 mn~~y~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~ 318 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTK 318 (364)
T ss_pred cCcccccccCccccccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCcc
Confidence 4322 223222222222 3445789999999999999999999999999999999987655333
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-54 Score=431.25 Aligned_cols=266 Identities=25% Similarity=0.394 Sum_probs=223.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++++.||+|+||.||+|+-+.||++||+|++++......
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~----------------------------------- 182 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKK----------------------------------- 182 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhh-----------------------------------
Confidence 367899999999999999999999999999999999987643211
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+....+..|-.+|...++|+||+||.
T Consensus 183 ------------------------------------------------------~Qv~hV~aERdiL~~~ds~~vVKLyY 208 (550)
T KOG0605|consen 183 ------------------------------------------------------NQVEHVRAERDILAEVDSPWVVKLYY 208 (550)
T ss_pred ------------------------------------------------------hhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence 11124566888888889999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.|++..++||||||++| |+..+|.. .+.|++..++.|+.+++.|++-||+.|+|||||||+|+|||..|++||+||||
T Consensus 209 sFQD~~~LYLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 209 SFQDKEYLYLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred EecCCCeeEEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccc
Confidence 99999999999999995 77777665 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCC----------------------CCcc-------------------------ccCCcccccccchhhccCCCCCC
Q psy12305 327 ARAKSV----------------------PTKT-------------------------FSNEVVTLWYRPPDVLLGSTEYS 359 (516)
Q Consensus 327 a~~~~~----------------------~~~~-------------------------~~~~~gt~~y~APE~l~~~~~~~ 359 (516)
|..... .... ....+|||-|||||++++..|..
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 953210 0000 01258999999999999999888
Q ss_pred ceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHH
Q psy12305 360 TSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQK 439 (516)
Q Consensus 360 ~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~ 439 (516)
.+|+||||||+||||.|.+||.+++..+..++|...-. .+.......++++++|||.+
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~----------------------~l~fP~~~~~s~eA~DLI~r 425 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE----------------------TLKFPEEVDLSDEAKDLITR 425 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh----------------------hccCCCcCcccHHHHHHHHH
Confidence 89989999999999999999999999999999865321 11112223678999999999
Q ss_pred ccccCcCCCCC---HHHHHcCCCCCCCCCC
Q psy12305 440 FLMYDAKQRIS---AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 440 ~L~~dP~~R~t---a~e~l~Hp~f~~~~~~ 466 (516)
||. ||++|+. ++||.+||||+.+.|.
T Consensus 426 ll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 426 LLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred Hhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 999 9999995 8999999999988754
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=431.53 Aligned_cols=283 Identities=31% Similarity=0.489 Sum_probs=227.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcC-CCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~E 169 (516)
.+|++++.||+|+||.|.||.+..|++.||||+|+....-- .+...|+.+|..|+ |.+=
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~--~Q~~~Ei~iL~~ln~~d~~------------------ 245 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFL--RQAQIEIRILELLNKHDPD------------------ 245 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHH--HHHHHHHHHHHHHhccCCC------------------
Confidence 36999999999999999999999999999999997653211 13344444444442 2210
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
+--|+|+++++|
T Consensus 246 --------------------------------------------------------------------~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 246 --------------------------------------------------------------------DKYNIVRMLDYF 257 (586)
T ss_pred --------------------------------------------------------------------CCeeEEEeeecc
Confidence 124899999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC--CEEEeeecc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG--ELKLADFGL 326 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~vkL~DFGl 326 (516)
...+++|||+|+++.+|.++++.++ ..++...++.|+.||+.||.+||+.||||+|||||||||.+.+ .|||+|||.
T Consensus 258 ~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 258 YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 9999999999999999999999765 5699999999999999999999999999999999999997654 699999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+.... .....+.+..|+|||+++|.+|+.+-|+||||||++||++|.+.|+|++..+++..|.+++|.||..+...
T Consensus 338 Sc~~~q---~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 338 SCFESQ---RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccccCC---cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 987543 22366789999999999999999999999999999999999999999999999999999999999887632
Q ss_pred cc-----ccc---CCCCCCch------------------hhhhcCC-----------CCCCHHHHHHHHHccccCcCCCC
Q psy12305 407 LE-----FCI---TPVYPSES------------------KLQLLAP-----------EQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 407 ~~-----~~~---~~~~~~~~------------------~~~~~~p-----------~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
.. |.. .+....+. ......| ......+.|||.+||++||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 11 000 00000000 0111122 12235679999999999999999
Q ss_pred CHHHHHcCCCCCCCC
Q psy12305 450 SAANAMRHPYFNSLG 464 (516)
Q Consensus 450 ta~e~l~Hp~f~~~~ 464 (516)
|+.|+|+||||+...
T Consensus 495 tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 495 TPAQALNHPFLTGTS 509 (586)
T ss_pred CHHHHhcCccccccc
Confidence 999999999998543
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=436.50 Aligned_cols=283 Identities=23% Similarity=0.351 Sum_probs=241.4
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.-.+++|.+++.||+|+||+|++|..+.++++||||.++++.--+.
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~---------------------------------- 409 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQR---------------------------------- 409 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceecc----------------------------------
Confidence 3457899999999999999999999999999999999987632111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeE
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTL 245 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 245 (516)
+.......|.+|+... +||+++.|
T Consensus 410 -------------------------------------------------------d~Ve~~~~EkrI~~la~~HPFL~~L 434 (694)
T KOG0694|consen 410 -------------------------------------------------------DEVESLMCEKRIFELANRHPFLVNL 434 (694)
T ss_pred -------------------------------------------------------ccHHHHHHHHHHHHHhccCCeEeec
Confidence 1122445677777666 59999999
Q ss_pred eeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 246 HDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+..|++.+++|+||||+.|+. -+.......+++..++.|+..|+.||+|||++|||+||||.+|||+|.+|.+||+|||
T Consensus 435 ~~~fQT~~~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 435 FSCFQTKEHLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred ccccccCCeEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccc
Confidence 999999999999999999744 2223344679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+.........+++||||.|||||++.+..|+...|+|||||+|||||.|++||+|++.++....|..
T Consensus 514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~----------- 582 (694)
T KOG0694|consen 514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN----------- 582 (694)
T ss_pred cccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-----------
Confidence 999876566677889999999999999998887777777999999999999999999999999888843
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQSIFSLP 480 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~ 480 (516)
.....|..++.++.++|+++|..||++|+. ++++.+||||++++|.........++|. |
T Consensus 583 ---------------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~-P 646 (694)
T KOG0694|consen 583 ---------------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFV-P 646 (694)
T ss_pred ---------------CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCC-c
Confidence 334456689999999999999999999996 5789999999999999888888888774 4
Q ss_pred cccccC
Q psy12305 481 HIKLTS 486 (516)
Q Consensus 481 ~~~~~~ 486 (516)
.++...
T Consensus 647 ~i~~~~ 652 (694)
T KOG0694|consen 647 TIKGPE 652 (694)
T ss_pred ccCChh
Confidence 444443
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=414.33 Aligned_cols=281 Identities=68% Similarity=1.151 Sum_probs=235.1
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
|+.+++|+++++||+|+||+||+|++..+++.||+|++........
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------- 46 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA---------------------------------- 46 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCc----------------------------------
Confidence 5778999999999999999999999999999999998864322111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
...+.+|+.+++.++||||++++
T Consensus 47 ---------------------------------------------------------~~~~~~E~~~l~~l~h~niv~~~ 69 (288)
T cd07871 47 ---------------------------------------------------------PCTAIREVSLLKNLKHANIVTLH 69 (288)
T ss_pred ---------------------------------------------------------chhHHHHHHHHHhCCCCCEeeEE
Confidence 12455788888888888888899
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+++.++...++||||++++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 70 DIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred EEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcc
Confidence 99988889999999999999999987777789999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
++.............||+.|+|||++.+ ..+..++|+||+||++|+|++|++||.+.+..+.+..+....+.|+.+.|.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 150 ARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWP 229 (288)
T ss_pred eeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhh
Confidence 9875544444556678999999999876 446778999999999999999999999999999999999999999988775
Q ss_pred hccc----c--cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 406 KLEF----C--ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 406 ~~~~----~--~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.... . ..+.+.... ... ....++++++|||.+||++||.+|||++|+++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQP-LIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccchhhhccccCccCCCc-hHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 4321 1 111111111 111 123678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-52 Score=424.92 Aligned_cols=261 Identities=31% Similarity=0.484 Sum_probs=226.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...+.|.+.+.||+|+||+|++|++..+|+.||||++.+......
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~----------------------------------- 58 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSK----------------------------------- 58 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccccc-----------------------------------
Confidence 456789999999999999999999999999999997755311000
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 246 (516)
. ......+.+|+.+++.++ ||||++++
T Consensus 59 ---------------------------------------------------~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ 86 (370)
T KOG0583|consen 59 ---------------------------------------------------S-QKLDELIKREISILRRLRSHPNIIRLL 86 (370)
T ss_pred ---------------------------------------------------c-cccchhhHHHHHHHHHhccCCCEeEEE
Confidence 0 001113448999999998 99999999
Q ss_pred eeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCEEEeee
Q psy12305 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GELKLADF 324 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~DF 324 (516)
+++.+...+|+|||||.| +|++++.+ .+++.+..++.+++||+.|++|||++||+||||||+|||++.+ +++||+||
T Consensus 87 ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 87 EVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred EEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence 999999999999999995 99999999 6789999999999999999999999999999999999999999 99999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCC-CC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|++...........+.|||+.|+|||++.+.. |. .++|+||+||+||.|++|..||...+....+..|..
T Consensus 166 G~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~-------- 237 (370)
T KOG0583|consen 166 GLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK-------- 237 (370)
T ss_pred ccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc--------
Confidence 99987744455677889999999999999876 54 678899999999999999999999887777777632
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCC-CHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQM-DSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~-s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....+|..+ ++++++|+.+||..||.+|+|+.+++.||||+.
T Consensus 238 ------------------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 ------------------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ------------------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 334456677 999999999999999999999999999999986
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-53 Score=427.29 Aligned_cols=256 Identities=32% Similarity=0.504 Sum_probs=225.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|.+.+.||+|+||+|||||.+.|.+.||+|.+.+.....
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-------------------------------------- 42 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-------------------------------------- 42 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch--------------------------------------
Confidence 367999999999999999999999999999999986643211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|++|++.++|||||.++++|
T Consensus 43 ----------------------------------------------------k~l~~l~~ev~i~r~lkHpniv~m~esf 70 (808)
T KOG0597|consen 43 ----------------------------------------------------KELKNLRQEVRILRSLKHPNIVEMLESF 70 (808)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhcCCcchhhHHHhh
Confidence 1122466788888888999999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++..++|+|+|||.|+|..++.+. +.++++.++.++.|++.||.|||+.+|+|||+||+|||++..|.+|+||||+|+.
T Consensus 71 Et~~~~~vVte~a~g~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~ 149 (808)
T KOG0597|consen 71 ETSAHLWVVTEYAVGDLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARA 149 (808)
T ss_pred cccceEEEEehhhhhhHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhh
Confidence 999999999999999999999875 4599999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
........+..-|||.|||||+..+.+|+-.+|.||+||++|||++|++||...+.......|..--.
T Consensus 150 m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v------------ 217 (808)
T KOG0597|consen 150 MSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV------------ 217 (808)
T ss_pred cccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC------------
Confidence 88777777778899999999999999999999999999999999999999988776666665543211
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..|...+.++.+||..+|.+||.+|+|..+++.|||++.
T Consensus 218 --------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 218 --------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred --------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 223478999999999999999999999999999999875
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-54 Score=399.26 Aligned_cols=251 Identities=30% Similarity=0.463 Sum_probs=209.6
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+...+.+|+++++||+|+||+|||+.+..+|..||.|.|+.+..+..
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k--------------------------------- 60 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAK--------------------------------- 60 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHH---------------------------------
Confidence 44677889999999999999999999999999999999875433221
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.......|+.+|++|+|||||++
T Consensus 61 ---------------------------------------------------------~rq~~v~Ei~lLkQL~HpNIVqY 83 (375)
T KOG0591|consen 61 ---------------------------------------------------------ARQDCVKEISLLKQLNHPNIVQY 83 (375)
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHhcCCchHHHH
Confidence 12244556666666666666666
Q ss_pred ee-eEeeCce-eeEeeehhh-chHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhh--CC--cEeeecCCCCEEEcc
Q psy12305 246 HD-IIHTEKC-LTLVFEYLE-KDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHS--RR--ILHRDLKPQNLLINE 315 (516)
Q Consensus 246 ~~-~~~~~~~-~~lV~E~~~-g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~--~~--ivHrDlKp~NILl~~ 315 (516)
++ .|..++. ++||||||+ |||.+.++. .++.+++..+++++.|+|.||..||+ .. |+||||||.||+|+.
T Consensus 84 y~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~ 163 (375)
T KOG0591|consen 84 YAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTA 163 (375)
T ss_pred HHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcC
Confidence 66 3444444 899999999 788877754 45679999999999999999999998 44 999999999999999
Q ss_pred CCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHh
Q psy12305 316 RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395 (516)
Q Consensus 316 ~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~ 395 (516)
+|.+||+|||+++.+..........+|||.||+||.+.+.+|+.++|+||+||++|||+.-++||.|.+..+.-.+|...
T Consensus 164 ~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg 243 (375)
T KOG0591|consen 164 NGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG 243 (375)
T ss_pred CCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence 99999999999999987777777889999999999999999999999999999999999999999999877777777543
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCC-CCCCHHHHHHHHHccccCcCCCCCH
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAP-EQMDSDALDLVQKFLMYDAKQRISA 451 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p-~~~s~~~~dLl~~~L~~dP~~R~ta 451 (516)
--+| .| +.+|.++..||..|+..||+.||+.
T Consensus 244 d~~~-------------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 244 DYPP-------------------------LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCC-------------------------CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 1110 12 4788999999999999999999984
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=412.61 Aligned_cols=293 Identities=57% Similarity=0.868 Sum_probs=234.0
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
|+..++|+++++||+|+||+||+|++..+|+.||||++........
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~---------------------------------- 46 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT---------------------------------- 46 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccccc----------------------------------
Confidence 5677899999999999999999999999999999998864322111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
...+.+|+.+++.++||||++++
T Consensus 47 ---------------------------------------------------------~~~~~~E~~~l~~l~h~niv~~~ 69 (303)
T cd07869 47 ---------------------------------------------------------PFTAIREASLLKGLKHANIVLLH 69 (303)
T ss_pred ---------------------------------------------------------chhHHHHHHHHhhCCCCCcCeEE
Confidence 11455788888888888889999
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+++.++...|+||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999999999999999999999988777799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++............+||+.|+|||++.+.. +..++|+||+||++|+|++|..||.+. +..+.+..+....+.+....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (303)
T cd07869 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229 (303)
T ss_pred ceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhc
Confidence 976554444445567899999999987644 566789999999999999999999874 445667777777777766555
Q ss_pred hhccccc------CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcccC
Q psy12305 405 SKLEFCI------TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHEL 470 (516)
Q Consensus 405 ~~~~~~~------~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~~ 470 (516)
....... ..................++++.|||.+||++||++|||++|+++||||+++.+...++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~~~~~ 301 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPRLWEL 301 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChhhhhc
Confidence 3322110 00000001111111223567899999999999999999999999999999987765544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=423.11 Aligned_cols=259 Identities=29% Similarity=0.471 Sum_probs=229.8
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..++-|.+.+.||.|+-|.|-+|+|..||+.+|||+|.+.....
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s------------------------------------ 52 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELS------------------------------------ 52 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccc------------------------------------
Confidence 56677999999999999999999999999999999997642111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+.....+.+||-||+-+.||||+++|+
T Consensus 53 -----------------------------------------------------~s~~~~IerEIviMkLi~HpnVl~Lyd 79 (786)
T KOG0588|consen 53 -----------------------------------------------------SSQPAGIEREIVIMKLIEHPNVLRLYD 79 (786)
T ss_pred -----------------------------------------------------cccccchhhhhHHHHHhcCCCeeeeee
Confidence 122335678999999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+|++..++|+|.||++ |.|++++...+ ++++.++.++++||+.|+.|||..+|+||||||+|+|++..+++||+|||+
T Consensus 80 Vwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGM 158 (786)
T KOG0588|consen 80 VWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGM 158 (786)
T ss_pred eeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccce
Confidence 9999999999999999 58999998754 599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
|.. ..++....+.||+|.|.|||++.|.+|. .++|+||+|||||.||||+.||.+++....+.++..
T Consensus 159 AsL-e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~----------- 226 (786)
T KOG0588|consen 159 ASL-EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR----------- 226 (786)
T ss_pred eec-ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc-----------
Confidence 965 4467778889999999999999998885 568899999999999999999999888888877743
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.....|..++++++|||.+||..||.+|+|.+|+++|||+...
T Consensus 227 ---------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 227 ---------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred ---------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcC
Confidence 3345677999999999999999999999999999999999764
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=407.43 Aligned_cols=300 Identities=69% Similarity=1.145 Sum_probs=246.4
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+|+.+++|.++++||+|+||+||+|++..+++.||||.+........
T Consensus 1 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------- 47 (309)
T cd07872 1 GFGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGA--------------------------------- 47 (309)
T ss_pred CCCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCc---------------------------------
Confidence 47888999999999999999999999999999999998865432211
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
...+.+|+.+++.++||||+++
T Consensus 48 ----------------------------------------------------------~~~~~~E~~~l~~l~h~~iv~~ 69 (309)
T cd07872 48 ----------------------------------------------------------PCTAIREVSLLKDLKHANIVTL 69 (309)
T ss_pred ----------------------------------------------------------chhHHHHHHHHHhCCCCCcceE
Confidence 1134568888888888888889
Q ss_pred eeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 246 HDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++++..++..|+||||+++++.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg 149 (309)
T cd07872 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFG 149 (309)
T ss_pred EEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccc
Confidence 99998889999999999999999998877779999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+++.............+|+.|+|||++.+. .+..++|+||+||++|+|++|++||.+.+..+.+..+....+.++.+.|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 229 (309)
T cd07872 150 LARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229 (309)
T ss_pred cceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 998655444444556789999999998653 4677889999999999999999999999999999999999999888776
Q ss_pred hhcccc------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcccCCCCCCCCC
Q psy12305 405 SKLEFC------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFS 478 (516)
Q Consensus 405 ~~~~~~------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~~~~~~~~~~ 478 (516)
...... ..+.+.... ..... ..+++++.|||.+||++||.+|||++|+++||||+........+++.-+.|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~ 307 (309)
T cd07872 230 PGISSNDEFKNYNFPKYKPQP-LINHA-PRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPESISIFS 307 (309)
T ss_pred hhhcchhhhhhhhcCccCCCc-hhhhc-cCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCcceeeec
Confidence 443211 111111111 11111 2578999999999999999999999999999999988776666665555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=404.93 Aligned_cols=276 Identities=24% Similarity=0.349 Sum_probs=220.8
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+-..+++|++.+.||+|.||.|-+|++..+++.||||++.+....... -.++
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~-------------~~~~--------------- 143 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQY-------------GFPR--------------- 143 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhc-------------cccc---------------
Confidence 346789999999999999999999999999999999999765322110 0000
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.+|.+.+ ......+||.+|++|.|||||+|
T Consensus 144 -------------------------------------------~~a~~~~-------~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 144 -------------------------------------------QPAMKLM-------PIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred -------------------------------------------ccccccC-------cHHHHHHHHHHHHhcCCcCeeEE
Confidence 0122221 23467899999999999999999
Q ss_pred eeeEeeC--ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 246 HDIIHTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 246 ~~~~~~~--~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+++..+. +.+|||+|||..+-..+.......+++.+++.|+++++.||+|||.+|||||||||+|+|++.+|++||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 9999875 58999999999544443333222389999999999999999999999999999999999999999999999
Q ss_pred eccccccC-----CCCccccCCcccccccchhhccCCC---C-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Q psy12305 324 FGLARAKS-----VPTKTFSNEVVTLWYRPPDVLLGST---E-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS 394 (516)
Q Consensus 324 FGla~~~~-----~~~~~~~~~~gt~~y~APE~l~~~~---~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~ 394 (516)
||.+.... .........+|||.|+|||.+.++. + ..+.|+||+||+||.|+.|+.||.++...+...+|..
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 99987652 1222345579999999999997732 2 4566889999999999999999999998888888864
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.. +.....+.+.++++|||.+||++||++|++..++..|||...-
T Consensus 334 ~p------------------------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 334 DP------------------------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred Cc------------------------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 21 1111112578999999999999999999999999999998654
|
|
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-52 Score=378.58 Aligned_cols=259 Identities=29% Similarity=0.387 Sum_probs=218.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-+.|++-+.||+|.|+.||++.+.-+|+.+|+|+|.......
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-------------------------------------- 51 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------------------------------------- 51 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc--------------------------------------
Confidence 356999999999999999999999999999999886432211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+.+|++|-+.|+|||||+|++.+
T Consensus 52 ----------------------------------------------------~~~e~l~rEarIC~~LqHP~IvrL~~ti 79 (355)
T KOG0033|consen 52 ----------------------------------------------------RDFQKLEREARICRKLQHPNIVRLHDSI 79 (355)
T ss_pred ----------------------------------------------------ccHHHHHHHHHHHHhcCCCcEeehhhhh
Confidence 0112455677777777777777778888
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC---CCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER---GELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkL~DFG 325 (516)
......|||||+++| +|...+-.+ ..+++..+..+++||+.||.|||.+||||||+||+|+|+... .-+||+|||
T Consensus 80 ~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 80 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred cccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccc
Confidence 888899999999996 776666554 458999999999999999999999999999999999999654 349999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|.... .......++|||.|||||++...+++.+.|+|+.||+||-|+.|.+||.+.+..+.+..|...--..|.
T Consensus 159 vAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~---- 233 (355)
T KOG0033|consen 159 LAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS---- 233 (355)
T ss_pred eEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC----
Confidence 998877 666778889999999999999999999999999999999999999999999999999888654322211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
...+.+++++++|+++||..||.+|+|+.|+|+|||+..
T Consensus 234 ------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 234 ------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 112378999999999999999999999999999999975
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=393.78 Aligned_cols=280 Identities=34% Similarity=0.586 Sum_probs=226.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|+++.+++.||||++.......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--------------------------------------- 41 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE--------------------------------------- 41 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccc---------------------------------------
Confidence 47999999999999999999999999999999986532111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 42 ---------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 70 (287)
T cd07848 42 ---------------------------------------------------EVKETTLRELKMLRTLKQENIVELKEAFR 70 (287)
T ss_pred ---------------------------------------------------cchhhHHHHHHHHHhCCCccccchhhhEe
Confidence 01124556788888888888888888888
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.++.+|+||||+++++...+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~ 150 (287)
T cd07848 71 RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNL 150 (287)
T ss_pred cCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence 88899999999998877777766667999999999999999999999999999999999999999999999999999865
Q ss_pred CCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 331 SVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 331 ~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... .......||+.|+|||++.+..++.++|+||+||++|||++|++||++.+..+.+..+....++.|.+.+.....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 151 SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred cccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 4322 223345789999999999888888899999999999999999999999888888888888888877655432111
Q ss_pred c------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 C------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ~------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
. ..+...............++.++.|||.+||++||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 01111111111122223578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-49 Score=394.64 Aligned_cols=294 Identities=69% Similarity=1.132 Sum_probs=243.0
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+++.+++|+++++||+|+||.||+|++..+++.||+|.+........
T Consensus 1 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------- 47 (301)
T cd07873 1 GFGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGA--------------------------------- 47 (301)
T ss_pred CCccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCc---------------------------------
Confidence 46788999999999999999999999999999999998864322111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
...+.+|+.+++.++||||+++
T Consensus 48 ----------------------------------------------------------~~~~~~E~~~l~~l~h~nI~~~ 69 (301)
T cd07873 48 ----------------------------------------------------------PCTAIREVSLLKDLKHANIVTL 69 (301)
T ss_pred ----------------------------------------------------------hhHHHHHHHHHHhcCCCCcceE
Confidence 1245578888888899999999
Q ss_pred eeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 246 HDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++++..++..|+||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 149 (301)
T cd07873 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFG 149 (301)
T ss_pred EEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCc
Confidence 99999999999999999999999998777779999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++..............+++.|+|||++.+.. +..++|+|||||++|+|++|++||.+.+..+....+...++.++...|
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 229 (301)
T cd07873 150 LARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229 (301)
T ss_pred chhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc
Confidence 9986554444445567799999999987643 566789999999999999999999999998999999999888887666
Q ss_pred hhccc----c--cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcccCCC
Q psy12305 405 SKLEF----C--ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472 (516)
Q Consensus 405 ~~~~~----~--~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~~~~ 472 (516)
..... . ..+.+.. ... ......+++++.+||.+||+.||.+|||++|+++||||..+..+.+.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~~~ 301 (301)
T cd07873 230 PGILSNEEFKSYNYPKYRA-DCL-HNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLPD 301 (301)
T ss_pred hhhhccccccccccCcccc-ccH-HhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcCCC
Confidence 43211 1 0111110 001 11223678899999999999999999999999999999999888776653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=405.29 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=217.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
....|...++||+|+-|.||.|+...+++.||||++........+ -+++|+.+|+.++|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~ke-LilnEi~Vm~~~~H~NiV---------------- 333 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKE-LLLNEILVMRDLHHPNIV---------------- 333 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchh-hhHHHHHHHHhccchHHH----------------
Confidence 456699999999999999999999999999999999775443221 344555555555555554
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.+++.
T Consensus 334 ---------------------------------------------------------------------------nfl~S 338 (550)
T KOG0578|consen 334 ---------------------------------------------------------------------------NFLDS 338 (550)
T ss_pred ---------------------------------------------------------------------------HHHHH
Confidence 44454
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
|.-.+.+|.||||++| +|.+.+.. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|
T Consensus 339 ylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFc 416 (550)
T KOG0578|consen 339 YLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFC 416 (550)
T ss_pred hcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeee
Confidence 5555679999999995 66666654 34999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
...........+.+|||+|||||++....|+.+.|+||||++++||+-|++||-.++....+.+|...
T Consensus 417 aqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n------------ 484 (550)
T KOG0578|consen 417 AQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN------------ 484 (550)
T ss_pred eccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc------------
Confidence 98887777788899999999999999999999999999999999999999999988887777777542
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.......|+.+|+.++|||.+||+.|+++|++|.|+|+||||+..
T Consensus 485 -----------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 485 -----------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred -----------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 223344567899999999999999999999999999999999644
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=413.67 Aligned_cols=288 Identities=31% Similarity=0.512 Sum_probs=224.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
...+|.+.+.||+|+||+||+|++..+++.||||++.... ....+|+.+|+.++|||||++++++....
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~------ 132 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTEC------ 132 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecc------
Confidence 4467999999999999999999999999999999885431 13346777777777777776665432211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
+..
T Consensus 133 -----------------------------------------------------------------------------~~~ 135 (440)
T PTZ00036 133 -----------------------------------------------------------------------------FKK 135 (440)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 000
Q ss_pred EeeCceeeEeeehhhchHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-CEEEeee
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-ELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkL~DF 324 (516)
......+++||||+++++.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+||
T Consensus 136 ~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 011235789999999988777653 346699999999999999999999999999999999999998665 6999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
|+|+...... .....+||+.|+|||++.+. .+..++|+|||||++|||++|.+||.+.+..+.+..+...+|.|+.+.
T Consensus 216 Gla~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~ 294 (440)
T PTZ00036 216 GSAKNLLAGQ-RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294 (440)
T ss_pred ccchhccCCC-CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 9998654322 22345789999999998764 467788999999999999999999999999999999999999988765
Q ss_pred hhhcccc----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 404 KSKLEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 404 ~~~~~~~----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
....... ..+.... ..+...+|...++++.+||.+||++||.+|||+.|+|+||||..+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~-~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKP-KDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred HHHhchhhhcccCCccCc-hhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 5332111 1111111 334455677789999999999999999999999999999999876543
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=393.06 Aligned_cols=260 Identities=28% Similarity=0.444 Sum_probs=203.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
..++...+.||+|+||+||++.+..+|...|||.+....... .+.+.+|+.+|++|+|||||++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~--------------- 79 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQY--------------- 79 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEee---------------
Confidence 456899999999999999999999999999999987652222 2234455555555555555554
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
++..
T Consensus 80 ----------------------------------------------------------------------------~G~~ 83 (313)
T KOG0198|consen 80 ----------------------------------------------------------------------------YGSS 83 (313)
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 4432
Q ss_pred eeCc--eeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-CCCEEEeeec
Q psy12305 250 HTEK--CLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFG 325 (516)
Q Consensus 250 ~~~~--~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkL~DFG 325 (516)
.... .+++.|||+. |+|.+++...++.+++..++.+.+||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 84 ~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG 163 (313)
T KOG0198|consen 84 SSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFG 163 (313)
T ss_pred ccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCc
Confidence 2222 5889999999 5899999887768999999999999999999999999999999999999999 7999999999
Q ss_pred cccccCC---CCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHhcCCCC
Q psy12305 326 LARAKSV---PTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPP 400 (516)
Q Consensus 326 la~~~~~---~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i~~~~~~~p 400 (516)
+++.... .........||+.|||||++..+. ....+|+||+||++.||+||.+||... ...+.+..+..
T Consensus 164 ~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~------ 237 (313)
T KOG0198|consen 164 LAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR------ 237 (313)
T ss_pred cccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc------
Confidence 9987653 112234568999999999998532 234899999999999999999999763 22222222211
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.......|..+++++++||.+||.+||++||||+++|+|||.....+
T Consensus 238 ------------------~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 238 ------------------EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ------------------cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 01112456689999999999999999999999999999999976443
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-50 Score=376.75 Aligned_cols=286 Identities=38% Similarity=0.639 Sum_probs=219.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCC----cEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccce
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTD----NLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 162 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g----~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 162 (516)
..+..|+.+.+||+|+||.||||....++ +.+|||+++.... .+....+
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SA-------------------------- 74 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSA-------------------------- 74 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHH--------------------------
Confidence 45678999999999999999999655543 3789998875432 3333344
Q ss_pred eeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccce
Q psy12305 163 CLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 242 (516)
Q Consensus 163 ~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 242 (516)
.+|+.+++.++||||
T Consensus 75 -----------------------------------------------------------------cREiaL~REl~h~nv 89 (438)
T KOG0666|consen 75 -----------------------------------------------------------------CREIALLRELKHPNV 89 (438)
T ss_pred -----------------------------------------------------------------HHHHHHHHHhcCCcc
Confidence 455555555555555
Q ss_pred eeEeeeEee-CceeeEeeehhhchHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-
Q psy12305 243 VTLHDIIHT-EKCLTLVFEYLEKDLKRYMDDC----SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER- 316 (516)
Q Consensus 243 v~l~~~~~~-~~~~~lV~E~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~- 316 (516)
+.|..+|.+ +..+++++||++.||.+.++-+ .+.++...++.+++||+.|+.|||++-|+||||||.|||+..+
T Consensus 90 i~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg 169 (438)
T KOG0666|consen 90 ISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG 169 (438)
T ss_pred hhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC
Confidence 555555544 6678899999999998887643 2458999999999999999999999999999999999999887
Q ss_pred ---CCEEEeeeccccccCCCCccc---cCCcccccccchhhccCCCCCCce-eeehHHHHHHHHHcCCCCCCCC------
Q psy12305 317 ---GELKLADFGLARAKSVPTKTF---SNEVVTLWYRPPDVLLGSTEYSTS-IDMGVGCIFHEMSSGRPLFPGS------ 383 (516)
Q Consensus 317 ---~~vkL~DFGla~~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~-d~~SlGvil~elltG~~pF~~~------ 383 (516)
|.|||+|||+||....+-.+. ...+.|.||+|||.++|...|+++ |+||+|||+.||+|-++.|.+.
T Consensus 170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~ 249 (438)
T KOG0666|consen 170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKT 249 (438)
T ss_pred CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhccc
Confidence 899999999999987766544 345679999999999998776665 6689999999999999999774
Q ss_pred ---CHHHHHHHHHHhcCCCChhhhhhcccccCCCC------------CCchhhh-hcCCCCCCHHHHHHHHHccccCcCC
Q psy12305 384 ---TIEDELRLICSILGPPPDELKSKLEFCITPVY------------PSESKLQ-LLAPEQMDSDALDLVQKFLMYDAKQ 447 (516)
Q Consensus 384 ---~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~------------~~~~~~~-~~~p~~~s~~~~dLl~~~L~~dP~~ 447 (516)
-..+++.+|+.++|.|.++.|..+.. .|.+ .+..-.. ......-++.+.+|+.+||++||.+
T Consensus 250 ~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk--~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~k 327 (438)
T KOG0666|consen 250 KNPFQHDQLDRIFEVLGTPTDKDWPDLKK--MPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIK 327 (438)
T ss_pred CCCchHHHHHHHHHHcCCCccccchhhhh--CcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchh
Confidence 23578999999999999888754421 1111 1100000 0011124566999999999999999
Q ss_pred CCCHHHHHcCCCCCCCCCC
Q psy12305 448 RISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 448 R~ta~e~l~Hp~f~~~~~~ 466 (516)
|+|++++|+|+||....-.
T Consensus 328 RIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 328 RITAEQALEHPYFTEDPLP 346 (438)
T ss_pred hccHHHHhcccccccCCCC
Confidence 9999999999999875433
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=386.39 Aligned_cols=269 Identities=30% Similarity=0.369 Sum_probs=227.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.++.|++++.||+|.-|+||+|+.+.++..+|+|++.+......
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~r----------------------------------- 118 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASR----------------------------------- 118 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhh-----------------------------------
Confidence 345779999999999999999999999999999999976532110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
| ...++..|-.||+.++||.+++||.
T Consensus 119 ---------------------------------------------k---------Kl~Ra~tE~eIL~~lDHPFlPTLYa 144 (459)
T KOG0610|consen 119 ---------------------------------------------K---------KLKRAQTEREILSLLDHPFLPTLYA 144 (459)
T ss_pred ---------------------------------------------h---------HHHHHHHHHHHHHhcCCCccchhhh
Confidence 1 1125677999999999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
.|+++++.|+|||||.| +|...+++ .++.+++..++.|+.+++.||+|||-.|||.|||||+||||-++|++.|+||.
T Consensus 145 ~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 145 SFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecc
Confidence 99999999999999995 77776654 35779999999999999999999999999999999999999999999999999
Q ss_pred cccccCC---------------------------------C-C----------------------ccccCCcccccccch
Q psy12305 326 LARAKSV---------------------------------P-T----------------------KTFSNEVVTLWYRPP 349 (516)
Q Consensus 326 la~~~~~---------------------------------~-~----------------------~~~~~~~gt~~y~AP 349 (516)
|+..... . . .....++||-.|.||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 8743110 0 0 011235889999999
Q ss_pred hhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCC
Q psy12305 350 DVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQM 429 (516)
Q Consensus 350 E~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 429 (516)
|++.|...+.+.|+|+|||++|||+.|..||.|.+..+.+.+|+..--..| ....+
T Consensus 305 EvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp------------------------~~~~v 360 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP------------------------EEPEV 360 (459)
T ss_pred eeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC------------------------CCCcc
Confidence 999999999999999999999999999999999999999988864221111 11267
Q ss_pred CHHHHHHHHHccccCcCCCCC----HHHHHcCCCCCCCCCCccc
Q psy12305 430 DSDALDLVQKFLMYDAKQRIS----AANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 430 s~~~~dLl~~~L~~dP~~R~t----a~e~l~Hp~f~~~~~~~~~ 469 (516)
+..++|||+++|.+||.+|+. |+||.+||||..++|....
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir 404 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIR 404 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhhee
Confidence 789999999999999999998 9999999999999887443
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=365.46 Aligned_cols=260 Identities=26% Similarity=0.430 Sum_probs=229.3
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...+++|++.+.||+|-||.||.|+.+.++-.||+|++.+..-..
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~----------------------------------- 62 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILK----------------------------------- 62 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHH-----------------------------------
Confidence 467899999999999999999999999999999999987643111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.....++.+|++|-..|+||||+++|
T Consensus 63 ------------------------------------------------------~~v~~qlrREiEIqs~L~hpnilrlY 88 (281)
T KOG0580|consen 63 ------------------------------------------------------TQVEHQLRREIEIQSHLRHPNILRLY 88 (281)
T ss_pred ------------------------------------------------------hcchhhhhheeEeecccCCccHHhhh
Confidence 11223567888888899999999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++|.+...+||++||.. |.++..+... ...+++..+..|+.|++.||.|||.++||||||||+|+|++.+|.+||+||
T Consensus 89 ~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 89 GYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred hheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCC
Confidence 99999999999999998 7888888743 356999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|.+-... .....+.|||.-|.|||+..+..++...|.|++|++.||++.|.+||...+..+.+..|.+
T Consensus 169 GwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k---------- 236 (281)
T KOG0580|consen 169 GWSVHAP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK---------- 236 (281)
T ss_pred CceeecC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----------
Confidence 9986543 4455678999999999999999999999999999999999999999999888888888854
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.+..+|..++.++.|||.+||.++|.+|++..|++.|||+...
T Consensus 237 ----------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 237 ----------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ----------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 4455667999999999999999999999999999999998654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=398.06 Aligned_cols=279 Identities=35% Similarity=0.592 Sum_probs=216.3
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+|++.++||+|+||.||+|++..+|+.||||++..... ......+.
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--------------------------------- 47 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRIL--------------------------------- 47 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHH---------------------------------
Confidence 59999999999999999999999999999999864321 11112334
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+|+.+++.++||||+++++++.
T Consensus 48 ----------------------------------------------------------~E~~~l~~l~hpniv~~~~~~~ 69 (338)
T cd07859 48 ----------------------------------------------------------REIKLLRLLRHPDIVEIKHIML 69 (338)
T ss_pred ----------------------------------------------------------HHHHHHHhCCCCCEeeecceEe
Confidence 4555555555555555555443
Q ss_pred eC-----ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 251 TE-----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 251 ~~-----~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
.. ..+|+|||||+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg 148 (338)
T cd07859 70 PPSRREFKDIYVVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFG 148 (338)
T ss_pred ccCCCCCceEEEEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCc
Confidence 22 357999999999999888764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC---ccccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 326 LARAKSVPT---KTFSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 326 la~~~~~~~---~~~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
+++...... ......+||+.|+|||++.+ ..++.++|+|||||++|||++|++||.+.+....+..+....|.|+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 997643221 12234578999999999865 5677889999999999999999999999988888888888899888
Q ss_pred hhhhhhccccc--------CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 401 DELKSKLEFCI--------TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 401 ~~~~~~~~~~~--------~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.+......... ....+ .......| ..++++.+||.+||+.||++|||++++++||||+.+..
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQP--VPFSQKFP-NADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCC--CchHHhcC-CCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 76654322110 00000 01111122 56788999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=392.25 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=219.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++.+.||+|+||+||+|++..+|+.||||.+.......
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------------------------------------ 58 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK------------------------------------ 58 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh------------------------------------
Confidence 45688999999999999999999999999999999986432100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.++++++||||+++++
T Consensus 59 -----------------------------------------------------~~~~~~~~~E~~~l~~l~hp~iv~~~~ 85 (329)
T PTZ00263 59 -----------------------------------------------------MKQVQHVAQEKSILMELSHPFIVNMMC 85 (329)
T ss_pred -----------------------------------------------------hhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 001124667899999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..++.+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 86 SFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred EEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccC
Confidence 9999999999999998 4888888764 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
++..... ....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+....+...
T Consensus 165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~----------- 230 (329)
T PTZ00263 165 AKKVPDR---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG----------- 230 (329)
T ss_pred ceEcCCC---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 9865432 22357899999999999888888999999999999999999999887776665555321
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~ 466 (516)
....|..++..+.+||.+||+.||.+|++ ++++++||||....+.
T Consensus 231 ---------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 231 ---------------RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred ---------------CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 11234467889999999999999999997 7999999999876443
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=385.26 Aligned_cols=279 Identities=40% Similarity=0.679 Sum_probs=214.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcC-CCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRL-TDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~-~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
++|++++.||+|+||+||+|++.. +|+.||||.+...... .....+.+|+.+++.+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---------------------- 58 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL---------------------- 58 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhh----------------------
Confidence 369999999999999999999854 5789999998764321 1122233343333322
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
+.++||||++++++
T Consensus 59 ------------------------------------------------------------------~~~~hpniv~~~~~ 72 (290)
T cd07862 59 ------------------------------------------------------------------ETFEHPNVVRLFDV 72 (290)
T ss_pred ------------------------------------------------------------------cccCCCCcceEEEE
Confidence 22246666666666
Q ss_pred Ee-----eCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 249 IH-----TEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 249 ~~-----~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
+. ....+++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 73 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 73 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred EecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEc
Confidence 53 235689999999999999887643 458999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|||+++..... .......||+.|+|||++.+..+..++|+||+||++|||++|.+||.+.+..+.+..+....+.|..+
T Consensus 153 Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 153 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cccceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 99999765433 23344578999999999988888889999999999999999999999999889999998888776654
Q ss_pred hhhh-ccccc--CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 403 LKSK-LEFCI--TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 403 ~~~~-~~~~~--~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.+.. ..... ...... .......| .+++.+.+||.+||++||++|||+.++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 232 DWPRDVALPRQAFHSKSA-QPIEKFVT-DIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hchhhhcccchhccCCCC-CCHHHHcc-CCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 4321 11100 000000 11112222 578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=395.18 Aligned_cols=215 Identities=27% Similarity=0.393 Sum_probs=184.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++..++.+|+||||+++ +|..++... ..+++..++.++.||+.||+|||++||+||
T Consensus 41 ~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHr 119 (323)
T cd05571 41 HTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYR 119 (323)
T ss_pred HHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence 456788899999999999999999999999999999985 777777653 568999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+|+............+||+.|+|||++.+..+..++|+||+||++|||++|..||.+.+
T Consensus 120 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 99999999999999999999999764433334455689999999999998888999999999999999999999998877
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPY 459 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~ 459 (516)
.......+... ...+|..+++++.+||.+||+.||++|| ++.++++|||
T Consensus 200 ~~~~~~~~~~~--------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 200 HEKLFELILME--------------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred HHHHHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 66555544321 1123457889999999999999999999 8999999999
Q ss_pred CCCCCCCc
Q psy12305 460 FNSLGPQV 467 (516)
Q Consensus 460 f~~~~~~~ 467 (516)
|.++.+..
T Consensus 254 f~~~~~~~ 261 (323)
T cd05571 254 FASINWQD 261 (323)
T ss_pred cCCCCHHH
Confidence 98875543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=388.49 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=215.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|++..+|+.||||++........
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------------------------------------- 42 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRL-------------------------------------- 42 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhh--------------------------------------
Confidence 469999999999999999999999999999999865321100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 43 ---------------------------------------------------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 71 (291)
T cd05612 43 ---------------------------------------------------KQEQHVHNEKRVLKEVSHPFIIRLFWTEH 71 (291)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCcHhhhHhhhc
Confidence 00124567888888888888888888888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++.+|+||||+. ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~ 150 (291)
T cd05612 72 DQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKK 150 (291)
T ss_pred cCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence 8889999999998 5888888764 4689999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... ....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 151 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-------------- 213 (291)
T cd05612 151 LRDR---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-------------- 213 (291)
T ss_pred ccCC---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 5422 23357899999999999888888999999999999999999999988776666555321
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~ 466 (516)
....|...++.+++||.+||+.||.+|++ ++++++||||+.+.+.
T Consensus 214 ------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 214 ------------KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ------------CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 11234467889999999999999999995 9999999999876654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-48 Score=383.14 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=216.2
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|...+.||+|+||+||+|.+..+|+.||||.+........
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~--------------------------------------- 41 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--------------------------------------- 41 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhh---------------------------------------
Confidence 38899999999999999999999999999998865321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++|+||+++++++.+
T Consensus 42 --------------------------------------------------~~~~~~~~E~~il~~l~~~~iv~~~~~~~~ 71 (285)
T cd05631 42 --------------------------------------------------KGEAMALNEKRILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred --------------------------------------------------hhHHHHHHHHHHHHhcCCCcEEEEEEEEcc
Confidence 011245678888999999999999999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++.+++||||+++ +|..++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~ 151 (285)
T cd05631 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ 151 (285)
T ss_pred CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence 9999999999984 777666543 34689999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... ......+||+.|+|||++.+..++.++|+||+||++|||++|+.||.+.........+......
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~----------- 219 (285)
T cd05631 152 IPEG-ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE----------- 219 (285)
T ss_pred cCCC-CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc-----------
Confidence 5322 2334557899999999999888889999999999999999999999876543332222221111
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELS 471 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~ 471 (516)
.....+...++++.+||.+||+.||.+||| ++++++||||..+.+......
T Consensus 220 -----------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 220 -----------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred -----------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 111234467899999999999999999997 899999999998776554433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-48 Score=391.46 Aligned_cols=264 Identities=31% Similarity=0.412 Sum_probs=227.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..-..|++.+.||+|.||+||+|+++.||+.||+|.|.+....+..
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~---------------------------------- 77 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKE---------------------------------- 77 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccc----------------------------------
Confidence 3445699999999999999999999999999999999765432210
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 246 (516)
....+.+|+.+|+++. |||||+++
T Consensus 78 -------------------------------------------------------~~~~v~~Ev~il~~l~~hpniv~l~ 102 (382)
T KOG0032|consen 78 -------------------------------------------------------DREDVRREVAILQQLSGHPNIVQLK 102 (382)
T ss_pred -------------------------------------------------------cHHHHHHHHHHHHhccCCCCEEEEE
Confidence 1236778999999998 99999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC----CCEEE
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER----GELKL 321 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~----~~vkL 321 (516)
++|++...+++|||+|. |.|++.+... . +++..+..++.||+.|+.|||+.||+||||||+|+|+... +.+|+
T Consensus 103 ~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~ 180 (382)
T KOG0032|consen 103 DAFEDPDSVYLVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKL 180 (382)
T ss_pred EEEEcCCeEEEEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEE
Confidence 99999999999999999 5899888876 3 9999999999999999999999999999999999999643 47999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+|||+|..... .......+||+.|+|||++.+.++....|+||+||++|.|++|.+||.+.+.......|...--..+.
T Consensus 181 ~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~ 259 (382)
T KOG0032|consen 181 IDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTS 259 (382)
T ss_pred eeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCC
Confidence 99999988765 56677889999999999999889999999999999999999999999999888777766543221111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
+ ..+.++..++|||++||..||.+|+||.++|+|||+++...
T Consensus 260 ~----------------------~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 260 E----------------------PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred C----------------------CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 1 12377999999999999999999999999999999987533
|
|
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=365.18 Aligned_cols=268 Identities=26% Similarity=0.389 Sum_probs=224.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
+..+.|...+.||+|..++|-++.++.+|+.+|+|+|.........+. ..|
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~-~~~---------------------------- 64 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGET-PYE---------------------------- 64 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCcc-HHH----------------------------
Confidence 345668999999999999999999999999999999976543222111 111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
-....++|+.||+++ .||+|+++.
T Consensus 65 -------------------------------------------------------~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 65 -------------------------------------------------------MREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHHhcCCCcEEEee
Confidence 112456799999998 699999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++|+++..+++|+|.|. |.|.+++... -.++++.++.+++|++.|+.|||.++||||||||+|||++++.++||+|||
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccc
Confidence 99999999999999999 7999999764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCC------CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGS------TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
+|+... ++......||||+|.|||.+... .|+...|.||+|||+|.|+.|.+||......-.++.|.+.--..
T Consensus 169 Fa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF 247 (411)
T KOG0599|consen 169 FACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQF 247 (411)
T ss_pred eeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccccc
Confidence 998875 55667788999999999998543 35566788999999999999999999877766777775532111
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
......+++.+.+|||++||+.||.+|+|++|+|+||||..+
T Consensus 248 ----------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 248 ----------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred ----------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 111224788999999999999999999999999999999644
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=400.37 Aligned_cols=276 Identities=21% Similarity=0.288 Sum_probs=216.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|+++++||+|+||.||+|++..+++.||||.....
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~------------------------------------------ 128 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG------------------------------------------ 128 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh------------------------------------------
Confidence 35699999999999999999999999999999964211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.+.+|+.+|++++||||++++++|
T Consensus 129 --------------------------------------------------------~~~~E~~il~~l~HpnIv~~~~~~ 152 (391)
T PHA03212 129 --------------------------------------------------------GTATEAHILRAINHPSIIQLKGTF 152 (391)
T ss_pred --------------------------------------------------------hhHHHHHHHHhCCCCCCCCEeEEE
Confidence 234677777788888888888888
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
..+...++|||++.++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 153 ~~~~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~ 231 (391)
T PHA03212 153 TYNKFTCLILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231 (391)
T ss_pred EECCeeEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccc
Confidence 888899999999999999888764 4589999999999999999999999999999999999999999999999999975
Q ss_pred cCC-CCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC-------CHHHHHHHHHHhcCCCCh
Q psy12305 330 KSV-PTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS-------TIEDELRLICSILGPPPD 401 (516)
Q Consensus 330 ~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~-------~~~~~~~~i~~~~~~~p~ 401 (516)
... ........+||+.|+|||++.+..++.++|+||+||++|||++|..||.+. ....++..+....|.+|.
T Consensus 232 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~ 311 (391)
T PHA03212 232 PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPN 311 (391)
T ss_pred cccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChh
Confidence 322 122334467999999999998888888999999999999999999887543 234567778888887765
Q ss_pred hhhhhc---------ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 402 ELKSKL---------EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 402 ~~~~~~---------~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
++.... .....................++.++.+||.+||++||.+||||+|+|+||||+.+.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 312 EFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 432110 000000000000000000013567899999999999999999999999999998753
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=405.79 Aligned_cols=288 Identities=22% Similarity=0.361 Sum_probs=225.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|+++++||+|+||+||+|.+..+++.||||+++.... ....+.+|+.++..++|.|+.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~----------------- 188 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPA----------------- 188 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcc-----------------
Confidence 3679999999999999999999999999999999864321 122445666666666555531
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
+|+++++++++|
T Consensus 189 --------------------------------------------------------------------~~~~i~~i~~~~ 200 (467)
T PTZ00284 189 --------------------------------------------------------------------DRFPLMKIQRYF 200 (467)
T ss_pred --------------------------------------------------------------------cCcceeeeEEEE
Confidence 456788888888
Q ss_pred eeC-ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCC----------
Q psy12305 250 HTE-KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERG---------- 317 (516)
Q Consensus 250 ~~~-~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~---------- 317 (516)
..+ .++|+|||+++++|.+++... ..+++..++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 201 QNETGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred EcCCceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 765 579999999999999988765 469999999999999999999998 5999999999999998765
Q ss_pred ------CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHH
Q psy12305 318 ------ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRL 391 (516)
Q Consensus 318 ------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~ 391 (516)
.+||+|||++.... ......+||+.|+|||++.+..+..++|+|||||++|||++|++||.+.+..+.+..
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred cCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999886432 223456889999999999998888999999999999999999999999999999999
Q ss_pred HHHhcCCCChhhhhhcccc-----------cCCCCCCchhhhhc-----CCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 392 ICSILGPPPDELKSKLEFC-----------ITPVYPSESKLQLL-----APEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 392 i~~~~~~~p~~~~~~~~~~-----------~~~~~~~~~~~~~~-----~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
+...+|.+|.++....... ..+........... .....++.+.|||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 9999999988765432100 00111000000000 0001256788999999999999999999999
Q ss_pred cCCCCCCCCCCcc
Q psy12305 456 RHPYFNSLGPQVH 468 (516)
Q Consensus 456 ~Hp~f~~~~~~~~ 468 (516)
+||||....+...
T Consensus 437 ~Hp~~~~~~~~~~ 449 (467)
T PTZ00284 437 THPYVLKYYPECR 449 (467)
T ss_pred cCccccccCCccc
Confidence 9999987655443
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-50 Score=364.49 Aligned_cols=293 Identities=40% Similarity=0.654 Sum_probs=241.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...+.|+.+.+||+|.||.||||+.+.+|+.||+|++--.++ .+....++||+++|..|+|+|+++++++|......+
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~- 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT- 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc-
Confidence 345679999999999999999999999999999998765443 677779999999999999999999988875432100
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 93 -------------------------------------------------------------------------------- 92 (376)
T KOG0669|consen 93 -------------------------------------------------------------------------------- 92 (376)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
......+|+||.+|+.+|.-.+.....+++..+++.++.+++.||.|+|+..|+|||+||+|+||+.+|.+||+|||+
T Consensus 93 --~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 93 --NRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred --ccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 002235899999999999999988778899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----CccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 327 ARAKSVP----TKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 327 a~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|+.++.. ...+++.+.|.||++||.++|...+ .+.|+|+.||++.||+||.+.|.+.+...+++.|...+|....
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9876543 2346777889999999999987655 5567789999999999999999999999999999999999999
Q ss_pred hhhhhcccc-------cCCCCCCc--hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 402 ELKSKLEFC-------ITPVYPSE--SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 402 ~~~~~~~~~-------~~~~~~~~--~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
+.|.+.... ..|..... .-.....|-.-++++.||+.+||.+||.+|++++++++|.||..-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 988664322 01111000 011122233447899999999999999999999999999999753
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=391.69 Aligned_cols=263 Identities=22% Similarity=0.373 Sum_probs=214.6
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++..+|+.||||++.......
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------------------------- 41 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLE--------------------------------------- 41 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhh---------------------------------------
Confidence 47999999999999999999999999999999986532100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.+|+.++||||+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (364)
T cd05599 42 --------------------------------------------------KEQVAHVRAERDILAEADNPWVVKLYYSFQ 71 (364)
T ss_pred --------------------------------------------------hhHHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 001124567889999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++++|+|||||. |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 150 (364)
T cd05599 72 DENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG 150 (364)
T ss_pred cCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence 9999999999998 5788887664 4699999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCc--------------------------------------cccCCcccccccchhhccCCCCCCceeeehHHHHHH
Q psy12305 330 KSVPTK--------------------------------------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFH 371 (516)
Q Consensus 330 ~~~~~~--------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ 371 (516)
...... .....+||+.|+|||++.+..++.++|+|||||++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 230 (364)
T cd05599 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY 230 (364)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence 421110 011246999999999998888899999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-
Q psy12305 372 EMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS- 450 (516)
Q Consensus 372 elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t- 450 (516)
||++|.+||.+.+..+....+...... ........+++++.+||.+||. +|.+|++
T Consensus 231 el~~G~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~ 287 (364)
T cd05599 231 EMLVGYPPFCSDNPQETYRKIINWKET----------------------LQFPDEVPLSPEAKDLIKRLCC-EAERRLGN 287 (364)
T ss_pred HhhcCCCCCCCCCHHHHHHHHHcCCCc----------------------cCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC
Confidence 999999999988776665555321110 0011112568999999999997 9999998
Q ss_pred --HHHHHcCCCCCCCCCC
Q psy12305 451 --AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 451 --a~e~l~Hp~f~~~~~~ 466 (516)
++++++||||....+.
T Consensus 288 ~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 288 NGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCHHHHhcCCCcCCCCHH
Confidence 9999999999876543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-49 Score=378.81 Aligned_cols=257 Identities=24% Similarity=0.423 Sum_probs=221.8
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...-.+|++.+.||+|+||.|-+|+....|+.||||-|+++.-...
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkde---------------------------------- 94 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDE---------------------------------- 94 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccH----------------------------------
Confidence 3455679999999999999999999999999999999987532211
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.....+.+||+||..|+||||+.+|
T Consensus 95 -------------------------------------------------------qDlvhIRREIeIMSsLNHPhII~Iy 119 (668)
T KOG0611|consen 95 -------------------------------------------------------QDLVHIRREIEIMSSLNHPHIIQIY 119 (668)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHhhcCCCceeehh
Confidence 1122567889999999999999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++|++.+.+.|||||.. |.|.+|+..++ .+++.+++.|++||++|+.|||+++++|||||.+|||+|.++++||+|||
T Consensus 120 EVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 120 EVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred hhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccc
Confidence 99999999999999998 69999998865 49999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCc-eeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST-SIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++..+. ......++||+|.|.+||++.|.+|..+ .|.|||||+||.|+.|..||.|.+......+|....
T Consensus 199 LSNly~-~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga-------- 269 (668)
T KOG0611|consen 199 LSNLYA-DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA-------- 269 (668)
T ss_pred hhhhhc-cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc--------
Confidence 997654 4556778999999999999999887554 566999999999999999999998888888775421
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
...| ..+.++.-||+-||..||++|.|++++-.|=|.+
T Consensus 270 ------------------YrEP-~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 270 ------------------YREP-ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ------------------ccCC-CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 1112 4567899999999999999999999999998864
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=389.89 Aligned_cols=260 Identities=23% Similarity=0.315 Sum_probs=217.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCC-cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTD-NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g-~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|++.+.||+|+||.||+|.+..++ ..||||++.......
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~----------------------------------- 71 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIK----------------------------------- 71 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhh-----------------------------------
Confidence 46788999999999999999999977655 689999886532110
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
......+.+|+.+++.++||||++++
T Consensus 72 ------------------------------------------------------~~~~~~~~~E~~~l~~l~hp~Iv~~~ 97 (340)
T PTZ00426 72 ------------------------------------------------------QKQVDHVFSERKILNYINHPFCVNLY 97 (340)
T ss_pred ------------------------------------------------------hhhHHHHHHHHHHHHhCCCCCCcceE
Confidence 01112456788999999999999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++.+++.+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 98 GSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCC
Confidence 99999999999999998 5788887664 469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+++..... ....+||+.|+|||++.+..++.++|+||+||++|||++|.+||.+.+.......+....
T Consensus 177 ~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 244 (340)
T PTZ00426 177 FAKVVDTR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI--------- 244 (340)
T ss_pred CCeecCCC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence 99765422 234578999999999988888889999999999999999999999887766555553211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~ 466 (516)
...|..+++++.+||++||+.||.+|+ |++++++||||.++.+.
T Consensus 245 -----------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 245 -----------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 123457789999999999999999996 89999999999987654
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=391.42 Aligned_cols=264 Identities=20% Similarity=0.295 Sum_probs=213.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++..+++.||||++........
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~-------------------------------------- 42 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEK-------------------------------------- 42 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHh--------------------------------------
Confidence 479999999999999999999999999999999865321100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.++..++||||+++++.+.
T Consensus 43 ---------------------------------------------------~~~~~~~~E~~il~~~~~~~iv~~~~~~~ 71 (363)
T cd05628 43 ---------------------------------------------------EQVGHIRAERDILVEADSLWVVKMFYSFQ 71 (363)
T ss_pred ---------------------------------------------------hHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 01124567888999999999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++..+|+|||||+| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~ 150 (363)
T cd05628 72 DKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG 150 (363)
T ss_pred cCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence 99999999999985 788887764 5699999999999999999999999999999999999999999999999999875
Q ss_pred cCCCC-----------------------------------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHH
Q psy12305 330 KSVPT-----------------------------------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMS 374 (516)
Q Consensus 330 ~~~~~-----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ell 374 (516)
..... ......+||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell 230 (363)
T cd05628 151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (363)
T ss_pred ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence 42110 0012357999999999999888889999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC---CCCH
Q psy12305 375 SGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ---RISA 451 (516)
Q Consensus 375 tG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~---R~ta 451 (516)
+|.+||.+.+..+....+....... .......+++++++||.+|+. +|.+ ||++
T Consensus 231 ~G~~Pf~~~~~~~~~~~i~~~~~~~----------------------~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~ 287 (363)
T cd05628 231 IGYPPFCSETPQETYKKVMNWKETL----------------------IFPPEVPISEKAKDLILRFCC-EWEHRIGAPGV 287 (363)
T ss_pred hCCCCCCCCCHHHHHHHHHcCcCcc----------------------cCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH
Confidence 9999999888777666664321110 000011468899999999875 5554 5899
Q ss_pred HHHHcCCCCCCCCCCc
Q psy12305 452 ANAMRHPYFNSLGPQV 467 (516)
Q Consensus 452 ~e~l~Hp~f~~~~~~~ 467 (516)
+|+++||||....+..
T Consensus 288 ~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 288 EEIKTNPFFEGVDWEH 303 (363)
T ss_pred HHHhCCCCCCCCCHHH
Confidence 9999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=376.48 Aligned_cols=279 Identities=38% Similarity=0.667 Sum_probs=214.8
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+|++++.||+|+||+||+|+++.+|+.||||.+...... .......+|+.+++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l------------------------ 56 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL------------------------ 56 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHh------------------------
Confidence 589999999999999999999999999999998764321 1111233444333332
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+.++||||+++++++.
T Consensus 57 ----------------------------------------------------------------~~~~h~ni~~~~~~~~ 72 (288)
T cd07863 57 ----------------------------------------------------------------EAFDHPNIVRLMDVCA 72 (288)
T ss_pred ----------------------------------------------------------------hhcCCCCeeeeeeeec
Confidence 2224666666666554
Q ss_pred e-----CceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 251 T-----EKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 251 ~-----~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
. ...+++||||+.++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 73 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 73 TSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred cccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcc
Confidence 3 34589999999999988887643 45899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+++..... .......||+.|+|||++.+..+..++|+||+||++|+|++|.+||.+....+.+..+....+.+....+
T Consensus 153 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 153 GLARIYSCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred CccccccCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 999765432 2233457799999999998888889999999999999999999999998888888888888877765444
Q ss_pred hhcccccCCCCCC--chhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 405 SKLEFCITPVYPS--ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 405 ~~~~~~~~~~~~~--~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..........+.. ........ ..++.++.|||.+||++||++|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVV-PEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccccccccccCCCCCCchHHhC-cCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 3211000000000 01111122 2578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=372.62 Aligned_cols=274 Identities=28% Similarity=0.387 Sum_probs=234.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|..++.||+|+||.|-+|+-+.+|++||||++++.---.
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviia------------------------------------ 208 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIA------------------------------------ 208 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheee------------------------------------
Confidence 46789999999999999999999999999999999987531100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.......+.|-++|+..+||++..|-.
T Consensus 209 -----------------------------------------------------kdEVAHTlTE~RVL~~~~HPFLt~LKY 235 (516)
T KOG0690|consen 209 -----------------------------------------------------KDEVAHTLTENRVLQNCRHPFLTSLKY 235 (516)
T ss_pred -----------------------------------------------------hHHhhhhhhHHHHHHhccCcHHHHhhh
Confidence 001113456888899999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.|++.+++|+||||+.| .|.-.+.+ ...+++..++.+...|++||.|||+++||.||||.+|+|+|.+|++||+|||+
T Consensus 236 sFQt~drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGL 314 (516)
T KOG0690|consen 236 SFQTQDRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGL 314 (516)
T ss_pred hhccCceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeeccc
Confidence 99999999999999995 66666654 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+.......+..++||||.|+|||++....|....|+|.+||++|||++|+.||...+....+..|..
T Consensus 315 CKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~------------ 382 (516)
T KOG0690|consen 315 CKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM------------ 382 (516)
T ss_pred chhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh------------
Confidence 99877777788899999999999999888777777777999999999999999999888887777742
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQSIF 477 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~~~ 477 (516)
....+|..++++++.|+..+|.+||.+|+. |.|+++|+||.+++|+..-.....++|
T Consensus 383 --------------ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPf 444 (516)
T KOG0690|consen 383 --------------EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPF 444 (516)
T ss_pred --------------hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCC
Confidence 334567799999999999999999999985 789999999999987654444444444
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=384.29 Aligned_cols=213 Identities=26% Similarity=0.404 Sum_probs=182.5
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.++++++||||+++++++..++..|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 39 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~Hr 117 (312)
T cd05585 39 HTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYR 117 (312)
T ss_pred HHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence 45678889999999999999999999999999999998 4888888664 469999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..+..++|+||+||++|||++|..||.+.+
T Consensus 118 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred CCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999999764333333445679999999999998888889999999999999999999999877
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC---CHHHHHcCCCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI---SAANAMRHPYFN 461 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~---ta~e~l~Hp~f~ 461 (516)
..+....+... ....|..+++++.+||.+||+.||.+|| ++.++++||||.
T Consensus 198 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~ 251 (312)
T cd05585 198 VNEMYRKILQE--------------------------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS 251 (312)
T ss_pred HHHHHHHHHcC--------------------------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence 66655554321 1123457889999999999999999997 589999999998
Q ss_pred CCCC
Q psy12305 462 SLGP 465 (516)
Q Consensus 462 ~~~~ 465 (516)
...+
T Consensus 252 ~~~~ 255 (312)
T cd05585 252 QLSW 255 (312)
T ss_pred CCCH
Confidence 7643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=394.31 Aligned_cols=280 Identities=31% Similarity=0.506 Sum_probs=216.4
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+..+++|++++.||+|+||+||+|++..+|+.||||++..... ......+.+|+.++
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l---------------------- 74 (359)
T cd07876 17 FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLL---------------------- 74 (359)
T ss_pred hhhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHH----------------------
Confidence 3557889999999999999999999999999999999865422 11222344444444
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
+.++||||+++
T Consensus 75 ---------------------------------------------------------------------~~l~h~niv~~ 85 (359)
T cd07876 75 ---------------------------------------------------------------------KCVNHKNIISL 85 (359)
T ss_pred ---------------------------------------------------------------------HhCCCCCEeee
Confidence 44455555555
Q ss_pred eeeEeeC------ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCE
Q psy12305 246 HDIIHTE------KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGEL 319 (516)
Q Consensus 246 ~~~~~~~------~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~v 319 (516)
++++... ..+|+||||+++++.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~ 162 (359)
T cd07876 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162 (359)
T ss_pred eeeeccCCCccccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 5444322 34799999999988877643 48899999999999999999999999999999999999999999
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
||+|||+++.... ........||+.|+|||++.+..+..++|+|||||++|+|++|+.||.+.+..+.+..+....+.|
T Consensus 163 kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 241 (359)
T cd07876 163 KILDFGLARTACT-NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP 241 (359)
T ss_pred EEecCCCcccccc-CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999999975432 222344578999999999998888899999999999999999999999998888888899989988
Q ss_pred Chhhhhhcccc------cCCCCCCchhhhh-----------cCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 400 PDELKSKLEFC------ITPVYPSESKLQL-----------LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 400 p~~~~~~~~~~------~~~~~~~~~~~~~-----------~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
+.++....... ..+.++. ..... ......++++++||.+||.+||++|||+.|+|+||||..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 242 SAEFMNRLQPTVRNYVENRPQYPG-ISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred cHHHHHHHHHHHHHHHhhCCCCCC-cchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 87654322110 1111111 00000 111234678999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=387.61 Aligned_cols=213 Identities=27% Similarity=0.432 Sum_probs=181.8
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++..++.+|+||||+++ +|..++.. ...+++..++.++.||+.||+|||++||+||
T Consensus 41 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 119 (328)
T cd05593 41 HTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119 (328)
T ss_pred HHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence 456788899999999999999999999999999999985 77777655 3569999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+
T Consensus 120 Dikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 99999999999999999999998764333334445679999999999988888899999999999999999999998877
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPY 459 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~ 459 (516)
..+....+.. .....|..+++++.+||.+||+.||.+|+ ++.++++|||
T Consensus 200 ~~~~~~~~~~--------------------------~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 200 HEKLFELILM--------------------------EDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred HHHHHHHhcc--------------------------CCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 6655544421 11123457889999999999999999997 8999999999
Q ss_pred CCCCCC
Q psy12305 460 FNSLGP 465 (516)
Q Consensus 460 f~~~~~ 465 (516)
|....+
T Consensus 254 ~~~~~~ 259 (328)
T cd05593 254 FTGVNW 259 (328)
T ss_pred cCCCCH
Confidence 987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=392.12 Aligned_cols=288 Identities=31% Similarity=0.488 Sum_probs=220.0
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+..+++|++++.||+|+||.||+|++..+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~--- 96 (364)
T cd07875 20 FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK--- 96 (364)
T ss_pred hchhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccc---
Confidence 4557889999999999999999999999999999999875432 222234455555555555555555554332111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
T Consensus 97 -------------------------------------------------------------------------------- 96 (364)
T cd07875 97 -------------------------------------------------------------------------------- 96 (364)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 246 HDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
.+.....+|+||||+++++...+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 97 --~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 97 --SLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred --cccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCC
Confidence 0112235799999999998887753 48889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+++..... .......||+.|+|||++.+..+..++|+|||||++|+|++|+.||.+.+..+.+..+....+.|+.+++.
T Consensus 172 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 172 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred CccccCCC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 99765422 22344578999999999998888889999999999999999999999999999999999988888776654
Q ss_pred hcccc------cCCCCCCc---h-------hhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFC------ITPVYPSE---S-------KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~------~~~~~~~~---~-------~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
..... ..+.+... . ..........+.+++|||.+||+.||.+|||++++|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 32211 11111100 0 00001111245789999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=383.81 Aligned_cols=214 Identities=27% Similarity=0.408 Sum_probs=182.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||++++++|...+.+|+||||+++ +|..++.. ...+++..++.++.||+.||+|||++||+||
T Consensus 41 ~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~ 119 (323)
T cd05595 41 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYR 119 (323)
T ss_pred HHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 456788899999999999999999999999999999985 77766655 3468999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+
T Consensus 120 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998764333334445678999999999988888899999999999999999999998877
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPY 459 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~ 459 (516)
.......+... ....|..+++++.+||.+||+.||++|+ ++.++++|||
T Consensus 200 ~~~~~~~~~~~--------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 200 HERLFELILME--------------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred HHHHHHHHhcC--------------------------CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 66655554321 1123457889999999999999999998 8999999999
Q ss_pred CCCCCCC
Q psy12305 460 FNSLGPQ 466 (516)
Q Consensus 460 f~~~~~~ 466 (516)
|.+..+.
T Consensus 254 ~~~~~~~ 260 (323)
T cd05595 254 FLSINWQ 260 (323)
T ss_pred cCCCCHH
Confidence 9876543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=383.73 Aligned_cols=259 Identities=22% Similarity=0.342 Sum_probs=215.2
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||+|+||.||+|++..+++.||||++.......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~---------------------------------------- 40 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQ---------------------------------------- 40 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhh----------------------------------------
Confidence 5899999999999999999999999999999987532110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccc-ceeeEeeeEe
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA-NIVTLHDIIH 250 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~ 250 (516)
......+..|+.++..+.|+ +|+++++++.
T Consensus 41 -------------------------------------------------~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (324)
T cd05587 41 -------------------------------------------------DDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 71 (324)
T ss_pred -------------------------------------------------hhHHHHHHHHHHHHHhcCCCCceeeeEEEEE
Confidence 00112455677788888654 5788899999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
..+.+|+||||++ ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~ 150 (324)
T cd05587 72 TMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE 150 (324)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence 9999999999998 5787777654 4589999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
...........+||+.|+|||++.+..++.++|+||+||++|||++|+.||.+.+..+.+..+....
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (324)
T cd05587 151 NIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (324)
T ss_pred cCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence 4333334445678999999999998888889999999999999999999999888777666653211
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH-----HHHHcCCCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-----ANAMRHPYFNSLGPQ 466 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta-----~e~l~Hp~f~~~~~~ 466 (516)
...|..+++++.+||.+||..||.+|+++ +++++||||....+.
T Consensus 218 -------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 218 -------------VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred -------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 12344788999999999999999999986 899999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-47 Score=388.74 Aligned_cols=281 Identities=34% Similarity=0.519 Sum_probs=216.5
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+|++.++||+|+||+||+|++..+|+.||||++..... ......+.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--------------------------------- 47 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF--------------------------------- 47 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHH---------------------------------
Confidence 48899999999999999999999999999998854321 11112334
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+|+.+++.++||||+++++++.
T Consensus 48 ----------------------------------------------------------~E~~~l~~l~h~niv~~~~~~~ 69 (372)
T cd07853 48 ----------------------------------------------------------RELKMLCFFKHDNVLSALDILQ 69 (372)
T ss_pred ----------------------------------------------------------HHHHHHHhCCCCCcCCHhheec
Confidence 4555555555555555555554
Q ss_pred eCc-----eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 251 TEK-----CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 251 ~~~-----~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
... .+|+||||+.++|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg 148 (372)
T cd07853 70 PPHIDPFEEIYVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG 148 (372)
T ss_pred CCCccccceEEEEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccc
Confidence 443 68999999999988887653 469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-ccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 326 LARAKSVPT-KTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 326 la~~~~~~~-~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
+|+...... .......+|+.|+|||++.+.. +..++|+||+||++|||++|++||.+.+..+++..+...+|.++.+.
T Consensus 149 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 149 LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 998654322 2233456799999999998754 56778999999999999999999999999999999999999887654
Q ss_pred hhhcc-----cc-cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 404 KSKLE-----FC-ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 404 ~~~~~-----~~-~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..... .. ..+..+.............++++.+||.+||++||.+|||++|+++||||....
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 32110 00 111111111111122335688999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=388.21 Aligned_cols=287 Identities=31% Similarity=0.475 Sum_probs=217.2
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 89 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK---- 89 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccc----
Confidence 4578899999999999999999999999999999998654321 11223445555555555555555544332111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 90 -------------------------------------------------------------------------------- 89 (355)
T cd07874 90 -------------------------------------------------------------------------------- 89 (355)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.+......|+||||+++++.+.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 90 -~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 90 -SLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred -cccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 0011235799999999988887753 488999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
++..... .......||+.|+|||++.+..+..++|+|||||++|+|++|+.||.+.+..+.+..+...++.+..+.+..
T Consensus 166 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 166 ARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 9765422 223445789999999999988888999999999999999999999999988888888888888877665433
Q ss_pred cccc------cCCCCCCc----------hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFC------ITPVYPSE----------SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~------~~~~~~~~----------~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
+... ..+.+... .......+...+.++++||.+||+.||++|||+.|+|+||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 2210 01111000 000011122346788999999999999999999999999999744
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=381.70 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=212.6
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|++++.||+|+||.||+|++..+|+.||||.+........
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~---------------------------------------- 40 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR---------------------------------------- 40 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh----------------------------------------
Confidence 7889999999999999999999999999999875421110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHH---HHhccccceeeEeeeE
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSL---LRELRHANIVTLHDII 249 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~i---l~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+ ++.++||||+++++++
T Consensus 41 -------------------------------------------------~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~ 71 (324)
T cd05589 41 -------------------------------------------------DEVESLMCEKRIFETANSERHPFLVNLFACF 71 (324)
T ss_pred -------------------------------------------------hHHHHHHHHHHHHHhccccCCCChhceeeEE
Confidence 001123344443 4566899999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+.+.+|+||||+++ +|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 72 ~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~ 149 (324)
T cd05589 72 QTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149 (324)
T ss_pred EcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence 999999999999995 77666643 469999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
............+||+.|+|||++.+..+..++|+|||||++|||++|..||.+.+..+....+...
T Consensus 150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~------------- 216 (324)
T cd05589 150 EGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND------------- 216 (324)
T ss_pred cCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------------
Confidence 5443333445568999999999999888888999999999999999999999988777666555331
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCc
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~ 467 (516)
....|..+++++.+||.+||+.||.+|| ++.++++||||..+.+..
T Consensus 217 -------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~ 267 (324)
T cd05589 217 -------------EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD 267 (324)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence 1123457889999999999999999999 799999999998875443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=382.82 Aligned_cols=214 Identities=24% Similarity=0.379 Sum_probs=181.8
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+..|..++..+ +||||+++++++.+.+.+|+||||+++ +|..++... ..+++..+..++.||+.||+|||++||+|
T Consensus 41 ~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH 119 (320)
T cd05590 41 CTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIY 119 (320)
T ss_pred HHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 345677777766 699999999999999999999999985 787777654 46999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..+..++|+||+||++|||++|+.||.+.
T Consensus 120 ~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred CCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999876443333445567999999999998888888999999999999999999999988
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH------HHHHcC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA------ANAMRH 457 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta------~e~l~H 457 (516)
+..+.+..+... ....|..++.++.+||.+||+.||.+||++ +++++|
T Consensus 200 ~~~~~~~~i~~~--------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 200 NEDDLFEAILND--------------------------EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CHHHHHHHHhcC--------------------------CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 877766655321 112344678999999999999999999998 999999
Q ss_pred CCCCCCCCC
Q psy12305 458 PYFNSLGPQ 466 (516)
Q Consensus 458 p~f~~~~~~ 466 (516)
|||..+.+.
T Consensus 254 ~~f~~~~~~ 262 (320)
T cd05590 254 PFFKELDWE 262 (320)
T ss_pred CCcCCCCHH
Confidence 999887543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=388.28 Aligned_cols=263 Identities=23% Similarity=0.332 Sum_probs=210.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|++++.||+|+||+||+|++..+++.||||++........
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~--------------------------------------- 42 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNR--------------------------------------- 42 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhh---------------------------------------
Confidence 59999999999999999999999999999999865321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++||||+++++++.+
T Consensus 43 --------------------------------------------------~~~~~~~~E~~il~~l~h~~iv~l~~~~~~ 72 (381)
T cd05626 43 --------------------------------------------------NQVAHVKAERDILAEADNEWVVKLYYSFQD 72 (381)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhcCCCCeeeeEEEEec
Confidence 011246678888999999999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
++++|+||||++ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 73 KDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 999999999998 4888887664 45899999999999999999999999999999999999999999999999997532
Q ss_pred CCCC-----------------------------------------------ccccCCcccccccchhhccCCCCCCceee
Q psy12305 331 SVPT-----------------------------------------------KTFSNEVVTLWYRPPDVLLGSTEYSTSID 363 (516)
Q Consensus 331 ~~~~-----------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~d~ 363 (516)
.... ......+||+.|+|||++.+..+..++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (381)
T cd05626 152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW 231 (381)
T ss_pred ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence 1000 00123479999999999988888889999
Q ss_pred ehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHcccc
Q psy12305 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMY 443 (516)
Q Consensus 364 ~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~ 443 (516)
|||||++|||++|.+||.+.+..+....+...... .....+..+++++.+||.+||..
T Consensus 232 wSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~~~~~~~s~~~~dli~~ll~~ 289 (381)
T cd05626 232 WSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT----------------------LHIPPQVKLSPEAVDLITKLCCS 289 (381)
T ss_pred eehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc----------------------cCCCCCCCCCHHHHHHHHHHccC
Confidence 99999999999999999887766555544321110 11111225789999999996654
Q ss_pred --CcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 444 --DAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 444 --dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
+|..|+|++++++||||....+.
T Consensus 290 ~~~~~~R~~~~~~l~hp~f~~~~~~ 314 (381)
T cd05626 290 AEERLGRNGADDIKAHPFFSEVDFS 314 (381)
T ss_pred cccccCCCCHHHHhcCcccCCCChh
Confidence 45559999999999999886543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=384.98 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=217.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.+++.||+|+||+||+|++..+|+.||||++.......
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK--------------------------------------- 41 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhh---------------------------------------
Confidence 47999999999999999999999999999999986532111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++..++||||+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (350)
T cd05573 42 --------------------------------------------------RNQIAHVRAERDILADADSPWIVKLYYSFQ 71 (350)
T ss_pred --------------------------------------------------ccHHHHHHHHHHHHHhcCCCCccchhhhee
Confidence 011124567888888888999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++++|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~ 150 (350)
T cd05573 72 DEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKK 150 (350)
T ss_pred cCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence 9999999999998 5888888765 5699999999999999999999999999999999999999999999999999976
Q ss_pred cCCCC-----------------------------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCC
Q psy12305 330 KSVPT-----------------------------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLF 380 (516)
Q Consensus 330 ~~~~~-----------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF 380 (516)
..... .......||+.|+|||++.+..+..++|+|||||++|||++|+.||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf 230 (350)
T cd05573 151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230 (350)
T ss_pred CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence 54332 1233457899999999999988899999999999999999999999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-HHHHHcCCC
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-AANAMRHPY 459 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-a~e~l~Hp~ 459 (516)
.+.+.......+...... ........+++++.+||.+||. ||.+|++ ++++++|||
T Consensus 231 ~~~~~~~~~~~i~~~~~~----------------------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 231 YSDTLQETYNKIINWKES----------------------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred CCCCHHHHHHHHhccCCc----------------------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 988766666555431110 0011112368999999999998 9999999 999999999
Q ss_pred CCCCCCC
Q psy12305 460 FNSLGPQ 466 (516)
Q Consensus 460 f~~~~~~ 466 (516)
|..+.+.
T Consensus 288 ~~~~~~~ 294 (350)
T cd05573 288 FKGIDWE 294 (350)
T ss_pred cCCCCHH
Confidence 9886543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=372.87 Aligned_cols=278 Identities=50% Similarity=0.895 Sum_probs=223.2
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||+|+||.||+|++..+|+.||+|.+........
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~--------------------------------------- 41 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG--------------------------------------- 41 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc---------------------------------------
Confidence 58999999999999999999999999999999865322110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.++++++||||+++++++.+
T Consensus 42 ---------------------------------------------------~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 70 (284)
T cd07839 42 ---------------------------------------------------VPSSALREICLLKELKHKNIVRLYDVLHS 70 (284)
T ss_pred ---------------------------------------------------CccchhHHHHHHHhcCCCCeeeHHHHhcc
Confidence 01134457777777777777777788888
Q ss_pred CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
....|+|+||++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 71 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 71 DKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 88899999999999999888766779999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHhcCCCChhhhhhcc-
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPL-FPGSTIEDELRLICSILGPPPDELKSKLE- 408 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~p-F~~~~~~~~~~~i~~~~~~~p~~~~~~~~- 408 (516)
..........+++.|+|||++.+.. ++.++|+||+||++|+|++|..| |.+.+..+.+..+....+.++...+....
T Consensus 151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence 4444445567799999999987644 57788999999999999998776 56777778888888888887766553322
Q ss_pred ---cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 ---FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ---~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
+...+.+.....+.... ..+++++.+||.+||..||.+|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVV-PKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cccccccCCCCCcchhhhhc-ccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 11122222211222222 3678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=386.27 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=214.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++..+|+.||||++.......
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLE--------------------------------------- 41 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhh---------------------------------------
Confidence 46999999999999999999999999999999986432110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++..++||||+++++.+.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 71 (360)
T cd05627 42 --------------------------------------------------KEQVAHIRAERDILVEADGAWVVKMFYSFQ 71 (360)
T ss_pred --------------------------------------------------hhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 011124567888999999999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++++|+||||++| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~ 150 (360)
T cd05627 72 DKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG 150 (360)
T ss_pred cCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence 99999999999985 788887654 4599999999999999999999999999999999999999999999999999874
Q ss_pred cCCCC-----------------------------------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHH
Q psy12305 330 KSVPT-----------------------------------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMS 374 (516)
Q Consensus 330 ~~~~~-----------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ell 374 (516)
..... ......+||+.|+|||++.+..++.++|+|||||++|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~ 230 (360)
T cd05627 151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230 (360)
T ss_pred cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence 32110 0012357999999999999988899999999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC---CH
Q psy12305 375 SGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI---SA 451 (516)
Q Consensus 375 tG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~---ta 451 (516)
+|.+||.+.+.......+...... ........+++++++||.+|+. ||.+|+ ++
T Consensus 231 tG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~ 287 (360)
T cd05627 231 IGYPPFCSETPQETYRKVMNWKET----------------------LVFPPEVPISEKAKDLILRFCT-DSENRIGSNGV 287 (360)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCc----------------------eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCH
Confidence 999999988777666555421100 0000111478899999999874 999999 48
Q ss_pred HHHHcCCCCCCCCCCc
Q psy12305 452 ANAMRHPYFNSLGPQV 467 (516)
Q Consensus 452 ~e~l~Hp~f~~~~~~~ 467 (516)
+++++||||..+.+..
T Consensus 288 ~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 288 EEIKSHPFFEGVDWGH 303 (360)
T ss_pred HHHhcCCCCCCCCHHH
Confidence 9999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-47 Score=382.89 Aligned_cols=214 Identities=27% Similarity=0.402 Sum_probs=181.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivH 303 (516)
.+.+|+.+++.++||||+++++++..++.+|+||||+++ +|..++.. ...+++..++.++.||+.||+|||+ +||+|
T Consensus 41 ~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivH 119 (325)
T cd05594 41 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119 (325)
T ss_pred HHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEe
Confidence 456788889999999999999999999999999999995 67766654 3569999999999999999999997 79999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.
T Consensus 120 rDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred cCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 99999999999999999999999875433333344567999999999998888889999999999999999999999887
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHP 458 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp 458 (516)
+.......+... ....|..+++++.+||.+||+.||++|+ ++.++++||
T Consensus 200 ~~~~~~~~i~~~--------------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 200 DHEKLFELILME--------------------------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CHHHHHHHHhcC--------------------------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 766655544221 1123457889999999999999999997 899999999
Q ss_pred CCCCCCCC
Q psy12305 459 YFNSLGPQ 466 (516)
Q Consensus 459 ~f~~~~~~ 466 (516)
||....+.
T Consensus 254 ~~~~~~~~ 261 (325)
T cd05594 254 FFAGIVWQ 261 (325)
T ss_pred CcCCCCHH
Confidence 99876433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=390.66 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=212.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+++++||+|+||+||+|++..+++.||||++.......
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~---------------------------------------- 41 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLL---------------------------------------- 41 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhh----------------------------------------
Confidence 5999999999999999999999999999999986432100
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
......+.+|+.++++++||||+++++.+.+
T Consensus 42 -------------------------------------------------~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~ 72 (382)
T cd05625 42 -------------------------------------------------RNQVAHVKAERDILAEADNEWVVRLYYSFQD 72 (382)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe
Confidence 0011245678899999999999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
++.+|+|||||+ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 73 ~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 73 KDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 999999999998 4788887664 46899999999999999999999999999999999999999999999999997532
Q ss_pred CCC-----------------------------------------------CccccCCcccccccchhhccCCCCCCceee
Q psy12305 331 SVP-----------------------------------------------TKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363 (516)
Q Consensus 331 ~~~-----------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~d~ 363 (516)
... .......+||+.|+|||++.+..++.++|+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di 231 (382)
T cd05625 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 231 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence 100 000123478999999999998889999999
Q ss_pred ehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHcccc
Q psy12305 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMY 443 (516)
Q Consensus 364 ~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~ 443 (516)
||+||++|||++|++||.+.+..+....+...... ........+++++.+||.+|+ .
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~p~~~~~s~~~~~li~~l~-~ 288 (382)
T cd05625 232 WSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTS----------------------LHIPPQAKLSPEASDLIIKLC-R 288 (382)
T ss_pred EechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCC----------------------cCCCCcccCCHHHHHHHHHHc-c
Confidence 99999999999999999988776655555431111 011112367899999999986 5
Q ss_pred CcCCCCC---HHHHHcCCCCCCCCCC
Q psy12305 444 DAKQRIS---AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 444 dP~~R~t---a~e~l~Hp~f~~~~~~ 466 (516)
||.+|++ ++++++||||....+.
T Consensus 289 ~p~~R~~~~~~~ei~~hp~f~~~~~~ 314 (382)
T cd05625 289 GPEDRLGKNGADEIKAHPFFKTIDFS 314 (382)
T ss_pred CHhHcCCCCCHHHHhcCCCcCCcChH
Confidence 9999997 9999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=379.37 Aligned_cols=214 Identities=22% Similarity=0.372 Sum_probs=182.5
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+..|..++..+ +||||+++++++..++.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+|
T Consensus 41 ~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 119 (321)
T cd05591 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIY 119 (321)
T ss_pred HHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 345677777765 799999999999999999999999985 777777654 46899999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.
T Consensus 120 rDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred cCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 99999999999999999999999976543444445567899999999998888888999999999999999999999988
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-------CHHHHHc
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-------SAANAMR 456 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-------ta~e~l~ 456 (516)
+..+.+..+... ....|..++.++.+||.+||+.||++|+ +++++++
T Consensus 200 ~~~~~~~~i~~~--------------------------~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 200 NEDDLFESILHD--------------------------DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CHHHHHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 877766665421 1123446789999999999999999999 9999999
Q ss_pred CCCCCCCCCC
Q psy12305 457 HPYFNSLGPQ 466 (516)
Q Consensus 457 Hp~f~~~~~~ 466 (516)
||||....+.
T Consensus 254 hp~~~~~~~~ 263 (321)
T cd05591 254 HPFFKEIDWV 263 (321)
T ss_pred CCccCCCCHH
Confidence 9999876544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=383.39 Aligned_cols=264 Identities=26% Similarity=0.408 Sum_probs=217.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||.||+|++..+|+.||||++.......
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--------------------------------------- 41 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFK--------------------------------------- 41 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---------------------------------------
Confidence 46999999999999999999999999999999986532110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++..++||||+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~ 71 (333)
T cd05600 42 --------------------------------------------------LNEVRHVLTERDILTTTKSEWLVKLLYAFQ 71 (333)
T ss_pred --------------------------------------------------hhHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 001124567888999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+++.|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~ 150 (333)
T cd05600 72 DDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKG 150 (333)
T ss_pred cCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence 9999999999998 4888877653 4689999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+....+.......
T Consensus 151 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------- 217 (333)
T cd05600 151 IVT---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------- 217 (333)
T ss_pred ccc---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence 543 3345678999999999998888899999999999999999999999888777666554321100
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
..+... .....+++++.+||.+||..+|.+|||++++++||||....+
T Consensus 218 -~~~~~~-------~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~ 265 (333)
T cd05600 218 -QRPVYD-------DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDW 265 (333)
T ss_pred -cCCCCC-------ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCH
Confidence 000000 000256899999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=380.91 Aligned_cols=262 Identities=21% Similarity=0.319 Sum_probs=217.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+++.||+|+||+||+|++..+++.||||.+.+......
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--------------------------------------- 41 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--------------------------------------- 41 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---------------------------------------
Confidence 58999999999999999999999999999999875321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeEe
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIH 250 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 250 (516)
........|..++..+ .|++|+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05616 42 --------------------------------------------------DDVECTMVEKRVLALSGKPPFLTQLHSCFQ 71 (323)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHhccCCCeEeeEEEEEe
Confidence 0111344566777666 5788999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
..+.+|+||||++ |+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~ 150 (323)
T cd05616 72 TMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence 9999999999998 5888777654 4589999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
...........+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+.+..+....
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05616 151 NMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred cCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 4433344455679999999999998888899999999999999999999999888777766664311
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCccc
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~ 469 (516)
...|..++.++.+|+.+||+.||.+|++ ..++++||||..+.+....
T Consensus 218 -------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~ 269 (323)
T cd05616 218 -------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 269 (323)
T ss_pred -------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHH
Confidence 1234478899999999999999999998 4899999999987654443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.02 Aligned_cols=259 Identities=27% Similarity=0.440 Sum_probs=225.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+=|.+.+.||+|.|.+|-+|+|..||..||||+|.+...+...
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s------------------------------------- 60 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS------------------------------------- 60 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-------------------------------------
Confidence 3499999999999999999999999999999999875432211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+..|++.|+-++|||||+||++..
T Consensus 61 -----------------------------------------------------t~hlfqEVRCMKLVQHpNiVRLYEViD 87 (864)
T KOG4717|consen 61 -----------------------------------------------------TGHLFQEVRCMKLVQHPNIVRLYEVID 87 (864)
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHhcCcCeeeeeehhc
Confidence 114556788888888888888888888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc-cCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-ERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkL~DFGla~ 328 (516)
+...+|||+|+-+ |+|.+|+.++...+.++.+++|+.||+.|+.|||+..+|||||||+|+.+- +-|-|||.|||++-
T Consensus 88 TQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 88 TQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred ccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 8889999999998 599999999988999999999999999999999999999999999999765 56899999999996
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCc-eeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST-SIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
.+. +.....+.||++.|-|||+++|..|+.+ .|+||||||||.|++|++||...++.+.+..|...
T Consensus 168 kf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC------------ 234 (864)
T KOG4717|consen 168 KFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC------------ 234 (864)
T ss_pred cCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc------------
Confidence 654 6777888999999999999999888755 46789999999999999999999999988888542
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
....|..++.+++|||.+||..||.+|.|.++|..|+|++...+.
T Consensus 235 --------------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 235 --------------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred --------------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 233466899999999999999999999999999999999876543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=389.61 Aligned_cols=262 Identities=23% Similarity=0.352 Sum_probs=212.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|++..+|+.||||++.......
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~--------------------------------------- 41 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLM--------------------------------------- 41 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHh---------------------------------------
Confidence 46999999999999999999999999999999986432100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.+|+.++||||+++++.+.
T Consensus 42 --------------------------------------------------~~~~~~~~~E~~il~~l~h~~iv~~~~~~~ 71 (376)
T cd05598 42 --------------------------------------------------RNQAAHVKAERDILAEADNEWVVKLYYSFQ 71 (376)
T ss_pred --------------------------------------------------hhhHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 001124567889999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++.+|+|||||+ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 72 ~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~ 150 (376)
T cd05598 72 DKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (376)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcc
Confidence 9999999999998 5888888664 4689999999999999999999999999999999999999999999999999753
Q ss_pred cCCC-------------------------------------------CccccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 330 KSVP-------------------------------------------TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 330 ~~~~-------------------------------------------~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
.... .......+||+.|+|||++.+..++.++|+|||
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 230 (376)
T cd05598 151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230 (376)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeec
Confidence 2100 000123479999999999998888899999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcC
Q psy12305 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAK 446 (516)
Q Consensus 367 Gvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~ 446 (516)
||++|||++|+.||.+.+..+....+...... ........+++++.+||.+|+ .+|.
T Consensus 231 Gvilyell~G~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~~~~~~~s~~~~~li~~l~-~~p~ 287 (376)
T cd05598 231 GVILYEMLVGQPPFLADTPAETQLKVINWETT----------------------LHIPSQAKLSREASDLILRLC-CGAE 287 (376)
T ss_pred cceeeehhhCCCCCCCCCHHHHHHHHhccCcc----------------------ccCCCCCCCCHHHHHHHHHHh-cCHh
Confidence 99999999999999988766655544321110 111112367899999999977 5999
Q ss_pred CCC---CHHHHHcCCCCCCCCC
Q psy12305 447 QRI---SAANAMRHPYFNSLGP 465 (516)
Q Consensus 447 ~R~---ta~e~l~Hp~f~~~~~ 465 (516)
+|+ |+.++++||||..+..
T Consensus 288 ~R~~~~t~~ell~h~~~~~~~~ 309 (376)
T cd05598 288 DRLGKNGADEIKAHPFFKGIDF 309 (376)
T ss_pred hcCCCCCHHHHhCCCCcCCCCH
Confidence 999 9999999999987653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=386.05 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=216.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++..+++.||||++........
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------ 84 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKR------------------------------------ 84 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------
Confidence 46789999999999999999999999999999999864321000
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+++.++||||++++++
T Consensus 85 -----------------------------------------------------~~~~~~~~e~~il~~~~h~~iv~~~~~ 111 (370)
T cd05596 85 -----------------------------------------------------SDSAFFWEERDIMAHANSEWIVQLHYA 111 (370)
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 011245678889999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++.+|+||||++ |+|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~ 189 (370)
T cd05596 112 FQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (370)
T ss_pred EecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence 999999999999998 578887765 34899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCC----CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGS----TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~----~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
+....... .....+||+.|+|||++.+. .+..++|+|||||++|||++|.+||.+.+....+..+......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---- 265 (370)
T cd05596 190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS---- 265 (370)
T ss_pred eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc----
Confidence 76543222 23456799999999998653 3567899999999999999999999988876666665431110
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCCc
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~~ 467 (516)
........++.++.+||.+||+.+|.+ |+|++++++||||+...+..
T Consensus 266 ------------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~~ 314 (370)
T cd05596 266 ------------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTF 314 (370)
T ss_pred ------------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChhh
Confidence 000111257899999999999999998 99999999999998765443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=386.82 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=211.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.++++||+|+||+||+|++..+|+.||||++.......
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFK--------------------------------------- 41 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHH---------------------------------------
Confidence 47999999999999999999999999999999886432100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.+++.++||||+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~~E~~il~~l~hp~iv~~~~~~~ 71 (377)
T cd05629 42 --------------------------------------------------KDQLAHVKAERDVLAESDSPWVVSLYYSFQ 71 (377)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHHhCCCCCcceEEEEEE
Confidence 001124567889999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+..++|+||||++ ++|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 72 ~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 72 DAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred cCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999998 5888888654 5689999999999999999999999999999999999999999999999999863
Q ss_pred cCCCCc-----------------------------------------------cccCCcccccccchhhccCCCCCCcee
Q psy12305 330 KSVPTK-----------------------------------------------TFSNEVVTLWYRPPDVLLGSTEYSTSI 362 (516)
Q Consensus 330 ~~~~~~-----------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~d 362 (516)
...... .....+||+.|+|||++.+..++.++|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 230 (377)
T cd05629 151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence 211000 001247999999999999888889999
Q ss_pred eehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccc
Q psy12305 363 DMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLM 442 (516)
Q Consensus 363 ~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~ 442 (516)
+|||||++|||++|.+||.+.+..+.+..+...... ........++.++.+||.+||.
T Consensus 231 iwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------------~~~p~~~~~s~~~~dli~~lL~ 288 (377)
T cd05629 231 WWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET----------------------LYFPDDIHLSVEAEDLIRRLIT 288 (377)
T ss_pred eEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc----------------------cCCCCCCCCCHHHHHHHHHHhc
Confidence 999999999999999999988776666655431110 0000112578999999999998
Q ss_pred cCcCCC---CCHHHHHcCCCCCCCCC
Q psy12305 443 YDAKQR---ISAANAMRHPYFNSLGP 465 (516)
Q Consensus 443 ~dP~~R---~ta~e~l~Hp~f~~~~~ 465 (516)
+|.+| +|+.++++||||+...+
T Consensus 289 -~~~~r~~r~~~~~~l~hp~~~~~~~ 313 (377)
T cd05629 289 -NAENRLGRGGAHEIKSHPFFRGVDW 313 (377)
T ss_pred -CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence 77776 59999999999987643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=381.10 Aligned_cols=264 Identities=25% Similarity=0.313 Sum_probs=216.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.+.+.||+|+||+||+|++..+|+.||||++........
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-------------------------------------- 42 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQ-------------------------------------- 42 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhh--------------------------------------
Confidence 469999999999999999999999999999999875321100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 43 ---------------------------------------------------~~~~~~~~e~~i~~~~~~~~i~~~~~~~~ 71 (330)
T cd05601 43 ---------------------------------------------------ETVSFFEEERDILSISNSPWIPQLQYAFQ 71 (330)
T ss_pred ---------------------------------------------------hHHHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence 01124567888888999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+.+.+|+||||++ ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~ 151 (330)
T cd05601 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR 151 (330)
T ss_pred cCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence 9999999999997 589998887767799999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCc-cccCCcccccccchhhcc------CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 330 KSVPTK-TFSNEVVTLWYRPPDVLL------GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 330 ~~~~~~-~~~~~~gt~~y~APE~l~------~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
...... .....+||+.|+|||++. +..+..++|+|||||++|||++|..||.+.+....+..+.....
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~----- 226 (330)
T cd05601 152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR----- 226 (330)
T ss_pred CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence 543322 223347899999999986 34566789999999999999999999988777666665543210
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.........+++++.+||.+||. ||.+|||++++++||||..+.+.
T Consensus 227 -----------------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~ 272 (330)
T cd05601 227 -----------------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWN 272 (330)
T ss_pred -----------------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHH
Confidence 00011112578999999999998 99999999999999999876543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=377.84 Aligned_cols=213 Identities=26% Similarity=0.409 Sum_probs=182.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|+.++||||+++++++..++.+|+||||+.+ +|..++... +.+++..++.++.||+.||+|||++||+||
T Consensus 46 ~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 124 (323)
T cd05584 46 HTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYR 124 (323)
T ss_pred HHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 456789999999999999999999999999999999985 787777654 468899999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..+..++|+|||||++|||++|++||.+.+
T Consensus 125 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred CCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999998754333333344578999999999988888889999999999999999999999877
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPY 459 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~ 459 (516)
....+..+... ....|..+++++.+||.+||+.||++|| +++++++|||
T Consensus 205 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 205 RKKTIDKILKG--------------------------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred HHHHHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 76655555321 1123447789999999999999999999 8999999999
Q ss_pred CCCCCC
Q psy12305 460 FNSLGP 465 (516)
Q Consensus 460 f~~~~~ 465 (516)
|....+
T Consensus 259 ~~~~~~ 264 (323)
T cd05584 259 FRHVNW 264 (323)
T ss_pred cCCCCH
Confidence 987543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=379.03 Aligned_cols=206 Identities=27% Similarity=0.401 Sum_probs=175.2
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCc-eeeEeeehhh-chHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCC-c
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEK-CLTLVFEYLE-KDLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRR-I 301 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~-g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~-i 301 (516)
.+.+|+.+|.+++|||||++++++.... .++|||||++ |+|.+++.. ....++...+..++.||+.||+|||+++ |
T Consensus 85 ~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~i 164 (362)
T KOG0192|consen 85 AFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPI 164 (362)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCe
Confidence 6677778888888888888888888777 7999999999 688888877 3678999999999999999999999999 9
Q ss_pred EeeecCCCCEEEccCC-CEEEeeeccccccCCCCccccCCcccccccchhhcc--CCCCCCceeeehHHHHHHHHHcCCC
Q psy12305 302 LHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL--GSTEYSTSIDMGVGCIFHEMSSGRP 378 (516)
Q Consensus 302 vHrDlKp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~d~~SlGvil~elltG~~ 378 (516)
|||||||+|||++.++ ++||+|||+++.........+...||+.|||||++. +..++.++|+||||++||||+||+.
T Consensus 165 IHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 165 IHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred eecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 9999999999999998 999999999987664434445578999999999999 5689999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 379 LFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 379 pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
||.+.........+.. ...+...|..+++.+.+|+.+||..||.+||++.+++
T Consensus 245 Pf~~~~~~~~~~~v~~------------------------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~ 297 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVV------------------------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIV 297 (362)
T ss_pred CCCCCCHHHHHHHHHh------------------------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHH
Confidence 9999877444444432 2223334556889999999999999999999999876
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=376.13 Aligned_cols=234 Identities=37% Similarity=0.624 Sum_probs=173.4
Q ss_pred HHHHHHHHHhccccceeeEeeeEee--CceeeEeeehhhchHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHH
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLEKDLKRYMDDC--------SNILSMNNVKLFLFQLLRGLAYC 296 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yL 296 (516)
+.+|+.+|+.++||||+++++++.. +..+|+||||++++|..++... ...+++..++.++.||+.||+||
T Consensus 45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 124 (317)
T cd07868 45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 124 (317)
T ss_pred HHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence 3456666666666666666666533 4568999999999988877532 12589999999999999999999
Q ss_pred hhCCcEeeecCCCCEEE----ccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCC-CCCCceeeehHHH
Q psy12305 297 HSRRILHRDLKPQNLLI----NERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGC 368 (516)
Q Consensus 297 H~~~ivHrDlKp~NILl----~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGv 368 (516)
|++||+||||||+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+. .+..++|+||+||
T Consensus 125 H~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 204 (317)
T cd07868 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred HhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHH
Confidence 99999999999999999 4567899999999986543222 23446789999999999874 4667789999999
Q ss_pred HHHHHHcCCCCCCCCCH---------HHHHHHHHHhcCCCChhhhhhccccc-C---------CCCCC--chhhhhcCCC
Q psy12305 369 IFHEMSSGRPLFPGSTI---------EDELRLICSILGPPPDELKSKLEFCI-T---------PVYPS--ESKLQLLAPE 427 (516)
Q Consensus 369 il~elltG~~pF~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~-~---------~~~~~--~~~~~~~~p~ 427 (516)
++|||++|++||.+... .+++..+...+|.|+...|....... . ..... ..........
T Consensus 205 il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (317)
T cd07868 205 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 284 (317)
T ss_pred HHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCC
Confidence 99999999999975432 46677888888888776554321100 0 00000 0000000111
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 428 ~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+.++.|||.+||++||.+|||++|+|+||||
T Consensus 285 ~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 285 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=381.29 Aligned_cols=257 Identities=26% Similarity=0.373 Sum_probs=216.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
..|..++.||+|+||.||||.+..+++.||||++........
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-------------------------------------- 54 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-------------------------------------- 54 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchh--------------------------------------
Confidence 348888999999999999999999999999999876543222
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+|.+++++||.++|+.|.
T Consensus 55 -----------------------------------------------------Iediqqei~~Ls~~~~~~it~yygsyl 81 (467)
T KOG0201|consen 55 -----------------------------------------------------IEDIQQEISVLSQCDSPNITEYYGSYL 81 (467)
T ss_pred -----------------------------------------------------hHHHHHHHHHHHhcCcchHHhhhhhee
Confidence 225667888888888888889999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+..+|++||||.| ++.+.+.. +..+++..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||.+..
T Consensus 82 ~g~~LwiiMey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~q 160 (467)
T KOG0201|consen 82 KGTKLWIIMEYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQ 160 (467)
T ss_pred ecccHHHHHHHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeee
Confidence 99999999999995 66666654 45569999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.........+++|||.|||||++.+..|+.++|+||||++.+||++|.+|+........+..|- ..+|+.
T Consensus 161 l~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp---k~~PP~------- 230 (467)
T KOG0201|consen 161 LTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP---KSAPPR------- 230 (467)
T ss_pred eechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc---CCCCCc-------
Confidence 8766666688999999999999999899999999999999999999999998766533222221 111110
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....++.+++|+..||.+||+.||||.++|+|+|++...
T Consensus 231 ---------------L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 231 ---------------LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred ---------------cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 1126788999999999999999999999999999998643
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=376.02 Aligned_cols=213 Identities=23% Similarity=0.380 Sum_probs=178.4
Q ss_pred HHHHHHHHHh-ccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 227 AIREVSLLRE-LRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 227 ~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
...|..++.. .+||||+++++++..+..+|+||||++ ++|..++... ..+++..++.++.||+.||+|||++||+||
T Consensus 42 ~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~ 120 (316)
T cd05592 42 TMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYR 120 (316)
T ss_pred HHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 3445555554 479999999999999999999999998 4777777654 469999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+|+............+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+
T Consensus 121 dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred CCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999765433344455679999999999998888899999999999999999999999887
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH-HHHHcCCCCCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-ANAMRHPYFNSL 463 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta-~e~l~Hp~f~~~ 463 (516)
..+....+... ....|..++.++.+||.+||..||.+||++ .++++||||...
T Consensus 201 ~~~~~~~i~~~--------------------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 201 EDELFDSILND--------------------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHHHHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 76665555321 112344678999999999999999999986 588899999887
Q ss_pred CCC
Q psy12305 464 GPQ 466 (516)
Q Consensus 464 ~~~ 466 (516)
.+.
T Consensus 255 ~~~ 257 (316)
T cd05592 255 DWE 257 (316)
T ss_pred CHH
Confidence 543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=367.86 Aligned_cols=281 Identities=69% Similarity=1.117 Sum_probs=226.4
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
|+.+++|++.+.||+|+||+||+|.++.+++.||||.+........
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~---------------------------------- 46 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA---------------------------------- 46 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC----------------------------------
Confidence 5778999999999999999999999998999999998865322111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
...+.+|+.+++.++||||++++
T Consensus 47 ---------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~~ 69 (291)
T cd07844 47 ---------------------------------------------------------PFTAIREASLLKDLKHANIVTLH 69 (291)
T ss_pred ---------------------------------------------------------chhHHHHHHHHhhCCCcceeeEE
Confidence 11345788888888899999999
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+++.++++.|+||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 149 (291)
T cd07844 70 DIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGL 149 (291)
T ss_pred EEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECcccc
Confidence 99999999999999999999999887767799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGST-IEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~-~~~~~~~i~~~~~~~p~~~~ 404 (516)
++.............++..|+|||++.+ ..+..++|+||+||++|+|++|..||.+.. ..+.+..+...++.+..+.+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07844 150 ARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229 (291)
T ss_pred ccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhh
Confidence 9765443333444567889999999876 346778899999999999999999998765 66777778888888776665
Q ss_pred hhcccc------cCCCCCCchhhhhcCCCCCC--HHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 405 SKLEFC------ITPVYPSESKLQLLAPEQMD--SDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 405 ~~~~~~------~~~~~~~~~~~~~~~p~~~s--~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
....-. ..+.... .......+ .++ .++.++|.+||+.||++|||+.++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 230 PGVSSNPEFKPYSFPFYPP-RPLINHAP-RLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhhccccccccccccCC-hhHHHhCc-CCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 332110 0011111 11111111 334 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=383.08 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=214.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||.||+|++..+++.||+|.+.+......
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------ 84 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKR------------------------------------ 84 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh------------------------------------
Confidence 45789999999999999999999999999999999864321100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+++.++||||++++++
T Consensus 85 -----------------------------------------------------~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (370)
T cd05621 85 -----------------------------------------------------SDSAFFWEERDIMAFANSPWVVQLFCA 111 (370)
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 011245678889999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.++..+|+|||||+ |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 112 FQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccc
Confidence 999999999999998 5888888653 4899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCC----CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGST----EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~----~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
........ .....+||+.|+|||++.+.. +..++|+||+||++|||++|.+||.+.+....+..+.......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--- 266 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL--- 266 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc---
Confidence 86543222 234567999999999987643 5678999999999999999999999888776666664321110
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCCc
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~~ 467 (516)
.......++..+++|+.+||..++.+ |+|++++++||||+...+..
T Consensus 267 -------------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~~ 314 (370)
T cd05621 267 -------------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNW 314 (370)
T ss_pred -------------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcCh
Confidence 00111256889999999999865544 88999999999998755433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=367.51 Aligned_cols=269 Identities=24% Similarity=0.344 Sum_probs=217.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.++||.|.-++||+|+..-++.+||||++..+.-...
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~------------------------------------ 67 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND------------------------------------ 67 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh------------------------------------
Confidence 45679999999999999999999999999999999876432221
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+..|+.++||||++++..
T Consensus 68 -------------------------------------------------------ld~l~kE~~~msl~~HPNIv~~~~s 92 (516)
T KOG0582|consen 68 -------------------------------------------------------LDALRKEVQTMSLIDHPNIVTYHCS 92 (516)
T ss_pred -------------------------------------------------------HHHHHHHHHHhhhcCCCCcceEEEE
Confidence 2256678888888899999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
|..+..+|+||.||. |++++.+... ...++|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.
T Consensus 93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgv 172 (516)
T KOG0582|consen 93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGV 172 (516)
T ss_pred EEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCcee
Confidence 999999999999999 6888888753 34599999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCc----cccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 327 ARAKSVPTK----TFSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 327 a~~~~~~~~----~~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
+..+..... .+...+||++|||||++.. ..|+.++|+||||++..||.+|..||..-.....+. ..+.+.||
T Consensus 173 sa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp 250 (516)
T KOG0582|consen 173 SASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL--LTLQNDPP 250 (516)
T ss_pred eeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH--HHhcCCCC
Confidence 765433222 1256689999999999643 468899999999999999999999998765554433 33445555
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.-...... ...-...+..++.++..||++||.+||||+++|+|+||+...
T Consensus 251 ~~~t~~~~--------------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 251 TLLTSGLD--------------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred CcccccCC--------------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 22111000 000114566899999999999999999999999999998643
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=367.40 Aligned_cols=277 Identities=48% Similarity=0.858 Sum_probs=223.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||+|+||.||+|++..+|+.||||++.......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE---------------------------------------- 40 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccC----------------------------------------
Confidence 5899999999999999999999999999999885432111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++||||+++++++..
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (285)
T cd07861 41 --------------------------------------------------GVPSTAIREISLLKELQHPNIVCLQDVLMQ 70 (285)
T ss_pred --------------------------------------------------CchHHHHHHHHHHHhcCCCCEeeeEEEEee
Confidence 111245678888899999999999999999
Q ss_pred CceeeEeeehhhchHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCS--NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+...|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 71 ~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 150 (285)
T cd07861 71 ESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150 (285)
T ss_pred CCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceee
Confidence 99999999999998888886533 5689999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
...+........+++.|+|||++.+.. +..++|+|||||++|+|++|++||.+.+..+....+....+.+....|....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 151 FGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred cCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 554444444557789999999987643 5677899999999999999999999988888888887777777666554322
Q ss_pred cc-----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FC-----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~-----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.. ..+.... ... ......+++++.+||.+||+.||++|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 231 SLPDYKNTFPKWKK-GSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhHHHHhhccccCc-chh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 10 0000000 001 11123578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=377.15 Aligned_cols=213 Identities=23% Similarity=0.366 Sum_probs=178.8
Q ss_pred HHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 227 AIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 227 ~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
...|..++..+ +||||+++++++.+++++|+||||+.+ +|..++... ..+++..+..++.||+.||+|||++||+||
T Consensus 42 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHr 120 (316)
T cd05620 42 TMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120 (316)
T ss_pred HHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 44566666654 899999999999999999999999985 787777654 468999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+||+||++|||++|..||.+.+
T Consensus 121 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred CCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998754333334455678999999999998888889999999999999999999999887
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH-HHHHcCCCCCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-ANAMRHPYFNSL 463 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta-~e~l~Hp~f~~~ 463 (516)
..+....+... ....|..++.++.+||.+||+.||++|+++ +++++||||...
T Consensus 201 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 201 EDELFESIRVD--------------------------TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HHHHHHHHHhC--------------------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 66655544221 112234678999999999999999999997 588899999887
Q ss_pred CCC
Q psy12305 464 GPQ 466 (516)
Q Consensus 464 ~~~ 466 (516)
.+.
T Consensus 255 ~~~ 257 (316)
T cd05620 255 NWT 257 (316)
T ss_pred CHH
Confidence 543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=380.48 Aligned_cols=284 Identities=34% Similarity=0.571 Sum_probs=219.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---- 88 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS---- 88 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc----
Confidence 346799999999999999999999999999999998754321 222345567777777777777666665432210
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
T Consensus 89 -------------------------------------------------------------------------------- 88 (343)
T cd07878 89 -------------------------------------------------------------------------------- 88 (343)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.......|+++|+++++|...+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 -~~~~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 89 -IENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred -ccccCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 001134789999998888877653 45999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+..... ....+||+.|+|||++.+ ..+..++|+||+||++|+|++|..||.+.+..+.+..+....+.++.+....
T Consensus 166 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 166 RQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred eecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 865432 234578999999999877 4566789999999999999999999999988888888888888887665433
Q ss_pred cccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 LEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.... ..+..+. ..+.... ...++.+.+||.+||+.||.+|||+.|+++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQ-QDLKKIF-RGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred cchhhHHHHhhccccccc-hhHHHhc-cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 2111 0111111 1111111 24677899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=377.48 Aligned_cols=212 Identities=26% Similarity=0.375 Sum_probs=178.7
Q ss_pred HHHHH-HHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeee
Q psy12305 228 IREVS-LLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305 (516)
Q Consensus 228 ~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrD 305 (516)
..|.. +++.++||||+++++++.+.+..|+||||+++ +|..++.. ...+++..++.++.||+.||+|||++||+|||
T Consensus 43 ~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~d 121 (323)
T cd05575 43 MAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121 (323)
T ss_pred HHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 34443 56778999999999999999999999999995 77777765 45699999999999999999999999999999
Q ss_pred cCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH
Q psy12305 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI 385 (516)
Q Consensus 306 lKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~ 385 (516)
|||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.
T Consensus 122 ikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 201 (323)
T cd05575 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201 (323)
T ss_pred CCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH
Confidence 99999999999999999999997644333444556799999999999988888899999999999999999999998877
Q ss_pred HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH----HHHHcCCCCC
Q psy12305 386 EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA----ANAMRHPYFN 461 (516)
Q Consensus 386 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta----~e~l~Hp~f~ 461 (516)
.+....+... ....+..+++++.+||.+||+.||.+||++ .++++||||.
T Consensus 202 ~~~~~~i~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~ 255 (323)
T cd05575 202 AEMYDNILNK--------------------------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255 (323)
T ss_pred HHHHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcC
Confidence 6665555321 011233678999999999999999999997 6999999998
Q ss_pred CCCCC
Q psy12305 462 SLGPQ 466 (516)
Q Consensus 462 ~~~~~ 466 (516)
+..+.
T Consensus 256 ~~~~~ 260 (323)
T cd05575 256 SINWD 260 (323)
T ss_pred CCCHH
Confidence 76543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=375.84 Aligned_cols=213 Identities=24% Similarity=0.418 Sum_probs=179.8
Q ss_pred HHHHHHHHHh-ccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 227 AIREVSLLRE-LRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 227 ~~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
...|..++.. ++||||+++++++.+++.+|+||||++ |+|..++... ..+++..+..++.||+.||+|||++||+||
T Consensus 42 ~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHr 120 (316)
T cd05619 42 TMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYR 120 (316)
T ss_pred HHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeC
Confidence 4456666765 489999999999999999999999998 5888887654 458999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+||+||++|||++|..||.+.+
T Consensus 121 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred CCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998754333333445678999999999998888999999999999999999999999877
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH-HHHcCCCCCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA-NAMRHPYFNSL 463 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~-e~l~Hp~f~~~ 463 (516)
..+....+... ....|..++.++.+||.+||+.||++||++. ++++||||..+
T Consensus 201 ~~~~~~~i~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 201 EEELFQSIRMD--------------------------NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred HHHHHHHHHhC--------------------------CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 66655554221 1112346788999999999999999999996 89999999987
Q ss_pred CCC
Q psy12305 464 GPQ 466 (516)
Q Consensus 464 ~~~ 466 (516)
.+.
T Consensus 255 ~~~ 257 (316)
T cd05619 255 DWS 257 (316)
T ss_pred CHH
Confidence 654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=376.47 Aligned_cols=214 Identities=23% Similarity=0.393 Sum_probs=181.3
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.++..+ +||||+++++++.+.+.+|+||||+++ +|..++... ..+++..+..++.||+.||.|||++||+|
T Consensus 41 ~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH 119 (318)
T cd05570 41 CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIY 119 (318)
T ss_pred HHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEc
Confidence 345677777777 699999999999999999999999985 777776654 46999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.
T Consensus 120 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred cCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999875433333344567899999999999988889999999999999999999999887
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH-----HHHHcCC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-----ANAMRHP 458 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta-----~e~l~Hp 458 (516)
+.......+... ....|..++.++.+||.+||..||.+|||+ .++++||
T Consensus 200 ~~~~~~~~i~~~--------------------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 200 DEDELFQSILED--------------------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred CHHHHHHHHHcC--------------------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 766655544321 112344678999999999999999999999 9999999
Q ss_pred CCCCCCCC
Q psy12305 459 YFNSLGPQ 466 (516)
Q Consensus 459 ~f~~~~~~ 466 (516)
||....+.
T Consensus 254 ~~~~~~~~ 261 (318)
T cd05570 254 FFREIDWD 261 (318)
T ss_pred CcCCCCHH
Confidence 99887543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=376.10 Aligned_cols=264 Identities=23% Similarity=0.335 Sum_probs=206.9
Q ss_pred cEeeeeeeccccceEEEEEEEc---CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSR---LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~---~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
+|++++.||+|+||+||+|++. .+|+.||+|++........
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------ 44 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQK------------------------------------ 44 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhh------------------------------------
Confidence 5899999999999999999874 4789999998864321100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
......+.+|+.+++.+ +||||+++++
T Consensus 45 ----------------------------------------------------~~~~~~~~~e~~~l~~l~~~~~i~~~~~ 72 (332)
T cd05614 45 ----------------------------------------------------AKTVEHTRTERNVLEHVRQSPFLVTLHY 72 (332)
T ss_pred ----------------------------------------------------hhHHHHHHHHHHHHHhccCCCCcccEEE
Confidence 01112456788888888 5899999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..++.+++||||+++ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~ 151 (332)
T cd05614 73 AFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGL 151 (332)
T ss_pred EEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999999999984 888887654 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-ccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPT-KTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~-~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++...... ......+||+.|+|||++.+.. +..++|+|||||++|||++|..||...........+....
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------- 223 (332)
T cd05614 152 SKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRI-------- 223 (332)
T ss_pred CccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHH--------
Confidence 97643222 2223457899999999997654 5677899999999999999999997532211111111100
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~ 466 (516)
.......|..+++.+.+||.+||+.||++|| +++++++||||+...+.
T Consensus 224 --------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 224 --------------LKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred --------------hcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 0011123446889999999999999999999 88999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=377.00 Aligned_cols=214 Identities=27% Similarity=0.406 Sum_probs=176.5
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|..++..+ +||||+++++++.+++.+|+||||+++ +|..++... +.+++..++.++.||+.||+|||++||+|
T Consensus 41 ~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH 119 (329)
T cd05588 41 WVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIY 119 (329)
T ss_pred HHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 456788888888 699999999999999999999999985 787777654 56999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+||+||++|+|++|+.||...
T Consensus 120 ~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred cCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 99999999999999999999999975433333445568999999999999888888999999999999999999999632
Q ss_pred CH--------HHH-HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC----
Q psy12305 384 TI--------EDE-LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS---- 450 (516)
Q Consensus 384 ~~--------~~~-~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t---- 450 (516)
.. .+. ...+. ......|..++.++.+||.+||+.||.+|+|
T Consensus 200 ~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 253 (329)
T cd05588 200 GMSDNPDQNTEDYLFQVIL--------------------------EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQ 253 (329)
T ss_pred cccccccccchHHHHHHHH--------------------------cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCC
Confidence 11 111 11110 0112235578899999999999999999997
Q ss_pred --HHHHHcCCCCCCCCCC
Q psy12305 451 --AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 451 --a~e~l~Hp~f~~~~~~ 466 (516)
++++++||||..+.+.
T Consensus 254 ~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 254 TGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred CCHHHHhcCCCCCCCCHH
Confidence 7899999999876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-46 Score=374.87 Aligned_cols=261 Identities=21% Similarity=0.325 Sum_probs=214.5
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+.++.||+|+||+||+|+++.+|+.||||++........
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------------- 41 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQD--------------------------------------- 41 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhh---------------------------------------
Confidence 47889999999999999999999999999999875321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeEe
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIH 250 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 250 (516)
.....+..|..++..+. |++|+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~ 71 (323)
T cd05615 42 --------------------------------------------------DDVECTMVEKRVLALQDKPPFLTQLHSCFQ 71 (323)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHhccCCCchhheeeEEe
Confidence 01123456777777775 567788999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+.+.+|+||||++ ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~ 150 (323)
T cd05615 72 TVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 150 (323)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence 9999999999998 5787777654 4599999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
...........+||+.|+|||++.+..++.++|+||+||++|||++|.+||.+.+.......+....
T Consensus 151 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~------------- 217 (323)
T cd05615 151 HMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN------------- 217 (323)
T ss_pred cCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence 4433333445678999999999988888889999999999999999999999887766666554311
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcc
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~ 468 (516)
...|..++.++.+|+.+||+.||.+|++ .+++++||||..+.+...
T Consensus 218 -------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~ 268 (323)
T cd05615 218 -------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268 (323)
T ss_pred -------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHH
Confidence 1234467899999999999999999997 579999999998765433
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=374.28 Aligned_cols=214 Identities=28% Similarity=0.417 Sum_probs=175.2
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.++.++ +||||+++++++..++.+|+||||+++ +|..++... ..+++..++.++.||+.||+|||++||+|
T Consensus 41 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH 119 (329)
T cd05618 41 WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIY 119 (329)
T ss_pred HHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 355677777766 799999999999999999999999995 777766553 56999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|..||...
T Consensus 120 ~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (329)
T cd05618 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred CCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccC
Confidence 99999999999999999999999976433333445568899999999999888888999999999999999999999531
Q ss_pred CH--------HH-HHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC----
Q psy12305 384 TI--------ED-ELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS---- 450 (516)
Q Consensus 384 ~~--------~~-~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t---- 450 (516)
.. .+ ....+. ......|..++.++.+||.+||+.||++|||
T Consensus 200 ~~~~~~~~~~~~~~~~~i~--------------------------~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~ 253 (329)
T cd05618 200 GSSDNPDQNTEDYLFQVIL--------------------------EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQ 253 (329)
T ss_pred CCcCCcccccHHHHHHHHh--------------------------cCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCC
Confidence 10 11 111110 1112245578899999999999999999998
Q ss_pred --HHHHHcCCCCCCCCCC
Q psy12305 451 --AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 451 --a~e~l~Hp~f~~~~~~ 466 (516)
++++++||||....+.
T Consensus 254 ~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 254 TGFADIQGHPFFRNVDWD 271 (329)
T ss_pred CCHHHHhcCCCCCCCCHH
Confidence 5899999999887543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=367.70 Aligned_cols=257 Identities=25% Similarity=0.401 Sum_probs=216.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+-|.++++||+|+||.||||.|+.+|+.||||++..+.+. ++
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDL---QE----------------------------------- 74 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDL---QE----------------------------------- 74 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchH---HH-----------------------------------
Confidence 3389999999999999999999999999999998765432 23
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
++.|+.|+++++.|++|++|+.|.
T Consensus 75 --------------------------------------------------------IIKEISIMQQC~S~yVVKYYGSYF 98 (502)
T KOG0574|consen 75 --------------------------------------------------------IIKEISIMQQCKSKYVVKYYGSYF 98 (502)
T ss_pred --------------------------------------------------------HHHHHHHHHHcCCchhhhhhhhhc
Confidence 445555555556666666666666
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
....+|||||||+ |+..+.++.+++++++.++..+++..+.||+|||...-||||||..|||++.+|..||+|||.|..
T Consensus 99 K~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQ 178 (502)
T KOG0574|consen 99 KHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQ 178 (502)
T ss_pred cCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccch
Confidence 6667999999999 789999998889999999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
+........+.+|||.|||||++..-.|...+|+||||++..||..|++||..-.. ++.|+-+...||.
T Consensus 179 LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP---MRAIFMIPT~PPP-------- 247 (502)
T KOG0574|consen 179 LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP---MRAIFMIPTKPPP-------- 247 (502)
T ss_pred hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc---cceeEeccCCCCC--------
Confidence 77655667788999999999999988899999999999999999999999976544 3334333333332
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
....|+.++.++-||+++||.++|++|-||.++++|||.++..
T Consensus 248 ------------TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 248 ------------TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred ------------CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 2234567899999999999999999999999999999998754
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=380.30 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=203.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|+.+++||+|+||+||+|++..+|+.||||++.......
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 114 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDT------------------------------------ 114 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHH------------------------------------
Confidence 45678999999999999999999999999999999885432111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
....+.+|+.+++.++|+||+++++
T Consensus 115 -------------------------------------------------------~~~~~~~E~~~l~~l~h~~iv~~~~ 139 (353)
T PLN00034 115 -------------------------------------------------------VRRQICREIEILRDVNHPNVVKCHD 139 (353)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHhCCCCCcceeee
Confidence 0124567888888888888888999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..++.+|+||||+++ +|.. ....++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~~~~~~lv~e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~ 214 (353)
T PLN00034 140 MFDHNGEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGV 214 (353)
T ss_pred EeccCCeEEEEEecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccccc
Confidence 99888999999999996 4432 22367788889999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCC-----CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGS-----TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
++............+||..|+|||++... ....++|+|||||++|||++|+.||......+....+......
T Consensus 215 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~--- 291 (353)
T PLN00034 215 SRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS--- 291 (353)
T ss_pred ceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc---
Confidence 98765433334456889999999987432 2234789999999999999999999743322222222111100
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....+..++.++.+||.+||..||++|||+.|+++||||....
T Consensus 292 -------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 292 -------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred -------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 01112346788999999999999999999999999999998743
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=380.47 Aligned_cols=274 Identities=26% Similarity=0.360 Sum_probs=209.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
..+|++++.||+|+||.||+|++..+++.||+|.....
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------------------------------------------ 102 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------------------------------------------ 102 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------------------------------------------
Confidence 35699999999999999999999999999999963211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....|+.++++++||||+++++++
T Consensus 103 --------------------------------------------------------~~~~E~~~l~~l~h~~iv~~~~~~ 126 (357)
T PHA03209 103 --------------------------------------------------------TTLIEAMLLQNVNHPSVIRMKDTL 126 (357)
T ss_pred --------------------------------------------------------ccHHHHHHHHhCCCCCCcChhheE
Confidence 123466777777777777788888
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
......++|||++.++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 127 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 206 (357)
T PHA03209 127 VSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206 (357)
T ss_pred EeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence 88888999999999999999988777899999999999999999999999999999999999999999999999999975
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCC-CCCCCCC---------HHHHHHHHHHhcCCC
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGR-PLFPGST---------IEDELRLICSILGPP 399 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~-~pF~~~~---------~~~~~~~i~~~~~~~ 399 (516)
... ........||+.|+|||++.+..+..++|+|||||++|||+++. ++|.... ....+..+...++..
T Consensus 207 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 207 PVV-APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred ccc-CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 332 22233457899999999999888899999999999999999854 4444321 123344444555554
Q ss_pred Chhhhh---------hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 400 PDELKS---------KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 400 p~~~~~---------~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
|..+.. ...+......+. ..........++.++.+||.+||++||.+||||.|+|+||||+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPY-TRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcc-cccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 443321 000000000000 011111112567889999999999999999999999999999864
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=365.62 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=214.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++.+.||+|+||+||+|++..+++.||||++........
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 41 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--------------------------------------- 41 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhh---------------------------------------
Confidence 48999999999999999999999999999999864321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++||||+++++.+.+
T Consensus 42 --------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 71 (285)
T cd05605 42 --------------------------------------------------KGEAMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred --------------------------------------------------hhHHHHHHHHHHHHhcCCCCEeeeeeeecC
Confidence 011245678888999999999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++.+|+||||++ ++|..++... ...+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+++.
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05605 72 KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVE 151 (285)
T ss_pred CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence 999999999998 4777776543 34699999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... ......+||+.|+|||++.+..++..+|+||+||++|||++|..||.+.+.......+......
T Consensus 152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----------- 219 (285)
T cd05605 152 IPEG-ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----------- 219 (285)
T ss_pred cCCC-CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh-----------
Confidence 5322 2233457899999999998888888899999999999999999999876654433333221110
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcc
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~ 468 (516)
.....+..+++.+.+||.+||..||.+|| +++++++||||....+...
T Consensus 220 -----------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 272 (285)
T cd05605 220 -----------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRL 272 (285)
T ss_pred -----------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHH
Confidence 11112346788999999999999999999 8999999999987655533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=373.95 Aligned_cols=213 Identities=28% Similarity=0.440 Sum_probs=183.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
...+|+.+|++++||||+++++++.+++.+|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||
T Consensus 44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~ 122 (318)
T cd05582 44 RTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYR 122 (318)
T ss_pred HHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 34578889999999999999999999999999999998 5888887653 468999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+|||++.++.+||+|||+++............+||+.|+|||++.+..+..++|+|||||++|||++|+.||.+.+
T Consensus 123 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 123 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred CCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 99999999999999999999999765444334445678999999999988888889999999999999999999999887
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPY 459 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~ 459 (516)
..+.+..+... ....|..+++++.+||.+||+.||++||| ++++++|||
T Consensus 203 ~~~~~~~i~~~--------------------------~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 203 RKETMTMILKA--------------------------KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred HHHHHHHHHcC--------------------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 76666555321 11234467899999999999999999999 778999999
Q ss_pred CCCCCC
Q psy12305 460 FNSLGP 465 (516)
Q Consensus 460 f~~~~~ 465 (516)
|....+
T Consensus 257 ~~~~~~ 262 (318)
T cd05582 257 FSTIDW 262 (318)
T ss_pred cCCCCH
Confidence 987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=372.66 Aligned_cols=211 Identities=27% Similarity=0.388 Sum_probs=176.8
Q ss_pred HHHH-HHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeee
Q psy12305 228 IREV-SLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305 (516)
Q Consensus 228 ~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrD 305 (516)
..|. .+++.++||||+++++++.+.+..|+||||+++ +|...+.. ...+++..++.++.||+.||+|||++||+|||
T Consensus 43 ~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~D 121 (321)
T cd05603 43 MAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121 (321)
T ss_pred HHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecc
Confidence 3444 467888999999999999999999999999995 77766654 45689999999999999999999999999999
Q ss_pred cCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH
Q psy12305 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI 385 (516)
Q Consensus 306 lKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~ 385 (516)
|||+|||++.+|.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+.
T Consensus 122 lkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (321)
T cd05603 122 LKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV 201 (321)
T ss_pred CCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence 99999999999999999999987643333344456789999999999888888899999999999999999999998876
Q ss_pred HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH----HHHHcCCCCC
Q psy12305 386 EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA----ANAMRHPYFN 461 (516)
Q Consensus 386 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta----~e~l~Hp~f~ 461 (516)
......+... ....|...+.++.++|.+||+.||.+|+++ .++++||||.
T Consensus 202 ~~~~~~i~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~ 255 (321)
T cd05603 202 SQMYDNILHK--------------------------PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFS 255 (321)
T ss_pred HHHHHHHhcC--------------------------CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcC
Confidence 6655544321 112344678899999999999999999975 5999999998
Q ss_pred CCCC
Q psy12305 462 SLGP 465 (516)
Q Consensus 462 ~~~~ 465 (516)
...+
T Consensus 256 ~~~~ 259 (321)
T cd05603 256 PINW 259 (321)
T ss_pred CCCH
Confidence 7654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=375.81 Aligned_cols=259 Identities=29% Similarity=0.451 Sum_probs=227.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|+.++.+|+|+||.++.++++.+++.|++|.|........
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~------------------------------------ 45 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP------------------------------------ 45 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch------------------------------------
Confidence 35789999999999999999999999999999999876543221
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.+..+.+|+.+++++.|||||.+.+.
T Consensus 46 ------------------------------------------------------~r~~A~~E~~lis~~~hP~iv~y~ds 71 (426)
T KOG0589|consen 46 ------------------------------------------------------ERRSAIQEMDLLSKLLHPNIVEYKDS 71 (426)
T ss_pred ------------------------------------------------------hhHHHHHHHHHHHhccCCCeeeeccc
Confidence 11245677777777888888888888
Q ss_pred EeeCce-eeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 249 IHTEKC-LTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 249 ~~~~~~-~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
|..+++ +||||+||+| ++.+.+...+ ..++++.+..++.|++.|+.|||+++|+|||||+.||+++.++.|||+|||
T Consensus 72 ~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 72 FEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred hhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchh
Confidence 887777 9999999995 8888887654 679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+....+.......+||+.||+||++.+.+|..++|+|||||++|||++-+++|.+.+.......|......|
T Consensus 152 laK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P------ 225 (426)
T KOG0589|consen 152 LAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP------ 225 (426)
T ss_pred hhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC------
Confidence 99998877656677899999999999999999999999999999999999999999999988888887654332
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.|...+.+++.||..||..+|..||++.++|.+|....
T Consensus 226 -------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 -------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred -------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 34578999999999999999999999999999998764
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=369.36 Aligned_cols=266 Identities=20% Similarity=0.284 Sum_probs=213.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++..+++.||||++.+.....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK--------------------------------------- 41 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhh---------------------------------------
Confidence 47999999999999999999999999999999986421100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++..++||||+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (331)
T cd05597 42 --------------------------------------------------RAETACFREERDVLVNGDRRWITNLHYAFQ 71 (331)
T ss_pred --------------------------------------------------hhhHHHHHHHHHHHHhCCCCCCCceEEEEe
Confidence 001124567888888999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++++|+||||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 151 (331)
T cd05597 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR 151 (331)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence 9999999999997 589888877667799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCc-cccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 330 KSVPTK-TFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 330 ~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
...... .....+||+.|+|||++.+ ..+..++|+||+||++|+|++|+.||.+.+..+....+.......
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~---- 227 (331)
T cd05597 152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHF---- 227 (331)
T ss_pred cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcc----
Confidence 543222 2223468999999999863 345668899999999999999999999877766665553321100
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~ 466 (516)
... .....+++++++||++||..++++ |++++++++||||....+.
T Consensus 228 ----------------~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~ 275 (331)
T cd05597 228 ----------------QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWD 275 (331)
T ss_pred ----------------cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHH
Confidence 000 011247899999999999765544 7899999999999876543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=364.02 Aligned_cols=269 Identities=28% Similarity=0.466 Sum_probs=204.2
Q ss_pred cceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc--c----ceeeEeeeEeeCceeeEeeehhhch
Q psy12305 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH--A----NIVTLHDIIHTEKCLTLVFEYLEKD 265 (516)
Q Consensus 192 ~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H--p----nIv~l~~~~~~~~~~~lV~E~~~g~ 265 (516)
.|+||.|.++.+..++..||+|+++.-.. ....+.-|+++|.++.+ | -+|++.++|.-.+++|||+|.++-+
T Consensus 99 eGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S 176 (415)
T KOG0671|consen 99 EGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLS 176 (415)
T ss_pred CCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChh
Confidence 34455555555444444555554442221 12245567777877742 2 3789999999999999999999999
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc--------------------CCCEEEeee
Q psy12305 266 LKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE--------------------RGELKLADF 324 (516)
Q Consensus 266 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--------------------~~~vkL~DF 324 (516)
+.+++..++ .+++...++.+++|++.+++|||+.+++|.||||+|||+.+ +..+||+||
T Consensus 177 ~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDF 256 (415)
T KOG0671|consen 177 TFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDF 256 (415)
T ss_pred HHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEec
Confidence 999998754 66999999999999999999999999999999999999832 235899999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|.|+...... +..+.|..|+|||+++|-+++.++|+||+||||+|++||...|++.+..+.+..+..++|++|..+.
T Consensus 257 GsAtf~~e~h---s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi 333 (415)
T KOG0671|consen 257 GSATFDHEHH---STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMI 333 (415)
T ss_pred CCcceeccCc---ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHh
Confidence 9998754333 5567799999999999999999999999999999999999999999999999999999999998766
Q ss_pred hhcc---ccc-----CCCCCCc----------hhhhh--cCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLE---FCI-----TPVYPSE----------SKLQL--LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~---~~~-----~~~~~~~----------~~~~~--~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.... +.. .+..... ..+.. ...+....++.|||++||.+||.+|+|+.|+|.||||+.+.
T Consensus 334 ~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 334 KKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLT 413 (415)
T ss_pred hhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence 4431 100 0100000 00000 01112234589999999999999999999999999998764
Q ss_pred C
Q psy12305 465 P 465 (516)
Q Consensus 465 ~ 465 (516)
+
T Consensus 414 ~ 414 (415)
T KOG0671|consen 414 P 414 (415)
T ss_pred C
Confidence 3
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=374.42 Aligned_cols=211 Identities=25% Similarity=0.387 Sum_probs=177.2
Q ss_pred HHHHH-HHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeee
Q psy12305 228 IREVS-LLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305 (516)
Q Consensus 228 ~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrD 305 (516)
..|.. +++.++||||+++++++..++..|+||||+.+ +|..++.. ...+++..++.++.||+.||+|||++||+|||
T Consensus 43 ~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~D 121 (325)
T cd05604 43 MAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRD 121 (325)
T ss_pred HHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 34443 56778999999999999999999999999985 77776654 45699999999999999999999999999999
Q ss_pred cCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH
Q psy12305 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI 385 (516)
Q Consensus 306 lKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~ 385 (516)
|||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+.
T Consensus 122 lkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred CCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 99999999999999999999987643333344556799999999999988888999999999999999999999998876
Q ss_pred HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH----HHHHcCCCCC
Q psy12305 386 EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA----ANAMRHPYFN 461 (516)
Q Consensus 386 ~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta----~e~l~Hp~f~ 461 (516)
.+....+... ....+...+..+.++|.+||+.||.+||++ .++++||||.
T Consensus 202 ~~~~~~~~~~--------------------------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~ 255 (325)
T cd05604 202 AEMYDNILHK--------------------------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFE 255 (325)
T ss_pred HHHHHHHHcC--------------------------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcC
Confidence 6655554321 111223678899999999999999999976 5999999998
Q ss_pred CCCC
Q psy12305 462 SLGP 465 (516)
Q Consensus 462 ~~~~ 465 (516)
...+
T Consensus 256 ~~~~ 259 (325)
T cd05604 256 SLSW 259 (325)
T ss_pred CCCH
Confidence 7654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=370.95 Aligned_cols=279 Identities=23% Similarity=0.342 Sum_probs=229.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..+.|..-..||+||||.||-|+-+.||+.||.|.+.+...
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRi--------------------------------------- 223 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRI--------------------------------------- 223 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHH---------------------------------------
Confidence 44678899999999999999999999999999998865321
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
+.. .....+++|-.+|.+++.++||.+-..
T Consensus 224 -----------------------------------------------Kkr---~ge~maLnEk~iL~kV~s~FiVslaYA 253 (591)
T KOG0986|consen 224 -----------------------------------------------KKR---KGETMALNEKQILEKVSSPFIVSLAYA 253 (591)
T ss_pred -----------------------------------------------HHh---hhhHHhhHHHHHHHHhccCcEEEEeee
Confidence 111 112367789999999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
|++.+.+|+||..|+| ||.-++.+.+ ..+++..++.|+.+|+.||++||+.+||.|||||+|||+|+.|+++|+|+|+
T Consensus 254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccce
Confidence 9999999999999995 8877776654 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|..... .......+||.+|||||++.+..|+...|+||+||++|||+.|+.||........-..+-...
T Consensus 334 Avei~~-g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~---------- 402 (591)
T KOG0986|consen 334 AVEIPE-GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT---------- 402 (591)
T ss_pred EEecCC-CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH----------
Confidence 987653 445556699999999999999887777777799999999999999997654433222221111
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQSIFSL 479 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~~~~~ 479 (516)
.......|+..|+++++|++.+|++||.+|+. ++++.+||||++++++..+..-..++|-.
T Consensus 403 ------------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiP 468 (591)
T KOG0986|consen 403 ------------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIP 468 (591)
T ss_pred ------------hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCC
Confidence 11223345688999999999999999999984 67999999999999887777666666544
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=403.02 Aligned_cols=261 Identities=25% Similarity=0.343 Sum_probs=222.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|++++.||+|+||.|..++++.|++.||+|++.+-...+.
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr------------------------------------- 116 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKR------------------------------------- 116 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhc-------------------------------------
Confidence 4779999999999999999999999999999999876432111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....-|..|-.+|..-+.+-|++++..|
T Consensus 117 ----------------------------------------------------~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 117 ----------------------------------------------------AETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred ----------------------------------------------------hhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 1112456677788888888999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+++.++|+||||++ |||..++.+.. +++++.+++|+..|+.||+-||+.|+|||||||+|||||..|++||+|||.|-
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999998 59999998877 89999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc-cccCCcccccccchhhcc----C-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 329 AKSVPTK-TFSNEVVTLWYRPPDVLL----G-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 329 ~~~~~~~-~~~~~~gt~~y~APE~l~----~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
.+..++. .....+|||-|.+||++. + +.|+..+|+||+||++|||+.|..||+.++..+.+.+|..-
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h------- 296 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH------- 296 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch-------
Confidence 7764443 456679999999999984 2 44666777779999999999999999999999999888642
Q ss_pred hhhhcccccCCCCCCchhhhhcCC--CCCCHHHHHHHHHccccCcCCCCC---HHHHHcCCCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAP--EQMDSDALDLVQKFLMYDAKQRIS---AANAMRHPYFNSLGP 465 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p--~~~s~~~~dLl~~~L~~dP~~R~t---a~e~l~Hp~f~~~~~ 465 (516)
.-...+| ..+|++++|||.++|. +|+.|++ ++++.+||||.++.|
T Consensus 297 -----------------k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 -----------------KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred -----------------hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 1112233 3689999999999886 7899998 999999999998876
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=376.58 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=213.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+++.||+|++........
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~------------------------------------ 84 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKR------------------------------------ 84 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhh------------------------------------
Confidence 34789999999999999999999999999999999864311000
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+++.++||||++++++
T Consensus 85 -----------------------------------------------------~~~~~~~~e~~i~~~~~hp~iv~~~~~ 111 (371)
T cd05622 85 -----------------------------------------------------SDSAFFWEERDIMAFANSPWVVQLFYA 111 (371)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 011245678889999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.++.++|+||||++ ++|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 112 ~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 112 FQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 999999999999998 5788877653 4899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCC----CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGST----EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~----~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
+....... .....+||+.|+|||++.+.. +..++|+|||||++|||++|.+||.+.+.......+......
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---- 265 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---- 265 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc----
Confidence 86543221 234567999999999987543 567899999999999999999999988877666665432111
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~ 466 (516)
.....+..++..+++||.+||..++.+ |++++++++||||....+.
T Consensus 266 ------------------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 266 ------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred ------------------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 111112368899999999999844433 7899999999999875443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.54 Aligned_cols=209 Identities=25% Similarity=0.359 Sum_probs=177.3
Q ss_pred HHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCC
Q psy12305 231 VSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309 (516)
Q Consensus 231 i~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~ 309 (516)
..+++.++||||+++++++...+.+|+||||+++ +|..++.. ...+++..++.++.||+.||+|||++||+||||||+
T Consensus 47 ~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~ 125 (325)
T cd05602 47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 125 (325)
T ss_pred HHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHH
Confidence 3456778999999999999999999999999995 77777765 456889999999999999999999999999999999
Q ss_pred CEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHH
Q psy12305 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDEL 389 (516)
Q Consensus 310 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~ 389 (516)
|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+||+||++|+|++|.+||.+.+..+.+
T Consensus 126 Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (325)
T cd05602 126 NILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205 (325)
T ss_pred HeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999999976443333445567999999999999888888999999999999999999999988777666
Q ss_pred HHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH----HHHcCCCCCCCCC
Q psy12305 390 RLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA----NAMRHPYFNSLGP 465 (516)
Q Consensus 390 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~----e~l~Hp~f~~~~~ 465 (516)
..+.... ...+..++..+.+||.+||+.||.+|+++. ++++|+||....+
T Consensus 206 ~~i~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~ 259 (325)
T cd05602 206 DNILNKP--------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259 (325)
T ss_pred HHHHhCC--------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCH
Confidence 5553210 112336789999999999999999999876 8999999987654
Q ss_pred C
Q psy12305 466 Q 466 (516)
Q Consensus 466 ~ 466 (516)
.
T Consensus 260 ~ 260 (325)
T cd05602 260 D 260 (325)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=365.04 Aligned_cols=284 Identities=37% Similarity=0.683 Sum_probs=225.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++.+.||+|+||.||+|.+..+|+.||+|.+........
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------ 48 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG------------------------------------ 48 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC------------------------------------
Confidence 56789999999999999999999999999999998865322111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+|+.++++++|+||++++++
T Consensus 49 ------------------------------------------------------~~~~~~~E~~~l~~l~h~~i~~~~~~ 74 (309)
T cd07845 49 ------------------------------------------------------IPISSLREITLLLNLRHPNIVELKEV 74 (309)
T ss_pred ------------------------------------------------------CcchhhHHHHHHHhCCCCCCcceEEE
Confidence 01123457777777777777777777
Q ss_pred EeeC--ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~--~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+... +.+++||||++++|.+++......+++..+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||+
T Consensus 75 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~ 154 (309)
T cd07845 75 VVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGL 154 (309)
T ss_pred EecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccce
Confidence 7654 46899999999999888887667799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+..............+++.|+|||++.+ ..++.++|+||+||++|||++|.+||.+.+..+.+..+....+.++...+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 155 ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred eeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 9876544333444456889999999876 346778999999999999999999999999999999999998888777654
Q ss_pred hccccc------CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 406 KLEFCI------TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 406 ~~~~~~------~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...... .+..+. ....... ...++++.+||.+||++||++|||++++++||||...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPY-NNLKHKF-PWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hhhcccccccccccCCCC-CchHHhc-cccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 321110 000000 0111111 13588999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.72 Aligned_cols=283 Identities=54% Similarity=0.834 Sum_probs=221.4
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
|+..++|.+++.||+|+||.||+|.+..+|+.||||.+......+.
T Consensus 1 ~~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~---------------------------------- 46 (291)
T cd07870 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV---------------------------------- 46 (291)
T ss_pred CCccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCC----------------------------------
Confidence 3556889999999999999999999999999999998864322111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
...+.+|+.+++.++|+||++++
T Consensus 47 ---------------------------------------------------------~~~~~~e~~~l~~l~h~ni~~~~ 69 (291)
T cd07870 47 ---------------------------------------------------------PFTAIREASLLKGLKHANIVLLH 69 (291)
T ss_pred ---------------------------------------------------------cHHHHHHHHHHHhcCCCCEeEEE
Confidence 11345678888888888888889
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+++..+...|+||||+.+++..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 70 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 149 (291)
T cd07870 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGL 149 (291)
T ss_pred EEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEecccc
Confidence 99988889999999999999888876666788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGST-IEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~-~~~~~~~i~~~~~~~p~~~~ 404 (516)
++.............+++.|+|||.+.+. .+...+|+|||||++|+|++|..||.+.. ..+.+..+....+.|+...+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred ccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence 97654444444555679999999998764 35677899999999999999999997643 44566667777777766554
Q ss_pred hhcccc------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 405 SKLEFC------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 405 ~~~~~~------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...... ..+.............-..+.++.+|+.+||..||.+|||+.|++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 322100 00000000000000011236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=369.20 Aligned_cols=266 Identities=21% Similarity=0.295 Sum_probs=214.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|++..+++.||+|.+.+.....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK--------------------------------------- 41 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHH---------------------------------------
Confidence 47999999999999999999999999999999985421100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++..++|+||+++++.+.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (332)
T cd05623 42 --------------------------------------------------RAETACFREERDVLVNGDNQWITTLHYAFQ 71 (332)
T ss_pred --------------------------------------------------hhHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 001123567888888999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++.+|+||||+. |+|.+++.+....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~ 151 (332)
T cd05623 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 151 (332)
T ss_pred cCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence 9999999999998 689999987667799999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCc-cccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 330 KSVPTK-TFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 330 ~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
...... .....+||+.|+|||++.+ ..+..++|+|||||++|||++|+.||.+.+..+.+..+.......+
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 228 (332)
T cd05623 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ--- 228 (332)
T ss_pred cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc---
Confidence 432222 2234578999999999862 3467789999999999999999999998877776666543111000
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~ 466 (516)
+ ...+..+++++.+||.+||..++.+ |++++++++||||..+.+.
T Consensus 229 -----------~-------p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~ 275 (332)
T cd05623 229 -----------F-------PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWD 275 (332)
T ss_pred -----------C-------CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHH
Confidence 0 0011357899999999999765554 6899999999999987643
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=370.71 Aligned_cols=217 Identities=27% Similarity=0.371 Sum_probs=177.4
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.++.++ +||||+.+++++.+.+.+|+||||+++ +|..++... +.+++..++.++.||+.||+|||++||+|
T Consensus 41 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivH 119 (327)
T cd05617 41 WVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIY 119 (327)
T ss_pred HHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 456788888877 699999999999999999999999985 777776553 46999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|+|||||++|||++|..||...
T Consensus 120 rDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred cCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999999975433333445568999999999999888888999999999999999999999642
Q ss_pred CH------HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC------H
Q psy12305 384 TI------EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS------A 451 (516)
Q Consensus 384 ~~------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t------a 451 (516)
.. .+...... . ......|..++..+.+||.+||+.||.+|++ +
T Consensus 200 ~~~~~~~~~~~~~~~~--~-----------------------~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~ 254 (327)
T cd05617 200 TDNPDMNTEDYLFQVI--L-----------------------EKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGF 254 (327)
T ss_pred CCCcccccHHHHHHHH--H-----------------------hCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCH
Confidence 11 11111111 0 0112235578899999999999999999998 5
Q ss_pred HHHHcCCCCCCCCCCcc
Q psy12305 452 ANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 452 ~e~l~Hp~f~~~~~~~~ 468 (516)
+++++||||..+.+...
T Consensus 255 ~~i~~h~~f~~~~~~~~ 271 (327)
T cd05617 255 SDIKSHTFFRSIDWDLL 271 (327)
T ss_pred HHHHcCCCCCCCCHHHH
Confidence 79999999998765443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=376.69 Aligned_cols=237 Identities=25% Similarity=0.338 Sum_probs=186.0
Q ss_pred HHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecC
Q psy12305 228 IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307 (516)
Q Consensus 228 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlK 307 (516)
.+|+.+|+.++||||+++++++......|+|||++.++|..++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 134 ~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlk 212 (392)
T PHA03207 134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVK 212 (392)
T ss_pred HHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 457778888888888888888888889999999999999998843 4569999999999999999999999999999999
Q ss_pred CCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC-
Q psy12305 308 PQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST- 384 (516)
Q Consensus 308 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~- 384 (516)
|+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+..
T Consensus 213 p~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 213 TENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred HHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 9999999999999999999976543222 2234578999999999998888899999999999999999999997643
Q ss_pred --HHHHHHHHHHhcCCCChhhhhhc---------ccc--cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH
Q psy12305 385 --IEDELRLICSILGPPPDELKSKL---------EFC--ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451 (516)
Q Consensus 385 --~~~~~~~i~~~~~~~p~~~~~~~---------~~~--~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta 451 (516)
....+..+...++..+.++.... .+. ..+.+.. .........+.++.+||.+||.+||++|||+
T Consensus 293 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa 369 (392)
T PHA03207 293 KSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTI---PPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA 369 (392)
T ss_pred CCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccc---cchhhccCcchhHHHHHHHHhccChhhCCCH
Confidence 45566677776666554332110 000 0010100 0011112457789999999999999999999
Q ss_pred HHHHcCCCCCCCCCCcc
Q psy12305 452 ANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 452 ~e~l~Hp~f~~~~~~~~ 468 (516)
.++|+||||....++..
T Consensus 370 ~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 370 QDILSLPLFTKEPINLL 386 (392)
T ss_pred HHHhhCchhhccchhhh
Confidence 99999999987655443
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=360.83 Aligned_cols=282 Identities=39% Similarity=0.706 Sum_probs=228.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++.+.||+|+||.||+|.+..+++.||||.++......
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------------------------------- 45 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKE------------------------------------- 45 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccc-------------------------------------
Confidence 3568999999999999999999999999999999886432211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.++++++||||++++++
T Consensus 46 -----------------------------------------------------~~~~~~~~e~~~l~~l~h~ni~~~~~~ 72 (293)
T cd07843 46 -----------------------------------------------------GFPITSLREINILLKLQHPNIVTVKEV 72 (293)
T ss_pred -----------------------------------------------------cchhhHHHHHHHHHhcCCCCEEEEEEE
Confidence 011134567888888888888888888
Q ss_pred EeeC--ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~--~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+... ...|+||||++++|...+......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 73 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~ 152 (293)
T cd07843 73 VVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGL 152 (293)
T ss_pred EEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCc
Confidence 8776 78999999999999888887666799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
++.............+++.|+|||.+.+.. ...++|+||+||++|+|++|.+||.+.+..+.+..+....+.|+.+.|.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred eeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 987655444444556789999999987644 4678899999999999999999999988888888888888888777664
Q ss_pred hcccccCC-----CCCCchhhhhcCCCC-CCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 406 KLEFCITP-----VYPSESKLQLLAPEQ-MDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 406 ~~~~~~~~-----~~~~~~~~~~~~p~~-~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
........ ...........++.. +++.+.+||++||+.||++|||+.|+++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 33211000 001111222334433 68899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=360.66 Aligned_cols=256 Identities=22% Similarity=0.288 Sum_probs=209.4
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccC--ChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hH
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEG--APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 266 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L 266 (516)
.|+|+||+||++.++.+++.||+|.+....... ....+..|+.+++.++||||+++++++..+...|+||||+++ +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 368999999999999999999999997653222 224567899999999999999999999999999999999984 77
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCccc
Q psy12305 267 KRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVT 343 (516)
Q Consensus 267 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt 343 (516)
..++.. ....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..............||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 666643 33568999999999999999999999999999999999999999999999999997655443334455789
Q ss_pred ccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhh
Q psy12305 344 LWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423 (516)
Q Consensus 344 ~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 423 (516)
+.|+|||++.+..++.++|+|||||++|||++|+.||...........+...... ...
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~----------------------~~~ 218 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILN----------------------DSV 218 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcc----------------------cCC
Confidence 9999999999888888999999999999999999999865432221111111000 011
Q ss_pred cCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCc
Q psy12305 424 LAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 424 ~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~ 467 (516)
..|..+++++.+|+.+||+.||++|| |++++++||||+...+..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 23446889999999999999999999 889999999998865543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=368.45 Aligned_cols=266 Identities=20% Similarity=0.283 Sum_probs=214.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++..+++.||||.+.......
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLK--------------------------------------- 41 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHh---------------------------------------
Confidence 57999999999999999999999999999999886421100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++..++|+||+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~ 71 (331)
T cd05624 42 --------------------------------------------------RAETACFREERNVLVNGDCQWITTLHYAFQ 71 (331)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 001123567888889999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++++.|+||||+. |+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 72 ~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~ 151 (331)
T cd05624 72 DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK 151 (331)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence 9999999999998 589888887667799999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCc-cccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 330 KSVPTK-TFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 330 ~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
...... .....+||+.|+|||++.+ ..+..++|+||+||++|||++|+.||.+.+..+.+..+......++
T Consensus 152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--- 228 (331)
T cd05624 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ--- 228 (331)
T ss_pred ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc---
Confidence 543322 2233578999999999875 3466788999999999999999999998777666655543111000
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~ 466 (516)
.. .....+++++++||.+||..++++ |++++++++||||....+.
T Consensus 229 -----------------~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~ 275 (331)
T cd05624 229 -----------------FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWE 275 (331)
T ss_pred -----------------CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHH
Confidence 00 001256899999999999976655 5689999999999876543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=367.69 Aligned_cols=278 Identities=23% Similarity=0.329 Sum_probs=213.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||.||+|++..+|..||+|.+......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------------------------------------- 44 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP--------------------------------------- 44 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCH---------------------------------------
Confidence 46799999999999999999999999999999988643110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+|++++||||+++++++
T Consensus 45 ----------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 72 (331)
T cd06649 45 ----------------------------------------------------AIRNQIIRELQVLHECNSPYIVGFYGAF 72 (331)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 0112567788899999999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
..++.+++||||+++ +|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 151 (331)
T cd06649 73 YSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151 (331)
T ss_pred EECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccc
Confidence 999999999999995 788877654 4589999999999999999999986 6999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh----h
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE----L 403 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~----~ 403 (516)
+..... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+ +.+... .
T Consensus 152 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~ 225 (331)
T cd06649 152 GQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGEEGE 225 (331)
T ss_pred cccccc--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccccCC
Confidence 765322 233457899999999999888888999999999999999999999876655433222 211100 0
Q ss_pred hhhcc-c-c---------cCCCCCCc-----------hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 404 KSKLE-F-C---------ITPVYPSE-----------SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 404 ~~~~~-~-~---------~~~~~~~~-----------~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
..... . . .....+.. ...........++++++||.+||++||++|||++++++||||+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 226 PHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred ccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 00000 0 0 00000000 0000011124678999999999999999999999999999998
Q ss_pred CCCC
Q psy12305 462 SLGP 465 (516)
Q Consensus 462 ~~~~ 465 (516)
....
T Consensus 306 ~~~~ 309 (331)
T cd06649 306 RSEV 309 (331)
T ss_pred hccc
Confidence 6543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=364.14 Aligned_cols=234 Identities=37% Similarity=0.627 Sum_probs=173.5
Q ss_pred HHHHHHHHHhccccceeeEeeeEe--eCceeeEeeehhhchHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHH
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIH--TEKCLTLVFEYLEKDLKRYMDDC--------SNILSMNNVKLFLFQLLRGLAYC 296 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yL 296 (516)
+.+|+.+++.++||||+++++++. .+..+|+||||++++|.+++... ...+++..++.++.||+.||.||
T Consensus 45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~l 124 (317)
T cd07867 45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124 (317)
T ss_pred HHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHH
Confidence 345666666667777777777663 34578999999999988877532 12488999999999999999999
Q ss_pred hhCCcEeeecCCCCEEE----ccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCC-CCCCceeeehHHH
Q psy12305 297 HSRRILHRDLKPQNLLI----NERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGC 368 (516)
Q Consensus 297 H~~~ivHrDlKp~NILl----~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGv 368 (516)
|++||+||||||+|||+ +.++.+||+|||+|+....... .....+||+.|+|||++.+. .+..++|+||+||
T Consensus 125 H~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~ 204 (317)
T cd07867 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 204 (317)
T ss_pred HhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHH
Confidence 99999999999999999 5667899999999986543322 23345789999999998764 4567789999999
Q ss_pred HHHHHHcCCCCCCCCCH---------HHHHHHHHHhcCCCChhhhhhcccc-c---------CCCCCCch--hhhhcCCC
Q psy12305 369 IFHEMSSGRPLFPGSTI---------EDELRLICSILGPPPDELKSKLEFC-I---------TPVYPSES--KLQLLAPE 427 (516)
Q Consensus 369 il~elltG~~pF~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~-~---------~~~~~~~~--~~~~~~p~ 427 (516)
++|||+||.+||..... ..++..+...+|.+..+.|...... . ...+.... ........
T Consensus 205 il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (317)
T cd07867 205 IFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKV 284 (317)
T ss_pred HHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccC
Confidence 99999999999975432 3456677788887776655432111 0 00000000 00011112
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 428 ~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 285 ~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 285 KPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=353.84 Aligned_cols=279 Identities=32% Similarity=0.616 Sum_probs=218.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|+++.+|+.||+|++.......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--------------------------------------- 41 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP--------------------------------------- 41 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc---------------------------------------
Confidence 47999999999999999999999999999999876432111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 42 ---------------------------------------------------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 70 (286)
T cd07847 42 ---------------------------------------------------VIKKIALREIRMLKQLKHPNLVNLIEVFR 70 (286)
T ss_pred ---------------------------------------------------cccHHHHHHHHHHHhCCCCCEeeeeeEEe
Confidence 01124567888888889999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.....++||||++++++..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 71 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07847 71 RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150 (286)
T ss_pred eCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceec
Confidence 99999999999998776666655567999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc--
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL-- 407 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~-- 407 (516)
...........++..|+|||++.+. .+..++|+||+||++|+|++|.+||.+.+..+.+..+....+..........
T Consensus 151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence 5443333445678999999998764 4567889999999999999999999988877777777665554433221111
Q ss_pred -ccc---cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 408 -EFC---ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 408 -~~~---~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.+. ..+............ ..++..+.+||.+||+.||++|||+.|++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKF-PNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccccCCCcccccCHHHHh-ccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 010 001000001111112 2568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=382.98 Aligned_cols=272 Identities=25% Similarity=0.279 Sum_probs=206.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
...|.+.+.||+|+||.||+|++..+++.||||.....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~------------------------------------------ 205 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA------------------------------------------ 205 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc------------------------------------------
Confidence 34699999999999999999999999999999953110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.+.+|+.+|++++|||||++++++
T Consensus 206 --------------------------------------------------------~~~~E~~iL~~L~HpnIv~l~~~~ 229 (461)
T PHA03211 206 --------------------------------------------------------SSVHEARLLRRLSHPAVLALLDVR 229 (461)
T ss_pred --------------------------------------------------------CHHHHHHHHHHCCCCCCCcEEEEE
Confidence 234577777777888888888888
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
..+...++|||++.++|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 230 ~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~ 309 (461)
T PHA03211 230 VVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACF 309 (461)
T ss_pred EECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCcee
Confidence 88888999999999999999887666799999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCC-C------CHHHHHHHHHHhcCCCC
Q psy12305 330 KSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG-S------TIEDELRLICSILGPPP 400 (516)
Q Consensus 330 ~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~-~------~~~~~~~~i~~~~~~~p 400 (516)
...... .....+||+.|+|||++.+..++.++|+|||||+||||++|..|+.. . ....++..+....+...
T Consensus 310 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~ 389 (461)
T PHA03211 310 ARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV 389 (461)
T ss_pred cccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc
Confidence 532211 12345789999999999998888899999999999999998765432 1 11233444444333221
Q ss_pred hhhh--------hhcc----cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 401 DELK--------SKLE----FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 401 ~~~~--------~~~~----~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.++. .... ....+...... +.. -..++.++.+||.+||++||.+|||+.|+|+||||++
T Consensus 390 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 390 DEFPQHAGSRLVSQYRHRAARNRRPAYTRPA-WTR--YYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ccCCCCcchHHHHHHHhhhhcccCCccCCcc-hhh--hccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1110 0000 00011110000 000 0145678999999999999999999999999999975
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=359.37 Aligned_cols=273 Identities=22% Similarity=0.338 Sum_probs=234.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccC--CcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEG--APCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
-++.+|..+..||+|+||.|.+|..+.+.+.||||+++++---+ +.+.
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvec------------------------------ 395 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVEC------------------------------ 395 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccc------------------------------
Confidence 45678999999999999999999999999999999998752111 1101
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceee
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVT 244 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 244 (516)
...|-++|... +-|.+++
T Consensus 396 -------------------------------------------------------------tm~EKrvLAL~~kppFL~q 414 (683)
T KOG0696|consen 396 -------------------------------------------------------------TMVEKRVLALPGKPPFLVQ 414 (683)
T ss_pred -------------------------------------------------------------eehhhhheecCCCCchHHH
Confidence 11233444444 4678899
Q ss_pred EeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 245 LHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
++..|++-+.+|+||||+.| +|.-.+.+.+ .+.+..+..|+.+|+.||-|||++|||.||||.+|||++.+|++||+|
T Consensus 415 lHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 415 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred HHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeee
Confidence 99999999999999999995 7877777654 599999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
||+++....+..+..++||||.|+|||++.-.+|....|+||+||+||||+.|++||.|++.++.++.|..
T Consensus 494 FGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~e--------- 564 (683)
T KOG0696|consen 494 FGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIME--------- 564 (683)
T ss_pred cccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---------
Confidence 99998877777788889999999999999988887777777999999999999999999999999888843
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH-----HHHHcCCCCCCCCCCcccCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-----ANAMRHPYFNSLGPQVHELSDTQSIFS 478 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta-----~e~l~Hp~f~~~~~~~~~~~~~~~~~~ 478 (516)
....+|..+|.++.+++..+|.+.|.+|+.+ .++..||||+.+.|...+..+.+++|.
T Consensus 565 -----------------hnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfk 627 (683)
T KOG0696|consen 565 -----------------HNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFK 627 (683)
T ss_pred -----------------ccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCC
Confidence 3344667899999999999999999999964 689999999999998888888887775
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.78 Aligned_cols=277 Identities=48% Similarity=0.831 Sum_probs=221.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||.|+||.||+|++..+|+.||||++........
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------------------------------------- 41 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEG--------------------------------------- 41 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccc---------------------------------------
Confidence 48999999999999999999999999999998764321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.++++++||||+++++++.+
T Consensus 42 ---------------------------------------------------~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 70 (284)
T cd07860 42 ---------------------------------------------------VPSTAIREISLLKELNHPNIVKLLDVIHT 70 (284)
T ss_pred ---------------------------------------------------cchHHHHHHHHHHhcCCCCCcchhhhccc
Confidence 11245567777777788888888888888
Q ss_pred CceeeEeeehhhchHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
++..++||||+.++|..++... ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...
T Consensus 71 ~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~ 150 (284)
T cd07860 71 ENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF 150 (284)
T ss_pred CCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence 8889999999998888888654 356899999999999999999999999999999999999999999999999999766
Q ss_pred CCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
...........+++.|+|||++.+.. ....+|+|||||++|+|+||+.||.+.+..+....+....+.++...+.....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 151 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred ccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 54444444556789999999887654 46678999999999999999999999888888888888888887665532111
Q ss_pred ----c-cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 ----C-ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ----~-~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
. ..+.... ...... ...+++++++||.+||+.||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 231 LPDYKPSFPKWAR-QDFSKV-VPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHHhhcccccc-cCHHHH-cccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 1111111 111111 22578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=369.14 Aligned_cols=211 Identities=26% Similarity=0.369 Sum_probs=174.6
Q ss_pred HHHHHHHHhc---cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 228 IREVSLLREL---RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 228 ~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
..|..++..+ +||||+++++++..+..+|+||||+. ++|..++.. ...+++..++.++.||+.||+|||++||+|
T Consensus 41 ~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivH 119 (330)
T cd05586 41 IGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVY 119 (330)
T ss_pred HHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 3455565554 69999999999999999999999998 478777765 456999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPG 382 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~ 382 (516)
|||||+|||++.++.+||+|||+++............+||+.|+|||++.+. .+..++|+||+||++|+|++|..||.+
T Consensus 120 rDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 120 RDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred ccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 9999999999999999999999997644333344556899999999998764 367789999999999999999999998
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC----CHHHHHcCC
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI----SAANAMRHP 458 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~----ta~e~l~Hp 458 (516)
.+..+....+...... .....+++++.+||.+||+.||.+|| +++++++||
T Consensus 200 ~~~~~~~~~i~~~~~~-------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 200 EDTQQMYRNIAFGKVR-------------------------FPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred CCHHHHHHHHHcCCCC-------------------------CCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 7766655554321100 01124688999999999999999998 799999999
Q ss_pred CCCCCC
Q psy12305 459 YFNSLG 464 (516)
Q Consensus 459 ~f~~~~ 464 (516)
||....
T Consensus 255 ~~~~~~ 260 (330)
T cd05586 255 FFADID 260 (330)
T ss_pred cccCCC
Confidence 998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=368.04 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=206.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.+.++++||+|-||.||+|++. ....||||.++......
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~--------------------------------------- 245 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP--------------------------------------- 245 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh---------------------------------------
Confidence 44788899999999999999985 33489999887643221
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
..+.+|+++|++|+|+|||++++++.
T Consensus 246 ------------------------------------------------------~~f~~Ea~iMk~L~H~~lV~l~gV~~ 271 (468)
T KOG0197|consen 246 ------------------------------------------------------EAFLREAQIMKKLRHEKLVKLYGVCT 271 (468)
T ss_pred ------------------------------------------------------hHHHHHHHHHHhCcccCeEEEEEEEe
Confidence 24556777777777777777777777
Q ss_pred eCceeeEeeehhh-chHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+..+|||||||. |+|++++.. .+..+...+...++.|||.|++||.++++|||||-+.|||+++++.+||+|||+|+
T Consensus 272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLAR 351 (468)
T ss_pred cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccc
Confidence 7778999999999 799999997 56779999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcccc-CCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPTKTFS-NEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
....+..... ..--...|.|||.+..+.++.++|+|||||+||||+| |+.||++.+..+.+..+-
T Consensus 352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le------------- 418 (468)
T KOG0197|consen 352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE------------- 418 (468)
T ss_pred ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-------------
Confidence 5432222111 1112667999999999999999999999999999999 999999999999888874
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
...+...|+.+++++.+++..||..+|++|||++.+.
T Consensus 419 ------------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 419 ------------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ------------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 4456667889999999999999999999999998654
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=379.90 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=215.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.-+-|+|+..||.|+||.||||.++.++-..|-|+|.......
T Consensus 30 P~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEE------------------------------------- 72 (1187)
T KOG0579|consen 30 PRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEE------------------------------------- 72 (1187)
T ss_pred HHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhH-------------------------------------
Confidence 3455899999999999999999999888888888875443211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...++-||.||..++||+||+|++.
T Consensus 73 -------------------------------------------------------LEDylVEIeILa~CdHP~ivkLl~a 97 (1187)
T KOG0579|consen 73 -------------------------------------------------------LEDYLVEIEILAECDHPVIVKLLSA 97 (1187)
T ss_pred -------------------------------------------------------HhhhhhhhhhhhcCCChHHHHHHHH
Confidence 1234456777777777777777777
Q ss_pred EeeCceeeEeeehhhch-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
|..++.+||..|||+|+ .-..+...+..+++.+++.+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+
T Consensus 98 yy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVS 177 (1187)
T KOG0579|consen 98 YYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVS 177 (1187)
T ss_pred HhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeeccccc
Confidence 77778899999999964 44555667788999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
............++|||+|||||+..+ .+|+..+|+||||++|.||..+.+|...-+....+-.|...
T Consensus 178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS------- 250 (1187)
T KOG0579|consen 178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------- 250 (1187)
T ss_pred ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc-------
Confidence 665545556677899999999999754 57889999999999999999999999887777666666431
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
......-|..++..+.|||.+||.+||+.||+++++|+||||++..
T Consensus 251 ----------------ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 251 ----------------EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred ----------------CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 1122344668899999999999999999999999999999998654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=369.60 Aligned_cols=286 Identities=32% Similarity=0.517 Sum_probs=217.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...++|++++.||+|+||+||+|++..+|+.||||.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 88 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQK---- 88 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCC----
Confidence 456789999999999999999999999999999999864321 111223344555555555555554444332111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 89 -------------------------------------------------------------------------------- 88 (353)
T cd07850 89 -------------------------------------------------------------------------------- 88 (353)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.+.+....|+||||+.++|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 89 -~~~~~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 89 -SLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred -CccccCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 00122357999999999988887643 89999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
++...... ......+|+.|+|||++.+..+..++|+|||||++|+|++|+.||.+.+..+....+...++.|+.++...
T Consensus 165 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 165 ARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred ceeCCCCC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 98654322 22344678999999999988888999999999999999999999999888888999999999998876544
Q ss_pred ccccc------CCCCCCchhhhhc------------CCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCI------TPVYPSESKLQLL------------APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~------~~~~~~~~~~~~~------------~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
..... .+.... ..+... .+...++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 244 LQPTVRNYVENRPKYAG-YSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred hhhhhhHHhhcCCCCCC-cchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 32110 110000 000000 022346678999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=357.31 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=210.1
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+..+.||+|+||.||+|.+..+++.||||.+........
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~--------------------------------------- 41 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--------------------------------------- 41 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccch---------------------------------------
Confidence 47889999999999999999999999999998864321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++|+||+.+++.+.+
T Consensus 42 --------------------------------------------------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05630 42 --------------------------------------------------KGESMALNEKQILEKVNSRFVVSLAYAYET 71 (285)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhCCCCCeeeeeEEEec
Confidence 011245678889999999999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++.+|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 72 ~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~ 151 (285)
T cd05630 72 KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVH 151 (285)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceee
Confidence 999999999998 57877775433 4589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... .......||..|+|||++.+..++.++|+||+||++|+|++|.+||.+...............
T Consensus 152 ~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~------------ 218 (285)
T cd05630 152 VPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK------------ 218 (285)
T ss_pred cCCC-ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh------------
Confidence 4322 223345789999999999888888899999999999999999999986432211111111100
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~ 466 (516)
......+...++++.+|+.+||+.||++||| ++|+++||||..+...
T Consensus 219 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 219 ----------EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred ----------hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 0111233467889999999999999999999 9999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=356.91 Aligned_cols=290 Identities=39% Similarity=0.635 Sum_probs=218.2
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|+++++||+|+||.||+|++..+++.||||.+...... .....+.+|+.++++++||||+++++++...+..
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-- 86 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP-- 86 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc--
Confidence 4567899999999999999999999999999999998654322 2222345566666666666666665544322100
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 87 -------------------------------------------------------------------------------- 86 (310)
T cd07865 87 -------------------------------------------------------------------------------- 86 (310)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
........++||||+++++.+.+......+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 87 -~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 -YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred -ccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 0011235799999999999888877666799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc----cccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 327 ARAKSVPTK----TFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 327 a~~~~~~~~----~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+........ ......++..|+|||.+.+.. +..++|+||+||++|||++|.+||.+.+.......+....|..+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 976543221 223446788999999886643 567889999999999999999999998888888888888887776
Q ss_pred hhhhhcccc------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 402 ELKSKLEFC------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 402 ~~~~~~~~~------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
+.+...... ..+............+...+..+.+||.+||..||.+|||++++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 654322100 00110000011111122346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=355.71 Aligned_cols=284 Identities=49% Similarity=0.850 Sum_probs=227.3
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|++.+.||+|+||+||+|++..+|+.||||.+.......
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------------------------------------- 42 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-------------------------------------- 42 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc--------------------------------------
Confidence 468999999999999999999999899999999875432110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 43 ----------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (294)
T PLN00009 43 ----------------------------------------------------GVPSTAIREISLLKEMQHGNIVRLQDVV 70 (294)
T ss_pred ----------------------------------------------------cchHHHHHHHHHHHhccCCCEeeEEEEE
Confidence 1112456788888889999999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-CCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkL~DFGla 327 (516)
..+...|+||||+++++.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++. ++.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~ 150 (294)
T PLN00009 71 HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA 150 (294)
T ss_pred ecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccc
Confidence 99999999999999998888865433 3688889999999999999999999999999999999985 457999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
..............+++.|+|||.+.+. .+..++|+||+||++|+|+||.+||...+..+.+..+....+.|+...|..
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 7654444444455778999999998663 467789999999999999999999998888888888888888887776642
Q ss_pred cccc-----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 407 LEFC-----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 407 ~~~~-----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.... ..+.+.. ..... .....++++.+++.+||+.||++||++.++++||||...+.
T Consensus 231 ~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 231 VTSLPDYKSAFPKWPP-KDLAT-VVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cccchhhhhhcccCCC-CCHHH-hCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 2111 0111111 11111 12367889999999999999999999999999999987653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=354.85 Aligned_cols=218 Identities=23% Similarity=0.355 Sum_probs=174.1
Q ss_pred HHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
+..|+.++++++||||+++++++.++.+.|+||||++| +|..++.... ..+++..+..++.||+.||+|||++||+||
T Consensus 40 ~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~ 119 (277)
T cd05607 40 ALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119 (277)
T ss_pred HHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEc
Confidence 45688899999999999999999999999999999984 7777765433 358899999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+||+++.++.++|+|||++...... .......||+.|+|||++.+..++.++|+||+||++|||++|..||.+..
T Consensus 120 dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 120 DMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred cCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999998765432 22234568999999999988888889999999999999999999997643
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH----HHHHcCCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA----ANAMRHPYF 460 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta----~e~l~Hp~f 460 (516)
.......+....-. .... .....+++++.+||.+||+.||.+|||+ +++++||||
T Consensus 199 ~~~~~~~~~~~~~~--------------------~~~~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f 257 (277)
T cd05607 199 EKVAKEELKRRTLE--------------------DEVK-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF 257 (277)
T ss_pred chhhHHHHHHHhhc--------------------cccc-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence 22111111110000 0000 0112578899999999999999999999 678899999
Q ss_pred CCCCCC
Q psy12305 461 NSLGPQ 466 (516)
Q Consensus 461 ~~~~~~ 466 (516)
..+.+.
T Consensus 258 ~~~~~~ 263 (277)
T cd05607 258 KTINFP 263 (277)
T ss_pred cCCCHH
Confidence 886543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=365.77 Aligned_cols=285 Identities=35% Similarity=0.594 Sum_probs=215.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.++||+|+||+||+|++..+|+.||||.+...........+.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS------- 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc-------
Confidence 4689999999999999999999999999999999864332222334455666666666666655554332111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
+
T Consensus 77 -------------------------------------------------------------------------------~ 77 (336)
T cd07849 77 -------------------------------------------------------------------------------F 77 (336)
T ss_pred -------------------------------------------------------------------------------c
Confidence 1
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
......|+|+||+++++.+.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 78 ESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred cccceEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 11235789999999998887754 4599999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCc---cccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 330 KSVPTK---TFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 330 ~~~~~~---~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
...... .....+||+.|+|||.+.+ ..+..++|+||+||++|+|++|++||.+.+.......+...++.++.+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 533221 2233578999999998765 356778899999999999999999999988888888888888887665443
Q ss_pred hcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 406 KLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 406 ~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..... ..+.... ..+....| ..++++.+||.+||+.||++|||+.++++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 236 CIISLRARNYIKSLPFKPK-VPWNKLFP-NADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred HhhchhhhhHHhhcCcCCc-ccHHHHhc-ccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 21100 0000000 11111122 5688899999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=352.65 Aligned_cols=276 Identities=57% Similarity=0.942 Sum_probs=224.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+++++||.|+||.||+|++..+|+.||||.+........
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~--------------------------------------- 41 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGT--------------------------------------- 41 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccc---------------------------------------
Confidence 58999999999999999999999999999998865432111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
...+.+|+.++++++||||+++++++..
T Consensus 42 ----------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 69 (284)
T cd07836 42 ----------------------------------------------------PSTAIREISLMKELKHENIVRLHDVIHT 69 (284)
T ss_pred ----------------------------------------------------hHHHHHHHHHHHhhcCCCEeeeeeeEee
Confidence 1244568888888888888899999998
Q ss_pred CceeeEeeehhhchHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCS--NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+..++||||++++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 70 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 70 ENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred CCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 89999999999999998887654 4689999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
............+|..|+|||++.+. .+..++|+|||||++|+|++|.+||.+.+..+....+....+.|....+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 150 FGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred hcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 65444444455678999999998664 35678899999999999999999999988888888888888777766654332
Q ss_pred cc-----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FC-----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~-----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.. ..+.... ....... +..++++.++|.+||+.||.+|||+.++++||||
T Consensus 230 ~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 QLPEYKPTFPRYPP-QDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred cCchhcccccCCCh-HHHHHHh-hhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 10 0111111 1111112 2568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=354.14 Aligned_cols=267 Identities=23% Similarity=0.366 Sum_probs=215.8
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|+..+.||+|+||+||+|.+..+++.||+|.+........
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~--------------------------------------- 41 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKR--------------------------------------- 41 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhh---------------------------------------
Confidence 37888999999999999999999999999998865321100
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+|+.++|+||+.+++.+..
T Consensus 42 --------------------------------------------------~~~~~~~~E~~il~~l~~~~i~~~~~~~~~ 71 (285)
T cd05632 42 --------------------------------------------------KGESMALNEKQILEKVNSQFVVNLAYAYET 71 (285)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHHcCCcCceeEEEEEec
Confidence 011245678889999999999999999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++..|+||||+.+ +|..++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~ 151 (285)
T cd05632 72 KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK 151 (285)
T ss_pred CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCccee
Confidence 9999999999995 777777553 34699999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... .......||+.|+|||++.+..+..++|+||+||++|+|++|..||.+.........+.......
T Consensus 152 ~~~~-~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~---------- 220 (285)
T cd05632 152 IPEG-ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLET---------- 220 (285)
T ss_pred cCCC-CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhcc----------
Confidence 5322 22334578999999999988888888999999999999999999998766544433332211110
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHEL 470 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~ 470 (516)
....+..+++++.+|+.+||+.||++||| +.++++||||.+........
T Consensus 221 ------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~ 274 (285)
T cd05632 221 ------------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEA 274 (285)
T ss_pred ------------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhc
Confidence 11123467889999999999999999999 88999999999886654443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=353.75 Aligned_cols=278 Identities=46% Similarity=0.803 Sum_probs=214.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++|++.+.||+|+||.||+|++..+|+.||||.+...... ....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~----------------------------------- 45 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPP----------------------------------- 45 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCch-----------------------------------
Confidence 4799999999999999999999999999999987654321 1111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDI 248 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~ 248 (516)
.+.+|+.+++.+. ||||++++++
T Consensus 46 --------------------------------------------------------~~~~E~~~l~~l~~~~~i~~~~~~ 69 (295)
T cd07837 46 --------------------------------------------------------TALREISLLQMLSESIYIVRLLDV 69 (295)
T ss_pred --------------------------------------------------------HHHHHHHHHHHccCCCCccceeee
Confidence 3344555555553 4666666666
Q ss_pred EeeCce-----eeEeeehhhchHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-CCC
Q psy12305 249 IHTEKC-----LTLVFEYLEKDLKRYMDDC----SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGE 318 (516)
Q Consensus 249 ~~~~~~-----~~lV~E~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~ 318 (516)
+..... .|+||||++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.
T Consensus 70 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~ 149 (295)
T cd07837 70 EHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL 149 (295)
T ss_pred EeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe
Confidence 554443 8999999999998888653 245899999999999999999999999999999999999998 889
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~ 397 (516)
+||+|||+++.............+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+....+..+....+
T Consensus 150 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~ 229 (295)
T cd07837 150 LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG 229 (295)
T ss_pred EEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999998655444444445678999999988653 457788999999999999999999999888888888888777
Q ss_pred CCChhhhhhcccc----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 398 PPPDELKSKLEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 398 ~~p~~~~~~~~~~----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
.++...+...... ..+.... ....... +.++.++.+||.+||.+||.+|||+++++.||||+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKP-QDLSRAV-PDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred CCChhhCcchhhccchhhcCcccc-hhHHHhc-cccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 7776554322111 1111110 1111112 25789999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=354.79 Aligned_cols=284 Identities=41% Similarity=0.683 Sum_probs=226.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||+|+||.||+|.+..+|+.||||.+.........
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~-------------------------------------- 42 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAK-------------------------------------- 42 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccccc--------------------------------------
Confidence 488999999999999999999999999999998654321100
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
......+..|+.+++.++|+||+++++++.+
T Consensus 43 -------------------------------------------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (298)
T cd07841 43 -------------------------------------------------DGINFTALREIKLLQELKHPNIIGLLDVFGH 73 (298)
T ss_pred -------------------------------------------------chhhHHHHHHHHHHhhcCCCCChhhhheeec
Confidence 0011245678888888899999999999999
Q ss_pred CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
++..++||||+.++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 74 ~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 74 KSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred CCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 89999999999889999887755579999999999999999999999999999999999999999999999999998765
Q ss_pred CCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
..........+++.|+|||.+.+. .+...+|+|||||++|||++|.+||.+.+..+.+..+....+.+....+......
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSL 233 (298)
T ss_pred CCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccc
Confidence 544444455678899999998653 4567789999999999999999999988888888888887777766555322111
Q ss_pred ----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 411 ----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 411 ----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
....... ...... ....+.++.+||.+||.+||++|||+.++++||||.+..
T Consensus 234 ~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 234 PDYVEFKPFPP-TPLKQI-FPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccccccCC-cchhhh-cccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 1111111 111111 235678999999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=383.10 Aligned_cols=267 Identities=21% Similarity=0.309 Sum_probs=207.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++|++.+.||+|+||+||+|++..+|+.||||++...... .....+.+|+.+|..++|+||+++++.+.....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~------ 105 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP------ 105 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc------
Confidence 5799999999999999999999999999999998764321 112244555555555555555554433211100
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.++
T Consensus 106 --------------------------------------------------------------------~~~--------- 108 (496)
T PTZ00283 106 --------------------------------------------------------------------RNP--------- 108 (496)
T ss_pred --------------------------------------------------------------------cCc---------
Confidence 000
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
.....+++||||+. |+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 01113689999998 5898888653 3468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCC--CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 326 LARAKSVP--TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 326 la~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
+++..... .......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+.+..+.....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------ 262 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------ 262 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence 99765422 1223446789999999999988888999999999999999999999998877666555432110
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
...|..+++++.+|+.+||+.||.+|||+.++++|||++....
T Consensus 263 -------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 263 -------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred -------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 1124478899999999999999999999999999999876443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=366.90 Aligned_cols=305 Identities=21% Similarity=0.302 Sum_probs=204.9
Q ss_pred ccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccc-ee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTE-KC 163 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 163 (516)
++|++.++||+|+||.||+|++. .+++.||||++...........+.+|+.+|.++ +|||||++++++... +.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 57999999999999999999853 355789999997544333345688999999999 899999999987654 34
Q ss_pred eeeeeehhhh-hhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccc
Q psy12305 164 LTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHAN 241 (516)
Q Consensus 164 ~~lv~Ey~~~-~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~Hpn 241 (516)
.+++|||+++ +|.+++......+..- ... .-....++ ....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~------------------------------~~~-------~~~~~~~~~~~~~ 129 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPY------------------------------REK-------SPKQRGRFRAMVE 129 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccc------------------------------ccc-------chhhhhhhhhhhh
Confidence 7888999875 6666664432110000 000 00001111 1111
Q ss_pred eeeEeeeEeeCceeeEeeehhh--c----hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc
Q psy12305 242 IVTLHDIIHTEKCLTLVFEYLE--K----DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE 315 (516)
Q Consensus 242 Iv~l~~~~~~~~~~~lV~E~~~--g----~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~ 315 (516)
..++...........+.-.+.. + ............+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~ 209 (338)
T cd05102 130 QSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSE 209 (338)
T ss_pred hhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcC
Confidence 1111111111000001111100 0 000011112346889999999999999999999999999999999999999
Q ss_pred CCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q psy12305 316 RGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLI 392 (516)
Q Consensus 316 ~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i 392 (516)
++.+||+|||+++....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |..||.+....+.+...
T Consensus 210 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 289 (338)
T cd05102 210 NNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR 289 (338)
T ss_pred CCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH
Confidence 99999999999976432211 1122345778999999988888899999999999999997 99999876543333222
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
... + .....|..+++++.+|+.+||+.||++|||+.++++
T Consensus 290 ~~~-~-----------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 290 LKD-G-----------------------TRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred Hhc-C-----------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 110 0 011124467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=350.74 Aligned_cols=278 Identities=40% Similarity=0.672 Sum_probs=225.0
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++.+.||+|+||.||+|++..+|+.||||++.......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~---------------------------------------- 40 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG---------------------------------------- 40 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc----------------------------------------
Confidence 5899999999999999999999899999999886532111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.++++++||||+++++++..
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (286)
T cd07832 41 --------------------------------------------------GIPNQALREIKALQACQHPYVVKLLDVFPH 70 (286)
T ss_pred --------------------------------------------------hhhHHHHHHHHHHHhCCCCCCcceeeEEec
Confidence 111256678888888889999999999999
Q ss_pred CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+...++||||+.++|.+++......+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 71 ~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~ 150 (286)
T cd07832 71 GSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS 150 (286)
T ss_pred CCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence 99999999999779999988767779999999999999999999999999999999999999999999999999998765
Q ss_pred CCC-ccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 332 VPT-KTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 332 ~~~-~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
... .......|+..|+|||++.+.. +..++|+||+||++|||++|.+||.+.+....+..+....+.+....|.....
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 332 1234457899999999986544 46788999999999999999999999888888888888888776654432110
Q ss_pred ------ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 410 ------CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 410 ------~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
...+.... ..+....+ ..+.++.+||.+||..||.+|||++++++||||.
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 231 LPDYNKITFPESKP-IPLEEIFP-DASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cchhhcccCCCCCc-chHHHhCC-CccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00111110 11112222 5678999999999999999999999999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=351.44 Aligned_cols=258 Identities=35% Similarity=0.546 Sum_probs=212.1
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|++.+.||+|+||+||+|++..+++.||+|++.........
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~--------------------------------------- 41 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE--------------------------------------- 41 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH---------------------------------------
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc---------------------------------------
Confidence 88999999999999999999999999999998765321110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
.....+|+.++++++||||+++++++...
T Consensus 42 ---------------------------------------------------~~~~~~e~~~~~~l~~~~i~~~~~~~~~~ 70 (260)
T PF00069_consen 42 ---------------------------------------------------REENIREIKILRRLRHPNIVQILDVFQDD 70 (260)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHTBTTBCHEEEEEEES
T ss_pred ---------------------------------------------------cchhhhhhhcccccccccccccccccccc
Confidence 01234588888999999999999999999
Q ss_pred ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 253 KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 253 ~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
...++||||+++ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||.+....
T Consensus 71 ~~~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~ 149 (260)
T PF00069_consen 71 NYLYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS 149 (260)
T ss_dssp SEEEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred ccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999997 89888873 3568999999999999999999999999999999999999999999999999997643
Q ss_pred CCCccccCCcccccccchhhcc-CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLL-GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
..........+|..|+|||++. +.....++|+||+|+++|+|++|..||......+....+...........
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 222 (260)
T PF00069_consen 150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS------- 222 (260)
T ss_dssp STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH-------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc-------
Confidence 3344555667899999999998 77788999999999999999999999998755555555544332211110
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.......++.+.+||.+||+.||++|||+.++++||||
T Consensus 223 ------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 ------------SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ------------TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ------------ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00001223789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=394.43 Aligned_cols=346 Identities=22% Similarity=0.311 Sum_probs=219.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|+.++.||+||||.|||||++.+|+.||||+|.............||+.+|++|+|||||++|..|........++
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 56789999999999999999999999999999999988765555568899999999999999999999997765555554
Q ss_pred ehhhhhhhccccc----cc-cc---------cccc----cccceee---EEEEEEEecC--------CceEEEEEeeccc
Q psy12305 169 EYLEKDLKRYMDD----CS-NI---------LSMN----NVKGTYA---TVFKGKSRLT--------DNLVALKEIKLEH 219 (516)
Q Consensus 169 Ey~~~~L~~~l~~----~s-~~---------l~~~----~~~G~~g---~V~~~~~~~~--------~~~vAiK~i~~~~ 219 (516)
|-...+-..+-.. +. .+ .... ...+..+ +-+.+....+ .+..+.- .....
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~-S~tS~ 635 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNL-SNTSD 635 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccc-ccccc
Confidence 4332211111100 00 00 0000 0000000 0000000000 0000000 00000
Q ss_pred ccCChhhHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHh
Q psy12305 220 EEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNIL-SMNNVKLFLFQLLRGLAYCH 297 (516)
Q Consensus 220 ~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l-~~~~~~~i~~qi~~aL~yLH 297 (516)
.++ ......+...-..+ .-.|-...--..+....+||-||||+.++++.+.+.+... ....++++++||+.||.|+|
T Consensus 636 ~e~-~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEG-SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCC-ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 000 00000011111111 1111111111222335789999999998887777665544 46789999999999999999
Q ss_pred hCCcEeeecCCCCEEEccCCCEEEeeeccccccC------------------CCCccccCCcccccccchhhccCCC---
Q psy12305 298 SRRILHRDLKPQNLLINERGELKLADFGLARAKS------------------VPTKTFSNEVVTLWYRPPDVLLGST--- 356 (516)
Q Consensus 298 ~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~------------------~~~~~~~~~~gt~~y~APE~l~~~~--- 356 (516)
++|||||||||.||+++.++.|||+|||+|+... ......+..+||..|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999997611 1122456779999999999997755
Q ss_pred CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc-CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHH
Q psy12305 357 EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALD 435 (516)
Q Consensus 357 ~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~d 435 (516)
|+.+.|+|||||+|+||+. ||... .+-...+..+. |..|.. ..+...--+.-..
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR~g~iP~~--------------------~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLRKGSIPEP--------------------ADFFDPEHPEEAS 849 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcccCCCCCC--------------------cccccccchHHHH
Confidence 7778888899999999985 56432 22222221111 111100 0011122345678
Q ss_pred HHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 436 LVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 436 Ll~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
+|+.||+.||.+||||.|+|++.||-
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhhccCCC
Confidence 99999999999999999999999997
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=362.25 Aligned_cols=288 Identities=33% Similarity=0.592 Sum_probs=218.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+|++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------- 77 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG------- 77 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-------
Confidence 679999999999999999999999999999999875432 122223444555555555555555444332111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
T Consensus 78 -------------------------------------------------------------------------------- 77 (334)
T cd07855 78 -------------------------------------------------------------------------------- 77 (334)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.....+++||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 78 ADFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred CCCceEEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 123468899999999888887654 4599999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCc----cccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 330 KSVPTK----TFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 330 ~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
...... .....+|+..|+|||++.+ ..+..++|+||+||++|||++|++||.+.+....+..+....|.|+.++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 432221 1234478999999999865 34677899999999999999999999999888889999999999887765
Q ss_pred hhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcc
Q psy12305 405 SKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 405 ~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~ 468 (516)
...... ..+.... ..+.... ...++++.+||.+||+.||++|||+++++.||||........
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~ 305 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQP-VPWSKIF-PKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305 (334)
T ss_pred hhhchhhHHHHHhhcccCCC-CCHHHHc-ccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcc
Confidence 432111 0010000 1111112 256899999999999999999999999999999987654433
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=350.30 Aligned_cols=280 Identities=37% Similarity=0.662 Sum_probs=225.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.++||+|+||.||+|.+..+++.||||.++......
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~--------------------------------------- 41 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDE--------------------------------------- 41 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccc---------------------------------------
Confidence 47999999999999999999999999999999875432110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++|+||+++++++.
T Consensus 42 ---------------------------------------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 70 (288)
T cd07833 42 ---------------------------------------------------DVKKTALREVKVLRQLRHENIVNLKEAFR 70 (288)
T ss_pred ---------------------------------------------------cchhHHHHHHHHHHhcCCCCeeehhheEE
Confidence 11125667888888888888888888888
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.++..++||||++++++..+......+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus 71 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~ 150 (288)
T cd07833 71 RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARAL 150 (288)
T ss_pred ECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence 88899999999998777776666667999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCc-cccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 331 SVPTK-TFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 331 ~~~~~-~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
..... ......++..|+|||++.+. .+..++|+||+||++|+|++|.+||.+....+.+..+....+..+........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 54433 33456778999999999887 67788999999999999999999999888888888887777776654332211
Q ss_pred cc------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FC------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.. ..+............+..++.++.+||++||..||++|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 10 00001111222333454568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=378.77 Aligned_cols=257 Identities=21% Similarity=0.276 Sum_probs=212.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCC-CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLT-DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~-g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
...|.+.+.||+|+||.||+|.+..+ ++.||+|.+......
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~-------------------------------------- 107 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDER-------------------------------------- 107 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHH--------------------------------------
Confidence 44599999999999999999998877 788999876432110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+|+.++||||++++++
T Consensus 108 ------------------------------------------------------~~~~~~~E~~~l~~l~Hpniv~~~~~ 133 (478)
T PTZ00267 108 ------------------------------------------------------QAAYARSELHCLAACDHFGIVKHFDD 133 (478)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 01245678899999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+..++++||||||++ |+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 134 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DF 213 (478)
T PTZ00267 134 FKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF 213 (478)
T ss_pred EEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeC
Confidence 999999999999998 5888777542 346899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 325 GLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 325 Gla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|+|+....... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+.+..+.....
T Consensus 214 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~----- 288 (478)
T PTZ00267 214 GFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY----- 288 (478)
T ss_pred cCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-----
Confidence 99986543221 23445799999999999888888899999999999999999999988777666555532110
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...|..+++++.+||.+||..||++|||+++++.|||++.+
T Consensus 289 --------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 --------------------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred --------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 01234678899999999999999999999999999998643
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.58 Aligned_cols=279 Identities=34% Similarity=0.597 Sum_probs=217.6
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||.||+|.+..+++.||+|++.......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--------------------------------------- 41 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK--------------------------------------- 41 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc---------------------------------------
Confidence 47999999999999999999999899999999875432111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 42 ---------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 70 (286)
T cd07846 42 ---------------------------------------------------MVKKIAMREIRMLKQLRHENLVNLIEVFR 70 (286)
T ss_pred ---------------------------------------------------hhhHHHHHHHHHHHhcCCcchhhHHHhcc
Confidence 01123556777777788888888888888
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.+...|+||||++++++..+......+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++...
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~ 150 (286)
T cd07846 71 RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150 (286)
T ss_pred cCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence 88889999999998666655555556999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc-
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE- 408 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~- 408 (516)
...........++..|+|||++.+.. +..++|+|||||++|||++|.+||.+.+..+....+....+..+........
T Consensus 151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 151 AAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred cCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhcc
Confidence 54444444567899999999987643 5567899999999999999999999888777777777766655433221110
Q ss_pred -----cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 -----FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 -----~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
....+........... ...++..+.+|+.+||..||++|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKR-FPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHhhccccccccCcchHHHh-CCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0011111111111111 23678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.38 Aligned_cols=274 Identities=36% Similarity=0.609 Sum_probs=218.6
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|.++++||+|+||.||+|.+..+++.||+|+++........
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~--------------------------------------- 41 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--------------------------------------- 41 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh---------------------------------------
Confidence 67899999999999999999999999999987643211111
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeEee
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHT 251 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 251 (516)
....+|+.++.++. ||||+++++++.+
T Consensus 42 ----------------------------------------------------~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 69 (282)
T cd07831 42 ----------------------------------------------------VNNLREIQALRRLSPHPNILRLIEVLFD 69 (282)
T ss_pred ----------------------------------------------------hhHHHHHHHHhhcCCCCCccceEEEEec
Confidence 12335677777774 8888888888887
Q ss_pred C--ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 E--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~--~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+ +.+++||||+++++.+.+......+++..+..++.||+.||+|||++||+||||||+||+++. +.+||+|||+++.
T Consensus 70 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~ 148 (282)
T cd07831 70 RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRG 148 (282)
T ss_pred CCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccc
Confidence 7 789999999999999998876667999999999999999999999999999999999999999 9999999999976
Q ss_pred cCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.... .......++..|+|||.+.+ .....++|+||+||++|||++|.+||.+.+..+....+....+.++..+.....
T Consensus 149 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 149 IYSK-PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred cccC-CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhc
Confidence 5432 22233567899999998754 345678999999999999999999999999888888998889988887643322
Q ss_pred cccCC--CCCCc--hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FCITP--VYPSE--SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~~~~--~~~~~--~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..... .++.. ...... ...++.++.+||.+||.+||++|||++++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKL-LPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccccccccCcccccccHHHH-cccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 11100 00000 011111 12568999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-44 Score=353.75 Aligned_cols=264 Identities=25% Similarity=0.352 Sum_probs=212.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.-+.|+++++||+|+||.||+|++..+++.||+|.+......
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~-------------------------------------- 51 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-------------------------------------- 51 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHH--------------------------------------
Confidence 336699999999999999999999999999999987543110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+++.++||||+++++.
T Consensus 52 ------------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~ 77 (292)
T cd06644 52 ------------------------------------------------------ELEDYMVEIEILATCNHPYIVKLLGA 77 (292)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCCCcEeeeEEE
Confidence 01245678888888899999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..+...|+||||+++ ++...+.+....+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 78 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 157 (292)
T cd06644 78 FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVS 157 (292)
T ss_pred EEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccc
Confidence 9989999999999996 666666665667999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
..............+++.|+|||++.+ ..++.++|+|||||++|||++|.+||...+.......+... .++
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~-- 233 (292)
T cd06644 158 AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS--EPP-- 233 (292)
T ss_pred eeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC--CCc--
Confidence 764333333344567899999999853 33566789999999999999999999876654443333211 110
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCc
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~ 467 (516)
....+..++.++.+||.+||..||++||+++++++||||.++.+..
T Consensus 234 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 234 -------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred -------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 1112346788999999999999999999999999999998876554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=366.67 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=218.5
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|.-+..||.|+||.||-|++..+.+.||||++........
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~--------------------------------------- 67 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN--------------------------------------- 67 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccH---------------------------------------
Confidence 48889999999999999999999999999999864322111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
..-..++.|+..|++++|||++.+.++|..
T Consensus 68 --------------------------------------------------EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 68 --------------------------------------------------EKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 112257789999999999999999999999
Q ss_pred CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+...|||||||-|+-.+.+.-..+++.+.++..|..+.+.||.|||+++.||||||..|||+++.|.|||+|||.|....
T Consensus 98 e~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~ 177 (948)
T KOG0577|consen 98 EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA 177 (948)
T ss_pred cchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC
Confidence 99999999999998888888778889999999999999999999999999999999999999999999999999997653
Q ss_pred CCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
+...++|||+|||||+++ .+.|+.+.|+||||++..||...+||...-+....+.-|...-.
T Consensus 178 ----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes----------- 242 (948)
T KOG0577|consen 178 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES----------- 242 (948)
T ss_pred ----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-----------
Confidence 345689999999999986 36788999999999999999999999887776666666643211
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
| .+....++..++.|+..||++-|.+|||++++|+|+|...-.|
T Consensus 243 ----P---------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 243 ----P---------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred ----C---------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 1 1112367899999999999999999999999999999875443
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=359.19 Aligned_cols=286 Identities=36% Similarity=0.624 Sum_probs=217.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.++|.+++.||+|+||+||+|++..+|+.||||.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~------ 77 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPH------ 77 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccc------
Confidence 3579999999999999999999999999999999865321 112223445555555555555555544332111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
T Consensus 78 -------------------------------------------------------------------------------- 77 (337)
T cd07858 78 -------------------------------------------------------------------------------- 77 (337)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.......|+||||++++|.+++... ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+++
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 78 REAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred ccccCcEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 0011347999999999998888764 469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
.............+|..|+|||.+.+ ..+..++|+|||||++|+|++|++||.+.+.......+....+.++.+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07858 157 TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI 236 (337)
T ss_pred ccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 76543333344567999999998865 45778899999999999999999999998888888888888888776554221
Q ss_pred ccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 408 EFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 408 ~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
... ..+.... ....... +.+++++.+||.+||+.||++|||++++++||||..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 237 RNEKARRYIRSLPYTPR-QSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CchhhhHHHHhcCcccc-cCHHHHc-ccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 110 0000000 1111112 36789999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=352.64 Aligned_cols=289 Identities=36% Similarity=0.644 Sum_probs=221.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|++.++||+|+||.||+|++..+++.||||++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 81 (311)
T cd07866 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD--- 81 (311)
T ss_pred cccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc---
Confidence 4478999999999999999999999999999999998765332 223356677777777777777777665432210
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 82 -------------------------------------------------------------------------------- 81 (311)
T cd07866 82 -------------------------------------------------------------------------------- 81 (311)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
........+++||||+++++...+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 00112345789999999988888877666799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-----------cccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Q psy12305 327 ARAKSVPTK-----------TFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS 394 (516)
Q Consensus 327 a~~~~~~~~-----------~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~ 394 (516)
++....... ......+++.|+|||.+.+. .+..++|+||+||++|||++|.+||.+.+.......+..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 976432211 12234668899999988654 466788999999999999999999999998888888888
Q ss_pred hcCCCChhhhhhcccccC----CCCC-CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 395 ILGPPPDELKSKLEFCIT----PVYP-SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+.++...+..+..... .... ......... ...++++.+||.+||+.||.+|||+.+++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERF-GKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHc-ccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 888776654433221110 0000 000111111 2456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=352.55 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=213.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|.+..++..||+|.+......
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------------------------------------- 44 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-------------------------------------- 44 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH--------------------------------------
Confidence 356799999999999999999999889999999987543111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.++++++||||++++++
T Consensus 45 ------------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~ 70 (280)
T cd06611 45 ------------------------------------------------------ELEDFMVEIDILSECKHPNIVGLYEA 70 (280)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCCCceeEEEEE
Confidence 01245678888888889999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..+...|+||||+++ +|..++......+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccc
Confidence 9989999999999995 788887776677999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
..............||+.|+|||++.. ..++.++|+|||||++|+|++|.+||.+.+....+..+.. +.++
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-- 226 (280)
T cd06611 151 AKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILK--SEPP-- 226 (280)
T ss_pred hhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhc--CCCC--
Confidence 765433333445578999999999753 3456689999999999999999999987765554443321 1110
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....|..++.++.+||.+||+.||.+|||++++++||||...
T Consensus 227 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 227 -------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred -------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 111234678899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=337.50 Aligned_cols=262 Identities=27% Similarity=0.354 Sum_probs=207.2
Q ss_pred ccccccEeee-eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccceee
Q psy12305 87 FGRIESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 87 ~~~~~~y~~~-~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 164 (516)
....++|.+. ++||-|--|.|..|.++.||+.+|+|++... ..+.||++..-.. .|||||+.+++|..
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeN---- 126 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYEN---- 126 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhh----
Confidence 3466788887 7899999999999999999999999987532 2566666665543 45555555554311
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
T Consensus 127 -------------------------------------------------------------------------------- 126 (400)
T KOG0604|consen 127 -------------------------------------------------------------------------------- 126 (400)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EeeeEeeCceeeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC---CCE
Q psy12305 245 LHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER---GEL 319 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~~v 319 (516)
.|....++.+|||.++| .|+..+.+++ ..+++.++..|++||+.|+.|||+.+|.||||||+|+|.... ..+
T Consensus 127 ---s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~l 203 (400)
T KOG0604|consen 127 ---SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPL 203 (400)
T ss_pred ---hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcce
Confidence 12235678999999995 8888887765 569999999999999999999999999999999999999754 469
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHh
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI----EDELRLICSI 395 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~----~~~~~~i~~~ 395 (516)
||+|||+|+.... .....+.|.||+|.|||++-...|+..+|.||+||++|-|++|.+||..... ...-.+|...
T Consensus 204 KLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 204 KLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred EecccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 9999999987543 3456677889999999999888888899999999999999999999976433 1223334333
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.-.+|.+-| ..+|++++|+|+++|..+|.+|+|+++++.|||+++..
T Consensus 283 qy~FP~pEW----------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 283 QYEFPEPEW----------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CccCCChhH----------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 323332222 26789999999999999999999999999999998754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=359.30 Aligned_cols=280 Identities=24% Similarity=0.341 Sum_probs=210.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.++||+|+||.||+|++..+|..||+|.+......
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~---------------------------------------- 44 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP---------------------------------------- 44 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCH----------------------------------------
Confidence 6799999999999999999999999999999987643110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 45 ---------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (333)
T cd06650 45 ---------------------------------------------------AIRNQIIRELQVLHECNSPYIVGFYGAFY 73 (333)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHCCCCcccceeEEEE
Confidence 01124667888999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.++++|+||||+. ++|.+++... +.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 74 SDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred ECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 9999999999998 4888888764 4589999999999999999999975 79999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-hcCCCChhhhhh-
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS-ILGPPPDELKSK- 406 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~-~~~~~p~~~~~~- 406 (516)
..... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||......+....+.. ..+.+.......
T Consensus 153 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 153 QLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhhhh--ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 54322 22345789999999999888888889999999999999999999987654433222110 111111100000
Q ss_pred c----ccc--cCCCCC-Cc-----------hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 L----EFC--ITPVYP-SE-----------SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~----~~~--~~~~~~-~~-----------~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
. ..+ ..+... .. ...........+.++++||.+||++||++|||++|+++||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0 000 000000 00 0000001113578899999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.43 Aligned_cols=258 Identities=23% Similarity=0.385 Sum_probs=210.6
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.+.+.||+|+||.||+|.+..+++.||||.+.........
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~------------------------------------- 44 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET------------------------------------- 44 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhh-------------------------------------
Confidence 4699999999999999999999999999999988654221100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++++++||||+++++++.
T Consensus 45 --------------------------------------------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 74 (263)
T cd06625 45 --------------------------------------------------KKEVNALECEIQLLKNLQHERIVQYYGCLR 74 (263)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHHhCCCCCeeeeEEEEc
Confidence 001124667899999999999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+..+++||||+++ +|.+.+... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.
T Consensus 75 ~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 75 DDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred cCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999985 777777654 4589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcc---ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 330 KSVPTKT---FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 330 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
....... .....|+..|+|||++.+...+.++|+||+||++|||++|+.||...+.......+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~----------- 222 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ----------- 222 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhcc-----------
Confidence 4322111 13346788999999999888888999999999999999999999776554443333211
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
......|...+.++.+||.+||..||.+|||+.++++||||
T Consensus 223 -------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 -------------PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -------------CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 11122345778999999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=348.81 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=207.8
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|+++++||+|+||.||+|++..++..||+|.+......
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~------------------------------------------ 44 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE------------------------------------------ 44 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHH------------------------------------------
Confidence 78899999999999999999999999999987543210
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
....+.+|+.+++.++||||+++++++..+
T Consensus 45 --------------------------------------------------~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~ 74 (282)
T cd06643 45 --------------------------------------------------ELEDYMVEIDILASCDHPNIVKLLDAFYYE 74 (282)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHCCCCCeeeEEEEEeeC
Confidence 011455688888888888888999988888
Q ss_pred ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 253 KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 253 ~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+..|+||||+++ +|..++......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 75 ~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 75 NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999999999995 6666666555679999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
..........+|+.|+|||++. +..++..+|+||+||++|+|++|.+||...+..+....+..... +
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~--~------ 226 (282)
T cd06643 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEP--P------ 226 (282)
T ss_pred ccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCC--C------
Confidence 3333334457899999999984 33456689999999999999999999987765554444432111 0
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....|..++.++.+||.+||+.||.+|||++++++||||...
T Consensus 227 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 ---------------TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ---------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 111234678899999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=347.03 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=195.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.|++.+.||+|+||.||+|++..+++.||||.+..... ....+.+|+.+++++.
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~----------------------- 60 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYS----------------------- 60 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhc-----------------------
Confidence 568999999999999999999999999999998864321 1123444444444441
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+||||+++++++.
T Consensus 61 -------------------------------------------------------------------~h~~i~~~~~~~~ 73 (272)
T cd06637 61 -------------------------------------------------------------------HHRNIATYYGAFI 73 (272)
T ss_pred -------------------------------------------------------------------CCCCeeeEeeEEe
Confidence 3555555555544
Q ss_pred e------CceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 251 T------EKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 251 ~------~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
. +..+|+||||+. ++|.+++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEc
Confidence 3 245899999998 4888887763 3568999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~ 397 (516)
|||++..............|++.|+|||++.+ ..+..++|+||+||++|||++|..||...........+...
T Consensus 154 Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~-- 231 (272)
T cd06637 154 DFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-- 231 (272)
T ss_pred cCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC--
Confidence 99999765433333445678999999999863 34667899999999999999999999765443333222110
Q ss_pred CCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 398 PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 398 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
......+..++.++.+||.+||..||.+|||+.++++||||
T Consensus 232 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 232 ----------------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ----------------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 00111223567899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=347.67 Aligned_cols=276 Identities=51% Similarity=0.877 Sum_probs=221.0
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|+++++||.|+||.||+|++..+|+.||||++........
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~---------------------------------------- 40 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG---------------------------------------- 40 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccccc----------------------------------------
Confidence 6788999999999999999999999999998865422110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
....+.+|+.+++.++||||+++++++.++
T Consensus 41 --------------------------------------------------~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~ 70 (283)
T cd07835 41 --------------------------------------------------VPSTAIREISLLKELNHPNIVRLLDVVHSE 70 (283)
T ss_pred --------------------------------------------------chhHHHHHHHHHHhcCCCCccCHhheeccC
Confidence 111345677777777888888888888888
Q ss_pred ceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 253 KCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 253 ~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+..|+||||++++|.+++.... ..+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||+++...
T Consensus 71 ~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 71 NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 8899999999988988887644 468999999999999999999999999999999999999999999999999997654
Q ss_pred CCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
..........++..|+|||++.+. .+..++|+|||||++|+|++|.+||.+.+..+.+..+....++|....|......
T Consensus 151 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 151 VPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred CCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc
Confidence 444344445678999999988664 3567899999999999999999999998888888888888888877665332111
Q ss_pred -----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 411 -----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 411 -----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+.... .... .....++.++.+||.+||+.||.+|||++++++||||
T Consensus 231 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 PDYKPTFPKWAR-QDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhhcccccc-cchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0111111 0111 1123678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=348.10 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=216.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|++..+++.||+|.+.......
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK--------------------------------------- 41 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhh---------------------------------------
Confidence 47999999999999999999999999999999886432110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++++++||||+++++++.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (290)
T cd05580 42 --------------------------------------------------LKQVEHVLNEKRILQSIRHPFLVNLYGSFQ 71 (290)
T ss_pred --------------------------------------------------hhHHHHHHHHHHHHHhCCCCCccceeeEEE
Confidence 001124667888999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.++.+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 150 (290)
T cd05580 72 DDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR 150 (290)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence 9999999999996 6888888765 5699999999999999999999999999999999999999999999999999977
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... ....+|++.|+|||.+.+...+.++|+||||+++|+|++|..||...+.......+...
T Consensus 151 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 213 (290)
T cd05580 151 VKGR---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG-------------- 213 (290)
T ss_pred cCCC---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--------------
Confidence 5433 23446899999999998877788899999999999999999999877755544444311
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcc
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~ 468 (516)
....|..++..+.++|.+||+.||.+|+ +++++++||||..+.+...
T Consensus 214 ------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~ 265 (290)
T cd05580 214 ------------KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL 265 (290)
T ss_pred ------------CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHH
Confidence 1123346789999999999999999999 9999999999988765443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=359.00 Aligned_cols=214 Identities=28% Similarity=0.424 Sum_probs=174.0
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|.+| .|.+||+|+||-..++++||||||-+-||.+.+.+....++.-.++.|..|++.|+.++|.+||||.
T Consensus 405 gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHS 484 (677)
T KOG0596|consen 405 GYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHS 484 (677)
T ss_pred HHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeec
Confidence 567888888888 4889999999999999999999999999999999887767766899999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcc--ccCCcccccccchhhccCCC-----------CCCceeeehHHHHHH
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGST-----------EYSTSIDMGVGCIFH 371 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~-----------~~~~~d~~SlGvil~ 371 (516)
||||.|+|+- .|.+||+|||+|.....+... ....+||+.|||||.+.... ...++|+||||||||
T Consensus 485 DLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILY 563 (677)
T KOG0596|consen 485 DLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILY 563 (677)
T ss_pred CCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHH
Confidence 9999999994 689999999999887655442 34569999999999985422 457899999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCH-HHHHHHHHccccCcCCCCC
Q psy12305 372 EMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDS-DALDLVQKFLMYDAKQRIS 450 (516)
Q Consensus 372 elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~-~~~dLl~~~L~~dP~~R~t 450 (516)
+|+.|++||..- .....++..+..+ .....+|..-+. ++.++++.||.+||.+|||
T Consensus 564 qMvYgktPf~~~--~n~~aKl~aI~~P---------------------~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~s 620 (677)
T KOG0596|consen 564 QMVYGKTPFGQI--INQIAKLHAITDP---------------------NHEIEFPDIPENDELIDVMKCCLARDPKKRWS 620 (677)
T ss_pred HHHhcCCchHHH--HHHHHHHHhhcCC---------------------CccccccCCCCchHHHHHHHHHHhcCcccCCC
Confidence 999999999542 2233333332211 112233333233 3999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q psy12305 451 AANAMRHPYFNSL 463 (516)
Q Consensus 451 a~e~l~Hp~f~~~ 463 (516)
+.++|+|||++..
T Consensus 621 i~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 621 IPELLQHPFLQIQ 633 (677)
T ss_pred cHHHhcCcccccc
Confidence 9999999999864
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=352.80 Aligned_cols=279 Identities=38% Similarity=0.648 Sum_probs=214.0
Q ss_pred cEeeeeeeccccceEEEEEEEcC--CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRL--TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~--~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+|.++++||+|+||.||+|.+.. +++.||||.+.......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~-------------------------------------- 42 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-------------------------------------- 42 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccc--------------------------------------
Confidence 48999999999999999999988 89999999987542110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
........+|+.+++.++||||+++++++
T Consensus 43 ---------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (316)
T cd07842 43 ---------------------------------------------------TGISQSACREIALLRELKHENVVSLVEVF 71 (316)
T ss_pred ---------------------------------------------------cCccHHHHHHHHHHHhcCCCCccceEEEE
Confidence 01112456788888888888888888888
Q ss_pred eeC--ceeeEeeehhhchHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc----CCCE
Q psy12305 250 HTE--KCLTLVFEYLEKDLKRYMDDC----SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE----RGEL 319 (516)
Q Consensus 250 ~~~--~~~~lV~E~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~----~~~v 319 (516)
.+. ..+++||||+++++...+... ...+++..++.++.||+.||.|||+++|+||||||+|||++. ++.+
T Consensus 72 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 72 LEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred eCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceE
Confidence 877 789999999998888776532 236899999999999999999999999999999999999999 8999
Q ss_pred EEeeeccccccCCCCc---cccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHH---------
Q psy12305 320 KLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE--------- 386 (516)
Q Consensus 320 kL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~--------- 386 (516)
||+|||+++....... .....++|+.|+|||++.+. .++.++|+|||||++|+|++|++||.+....
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9999999986543322 22344678999999988764 4667889999999999999999999865432
Q ss_pred HHHHHHHHhcCCCChhhhhhcc----cc------cCCCCCCchhhhhcCC--CCCCHHHHHHHHHccccCcCCCCCHHHH
Q psy12305 387 DELRLICSILGPPPDELKSKLE----FC------ITPVYPSESKLQLLAP--EQMDSDALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 387 ~~~~~i~~~~~~~p~~~~~~~~----~~------~~~~~~~~~~~~~~~p--~~~s~~~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
..+..+...++.++...+.... +. ....++. .......+ ...+.++.++|.+||+.||++|||+.|+
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~ei 310 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPS-NSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEA 310 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCC-ccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 3556677777766654442111 00 0011110 11111111 2567899999999999999999999999
Q ss_pred HcCCCC
Q psy12305 455 MRHPYF 460 (516)
Q Consensus 455 l~Hp~f 460 (516)
++||||
T Consensus 311 l~~~~f 316 (316)
T cd07842 311 LEHPYF 316 (316)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=349.07 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=211.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
...+|++++.||+|+||.||+|++..+++.||+|.+.......
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~------------------------------------- 60 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------------------------------------- 60 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-------------------------------------
Confidence 3367999999999999999999999999999999886432111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.+.||||+++++.
T Consensus 61 -------------------------------------------------------~~~~~~e~~~l~~~~h~~v~~~~~~ 85 (296)
T cd06654 61 -------------------------------------------------------KELIINEILVMRENKNPNIVNYLDS 85 (296)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 1245678888888888899999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..+.+.|+||||+.+ +|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~ 163 (296)
T cd06654 86 YLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (296)
T ss_pred EEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccc
Confidence 8888899999999985 78887754 35899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
..............|++.|+|||.+.+...+.++|+|||||++|+|++|+.||...........+.. .+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~-~~~~-------- 234 (296)
T cd06654 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTP-------- 234 (296)
T ss_pred hhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc-CCCC--------
Confidence 7654333333445789999999999888888899999999999999999999987765443332211 1110
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....+..++..+.+||.+||..||++|||+.++++||||...
T Consensus 235 --------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 235 --------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred --------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 011234678899999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=355.46 Aligned_cols=282 Identities=37% Similarity=0.602 Sum_probs=220.9
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+|++.+.||+|+||.||+|++..+|+.||||++..... ....+.+.
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~--------------------------------- 47 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL--------------------------------- 47 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHH---------------------------------
Confidence 58999999999999999999998999999998865432 22222344
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+|+.+++.++||||+++++++.
T Consensus 48 ----------------------------------------------------------~e~~~l~~l~~~~i~~~~~~~~ 69 (330)
T cd07834 48 ----------------------------------------------------------REIKLLRHLRHENIIGLLDILR 69 (330)
T ss_pred ----------------------------------------------------------HHHHHHHhcCCcchhhhhhhhc
Confidence 4555555555555555555554
Q ss_pred eCc-----eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 251 TEK-----CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 251 ~~~-----~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
... .+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 70 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg 148 (330)
T cd07834 70 PPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFG 148 (330)
T ss_pred ccCcccccceEEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccC
Confidence 443 689999999999888887644 79999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC---ccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 326 LARAKSVPT---KTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 326 la~~~~~~~---~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
++....... .......+|+.|+|||++.+. ....++|+||+||++|+|++|.+||.+.+..+.+..+....+.++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 228 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSE 228 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCCh
Confidence 998765443 223445679999999999887 6788899999999999999999999999999999999999998887
Q ss_pred hhhhhcccccCC------CCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 402 ELKSKLEFCITP------VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 402 ~~~~~~~~~~~~------~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
+.+......... .......+.... ..+++++.+||.+||++||++|||++++++||||......
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLF-PGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhc-ccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 655421111000 000011112222 2578999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=348.61 Aligned_cols=258 Identities=27% Similarity=0.427 Sum_probs=212.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
..+|++.+.||.|+||+||+|.+..+|+.||||.+.......
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-------------------------------------- 59 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-------------------------------------- 59 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch--------------------------------------
Confidence 356999999999999999999999999999999875432111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+++.++||||+++++++
T Consensus 60 ------------------------------------------------------~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (296)
T cd06655 60 ------------------------------------------------------KELIINEILVMKELKNPNIVNFLDSF 85 (296)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhcCCCceeeeeeeE
Confidence 12456788888888888888999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
...+..|+|+||+.+ +|..++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 86 LVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred ecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccch
Confidence 888999999999985 67776654 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.............++..|+|||.+.+..+..++|+|||||++|+|++|..||.+.+.......+... +.+
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~--------- 233 (296)
T cd06655 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP--------- 233 (296)
T ss_pred hcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCc---------
Confidence 6543333334457899999999998888888999999999999999999999887765554443221 110
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
....+..+++.+.+||.+||..||.+|||+.+++.||||+...
T Consensus 234 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 234 -------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred -------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 1112346788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.29 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=207.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||+|+||.||+|.+..+++.||||.+........
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--------------------------------------- 41 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR--------------------------------------- 41 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHH---------------------------------------
Confidence 48999999999999999999999999999999865322110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+++.++|||++++++.+..
T Consensus 42 ---------------------------------------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (257)
T cd08223 42 ---------------------------------------------------ERKAAEQEAQLLSQLKHPNIVAYRESWEG 70 (257)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhCCCCCeeeeeeeecC
Confidence 01134567777778888888888877764
Q ss_pred -CceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 252 -EKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 252 -~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+..+|+||||++ ++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~ 150 (257)
T cd08223 71 EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR 150 (257)
T ss_pred CCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceE
Confidence 446899999998 5888888763 3468999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.............+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+.+.......+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~----------- 219 (257)
T cd08223 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL----------- 219 (257)
T ss_pred EecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence 765433344455789999999999888888889999999999999999999987766554444322110
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...+...++++.+|+.+||+.||++|||+.++++||||
T Consensus 220 --------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 --------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 01223678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.52 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=211.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+.......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~---------------------------------------- 40 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR---------------------------------------- 40 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH----------------------------------------
Confidence 5889999999999999999999999999999886432110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++||||+++++++..
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 70 (256)
T cd08529 41 --------------------------------------------------REREEAIDEARVLAKLDSSYIIRYYESFLD 70 (256)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhcCCCCeehheeeecc
Confidence 011245678888888889999999999988
Q ss_pred CceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++..|+||||+. ++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~ 150 (256)
T cd08529 71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL 150 (256)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEccccccee
Confidence 899999999998 5888888764 46789999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
............|++.|+|||++.+..+..++|+|||||++|+|++|+.||...+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------ 218 (256)
T cd08529 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF------------ 218 (256)
T ss_pred ccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC------------
Confidence 65443333445789999999999888888899999999999999999999988776554444432110
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...+..++.++.+++.+||+.+|++||++.++++|||+
T Consensus 219 -------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 219 -------------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred -------------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 11223567899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=353.35 Aligned_cols=299 Identities=34% Similarity=0.558 Sum_probs=228.9
Q ss_pred cccccEeee-eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~-~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...++|..+ +.||+|+||+||+|++..+++.||||.+.........+...
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~----------------------------- 55 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDR----------------------------- 55 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccch-----------------------------
Confidence 344668755 67999999999999999999999999986543221100000
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
+.+ ........+.+|+.+++.++||||++++
T Consensus 56 ----------------------------------------------~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 56 ----------------------------------------------QLV---GMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ----------------------------------------------hhh---cccccchhHHHHHHHHHhCCCcceeeee
Confidence 000 0011122567899999999999999999
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+++..++..|+||||++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMASDLKKVVDRK-IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccccCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 999999999999999999999888653 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCC--------------CCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHH
Q psy12305 327 ARAKSV--------------PTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRL 391 (516)
Q Consensus 327 a~~~~~--------------~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~ 391 (516)
++.... .........+++.|+|||.+.+.. +..++|+||+||++|+|++|.+||.+.+..+.+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 976541 112223345688999999987643 56788999999999999999999999998888888
Q ss_pred HHHhcCCCChhhhhhccccc--CCCCC-CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 392 ICSILGPPPDELKSKLEFCI--TPVYP-SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 392 i~~~~~~~p~~~~~~~~~~~--~~~~~-~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
+....+.|+...|....... .+... ........ ....+.++.+||.+||+.||++|||+++++.||||+.....
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTI-FPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHh-CcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 88888887765443221110 00000 00111111 22568899999999999999999999999999999875444
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=383.34 Aligned_cols=264 Identities=29% Similarity=0.452 Sum_probs=206.6
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...+++|+++++||+|+||+||+|++..+++.||+|.+.......
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e----------------------------------- 53 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE----------------------------------- 53 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-----------------------------------
Confidence 356788999999999999999999999999999999886532111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.....+..|+.+|++|+|||||+++
T Consensus 54 -------------------------------------------------------~~~~~~~~EI~IL~~L~HPNIVrl~ 78 (1021)
T PTZ00266 54 -------------------------------------------------------REKSQLVIEVNVMRELKHKNIVRYI 78 (1021)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHHHcCCCCcCeEE
Confidence 0112456678888888888888888
Q ss_pred eeEee--CceeeEeeehhh-chHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-------CcEeeecCCCCEEE
Q psy12305 247 DIIHT--EKCLTLVFEYLE-KDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSR-------RILHRDLKPQNLLI 313 (516)
Q Consensus 247 ~~~~~--~~~~~lV~E~~~-g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-------~ivHrDlKp~NILl 313 (516)
++|.. ...+||||||++ ++|..++... ...+++..++.|+.||+.||.|||+. +||||||||+||||
T Consensus 79 d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL 158 (1021)
T PTZ00266 79 DRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158 (1021)
T ss_pred EEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEe
Confidence 87754 356899999999 5888888653 35699999999999999999999984 49999999999999
Q ss_pred cc-----------------CCCEEEeeeccccccCCCCccccCCcccccccchhhccCC--CCCCceeeehHHHHHHHHH
Q psy12305 314 NE-----------------RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS--TEYSTSIDMGVGCIFHEMS 374 (516)
Q Consensus 314 ~~-----------------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~d~~SlGvil~ell 374 (516)
+. .+.+||+|||++....... .....+||+.|+|||++.+. .+..++|+|||||+||||+
T Consensus 159 ~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL 237 (1021)
T PTZ00266 159 STGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237 (1021)
T ss_pred ecCccccccccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence 64 2348999999997654322 22345789999999998653 4677899999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q psy12305 375 SGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 375 tG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
+|..||........+...... .| .......+.++.+||.+||..||.+|||+.|+
T Consensus 238 TGk~PF~~~~~~~qli~~lk~--~p-----------------------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~Ql 292 (1021)
T PTZ00266 238 SGKTPFHKANNFSQLISELKR--GP-----------------------DLPIKGKSKELNILIKNLLNLSAKERPSALQC 292 (1021)
T ss_pred HCCCCCCcCCcHHHHHHHHhc--CC-----------------------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHH
Confidence 999999865544433222111 00 00112567899999999999999999999999
Q ss_pred HcCCCCCCCCCC
Q psy12305 455 MRHPYFNSLGPQ 466 (516)
Q Consensus 455 l~Hp~f~~~~~~ 466 (516)
|.||||..+.+.
T Consensus 293 L~h~~ik~i~~p 304 (1021)
T PTZ00266 293 LGYQIIKNVGPP 304 (1021)
T ss_pred hccHHHhhcCCC
Confidence 999999877554
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=360.22 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=221.3
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...++.|.++++||+|.||+|.+|++..+|..||||.|.+......
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~---------------------------------- 97 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS---------------------------------- 97 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH----------------------------------
Confidence 3567789999999999999999999999999999999876543221
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
......+|+.+|+.|+|||||+++
T Consensus 98 --------------------------------------------------------~~~k~~rev~imk~l~HPnIvkl~ 121 (596)
T KOG0586|consen 98 --------------------------------------------------------KRQKLGREVDIMKSLNHPNIVKLF 121 (596)
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHhcCCcceeeee
Confidence 112356788888888899999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
.+.+++..+|+||||+. |.+.+|+.+++. +.+..++.++.|+++|++|||+++|+|||||++|||++.+.++||+|||
T Consensus 122 ~v~~t~~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 122 SVIETEATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eeeeecceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccc
Confidence 99999999999999998 689999988664 6779999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++..+. ......+.||++.|.|||++.|..+. ...|+||+|++||-|+.|..||.|.+..+.-...
T Consensus 201 fS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv------------ 267 (596)
T KOG0586|consen 201 FSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV------------ 267 (596)
T ss_pred cceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh------------
Confidence 998876 55667788999999999999987765 5678899999999999999999987654432221
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.......|-.++.++.+||+++|..+|.+|+++++++.|.|.+.....
T Consensus 268 --------------l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 268 --------------LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred --------------eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 112223344688999999999999999999999999999998765433
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=350.14 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=212.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
..+|++++.||+|+||.||+|.+..+|+.||||.+.......
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------------- 59 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-------------------------------------- 59 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch--------------------------------------
Confidence 377999999999999999999999999999999875432111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+++.++||||+++++++
T Consensus 60 ------------------------------------------------------~~~~~~e~~~l~~~~h~~i~~~~~~~ 85 (297)
T cd06656 60 ------------------------------------------------------KELIINEILVMRENKNPNIVNYLDSY 85 (297)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 12456788888888999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
..+.+.|+||||+++ +|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 86 LVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred ecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccce
Confidence 999999999999985 78777754 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.............+++.|+|||.+.+..+..++|+||+||++|+|++|..||.+.+.......+.. .+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~--------- 233 (297)
T cd06656 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP--------- 233 (297)
T ss_pred EccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC---------
Confidence 654333333445789999999999888788889999999999999999999977554332221110 0111
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
....|..++..+.+|+.+||..||++|||++++++||||....+.
T Consensus 234 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 234 -------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred -------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 111234678889999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=345.72 Aligned_cols=291 Identities=35% Similarity=0.630 Sum_probs=217.6
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|++.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~--- 80 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQD--- 80 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcch---
Confidence 356789999999999999999999999999999999876432 2222234455555555555555555544322210
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
..
T Consensus 81 ------------------------------------------------------------------------------~~ 82 (302)
T cd07864 81 ------------------------------------------------------------------------------AL 82 (302)
T ss_pred ------------------------------------------------------------------------------hh
Confidence 00
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.++.....+|+||||+++++...+......+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred hccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 01112347899999999988888877666799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-ccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPT-KTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~-~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+....... .......++..|+|||.+.+. ....++|+||+||++|+|++|++||...+..+.+..+....+.++...+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 97654332 223334568889999988653 4567889999999999999999999988888888888888877766554
Q ss_pred hhcccc-cCCCC---C-CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 405 SKLEFC-ITPVY---P-SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 405 ~~~~~~-~~~~~---~-~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...... ..... . ........ ...++..+.+||.+||..||.+|||+++++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 322111 00000 0 00011111 22568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=343.68 Aligned_cols=257 Identities=25% Similarity=0.355 Sum_probs=205.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.+.++||+|+||.||+|++..+++.||+|.++......
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------------------------------------- 49 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED------------------------------------- 49 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH-------------------------------------
Confidence 3457999999999999999999999999999999886432100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||+++++.
T Consensus 50 -------------------------------------------------------~~~~~~e~~~~~~l~h~~ii~~~~~ 74 (267)
T cd06645 50 -------------------------------------------------------FAVVQQEIIMMKDCKHSNIVAYFGS 74 (267)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 1135578888888899999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..++..|+||||+++ +|.+++... +.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 75 YLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEeCCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999995 787777654 46999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
..............||+.|+|||++. ...+..++|+||+||++|+|++|..||...........+......++
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---- 229 (267)
T cd06645 154 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP---- 229 (267)
T ss_pred eEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCC----
Confidence 76543333334557899999999974 34567789999999999999999999976543333222211100000
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
.......++..+.+||.+||..||++|||++++++|||
T Consensus 230 -----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 230 -----------------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00011246788999999999999999999999999999
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=343.17 Aligned_cols=258 Identities=22% Similarity=0.358 Sum_probs=202.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||.||+|++..+|+.||||++.........
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------------------- 43 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ------------------------------------- 43 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHH-------------------------------------
Confidence 4799999999999999999999999999999988653211110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHH-HHhccccceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSL-LRELRHANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~ 249 (516)
..+..|+.+ ++.++||||+++++++
T Consensus 44 ------------------------------------------------------~~~~~e~~~~~~~~~~~~iv~~~~~~ 69 (283)
T cd06617 44 ------------------------------------------------------KRLLMDLDISMRSVDCPYTVTFYGAL 69 (283)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence 123334443 5566889999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
..++..|+||||++++|.+++.. ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||
T Consensus 70 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg 149 (283)
T cd06617 70 FREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149 (283)
T ss_pred ecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecc
Confidence 98899999999999988777654 235689999999999999999999997 99999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccC----CCCCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHhcCCCC
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLG----STEYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPP 400 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i~~~~~~~p 400 (516)
+++..... .......|+..|+|||++.+ ..++.++|+||+||++|+|++|+.||... ...+.+..+.. +.++
T Consensus 150 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~ 226 (283)
T cd06617 150 ISGYLVDS-VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE--EPSP 226 (283)
T ss_pred cccccccc-cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--cCCC
Confidence 98765322 12233467899999998865 33467889999999999999999999642 22222222211 1000
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
......++.++.+||.+||..||++|||++++++||||....
T Consensus 227 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 227 ----------------------QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ----------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 001124688999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=344.40 Aligned_cols=257 Identities=23% Similarity=0.329 Sum_probs=202.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++..+++.||||.+.......
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~--------------------------------------- 41 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--------------------------------------- 41 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChH---------------------------------------
Confidence 36889999999999999999999999999999886431100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+.++++++||||+++++++.
T Consensus 42 ----------------------------------------------------~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 69 (279)
T cd06619 42 ----------------------------------------------------LQKQIMSELEILYKCDSPYIIGFYGAFF 69 (279)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 0124667888888889999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.++..++||||+++..+... ..+++..+..++.|++.||+|||++||+|+||||+|||++.++.+||+|||++...
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~ 145 (279)
T cd06619 70 VENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL 145 (279)
T ss_pred ECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence 99999999999996433322 24788999999999999999999999999999999999999999999999999765
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHhcCCCChhhhhhc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE---LRLICSILGPPPDELKSKL 407 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~---~~~i~~~~~~~p~~~~~~~ 407 (516)
... .....+||..|+|||++.+..+..++|+|||||++|+|++|..||......+. ...........
T Consensus 146 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 215 (279)
T cd06619 146 VNS--IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------- 215 (279)
T ss_pred ccc--cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc--------
Confidence 322 23345789999999999888888899999999999999999999965321110 00000000000
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..........++++.+|+.+||+.||++||+++++++||||...+
T Consensus 216 ------------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 216 ------------DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ------------CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 000011225678999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.33 Aligned_cols=282 Identities=37% Similarity=0.617 Sum_probs=214.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++|.+.+.||+|+||.||+|++..+|+.||||++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------ 88 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVS------ 88 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheeccccc------
Confidence 579999999999999999999999999999999875422 1122244556666666666666555554322110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.
T Consensus 89 -------------------------------------------------------------------------------~ 89 (342)
T cd07879 89 -------------------------------------------------------------------------------G 89 (342)
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
......|+|+||+..++.... +..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 90 DEFQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred CCCceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 011346899999988776654 23589999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
... ......+|+.|+|||++.+ ..+..++|+|||||++|||++|+.||.+.+....+..+....+.++..+.....
T Consensus 167 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 167 ADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 432 2234567899999999876 346778999999999999999999999988888888888888887766654322
Q ss_pred cc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 409 FC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 409 ~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.. ..+..+. .......| ..++++.+||.+||+.||.+|||+++++.||||....+
T Consensus 244 ~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 244 DKAAKSYIKSLPKYPR-KDFSTLFP-KASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred ccchHHHHhhcCCccc-chHHHHhc-CCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 11 0111111 11112222 46788999999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=372.99 Aligned_cols=240 Identities=22% Similarity=0.256 Sum_probs=182.8
Q ss_pred hhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC
Q psy12305 225 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCS----NILSMNNVKLFLFQLLRGLAYCHSRR 300 (516)
Q Consensus 225 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ 300 (516)
..+.+|+.+|++++||||+++++++...+..|+|+|++.+++..++.... .......++.++.||+.||+|||++|
T Consensus 208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g 287 (501)
T PHA03210 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK 287 (501)
T ss_pred HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 35778999999999999999999999999999999999999888876432 22346678899999999999999999
Q ss_pred cEeeecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 301 ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
|+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|+|||||++|||++|..+
T Consensus 288 IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 288 LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred eecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999999987643322 22345789999999999988888999999999999999998754
Q ss_pred C-CC--CCHHHHHHHHHHhcCCCChhhh-------hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC
Q psy12305 380 F-PG--STIEDELRLICSILGPPPDELK-------SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 380 F-~~--~~~~~~~~~i~~~~~~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
+ .+ .....++..+...++.++.++. ...........+ ...........++.++.++|.+||++||.+||
T Consensus 368 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred CccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 4 32 2344555555555444333221 111110000000 00011111224678899999999999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q psy12305 450 SAANAMRHPYFNSLGP 465 (516)
Q Consensus 450 ta~e~l~Hp~f~~~~~ 465 (516)
|+.|+|+||||.....
T Consensus 447 sa~elL~hp~f~~~~~ 462 (501)
T PHA03210 447 GAAELLALPLFSAEEE 462 (501)
T ss_pred CHHHHhhChhhhcCCc
Confidence 9999999999987543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=347.47 Aligned_cols=265 Identities=28% Similarity=0.387 Sum_probs=215.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|.+..+++.||||.+........
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-------------------------------------- 42 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR-------------------------------------- 42 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchH--------------------------------------
Confidence 469999999999999999999999999999999865321110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++.+.
T Consensus 43 ---------------------------------------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (316)
T cd05574 43 ---------------------------------------------------NKVKRVLTEQEILATLDHPFLPTLYASFQ 71 (316)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCCchhheeeee
Confidence 01124667888888899999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.....|+||||+.+ +|.+++... +..+++..++.++.||+.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~ 151 (316)
T cd05574 72 TETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSK 151 (316)
T ss_pred cCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhh
Confidence 99999999999985 888887653 3569999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc-----------------------------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 329 AKSVPTK-----------------------------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 329 ~~~~~~~-----------------------------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
....... .....+||..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~p 231 (316)
T cd05574 152 QSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231 (316)
T ss_pred cccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCC
Confidence 5432111 11234678999999999988888899999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC----HHHHH
Q psy12305 380 FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS----AANAM 455 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t----a~e~l 455 (516)
|.+.+....+..+..... .......++.++.++|.+||..||++||| +++++
T Consensus 232 f~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll 287 (316)
T cd05574 232 FKGSNRDETFSNILKKEV------------------------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIK 287 (316)
T ss_pred CCCCchHHHHHHHhcCCc------------------------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHH
Confidence 988776665554432110 00111136889999999999999999999 99999
Q ss_pred cCCCCCCCCCCcc
Q psy12305 456 RHPYFNSLGPQVH 468 (516)
Q Consensus 456 ~Hp~f~~~~~~~~ 468 (516)
+||||++..+...
T Consensus 288 ~~~~~~~~~~~~~ 300 (316)
T cd05574 288 QHPFFRGVNWALI 300 (316)
T ss_pred cCchhhcCChhhc
Confidence 9999987654433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=359.93 Aligned_cols=252 Identities=26% Similarity=0.401 Sum_probs=197.5
Q ss_pred eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhh
Q psy12305 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLK 176 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~ 176 (516)
-.||+|+||+||-|||+.|....|||.|.-..... .+-+..
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~-~QPLhE-------------------------------------- 621 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE-VQPLHE-------------------------------------- 621 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchh-hccHHH--------------------------------------
Confidence 47999999999999999999999999986443221 113344
Q ss_pred ccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceee
Q psy12305 177 RYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 256 (516)
Q Consensus 177 ~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 256 (516)
||.+.++|+|.|||++++.+..++++-
T Consensus 622 -----------------------------------------------------EIaLH~~LrHkNIVrYLGs~senGf~k 648 (1226)
T KOG4279|consen 622 -----------------------------------------------------EIALHSTLRHKNIVRYLGSVSENGFFK 648 (1226)
T ss_pred -----------------------------------------------------HHHHHHHHhhHhHHHHhhccCCCCeEE
Confidence 455555555555555555555556677
Q ss_pred Eeeehhh-chHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-CCCEEEeeeccccccCC
Q psy12305 257 LVFEYLE-KDLKRYMDDCSNIL--SMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFGLARAKSV 332 (516)
Q Consensus 257 lV~E~~~-g~L~~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkL~DFGla~~~~~ 332 (516)
|.||-++ |+|...++..-+++ .+..+..|.+||+.||.|||++.|||||||-+|+|++. .|.+||+|||.++....
T Consensus 649 IFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg 728 (1226)
T KOG4279|consen 649 IFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG 728 (1226)
T ss_pred EEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence 8899988 58888888777777 78889999999999999999999999999999999975 68999999999988765
Q ss_pred CCccccCCcccccccchhhccCC--CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 333 PTKTFSNEVVTLWYRPPDVLLGS--TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 333 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
-.....++.||..|||||++..+ .|..++|+|||||++.||.||+|||..-..... .++++ | -
T Consensus 729 inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--AMFkV-G----------m-- 793 (1226)
T KOG4279|consen 729 INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--AMFKV-G----------M-- 793 (1226)
T ss_pred CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--hhhhh-c----------c--
Confidence 56666778899999999999754 467888999999999999999999975322111 11111 0 0
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
-+.....|+.++.+++.||.+|+..||.+||+|.++|..||++.-
T Consensus 794 --------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 794 --------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred --------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 112223566889999999999999999999999999999999754
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=341.44 Aligned_cols=258 Identities=26% Similarity=0.335 Sum_probs=203.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++.+.||+|+||.||+|++..+|+.||+|++.......
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~------------------------------------ 49 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD------------------------------------ 49 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch------------------------------------
Confidence 44567999999999999999999999999999999885431100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+.+|+.++++++||||+++++
T Consensus 50 --------------------------------------------------------~~~~~~e~~~l~~~~h~~ii~~~~ 73 (267)
T cd06646 50 --------------------------------------------------------FSLIQQEIFMVKECKHCNIVAYFG 73 (267)
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhcCCCCeeeeeE
Confidence 113457888888889999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..+...|+||||+++ +|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~ 152 (267)
T cd06646 74 SYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGV 152 (267)
T ss_pred EEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCcc
Confidence 99999999999999995 777777653 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
++.............|++.|+|||.+. ...+..++|+||+||++|||++|..||......+....+......+
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---- 228 (267)
T cd06646 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP---- 228 (267)
T ss_pred ceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCC----
Confidence 986543333334456889999999884 3345678899999999999999999996544332221111100000
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
.....+..++..+.+||.+||..||++|||++++++|+|
T Consensus 229 -----------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 229 -----------------PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred -----------------CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 001112356789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.16 Aligned_cols=237 Identities=20% Similarity=0.223 Sum_probs=173.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.+++.++||||+++++++..++..|+||||++ ++|.+++... ...+++..++.++.||+.||+|||++||+|
T Consensus 45 ~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH 124 (327)
T cd08227 45 FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124 (327)
T ss_pred HHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 45578889999999999999999999999999999998 5788887653 345899999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCc-------cccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHH
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTK-------TFSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMS 374 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~ell 374 (516)
|||||+|||++.++.++++|||.+........ ......++..|+|||++.+ ..++.++|+||+||++|||+
T Consensus 125 ~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~ 204 (327)
T cd08227 125 RSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 204 (327)
T ss_pred CCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999987544321111 1122356788999999876 34678899999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHhcCCCC----------hhhhhhcc-------cccCC----CCCC-chhhhhcCCCCCCHH
Q psy12305 375 SGRPLFPGSTIEDELRLICSILGPPP----------DELKSKLE-------FCITP----VYPS-ESKLQLLAPEQMDSD 432 (516)
Q Consensus 375 tG~~pF~~~~~~~~~~~i~~~~~~~p----------~~~~~~~~-------~~~~~----~~~~-~~~~~~~~p~~~s~~ 432 (516)
+|..||............. .+..+ ++...... .+... ..+. ...........++++
T Consensus 205 ~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (327)
T cd08227 205 NGHVPFKDMPATQMLLEKL--NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPH 282 (327)
T ss_pred HCCCCCCCcchhHHHHHHh--cCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHH
Confidence 9999998655443322221 12211 11100000 00000 0000 000001112245788
Q ss_pred HHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 433 ALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 433 ~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
+.+||.+||++||++|||++++++||||+.+.
T Consensus 283 ~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 283 FHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred HHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 99999999999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.13 Aligned_cols=260 Identities=25% Similarity=0.466 Sum_probs=209.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+...||+|+||.||+|.+..+++.||+|.+.............
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~---------------------------------- 46 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRK---------------------------------- 46 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHH----------------------------------
Confidence 4788899999999999999999899999999886543221100000
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
......+.+|+.++++++||||+++++++..
T Consensus 47 -------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (267)
T cd06628 47 -------------------------------------------------RSMLDALAREIALLKELQHENIVQYLGSSLD 77 (267)
T ss_pred -------------------------------------------------HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe
Confidence 0011256789999999999999999999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
..+.++||||+++ +|..++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 9999999999985 788887654 45899999999999999999999999999999999999999999999999998765
Q ss_pred CCCC------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 331 SVPT------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 331 ~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
.... .......|+..|+|||.+.+..+...+|+||+||++|+|++|..||.+.+.......+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN--------- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc---------
Confidence 4211 1112345788999999998877888899999999999999999999876554433332211
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.....|...+.++.+||.+||+.||.+||++.++++||||
T Consensus 228 ----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ----------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred ----------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0111234678999999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=335.10 Aligned_cols=254 Identities=23% Similarity=0.396 Sum_probs=211.2
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||+|+||.||++++..+|+.||||.+.......
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP---------------------------------------- 40 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh----------------------------------------
Confidence 5899999999999999999999999999999886432111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++||||+++++++..
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd08218 41 --------------------------------------------------KEREESRKEVAVLSNMKHPNIVQYQESFEE 70 (256)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhCCCCCeeeeEeeecC
Confidence 011245678888888889999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.++.|+||||+. ++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++..
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~ 150 (256)
T cd08218 71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV 150 (256)
T ss_pred CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceee
Confidence 999999999998 4888888654 34589999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
............|++.|+|||++.+.....++|+|||||++|+|++|..||......+....+... ..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~---------- 218 (256)
T cd08218 151 LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--SY---------- 218 (256)
T ss_pred cCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcC--CC----------
Confidence 544333333456788999999998888888999999999999999999999877666655444321 11
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...+...+.++.++|.+||+.+|++||++.++++||||
T Consensus 219 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 219 -------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 11234678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=342.57 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=196.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..+.|++.+.||.|+||.||+|++..+++.||+|.+...... ...+.+|+.+++++.
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~~~--------------------- 70 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE--EEEIKLEINMLKKYS--------------------- 70 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHH--HHHHHHHHHHHHHhc---------------------
Confidence 336799999999999999999999999999999987653211 123444555544441
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
+||||++++++
T Consensus 71 ---------------------------------------------------------------------~h~~i~~~~~~ 81 (282)
T cd06636 71 ---------------------------------------------------------------------HHRNIATYYGA 81 (282)
T ss_pred ---------------------------------------------------------------------CCCcEEEEeee
Confidence 34455555444
Q ss_pred Ee------eCceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEE
Q psy12305 249 IH------TEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELK 320 (516)
Q Consensus 249 ~~------~~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vk 320 (516)
+. ....+|++|||+++ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 82 ~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred hhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEE
Confidence 42 23568999999985 788777653 34588899999999999999999999999999999999999999999
Q ss_pred EeeeccccccCCCCccccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHh
Q psy12305 321 LADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395 (516)
Q Consensus 321 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~ 395 (516)
|+|||++..............|++.|+|||++. +..++.++|+|||||++|||++|.+||...........+..
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~- 240 (282)
T cd06636 162 LVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR- 240 (282)
T ss_pred EeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhh-
Confidence 999999876543333344567899999999986 34566789999999999999999999976554333322211
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+ ....+..++.++.+||.+||..||.+|||+.++++||||
T Consensus 241 --~~~---------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 241 --NPP---------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred --CCC---------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000 001123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.21 Aligned_cols=287 Identities=33% Similarity=0.554 Sum_probs=220.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..-++|++...||+|+||.||+|++..+++.||||++..... ......+.+|+.++++++||||+.+++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 88 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS--- 88 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc---
Confidence 445789999999999999999999999999999998865321 1122244556666666666666655544322110
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 89 -------------------------------------------------------------------------------- 88 (343)
T cd07851 89 -------------------------------------------------------------------------------- 88 (343)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.......|+|+||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 89 --~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 89 --LEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred --ccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccc
Confidence 011124899999999899888865 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+...... .....+|..|+|||.+.+. ..+.++|+||+||++|+|++|+.||.+....+.+..+....+.+++.++.
T Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (343)
T cd07851 165 ARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQ 241 (343)
T ss_pred ccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHh
Confidence 9765432 3344678999999998653 45678899999999999999999999988888888898888888877765
Q ss_pred hcccccC-------CCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 406 KLEFCIT-------PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 406 ~~~~~~~-------~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.+..... +.... ..+.... ...++++.+||.+||+.||.+|||+.++++||||......
T Consensus 242 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 242 KISSESARNYIQSLPQMPK-KDFKEVF-SGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred hccchhHHHHHHhccccCC-CCHHHHh-ccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 4432110 00000 1111111 2458899999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=336.19 Aligned_cols=256 Identities=30% Similarity=0.406 Sum_probs=209.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|++..+++.||+|.+......
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---------------------------------------- 42 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---------------------------------------- 42 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh----------------------------------------
Confidence 6799999999999999999999989999999988643211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+.+++.++||||+++++++.
T Consensus 43 ----------------------------------------------------~~~~~~~e~~~l~~~~h~~i~~~~~~~~ 70 (262)
T cd06613 43 ----------------------------------------------------DFEIIQQEISMLKECRHPNIVAYFGSYL 70 (262)
T ss_pred ----------------------------------------------------hHHHHHHHHHHHHhCCCCChhceEEEEE
Confidence 1124567888888888999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+..+|++|||+++ +|..++......+++..+..++.|++.||+|||++||+|+||||+||+++.++.+||+|||++..
T Consensus 71 ~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 150 (262)
T cd06613 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ 150 (262)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchh
Confidence 99999999999995 77777776556799999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCccccCCcccccccchhhccCC---CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGS---TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
............++..|+|||.+.+. .++..+|+|||||++|+|++|.+||.+.+.......+....-.++
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~------ 224 (262)
T cd06613 151 LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP------ 224 (262)
T ss_pred hhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc------
Confidence 55433333445788999999998776 677889999999999999999999987765554433322100000
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
....+...+.++.+||.+||..||.+|||+.+++.|||
T Consensus 225 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ---------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00112245678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=345.20 Aligned_cols=232 Identities=22% Similarity=0.310 Sum_probs=181.4
Q ss_pred CCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC----------
Q psy12305 206 TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------- 274 (516)
Q Consensus 206 ~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------- 274 (516)
++..||+|.++..........+.+|+.++..++||||+++++++.+.+..++||||+. ++|.+++....
T Consensus 45 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (304)
T cd05096 45 RPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124 (304)
T ss_pred cceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccc
Confidence 4456888887654433344568899999999999999999999999999999999998 58888875431
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccc
Q psy12305 275 --------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTL 344 (516)
Q Consensus 275 --------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~ 344 (516)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......++.
T Consensus 125 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~ 204 (304)
T cd05096 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPI 204 (304)
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCc
Confidence 2367788999999999999999999999999999999999999999999999976533221 122334578
Q ss_pred cccchhhccCCCCCCceeeehHHHHHHHHHc--CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhh
Q psy12305 345 WYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS--GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422 (516)
Q Consensus 345 ~y~APE~l~~~~~~~~~d~~SlGvil~ellt--G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 422 (516)
.|+|||++.+..++.++|+|||||++|||++ +..||.+.+..+.+..+........ ....
T Consensus 205 ~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~~ 266 (304)
T cd05096 205 RWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQG------------------RQVY 266 (304)
T ss_pred cccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc------------------cccc
Confidence 8999999988888899999999999999987 5678877665555444332211000 0001
Q ss_pred hcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 423 ~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
...|..++..+.+|+.+||..||++|||++++.
T Consensus 267 ~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 267 LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 112346788999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=349.18 Aligned_cols=294 Identities=33% Similarity=0.534 Sum_probs=218.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|++.+.||.|+||+||+|++..+|+.||+|++..... ...+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~----- 77 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD----- 77 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccc-----
Confidence 3679999999999999999999999999999999876543 3334678899999999999999988776443200
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...-...+
T Consensus 78 ------------------------------------------------------------------------~~~~~~~~ 85 (342)
T cd07854 78 ------------------------------------------------------------------------LTEDVGSL 85 (342)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00001123
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-CCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkL~DFGla~ 328 (516)
......|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++
T Consensus 86 ~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~ 163 (342)
T cd07854 86 TELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR 163 (342)
T ss_pred cccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccce
Confidence 34456899999999988888764 35899999999999999999999999999999999999975 5578999999997
Q ss_pred ccCCCCc---cccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 329 AKSVPTK---TFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 329 ~~~~~~~---~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
....... ......++..|+|||++.+ ..+..++|+|||||++|+|++|+.||.+.+..+....+......+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07854 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDR 243 (342)
T ss_pred ecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 6532211 1223467889999998755 44667889999999999999999999988777766666554433332211
Q ss_pred hhcc-----cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLE-----FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~-----~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.... ................. ..++.++.+||.+||+.||.+|||++++++||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 244 NELLNVIPSFVRNDGGEPRRPLRDLL-PGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hhhhhhhhhhhhhcccccCCCHHHHc-cCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 1100 00000000001111112 26788999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=341.63 Aligned_cols=276 Identities=46% Similarity=0.762 Sum_probs=223.1
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|.+.+.||+|+||.||+|.+..+|+.||+|.+.......
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~----------------------------------------- 39 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE----------------------------------------- 39 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-----------------------------------------
Confidence 677889999999999999998899999999876432110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
.....+.+|+.+++.++||||+++++++..+
T Consensus 40 -------------------------------------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 70 (283)
T cd05118 40 -------------------------------------------------GIPKTALREIKLLKELNHPNIIKLLDVFRHK 70 (283)
T ss_pred -------------------------------------------------hhHHHHHHHHHHHHHhcCCCcchHHHhhccC
Confidence 1112455677777777788888888888888
Q ss_pred ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCC
Q psy12305 253 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSV 332 (516)
Q Consensus 253 ~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~ 332 (516)
...++||||+++++.+++......+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+.....
T Consensus 71 ~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~ 150 (283)
T cd05118 71 GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGS 150 (283)
T ss_pred CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence 88999999999999998887667799999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc-
Q psy12305 333 PTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC- 410 (516)
Q Consensus 333 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~- 410 (516)
.........++..|+|||.+.+. ....++|+||+||++|+|++|+.||++.+..+.+..+...++.+..+.+......
T Consensus 151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence 44344445678899999998776 6778899999999999999999999999888888888888888776655433221
Q ss_pred -----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 411 -----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 411 -----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+.... ..... ....++.++.+||.+||..||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 231 RNYKFSFPKKAG-MPLPK-LFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhhccccc-cCHHH-hhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0111111 01111 122578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=324.82 Aligned_cols=265 Identities=20% Similarity=0.319 Sum_probs=213.6
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++.+.+..||.|+.|+|||++.+.+|...|||.+.........+
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~k--------------------------------- 135 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENK--------------------------------- 135 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHH---------------------------------
Confidence 46788889999999999999999999999999999987754433322
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
+++..+.++... ..|+||+-+
T Consensus 136 ----------------------------------------------------------RILmDldvv~~s~dcpyIV~c~ 157 (391)
T KOG0983|consen 136 ----------------------------------------------------------RILMDLDVVLKSHDCPYIVQCF 157 (391)
T ss_pred ----------------------------------------------------------HHHHhhhHHhhccCCCeeeeee
Confidence 334444444333 478888888
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++|..+..+++.||.|..-+..+++.-.+++++..+-.+...++.||.||-. +||+|||+||+|||+|..|++||||||
T Consensus 158 GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFG 237 (391)
T KOG0983|consen 158 GYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFG 237 (391)
T ss_pred eEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccc
Confidence 8888888899999999877777777767789999999999999999999984 689999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccC---CCCCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHhcCCCCh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLG---STEYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPPD 401 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i~~~~~~~p~ 401 (516)
++..+. +....+...|.+.|||||-+.- ..|+-.+|+||||++++||.||+.||.+. +..+.+..+.. ..||.
T Consensus 238 IsGrlv-dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln--~ePP~ 314 (391)
T KOG0983|consen 238 ISGRLV-DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN--EEPPL 314 (391)
T ss_pred ccceee-cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh--cCCCC
Confidence 997765 3344556688999999999853 35778899999999999999999999984 45556666654 11211
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCc
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~ 467 (516)
+ ......|+++++|+..||++|+.+||...++|+|||+....+..
T Consensus 315 -L--------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~ 359 (391)
T KOG0983|consen 315 -L--------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAE 359 (391)
T ss_pred -C--------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhh
Confidence 0 00114789999999999999999999999999999997654433
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=337.03 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=209.6
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|++..+++.||+|.+.....
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----------------------------------------- 41 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------------------------------------- 41 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----------------------------------------
Confidence 679999999999999999999988899999998754311
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+++.++||||+++++++.
T Consensus 42 -----------------------------------------------------~~~~~~e~~~~~~l~~~~i~~~~~~~~ 68 (256)
T cd06612 42 -----------------------------------------------------LQEIIKEISILKQCDSPYIVKYYGSYF 68 (256)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhCCCCcEeeeeeeee
Confidence 124567788888888888888888888
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+...|+++||+.+ +|.+++......+++..++.++.|++.||.|||+.+|+||||+|+||+++.++.+||+|||++..
T Consensus 69 ~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~ 148 (256)
T cd06612 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ 148 (256)
T ss_pred cCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchh
Confidence 88999999999995 88888877677799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
............++..|+|||++.+..++.++|+||+||++|+|++|+.||...........+.. .+
T Consensus 149 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~---~~---------- 215 (256)
T cd06612 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPN---KP---------- 215 (256)
T ss_pred cccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhcc---CC----------
Confidence 65443333445678899999999888888889999999999999999999987654433222211 00
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
......+..++.++.+||.+||+.||++|||+.++++||||
T Consensus 216 ----------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 216 ----------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----------CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00111233577899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=339.83 Aligned_cols=256 Identities=25% Similarity=0.343 Sum_probs=212.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||.|+||.||+|++..+++.||+|.+.......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--------------------------------------- 41 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED--------------------------------------- 41 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccch---------------------------------------
Confidence 46899999999999999999999999999999875432111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+.+++.++||||+++++++.
T Consensus 42 ----------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 69 (274)
T cd06609 42 ----------------------------------------------------EIEDIQQEIQFLSQCRSPYITKYYGSFL 69 (274)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHcCCCCeeeeeEEEE
Confidence 1124567888888889999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++...|+|+||+.+ +|.+++... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++.
T Consensus 70 ~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 70 KGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred ECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccccccee
Confidence 99999999999985 888887754 689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
............+++.|+|||.+.+..++.++|+|||||++|+|++|.+||...+.......+.... +
T Consensus 148 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--~---------- 215 (274)
T cd06609 148 LTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--P---------- 215 (274)
T ss_pred ecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--C----------
Confidence 6644344445678899999999988888889999999999999999999998765444333332110 0
Q ss_pred ccCCCCCCchhhhhcCCCC-CCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQ-MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~-~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...+.. ++.++.+++.+||..||++|||++++++||||....
T Consensus 216 -------------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 216 -------------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred -------------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 001112 678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=338.99 Aligned_cols=278 Identities=43% Similarity=0.740 Sum_probs=220.7
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|+++++||+|+||.||+|++..+|+.||+|++.......
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~----------------------------------------- 39 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKE----------------------------------------- 39 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccc-----------------------------------------
Confidence 688999999999999999999899999999987543110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
.....+.+|+.+++.++|||++++++++...
T Consensus 40 -------------------------------------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 70 (287)
T cd07840 40 -------------------------------------------------GFPITAIREIKLLQKLRHPNIVRLKEIVTSK 70 (287)
T ss_pred -------------------------------------------------cchHHHHHHHHHHHhccCCCeeeheeeEecC
Confidence 1112455677777777788888888887777
Q ss_pred --ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 253 --KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 253 --~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
...++||||++++|..++......+++..++.++.||+.||+|||++|++|+||||+||+++.++.+||+|||++...
T Consensus 71 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~ 150 (287)
T cd07840 71 GKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150 (287)
T ss_pred CCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeec
Confidence 789999999999999888776567999999999999999999999999999999999999999999999999999866
Q ss_pred CCCCc-cccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 331 SVPTK-TFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 331 ~~~~~-~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
..... ......++..|+|||.+.+. .+..++|+|||||++|||++|..||...+..+.+..+....+.++...+....
T Consensus 151 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 151 TKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred cCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccc
Confidence 54321 23344668899999987653 45678899999999999999999999988888888888888877665553321
Q ss_pred cc-----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FC-----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~-----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.. ..+...............+++++.+++.+||..||.+|||++++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 11 00111111112222222348899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=337.22 Aligned_cols=258 Identities=25% Similarity=0.407 Sum_probs=203.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|+..+.||+|+||.||+|.+..+|+.||+|.+.........
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~------------------------------------- 44 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPET------------------------------------- 44 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchh-------------------------------------
Confidence 3689999999999999999999999999999988654321110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.+++.++||||+++++++.
T Consensus 45 --------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 74 (266)
T cd06651 45 --------------------------------------------------SKEVSALECEIQLLKNLQHERIVQYYGCLR 74 (266)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHHHcCCCCeeeEEEEEE
Confidence 001124567888888888888888888876
Q ss_pred e--CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 251 T--EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 251 ~--~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
. +..++++|||+++ +|.+++... ..+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus 75 ~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 75 DRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred cCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 5 3578999999985 788887654 35899999999999999999999999999999999999999999999999998
Q ss_pred cccCCC---CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVP---TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+..... ........++..|+|||.+.+..++..+|+||+||++|||++|+.||...........+.. .+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~---~~----- 225 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT---QP----- 225 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc---CC-----
Confidence 754321 1122234578999999999888788889999999999999999999976544333332211 00
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
.....|..+++.+.+|| +||..||++|||++|+++||||+
T Consensus 226 ----------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 226 ----------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ----------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 01122346778899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=338.67 Aligned_cols=276 Identities=54% Similarity=0.914 Sum_probs=223.6
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|+..+.||+|+||.||+|.+..+++.||+|.+.......
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~----------------------------------------- 39 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE----------------------------------------- 39 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccc-----------------------------------------
Confidence 677889999999999999999899999999886543111
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
.....+..|+.+++.++||||+++++++...
T Consensus 40 -------------------------------------------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 70 (282)
T cd07829 40 -------------------------------------------------GIPSTALREISLLKELKHPNIVKLLDVIHTE 70 (282)
T ss_pred -------------------------------------------------cccHHHHHHHHHHHhcCCCCHHHHHhhhhcC
Confidence 0111344567777777777777777777777
Q ss_pred ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCC
Q psy12305 253 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSV 332 (516)
Q Consensus 253 ~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~ 332 (516)
...++||||++++|.+++......+++..+..++.|++.||+|||++||+||||+|+||+++.++.+||+|||+++....
T Consensus 71 ~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 71 RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 88999999999999999987656799999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc-
Q psy12305 333 PTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC- 410 (516)
Q Consensus 333 ~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~- 410 (516)
.........++..|+|||.+.+. .+..++|+|||||++|||++|.+||.+.+..+.+..+....+.+....|......
T Consensus 151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence 44444455668899999998766 6677889999999999999999999999988899999998888887766433221
Q ss_pred ----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 411 ----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 411 ----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+.+.. .......| ..+.++.++|.+||..||++||++++++.||||
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 DYKPTFPKFPP-KDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccccccccCc-cchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1111111 11122233 458899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=339.36 Aligned_cols=220 Identities=27% Similarity=0.395 Sum_probs=179.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.+++.++||||+++++++...+..|+||||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++|
T Consensus 39 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H 118 (277)
T cd05577 39 MALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118 (277)
T ss_pred HHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 45678899999999999999999999999999999999 58888876644 36899999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|||||+||+++.++.+||+|||++..... ........++..|+|||++.+..++.++|+||+||++|+|++|+.||...
T Consensus 119 ~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 119 RDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999876543 22233456788999999998887888899999999999999999999765
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHP 458 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp 458 (516)
........+.... .......+...++++.+||.+||+.||.+|| ++.++++||
T Consensus 198 ~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~ 255 (277)
T cd05577 198 KEKVEKEELKRRT----------------------LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255 (277)
T ss_pred cccccHHHHHhcc----------------------ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhCh
Confidence 4321111111100 0011123446789999999999999999999 899999999
Q ss_pred CCCCCCCCcc
Q psy12305 459 YFNSLGPQVH 468 (516)
Q Consensus 459 ~f~~~~~~~~ 468 (516)
||..+++...
T Consensus 256 ~~~~~~~~~~ 265 (277)
T cd05577 256 LFKDLNWRRL 265 (277)
T ss_pred hhhcCChhhh
Confidence 9998776544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=331.20 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=212.2
Q ss_pred ccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chH
Q psy12305 189 NNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDL 266 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L 266 (516)
..|+|+|+.|-.+.+..|+..||||+|.+. ....+.++.+|++++.++ .|+||++|+++|+++..+|||||-|. |.|
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 357999999999999999999999999877 455667889999999999 59999999999999999999999999 588
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC---EEEeeeccccccC-------CCCcc
Q psy12305 267 KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKS-------VPTKT 336 (516)
Q Consensus 267 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkL~DFGla~~~~-------~~~~~ 336 (516)
+..+.++ ..+++.++.++.++|+.||+|||.+||.||||||+|||....+. +|||||.++.... .....
T Consensus 164 LshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 164 LSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 8888774 45999999999999999999999999999999999999976654 7999999875432 12334
Q ss_pred ccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCCCH---------------HHHHHHHHHhc
Q psy12305 337 FSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI---------------EDELRLICSIL 396 (516)
Q Consensus 337 ~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~~~---------------~~~~~~i~~~~ 396 (516)
..+++|+..|||||+.. ...|+..+|.||||||||-||+|.+||.|... ...+..|....
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 56789999999999863 23567788899999999999999999987532 22344444443
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
-..|++-|. .+|.+++||++.+|..|+.+|.+|.++++|||++...+.
T Consensus 323 YeFPdkdWa----------------------hIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 323 YEFPDKDWA----------------------HISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred CcCChhhhH----------------------HhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 344443332 689999999999999999999999999999999876543
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=339.62 Aligned_cols=257 Identities=24% Similarity=0.380 Sum_probs=200.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.+.+.||+|+||.||+|.+..+++.||+|.+..... ..
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~----------------------------------- 62 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VD----------------------------------- 62 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HH-----------------------------------
Confidence 35779999999999999999999999999999998753211 01
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
..+.+|+.+++++ +||||+++++
T Consensus 63 --------------------------------------------------------~~~~~e~~~l~~l~~h~ni~~~~~ 86 (291)
T cd06639 63 --------------------------------------------------------EEIEAEYNILQSLPNHPNVVKFYG 86 (291)
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhcCCCCeEEEEE
Confidence 1234456666666 5677777776
Q ss_pred eEeeC-----ceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC
Q psy12305 248 IIHTE-----KCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE 318 (516)
Q Consensus 248 ~~~~~-----~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 318 (516)
++... ...|+||||+++ +|.+++.. .+..+++..++.++.|++.||+|||++||+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred EEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC
Confidence 66532 358999999985 77776653 3456899999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCCC-----CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-----EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-----~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
+||+|||++..............|+..|+|||++.... ++.++|+||+||++|||++|++||........+..+.
T Consensus 167 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 246 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP 246 (291)
T ss_pred EEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence 99999999876543333333457889999999975432 4678999999999999999999998766544443332
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
.. ++ .....+...+.++.+||.+||+.||++|||+.++++||||+
T Consensus 247 ~~---~~--------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 247 RN---PP--------------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cC---CC--------------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 11 10 01112335677899999999999999999999999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=349.73 Aligned_cols=277 Identities=35% Similarity=0.559 Sum_probs=211.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++|++++.||+|+||.||+|.+..+|+.||||++...... ...+.+.+|+.++++++||||+
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv----------------- 79 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----------------- 79 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccc-----------------
Confidence 7799999999999999999999999999999998754221 1122344455555555555554
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
++++++
T Consensus 80 --------------------------------------------------------------------------~~~~~~ 85 (345)
T cd07877 80 --------------------------------------------------------------------------GLLDVF 85 (345)
T ss_pred --------------------------------------------------------------------------ceeeee
Confidence 444444
Q ss_pred ee------CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 250 HT------EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 250 ~~------~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
.. ....|+++++++++|.+.+.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|
T Consensus 86 ~~~~~~~~~~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred eecccccccccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEec
Confidence 32 234789999998888777654 3589999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
||+++.... ......+|..|+|||.+.+ ..+..++|+||+||++|+|++|++||.+.+....+..+....+.++..
T Consensus 164 fg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 164 FGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred ccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999876432 2234567899999999866 356678899999999999999999999888888888888888877766
Q ss_pred hhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 403 LKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 403 ~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
+....... ..+..+. ..... .....++++.+||.+||+.||.+|||+.++++||||.....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPK-MNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCC-cchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 65332211 0000000 00000 01146788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=344.75 Aligned_cols=279 Identities=24% Similarity=0.328 Sum_probs=209.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.++||+|+||.||+|++..+|..||+|.+......
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~---------------------------------------- 40 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKP---------------------------------------- 40 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCH----------------------------------------
Confidence 4699999999999999999999999999999987542110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.++++++||||+++++++.
T Consensus 41 ---------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 69 (308)
T cd06615 41 ---------------------------------------------------AIRNQIIRELKVLHECNSPYIVGFYGAFY 69 (308)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 01124667888899999999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.++.+|+||||+++ +|.+++... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++.
T Consensus 70 ~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 70 SDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred eCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 99999999999985 888887764 568999999999999999999997 699999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh-hhc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK-SKL 407 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~-~~~ 407 (516)
..... .....+|++.|+|||.+.+..+..++|+|||||++|+|++|+.||...+.......+.......+.... ...
T Consensus 149 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 149 QLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ccccc--ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 54322 223457899999999998877888899999999999999999999876543332222111100000000 000
Q ss_pred --ccccCCCCC---------CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 408 --EFCITPVYP---------SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 408 --~~~~~~~~~---------~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.....+... ............++.++.+|+.+||..||++|||+.++++||||...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000000000 00000001112367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=355.14 Aligned_cols=207 Identities=20% Similarity=0.338 Sum_probs=167.7
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------------------------
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS----------------------------- 274 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~----------------------------- 274 (516)
.+.+|+.+++.+ +||||+++++++.....+++|||||. |+|.+++....
T Consensus 87 ~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (374)
T cd05106 87 ALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKY 166 (374)
T ss_pred HHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccc
Confidence 567899999998 89999999999999999999999998 58888875421
Q ss_pred ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc
Q psy12305 275 ----------------------------------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN 314 (516)
Q Consensus 275 ----------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 314 (516)
.++++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~ 246 (374)
T cd05106 167 IRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT 246 (374)
T ss_pred ccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe
Confidence 2478888999999999999999999999999999999999
Q ss_pred cCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q psy12305 315 ERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRL 391 (516)
Q Consensus 315 ~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~ 391 (516)
.++.+||+|||+++....... ......+++.|+|||++.+..++.++|+|||||++|||++ |..||+..........
T Consensus 247 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~ 326 (374)
T cd05106 247 DGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326 (374)
T ss_pred CCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH
Confidence 999999999999976533221 1112234678999999988888899999999999999997 9999987554433333
Q ss_pred HHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 392 ICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 392 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+... ......|...++++.+++.+||+.||++|||+.++++
T Consensus 327 ~~~~------------------------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 327 MVKR------------------------GYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHc------------------------ccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2211 0111223456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=339.75 Aligned_cols=256 Identities=23% Similarity=0.338 Sum_probs=196.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+++.||+|.+...... ..
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~---------------------------------- 59 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI--DE---------------------------------- 59 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch--HH----------------------------------
Confidence 457899999999999999999999999999999987532111 11
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
.+.+|+.+++.+ +||||+++++
T Consensus 60 ---------------------------------------------------------~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 60 ---------------------------------------------------------EIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHhcCCCeeeeee
Confidence 233455555555 4666666666
Q ss_pred eE-----eeCceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC
Q psy12305 248 II-----HTEKCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE 318 (516)
Q Consensus 248 ~~-----~~~~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 318 (516)
++ ..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG 162 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC
Confidence 55 234578999999985 77776642 3356889999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
+||+|||+++.............|++.|+|||++.+ ..+..++|+||+||++|||++|+.||........+..+.
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~ 242 (286)
T cd06638 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242 (286)
T ss_pred EEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc
Confidence 999999999765433333344578999999999753 345678899999999999999999998765433332221
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.. . ......|...+.++.+||.+||+.||++|||+.++++||||
T Consensus 243 ~~--~---------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 RN--P---------------------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cc--C---------------------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 10 0 00111233567889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=352.54 Aligned_cols=279 Identities=23% Similarity=0.329 Sum_probs=235.3
Q ss_pred cccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 84 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
++....+.++.++..||-||||.|=+++.......+|+|.+++.+- |
T Consensus 413 e~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI----------------------V----------- 459 (732)
T KOG0614|consen 413 EFAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI----------------------V----------- 459 (732)
T ss_pred hhcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc----------------------c-----------
Confidence 4556778889999999999999999998766555688888765432 1
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccccee
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 243 (516)
+......+..|-+||..++.|+||
T Consensus 460 --------------------------------------------------------dtkQqeHv~sEr~Im~~~~s~fIv 483 (732)
T KOG0614|consen 460 --------------------------------------------------------DTKQQEHVFSERNIMMECRSDFIV 483 (732)
T ss_pred --------------------------------------------------------chhHHHHHHhHHHHHHhcCchHHH
Confidence 011122445677777777777778
Q ss_pred eEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 244 TLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 244 ~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
++|..|.+..++|+.||-|- |.+...+.+++ .+++..++.++..++.|++|||++|||.|||||+|++++.+|.+||.
T Consensus 484 rLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 484 RLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred HHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEe
Confidence 88888888889999999987 58888887754 59999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|||+|+......++ .++||||.|.|||+++....+...|.||||+++|||++|.+||.+.+....+..|.+.+
T Consensus 563 DFGFAKki~~g~KT-wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------ 635 (732)
T KOG0614|consen 563 DFGFAKKIGSGRKT-WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------ 635 (732)
T ss_pred ehhhHHHhccCCce-eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------
Confidence 99999988765554 46899999999999999999999999999999999999999999999999999987643
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQSIF 477 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~~~ 477 (516)
....+|..++..+.+||+++...+|.+|+. +.++.+|.||.+++|.-.......+++
T Consensus 636 ------------------d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi 697 (732)
T KOG0614|consen 636 ------------------DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPI 697 (732)
T ss_pred ------------------hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCc
Confidence 234456789999999999999999999996 889999999999998877666555544
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=350.58 Aligned_cols=255 Identities=28% Similarity=0.383 Sum_probs=212.9
Q ss_pred Eeee--eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 93 YFKL--DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 93 y~~~--~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
|++. +.||.|.||+||-|.++.+|+.||||+|.+-.....
T Consensus 564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-------------------------------------- 605 (888)
T KOG4236|consen 564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-------------------------------------- 605 (888)
T ss_pred HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCc--------------------------------------
Confidence 5554 899999999999999999999999999976432211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+|+.||+++.||.||.+...|+
T Consensus 606 ----------------------------------------------------qesqlR~EVaILq~l~HPGiV~le~M~E 633 (888)
T KOG4236|consen 606 ----------------------------------------------------QESQLRNEVAILQNLHHPGIVNLECMFE 633 (888)
T ss_pred ----------------------------------------------------hHHHHHHHHHHHHhcCCCCeeEEEEeec
Confidence 1235678999999999999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC---CEEEeeecc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG---ELKLADFGL 326 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkL~DFGl 326 (516)
+.+.++.|||-+.||+++.+.. ..+++++...+.++.||+.||.|||-++|+|+||||+|||+.... ++||||||+
T Consensus 634 T~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 634 TPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred CCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccc
Confidence 9999999999999998887764 457899999999999999999999999999999999999997653 699999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
||...... .....+|||.|+|||++....|...-|.||+|||+|--++|..||..+ +..++++.. .-..|.+-
T Consensus 714 ARiIgEks-FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNA---aFMyPp~P-- 787 (888)
T KOG4236|consen 714 ARIIGEKS-FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNA---AFMYPPNP-- 787 (888)
T ss_pred eeecchhh-hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcc---ccccCCCc--
Confidence 99876433 345579999999999999999999999999999999999999999753 333333322 11111111
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+++++.|||..+|+..-.+|.|.+..|.|||+++.
T Consensus 788 --------------------W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 788 --------------------WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred --------------------hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 12788999999999999999999999999999999753
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=341.47 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=207.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++..+|+.||+|.+.......
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~--------------------------------------- 41 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--------------------------------------- 41 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHH---------------------------------------
Confidence 46999999999999999999999899999999875431111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+.++++++||||+++++.+.
T Consensus 42 ----------------------------------------------------~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (286)
T cd06622 42 ----------------------------------------------------KFNQIIMELDILHKAVSPYIVDFYGAFF 69 (286)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhcCCCcHHhhhhhee
Confidence 0124567788888888888888888888
Q ss_pred eCceeeEeeehhhc-hHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDC--SNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.++..|+||||+++ +|..++... ...+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||+
T Consensus 70 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~ 149 (286)
T cd06622 70 IEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149 (286)
T ss_pred cCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCC
Confidence 88999999999996 777776653 2368999999999999999999996 5999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCC------CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGST------EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~------~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
+...... ......+++.|+|||.+.+.. +..++|+||+||++|+|++|..||...........+......++
T Consensus 150 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 150 SGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred cccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 8765322 223346788999999985543 36688999999999999999999977554444433332222111
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
...|..++.++.+||.+||+.||++||+++++++||||......
T Consensus 228 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 228 ----------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred ----------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 11233578999999999999999999999999999999765433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.92 Aligned_cols=254 Identities=24% Similarity=0.386 Sum_probs=213.1
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+.++.||+|+||.||.+++..+++.||+|.+.......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------------------------------------- 40 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---------------------------------------- 40 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch----------------------------------------
Confidence 5899999999999999999999999999999875432111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.++++++|+||+++++++.+
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 70 (256)
T cd08221 41 --------------------------------------------------KERRDALNEIVILSLLQHPNIIAYYNHFMD 70 (256)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHhCCCCCeeEEEeEEec
Confidence 111245678888888999999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
...+++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 71 ~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~ 150 (256)
T cd08221 71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI 150 (256)
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEE
Confidence 999999999998 5898888765 45689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
............|++.|+|||.+.+..+..++|+||+||++|+|++|..||...+..+....+.. +.++
T Consensus 151 ~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~--------- 219 (256)
T cd08221 151 LGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--GNYT--------- 219 (256)
T ss_pred cccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc--CCCC---------
Confidence 65443334456789999999999887778889999999999999999999988776666555532 1111
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+...+.++.++|.+||..||.+|||+.++++|||+
T Consensus 220 --------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 220 --------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred --------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0123678899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=345.10 Aligned_cols=260 Identities=23% Similarity=0.381 Sum_probs=208.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-+.|....+||+|+||.||+|.+..++..||||.+......
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------- 61 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ--------------------------------------- 61 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH---------------------------------------
Confidence 35567778999999999999999989999999987542110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+++.++||||+++++.+
T Consensus 62 -----------------------------------------------------~~~~~~~e~~~l~~l~h~~ii~~~~~~ 88 (292)
T cd06658 62 -----------------------------------------------------RRELLFNEVVIMRDYHHENVVDMYNSY 88 (292)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhCCCCcHHHHHHhe
Confidence 011355677777777888888888888
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
..++..|+||||+++ +|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~ 166 (292)
T cd06658 89 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA 166 (292)
T ss_pred ecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchh
Confidence 888889999999986 66666543 358999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.............|+..|+|||.+.+..++.++|+||+||++|||++|..||.+.+....+..+.......
T Consensus 167 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 237 (292)
T cd06658 167 QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR--------- 237 (292)
T ss_pred hcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc---------
Confidence 65433333344578999999999988888889999999999999999999998876655554443221110
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.......+..+.+||.+||..||.+|||++++++||||....+.
T Consensus 238 --------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 238 --------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred --------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 01112567889999999999999999999999999999876544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=346.88 Aligned_cols=278 Identities=36% Similarity=0.599 Sum_probs=212.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
-++|++++.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l------------------------- 68 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLL------------------------- 68 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHH-------------------------
Confidence 4679999999999999999999999999999998864321 11112334444444
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
+.++||||++++++
T Consensus 69 ------------------------------------------------------------------~~l~h~~iv~~~~~ 82 (343)
T cd07880 69 ------------------------------------------------------------------KHMKHENVIGLLDV 82 (343)
T ss_pred ------------------------------------------------------------------HhcCCCCccceeee
Confidence 44455555555544
Q ss_pred EeeCc------eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 249 IHTEK------CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 249 ~~~~~------~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
+..+. ..++||||++++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 83 FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ecCCccccccceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEe
Confidence 44322 3689999998888877764 458999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|||++...... .....+++.|+|||.+.+ ...+.++|+||+||++|+|++|.+||.+.+.......+....+.++.
T Consensus 161 dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 161 DFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred ecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 99999765322 233467899999999876 34667789999999999999999999998888888888888888777
Q ss_pred hhhhhccccc-------CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 402 ELKSKLEFCI-------TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 402 ~~~~~~~~~~-------~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
++...+.... .+.... ..... ....+++++.++|.+||..||.+|||+.+++.||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRK-KDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCc-chHHH-hccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 6654332110 011100 11111 12367889999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=347.26 Aligned_cols=283 Identities=39% Similarity=0.652 Sum_probs=221.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++.+.||+|+||.||+|.+..+|+.||||++........
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~----------------------------------- 48 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT----------------------------------- 48 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcch-----------------------------------
Confidence 345789999999999999999999998999999998753211000
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
....+.+|+.+++++ +||||++++
T Consensus 49 -------------------------------------------------------~~~~~~~E~~~l~~l~~h~ni~~~~ 73 (337)
T cd07852 49 -------------------------------------------------------DAQRTFREIMFLQELGDHPNIVKLL 73 (337)
T ss_pred -------------------------------------------------------hhhhhhHHHHHHHHhcCCCCcccee
Confidence 011344678888888 888888888
Q ss_pred eeEeeC--ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 247 DIIHTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 247 ~~~~~~--~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+++... ...|+||||++++|..++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+||
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~ 151 (337)
T cd07852 74 NVIKAENDKDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADF 151 (337)
T ss_pred eeeccCCCceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeec
Confidence 877543 468999999999998888754 6889999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC-----ccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 325 GLARAKSVPT-----KTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 325 Gla~~~~~~~-----~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
|+++...... .......||..|+|||.+.+ .....++|+|||||++|+|++|++||.+....+....+....+.
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 9997654322 12234568999999998765 34567889999999999999999999998888888888888887
Q ss_pred CChhhhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 399 PPDELKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 399 ~p~~~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
++.+.+..+... ..+.. .........+ .++.++.+||.+||+.||++|||+.++++||||+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSR-PRKPLDELLP-KASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccc-cccchhhhcc-CCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 776543322100 00000 0011122233 3789999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=334.52 Aligned_cols=262 Identities=24% Similarity=0.438 Sum_probs=206.5
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+..+.||+|+||.||+|++..+++.||+|.+.........
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~-------------------------------------- 42 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSE-------------------------------------- 42 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchh--------------------------------------
Confidence 488889999999999999999999999999998653221110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.......+.+|+.+++.++||||+++++++..
T Consensus 43 ------------------------------------------------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 74 (268)
T cd06630 43 ------------------------------------------------QEEVVEALRKEIRLMARLNHPHIIRMLGATCE 74 (268)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence 00011256678888888889999999999988
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-CEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-ELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkL~DFGla~~ 329 (516)
.+..++||||+.+ +|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++..
T Consensus 75 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 75 DSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred CCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 8999999999995 777777653 4689999999999999999999999999999999999998776 599999999876
Q ss_pred cCCCCc----cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 330 KSVPTK----TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 330 ~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
...... ......||..|+|||.+.+..+..++|+||+||++|+|++|..||...........+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-------- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc--------
Confidence 543211 11234678899999999888888899999999999999999999975443332222221110
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
.......|..+++++.+++.+||..||++|||+.++++||||.
T Consensus 226 -------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 226 -------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0001123346789999999999999999999999999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.64 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=209.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
..|.+.+.||+|+||+||+|.+..+|+.||+|.+........
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~-------------------------------------- 56 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-------------------------------------- 56 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcH--------------------------------------
Confidence 459999999999999999999998999999998854321110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 57 ---------------------------------------------------~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 57 ---------------------------------------------------EKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 00124567888899999999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.++..|+||||+.|++.+++......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 86 REHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred eCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence 99999999999999988888766667999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
... ....+++.|+|||++. ...+..++|+|||||++|||++|.+||.+.+.......+.. +.++
T Consensus 166 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~------- 232 (307)
T cd06607 166 SPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSP------- 232 (307)
T ss_pred CCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc--CCCC-------
Confidence 322 2346788999999874 34567789999999999999999999987665544333321 0100
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...+..++.++.+||.+||..||++|||+.+++.||||....
T Consensus 233 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 233 ---------------TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred ---------------CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 011224678899999999999999999999999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.53 Aligned_cols=262 Identities=25% Similarity=0.351 Sum_probs=211.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||.||+|++..+++.||||.+.......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~--------------------------------------- 41 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLIL--------------------------------------- 41 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhh---------------------------------------
Confidence 47999999999999999999999999999999876432100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.+++.++||||+++++.+.
T Consensus 42 --------------------------------------------------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 71 (305)
T cd05609 42 --------------------------------------------------RNQIQQVFVERDILTFAENPFVVSMFCSFE 71 (305)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHHhCCCCCeeeeEEEEe
Confidence 001124567888999999999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.++++++||||++| +|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 72 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 72 TKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred cCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999985 788887664 4689999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCc---------------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Q psy12305 330 KSVPTK---------------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS 394 (516)
Q Consensus 330 ~~~~~~---------------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~ 394 (516)
...... ......|+..|+|||.+.+..+..++|+|||||++|||++|..||.+.+..+.+..+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~ 230 (305)
T cd05609 151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 230 (305)
T ss_pred cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 211000 01123568899999999888888999999999999999999999998776665555433
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC---HHHHHcCCCCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS---AANAMRHPYFNSLGP 465 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t---a~e~l~Hp~f~~~~~ 465 (516)
.....|. .+..++.++.+||.+||+.||++||| +.++++||||...+.
T Consensus 231 ~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~ 281 (305)
T cd05609 231 DDIEWPE-----------------------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW 281 (305)
T ss_pred cccCCCC-----------------------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence 2111110 11256889999999999999999998 799999999977543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=352.29 Aligned_cols=208 Identities=22% Similarity=0.349 Sum_probs=168.8
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------------------------
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS----------------------------- 274 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~----------------------------- 274 (516)
.+.+|+.+|+.+ +||||+++++++......++|||||+ |+|.+++....
T Consensus 84 ~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (375)
T cd05104 84 ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCD 163 (375)
T ss_pred HHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccch
Confidence 567899999999 89999999999999999999999999 58888876432
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCC
Q psy12305 275 ---------------------------------------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309 (516)
Q Consensus 275 ---------------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~ 309 (516)
..+++..+..++.||+.||+|||++||+||||||+
T Consensus 164 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 243 (375)
T cd05104 164 SLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAAR 243 (375)
T ss_pred hhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchh
Confidence 24778889999999999999999999999999999
Q ss_pred CEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHH
Q psy12305 310 NLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIE 386 (516)
Q Consensus 310 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~ 386 (516)
|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|+|||||++|||++ |..||.+....
T Consensus 244 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~ 323 (375)
T cd05104 244 NILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD 323 (375)
T ss_pred hEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch
Confidence 99999999999999999976543221 1112334677999999998888999999999999999998 89999876544
Q ss_pred HHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 387 DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 387 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.....+... ......|...+.++.+||.+||+.||++|||+.++++.
T Consensus 324 ~~~~~~~~~------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 324 SKFYKMIKE------------------------GYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHh------------------------CccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 333322210 01111233567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=331.90 Aligned_cols=258 Identities=26% Similarity=0.408 Sum_probs=207.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||+|+||.||+|.+ .+|+.||||.+.........
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~-------------------------------------- 41 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLA-------------------------------------- 41 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhh--------------------------------------
Confidence 478899999999999999987 48899999988653211100
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.......+.+|+.+++.++|+||+++++++..
T Consensus 42 ------------------------------------------------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (265)
T cd06631 42 ------------------------------------------------AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73 (265)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence 00011256789999999999999999999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
....++||||+++ +|.+++.+. ..+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 74 DNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred CCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999985 788887654 45899999999999999999999999999999999999999999999999998754
Q ss_pred CCC------CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 331 SVP------TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 331 ~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
... ........|+..|+|||.+.+..+...+|+|||||++|+|++|..||...+.......+....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 227 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----- 227 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC-----
Confidence 211 111233467999999999988888889999999999999999999998755444333332211111
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...+..++.++.+||++||..||++|||+.++++||||
T Consensus 228 ------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 228 ------------------PRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ------------------CCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 11234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=335.28 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=199.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|.+..+++.||+|++...... .
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~----------------------------------- 46 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE--E----------------------------------- 46 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh--H-----------------------------------
Confidence 457899999999999999999999989999999988653221 1
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
..+.+|+.+++++ +||||+++++
T Consensus 47 --------------------------------------------------------~~~~~e~~~l~~~~~h~~i~~~~~ 70 (275)
T cd06608 47 --------------------------------------------------------EEIKEEYNILRKYSNHPNIATFYG 70 (275)
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhcCCCChheEEE
Confidence 1344566666665 4666666666
Q ss_pred eEeeC------ceeeEeeehhhc-hHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC
Q psy12305 248 IIHTE------KCLTLVFEYLEK-DLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317 (516)
Q Consensus 248 ~~~~~------~~~~lV~E~~~g-~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 317 (516)
++... ..+|+||||+++ +|.+++... +..+++..++.++.|++.||.|||++|++|+||+|+||+++.++
T Consensus 71 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~ 150 (275)
T cd06608 71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA 150 (275)
T ss_pred EEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC
Confidence 66543 358999999995 677666542 46799999999999999999999999999999999999999999
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCC-----CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-----TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLI 392 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i 392 (516)
.+||+|||++..............|++.|+|||++.+. .+..++|+|||||++|+|++|.+||........+..+
T Consensus 151 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 230 (275)
T cd06608 151 EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230 (275)
T ss_pred eEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh
Confidence 99999999987654433344456789999999987542 3456789999999999999999999765544444333
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
... ++. ....+..++.++.+||.+||..||++|||++++++|||+
T Consensus 231 ~~~---~~~--------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 231 PRN---PPP--------------------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcc---CCC--------------------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 211 100 111223467899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.21 Aligned_cols=280 Identities=36% Similarity=0.612 Sum_probs=221.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||.||+|++..+|+.||||++.......
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 50 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTP------------------------------------- 50 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccccc-------------------------------------
Confidence 3467999999999999999999999999999999875432111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+++.++||||++++++
T Consensus 51 -----------------------------------------------------~~~~~~~~E~~~l~~l~hpniv~~~~~ 77 (328)
T cd07856 51 -----------------------------------------------------VLAKRTYRELKLLKHLRHENIISLSDI 77 (328)
T ss_pred -----------------------------------------------------chhHHHHHHHHHHHhcCCCCeeeEeee
Confidence 011244567778888888888888887
Q ss_pred Eee-CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHT-EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~-~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
|.. ....|+||||++++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 78 FISPLEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred EecCCCcEEEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccc
Confidence 765 457899999999888877764 35888999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
..... ......+++.|+|||.+.+ ..+..++|+||+||++|+|++|.+||++.........+...+|.+|.++...
T Consensus 156 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 156 RIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 75432 2233467889999998765 4567888999999999999999999999888888888888999998877643
Q ss_pred cccccCC----CCC--CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 LEFCITP----VYP--SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~~~~~~~----~~~--~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
....... ... ......... ..+++++.++|.+||+.||++|||+++++.||||....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHc-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 2111000 000 000111111 25778999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=337.86 Aligned_cols=203 Identities=20% Similarity=0.218 Sum_probs=165.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEee----CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-C
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHT----EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-R 299 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~ 299 (516)
.+.+|+.+|++++||||+++++++.+ ...+++||||+++ +|.+++... ..+++.....++.|++.||.|||+ .
T Consensus 64 ~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~ 142 (283)
T PHA02988 64 ITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYT 142 (283)
T ss_pred HHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcC
Confidence 44567777777777777777777755 3468999999995 788888764 468999999999999999999998 4
Q ss_pred CcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHHcCC
Q psy12305 300 RILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMSSGR 377 (516)
Q Consensus 300 ~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~elltG~ 377 (516)
+++||||||+|||++.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|+|||||++|||++|.
T Consensus 143 ~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~ 219 (283)
T PHA02988 143 NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219 (283)
T ss_pred CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCC
Confidence 99999999999999999999999999998654322 23567999999999876 56788999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 378 PLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 378 ~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.||.+.+..+....+..... ....|...++.+.+|+.+||+.||++|||++++++
T Consensus 220 ~Pf~~~~~~~~~~~i~~~~~------------------------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 220 IPFENLTTKEIYDLIINKNN------------------------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCCCCCCHHHHHHHHHhcCC------------------------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 99998776666555533211 11123367889999999999999999999999974
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=336.05 Aligned_cols=209 Identities=23% Similarity=0.396 Sum_probs=167.0
Q ss_pred HHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCE
Q psy12305 233 LLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311 (516)
Q Consensus 233 il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NI 311 (516)
++...+||||+.+++++..++..++||||+.+ +|..++... +.+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Ni 128 (279)
T cd05633 50 LVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANI 128 (279)
T ss_pred HHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHE
Confidence 33445799999999999999999999999995 777777654 4599999999999999999999999999999999999
Q ss_pred EEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHH
Q psy12305 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELR 390 (516)
Q Consensus 312 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~ 390 (516)
|++.++.++|+|||++...... ......||+.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.......
T Consensus 129 l~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~- 205 (279)
T cd05633 129 LLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH- 205 (279)
T ss_pred EECCCCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-
Confidence 9999999999999998754322 2233578999999999864 45677889999999999999999999764322111
Q ss_pred HHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCC
Q psy12305 391 LICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGP 465 (516)
Q Consensus 391 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~ 465 (516)
.+.... .......|+.+++++.+||.+||..||.+|+ |+.++++||||+....
T Consensus 206 ~~~~~~----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~ 263 (279)
T cd05633 206 EIDRMT----------------------LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDW 263 (279)
T ss_pred HHHHHh----------------------hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCH
Confidence 111100 0011123456789999999999999999999 6999999999998664
Q ss_pred Cc
Q psy12305 466 QV 467 (516)
Q Consensus 466 ~~ 467 (516)
..
T Consensus 264 ~~ 265 (279)
T cd05633 264 QQ 265 (279)
T ss_pred hH
Confidence 43
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=344.59 Aligned_cols=252 Identities=21% Similarity=0.313 Sum_probs=197.6
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcE----EEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNL----VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~----vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
...+|++++.||+|+||+||+|++..+|.. ||||.+.........
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~------------------------------- 53 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN------------------------------- 53 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHH-------------------------------
Confidence 345799999999999999999998777664 899987543221111
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
..+.+|+.+++.++||||++
T Consensus 54 ------------------------------------------------------------~~~~~e~~~l~~l~h~niv~ 73 (316)
T cd05108 54 ------------------------------------------------------------KEILDEAYVMASVDNPHVCR 73 (316)
T ss_pred ------------------------------------------------------------HHHHHHHHHHHhCCCCCCCe
Confidence 13455666777777777777
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+++++... ..++|+||+. |+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 74 ~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 74 LLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred EEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcc
Confidence 77766654 4678999988 689999988777789999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccc--cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 324 FGLARAKSVPTKTF--SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 324 FGla~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
||+++......... ....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+.. .+....
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~---- 227 (316)
T cd05108 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKG---- 227 (316)
T ss_pred ccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCC----
Confidence 99998765332221 22234678999999988888899999999999999998 99999876654432 222211
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.....+..++.++.+++.+||..||++|||+.+++.+
T Consensus 228 --------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 228 --------------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred --------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111233567889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=332.36 Aligned_cols=258 Identities=24% Similarity=0.383 Sum_probs=203.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|++..+|+.||||.+.........
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~------------------------------------- 44 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET------------------------------------- 44 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCccc-------------------------------------
Confidence 4699999999999999999999999999999988643211110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.+++.++||||+++++++.
T Consensus 45 --------------------------------------------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 74 (265)
T cd06652 45 --------------------------------------------------SKEVNALECEIQLLKNLLHERIVQYYGCLR 74 (265)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHHhcCCCCeeeEEeEec
Confidence 001124566888888888888888888776
Q ss_pred eC--ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 251 TE--KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 251 ~~--~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+. ..+++||||+++ +|.+++... ..+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 75 DPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred cCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 53 468899999984 788887654 45889999999999999999999999999999999999999999999999998
Q ss_pred cccCCC---CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVP---TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+..... ........|+..|+|||++.+.....++|+|||||++|+|++|+.||...........+. ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~----- 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA---TQP----- 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh---cCC-----
Confidence 754321 112233467899999999988878888999999999999999999997654443332221 111
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
.....|...+..+.++|.+||. +|.+|||++++++|||++
T Consensus 226 ----------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 ----------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 0112344678889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=333.64 Aligned_cols=206 Identities=18% Similarity=0.231 Sum_probs=171.8
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.++++++||||+++++++..++..++||||+++ +|.+++......+++..++.++.||+.||+|||++|++||
T Consensus 52 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~ 131 (266)
T cd05064 52 GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHK 131 (266)
T ss_pred HHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 567899999999999999999999999999999999995 7777887766679999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPG 382 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~ 382 (516)
||||+|||++.++.+||+|||.+........ ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+
T Consensus 132 dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 132 GLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 9999999999999999999998765322111 1112234678999999988888889999999999999775 9999998
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+..+....+.... ....|..++..+.+++.+||+.||++|||++++++
T Consensus 212 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 212 MSGQDVIKAVEDGF-------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCHHHHHHHHHCCC-------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 77766555543211 11124467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.63 Aligned_cols=259 Identities=24% Similarity=0.306 Sum_probs=207.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||.|+||+||+|.+..++..||+|++........
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 42 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS-------------------------------------- 42 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchH--------------------------------------
Confidence 479999999999999999999988999999998754321111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+++.++|+||+++++.+.
T Consensus 43 -----------------------------------------------------~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (267)
T cd06610 43 -----------------------------------------------------VDELRKEVQAMSQCNHPNVVKYYTSFV 69 (267)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhcCCCCEEEEEEEEe
Confidence 124567788888888888888888888
Q ss_pred eCceeeEeeehhhc-hHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDC--SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.++..|+|||++++ +|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 70 ~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 70 VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred eCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 88999999999985 788887653 246899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcc----ccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTKT----FSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~~----~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
......... ....+|+..|+|||++... ....++|+|||||++|+|++|+.||...+....+..+... .+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~ 226 (267)
T cd06610 150 ASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPS 226 (267)
T ss_pred HHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCC
Confidence 765533222 1334689999999998776 6778899999999999999999999876554443333221 1100
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
+ .. ......+++++.+|+.+||..||++|||++++++||||
T Consensus 227 ~------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 227 L------------ET-----GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred c------------CC-----ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0 00 00112667899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=333.17 Aligned_cols=212 Identities=24% Similarity=0.373 Sum_probs=168.4
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNIL--SMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l--~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+++.++|+||+++++++..++..++||||+. ++|..++......+ ++..+..++.||+.||+|||++||+
T Consensus 51 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~ 130 (268)
T cd06624 51 PLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130 (268)
T ss_pred HHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 45678888888888888899998888899999999998 58888887654445 8888999999999999999999999
Q ss_pred eeecCCCCEEEcc-CCCEEEeeeccccccCCCCccccCCcccccccchhhccCCC--CCCceeeehHHHHHHHHHcCCCC
Q psy12305 303 HRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST--EYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 303 HrDlKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~d~~SlGvil~elltG~~p 379 (516)
||||||+||+++. ++.++|+|||++..............|++.|+|||.+.+.. +..++|+||+||++|+|++|..|
T Consensus 131 h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p 210 (268)
T cd06624 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210 (268)
T ss_pred ecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999976 67999999999876543333333446789999999986543 66789999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 380 FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
|............... .......|..+++++.+|+.+||..+|.+|||+.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 211 FIELGEPQAAMFKVGM-----------------------FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred CccccChhhhHhhhhh-----------------------hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 9753321111100000 00111234467889999999999999999999999999999
Q ss_pred C
Q psy12305 460 F 460 (516)
Q Consensus 460 f 460 (516)
|
T Consensus 268 ~ 268 (268)
T cd06624 268 L 268 (268)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=332.91 Aligned_cols=276 Identities=41% Similarity=0.713 Sum_probs=212.9
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|++.+.||+|+||.||+|+++.+++.||||.+........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~---------------------------------------- 40 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG---------------------------------------- 40 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccch----------------------------------------
Confidence 6789999999999999999988899999999865322110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc---cccceeeEeeeE
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL---RHANIVTLHDII 249 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~ 249 (516)
....+.+|+.+++++ +||||+++++++
T Consensus 41 --------------------------------------------------~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~ 70 (287)
T cd07838 41 --------------------------------------------------IPLSTLREIALLKQLESFEHPNIVRLLDVC 70 (287)
T ss_pred --------------------------------------------------hhhhHHHHHHHHHHhhccCCCCcceEEEEE
Confidence 011233455555444 588888888888
Q ss_pred eeCce-----eeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 250 HTEKC-----LTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 250 ~~~~~-----~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
..... ++++|||+.++|.+++.... ..+++..++.++.||+.||.|||+++++|+||||+||+++.++.+||+|
T Consensus 71 ~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~d 150 (287)
T cd07838 71 HGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIAD 150 (287)
T ss_pred eeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEec
Confidence 77665 99999999998888887643 3589999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
||++........ .....++..|+|||++.+..+..++|+||+||++|+|++|.+||.+.+..+.+..+....+.+....
T Consensus 151 fg~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 151 FGLARIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred cCcceeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 999977543322 2334578899999999988888899999999999999999999999988888888877665544322
Q ss_pred hhhcccccCCCCCCc--hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 404 KSKLEFCITPVYPSE--SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~--~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
+........+.++.. ....... ..+++.+.+||.+||+.||.+||+++++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFV-PEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred cCCCcccchhhcccccccchhhhh-hhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 211110000000000 0011111 2457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=333.05 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=206.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++.+.||.|+||.||+|++..+++.||+|.+........
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------------------------------------- 41 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK--------------------------------------- 41 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcch---------------------------------------
Confidence 48999999999999999999998999999999875321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.++++++||||+++++.+.+
T Consensus 42 --------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 71 (258)
T cd05578 42 --------------------------------------------------GSVRNVLNERRILQELNHPFLVNLWYSFQD 71 (258)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHhCCCCChHHHHHhhcC
Confidence 011245667777888888888888888888
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
+...++|+||+.+ +|..++... ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 72 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~ 150 (258)
T cd05578 72 EENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV 150 (258)
T ss_pred CCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence 8899999999985 788877664 56999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHhcCCCChhhhhhcc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI--EDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~--~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.... ......|+..|+|||.+.+.....++|+||+||++|+|++|..||...+. .+.+.....
T Consensus 151 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 215 (258)
T cd05578 151 TPDT-LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-------------- 215 (258)
T ss_pred CCCc-cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc--------------
Confidence 4332 23345678899999999888888999999999999999999999987653 222111110
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH--HHHHcCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA--ANAMRHPYF 460 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta--~e~l~Hp~f 460 (516)
......|...+.++.++|.+||..||.+||++ .++++||||
T Consensus 216 -----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 216 -----------TADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------cccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 01122344678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=352.39 Aligned_cols=204 Identities=22% Similarity=0.340 Sum_probs=175.5
Q ss_pred HHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecC
Q psy12305 229 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307 (516)
Q Consensus 229 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlK 307 (516)
.+|.-|++|+||||+.+.++|....++|||||||. |.|...++. ++.++......|..+|+.|+.|||.+.|||||||
T Consensus 161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLK 239 (904)
T KOG4721|consen 161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLK 239 (904)
T ss_pred hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccC
Confidence 46778888899999999999999999999999999 678887776 4568888888999999999999999999999999
Q ss_pred CCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHH
Q psy12305 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIED 387 (516)
Q Consensus 308 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~ 387 (516)
.-||||+.+..|||+|||.++..... .+...++||..|||||+|...+...+.|+|||||+|||||||..||..-+..
T Consensus 240 SPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss- 317 (904)
T KOG4721|consen 240 SPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS- 317 (904)
T ss_pred CCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-
Confidence 99999999999999999999876543 5566789999999999999999999999999999999999999999764322
Q ss_pred HHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCC
Q psy12305 388 ELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458 (516)
Q Consensus 388 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp 458 (516)
+.|.. .| ...+....|..+++-++=||+.||+-.|..||++.++|.|=
T Consensus 318 --AIIwG-VG--------------------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 318 --AIIWG-VG--------------------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred --eeEEe-cc--------------------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 11211 11 13455667788899999999999999999999999999884
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=333.69 Aligned_cols=212 Identities=25% Similarity=0.423 Sum_probs=169.4
Q ss_pred HHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCC
Q psy12305 231 VSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309 (516)
Q Consensus 231 i~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~ 309 (516)
+.+++...||||+++++++..++..|+||||+.| +|..++.. ...+++..++.++.|++.||.|||+.+|+||||||+
T Consensus 48 ~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ 126 (278)
T cd05606 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPA 126 (278)
T ss_pred HHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHH
Confidence 3445556899999999999999999999999985 67666654 456999999999999999999999999999999999
Q ss_pred CEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH
Q psy12305 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE 388 (516)
Q Consensus 310 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~ 388 (516)
||+++.++.+||+|||++...... .....+||..|+|||++.+. .++.++|+||+||++|+|++|..||.+......
T Consensus 127 nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~ 204 (278)
T cd05606 127 NILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204 (278)
T ss_pred HEEECCCCCEEEccCcCccccCcc--CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch
Confidence 999999999999999998754322 22345789999999998754 467788999999999999999999976532211
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCC
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~ 463 (516)
........ ......|...+.++.+++.+||..||.+|| ++.++++||||...
T Consensus 205 ~~~~~~~~-----------------------~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 205 HEIDRMTL-----------------------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHHhh-----------------------ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 11110000 011123346789999999999999999999 99999999999887
Q ss_pred CCCcc
Q psy12305 464 GPQVH 468 (516)
Q Consensus 464 ~~~~~ 468 (516)
.+...
T Consensus 262 ~~~~~ 266 (278)
T cd05606 262 DWQMV 266 (278)
T ss_pred CchHh
Confidence 65443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=335.77 Aligned_cols=269 Identities=29% Similarity=0.430 Sum_probs=203.0
Q ss_pred ceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-----c---cceeeEeeeEee----CceeeEeee
Q psy12305 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-----H---ANIVTLHDIIHT----EKCLTLVFE 260 (516)
Q Consensus 193 G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-----H---pnIv~l~~~~~~----~~~~~lV~E 260 (516)
|.|++||+|.+..+.+.||+|+++... ...+.++.||.+|++++ | ..||+|++.|.. +.++|+|+|
T Consensus 89 GHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfE 166 (590)
T KOG1290|consen 89 GHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFE 166 (590)
T ss_pred cccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEeh
Confidence 445555555555555555555554332 22336788999999983 3 369999999974 569999999
Q ss_pred hhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEc------------------------
Q psy12305 261 YLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLIN------------------------ 314 (516)
Q Consensus 261 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~------------------------ 314 (516)
+++.+|+.++.... +.++...++.|++||+.||.|||. .||||.||||+|||+.
T Consensus 167 vLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s 246 (590)
T KOG1290|consen 167 VLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMS 246 (590)
T ss_pred hhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCC
Confidence 99999999998754 569999999999999999999995 6999999999999980
Q ss_pred --------------------------------------------------------------------------------
Q psy12305 315 -------------------------------------------------------------------------------- 314 (516)
Q Consensus 315 -------------------------------------------------------------------------------- 314 (516)
T Consensus 247 ~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~ 326 (590)
T KOG1290|consen 247 PSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSN 326 (590)
T ss_pred cccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccc
Confidence
Q ss_pred ----------c----------------------------------------------------CCCEEEeeeccccccCC
Q psy12305 315 ----------E----------------------------------------------------RGELKLADFGLARAKSV 332 (516)
Q Consensus 315 ----------~----------------------------------------------------~~~vkL~DFGla~~~~~ 332 (516)
. +-++||+|||-|+...
T Consensus 327 ~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~- 405 (590)
T KOG1290|consen 327 ENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH- 405 (590)
T ss_pred cccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh-
Confidence 0 0036888888887643
Q ss_pred CCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCC------CCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 333 PTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG------STIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 333 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~------~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
..++..+.|..|+|||+++|..|...+|+||++|++|||+||..+|.. ..+++.++.|.+++|..|..+.-.
T Consensus 406 --khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~ 483 (590)
T KOG1290|consen 406 --KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALG 483 (590)
T ss_pred --hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhc
Confidence 345566779999999999999999999999999999999999999953 356889999999999999876421
Q ss_pred ----ccc-ccCCCCCCch-----------hhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 407 ----LEF-CITPVYPSES-----------KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 407 ----~~~-~~~~~~~~~~-----------~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.+| .......... .....++.....++.|||.-||+++|++|+||.++|+|||+++....
T Consensus 484 Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 484 GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence 011 1100000000 01122333445678999999999999999999999999999976543
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=330.05 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=205.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||.|+||.||+|.+..+|+.||+|.+........
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~--------------------------------------- 41 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK--------------------------------------- 41 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHH---------------------------------------
Confidence 58999999999999999999999999999998864321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+++.++||||+++++++..
T Consensus 42 ---------------------------------------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (265)
T cd08217 42 ---------------------------------------------------EKQQLVSEVNILRELKHPNIVRYYDRIID 70 (265)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhcCCCccceeeeeeec
Confidence 01245567777777778888887776643
Q ss_pred --CceeeEeeehhh-chHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHh-----hCCcEeeecCCCCEEEccCCCEE
Q psy12305 252 --EKCLTLVFEYLE-KDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCH-----SRRILHRDLKPQNLLINERGELK 320 (516)
Q Consensus 252 --~~~~~lV~E~~~-g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH-----~~~ivHrDlKp~NILl~~~~~vk 320 (516)
+...|++|||++ ++|.+++... ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+|
T Consensus 71 ~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~k 150 (265)
T cd08217 71 RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVK 150 (265)
T ss_pred CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEE
Confidence 456899999998 4888887653 467999999999999999999999 89999999999999999999999
Q ss_pred EeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 321 LADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 321 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
|+|||++..............+++.|+|||++.+...+.++|+||||+++|+|++|..||...+.......+....
T Consensus 151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---- 226 (265)
T cd08217 151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK---- 226 (265)
T ss_pred EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC----
Confidence 9999999876544432344578999999999988777888999999999999999999998876544433332110
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
....+...+.++.+|+.+||..||++|||+.++++|||+
T Consensus 227 ---------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 227 ---------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 011234678899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=327.87 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=208.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++++.||+|+||.||+|.+..+++.||||.+.......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK---------------------------------------- 40 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc----------------------------------------
Confidence 5899999999999999999999999999999986432110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++||||+++++.+..
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 70 (256)
T cd08220 41 --------------------------------------------------DERLAAQNECQVLKLLSHPNIIEYYENFLE 70 (256)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhhCCCCchhheeeeEec
Confidence 011246678888888899999999999988
Q ss_pred CceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-CEEEeeecccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-ELKLADFGLAR 328 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkL~DFGla~ 328 (516)
++..++||||+++ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (256)
T cd08220 71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150 (256)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCce
Confidence 8999999999985 888888764 34589999999999999999999999999999999999998654 58999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
...... ......|+..|+|||.+.+.....++|+||+||++|+|++|..||.+.+.......+....
T Consensus 151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~------------ 217 (256)
T cd08220 151 ILSSKS-KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT------------ 217 (256)
T ss_pred ecCCCc-cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC------------
Confidence 664332 2233567899999999988778888999999999999999999998876655444442211
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
....+..++.++.+++.+||..||++|||+.++++||||
T Consensus 218 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 -------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 111234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=340.33 Aligned_cols=258 Identities=26% Similarity=0.410 Sum_probs=209.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|.+++.||+|+||+||+|.+..+++.||+|.+.......
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-------------------------------------- 59 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-------------------------------------- 59 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH--------------------------------------
Confidence 467999999999999999999998899999999875321110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+++.++||||+++++++
T Consensus 60 ------------------------------------------------------~~~~~~e~~~l~~l~hp~i~~~~~~~ 85 (293)
T cd06647 60 ------------------------------------------------------KELIINEILVMRENKHPNIVNYLDSY 85 (293)
T ss_pred ------------------------------------------------------HHHHHHHHHHHhhcCCCCeeehhhee
Confidence 12456677788888888888888888
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
...+..|+|+||++ ++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.
T Consensus 86 ~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 86 LVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred eeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 88888999999998 4888887653 48899999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.............|++.|+|||.+.+..+...+|+|||||++|+|++|..||...+..+.+..+.. .+.
T Consensus 164 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~---------- 232 (293)
T cd06647 164 QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGT---------- 232 (293)
T ss_pred cccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCC----------
Confidence 654433333445688999999999887778889999999999999999999987655433222211 000
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....+..++..+.+||.+||..||++||++.+++.||||....
T Consensus 233 ------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 233 ------------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 01112335678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=338.11 Aligned_cols=261 Identities=18% Similarity=0.329 Sum_probs=202.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+.++.||+|+||.||++++..+|+.||||.+........
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~-------------------------------------- 45 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-------------------------------------- 45 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHH--------------------------------------
Confidence 467888999999999999999999999999998764321111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~ 249 (516)
...+.+|+.++.++. ||||+++++++
T Consensus 46 -----------------------------------------------------~~~~~~e~~~l~~~~~~~~iv~~~~~~ 72 (288)
T cd06616 46 -----------------------------------------------------QKRLLMDLDVVMRSSDCPYIVKFYGAL 72 (288)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhcCCCCEeeeeeEE
Confidence 124556777777775 88888888888
Q ss_pred eeCceeeEeeehhhchHHHH---HHh-cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 250 HTEKCLTLVFEYLEKDLKRY---MDD-CSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~---l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
..+...+++|||+.+++..+ +.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 73 ~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 73 FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred ecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeec
Confidence 88888999999998654443 222 23569999999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCC---CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC-CCC
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGS---TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG-PPP 400 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~-~~p 400 (516)
|+++...... ......||+.|+|||++.+. .+..++|+||+||++|+|++|++||.... .....+..... .+|
T Consensus 153 g~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~ 229 (288)
T cd06616 153 GISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPP 229 (288)
T ss_pred chhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCC
Confidence 9997654322 22334678999999998765 56778999999999999999999997643 12222222211 111
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
. .....+..++.++.+||.+||+.||++|||++++++||||....
T Consensus 230 ~-------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 230 I-------------------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred c-------------------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 0 00111235788999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=340.81 Aligned_cols=258 Identities=21% Similarity=0.363 Sum_probs=207.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
....|....+||+|+||.||+|++..+++.||||.+.......
T Consensus 19 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~------------------------------------- 61 (297)
T cd06659 19 PRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR------------------------------------- 61 (297)
T ss_pred chhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch-------------------------------------
Confidence 3344666778999999999999999899999999875422110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||+++++.
T Consensus 62 -------------------------------------------------------~~~~~~e~~~l~~l~hp~i~~~~~~ 86 (297)
T cd06659 62 -------------------------------------------------------RELLFNEVVIMRDYQHQNVVEMYKS 86 (297)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCchhhhhhh
Confidence 1245567777888888888888888
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..++..|+||||+++ +|..++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 87 ~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 87 YLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred eeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence 8888899999999995 66665543 45899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
.............+|+..|+|||++.+..+..++|+|||||++|||++|..||...+..+.+..+.. .++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~------ 235 (297)
T cd06659 165 AQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---SPPP------ 235 (297)
T ss_pred hhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---cCCC------
Confidence 7654333334456789999999999888888889999999999999999999987766555544321 1110
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....+..++.++.++|.+||+.||.+|||++++++||||...
T Consensus 236 --------------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 236 --------------KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred --------------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 011123567889999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.79 Aligned_cols=274 Identities=37% Similarity=0.655 Sum_probs=216.3
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|.+.+.||+|+||+||+|.+..+++.||||++.........
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~--------------------------------------- 41 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEE--------------------------------------- 41 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhH---------------------------------------
Confidence 67899999999999999999989999999988643221111
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeEee
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHT 251 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 251 (516)
....+|+..+++++ ||||+++++++..
T Consensus 42 ----------------------------------------------------~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 69 (283)
T cd07830 42 ----------------------------------------------------CMNLREVKSLRKLNEHPNIVKLKEVFRE 69 (283)
T ss_pred ----------------------------------------------------HHHHHHHHHHHhccCCCCchhHHHHhhc
Confidence 12234666666776 7777777777777
Q ss_pred CceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
++..|+||||+++++.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 70 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~ 149 (283)
T cd07830 70 NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI 149 (283)
T ss_pred CCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceec
Confidence 78899999999889988887654 56899999999999999999999999999999999999999999999999999765
Q ss_pred CCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
... .......++..|+|||++.+ .....++|+|||||++|||++|.+||++.+..+.+..+...++.++...+.....
T Consensus 150 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 150 RSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred cCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 432 22334567899999998754 3457789999999999999999999999999999999999888887665432110
Q ss_pred ---c---cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 ---C---ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ---~---~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
. ..+.... .......+ ..+.++.+||.+||+.||++|||++|++.||||
T Consensus 229 ~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 229 LASKLGFRFPQFAP-TSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hhcccccccccccc-ccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0011111 11112222 337899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=341.27 Aligned_cols=278 Identities=36% Similarity=0.569 Sum_probs=212.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCC--CcEEEEEEeecccccC-CcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLT--DNLVALKEIKLEHEEG-APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~--g~~vAvK~i~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
+|.+.+.||+|+||.||+|++..+ +..||||.+....... ..+.
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~--------------------------------- 47 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR--------------------------------- 47 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHH---------------------------------
Confidence 489999999999999999999888 8999999886432111 1122
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
+.+|+.+++++ +||||+++++
T Consensus 48 ----------------------------------------------------------~~~E~~~l~~l~~h~~iv~~~~ 69 (332)
T cd07857 48 ----------------------------------------------------------ALRELKLLRHFRGHKNITCLYD 69 (332)
T ss_pred ----------------------------------------------------------HHHHHHHHHHhcCCCChheeee
Confidence 33455555555 3555555555
Q ss_pred eEe----eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 248 IIH----TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 248 ~~~----~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
.+. ....+|+++||++++|...+... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 70 ~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~D 148 (332)
T cd07857 70 MDIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICD 148 (332)
T ss_pred eeeeccccCCcEEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCc
Confidence 432 12457899999999998888653 4689999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCc----cccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 324 FGLARAKSVPTK----TFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 324 FGla~~~~~~~~----~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
||+++....... ......||+.|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+.+....+..+...+|.
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 999976542211 1233578999999998765 45677889999999999999999999998888899999999998
Q ss_pred CChhhhhhccccc-------CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 399 PPDELKSKLEFCI-------TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 399 ~p~~~~~~~~~~~-------~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
++.+.+..+.... ....+. ..+....+ ..+.++.+|+.+||+.||.+|||+.+++.||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPK-KPFESIFP-NANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCC-cchHhhCC-CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 8876654321110 000000 11111122 467899999999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=334.25 Aligned_cols=257 Identities=24% Similarity=0.404 Sum_probs=209.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|...++||+|+||.||+|.+..+++.||||++.......
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---------------------------------------- 59 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---------------------------------------- 59 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhH----------------------------------------
Confidence 3555679999999999999999899999999875321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
...+.+|+.+++.++||||+++++++..
T Consensus 60 ----------------------------------------------------~~~~~~e~~~l~~~~h~~vv~~~~~~~~ 87 (285)
T cd06648 60 ----------------------------------------------------RELLFNEVVIMRDYQHPNIVEMYSSYLV 87 (285)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHcCCCChheEEEEEEc
Confidence 1135678888888888888999998888
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.+..++|+||+.+ +|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...
T Consensus 88 ~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 88 GDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred CCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 8999999999985 78877766 45899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
...........|++.|+|||.+.+..+..++|+||+||++|+|++|..||...+.......+.... ++
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~--~~---------- 233 (285)
T cd06648 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL--PP---------- 233 (285)
T ss_pred ccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC--CC----------
Confidence 433333344568999999999988888889999999999999999999998776655554443211 00
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
....+..++..+.+|+.+||..||++|||+.++++||||....+
T Consensus 234 -----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 234 -----------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred -----------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 00112247789999999999999999999999999999987553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=334.10 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=205.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+..+.||+|+||.||+|.+..+++.||+|.+........
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 42 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-------------------------------------- 42 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHH--------------------------------------
Confidence 468899999999999999999999999999998865422111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+++.++||||+++++.+.
T Consensus 43 -----------------------------------------------------~~~~~~e~~~l~~~~~~~i~~~~~~~~ 69 (265)
T cd06605 43 -----------------------------------------------------QKQILRELDILHKCNSPYIVGFYGAFY 69 (265)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHCCCCchhhhheeee
Confidence 124556777777788888888888888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.++..++|+||++ ++|.+++......+++..+..++.|++.||+|||+ .|++||||||+||+++.++.++|+|||.+.
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 70 NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred cCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccch
Confidence 8889999999999 58888887765779999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI--EDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~--~~~~~~i~~~~~~~p~~~~~~ 406 (516)
........ ...++..|+|||.+.+..+..++|+||+||++|+|++|..||..... ......+......++
T Consensus 150 ~~~~~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------ 221 (265)
T cd06605 150 QLVNSLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP------ 221 (265)
T ss_pred hhHHHHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC------
Confidence 65322211 25678999999999888888899999999999999999999975421 111111111111110
Q ss_pred cccccCCCCCCchhhhhcCCC-CCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPE-QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~-~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
...+. .++.++.+||.+||..||++|||+.+++.||||+.
T Consensus 222 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 222 ----------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred ----------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 00111 27889999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=326.14 Aligned_cols=286 Identities=32% Similarity=0.498 Sum_probs=228.8
Q ss_pred ccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 85 IGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 85 ~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..|....+|.-+..+|.|.= .|--|-|..+++.||+|++..... ....+++.||...|..+.|+||++++.+|.....
T Consensus 11 s~ftv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~ 89 (369)
T KOG0665|consen 11 STFTVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKT 89 (369)
T ss_pred cceeeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcccc
Confidence 34556678999999999998 888899999999999999876533 3334466777777777777777777766544321
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccccee
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 243 (516)
.
T Consensus 90 l------------------------------------------------------------------------------- 90 (369)
T KOG0665|consen 90 L------------------------------------------------------------------------------- 90 (369)
T ss_pred H-------------------------------------------------------------------------------
Confidence 0
Q ss_pred eEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 244 TLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 244 ~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
.....+|+||||+..+|.+.+.. .++-+.++.++.|++.|++|||+.||+||||||+||++..++.+||.|
T Consensus 91 ------~~~~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~d 161 (369)
T KOG0665|consen 91 ------EEFQEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILD 161 (369)
T ss_pred ------HHHHhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeecc
Confidence 01124789999999999888763 377788999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
||+|+..... ...+..+.|..|+|||++.+..+....|+||+||++.||++|...|+|.+..++..++.+.+|+|.+.+
T Consensus 162 fg~ar~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 162 FGLARTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred chhhcccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 9999876533 455667889999999999999888899999999999999999999999999999999999999999887
Q ss_pred hhhcccc------cCCCCCCchhhhhcCCC-----------CCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 404 KSKLEFC------ITPVYPSESKLQLLAPE-----------QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 404 ~~~~~~~------~~~~~~~~~~~~~~~p~-----------~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
...+.-. ..|.+.. ..+...+|+ .-+..++||+.+||..||++|++++++|+||||+
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhHHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 6543211 1222211 111122221 2345689999999999999999999999999997
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=327.34 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=207.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++.++||+|+||.||+|.+..+++.||+|.+.......
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~---------------------------------------- 40 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS---------------------------------------- 40 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchH----------------------------------------
Confidence 5899999999999999999999999999999875432111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+++.++||||+++++.+.+
T Consensus 41 ---------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 69 (255)
T cd08219 41 ---------------------------------------------------AVEDSRKEAVLLAKMKHPNIVAFKESFEA 69 (255)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhCCCCCcceEEEEEEE
Confidence 11245578888888999999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
++.+|+||||++ +++.+++.. .+..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++.
T Consensus 70 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 70 DGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred CCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCccee
Confidence 999999999998 588888765 345689999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
............|++.|+|||++.+..+..++|+||+||++|+|++|..||...+.......+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 216 (255)
T cd08219 150 LTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS------------- 216 (255)
T ss_pred ecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC-------------
Confidence 6544443445678999999999988888889999999999999999999998876655544442210
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|..++.++.+||.+||+.||++|||+.+++.-
T Consensus 217 ------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 217 ------------YKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------------CCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011234678899999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=313.71 Aligned_cols=258 Identities=22% Similarity=0.318 Sum_probs=200.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|||+.||++++..+++.||+|+|.... ....+.+++|++..++++||||++++++...+..
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~------- 92 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK------- 92 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc-------
Confidence 56999999999999999999999999999999998776 3445588999999999999999988775422210
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.
T Consensus 93 -------------------------------------------------------------------------------D 93 (302)
T KOG2345|consen 93 -------------------------------------------------------------------------------D 93 (302)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred eCceeeEeeehhh-chHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccCCCEEEeee
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
.....||+++|.. |+|++.+.. .+..+++.++..|+.+|++||++||+.. .+||||||.|||++..+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 2234789999987 788888765 3457999999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCC---------ccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q psy12305 325 GLARAKSVPT---------KTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLI 392 (516)
Q Consensus 325 Gla~~~~~~~---------~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i 392 (516)
|.++...... +......+|..|+|||.+. +...+.+.|+|||||+||+|+.|..||...
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~--------- 244 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI--------- 244 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH---------
Confidence 9987643221 1123345699999999984 456688999999999999999999999421
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|...-.+ .. ...........|+.+.+||..||+.||.+||++.+++.+
T Consensus 245 ~~~GgSlaLAv-------~n------~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 245 YQQGGSLALAV-------QN------AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred hhcCCeEEEee-------ec------cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 11011000000 00 011111112478999999999999999999999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=333.18 Aligned_cols=256 Identities=26% Similarity=0.415 Sum_probs=205.2
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|++++.||+|+||.||+|.+..+++.||||.+.........
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~-------------------------------------- 43 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV-------------------------------------- 43 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhH--------------------------------------
Confidence 488899999999999999999999999999988653221111
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc---ccceeeEeee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR---HANIVTLHDI 248 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~ 248 (516)
..+.+|+.+++.+. |||+++++++
T Consensus 44 -----------------------------------------------------~~~~~e~~~l~~l~~~~~~~vi~~~~~ 70 (277)
T cd06917 44 -----------------------------------------------------SDIQREVALLSQLRQSQPPNITKYYGS 70 (277)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhccCCCCCeeeEeee
Confidence 13456777777775 8999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..+...|+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus 71 ~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06917 71 YLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVA 148 (277)
T ss_pred eeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCce
Confidence 9888899999999985 77777754 36899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
..............|+..|+|||.+.+. .+...+|+|||||++|+|++|..||.+.........+... .++
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~--~~~------ 220 (277)
T cd06917 149 ALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS--KPP------ 220 (277)
T ss_pred eecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC--CCC------
Confidence 8765444444455789999999998653 4567899999999999999999999876543322211100 000
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.......+.++.+++.+||+.||++|||+.+++.||||+...
T Consensus 221 ----------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 221 ----------------RLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred ----------------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 011113678999999999999999999999999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=333.13 Aligned_cols=215 Identities=19% Similarity=0.334 Sum_probs=174.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------NILSMNNVKLFLFQLLRGLAY 295 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~y 295 (516)
.+.+|+.+++.++||||+++++++......|+||||+. |+|.+++.... ..++...+..++.||+.||.|
T Consensus 55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (288)
T cd05061 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 134 (288)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 45678888888999999999999988889999999998 68988886532 234667889999999999999
Q ss_pred HhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHH
Q psy12305 296 CHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEM 373 (516)
Q Consensus 296 LH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~el 373 (516)
||+++|+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||
T Consensus 135 lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el 214 (288)
T cd05061 135 LNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI 214 (288)
T ss_pred HHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999975432221 11223457789999999888888899999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH
Q psy12305 374 SS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452 (516)
Q Consensus 374 lt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~ 452 (516)
++ |..||.+....+....+.... ....+...++.+.+++.+||+.||++|||+.
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 269 (288)
T cd05061 215 TSLAEQPYQGLSNEQVLKFVMDGG-------------------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFL 269 (288)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCC-------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHH
Confidence 98 799998877666554442210 0112335678999999999999999999999
Q ss_pred HHHc------CCCCCCCCC
Q psy12305 453 NAMR------HPYFNSLGP 465 (516)
Q Consensus 453 e~l~------Hp~f~~~~~ 465 (516)
++++ ||||.++.+
T Consensus 270 ~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 270 EIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHhhcCCCCCCCCC
Confidence 9986 999988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=327.02 Aligned_cols=254 Identities=24% Similarity=0.440 Sum_probs=206.0
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||+|+||.||+|.+..+|..||+|.+........
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------------------------------------- 41 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK--------------------------------------- 41 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccch---------------------------------------
Confidence 58999999999999999999999999999998865321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+++.++|+||+++++.+..
T Consensus 42 ---------------------------------------------------~~~~~~~E~~~l~~~~h~~i~~~~~~~~~ 70 (257)
T cd08225 42 ---------------------------------------------------EKEASKKEVILLAKMKHPNIVTFFASFQE 70 (257)
T ss_pred ---------------------------------------------------hhHHHHHHHHHHHhCCCCChhhhhheecc
Confidence 01245567778888888888888888888
Q ss_pred CceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC-EEEeeecccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE-LKLADFGLAR 328 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~-vkL~DFGla~ 328 (516)
....++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+.
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~ 150 (257)
T cd08225 71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR 150 (257)
T ss_pred CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccch
Confidence 889999999998 48888886543 35899999999999999999999999999999999999998864 6999999997
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.............|++.|+|||++.+.....++|+|||||++|+|++|..||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 218 (257)
T cd08225 151 QLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY------------ 218 (257)
T ss_pred hccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc------------
Confidence 76543333334468999999999988788889999999999999999999998766555443332110
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
. ...+...+.++.++|.+||..+|++|||+.++++||||
T Consensus 219 ------------~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 ------------F-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------C-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 01123567899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.45 Aligned_cols=205 Identities=29% Similarity=0.407 Sum_probs=169.9
Q ss_pred HHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEE
Q psy12305 234 LRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312 (516)
Q Consensus 234 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NIL 312 (516)
....+||||+++++++..++.+|+||||+++ +|..++... ..+++..+..++.||+.||.|||+.+++||||+|+||+
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil 129 (260)
T cd05611 51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129 (260)
T ss_pred hhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 4455899999999999999999999999985 787777654 45899999999999999999999999999999999999
Q ss_pred EccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q psy12305 313 INERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLI 392 (516)
Q Consensus 313 l~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i 392 (516)
++.++.+||+|||+++.... .....|++.|+|||.+.+..+..++|+||+|+++|+|++|.+||...+.......+
T Consensus 130 ~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 130 IDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred ECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999999876432 22346788999999998877788899999999999999999999887766555444
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC---HHHHHcCCCCCCCCC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS---AANAMRHPYFNSLGP 465 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t---a~e~l~Hp~f~~~~~ 465 (516)
....... ....+..+++++.++|.+||+.||++||| ++|++.||||.+..|
T Consensus 206 ~~~~~~~----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 206 LSRRINW----------------------PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred HhcccCC----------------------CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 3211110 11112357899999999999999999995 479999999987655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.55 Aligned_cols=257 Identities=25% Similarity=0.364 Sum_probs=210.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.|...++||+|+||+||+|++..+|+.||||++........
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~-------------------------------------- 62 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTN-------------------------------------- 62 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCch--------------------------------------
Confidence 338888999999999999999999999999998864321110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++|||++++++++.
T Consensus 63 ---------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 91 (313)
T cd06633 63 ---------------------------------------------------EKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91 (313)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 01124567888899999999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
+....|+||||+.+++...+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 92 KEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred eCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 99999999999999998888776777999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
. ......|+..|+|||++. +..+...+|+|||||++|+|++|.+||...+.......+... .++
T Consensus 172 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--~~~------- 238 (313)
T cd06633 172 S----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DSP------- 238 (313)
T ss_pred C----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhc--CCC-------
Confidence 2 223457899999999984 345677889999999999999999999877655555444221 110
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
......++..+.+|+.+||+++|.+|||+.++++||||....
T Consensus 239 ---------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 239 ---------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ---------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 011125677899999999999999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=335.47 Aligned_cols=259 Identities=23% Similarity=0.351 Sum_probs=211.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
..|...+.||+|+||.||+|++..+|..||||++........
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~-------------------------------------- 66 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN-------------------------------------- 66 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCch--------------------------------------
Confidence 448999999999999999999999999999998864321110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++|||++++++++.
T Consensus 67 ---------------------------------------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (317)
T cd06635 67 ---------------------------------------------------EKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95 (317)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 01124667888888899999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.+...++||||+.|++.+.+......+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++...
T Consensus 96 ~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~ 175 (317)
T cd06635 96 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175 (317)
T ss_pred eCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence 99999999999999988888776677999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
.. .....|++.|+|||.+. +.....++|+||+||++|||++|.+||...........+......
T Consensus 176 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--------- 242 (317)
T cd06635 176 SP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------- 242 (317)
T ss_pred CC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC---------
Confidence 32 22346789999999974 345677899999999999999999999876655554444321111
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
...+...++.+.+|+.+||+.||.+|||+.++++|||+....+.
T Consensus 243 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 243 ---------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred ---------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 01123567889999999999999999999999999999665443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=324.87 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=207.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+..+.||+|+||.||+|.+..+++.||+|.+.........
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~-------------------------------------- 42 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTG-------------------------------------- 42 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccc--------------------------------------
Confidence 478889999999999999999889999999988654321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
......+.+|+.+++.++||||+++++++..
T Consensus 43 -------------------------------------------------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 73 (258)
T cd06632 43 -------------------------------------------------QEAVKQLEQEIALLSKLQHPNIVQYLGTERE 73 (258)
T ss_pred -------------------------------------------------hHHHHHHHHHHHHHHhcCCCCchheeeeEec
Confidence 0111246678888999999999999999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
+...++||||+++ +|.+++... ..+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++...
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 74 EDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred CCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 9999999999985 888887664 45899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
.... ......|+..|+|||.+.... +..++|+|||||++|+|++|..||......+....+....
T Consensus 153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~------------- 218 (258)
T cd06632 153 VEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK------------- 218 (258)
T ss_pred cccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc-------------
Confidence 4332 233456789999999987665 6778999999999999999999997665433333322100
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.....+..+++++.+|+.+||..||++|||+.+++.|||+
T Consensus 219 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 219 -----------ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred -----------cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 0112344678999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=345.45 Aligned_cols=307 Identities=18% Similarity=0.279 Sum_probs=206.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeeccccccc-cee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHT-EKC 163 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~~ 163 (516)
++|++.+.||+|+||.||+|++.. +++.||+|++...........+.+|+.++.++ +||||+++++++.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 469999999999999999997543 45789999987543333334678899999999 89999999998764 456
Q ss_pred eeeeeehhhh-hhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc--ccc
Q psy12305 164 LTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL--RHA 240 (516)
Q Consensus 164 ~~lv~Ey~~~-~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l--~Hp 240 (516)
.+++|||+.. ++..++............ .. .+....... ...
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~-----------------------------~~------~~~~~~~~~~~~~~ 131 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRN-----------------------------KS------TRKREMKQKEGKKQ 131 (337)
T ss_pred EEEEEecCCCCCHHHHHHhcccccccccc-----------------------------cc------cccccccccccccc
Confidence 7889999975 666665433211000000 00 000000000 011
Q ss_pred ceeeEeeeEeeCceeeEeeehhhc---hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC
Q psy12305 241 NIVTLHDIIHTEKCLTLVFEYLEK---DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317 (516)
Q Consensus 241 nIv~l~~~~~~~~~~~lV~E~~~g---~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 317 (516)
.+...- ............++... ............+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 132 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~ 210 (337)
T cd05054 132 RLDSVS-SSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN 210 (337)
T ss_pred ccccCC-ccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC
Confidence 111000 00111111122222110 00000111124699999999999999999999999999999999999999999
Q ss_pred CEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHH
Q psy12305 318 ELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICS 394 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~ 394 (516)
.+||+|||+++....... ......++..|+|||++.+..++.++|+|||||++|||++ |..||.+....+.+.....
T Consensus 211 ~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~ 290 (337)
T cd05054 211 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK 290 (337)
T ss_pred cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh
Confidence 999999999986532221 1223345778999999999889999999999999999998 9999987544333222211
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
. ......|...++++.+++.+||+.+|++|||++++++|
T Consensus 291 ~------------------------~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 291 E------------------------GTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred c------------------------cCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 01112244678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=324.35 Aligned_cols=275 Identities=26% Similarity=0.368 Sum_probs=227.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|.++..||+|+|..|..++++.|.+.||+|++++.--...+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndde----------------------------------- 292 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDE----------------------------------- 292 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcc-----------------------------------
Confidence 468899999999999999999999999999999998764221111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
...-...|-.+..+- +||++|-++.
T Consensus 293 ------------------------------------------------------didwvqtek~vfe~asn~pflvglhs 318 (593)
T KOG0695|consen 293 ------------------------------------------------------DIDWVQTEKHVFEQASNNPFLVGLHS 318 (593)
T ss_pred ------------------------------------------------------cchhHHhhHHHHHhccCCCeEEehhh
Confidence 111233455555554 7999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+|+++..+++|.||++| +|...+.+ .+.++++.++.+...|+.||.|||++|||.||||.+|+|++..|++||.|+|+
T Consensus 319 cfqtesrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygm 397 (593)
T KOG0695|consen 319 CFQTESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGM 397 (593)
T ss_pred hhcccceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccch
Confidence 99999999999999995 77666655 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCC-------CCHHHHHHHHHHhcCCC
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG-------STIEDELRLICSILGPP 399 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~-------~~~~~~~~~i~~~~~~~ 399 (516)
++....+....+++||||.|.|||++.|..|....|+|+|||+++||+.|+.||.- .+.++-+.++.
T Consensus 398 cke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi------ 471 (593)
T KOG0695|consen 398 CKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI------ 471 (593)
T ss_pred hhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH------
Confidence 99877778888899999999999999998888778878999999999999999952 22333333221
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC------HHHHHcCCCCCCCCCCcccCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS------AANAMRHPYFNSLGPQVHELSDT 473 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t------a~e~l~Hp~f~~~~~~~~~~~~~ 473 (516)
.......|..+|-.+..+++..|++||.+|+. ..++..||||+.+.|...+...+
T Consensus 472 -------------------lekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v 532 (593)
T KOG0695|consen 472 -------------------LEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQV 532 (593)
T ss_pred -------------------hhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhccc
Confidence 11233456678888999999999999999985 68999999999999888877777
Q ss_pred CCCCC
Q psy12305 474 QSIFS 478 (516)
Q Consensus 474 ~~~~~ 478 (516)
.++|.
T Consensus 533 ~ppf~ 537 (593)
T KOG0695|consen 533 LPPFQ 537 (593)
T ss_pred CCCCC
Confidence 76664
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=327.20 Aligned_cols=248 Identities=22% Similarity=0.369 Sum_probs=202.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|.+.++||+|+||.||+|.+..+++.||+|.+..+.. .
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~-------------------------------------- 45 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--E-------------------------------------- 45 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--H--------------------------------------
Confidence 469999999999999999999999999999998753210 0
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+++.++||||+++++++.
T Consensus 46 -----------------------------------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (263)
T cd05052 46 -----------------------------------------------------VEEFLKEAAVMKEIKHPNLVQLLGVCT 72 (263)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhCCCCChhheEEEEc
Confidence 114556777888888888888888888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+..+++||||++ ++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 8888999999997 58888886543 458999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccc-cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPTKTF-SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
......... ....++..|+|||.+.+..++.++|+|||||++|||++ |..||++.+..+....+...
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~----------- 221 (263)
T cd05052 153 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG----------- 221 (263)
T ss_pred ccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-----------
Confidence 754332211 12233667999999988888889999999999999998 99999987766554444221
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....|..++.++.+|+.+||..||++|||+.++++
T Consensus 222 --------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 222 --------------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=327.94 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=203.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|++.+.||+|+||.||+|++..+++.||||.+.......
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-------------------------------------- 42 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMD-------------------------------------- 42 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCC--------------------------------------
Confidence 468999999999999999999999999999999875421111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
......+.+|+.+++.++||||+++++++
T Consensus 43 ---------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 71 (267)
T cd08228 43 ---------------------------------------------------AKARQDCVKEIDLLKQLNHPNVIKYLDSF 71 (267)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHhCCCcceeeeeeeE
Confidence 01112466788899999999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
...+..++||||+++ +|..++.. ....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 72 IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccc
Confidence 999999999999995 77766643 33458999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHhcCCCChhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI--EDELRLICSILGPPPDEL 403 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~--~~~~~~i~~~~~~~p~~~ 403 (516)
++..............|++.|+|||.+.+.....++|+||+||++|||++|..||..... .+....+ ...+.++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--- 227 (267)
T cd08228 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI-EQCDYPP--- 227 (267)
T ss_pred cceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHH-hcCCCCC---
Confidence 987654333333345688999999999887788899999999999999999999965432 2222221 1111111
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
..+...+.++.+||.+||..||++|||+.++++.
T Consensus 228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 1122567889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=332.38 Aligned_cols=207 Identities=25% Similarity=0.364 Sum_probs=173.5
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQL 289 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~qi 289 (516)
.+.+|+.+++.++||||+++++++......|++|||++ ++|.+++.... ..+++..+..++.||
T Consensus 54 ~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 133 (283)
T cd05048 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133 (283)
T ss_pred HHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHH
Confidence 56778899999999999999999999999999999998 58888887542 457888999999999
Q ss_pred HHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHH
Q psy12305 290 LRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVG 367 (516)
Q Consensus 290 ~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlG 367 (516)
+.||.|||++||+||||||+||+++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++|+||||
T Consensus 134 ~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG 213 (283)
T cd05048 134 AAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFG 213 (283)
T ss_pred HHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHH
Confidence 999999999999999999999999999999999999997643222 122334568899999999888888899999999
Q ss_pred HHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcC
Q psy12305 368 CIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAK 446 (516)
Q Consensus 368 vil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~ 446 (516)
|++|||++ |..||.+.+..+....+.... ....|..+++++.+|+.+||+.||.
T Consensus 214 ~il~el~~~g~~p~~~~~~~~~~~~i~~~~-------------------------~~~~~~~~~~~~~~l~~~c~~~~p~ 268 (283)
T cd05048 214 VVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-------------------------LLPCPEDCPARVYALMIECWNEIPA 268 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-------------------------cCCCcccCCHHHHHHHHHHccCChh
Confidence 99999998 999999877766655543211 0112447889999999999999999
Q ss_pred CCCCHHHHHcC
Q psy12305 447 QRISAANAMRH 457 (516)
Q Consensus 447 ~R~ta~e~l~H 457 (516)
+|||+.+++++
T Consensus 269 ~Rp~~~~i~~~ 279 (283)
T cd05048 269 RRPRFKDIHTR 279 (283)
T ss_pred hCcCHHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.18 Aligned_cols=206 Identities=22% Similarity=0.325 Sum_probs=170.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++..+...++||||++ ++|.+++......+++..+..++.|++.||+|||++||+||
T Consensus 45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 124 (256)
T cd05114 45 DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124 (256)
T ss_pred HHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 45678888888888888999998888889999999998 58888887655668999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPG 382 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~ 382 (516)
||||+||+++.++.+||+|||+++....... ......++..|+|||++.+..+..++|+|||||++|||++ |+.||..
T Consensus 125 dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred ccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999876432221 1122234668999999988788889999999999999999 9999988
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+..+.+..+.... ....|...+.++.+|+.+||..||++|||++++++
T Consensus 205 ~~~~~~~~~i~~~~-------------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 205 KSNYEVVEMISRGF-------------------------RLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCHHHHHHHHHCCC-------------------------CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 77666655553311 11123356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=357.18 Aligned_cols=251 Identities=23% Similarity=0.324 Sum_probs=197.9
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcC-CCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++++.+.|-+|||+.||.|++...|..||+|++-.. +......+.+||++|++|+ |+|||.|++.......
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~------- 109 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS------- 109 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc-------
Confidence 488999999999999999999888899999999877 4444557789999999996 9999988874211110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
-.
T Consensus 110 ------------------------------------------------------------------------------~~ 111 (738)
T KOG1989|consen 110 ------------------------------------------------------------------------------SN 111 (738)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred e-CceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccCCCEEEeeec
Q psy12305 251 T-EKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 251 ~-~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
. .-.+.|.||||. |+|.+++..+ ...|++.++++|+.|+++|+.+||... |||||||-|||||+.+|..||||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccc
Confidence 0 113678999999 6999999853 355999999999999999999999987 9999999999999999999999999
Q ss_pred cccccCCCCccc---------cCCcccccccchhhc---cCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 326 LARAKSVPTKTF---------SNEVVTLWYRPPDVL---LGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 326 la~~~~~~~~~~---------~~~~gt~~y~APE~l---~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
.|.......... ....-|+.|+|||++ .+.+.+.++|+|+|||+||-|+....||.+..... |+
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la----Il 267 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA----IL 267 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----EE
Confidence 997543222110 112339999999997 46788999999999999999999999997643211 11
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
. .++.....+.++..+.+||+.||+.||++||++-|++.
T Consensus 268 n------------------------g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 268 N------------------------GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred e------------------------ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 0 11222222378899999999999999999999988874
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=349.44 Aligned_cols=253 Identities=20% Similarity=0.295 Sum_probs=203.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++..+...||+|.||+||+|+|. ..||||++..+....
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~------------------------------------- 429 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTP------------------------------------- 429 (678)
T ss_pred CHHHhhccceeccccccceeecccc---cceEEEEEecCCCCH-------------------------------------
Confidence 4566888999999999999999985 579999987653221
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.|.+|+..+++-+|-||+-+.|+
T Consensus 430 -----------------------------------------------------~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 430 -----------------------------------------------------EQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhhcchhhheeeehh
Confidence 122357778888888888888888888
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..+.. .||+-+|+| +|+.++......+.+...+.|++||++|+.|||.++|||||||..||++.++++|||+|||++
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccce
Confidence 888777 899999997 899999887778999999999999999999999999999999999999999999999999999
Q ss_pred cccCC--CCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSV--PTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~--~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
..... .........|...|||||++. ..+++..+|+|||||++|||+||..||.....+..+..+-...+.|..
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~- 614 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL- 614 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc-
Confidence 76432 233445556788999999985 346788899999999999999999999865554443333222111111
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
......++.++++|+..||.+++++||++.++|.
T Consensus 615 --------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 615 --------------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1111256779999999999999999999999875
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=332.23 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=210.6
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
..|+.+++||.|+||.||+|.+..++..||||.+.......
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~--------------------------------------- 44 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--------------------------------------- 44 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHH---------------------------------------
Confidence 45888999999999999999998899999999875431100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+.+++.++||||+++++++.
T Consensus 45 ----------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 72 (277)
T cd06640 45 ----------------------------------------------------EIEDIQQEITVLSQCDSPYVTKYYGSYL 72 (277)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 0125667888899999999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++..|+||||+++ +|.+++.. ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++..
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~ 150 (277)
T cd06640 73 KGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ 150 (277)
T ss_pred ECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEccccccee
Confidence 99999999999985 78887764 4589999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
............++..|+|||++.+...+.++|+|||||++|||++|.+||.+.+.......+.. +.+
T Consensus 151 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~---------- 218 (277)
T cd06640 151 LTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK--NNP---------- 218 (277)
T ss_pred ccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc--CCC----------
Confidence 54433333344678899999999888888899999999999999999999987665443332211 000
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
...+..++.++.+|+.+||+.||++|||++++++||||.....
T Consensus 219 -------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 219 -------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred -------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 1122356788999999999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.82 Aligned_cols=266 Identities=24% Similarity=0.395 Sum_probs=206.0
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||.|+||.||+|.+..+|+.||||.+........... .+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~-~~--------------------------------- 47 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD-SR--------------------------------- 47 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccc-hH---------------------------------
Confidence 48899999999999999999988999999998865322111000 00
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.......+.+|+.+++.++||||+++++++..
T Consensus 48 ------------------------------------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 79 (272)
T cd06629 48 ------------------------------------------------QKDMVKALRSEIETLKDLDHLNIVQYLGFETT 79 (272)
T ss_pred ------------------------------------------------HHHHHHHHHHHHHHHHhcCCCCcceEEEEecc
Confidence 00011245678999999999999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.+..++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++++||||||+||+++.++.++|+|||+++..
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 80 EEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred CCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 999999999998 4788887765 46899999999999999999999999999999999999999999999999999764
Q ss_pred CCCC--ccccCCcccccccchhhccCCC--CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 331 SVPT--KTFSNEVVTLWYRPPDVLLGST--EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 331 ~~~~--~~~~~~~gt~~y~APE~l~~~~--~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
.... .......|+..|+|||.+.+.. ++.++|+|||||++|+|++|..||........+..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 230 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA-------- 230 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC--------
Confidence 3211 1122345788999999987654 677889999999999999999999765444333322111000
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
+.. .......++.++.+||.+||..||++|||++++++||||
T Consensus 231 ------~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 231 ------PPI------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ------CcC------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 000 000112568899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=331.50 Aligned_cols=262 Identities=24% Similarity=0.367 Sum_probs=199.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+.+++||.|+||.||+|++..+++.||+|.+.........
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~------------------------------------- 43 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ------------------------------------- 43 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHH-------------------------------------
Confidence 4799999999999999999999999999999988654222111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
..+.+|+++++.++||||+++++++.
T Consensus 44 ------------------------------------------------------~~~~~e~~~l~~l~h~~iv~~~~~~~ 69 (287)
T cd06621 44 ------------------------------------------------------KQILRELEINKSCKSPYIVKYYGAFL 69 (287)
T ss_pred ------------------------------------------------------HHHHHHHHHHHhCCCCCeeeeeeEEE
Confidence 13456666677777777777777664
Q ss_pred e--CceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 251 T--EKCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 251 ~--~~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
. .+.+|+||||+++ +|.+++.. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 70 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 70 DESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred ccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeec
Confidence 4 3468999999984 77666543 3456899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHhcCCC
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI-----EDELRLICSILGPP 399 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~-----~~~~~~i~~~~~~~ 399 (516)
|++........ ....++..|+|||.+.+..++..+|+||+||++|+|++|..||..... .+....+.. ..
T Consensus 150 g~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~ 224 (287)
T cd06621 150 GVSGELVNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN---MP 224 (287)
T ss_pred ccccccccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc---CC
Confidence 99875432221 234568899999999888888899999999999999999999976521 121111111 00
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
+..+.. ........++.+.+||.+||..||.+|||+.|+++||||....
T Consensus 225 ~~~~~~----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 273 (287)
T cd06621 225 NPELKD----------------EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM 273 (287)
T ss_pred chhhcc----------------CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence 000000 0000013467899999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=329.87 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=208.1
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
-|.+++.||.|+||.||+|.+..+++.||||.+.......
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~---------------------------------------- 44 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED---------------------------------------- 44 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchH----------------------------------------
Confidence 3888999999999999999998899999999874321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+++.++||||+++++.+..
T Consensus 45 ---------------------------------------------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 73 (277)
T cd06641 45 ---------------------------------------------------EIEDIQQEITVLSQCDSPYVTKYYGSYLK 73 (277)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhcCCCCEeEEEEEEEe
Confidence 01245678888888899999999999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
+...|+||||+++ +|..++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06641 74 DTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL 151 (277)
T ss_pred CCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceec
Confidence 9999999999985 77777754 45899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
...........++..|+|||.+.+......+|+||+||++|+|++|..||...........+... .+
T Consensus 152 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------- 218 (277)
T cd06641 152 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP----------- 218 (277)
T ss_pred ccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC-----------
Confidence 44333334456788999999998877788899999999999999999999876544433332110 00
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+..++.++.+++.+||..||.+||++.++++||||...
T Consensus 219 ------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 219 ------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 01223678899999999999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.81 Aligned_cols=197 Identities=25% Similarity=0.352 Sum_probs=163.2
Q ss_pred cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC
Q psy12305 238 RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER 316 (516)
Q Consensus 238 ~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 316 (516)
+||||+++++.+..++..|+||||++ ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.+
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA 145 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCC
Confidence 69999999999999999999999998 58988887654 79999999999999999999999999999999999999999
Q ss_pred C-CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH-HHHHHH
Q psy12305 317 G-ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE-LRLICS 394 (516)
Q Consensus 317 ~-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~-~~~i~~ 394 (516)
+ .++|+|||+++..... ....|+..|+|||++.+..+..++|+||+||++|+|++|..||......+. ...+..
T Consensus 146 ~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 221 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLK 221 (267)
T ss_pred CCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHH
Confidence 8 9999999998765422 234678999999999888888889999999999999999999986543321 111111
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-HHHHHcCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-AANAMRHPYFNS 462 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-a~e~l~Hp~f~~ 462 (516)
... .....+...++.+.+||.+||+.||.+||+ ++++|+||||.+
T Consensus 222 ~~~-----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 222 RQQ-----------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred hhc-----------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 000 011122368899999999999999999996 599999999964
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=325.73 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=211.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|.+..+|+.||||++.......
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~--------------------------------------- 41 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE--------------------------------------- 41 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchH---------------------------------------
Confidence 46999999999999999999999999999999886542211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+..+..++||||+++++++.
T Consensus 42 ----------------------------------------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 69 (264)
T cd06623 42 ----------------------------------------------------FRKQLLRELKTLRSCESPYVVKCYGAFY 69 (264)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhcCCCCeeeEEEEEc
Confidence 1124667888888888888888898888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.....++||||++ ++|.+++... ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||++.
T Consensus 70 ~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 70 KEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred cCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccce
Confidence 8899999999999 5888888764 569999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHhcCCCChhhhh
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST---IEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~---~~~~~~~i~~~~~~~p~~~~~ 405 (516)
.............++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+....+.. ...
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~~----- 220 (264)
T cd06623 149 VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GPP----- 220 (264)
T ss_pred ecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CCC-----
Confidence 76544444335567899999999988888888999999999999999999997763 2222222221 100
Q ss_pred hcccccCCCCCCchhhhhcCCCC-CCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQ-MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~-~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+.. ++..+.++|.+||..+|++|||+.++++||||+..
T Consensus 221 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 221 -----------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -----------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 011223 78899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=325.58 Aligned_cols=207 Identities=20% Similarity=0.344 Sum_probs=173.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++......++||||+.+ +|.+++......+++..+..++.|++.||+|||+++|+||
T Consensus 51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~ 130 (266)
T cd05033 51 DFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR 130 (266)
T ss_pred HHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 567789999999999999999999999999999999985 8888887766679999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccc--cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTF--SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
||||+|||++.++.++|+|||+++......... ....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.
T Consensus 131 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 131 DLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred CCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 999999999999999999999998764222211 12234678999999988888889999999999999998 999998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.....+....+..... ...+...++.+.+|+.+||+.||++||++++++++
T Consensus 211 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 211 DMSNQDVIKAVEDGYR-------------------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCHHHHHHHHHcCCC-------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 7666555544432111 11233678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.06 Aligned_cols=249 Identities=25% Similarity=0.357 Sum_probs=209.4
Q ss_pred ccceeeEEEEEEEecCCceEEEEEeecccc--cCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHH
Q psy12305 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLK 267 (516)
Q Consensus 191 ~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~ 267 (516)
|.|+||.||++.+..++..||+|.+..... ......+.+|+.+++.++||||+++++.+.++...|+||||++ ++|.
T Consensus 2 g~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (262)
T cd05572 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81 (262)
T ss_pred CCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHH
Confidence 679999999999999999999999976542 2344568899999999999999999999999999999999998 5888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCccccccc
Q psy12305 268 RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYR 347 (516)
Q Consensus 268 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~ 347 (516)
+++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....... ......|++.|+
T Consensus 82 ~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~ 159 (262)
T cd05572 82 TILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYV 159 (262)
T ss_pred HHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCcc
Confidence 888764 458999999999999999999999999999999999999999999999999998765432 223346789999
Q ss_pred chhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcC
Q psy12305 348 PPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST--IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425 (516)
Q Consensus 348 APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~--~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (516)
|||.+.+..++.++|+||+||++|+|++|..||.... ..+....+... ......
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------------------------~~~~~~ 215 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG------------------------NGKLEF 215 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc------------------------CCCCCC
Confidence 9999988778888999999999999999999998765 33333333210 111223
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCC
Q psy12305 426 PEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGP 465 (516)
Q Consensus 426 p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~ 465 (516)
|...++++.++|.+||..||++||| ++|+++||||++..+
T Consensus 216 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 260 (262)
T cd05572 216 PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260 (262)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCC
Confidence 4456889999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=332.20 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=204.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|+++++||+|+||+||+|++..+|+.||+|++.......
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~-------------------------------------- 45 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSS-------------------------------------- 45 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcch--------------------------------------
Confidence 467999999999999999999999999999999875431111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+++.++||||+++++++
T Consensus 46 -----------------------------------------------------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 72 (284)
T cd06620 46 -----------------------------------------------------VRKQILRELQIMHECRSPYIVSFYGAF 72 (284)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHcCCCCcceEeeeE
Confidence 122566788888888999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
......++||||+++ +|..++.. .+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 73 LNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred ecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 999999999999995 67666655 3568999999999999999999996 69999999999999999999999999998
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH--------HHHHHHhcCCC
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE--------LRLICSILGPP 399 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~--------~~~i~~~~~~~ 399 (516)
...... .....+||..|+|||++.+.....++|+||+||++|+|++|..||........ ...+.......
T Consensus 152 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 152 GELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred cchhhh--ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 654322 12235789999999999887888899999999999999999999986543211 11111110000
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
+ ........+.++.+|+.+||+.||++|||++|+++||||..
T Consensus 230 ~---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 230 P---------------------PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred C---------------------CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0 00001136788999999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=328.91 Aligned_cols=207 Identities=23% Similarity=0.358 Sum_probs=170.8
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhc----------------CCCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC----------------SNILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~----------------~~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++.++||||+++++++..+...|+||||+. ++|.+++... ...+++..+..++.|
T Consensus 53 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 132 (283)
T cd05090 53 EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132 (283)
T ss_pred HHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHH
Confidence 46679999999999999999999999999999999998 5888887532 124788889999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
++.||+|||++||+||||||+|||++.++.+||+|||+++...... .......++..|+|||.+.+..++.++|+|||
T Consensus 133 i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 133 IAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred HHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 9999999999999999999999999999999999999997653221 12233445778999999988888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|||++ |.+||.+....+....+.... ....+..+++.+.+++.+||+.||
T Consensus 213 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~cl~~~p 267 (283)
T cd05090 213 GVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-------------------------LLPCSEDCPPRMYSLMTECWQEGP 267 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-------------------------cCCCCCCCCHHHHHHHHHHcccCc
Confidence 999999998 999998876655444442210 011234678899999999999999
Q ss_pred CCCCCHHHHHcC
Q psy12305 446 KQRISAANAMRH 457 (516)
Q Consensus 446 ~~R~ta~e~l~H 457 (516)
.+||++.+++++
T Consensus 268 ~~Rp~~~~i~~~ 279 (283)
T cd05090 268 SRRPRFKDIHTR 279 (283)
T ss_pred ccCcCHHHHHHH
Confidence 999999999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=309.27 Aligned_cols=282 Identities=30% Similarity=0.581 Sum_probs=213.0
Q ss_pred ccccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcC-CCCeeecccccccc
Q psy12305 83 SEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTE 161 (516)
Q Consensus 83 ~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 161 (516)
-.+..+..++|++..++|+|.|+.||.|++..+++.+.||+++.... +.+.||++||..|. ||||+.|+++....
T Consensus 30 ~~i~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk----kKIkREikIL~nL~gg~NIi~L~DiV~Dp 105 (338)
T KOG0668|consen 30 LVIDWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK----KKIKREIKILQNLRGGPNIIKLLDIVKDP 105 (338)
T ss_pred eeeeccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH----HHHHHHHHHHHhccCCCCeeehhhhhcCc
Confidence 34567899999999999999999999999999999999999875321 14556666666553 55555555543222
Q ss_pred eeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc
Q psy12305 162 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 241 (516)
Q Consensus 162 ~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn 241 (516)
.
T Consensus 106 ~------------------------------------------------------------------------------- 106 (338)
T KOG0668|consen 106 E------------------------------------------------------------------------------- 106 (338)
T ss_pred c-------------------------------------------------------------------------------
Confidence 1
Q ss_pred eeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCE
Q psy12305 242 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GEL 319 (516)
Q Consensus 242 Iv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~v 319 (516)
.....||+||++. +...... .++...++.++.|++.||.|||++||+|||+||.|++|+.. ..+
T Consensus 107 ----------SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkL 172 (338)
T KOG0668|consen 107 ----------SKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKL 172 (338)
T ss_pred ----------ccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhcee
Confidence 1235689999986 4444432 37888999999999999999999999999999999999976 469
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHhcC
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPL-FPGSTIEDELRLICSILG 397 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~p-F~~~~~~~~~~~i~~~~~ 397 (516)
+|+|+|+|.... +...++..+.+..|.-||.+..-.. +..-|.|||||+|..|+..+-| |.|.+..+++.+|..++|
T Consensus 173 rlIDWGLAEFYH-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG 251 (338)
T KOG0668|consen 173 RLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG 251 (338)
T ss_pred eeeecchHhhcC-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC
Confidence 999999998776 5666777888999999999977544 4556779999999999997655 578999999999999999
Q ss_pred CCChhhhh---hcccccCCC-------CCCchhhhhcCCC---CCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 398 PPPDELKS---KLEFCITPV-------YPSESKLQLLAPE---QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 398 ~~p~~~~~---~~~~~~~~~-------~~~~~~~~~~~p~---~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
+. ++.. +.+....|. .....+.....++ -.++++.|||.++|.+|..+|+||.|++.||||....
T Consensus 252 t~--el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 252 TD--ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred hH--HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 74 3322 111111111 1111111122221 3569999999999999999999999999999997653
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=333.87 Aligned_cols=206 Identities=25% Similarity=0.334 Sum_probs=167.8
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.++.++ +||||+++++++..++.+|+||||++ ++|.+++...+ ..+++..++.++.|
T Consensus 53 ~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 132 (303)
T cd05088 53 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132 (303)
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHH
Confidence 566788888888 89999999999999999999999998 58888886532 25789999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGC 368 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGv 368 (516)
|+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++|+|||||
T Consensus 133 i~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 211 (303)
T cd05088 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 211 (303)
T ss_pred HHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhhh-cccCCCcccccCHHHHhccCCcccccchhhhh
Confidence 99999999999999999999999999999999999999864321111 11123366799999998887888999999999
Q ss_pred HHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC
Q psy12305 369 IFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ 447 (516)
Q Consensus 369 il~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~ 447 (516)
++|||+| |.+||.+.+..+....+... .....+...++++.+|+.+||+.||++
T Consensus 212 il~ellt~g~~p~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~ 266 (303)
T cd05088 212 LLWEIVSLGGTPYCGMTCAELYEKLPQG-------------------------YRLEKPLNCDDEVYDLMRQCWREKPYE 266 (303)
T ss_pred HHHHHHhcCCCCcccCChHHHHHHHhcC-------------------------CcCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 9999998 99999877665544333110 011123356789999999999999999
Q ss_pred CCCHHHHHcC
Q psy12305 448 RISAANAMRH 457 (516)
Q Consensus 448 R~ta~e~l~H 457 (516)
|||+++++++
T Consensus 267 Rp~~~~il~~ 276 (303)
T cd05088 267 RPSFAQILVS 276 (303)
T ss_pred CcCHHHHHHH
Confidence 9999999876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=327.53 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=199.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcE----EEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNL----VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~----vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
..++|+++++||+|+||+||+|++..+|+. ||||.+......
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~---------------------------------- 50 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP---------------------------------- 50 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH----------------------------------
Confidence 456799999999999999999998877764 788876532111
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
.....+.+|+.+++.++||||++
T Consensus 51 ---------------------------------------------------------~~~~~~~~e~~~l~~~~~~~i~~ 73 (279)
T cd05109 51 ---------------------------------------------------------KANKEILDEAYVMAGVGSPYVCR 73 (279)
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHHhcCCCCCce
Confidence 11124567888888888999999
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+++++... ..+++|||++ |+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|
T Consensus 74 ~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~d 152 (279)
T cd05109 74 LLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITD 152 (279)
T ss_pred EEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECC
Confidence 99888654 5789999998 689998887667799999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCcc--ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 324 FGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 324 FGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
||+++........ .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||...........+... ..
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~-- 229 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ER-- 229 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-Cc--
Confidence 9999876432221 112234678999999988888889999999999999998 99999776554443333211 11
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...+...+.++.+++.+||..||++|||+.+++.
T Consensus 230 ----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 230 ----------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ----------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1112367889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=327.47 Aligned_cols=205 Identities=21% Similarity=0.256 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+..|+.+++.++||||+++++++. ....++++||+. |+|.+++......+++..+..++.||+.||+|||++|++||
T Consensus 55 ~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 133 (279)
T cd05111 55 EITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHR 133 (279)
T ss_pred HHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence 4556777888899999999999875 455788999998 69999998777779999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.
T Consensus 134 dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred ccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999976532221 2233456778999999988888899999999999999998 999998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+.........+... .....+...+.++.+++.+||..||++|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 214 GMRPHEVPDLLEKG-------------------------ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCHHHHHHHHHCC-------------------------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 87654433332110 011122346778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=329.37 Aligned_cols=254 Identities=28% Similarity=0.452 Sum_probs=207.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.+.+.||+|+||.||+|.+..+|+.||||++........
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 42 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-------------------------------------- 42 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccch--------------------------------------
Confidence 479999999999999999999999999999998865321100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~ 249 (516)
.....+.+|+.+++++. ||||+++++++
T Consensus 43 ---------------------------------------------------~~~~~~~~e~~~~~~l~~~~~i~~~~~~~ 71 (280)
T cd05581 43 ---------------------------------------------------KKVKYVKIEKEVLTRLNGHPGIIKLYYTF 71 (280)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhcccCCCchhHHHHh
Confidence 00124556777777777 88888888888
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
..++..++||||++ ++|.+++... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 72 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~ 150 (280)
T cd05581 72 QDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAK 150 (280)
T ss_pred cCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence 88888999999996 6888888765 369999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCC--------------------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH
Q psy12305 329 AKSVPT--------------------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE 388 (516)
Q Consensus 329 ~~~~~~--------------------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~ 388 (516)
...... .......|+..|+|||++.+......+|+|||||++|+|++|..||...+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 230 (280)
T cd05581 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230 (280)
T ss_pred ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 654322 122234578899999999887788889999999999999999999987765444
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH----HHHHcCCCC
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA----ANAMRHPYF 460 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta----~e~l~Hp~f 460 (516)
+..+.. .....|..+++.+.+||.+||+.||.+|||+ +++++||||
T Consensus 231 ~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 231 FQKILK--------------------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHh--------------------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 444321 1122344678899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=339.46 Aligned_cols=283 Identities=29% Similarity=0.469 Sum_probs=220.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.+....|+|-||+|..|+|..-|..||||+|..+..- -+.-++|+.||.+|....=
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M--~KtGl~EleiLkKL~~AD~------------------- 490 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM--HKTGLKELEILKKLNDADP------------------- 490 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH--hhhhhHHHHHHHHhhccCc-------------------
Confidence 6799999999999999999999999999999999765321 1133445555544421100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+ ..-++++|+..|.
T Consensus 491 --------------------------------------------------E----------------dk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 491 --------------------------------------------------E----------------DKFHCLRLFRHFK 504 (752)
T ss_pred --------------------------------------------------h----------------hhhHHHHHHHHhh
Confidence 0 1236777888888
Q ss_pred eCceeeEeeehhhchHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-CEEEeeeccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-ELKLADFGLA 327 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkL~DFGla 327 (516)
..+++|||||-+.-+|.+.++..+. .|....++.|+.|+..||..|-..||+|.||||+|||+++.. .+||||||.|
T Consensus 505 hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccc
Confidence 8899999999999999999988653 488889999999999999999999999999999999999764 5899999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
...... ..+.+..+..|+|||+++|-+|+.+-|.||+||+||||+||+..|+|.+..+++..+..+-|+.|..+..+-
T Consensus 585 ~~~~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 585 SFASEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cccccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 765432 333445688999999999999999999999999999999999999999999999999999999998876432
Q ss_pred cccc-----------C---CC-----------CCCchhhh--hcCCCCCC-------HHHHHHHHHccccCcCCCCCHHH
Q psy12305 408 EFCI-----------T---PV-----------YPSESKLQ--LLAPEQMD-------SDALDLVQKFLMYDAKQRISAAN 453 (516)
Q Consensus 408 ~~~~-----------~---~~-----------~~~~~~~~--~~~p~~~s-------~~~~dLl~~~L~~dP~~R~ta~e 453 (516)
.|.. . .+ ..+...+. +..-..++ ..+.|||.+||..||++|+|..|
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 2210 0 00 00000000 00001122 35899999999999999999999
Q ss_pred HHcCCCCCC
Q psy12305 454 AMRHPYFNS 462 (516)
Q Consensus 454 ~l~Hp~f~~ 462 (516)
+|+||||+.
T Consensus 743 AL~HpFi~~ 751 (752)
T KOG0670|consen 743 ALKHPFITE 751 (752)
T ss_pred HhcCCcccC
Confidence 999999963
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=322.74 Aligned_cols=256 Identities=27% Similarity=0.470 Sum_probs=203.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||+|+||.||+|.+..+++.||||.+.......
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDP---------------------------------------- 40 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccch----------------------------------------
Confidence 5899999999999999999998899999999986542210
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++|+||+++++.+.+
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~ 70 (264)
T cd06626 41 --------------------------------------------------KTIKEIADEMKVLELLKHPNLVKYYGVEVH 70 (264)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhCCCCChhheeeeEec
Confidence 011256678888888888889999998888
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.+..++|+||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++...
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~ 149 (264)
T cd06626 71 REKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKL 149 (264)
T ss_pred CCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccccccccc
Confidence 8899999999984 777777653 45899999999999999999999999999999999999999999999999998775
Q ss_pred CCCCccc----cCCcccccccchhhccCCC---CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 331 SVPTKTF----SNEVVTLWYRPPDVLLGST---EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 331 ~~~~~~~----~~~~gt~~y~APE~l~~~~---~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
....... ....+++.|+|||++.+.. ...++|+|||||++|+|++|..||.+............. +..+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~--- 225 (264)
T cd06626 150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP--- 225 (264)
T ss_pred CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence 4332221 2346788999999987765 678899999999999999999999765322222211111 1110
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
. ......+++.+.+||.+||+.||.+|||+++++.|||+
T Consensus 226 ----------~--------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 226 ----------P--------IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----------C--------CCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0 00011347889999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=322.94 Aligned_cols=207 Identities=22% Similarity=0.338 Sum_probs=169.9
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++......++||||+. ++|.+++......+++..+..++.||+.||+|||++|++|+
T Consensus 45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 124 (256)
T cd05113 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124 (256)
T ss_pred HHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 45678888888888888888888888888999999998 57888887766679999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPG 382 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~ 382 (516)
||||+||+++.++.+||+|||+++....... ......++..|+|||.+.+..+..++|+|||||++|+|++ |..||..
T Consensus 125 dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred ccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 9999999999999999999999876533221 1122334678999999988778889999999999999998 9999987
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....+....+..... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 205 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 205 FNNSETVEKVSQGLR-------------------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCHHHHHHHHhcCCC-------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 766555544432111 11223467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.55 Aligned_cols=207 Identities=21% Similarity=0.353 Sum_probs=167.6
Q ss_pred hHHHHHHHHHhcc-ccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------------------------
Q psy12305 226 TAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS----------------------------- 274 (516)
Q Consensus 226 ~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~----------------------------- 274 (516)
.+.+|+.+|+++. ||||+++++++.....+|||||||+ |+|.+++....
T Consensus 86 ~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (400)
T cd05105 86 ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRS 165 (400)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccc
Confidence 5678999999996 9999999999999999999999998 58888775421
Q ss_pred ------------------------------------------------------------------CCCCHHHHHHHHHH
Q psy12305 275 ------------------------------------------------------------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 275 ------------------------------------------------------------------~~l~~~~~~~i~~q 288 (516)
..+++..+..++.|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~q 245 (400)
T cd05105 166 YVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQ 245 (400)
T ss_pred hhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHH
Confidence 24778888999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+..+..++|+|||
T Consensus 246 i~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 246 VARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred HHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 99999999999999999999999999999999999999976532221 1223456788999999988888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|||++ |..||++......+...... ......+..++.++.+++.+||+.||
T Consensus 326 Gvil~ellt~g~~P~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~li~~cl~~dP 381 (400)
T cd05105 326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKS------------------------GYRMAKPDHATQEVYDIMVKCWNSEP 381 (400)
T ss_pred HHHHHHHHHCCCCCCcccchhHHHHHHHhc------------------------CCCCCCCccCCHHHHHHHHHHCccCH
Confidence 999999997 99999875443333222111 01112234678899999999999999
Q ss_pred CCCCCHHHHHc
Q psy12305 446 KQRISAANAMR 456 (516)
Q Consensus 446 ~~R~ta~e~l~ 456 (516)
++|||+.++.+
T Consensus 382 ~~RPt~~~l~~ 392 (400)
T cd05105 382 EKRPSFLHLSD 392 (400)
T ss_pred hHCcCHHHHHH
Confidence 99999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=341.76 Aligned_cols=261 Identities=25% Similarity=0.374 Sum_probs=209.1
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|..++.||-|+||.|.+++-.+|...||+|.+.+.. +|.+-
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaD-------------Vl~rn-------------------------- 671 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKAD-------------VLMRN-------------------------- 671 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHH-------------HHhhh--------------------------
Confidence 999999999999999999999999999999876542 11110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
....+..|-.||..-+.+-||+||..|+++
T Consensus 672 --------------------------------------------------QvaHVKAERDILAEADn~WVVrLyySFQDk 701 (1034)
T KOG0608|consen 672 --------------------------------------------------QVAHVKAERDILAEADNEWVVRLYYSFQDK 701 (1034)
T ss_pred --------------------------------------------------hhhhhhhhhhhHhhcCCcceEEEEEEeccC
Confidence 011234577888888899999999999999
Q ss_pred ceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 253 KCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 253 ~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+++|+||+|+. ||+..+|.+. +.+.++.+++|+.++..|+++.|+.|+|||||||+|||||.+|++||.|||||.-+.
T Consensus 702 dnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 702 DNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred CceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999 5888887764 469999999999999999999999999999999999999999999999999996321
Q ss_pred ---------CCC-----------------c----------------cccCCcccccccchhhccCCCCCCceeeehHHHH
Q psy12305 332 ---------VPT-----------------K----------------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCI 369 (516)
Q Consensus 332 ---------~~~-----------------~----------------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvi 369 (516)
... . .....+||+.|+|||++....+...+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 000 0 0012479999999999999888888898899999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC
Q psy12305 370 FHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 370 l~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
||||+.|++||...+..+...++... . ..+.+..-.+++.++.+||.+++ .+++.|+
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw--------~--------------~~l~~~~~~~ls~e~~~li~kLc-~sad~RL 917 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINW--------R--------------NFLHIPYQGNLSKEALDLIQKLC-CSADSRL 917 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeeh--------h--------------hccccccccccCHHHHHHHHHHh-cChhhhh
Confidence 99999999999876654443333211 0 12222333478999999999965 5889998
Q ss_pred C---HHHHHcCCCCCCCCCC
Q psy12305 450 S---AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 450 t---a~e~l~Hp~f~~~~~~ 466 (516)
. ++++..||||+.++..
T Consensus 918 Gkng~d~vKaHpfFkgIDfs 937 (1034)
T KOG0608|consen 918 GKNGADQVKAHPFFKGIDFS 937 (1034)
T ss_pred cccchhhhhcCccccccchH
Confidence 4 7889999999987643
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=319.77 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=210.9
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||.|+||.||+|.+..+++.||+|++.......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSE---------------------------------------- 40 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCCh----------------------------------------
Confidence 5899999999999999999998899999999886532210
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+++++.++|||++++++.+..
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 70 (258)
T cd08215 41 --------------------------------------------------KEREDALNEVKILKKLNHPNIIKYYESFEE 70 (258)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhcCCCChhheEEEEec
Confidence 112245678888888888899999998888
Q ss_pred CceeeEeeehhhc-hHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+...++|+||+++ +|..++... +..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 71 KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccce
Confidence 8999999999985 888888765 367999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
..............|++.|+|||.+.+.....++|+||+|+++|+|++|..||...+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 219 (258)
T cd08215 151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ----------- 219 (258)
T ss_pred eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-----------
Confidence 776544323344578899999999988888889999999999999999999998766544443332110
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
....|...+.++.+++.+||..||++|||+.++++||||
T Consensus 220 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 --------------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 011233678899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=364.36 Aligned_cols=255 Identities=22% Similarity=0.299 Sum_probs=199.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|++.++||+|+||+||+|++..+|+.||||++........
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e------------------------------------- 43 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP------------------------------------- 43 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCH-------------------------------------
Confidence 4689999999999999999999999999999999864321110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 44 ----------------------------------------------------~~~~rflrEi~ILs~L~HPNIVkl~~v~ 71 (932)
T PRK13184 44 ----------------------------------------------------LLKKRFLREAKIAADLIHPGIVPVYSIC 71 (932)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhCCCcCcCeEEEEE
Confidence 0112567888899999999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDC----------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE 318 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~----------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 318 (516)
.+++..|+||||++| +|.+++... ...++...+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 72 ~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~ 151 (932)
T PRK13184 72 SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE 151 (932)
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC
Confidence 999999999999985 787777532 123556778899999999999999999999999999999999999
Q ss_pred EEEeeeccccccCCCC------------------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCC
Q psy12305 319 LKLADFGLARAKSVPT------------------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLF 380 (516)
Q Consensus 319 vkL~DFGla~~~~~~~------------------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF 380 (516)
+||+|||+|+...... ......+||+.|+|||++.+..++.++|+||+||++|||+||..||
T Consensus 152 vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 152 VVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred EEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 9999999997652110 0112347899999999999988888999999999999999999999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+......... .....| . .......+++.+.+++.+||..||++|++..+.+.
T Consensus 232 ~~~~~~ki~~~--~~i~~P-~--------------------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 232 RRKKGRKISYR--DVILSP-I--------------------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred CCcchhhhhhh--hhccCh-h--------------------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 87544322211 111111 0 00111267889999999999999999988766553
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=322.11 Aligned_cols=248 Identities=22% Similarity=0.322 Sum_probs=201.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|+++++||+|+||.||+|.+. ++..||+|.+.....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---------------------------------------- 43 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---------------------------------------- 43 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----------------------------------------
Confidence 467999999999999999999974 667899998653211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+++.++||||+++++.+
T Consensus 44 -----------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05072 44 -----------------------------------------------------SVQAFLEEANLMKTLQHDKLVRLYAVV 70 (261)
T ss_pred -----------------------------------------------------hHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 012456788888888888888988888
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
......++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+|||++
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred cCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccc
Confidence 88889999999997 5888888653 456889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+....... ......++..|+|||.+.+..+..++|+|||||++|+|++ |..||.+.+..+....+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 222 (261)
T cd05072 151 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-------- 222 (261)
T ss_pred eecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 86543221 1222345678999999988778888999999999999998 9999988776665555432111
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...+..++.++.+|+.+||..||++|||++++.+
T Consensus 223 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 -----------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1112357789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=325.56 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=205.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||.|+||+||+|++.. ++.||+|.+.......
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~--------------------------------------- 45 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLK--------------------------------------- 45 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhh---------------------------------------
Confidence 569999999999999999999976 8999999876432110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+++.++||||+++++++.
T Consensus 46 -----------------------------------------------------~~~~~~e~~~l~~l~~~~i~~~~~~~~ 72 (261)
T cd05148 46 -----------------------------------------------------QQDFQKEVQALKRLRHKHLISLFAVCS 72 (261)
T ss_pred -----------------------------------------------------HHHHHHHHHHHhcCCCcchhheeeeEe
Confidence 114567888888888999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.....++||||+++ +|.+++... +..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~ 152 (261)
T cd05148 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR 152 (261)
T ss_pred cCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchh
Confidence 99999999999985 899988763 3568999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
.............++..|+|||.+.+..+..++|+|||||++|+|++ |+.||.+.+..+.+..+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~----------- 221 (261)
T cd05148 153 LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY----------- 221 (261)
T ss_pred hcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC-----------
Confidence 65433322233345778999999988888889999999999999998 899998877666665554211
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..+++.+.+++.+||+.||.+|||+.++++
T Consensus 222 --------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 222 --------------RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred --------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 11223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=328.38 Aligned_cols=206 Identities=23% Similarity=0.374 Sum_probs=169.5
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-------------CCCCHHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-------------NILSMNNVKLFLFQLLR 291 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~ 291 (516)
.+.+|+.+++.++||||+++++++......++||||++ ++|.+++...+ ..+++..+..++.||+.
T Consensus 54 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 133 (280)
T cd05049 54 DFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIAS 133 (280)
T ss_pred HHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHH
Confidence 56678888888888888888888888889999999998 58888886542 34788899999999999
Q ss_pred HHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHH
Q psy12305 292 GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCI 369 (516)
Q Consensus 292 aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvi 369 (516)
||.|||++|++||||||+||+++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|+|||||+
T Consensus 134 ~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 213 (280)
T cd05049 134 GMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVV 213 (280)
T ss_pred HHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHH
Confidence 99999999999999999999999999999999999875432211 1223345788999999998888889999999999
Q ss_pred HHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCC
Q psy12305 370 FHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR 448 (516)
Q Consensus 370 l~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R 448 (516)
+|||++ |..||.+.+..+....+..... ...+...+..+.+|+.+||+.||++|
T Consensus 214 l~e~~~~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 268 (280)
T cd05049 214 LWEIFTYGKQPWYGLSNEEVIECITQGRL-------------------------LQRPRTCPSEVYDIMLGCWKRDPQQR 268 (280)
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCCc-------------------------CCCCCCCCHHHHHHHHHHcCCCcccC
Confidence 999998 9999988776665555432110 11233678899999999999999999
Q ss_pred CCHHHHHc
Q psy12305 449 ISAANAMR 456 (516)
Q Consensus 449 ~ta~e~l~ 456 (516)
||+.|+++
T Consensus 269 p~~~eil~ 276 (280)
T cd05049 269 INIKDIHE 276 (280)
T ss_pred CCHHHHHH
Confidence 99999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=343.47 Aligned_cols=244 Identities=29% Similarity=0.400 Sum_probs=199.6
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..+.|++...+|.|+||.|-.+.+..+++.+|+|++......
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------------------------------------- 361 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------------------------------------- 361 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc--------------------------------------
Confidence 456799999999999999999999999999999998764211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHH-hccccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLR-ELRHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~ 247 (516)
..+|+.++. .-+||||+++++
T Consensus 362 ----------------------------------------------------------~~~e~~~~~~~~~h~niv~~~~ 383 (612)
T KOG0603|consen 362 ----------------------------------------------------------NQDEIPISLLVRDHPNIVKSHD 383 (612)
T ss_pred ----------------------------------------------------------cccccchhhhhcCCCcceeecc
Confidence 112443333 337999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE-ccCCCEEEeeec
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI-NERGELKLADFG 325 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl-~~~~~vkL~DFG 325 (516)
.+.++.+.|+|||++.| .+++.+.... .....+..|+.||+.|+.|||++||+||||||+|||+ +..|+++|+|||
T Consensus 384 v~~~~~~~~~v~e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 384 VYEDGKEIYLVMELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred eecCCceeeeeehhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEec
Confidence 99999999999999996 4555554422 2237788899999999999999999999999999999 689999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
.++..... +...|-|..|.|||++....++..+|+||||++||+||+|+.||....... .|...++.++.
T Consensus 462 ~a~~~~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~~---- 531 (612)
T KOG0603|consen 462 FWSELERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPKF---- 531 (612)
T ss_pred hhhhCchh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCCcc----
Confidence 99876533 445567999999999998888999999999999999999999998655442 22222222211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...+|++++|||++||+.||.+|+++.+++.||||
T Consensus 532 --------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 --------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --------------------ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 14789999999999999999999999999999999
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.99 Aligned_cols=256 Identities=23% Similarity=0.396 Sum_probs=207.7
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|....+||+|+||.||+|.+..+|+.||||++.....
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~------------------------------------------- 58 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ------------------------------------------- 58 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-------------------------------------------
Confidence 4556789999999999999999999999998643211
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
.....+.+|+.+++.++||||+++++.+..+
T Consensus 59 -------------------------------------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 89 (292)
T cd06657 59 -------------------------------------------------QRRELLFNEVVIMRDYQHENVVEMYNSYLVG 89 (292)
T ss_pred -------------------------------------------------hHHHHHHHHHHHHHhcCCcchhheeeEEEeC
Confidence 0112456788888888899999999999999
Q ss_pred ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 253 KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 253 ~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+..++||||+++ +|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 90 DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167 (292)
T ss_pred CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecc
Confidence 999999999986 66665543 358999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccccc
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCI 411 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~ 411 (516)
..........||+.|+|||.+.+..++.++|+||+||++|+|++|..||.+....+....+......
T Consensus 168 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~------------- 234 (292)
T cd06657 168 KEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP------------- 234 (292)
T ss_pred cccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCc-------------
Confidence 3333334457899999999988777788899999999999999999999887665554444321100
Q ss_pred CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 412 ~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.......+++++.+++.+||..||.+||++.++++||||....+
T Consensus 235 ----------~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 235 ----------KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred ----------ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 01112356889999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=374.48 Aligned_cols=257 Identities=26% Similarity=0.391 Sum_probs=203.1
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+++...+||.|.||.||-|.+..+|..-|+|.|+..... ....
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~------------------------------------ 1279 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFK------------------------------------ 1279 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCc------------------------------------
Confidence 477788999999999999999999999999988654321 1111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.+.+|..+|..++|||+|++|++-.
T Consensus 1280 -------------------------------------------------------~i~eEm~vlE~lnHpNlV~YyGVEv 1304 (1509)
T KOG4645|consen 1280 -------------------------------------------------------LIAEEMKVLEGLNHPNLVRYYGVEV 1304 (1509)
T ss_pred -------------------------------------------------------chHHHHHHHHhccCccccccCceee
Confidence 2345666666667777777777766
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.++.++|.||||+|+.+.-+.++++..++...+.|..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|...
T Consensus 1305 HRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred cHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEe
Confidence 77778999999996544445555677899999999999999999999999999999999999999999999999999876
Q ss_pred CCCCc----cccCCcccccccchhhccCC---CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 331 SVPTK----TFSNEVVTLWYRPPDVLLGS---TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 331 ~~~~~----~~~~~~gt~~y~APE~l~~~---~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
..... ......||+.|||||++.+. ....++|+||+||++.||+||+.||..-+..-++.-.+.. |
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~-g------ 1457 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA-G------ 1457 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc-c------
Confidence 54432 23456899999999999764 4677889999999999999999999764333222211111 1
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....+|+.++.+.+|||.+||+.||++|.++.|+++|.|-+.-
T Consensus 1458 -----------------h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1458 -----------------HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -----------------CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 2233566899999999999999999999999999999997653
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=322.13 Aligned_cols=207 Identities=21% Similarity=0.288 Sum_probs=170.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++......|+||||++ ++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus 45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 124 (256)
T cd05059 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124 (256)
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 45678888888889999999999988889999999998 58999888766678999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcc-ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKT-FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPG 382 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~ 382 (516)
||||+||+++.++.+||+|||+++........ .....++..|+|||.+.+..+..++|+|||||++|+|++ |..||.+
T Consensus 125 dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred cccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 99999999999999999999998765322111 111223457999999988888889999999999999999 8999987
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.+..+....+.... ....|...+.++.+++.+||..+|++|||+.++++.
T Consensus 205 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 205 FSNSEVVESVSAGY-------------------------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCHHHHHHHHHcCC-------------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 76655544442211 112234678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=330.91 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=208.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.|...+.||+|+||+||+|++..+++.||||.+........
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 56 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-------------------------------------- 56 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccCh--------------------------------------
Confidence 448889999999999999999999999999998754211100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++|+|++++++++.
T Consensus 57 ---------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 85 (308)
T cd06634 57 ---------------------------------------------------EKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (308)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCCcccEEEEEE
Confidence 01124567888888899999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.....++||||+.+++...+......+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred cCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 88999999999999888888766677999999999999999999999999999999999999999999999999998764
Q ss_pred CCCCccccCCcccccccchhhccC---CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLG---STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
... ....|++.|+|||.+.+ .....++|+|||||++|+|++|..||...+..+....+.....
T Consensus 166 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------- 231 (308)
T cd06634 166 APA----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---------- 231 (308)
T ss_pred cCc----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC----------
Confidence 322 23467899999999752 3466789999999999999999999977655444433322110
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
....+...+..+.+||.+||..+|++|||++++++|||+....+
T Consensus 232 --------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 232 --------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred --------------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 00112356788999999999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=326.28 Aligned_cols=263 Identities=28% Similarity=0.453 Sum_probs=216.2
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...+.|+..+.||+|+||.||+|.+..+++.||+|++.....
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------------------------------------- 57 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-------------------------------------- 57 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--------------------------------------
Confidence 445669999999999999999999988899999998864321
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
....+.+|+.+++.++|+||+++++
T Consensus 58 -------------------------------------------------------~~~~~~~e~~~l~~l~~~~i~~~~~ 82 (286)
T cd06614 58 -------------------------------------------------------NKELIINEILIMKDCKHPNIVDYYD 82 (286)
T ss_pred -------------------------------------------------------hHHHHHHHHHHHHHCCCCCeeEEEE
Confidence 1124567888888888999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.+..+...|+|+||++ ++|.+++......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~ 162 (286)
T cd06614 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGF 162 (286)
T ss_pred EEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccch
Confidence 9999999999999999 689988887655799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+..............++..|+|||++.+..++.++|+|||||++|+|++|..||...........+... +.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~------- 234 (286)
T cd06614 163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIP------- 234 (286)
T ss_pred hhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCC-------
Confidence 876543333333445788999999998888888999999999999999999999876655544443221 000
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
....+..++.++.+||.+||+.||.+|||+.++++||||....+.
T Consensus 235 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 279 (286)
T cd06614 235 ---------------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPK 279 (286)
T ss_pred ---------------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCch
Confidence 011122477899999999999999999999999999999875443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=320.74 Aligned_cols=257 Identities=23% Similarity=0.395 Sum_probs=204.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|++.+.||+|+||.||+|++..+|+.||+|.+.........
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~------------------------------------- 44 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQET------------------------------------- 44 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchh-------------------------------------
Confidence 4699999999999999999999999999999987543211100
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
......+.+|+.++++++||||+++++++.
T Consensus 45 --------------------------------------------------~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~ 74 (264)
T cd06653 45 --------------------------------------------------SKEVNALECEIQLLKNLRHDRIVQYYGCLR 74 (264)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHHHcCCCCcceEEEEEE
Confidence 001124567888888888888888888876
Q ss_pred eC--ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 251 TE--KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 251 ~~--~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+. ..+++||||+++ +|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++
T Consensus 75 ~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 75 DPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 54 468899999985 788887654 34899999999999999999999999999999999999999999999999999
Q ss_pred cccCCC---CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVP---TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+..... ........|+..|+|||.+.+.....++|+|||||++|+|++|+.||...........+. ..+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~----- 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQP----- 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCC-----
Confidence 764321 112233467999999999988777888999999999999999999998765444333322 111
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.....|..+++.+.++|.+||+ +|.+|||+.+++.|||.
T Consensus 226 ----------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 ----------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ----------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 1122355788999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=338.58 Aligned_cols=307 Identities=20% Similarity=0.300 Sum_probs=204.4
Q ss_pred cccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccc-e
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTE-K 162 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 162 (516)
.++|++.+.||+|+||+||+|++. .+++.||||+++..........+.+|+.+|.++ +|||||++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 357999999999999999999853 467899999997654333344688999999999 789999999987654 4
Q ss_pred eeeeeeehhhh-hhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc
Q psy12305 163 CLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 241 (516)
Q Consensus 163 ~~~lv~Ey~~~-~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn 241 (516)
..+++|||+++ +|.+++........ ++. .+. .........+..
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~----------~~~-----------~~~---------------~~~~~~~~~~~~ 129 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFV----------PYK-----------TKD---------------ARFRQGKSGYGD 129 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccc----------ccc-----------ccc---------------cccccccccccc
Confidence 57899999976 67666644321100 000 000 000000111111
Q ss_pred eeeEe----eeEeeCceeeEeeehhhc--------hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCC
Q psy12305 242 IVTLH----DIIHTEKCLTLVFEYLEK--------DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309 (516)
Q Consensus 242 Iv~l~----~~~~~~~~~~lV~E~~~g--------~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~ 309 (516)
+.... +..... .......+... ............+++..+..++.||+.||+|||++||+||||||+
T Consensus 130 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~ 208 (343)
T cd05103 130 ISEDLKRRLDSITSS-QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAAR 208 (343)
T ss_pred hhhhhhhhccccccc-cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccC
Confidence 11100 000000 00000011100 000000011235889999999999999999999999999999999
Q ss_pred CEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHH
Q psy12305 310 NLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIE 386 (516)
Q Consensus 310 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~ 386 (516)
|||++.++.+||+|||+++....... ......++..|+|||.+.+..+..++|+|||||++|+|++ |..||++....
T Consensus 209 Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 288 (343)
T cd05103 209 NILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288 (343)
T ss_pred eEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc
Confidence 99999999999999999976432211 1122234678999999988888889999999999999997 99999875433
Q ss_pred HHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 387 DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 387 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
......... ......|...++++.+++.+||+.||++|||+.++++|
T Consensus 289 ~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 289 EEFCRRLKE------------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHhc------------------------cCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 222221110 01111233567889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=326.94 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=205.1
Q ss_pred cEeeeeeeccccceEEEEEEEc---CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSR---LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~---~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
+|++.+.||+|+||.||+|++. .+|+.||+|.+........
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~------------------------------------ 44 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQK------------------------------------ 44 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhc------------------------------------
Confidence 4899999999999999999975 3789999998764321100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
......+.+|+.+++.+ +|+||+++++
T Consensus 45 ----------------------------------------------------~~~~~~~~~e~~~l~~l~~~~~i~~~~~ 72 (290)
T cd05613 45 ----------------------------------------------------AKTTEHTRTERQVLEHIRQSPFLVTLHY 72 (290)
T ss_pred ----------------------------------------------------chHHHHHHHHHHHHHhcccCCChhceee
Confidence 01112456788888888 5899999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.+..+...|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 151 (290)
T cd05613 73 AFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL 151 (290)
T ss_pred EeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCcc
Confidence 99999999999999994 888888764 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-ccccCCcccccccchhhccCC--CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 327 ARAKSVPT-KTFSNEVVTLWYRPPDVLLGS--TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 327 a~~~~~~~-~~~~~~~gt~~y~APE~l~~~--~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
++...... .......|+..|+|||.+.+. ......|+|||||++|+|++|..||...........+.....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~------ 225 (290)
T cd05613 152 SKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL------ 225 (290)
T ss_pred ceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh------
Confidence 97654322 122345689999999998653 345678999999999999999999964332222122211100
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGP 465 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~ 465 (516)
......|..+++.+.+|+.+||..||++|| ++++++.||||+...+
T Consensus 226 ----------------~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 226 ----------------KSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred ----------------ccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 001112346788999999999999999997 8999999999988764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=326.69 Aligned_cols=206 Identities=21% Similarity=0.345 Sum_probs=169.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC------------CCCCHHHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS------------NILSMNNVKLFLFQLLRG 292 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~a 292 (516)
.+.+|+.++++++||||+++++++...+..++||||++ ++|.+++...+ ..+++..+..++.||+.|
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~a 132 (288)
T cd05093 53 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132 (288)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence 46678888888888999999999988899999999998 58888886533 248999999999999999
Q ss_pred HHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHH
Q psy12305 293 LAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIF 370 (516)
Q Consensus 293 L~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil 370 (516)
|+|||++|++||||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|+|||||++
T Consensus 133 L~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il 212 (288)
T cd05093 133 MVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 212 (288)
T ss_pred HHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 9999999999999999999999999999999999975432211 11223457789999999888888899999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC
Q psy12305 371 HEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 371 ~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
|+|++ |.+||.+....+....+.... . ...+...+.++.+|+.+||+.||.+||
T Consensus 213 ~~l~t~g~~p~~~~~~~~~~~~i~~~~--~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp 267 (288)
T cd05093 213 WEIFTYGKQPWYQLSNNEVIECITQGR--V-----------------------LQRPRTCPKEVYDLMLGCWQREPHMRL 267 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCC--c-----------------------CCCCCCCCHHHHHHHHHHccCChhhCC
Confidence 99998 999998877666555543211 0 112335678999999999999999999
Q ss_pred CHHHHHc
Q psy12305 450 SAANAMR 456 (516)
Q Consensus 450 ta~e~l~ 456 (516)
|+.++++
T Consensus 268 t~~~v~~ 274 (288)
T cd05093 268 NIKEIHS 274 (288)
T ss_pred CHHHHHH
Confidence 9999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=325.08 Aligned_cols=207 Identities=20% Similarity=0.321 Sum_probs=170.0
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------NILSMNNVKLFLFQLLRGLAY 295 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~y 295 (516)
.+.+|+.+++.++||||+++++++..+...++||||+. ++|.+++.... ..+++..+..++.|++.||.|
T Consensus 55 ~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (277)
T cd05062 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY 134 (277)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999999999999999998 58888886532 235677889999999999999
Q ss_pred HhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHH
Q psy12305 296 CHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEM 373 (516)
Q Consensus 296 LH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~el 373 (516)
||+.|++||||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++..+|+|||||++|||
T Consensus 135 lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 214 (277)
T cd05062 135 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214 (277)
T ss_pred HHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHH
Confidence 9999999999999999999999999999999875432221 11223457889999999888888899999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH
Q psy12305 374 SS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452 (516)
Q Consensus 374 lt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~ 452 (516)
++ |..||.+.+..+....+..... ...+..++..+.+++.+||+.||++|||+.
T Consensus 215 ~~~~~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 269 (277)
T cd05062 215 ATLAEQPYQGMSNEQVLRFVMEGGL-------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFL 269 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCc-------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99 7899988776655544432110 112346778899999999999999999999
Q ss_pred HHHcC
Q psy12305 453 NAMRH 457 (516)
Q Consensus 453 e~l~H 457 (516)
+++++
T Consensus 270 e~l~~ 274 (277)
T cd05062 270 EIISS 274 (277)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=328.32 Aligned_cols=263 Identities=18% Similarity=0.298 Sum_probs=204.6
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++.+.||+|+||.||+|.+..+++.||||.+.........
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~---------------------------------- 57 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN---------------------------------- 57 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHH----------------------------------
Confidence 4568899999999999999999999988999999998643211111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
..+.+|+.++..+ .||||++++
T Consensus 58 ---------------------------------------------------------~~~~~e~~~~~~~~~~~~i~~~~ 80 (296)
T cd06618 58 ---------------------------------------------------------KRILMDLDVVLKSHDCPYIVKCY 80 (296)
T ss_pred ---------------------------------------------------------HHHHHHHHHHHhccCCCchHhhh
Confidence 1334455555555 488888888
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++.++...|+||||+++.+...+......+++..+..++.||+.||+|||+ .||+||||+|+||+++.++.+||+|||
T Consensus 81 ~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 81 GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred eeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccc
Confidence 8888888999999999988777777656679999999999999999999997 699999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCC----CCCceeeehHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHhcCCCC
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGST----EYSTSIDMGVGCIFHEMSSGRPLFPGSTI-EDELRLICSILGPPP 400 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~~d~~SlGvil~elltG~~pF~~~~~-~~~~~~i~~~~~~~p 400 (516)
++....... ......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||..... .+.+..+.... .+
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~ 237 (296)
T cd06618 161 ISGRLVDSK-AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE--PP 237 (296)
T ss_pred cchhccCCC-cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC--CC
Confidence 987654222 223345788999999987543 56788999999999999999999975322 22222221110 00
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.......++.++.+|+.+||..||.+|||++++++||||.....
T Consensus 238 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 238 ---------------------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 00011146788999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=324.11 Aligned_cols=251 Identities=22% Similarity=0.346 Sum_probs=199.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
++|.+.+.||+|+||.||+|.+.. ++..||+|.+.......
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~---------------------------------- 51 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ---------------------------------- 51 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH----------------------------------
Confidence 569999999999999999999976 67788888764321111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
....+.+|+.+++.++|+||+++
T Consensus 52 ---------------------------------------------------------~~~~~~~e~~~l~~l~~~~i~~~ 74 (277)
T cd05036 52 ---------------------------------------------------------DESDFLMEALIMSKFNHQNIVRL 74 (277)
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHhCCCCCEeeE
Confidence 11246678888888888888888
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDCS------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG- 317 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~- 317 (516)
++++......++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+|||++.++
T Consensus 75 ~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~ 154 (277)
T cd05036 75 IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGP 154 (277)
T ss_pred EEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCC
Confidence 888888888999999997 58888887643 2588999999999999999999999999999999999998765
Q ss_pred --CEEEeeeccccccCCCCcc--ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q psy12305 318 --ELKLADFGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLI 392 (516)
Q Consensus 318 --~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i 392 (516)
.+||+|||+++........ ......+..|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~ 234 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 5999999999865322111 112233567999999988888999999999999999997 99999987766554433
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.... ....|..++..+.+++.+||+.||++|||+.++++|
T Consensus 235 ~~~~-------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 235 TGGG-------------------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HcCC-------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2110 111234678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=325.96 Aligned_cols=207 Identities=23% Similarity=0.413 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhc---------------CCCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC---------------SNILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~---------------~~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++.+ +||||+++++++..+..++++|||+. ++|..++... ...+++..+..++.|
T Consensus 61 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 140 (293)
T cd05053 61 DLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQ 140 (293)
T ss_pred HHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence 456788888888 79999999999988889999999998 5888887642 345889999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|+|||
T Consensus 141 i~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 220 (293)
T cd05053 141 VARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 220 (293)
T ss_pred HHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeeh
Confidence 99999999999999999999999999999999999999986543221 1122234678999999988888899999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|||++ |..||.+....+....+... .....|...+.++.+|+.+||..||
T Consensus 221 G~il~el~~~g~~p~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p 275 (293)
T cd05053 221 GVLLWEIFTLGGSPYPGIPVEELFKLLKEG-------------------------YRMEKPQNCTQELYHLMRDCWHEVP 275 (293)
T ss_pred hhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------------------------CcCCCCCCCCHHHHHHHHHHcccCc
Confidence 999999998 99999887766555444221 0111234678899999999999999
Q ss_pred CCCCCHHHHHcC
Q psy12305 446 KQRISAANAMRH 457 (516)
Q Consensus 446 ~~R~ta~e~l~H 457 (516)
++|||+.+++++
T Consensus 276 ~~Rps~~eil~~ 287 (293)
T cd05053 276 SQRPTFKQLVED 287 (293)
T ss_pred ccCcCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=327.38 Aligned_cols=207 Identities=20% Similarity=0.305 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhc---------------CCCCCHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC---------------SNILSMNNVKLFLFQL 289 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~---------------~~~l~~~~~~~i~~qi 289 (516)
.+.+|+.++..++||||+++++++......++++||+. ++|..++... ...+++..+..++.|+
T Consensus 54 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql 133 (283)
T cd05091 54 EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQI 133 (283)
T ss_pred HHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence 56678999999999999999999999999999999998 5787777431 2347888899999999
Q ss_pred HHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHH
Q psy12305 290 LRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVG 367 (516)
Q Consensus 290 ~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlG 367 (516)
+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..+..++|+||||
T Consensus 134 ~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 213 (283)
T cd05091 134 AAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213 (283)
T ss_pred HHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHH
Confidence 9999999999999999999999999999999999999876532221 12334557899999999888888899999999
Q ss_pred HHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcC
Q psy12305 368 CIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAK 446 (516)
Q Consensus 368 vil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~ 446 (516)
|++|||++ |..||.+....+....+..... ...+..++..+.+|+.+||+.||+
T Consensus 214 ~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-------------------------~~~~~~~~~~~~~li~~cl~~~p~ 268 (283)
T cd05091 214 VVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-------------------------LPCPDDCPAWVYTLMLECWNEFPS 268 (283)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-------------------------CCCCCCCCHHHHHHHHHHhCCCcc
Confidence 99999998 8899988777666555532111 112447888999999999999999
Q ss_pred CCCCHHHHHcC
Q psy12305 447 QRISAANAMRH 457 (516)
Q Consensus 447 ~R~ta~e~l~H 457 (516)
+||++.++++.
T Consensus 269 ~RP~~~~i~~~ 279 (283)
T cd05091 269 RRPRFKDIHSR 279 (283)
T ss_pred cCCCHHHHHHH
Confidence 99999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=323.93 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=202.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|++.+.||+|+||.||+|++..+|+.||||.+........
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~------------------------------------- 43 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA------------------------------------- 43 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhH-------------------------------------
Confidence 4679999999999999999999999999999998764321100
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 44 ----------------------------------------------------~~~~~~~~e~~~l~~~~h~~i~~~~~~~ 71 (267)
T cd08229 44 ----------------------------------------------------KARADCIKEIDLLKQLNHPNVIKYYASF 71 (267)
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHccCCchhhhhhee
Confidence 0112566788888889999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
..++..+++|||+++ +|.+++.. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||
T Consensus 72 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 72 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcch
Confidence 999999999999985 78777753 23568999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHhcCCCChhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE--DELRLICSILGPPPDEL 403 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~--~~~~~i~~~~~~~p~~~ 403 (516)
++..............|+..|+|||.+.+.....++|+|||||++|+|++|..||.+.... .....+... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------ 224 (267)
T cd08229 152 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-D------ 224 (267)
T ss_pred hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC-C------
Confidence 9876654333334457899999999998888888899999999999999999999764332 111111110 0
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+...++++.+||.+||..||.+|||+.++++
T Consensus 225 -----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 -----------------YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 001112357789999999999999999999997753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=327.71 Aligned_cols=206 Identities=22% Similarity=0.315 Sum_probs=168.3
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.++.++ +||||+++++++.....+|+||||++ ++|.+++.... ..+++..++.++.|
T Consensus 48 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 127 (297)
T cd05089 48 DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127 (297)
T ss_pred HHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHH
Confidence 466788888888 69999999999999999999999998 58888886532 34888999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGC 368 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGv 368 (516)
|+.||+|||++||+||||||+|||++.++.+||+|||++........ ......+..|+|||.+.+..++.++|+|||||
T Consensus 128 i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~ 206 (297)
T cd05089 128 VATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGV 206 (297)
T ss_pred HHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHH
Confidence 99999999999999999999999999999999999999864321111 11122355799999998888888999999999
Q ss_pred HHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC
Q psy12305 369 IFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ 447 (516)
Q Consensus 369 il~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~ 447 (516)
++|||++ |..||.+.+..+....+.... ....|..++.++.+|+.+||+.||.+
T Consensus 207 il~el~t~g~~pf~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~ 261 (297)
T cd05089 207 LLWEIVSLGGTPYCGMTCAELYEKLPQGY-------------------------RMEKPRNCDDEVYELMRQCWRDRPYE 261 (297)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhcCC-------------------------CCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 9999997 999998877666554442211 11123467899999999999999999
Q ss_pred CCCHHHHHcC
Q psy12305 448 RISAANAMRH 457 (516)
Q Consensus 448 R~ta~e~l~H 457 (516)
|||++++++.
T Consensus 262 Rp~~~~i~~~ 271 (297)
T cd05089 262 RPPFAQISVQ 271 (297)
T ss_pred CcCHHHHHHH
Confidence 9999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=318.71 Aligned_cols=247 Identities=23% Similarity=0.352 Sum_probs=199.6
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|.+. +++.||||.++.....
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~---------------------------------------- 44 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMD---------------------------------------- 44 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCccc----------------------------------------
Confidence 56999999999999999999974 5678999987542110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.++++++||||+++++++.
T Consensus 45 -----------------------------------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 45 -----------------------------------------------------PKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 124566788888888888888888888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
..+..|+||||+. ++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 8889999999996 68998887643 568999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcc-ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPTKT-FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
........ .....++..|+|||.+.+..++.++|+|||||++|||++ |+.||.+.+....+..+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05068 152 VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---------- 221 (261)
T ss_pred EccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence 75422111 111122457999999988888889999999999999999 999998877666555443211
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+...+.++.+++.+||+.||++||++.++++
T Consensus 222 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 222 ---------------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred ---------------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 11123367789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=321.93 Aligned_cols=256 Identities=30% Similarity=0.443 Sum_probs=203.3
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.++||+|+||+||+|++..++..+++|.++.......
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------------------- 41 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL--------------------------------------- 41 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc---------------------------------------
Confidence 58999999999999999999988877788877643211000
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.......+.+|+.+++.++||||+++++++.+
T Consensus 42 ------------------------------------------------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (260)
T cd08222 42 ------------------------------------------------NPNETVQANQEAQLLSKLDHPAIVKFHASFLE 73 (260)
T ss_pred ------------------------------------------------CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc
Confidence 01111245567888888888888888888888
Q ss_pred CceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
....++||||+++ +|..++.. ....+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||++
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~ 152 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVS 152 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCce
Confidence 8899999999985 77766653 3456999999999999999999999999999999999999974 67999999998
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
..............|++.|+|||.+.+..+..++|+||+|+++|+|++|..||.+.........+.. +.++
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~------- 223 (260)
T cd08222 153 RLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP------- 223 (260)
T ss_pred eecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC-------
Confidence 7654433333445678899999998877778889999999999999999999987655444433321 1111
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+..++.++.++|.+||..||++||++.++++||||
T Consensus 224 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 224 ----------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ----------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 1234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=315.72 Aligned_cols=253 Identities=29% Similarity=0.479 Sum_probs=209.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++.+.||+|+||.||+|++..+++.||+|.+.......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~---------------------------------------- 40 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKE---------------------------------------- 40 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCH----------------------------------------
Confidence 5899999999999999999999899999999886532110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.++++++|||++++++++.+
T Consensus 41 --------------------------------------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (254)
T cd06627 41 --------------------------------------------------EALKSIMQEIDLLKNLKHPNIVKYIGSIET 70 (254)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHhCCCCCccEEEEEEEe
Confidence 011256678888888999999999999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
++..++||||+++ +|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 149 (254)
T cd06627 71 SDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKL 149 (254)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceec
Confidence 9999999999985 787777654 56999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
...........++..|+|||.+.+.....++|+||+|+++|+|++|..||...+.......+.. .
T Consensus 150 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~------------- 214 (254)
T cd06627 150 NDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ--D------------- 214 (254)
T ss_pred CCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc--c-------------
Confidence 5444434455779999999998877777889999999999999999999986554333332211 0
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.....+..++..+.+++.+||..+|++|||+.+++.||||
T Consensus 215 ----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 ----------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred ----------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0111234678899999999999999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=321.66 Aligned_cols=206 Identities=21% Similarity=0.373 Sum_probs=169.7
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------NILSMNNVKLFLFQLLRGLAY 295 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~y 295 (516)
.+.+|+.+++.++||||+++++++......++||||++ ++|.+++.... ..+++..+..++.||+.||.|
T Consensus 55 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 134 (277)
T cd05032 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134 (277)
T ss_pred HHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 45678888888999999999999999999999999998 68888886432 236788899999999999999
Q ss_pred HhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHH
Q psy12305 296 CHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEM 373 (516)
Q Consensus 296 LH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~el 373 (516)
||+.+|+||||||+|||++.++.+||+|||+++....... ......+|..|+|||.+.+.....++|+|||||++|||
T Consensus 135 lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 214 (277)
T cd05032 135 LAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214 (277)
T ss_pred HHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHh
Confidence 9999999999999999999999999999999976533221 12234567899999999888888899999999999999
Q ss_pred Hc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH
Q psy12305 374 SS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452 (516)
Q Consensus 374 lt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~ 452 (516)
++ |..||.+.+..+....+.. +. ....|...+.++.+|+.+||+.||++|||+.
T Consensus 215 ~t~g~~p~~~~~~~~~~~~~~~--~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 269 (277)
T cd05032 215 ATLAEQPYQGLSNEEVLKFVID--GG-----------------------HLDLPENCPDKLLELMRMCWQYNPKMRPTFL 269 (277)
T ss_pred hccCCCCCccCCHHHHHHHHhc--CC-----------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 98 9999988776665544431 10 1112345688999999999999999999999
Q ss_pred HHHc
Q psy12305 453 NAMR 456 (516)
Q Consensus 453 e~l~ 456 (516)
++++
T Consensus 270 ~l~~ 273 (277)
T cd05032 270 EIVS 273 (277)
T ss_pred HHHH
Confidence 9975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=316.00 Aligned_cols=284 Identities=31% Similarity=0.530 Sum_probs=219.7
Q ss_pred eeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 94 FKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 94 ~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
+--..||-|+||+||.+.|..+|+.||+|++..... ....+.+.+|++.|...+|.||..++++.....-
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~--------- 126 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANP--------- 126 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCc---------
Confidence 445689999999999999999999999998854322 2223467788888888888887766655433220
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
.+..
T Consensus 127 -----------------------------------------------------dfFq----------------------- 130 (449)
T KOG0664|consen 127 -----------------------------------------------------SFFQ----------------------- 130 (449)
T ss_pred -----------------------------------------------------hHHH-----------------------
Confidence 1111
Q ss_pred ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCC
Q psy12305 253 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSV 332 (516)
Q Consensus 253 ~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~ 332 (516)
.+|.++|++..+|...+.. ...++.+.++.+++||++||+|||+.+|+||||||.|+|++.+..+||||||+|+....
T Consensus 131 -EiYV~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 131 -ELYVLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred -HHHHHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 2577888888888777665 34689999999999999999999999999999999999999999999999999997654
Q ss_pred CC-ccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh-ccc
Q psy12305 333 PT-KTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK-LEF 409 (516)
Q Consensus 333 ~~-~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~-~~~ 409 (516)
.. ...+..+.|-+|+|||++.|... +...|+||+|||+.||+..+..|...+..+++..|...+|+|..+-... .+.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 32 34556678999999999998655 4566889999999999999999999999999999999999998765421 110
Q ss_pred -----cc-CCCCCCc-hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 410 -----CI-TPVYPSE-SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 410 -----~~-~~~~~~~-~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.. .+..++. .-.....|..-..++.+++.++|.+||++|++.++++.|++.....
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 01 1111111 1122333445567889999999999999999999999999987554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=360.82 Aligned_cols=150 Identities=27% Similarity=0.448 Sum_probs=129.6
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|.++++||+|+||+||+|++..+++.||||++........
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~------------------------------------ 45 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINK------------------------------------ 45 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCH------------------------------------
Confidence 36789999999999999999999999999999999864321100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+++.++||||++++++
T Consensus 46 -----------------------------------------------------~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 72 (669)
T cd05610 46 -----------------------------------------------------NMVHQVQAERDALALSKSPFIVHLYYS 72 (669)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhcCCCCcCeEEEE
Confidence 011246678888899999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+....++||||||+. ++|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 73 ~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls 151 (669)
T cd05610 73 LQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151 (669)
T ss_pred EEECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCC
Confidence 999999999999997 5888887654 45899999999999999999999999999999999999999999999999998
Q ss_pred c
Q psy12305 328 R 328 (516)
Q Consensus 328 ~ 328 (516)
+
T Consensus 152 ~ 152 (669)
T cd05610 152 K 152 (669)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=314.18 Aligned_cols=252 Identities=29% Similarity=0.470 Sum_probs=207.6
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|+..+.||+|+||.||+|.+..+++.||+|++.....
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~------------------------------------------ 38 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK------------------------------------------ 38 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch------------------------------------------
Confidence 48899999999999999999988999999998865321
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
.....+.+|+.+++.++||||+++++++..
T Consensus 39 --------------------------------------------------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 68 (253)
T cd05122 39 --------------------------------------------------EKKEKIINEIQILKKCKHPNIVKYYGSYLK 68 (253)
T ss_pred --------------------------------------------------hHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 011256678888888889999999999988
Q ss_pred CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
+...++++||++ ++|.+++......+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+...
T Consensus 69 ~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~ 148 (253)
T cd05122 69 KDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148 (253)
T ss_pred CCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccc
Confidence 899999999999 5888888776567999999999999999999999999999999999999999999999999998766
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
..... .....++..|+|||.+.+.....++|+|||||++|+|++|..||...+.......+.. ...+
T Consensus 149 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---------- 215 (253)
T cd05122 149 SDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT--NGPP---------- 215 (253)
T ss_pred ccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh--cCCC----------
Confidence 53322 3445678999999999887778889999999999999999999987654444333321 1000
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
....+..++..+.++|.+||+.||++|||+.++++|||
T Consensus 216 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 216 -----------GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred -----------CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 01111234788999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=334.36 Aligned_cols=240 Identities=20% Similarity=0.235 Sum_probs=173.9
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.+++.++||||++++++|..+...|+||||+.+ ++.+++.... ..+++..+..++.||+.||+|||++||+|
T Consensus 45 ~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH 124 (328)
T cd08226 45 ALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIH 124 (328)
T ss_pred HHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 566788888889999999999999999999999999994 8888776542 45899999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCcc-------ccCCcccccccchhhccCC--CCCCceeeehHHHHHHHHH
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKT-------FSNEVVTLWYRPPDVLLGS--TEYSTSIDMGVGCIFHEMS 374 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~-------~~~~~gt~~y~APE~l~~~--~~~~~~d~~SlGvil~ell 374 (516)
|||||+|||++.++.+|++|||.+......... .....++..|+|||++.+. .+...+|+||+||++|+|+
T Consensus 125 rDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~ 204 (328)
T cd08226 125 RNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELA 204 (328)
T ss_pred CCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999865432211110 0112346679999998764 3567889999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc-----------c-------ccCC---CCCCchhhhhcCCCCCCHHH
Q psy12305 375 SGRPLFPGSTIEDELRLICSILGPPPDELKSKLE-----------F-------CITP---VYPSESKLQLLAPEQMDSDA 433 (516)
Q Consensus 375 tG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~-----------~-------~~~~---~~~~~~~~~~~~p~~~s~~~ 433 (516)
+|.+||.+......+..+.......|........ . .... ............+...++++
T Consensus 205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (328)
T cd08226 205 TGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284 (328)
T ss_pred hCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHH
Confidence 9999998766554443333221111110000000 0 0000 00000011111223467889
Q ss_pred HHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 434 LDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 434 ~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.+||++||++||++|||++++++||||.....
T Consensus 285 ~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 285 QNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred HHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 99999999999999999999999999976543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=341.76 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=209.5
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeeccc---ccCChhhHHHHHHHHHhccccceeeEeeeEeeCce--eeEeeeh
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC--LTLVFEY 261 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~lV~E~ 261 (516)
....|+|+|-+||+|.+..+|..||+-.++... ......++..|+.+|+.|+||||+++|++|.+... +.+|+|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 455689999999999999999999998887654 33334688899999999999999999999987654 8899999
Q ss_pred hh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccC-CCEEEeeeccccccCCCCccc
Q psy12305 262 LE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTF 337 (516)
Q Consensus 262 ~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~-~~vkL~DFGla~~~~~~~~~~ 337 (516)
+. |+|..|+++.+ .++.+.++.|++||+.||.|||++. |||||||.+||+|+.+ |.|||+|+|||....... .
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~--a 201 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH--A 201 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc--c
Confidence 98 79999998865 5899999999999999999999985 9999999999999865 899999999998875433 3
Q ss_pred cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCC
Q psy12305 338 SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG-STIEDELRLICSILGPPPDELKSKLEFCITPVYP 416 (516)
Q Consensus 338 ~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~-~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~ 416 (516)
...+|||.|||||+.. ..|+...|+||||+++.||+|+..||.. .+....+.++.+ |..|..+..
T Consensus 202 ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~S--GiKP~sl~k----------- 267 (632)
T KOG0584|consen 202 KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTS--GIKPAALSK----------- 267 (632)
T ss_pred ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHc--CCCHHHhhc-----------
Confidence 3479999999999986 5688899999999999999999999976 445555555543 334433311
Q ss_pred CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 417 ~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
--++++++||.+||.. ..+|+||.|+|+||||..-
T Consensus 268 -----------V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 -----------VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred -----------cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 2368999999999999 9999999999999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=318.41 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=199.8
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHH
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKR 268 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~ 268 (516)
.+.|+||.||+|+++.++..||+|.+...........+.+|+.+++.++||||+++++++......++||||+. ++|.+
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 82 (252)
T cd05084 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 82 (252)
T ss_pred cCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHH
Confidence 57899999999999999999999998755444445578899999999999999999999999999999999998 48888
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccc--cCCcccccc
Q psy12305 269 YMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF--SNEVVTLWY 346 (516)
Q Consensus 269 ~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~y 346 (516)
++......+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......... ....++..|
T Consensus 83 ~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y 162 (252)
T cd05084 83 FLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW 162 (252)
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceee
Confidence 887666678999999999999999999999999999999999999999999999999987543211111 111224569
Q ss_pred cchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcC
Q psy12305 347 RPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425 (516)
Q Consensus 347 ~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (516)
+|||.+.+..+..++|+|||||++|||++ |.+||...+.......+... .....
T Consensus 163 ~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~-------------------------~~~~~ 217 (252)
T cd05084 163 TAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG-------------------------VRLPC 217 (252)
T ss_pred cCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC-------------------------CCCCC
Confidence 99999988888889999999999999998 89999766555443333211 01122
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 426 p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+...+..+.+|+.+||+.||++|||+.++++
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3466889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=326.67 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=207.1
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHH
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKR 268 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~ 268 (516)
.+.|+||.||+|.+..++..||+|.++..........+.+|+.+++.++||||+++++.+..++..|+||||+++ +|.+
T Consensus 12 l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (277)
T cd06642 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD 91 (277)
T ss_pred hcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHH
Confidence 578999999999999999999999987654444455788999999999999999999999999999999999995 7777
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccc
Q psy12305 269 YMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRP 348 (516)
Q Consensus 269 ~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~A 348 (516)
++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..............|+..|+|
T Consensus 92 ~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~a 169 (277)
T cd06642 92 LLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMA 169 (277)
T ss_pred Hhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccC
Confidence 7653 45899999999999999999999999999999999999999999999999999765543333334567899999
Q ss_pred hhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCC
Q psy12305 349 PDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428 (516)
Q Consensus 349 PE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 428 (516)
||.+.+..+..++|+|||||++|||++|..||...........+.. + .....+..
T Consensus 170 PE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~--~-----------------------~~~~~~~~ 224 (277)
T cd06642 170 PEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPK--N-----------------------SPPTLEGQ 224 (277)
T ss_pred HHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhc--C-----------------------CCCCCCcc
Confidence 9999888888899999999999999999999976544333222110 0 00112235
Q ss_pred CCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 429 ~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.+.++.+||.+||..+|++|||+.++++||||....
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 225 YSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 678899999999999999999999999999997654
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.20 Aligned_cols=233 Identities=20% Similarity=0.297 Sum_probs=184.7
Q ss_pred CCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC----------
Q psy12305 206 TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------- 274 (516)
Q Consensus 206 ~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------- 274 (516)
.+..||+|.+...........+.+|+.++++++||||+++++++..+...++||||+. ++|..++....
T Consensus 45 ~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05051 45 APVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124 (296)
T ss_pred CceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccC
Confidence 4567888887755444444567889999999999999999999999999999999998 58888887643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhc
Q psy12305 275 NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVL 352 (516)
Q Consensus 275 ~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l 352 (516)
..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++...... .......+|+.|+|||.+
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 204 (296)
T cd05051 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESV 204 (296)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHh
Confidence 258999999999999999999999999999999999999999999999999987643222 112234557889999999
Q ss_pred cCCCCCCceeeehHHHHHHHHHc--CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCC
Q psy12305 353 LGSTEYSTSIDMGVGCIFHEMSS--GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMD 430 (516)
Q Consensus 353 ~~~~~~~~~d~~SlGvil~ellt--G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s 430 (516)
.+..+..++|+|||||++|||++ |..||...+..+.+..+........ .......+...+
T Consensus 205 ~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~ 266 (296)
T cd05051 205 LLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDG------------------RQIYLPRPPNCP 266 (296)
T ss_pred hcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccc------------------ccccCCCccCCC
Confidence 88788899999999999999998 7788877665555544432211000 000111233567
Q ss_pred HHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 431 SDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 431 ~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.++.+|+.+||+.||.+|||+.++++
T Consensus 267 ~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 267 KDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHHHHhccChhcCCCHHHHHH
Confidence 89999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=320.69 Aligned_cols=206 Identities=18% Similarity=0.290 Sum_probs=157.6
Q ss_pred HHHHHHHHHhccccceeeEeeeEeeCc------eeeEeeehhh-chHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHH
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHTEK------CLTLVFEYLE-KDLKRYMDDC-----SNILSMNNVKLFLFQLLRGLA 294 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~~~------~~~lV~E~~~-g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~ 294 (516)
+.+|+.+++.++||||+++++++.... ..++||||+. ++|..++... ...+++..+..++.|++.||.
T Consensus 48 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~ 127 (273)
T cd05035 48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME 127 (273)
T ss_pred HHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHH
Confidence 344555555555555555555543322 4799999998 5787776432 235899999999999999999
Q ss_pred HHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCcc--ccCCcccccccchhhccCCCCCCceeeehHHHHHHH
Q psy12305 295 YCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHE 372 (516)
Q Consensus 295 yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~e 372 (516)
|||+++|+||||||+||++++++.+||+|||+++........ .....++..|+|||.+.+..+..++|+|||||++||
T Consensus 128 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~e 207 (273)
T cd05035 128 YLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWE 207 (273)
T ss_pred HHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHH
Confidence 999999999999999999999999999999999865432211 112234678999999988888889999999999999
Q ss_pred HHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH
Q psy12305 373 MSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451 (516)
Q Consensus 373 llt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta 451 (516)
|++ |.+||.+....+.+..+... .....|...+.++.+++.+||+.||++|||+
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 262 (273)
T cd05035 208 IATRGQTPYPGVENHEIYDYLRHG-------------------------NRLKQPEDCLDELYDLMYSCWRADPKDRPTF 262 (273)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC-------------------------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999 99999887665554433221 0111234678899999999999999999999
Q ss_pred HHHHcC
Q psy12305 452 ANAMRH 457 (516)
Q Consensus 452 ~e~l~H 457 (516)
.+++++
T Consensus 263 ~e~~~~ 268 (273)
T cd05035 263 TKLREV 268 (273)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=320.16 Aligned_cols=250 Identities=32% Similarity=0.490 Sum_probs=208.8
Q ss_pred ccceeeEEEEEEEecCCceEEEEEeecccc--cCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHH
Q psy12305 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLK 267 (516)
Q Consensus 191 ~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~ 267 (516)
+.|+||.||++.+..+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+..+...|+||||+.+ +|.
T Consensus 2 g~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (265)
T cd05579 2 SKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLA 81 (265)
T ss_pred CCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHH
Confidence 579999999999999999999999875432 23445678899999999999999999999999999999999985 888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--------cccC
Q psy12305 268 RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--------TFSN 339 (516)
Q Consensus 268 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--------~~~~ 339 (516)
.++...+ .+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++........ ....
T Consensus 82 ~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 82 SLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 8877644 689999999999999999999999999999999999999999999999999876443211 2234
Q ss_pred CcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCch
Q psy12305 340 EVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419 (516)
Q Consensus 340 ~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~ 419 (516)
..++..|+|||.+.+.....++|+|||||++|+|++|..||......+....+....-.++
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------- 221 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP------------------- 221 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC-------------------
Confidence 4678899999999887778889999999999999999999988776655544432110000
Q ss_pred hhhhcCCCCCCHHHHHHHHHccccCcCCCCCH---HHHHcCCCCCCCCC
Q psy12305 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISA---ANAMRHPYFNSLGP 465 (516)
Q Consensus 420 ~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta---~e~l~Hp~f~~~~~ 465 (516)
.....+..+.+|+.+||+.||++|||+ .++++||||+++.|
T Consensus 222 -----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 -----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred -----ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 001248899999999999999999999 99999999987754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=319.21 Aligned_cols=247 Identities=25% Similarity=0.341 Sum_probs=194.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.++||+|+||+||+|++..+ ..||||++..... .
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~------------------------------------- 44 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S------------------------------------- 44 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--C-------------------------------------
Confidence 35699999999999999999998655 4699998764211 0
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+++.++||||+++++.+
T Consensus 45 ------------------------------------------------------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (262)
T cd05071 45 ------------------------------------------------------PEAFLQEAQVMKKLRHEKLVQLYAVV 70 (262)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 11355677777777777777777766
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
. +...|+||||+. ++|.+++... +..+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 71 S-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred C-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCce
Confidence 4 345789999998 5888888753 345889999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcc-ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPTKT-FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+........ .....++..|+|||.+.+..++..+|+|||||++|+|++ |..||.+....+....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-------- 221 (262)
T cd05071 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-------- 221 (262)
T ss_pred eeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC--------
Confidence 765432221 122345778999999988888889999999999999999 8999988766655544422110
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...+..++.++.+|+.+||+.||++|||+.++++
T Consensus 222 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 222 -----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 1112357889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=317.56 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=196.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||.||+|.+. +++.||+|.+......
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---------------------------------------- 44 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---------------------------------------- 44 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----------------------------------------
Confidence 56999999999999999999864 6788999987532110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+++.++||||+++++++.
T Consensus 45 -----------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 45 -----------------------------------------------------PEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 124556777777778888888877763
Q ss_pred eCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
....++||||+. ++|.+++... +..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 456899999998 5888887653 3468999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
...... .......++..|+|||++.+..+..++|+|||||++|||++ |++||.+.+..+....+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 220 (260)
T cd05067 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY---------- 220 (260)
T ss_pred ecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCC----------
Confidence 654222 12223345678999999988888889999999999999999 999998877665554442211
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+...+.++.+|+.+||..||++|||++++++
T Consensus 221 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 221 ---------------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11123466789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=327.49 Aligned_cols=207 Identities=23% Similarity=0.394 Sum_probs=169.9
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++.+ +||||+++++++...+..|+||||+. ++|.+++.... ..+++..+..++.|
T Consensus 69 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 148 (307)
T cd05098 69 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQ 148 (307)
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence 566788999999 79999999999999999999999998 58998887642 24788999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCcc--ccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
++.||+|||++|++||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..+..++|+|||
T Consensus 149 i~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 228 (307)
T cd05098 149 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 228 (307)
T ss_pred HHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHH
Confidence 999999999999999999999999999999999999998765322111 111233568999999988888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|||++ |..||.+....+....+... .....|...+.++.+|+.+||..+|
T Consensus 229 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p 283 (307)
T cd05098 229 GVLLWEIFTLGGSPYPGVPVEELFKLLKEG-------------------------HRMDKPSNCTNELYMMMRDCWHAVP 283 (307)
T ss_pred HHHHHHHHcCCCCCCCcCCHHHHHHHHHcC-------------------------CCCCCCCcCCHHHHHHHHHHcccCh
Confidence 999999998 89999877665544443211 0112234678899999999999999
Q ss_pred CCCCCHHHHHcC
Q psy12305 446 KQRISAANAMRH 457 (516)
Q Consensus 446 ~~R~ta~e~l~H 457 (516)
++|||+.+++++
T Consensus 284 ~~Rps~~evl~~ 295 (307)
T cd05098 284 SQRPTFKQLVED 295 (307)
T ss_pred hhCcCHHHHHHH
Confidence 999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=317.01 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=202.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.......
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-------------------------------------- 43 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA-------------------------------------- 43 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccch--------------------------------------
Confidence 679999999999999999999998999999998864321110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.++++++|+||+++++++.
T Consensus 44 ---------------------------------------------------~~~~~~~~ei~~l~~~~~~~i~~~~~~~~ 72 (267)
T cd08224 44 ---------------------------------------------------KARQDCLKEIDLLKQLDHPNVIKYLASFI 72 (267)
T ss_pred ---------------------------------------------------hhHHHHHHHHHHHHhCCCCCeeeeeeeee
Confidence 11225667888888888999999999998
Q ss_pred eCceeeEeeehhh-chHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.++..++||||++ ++|..++... ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||+
T Consensus 73 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~ 152 (267)
T cd08224 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred cCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccce
Confidence 8899999999998 4888877642 34589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI--EDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~--~~~~~~i~~~~~~~p~~~~ 404 (516)
+..............+++.|+|||.+.+..+..++|+||+||++|+|++|..||..... .+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 224 (267)
T cd08224 153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD-------- 224 (267)
T ss_pred eeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC--------
Confidence 87654433333445688999999999888888899999999999999999999965432 11111111100
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.........+.++.++|.+||..+|++|||+.++++
T Consensus 225 ----------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 ----------------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000111256788999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=326.14 Aligned_cols=207 Identities=21% Similarity=0.372 Sum_probs=168.6
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+++++ +||||+++++++...+..|+||||+. ++|.+++.... ..+++..+..++.||+.||+|||+++|+
T Consensus 84 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~iv 163 (302)
T cd05055 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCI 163 (302)
T ss_pred HHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 466788888888 78999999999988889999999998 68888887543 3489999999999999999999999999
Q ss_pred eeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCC
Q psy12305 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPL 379 (516)
Q Consensus 303 HrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~p 379 (516)
|+||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|+||+||++|||++ |.+|
T Consensus 164 H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p 243 (302)
T cd05055 164 HRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243 (302)
T ss_pred hhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999976543221 1122345788999999988888889999999999999998 9999
Q ss_pred CCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 380 FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
|.+....+......... .....+...++++.+|+.+||..||++|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 244 YPGMPVDSKFYKLIKEG------------------------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred cCCCCchHHHHHHHHcC------------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 98766554443332210 011123356789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=352.11 Aligned_cols=220 Identities=29% Similarity=0.414 Sum_probs=187.4
Q ss_pred EEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------C----
Q psy12305 210 VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------N---- 275 (516)
Q Consensus 210 vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------~---- 275 (516)
||||.++...+......|.+|+++|..++|||||+|+|++..++.+|+|||||. |||.++|..+. .
T Consensus 519 VAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~ 598 (774)
T KOG1026|consen 519 VAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPP 598 (774)
T ss_pred hhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCC
Confidence 333444333333345688999999999999999999999999999999999999 89999998642 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhcc
Q psy12305 276 ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLL 353 (516)
Q Consensus 276 ~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~ 353 (516)
+++..+...++.||+.|++||-++.+|||||-..|+||+++..|||+|||++|..-..+. ...+..-...|||||.|+
T Consensus 599 ~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIl 678 (774)
T KOG1026|consen 599 PLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESIL 678 (774)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhh
Confidence 278889999999999999999999999999999999999999999999999986432221 111233478899999999
Q ss_pred CCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHH
Q psy12305 354 GSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSD 432 (516)
Q Consensus 354 ~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 432 (516)
.+.+++.+|+||+||+|||+++ |..|+.+.+.++.+..|.+ ... ...|++++.+
T Consensus 679 y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~------------------------g~l-L~~Pe~CP~~ 733 (774)
T KOG1026|consen 679 YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA------------------------GQL-LSCPENCPTE 733 (774)
T ss_pred cCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc------------------------CCc-ccCCCCCCHH
Confidence 9999999999999999999999 9999999999998888854 222 5567899999
Q ss_pred HHHHHHHccccCcCCCCCHHHH
Q psy12305 433 ALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 433 ~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
+.+|+..||+.+|.+||++.||
T Consensus 734 vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 734 VYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHHHHHhhcCcccCCCHHHH
Confidence 9999999999999999999987
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=317.33 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=195.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|+++++||+|+||.||+|.+. ++..||+|.+......
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~--------------------------------------- 44 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS--------------------------------------- 44 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---------------------------------------
Confidence 357999999999999999999875 5677999987542210
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.++++++||||+++++++
T Consensus 45 ------------------------------------------------------~~~~~~E~~~l~~l~~~~i~~~~~~~ 70 (260)
T cd05070 45 ------------------------------------------------------PESFLEEAQIMKKLRHDKLVQLYAVV 70 (260)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhcCCCceEEEEeEE
Confidence 11355677777777777777777776
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
. ....++||||+. ++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 71 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 71 S-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred C-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceee
Confidence 4 445789999998 5888888754 345899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
........ ......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||.+.+..+....+....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------- 220 (260)
T cd05070 150 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--------- 220 (260)
T ss_pred eeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------
Confidence 76543221 1122345678999999988888889999999999999999 899998877666555543211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
....+...+..+.+|+.+||..||++|||++++.
T Consensus 221 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 221 ----------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred ----------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 1112346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=319.08 Aligned_cols=206 Identities=21% Similarity=0.308 Sum_probs=170.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++..++..|+||||++ ++|.+++......+++..+..++.|++.||.|||++|++||
T Consensus 51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~ 130 (267)
T cd05066 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHR 130 (267)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeh
Confidence 46678888888999999999999998899999999998 58888888766678999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcc---ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKT---FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.++|+|||++......... .....++..|+|||.+.+..+..++|+|||||++||+++ |..||
T Consensus 131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred hhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 99999999999999999999999865432221 112223568999999988888889999999999999886 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+.+..+....+..... ...+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus 211 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 211 WEMSNQDVIKAIEEGYR-------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ccCCHHHHHHHHhCCCc-------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 87766655544432111 1122356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=312.96 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=207.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|.+.+.||+|+||.||+|.+..+++.||+|++......
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~----------------------------------------- 39 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS----------------------------------------- 39 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-----------------------------------------
Confidence 488899999999999999999989999999988654211
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
......+.+|+.++++++||||+++++.+..
T Consensus 40 -------------------------------------------------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (260)
T cd06606 40 -------------------------------------------------EEELEALEREIRILSSLQHPNIVRYYGSERD 70 (260)
T ss_pred -------------------------------------------------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEec
Confidence 0112256678888888888888888888888
Q ss_pred C--ceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 252 E--KCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 252 ~--~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
. ...++|+||++ ++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 71 ~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~ 149 (260)
T cd06606 71 EEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK 149 (260)
T ss_pred CCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEE
Confidence 7 88999999996 58888877654 79999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
....... ......++..|+|||.+.+.....++|+|||||++|+|++|..||..... ....+.....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~--------- 218 (260)
T cd06606 150 RLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYKIGS--------- 218 (260)
T ss_pred ecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHhccc---------
Confidence 7654432 13445678999999999887788899999999999999999999987651 1112211110
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.......|...+..+.+||.+||+.||++||++.++++||||
T Consensus 219 ------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 219 ------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 011112344678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.48 Aligned_cols=207 Identities=22% Similarity=0.355 Sum_probs=178.5
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+++|++++|||||++||+...+..++||||+|. |+|.+++.+.+..++..+...++.+.+.||+|||++++|||
T Consensus 207 e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHR 286 (474)
T KOG0194|consen 207 EFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHR 286 (474)
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcch
Confidence 67788889999999999999999999999999999999 59999999988789999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGS 383 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~ 383 (516)
||-.+|+|++.++.+||+|||+++............--...|+|||.+....++.++|+|||||++||+++ |..||++.
T Consensus 287 DIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 287 DIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred hHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 99999999999999999999999876422211111124678999999999889999999999999999999 88999999
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...+....|.. ...+...|...+.++..++.+|+..||++|||+.++.+
T Consensus 367 ~~~~v~~kI~~------------------------~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 367 KNYEVKAKIVK------------------------NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CHHHHHHHHHh------------------------cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 98888877743 22333445577888999999999999999999988753
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.78 Aligned_cols=252 Identities=25% Similarity=0.398 Sum_probs=205.2
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|++.++||+|+||.||+|.+..+++.||||.+........
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--------------------------------------- 41 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQK--------------------------------------- 41 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHH---------------------------------------
Confidence 58999999999999999999999999999998865321110
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+++.++||||+++++++..
T Consensus 42 ---------------------------------------------------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 70 (256)
T cd08530 42 ---------------------------------------------------EREDAVNEIRILASVNHPNIISYKEAFLD 70 (256)
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhCCCCCchhhhhhhcc
Confidence 01134567777888888888888888888
Q ss_pred CceeeEeeehhhc-hHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
....|+||||+++ +|..++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccch
Confidence 8889999999985 788877652 356899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
...... ......+++.|+|||.+.+..+..++|+||+|+++|+|++|+.||...+.......+.....
T Consensus 151 ~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 218 (256)
T cd08530 151 KVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY---------- 218 (256)
T ss_pred hhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC----------
Confidence 776543 22335678999999999888788889999999999999999999988766544333321100
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...+...+.++.+++.+||+.+|++|||+.++++||++
T Consensus 219 ---------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 ---------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred ---------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 01123567899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.66 Aligned_cols=230 Identities=20% Similarity=0.298 Sum_probs=177.6
Q ss_pred eEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------CC
Q psy12305 209 LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-----------NI 276 (516)
Q Consensus 209 ~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-----------~~ 276 (516)
.||+|.++..........+.+|++++++++||||+++++++......++||||+. ++|.+++.... ..
T Consensus 46 ~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 125 (295)
T cd05097 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125 (295)
T ss_pred EEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCc
Confidence 4666666544333333467889999999999999999999999999999999998 48888775432 13
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccC
Q psy12305 277 LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLG 354 (516)
Q Consensus 277 l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~ 354 (516)
+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++....... ......++..|+|||++.+
T Consensus 126 ~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 205 (295)
T cd05097 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205 (295)
T ss_pred ccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc
Confidence 67888999999999999999999999999999999999999999999999976432211 1122345778999999988
Q ss_pred CCCCCceeeehHHHHHHHHHc--CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHH
Q psy12305 355 STEYSTSIDMGVGCIFHEMSS--GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSD 432 (516)
Q Consensus 355 ~~~~~~~d~~SlGvil~ellt--G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 432 (516)
..++.++|+|||||++|+|++ |..||...+..+....+........ .......+...++.
T Consensus 206 ~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~ 267 (295)
T cd05097 206 GKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQG------------------RQIYLSQTPLCPSP 267 (295)
T ss_pred CCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcc------------------ccccCCCCCCCCHH
Confidence 888899999999999999998 6788887666555444332110000 00001123356789
Q ss_pred HHHHHHHccccCcCCCCCHHHHHc
Q psy12305 433 ALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 433 ~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+.+|+.+||..||++|||++++++
T Consensus 268 l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 268 VFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=321.82 Aligned_cols=206 Identities=22% Similarity=0.352 Sum_probs=168.9
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC--------------CCCCHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS--------------NILSMNNVKLFLFQLL 290 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~ 290 (516)
.+.+|+.+++.++||||+++++++......++||||+. ++|.+++.... ..+++..+..++.||+
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 132 (280)
T cd05092 53 DFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132 (280)
T ss_pred HHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHH
Confidence 56678888888899999999999988889999999998 58888886543 2478899999999999
Q ss_pred HHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHH
Q psy12305 291 RGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGC 368 (516)
Q Consensus 291 ~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGv 368 (516)
.||+|||++||+||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|+|||||
T Consensus 133 ~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 212 (280)
T cd05092 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGV 212 (280)
T ss_pred HHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHH
Confidence 999999999999999999999999999999999999875432211 112234577899999998888888999999999
Q ss_pred HHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC
Q psy12305 369 IFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ 447 (516)
Q Consensus 369 il~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~ 447 (516)
++|||++ |.+||......+....+.... ....+..+++.+.+||.+||+.||.+
T Consensus 213 il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~cl~~~P~~ 267 (280)
T cd05092 213 VLWEIFTYGKQPWYQLSNTEAIECITQGR-------------------------ELERPRTCPPEVYAIMQGCWQREPQQ 267 (280)
T ss_pred HHHHHHcCCCCCCccCCHHHHHHHHHcCc-------------------------cCCCCCCCCHHHHHHHHHHccCChhh
Confidence 9999998 999998766655544442211 11223467889999999999999999
Q ss_pred CCCHHHHHc
Q psy12305 448 RISAANAMR 456 (516)
Q Consensus 448 R~ta~e~l~ 456 (516)
||+++++++
T Consensus 268 Rp~~~~l~~ 276 (280)
T cd05092 268 RMVIKDIHS 276 (280)
T ss_pred CCCHHHHHH
Confidence 999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=316.50 Aligned_cols=204 Identities=23% Similarity=0.330 Sum_probs=163.4
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++. .+..++||||+. ++|.+++.... .+++..+..++.|++.||+|||.++++||
T Consensus 42 ~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~ 119 (257)
T cd05060 42 EFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHR 119 (257)
T ss_pred HHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 4556777777777888888877665 345799999998 58988887654 68999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcccc---CCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFS---NEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~---~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.+||+|||+++.......... ...++..|+|||.+.+..+..++|+|||||++|+|++ |.+||
T Consensus 120 di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred CcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999986543322211 1123467999999988888889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...+..+....+... .....|..++..+.++|.+||..||++|||+.++++
T Consensus 200 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 200 GEMKGAEVIAMLESG-------------------------ERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ccCCHHHHHHHHHcC-------------------------CcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 876665544443221 011234467889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.04 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=201.3
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||.||+|.+. +++.+|+|.+......
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~--------------------------------------- 42 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS--------------------------------------- 42 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC---------------------------------------
Confidence 357999999999999999999885 5778999987532110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.++++++||||+++++++
T Consensus 43 ------------------------------------------------------~~~~~~e~~~l~~l~~~~i~~~~~~~ 68 (256)
T cd05112 43 ------------------------------------------------------EEDFIEEAQVMMKLSHPKLVQLYGVC 68 (256)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 11456788888888899999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
......++||||+.+ +|.+++......+++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++
T Consensus 69 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred ccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCccee
Confidence 888899999999985 7888887666678999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
....... ......++..|+|||.+.+..+..++|+||+||++|||++ |..||...........+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~----------- 217 (256)
T cd05112 149 FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG----------- 217 (256)
T ss_pred ecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-----------
Confidence 5432211 1122334678999999988888888999999999999998 99999877665554444211
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.....|...+..+.+|+.+||+.+|++|||+.+++++
T Consensus 218 --------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 218 --------------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 1112233567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=316.33 Aligned_cols=204 Identities=21% Similarity=0.314 Sum_probs=164.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++. ....++||||++ ++|.+++... ..+++..+..++.|++.||+|||++||+||
T Consensus 42 ~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~ 119 (257)
T cd05116 42 ELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHR 119 (257)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 4566777777788888888887765 345789999999 5788887654 468999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcc---ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKT---FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||.||+++.++.+||+|||+++........ .....+++.|+|||.+.+.....++|+|||||++|||++ |.+||
T Consensus 120 dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 199 (257)
T cd05116 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199 (257)
T ss_pred ccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999765433221 122234678999999987777888999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+....+....+.... ....|..+++++.+||.+||+.||++||+++++..
T Consensus 200 ~~~~~~~~~~~i~~~~-------------------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 200 KGMKGNEVTQMIESGE-------------------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCCHHHHHHHHHCCC-------------------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 8877666555543211 11234468899999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=315.34 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=201.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.++||+|+||+||+|.+. +++.||||.+.....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---------------------------------------- 43 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM---------------------------------------- 43 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----------------------------------------
Confidence 467999999999999999999975 568899998753211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+++.++||||+++++++
T Consensus 44 -----------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~ 70 (261)
T cd05034 44 -----------------------------------------------------SPEAFLQEAQIMKKLRHDKLVQLYAVC 70 (261)
T ss_pred -----------------------------------------------------CHHHHHHHHHHHhhCCCCCEeeeeeee
Confidence 012456788888888888889999988
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
..+...++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 71 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~ 150 (261)
T cd05034 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150 (261)
T ss_pred ecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccc
Confidence 88888999999998 58888887643 46899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+....... ......++..|+|||.+.+.....++|+||+||++|+|++ |+.||.+.+....+..+.....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 222 (261)
T cd05034 151 RLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR-------- 222 (261)
T ss_pred eeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------
Confidence 76542211 1112234668999999988888888999999999999998 9999988777666655533211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...+...+.++.+++.+||+.||++|||++++.+
T Consensus 223 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 -----------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -----------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1123356789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=318.50 Aligned_cols=206 Identities=18% Similarity=0.294 Sum_probs=155.7
Q ss_pred HHHHHHHHHhccccceeeEeeeEee------CceeeEeeehhh-chHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHH
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHT------EKCLTLVFEYLE-KDLKRYMDD-----CSNILSMNNVKLFLFQLLRGLA 294 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~------~~~~~lV~E~~~-g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~ 294 (516)
+.+|+.+++.++||||+++++++.. ....+++|||+. ++|..++.. ....+++..+..++.||+.||+
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 126 (272)
T cd05075 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126 (272)
T ss_pred HHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHH
Confidence 3344555555555555555544321 124789999998 588777642 2245889999999999999999
Q ss_pred HHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHH
Q psy12305 295 YCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHE 372 (516)
Q Consensus 295 yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~e 372 (516)
|||+++|+||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|+|||||++||
T Consensus 127 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~e 206 (272)
T cd05075 127 YLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWE 206 (272)
T ss_pred HHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999986543221 1122245778999999988888889999999999999
Q ss_pred HHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH
Q psy12305 373 MSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451 (516)
Q Consensus 373 llt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta 451 (516)
|++ |.+||.+....+....+.... ....+..++..+.++|.+||+.||++|||+
T Consensus 207 l~~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 261 (272)
T cd05075 207 IATRGQTPYPGVENSEIYDYLRQGN-------------------------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSF 261 (272)
T ss_pred HHcCCCCCCCCCCHHHHHHHHHcCC-------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence 999 899998876655444432210 011233677889999999999999999999
Q ss_pred HHHHcC
Q psy12305 452 ANAMRH 457 (516)
Q Consensus 452 ~e~l~H 457 (516)
++++++
T Consensus 262 ~~l~~~ 267 (272)
T cd05075 262 ETLRCE 267 (272)
T ss_pred HHHHHH
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=322.46 Aligned_cols=218 Identities=24% Similarity=0.380 Sum_probs=172.4
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.++.++ +||||+++++.+..+...|+||||+.+ +|..++... ..+++..++.++.|++.||.|||+.+++|
T Consensus 50 ~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H 128 (288)
T cd05583 50 HTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIY 128 (288)
T ss_pred HHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 456788888888 589999999999999999999999984 888887653 45899999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCcc-ccCCcccccccchhhccCCC--CCCceeeehHHHHHHHHHcCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKT-FSNEVVTLWYRPPDVLLGST--EYSTSIDMGVGCIFHEMSSGRPLF 380 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~APE~l~~~~--~~~~~d~~SlGvil~elltG~~pF 380 (516)
|||||.||+++.++.++|+|||+++........ .....|+..|+|||.+.+.. ...++|+||||+++|+|++|..||
T Consensus 129 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~ 208 (288)
T cd05583 129 RDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208 (288)
T ss_pred cCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence 999999999999999999999998765432221 22346789999999987654 567889999999999999999999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC---HHHHHcC
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS---AANAMRH 457 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t---a~e~l~H 457 (516)
...........+.... .......|..++.++.++|.+||+.||++||| +.++|+|
T Consensus 209 ~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 209 TVDGEQNSQSEISRRI----------------------LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ccCcccchHHHHHHHH----------------------HccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 6432211111111100 00011123457889999999999999999998 5678999
Q ss_pred CCCCCCCCC
Q psy12305 458 PYFNSLGPQ 466 (516)
Q Consensus 458 p~f~~~~~~ 466 (516)
|||+.+.+.
T Consensus 267 ~~~~~~~~~ 275 (288)
T cd05583 267 PFFQGIDWD 275 (288)
T ss_pred cccccCCHH
Confidence 999988664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.31 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=201.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCc---EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~---~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
++|+..+.||+|+||.||+|++..+++ .||||.+......
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~------------------------------------- 47 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE------------------------------------- 47 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH-------------------------------------
Confidence 578999999999999999999876665 6888877543110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.+++.++||||+++++
T Consensus 48 ------------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~ 73 (268)
T cd05063 48 ------------------------------------------------------KQRQDFLSEASIMGQFSHHNIIRLEG 73 (268)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhcCCCCCeeEEEE
Confidence 01124567888888889999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++...+..++||||+++ +|..++......+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+
T Consensus 74 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 74 VVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred EEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCcc
Confidence 99998999999999994 88888877667799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcc-cc--CCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 327 ARAKSVPTKT-FS--NEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 327 a~~~~~~~~~-~~--~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
+......... .. ....+..|+|||++.+..++.++|+|||||++|||++ |..||...+..+....+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~---- 229 (268)
T cd05063 154 SRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---- 229 (268)
T ss_pred ceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC----
Confidence 8765432211 11 1123457999999988788889999999999999997 99999887766665555432111
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..+...+.++.+|+.+||+.||++||++.++++
T Consensus 230 ---------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 230 ---------------------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred ---------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=321.88 Aligned_cols=206 Identities=21% Similarity=0.352 Sum_probs=169.0
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQL 289 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~qi 289 (516)
.+.+|+.+++.++||||+++++++......++||||++ ++|.+++.... ..+++..+..++.||
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 132 (291)
T cd05094 53 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132 (291)
T ss_pred HHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHH
Confidence 46678888889999999999999999899999999998 58888886532 347899999999999
Q ss_pred HHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHH
Q psy12305 290 LRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVG 367 (516)
Q Consensus 290 ~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlG 367 (516)
+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..+..++|+||||
T Consensus 133 ~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 212 (291)
T cd05094 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG 212 (291)
T ss_pred HHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHH
Confidence 9999999999999999999999999999999999999976433221 12334567889999999888888899999999
Q ss_pred HHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcC
Q psy12305 368 CIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAK 446 (516)
Q Consensus 368 vil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~ 446 (516)
|++|||++ |..||...+..+....+... .. ...+...+.++.+|+.+||+.||+
T Consensus 213 ~il~el~t~g~~p~~~~~~~~~~~~~~~~--~~-----------------------~~~~~~~~~~~~~li~~~l~~~P~ 267 (291)
T cd05094 213 VILWEIFTYGKQPWFQLSNTEVIECITQG--RV-----------------------LERPRVCPKEVYDIMLGCWQREPQ 267 (291)
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHhCC--CC-----------------------CCCCccCCHHHHHHHHHHcccChh
Confidence 99999999 99999877665544433211 00 011235678899999999999999
Q ss_pred CCCCHHHHHc
Q psy12305 447 QRISAANAMR 456 (516)
Q Consensus 447 ~R~ta~e~l~ 456 (516)
+|||+.++++
T Consensus 268 ~Rpt~~~v~~ 277 (291)
T cd05094 268 QRLNIKEIYK 277 (291)
T ss_pred hCcCHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.51 Aligned_cols=203 Identities=24% Similarity=0.381 Sum_probs=164.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeE-eeCceeeEeeehhh-chHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDII-HTEKCLTLVFEYLE-KDLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~E~~~-g~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+++.++|+|++++++++ ..+...++||||++ ++|.+++..... .+++..+..++.||+.||+|||++||+
T Consensus 45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 124 (256)
T cd05082 45 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124 (256)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 455677777777888888888764 45567899999998 589888876443 488999999999999999999999999
Q ss_pred eeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 303 HrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
||||||+||+++.++.+||+|||+++...... ....++..|+|||++.+..+..++|+|||||++|+|++ |+.||.
T Consensus 125 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ccccchheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999987543222 22334678999999988888889999999999999997 999998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..+..+....+... .....+..+++.+.+++.+||+.||++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 202 RIPLKDVVPRVEKG-------------------------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCHHHHHHHHhcC-------------------------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 77665544444221 011123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.61 Aligned_cols=206 Identities=20% Similarity=0.285 Sum_probs=166.4
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++... ..++++||+. |+|.+++......+++..+..++.|++.||+|||++||+||
T Consensus 55 ~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~ 133 (303)
T cd05110 55 EFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133 (303)
T ss_pred HHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence 456788888888899999999988654 4679999998 68999888766678999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.
T Consensus 134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986543222 1222345778999999988888889999999999999997 999998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+....+....+.. .. ....+...+.++.+++.+||..||++||+++++++.
T Consensus 214 ~~~~~~~~~~~~~-~~------------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 214 GIPTREIPDLLEK-GE------------------------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCHHHHHHHHHC-CC------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7654443332211 10 011223567889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=313.71 Aligned_cols=205 Identities=21% Similarity=0.346 Sum_probs=164.7
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.+++.++||||+++++++. .+..++||||+.+ +|.+++... ...+++..+..++.|++.||.|||+.||+|
T Consensus 47 ~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H 125 (260)
T cd05069 47 AFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIH 125 (260)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEee
Confidence 4556777777788888888877764 4568899999984 899988764 345889999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
|||||+||+++.++.++|+|||+++....... ......++..|+|||.+.+......+|+|||||++|+|++ |..||.
T Consensus 126 ~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred cccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999976533221 1122345778999999988888889999999999999999 999999
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+....+....+.... ....+...+..+.+|+.+||..||++||+++++++
T Consensus 206 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 206 GMVNREVLEQVERGY-------------------------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCHHHHHHHHHcCC-------------------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 877666555443211 01123367889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.53 Aligned_cols=205 Identities=24% Similarity=0.335 Sum_probs=165.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++.+ ...|+||||+. ++|.+++......+++..+..++.|++.||+|||++|++||
T Consensus 53 ~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~ 131 (270)
T cd05056 53 KFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHR 131 (270)
T ss_pred HHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 45567777777777777887777764 45789999998 58999988766678999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcc-ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKT-FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPG 382 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~ 382 (516)
||||+|||++.++.+||+|||+++........ .....++..|+|||.+.+..+...+|+|||||++|||++ |..||.+
T Consensus 132 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999765433211 112233568999999988888889999999999999996 9999988
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+..+....+... .....|..++.++.+++.+||..+|++|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 212 VKNNDVIGRIENG-------------------------ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCHHHHHHHHHcC-------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7766555444211 011234477889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=321.21 Aligned_cols=206 Identities=22% Similarity=0.405 Sum_probs=168.8
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------------------CCCCHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-----------------------NILSMNN 281 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-----------------------~~l~~~~ 281 (516)
.+.+|+.+++.++||||+++++.+..++..++||||+. ++|.+++.... ..+++..
T Consensus 49 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 128 (290)
T cd05045 49 DLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD 128 (290)
T ss_pred HHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHH
Confidence 56778999999999999999999999999999999999 57888775421 3478889
Q ss_pred HHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCC
Q psy12305 282 VKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYS 359 (516)
Q Consensus 282 ~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~ 359 (516)
+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.
T Consensus 129 ~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 208 (290)
T cd05045 129 LISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208 (290)
T ss_pred HHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence 999999999999999999999999999999999999999999999976432221 112234577899999998888888
Q ss_pred ceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHH
Q psy12305 360 TSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQ 438 (516)
Q Consensus 360 ~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~ 438 (516)
++|+|||||++|||++ |..||.+.........+... .....|..++.++.+|+.
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~ 263 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-------------------------YRMERPENCSEEMYNLML 263 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-------------------------CCCCCCCCCCHHHHHHHH
Confidence 9999999999999998 99999887655544333211 111234567889999999
Q ss_pred HccccCcCCCCCHHHHHc
Q psy12305 439 KFLMYDAKQRISAANAMR 456 (516)
Q Consensus 439 ~~L~~dP~~R~ta~e~l~ 456 (516)
+||+.||++||++.++++
T Consensus 264 ~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 264 TCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=322.95 Aligned_cols=206 Identities=25% Similarity=0.412 Sum_probs=170.1
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++.+ +||||+++++++..+...|+||||+. ++|.+++.... ..+++..+..++.|
T Consensus 63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (314)
T cd05099 63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQ 142 (314)
T ss_pred HHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHH
Confidence 466789999999 69999999999999999999999998 58888886532 34888899999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|+|||
T Consensus 143 i~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 222 (314)
T cd05099 143 VARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (314)
T ss_pred HHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHH
Confidence 99999999999999999999999999999999999999976542211 1112234567999999988888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|+|++ |..||.+....+....+.... ....+..++.++.+|+.+||..||
T Consensus 223 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~cl~~~p 277 (314)
T cd05099 223 GILMWEIFTLGGSPYPGIPVEELFKLLREGH-------------------------RMDKPSNCTHELYMLMRECWHAVP 277 (314)
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------------CCCCCCCCCHHHHHHHHHHcCCCc
Confidence 999999999 899998877666555443210 111234678899999999999999
Q ss_pred CCCCCHHHHHc
Q psy12305 446 KQRISAANAMR 456 (516)
Q Consensus 446 ~~R~ta~e~l~ 456 (516)
++|||+.++++
T Consensus 278 ~~Rps~~~ll~ 288 (314)
T cd05099 278 TQRPTFKQLVE 288 (314)
T ss_pred ccCcCHHHHHH
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=320.58 Aligned_cols=232 Identities=20% Similarity=0.289 Sum_probs=179.6
Q ss_pred CceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC----------C
Q psy12305 207 DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS----------N 275 (516)
Q Consensus 207 ~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~----------~ 275 (516)
+..||+|.++..........+.+|+.+++.++||||+++++++..+...++||||+. ++|.+++.... .
T Consensus 46 ~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 125 (296)
T cd05095 46 PVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125 (296)
T ss_pred eeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccc
Confidence 446788887655433344578899999999999999999999999999999999998 58888886532 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhcc
Q psy12305 276 ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLL 353 (516)
Q Consensus 276 ~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~ 353 (516)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++....... ......+++.|+|||...
T Consensus 126 ~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~ 205 (296)
T cd05095 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESIL 205 (296)
T ss_pred ccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHh
Confidence 367788999999999999999999999999999999999999999999999976432221 112233467899999988
Q ss_pred CCCCCCceeeehHHHHHHHHHc--CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCH
Q psy12305 354 GSTEYSTSIDMGVGCIFHEMSS--GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDS 431 (516)
Q Consensus 354 ~~~~~~~~d~~SlGvil~ellt--G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 431 (516)
+..++.++|+|||||++|||++ |..||...+..+.......... ... .......+..+++
T Consensus 206 ~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~-------~~~-----------~~~~~~~~~~~~~ 267 (296)
T cd05095 206 LGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFR-------DQG-----------RQVYLPKPALCPD 267 (296)
T ss_pred cCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHh-------hcc-----------ccccCCCCCCCCH
Confidence 8888889999999999999998 7789977655544332211100 000 0001112335678
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 432 DALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 432 ~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+.+|+.+||+.||++|||+.++++
T Consensus 268 ~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 268 SLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=316.94 Aligned_cols=205 Identities=20% Similarity=0.318 Sum_probs=168.8
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++.. ...++||||+. ++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus 55 ~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~ 133 (279)
T cd05057 55 EILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHR 133 (279)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEec
Confidence 56678888888899999999998877 78999999998 58999988776779999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccc--cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTF--SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
||||+|||++.++.+||+|||+++......... ....++..|+|||.+....+..++|+|||||++|||++ |..||.
T Consensus 134 di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred ccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999998654322211 11223567999999987788889999999999999998 999998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+....+....+... .....|...+.++.+++.+||..||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 214 GIPAVEIPDLLEKG-------------------------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCHHHHHHHHhCC-------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 87665544444221 011223356788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=321.66 Aligned_cols=207 Identities=21% Similarity=0.385 Sum_probs=172.1
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++.+ +||||+++++++......|+||||+. ++|.+++.... ..+++..+..++.|
T Consensus 66 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 145 (304)
T cd05101 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQ 145 (304)
T ss_pred HHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHH
Confidence 567899999999 89999999999999999999999998 58888887642 24778889999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCcc--ccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||.|||++||+||||||+|||++.++.+||+|||+++........ .....+++.|+|||++.+..+..++|+|||
T Consensus 146 i~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 225 (304)
T cd05101 146 VARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225 (304)
T ss_pred HHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHH
Confidence 999999999999999999999999999999999999999865432221 222345678999999988888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|+|++ |..||.+.+..+....+... .....+..++.++.+|+.+||..+|
T Consensus 226 G~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~cl~~~p 280 (304)
T cd05101 226 GVLMWEIFTLGGSPYPGIPVEELFKLLKEG-------------------------HRMDKPANCTNELYMMMRDCWHAIP 280 (304)
T ss_pred HHHHHHHHcCCCCCcccCCHHHHHHHHHcC-------------------------CcCCCCCCCCHHHHHHHHHHcccCh
Confidence 999999998 88999887766655544221 1111234678899999999999999
Q ss_pred CCCCCHHHHHcC
Q psy12305 446 KQRISAANAMRH 457 (516)
Q Consensus 446 ~~R~ta~e~l~H 457 (516)
.+|||+.++++.
T Consensus 281 ~~Rps~~e~l~~ 292 (304)
T cd05101 281 SHRPTFKQLVED 292 (304)
T ss_pred hhCCCHHHHHHH
Confidence 999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=315.22 Aligned_cols=251 Identities=20% Similarity=0.336 Sum_probs=202.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCc---EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~---~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
+++|.+.+.||+|+||.||+|++..+++ .||||.+.....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~------------------------------------- 45 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT------------------------------------- 45 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-------------------------------------
Confidence 4569999999999999999999987765 599998753211
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
......+..|+.+++.++||||++++
T Consensus 46 ------------------------------------------------------~~~~~~~~~e~~~l~~l~h~ni~~~~ 71 (269)
T cd05065 46 ------------------------------------------------------EKQRRDFLSEASIMGQFDHPNIIHLE 71 (269)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHHhCCCcCcceEE
Confidence 01112566788899999999999999
Q ss_pred eeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++.++...++||||+++ +|.+++....+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus 72 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred EEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCc
Confidence 999999999999999985 7888887766679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc--cccCCc---ccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 326 LARAKSVPTK--TFSNEV---VTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 326 la~~~~~~~~--~~~~~~---gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
++........ ...... ++..|+|||.+.+..+..++|+||+||++|||++ |..||...+..+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--- 228 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--- 228 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC---
Confidence 9875432211 111111 2457999999988888889999999999999886 999998876665555442211
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..++..+.+++.+||..+|++||++++++.
T Consensus 229 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 229 ----------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11123367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=313.30 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=197.4
Q ss_pred cccceeeEEEEEEEe--cCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chH
Q psy12305 190 NVKGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDL 266 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L 266 (516)
.++|+||.||+|..+ .++..||+|.+...........+.+|+.++++++||||+++++++.. ...++||||++ ++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 578999999999876 44567999999766544445568899999999999999999998864 57899999998 588
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccc---cCCccc
Q psy12305 267 KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF---SNEVVT 343 (516)
Q Consensus 267 ~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~~gt 343 (516)
.+++......+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++......... ....++
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05115 82 NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161 (257)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCC
Confidence 88887666779999999999999999999999999999999999999999999999999997654332211 112235
Q ss_pred ccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhh
Q psy12305 344 LWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422 (516)
Q Consensus 344 ~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 422 (516)
..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....+... ..
T Consensus 162 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-------------------------~~ 216 (257)
T cd05115 162 LKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-------------------------KR 216 (257)
T ss_pred cccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-------------------------CC
Confidence 78999999988778889999999999999996 99999887666554444221 11
Q ss_pred hcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 423 ~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...|...++++.+||.+||.+||++||++.++.+
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1233467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=319.08 Aligned_cols=266 Identities=15% Similarity=0.193 Sum_probs=195.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCC---CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~---g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
++|.+.+.||+|+||+||+|++..+ +..+|+|....... ....|...+..+.+++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~-----~~~~e~~~~~~~~~~~----------------- 69 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENE-----TIVMETLVYNNIYDID----------------- 69 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCC-----chhhHHHHHHhhhhHH-----------------
Confidence 4699999999999999999999877 67788876443221 3344554444433322
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+...+..+.|+||+++++
T Consensus 70 -----------------------------------------------------------~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 70 -----------------------------------------------------------KIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred -----------------------------------------------------------HHHHHHHhccCCCCCCCcEEE
Confidence 223445566778999999998
Q ss_pred eEeeCc----eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 248 IIHTEK----CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 248 ~~~~~~----~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
...... ..++++|++..++...+... ...++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 765543 45788998887766665543 3467888999999999999999999999999999999999999999999
Q ss_pred eccccccCCCC-------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc
Q psy12305 324 FGLARAKSVPT-------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396 (516)
Q Consensus 324 FGla~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~ 396 (516)
||+|+...... .......||+.|+|||++.+..++.++|+||+||++|||++|.+||.+......+......
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~- 248 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC- 248 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH-
Confidence 99997653221 1122346899999999999888889999999999999999999999876332221111100
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
++.... ..... .+...++.+.+++..|+..+|++||+++++++
T Consensus 249 -----~~~~~~-----------~~~~~-~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 249 -----DFIKRL-----------HEGKI-KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -----HHHHHh-----------hhhhh-ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000000 00000 12256788999999999999999999999874
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=319.49 Aligned_cols=217 Identities=23% Similarity=0.321 Sum_probs=158.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEee--CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+|+.++||||+++++++.. ...+++||||+. ++|.+++... .+++..++.++.|++.||+|||++||+
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~ 129 (283)
T cd05080 52 GWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYI 129 (283)
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34556677777777777777776654 346889999998 4788877653 499999999999999999999999999
Q ss_pred eeecCCCCEEEccCCCEEEeeeccccccCCCCcc---ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKT---FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 303 HrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
||||||+|||++.++.+||+|||+++........ .....++..|+|||.+.+...+.++|+|||||++|||++|..|
T Consensus 130 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p 209 (283)
T cd05080 130 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDS 209 (283)
T ss_pred ccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999765432211 1223456779999999888888899999999999999999999
Q ss_pred CCCCCHHHHHHHHHH-hcCCCC-hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 380 FPGSTIEDELRLICS-ILGPPP-DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 380 F~~~~~~~~~~~i~~-~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
|...... +..+.. ..+... ..+..... .......+...+..+.+++.+||+.||++|||++++++
T Consensus 210 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 210 KQSPPKK--FEEMIGPKQGQMTVVRLIELLE----------RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCcch--hhhhhcccccccchhhhhhhhh----------cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 8653321 111110 000000 00000000 01111234567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=312.76 Aligned_cols=244 Identities=23% Similarity=0.358 Sum_probs=199.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||.||+|.+ .|+.||||.+..... .
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~--~------------------------------------- 43 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST--A------------------------------------- 43 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh--H-------------------------------------
Confidence 46799999999999999999986 489999998854321 0
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+++.++|+||+++++++
T Consensus 44 ------------------------------------------------------~~~~~~e~~~l~~l~~~~i~~~~~~~ 69 (256)
T cd05039 44 ------------------------------------------------------AQAFLAEASVMTTLRHPNLVQLLGVV 69 (256)
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhcCCcceeeeEEEE
Confidence 12456778888888888888888888
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.+....++||||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+
T Consensus 70 ~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred cCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccc
Confidence 88888999999999 58988887654 36899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+....... ...++..|+|||.+.+..+..++|+|||||++|+|++ |..||...+..+....+...
T Consensus 150 ~~~~~~~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------- 215 (256)
T cd05039 150 KEASQGQD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------- 215 (256)
T ss_pred cccccccc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC-----------
Confidence 76532211 2234667999999988778888999999999999997 99999877665544333211
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+...++++.+||.+||..+|++|||++++++
T Consensus 216 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 --------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 011123467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=311.37 Aligned_cols=268 Identities=19% Similarity=0.284 Sum_probs=200.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++.+-+..||.|+||+|+|-.++.+|+..|||+|+........++++.|.++..+-
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks------------------------ 119 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKS------------------------ 119 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhh------------------------
Confidence 44677889999999999999999999999999998876655555666666544332
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
-+.||||++|+...
T Consensus 120 ------------------------------------------------------------------~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 120 ------------------------------------------------------------------SNCPNIVKFYGALF 133 (361)
T ss_pred ------------------------------------------------------------------cCCcHHHHHhhhhh
Confidence 23455555555555
Q ss_pred eCceeeEeeehhhchHHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 251 TEKCLTLVFEYLEKDLKRYM---DD-CSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l---~~-~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
.++..||.||+|+-++-.+. .. ....+++..+-.+....+.||+||-. ..|||||+||+|||++..|.+||||||
T Consensus 134 ~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFG 213 (361)
T KOG1006|consen 134 SEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFG 213 (361)
T ss_pred cCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeeccc
Confidence 55667788888875443322 21 24569999999999999999999985 689999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc-CCCChh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDE 402 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~-~~~p~~ 402 (516)
++..+.. ....+..+|...|||||-+.. ..|+-++|+||||++|||+.||..|+.+-+ ..+.++..+. |.||.
T Consensus 214 IcGqLv~-SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--svfeql~~Vv~gdpp~- 289 (361)
T KOG1006|consen 214 ICGQLVD-SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--SVFEQLCQVVIGDPPI- 289 (361)
T ss_pred chHhHHH-HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--HHHHHHHHHHcCCCCe-
Confidence 9976542 233455688999999999853 347789999999999999999999997632 2444444332 44432
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCccc
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~ 469 (516)
+.... .--+.+..+..||.-||.+|-+.||...+++++||++.......+
T Consensus 290 l~~~~-----------------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 290 LLFDK-----------------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred ecCcc-----------------cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 11000 001478899999999999999999999999999999865443333
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=345.10 Aligned_cols=210 Identities=22% Similarity=0.237 Sum_probs=144.2
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCC-------------------CCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCC
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNI-------------------LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~-------------------l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~N 310 (516)
.+...++||||++ ++|.+++...... .....+..++.||+.||+|||+++|+||||||+|
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N 285 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN 285 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence 4567899999998 4787777653211 1234467899999999999999999999999999
Q ss_pred EEEcc-CCCEEEeeeccccccCCCC-ccccCCcccccccchhhccCCC----------------------CCCceeeehH
Q psy12305 311 LLINE-RGELKLADFGLARAKSVPT-KTFSNEVVTLWYRPPDVLLGST----------------------EYSTSIDMGV 366 (516)
Q Consensus 311 ILl~~-~~~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~APE~l~~~~----------------------~~~~~d~~Sl 366 (516)
||++. ++.+||+|||+|+...... ......++|+.|+|||.+.... +..+.|+||+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 5799999999997653222 2234567899999999764322 2234599999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcC
Q psy12305 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAK 446 (516)
Q Consensus 367 Gvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~ 446 (516)
||+||||+++..++ ......+..+....+.....+...... .............+..+..+.|||.+||++||+
T Consensus 366 GviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVEP----RASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhcc----ccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999966543 333444444444444333332221110 000000001111122345678999999999999
Q ss_pred CCCCHHHHHcCCCCCCCCCC
Q psy12305 447 QRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 447 ~R~ta~e~l~Hp~f~~~~~~ 466 (516)
+|||+.++|+||||+.....
T Consensus 440 kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 440 QRISAKAALAHPYFDREGLL 459 (566)
T ss_pred cCCCHHHHhCCcCcCCCCcc
Confidence 99999999999999886654
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=329.72 Aligned_cols=261 Identities=26% Similarity=0.358 Sum_probs=187.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|..-..||+||||+||+|... +|..||||++....... ..
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~------------------------------------ 116 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-ER------------------------------------ 116 (361)
T ss_pred hCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hh------------------------------------
Confidence 77999999999999999999874 55899999776543221 22
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.|.+|+.++.+++|||+|+|+|||.
T Consensus 117 -------------------------------------------------------eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 117 -------------------------------------------------------EFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred -------------------------------------------------------HHHHHHHHHhcCCCcCcccEEEEEe
Confidence 3555666666666666666677776
Q ss_pred eCc-eeeEeeehhh-chHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC---cEeeecCCCCEEEccCCCEEEeee
Q psy12305 251 TEK-CLTLVFEYLE-KDLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRR---ILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 251 ~~~-~~~lV~E~~~-g~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+.+ ..+||+||+. |+|.+.+..... .++|....+|+.+++.||+|||... ||||||||+|||+|++.++||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 666 4899999999 799999987666 8999999999999999999999753 999999999999999999999999
Q ss_pred ccccccCCCCccccCC-cccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHhcCCCC
Q psy12305 325 GLARAKSVPTKTFSNE-VVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE--LRL-ICSILGPPP 400 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~--~~~-i~~~~~~~p 400 (516)
|+|+............ .||.+|+|||.+..+..+.++|+|||||+|.||+||+.+......... +.. ....+...
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~- 300 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG- 300 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-
Confidence 9997654311122222 789999999999887888999999999999999999988764321111 111 11111000
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCC-CCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPE-QMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
.......|.... ...+. ..-..+..+..+|++.+|.+||++.|++
T Consensus 301 -----~~~eiiD~~l~~-----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 301 -----KLREIVDPRLKE-----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred -----chhheeCCCccC-----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 000001111000 00000 0112356777899999999999999974
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.78 Aligned_cols=243 Identities=26% Similarity=0.426 Sum_probs=207.4
Q ss_pred cccceeeEEEEEEEecC---CceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-ch
Q psy12305 190 NVKGTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KD 265 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~---~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~ 265 (516)
.++|+||.||+|..... +..||+|.++..........+.+|+.+++.++|+||+++++++.....+++||||+. ++
T Consensus 3 ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 82 (262)
T cd00192 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGD 82 (262)
T ss_pred cccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCc
Confidence 57899999999999876 899999999876554445678899999999999999999999999999999999996 68
Q ss_pred HHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--c
Q psy12305 266 LKRYMDDC--------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT--K 335 (516)
Q Consensus 266 L~~~l~~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~ 335 (516)
|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||.+....... .
T Consensus 83 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 162 (262)
T cd00192 83 LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYR 162 (262)
T ss_pred HHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccc
Confidence 99988876 4679999999999999999999999999999999999999999999999999998755332 2
Q ss_pred cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCC
Q psy12305 336 TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414 (516)
Q Consensus 336 ~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~ 414 (516)
......+++.|+|||.+.+..+..++|+||+||++|+|++ |..||......+....+..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------------------- 222 (262)
T cd00192 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-------------------- 222 (262)
T ss_pred cccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2334456889999999988788889999999999999999 6999988766655554432
Q ss_pred CCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 415 ~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
......|..++.++.+++.+||+.||++|||++++++|
T Consensus 223 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 -----GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -----CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 01112344678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=318.64 Aligned_cols=206 Identities=27% Similarity=0.369 Sum_probs=166.7
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------------CCCCHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------------NILSMNNVK 283 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------------~~l~~~~~~ 283 (516)
.+.+|+.+++.++||||+++++++..+...++||||++ ++|.+++.... ..+++..+.
T Consensus 54 ~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 133 (288)
T cd05050 54 DFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133 (288)
T ss_pred HHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHH
Confidence 46678888888888888899998888889999999998 58888886432 247788899
Q ss_pred HHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCce
Q psy12305 284 LFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTS 361 (516)
Q Consensus 284 ~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~ 361 (516)
.++.||+.||.|||+++++||||||+|||++.++.+||+|||+++....... ......+++.|+|||.+.+..+..++
T Consensus 134 ~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 213 (288)
T cd05050 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES 213 (288)
T ss_pred HHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchh
Confidence 9999999999999999999999999999999999999999999875432211 11223446789999999888888899
Q ss_pred eeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHc
Q psy12305 362 IDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKF 440 (516)
Q Consensus 362 d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~ 440 (516)
|+|||||++|||++ |..||.+.+..+....+.... ....|...+.++.+||.+|
T Consensus 214 Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~ 268 (288)
T cd05050 214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-------------------------VLSCPDNCPLELYNLMRLC 268 (288)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-------------------------CCCCCCCCCHHHHHHHHHH
Confidence 99999999999998 888998777666554442210 0112346788999999999
Q ss_pred cccCcCCCCCHHHHHc
Q psy12305 441 LMYDAKQRISAANAMR 456 (516)
Q Consensus 441 L~~dP~~R~ta~e~l~ 456 (516)
|+.||++|||+.|+++
T Consensus 269 l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 269 WSKLPSDRPSFASINR 284 (288)
T ss_pred cccCcccCCCHHHHHH
Confidence 9999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=318.62 Aligned_cols=262 Identities=23% Similarity=0.377 Sum_probs=194.4
Q ss_pred EeeeeeeccccceEEEEEEE----cCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 93 YFKLDKLGQGTYATVFKGKS----RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~----~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
|+++++||+|+||.||+|+. ..+++.||+|.+........
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~------------------------------------ 49 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH------------------------------------ 49 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHH------------------------------------
Confidence 78999999999999999974 45789999998764321111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||++++++
T Consensus 50 -------------------------------------------------------~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (284)
T cd05079 50 -------------------------------------------------------IADLKKEIEILRNLYHENIVKYKGI 74 (284)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 1245567777777778888888777
Q ss_pred EeeC--ceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 249 IHTE--KCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 249 ~~~~--~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+... ...++||||++ ++|.+++......+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 75 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg 154 (284)
T cd05079 75 CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 154 (284)
T ss_pred EecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCc
Confidence 7664 56899999998 58888887665668999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 326 LARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 326 la~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
+++....... ......++..|+|||++.+..++.++|+|||||++|||+++..|+..... ......++...+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~ 229 (284)
T cd05079 155 LTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQ 229 (284)
T ss_pred cccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccc
Confidence 9986543221 11234567789999999888888899999999999999998876543211 111111211111
Q ss_pred hh--hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 403 LK--SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 403 ~~--~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.. ....... .......+..++.++.+|+.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 230 MTVTRLVRVLE-------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccHHHHHHHHH-------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 0000000 001112234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=323.74 Aligned_cols=272 Identities=20% Similarity=0.240 Sum_probs=202.3
Q ss_pred ccceeeEEEEEEEecCCceEEEEEeeccc-ccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHH
Q psy12305 191 VKGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKR 268 (516)
Q Consensus 191 ~~G~~g~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~ 268 (516)
+-|+++.|+.++...++..||+|.++... .......+.+|+.+++.++||||+++++++...+..+++|||++ +++.+
T Consensus 9 ~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 34566777888888899999999998652 33445578899999999999999999999999999999999999 57777
Q ss_pred HHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc-------cccCC
Q psy12305 269 YMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK-------TFSNE 340 (516)
Q Consensus 269 ~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~ 340 (516)
++... ...+++..+..++.|++.||+|||+++|+||||||+||+++.++.+||+|||.+........ .....
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 77653 35689999999999999999999999999999999999999999999999998865432111 11233
Q ss_pred cccccccchhhccCC--CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh--------cccc
Q psy12305 341 VVTLWYRPPDVLLGS--TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK--------LEFC 410 (516)
Q Consensus 341 ~gt~~y~APE~l~~~--~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~--------~~~~ 410 (516)
.++..|+|||++.+. .+..++|+||+||++|||++|..||........+.. ...+..+..+... ....
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE--KVRGTVPCLLDKSTYPLYEDSMSQS 246 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhccCccccccCchhhhcCCcCcc
Confidence 567889999998663 466789999999999999999999987554333221 1222221111000 0000
Q ss_pred cCCCCC--CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 411 ITPVYP--SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 411 ~~~~~~--~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..+... .........+...+.++.+|+.+||++||++|||++++++||||+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 247 RSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred cccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000000 001111112224567899999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=321.38 Aligned_cols=266 Identities=27% Similarity=0.452 Sum_probs=205.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.++..||+|||+.||||.|....++||+|+-..+..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~----------------------------------------- 501 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKN----------------------------------------- 501 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccc-----------------------------------------
Confidence 569999999999999999999999999999998654321
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.+-+..+.....+.+|..|.+.|+||.||++|++|.
T Consensus 502 --------------------------------------------WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 502 --------------------------------------------WRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred --------------------------------------------hhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 111111122235678999999999999999999997
Q ss_pred eC-ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--CcEeeecCCCCEEEcc---CCCEEEee
Q psy12305 251 TE-KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR--RILHRDLKPQNLLINE---RGELKLAD 323 (516)
Q Consensus 251 ~~-~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~ivHrDlKp~NILl~~---~~~vkL~D 323 (516)
-+ +.+|-|+|||+| +|..|++. .+.+++.+++.|+.||+.||.||... .|||-||||.|||+.. -|.+||.|
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQ-hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQ-HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred eccccceeeeeecCCCchhHHHHh-hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence 54 579999999998 55555554 56799999999999999999999975 5999999999999954 47799999
Q ss_pred eccccccCCCCcc-------ccCCcccccccchhhccCC----CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q psy12305 324 FGLARAKSVPTKT-------FSNEVVTLWYRPPDVLLGS----TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLI 392 (516)
Q Consensus 324 FGla~~~~~~~~~-------~~~~~gt~~y~APE~l~~~----~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i 392 (516)
||+++.+..+... .+...||.||++||.+.-+ ..+.+.|+||+|||+|..+.|+.||...-....+..-
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999987644332 2445789999999988533 3467889999999999999999999654322211111
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..++.. ....+...+.++.++++||++||.+.-++|+...++-.||||..
T Consensus 697 NTIlkA--------------------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 697 NTILKA--------------------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hchhcc--------------------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111100 11111122368999999999999999999999999999999964
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=315.13 Aligned_cols=208 Identities=23% Similarity=0.332 Sum_probs=171.0
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS--------NILSMNNVKLFLFQLLRGLAYC 296 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yL 296 (516)
.+.+|+.++++++||||+++++++.+....|+||||++ ++|.+++.... ..+++..+..++.||+.||+||
T Consensus 54 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L 133 (275)
T cd05046 54 EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL 133 (275)
T ss_pred HHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHh
Confidence 56789999999999999999999999999999999998 58888887543 1589999999999999999999
Q ss_pred hhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc
Q psy12305 297 HSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS 375 (516)
Q Consensus 297 H~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt 375 (516)
|+++|+||||||+|||++.++.++|+|||+++...... .......+++.|+|||.+.+.....++|+|||||++|+|++
T Consensus 134 H~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~ 213 (275)
T cd05046 134 SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213 (275)
T ss_pred hhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999999987543221 12334466788999999887777888999999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q psy12305 376 -GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 376 -G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
|..||.+......+..+... ......+...+..+.+++.+||+.||.+|||+.++
T Consensus 214 ~~~~p~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~ 269 (275)
T cd05046 214 QGELPFYGLSDEEVLNRLQAG------------------------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269 (275)
T ss_pred CCCCCccccchHHHHHHHHcC------------------------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 88999776555444433211 11111234678899999999999999999999999
Q ss_pred HcC
Q psy12305 455 MRH 457 (516)
Q Consensus 455 l~H 457 (516)
+++
T Consensus 270 l~~ 272 (275)
T cd05046 270 VSA 272 (275)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=314.46 Aligned_cols=206 Identities=20% Similarity=0.335 Sum_probs=160.2
Q ss_pred hHHHHHHHHHhccccceeeEeeeEe-eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIH-TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.+++.++||||+++++++. .+...++||||+. ++|.+++......+++..+..++.||+.||+|||+.+++|
T Consensus 42 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 121 (262)
T cd05058 42 QFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121 (262)
T ss_pred HHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3445666777777777777777654 3456789999998 5898888776666788888999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCC----ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPT----KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRP 378 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~ 378 (516)
|||||+|||++.++.+||+|||+++...... .......++..|+|||.+.+..+..++|+|||||++|||++ |.+
T Consensus 122 ~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred cccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999997543211 11122345778999999988888889999999999999999 577
Q ss_pred CCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 379 LFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 379 pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
||...+..+....+... .....+...++.+.+++.+||..||++||++.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 202 PYPDVDSFDITVYLLQG-------------------------RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred CCCCCCHHHHHHHHhcC-------------------------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 78766554443333211 011123356788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=316.92 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=194.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcC----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRL----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
-++|++.+.||+|+||.||+|.+.. ++..||+|++.........
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~-------------------------------- 52 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV-------------------------------- 52 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHH--------------------------------
Confidence 3679999999999999999999876 3588999987533211111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
..+.+|+.+++.++||||+++
T Consensus 53 -----------------------------------------------------------~~~~~e~~~l~~l~h~ni~~~ 73 (280)
T cd05043 53 -----------------------------------------------------------TLLLQESCLLYGLSHQNILPI 73 (280)
T ss_pred -----------------------------------------------------------HHHHHHHHHHHhCCCCCCCeE
Confidence 134566777777777777777
Q ss_pred eeeEee-CceeeEeeehhh-chHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC
Q psy12305 246 HDIIHT-EKCLTLVFEYLE-KDLKRYMDDCS-------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER 316 (516)
Q Consensus 246 ~~~~~~-~~~~~lV~E~~~-g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 316 (516)
++++.. +...++++||+. ++|..++.... ..+++..+..++.||+.||+|||+++++||||||+||+++.+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~ 153 (280)
T cd05043 74 LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE 153 (280)
T ss_pred EEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCC
Confidence 776544 456889999988 68888876532 458999999999999999999999999999999999999999
Q ss_pred CCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q psy12305 317 GELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 317 ~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~ 393 (516)
+.+||+|||+++....... ......++..|+|||++.+..+..++|+|||||++||+++ |+.||...+..+....+.
T Consensus 154 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 233 (280)
T cd05043 154 LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK 233 (280)
T ss_pred CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH
Confidence 9999999999976432221 1122345678999999988888899999999999999999 999998776555433332
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
... ....+..+++++.+++.+||..||++|||+.++++
T Consensus 234 ~~~-------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 234 DGY-------------------------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred cCC-------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 110 01112356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=324.86 Aligned_cols=208 Identities=22% Similarity=0.381 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++++ +||||+++++++..++.++++|||+. ++|.+++.... ..+++..+..++.|
T Consensus 63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (334)
T cd05100 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQ 142 (334)
T ss_pred HHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence 567889999999 79999999999999999999999998 58888886532 24778888999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCcc--ccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||.|||++||+||||||+|||++.++.+||+|||+++........ .....++..|+|||++.+..+..++|+|||
T Consensus 143 i~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 222 (334)
T cd05100 143 VARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222 (334)
T ss_pred HHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHH
Confidence 999999999999999999999999999999999999999765432211 122233567999999988888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|||++ |..||.+.+..+....+.... ....+...+.++.+|+.+||..+|
T Consensus 223 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~cl~~~p 277 (334)
T cd05100 223 GVLLWEIFTLGGSPYPGIPVEELFKLLKEGH-------------------------RMDKPANCTHELYMIMRECWHAVP 277 (334)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------------------CCCCCCCCCHHHHHHHHHHcccCh
Confidence 999999998 899999887766655543211 111234667899999999999999
Q ss_pred CCCCCHHHHHcCC
Q psy12305 446 KQRISAANAMRHP 458 (516)
Q Consensus 446 ~~R~ta~e~l~Hp 458 (516)
.+|||+.+++++-
T Consensus 278 ~~Rps~~ell~~l 290 (334)
T cd05100 278 SQRPTFKQLVEDL 290 (334)
T ss_pred hhCcCHHHHHHHH
Confidence 9999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.36 Aligned_cols=222 Identities=22% Similarity=0.325 Sum_probs=158.9
Q ss_pred hHHHHHHHHHhccccceeeEeeeEee--CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+++.++||||+++++++.. ...+++||||++ ++|.+++......+++..+..++.|++.||+|||++||+
T Consensus 51 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~ 130 (284)
T cd05081 51 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYV 130 (284)
T ss_pred HHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 34556667777777777777766532 346899999998 589998877666799999999999999999999999999
Q ss_pred eeecCCCCEEEccCCCEEEeeeccccccCCCCcc---ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKT---FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 303 HrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
||||||+||+++.++.+||+|||+++........ .....++..|+|||++.+..++.++|+|||||++|||++|..+
T Consensus 131 H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 210 (284)
T cd05081 131 HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDK 210 (284)
T ss_pred eccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCc
Confidence 9999999999999999999999999865432221 1112234569999999888888889999999999999999877
Q ss_pred CCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 380 FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+..... .....+...... +.......+... .......+..++.++.+|+.+||..||++|||+.++++
T Consensus 211 ~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 211 SCSPPA-EFMRMMGNDKQG-QMIVYHLIELLK-------NNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred CCCcch-hhhhhccccccc-ccchHHHHHHHh-------cCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 644321 111111000000 000000000000 00111234467889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=316.51 Aligned_cols=219 Identities=19% Similarity=0.266 Sum_probs=173.3
Q ss_pred CceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHH
Q psy12305 207 DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLF 285 (516)
Q Consensus 207 ~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i 285 (516)
...||+|.+..... .....+.+|+.+++.++||||+++++++..+...++||||+++ +|..++....+.+++..+..+
T Consensus 44 ~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i 122 (274)
T cd05076 44 ELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122 (274)
T ss_pred eeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHH
Confidence 45688888865432 1233567889999999999999999999999999999999995 677777665667999999999
Q ss_pred HHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-------CEEEeeeccccccCCCCccccCCcccccccchhhccC-CCC
Q psy12305 286 LFQLLRGLAYCHSRRILHRDLKPQNLLINERG-------ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STE 357 (516)
Q Consensus 286 ~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~ 357 (516)
+.||+.||+|||++||+||||||+|||++..+ .+||+|||++...... ....++..|+|||.+.+ ..+
T Consensus 123 ~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~ 198 (274)
T cd05076 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSL 198 (274)
T ss_pred HHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCC
Confidence 99999999999999999999999999997654 3899999988643221 22356888999998865 446
Q ss_pred CCceeeehHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHH
Q psy12305 358 YSTSIDMGVGCIFHEMS-SGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDL 436 (516)
Q Consensus 358 ~~~~d~~SlGvil~ell-tG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dL 436 (516)
+.++|+|||||++|||+ +|..||.+....+....+.. ....|...++++.+|
T Consensus 199 ~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~l 251 (274)
T cd05076 199 STAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK---------------------------KHRLPEPSCKELATL 251 (274)
T ss_pred CcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh---------------------------ccCCCCCCChHHHHH
Confidence 77889999999999995 69999987654433221110 011223456789999
Q ss_pred HHHccccCcCCCCCHHHHHcC
Q psy12305 437 VQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 437 l~~~L~~dP~~R~ta~e~l~H 457 (516)
|.+||+.||++|||+.+++++
T Consensus 252 i~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 252 ISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHcccChhhCcCHHHHHHh
Confidence 999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.82 Aligned_cols=217 Identities=20% Similarity=0.263 Sum_probs=168.2
Q ss_pred eEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHH
Q psy12305 209 LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLF 287 (516)
Q Consensus 209 ~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~ 287 (516)
.||+|.+..... .....+.+|+.+++.++||||+++++++..+...++||||+++ .|..++......+++..+..++.
T Consensus 34 ~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~ 112 (262)
T cd05077 34 KVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAK 112 (262)
T ss_pred eEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHH
Confidence 355555443321 2233567788999999999999999999999999999999995 66666665556799999999999
Q ss_pred HHHHHHHHHhhCCcEeeecCCCCEEEccCCC-------EEEeeeccccccCCCCccccCCcccccccchhhcc-CCCCCC
Q psy12305 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGE-------LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL-GSTEYS 359 (516)
Q Consensus 288 qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~-------vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~ 359 (516)
||+.||+|||++||+||||||+|||++.++. +|++|||++..... .....++..|+|||.+. +..+..
T Consensus 113 qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~ 188 (262)
T cd05077 113 QLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSI 188 (262)
T ss_pred HHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCc
Confidence 9999999999999999999999999987664 89999999865432 12345788999999886 455777
Q ss_pred ceeeehHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHH
Q psy12305 360 TSIDMGVGCIFHEMS-SGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQ 438 (516)
Q Consensus 360 ~~d~~SlGvil~ell-tG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~ 438 (516)
++|+|||||++|||+ +|..||......+..... .. .. ......++++.+||.
T Consensus 189 ~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~------------------------~~--~~~~~~~~~~~~li~ 241 (262)
T cd05077 189 AADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EG------------------------QC--MLVTPSCKELADLMT 241 (262)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hc------------------------Cc--cCCCCChHHHHHHHH
Confidence 899999999999998 588998765443322111 00 00 011134578999999
Q ss_pred HccccCcCCCCCHHHHHcC
Q psy12305 439 KFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 439 ~~L~~dP~~R~ta~e~l~H 457 (516)
+||+.||.+||++.+++++
T Consensus 242 ~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 242 HCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHcCCChhhCcCHHHHHHh
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.25 Aligned_cols=243 Identities=29% Similarity=0.419 Sum_probs=207.2
Q ss_pred ccceeeEEEEEEEecCCceEEEEEeeccccc--CChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHH
Q psy12305 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEE--GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLK 267 (516)
Q Consensus 191 ~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~ 267 (516)
|.|+||.||++.+..+++.+|+|.++..... .....+.+|+.+++.++||||+++++.+..+...|+||||+. ++|.
T Consensus 2 g~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 81 (250)
T cd05123 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81 (250)
T ss_pred CCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHH
Confidence 6799999999999999999999998765432 234467889999999999999999999999999999999995 6888
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCccccccc
Q psy12305 268 RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYR 347 (516)
Q Consensus 268 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~ 347 (516)
+++.... .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++..............++..|+
T Consensus 82 ~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 82 SHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 8887643 589999999999999999999999999999999999999999999999999876544323334456788999
Q ss_pred chhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCC
Q psy12305 348 PPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427 (516)
Q Consensus 348 APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~ 427 (516)
|||.+.+......+|+|||||++|+|++|..||...........+.. .....|.
T Consensus 161 ~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--------------------------~~~~~~~ 214 (250)
T cd05123 161 APEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--------------------------DPLRFPE 214 (250)
T ss_pred ChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--------------------------CCCCCCC
Confidence 99999887778889999999999999999999987665444443322 1112344
Q ss_pred CCCHHHHHHHHHccccCcCCCCCH---HHHHcCCCC
Q psy12305 428 QMDSDALDLVQKFLMYDAKQRISA---ANAMRHPYF 460 (516)
Q Consensus 428 ~~s~~~~dLl~~~L~~dP~~R~ta---~e~l~Hp~f 460 (516)
..+.++.++|.+||..||++|||+ +++++||||
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 668899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=315.61 Aligned_cols=201 Identities=16% Similarity=0.241 Sum_probs=162.7
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++..+...++||||++ |+|..++...+..+++..+..++.||+.||+|||++||+||
T Consensus 45 ~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~ 124 (258)
T cd05078 45 SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHG 124 (258)
T ss_pred HHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 45678888999999999999999999899999999998 57888887766678999999999999999999999999999
Q ss_pred ecCCCCEEEccCCC--------EEEeeeccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHc
Q psy12305 305 DLKPQNLLINERGE--------LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSS 375 (516)
Q Consensus 305 DlKp~NILl~~~~~--------vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~ellt 375 (516)
||||+|||++.++. ++++|||++..... .....+++.|+|||++.+. .+...+|+|||||++|||++
T Consensus 125 dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 200 (258)
T cd05078 125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200 (258)
T ss_pred CCccceEEEecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc
Confidence 99999999987765 69999999865432 1234678899999998763 45678899999999999999
Q ss_pred C-CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q psy12305 376 G-RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 376 G-~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
| .+||...+........ .. ....|...+.++.+||.+||+.||++|||++++
T Consensus 201 g~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 253 (258)
T cd05078 201 GGDKPLSALDSQKKLQFY-ED--------------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAI 253 (258)
T ss_pred CCCCChhhccHHHHHHHH-Hc--------------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHH
Confidence 8 5666554443322211 10 111233556789999999999999999999999
Q ss_pred HcC
Q psy12305 455 MRH 457 (516)
Q Consensus 455 l~H 457 (516)
++.
T Consensus 254 l~~ 256 (258)
T cd05078 254 IRD 256 (258)
T ss_pred HHh
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=307.27 Aligned_cols=205 Identities=19% Similarity=0.336 Sum_probs=164.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.+++.++|+||+++++.+.. ...+++|||++ ++|.+++... +..+++..+..++.||+.||.|||+.|++|
T Consensus 47 ~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H 125 (260)
T cd05073 47 AFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125 (260)
T ss_pred HHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 45567777777788888888777776 67899999998 5898888753 345788899999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
|||||+||+++.++.+||+|||++........ ......++..|+|||++.+..+..++|+|||||++|+|++ |..||.
T Consensus 126 ~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred cccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999999876532221 1122345677999999988778888999999999999999 999998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+.+..+....+.... ....+...+.++.+++.+||..||++||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 206 GMSNPEVIRALERGY-------------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCHHHHHHHHhCCC-------------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 877665554442211 11122367789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=307.50 Aligned_cols=206 Identities=27% Similarity=0.430 Sum_probs=170.4
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+..|+.+++.++|+||+++++++.+.+..+++|||+++ +|.+++...... +++..+..++.|++.||+|||+.|++|
T Consensus 47 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h 126 (258)
T smart00219 47 EFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIH 126 (258)
T ss_pred HHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeee
Confidence 566788888888899999999999888999999999984 888888765444 899999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCcccc-CCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFS-NEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
|||||+||+++.++.++|+|||+++.......... ...+++.|+|||.+.+..+..++|+||+||++|+|++ |.+||.
T Consensus 127 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 127 RDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred cccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999976543322111 1236789999999977778889999999999999998 899998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..+..+....+.... ....+...+.++.+++.+||..||++|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 207 GMSNEEVLEYLKKGY-------------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCHHHHHHHHhcCC-------------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 876666555543211 11123357889999999999999999999999975
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=314.04 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=199.3
Q ss_pred ccccccceeeEEEEEEEe----cCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehh
Q psy12305 187 SMNNVKGTYATVFKGKSR----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 262 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 262 (516)
...+|.|+||.||+|... ..+..|+||.++..........+.+|+..+++++||||+++++++...+..++||||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 345789999999999998 4567899999965444334568899999999999999999999999888899999999
Q ss_pred h-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--ccc
Q psy12305 263 E-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFS 338 (516)
Q Consensus 263 ~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~ 338 (516)
. |+|.+++... ...+++.....++.||+.||.|||+++++|+||+|+|||++.++.+||+|||++........ ...
T Consensus 84 ~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~ 163 (259)
T PF07714_consen 84 PGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDS 163 (259)
T ss_dssp TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEEST
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 8 6899999887 56799999999999999999999999999999999999999999999999999987632211 223
Q ss_pred CCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCC
Q psy12305 339 NEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417 (516)
Q Consensus 339 ~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 417 (516)
...+...|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+....+...
T Consensus 164 ~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~---------------------- 221 (259)
T PF07714_consen 164 SQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQG---------------------- 221 (259)
T ss_dssp TSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTT----------------------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------------
Confidence 3345788999999988888889999999999999999 78999888777666665321
Q ss_pred chhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 418 ~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+..++..+.++|.+||..||++|||+.++++
T Consensus 222 ---~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 222 ---QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 122234578899999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=307.36 Aligned_cols=243 Identities=25% Similarity=0.412 Sum_probs=193.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++.+.||+|+||.||+|. .+++.||+|.+.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~--------------------------------------- 42 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVT--------------------------------------- 42 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcch---------------------------------------
Confidence 34679999999999999999987 4788999998743210
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||++++++
T Consensus 43 -------------------------------------------------------~~~~~~e~~~l~~~~~~~i~~~~~~ 67 (254)
T cd05083 43 -------------------------------------------------------AQAFLEETAVMTKLHHKNLVRLLGV 67 (254)
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 1145567777777777777777777
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+..+ ..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+
T Consensus 68 ~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 68 ILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 7544 4789999998 58988887643 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+...... ......+..|+|||.+.+..+...+|+|||||++|+|++ |.+||.+.+..+....+....
T Consensus 147 ~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--------- 214 (254)
T cd05083 147 ARVGSMG---VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY--------- 214 (254)
T ss_pred ceecccc---CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC---------
Confidence 8754321 122234678999999988888888999999999999998 999998877655444432211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..++..+.+|+.+||+.+|++|||+++++.
T Consensus 215 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 215 ----------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ----------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=326.40 Aligned_cols=254 Identities=20% Similarity=0.297 Sum_probs=203.1
Q ss_pred cccccccccccccceeeEEEEEEEe-----cCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeEeeCc
Q psy12305 180 DDCSNILSMNNVKGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEK 253 (516)
Q Consensus 180 ~~~s~~l~~~~~~G~~g~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 253 (516)
......+....|+|+||.||+|++. .++..||+|.++..........+.+|+.+|..+. ||||+++++++....
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3334455677899999999999864 3556899999986544444456889999999997 999999999999999
Q ss_pred eeeEeeehhh-chHHHHHHhcC----------------------------------------------------------
Q psy12305 254 CLTLVFEYLE-KDLKRYMDDCS---------------------------------------------------------- 274 (516)
Q Consensus 254 ~~~lV~E~~~-g~L~~~l~~~~---------------------------------------------------------- 274 (516)
.+++|||||. |+|.+++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999 58988886532
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc
Q psy12305 275 ---------------------------------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE 315 (516)
Q Consensus 275 ---------------------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~ 315 (516)
..+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~ 274 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICE 274 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeC
Confidence 13566778899999999999999999999999999999999
Q ss_pred CCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q psy12305 316 RGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLI 392 (516)
Q Consensus 316 ~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i 392 (516)
++.+||+|||+++...... .......+++.|+|||.+.+..+..++|+|||||++|||++ |..||......+.....
T Consensus 275 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~ 354 (401)
T cd05107 275 GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA 354 (401)
T ss_pred CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHH
Confidence 9999999999997643221 11223456889999999988888888999999999999998 89999875544443332
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
... ......|..++.++.+|+.+||..||.+||+++++++.
T Consensus 355 ~~~------------------------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 355 IKR------------------------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHc------------------------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 211 01112344678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=304.81 Aligned_cols=241 Identities=23% Similarity=0.352 Sum_probs=199.1
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHH
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKR 268 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~ 268 (516)
.+.|+||.||+|... ++..+|+|.++..........+.+|+.+++.++||||+++++++......++||||++ ++|.+
T Consensus 3 ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 3 LGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred cCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 578999999999854 6889999998765443344467899999999999999999999999999999999998 58888
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccc-cCCccccccc
Q psy12305 269 YMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF-SNEVVTLWYR 347 (516)
Q Consensus 269 ~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~~gt~~y~ 347 (516)
++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......... ....++..|+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~ 161 (250)
T cd05085 82 FLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT 161 (250)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccccc
Confidence 887666678999999999999999999999999999999999999999999999999987543221111 1223366799
Q ss_pred chhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCC
Q psy12305 348 PPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426 (516)
Q Consensus 348 APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p 426 (516)
|||++.+..+..++|+|||||++|+|++ |..||.+.........+... .....+
T Consensus 162 aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-------------------------~~~~~~ 216 (250)
T cd05085 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-------------------------YRMSCP 216 (250)
T ss_pred CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------------------------CCCCCC
Confidence 9999988878888999999999999998 99999887665544443211 111223
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 427 EQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 427 ~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..++.++.+|+.+||..||++|||+.++++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=334.47 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=209.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 167 (516)
+-+.|++.+.||+|.||.||+++++.+|+.+|||+...+..... +.-.|.++|+.+ +|||++.+|+++...+
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de--EiE~eynil~~~~~hpnv~~fyg~~~k~~----- 89 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE--EIELEYNMLKKYSHHPNVATFYGAFIKKD----- 89 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH--HHHHHHHHHHhccCCCCcceEEEEEEEec-----
Confidence 44569999999999999999999999999999999876544332 344455555544 4555555544431110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.
T Consensus 90 -------------------------------------------------~------------------------------ 90 (953)
T KOG0587|consen 90 -------------------------------------------------P------------------------------ 90 (953)
T ss_pred -------------------------------------------------C------------------------------
Confidence 0
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
-.++.+|||||||.| +.-++++.. +.++.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||
T Consensus 91 --~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 91 --GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred --CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 134679999999994 555555432 5679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCC-----CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGS-----TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
++...........+.+|||.|||||++... .|+..+|+||||++..||.-|.+|+........+.+ +...||
T Consensus 169 vSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~---IpRNPP 245 (953)
T KOG0587|consen 169 VSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---IPRNPP 245 (953)
T ss_pred eeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc---CCCCCC
Confidence 999888777777888999999999999653 467789999999999999999999987665444333 333343
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.. ...|..++.++.|||..||.+|-.+||+..++|+|||++.
T Consensus 246 Pk--------------------Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 246 PK--------------------LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred cc--------------------ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 32 2334577899999999999999999999999999999973
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.43 Aligned_cols=229 Identities=25% Similarity=0.330 Sum_probs=189.8
Q ss_pred cceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHH
Q psy12305 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 270 (516)
Q Consensus 192 ~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l 270 (516)
-|.||.||++.++.+++.||+|.++... ...+|...+....||||+++++++...+..++||||+++ +|.+++
T Consensus 3 ~g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 3 LGVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred ccccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 4899999999999999999999997653 223455556666799999999999999999999999994 888887
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchh
Q psy12305 271 DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPD 350 (516)
Q Consensus 271 ~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE 350 (516)
... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+...... .....++..|+|||
T Consensus 77 ~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE 152 (237)
T cd05576 77 SKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE 152 (237)
T ss_pred HHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence 664 35899999999999999999999999999999999999999999999999987654322 23345677899999
Q ss_pred hccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCC
Q psy12305 351 VLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMD 430 (516)
Q Consensus 351 ~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s 430 (516)
.+.+..++.++|+||+||++|||++|..||...... + . .......|..++
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~-----------~--------------~~~~~~~~~~~~ 202 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----I-----------N--------------THTTLNIPEWVS 202 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c-----------c--------------cccccCCcccCC
Confidence 988777888899999999999999999887532110 0 0 001112345678
Q ss_pred HHHHHHHHHccccCcCCCCCH-----HHHHcCCCC
Q psy12305 431 SDALDLVQKFLMYDAKQRISA-----ANAMRHPYF 460 (516)
Q Consensus 431 ~~~~dLl~~~L~~dP~~R~ta-----~e~l~Hp~f 460 (516)
+.+.+||.+||+.||++|||+ +++++||||
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=307.11 Aligned_cols=259 Identities=25% Similarity=0.422 Sum_probs=203.5
Q ss_pred cEeeeeeeccccceEEEEEEEcC-CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRL-TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~-~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+|++.+.||+|+||.||+|++.. +++.||||.+..........
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~------------------------------------ 44 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKD------------------------------------ 44 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccc------------------------------------
Confidence 48899999999999999999987 68999999886532211000
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHh-ccccceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE-LRHANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~ 249 (516)
| .........+.+|+.++.+ ++||||+++++++
T Consensus 45 ------------------------------------------~----~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 78 (269)
T cd08528 45 ------------------------------------------K----RERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF 78 (269)
T ss_pred ------------------------------------------c----ccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE
Confidence 0 0001112245678887765 7999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMD---DCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
..++..++||||+++ +|.+++. .....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+||
T Consensus 79 ~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 79 LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999985 6766653 344569999999999999999999996 78999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|++....... ......|+..|+|||.+.+..+..++|+|||||++|+|++|.+||...........+......+
T Consensus 159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----- 232 (269)
T cd08528 159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP----- 232 (269)
T ss_pred cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-----
Confidence 9997654332 3345578999999999988888889999999999999999999998766555444443211110
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
......++++.+||.+||+.||++|||+.|+..+
T Consensus 233 -------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 233 -------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 0112567899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=308.69 Aligned_cols=241 Identities=24% Similarity=0.310 Sum_probs=195.5
Q ss_pred cccceeeEEEEEEEecCCc--eEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-ch
Q psy12305 190 NVKGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KD 265 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~--~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~ 265 (516)
.++|+||.||+|+...++. .+|+|.++..........+.+|+.++.++ +||||+++++++......|+||||+. ++
T Consensus 3 lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 82 (270)
T cd05047 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 82 (270)
T ss_pred CCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCc
Confidence 5789999999999988876 46888887544444445778899999999 89999999999999999999999998 68
Q ss_pred HHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 266 LKRYMDDCS---------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 266 L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++...
T Consensus 83 L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~ 162 (270)
T cd05047 83 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 162 (270)
T ss_pred HHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcccc
Confidence 988886532 24789999999999999999999999999999999999999999999999998643
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
..... ......+..|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+...
T Consensus 163 ~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-------------- 227 (270)
T cd05047 163 EVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-------------- 227 (270)
T ss_pred chhhh-ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC--------------
Confidence 21111 111233567999999988888889999999999999997 99999877665544443211
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+...+.++.+|+.+||..||.+|||+.++++
T Consensus 228 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 -----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 011123356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=346.41 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=214.4
Q ss_pred cccccccceeeEEEEEEEecCCc-----eEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeee
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 260 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 260 (516)
+....|+|.||.||.|....-.. .||+|.++...+......|++|..+|+.++|||||++++++.+....+|++|
T Consensus 696 l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~le 775 (1025)
T KOG1095|consen 696 LLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLE 775 (1025)
T ss_pred eeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEeh
Confidence 44567899999999998765433 4999999988888888899999999999999999999999999999999999
Q ss_pred hhh-chHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCC
Q psy12305 261 YLE-KDLKRYMDDC------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVP 333 (516)
Q Consensus 261 ~~~-g~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~ 333 (516)
||+ |||+.++++. ...++..+...++.||++|+.||+++++|||||-..|+|++....+||+|||+|+.....
T Consensus 776 yM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~ 855 (1025)
T KOG1095|consen 776 YMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDK 855 (1025)
T ss_pred hcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhc
Confidence 999 6999999987 677999999999999999999999999999999999999999999999999999943322
Q ss_pred Cccc-cCC-cccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 334 TKTF-SNE-VVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 334 ~~~~-~~~-~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
.... ... .-...|||||.+....+++++|+|||||+|||++| |..||++.+..+.+.....
T Consensus 856 ~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~---------------- 919 (1025)
T KOG1095|consen 856 DYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE---------------- 919 (1025)
T ss_pred hheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh----------------
Confidence 2111 111 12568999999999999999999999999999999 9999999888877765532
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..+...|..+++.+.++|..||+.+|++||++..+++
T Consensus 920 ---------ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 920 ---------GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ---------CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2255667799999999999999999999999999986
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=303.73 Aligned_cols=241 Identities=23% Similarity=0.342 Sum_probs=200.3
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHH
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKR 268 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~ 268 (516)
.+.|+||.||++.+.. ++.||+|.++..........+.+|+.++++++||||+++++++......++||||+. ++|.+
T Consensus 3 lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 3 IGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred cccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 5789999999999888 999999998765443344578899999999999999999999999999999999997 58888
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccc--cCCcccccc
Q psy12305 269 YMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF--SNEVVTLWY 346 (516)
Q Consensus 269 ~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~y 346 (516)
++......+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|||++.......... ....++..|
T Consensus 82 ~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y 161 (251)
T cd05041 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW 161 (251)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceecc
Confidence 887766678999999999999999999999999999999999999999999999999997643221111 112335679
Q ss_pred cchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcC
Q psy12305 347 RPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425 (516)
Q Consensus 347 ~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (516)
+|||.+.+..+...+|+|||||++|||++ |..||.+.........+.... ....
T Consensus 162 ~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-------------------------~~~~ 216 (251)
T cd05041 162 TAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-------------------------RMPA 216 (251)
T ss_pred CChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-------------------------CCCC
Confidence 99999988888889999999999999999 899998776555444432111 1122
Q ss_pred CCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 426 p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
|...+.++.+++.+||+.+|.+|||+.++++
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3467889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=326.22 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=197.7
Q ss_pred EeeeeeeccccceEEEEEEEcCC----CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLT----DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~----g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
-++.+.||.|.||.||+|..... .--||||..+.+......+.|+.|..+|++++|||||+|+|+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~---------- 460 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC---------- 460 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee----------
Confidence 34457899999999999986543 2349999988766544444555555555555555555555544
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
T Consensus 461 -------------------------------------------------------------------------------- 460 (974)
T KOG4257|consen 461 -------------------------------------------------------------------------------- 460 (974)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.. ...|||||++. |.|..|+..+...++......|+.||+.||.|||+.++|||||-..|||+.....|||+|||++
T Consensus 461 -~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 461 -VE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred -ec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence 32 34899999999 8999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcc--cccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVPTKTFSNEVV--TLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|........... .| ...|||||.+.-..+++++|+|-|||++||++. |..||.|-...|.+..|
T Consensus 539 R~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i------------ 605 (974)
T KOG4257|consen 539 RYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI------------ 605 (974)
T ss_pred hhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe------------
Confidence 987654433222 33 667999999988889999999999999999987 99999987665544333
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
+...+...|+++++.+..|+.+||.+||.+||++.++.
T Consensus 606 -------------EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 606 -------------ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred -------------cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 13445667889999999999999999999999986653
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.91 Aligned_cols=242 Identities=22% Similarity=0.278 Sum_probs=201.2
Q ss_pred cccceeeEEEEEEEec-CC--ceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-ch
Q psy12305 190 NVKGTYATVFKGKSRL-TD--NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KD 265 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~-~~--~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~ 265 (516)
.++|+||.||+|.+.. .+ ..||+|.++..........+.+|+.++++++||||+++++++.. ...++||||++ ++
T Consensus 3 ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~ 81 (257)
T cd05040 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGS 81 (257)
T ss_pred CCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCc
Confidence 4789999999999866 33 36999999876554445578899999999999999999999988 89999999997 68
Q ss_pred HHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCcc---ccCCc
Q psy12305 266 LKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT---FSNEV 341 (516)
Q Consensus 266 L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~ 341 (516)
|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++........ .....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 161 (257)
T cd05040 82 LLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161 (257)
T ss_pred HHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecccCCC
Confidence 999887755 56899999999999999999999999999999999999999999999999999875432211 12235
Q ss_pred ccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchh
Q psy12305 342 VTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420 (516)
Q Consensus 342 gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 420 (516)
++..|+|||.+.+..+..++|+|||||++|||++ |..||...+..+....+.....
T Consensus 162 ~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~----------------------- 218 (257)
T cd05040 162 VPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE----------------------- 218 (257)
T ss_pred CCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------------------
Confidence 6788999999988888888999999999999998 9999988777666555532110
Q ss_pred hhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 421 ~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+...+.++.+++.+||+.+|++|||+.++++
T Consensus 219 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 219 -RLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 11123356789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=331.87 Aligned_cols=270 Identities=25% Similarity=0.342 Sum_probs=197.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
..+..-+.||+||||-||+|+++.+|+.||||.++........+...+|+++|++|+|||||+++++-.+... +
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~-~----- 86 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL-G----- 86 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc-C-----
Confidence 4578889999999999999999999999999999887766666677888888888888888888775432210 0
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.
T Consensus 87 -------------------------------------------------------------------------------~ 87 (732)
T KOG4250|consen 87 -------------------------------------------------------------------------------L 87 (732)
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred eCceeeEeeehhh-chHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc--cCCC--EEEee
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDC--SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN--ERGE--LKLAD 323 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~--vkL~D 323 (516)
-.....+|||||. |+|...+.+. ...+++.+.+.++..++.||.|||++||+||||||.||++. .+|+ .||+|
T Consensus 88 ~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 88 VTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 1123569999999 5899998763 34599999999999999999999999999999999999984 3343 69999
Q ss_pred eccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHhcCCCCh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPPD 401 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i~~~~~~~p~ 401 (516)
||.|+...... .....+||+.|.+||+... ..+....|-|||||++|+.+||..||... ......+.+.......|.
T Consensus 168 fG~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 168 FGAARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 99999887544 6777899999999999984 67777888899999999999999999532 111111122222222332
Q ss_pred hhhhhcccc-cCCCCCCchhhhhcCCCCCCH----HHHHHHHHccccCcCCCC
Q psy12305 402 ELKSKLEFC-ITPVYPSESKLQLLAPEQMDS----DALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 402 ~~~~~~~~~-~~~~~~~~~~~~~~~p~~~s~----~~~dLl~~~L~~dP~~R~ 449 (516)
......... ..|. .......+|..+++ .+-.+|..+|..+|++|.
T Consensus 247 ~v~i~~~~~eNgpv---~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPV---EWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCce---eeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 221111000 1111 01122223334443 345788899999999998
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=329.39 Aligned_cols=282 Identities=20% Similarity=0.295 Sum_probs=189.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcC----------------CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRL----------------TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~----------------~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv 152 (516)
..++|.+.++||+|+||+||+|.+.. .++.||||++..... ...+.+.+|..+++...|+++
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-~~~~~fl~e~~~~~~~~e~~~- 220 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-GVRQDFLKTGTLAKGSAETGM- 220 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-hhHHHHHhhhhhhhcccchhH-
Confidence 45789999999999999999997532 346789998865432 222244555555444444433
Q ss_pred ecccccccceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHH
Q psy12305 153 TLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS 232 (516)
Q Consensus 153 ~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~ 232 (516)
.|+.
T Consensus 221 ----------------------------------------------------------------------------vE~~ 224 (507)
T PLN03224 221 ----------------------------------------------------------------------------VEAY 224 (507)
T ss_pred ----------------------------------------------------------------------------HHHH
Confidence 3555
Q ss_pred HHHhccccc-----eeeEeeeEee--------CceeeEeeehhh-chHHHHHHhcC-----------------------C
Q psy12305 233 LLRELRHAN-----IVTLHDIIHT--------EKCLTLVFEYLE-KDLKRYMDDCS-----------------------N 275 (516)
Q Consensus 233 il~~l~Hpn-----Iv~l~~~~~~--------~~~~~lV~E~~~-g~L~~~l~~~~-----------------------~ 275 (516)
++.+++|.+ +++++++|.. +...||||||++ ++|.+++.... .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 555555544 3556666542 356899999999 47777765321 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcccccccchhhccC
Q psy12305 276 ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLG 354 (516)
Q Consensus 276 ~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~ 354 (516)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++..
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 245677899999999999999999999999999999999999999999999975432211 1112234889999999854
Q ss_pred CCC----------------------CCceeeehHHHHHHHHHcCCC-CCCCCCHHHH-HHHHHHhcCCCChhhhhhcccc
Q psy12305 355 STE----------------------YSTSIDMGVGCIFHEMSSGRP-LFPGSTIEDE-LRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 355 ~~~----------------------~~~~d~~SlGvil~elltG~~-pF~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
... ....|+||+||++|+|++|.. ||.+...... +... ...-. .|....
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~-~~r~~~-- 457 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLN-RWRMYK-- 457 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHH-HHHhhc--
Confidence 221 123599999999999999875 7754221111 1000 00000 000000
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc---CCCCCHHHHHcCCCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA---KQRISAANAMRHPYFNS 462 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP---~~R~ta~e~l~Hp~f~~ 462 (516)
. ........+..++.++||+.+||..+| .+|+|++|+|+||||..
T Consensus 458 -~------~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 -G------QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred -c------cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0 011111234678999999999999876 68999999999999964
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=305.07 Aligned_cols=210 Identities=18% Similarity=0.232 Sum_probs=162.4
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCCc
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---NILSMNNVKLFLFQLLRGLAYCHSRRI 301 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~i 301 (516)
.+.+|+.+++.++||||+++++.+......|+||||++ ++|.+++.... ...++..++.++.||+.||+|||+++|
T Consensus 41 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 120 (268)
T cd05086 41 EFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120 (268)
T ss_pred HHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCe
Confidence 56778888888899999999999998899999999999 58888887532 346677888999999999999999999
Q ss_pred EeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccC-------CCCCCceeeehHHHHHHH
Q psy12305 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLG-------STEYSTSIDMGVGCIFHE 372 (516)
Q Consensus 302 vHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~-------~~~~~~~d~~SlGvil~e 372 (516)
+||||||+|||++.++.+||+|||++....... ......+++..|+|||++.+ ..++.++|+|||||++||
T Consensus 121 ~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (268)
T cd05086 121 LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200 (268)
T ss_pred eccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHH
Confidence 999999999999999999999999986432111 12234567899999998743 223567899999999999
Q ss_pred HHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH
Q psy12305 373 MSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451 (516)
Q Consensus 373 llt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta 451 (516)
|++ |..||...+..+.+..+...... .......+...++.+.+++..|| .+|++|||+
T Consensus 201 l~~~~~~p~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~ 259 (268)
T cd05086 201 LFENAAQPYSHLSDREVLNHVIKDQQV--------------------KLFKPQLELPYSERWYEVLQFCW-LSPEKRATA 259 (268)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhhccc--------------------ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCH
Confidence 997 57888776666555544321110 00111122356788999999999 689999999
Q ss_pred HHHHc
Q psy12305 452 ANAMR 456 (516)
Q Consensus 452 ~e~l~ 456 (516)
+++++
T Consensus 260 ~~i~~ 264 (268)
T cd05086 260 EEVHR 264 (268)
T ss_pred HHHHH
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=304.28 Aligned_cols=200 Identities=19% Similarity=0.246 Sum_probs=160.3
Q ss_pred hhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 225 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 225 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
..+.+|+.+++.++||||+++++++.. ...++||||+. ++|.+++......+++..+..++.||+.||+|||++||+|
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 124 (259)
T cd05037 46 LAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVH 124 (259)
T ss_pred HHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 356778888888888888888888877 77899999998 5788888776657999999999999999999999999999
Q ss_pred eecCCCCEEEccCC-------CEEEeeeccccccCCCCccccCCcccccccchhhccCC--CCCCceeeehHHHHHHHHH
Q psy12305 304 RDLKPQNLLINERG-------ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS--TEYSTSIDMGVGCIFHEMS 374 (516)
Q Consensus 304 rDlKp~NILl~~~~-------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~d~~SlGvil~ell 374 (516)
|||||+|||++.++ .+||+|||++..... .....++..|+|||++.+. .+..++|+|||||++|+|+
T Consensus 125 ~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 125 GNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred ccCccceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 99999999999888 799999999976543 2234567789999998776 6778899999999999999
Q ss_pred c-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHH
Q psy12305 375 S-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAAN 453 (516)
Q Consensus 375 t-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e 453 (516)
+ |..||...+......... .. ...+.....++.+||.+||..||.+|||+.+
T Consensus 201 ~~~~~p~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 201 SNGEEPLSTLSSSEKERFYQ-DQ--------------------------HRLPMPDCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred hCCCCCcccCCchhHHHHHh-cC--------------------------CCCCCCCchHHHHHHHHHhccChhhCCCHHH
Confidence 9 588886654322221111 00 0011122378999999999999999999999
Q ss_pred HHc
Q psy12305 454 AMR 456 (516)
Q Consensus 454 ~l~ 456 (516)
+++
T Consensus 254 il~ 256 (259)
T cd05037 254 ILR 256 (259)
T ss_pred HHH
Confidence 975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=308.71 Aligned_cols=219 Identities=24% Similarity=0.388 Sum_probs=162.9
Q ss_pred hHHHHHHHHHhccccceeeEeeeEee--CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+++.++||||+++++++.. +...++||||++ ++|.+++......+++..+..++.|++.||+|||++|++
T Consensus 52 ~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~ 131 (284)
T cd05038 52 DFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYI 131 (284)
T ss_pred HHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 45667777777788888888777766 557899999998 589999887666799999999999999999999999999
Q ss_pred eeecCCCCEEEccCCCEEEeeeccccccCCCCccc---cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTF---SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 303 HrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
||||||+||+++.++.++|+|||++.......... ....++..|+|||.+.+......+|+|||||++|||++|..|
T Consensus 132 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p 211 (284)
T cd05038 132 HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDP 211 (284)
T ss_pred cCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCC
Confidence 99999999999999999999999998764222111 122345679999999888888899999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCChh-hhhhc-ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 380 FPGSTIEDELRLICSILGPPPDE-LKSKL-EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~-~~~~~-~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
|....... ....+..... ....+ .... .......+..++.++.+|+.+||+.||++|||+.++++
T Consensus 212 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 212 SQSPPAEF-----LRMIGIAQGQMIVTRLLELLK-------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cccccchh-----ccccccccccccHHHHHHHHH-------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 86533211 0001110000 00000 0000 00111223456788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=304.93 Aligned_cols=246 Identities=19% Similarity=0.242 Sum_probs=190.4
Q ss_pred cccceeeEEEEEEEec--CCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chH
Q psy12305 190 NVKGTYATVFKGKSRL--TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDL 266 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~--~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L 266 (516)
.|+|+||.||+|.... ....+|+|.+...........+.+|+.+++.++||||+++++.+......|+||||++ ++|
T Consensus 3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L 82 (269)
T cd05042 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL 82 (269)
T ss_pred CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcH
Confidence 5789999999996543 3457888887654433344567889999999999999999999999999999999998 588
Q ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCC
Q psy12305 267 KRYMDDCS----NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNE 340 (516)
Q Consensus 267 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~ 340 (516)
.+++.... ...++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 162 (269)
T cd05042 83 KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162 (269)
T ss_pred HHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccCCC
Confidence 88887643 2246778899999999999999999999999999999999999999999999865332211 11233
Q ss_pred cccccccchhhccC-------CCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccC
Q psy12305 341 VVTLWYRPPDVLLG-------STEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412 (516)
Q Consensus 341 ~gt~~y~APE~l~~-------~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 412 (516)
.+++.|+|||++.. .....++|+|||||++|||++ |..||......+.+..+........
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~------------ 230 (269)
T cd05042 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL------------ 230 (269)
T ss_pred CCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC------------
Confidence 45778999998743 345678899999999999999 8899987766655554432211100
Q ss_pred CCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 413 ~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+...++...+++..|+ .||++|||++++++
T Consensus 231 --------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 231 --------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred --------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 001122367788999999998 59999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=315.72 Aligned_cols=260 Identities=21% Similarity=0.334 Sum_probs=222.7
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
|+...+.-.+.-++..........|.|.||.||.|.+++....||||.++.+.. ....|+.|+.+|+.++|||+|+|+
T Consensus 252 vygvSPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLL 329 (1157)
T KOG4278|consen 252 VYGVSPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLL 329 (1157)
T ss_pred eeeecCCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHh
Confidence 444444444455666677778888999999999999999999999999986543 245789999999999999999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++|..+..+|||+|||. |+|++|++.+++. ++.-....++.||.+|++||..+++|||||-..|+|+.++..||++||
T Consensus 330 GVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 330 GVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred hhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeecc
Confidence 99999999999999998 8999999988653 555666778899999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcc---cccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 325 GLARAKSVPTKTFSNEVV---TLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~g---t~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
|+++.+..+.. +...| ...|.|||-+.-..+..++|+|+|||+|||+.| |-.||+|-+....+.++-
T Consensus 410 GLsRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE------- 480 (1157)
T KOG4278|consen 410 GLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE------- 480 (1157)
T ss_pred chhhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------
Confidence 99998875443 33344 677999999988899999999999999999998 899999988766655542
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
..++..-|+.+++...+|++.||+|.|.+||+++|+-
T Consensus 481 ------------------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 481 ------------------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred ------------------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 3455666889999999999999999999999998873
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.30 Aligned_cols=242 Identities=21% Similarity=0.356 Sum_probs=197.8
Q ss_pred cccceeeEEEEEEEecCC------ceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh
Q psy12305 190 NVKGTYATVFKGKSRLTD------NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 263 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~------~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 263 (516)
.+.|+||.||+|+..... ..+|+|.+...........+.+|+.+++.++||||+++++++......++||||++
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (269)
T cd05044 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELME 82 (269)
T ss_pred cccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccC
Confidence 578999999999886544 78999998765444455678899999999999999999999999999999999998
Q ss_pred -chHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-----CEEEeeeccccccC
Q psy12305 264 -KDLKRYMDDC------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-----ELKLADFGLARAKS 331 (516)
Q Consensus 264 -g~L~~~l~~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-----~vkL~DFGla~~~~ 331 (516)
++|.+++... ...+++..+..++.||+.||.|||+++++|+||||+||+++.++ .+||+|||+++...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~ 162 (269)
T cd05044 83 GGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162 (269)
T ss_pred CCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccc
Confidence 5888888652 23478899999999999999999999999999999999999887 89999999987543
Q ss_pred CCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 332 VPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 332 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
.... ......++..|+|||.+.+.....++|+|||||++|||++ |..||...+..+....+...
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~------------- 229 (269)
T cd05044 163 KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG------------- 229 (269)
T ss_pred cccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-------------
Confidence 2211 1122345788999999988888899999999999999998 99999877665544433210
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+..++.++.+||.+||+.+|.+||+++++++
T Consensus 230 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 ------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111223467889999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=303.92 Aligned_cols=206 Identities=18% Similarity=0.293 Sum_probs=155.1
Q ss_pred HHHHHHHHHhccccceeeEeeeEeeC------ceeeEeeehhh-chHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHH
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHTE------KCLTLVFEYLE-KDLKRYMDDC-----SNILSMNNVKLFLFQLLRGLA 294 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~-g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~aL~ 294 (516)
+.+|+.+++.++||||+++++++... ...++++||+. ++|..++... ...+++..+..++.||+.||+
T Consensus 48 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~ 127 (273)
T cd05074 48 FLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGME 127 (273)
T ss_pred HHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH
Confidence 34455555555566666666555332 12478899998 5777666432 124788999999999999999
Q ss_pred HHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHH
Q psy12305 295 YCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHE 372 (516)
Q Consensus 295 yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~e 372 (516)
|||++||+||||||+||+++.++.+||+|||+++....... ......+++.|++||.+.+.....++|+|||||++|+
T Consensus 128 ~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~e 207 (273)
T cd05074 128 YLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWE 207 (273)
T ss_pred HHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHH
Confidence 99999999999999999999999999999999986532221 1122345678999999988888889999999999999
Q ss_pred HHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH
Q psy12305 373 MSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451 (516)
Q Consensus 373 llt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta 451 (516)
|++ |.+||.+.+..+....+.... ....+...+..+.+++.+||..+|++|||+
T Consensus 208 l~~~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~ 262 (273)
T cd05074 208 IMTRGQTPYAGVENSEIYNYLIKGN-------------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSF 262 (273)
T ss_pred HhhCCCCCCCCCCHHHHHHHHHcCC-------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 999 899998776655444433210 011123567899999999999999999999
Q ss_pred HHHHcC
Q psy12305 452 ANAMRH 457 (516)
Q Consensus 452 ~e~l~H 457 (516)
.+++++
T Consensus 263 ~~~~~~ 268 (273)
T cd05074 263 QHLRDQ 268 (273)
T ss_pred HHHHHH
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=301.10 Aligned_cols=246 Identities=20% Similarity=0.228 Sum_probs=189.7
Q ss_pred cccceeeEEEEEEEe--cCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chH
Q psy12305 190 NVKGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDL 266 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~--~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L 266 (516)
.|+|+||.||+|... .++..+|+|.++..........+.+|+.+++.++||||+++++++.+....++||||++ ++|
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 82 (269)
T cd05087 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL 82 (269)
T ss_pred ccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcH
Confidence 578999999999864 45678999998765543344567889999999999999999999999999999999999 588
Q ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCC
Q psy12305 267 KRYMDDCS----NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNE 340 (516)
Q Consensus 267 ~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~ 340 (516)
.+++.... ...++..++.++.|++.||+|||+++++||||||+||+++.++.+||+|||+++....... .....
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 162 (269)
T cd05087 83 KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQL 162 (269)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCc
Confidence 88886532 2456778889999999999999999999999999999999999999999999875432211 12234
Q ss_pred cccccccchhhccCC-------CCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccC
Q psy12305 341 VVTLWYRPPDVLLGS-------TEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412 (516)
Q Consensus 341 ~gt~~y~APE~l~~~-------~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~ 412 (516)
.++..|+|||++.+. .+..++|+|||||++|||++ |..||+.....+............
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~------------- 229 (269)
T cd05087 163 WVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK------------- 229 (269)
T ss_pred CCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC-------------
Confidence 568889999998542 24568899999999999996 999998766554433221110000
Q ss_pred CCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 413 ~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..........++.+.+++.+|+ .||++|||+++++.
T Consensus 230 -------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 230 -------LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0000011245678999999998 68999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=319.63 Aligned_cols=255 Identities=21% Similarity=0.285 Sum_probs=205.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCC---cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTD---NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g---~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..+.-.+.++||+|.||+|++|.|...+ ..||||.++.+........|++|+.+|.+|+|||++|||+
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyG--------- 178 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYG--------- 178 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEee---------
Confidence 4456777899999999999999998743 4589999987655444445555555555555555555554
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
T Consensus 179 -------------------------------------------------------------------------------- 178 (1039)
T KOG0199|consen 179 -------------------------------------------------------------------------------- 178 (1039)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+..+ ..+.+|||++. |+|++.+.+ ....|-......|+.||+.|+.||-++++|||||-..|+|+.....|||+|
T Consensus 179 --vVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~D 255 (1039)
T KOG0199|consen 179 --VVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICD 255 (1039)
T ss_pred --eecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeec
Confidence 4443 44678999999 799999887 556688888999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccc---cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 324 FGLARAKSVPTKTF---SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 324 FGla~~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
|||.|.+......+ ...-....|.|||.+....++.++|+|++||++|||+| |+-||.|....+.+++|-
T Consensus 256 FGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------ 329 (1039)
T KOG0199|consen 256 FGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------ 329 (1039)
T ss_pred ccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc------
Confidence 99999876544332 11122567999999999999999999999999999999 899999999988888773
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...+...|+.+++++.+++..||..+|.+|||+..|.+.-+.
T Consensus 330 -------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 -------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 233455677899999999999999999999999888644443
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=324.59 Aligned_cols=223 Identities=21% Similarity=0.317 Sum_probs=194.3
Q ss_pred EEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHH
Q psy12305 210 VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQ 288 (516)
Q Consensus 210 vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~q 288 (516)
||||.++....+..+..|+.|+.||.+++||||++|.++......+.||+|||+ |.|-.+|+.+.+.++.-+...+++.
T Consensus 660 VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrG 739 (996)
T KOG0196|consen 660 VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRG 739 (996)
T ss_pred EEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHH
Confidence 344444444445556689999999999999999999999999999999999999 7999999999888999999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc-cccCCcc--cccccchhhccCCCCCCceeeeh
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TFSNEVV--TLWYRPPDVLLGSTEYSTSIDMG 365 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~g--t~~y~APE~l~~~~~~~~~d~~S 365 (516)
|+.|++||-++|.|||||-..|||++.+-.+|++|||++|....+.. .+++.-| ...|.|||.|.-..+.+.+|+||
T Consensus 740 IAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWS 819 (996)
T KOG0196|consen 740 IASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWS 819 (996)
T ss_pred HHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccc
Confidence 99999999999999999999999999999999999999998754443 3333333 67899999999999999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccC
Q psy12305 366 VGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYD 444 (516)
Q Consensus 366 lGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~d 444 (516)
+||+|||.++ |..||..-+..+.+..|-. .++...|-+++..+..|+..||++|
T Consensus 820 yGIVmWEVmSyGERPYWdmSNQdVIkaIe~-------------------------gyRLPpPmDCP~aL~qLMldCWqkd 874 (996)
T KOG0196|consen 820 YGIVMWEVMSYGERPYWDMSNQDVIKAIEQ-------------------------GYRLPPPMDCPAALYQLMLDCWQKD 874 (996)
T ss_pred cceEEEEecccCCCcccccchHHHHHHHHh-------------------------ccCCCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999776 9999999999998888854 3445556799999999999999999
Q ss_pred cCCCCCHHHHHcC
Q psy12305 445 AKQRISAANAMRH 457 (516)
Q Consensus 445 P~~R~ta~e~l~H 457 (516)
-.+||++.|++.+
T Consensus 875 R~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 875 RNRRPKFAQIVST 887 (996)
T ss_pred hhcCCCHHHHHHH
Confidence 9999999999863
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=302.07 Aligned_cols=253 Identities=20% Similarity=0.236 Sum_probs=212.9
Q ss_pred cccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh
Q psy12305 184 NILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 263 (516)
Q Consensus 184 ~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 263 (516)
-++...+|+|.||.|..|.-.. +..||+|.++..........|.+|+.+|.+|+||||+.|+++|..++.+|+|+||++
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred eehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 3456778999999999997654 789999999988877778899999999999999999999999999999999999999
Q ss_pred -chHHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccC
Q psy12305 264 -KDLKRYMDDCSNIL-SMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSN 339 (516)
Q Consensus 264 -g~L~~~l~~~~~~l-~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~ 339 (516)
|+|.+++..+.-+. .......++.||++|++||.+.++|||||.+.|+|++.++++||+|||++|.+-.... ....
T Consensus 619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr 698 (807)
T KOG1094|consen 619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGR 698 (807)
T ss_pred cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeeecc
Confidence 89999998874333 4555667999999999999999999999999999999999999999999996543222 2223
Q ss_pred CcccccccchhhccCCCCCCceeeehHHHHHHHHHc--CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCC
Q psy12305 340 EVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS--GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417 (516)
Q Consensus 340 ~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt--G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 417 (516)
.+-...|||||.++-+.+++++|+|+||+++||+++ .+.||...+.++........+...+.
T Consensus 699 ~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~---------------- 762 (807)
T KOG1094|consen 699 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGR---------------- 762 (807)
T ss_pred eeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCc----------------
Confidence 355789999999998899999999999999999876 78899887777776666555443322
Q ss_pred chhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 418 ~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
..-...|.-++..+.+||.+||.+|-.+|||++++-
T Consensus 763 --~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 763 --QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred --ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 122334567889999999999999999999999984
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=294.55 Aligned_cols=278 Identities=29% Similarity=0.467 Sum_probs=203.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcC---CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRL---TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~---~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..+.|..+++||+|+|++||+|.+.. ..++||+|.|.....
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~------------------------------------ 77 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS------------------------------------ 77 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC------------------------------------
Confidence 34569999999999999999999887 678899998754321
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceee
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVT 244 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 244 (516)
+.++.+|+++|..+ .+.||++
T Consensus 78 ----------------------------------------------------------p~ri~~El~~L~~~gG~~ni~~ 99 (418)
T KOG1167|consen 78 ----------------------------------------------------------PSRILNELEMLYRLGGSDNIIK 99 (418)
T ss_pred ----------------------------------------------------------chHHHHHHHHHHHhccchhhhc
Confidence 12566777777777 4788888
Q ss_pred EeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCEEEe
Q psy12305 245 LHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GELKLA 322 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~ 322 (516)
+.+.+..++...+||||++. ...++... ++...++.+++.++.||.++|.+|||||||||.|+|.+.. ++-.|+
T Consensus 100 ~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~Lv 175 (418)
T KOG1167|consen 100 LNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLV 175 (418)
T ss_pred chhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEE
Confidence 88999999999999999995 45555443 7789999999999999999999999999999999999864 678999
Q ss_pred eeccccccCC----------------C----------------------------CccccCCcccccccchhhccCCC-C
Q psy12305 323 DFGLARAKSV----------------P----------------------------TKTFSNEVVTLWYRPPDVLLGST-E 357 (516)
Q Consensus 323 DFGla~~~~~----------------~----------------------------~~~~~~~~gt~~y~APE~l~~~~-~ 357 (516)
|||+|..... + .....+..||++|+|||++...+ .
T Consensus 176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q 255 (418)
T KOG1167|consen 176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ 255 (418)
T ss_pred echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence 9999961100 0 00012357899999999997754 4
Q ss_pred CCceeeehHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHhcCCCCh--------h--hhhhcc----------c--c-cCC
Q psy12305 358 YSTSIDMGVGCIFHEMSSGRPLFPG-STIEDELRLICSILGPPPD--------E--LKSKLE----------F--C-ITP 413 (516)
Q Consensus 358 ~~~~d~~SlGvil~elltG~~pF~~-~~~~~~~~~i~~~~~~~p~--------~--~~~~~~----------~--~-~~~ 413 (516)
+++.|+||.|||+..+++++.||.. .++.+.+..|..+.|.-.- . +|+... | + ...
T Consensus 256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~ 335 (418)
T KOG1167|consen 256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES 335 (418)
T ss_pred CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence 5667889999999999999999854 4445555556555554221 1 111000 0 0 001
Q ss_pred CCCCch--hhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 414 VYPSES--KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 414 ~~~~~~--~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.++... .......+..+..+.||+.+||+.||.+|+||+++|+||||....
T Consensus 336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 111111 111222234566899999999999999999999999999998554
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=279.29 Aligned_cols=242 Identities=36% Similarity=0.570 Sum_probs=201.5
Q ss_pred eeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHh
Q psy12305 194 TYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 272 (516)
Q Consensus 194 ~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~ 272 (516)
+||.||+|....++..+|+|.+...........+.+|+..+++++|+||+++++.+......+++|||+++ +|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999999999999998665443356788999999999999999999999999999999999996 88888876
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhc
Q psy12305 273 CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL 352 (516)
Q Consensus 273 ~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l 352 (516)
... +++..+..++.+++.||.|||+.+|+|+||+|.||+++.++.++|+|||.+....... ......++..|+|||.+
T Consensus 81 ~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 81 RGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVL 158 (244)
T ss_pred ccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHH
Confidence 443 8999999999999999999999999999999999999999999999999998765332 33445678899999999
Q ss_pred cCCCCCCceeeehHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCH
Q psy12305 353 LGSTEYSTSIDMGVGCIFHEMSSGRPLFPG-STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDS 431 (516)
Q Consensus 353 ~~~~~~~~~d~~SlGvil~elltG~~pF~~-~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 431 (516)
.+.....++|+||+|+++|+|++|..||.. .........+......+ ......++.
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~ 215 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF-----------------------PPPEWKISP 215 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC-----------------------ccccccCCH
Confidence 877788899999999999999999999977 33333332222111000 000001778
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 432 DALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 432 ~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
++.+++.+||..||++||++.++++||||
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=314.16 Aligned_cols=216 Identities=29% Similarity=0.388 Sum_probs=167.2
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCC--CCCH-HHHHHHHHHHHHHHHHHhhCCc
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSN--ILSM-NNVKLFLFQLLRGLAYCHSRRI 301 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~--~l~~-~~~~~i~~qi~~aL~yLH~~~i 301 (516)
.+.+|+.+|+.- +|||||++|+.-.++.+.||+.|+|..+|.+++..... .... ...+..+.|++.||++||+.+|
T Consensus 548 ~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~i 627 (903)
T KOG1027|consen 548 FAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKI 627 (903)
T ss_pred HHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhccc
Confidence 456788888777 58999999988899999999999999999999987411 1111 4467889999999999999999
Q ss_pred EeeecCCCCEEEcc---CC--CEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHH
Q psy12305 302 LHRDLKPQNLLINE---RG--ELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEM 373 (516)
Q Consensus 302 vHrDlKp~NILl~~---~~--~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~el 373 (516)
|||||||+||||+. ++ +++|+|||+|+....... ...+..||-+|+|||++.......+.|++|+||++|+.
T Consensus 628 VHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYv 707 (903)
T KOG1027|consen 628 VHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYV 707 (903)
T ss_pred ccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEE
Confidence 99999999999976 34 689999999998764433 24556789999999999988777777888999999999
Q ss_pred HcC-CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH
Q psy12305 374 SSG-RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452 (516)
Q Consensus 374 ltG-~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~ 452 (516)
++| ..||...... -..|.. |. ..+....| ..+.++.|||.+||.+||..||+|.
T Consensus 708 ltgG~HpFGd~~~R--~~NIl~--~~--------------------~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RPsa~ 762 (903)
T KOG1027|consen 708 LTGGSHPFGDSLER--QANILT--GN--------------------YTLVHLEP-LPDCEAKDLISRMLNPDPQLRPSAT 762 (903)
T ss_pred ecCCccCCCchHHh--hhhhhc--Cc--------------------cceeeecc-CchHHHHHHHHHhcCCCcccCCCHH
Confidence 996 8999653221 122221 10 11111222 1122899999999999999999999
Q ss_pred HHHcCCCCCCCCCC
Q psy12305 453 NAMRHPYFNSLGPQ 466 (516)
Q Consensus 453 e~l~Hp~f~~~~~~ 466 (516)
++|.||||.+...+
T Consensus 763 ~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 763 DVLNHPLFWDSEKR 776 (903)
T ss_pred HHhCCCccCChHHH
Confidence 99999999865443
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.73 Aligned_cols=262 Identities=24% Similarity=0.348 Sum_probs=216.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..-++|+++..+|.|+||-||||||+.+++..|||+++........
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~---------------------------------- 57 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFS---------------------------------- 57 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcccc----------------------------------
Confidence 4557899999999999999999999999999999999865432210
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
....|+-+++.++|||||.+++
T Consensus 58 ----------------------------------------------------------~iqqei~~~~dc~h~nivay~g 79 (829)
T KOG0576|consen 58 ----------------------------------------------------------GIQQEIGMLRDCRHPNIVAYFG 79 (829)
T ss_pred ----------------------------------------------------------ccccceeeeecCCCcChHHHHh
Confidence 2335667777788888888888
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.+.....+|++||||+|+-++-+....+++++.++....+..+.||+|||++|-+|||||-.|||+++.|.+|++|||.+
T Consensus 80 sylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 80 SYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred hhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCch
Confidence 88888899999999997666666666678999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhc---cCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVL---LGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l---~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
............++||++|||||+. ..+.|...+|+|++|++..|+.--++|-........+..+.+-.-.||
T Consensus 160 aqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp---- 235 (829)
T KOG0576|consen 160 AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP---- 235 (829)
T ss_pred hhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC----
Confidence 8766555666778999999999986 345688999999999999999998988766665555555443322222
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....+...++.+-+|++.+|..+|++|||++.+|.|||...
T Consensus 236 -----------------~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 236 -----------------TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred -----------------cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 11223367888999999999999999999999999999864
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=301.78 Aligned_cols=205 Identities=21% Similarity=0.308 Sum_probs=169.9
Q ss_pred hhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 225 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 225 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
..++.|+-+|.+++|||+++|++++.... +-||++|++ |.|++|++.++..+-......|..||++||.|||.++++|
T Consensus 743 ~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVH 821 (1177)
T KOG1025|consen 743 IELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVH 821 (1177)
T ss_pred HHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhh
Confidence 34555555555556666666666665554 779999999 7999999998888999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcc--cccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV--TLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
|||-..|+|+..-..+||.|||+|+........+....| .+.|||-|.+....+...+|+|||||++||++| |..|+
T Consensus 822 rdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py 901 (1177)
T KOG1025|consen 822 RDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPY 901 (1177)
T ss_pred hhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCcc
Confidence 999999999999999999999999988766666555544 677999999999999999999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
.+....+.-..+. ...+..-|+.++-++.-++.+||..|+..||+++++-
T Consensus 902 ~gi~~~eI~dlle-------------------------~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 902 DGIPAEEIPDLLE-------------------------KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred CCCCHHHhhHHHh-------------------------ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 8877655433321 2233455678999999999999999999999998764
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=260.92 Aligned_cols=212 Identities=18% Similarity=0.298 Sum_probs=170.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++..-+..||+|+||.|=+-|+..+|...|+|++...-..+..++.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~---------------------------------- 91 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRL---------------------------------- 91 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHH----------------------------------
Confidence 5567788999999999999999999999999999765433333333
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHh-ccccceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE-LRHANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~ 249 (516)
++|+.+..+ ..+|++|++|+.+
T Consensus 92 ---------------------------------------------------------L~dldi~~r~~~CPf~V~FyGa~ 114 (282)
T KOG0984|consen 92 ---------------------------------------------------------LMDLDIIMRTVDCPFTVHFYGAL 114 (282)
T ss_pred ---------------------------------------------------------HHhhhhhccCCCCCeEEEeehhh
Confidence 344444333 3578888888888
Q ss_pred eeCceeeEeeehhhchHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYM---DDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l---~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
..+..+||.||.|+.+|..+. .+.+..+++..+-+++..++.||.|||++ .|||||+||.||||+.+|++|+||||
T Consensus 115 ~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 115 FREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred hccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 888889999999997665544 34677899999999999999999999975 89999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccC----CCCCCceeeehHHHHHHHHHcCCCCCCC-CCHHHHHHHHHH
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLG----STEYSTSIDMGVGCIFHEMSSGRPLFPG-STIEDELRLICS 394 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~d~~SlGvil~elltG~~pF~~-~~~~~~~~~i~~ 394 (516)
.+..+.... ..+-..|.-.|||||.+.. ..|+-++|+||||+++.||.+++.||+. .+..+++.+++.
T Consensus 195 IsG~L~dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe 267 (282)
T KOG0984|consen 195 ISGYLVDSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE 267 (282)
T ss_pred cceeehhhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence 997664322 2233467889999999853 3577899999999999999999999964 566777776654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=328.01 Aligned_cols=211 Identities=19% Similarity=0.263 Sum_probs=151.7
Q ss_pred HHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCcEee
Q psy12305 229 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH---SRRILHR 304 (516)
Q Consensus 229 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~~ivHr 304 (516)
.|+.++++++|||||++++++.++...|+||||++ |+|.+++.. +++..+..++.||+.||+||| +.+|+||
T Consensus 732 ~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~ 807 (968)
T PLN00113 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807 (968)
T ss_pred HHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecC
Confidence 35677788888888888999888888999999998 588888853 889999999999999999999 6699999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
||||+||+++.++..++. ||.+..... .....||+.|+|||++.+..++.++|+|||||++|||+||+.||....
T Consensus 808 dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCT----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred CCCHHhEEECCCCceEEE-ecccccccc----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 999999999999888876 666543321 122367899999999998888999999999999999999999995321
Q ss_pred HH-HHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 385 IE-DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 385 ~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.. ..........-.. ...... ..+.... ....+.....++.+++.+||+.||++|||++|+++.
T Consensus 883 ~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~----~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 883 GVHGSIVEWARYCYSD-CHLDMW----IDPSIRG----DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCCcHHHHHHHhcCc-cchhhe----eCccccC----CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 10 0011111000000 000000 0000000 000111122457899999999999999999999864
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=290.20 Aligned_cols=211 Identities=26% Similarity=0.342 Sum_probs=178.3
Q ss_pred cccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 84 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
|.....+.+|..+.+||.|+||.|+.|.++.+...|.||.|.+..- |.+.|..+.
T Consensus 554 e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRI------------------------L~DtWvrDr- 608 (772)
T KOG1152|consen 554 EKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERI------------------------LVDTWVRDR- 608 (772)
T ss_pred eeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhh------------------------hhhhhhccc-
Confidence 3445677889999999999999999999999999999999976521 111111110
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc---cc
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR---HA 240 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~---Hp 240 (516)
..-.+-.||+||..|+ |+
T Consensus 609 -----------------------------------------------------------kLGtVp~EIqIla~l~~~sH~ 629 (772)
T KOG1152|consen 609 -----------------------------------------------------------KLGTVPSEIQILATLNKHSHE 629 (772)
T ss_pred -----------------------------------------------------------ccCccchhHHHHHHhhhcCcc
Confidence 1113456999999997 99
Q ss_pred ceeeEeeeEeeCceeeEeeehhh-c-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC
Q psy12305 241 NIVTLHDIIHTEKCLTLVFEYLE-K-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE 318 (516)
Q Consensus 241 nIv~l~~~~~~~~~~~lV~E~~~-g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 318 (516)
||++++++|++++++||+||--+ | +|.+++... ..+++.+++.|++||+.|+++||++||||||||-+|+.++.+|-
T Consensus 630 NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k-p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~ 708 (772)
T KOG1152|consen 630 NILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK-PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF 708 (772)
T ss_pred chhhhhheeecCCeeEEEecCCCCCcchhhhhhcc-CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe
Confidence 99999999999999999999887 5 899998764 45999999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCC
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFP 381 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~ 381 (516)
+||+|||.|.... ..++..++||..|.|||++.|..| ....|+|++|++||.++....||.
T Consensus 709 ~klidfgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 709 VKLIDFGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred EEEeeccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999986543 345667899999999999988776 456788999999999999999985
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=300.28 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=206.2
Q ss_pred ccccccccceeeEEEEEEEec-------CCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeEeeCceee
Q psy12305 185 ILSMNNVKGTYATVFKGKSRL-------TDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLT 256 (516)
Q Consensus 185 ~l~~~~~~G~~g~V~~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 256 (516)
.+....|.|.||.|++|.-.. ....||+|.++..........+..|+.+|+.+ .||||+.+.+++..+..++
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 344478999999999997431 14579999999777667777889999999999 6999999999999999999
Q ss_pred Eeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEE
Q psy12305 257 LVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELK 320 (516)
Q Consensus 257 lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vk 320 (516)
+|+||+. |+|..+++.+. ..++..+...+++||+.|++||++.+++||||-..|||+..+..+|
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~k 458 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIK 458 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEE
Confidence 9999999 89999999876 3489999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCCCCccc-cCCcc--cccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCC-HHHHHHHHHHh
Q psy12305 321 LADFGLARAKSVPTKTF-SNEVV--TLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGST-IEDELRLICSI 395 (516)
Q Consensus 321 L~DFGla~~~~~~~~~~-~~~~g--t~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~-~~~~~~~i~~~ 395 (516)
|+|||+|+......... ....| ...|||||.+....++.++|+||+||+|||++| |..||++-. ..+.+..+.
T Consensus 459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~-- 536 (609)
T KOG0200|consen 459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK-- 536 (609)
T ss_pred EccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh--
Confidence 99999998643322221 22222 445999999999899999999999999999999 899999854 334333222
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
...+...|..+++++.++++.||+.+|++||++.++.
T Consensus 537 -----------------------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 537 -----------------------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred -----------------------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 3344556778999999999999999999999998876
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=266.44 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=182.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHh--cCCCCeeecccccccceeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE--LRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+-++.+.||+|-||.||+|+++ |..||||++... ++....||.+|..- |+|+||.++++.-..+..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g----- 279 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR----DERSWFRETEIYQTVMLRHENILGFIAADNKDNG----- 279 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEeccc----chhhhhhHHHHHHHHHhccchhhhhhhccccCCC-----
Confidence 34789999999999999999997 899999998643 33466778777764 488888777654322110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
T Consensus 280 -------------------------------------------------------------------------------- 279 (513)
T KOG2052|consen 280 -------------------------------------------------------------------------------- 279 (513)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-----C---CcEeeecCCCCEEEccCCCE
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-----R---RILHRDLKPQNLLINERGEL 319 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-----~---~ivHrDlKp~NILl~~~~~v 319 (516)
.-..+|||++|-+ |+|.+|+.. ..++.+...+++..++.||++||- + .|.|||||..|||+.++|.+
T Consensus 280 --s~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 280 --SWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred --ceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 0124899999999 899999987 459999999999999999999994 2 49999999999999999999
Q ss_pred EEeeeccccccCCCC----ccccCCcccccccchhhccCC------CCCCceeeehHHHHHHHHHcC----------CCC
Q psy12305 320 KLADFGLARAKSVPT----KTFSNEVVTLWYRPPDVLLGS------TEYSTSIDMGVGCIFHEMSSG----------RPL 379 (516)
Q Consensus 320 kL~DFGla~~~~~~~----~~~~~~~gt~~y~APE~l~~~------~~~~~~d~~SlGvil~elltG----------~~p 379 (516)
.|+|+|||-...... ...+..+||..|||||++... ..+..+|+||||.++||++.. ++|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999997654432 234667999999999998543 235678999999999999852 367
Q ss_pred CCCC----CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCC-----CHHHHHHHHHccccCcCCCCC
Q psy12305 380 FPGS----TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQM-----DSDALDLVQKFLMYDAKQRIS 450 (516)
Q Consensus 380 F~~~----~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-----s~~~~dLl~~~L~~dP~~R~t 450 (516)
|.+- ...+.+..++ |. .+++..+|..+ -..+..|++.||..+|.-|.|
T Consensus 436 yyd~Vp~DPs~eeMrkVV----------------Cv-------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVV----------------CV-------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred cccCCCCCCCHHHHhcce----------------ee-------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 7542 1222222221 10 11111122121 134668899999999999999
Q ss_pred HHHHH
Q psy12305 451 AANAM 455 (516)
Q Consensus 451 a~e~l 455 (516)
|-.+.
T Consensus 493 ALriK 497 (513)
T KOG2052|consen 493 ALRIK 497 (513)
T ss_pred HHHHH
Confidence 86654
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=274.46 Aligned_cols=263 Identities=23% Similarity=0.285 Sum_probs=182.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHh--cCCCCeeecccccccceeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE--LRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~~~~l 166 (516)
.+..-++++.||+|.||.||||.. +++.||||++.... .+.+.+|-+|.+- |+|+||+++++.-....
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t---- 277 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGT---- 277 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCC----
Confidence 355678899999999999999984 67999999986432 2255666666553 46666666554321110
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 278 -------------------------------------------------------------------------------- 277 (534)
T KOG3653|consen 278 -------------------------------------------------------------------------------- 277 (534)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---------CCcEeeecCCCCEEEccC
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS---------RRILHRDLKPQNLLINER 316 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~---------~~ivHrDlKp~NILl~~~ 316 (516)
.....++||+||.+ |+|.+|+..+ .+++....+++..+++||+|||+ ..|+|||||..|||+..|
T Consensus 278 ---~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~D 352 (534)
T KOG3653|consen 278 ---ADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKND 352 (534)
T ss_pred ---ccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccC
Confidence 01225899999998 7999999874 59999999999999999999995 359999999999999999
Q ss_pred CCEEEeeeccccccCCC--CccccCCcccccccchhhccCCCCC------CceeeehHHHHHHHHHcCCCCCC-CCCHHH
Q psy12305 317 GELKLADFGLARAKSVP--TKTFSNEVVTLWYRPPDVLLGSTEY------STSIDMGVGCIFHEMSSGRPLFP-GSTIED 387 (516)
Q Consensus 317 ~~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~------~~~d~~SlGvil~elltG~~pF~-~~~~~~ 387 (516)
++..|+|||+|..+... .....+.+||..|||||++.|.... ...|+||+|.+||||++.-.-+. +....-
T Consensus 353 lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 353 LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcc
Confidence 99999999999876522 2234457999999999999775433 35688899999999998654442 221111
Q ss_pred HHHHHHHhcCCCC--hhhhhh-cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH
Q psy12305 388 ELRLICSILGPPP--DELKSK-LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452 (516)
Q Consensus 388 ~~~~i~~~~~~~p--~~~~~~-~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~ 452 (516)
++- +-...|.-| ++++.. ...+..|.++... ... ..-.-+++.+..||..||+.|+||.
T Consensus 433 qlp-fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W-~~h----~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 433 QLP-FEAEVGNHPTLEEMQELVVRKKQRPKIPDAW-RKH----AGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred cCc-hhHHhcCCCCHHHHHHHHHhhccCCCChhhh-hcC----ccHHHHHHHHHHHcCCchhhhhhhH
Confidence 111 111122222 122211 1222333333211 111 2235688999999999999999985
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=302.51 Aligned_cols=202 Identities=14% Similarity=0.199 Sum_probs=152.2
Q ss_pred Hhccc-cceeeEeeeE-------eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeec
Q psy12305 235 RELRH-ANIVTLHDII-------HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306 (516)
Q Consensus 235 ~~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl 306 (516)
+.++| +||+.++++| .....++++|||++++|.+++......+++..++.++.||+.||+|||++||+||||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 45567 6888899988 233568899999999999999876667999999999999999999999999999999
Q ss_pred CCCCEEEccC-------------------CCEEEeeeccccccCCCC----------------ccccCCcccccccchhh
Q psy12305 307 KPQNLLINER-------------------GELKLADFGLARAKSVPT----------------KTFSNEVVTLWYRPPDV 351 (516)
Q Consensus 307 Kp~NILl~~~-------------------~~vkL~DFGla~~~~~~~----------------~~~~~~~gt~~y~APE~ 351 (516)
||+||||+.. +.+||+|||+++...... ......+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999653 455666666665321000 00112467999999999
Q ss_pred ccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCH
Q psy12305 352 LLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDS 431 (516)
Q Consensus 352 l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 431 (516)
+.+..+..++|+|||||+||||++|.+||.... ..+..+.... .|+. . ....+
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~~~-----------------------~-~~~~~ 239 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LPPQ-----------------------I-LLNWP 239 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cChh-----------------------h-hhcCH
Confidence 999889999999999999999999988875321 1111111110 0000 0 01235
Q ss_pred HHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 432 DALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 432 ~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+++.+||..||.+|||+.|+++||||...
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 57799999999999999999999999999753
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=234.58 Aligned_cols=211 Identities=36% Similarity=0.546 Sum_probs=184.7
Q ss_pred ccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHH
Q psy12305 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRY 269 (516)
Q Consensus 191 ~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~ 269 (516)
+.|++|.||++....++..+++|.+...........+.+|+..++.+.|++|+++++++......+++|||++ ++|.++
T Consensus 2 ~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~ 81 (215)
T cd00180 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDL 81 (215)
T ss_pred CcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHH
Confidence 5799999999999999999999999866543334578899999999999999999999999999999999999 688888
Q ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-CCCEEEeeeccccccCCCCccccCCcccccccc
Q psy12305 270 MDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFGLARAKSVPTKTFSNEVVTLWYRP 348 (516)
Q Consensus 270 l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~A 348 (516)
+......++...+..++.+++.+|+|||++|++|+||+|.||+++. ++.++|+|||.+..............++..|++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (215)
T cd00180 82 LKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMA 161 (215)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccC
Confidence 8775456899999999999999999999999999999999999999 899999999999766543322334556889999
Q ss_pred hhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCC
Q psy12305 349 PDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427 (516)
Q Consensus 349 PE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~ 427 (516)
||.+... ......|+|++|+++++|
T Consensus 162 pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------------ 187 (215)
T cd00180 162 PEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------------ 187 (215)
T ss_pred hhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------------
Confidence 9998776 667788999999999999
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHcCC
Q psy12305 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHP 458 (516)
Q Consensus 428 ~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp 458 (516)
..+.+++.+||..||++||+++++++|+
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2467899999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=247.84 Aligned_cols=210 Identities=16% Similarity=0.203 Sum_probs=175.2
Q ss_pred CChhhHHHHHHHHHhccccceeeEeeeEeeC-ceeeEeeehhh-chHHHHHHhcC-------CCCCHHHHHHHHHHHHHH
Q psy12305 222 GAPCTAIREVSLLRELRHANIVTLHDIIHTE-KCLTLVFEYLE-KDLKRYMDDCS-------NILSMNNVKLFLFQLLRG 292 (516)
Q Consensus 222 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~-g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~a 292 (516)
-....++.|..++..+.|||+..+.++...+ ...+.++.+++ |+|..++..+. ..++..+...++.|++.|
T Consensus 329 iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~a 408 (563)
T KOG1024|consen 329 IQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMA 408 (563)
T ss_pred HHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHH
Confidence 3344678899999999999999999987654 46677788888 89999998442 346777788899999999
Q ss_pred HHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccc--cCCcccccccchhhccCCCCCCceeeehHHHHH
Q psy12305 293 LAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF--SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIF 370 (516)
Q Consensus 293 L~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil 370 (516)
++|||++||||.||-..|.+|++.-++||+|=.++|..-...... .+.--...||+||.+....+++.+|+|||||+|
T Consensus 409 m~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll 488 (563)
T KOG1024|consen 409 MEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL 488 (563)
T ss_pred HHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH
Confidence 999999999999999999999999999999999998754322211 111226789999999999999999999999999
Q ss_pred HHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC
Q psy12305 371 HEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 371 ~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
|||+| |+.|+..-++.+..+.+. ...+...|-++++++...+.-||..+|++||
T Consensus 489 WELmtlg~~PyaeIDPfEm~~ylk-------------------------dGyRlaQP~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 489 WELMTLGKLPYAEIDPFEMEHYLK-------------------------DGYRLAQPFNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred HHHHhcCCCCccccCHHHHHHHHh-------------------------ccceecCCCCCcHHHHHHHHHHHhcCcccCC
Confidence 99999 999999988888776664 3445566779999999999999999999999
Q ss_pred CHHHHHc
Q psy12305 450 SAANAMR 456 (516)
Q Consensus 450 ta~e~l~ 456 (516)
+++|+..
T Consensus 544 sf~Qlv~ 550 (563)
T KOG1024|consen 544 SFSQLVI 550 (563)
T ss_pred CHHHHHH
Confidence 9999753
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-31 Score=243.13 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=186.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.+.|.+.+.||+|-||.+-+|+|+.+...+++|.+..... ..+.|.||...--.|.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t--t~~dF~rEfhY~~~Ls---------------------- 78 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT--TQADFVREFHYSFFLS---------------------- 78 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh--hHHHHHHHhccceeec----------------------
Confidence 3669999999999999999999999999999998876432 2224555543322220
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee-e
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD-I 248 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~ 248 (516)
.|.||+.-|+ .
T Consensus 79 --------------------------------------------------------------------~H~hIi~tY~va 90 (378)
T KOG1345|consen 79 --------------------------------------------------------------------PHQHIIDTYEVA 90 (378)
T ss_pred --------------------------------------------------------------------cchhhhHHHHHH
Confidence 3666666555 4
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc--CCCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE--RGELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkL~DFG 325 (516)
|++.+.+.+++||++ |+|..-+... .+.+...+.++.|+++||.|+|++++||||||.+||||-. ..++||||||
T Consensus 91 Fqt~d~YvF~qE~aP~gdL~snv~~~--GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 91 FQTSDAYVFVQEFAPRGDLRSNVEAA--GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred hhcCceEEEeeccCccchhhhhcCcc--cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecc
Confidence 777888899999999 8988877663 4889999999999999999999999999999999999943 3479999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCC-----CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHhcCCC
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGS-----TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE-LRLICSILGPP 399 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~-~~~i~~~~~~~ 399 (516)
+.+.......... -+..|-|||.+... ......|+|.||+++|..+||.+||+.....+. +....
T Consensus 169 ~t~k~g~tV~~~~---~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~------ 239 (378)
T KOG1345|consen 169 LTRKVGTTVKYLE---YVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE------ 239 (378)
T ss_pred cccccCceehhhh---hhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH------
Confidence 9876442222111 15578999987432 235678999999999999999999975433221 11111
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCC---CCHHHHHcCCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR---ISAANAMRHPYFNS 462 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R---~ta~e~l~Hp~f~~ 462 (516)
.+.....+..|. .+ ...++.+..+.++.|..+|++| -++......-|..+
T Consensus 240 ------~w~~rk~~~~P~------~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 240 ------QWLKRKNPALPK------KF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ------HHhcccCccCch------hh-cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 111111111111 11 1568889999999999999999 67777777778654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=234.63 Aligned_cols=209 Identities=34% Similarity=0.480 Sum_probs=169.5
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|.+.+.||.|+||.||+|.+..+++.||||.+.......
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~----------------------------------------- 39 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEK----------------------------------------- 39 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchH-----------------------------------------
Confidence 567889999999999999998889999999886532210
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
....+.+|+..++.++|+|++++++++...
T Consensus 40 --------------------------------------------------~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~ 69 (225)
T smart00221 40 --------------------------------------------------QREEFLREIRILKKLKHPNIVKLYGVFEDP 69 (225)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHhCCCCChhhheeeeecC
Confidence 112456677888888888888888888888
Q ss_pred ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 253 KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 253 ~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
...++++||+++ +|.+++......+++..+..++.|++.+|.|||+++++|+||+|.||+++.++.++|+|||++....
T Consensus 70 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~ 149 (225)
T smart00221 70 EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIH 149 (225)
T ss_pred CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEec
Confidence 889999999996 8888887654338899999999999999999999999999999999999999999999999988765
Q ss_pred CCC-ccccCCcccccccchhhc-cCCCCCCceeeehHHHHHHHHHcCCCCCCC-CCHH-HHHHHH
Q psy12305 332 VPT-KTFSNEVVTLWYRPPDVL-LGSTEYSTSIDMGVGCIFHEMSSGRPLFPG-STIE-DELRLI 392 (516)
Q Consensus 332 ~~~-~~~~~~~gt~~y~APE~l-~~~~~~~~~d~~SlGvil~elltG~~pF~~-~~~~-~~~~~i 392 (516)
... .......++..|++||.+ ....+...+|+||||+++|+|++|+.||.. .... .....+
T Consensus 150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~ 214 (225)
T smart00221 150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVW 214 (225)
T ss_pred CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHH
Confidence 332 122345678899999998 555666788889999999999999999977 3333 333444
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=224.97 Aligned_cols=166 Identities=17% Similarity=0.134 Sum_probs=129.8
Q ss_pred chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCccc
Q psy12305 264 KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVT 343 (516)
Q Consensus 264 g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt 343 (516)
|+|.+++...+..+++..++.++.||+.||+|||+++ ||+|||++.++.+|+ ||+++..... ...||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 5788888876777999999999999999999999998 999999999999999 9999765432 22689
Q ss_pred ccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhh
Q psy12305 344 LWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE-DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422 (516)
Q Consensus 344 ~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~-~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 422 (516)
+.|||||++.+..+..++|+|||||++|||++|+.||...... ..+..+........ ...
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------------~~~ 128 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-------------------PRD 128 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-------------------ccc
Confidence 9999999999988899999999999999999999999764332 22222222111000 000
Q ss_pred hcCCCCCCH--HHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 423 LLAPEQMDS--DALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 423 ~~~p~~~s~--~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
...+..++. ++.+||.+||..||.+|||+.++++|+|+.
T Consensus 129 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 129 RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 000112233 699999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=251.60 Aligned_cols=212 Identities=25% Similarity=0.378 Sum_probs=177.5
Q ss_pred HHHHHHHhcc-ccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeec
Q psy12305 229 REVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306 (516)
Q Consensus 229 ~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl 306 (516)
.|..++..++ ||.+|+++..|+.+..+++++++..| ++...+.. ...+.+..++.+...++.|++++|+.+|+|||+
T Consensus 45 ~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~ 123 (612)
T KOG0603|consen 45 QERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDY 123 (612)
T ss_pred cHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcc
Confidence 4667777886 99999999999999999999999996 67666554 345888899999999999999999999999999
Q ss_pred CCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHH
Q psy12305 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE 386 (516)
Q Consensus 307 Kp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~ 386 (516)
|++||+++.+|++++.|||+++........ |||..|||||++. .....+|.||+|++++||+||..||.+
T Consensus 124 k~enilld~~Ghi~~tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---- 193 (612)
T KOG0603|consen 124 KLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---- 193 (612)
T ss_pred cccceeecccCccccCCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----
Confidence 999999999999999999999875433322 8999999999998 456788888999999999999999987
Q ss_pred HHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH-----HHHHcCCCCC
Q psy12305 387 DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-----ANAMRHPYFN 461 (516)
Q Consensus 387 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta-----~e~l~Hp~f~ 461 (516)
+.+..|.. .....|..++..+++++..++..+|.+|..+ .++++|+||+
T Consensus 194 ~~~~~Il~--------------------------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~ 247 (612)
T KOG0603|consen 194 DTMKRILK--------------------------AELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQ 247 (612)
T ss_pred HHHHHHhh--------------------------hccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhe
Confidence 55555533 2334556788999999999999999999864 7999999999
Q ss_pred CCCCCcccCCCCCCCC
Q psy12305 462 SLGPQVHELSDTQSIF 477 (516)
Q Consensus 462 ~~~~~~~~~~~~~~~~ 477 (516)
.+.+.........+.|
T Consensus 248 ~i~~~~l~~r~~~~~f 263 (612)
T KOG0603|consen 248 SIDWNELEARSRPPPF 263 (612)
T ss_pred eeeHhhHhhcCCCCCC
Confidence 9887755444444444
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-28 Score=259.53 Aligned_cols=258 Identities=25% Similarity=0.279 Sum_probs=194.5
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecc-----cccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLE-----HEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 264 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 264 (516)
.+.|++|.|+.+........++.|..+.. ........+..|+.+-..+.|||++..+..+......+-+||||++
T Consensus 326 ~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~ 405 (601)
T KOG0590|consen 326 LGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY 405 (601)
T ss_pred eeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhcccH
Confidence 46788998888887777776766655421 1111111255677788889999998888877766655555999999
Q ss_pred hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc----cccCC
Q psy12305 265 DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK----TFSNE 340 (516)
Q Consensus 265 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~ 340 (516)
||...+... ..++..++..+++|++.||+|||++||.||||||+|+++..+|.+||+|||.+.....+.. .....
T Consensus 406 Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~ 484 (601)
T KOG0590|consen 406 DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGI 484 (601)
T ss_pred HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCc
Confidence 888888764 4589999999999999999999999999999999999999999999999999987654433 34567
Q ss_pred cccccccchhhccCCCCCCc-eeeehHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHhcCCCChhhhhhcccccCCCCCCc
Q psy12305 341 VVTLWYRPPDVLLGSTEYST-SIDMGVGCIFHEMSSGRPLFPGSTIEDELR-LICSILGPPPDELKSKLEFCITPVYPSE 418 (516)
Q Consensus 341 ~gt~~y~APE~l~~~~~~~~-~d~~SlGvil~elltG~~pF~~~~~~~~~~-~i~~~~~~~p~~~~~~~~~~~~~~~~~~ 418 (516)
+|+..|+|||++.+..|... .|+||.|+++..|.+|+.||.-....+... .+.. .. + .....
T Consensus 485 ~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~--~~---------~---~~~~~-- 548 (601)
T KOG0590|consen 485 VGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY--SD---------Q---RNIFE-- 548 (601)
T ss_pred ccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc--cc---------c---ccccc--
Confidence 89999999999988777654 577899999999999999997654433221 0000 00 0 00000
Q ss_pred hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 419 ~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
... ..-..++...+.+|.+||+.||.+|+|+++|++.+||+++.-.
T Consensus 549 ~~~--~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 549 GPN--RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred ChH--HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 000 0112567889999999999999999999999999999987543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=231.34 Aligned_cols=168 Identities=23% Similarity=0.173 Sum_probs=121.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcC-CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRL-TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~-~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..++|.+.+.||+|+||+||+|+++. +++.||||++.........
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~---------------------------------- 61 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSK---------------------------------- 61 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEeccccccccc----------------------------------
Confidence 34669999999999999999999876 7888899987522110000
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee-Ee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT-LH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~-l~ 246 (516)
......+.+|+.+|++++|+||+. ++
T Consensus 62 -----------------------------------------------------~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 62 -----------------------------------------------------PLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 001124566777777777777763 43
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeec-CCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL-KPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl-Kp~NILl~~~~~vkL~DFG 325 (516)
+. +..|+||||++|..+..+.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||
T Consensus 89 ~~----~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 89 AT----GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred Ec----CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 32 35799999999743332211 11 2468899999999999999999999 9999999999999999999
Q ss_pred cccccCCCCc--------cccCCcccccccchhhccC
Q psy12305 326 LARAKSVPTK--------TFSNEVVTLWYRPPDVLLG 354 (516)
Q Consensus 326 la~~~~~~~~--------~~~~~~gt~~y~APE~l~~ 354 (516)
+|+....... ...+..+++.|+|||.+..
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9986543221 1134567888999999853
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-25 Score=221.10 Aligned_cols=256 Identities=20% Similarity=0.159 Sum_probs=184.7
Q ss_pred cEeeeeeeccccceEEEEEEEcCCC-cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTD-NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g-~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+|.+.++||+|+||.||+|.+..++ ..+|+|........... .+..|+.+|..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~---------------------- 75 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEK---------------------- 75 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhh----------------------
Confidence 7999999999999999999997764 67888877654332222 34444444443321
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE-
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII- 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~- 249 (516)
.-.-+++..+++..
T Consensus 76 -----------------------------------------------------------------~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 76 -----------------------------------------------------------------KNGPSHFPKLLDHGR 90 (322)
T ss_pred -----------------------------------------------------------------hcCCCCCCEEEEecc
Confidence 00124677777777
Q ss_pred eeCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-----CCEEEee
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-----GELKLAD 323 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-----~~vkL~D 323 (516)
..+.+-|+||+.++.+|.++..... +.++..++..++.|++.+|++||+.|++||||||+|+++... ..+.|.|
T Consensus 91 ~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 91 STEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 4777899999999999999886655 789999999999999999999999999999999999999865 3599999
Q ss_pred ecccc--ccCCCC--------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 324 FGLAR--AKSVPT--------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 324 FGla~--~~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
||+|+ ...... .......||..|.++.+..+.......|.||++-++.||+.|..||.+.........+.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 321111 11234569999999999988877777777899999999999999997755433332222
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhc-CCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLL-APEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
...... ... .....+..+.++...+-..+...+|....+...
T Consensus 251 ~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KDPRKL----------------------LTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHhhhh----------------------ccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 211000 000 111334566667766666788888877665443
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-26 Score=207.13 Aligned_cols=207 Identities=27% Similarity=0.386 Sum_probs=169.4
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
+-..+.|.++++||.|+||-+|.|.+..+|..||||.-.... +||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a------------------~hp----------------- 55 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA------------------KHP----------------- 55 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC------------------CCc-----------------
Confidence 456688999999999999999999999999999999754321 222
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc-cceeeE
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH-ANIVTL 245 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l 245 (516)
....|..+.+.|++ ..|..+
T Consensus 56 -----------------------------------------------------------qL~yEskvY~iL~~g~GiP~i 76 (341)
T KOG1163|consen 56 -----------------------------------------------------------QLLYESKVYRILQGGVGIPHI 76 (341)
T ss_pred -----------------------------------------------------------chhHHHHHHHHhccCCCCchh
Confidence 23456777777754 567777
Q ss_pred eeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC---CCEEEe
Q psy12305 246 HDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER---GELKLA 322 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkL~ 322 (516)
..+..++.+-.+||++++.+|.+.+.-+.+.++...+..++-|++.-++|+|.++.|||||||+|+|..-+ ..+.|+
T Consensus 77 ~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 77 RHYGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred hhhccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEE
Confidence 78888888999999999999988888888889999999999999999999999999999999999998643 568999
Q ss_pred eeccccccCC-------CCccccCCcccccccchhhccCCCCCCceeee-hHHHHHHHHHcCCCCCCCCCHHHH
Q psy12305 323 DFGLARAKSV-------PTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDE 388 (516)
Q Consensus 323 DFGla~~~~~-------~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~-SlGvil~elltG~~pF~~~~~~~~ 388 (516)
|||+|+.... +...-.+..||..|.+--...+. ..+..||+ |+|.+|..+..|..||+|-.....
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk 229 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK 229 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhhH
Confidence 9999986432 22233456899999998877664 45677777 999999999999999998654433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=216.52 Aligned_cols=221 Identities=34% Similarity=0.521 Sum_probs=167.3
Q ss_pred hHHHHHHHHHhcccc-ceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCCc
Q psy12305 226 TAIREVSLLRELRHA-NIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS--NILSMNNVKLFLFQLLRGLAYCHSRRI 301 (516)
Q Consensus 226 ~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~i 301 (516)
.+.+|+.++..+.|+ +|+++.+.+......+++++++.+ ++.+++.... ..++...+..++.|++.++.|+|+.++
T Consensus 43 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~ 122 (384)
T COG0515 43 RFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGI 122 (384)
T ss_pred HHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 566777788888777 688888888777778999999995 6665555443 269999999999999999999999999
Q ss_pred EeeecCCCCEEEccCC-CEEEeeeccccccCCCCc------cccCCcccccccchhhccC---CCCCCceeeehHHHHHH
Q psy12305 302 LHRDLKPQNLLINERG-ELKLADFGLARAKSVPTK------TFSNEVVTLWYRPPDVLLG---STEYSTSIDMGVGCIFH 371 (516)
Q Consensus 302 vHrDlKp~NILl~~~~-~vkL~DFGla~~~~~~~~------~~~~~~gt~~y~APE~l~~---~~~~~~~d~~SlGvil~ 371 (516)
+|||+||+||+++..+ .++++|||.++....... .....+||..|+|||.+.+ .......|+||+|++++
T Consensus 123 ~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~ 202 (384)
T COG0515 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202 (384)
T ss_pred eccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHH
Confidence 9999999999999988 799999999985543332 3466789999999999987 46777888899999999
Q ss_pred HHHcCCCCCCCCCH---HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCC
Q psy12305 372 EMSSGRPLFPGSTI---EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR 448 (516)
Q Consensus 372 elltG~~pF~~~~~---~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R 448 (516)
++++|..||..... .............+. ...+. ....+......+.+++.+++..+|..|
T Consensus 203 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~r 266 (384)
T COG0515 203 ELLTGLPPFEGEKNSSATSQTLKIILELPTPS---------LASPL-------SPSNPELISKAASDLLKKLLAKDPKNR 266 (384)
T ss_pred HHHhCCCCCCCCCccccHHHHHHHHHhcCCcc---------ccccc-------CccccchhhHHHHHHHHHHHhcCchhc
Confidence 99999999877653 222222222222110 00000 000001223678999999999999999
Q ss_pred CCHHHHHcCCCCCC
Q psy12305 449 ISAANAMRHPYFNS 462 (516)
Q Consensus 449 ~ta~e~l~Hp~f~~ 462 (516)
.++.+...++|...
T Consensus 267 ~~~~~~~~~~~~~~ 280 (384)
T COG0515 267 LSSSSDLSHDLLAH 280 (384)
T ss_pred CCHHHHhhchHhhC
Confidence 99999998877654
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=241.03 Aligned_cols=154 Identities=31% Similarity=0.377 Sum_probs=132.7
Q ss_pred HHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc---------------cccCCcccccccchhhccC
Q psy12305 290 LRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK---------------TFSNEVVTLWYRPPDVLLG 354 (516)
Q Consensus 290 ~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~---------------~~~~~~gt~~y~APE~l~~ 354 (516)
+.|++|||+.||+|||+||+|.||..-|++|+.|||+++....... .....|||+.|+|||++..
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 7899999999999999999999999999999999999875321111 1133589999999999998
Q ss_pred CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHH
Q psy12305 355 STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDAL 434 (516)
Q Consensus 355 ~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 434 (516)
..|..+.|+|++|+|+||.+-|..||.|++.++.+..++.....+|++. +.++++++
T Consensus 233 qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d-----------------------ea~p~Ea~ 289 (1205)
T KOG0606|consen 233 QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED-----------------------EALPPEAQ 289 (1205)
T ss_pred hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC-----------------------cCCCHHHH
Confidence 8888888888999999999999999999999999998888776666532 25778999
Q ss_pred HHHHHccccCcCCCC---CHHHHHcCCCCCCCCCC
Q psy12305 435 DLVQKFLMYDAKQRI---SAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 435 dLl~~~L~~dP~~R~---ta~e~l~Hp~f~~~~~~ 466 (516)
|+|.++|+.+|..|. .+-++.+|+||+.+.+.
T Consensus 290 dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 290 DLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred HHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 999999999999997 46788999999988876
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=207.32 Aligned_cols=206 Identities=25% Similarity=0.381 Sum_probs=170.0
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|.+.++||+|+||+.+.|.+..+++.||||.-.....
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~------------------------------------------ 66 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE------------------------------------------ 66 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC------------------------------------------
Confidence 49999999999999999999999999999997543221
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeEe
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIH 250 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 250 (516)
..++..|.+..+.| ..++|...|.+-+
T Consensus 67 ----------------------------------------------------APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 67 ----------------------------------------------------APQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred ----------------------------------------------------cchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 11344566666666 3578888888888
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-----CEEEeeec
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-----ELKLADFG 325 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-----~vkL~DFG 325 (516)
.+.+-.||+|+++.+|.+++.-|++.++.+.+..++.|++.-++|+|++.+|.|||||+|+||...+ .+.|+|||
T Consensus 95 eG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 95 EGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred ccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEecc
Confidence 8889999999999999999999999999999999999999999999999999999999999997544 48999999
Q ss_pred cccccCCCCc-------cccCCcccccccchhhccCCCCCCceeee-hHHHHHHHHHcCCCCCCCC---CHHHHHHHH
Q psy12305 326 LARAKSVPTK-------TFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGS---TIEDELRLI 392 (516)
Q Consensus 326 la~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~d~~-SlGvil~elltG~~pF~~~---~~~~~~~~i 392 (516)
+|+....+.. ......||..||+--..+|. ..+..||. |||=++.+.|-|..||.|- +..+.+++|
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGr-EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGR-EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccc-hhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 9987654332 23455789999998887775 45667777 9999999999999999874 444444444
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-26 Score=232.07 Aligned_cols=342 Identities=23% Similarity=0.313 Sum_probs=220.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|+....+|.||||+|+.+....++-.+|||+|............++|+..++++-|++++++...|...+..-..
T Consensus 46 r~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~~~~~~q 125 (516)
T KOG1033|consen 46 REANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYERPPLGWQ 125 (516)
T ss_pred hhhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecCCCCccc
Confidence 45678999999999999999999999888899999999888777777899999999999999999998777543221110
Q ss_pred e--------ehh---hhhhhccccc-------------------c----cccc---------------------------
Q psy12305 168 F--------EYL---EKDLKRYMDD-------------------C----SNIL--------------------------- 186 (516)
Q Consensus 168 ~--------Ey~---~~~L~~~l~~-------------------~----s~~l--------------------------- 186 (516)
- .+. ..++..+... + ...+
T Consensus 126 e~~d~~~l~~~~~~~~~~l~sl~~~~~~~~q~~~~~~~~~A~e~s~~~~~~~v~~~~~s~s~~~~~s~s~~~~~~~~~rk 205 (516)
T KOG1033|consen 126 EEMDLKLLDDETSSERSNLPSLSERRTSKRQTAELPRVSAAAESSFHVFRAIVPVENQSHSQESSSSISQHNGSRSEFRK 205 (516)
T ss_pred chhhhhhhhccCCcchhccccccchhccchhhhhcccccccchhhhccccccCchhhcccCcccccchhhcccchhhhhh
Confidence 0 000 0000000000 0 0000
Q ss_pred -------------------------------ccccccceeeEEEEEEEecCCceEEEEEeeccc-------------cc-
Q psy12305 187 -------------------------------SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEH-------------EE- 221 (516)
Q Consensus 187 -------------------------------~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~-------------~~- 221 (516)
+.....++++.+.++........+-.|...... ..
T Consensus 206 ~s~~k~~~~~~~~~tdsd~~ed~~~~~~s~~~~~~~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~ 285 (516)
T KOG1033|consen 206 TSVSKASRFEGPDCTDSDLEEDEMQGSDSKESSRHEESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL 285 (516)
T ss_pred hhhccccccCCCccccccccccccccCcccCcccccccccccccccccccccCCchhhhhcccchhhhhccchhhhccch
Confidence 000011122223333322222222222221110 00
Q ss_pred CChhhHHHHHHHHHhccccceeeEee-------eEee-----CceeeEeeehhh-chHHHHHHhc--CCCCCHHHHHHHH
Q psy12305 222 GAPCTAIREVSLLRELRHANIVTLHD-------IIHT-----EKCLTLVFEYLE-KDLKRYMDDC--SNILSMNNVKLFL 286 (516)
Q Consensus 222 ~~~~~~~~Ei~il~~l~HpnIv~l~~-------~~~~-----~~~~~lV~E~~~-g~L~~~l~~~--~~~l~~~~~~~i~ 286 (516)
..-....+++-.+....|.+..-+.+ .+.. ..++||.|++|. .+|.+++... ....+....+.++
T Consensus 286 ~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~ 365 (516)
T KOG1033|consen 286 CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIF 365 (516)
T ss_pred hhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHH
Confidence 00001123333333333433333332 1111 236899999999 5888888643 3446778899999
Q ss_pred HHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC------ccccCCcccccccchhhccCCCCCCc
Q psy12305 287 FQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT------KTFSNEVVTLWYRPPDVLLGSTEYST 360 (516)
Q Consensus 287 ~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~ 360 (516)
.|++.|++| +|.+|||+||.||+...+..+||.|||+........ ...+..+||.+||+||.+.+..|..+
T Consensus 366 ~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k 442 (516)
T KOG1033|consen 366 KQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK 442 (516)
T ss_pred Hhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh
Confidence 999999999 999999999999999999999999999987654332 23455689999999999999999999
Q ss_pred eeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHH
Q psy12305 361 SIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQK 439 (516)
Q Consensus 361 ~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~ 439 (516)
.|+||||++|+|++. -...|.... .+..+.. |..|++.+ .-.++-.+|+.+
T Consensus 443 vdIyaLGlil~EL~~~f~T~~er~~---t~~d~r~--g~ip~~~~-----------------------~d~p~e~~ll~~ 494 (516)
T KOG1033|consen 443 VDIYALGLILAELLIQFSTQFERIA---TLTDIRD--GIIPPEFL-----------------------QDYPEEYTLLQQ 494 (516)
T ss_pred cchhhHHHHHHHHHHHhccHHHHHH---hhhhhhc--CCCChHHh-----------------------hcCcHHHHHHHH
Confidence 999999999999998 333332111 1111111 12221111 112456799999
Q ss_pred ccccCcCCCCCHHHHHcCCCC
Q psy12305 440 FLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 440 ~L~~dP~~R~ta~e~l~Hp~f 460 (516)
||...|.+||++.+.--|+|.
T Consensus 495 lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 495 LLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCcccCchHHHHhhhhhc
Confidence 999999999988888778775
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=195.60 Aligned_cols=100 Identities=24% Similarity=0.311 Sum_probs=78.7
Q ss_pred HHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhch-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-hhCCcEee
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYC-HSRRILHR 304 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g~-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~ivHr 304 (516)
..+|+.++.++.++++.....+... ..+|||||++|+ +...... ...+++..+..++.|++.+|.|| |+.||+||
T Consensus 66 ~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr 142 (190)
T cd05147 66 AEKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHA 142 (190)
T ss_pred HHHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 3569999999988777544333222 238999999974 3333222 35689999999999999999999 79999999
Q ss_pred ecCCCCEEEccCCCEEEeeecccccc
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
||||+|||++ ++.++|+|||+|...
T Consensus 143 DlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 143 DLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCHHHEEEE-CCcEEEEEccccccC
Confidence 9999999998 588999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=201.67 Aligned_cols=189 Identities=22% Similarity=0.254 Sum_probs=143.5
Q ss_pred cccceeeEeeeEee---------------------------CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHH
Q psy12305 238 RHANIVTLHDIIHT---------------------------EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLL 290 (516)
Q Consensus 238 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~ 290 (516)
+|||||.+...|.+ ...+|+||.-...+|.+++.... .+....+.++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence 69999998877654 23589999999999999998743 67888899999999
Q ss_pred HHHHHHhhCCcEeeecCCCCEEEc--cCC--CEEEeeeccccccCCCC------ccccCCcccccccchhhccCCC----
Q psy12305 291 RGLAYCHSRRILHRDLKPQNLLIN--ERG--ELKLADFGLARAKSVPT------KTFSNEVVTLWYRPPDVLLGST---- 356 (516)
Q Consensus 291 ~aL~yLH~~~ivHrDlKp~NILl~--~~~--~vkL~DFGla~~~~~~~------~~~~~~~gt~~y~APE~l~~~~---- 356 (516)
+|+.|||++||.|||+|.+|||+. +|+ .+.|+|||+|-...... ...-..-|...-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999984 343 47899999986543311 1112234677899999986432
Q ss_pred --CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHH
Q psy12305 357 --EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDAL 434 (516)
Q Consensus 357 --~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 434 (516)
.|.++|.|+.|.+.||+++...||.+......-..-.. +..-...|+.+++.++
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq------------------------e~qLPalp~~vpp~~r 487 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ------------------------ESQLPALPSRVPPVAR 487 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh------------------------hhhCCCCcccCChHHH
Confidence 47889999999999999999999987332111000000 1111224568899999
Q ss_pred HHHHHccccCcCCCCCHH
Q psy12305 435 DLVQKFLMYDAKQRISAA 452 (516)
Q Consensus 435 dLl~~~L~~dP~~R~ta~ 452 (516)
+|+..+|+.||.+|+++.
T Consensus 488 qlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 488 QLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred HHHHHHhcCCccccCCcc
Confidence 999999999999999853
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=191.00 Aligned_cols=101 Identities=20% Similarity=0.209 Sum_probs=81.5
Q ss_pred HHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhch-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEee
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHR 304 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g~-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHr 304 (516)
..+|...+.++.|++|.....+.... .||||||++|. +...... ...++...+..++.|++.+|.+||+ +||+||
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr 142 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG 142 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 45799999999999886554443332 48999999974 3322222 2457888999999999999999999 999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
||||+|||++ ++.++|+|||+|+...
T Consensus 143 DlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 143 DLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCChhhEEEE-CCCEEEEEcccceecC
Confidence 9999999998 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=188.01 Aligned_cols=125 Identities=14% Similarity=0.177 Sum_probs=92.0
Q ss_pred HHHHHHHHHhccccceeeEeeeEeeC--------ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIHTE--------KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH 297 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH 297 (516)
+.+|+..+.++.||+|..+.+++... ...+|||||++| +|.+.. .+++ ....+++.+|..||
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH 152 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLH 152 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHH
Confidence 45677777777777777777765532 458999999997 665542 1333 24669999999999
Q ss_pred hCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHH
Q psy12305 298 SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEM 373 (516)
Q Consensus 298 ~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~el 373 (516)
+.|++|||+||+||+++.+| ++|+|||.++........ ..+++...+.-.+|+||||+++.-+
T Consensus 153 ~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 153 QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHH
Confidence 99999999999999999988 999999988654311110 1133444555689999999988654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.8e-22 Score=192.43 Aligned_cols=161 Identities=19% Similarity=0.265 Sum_probs=102.4
Q ss_pred eeEeeehhhchHHHHHH---hcCCC-CC-HHHH-HHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 255 LTLVFEYLEKDLKRYMD---DCSNI-LS-MNNV-KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 255 ~~lV~E~~~g~L~~~l~---~~~~~-l~-~~~~-~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+++|+-+.++|...+. ..... .. ...+ ..+..|+++.+++||+.||+|+||||+|++++.+|.+.|+||+...
T Consensus 114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~ 193 (288)
T PF14531_consen 114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV 193 (288)
T ss_dssp EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence 57888888887766643 32222 11 1223 3445899999999999999999999999999999999999999876
Q ss_pred ccCCCCccccCCcccccccchhhccCC--------CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGS--------TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~--------~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
....... ....+..|.+||..... .++...|.|+||+++|.|++|..||........ +
T Consensus 194 r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~----------~- 259 (288)
T PF14531_consen 194 RAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD----------P- 259 (288)
T ss_dssp ETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST----------S-
T ss_pred ecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc----------c-
Confidence 5432111 13346789999987432 345566889999999999999999976432110 0
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR 448 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R 448 (516)
+ ..+... . ++++..++||.+||++||.+|
T Consensus 260 ~-----------------~~f~~C-~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 260 E-----------------WDFSRC-R-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp G-----------------GGGTTS-S----HHHHHHHHHHT-SSGGGS
T ss_pred c-----------------ccchhc-C-CcCHHHHHHHHHHccCCcccC
Confidence 0 011111 1 678899999999999999988
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.3e-22 Score=214.30 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=172.1
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|...+.||.+-|=+|.+|+++ .| .|.||+.-+....-....+.+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG-~vVvKVFvk~~p~~sL~~~~q--------------------------------- 68 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EG-LVVVKVFVKQDPTISLRPFKQ--------------------------------- 68 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cc-eEEEEEEeccCCCCCchHHHH---------------------------------
Confidence 7899999999999999999985 34 499998866543332222211
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
-+.|++ ...++|||++.+.-+..+
T Consensus 69 -------------------------------------------------------rL~~ik-~~l~~~pn~lPfqk~~~t 92 (1431)
T KOG1240|consen 69 -------------------------------------------------------RLEEIK-FALMKAPNCLPFQKVLVT 92 (1431)
T ss_pred -------------------------------------------------------HHHHHH-HHhhcCCcccchHHHHHh
Confidence 122333 334456666666666666
Q ss_pred CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+...|||=+|...+|.+.+..+ ..+..-+-+.|+.||+.||.-||..||+|+|||.+||||+.-+.+.|+||..-+..-
T Consensus 93 ~kAAylvRqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY 171 (1431)
T KOG1240|consen 93 DKAAYLVRQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY 171 (1431)
T ss_pred hHHHHHHHHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc
Confidence 6677888888888888877653 347777889999999999999999999999999999999999999999998765432
Q ss_pred CCCccc---cCCcc----cccccchhhccCCC-----------CCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q psy12305 332 VPTKTF---SNEVV----TLWYRPPDVLLGST-----------EYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLI 392 (516)
Q Consensus 332 ~~~~~~---~~~~g----t~~y~APE~l~~~~-----------~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i 392 (516)
.+.... .-+.- -..|.|||-+.... -..+-|++|+||+++||++ |++||.- .++-..
T Consensus 172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aY 247 (1431)
T KOG1240|consen 172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAY 247 (1431)
T ss_pred CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhH
Confidence 221111 11111 23599999885421 2334566799999999998 8999942 111111
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
...-...++.. ++ . --+...++||..|++.||++|.+|++.|+.
T Consensus 248 r~~~~~~~e~~-----------------Le-~---Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQL-----------------LE-K---IEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHH-----------------HH-h---CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11100011111 11 1 124579999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=182.08 Aligned_cols=86 Identities=22% Similarity=0.268 Sum_probs=67.4
Q ss_pred cccceeeEeeeEeeCc---e-eeEeeehhh---chHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHhhCCcEeeecCCC
Q psy12305 238 RHANIVTLHDIIHTEK---C-LTLVFEYLE---KDLKRYMDDCSNILSMNNVKLFLFQLLRGL-AYCHSRRILHRDLKPQ 309 (516)
Q Consensus 238 ~HpnIv~l~~~~~~~~---~-~~lV~E~~~---g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL-~yLH~~~ivHrDlKp~ 309 (516)
+||||++++++++++. . +.+||||++ ++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 5788888888887763 4 347899954 5899999663 36655 35688888888 9999999999999999
Q ss_pred CEEEccC----CCEEEeeeccc
Q psy12305 310 NLLINER----GELKLADFGLA 327 (516)
Q Consensus 310 NILl~~~----~~vkL~DFGla 327 (516)
|||++.. +.++|+||+.+
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCC
Confidence 9999743 37999995544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-21 Score=177.39 Aligned_cols=181 Identities=17% Similarity=0.064 Sum_probs=131.0
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeeccccc---CChhhHHHHHHHHHhcc-ccceeeEeeeEeeCceeeEeeehhhch
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEE---GAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEKD 265 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~---~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g~ 265 (516)
.++|+||+|+.+.. .+..++.+.+...... -....+.+|+++|++|. |++|++++++ +..|++|||+.|.
T Consensus 10 l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~ 83 (218)
T PRK12274 10 LKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGA 83 (218)
T ss_pred ecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCc
Confidence 46899999996655 6777777766544321 12235789999999995 5889999886 4469999999984
Q ss_pred -HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeec-CCCCEEEccCCCEEEeeeccccccCCCCcc---cc--
Q psy12305 266 -LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL-KPQNLLINERGELKLADFGLARAKSVPTKT---FS-- 338 (516)
Q Consensus 266 -L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl-Kp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~-- 338 (516)
|.+... .. ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......... ..
T Consensus 84 ~L~~~~~-------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~r 155 (218)
T PRK12274 84 AMYQRPP-------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLARE 155 (218)
T ss_pred cHHhhhh-------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHH
Confidence 433221 11 2357889999999999999999999 799999999999999999999754432210 00
Q ss_pred --------CCcccccccchhhccCC-CCCCceeee-hHHHHHHHHHcCCCCCCCCC
Q psy12305 339 --------NEVVTLWYRPPDVLLGS-TEYSTSIDM-GVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 339 --------~~~gt~~y~APE~l~~~-~~~~~~d~~-SlGvil~elltG~~pF~~~~ 384 (516)
-...++.|++|+.-.-- ..+-..-+| +.|+-+|.++|+..|+.++.
T Consensus 156 Dl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 156 DLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 01247788888753221 223234457 99999999999999987654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=180.23 Aligned_cols=100 Identities=18% Similarity=0.151 Sum_probs=76.9
Q ss_pred hHHHHHHHHHhccccc--eeeEeeeEeeCceeeEeeehhhch-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC-c
Q psy12305 226 TAIREVSLLRELRHAN--IVTLHDIIHTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR-I 301 (516)
Q Consensus 226 ~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~g~-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~-i 301 (516)
.+.+|+.++.++.+.. +.++++ .. ..++||||++|. +...... ...+....+..++.||+.+|.+||++| |
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~i 170 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGEL 170 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeE---ec-CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCE
Confidence 3567999999997633 333333 22 358999999984 4433322 234666678899999999999999999 9
Q ss_pred EeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 302 LHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 302 vHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+||||||+||+++ ++.++|+|||.|....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 9999999999999 8899999999986543
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=6e-21 Score=177.29 Aligned_cols=199 Identities=16% Similarity=0.208 Sum_probs=158.9
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--c
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRR--I 301 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--i 301 (516)
.|..|.-.|+-+.||||+.+++.+....++.++..||+ |+|+..+.... -..+..++.+++.++++|++|||+.. |
T Consensus 233 dfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~i 312 (448)
T KOG0195|consen 233 DFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMI 312 (448)
T ss_pred hhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhh
Confidence 55667778888899999999999999999999999999 79999887643 34677889999999999999999864 4
Q ss_pred EeeecCCCCEEEccCCCEEEe--eeccccccCCCCccccCCcccccccchhhccCCCC---CCceeeehHHHHHHHHHcC
Q psy12305 302 LHRDLKPQNLLINERGELKLA--DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE---YSTSIDMGVGCIFHEMSSG 376 (516)
Q Consensus 302 vHrDlKp~NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---~~~~d~~SlGvil~elltG 376 (516)
.---|....++||++-+.+|. |--++.. .. ...-+|.||+||.+...+. ...+|.|||.+++|||.|.
T Consensus 313 pr~~lns~hvmidedltarismad~kfsfq--e~-----gr~y~pawmspealqrkped~n~raadmwsfaillwel~tr 385 (448)
T KOG0195|consen 313 PRFYLNSKHVMIDEDLTARISMADTKFSFQ--EV-----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTR 385 (448)
T ss_pred hhhhcccceEEecchhhhheecccceeeee--cc-----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcc
Confidence 444688899999998776653 4333211 11 1223789999999976554 3568889999999999999
Q ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 377 RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 377 ~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
..||..-+..+.-.+|.- +.++...|+.+++....|+.-|++-||.+||.++.+.
T Consensus 386 evpfadlspmecgmkial------------------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 386 EVPFADLSPMECGMKIAL------------------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ccccccCCchhhhhhhhh------------------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 999988777665555432 5667778889999999999999999999999987653
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=196.59 Aligned_cols=137 Identities=23% Similarity=0.262 Sum_probs=113.6
Q ss_pred ceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc----
Q psy12305 241 NIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE---- 315 (516)
Q Consensus 241 nIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---- 315 (516)
.|..++..+.-.+.-+||+||.+ |+|++++. ..+.+++..+..+..|++.-++.||.++|||+||||+|+||..
T Consensus 755 ~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 755 SIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred chHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 34444555555666789999999 89999988 4566999999999999999999999999999999999999943
Q ss_pred ---CCCEEEeeeccccccC--CCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCC
Q psy12305 316 ---RGELKLADFGLARAKS--VPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRP 378 (516)
Q Consensus 316 ---~~~vkL~DFGla~~~~--~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~ 378 (516)
.--++|+|||.|-.+. .+...+...++|-.+-.+|+..|.++....|-+.+..++|-||.|+.
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 2348999999986432 23446677788999999999999998888887799999999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.1e-19 Score=167.42 Aligned_cols=158 Identities=19% Similarity=0.216 Sum_probs=109.9
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
|.+.+.||+|+||.||+|.+. +|+.||||++........ ......+.+....+++.+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-------------------- 73 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFR--KVKRKRDYLGDRKHASWL-------------------- 73 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhh--hhcchHHHHhccccchhH--------------------
Confidence 788899999999999999885 899999999876431110 111111111111111110
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc--eeeEeeeEe
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN--IVTLHDIIH 250 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~ 250 (516)
........+|+.++..+.|++ ++..++
T Consensus 74 ------------------------------------------------~~~~~~~~~E~~~l~~l~~~~i~v~~~~~--- 102 (198)
T cd05144 74 ------------------------------------------------YLSRLAAQKEFAALKALYEEGFPVPKPID--- 102 (198)
T ss_pred ------------------------------------------------HHhHHHHHHHHHHHHHHHHcCCCCCceee---
Confidence 111224567899999998874 344433
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
....++||||++|..+..+.. ......++.+++.++.++|+.||+||||||+||+++.++.++|+|||+|...
T Consensus 103 -~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 103 -WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred -cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 234589999999743322211 1346778999999999999999999999999999999999999999999655
Q ss_pred C
Q psy12305 331 S 331 (516)
Q Consensus 331 ~ 331 (516)
.
T Consensus 176 ~ 176 (198)
T cd05144 176 D 176 (198)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=164.94 Aligned_cols=98 Identities=27% Similarity=0.393 Sum_probs=83.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.++..+.|++|.....++......++||||++| +|.+.+.... . ....++.+++.+|.++|+.|++||
T Consensus 45 ~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~ 119 (211)
T PRK14879 45 RTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHG 119 (211)
T ss_pred HHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccC
Confidence 456788888888888887777777777788999999986 7777765422 2 778899999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccc
Q psy12305 305 DLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
|++|.|||++ ++.++|+|||+++.
T Consensus 120 Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 120 DLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999 88999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=162.14 Aligned_cols=159 Identities=20% Similarity=0.221 Sum_probs=107.5
Q ss_pred eeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhh
Q psy12305 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDL 175 (516)
Q Consensus 96 ~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L 175 (516)
.+.||+|+||+||+|++. +|+.||||++..............+...+....|++...+...
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------ 62 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRL------------------ 62 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhH------------------
Confidence 568999999999999986 8999999998764322211111111244555555554322211
Q ss_pred hccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc--eeeEeeeEeeCc
Q psy12305 176 KRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN--IVTLHDIIHTEK 253 (516)
Q Consensus 176 ~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~ 253 (516)
....|...+..+.+.. +.+.++. .
T Consensus 63 --------------------------------------------------~~~~e~~~l~~l~~~~~~~~~~~~~----~ 88 (187)
T cd05119 63 --------------------------------------------------WAEKEFRNLKRLYEAGVPVPKPIDL----N 88 (187)
T ss_pred --------------------------------------------------HHHHHHHHHHHHHHcCCCCCceEec----C
Confidence 2235666666665443 3444433 2
Q ss_pred eeeEeeehhhch-HH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 254 CLTLVFEYLEKD-LK-RYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 254 ~~~lV~E~~~g~-L~-~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
..++||||++++ +. ..+.... . ...++.++.+++.++.++|. +||+||||||+||+++ ++.++|+|||.|...
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 358999999972 11 1111111 1 16688999999999999999 9999999999999999 899999999999754
Q ss_pred C
Q psy12305 331 S 331 (516)
Q Consensus 331 ~ 331 (516)
.
T Consensus 165 ~ 165 (187)
T cd05119 165 D 165 (187)
T ss_pred c
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.6e-18 Score=181.96 Aligned_cols=95 Identities=28% Similarity=0.347 Sum_probs=82.0
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++|++|+....++......++||||++| +|.+++. ....++.|++.+|.|||+.||+||
T Consensus 382 ~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHr 452 (535)
T PRK09605 382 RTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHG 452 (535)
T ss_pred HHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccC
Confidence 566889999999999988877777777778999999986 7777664 356789999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeecccccc
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
||||+|||+ .++.++|+|||+|+..
T Consensus 453 Dlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 453 DLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999 6789999999998653
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=172.01 Aligned_cols=203 Identities=23% Similarity=0.277 Sum_probs=152.9
Q ss_pred HHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCc-EeeecCCCCE
Q psy12305 234 LRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI-LHRDLKPQNL 311 (516)
Q Consensus 234 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~i-vHrDlKp~NI 311 (516)
|+.+.|.|+.++++.+.++...++|.+||. |+|.+.+......+++.-...++++|+.||+|||...| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 457899999999999999999999999999 78999888867778888889999999999999998765 9999999999
Q ss_pred EEccCCCEEEeeeccccccCC--CCccccCCcccccccchhhccCCC-------CCCceeeehHHHHHHHHHcCCCCCCC
Q psy12305 312 LINERGELKLADFGLARAKSV--PTKTFSNEVVTLWYRPPDVLLGST-------EYSTSIDMGVGCIFHEMSSGRPLFPG 382 (516)
Q Consensus 312 Ll~~~~~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~APE~l~~~~-------~~~~~d~~SlGvil~elltG~~pF~~ 382 (516)
+++....+||.|||+...... .........-..-|.|||.+.+.. .....|+||+|++++|+++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532 111111112245699999987642 34558899999999999999999975
Q ss_pred CC----HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 383 ST----IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 383 ~~----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
.. ..+....+.. .+..+ ..|...... ...+++..++.+||.-+|.+||+++++.
T Consensus 161 ~~~~~~~~eii~~~~~-~~~~~-------------~rP~i~~~~-----e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKK-GGSNP-------------FRPSIELLN-----ELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccCChHHHHHHHHh-cCCCC-------------cCcchhhhh-----hcchHHHHHHHHhcccChhhCccHHHHH
Confidence 22 2223333322 11110 000000000 3445799999999999999999998875
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.3e-19 Score=191.90 Aligned_cols=254 Identities=23% Similarity=0.301 Sum_probs=196.2
Q ss_pred cccccceeeEEEEEEEec-CCceEEEEEeeccc-ccCChhhHHHHHHHHHhcc-ccceeeEeeeEeeCceeeEeeehhhc
Q psy12305 188 MNNVKGTYATVFKGKSRL-TDNLVALKEIKLEH-EEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK 264 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~-~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 264 (516)
...++|+|+.|-.+.... ....+|.|.+.... ..........|..+-+.+. |+|++.+++........+++++|..|
T Consensus 26 ~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g 105 (601)
T KOG0590|consen 26 RSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDG 105 (601)
T ss_pred ccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccc
Confidence 345799999998887754 45567888776553 3333344556888888887 99999999999999999999999885
Q ss_pred -hHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHh-hCCcEeeecCCCCEEEccCC-CEEEeeeccccccCC---CCccc
Q psy12305 265 -DLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCH-SRRILHRDLKPQNLLINERG-ELKLADFGLARAKSV---PTKTF 337 (516)
Q Consensus 265 -~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH-~~~ivHrDlKp~NILl~~~~-~vkL~DFGla~~~~~---~~~~~ 337 (516)
++...+..... ..+...+..++.|+..|+.|+| ..++.||||||+|.+++..+ .+|++|||+|..... .....
T Consensus 106 ~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~ 185 (601)
T KOG0590|consen 106 GSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSL 185 (601)
T ss_pred cccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceee
Confidence 66666622232 5788889999999999999999 99999999999999999999 999999999987654 22344
Q ss_pred cCCcc-cccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCC
Q psy12305 338 SNEVV-TLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415 (516)
Q Consensus 338 ~~~~g-t~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~ 415 (516)
...+| ++.|+|||...+. ......|+||+|+++.-|++|..|+......+... ....+.+
T Consensus 186 ~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-------------~~~~~~~----- 247 (601)
T KOG0590|consen 186 KDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-------------SSWKSNK----- 247 (601)
T ss_pred ecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-------------eeecccc-----
Confidence 56688 9999999999884 34556778899999999999999986543322100 0000000
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 416 ~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..........++....+++.++|..+|..|.+.+++..+||+..
T Consensus 248 ---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 248 ---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ---cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 11122334477889999999999999999999999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.4e-17 Score=152.77 Aligned_cols=129 Identities=26% Similarity=0.298 Sum_probs=102.8
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccC-------ChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehh
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEG-------APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 262 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~-------~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 262 (516)
.++|+||.||++.. ++..+++|......... ....+.+|+.++..+.|+++....-++......++||||+
T Consensus 2 ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 2 IAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 47899999999984 67889999865432111 1245668999999999987766555566677789999999
Q ss_pred hc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 263 EK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 263 ~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+| +|.+.+.... ..++.|++.+|.+||+.|++|||+||.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~--------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN--------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH--------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 86 6666654321 17899999999999999999999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-18 Score=175.19 Aligned_cols=340 Identities=21% Similarity=0.178 Sum_probs=245.2
Q ss_pred ccEeeeeeecc--ccceEEEEEEE--cCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhc-CCCCeeecccccccceee
Q psy12305 91 ESYFKLDKLGQ--GTYATVFKGKS--RLTDNLVALKEIKLEHE-EGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 91 ~~y~~~~~LG~--G~fG~Vyka~~--~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 164 (516)
..|.+...+|. |++|.||+++. ..++..+|+|+-+.... ......-.+|+...+++ .|+|.|+.+..|...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 44778899999 99999999998 88999999998544332 33444678899888888 599999999999999999
Q ss_pred eeeeehhhhhhhccccccccc------------------------------------------------------ccccc
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNI------------------------------------------------------LSMNN 190 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~------------------------------------------------------l~~~~ 190 (516)
++..|++...+..+...-... +...+
T Consensus 194 fiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 194 FIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred eeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 999999887777665432110 01234
Q ss_pred ccceeeEEEEEEEe-cCCceEEEEEeecccc-cCChhhHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhchHH
Q psy12305 191 VKGTYATVFKGKSR-LTDNLVALKEIKLEHE-EGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLK 267 (516)
Q Consensus 191 ~~G~~g~V~~~~~~-~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~ 267 (516)
+.|.|+.|+....+ .++..|++|.+..... .........|+.+...+ .|.+++.+...|......|+-.|||++...
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~ 353 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSS 353 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcch
Confidence 56777777777655 6788899998765432 22223445678777777 599999999988888888899999985322
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCEEEeeeccccccCCCCccccCCcccccc
Q psy12305 268 RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTFSNEVVTLWY 346 (516)
Q Consensus 268 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~gt~~y 346 (516)
..-......+++...++...|++.|+.++|++.++|+|+||+||++..+ +..++.|||++........ ....+-++
T Consensus 354 ~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~---~~~~~~r~ 430 (524)
T KOG0601|consen 354 SLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG---VFHHIDRL 430 (524)
T ss_pred hhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceecc---cccccccc
Confidence 2222333447888899999999999999999999999999999999886 7789999999864221111 11223344
Q ss_pred c--chhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhc
Q psy12305 347 R--PPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424 (516)
Q Consensus 347 ~--APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 424 (516)
. +|.......+..+.|++|||..+.+.++|.+.-..... ...|. ......
T Consensus 431 ~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~i~-------------------------~~~~p~ 482 (524)
T KOG0601|consen 431 YPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLTIR-------------------------SGDTPN 482 (524)
T ss_pred cccchhhccccccccccccccccccccccccCcccCccccc---ceeee-------------------------cccccC
Confidence 4 55555556677788889999999999998653221110 00110 000011
Q ss_pred CCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 425 ~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.| ....++..+...++..|+..|+.+.++..|+-|..
T Consensus 483 ~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 483 LP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred CC-chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 11 33477888999999999999999999999887753
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.9e-17 Score=177.38 Aligned_cols=208 Identities=27% Similarity=0.355 Sum_probs=166.0
Q ss_pred cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC
Q psy12305 238 RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER 316 (516)
Q Consensus 238 ~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 316 (516)
.+|.++...-.+......+||++|+++ +|...+...+ +.+.+-++.+...+..+++|||...+.|||++|.|+|+..+
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~ 940 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD 940 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhccc
Confidence 456666655556667789999999985 7777766543 57888889999999999999999999999999999999999
Q ss_pred CCEEEeeeccccccCCC----------------------------C---ccccCCcccccccchhhccCCCCCCceeeeh
Q psy12305 317 GELKLADFGLARAKSVP----------------------------T---KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG 365 (516)
Q Consensus 317 ~~vkL~DFGla~~~~~~----------------------------~---~~~~~~~gt~~y~APE~l~~~~~~~~~d~~S 365 (516)
|..++.|||.......- . ......+||+.|.|||.+++......+|+|+
T Consensus 941 gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~ 1020 (1205)
T KOG0606|consen 941 GHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWS 1020 (1205)
T ss_pred CCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhh
Confidence 99999999843321000 0 0112346799999999999998888999889
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 366 lGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
+|++++|.++|.+||...+....+..|...--++|. -|...+.++++++.++|..+|
T Consensus 1021 ~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~-----------------------g~~~~s~~aq~~~~~ll~~~~ 1077 (1205)
T KOG0606|consen 1021 SGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPE-----------------------GPEEGSYEAQDLINRLLTEEP 1077 (1205)
T ss_pred hhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCC-----------------------CccccChhhhhhhhhhhccCc
Confidence 999999999999999998888877766543333221 234678899999999999999
Q ss_pred CCCCCHH---HHHcCCCCCCCCCCccc
Q psy12305 446 KQRISAA---NAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 446 ~~R~ta~---e~l~Hp~f~~~~~~~~~ 469 (516)
.+|.++. +.-.||||+..+|....
T Consensus 1078 ~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1078 TQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred hhccCcccccccccCCccCCCCccccc
Confidence 9999987 88999999988776543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=153.10 Aligned_cols=99 Identities=23% Similarity=0.292 Sum_probs=78.6
Q ss_pred hhHHHHHHHHHhccccce--eeEeeeEeeCc----eeeEeeehhhc--hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q psy12305 225 CTAIREVSLLRELRHANI--VTLHDIIHTEK----CLTLVFEYLEK--DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYC 296 (516)
Q Consensus 225 ~~~~~Ei~il~~l~HpnI--v~l~~~~~~~~----~~~lV~E~~~g--~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yL 296 (516)
..+.+|+.++..|.|++| +..+++...+. ..++|||+++| +|.+++.. ..+++. .+.||+.+|.+|
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~l 158 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARF 158 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHH
Confidence 367789999999988775 66666543322 23599999995 67777654 235544 367899999999
Q ss_pred hhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 297 HSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 297 H~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
|++||+||||||+|||++.++.++|+|||.++.
T Consensus 159 H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 159 HDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999999999999999999999999998865
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-15 Score=156.02 Aligned_cols=247 Identities=23% Similarity=0.193 Sum_probs=190.6
Q ss_pred cccc--ceeeEEEEEEE--ecCCceEEEEEeeccc-ccCChhhHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehh
Q psy12305 189 NNVK--GTYATVFKGKS--RLTDNLVALKEIKLEH-EEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYL 262 (516)
Q Consensus 189 ~~~~--G~~g~V~~~~~--~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 262 (516)
..+. |.+|.||.+.. ..++..+|+|.-+... ......+-.+|+.-.+.+ .|+|.++.+..++..+..++-+|+|
T Consensus 121 ~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~ 200 (524)
T KOG0601|consen 121 RTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC 200 (524)
T ss_pred ccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc
Confidence 3455 99999999998 8899999999844332 222333456777777777 5999999999999999999999999
Q ss_pred hchHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHhhCCcEeeecCCCCEEEccC-CCEEEeeeccccccCCCCcc-
Q psy12305 263 EKDLKRYMDDCSNILSMNNVKLFLFQLLR----GLAYCHSRRILHRDLKPQNLLINER-GELKLADFGLARAKSVPTKT- 336 (516)
Q Consensus 263 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~----aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~DFGla~~~~~~~~~- 336 (516)
+.++..+.......++...++..+.+... ||.++|+.+++|-|+||+||++..+ ...+++|||+..........
T Consensus 201 ~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~ 280 (524)
T KOG0601|consen 201 GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSS 280 (524)
T ss_pred cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCcccc
Confidence 99999999887777999999999999999 9999999999999999999999999 88999999998776543321
Q ss_pred ----ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 337 ----FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS--TIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 337 ----~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~--~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
....-|...|++||.+.+ .+....|++|+|.++.+..+|..++... +...++..+.
T Consensus 281 ~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~----------------- 342 (524)
T KOG0601|consen 281 VFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY----------------- 342 (524)
T ss_pred ceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-----------------
Confidence 122256778999999766 4566677779999999999987666432 1111111110
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....+-+..+.++...+..|+..||..|++++.+++|++..+.
T Consensus 343 ----------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 343 ----------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred ----------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 0000112345566669999999999999999999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-14 Score=127.84 Aligned_cols=128 Identities=21% Similarity=0.183 Sum_probs=106.3
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc--cceeeEeeeEeeCceeeEeeehhhchHH
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH--ANIVTLHDIIHTEKCLTLVFEYLEKDLK 267 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~g~L~ 267 (516)
.+.|.++.||++.... ..+++|....... ...+.+|+.+++.+.| .++++++.++...+..+++|||++|...
T Consensus 6 i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 6 LKGGLTNRVYLLGTKD--EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred cccccccceEEEEecC--CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 5689999999999754 6789998865433 4568899999999987 5899999998888899999999986432
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 268 RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR---RILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 268 ~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
..+ +......++.+++.+|.+||.. +++|+|++|+||+++..+.++++|||.++.
T Consensus 81 ~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 211 4455677899999999999984 799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.1e-14 Score=152.22 Aligned_cols=176 Identities=19% Similarity=0.203 Sum_probs=106.6
Q ss_pred eeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccce----eeeeeeehh
Q psy12305 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK----CLTLVFEYL 171 (516)
Q Consensus 96 ~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~Ey~ 171 (516)
.+.||.|++|.||+|+.+ +|+.||||+.+... .+.+..++.+|..+. ++.+...... ...++-|+.
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i----~~~i~~Dl~~l~~~~-----~~~~~~~~~~~~~~~~~~~~e~~ 191 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGI----EKTIAADIALLYRLA-----RIVERLSPDSRRLRPTEVVKEFE 191 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCc----HHHHHHHHHHHHHHH-----HHHHHhCccccccCHHHHHHHHH
Confidence 367999999999999974 89999999986432 335667777766541 0000000000 000000000
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-----ccceeeEe
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-----HANIVTLH 246 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~ 246 (516)
. .-.....+.+|...+.++. +++|.-..
T Consensus 192 ~-----------------------------------------------~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~ 224 (437)
T TIGR01982 192 K-----------------------------------------------TLRRELDLRREAANASELGENFKNDPGVYVPE 224 (437)
T ss_pred H-----------------------------------------------HHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCC
Confidence 0 0001114556777666663 34432222
Q ss_pred eeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLR-GLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~-aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
-+.......+|||||++| ++.+......... ....++.+++. .+..+|..|++|+|+||.||+++.+|.++|+||
T Consensus 225 v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDf 301 (437)
T TIGR01982 225 VYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDF 301 (437)
T ss_pred EehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeC
Confidence 122223456899999997 5554443221112 23445666655 478899999999999999999999999999999
Q ss_pred ccccccC
Q psy12305 325 GLARAKS 331 (516)
Q Consensus 325 Gla~~~~ 331 (516)
|++....
T Consensus 302 G~~~~l~ 308 (437)
T TIGR01982 302 GIVGRLS 308 (437)
T ss_pred CCeeECC
Confidence 9987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.9e-15 Score=155.17 Aligned_cols=178 Identities=15% Similarity=0.248 Sum_probs=105.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee----ee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC----LT 165 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~ 165 (516)
+.+|.. +.||.|++|.||+|+.+.+|+.||||+++..-. +.+..++.+|..+- ++.+.+..... ..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~----~~I~~Dl~~l~~~a-----~~l~~~~~~~~~l~~~~ 188 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDIL----PVIDADLALMYRLA-----RWVERLLPDGRRLKPRE 188 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchH----HHHHHHHHHHHHHH-----HHHHHhCcccccCCHHH
Confidence 345776 899999999999999988899999999975432 24455566665430 00000000000 00
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc----ccc
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR----HAN 241 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~----Hpn 241 (516)
++-|+... + ..+-.+.+|+..+.++. +.+
T Consensus 189 ~v~e~~~~-----------------------------------------l------~~ElD~~~Ea~N~~~~~~~f~~~~ 221 (537)
T PRK04750 189 VVAEFEKT-----------------------------------------L------HDELDLMREAANASQLRRNFEDSD 221 (537)
T ss_pred HHHHHHHH-----------------------------------------H------HHhhCHHHHHHHHHHHHHHccCCC
Confidence 00000000 0 00113444555444442 333
Q ss_pred eeeEeeeEee-CceeeEeeehhhc-hHHHH--HHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc
Q psy12305 242 IVTLHDIIHT-EKCLTLVFEYLEK-DLKRY--MDDCSN---ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN 314 (516)
Q Consensus 242 Iv~l~~~~~~-~~~~~lV~E~~~g-~L~~~--l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 314 (516)
.+.+-.++.+ ...-+|||||++| .+.+. +...+. .+.+..+..++.|++ ..|++|+|+||.||+++
T Consensus 222 ~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~ 294 (537)
T PRK04750 222 MLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVS 294 (537)
T ss_pred CeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEe
Confidence 3333333322 3456799999997 55442 222221 244555666666665 58999999999999999
Q ss_pred cCC----CEEEeeeccccccC
Q psy12305 315 ERG----ELKLADFGLARAKS 331 (516)
Q Consensus 315 ~~~----~vkL~DFGla~~~~ 331 (516)
.+| +++++|||++...+
T Consensus 295 ~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 295 YDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred cCCCCCCeEEEEecceEEECC
Confidence 988 99999999987654
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.4e-15 Score=143.86 Aligned_cols=237 Identities=18% Similarity=0.180 Sum_probs=158.2
Q ss_pred EEEEEEEecCCceEEEEEeeccc---ccCChhhHHHHHHHHHhccccceeeEeeeEeeCc-----eeeEeeehhh-chHH
Q psy12305 197 TVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK-----CLTLVFEYLE-KDLK 267 (516)
Q Consensus 197 ~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~-g~L~ 267 (516)
.||.+.+...|..|..-.+.... ..........-+.-|-++.|.|||+++.|+.+.+ ...++.||+. |++.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 35556666666666665554221 1111112222345567778999999999987654 4889999999 7888
Q ss_pred HHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccCCCEEEeeeccccc----cCCCCcccc
Q psy12305 268 RYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINERGELKLADFGLARA----KSVPTKTFS 338 (516)
Q Consensus 268 ~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkL~DFGla~~----~~~~~~~~~ 338 (516)
+++++ ++..+.....++|+.||+.||.|||+.. |+|+++..+-|++..+|-+|+.----... .........
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 77764 4567889999999999999999999874 99999999999999999888752111100 000011112
Q ss_pred CCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCC
Q psy12305 339 NEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL-FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417 (516)
Q Consensus 339 ~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p-F~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~ 417 (516)
...+-++|.|||.=.......+.|+|++|.+..||..|..- -.+.+.......|....-
T Consensus 241 ~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~-------------------- 300 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII-------------------- 300 (458)
T ss_pred ccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee--------------------
Confidence 23456789999975444556778889999999999988643 222222111111111100
Q ss_pred chhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 418 ~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.-.+.--++++.+||+-.|..||+|.+++.||.+-.
T Consensus 301 ---------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 301 ---------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred ---------eccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 011223457899999999999999999999998643
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.7e-12 Score=131.29 Aligned_cols=169 Identities=25% Similarity=0.354 Sum_probs=128.0
Q ss_pred EEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCH
Q psy12305 200 KGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSM 279 (516)
Q Consensus 200 ~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~ 279 (516)
.|..+.++.+|.+...+.... .......+-+.-|+.++||||+++++.++.++.+|||+|-+.. |-.++.+ +..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~----l~~ 103 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKE----LGK 103 (690)
T ss_pred ccceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHH----hHH
Confidence 467788899999998887766 3344567788899999999999999999999999999998873 2222322 335
Q ss_pred HHHHHHHHHHHHHHHHHh-hCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCC
Q psy12305 280 NNVKLFLFQLLRGLAYCH-SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY 358 (516)
Q Consensus 280 ~~~~~i~~qi~~aL~yLH-~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 358 (516)
..+..-++||+.||.||| +.+++|++|.-+.|+++..|..||++|-++..............---.|..|+.+....
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~-- 181 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE-- 181 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--
Confidence 667788999999999998 67899999999999999999999999998865432221111111122366776543222
Q ss_pred CceeeehHHHHHHHHHcC
Q psy12305 359 STSIDMGVGCIFHEMSSG 376 (516)
Q Consensus 359 ~~~d~~SlGvil~elltG 376 (516)
-..|-|.|||+++|++.|
T Consensus 182 ~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cchhhhhHHHHHHHHhCc
Confidence 235778999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.9e-12 Score=119.68 Aligned_cols=98 Identities=19% Similarity=0.286 Sum_probs=75.3
Q ss_pred HHHHHHHHHhccc--cceeeEeeeEeeCceeeEeeehhhch-HH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHH-hhCCc
Q psy12305 227 AIREVSLLRELRH--ANIVTLHDIIHTEKCLTLVFEYLEKD-LK-RYMDDCSNILSMNNVKLFLFQLLRGLAYC-HSRRI 301 (516)
Q Consensus 227 ~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~g~-L~-~~l~~~~~~l~~~~~~~i~~qi~~aL~yL-H~~~i 301 (516)
+.+|+..|+++.. -++.+++++ ..-+|||||++++ +. ..+.+ ..++...+..++.|++.+|..| |+.||
T Consensus 73 a~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~gl 146 (197)
T cd05146 73 AEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNL 146 (197)
T ss_pred HHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4589999999964 456666654 4578999999863 21 12222 2355667778899999999999 89999
Q ss_pred EeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 302 LHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 302 vHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
+|+||++.|||+. ++.+.|+|||.|-...
T Consensus 147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred ecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 9999999999996 5789999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.9e-12 Score=115.76 Aligned_cols=89 Identities=26% Similarity=0.224 Sum_probs=60.8
Q ss_pred HHHHHHHHhccccce-eeEeeeEeeCceeeEeeehhhch-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCc----
Q psy12305 228 IREVSLLRELRHANI-VTLHDIIHTEKCLTLVFEYLEKD-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI---- 301 (516)
Q Consensus 228 ~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~g~-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~i---- 301 (516)
.+|+.+++.+.+.++ .+++... ....++||||++|. +... ......++.+++.+|..||+.++
T Consensus 40 ~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~ 108 (170)
T cd05151 40 ENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLV 108 (170)
T ss_pred HHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCce
Confidence 345555555543332 2333332 22357999999973 3211 01123467899999999999885
Q ss_pred -EeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 302 -LHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 302 -vHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+|+|++|.||+++ ++.++++|||.+.
T Consensus 109 ~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 109 PCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred eecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999999999998 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.9e-13 Score=140.15 Aligned_cols=209 Identities=20% Similarity=0.148 Sum_probs=142.3
Q ss_pred HHHHHHHHHhccccc-eeeEeeeEeeCceeeEeeehhhch--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 227 AIREVSLLRELRHAN-IVTLHDIIHTEKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 227 ~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~g~--L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
..-++++|.+++||| .+..++-++.+.+.+++++++.+. ....+....-.+.+-+.....+.-+.+|+|+|+.-=+|
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~ 359 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVH 359 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccC
Confidence 345889999999999 777788888889999999999853 22111111112333344556667778999999887789
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
|| ||+..+ +..|..||+.+..+.... ......+|+.++|||+.....+....+.||+|+-..+|.-|.+|-...
T Consensus 360 ~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P 433 (829)
T KOG0576|consen 360 RD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP 433 (829)
T ss_pred cc----cccccc-cccccccccCCcccCccc-ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC
Confidence 99 887754 779999999987765332 445667899999999999988989999999998777888887775431
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
-. .. ...|..|. .+.......+.. ..-.++...|+...|..|++...++.|.+|+..
T Consensus 434 ~~--~~----~~~g~~p~----------s~~L~~~~aw~~-------~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 434 PA--VL----PMIGNGPN----------SPMLTDKSAWSP-------VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred cc--cc----CCCCCCCC----------ccccchhhhcCc-------ccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00 00 00011110 000000000111 111257788999999999999999999999764
Q ss_pred C
Q psy12305 464 G 464 (516)
Q Consensus 464 ~ 464 (516)
.
T Consensus 491 p 491 (829)
T KOG0576|consen 491 P 491 (829)
T ss_pred c
Confidence 3
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.21 E-value=3e-10 Score=115.55 Aligned_cols=210 Identities=16% Similarity=0.246 Sum_probs=150.6
Q ss_pred eeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee----CceeeEeeehhhc--hHHH
Q psy12305 195 YATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT----EKCLTLVFEYLEK--DLKR 268 (516)
Q Consensus 195 ~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g--~L~~ 268 (516)
-.+-|++....+|..|++|.+....... ......-++.++++.|+|||++.++|.+ +..+++|++|.++ +|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3578999999999999999994332211 1123345788999999999999999984 4579999999984 7776
Q ss_pred HHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC
Q psy12305 269 YMDDC--------------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT 334 (516)
Q Consensus 269 ~l~~~--------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~ 334 (516)
+.-.. +...+++.++.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+..|.......+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP 447 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence 54321 2347789999999999999999999999999999999999988889988777654433221
Q ss_pred ccccCCcccccccchhhccCCCCCCceeee-hHHHHHHHHHcCCCC-CCCCCHHHH-HHHHHHhcCCCChhhhhhccccc
Q psy12305 335 KTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPL-FPGSTIEDE-LRLICSILGPPPDELKSKLEFCI 411 (516)
Q Consensus 335 ~~~~~~~gt~~y~APE~l~~~~~~~~~d~~-SlGvil~elltG~~p-F~~~~~~~~-~~~i~~~~~~~p~~~~~~~~~~~ 411 (516)
. |-+. ....+|+ .||.+++.|.||..- +..+..... +..|.
T Consensus 448 ------------~--~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------------------ 491 (655)
T KOG3741|consen 448 ------------T--EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT------------------ 491 (655)
T ss_pred ------------C--cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh------------------
Confidence 0 1111 2345677 999999999999532 111111111 22221
Q ss_pred CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 412 ~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
...+.|++++|.-+...++++ -++.+++.|
T Consensus 492 ---------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 ---------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 256788888888888888875 566666654
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.8e-11 Score=124.14 Aligned_cols=94 Identities=21% Similarity=0.305 Sum_probs=78.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcC-CCCeeecccccccce
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEK 162 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 162 (516)
..++|.+.++||+|+||.||+|+++ .+++.||||++...........+.+|+.+|.++. |||||++++++..++
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456899999999999999999964 3457899999986544443447889999999997 999999999999999
Q ss_pred eeeeeeehhhh-hhhcccccc
Q psy12305 163 CLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 163 ~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
..+++|||+.. +|.+++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~ 135 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRN 135 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhc
Confidence 99999999975 888877644
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.9e-11 Score=123.78 Aligned_cols=91 Identities=24% Similarity=0.422 Sum_probs=80.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+...+.++||+|-||.|.+|.-. .+..||||+++..........|.+||++|.+|+|||||+|+++|..++...+++||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44788999999999999999863 35999999999877666667999999999999999999999999999999999999
Q ss_pred hhh-hhhcccccc
Q psy12305 171 LEK-DLKRYMDDC 182 (516)
Q Consensus 171 ~~~-~L~~~l~~~ 182 (516)
++. +|.+++-..
T Consensus 617 mEnGDLnqFl~ah 629 (807)
T KOG1094|consen 617 MENGDLNQFLSAH 629 (807)
T ss_pred HhcCcHHHHHHhc
Confidence 986 888887554
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.6e-11 Score=131.64 Aligned_cols=91 Identities=25% Similarity=0.414 Sum_probs=82.1
Q ss_pred cEeeeeeeccccceEEEEEEEcCC-Cc----EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLT-DN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~-g~----~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.-++.+.||+|.||.||+|....- |. .||||.+......+....|++|..+|++++|||||++++++...+..++
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 367889999999999999987653 32 3999999998888888899999999999999999999999999999999
Q ss_pred eeehhhh-hhhcccccc
Q psy12305 167 VFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 167 v~Ey~~~-~L~~~l~~~ 182 (516)
++|||++ ||..+++..
T Consensus 773 ~leyM~gGDL~sflr~~ 789 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRES 789 (1025)
T ss_pred EehhcccCcHHHHHHhc
Confidence 9999987 999999887
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-09 Score=96.24 Aligned_cols=105 Identities=21% Similarity=0.265 Sum_probs=83.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc--hHHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK--DLKRYMDDCSNILSMNNV-KLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g--~L~~~l~~~~~~l~~~~~-~~i~~qi~~aL~yLH~~~iv 302 (516)
+..+|+++|.++.--.|.-..=+|.+...-+|+|||++| ++.+++...-..-.++.. ..++++|-..+.-||..+|+
T Consensus 56 Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndii 135 (229)
T KOG3087|consen 56 RTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDII 135 (229)
T ss_pred HHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCee
Confidence 556788888888766665555567777778899999998 888888765443333333 78899999999999999999
Q ss_pred eeecCCCCEEEccCCC---EEEeeecccccc
Q psy12305 303 HRDLKPQNLLINERGE---LKLADFGLARAK 330 (516)
Q Consensus 303 HrDlKp~NILl~~~~~---vkL~DFGla~~~ 330 (516)
|+||..+||++..+|. +.|+|||++...
T Consensus 136 HGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 136 HGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred cccccccceEEecCCCcCceEEEeecchhcc
Confidence 9999999999977653 589999998543
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.4e-09 Score=97.61 Aligned_cols=128 Identities=20% Similarity=0.218 Sum_probs=92.5
Q ss_pred ccceeeEEEEEEEecCCceEEEEEeecccc-------cCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh
Q psy12305 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHE-------EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 263 (516)
Q Consensus 191 ~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 263 (516)
.+|+-+.++.+.. -|..+++|.=..... .-...+..+|+.++.++.-..|....=++.+.+...|+|||++
T Consensus 5 ~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 5 KQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 4677788888754 344455664322211 1112345689999999987777666666777778889999999
Q ss_pred chHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 264 KDLK-RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 264 g~L~-~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
|.++ +.+... ...++..+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus 83 G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 8554 466553 134667777778889999999999999999997654 99999999864
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-10 Score=111.52 Aligned_cols=84 Identities=23% Similarity=0.477 Sum_probs=72.1
Q ss_pred eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hh
Q psy12305 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 175 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L 175 (516)
+.||+|+||+||+|++..+|+.||+|.+...........+.+|+++++.++||||+++++++..+...+++|||+.+ ++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999999999999999886543333345789999999999999999999999999999999999975 66
Q ss_pred hcccc
Q psy12305 176 KRYMD 180 (516)
Q Consensus 176 ~~~l~ 180 (516)
.+++.
T Consensus 81 ~~~~~ 85 (252)
T cd05084 81 LTFLR 85 (252)
T ss_pred HHHHH
Confidence 66654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-10 Score=118.99 Aligned_cols=90 Identities=26% Similarity=0.463 Sum_probs=81.6
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
-...++||-|.||.||.|.|+...-.||||.++-+.+. ..+|+.|..+|+.++|||+|+|+++|..+...||+.|||.
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 56679999999999999999999999999999866543 4489999999999999999999999999999999999997
Q ss_pred h-hhhcccccccc
Q psy12305 173 K-DLKRYMDDCSN 184 (516)
Q Consensus 173 ~-~L~~~l~~~s~ 184 (516)
. +|.+|++.|..
T Consensus 347 yGNLLdYLRecnr 359 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR 359 (1157)
T ss_pred CccHHHHHHHhch
Confidence 5 99999998864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-09 Score=101.48 Aligned_cols=137 Identities=18% Similarity=0.143 Sum_probs=99.0
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc--cceeeEeeeEeeC---ceeeEeeehhhc
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH--ANIVTLHDIIHTE---KCLTLVFEYLEK 264 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lV~E~~~g 264 (516)
.+.|..+.||++.... |..+++|.............+.+|+.+++.+.+ .++.+++.+.... +..++||||++|
T Consensus 6 l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G 84 (223)
T cd05154 6 LSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDG 84 (223)
T ss_pred cCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCC
Confidence 4578899999987643 678999987654332234567899999999976 3456677766553 367899999997
Q ss_pred h-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---------------------------------------------
Q psy12305 265 D-LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS--------------------------------------------- 298 (516)
Q Consensus 265 ~-L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------------------------------------------- 298 (516)
. +...+.. ..++......++.+++.+|..||+
T Consensus 85 ~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 85 RVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred EecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 4 3322211 235666666777777777777773
Q ss_pred -----------CCcEeeecCCCCEEEcc--CCCEEEeeeccccc
Q psy12305 299 -----------RRILHRDLKPQNLLINE--RGELKLADFGLARA 329 (516)
Q Consensus 299 -----------~~ivHrDlKp~NILl~~--~~~vkL~DFGla~~ 329 (516)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.4e-10 Score=118.26 Aligned_cols=160 Identities=21% Similarity=0.354 Sum_probs=116.0
Q ss_pred HHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCcc----cc-----CCcccccccchhhccCC
Q psy12305 286 LFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT----FS-----NEVVTLWYRPPDVLLGS 355 (516)
Q Consensus 286 ~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~----~~-----~~~gt~~y~APE~l~~~ 355 (516)
+.+++.||.|+|. .++||++|.|++|.++..|..||+.|+++-....+... +. ...-...|.|||.+.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4456699999995 58999999999999999999999999988654321110 00 01125679999999987
Q ss_pred CCCCceeeehHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHH
Q psy12305 356 TEYSTSIDMGVGCIFHEMS-SGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDAL 434 (516)
Q Consensus 356 ~~~~~~d~~SlGvil~ell-tG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~ 434 (516)
.....+|.+|+||++|.+. .|+..|.+.........-.... .......+..++.+++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~----------------------~~~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL----------------------NAGAFGYSNNLPSELR 242 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc----------------------ccccccccccCcHHHH
Confidence 7777888889999999999 5777776543322221111110 0111122347889999
Q ss_pred HHHHHccccCcCCCCCHHHHHcCCCCCCCCCCc
Q psy12305 435 DLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 435 dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~ 467 (516)
+-|.++|..|+..||++.+++.-|||.+.+-..
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~~~a 275 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLLSIPFFSDPGLKA 275 (700)
T ss_pred HHHHHHhcCCcccCcchhhhhcccccCCchhhh
Confidence 999999999999999999999999998765443
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.4e-10 Score=112.46 Aligned_cols=89 Identities=26% Similarity=0.406 Sum_probs=77.2
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.|+.++.||+|+||.||+|.+..+++.||||.+...........+.+|+.++++++||||+++++++..++..++++||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 34888899999999999999999899999999987654444445788999999999999999999999999999999999
Q ss_pred hhh-hhhccc
Q psy12305 171 LEK-DLKRYM 179 (516)
Q Consensus 171 ~~~-~L~~~l 179 (516)
+++ ++.+++
T Consensus 84 ~~~~~L~~~~ 93 (277)
T cd06642 84 LGGGSALDLL 93 (277)
T ss_pred cCCCcHHHHh
Confidence 986 665555
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.1e-10 Score=109.57 Aligned_cols=81 Identities=26% Similarity=0.316 Sum_probs=68.8
Q ss_pred eccccceEEEEEEEcCCCcEEEEEEeecccccC--CcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hh
Q psy12305 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEG--APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 175 (516)
Q Consensus 99 LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L 175 (516)
||+|+||+||+|.+..+|+.||+|.+....... ....+.+|+.+|+.++||||+++++++..+...+++|||+++ +|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999999999999997653322 224677899999999999999999999999999999999975 56
Q ss_pred hccc
Q psy12305 176 KRYM 179 (516)
Q Consensus 176 ~~~l 179 (516)
..++
T Consensus 81 ~~~~ 84 (280)
T cd05608 81 RYHI 84 (280)
T ss_pred HHHH
Confidence 5444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.96 E-value=5.8e-10 Score=108.90 Aligned_cols=89 Identities=28% Similarity=0.459 Sum_probs=72.7
Q ss_pred eeeeeeccccceEEEEEEEc----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 94 FKLDKLGQGTYATVFKGKSR----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 94 ~~~~~LG~G~fG~Vyka~~~----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.+.+.||.|+||.||+|.+. ..+..||||.++........+.+.+|++.+++++||||+++++++...+..++++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999988 35678999999654433345689999999999999999999999998888999999
Q ss_pred hhhh-hhhcccccc
Q psy12305 170 YLEK-DLKRYMDDC 182 (516)
Q Consensus 170 y~~~-~L~~~l~~~ 182 (516)
|++. +|.+++...
T Consensus 82 ~~~~g~L~~~L~~~ 95 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK 95 (259)
T ss_dssp --TTEBHHHHHHHT
T ss_pred cccccccccccccc
Confidence 9985 888887665
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.9e-09 Score=98.21 Aligned_cols=99 Identities=27% Similarity=0.328 Sum_probs=68.1
Q ss_pred hHHHHHHHHHhcccc--ceeeEeeeEeeCceeeEeeehhh--chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HhhCC
Q psy12305 226 TAIREVSLLRELRHA--NIVTLHDIIHTEKCLTLVFEYLE--KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAY-CHSRR 300 (516)
Q Consensus 226 ~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~--g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~y-LH~~~ 300 (516)
...+|.+.|.++... ++.+++++. .-+|||||++ |..+..+.... ++......++.+++..+.. +|+.|
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~g 127 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAG 127 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcC
Confidence 567899999999766 456666442 3479999999 64444343321 2245677788899886666 57999
Q ss_pred cEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 301 ILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 301 ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
|+|+||.+.|||++.+ .+.|+|||.|....
T Consensus 128 ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 128 IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 9999999999999877 89999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.5e-09 Score=101.06 Aligned_cols=123 Identities=18% Similarity=0.090 Sum_probs=89.3
Q ss_pred CCceEEEEEeecccc---------c-CChhhHHHHHHHHHhccccceee--EeeeEee-----CceeeEeeehhhc--hH
Q psy12305 206 TDNLVALKEIKLEHE---------E-GAPCTAIREVSLLRELRHANIVT--LHDIIHT-----EKCLTLVFEYLEK--DL 266 (516)
Q Consensus 206 ~~~~vAiK~i~~~~~---------~-~~~~~~~~Ei~il~~l~HpnIv~--l~~~~~~-----~~~~~lV~E~~~g--~L 266 (516)
.|+.|.+|....... . .....+.+|...+..|..-+|.. +..+... ...-+||||++++ +|
T Consensus 44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL 123 (268)
T PRK15123 44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL 123 (268)
T ss_pred CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence 566788886532220 0 11124789999998886555433 3444433 2357899999997 67
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-------CCCEEEeeecccc
Q psy12305 267 KRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-------RGELKLADFGLAR 328 (516)
Q Consensus 267 ~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-------~~~vkL~DFGla~ 328 (516)
.+++... ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.++
T Consensus 124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 7777542 234566778899999999999999999999999999999975 4679999999875
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.7e-09 Score=105.90 Aligned_cols=85 Identities=24% Similarity=0.377 Sum_probs=70.3
Q ss_pred eeeccccceEEEEEEEc--CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-
Q psy12305 97 DKLGQGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK- 173 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~--~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~- 173 (516)
+.||+|+||.||+|.+. .++..+|+|.+...........+.+|+.++++++||||+++++++......+++|||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36999999999999864 355789999987655433344788999999999999999999999988889999999974
Q ss_pred hhhccccc
Q psy12305 174 DLKRYMDD 181 (516)
Q Consensus 174 ~L~~~l~~ 181 (516)
+|.+++..
T Consensus 81 ~L~~~l~~ 88 (269)
T cd05087 81 DLKGYLRS 88 (269)
T ss_pred cHHHHHHH
Confidence 77777644
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.7e-09 Score=103.16 Aligned_cols=83 Identities=25% Similarity=0.453 Sum_probs=69.5
Q ss_pred eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hh
Q psy12305 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 175 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L 175 (516)
+.||+|+||.||+|... +++.||+|.+...........+.+|+.++++++||||+++++++...+..+++|||+++ ++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 47999999999999864 78899999987654333334688999999999999999999999999999999999975 66
Q ss_pred hcccc
Q psy12305 176 KRYMD 180 (516)
Q Consensus 176 ~~~l~ 180 (516)
..++.
T Consensus 80 ~~~~~ 84 (250)
T cd05085 80 LSFLR 84 (250)
T ss_pred HHHHH
Confidence 65553
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.7e-08 Score=92.81 Aligned_cols=106 Identities=27% Similarity=0.294 Sum_probs=83.8
Q ss_pred ChhhHHHHHHHHHhccccce--eeEeeeEeeC----ceeeEeeehhhc--hHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q psy12305 223 APCTAIREVSLLRELRHANI--VTLHDIIHTE----KCLTLVFEYLEK--DLKRYMDDCSNILSMNNVKLFLFQLLRGLA 294 (516)
Q Consensus 223 ~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~~----~~~~lV~E~~~g--~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~ 294 (516)
....+.+|...+..|..-.| ++.+.+.... ...+||+|++++ +|.+++..... .+......++.+++..+.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHH
Confidence 34467889998888865444 3445554442 245899999996 67777776333 667778899999999999
Q ss_pred HHhhCCcEeeecCCCCEEEccCC---CEEEeeeccccc
Q psy12305 295 YCHSRRILHRDLKPQNLLINERG---ELKLADFGLARA 329 (516)
Q Consensus 295 yLH~~~ivHrDlKp~NILl~~~~---~vkL~DFGla~~ 329 (516)
-||..||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.5e-09 Score=103.63 Aligned_cols=86 Identities=26% Similarity=0.397 Sum_probs=69.5
Q ss_pred eeeccccceEEEEEEEcC--CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-
Q psy12305 97 DKLGQGTYATVFKGKSRL--TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK- 173 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~--~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~- 173 (516)
++||+|+||.||+|.... ....||+|.+...........+.+|+.+++.++||||+++++.+......+++|||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 469999999999997533 34578999876544333344678999999999999999999999999999999999975
Q ss_pred hhhcccccc
Q psy12305 174 DLKRYMDDC 182 (516)
Q Consensus 174 ~L~~~l~~~ 182 (516)
+|.+++...
T Consensus 81 ~L~~~l~~~ 89 (269)
T cd05042 81 DLKNYLRSN 89 (269)
T ss_pred cHHHHHHhc
Confidence 777776543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=98.79 E-value=6.7e-09 Score=104.81 Aligned_cols=91 Identities=27% Similarity=0.416 Sum_probs=77.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcC-----CC---Ceeecccccccc-
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-----HA---NIVTLHDIIHTE- 161 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~-----h~---niv~l~~~~~~~- 161 (516)
++|.+..+||.|.|+|||+|.|..+.++||+|+.+.... ..+.++.||++|++++ |+ .||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh--YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH--YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH--HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 789999999999999999999999999999999976543 3347899999999883 33 799999999653
Q ss_pred ---eeeeeeeehhhhhhhccccccc
Q psy12305 162 ---KCLTLVFEYLEKDLKRYMDDCS 183 (516)
Q Consensus 162 ---~~~~lv~Ey~~~~L~~~l~~~s 183 (516)
..+++|+|+...+|..++..+.
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~ 180 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSN 180 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhC
Confidence 4488999999999998887653
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.2e-09 Score=100.66 Aligned_cols=83 Identities=23% Similarity=0.418 Sum_probs=71.0
Q ss_pred eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hh
Q psy12305 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 175 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L 175 (516)
++||+|+||.||+|.+.. ++.||+|.+...........+.+|++++++++||||+++++++......+++|||+++ ++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 479999999999999876 9999999987654433345788999999999999999999999999999999999964 66
Q ss_pred hcccc
Q psy12305 176 KRYMD 180 (516)
Q Consensus 176 ~~~l~ 180 (516)
.+++.
T Consensus 80 ~~~l~ 84 (251)
T cd05041 80 LTFLR 84 (251)
T ss_pred HHHHH
Confidence 66654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=98.76 E-value=8.8e-09 Score=100.34 Aligned_cols=82 Identities=27% Similarity=0.439 Sum_probs=66.3
Q ss_pred eeccccceEEEEEEEc--CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-h
Q psy12305 98 KLGQGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-D 174 (516)
Q Consensus 98 ~LG~G~fG~Vyka~~~--~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~ 174 (516)
.||+|+||.||+|.+. .++..||+|++.........+.+.+|+.++++++||||+++++++.. ...+++|||++. +
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999875 34567999999765444444578899999999999999999998754 468999999975 6
Q ss_pred hhcccc
Q psy12305 175 LKRYMD 180 (516)
Q Consensus 175 L~~~l~ 180 (516)
|.+++.
T Consensus 81 L~~~l~ 86 (257)
T cd05115 81 LNKFLS 86 (257)
T ss_pred HHHHHH
Confidence 666654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.75 E-value=7.7e-09 Score=101.41 Aligned_cols=85 Identities=24% Similarity=0.370 Sum_probs=70.5
Q ss_pred eeeccccceEEEEEEEcCCCc--EEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh
Q psy12305 97 DKLGQGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK 173 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g~--~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~ 173 (516)
+.||+|+||.||+|++..++. .+|+|.+...........+.+|+.+++++ +||||+++++++...+..+++|||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999999988876 46888887543333445788999999999 899999999999999999999999975
Q ss_pred -hhhccccc
Q psy12305 174 -DLKRYMDD 181 (516)
Q Consensus 174 -~L~~~l~~ 181 (516)
+|.+++..
T Consensus 81 ~~L~~~i~~ 89 (270)
T cd05047 81 GNLLDFLRK 89 (270)
T ss_pred CcHHHHHHh
Confidence 77777654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.2e-09 Score=102.32 Aligned_cols=85 Identities=25% Similarity=0.413 Sum_probs=71.0
Q ss_pred eeeccccceEEEEEEEcCCC------cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 97 DKLGQGTYATVFKGKSRLTD------NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g------~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.||+|+||.||+|++...+ +.||||.+...........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 36999999999999986543 789999987654334455788999999999999999999999999999999999
Q ss_pred hhh-hhhccccc
Q psy12305 171 LEK-DLKRYMDD 181 (516)
Q Consensus 171 ~~~-~L~~~l~~ 181 (516)
+++ ++.+++..
T Consensus 81 ~~~~~L~~~l~~ 92 (269)
T cd05044 81 MEGGDLLSYLRD 92 (269)
T ss_pred cCCCcHHHHHHH
Confidence 975 77776644
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.3e-08 Score=99.11 Aligned_cols=83 Identities=28% Similarity=0.351 Sum_probs=71.4
Q ss_pred eccccceEEEEEEEcCCCcEEEEEEeecccc--cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hh
Q psy12305 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 175 (516)
Q Consensus 99 LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L 175 (516)
||.|+||.||+|++..+++.||||.+..... ....+.+.+|+.+++.++||||+++++.+..+...++++||+++ +|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999998999999999976542 23345788999999999999999999999999999999999875 77
Q ss_pred hccccc
Q psy12305 176 KRYMDD 181 (516)
Q Consensus 176 ~~~l~~ 181 (516)
.+++..
T Consensus 81 ~~~l~~ 86 (262)
T cd05572 81 WTILRD 86 (262)
T ss_pred HHHHhh
Confidence 776644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.1e-08 Score=98.96 Aligned_cols=86 Identities=34% Similarity=0.562 Sum_probs=74.4
Q ss_pred eeeccccceEEEEEEEcCC---CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh-
Q psy12305 97 DKLGQGTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE- 172 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~---g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~- 172 (516)
+.||+|+||.||+|.+... +..||||.+...........+.+|+++++.++|+||+++++++......+++|||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4799999999999999866 899999999876554445688899999999999999999999999999999999995
Q ss_pred hhhhcccccc
Q psy12305 173 KDLKRYMDDC 182 (516)
Q Consensus 173 ~~L~~~l~~~ 182 (516)
++|..++...
T Consensus 81 ~~L~~~l~~~ 90 (262)
T cd00192 81 GDLLDYLRKS 90 (262)
T ss_pred CcHHHHHhhc
Confidence 5787776554
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.4e-08 Score=98.58 Aligned_cols=83 Identities=28% Similarity=0.426 Sum_probs=71.3
Q ss_pred eccccceEEEEEEEcCCCcEEEEEEeecccc--cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hh
Q psy12305 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DL 175 (516)
Q Consensus 99 LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L 175 (516)
||.|+||.||+|++..+|+.||+|.+..... ......+.+|++++++++||||+++++.+..+...++++||+.+ +|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6999999999999998999999999976543 23345788999999999999999999999999999999999975 77
Q ss_pred hccccc
Q psy12305 176 KRYMDD 181 (516)
Q Consensus 176 ~~~l~~ 181 (516)
..++..
T Consensus 81 ~~~l~~ 86 (265)
T cd05579 81 ASLLEN 86 (265)
T ss_pred HHHHHH
Confidence 766643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.3e-08 Score=98.65 Aligned_cols=84 Identities=24% Similarity=0.353 Sum_probs=69.1
Q ss_pred eeeccccceEEEEEEEcC-CCc--EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh
Q psy12305 97 DKLGQGTYATVFKGKSRL-TDN--LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 173 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~-~g~--~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 173 (516)
+.||+|+||+||+|.+.. .++ .||||.+.........+.+.+|+.++++++|||||++++.+.. ...++++||++.
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 478999999999999866 333 6999999876554445578899999999999999999999888 889999999964
Q ss_pred -hhhccccc
Q psy12305 174 -DLKRYMDD 181 (516)
Q Consensus 174 -~L~~~l~~ 181 (516)
+|.+++..
T Consensus 80 ~~L~~~l~~ 88 (257)
T cd05040 80 GSLLDRLRK 88 (257)
T ss_pred CcHHHHHHh
Confidence 67666543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=98.68 E-value=6.2e-09 Score=99.91 Aligned_cols=86 Identities=28% Similarity=0.337 Sum_probs=73.0
Q ss_pred Eeee-eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccceeeeeeeeh
Q psy12305 93 YFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 93 y~~~-~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
|.+. +.||+|+||.|--|....+|..||||+|.+... -...+..||++++... .|+||++|+++|..+...|+|||-
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g-HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG-HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc-hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 4443 789999999999999999999999999988733 3344889999999998 699999999999999999999999
Q ss_pred hhh-hhhccc
Q psy12305 171 LEK-DLKRYM 179 (516)
Q Consensus 171 ~~~-~L~~~l 179 (516)
+.+ .+.+.+
T Consensus 158 m~GGplLshI 167 (463)
T KOG0607|consen 158 MRGGPLLSHI 167 (463)
T ss_pred ccCchHHHHH
Confidence 865 444433
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=8.6e-08 Score=101.30 Aligned_cols=174 Identities=17% Similarity=0.225 Sum_probs=101.3
Q ss_pred eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee----eeeehhh
Q psy12305 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT----LVFEYLE 172 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~Ey~~ 172 (516)
+.|+.++-|-||+|+.+ +|+.||||+.+.+-. ..+...+.+|+.+ .++...+...+..+ ++-|+..
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~----~~i~~DL~il~~~-----a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIR----ERIEADLKLLRRL-----ARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChH----HHHHHHHHHHHHH-----HHHHHHcCCccccCChHHHHHHHHH
Confidence 78999999999999985 599999999875432 2455666666654 11111111110000 0111100
Q ss_pred hhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-----ccceeeEee
Q psy12305 173 KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-----HANIVTLHD 247 (516)
Q Consensus 173 ~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~l~~ 247 (516)
. -..+..+.+|...+.++. .|++.-..=
T Consensus 201 -~----------------------------------------------l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V 233 (517)
T COG0661 201 -R----------------------------------------------LREELDYRREAANAERFRENFKDDPDVYVPKV 233 (517)
T ss_pred -H----------------------------------------------HHHHhCHHHHHHHHHHHHHHcCCCCCeEecee
Confidence 0 001124456766666653 355443333
Q ss_pred eEeeCceeeEeeehhhc-hHHHH--HHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRY--MDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~--l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+++-...-.|+|||++| .+.+. +.. ..++.+.+...+.++. +.-+-..|+.|.|..|.||+++.+|++.+.||
T Consensus 234 ~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDf 309 (517)
T COG0661 234 YWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDF 309 (517)
T ss_pred ehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcC
Confidence 44445566899999998 33333 333 2244222222111111 22223489999999999999999999999999
Q ss_pred ccccccC
Q psy12305 325 GLARAKS 331 (516)
Q Consensus 325 Gla~~~~ 331 (516)
|+....+
T Consensus 310 Gi~g~l~ 316 (517)
T COG0661 310 GIVGRLD 316 (517)
T ss_pred cceecCC
Confidence 9987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=1e-07 Score=90.76 Aligned_cols=96 Identities=25% Similarity=0.295 Sum_probs=72.8
Q ss_pred hhhHHHHHHHHHhcccc--ceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCc
Q psy12305 224 PCTAIREVSLLRELRHA--NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301 (516)
Q Consensus 224 ~~~~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~i 301 (516)
...+.+|..+|..|... .+.+.+++ +...+||||++|-.+.-+ +++.+++..++..|+.-+.-+-..||
T Consensus 153 Rl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~Gi 223 (304)
T COG0478 153 RLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGI 223 (304)
T ss_pred HHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCc
Confidence 34678899999999644 56655543 456899999998433222 12455667777777777776668999
Q ss_pred EeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 302 LHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 302 vHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
||+|+.+=||+++++|.+.++||--+.
T Consensus 224 VHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 224 VHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred cccCCchheEEEecCCCEEEEeCcccc
Confidence 999999999999999999999997553
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=98.60 E-value=4.6e-08 Score=94.32 Aligned_cols=83 Identities=29% Similarity=0.398 Sum_probs=71.0
Q ss_pred eccccceEEEEEEEcCCCcEEEEEEeecccccC--CcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh-hhh
Q psy12305 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEG--APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDL 175 (516)
Q Consensus 99 LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~-~~L 175 (516)
||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.++++++||||+++++.+..++..+++|||++ .++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999998899999999997654322 34478899999999999999999999999999999999994 577
Q ss_pred hccccc
Q psy12305 176 KRYMDD 181 (516)
Q Consensus 176 ~~~l~~ 181 (516)
.+++..
T Consensus 81 ~~~l~~ 86 (250)
T cd05123 81 FSHLSK 86 (250)
T ss_pred HHHHHh
Confidence 666643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=80.73 Aligned_cols=138 Identities=16% Similarity=0.115 Sum_probs=98.7
Q ss_pred ccccceeeEEEEEEEecCCceEEEEEeeccc-----ccCChhhHHHHHHHHHhccccc--eeeEeeeEe---e--Cceee
Q psy12305 189 NNVKGTYATVFKGKSRLTDNLVALKEIKLEH-----EEGAPCTAIREVSLLRELRHAN--IVTLHDIIH---T--EKCLT 256 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~---~--~~~~~ 256 (516)
+.++|+-+.|++-..... .+=+|.-.... -.-....+.+|+..+.+|..-+ +.+.. ++. . ...-+
T Consensus 25 N~~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CcCCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 345688888887654322 56667654111 1234558899999999996443 33333 222 1 12478
Q ss_pred Eeeehhhc--hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC--EEEeeeccccc
Q psy12305 257 LVFEYLEK--DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE--LKLADFGLARA 329 (516)
Q Consensus 257 lV~E~~~g--~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--vkL~DFGla~~ 329 (516)
||+|-++| +|.+++.+.. .+.+...-..++.+++..+.-||+.|+.|+|+.+.|||++.+|. ++++||--++.
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99998884 8888775532 34567777889999999999999999999999999999987777 99999986653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.6e-06 Score=86.80 Aligned_cols=107 Identities=14% Similarity=0.197 Sum_probs=87.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhcc--
Q psy12305 276 ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL-- 353 (516)
Q Consensus 276 ~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~-- 353 (516)
...+..+.+.++.|+.|.+-||..|-+-+|+.++|+|+++++.+.|.|=..-.. ......+...+|...|.+||.-.
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi-~~ng~~~~cpVg~~eftPPElQ~~~ 191 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI-NANGTLHLCPVGVSEFTPPELQTLP 191 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee-ccCCceEecccCccccCCHHHhccc
Confidence 477888999999999999999999999999999999999999999997432211 12344566778999999999743
Q ss_pred ---CCCCCCceeeehHHHHHHHHHcC-CCCCCCC
Q psy12305 354 ---GSTEYSTSIDMGVGCIFHEMSSG-RPLFPGS 383 (516)
Q Consensus 354 ---~~~~~~~~d~~SlGvil~elltG-~~pF~~~ 383 (516)
+..-....|-+.||+++++++.| +.||.|-
T Consensus 192 sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 192 SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 33445667888999999999996 9999773
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.3e-07 Score=94.72 Aligned_cols=84 Identities=21% Similarity=0.269 Sum_probs=66.3
Q ss_pred eeccc--cceEEEEEEEcCCCcEEEEEEeeccc-ccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-
Q psy12305 98 KLGQG--TYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK- 173 (516)
Q Consensus 98 ~LG~G--~fG~Vyka~~~~~g~~vAvK~i~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~- 173 (516)
+||+| ++|.||.+++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++..++..+++|||++.
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34444 55666666666799999999998752 333445788999999999999999999999999999999999975
Q ss_pred hhhccccc
Q psy12305 174 DLKRYMDD 181 (516)
Q Consensus 174 ~L~~~l~~ 181 (516)
++.+++..
T Consensus 85 ~l~~~l~~ 92 (314)
T cd08216 85 SCEDLLKT 92 (314)
T ss_pred CHHHHHHH
Confidence 66666543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=98.45 E-value=3e-07 Score=89.15 Aligned_cols=53 Identities=45% Similarity=0.785 Sum_probs=48.5
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeeccc-ccCChhhHHHHHHHHHhccccce
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANI 242 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnI 242 (516)
+.+|+||.||+|+++.|++.||+|.++-+. .++.+-..+|||.+|.+++||||
T Consensus 84 I~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NI 137 (419)
T KOG0663|consen 84 IEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNI 137 (419)
T ss_pred cccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCe
Confidence 568999999999999999999999998764 56778889999999999999997
|
|
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.1e-06 Score=92.59 Aligned_cols=174 Identities=17% Similarity=0.194 Sum_probs=98.4
Q ss_pred eeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhh
Q psy12305 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDL 175 (516)
Q Consensus 96 ~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L 175 (516)
-+.||.-+.|.||+|+.+. |+.||||+-+..-. +.+...+.+++-+ +.+++.+..+-....+.+.+.+++
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~----~~~~~Dl~~~~~~-----~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLE----KLIMLDLRNLRLL-----AKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChH----HHHHHHHHHHHHH-----HHHHHHhCcCCchhhHHHHHHhhh
Confidence 3689999999999999864 99999998654322 2333444433322 122222222111222222222221
Q ss_pred hccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHH----Hhccccc------eeeE
Q psy12305 176 KRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLL----RELRHAN------IVTL 245 (516)
Q Consensus 176 ~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il----~~l~Hpn------Iv~l 245 (516)
..-+ .+.+|++-. +.+.|-+ |.++
T Consensus 236 ~~EL----------------------------------------------DF~~EA~Nae~~~~~f~~~~~~~~V~VP~V 269 (538)
T KOG1235|consen 236 PQEL----------------------------------------------DFTKEAKNAERFRENFKDFSLLTYVLVPKV 269 (538)
T ss_pred Hhhc----------------------------------------------chHHHHHhHHHHHHHHHhcccccceeCCee
Confidence 1111 334444433 3334444 3333
Q ss_pred eeeEeeCceeeEeeehhhc---hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc----CCC
Q psy12305 246 HDIIHTEKCLTLVFEYLEK---DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE----RGE 318 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g---~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~----~~~ 318 (516)
|-.+ ...-.|+||||+| +-.+.+.+.+ ++...+..-+.+... +-|-..|++|+|-.|.||++.. ++.
T Consensus 270 y~~~--st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ 343 (538)
T KOG1235|consen 270 YWDL--STKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEE 343 (538)
T ss_pred hhhc--CcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCcc
Confidence 3322 2345799999997 3446666544 555544433333322 2223568999999999999984 568
Q ss_pred EEEeeeccccccC
Q psy12305 319 LKLADFGLARAKS 331 (516)
Q Consensus 319 vkL~DFGla~~~~ 331 (516)
+.+.|||+.....
T Consensus 344 ivllDhGl~~~is 356 (538)
T KOG1235|consen 344 IVLLDHGLYAVIS 356 (538)
T ss_pred EEEEccccccccc
Confidence 9999999987654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.1e-07 Score=83.00 Aligned_cols=84 Identities=36% Similarity=0.559 Sum_probs=72.7
Q ss_pred eccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh-hhhhc
Q psy12305 99 LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKR 177 (516)
Q Consensus 99 LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~-~~L~~ 177 (516)
||+|+||.||+|.+..+|+.++||++...........+.+|+.+++.++|++|+++++++......++++|++. .++..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 79999999999999888999999999876543234578999999999999999999999999999999999998 57777
Q ss_pred ccccc
Q psy12305 178 YMDDC 182 (516)
Q Consensus 178 ~l~~~ 182 (516)
++...
T Consensus 81 ~~~~~ 85 (215)
T cd00180 81 LLKEN 85 (215)
T ss_pred HHHhc
Confidence 76543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.37 E-value=7.9e-06 Score=75.51 Aligned_cols=55 Identities=33% Similarity=0.433 Sum_probs=41.3
Q ss_pred eeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 255 LTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 255 ~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
..||.||+...- .++. .-+.+|++-|..+|..||+=+|+|+.|.. .-||+|||.+
T Consensus 152 ~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 152 RAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred EEEEEeecCCcc---------ccch----hHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 468888887532 1222 23557778889999999999999999986 3589999964
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.1e-06 Score=81.06 Aligned_cols=98 Identities=19% Similarity=0.232 Sum_probs=70.2
Q ss_pred HHHHHHHHHhcccc--ceeeEeeeEeeCceeeEeeehhhch--HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCc
Q psy12305 227 AIREVSLLRELRHA--NIVTLHDIIHTEKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRI 301 (516)
Q Consensus 227 ~~~Ei~il~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~g~--L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~i 301 (516)
...|+.-|+++... .+.+.+.+.. -.|||||++.. -.-.|.+ -.+...++..+..+++..+.-|-. .++
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~L 188 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGL 188 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCc
Confidence 34688888888533 3444454432 46999999843 1222222 123444688889999999988876 899
Q ss_pred EeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 302 LHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 302 vHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
||+||..=|||+. ++.+.|+|||-|....
T Consensus 189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ccccchhhheEEE-CCeEEEEECccccccC
Confidence 9999999999998 8899999999875443
|
|
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=98.32 E-value=1e-07 Score=99.32 Aligned_cols=87 Identities=24% Similarity=0.377 Sum_probs=69.9
Q ss_pred eeeeccccceEEEEEEEcCCCcEEEEEEeecc---cccCCcchhHHHHHHHHhcCCCCeeeccccccccee--eeeeeeh
Q psy12305 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC--LTLVFEY 170 (516)
Q Consensus 96 ~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~Ey 170 (516)
..+||+|+|=+||||.|..+|..||=-.++.. ......+.+..|+.+|+.|+|||||++|++|..... .-++.|+
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 47899999999999999999999986544433 233334688999999999999999999999987655 7788998
Q ss_pred hhh-hhhcccccc
Q psy12305 171 LEK-DLKRYMDDC 182 (516)
Q Consensus 171 ~~~-~L~~~l~~~ 182 (516)
+.+ +|..|....
T Consensus 125 ~TSGtLr~Y~kk~ 137 (632)
T KOG0584|consen 125 FTSGTLREYRKKH 137 (632)
T ss_pred ccCCcHHHHHHHh
Confidence 865 777776554
|
|
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.8e-07 Score=100.84 Aligned_cols=94 Identities=33% Similarity=0.502 Sum_probs=83.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
.+-+..++||+|.||+||+|+... +...||||.++.....+..+.|.||++.|+.|+|||||+|+|+|..++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 456778999999999999998654 336799999998887777789999999999999999999999999999999
Q ss_pred eeeehhhh-hhhcccccccc
Q psy12305 166 LVFEYLEK-DLKRYMDDCSN 184 (516)
Q Consensus 166 lv~Ey~~~-~L~~~l~~~s~ 184 (516)
+|+|||.- ||.+++...+.
T Consensus 566 MvFEYm~~GDL~eFLra~sP 585 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSP 585 (774)
T ss_pred EEEEecccccHHHHHHhhCC
Confidence 99999974 99999987654
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=98.29 E-value=5.7e-07 Score=98.51 Aligned_cols=91 Identities=26% Similarity=0.324 Sum_probs=78.6
Q ss_pred EeeeeeeccccceEEEEEEEcC-------CCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccceee
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRL-------TDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 164 (516)
..+.+.||+|.||.|++|.... ....||||.++........+.+..|+++|+.+ +|||||.++++|..++..
T Consensus 298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 3566699999999999997432 14579999998877766677899999999998 799999999999999999
Q ss_pred eeeeehhhh-hhhccccccc
Q psy12305 165 TLVFEYLEK-DLKRYMDDCS 183 (516)
Q Consensus 165 ~lv~Ey~~~-~L~~~l~~~s 183 (516)
+++.||+.. +|..+++.+.
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r 397 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKR 397 (609)
T ss_pred EEEEEeccCCcHHHHHHhcc
Confidence 999999986 9999998876
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.3e-07 Score=97.95 Aligned_cols=66 Identities=33% Similarity=0.475 Sum_probs=59.2
Q ss_pred ccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCce
Q psy12305 189 NNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 254 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 254 (516)
..|+|+||.||+++++.||+.||||.++............+|+++|++|+|||||+++++-++...
T Consensus 20 ~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~ 85 (732)
T KOG4250|consen 20 RLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFL 85 (732)
T ss_pred hhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcccc
Confidence 468999999999999999999999999987766777788899999999999999999998776654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.2e-06 Score=82.31 Aligned_cols=73 Identities=23% Similarity=0.209 Sum_probs=61.6
Q ss_pred ccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 102 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 102 G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
|.||.||+|++..+|+.||+|++.... ...+|...+....||||+++++++......+++|||+++ +|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 999999999999999999999997653 234566666677899999999999999999999999975 6666653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-07 Score=92.01 Aligned_cols=44 Identities=34% Similarity=0.468 Sum_probs=35.1
Q ss_pred ccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc
Q psy12305 189 NNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR 238 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~ 238 (516)
..|.|+||.||+|+.+.++..||||.++.... ...|..-|+.++
T Consensus 17 klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~------s~ee~~nLREvk 60 (538)
T KOG0661|consen 17 KLGDGTFGSVYLAKSKETGELVAIKKMKKKFY------SWEECMNLREVK 60 (538)
T ss_pred HhcCCcceeEEEeeecCCCceeeHHHHHhhhc------cHHHHHHHHHHH
Confidence 45899999999999999999999999986542 256666666653
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.8e-06 Score=81.93 Aligned_cols=59 Identities=29% Similarity=0.451 Sum_probs=51.1
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCc
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 253 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 253 (516)
.|.|+||.||+|....+++.||||.+-.+.... .+|+.+|+.++|||||+|.-+|....
T Consensus 32 iG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----nrEl~im~~l~HpNIV~L~~~f~~~~ 90 (364)
T KOG0658|consen 32 IGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----NRELQIMRKLDHPNIVRLLYFFSSST 90 (364)
T ss_pred EeecccceEEEEEEcCCCceeEEEEecCCCCcC-----cHHHHHHHhcCCcCeeeEEEEEEecC
Confidence 578999999999999999999999987655433 37999999999999999998887654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=98.09 E-value=4e-06 Score=79.73 Aligned_cols=79 Identities=35% Similarity=0.555 Sum_probs=68.3
Q ss_pred cceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 103 TYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 103 ~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+||.||+|.+..+|+.||+|++...........+.+|+..+++++|+||+++++.+......++++||++. ++..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 69999999998889999999998765443245889999999999999999999999998999999999987 77766543
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.07 E-value=4.1e-05 Score=73.19 Aligned_cols=132 Identities=16% Similarity=0.165 Sum_probs=80.2
Q ss_pred ccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc--eeeEeeeEeeCceeeEeeehhhch-
Q psy12305 189 NNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN--IVTLHDIIHTEKCLTLVFEYLEKD- 265 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~g~- 265 (516)
..+.|..+.||+. .+..+++|..... .......+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 8 ~i~~G~t~~~y~~----~~~~~VlR~~~~~---~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 8 QTGEGGNGESYTH----KTGKWMLKLYNPG---FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eecCCCCcceeEe----cCCCEEEEeCCCC---CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 3568889999973 2445667776532 23345788999999986543 466777777777788999999873
Q ss_pred -HH--------------HHHHh-----cC---CCCCHHH-HHHHHHH----------HHH-HHHHHh----hCCcEeeec
Q psy12305 266 -LK--------------RYMDD-----CS---NILSMNN-VKLFLFQ----------LLR-GLAYCH----SRRILHRDL 306 (516)
Q Consensus 266 -L~--------------~~l~~-----~~---~~l~~~~-~~~i~~q----------i~~-aL~yLH----~~~ivHrDl 306 (516)
+. ..+.. +. ...+... ...+..+ +.. ...+|. ...++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 11 11110 00 0011110 0011101 111 122222 124789999
Q ss_pred CCCCEEEccCCCEEEeeecccc
Q psy12305 307 KPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 307 Kp~NILl~~~~~vkL~DFGla~ 328 (516)
.|.||+++.++ +.|+||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.2e-06 Score=77.47 Aligned_cols=80 Identities=23% Similarity=0.196 Sum_probs=58.8
Q ss_pred eeccccceEEEEEEEcCCCcEEEEEEeecccccC-------CcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEG-------APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 98 ~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.||+|+||+||+|++ +|+.|+||......... ...++.+|++++..++|+++....-++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 68899999865432111 123567899999999998766555555556667899999
Q ss_pred hhh-hhhccc
Q psy12305 171 LEK-DLKRYM 179 (516)
Q Consensus 171 ~~~-~L~~~l 179 (516)
+++ ++.+++
T Consensus 79 ~~g~~l~~~~ 88 (199)
T TIGR03724 79 IEGKPLKDVI 88 (199)
T ss_pred ECCccHHHHH
Confidence 975 555544
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.6e-05 Score=71.33 Aligned_cols=67 Identities=21% Similarity=0.387 Sum_probs=50.5
Q ss_pred ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 253 KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 253 ~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
...+|+|||++| .|.+... +++ .+...|..++.-||+.|++|+|..|.|++++.+ .++++||+..+.
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k~~ 183 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGKRM 183 (229)
T ss_pred eEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccccc
Confidence 345689999998 4433221 222 244567788999999999999999999999854 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.2e-05 Score=87.82 Aligned_cols=197 Identities=21% Similarity=0.305 Sum_probs=132.4
Q ss_pred HHHHHHHhccccceeeEeeeEeeCcee----eEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 229 REVSLLRELRHANIVTLHDIIHTEKCL----TLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 229 ~Ei~il~~l~HpnIv~l~~~~~~~~~~----~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.|+..+.++.|+|++.++.|-..+... .+..|+|.+ ++...+.. -..++.+.++.+..+++.||.|+|+....|
T Consensus 231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 466677888999999999886554333 334466665 44444443 456899999999999999999999986666
Q ss_pred eecCCC---CEEEccCCCEEEe--eeccccccCCCCccccCCcccccccchhhccCCCCCCc--eeeehHHHHHHHHHcC
Q psy12305 304 RDLKPQ---NLLINERGELKLA--DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST--SIDMGVGCIFHEMSSG 376 (516)
Q Consensus 304 rDlKp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~--~d~~SlGvil~elltG 376 (516)
.-|-.. +-..+..+.+.++ ||+.+........... ...+..+-|||.......... .|.|.+|..+..+..|
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~ 388 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQG 388 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccchhhhhhHHHHHHHHHhhhhhc
Confidence 555444 3344555666666 8888776554333322 233566788887765544333 4889999999988887
Q ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 377 RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 377 ~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..+-.-. ......+ +........+++.+|+.-|+++|+++.+++.
T Consensus 389 ~~i~~~~------~~~~~~l-----------------------------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 389 EDISEKS------AVPVSLL-----------------------------DVLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred Ccccccc------cchhhhh-----------------------------ccccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 6432110 0000000 0011126788999999999999999999999
Q ss_pred CCCCCC
Q psy12305 457 HPYFNS 462 (516)
Q Consensus 457 Hp~f~~ 462 (516)
|||.+.
T Consensus 434 ~~f~~~ 439 (1351)
T KOG1035|consen 434 HPFLRF 439 (1351)
T ss_pred chhccc
Confidence 999864
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=97.90 E-value=6.9e-06 Score=81.85 Aligned_cols=62 Identities=34% Similarity=0.547 Sum_probs=51.8
Q ss_pred cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 117 NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 117 ~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+.++.|.+.++..+ .+..|+.+|++++|||||+|++++..++..|+|||||++ ||..|+...
T Consensus 41 K~i~~~~l~~k~~e----~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~ 103 (429)
T KOG0595|consen 41 KCIAKKKLNKKLVE----LLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR 103 (429)
T ss_pred eeehhhccCHHHHH----HHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc
Confidence 45666766444332 678999999999999999999999999999999999984 999888765
|
|
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=97.90 E-value=1.1e-05 Score=79.24 Aligned_cols=64 Identities=34% Similarity=0.460 Sum_probs=55.6
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeeccc-ccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
...|+|+||.|+.|.++.||+.||||.+.... ......+..+|+.+|+.++|+||+.+.+++..
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 45789999999999999999999999997443 33445678899999999999999999999876
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00013 Score=70.38 Aligned_cols=63 Identities=19% Similarity=0.086 Sum_probs=45.1
Q ss_pred eEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeEeeCceeeEeeehhhc
Q psy12305 196 ATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK 264 (516)
Q Consensus 196 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 264 (516)
+.||+.... +..+.+|...... .....+|+.+++.+. +--+.+++++...++..++|||+++|
T Consensus 13 ~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 13 ATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred CeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 788888653 3567777765432 235678999998884 34456777777776778999999987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=97.85 E-value=1.3e-05 Score=82.84 Aligned_cols=93 Identities=22% Similarity=0.209 Sum_probs=78.6
Q ss_pred cccEeeeeeeccccceEEEEEEE-----cCCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeeccccccccee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKS-----RLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKC 163 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 163 (516)
.++|++.++||+|+||+||+|.+ ..++..||||+++........+.+.+|+.+|+.+ +|||||++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999974 3467789999997654444455788999999999 89999999999999999
Q ss_pred eeeeeehhhh-hhhcccccc
Q psy12305 164 LTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 164 ~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+++|||+++ +|.+++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~ 133 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRK 133 (375)
T ss_pred ceeeehhccCCcHHHHHHhc
Confidence 9999999976 787777543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 516 | ||||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-121 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-81 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-81 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-79 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-79 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-79 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-74 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-74 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-73 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-71 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-71 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-71 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-71 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 7e-71 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-71 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-71 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 7e-71 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-71 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-71 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-70 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-70 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-70 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-70 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-70 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-70 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-70 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-70 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-70 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-70 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-70 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-70 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-70 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-70 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-70 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-70 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-70 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-70 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-70 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-70 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-70 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-70 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-70 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-70 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-70 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-62 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-51 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-48 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-48 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-48 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-47 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-47 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-47 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-47 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-46 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-46 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-46 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-44 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-42 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-42 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-42 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-41 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-41 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-41 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-41 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-41 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-41 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-41 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-41 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-41 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-41 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-41 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-41 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-41 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-41 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-41 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-41 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-41 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-41 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-41 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-41 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-41 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-41 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-41 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-41 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-40 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-40 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-39 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-38 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-37 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-37 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-37 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-36 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-36 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-36 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-36 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-36 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-36 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-36 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-36 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-36 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-36 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-36 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-36 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-36 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-36 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-36 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-36 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-36 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-36 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-36 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-36 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-36 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-36 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-35 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-35 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-35 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-35 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-35 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-35 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-35 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-35 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-35 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-35 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-35 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-35 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-35 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-35 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-35 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-35 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-35 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-35 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-35 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-35 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-35 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-35 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-35 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-35 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-35 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-35 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-35 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-35 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-35 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-35 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-35 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-35 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-35 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-35 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-35 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-35 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-35 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-35 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-34 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-34 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-34 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-34 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-34 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-34 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-33 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-32 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-32 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-32 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-32 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-32 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-32 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-32 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-32 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-32 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-32 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-32 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-32 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-32 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-32 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-32 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-32 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-32 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-32 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-32 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-32 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-31 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-31 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-30 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-30 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-30 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-29 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-29 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-29 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-28 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-28 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-28 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-28 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-28 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-28 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-28 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-28 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-28 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-28 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-28 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-28 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-28 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-28 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 1e-27 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-27 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-27 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-27 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-27 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-27 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-27 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-27 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-27 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-27 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-27 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-27 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-27 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-27 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-27 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-27 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-27 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-26 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-26 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-25 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-24 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-24 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-24 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-24 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-24 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-24 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-24 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-24 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-24 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-24 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-24 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-23 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-23 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-23 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-23 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-23 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-23 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-23 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-23 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-23 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-23 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-23 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-23 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-23 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-22 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-22 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-22 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-22 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-22 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-22 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-22 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-22 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-22 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-22 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-22 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-22 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-22 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-22 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-22 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-22 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-22 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-22 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-22 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 7e-22 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-22 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-22 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-22 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-22 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-21 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-21 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-21 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-21 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-21 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-21 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-21 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-21 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 5e-20 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-20 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-20 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-19 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-19 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 9e-19 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-19 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-18 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-18 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-18 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-17 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-17 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-17 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-17 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-17 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-17 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-17 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-17 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-17 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 9e-17 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-16 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-16 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-16 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-16 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-16 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-16 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-16 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-16 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-16 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-16 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-16 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-16 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-16 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-16 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-16 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-16 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-16 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-16 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 9e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-15 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-15 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-15 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-15 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-15 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-15 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-15 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-14 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-14 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-14 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-14 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-14 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 9e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-13 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-13 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-13 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-13 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-12 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-12 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-12 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-12 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-12 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-12 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-12 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 9e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-11 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 6e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-10 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-10 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-10 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-10 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 6e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-10 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-10 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 7e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-10 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 9e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-09 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 3e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-09 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 8e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-08 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-08 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-07 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 9e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-06 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-06 |
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-163
Identities = 209/302 (69%), Positives = 249/302 (82%), Gaps = 7/302 (2%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HANIVTLHDIIHTE
Sbjct: 13 GTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE 72
Query: 253 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
K LTLVFEYL+KDLK+Y+DDC NI++M+NVKLFLFQLLRGLAYCH +++LHRDLKPQNLL
Sbjct: 73 KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLL 132
Query: 313 INERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFH 371
INERGELKLADFGLARAKS+PTKT+ NEVVTLWYRPPD+LLGST+YST IDM GVGCIF+
Sbjct: 133 INERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY 192
Query: 372 EMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFCITPVYP--SESKLQLLAP 426
EM++GRPLFPGST+E++L I ILG P +E E T YP L AP
Sbjct: 193 EMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAP 252
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKLTS 486
++DSD DL+ K L ++ + RISA +AM+HP+F SLG ++H+L DT SIF+L I+L
Sbjct: 253 -RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQK 311
Query: 487 NP 488
Sbjct: 312 EA 313
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-53
Identities = 85/103 (82%), Positives = 100/103 (97%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
+E+Y KLDKLG+GTYATV+KGKS+LTDNLVALKEI+LEHEEGAPCTAIREVSLL++L+HA
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 60
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
NIVTLHDIIHTEK LTLVFEYL+KDLK+Y+DDC NI++M+NVK
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVK 103
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 440 bits (1133), Expect = e-153
Identities = 148/288 (51%), Positives = 191/288 (66%), Gaps = 14/288 (4%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252
GTYATV+KG ++ T VALKE+KL+ EEG P TAIRE+SL++EL+H NIV L+D+IHTE
Sbjct: 16 GTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE 75
Query: 253 KCLTLVFEYLEKDLKRYMDDCSNI-----LSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
LTLVFE+++ DLK+YMD + L +N VK F +QLL+GLA+CH +ILHRDLK
Sbjct: 76 NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
PQNLLIN+RG+LKL DFGLARA +P TFS+EVVTLWYR PDVL+GS YSTSID+
Sbjct: 136 PQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSC 195
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL--------KSKLEFCITPVYPSE 418
GCI EM +G+PLFPG+ E++L+LI I+G P + L K P
Sbjct: 196 GCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLR 255
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
LQ E +D + +D + L + R+SA A+ HP+F
Sbjct: 256 QVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-51
Identities = 59/109 (54%), Positives = 79/109 (72%), Gaps = 5/109 (4%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 148
+ +L+KLG GTYATV+KG ++ T VALKE+KL+ EEG P TAIRE+SL++EL+H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNI-----LSMNNVK 192
NIV L+D+IHTE LTLVFE+++ DLK+YMD + L +N VK
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 434 bits (1119), Expect = e-152
Identities = 150/280 (53%), Positives = 204/280 (72%), Gaps = 8/280 (2%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY TVFK K+R T +VALK ++L+ + EG P +A+RE+ LL+EL+H NIV LHD++H+
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS 72
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LTLVFE+ ++DLK+Y D C+ L VK FLFQLL+GL +CHSR +LHRDLKPQNL
Sbjct: 73 DKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LIN GELKLA+FGLARA +P + +S EVVTLWYRPPDVL G+ YSTSIDM GCIF
Sbjct: 133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 192
Query: 371 HEM-SSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKL-EFCITPVYPSESKLQLLA 425
E+ ++GRPLFPG+ ++D+L+ I +LG P +E +KL ++ P+YP+ + L +
Sbjct: 193 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVV 252
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
P ++++ DL+Q L + QRISA A++HPYF+ P
Sbjct: 253 P-KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-50
Identities = 54/104 (51%), Positives = 79/104 (75%), Gaps = 1/104 (0%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
++ Y KL+K+G+GTY TVFK K+R T +VALK ++L+ + EG P +A+RE+ LL+EL+H
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
NIV LHD++H++K LTLVFE+ ++DLK+Y D C+ L VK
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK 104
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 8e-49
Identities = 53/105 (50%), Positives = 79/105 (75%), Gaps = 2/105 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
+E++ K++K+G+GTY V+K +++LT +VALK+I+L+ E EG P TAIRE+SLL+EL H
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 61
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVK 192
NIV L D+IHTE L LVFE+L +DLK++MD + + + +K
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK 106
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-149
Identities = 147/282 (52%), Positives = 194/282 (68%), Gaps = 9/282 (3%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V+K K +VALK I+L+ E EG P TAIRE+SLL+EL H NIV+L D+IH+
Sbjct: 32 GTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS 90
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
E+CLTLVFE++EKDLK+ +D+ L + +K++L+QLLRG+A+CH RILHRDLKPQNL
Sbjct: 91 ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LIN G LKLADFGLARA +P +++++EVVTLWYR PDVL+GS +YSTS+D+ +GCIF
Sbjct: 151 LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIF 210
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFCITPVYPSESK--LQLLA 425
EM +G+PLFPG T +D+L I SILG P +L + K +
Sbjct: 211 AEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSII 270
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467
P + +DL+ L +D +RISA +AM HPYF L PQ+
Sbjct: 271 P-GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQI 311
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-49
Identities = 61/125 (48%), Positives = 85/125 (68%), Gaps = 4/125 (3%)
Query: 69 IDAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH 128
+ SS R++L G +E Y KL+K+G+GTY V+K K +VALK I+L+
Sbjct: 1 MHHHHHHSSGRENLY--FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA 57
Query: 129 E-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILS 187
E EG P TAIRE+SLL+EL H NIV+L D+IH+E+CLTLVFE++EKDLK+ +D+ L
Sbjct: 58 EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ 117
Query: 188 MNNVK 192
+ +K
Sbjct: 118 DSQIK 122
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 426 bits (1099), Expect = e-149
Identities = 140/281 (49%), Positives = 181/281 (64%), Gaps = 16/281 (5%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V+K ++ ALK+I+LE E EG P T IRE+S+L+EL+H+NIV L+D+IHT
Sbjct: 13 GTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K L LVFE+L++DLK+ +D C L K FL QLL G+AYCH RR+LHRDLKPQNL
Sbjct: 72 KKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL 131
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LIN GELK+ADFGLARA +P + +++E+VTLWYR PDVL+GS +YST+ID+ VGCIF
Sbjct: 132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIF 191
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDEL--------KSKLEFCITPVYPSESKLQ 422
EM +G PLFPG + D+L I ILG P + K F VY +
Sbjct: 192 AEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF---TVYEPLP-WE 247
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+D +DL+ K L D QRI+A A+ H YF
Sbjct: 248 SFLK-GLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-49
Identities = 51/104 (49%), Positives = 73/104 (70%), Gaps = 2/104 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
+E Y L+K+G+GTY V+K ++ ALK+I+LE E EG P T IRE+S+L+EL+H
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
+NIV L+D+IHT+K L LVFE+L++DLK+ +D C L K
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK 103
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 426 bits (1098), Expect = e-148
Identities = 134/285 (47%), Positives = 182/285 (63%), Gaps = 14/285 (4%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GTY V+K +T+ VA+K I+LEHE EG P TAIREVSLL+EL+H NI+ L +IH
Sbjct: 45 GTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
L L+FEY E DLK+YMD + +SM +K FL+QL+ G+ +CHSRR LHRDLKPQNL
Sbjct: 105 NHRLHLIFEYAENDLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163
Query: 312 LIN-----ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-G 365
L++ E LK+ DFGLARA +P + F++E++TLWYRPP++LLGS YSTS+D+
Sbjct: 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWS 223
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFCIT--PVYPSESK 420
+ CI+ EM PLFPG + D+L I +LG P D + L P + ++
Sbjct: 224 IACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTL 283
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
++L +D + LDL+ L D +RISA NA+ HPYF+
Sbjct: 284 KRVL-GALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-50
Identities = 55/124 (44%), Positives = 75/124 (60%), Gaps = 2/124 (1%)
Query: 70 DAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE 129
+A + I+ Y ++ KLG+GTY V+K +T+ VA+K I+LEHE
Sbjct: 13 EAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE 72
Query: 130 -EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSM 188
EG P TAIREVSLL+EL+H NI+ L +IH L L+FEY E DLK+YMD + +SM
Sbjct: 73 EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD-VSM 131
Query: 189 NNVK 192
+K
Sbjct: 132 RVIK 135
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 426 bits (1097), Expect = e-148
Identities = 92/290 (31%), Positives = 155/290 (53%), Gaps = 9/290 (3%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G+Y V K +++ T +VA+K+ + + A+RE+ LL++LRH N+V L ++
Sbjct: 36 GSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
+K LVFE+++ + ++ N L V+ +LFQ++ G+ +CHS I+HRD+KP+N+
Sbjct: 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
L+++ G +KL DFG AR + P + + +EV T WYR P++L+G +Y ++D+ +GC+
Sbjct: 156 LVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV 215
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDELK---SKLEFCIT---PVYPSESKLQLL 424
EM G PLFPG + D+L I LG + +K P L+
Sbjct: 216 TEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERR 275
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQ 474
P ++ +DL +K L D +R A + H +F G + Q
Sbjct: 276 YP-KLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQ 324
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 7e-50
Identities = 33/119 (27%), Positives = 61/119 (51%), Gaps = 1/119 (0%)
Query: 75 RSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAP 133
S + F +E Y L +G+G+Y V K +++ T +VA+K+ + +
Sbjct: 9 SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK 68
Query: 134 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
A+RE+ LL++LRH N+V L ++ +K LVFE+++ + ++ N L V+
Sbjct: 69 KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ 127
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 424 bits (1093), Expect = e-148
Identities = 94/299 (31%), Positives = 156/299 (52%), Gaps = 19/299 (6%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G+Y VFK ++R T +VA+K+ + A+RE+ +L++L+H N+V L ++
Sbjct: 14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR 73
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
++ L LVFEY + + +D + + VK +Q L+ + +CH +HRD+KP+N+
Sbjct: 74 KRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
LI + +KL DFG AR + P+ + +EV T WYR P++L+G T+Y +D+ +GC+F
Sbjct: 134 LITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVF 193
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDE---------LKSKLEFCITPVYPSESKL 421
E+ SG PL+PG + D+L LI LG S ++ P L
Sbjct: 194 AELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKI---PDPEDMEPL 250
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLP 480
+L P + AL L++ L D +R++ + HPYF ++ E+ D P
Sbjct: 251 ELKFP-NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI----REIEDLAKEHDKP 304
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 1e-47
Identities = 33/103 (32%), Positives = 59/103 (57%), Gaps = 1/103 (0%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHA 149
E Y K+ K+G+G+Y VFK ++R T +VA+K+ + A+RE+ +L++L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
N+V L ++ ++ L LVFEY + + +D + + VK
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK 105
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 425 bits (1096), Expect = e-147
Identities = 106/280 (37%), Positives = 165/280 (58%), Gaps = 11/280 (3%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE----EGAPCTAIREVSLLRELRHANIVTLHDI 248
G +ATV+K + + T+ +VA+K+IKL H +G TA+RE+ LL+EL H NI+ L D
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDA 80
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+ ++LVF+++E DL+ + D S +L+ +++K ++ L+GL Y H ILHRDLKP
Sbjct: 81 FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKP 140
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
NLL++E G LKLADFGLA++ P + ++++VVT WYR P++L G+ Y +DM VG
Sbjct: 141 NNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVG 200
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKL-EFCITPVYPSESKLQL 423
CI E+ P PG + D+L I LG P +E L ++ +P L
Sbjct: 201 CILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIP-LHH 259
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ D LDL+Q +++ RI+A A++ YF++
Sbjct: 260 IFS-AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 44/108 (40%), Positives = 72/108 (66%), Gaps = 4/108 (3%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE----EGAPCTAIREVSLLR 144
R + Y KLD LG+G +ATV+K + + T+ +VA+K+IKL H +G TA+RE+ LL+
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 145 ELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVK 192
EL H NI+ L D + ++LVF+++E DL+ + D S +L+ +++K
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIK 115
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 396 bits (1020), Expect = e-136
Identities = 116/293 (39%), Positives = 166/293 (56%), Gaps = 19/293 (6%)
Query: 193 GTYATVFKGKS-RLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELR---HANIVTLHD 247
G Y VFK + + VALK ++++ EG P + IREV++LR L H N+V L D
Sbjct: 22 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 81
Query: 248 IIHT-----EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRI 301
+ E LTLVFE++++DL Y+D + +K +FQLLRGL + HS R+
Sbjct: 82 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV 141
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
+HRDLKPQN+L+ G++KLADFGLAR S ++ VVTLWYR P+VLL S+ Y+T
Sbjct: 142 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATP 199
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFCITPVYPS 417
+D+ VGCIF EM +PLF GS+ D+L I ++G P +E L +
Sbjct: 200 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 259
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHEL 470
+ ++ +D DL+ K L ++ +RISA +A+ HPYF L L
Sbjct: 260 QP-IEKFVT-DIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENL 310
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 5e-41
Identities = 38/114 (33%), Positives = 61/114 (53%), Gaps = 11/114 (9%)
Query: 90 IESYFKLDKLGQGTYATVFKGKS-RLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELR 147
+ Y + ++G+G Y VFK + + VALK ++++ EG P + IREV++LR L
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 148 ---HANIVTLHDIIHT-----EKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVK 192
H N+V L D+ E LTLVFE++++DL Y+D + +K
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 123
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-136
Identities = 109/291 (37%), Positives = 163/291 (56%), Gaps = 21/291 (7%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGA----PCTAIREVSLLRELR---HANIVTL 245
G Y TV+K + + + VALK +++ + G P + +REV+LLR L H N+V L
Sbjct: 20 GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRL 79
Query: 246 HDIIHTEKC-----LTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSR 299
D+ T + +TLVFE++++DL+ Y+D L +K + Q LRGL + H+
Sbjct: 80 MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN 139
Query: 300 RILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
I+HRDLKP+N+L+ G +KLADFGLAR S + VVTLWYR P+VLL ST Y+
Sbjct: 140 CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQST-YA 197
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFCITPVY 415
T +DM VGCIF EM +PLF G++ D+L I ++G PP++ L P
Sbjct: 198 TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPR 257
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
+Q + P +M+ L+ + L ++ +RISA A++H Y +
Sbjct: 258 GP-RPVQSVVP-EMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEGN 306
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 3e-42
Identities = 38/121 (31%), Positives = 64/121 (52%), Gaps = 13/121 (10%)
Query: 85 IGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGA----PCTAIREV 140
+G Y + ++G G Y TV+K + + + VALK +++ + G P + +REV
Sbjct: 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREV 62
Query: 141 SLLRELR---HANIVTLHDIIHTEKC-----LTLVFEYLEKDLKRYMDDCSNI-LSMNNV 191
+LLR L H N+V L D+ T + +TLVFE++++DL+ Y+D L +
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI 122
Query: 192 K 192
K
Sbjct: 123 K 123
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-128
Identities = 112/290 (38%), Positives = 163/290 (56%), Gaps = 20/290 (6%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
GT+ VFK + R T VALK++ +E+E EG P TA+RE+ +L+ L+H N+V L +I T
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRT 87
Query: 252 EK--------CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+ + LVF++ E DL + + +++ +K + LL GL Y H +ILH
Sbjct: 88 KASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKT----FSNEVVTLWYRPPDVLLGSTEYS 359
RD+K N+LI G LKLADFGLARA S+ + ++N VVTLWYRPP++LLG +Y
Sbjct: 148 RDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYG 207
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFC--ITP 413
ID+ G GCI EM + P+ G+T + +L LI + G E+ E +
Sbjct: 208 PPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLEL 267
Query: 414 VYPSESKL-QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462
V + K+ L D ALDL+ K L+ D QRI + +A+ H +F S
Sbjct: 268 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 317
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-40
Identities = 43/126 (34%), Positives = 71/126 (56%), Gaps = 10/126 (7%)
Query: 77 SRRQSLSEIGFGR-IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPC 134
+++ E F + Y KL K+GQGT+ VFK + R T VALK++ +E+E EG P
Sbjct: 2 AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 61
Query: 135 TAIREVSLLRELRHANIVTLHDIIHTEK--------CLTLVFEYLEKDLKRYMDDCSNIL 186
TA+RE+ +L+ L+H N+V L +I T+ + LVF++ E DL + +
Sbjct: 62 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 121
Query: 187 SMNNVK 192
+++ +K
Sbjct: 122 TLSEIK 127
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 350 bits (900), Expect = e-117
Identities = 103/313 (32%), Positives = 159/313 (50%), Gaps = 46/313 (14%)
Query: 193 GTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII- 249
GTY V+K K + D ALK+I+ G +A RE++LLREL+H N+++L +
Sbjct: 32 GTYGHVYKAKRKDGKDDKDYALKQIE---GTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 250 -HTEKCLTLVFEYLEKDLKRYMDDCSN--------ILSMNNVKLFLFQLLRGLAYCHSRR 300
H ++ + L+F+Y E DL + L VK L+Q+L G+ Y H+
Sbjct: 89 SHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148
Query: 301 ILHRDLKPQNLLI----NERGELKLADFGLARAKSVPTKTFSN---EVVTLWYRPPDVLL 353
+LHRDLKP N+L+ ERG +K+AD G AR + P K ++ VVT WYR P++LL
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 354 GSTEYSTSIDM-GVGCIFHEMSSGRPLFPGST---------IEDELRLICSILGPP---- 399
G+ Y+ +ID+ +GCIF E+ + P+F D+L I +++G P
Sbjct: 209 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268
Query: 400 -------PDELKSKLEFCITPVYPSESKLQLLAPE--QMDSDALDLVQKFLMYDAKQRIS 450
P+ +F Y + S ++ + + DS A L+QK L D +RI+
Sbjct: 269 WEDIKKMPEHSTLMKDFRRNT-YTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 327
Query: 451 AANAMRHPYFNSL 463
+ AM+ PYF
Sbjct: 328 SEQAMQDPYFLED 340
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-113
Identities = 95/318 (29%), Positives = 164/318 (51%), Gaps = 32/318 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G++ VF+ K + + VA+K++ + RE+ ++R ++H N+V L ++
Sbjct: 50 NGSFGVVFQAKLVES-DEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYS 103
Query: 252 ------EKCLTLVFEYLEKDLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCHSRRIL 302
E L LV EY+ + + R + + M +KL+++QLLR LAY HS I
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGIC 163
Query: 303 HRDLKPQNLLINER-GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
HRD+KPQNLL++ G LKL DFG A+ + + + + + +YR P+++ G+T Y+T+
Sbjct: 164 HRDIKPQNLLLDPPSGVLKLIDFGSAKI-LIAGEPNVSYICSRYYRAPELIFGATNYTTN 222
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE-------LKSKLEFCITP 413
ID+ GC+ E+ G+PLFPG + D+L I +LG P E + +F P
Sbjct: 223 IDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKF---P 279
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDT 473
++ P + DA+DL+ + L Y R++A A+ HP+F+ L + +
Sbjct: 280 QIRPHPFSKVFRP-RTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNG 338
Query: 474 QSI---FSLPHIKLTSNP 488
+ + F+ +L+ P
Sbjct: 339 RELPPLFNWTKEELSVRP 356
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 32/138 (23%), Positives = 59/138 (42%), Gaps = 15/138 (10%)
Query: 64 AKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKE 123
K N +D P S + G R +Y +G G++ VF+ K + + VA+K+
Sbjct: 13 VKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES-DEVAIKK 71
Query: 124 IKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT------EKCLTLVFEYLEKDLKR 177
+ + RE+ ++R ++H N+V L ++ E L LV EY+ + + R
Sbjct: 72 VLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYR 126
Query: 178 YMDDCSN---ILSMNNVK 192
+ + M +K
Sbjct: 127 ASRHYAKLKQTMPMLLIK 144
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 317 bits (813), Expect = e-104
Identities = 89/290 (30%), Positives = 150/290 (51%), Gaps = 28/290 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G++ V++ K + LVA+K++ + RE+ ++R+L H NIV L ++
Sbjct: 64 NGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYS 118
Query: 252 ------EKCLTLVFEYLEKDLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCHSRRIL 302
E L LV +Y+ + + R S L + VKL+++QL R LAY HS I
Sbjct: 119 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 178
Query: 303 HRDLKPQNLLINER-GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
HRD+KPQNLL++ LKL DFG A+ V + + + + +YR P+++ G+T+Y++S
Sbjct: 179 HRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPELIFGATDYTSS 237
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE-------LKSKLEFCITP 413
ID+ GC+ E+ G+P+FPG + D+L I +LG P E ++ +F P
Sbjct: 238 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKF---P 294
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ ++ P + +A+ L + L Y R++ A H +F+ L
Sbjct: 295 QIKAHPWTKVFRP-RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 35/165 (21%), Positives = 65/165 (39%), Gaps = 19/165 (11%)
Query: 38 RPKRSSE-DINKRLSLPADLHLPESFLAKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKL 96
RP+ +S + K + P+ + K + + + SY
Sbjct: 4 RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQE----VSYTDT 59
Query: 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 156
+G G++ V++ K + LVA+K++ + RE+ ++R+L H NIV L
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRY 114
Query: 157 IIHT------EKCLTLVFEYLEKDLKRYMDDCSN---ILSMNNVK 192
++ E L LV +Y+ + + R S L + VK
Sbjct: 115 FFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 159
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 5e-99
Identities = 90/296 (30%), Positives = 147/296 (49%), Gaps = 31/296 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR---HANIVTLHDI 248
+GT+ TV GK + T VA+K++ ++ P RE+ ++++L H NIV L
Sbjct: 33 QGTFGTVQLGKEKSTGMSVAIKKV-IQD----PRFRNRELQIMQDLAVLHHPNIVQLQSY 87
Query: 249 IHT-------EKCLTLVFEYLEKDLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCH- 297
+T + L +V EY+ L R + +K+FLFQL+R + H
Sbjct: 88 FYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHL 147
Query: 298 -SRRILHRDLKPQNLLINER-GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS 355
S + HRD+KP N+L+NE G LKL DFG A+ P++ + + +YR P+++ G+
Sbjct: 148 PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK-LSPSEPNVAYICSRYYRAPELIFGN 206
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE-------LKSKL 407
Y+T++D+ VGCIF EM G P+F G +L I +LG P E + +
Sbjct: 207 QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDV 266
Query: 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ + P + + + +A DL+ L Y ++R+ A+ HPYF+ L
Sbjct: 267 DLYNSKGIPWSNVFSDHSL-KDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL 321
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 30/127 (23%), Positives = 52/127 (40%), Gaps = 18/127 (14%)
Query: 79 RQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR 138
+ E ++ + GQGT+ TV GK + T VA+K++ ++ P R
Sbjct: 11 AAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQD----PRFRNR 65
Query: 139 EVSLLRELR---HANIVTLHDIIHT-------EKCLTLVFEYLEKDLKRYMDDCSN---I 185
E+ ++++L H NIV L +T + L +V EY+ L R +
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVA 125
Query: 186 LSMNNVK 192
+K
Sbjct: 126 PPPILIK 132
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 8e-95
Identities = 83/290 (28%), Positives = 147/290 (50%), Gaps = 27/290 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIH 250
+G Y+ VF+ + + V +K +K ++ RE+ +L LR NI+TL DI+
Sbjct: 46 RGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLADIVK 101
Query: 251 --TEKCLTLVFEYL-EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ LVFE++ D K+ L+ +++ +++++L+ L YCHS I+HRD+K
Sbjct: 102 DPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 157
Query: 308 PQNLLIN-ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-G 365
P N++I+ E +L+L D+GLA P + ++ V + +++ P++L+ Y S+DM
Sbjct: 158 PHNVMIDHEHRKLRLIDWGLAEF-YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 216
Query: 366 VGCIFHEMSSGR-PLFPGSTIEDELRLICSILG-PPPDELKSKLEFCITPVY----PSES 419
+GC+ M + P F G D+L I +LG + K + P + S
Sbjct: 217 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 276
Query: 420 KLQL------LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ + + +ALD + K L YD + R++A AM HPYF ++
Sbjct: 277 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 85 IGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLR 144
+ +G + Y + KLG+G Y+ VF+ + + V +K +K ++ RE+ +L
Sbjct: 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILE 85
Query: 145 ELR-HANIVTLHDIIH--TEKCLTLVFEYL-EKDLKRYMDDCSN 184
LR NI+TL DI+ + LVFE++ D K+ ++
Sbjct: 86 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTD 129
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 4e-91
Identities = 92/322 (28%), Positives = 151/322 (46%), Gaps = 60/322 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G++ V + + ALK++ + P RE+ +++ L H NI+ L D +T
Sbjct: 17 TGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHVNIIKLVDYFYT 71
Query: 252 --------------------------------------EKCLTLVFEYLEKDLKRYMDDC 273
K L ++ EY+ L + +
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF 131
Query: 274 SN---ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-ERGELKLADFGLARA 329
+ MN + ++++QL R + + HS I HRD+KPQNLL+N + LKL DFG A+
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191
Query: 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDE 388
+P++ + + +YR P+++LG+TEY+ SID+ +GC+F E+ G+PLF G T D+
Sbjct: 192 -LIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ 250
Query: 389 LRLICSILGPPPDELKSKLEFCITPVYPSES-------KLQLLAPEQMDSDALDLVQKFL 441
L I I+G P E + P Y + + PE S A+DL+++ L
Sbjct: 251 LVRIIQIMGTPTKEQMI----RMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306
Query: 442 MYDAKQRISAANAMRHPYFNSL 463
Y+ RI+ AM HP+F+ L
Sbjct: 307 RYEPDLRINPYEAMAHPFFDHL 328
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 6e-84
Identities = 98/363 (26%), Positives = 151/363 (41%), Gaps = 80/363 (22%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
G+Y V + +L +VA+K+I E +RE+++L L H ++V + DI+
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI 122
Query: 251 TEKC-----LTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ L +V E + D K+ L+ ++K L+ LL G+ Y HS ILHRD
Sbjct: 123 PKDVEKFDELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRD 181
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSN-------------------------- 339
LKP N L+N+ +K+ DFGLAR P S
Sbjct: 182 LKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLT 241
Query: 340 -EVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEM-----------SSGRPLFPGS--- 383
VVT WYR P+++L Y+ +ID+ +GCIF E+ + PLFPGS
Sbjct: 242 GHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCF 301
Query: 384 -----------------TIEDELRLICSILGPPPDELKSKLEFCITPVY----PSESKLQ 422
D+L +I +ILG P +E LE Y P
Sbjct: 302 PLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTD 361
Query: 423 L--LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD---TQSIF 477
L P +DA+ L+++ L+++ +RI+ + HP+F +
Sbjct: 362 LAERFP-ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV----RIAEVETNATEKV 416
Query: 478 SLP 480
LP
Sbjct: 417 RLP 419
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 1e-80
Identities = 98/306 (32%), Positives = 144/306 (47%), Gaps = 34/306 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G VF D VA+K+I L + +RE+ ++R L H NIV + +I+
Sbjct: 21 CGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREIKIIRRLDHDNIVKVFEILGP 79
Query: 252 EKCLT--------------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH 297
+V EY+E DL ++ L + +LF++QLLRGL Y H
Sbjct: 80 SGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIH 137
Query: 298 SRRILHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKT---FSNEVVTLWYRPPDVLL 353
S +LHRDLKP NL IN LK+ DFGLAR S +VT WYR P +LL
Sbjct: 138 SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL 197
Query: 354 GSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLE 408
Y+ +IDM GCIF EM +G+ LF G+ ++++LI + +E L S +
Sbjct: 198 SPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIP 257
Query: 409 FCIT--PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
I P + QLL + +A+D +++ L + R++A A+ HPY +
Sbjct: 258 VYIRNDMTEPHKPLTQLLP--GISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY--- 312
Query: 467 VHELSD 472
D
Sbjct: 313 -SFPMD 317
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 32/121 (26%), Positives = 48/121 (39%), Gaps = 17/121 (14%)
Query: 81 SLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREV 140
S++ GF Y L LG G VF D VA+K+I L + +RE+
Sbjct: 1 SMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-LREI 59
Query: 141 SLLRELRHANIVTLHDIIHTEKCLT--------------LVFEYLEKDLKRYMDDCSNIL 186
++R L H NIV + +I+ +V EY+E DL ++ L
Sbjct: 60 KIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE--QGPL 117
Query: 187 S 187
Sbjct: 118 L 118
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-79
Identities = 107/288 (37%), Positives = 150/288 (52%), Gaps = 20/288 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G Y V L VA+K+I EH+ T +RE+ +L RH NI+ ++DII
Sbjct: 37 EGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENIIGINDIIR 95
Query: 251 TEKCLT-----LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+V + +E DL + + + LS +++ FL+Q+LRGL Y HS +LHRD
Sbjct: 96 APTIEQMKDVYIVQDLMETDLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLHRD 153
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTF---SNEVVTLWYRPPDVLLGSTEYSTSI 362
LKP NLL+N +LK+ DFGLAR + V T WYR P+++L S Y+ SI
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI 213
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY----PS 417
D+ VGCI EM S RP+FPG D+L I ILG P E + + Y P
Sbjct: 214 DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH 273
Query: 418 ESKLQL--LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
++K+ L P DS ALDL+ K L ++ +RI A+ HPY
Sbjct: 274 KNKVPWNRLFP-NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 30/101 (29%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVSLLRELRHANI 151
Y L +G+G Y V L VA+K+I EH+ T +RE+ +L RH NI
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT-LREIKILLRFRHENI 87
Query: 152 VTLHDIIHTEKCLT-----LVFEYLEKDLKRYMDDCSNILS 187
+ ++DII +V + +E DL + + + LS
Sbjct: 88 IGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK--TQHLS 126
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-79
Identities = 102/297 (34%), Positives = 154/297 (51%), Gaps = 28/297 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G Y V T VA+K++ + E A RE+ LL+ +RH N++ L D+
Sbjct: 35 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMRHENVIGLLDVF 93
Query: 250 HTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
++ L LV ++ DL + M L + ++ ++Q+L+GL Y H+ I+H
Sbjct: 94 TPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIH 151
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RDLKP NL +NE ELK+ DFGLAR T VVT WYR P+V+L Y+ ++D
Sbjct: 152 RDLKPGNLAVNEDCELKILDFGLARQAD-SEMT--GYVVTRWYRAPEVILNWMRYTQTVD 208
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE-----FCIT--PVY 415
+ VGCI EM +G+ LF GS D+L+ I + G PP E +L+ + P
Sbjct: 209 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 268
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
+ +L A++L++K L+ DA+QR++A A+ HPYF SL H+ D
Sbjct: 269 EKKDFASILT--NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL----HDTED 319
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 31/124 (25%), Positives = 51/124 (41%), Gaps = 11/124 (8%)
Query: 72 PLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK--LEHE 129
P RQ +++ + Y L +G G Y V T VA+K++ + E
Sbjct: 6 PARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE 65
Query: 130 EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCS 183
A RE+ LL+ +RH N++ L D+ ++ L LV ++ DL + M
Sbjct: 66 LFAKRA-YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--H 122
Query: 184 NILS 187
L
Sbjct: 123 EKLG 126
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-79
Identities = 83/305 (27%), Positives = 138/305 (45%), Gaps = 32/305 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCT----------AIREVSLLRELRHAN 241
G+Y V G VA+K + +G +RE+ LL H N
Sbjct: 32 SGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN 90
Query: 242 IVTLHDIIHTEKCLT-----LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYC 296
I+ L DI + LV E + DL + + D ++S +++ F++ +L GL
Sbjct: 91 ILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL 150
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST 356
H ++HRDL P N+L+ + ++ + DF LAR + ++ V WYR P++++
Sbjct: 151 HEAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYVTHRWYRAPELVMQFK 209
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE------- 408
++ +DM GC+ EM + + LF GST ++L I ++G P E
Sbjct: 210 GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDY 269
Query: 409 -FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467
P+ + ++ D ALDL+ K L ++ ++RIS A+RHPYF SL
Sbjct: 270 LRNSLSNVPARAWTAVVP--TADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL---- 323
Query: 468 HELSD 472
+ D
Sbjct: 324 FDPLD 328
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 27/128 (21%), Positives = 43/128 (33%), Gaps = 16/128 (12%)
Query: 75 RSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC 134
+ + L Y + G+Y V G VA+K + +G
Sbjct: 6 GEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTV 64
Query: 135 T----------AIREVSLLRELRHANIVTLHDIIHTEKCLT-----LVFEYLEKDLKRYM 179
+RE+ LL H NI+ L DI + LV E + DL + +
Sbjct: 65 NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI 124
Query: 180 DDCSNILS 187
D ++S
Sbjct: 125 HDQRIVIS 132
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 6e-79
Identities = 96/308 (31%), Positives = 161/308 (52%), Gaps = 38/308 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G Y V + T +VA+K+I+ + A T +RE+ +L+ +H NI+T+ +I
Sbjct: 21 EGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIKILKHFKHENIITIFNIQR 79
Query: 251 TEKCLT-----LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ ++ E ++ DL R + + +LS ++++ F++Q LR + H ++HRD
Sbjct: 80 PDSFENFNEVYIIQELMQTDLHRVIS--TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRD 137
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNE----------VVTLWYRPPDVLLGS 355
LKP NLLIN +LK+ DFGLAR S V T WYR P+V+L S
Sbjct: 138 LKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS 197
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT-- 412
+YS ++D+ GCI E+ RP+FPG +L LI I+G P + + L +
Sbjct: 198 AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD--NDLRCIESPR 255
Query: 413 --------PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464
P+YP+ L+ + P +++ +DL+Q+ L++D +RI+A A+ HPY +
Sbjct: 256 AREYIKSLPMYPAAP-LEKMFP-RVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY- 312
Query: 465 PQVHELSD 472
H+ +D
Sbjct: 313 ---HDPND 317
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 27/111 (24%), Positives = 52/111 (46%), Gaps = 9/111 (8%)
Query: 83 SEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK-LEHEEGAPCTAIREVS 141
I + + LG+G Y V + T +VA+K+I+ + A T +RE+
Sbjct: 3 KRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-LREIK 61
Query: 142 LLRELRHANIVTLHDIIHTEKCLT-----LVFEYLEKDLKRYMDDCSNILS 187
+L+ +H NI+T+ +I + ++ E ++ DL R + + +LS
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS--TQMLS 110
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 1e-78
Identities = 96/297 (32%), Positives = 146/297 (49%), Gaps = 29/297 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G Y +V + + VA+K++ + E A RE+ LL+ ++H N++ L D+
Sbjct: 34 SGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQHENVIGLLDVF 92
Query: 250 HTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
L LV +++ DL++ M S ++ ++Q+L+GL Y HS ++H
Sbjct: 93 TPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAGVVH 149
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RDLKP NL +NE ELK+ DFGLAR T VVT WYR P+V+L Y+ ++D
Sbjct: 150 RDLKPGNLAVNEDCELKILDFGLARHAD-AEMT--GYVVTRWYRAPEVILSWMHYNQTVD 206
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT-------PVY 415
+ VGCI EM +G+ LF G D+L I + G P E KL P
Sbjct: 207 IWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQT 266
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
P + QL + A DL++K L D +R++AA A+ HP+F + +
Sbjct: 267 PRKDFTQLFP--RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF----RDPEE 317
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 24/97 (24%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRH 148
++Y +G G Y +V + + VA+K++ + E A RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQH 82
Query: 149 ANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYM 179
N++ L D+ L LV +++ DL++ M
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM 119
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-78
Identities = 100/297 (33%), Positives = 153/297 (51%), Gaps = 28/297 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKL--EHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G Y +V T VA+K++ + A T RE+ LL+ ++H N++ L D+
Sbjct: 39 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMKHENVIGLLDVF 97
Query: 250 HTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+ L LV + DL + L+ ++V+ ++Q+LRGL Y HS I+H
Sbjct: 98 TPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIH 155
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RDLKP NL +NE ELK+ DFGLAR + T V T WYR P+++L Y+ ++D
Sbjct: 156 RDLKPSNLAVNEDCELKILDFGLARHTA-DEMT--GYVATRWYRAPEIMLNWMHYNQTVD 212
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE-----FCIT--PVY 415
+ VGCI E+ +GR LFPG+ D+L+LI ++G P EL K+ I
Sbjct: 213 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 272
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
P + + + A+DL++K L+ D+ +RI+AA A+ H YF H+ D
Sbjct: 273 PKMNFANVFI--GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY----HDPDD 323
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 26/103 (25%), Positives = 43/103 (41%), Gaps = 11/103 (10%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKL--EHEEGAPCTAIREVSLLRELRHAN 150
Y L +G G Y +V T VA+K++ + A T RE+ LL+ ++H N
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-YRELRLLKHMKHEN 89
Query: 151 IVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSNILS 187
++ L D+ + L LV + DL + L+
Sbjct: 90 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLT 130
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-76
Identities = 101/341 (29%), Positives = 168/341 (49%), Gaps = 58/341 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELR-HANIVTLHDI 248
KG Y V+K R T +VA+K+I ++ A T RE+ +L EL H NIV L ++
Sbjct: 19 KGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELSGHENIVNLLNV 77
Query: 249 IHTE--KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ + + + LVF+Y+E DL + +NIL + + ++QL++ + Y HS +LHRD+
Sbjct: 78 LRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDM 135
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNE---------------------VVTLW 345
KP N+L+N +K+ADFGL+R+ + +N V T W
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRW 195
Query: 346 YRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404
YR P++LLGST+Y+ IDM +GCI E+ G+P+FPGS+ ++L I ++ P +E
Sbjct: 196 YRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDV 255
Query: 405 SKL---------------------EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMY 443
+ L++ + +ALDL+ K L +
Sbjct: 256 ESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315
Query: 444 DAKQRISAANAMRHPYFNSLGPQVHELSD---TQSIFSLPH 481
+ +RISA +A++HP+ + H ++ I ++P
Sbjct: 316 NPNKRISANDALKHPFVSIF----HNPNEEPNCDHIITIPI 352
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 36/100 (36%), Positives = 56/100 (56%), Gaps = 8/100 (8%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELR-HA 149
Y + KLG+G Y V+K R T +VA+K+I ++ A T RE+ +L EL H
Sbjct: 11 YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELSGHE 69
Query: 150 NIVTLHDIIHTE--KCLTLVFEYLEKDLKRYMDDCSNILS 187
NIV L +++ + + + LVF+Y+E DL + +NIL
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR--ANILE 107
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-72
Identities = 90/306 (29%), Positives = 146/306 (47%), Gaps = 35/306 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G V + + VA+K++ +++ A RE+ L++ + H NI+ L ++
Sbjct: 35 SGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKNIIGLLNVF 93
Query: 250 HTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+K L +V E ++ +L + + L + L+Q+L G+ + HS I+H
Sbjct: 94 TPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIH 150
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RDLKP N+++ LK+ DFGLAR + + VVT +YR P+V+LG Y ++D
Sbjct: 151 RDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGM-GYKENVD 208
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYP 416
+ VGCI EM G LFPG+ D+ + LG P E L+ + + P Y
Sbjct: 209 IWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYA 268
Query: 417 SESKLQL----------LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
S +L + S A DL+ K L+ DA +RIS A++HPY N
Sbjct: 269 GYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW--- 325
Query: 467 VHELSD 472
++ S+
Sbjct: 326 -YDPSE 330
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 21/95 (22%), Positives = 44/95 (46%), Gaps = 9/95 (9%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHAN 150
Y L +G G V + + VA+K++ +++ A RE+ L++ + H N
Sbjct: 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKN 85
Query: 151 IVTLHDIIHTEKCLT------LVFEYLEKDLKRYM 179
I+ L ++ +K L +V E ++ +L + +
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI 120
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 2e-72
Identities = 87/306 (28%), Positives = 143/306 (46%), Gaps = 35/306 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G V + D VA+K++ +++ A RE+ L++ + H NI++L ++
Sbjct: 72 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKNIISLLNVF 130
Query: 250 HTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+K L LV E ++ +L + + L + L+Q+L G+ + HS I+H
Sbjct: 131 TPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIH 187
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
RDLKP N+++ LK+ DFGLAR + + VVT +YR P+V+L Y ++D
Sbjct: 188 RDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL-GMGYKENVD 245
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCIT--PVYP 416
+ VGCI EM + LFPG D+ + LG P E L+ + + P Y
Sbjct: 246 IWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYA 305
Query: 417 ----------SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
S + S A DL+ K L+ D +RIS +A++HPY N
Sbjct: 306 GLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW--- 362
Query: 467 VHELSD 472
++ ++
Sbjct: 363 -YDPAE 367
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 23/95 (24%), Positives = 45/95 (47%), Gaps = 9/95 (9%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHAN 150
Y L +G G V + D VA+K++ +++ A RE+ L++ + H N
Sbjct: 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKN 122
Query: 151 IVTLHDIIHTEKCLT------LVFEYLEKDLKRYM 179
I++L ++ +K L LV E ++ +L + +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 157
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 7e-71
Identities = 90/357 (25%), Positives = 152/357 (42%), Gaps = 76/357 (21%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
+G+Y V+ + T+ VA+K++ E +RE+++L L+ I+ L+D+I
Sbjct: 36 RGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI-LREITILNRLKSDYIIRLYDLI 94
Query: 250 HTEKCLT-----LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ L +V E + DLK+ L+ ++K L+ LL G + H I+HR
Sbjct: 95 IPDDLLKFDELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHR 153
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNE----------------------VV 342
DLKP N L+N+ +K+ DFGLAR + T VV
Sbjct: 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVV 213
Query: 343 TLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSG-----------RPLFPGSTIE---- 386
T WYR P+++L Y+ SID+ GCIF E+ + PLFPGS+
Sbjct: 214 TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSP 273
Query: 387 -------------DELRLICSILGPPPDELKSKLE-------FCITPVYPSESKLQLLAP 426
D+L +I +I+G P ++ + + P + L+ P
Sbjct: 274 DRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN-LKQKYP 332
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD---TQSIFSLP 480
+ D ++L++ L ++ +RI+ A+ HPY + + + LP
Sbjct: 333 -SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDV----RKKKLENFSTKKIILP 384
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-55
Identities = 70/300 (23%), Positives = 128/300 (42%), Gaps = 42/300 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRH--ANIVTLHDI 248
G + VF+ + + A+K + LE + + E++ L +L+ I+ L+D
Sbjct: 38 SGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
T++ + +V E DL ++ + K + +L + H I+H DLKP
Sbjct: 97 EITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVV--TLWYRPPDVLLGS----------T 356
N LI + G LKL DFG+A T + + T+ Y PP+ + +
Sbjct: 156 ANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
+ S D+ +GCI + M+ G+ F I +++ + +I+ P ++EF
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDP-----NHEIEF------ 261
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQS 475
P+ + D D+++ L D KQRIS + HPY V++++ +
Sbjct: 262 ----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTT 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-52
Identities = 71/315 (22%), Positives = 131/315 (41%), Gaps = 51/315 (16%)
Query: 183 SNILSMNNV---------KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVS 232
+ +S+ G + VF+ + + A+K + LE + + E++
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIA 59
Query: 233 LLRELRH--ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLL 290
L +L+ I+ L+D T++ + +V E DL ++ + K + +L
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 118
Query: 291 RGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV--TLWYRP 348
+ H I+H DLKP N LI + G LKL DFG+A T + + T+ Y P
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177
Query: 349 PDVLLGS----------TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397
P+ + ++ S D+ +GCI + M+ G+ F I +++ + +I+
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIID 235
Query: 398 PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
P ++EF P+ + D D+++ L D KQRIS + H
Sbjct: 236 P-----NHEIEF----------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274
Query: 458 PYFNSLGPQVHELSD 472
PY V++++
Sbjct: 275 PYVQIQTHPVNQMAK 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 7e-51
Identities = 69/297 (23%), Positives = 126/297 (42%), Gaps = 42/297 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRH--ANIVTLHDI 248
G + VF+ + + A+K + LE + + E++ L +L+ I+ L+D
Sbjct: 66 SGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
T++ + +V E DL ++ + K + +L + H I+H DLKP
Sbjct: 125 EITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVV--TLWYRPPDVLLGS----------T 356
N LI + G LKL DFG+A T + + + Y PP+ + +
Sbjct: 184 ANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
+ S D+ +GCI + M+ G+ F I +++ + +I+ P ++EF
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQ--IINQISKLHAIIDP-----NHEIEF------ 289
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
P+ + D D+++ L D KQRIS + HPY V++++
Sbjct: 290 ----------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-50
Identities = 65/299 (21%), Positives = 111/299 (37%), Gaps = 55/299 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD---- 247
+G + V K ++ L A+K+I+ E+ + T + EV LL L H +V +
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAWLE 73
Query: 248 ---------IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH 297
+ + L + EY E L + + + Q+L L+Y H
Sbjct: 74 RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH 133
Query: 298 SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV--------------T 343
S+ I+HRDLKP N+ I+E +K+ DFGLA+ + T
Sbjct: 134 SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGT 193
Query: 344 LWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402
Y +VL G+ Y+ IDM +G IF EM P G + L+ + S+ P +
Sbjct: 194 AMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNILKKLRSVSIEFPPD 251
Query: 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
+ +++ + +D +R A + +
Sbjct: 252 F----------------------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 8e-50
Identities = 66/318 (20%), Positives = 123/318 (38%), Gaps = 32/318 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G++ KS +KEI + + REV++L ++H NIV +
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 251 TEKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
L +V +Y E DL + ++ + + + + Q+ L + H R+ILHRD+K
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM-GV 366
QN+ + + G ++L DFG+AR + T + + T +Y P++ Y+ D+ +
Sbjct: 154 QNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENK-PYNNKSDIWAL 211
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
GC+ +E+ + + F ++++ + I S G P PV
Sbjct: 212 GCVLYELCTLKHAFEAGSMKNLVLKIIS--GSFP------------PV-----------S 246
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKLTS 486
D LV + + + R S + + + + F L
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
Query: 487 NPTDGGLLPFYGQKSEKR 504
+ P GQ S
Sbjct: 307 SQPIPAKRPASGQNSISV 324
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 2/107 (1%)
Query: 75 RSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAP 133
S + F +E Y +L K+G+G++ KS +KEI +
Sbjct: 8 SSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER 67
Query: 134 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179
+ REV++L ++H NIV + L +V +Y E DL + +
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI 114
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-48
Identities = 78/318 (24%), Positives = 131/318 (41%), Gaps = 49/318 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG++ V K VALK ++ +E+ A E+ +L LR + ++IH
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164
Query: 252 EKC------LTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ + + FE L +L + S+ V+ F +L+ L H RI+H
Sbjct: 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHC 224
Query: 305 DLKPQNLLINE--RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
DLKP+N+L+ + R +K+ DFG + + + + +YR P+V+LG Y I
Sbjct: 225 DLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSRFYRAPEVILG-ARYGMPI 280
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL-----KSKLEF------- 409
DM +GCI E+ +G PL PG D+L + +LG P +L ++K
Sbjct: 281 DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPR 340
Query: 410 ---------------------CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR 448
P + D LD +++ L +D R
Sbjct: 341 YCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400
Query: 449 ISAANAMRHPYFNSLGPQ 466
++ A+RHP+ P+
Sbjct: 401 MTPGQALRHPWLRRRLPK 418
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 21/86 (24%), Positives = 38/86 (44%), Gaps = 8/86 (9%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
L +G+G++ V K VALK ++ +E+ A E+ +L LR +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 156 DIIHTEKC------LTLVFEYLEKDL 175
++IH + + + FE L +L
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNL 185
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-48
Identities = 71/295 (24%), Positives = 116/295 (39%), Gaps = 41/295 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIH 250
G T+ + + VA+K I E A REV LLRE H N++
Sbjct: 34 HGAEGTIVY-RGMFDNRDVAVKRILPECFSFA----DREVQLLRESDEHPNVIRYFCTEK 88
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + E L+ Y++ L Q GLA+ HS I+HRDLKP N
Sbjct: 89 DRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHN 148
Query: 311 LLINERGE-----LKLADFGLARAKSVPTKTFSN---EVVTLWYRPPDVLLGSTE--YST 360
+LI+ ++DFGL + +V +FS T + P++L + +
Sbjct: 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTY 208
Query: 361 SIDM-GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
++D+ GC+F+ + S G F S L+ +
Sbjct: 209 TVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP---------------- 252
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDT 473
+ D A +L++K + D ++R SA + ++HP+F SL Q+ D
Sbjct: 253 -------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDV 300
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 27/108 (25%), Positives = 42/108 (38%), Gaps = 7/108 (6%)
Query: 73 LTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGA 132
L + + S + G+I + D LG G T+ + + VA+K I E A
Sbjct: 7 LEQDDGDEETSVVIVGKIS-FCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFA 64
Query: 133 PCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179
REV LLRE H N++ + + E L+ Y+
Sbjct: 65 ----DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYV 108
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-48
Identities = 62/297 (20%), Positives = 112/297 (37%), Gaps = 56/297 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD---- 247
G + VFK K R+ +K +K +E+ A REV L +L H NIV +
Sbjct: 21 SGGFGQVFKAKHRIDGKTYVIKRVKYNNEK-----AEREVKALAKLDHVNIVHYNGCWDG 75
Query: 248 ------------IIHTEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGL 293
KCL + E+ +K L+++++ L Q+ +G+
Sbjct: 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGV 135
Query: 294 AYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL 353
Y HS+++++RDLKP N+ + + ++K+ DFGL + + TL Y P+ +
Sbjct: 136 DYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-NDGKRTRSKGTLRYMSPEQIS 194
Query: 354 GSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412
+Y +D+ +G I E+ L T + + +
Sbjct: 195 SQ-DYGKEVDLYALGLILAEL-----LHVCDTAFETSKFFTDLRDGII------------ 236
Query: 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHE 469
+ D L+QK L + R + + +R P+ +E
Sbjct: 237 -------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 5e-48
Identities = 70/315 (22%), Positives = 130/315 (41%), Gaps = 58/315 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIH 250
G+ TV + VA+K + ++ + A+ E+ LL E H N++ +
Sbjct: 25 YGSSGTVVF-QGSFQGRPVAVKRMLIDFCD----IALMEIKLLTESDDHPNVIRYYCSET 79
Query: 251 TEKCLTLVFEYLEKDL------KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
T++ L + E +L K D+ + N L Q+ G+A+ HS +I+HR
Sbjct: 80 TDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHR 139
Query: 305 DLKPQNLLI-------------NERGELKLADFGLAR----AKSVPTKTFSNEVVTLWYR 347
DLKPQN+L+ E + ++DFGL + +S +N T +R
Sbjct: 140 DLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWR 199
Query: 348 PPDVLLGSTE------YSTSIDM-GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPP 399
P++L S + SID+ +GC+F+ + S G+ F + +I
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-----NI---- 250
Query: 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
++ +++ L + ++A DL+ + + +D +R +A +RHP
Sbjct: 251 ---IRGIFSL---------DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 460 FNSLGPQVHELSDTQ 474
F ++ L
Sbjct: 299 FWPKSKKLEFLLKVS 313
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-47
Identities = 47/312 (15%), Positives = 81/312 (25%), Gaps = 56/312 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G + VF + ALK + E L + D
Sbjct: 72 VGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131
Query: 250 HTEKCLT--------------------------LVFEYLEKDLKRYMDDCSNILSMNN-- 281
L+ DL+ +
Sbjct: 132 RLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDE 191
Query: 282 ----VKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF 337
+ + QL+R A S+ ++H P NL I G L L D
Sbjct: 192 GILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS 251
Query: 338 SNEVVTLWYRPPDVLLGS-TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395
V + Y P + L S ++ +++ +G + + F T +
Sbjct: 252 ---SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPS 308
Query: 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455
L P L + + L+ +FL +D ++R+ AM
Sbjct: 309 LRVPG-----------------TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351
Query: 456 RHPYFNSLGPQV 467
P F L ++
Sbjct: 352 ETPEFLQLQNEI 363
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 70/282 (24%), Positives = 113/282 (40%), Gaps = 39/282 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHD--I 248
G+Y K + + ++ KE+ E + EV+LLREL+H NIV +D I
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCHSRR---- 300
T L +V EY E DL + + L V + QL L CH R
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 301 -ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
+LHRDLKP N+ ++ + +KL DFGLAR + T V T +Y P+ + Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYN 194
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
D+ +GC+ +E+ + P F + ++ I G +
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--GKFR------------RI---- 236
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
P + + +++ + L R S + +P
Sbjct: 237 -------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-47
Identities = 86/413 (20%), Positives = 146/413 (35%), Gaps = 90/413 (21%)
Query: 75 RSSRRQSLSEIG--FGRIESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEG 131
SS R++L G ++ + L +GQG+Y V T + A+K +
Sbjct: 7 HSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQ 66
Query: 132 APCTAI----REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNIL 186
+ EV L+++L H NI L+++ E+ + LV E L
Sbjct: 67 INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL----------- 115
Query: 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
L ++ + ++ A+ V
Sbjct: 116 -------------------------LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ +L F EK + M Q+ L Y H++ I HRD+
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMR----------------QIFSALHYLHNQGICHRDI 194
Query: 307 KPQNLLI--NERGELKLADFGLAR----AKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YS 359
KP+N L N+ E+KL DFGL++ + + + T ++ P+VL + E Y
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
D G + H + G FPG D + + L KL F P Y
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV----------LNKKLCF-ENPNYNVL 303
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELS 471
S A DL+ L + +R A A++HP+ + +++++S
Sbjct: 304 SP-----------LARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 8e-46
Identities = 61/272 (22%), Positives = 96/272 (35%), Gaps = 33/272 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCT-AIREVSLLREL-RHANIVTLHDII 249
G+Y VFK +S+ L A+K + EV ++ +H V L
Sbjct: 67 HGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW 126
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
L L E L+++ + L V +L L LA+ HS+ ++H D+KP
Sbjct: 127 EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
N+ + RG KL DFGL + Y P++L GS Y T+ D+ +G
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPRYMAPELLQGS--YGTAADVFSLGL 243
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
E++ L E +L L P
Sbjct: 244 TILEVACNMELP--HGGEGWQQLRQGYLPPEF-------------------------TAG 276
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ S+ ++ L D K R +A + P
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-45
Identities = 77/329 (23%), Positives = 131/329 (39%), Gaps = 68/329 (20%)
Query: 192 KGTYATVFKGKSRLTDN-LVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHD 247
+GT+ V + VALK I+ E A E+++L++++ +
Sbjct: 29 EGTFGKVVECLDHARGKSQVALKIIRNVGKYRE-----AARLEINVLKKIKEKDKENKFL 83
Query: 248 IIHTEKC------LTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRR 300
+ + + FE L K+ ++ + + + +V+ +QL L + H +
Sbjct: 84 CVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ 143
Query: 301 ILHRDLKPQNLLINE-------------------RGELKLADFGLARAKSVPTKTFSNE- 340
+ H DLKP+N+L +++ADFG A TF +E
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--------TFDHEH 195
Query: 341 ----VVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395
V T YRPP+V+L ++ D+ +GCI E G LF + L ++ I
Sbjct: 196 HTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254
Query: 396 LGPPPDEL-----KSKLEFCITPVYPSESKLQ-------------LLAPEQMDSDALDLV 437
LGP P + K K + V+ S +L DL+
Sbjct: 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314
Query: 438 QKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
++ L +D QRI+ A A+ HP+F L P+
Sbjct: 315 RRMLEFDPAQRITLAEALLHPFFAGLTPE 343
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 4e-45
Identities = 84/333 (25%), Positives = 134/333 (40%), Gaps = 72/333 (21%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V K R+ VA+K IK + A EV LL + + + I
Sbjct: 64 KGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN-----QAQIEVRLLELMNKHDTEMKYYI 118
Query: 249 IHTEKC------LTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRR- 300
+H ++ L LVFE L +L + + + +S+N + F Q+ L + +
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPEL 178
Query: 301 -ILHRDLKPQNLLI--NERGELKLADFGLARAKSVPTKTFSNE-----VVTLWYRPPDVL 352
I+H DLKP+N+L+ +R +K+ DFG + + + + +YR P+VL
Sbjct: 179 SIIHCDLKPENILLCNPKRSAIKIVDFGSS--------CQLGQRIYQYIQSRFYRSPEVL 230
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL-------- 403
LG Y +IDM +GCI EM +G PLF G+ D++ I +LG PP +
Sbjct: 231 LG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKAR 289
Query: 404 ---------------------------KSKLEFCI--TPVYPSESKLQLLAPEQMDSDAL 434
KL + P + D
Sbjct: 290 KFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKF 349
Query: 435 -DLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
DL+ + L YD K RI A++H +F +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-45
Identities = 72/326 (22%), Positives = 135/326 (41%), Gaps = 68/326 (20%)
Query: 192 KGTYATVFKGKSRLTDN-LVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V + VA+K +K E A E+ +L L + +
Sbjct: 24 EGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE-----AARSEIQVLEHLNTTDPNSTFR 78
Query: 248 IIHTEKC------LTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRR 300
+ + + +VFE L ++ + + +++++ +Q+ + + + HS +
Sbjct: 79 CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK 138
Query: 301 ILHRDLKPQNLLINE-------------------RGELKLADFGLARAKSVPTKTFSNE- 340
+ H DLKP+N+L + ++K+ DFG A T+ +E
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--------TYDDEH 190
Query: 341 ----VVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395
V T YR P+V+L +S D+ +GCI E G +FP ++ L ++ I
Sbjct: 191 HSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249
Query: 396 LGPPPDEL-----------KSKLEFCITP-----VYPSESKLQ--LLAPEQMDSDALDLV 437
LGP P + +L++ V + L+ +L+ + DL+
Sbjct: 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLI 309
Query: 438 QKFLMYDAKQRISAANAMRHPYFNSL 463
QK L YD +RI+ A++HP+F+ L
Sbjct: 310 QKMLEYDPAKRITLREALKHPFFDLL 335
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 5e-45
Identities = 59/300 (19%), Positives = 114/300 (38%), Gaps = 21/300 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII-- 249
+G A VF+G+ + T +L A+K +RE +L++L H NIV L I
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNI--LSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
T + L+ E+ L +++ SN L + + L ++ G+ + I+HR++
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 307 KPQNLLI----NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST------ 356
KP N++ + + KL DFG AR + + F + T Y PD+ +
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 357 -EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICS--ILGPPPDELKSKLEFCIT 412
+Y ++D+ +G F+ ++G F + + I G P + +
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257
Query: 413 PV-YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELS 471
P+ + + + + ++ L D ++ H
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRGNSHHHH 317
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 29/100 (29%), Positives = 46/100 (46%), Gaps = 3/100 (3%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+ D LGQG A VF+G+ + T +L A+K +RE +L++L H NIV
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 153 TLHDII--HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMN 189
L I T + L+ E+ L +++ SN +
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP 110
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 76/319 (23%), Positives = 129/319 (40%), Gaps = 58/319 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK---LEHEEGAPCTAIREVSLLRELRHA-------- 240
G ++TV+ K + + VA+K ++ + E A E+ LL+ + A
Sbjct: 29 WGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-----AAEDEIKLLQRVNDADNTKEDSM 83
Query: 241 ---NIVTLHDI-IHTEKCLT---LVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRG 292
+I+ L D H +VFE L ++L + + + + VK QLL G
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 143
Query: 293 LAYCHSR-RILHRDLKPQNLLINE------RGELKLADFGLARAKSVPTKTFSNEVVTLW 345
L Y H R I+H D+KP+N+L+ ++K+AD G A + ++N + T
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQTRE 200
Query: 346 YRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIE------DELRLICSILGP 398
YR P+VLLG+ + D+ C+ E+ +G LF D + I +LG
Sbjct: 201 YRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259
Query: 399 PPDEL-----KSKLEF---------CITPVYPSESKL--QLLAPEQMDSDALDLVQKFLM 442
P L ++ F +P E L + + + D + L
Sbjct: 260 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 319
Query: 443 YDAKQRISAANAMRHPYFN 461
D ++R A + HP+
Sbjct: 320 LDPRKRADAGGLVNHPWLK 338
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 71/274 (25%), Positives = 123/274 (44%), Gaps = 36/274 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V+ + + + ++ALK + + G REV + LRH NI+ L+
Sbjct: 19 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 78
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
H + L+ EY + R + S ++ +L L+YCHS+R++HRD+KP
Sbjct: 79 HDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 309 QNLLINERGELKLADFGLA-RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
+NLL+ GELK+ADFG + A S TL Y PP+++ G + +D+ +
Sbjct: 138 ENLLLGSAGELKIADFGWSVHAPSSRRTDLCG---TLDYLPPEMIEGR-MHDEKVDLWSL 193
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +E G+P F +T ++ + I + + F P
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRI----------SRVEFTF----------------P 227
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ + A DL+ + L ++ QR + HP+
Sbjct: 228 DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 22/87 (25%), Positives = 39/87 (44%), Gaps = 2/87 (2%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLREL 146
+E + LG+G + V+ + + + ++ALK + + G REV + L
Sbjct: 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEK 173
RH NI+ L+ H + L+ EY
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPL 93
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 70/331 (21%), Positives = 124/331 (37%), Gaps = 78/331 (23%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHA-----NIV 243
GT+ V + A+K ++ +A E +L+++++ NIV
Sbjct: 45 DGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR-----SAKIEADILKKIQNDDINNNNIV 99
Query: 244 TLHD--IIHTEKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRR 300
H + + CL +FE L L + + + ++KL+ ++L+ L Y
Sbjct: 100 KYHGKFMYYDHMCL--IFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS 157
Query: 301 ILHRDLKPQNLLINE-------------------------RGELKLADFGLARAKSVPTK 335
+ H DLKP+N+L+++ +KL DFG A
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA-------- 209
Query: 336 TFSNE-----VVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDEL 389
TF ++ + T YR P+V+L + S DM GC+ E+ +G LF + L
Sbjct: 210 TFKSDYHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHL 268
Query: 390 RLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE--------------------QM 429
++ SI+ P P + + Y ++ +L+L PE
Sbjct: 269 AMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK 328
Query: 430 DSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
D + L D R S A ++H +
Sbjct: 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-44
Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 36/278 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC--TAIREVSLLRELRHANIVTLHDII 249
+G ++ V++ L VALK++++ A I+E+ LL++L H N++ +
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101
Query: 250 HTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ L +V E L + +K + I V + QL L + HSRR++HR
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLI-PERTVWKYFVQLCSALEHMHSRRVMHR 160
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSID 363
D+KP N+ I G +KL D GL R S T ++ +V T +Y P+ + + Y+ D
Sbjct: 161 DIKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHEN-GYNFKSD 218
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPSESKL 421
+ +GC+ +EM++ + F G + L I P
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEQCDYPP-------------------- 257
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
L + + LV + D ++R
Sbjct: 258 --LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 24/109 (22%), Positives = 53/109 (48%), Gaps = 3/109 (2%)
Query: 74 TRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAP 133
++ ++G+ + ++ K+G+G ++ V++ L VALK++++ A
Sbjct: 15 QFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK 74
Query: 134 C--TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179
I+E+ LL++L H N++ + + L +V E + DL R +
Sbjct: 75 ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI 123
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-44
Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 44/285 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V+ + + ++ALK + +EG RE+ + LRH NI+ +++
Sbjct: 24 KGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83
Query: 250 HTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
H K + L+ E+ L K+L++ F+ +L L YCH R+++HR
Sbjct: 84 HDRKRIYLMLEFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHERKVIHR 138
Query: 305 DLKPQNLLINERGELKLADFGL-ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
D+KP+NLL+ +GELK+ADFG A S+ +T TL Y PP+++ G + +D
Sbjct: 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG---TLDYLPPEMIEGK-THDEKVD 194
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
+ G + +E G P F + + R I + L+F
Sbjct: 195 LWCAGVLCYEFLVGMPPFDSPSHTETHRRI----------VNVDLKF------------- 231
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467
P + + DL+ K L Y QR+ M HP+ + +V
Sbjct: 232 ---PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 21/80 (26%), Positives = 41/80 (51%), Gaps = 3/80 (3%)
Query: 94 FKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHAN 150
F + + LG+G + V+ + + ++ALK + +EG RE+ + LRH N
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 151 IVTLHDIIHTEKCLTLVFEY 170
I+ +++ H K + L+ E+
Sbjct: 76 ILRMYNYFHDRKRIYLMLEF 95
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-43
Identities = 64/300 (21%), Positives = 107/300 (35%), Gaps = 56/300 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD---- 247
+G + VF+ K+++ D A+K I+L + E A +REV L +L H IV +
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLE 74
Query: 248 --------IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSM--NNVKLFLFQLLRGLAYC 296
+ L + + K +LK +M+ I + Q+ + +
Sbjct: 75 KNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFL 134
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLARA------------KSVPTKTFSNEVVTL 344
HS+ ++HRDLKP N+ +K+ DFGL A + +V T
Sbjct: 135 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTK 194
Query: 345 WYRPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403
Y P+ + G+ YS +D+ +G I E+ P L + + P
Sbjct: 195 LYMSPEQIHGN-SYSHKVDIFSLGLILFELL--YPFSTQMERVRTLTDVRN--LKFPPL- 248
Query: 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
Q +VQ L +R A N + + F L
Sbjct: 249 ----------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-43
Identities = 72/277 (25%), Positives = 127/277 (45%), Gaps = 37/277 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG++A V++ +S T VA+K I K ++ G EV + +L+H +I+ L++
Sbjct: 21 KGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF 80
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+ LV E ++ RY+ + S N + F+ Q++ G+ Y HS ILHRDL
Sbjct: 81 EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140
Query: 309 QNLLINERGELKLADFGLARAKSVPT---KTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
NLL+ +K+ADFGLA +P T T Y P++ S + D+
Sbjct: 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCG---TPNYISPEIATRS-AHGLESDVW 196
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
+GC+F+ + GRP F T+++ L + ++ +
Sbjct: 197 SLGCMFYTLLIGRPPFDTDTVKNTLNKV------------VLADYEM------------- 231
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
P + +A DL+ + L + R+S ++ + HP+ +
Sbjct: 232 -PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 60.6 bits (148), Expect = 2e-10
Identities = 24/84 (28%), Positives = 44/84 (52%), Gaps = 2/84 (2%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLREL 146
+IE + + LG+G++A V++ +S T VA+K I K ++ G EV + +L
Sbjct: 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL 68
Query: 147 RHANIVTLHDIIHTEKCLTLVFEY 170
+H +I+ L++ + LV E
Sbjct: 69 KHPSILELYNYFEDSNYVYLVLEM 92
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-43
Identities = 66/289 (22%), Positives = 109/289 (37%), Gaps = 52/289 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G++ V + T A K+I +E + +E+ +++ L H NI+ L++
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD----RFKQEIEIMKSLDHPNIIRLYET 74
Query: 249 IHTEKCLTLVFEYLE--------KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
+ LV E + + ++ + +L +AYCH
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVF--------RESDAARIMKDVLSAVAYCHKLN 126
Query: 301 ILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE 357
+ HRDLKP+N L LKL DFGLA + P K +V T +Y P VL G
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKVGTPYYVSPQVLEGL-- 183
Query: 358 YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYP 416
Y D G + + + G P F T + + I + F +
Sbjct: 184 YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI----------REGTFTF-PEKDWL 232
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ S A L+++ L KQRI++ A+ H +F
Sbjct: 233 NVSP-----------QAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 21/90 (23%), Positives = 40/90 (44%), Gaps = 8/90 (8%)
Query: 87 FGRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSL 142
G I Y+ L+ +G+G++ V + T A K+I +E + +E+ +
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD----RFKQEIEI 59
Query: 143 LRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
++ L H NI+ L++ + LV E
Sbjct: 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCT 89
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 6e-43
Identities = 80/297 (26%), Positives = 127/297 (42%), Gaps = 46/297 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIH 250
KG++ V K K R+T A+K I + + I REV LL++L H NI+ L +I+
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 251 TEKCLTLVFEYLE--------KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
+V E KR+ S ++ + Q+ G+ Y H I+
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRF--------SEHDAARIIKQVFSGITYMHKHNIV 143
Query: 303 HRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
HRDLKP+N+L+ + + +K+ DFGL+ + + T +Y P+VL G+ Y
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAPEVLRGT--YD 200
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
D+ G I + + SG P F G D L+ + K F P + +
Sbjct: 201 EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV----------ETGKYAF-DLPQWRTI 249
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQS 475
S DA DL++K L + RI+A + HP+ + +SD S
Sbjct: 250 S-----------DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPS 295
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRE 145
G + + LG+G++ V K K R+T A+K I + + I REV LL++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLE 172
L H NI+ L +I+ +V E
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYT 104
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-43
Identities = 60/279 (21%), Positives = 115/279 (41%), Gaps = 38/279 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V + R + +K I + + E+ +L+ L H NI+ + ++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED 91
Query: 252 EKCLTLVFEY------LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ +V E LE+ + + LS V + Q++ LAY HS+ ++H+D
Sbjct: 92 YHNMYIVMETCEGGELLERIVSAQARGKA--LSEGYVAELMKQMMNALAYFHSQHVVHKD 149
Query: 306 LKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
LKP+N+L + +K+ DFGLA + +N T Y P+V +
Sbjct: 150 LKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAAGTALYMAPEVFKRD--VTFKC 206
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D+ G + + + +G F G+++E+ + + + E
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA----------TYKEPNY------AVE--- 247
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ A+DL+++ L D ++R SAA + H +F
Sbjct: 248 ----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 19/86 (22%), Positives = 36/86 (41%), Gaps = 1/86 (1%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL 146
G I+ F + LG G + V + R + +K I + + E+ +L+ L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLE 172
H NI+ + ++ + +V E E
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCE 103
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-43
Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 32/290 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIH 250
G Y V + ++T A+K I+ + + + EV++L+ L H NI+ L+D
Sbjct: 47 SGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE 106
Query: 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
++ LV E + +L + + + + + Q+L G+ Y H I+HRDLKP+
Sbjct: 107 DKRNYYLVMECYKGGELFDEIIHRMK-FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPE 165
Query: 310 NLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-G 365
NLL+ + + +K+ DFGL+ K + T +Y P+VL Y D+
Sbjct: 166 NLLLESKEKDALIKIVDFGLSA-VFENQKKMKERLGTAYYIAPEVLRKK--YDEKCDVWS 222
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425
+G I + +G P F G T ++ LR + K K F +P + + S
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKV----------EKGKYTF-DSPEWKNVS------ 265
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQS 475
A DL+++ L +D+++RISA A+ HP+ + + + S
Sbjct: 266 -----EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPS 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 2/87 (2%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRE 145
G + ++ K LG G Y V + ++T A+K I+ + + + EV++L+
Sbjct: 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLE 172
L H NI+ L+D ++ LV E +
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYLVMECYK 119
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-42
Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 40/295 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVSLLRELRHANIVTLH 246
G +A V K + + T A K I +L REV++LRE+RH NI+TLH
Sbjct: 15 SGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLH 74
Query: 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDC--SNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
DI + + L+ E + +L D L+ + FL Q+L G+ Y HS+RI H
Sbjct: 75 DIFENKTDVVLILELVSGGEL---FDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAH 131
Query: 304 RDLKPQNLLINERGE----LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
DLKP+N+++ ++ +KL DFG+A K F N T + P+++
Sbjct: 132 FDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEFKNIFGTPEFVAPEIVNY-EPLG 189
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
DM +G I + + SG F G E + + +I +F + +
Sbjct: 190 LEADMWSIGVITYILLSGASPFLG---ETKQETLTNI-------SAVNYDF-DEEYFSNT 238
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDT 473
S+ A D +++ L+ D K+R++ A ++ H + ++ + D+
Sbjct: 239 SE-----------LAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGEDS 282
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 29/89 (32%), Positives = 47/89 (52%), Gaps = 6/89 (6%)
Query: 90 IESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVSLL 143
+E ++++ + LG G +A V K + + T A K I +L REV++L
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 144 RELRHANIVTLHDIIHTEKCLTLVFEYLE 172
RE+RH NI+TLHDI + + L+ E +
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVS 91
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 153 bits (387), Expect = 3e-42
Identities = 76/389 (19%), Positives = 135/389 (34%), Gaps = 78/389 (20%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ + +G+G + VF+ K+++ D A+K I+L + E A +REV L +L H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLV 210
IV + E E LK D +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV--------------- 110
Query: 211 ALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 269
++ + N V + L + + K +LK +
Sbjct: 111 -------------------KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDW 151
Query: 270 MDDCSNILSMNNVK-LFLF-QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327
M+ ++ + L +F Q+ + + HS+ ++HRDLKP N+ +K+ DFGL
Sbjct: 152 MNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
Query: 328 RA------------KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEMS 374
A T + +V T Y P+ + G+ YS +D+ +G I E+
Sbjct: 212 TAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFEL- 269
Query: 375 SGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDAL 434
L+ ST + +R+I + +P Q
Sbjct: 270 ----LYSFSTQMERVRIITDV---------------RNLKFPLL-------FTQKYPQEH 303
Query: 435 DLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+VQ L +R A + + + F +L
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 4e-42
Identities = 53/287 (18%), Positives = 103/287 (35%), Gaps = 44/287 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G ++ V + + ALK I ++ A RE + R H NI+ L
Sbjct: 39 EGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPNILRLVAYCLR 97
Query: 252 EKCLT----LVFEYLEK-DLKRYMDDCSNI---LSMNNVKLFLFQLLRGLAYCHSRRILH 303
E+ L+ + ++ L ++ + L+ + + L + RGL H++ H
Sbjct: 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAH 157
Query: 304 RDLKPQNLLINERGELKLADFGLARAKSVPTKT---------FSNEVVTLWYRPPDVLLG 354
RDLKP N+L+ + G+ L D G + + ++ + T+ YR P++
Sbjct: 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217
Query: 355 S--TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCI 411
D+ +GC+ + M G + + + + ++++L
Sbjct: 218 QSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---------VQNQLSI-- 266
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
P P S S L+ + D QR +
Sbjct: 267 -PQSPRHS-----------SALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 21/98 (21%), Positives = 39/98 (39%), Gaps = 6/98 (6%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ Y + KLG+G ++ V + + ALK I ++ A RE + R H N
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE-EAQREADMHRLFNHPN 87
Query: 151 IVTLHDIIHTEKCLT----LVFEYLEK-DLKRYMDDCS 183
I+ L E+ L+ + ++ L ++
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 78/299 (26%), Positives = 133/299 (44%), Gaps = 33/299 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
KG++ V K ++T A+K I + +REV LL++L H NI+ L++
Sbjct: 36 KGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF 95
Query: 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+ LV E +L + S + + Q+L G+ Y H +I+HRDLKP
Sbjct: 96 EDKGYFYLVGEVYTGGELFDEIISRKR-FSEVDAARIIRQVLSGITYMHKNKIVHRDLKP 154
Query: 309 QNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
+NLL+ + + +++ DFGL+ +K +++ T +Y P+VL G+ Y D+
Sbjct: 155 ENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVW 211
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
G I + + SG P F G+ D L+ + K K F P + S
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKV----------EKGKYTF-ELPQWKKVS----- 255
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIK 483
A DL++K L Y RISA +A+ H + + + + ++ +I+
Sbjct: 256 ------ESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIR 308
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 23/88 (26%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLR 144
+K + LG+G++ V K ++T A+K I + +REV LL+
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 145 ELRHANIVTLHDIIHTEKCLTLVFEYLE 172
+L H NI+ L++ + LV E
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYT 109
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-42
Identities = 65/271 (23%), Positives = 111/271 (40%), Gaps = 29/271 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V + R T N A K + HE T +E+ + LRH +V LHD
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFED 225
Query: 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + +++E++ +L + D N +S + ++ Q+ +GL + H +H DLKP+N
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 285
Query: 311 LLINERGE--LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
++ + LKL DFGL P ++ T + P+V G DM VG
Sbjct: 286 IMFTTKRSNELKLIDFGLTA-HLDPKQSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVG 343
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ + + SG F G ++ LR + + S+
Sbjct: 344 VLSYILLSGLSPFGGENDDETLRNV----------KSCDWNM-DDSAFSGISE------- 385
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
D D ++K L+ D R++ A+ HP
Sbjct: 386 ----DGKDFIRKLLLADPNTRMTIHQALEHP 412
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 30/170 (17%), Positives = 59/170 (34%), Gaps = 17/170 (10%)
Query: 6 VVHENPKIGSE--EELEEVQDNLSKPVEVVKVRQRPKRSSEDINKRLSLPADLHLPESFL 63
++ EN S+ E V + + +S D ++ +
Sbjct: 82 IIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFD--- 138
Query: 64 AKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKL-DKLGQGTYATVFKGKSRLTDNLVALK 122
EI + ++ + ++LG G + V + R T N A K
Sbjct: 139 ----------IWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAK 188
Query: 123 EIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
+ HE T +E+ + LRH +V LHD + + +++E++
Sbjct: 189 FVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 8e-42
Identities = 73/281 (25%), Positives = 119/281 (42%), Gaps = 40/281 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI-REVSLLRELRHANIVTLHD 247
KG ++ V + +R T A+K + K G + RE S+ L+H +IV L +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93
Query: 248 IIHTEKCLTLVFEYLE------KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
++ L +VFE+++ + +KR D + S ++ Q+L L YCH I
Sbjct: 94 TYSSDGMLYMVFEFMDGADLCFEIVKR--ADAGFVYSEAVASHYMRQILEALRYCHDNNI 151
Query: 302 LHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY 358
+HRD+KP +L+ + +KL FG+A V T + P+V+ Y
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PY 210
Query: 359 STSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417
+D+ G G I + SG F G+ E I +K K + +
Sbjct: 211 GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGI----------IKGKYKM-NPRQWSH 258
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
S+ A DLV++ LM D +RI+ A+ HP
Sbjct: 259 ISE-----------SAKDLVRRMLMLDPAERITVYEALNHP 288
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 23/90 (25%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI-REVSL 142
E ++L + +G+G ++ V + +R T A+K + K G + RE S+
Sbjct: 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASI 79
Query: 143 LRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
L+H +IV L + ++ L +VFE+++
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMD 109
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-41
Identities = 77/288 (26%), Positives = 118/288 (40%), Gaps = 62/288 (21%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIH 250
KG++ V K K R+T A+K I + + I REV LL++L H NI+ L +I+
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 251 TEKCLTLVFEYL----------------EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLA 294
+V E E D R + Q+ G+
Sbjct: 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII----------------KQVFSGIT 135
Query: 295 YCHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDV 351
Y H I+HRDLKP+N+L+ + + +K+ DFGL+ + + T +Y P+V
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAPEV 194
Query: 352 LLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410
L G+ Y D+ G I + + SG P F G D L+ + K F
Sbjct: 195 LRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV----------ETGKYAF- 241
Query: 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
P + + S DA DL++K L + RI+A + HP
Sbjct: 242 DLPQWRTISD-----------DAKDLIRKMLTFHPSLRITATQCLEHP 278
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 26/87 (29%), Positives = 41/87 (47%), Gaps = 2/87 (2%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRE 145
G + + LG+G++ V K K R+T A+K I + + I REV LL++
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLE 172
L H NI+ L +I+ +V E
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYT 104
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-41
Identities = 68/309 (22%), Positives = 125/309 (40%), Gaps = 43/309 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI---------REVSLLRELRH 239
G Y V K + + A+K I + + + E+SLL+ L H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 240 ANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS 298
NI+ L D+ +K LV E+ E +L + + + + Q+L G+ Y H
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECDAANIMKQILSGICYLHK 164
Query: 299 RRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS 355
I+HRD+KP+N+L+ + +K+ DFGL+ + + T +Y P+VL
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKLRDRLGTAYYIAPEVLKKK 223
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
Y+ D+ G I + + G P F G +D ++ + K K F
Sbjct: 224 --YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV----------EKGKYYF-DFND 270
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQ 474
+ + S +A +L++ L YD +R +A A+ + +++
Sbjct: 271 WKNISD-----------EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKT 319
Query: 475 SIFSLPHIK 483
+L +++
Sbjct: 320 LCGALSNMR 328
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 26/98 (26%), Positives = 41/98 (41%), Gaps = 13/98 (13%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI------ 137
G+I + + LG G Y V K + + A+K I + + +
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 138 ---REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
E+SLL+ L H NI+ L D+ +K LV E+ E
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE 129
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 75/298 (25%), Positives = 118/298 (39%), Gaps = 54/298 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G ++ VF K RLT L ALK I + + E+++L++++H NIVTL DI
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS----SLENEIAVLKKIKHENIVTLEDI 74
Query: 249 IHTEKCLTLVFEYLE--------KDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSR 299
+ LV + + + Y D S ++ Q+L + Y H
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ---------QVLSAVKYLHEN 125
Query: 300 RILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST 356
I+HRDLKP+NLL E + + DFGL +K S T Y P+VL
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGL--SKMEQNGIMSTACGTPGYVAPEVLAQ-K 182
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
YS ++D +G I + + G P F T I + EF +P +
Sbjct: 183 PYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI----------KEGYYEF-ESPFW 231
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDT 473
S+ A D + L D +R + A+ HP+ + ++ +
Sbjct: 232 DDISE-----------SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 8/89 (8%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLL 143
I F + LG G ++ VF K RLT L ALK I + + E+++L
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS----SLENEIAVL 60
Query: 144 RELRHANIVTLHDIIHTEKCLTLVFEYLE 172
++++H NIVTL DI + LV + +
Sbjct: 61 KKIKHENIVTLEDIYESTTHYYLVMQLVS 89
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-41
Identities = 74/304 (24%), Positives = 129/304 (42%), Gaps = 39/304 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVSLLRELRHANIVTLH 246
G +A V K + + T A K I + REVS+LR++ H N++TLH
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 247 DIIHTEKCLTLVFEYLEK-DL-KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
D+ + L+ E + +L LS F+ Q+L G+ Y H+++I H
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHF 139
Query: 305 DLKPQNLLI----NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
DLKP+N+++ +KL DFGLA + F N T + P+++
Sbjct: 140 DLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNY-EPLGL 197
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
DM +G I + + SG F G T ++ L I +F + S
Sbjct: 198 EADMWSIGVITYILLSGASPFLGDTKQETLANI----------TSVSYDF-DEEFFSHTS 246
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSL 479
+ A D ++K L+ + ++R++ A+RHP+ + Q + +S+ +L
Sbjct: 247 E-----------LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ-QAMVRRESVVNL 294
Query: 480 PHIK 483
+ +
Sbjct: 295 ENFR 298
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 25/91 (27%), Positives = 44/91 (48%), Gaps = 6/91 (6%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVS 141
++E ++ + + LG G +A V K + + T A K I + REVS
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 142 LLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
+LR++ H N++TLHD+ + L+ E +
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVS 98
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 58/292 (19%), Positives = 115/292 (39%), Gaps = 29/292 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V + + T + K I + T E+S++ +L H ++ LHD
Sbjct: 61 SGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFED 119
Query: 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + L+ E+L +L + +S V ++ Q GL + H I+H D+KP+N
Sbjct: 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 179
Query: 311 LLINERGE--LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
++ + +K+ DFGLA K P + T + P+++ DM +G
Sbjct: 180 IMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIG 237
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ + + SG F G + L+ + + EF + S S
Sbjct: 238 VLGYVLLSGLSPFAGEDDLETLQNV----------KRCDWEF-DEDAFSSVSP------- 279
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSL 479
+A D ++ L + ++R++ +A+ HP+ + + +
Sbjct: 280 ----EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI 327
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 20/86 (23%), Positives = 39/86 (45%), Gaps = 2/86 (2%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL 146
G + Y+ + + LG G + V + + T + K I + T E+S++ +L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQL 105
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLE 172
H ++ LHD + + L+ E+L
Sbjct: 106 HHPKLINLHDAFEDKYEMVLILEFLS 131
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 46/282 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG +A F+ T + A K + L + E+S+ R L H ++V H
Sbjct: 25 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84
Query: 250 HTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ +V E L + KR L+ + +L Q++ G Y H R++HR
Sbjct: 85 EDNDFVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPT---KTFSNEVVTLWYRPPDVLLGSTEYSTS 361
DLK NL +NE E+K+ DFGLA K T Y P+VL +S
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIAPEVLSKKG-HSFE 195
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
+D+ +GCI + + G+P F S +++ I K E+ I
Sbjct: 196 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------------KKNEYSI--------- 234
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462
P+ ++ A L+QK L D R + + +F S
Sbjct: 235 -----PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 271
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 6e-11
Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 2/84 (2%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLREL 146
Y + LG+G +A F+ T + A K + L + E+S+ R L
Sbjct: 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 72
Query: 147 RHANIVTLHDIIHTEKCLTLVFEY 170
H ++V H + +V E
Sbjct: 73 AHQHVVGFHGFFEDNDFVFVVLEL 96
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-41
Identities = 72/282 (25%), Positives = 113/282 (40%), Gaps = 46/282 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG +A F+ T + A K + L + E+S+ R L H ++V H
Sbjct: 51 KGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110
Query: 250 HTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ +V E L + KR L+ + +L Q++ G Y H R++HR
Sbjct: 111 EDNDFVFVVLELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPT---KTFSNEVVTLWYRPPDVLLGSTEYSTS 361
DLK NL +NE E+K+ DFGLA K T Y P+VL +S
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG---TPNYIAPEVLSKKG-HSFE 221
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
+D+ +GCI + + G+P F S +++ I K E+ I
Sbjct: 222 VDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------------KKNEYSI--------- 260
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462
P+ ++ A L+QK L D R + + +F S
Sbjct: 261 -----PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 19/84 (22%), Positives = 32/84 (38%), Gaps = 2/84 (2%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEI--KLEHEEGAPCTAIREVSLLREL 146
Y + LG+G +A F+ T + A K + L + E+S+ R L
Sbjct: 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL 98
Query: 147 RHANIVTLHDIIHTEKCLTLVFEY 170
H ++V H + +V E
Sbjct: 99 AHQHVVGFHGFFEDNDFVFVVLEL 122
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 75/298 (25%), Positives = 125/298 (41%), Gaps = 40/298 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVSLLRELRHANIVTLH 246
G +A V K + + T A K I + C REVS+LR++ H NI+TLH
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDC--SNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
D+ + L+ E + +L D LS F+ Q+L G+ Y H+++I H
Sbjct: 82 DVYENRTDVVLILELVSGGEL---FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138
Query: 304 RDLKPQNLLI----NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
DLKP+N+++ +KL DFGLA + F N T + P+++
Sbjct: 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNY-EPLG 196
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
DM +G I + + SG F G T ++ L I +F +
Sbjct: 197 LEADMWSIGVITYILLSGASPFLGDTKQETLANI----------TAVSYDF-DEEFFSQT 245
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSI 476
S+ A D ++K L+ + ++R++ A+RHP+ + Q + +
Sbjct: 246 SE-----------LAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVV 292
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVS 141
++E ++ + + LG G +A V K + + T A K I + C REVS
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 142 LLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
+LR++ H NI+TLHD+ + L+ E +
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVS 98
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 76/301 (25%), Positives = 125/301 (41%), Gaps = 51/301 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG ++ V + + T A K I KL + RE + R+L+H NIV LHD
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL--EREARICRKLQHPNIVRLHDS 73
Query: 249 IHTEKCLTLVFEYLE--------KDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSR 299
I E LVF+ + + Y D S+ + Q+L +AYCHS
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---------QILESIAYCHSN 124
Query: 300 RILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST 356
I+HR+LKP+NLL+ + + +KLADFGLA + ++ + T Y P+VL
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFAGTPGYLSPEVLKKD- 182
Query: 357 EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
YS +D+ G I + + G P F I ++ +P +
Sbjct: 183 PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI----------KAGAYDY-PSPEW 231
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQS 475
+ + +A L+ L + K+RI+A A++ P+ + + +
Sbjct: 232 DTVTP-----------EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDT 280
Query: 476 I 476
+
Sbjct: 281 V 281
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLL 143
+ + + + LG+G ++ V + + T A K I KL + RE +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL--EREARIC 59
Query: 144 RELRHANIVTLHDIIHTEKCLTLVFEYLE 172
R+L+H NIV LHD I E LVF+ +
Sbjct: 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVT 88
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-41
Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 38/297 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVSLLRELRHANIVTLH 246
G +A V K + + T A K I + + REVS+L+E++H N++TLH
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 247 DIIHTEKCLTLVFEYLE-KDL-KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
++ + + L+ E + +L + S L+ FL Q+L G+ Y HS +I H
Sbjct: 81 EVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEFLKQILNGVYYLHSLQIAHF 138
Query: 305 DLKPQNLLINERGE----LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
DLKP+N+++ +R +K+ DFGLA K F N T + P+++
Sbjct: 139 DLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEFKNIFGTPEFVAPEIVNY-EPLGL 196
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
DM +G I + + SG F G T ++ L + EF + + S
Sbjct: 197 EADMWSIGVITYILLSGASPFLGDTKQETLANV----------SAVNYEF-EDEYFSNTS 245
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSI 476
A D +++ L+ D K+R++ ++++HP+ Q ++
Sbjct: 246 A-----------LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAV 291
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 24/91 (26%), Positives = 45/91 (49%), Gaps = 6/91 (6%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVS 141
++ Y+ + LG G +A V K + + T A K I + + REVS
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 142 LLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
+L+E++H N++TLH++ + + L+ E +
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVA 97
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 29/279 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V K + T +A K IK + E+S++ +L HAN++ L+D +
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE-EVKNEISVMNQLDHANLIQLYDAFES 157
Query: 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + LV EY++ +L + D S L+ + LF+ Q+ G+ + H ILH DLKP+N
Sbjct: 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN 217
Query: 311 LLINERGE--LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
+L R +K+ DFGLAR + P + T + P+V+ S DM VG
Sbjct: 218 ILCVNRDAKQIKIIDFGLAR-RYKPREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVG 275
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
I + + SG F G + L I L + + + S+
Sbjct: 276 VIAYMLLSGLSPFLGDNDAETLNNI----------LACRWDL-EDEEFQDISE------- 317
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
+A + + K L+ + RISA+ A++HP+ +
Sbjct: 318 ----EAKEFISKLLIKEKSWRISASEALKHPWLSDHKLH 352
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 31/168 (18%), Positives = 66/168 (39%), Gaps = 11/168 (6%)
Query: 8 HENPKIGSEEELEEVQDNLSKPVEVVKVRQRPKRSSEDINKRLSLPADLHLPESFLAKTN 67
+ ++++ + + S+ D+ +R+ +S
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMP-------VKSKRTSAL 62
Query: 68 IIDAPLTRSSRRQSLSEIGFGRIESYFKLDK---LGQGTYATVFKGKSRLTDNLVALKEI 124
+D P + + G + S++ + K LG G + V K + T +A K I
Sbjct: 63 AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122
Query: 125 KLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
K + E+S++ +L HAN++ L+D ++ + LV EY++
Sbjct: 123 KTRGMKDKE-EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 46/299 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIH 250
KG ++ V + L A I + + RE + R L+H NIV LHD I
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80
Query: 251 TEKCLTLVFEYLE--------KDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
E L+F+ + + Y D S+ + Q+L + +CH +
Sbjct: 81 EEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ---------QILEAVLHCHQMGV 131
Query: 302 LHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY 358
+HR+LKP+NLL+ + + +KLADFGLA + + T Y P+VL Y
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKD-PY 190
Query: 359 STSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417
+D+ G I + + G P F + I +F +P + +
Sbjct: 191 GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI----------KAGAYDF-PSPEWDT 239
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSI 476
+ +A DL+ K L + +RI+AA A++HP+ + + +++
Sbjct: 240 VTP-----------EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETV 287
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 2/87 (2%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRE 145
R ++L + LG+G ++ V + L A I + + RE + R
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLE 172
L+H NIV LHD I E L+F+ +
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVT 93
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 76/308 (24%), Positives = 122/308 (39%), Gaps = 65/308 (21%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG ++ V + + T A K I KL + RE + R+L+H NIV LHD
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQ--KLEREARICRKLQHPNIVRLHDS 96
Query: 249 IHTEKCLTLVFE----------------YLEKDLKRYMDDCSNILSMNNVKLFLFQLLRG 292
I E LVF+ Y E D + Q+L
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCI----------------QQILES 140
Query: 293 LAYCHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPP 349
+AYCHS I+HR+LKP+NLL+ + + +KLADFGLA + ++ + T Y P
Sbjct: 141 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFAGTPGYLSP 199
Query: 350 DVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408
+VL YS +D+ G I + + G P F I +
Sbjct: 200 EVLKKD-PYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI----------KAGAYD 248
Query: 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVH 468
+ +P + + + +A L+ L + K+RI+A A++ P+ +
Sbjct: 249 Y-PSPEWDTVTP-----------EAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS 296
Query: 469 ELSDTQSI 476
+ ++
Sbjct: 297 AIHRQDTV 304
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 27/102 (26%), Positives = 43/102 (42%), Gaps = 6/102 (5%)
Query: 75 RSSRRQSLSEIGFGRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEE 130
+ R + + + + LG+G ++ V + + T A K I KL +
Sbjct: 12 QMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD 71
Query: 131 GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
RE + R+L+H NIV LHD I E LVF+ +
Sbjct: 72 FQ--KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVT 111
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 77/308 (25%), Positives = 121/308 (39%), Gaps = 66/308 (21%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI-KLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G + V++ K + T ALK + K ++ E+ +L L H NI+ L +I
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLKKTVDKK----IVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 251 TEKCLTLVFE----------------YLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLA 294
T ++LV E Y E+D + Q+L +A
Sbjct: 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV----------------KQILEAVA 162
Query: 295 YCHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDV 351
Y H I+HRDLKP+NLL LK+ADFGL++ T Y P++
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMKTVCGTPGYCAPEI 221
Query: 352 LLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDEL-RLICSILGPPPDELKSKLEF 409
L G Y +DM VG I + + G F + + R I L + F
Sbjct: 222 LRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI----------LNCEYYF 270
Query: 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHE 469
I+P + S +A DLV+K ++ D K+R++ A++HP+
Sbjct: 271 -ISPWWDEVSL-----------NAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH 318
Query: 470 LSDTQSIF 477
+ Q
Sbjct: 319 MDTAQKKL 326
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 26/128 (20%), Positives = 52/128 (40%), Gaps = 6/128 (4%)
Query: 47 NKRLSLPADLHLPESFLAKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDK-LGQGTYA 105
+ + L + +S + T + + +F+++ LG+G +
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 106 TVFKGKSRLTDNLVALKEI-KLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164
V++ K + T ALK + K ++ E+ +L L H NI+ L +I T +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKKTVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123
Query: 165 TLVFEYLE 172
+LV E +
Sbjct: 124 SLVLELVT 131
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 70/301 (23%), Positives = 116/301 (38%), Gaps = 70/301 (23%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK--------LEHEEGAPCTAIREVSLLREL-RHANI 242
+G + V + + T A+K I E + ++EV +LR++ H NI
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 243 VTLHDIIHTEKCLTLVFE----------------YLEKDLKRYMDDCSNILSMNNVKLFL 286
+ L D T LVF+ EK+ ++ M
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM---------------- 130
Query: 287 FQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWY 346
LL + H I+HRDLKP+N+L+++ +KL DFG + + P + T Y
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVCGTPSY 189
Query: 347 RPPDVLLGSTE-----YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400
P+++ S Y +DM G I + + +G P F LR+I
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-------- 241
Query: 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ +F +P + S DLV +FL+ ++R +A A+ HP+F
Sbjct: 242 --MSGNYQF-GSPEWDDYS-----------DTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287
Query: 461 N 461
Sbjct: 288 Q 288
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 10/95 (10%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIK--------LEHEEGAPCTAIR 138
++ + LG+G + V + + T A+K I E + ++
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 139 EVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE 172
EV +LR++ H NI+ L D T LVF+ ++
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 107
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-40
Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 49/282 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRELRHANIVTLHDIIH 250
G+Y+ + + T+ A+K I + E+ LLR +H NI+TL D+
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT-----EEIEILLRYGQHPNIITLKDVYD 86
Query: 251 TEKCLTLVFEYLE--------KDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
K + +V E ++ K + + S +L + + + Y H++ +
Sbjct: 87 DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF---------TITKTVEYLHAQGV 137
Query: 302 LHRDLKPQNLLINERGE----LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE 357
+HRDLKP N+L + +++ DFG A+ T + P+VL
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER-QG 196
Query: 358 YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYP 416
Y + D+ +G + + M +G F + ++ I K +
Sbjct: 197 YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI-------GSGKFSLS-GGYWN 248
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
S S A DLV K L D QR++AA +RHP
Sbjct: 249 SVS-----------DTAKDLVSKMLHVDPHQRLTAALVLRHP 279
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 20/87 (22%), Positives = 41/87 (47%), Gaps = 7/87 (8%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRE 145
+ +++ + +G G+Y+ + + T+ A+K I + E+ LLR
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT-----EEIEILLRY 72
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLE 172
+H NI+TL D+ K + +V E ++
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMK 99
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-40
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 54/306 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI----REVSLLRELRHANIVT 244
G V R T VA++ I K E+ +L++L H I+
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNV-----KLFLFQLLRGLAYCHS 298
+ + E +V E +E +L D ++ + KL+ +Q+L + Y H
Sbjct: 205 IKNFFDAED-YYIVLELMEGGEL---FDK---VVGNKRLKEATCKLYFYQMLLAVQYLHE 257
Query: 299 RRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLG 354
I+HRDLKP+N+L++ + E +K+ DFG +K + + + T Y P+VL+
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGH--SKILGETSLMRTLCGTPTYLAPEVLVS 315
Query: 355 STE--YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDEL-RLICSILGPPPDELKSKLEFC 410
Y+ ++D +G I SG P F + L I K F
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----------TSGKYNF- 364
Query: 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP--QVH 468
I V+ S+ ALDLV+K L+ D K R + A+RHP+ +
Sbjct: 365 IPEVWAEVSE-----------KALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 413
Query: 469 ELSDTQ 474
+L +
Sbjct: 414 DLLSEE 419
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 20/93 (21%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI----RE 139
+ + + K LG G V R T VA++ I K E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 140 VSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
+ +L++L H I+ + + E +V E +E
Sbjct: 191 IEILKKLNHPCIIKIKNFFDAED-YYIVLELME 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 61/280 (21%), Positives = 124/280 (44%), Gaps = 30/280 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V + + K +K++ + +E+S+L RH NI+ LH+ +
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--LVKKEISILNIARHRNILHLHESFES 72
Query: 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ L ++FE++ D+ ++ + L+ + ++ Q+ L + HS I H D++P+N
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 311 LLI--NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
++ +K+ +FG AR + P F Y P+V ST+ DM +G
Sbjct: 133 IIYQTRRSSTIKIIEFGQAR-QLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLG 190
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ + + SG F E ++I +I + ++ F + S
Sbjct: 191 TLVYVLLSGINPFLA---ETNQQIIENI-------MNAEYTFD-EEAFKEIS-------- 231
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467
+A+D V + L+ + K R++A+ A++HP+ +V
Sbjct: 232 ---IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 18/85 (21%), Positives = 41/85 (48%), Gaps = 3/85 (3%)
Query: 89 RIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR 147
+ + + + LG+G + V + + K +K++ + +E+S+L R
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV--LVKKEISILNIAR 59
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLE 172
H NI+ LH+ + + L ++FE++
Sbjct: 60 HRNILHLHESFESMEELVMIFEFIS 84
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-39
Identities = 60/303 (19%), Positives = 117/303 (38%), Gaps = 21/303 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII-- 249
+G A VF+G+ + T +L A+K +RE +L++L H NIV L I
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSM--NNVKLFLFQLLRGLAYCHSRRILHRDL 306
T + L+ E+ L +++ SN + + + L ++ G+ + I+HR++
Sbjct: 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNI 138
Query: 307 KPQNLLI----NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST------ 356
KP N++ + + KL DFG AR + + F + T Y PD+ +
Sbjct: 139 KPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 357 -EYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICS--ILGPPPDELKSKLEFCIT 412
+Y ++D+ +G F+ ++G F + + I G P + +
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257
Query: 413 PV-YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELS 471
P+ + + + + ++ L D ++ +H S
Sbjct: 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFS 317
Query: 472 DTQ 474
Q
Sbjct: 318 LQQ 320
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 26/80 (32%), Positives = 39/80 (48%), Gaps = 2/80 (2%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+ D LGQG A VF+G+ + T +L A+K +RE +L++L H NIV
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 153 TLHDII--HTEKCLTLVFEY 170
L I T + L+ E+
Sbjct: 71 KLFAIEEETTTRHKVLIMEF 90
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 61/283 (21%), Positives = 121/283 (42%), Gaps = 32/283 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHA-NIVTLHDII 249
+G +A V + S+ T A K +K I E+++L + ++ LH++
Sbjct: 39 RGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 250 HTEKCLTLVFEYLEK-DL-KRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L+ EY ++ + + + ++S N+V + Q+L G+ Y H I+H DLK
Sbjct: 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLK 158
Query: 308 PQNLLI---NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
PQN+L+ G++K+ DFG++R K + T Y P++L +T+ DM
Sbjct: 159 PQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLAPEILNYD-PITTATDM 216
Query: 365 -GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
+G I + + + F G ++ I + +++ + S S+
Sbjct: 217 WNIGIIAYMLLTHTSPFVGEDNQETYLNI----------SQVNVDY-SEETFSSVSQ--- 262
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
A D +Q L+ + ++R +A + H + +
Sbjct: 263 --------LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 20/105 (19%), Positives = 40/105 (38%), Gaps = 4/105 (3%)
Query: 72 PLTRSSRRQSLSEIGFGRIESYFKLDK--LGQGTYATVFKGKSRLTDNLVALKEIKLEHE 129
++L +++ L LG+G +A V + S+ T A K +K
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 130 EGAPCTAI-REVSLLRELRHA-NIVTLHDIIHTEKCLTLVFEYLE 172
I E+++L + ++ LH++ + L+ EY
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 54/303 (17%), Positives = 123/303 (40%), Gaps = 49/303 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK---LEHEEGAPCTAI-------------REVSLLR 235
+G + + + + ALK+ + LE + + E+ ++
Sbjct: 41 QGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 236 ELRHANIVTLHDIIHTEKCLTLVFEYLEK--------DLKRYMDDCSNILSMNNVKLFLF 287
++++ +T II + +++EY+E + + + + +K +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158
Query: 288 QLLRGLAYCHSRR-ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWY 346
+L +Y H+ + I HRD+KP N+L+++ G +KL+DFG ++ + K T +
Sbjct: 159 SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGE--SEYMVDKKIKGSRGTYEF 216
Query: 347 RPPDVLLGSTEYS-TSID---MGVGCIFHEMSSGRPLFPGSTIEDEL-RLICSILGPPPD 401
PP+ + Y+ +D +G+ + M F EL I
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGI--CLYVMFYNVVPFSLKISLVELFNNI--------- 265
Query: 402 ELKSKLEF---CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
+E+ +YP +K + + ++ +D ++ FL + +RI++ +A++H
Sbjct: 266 -RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324
Query: 459 YFN 461
+
Sbjct: 325 WLA 327
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 17/101 (16%), Positives = 39/101 (38%), Gaps = 18/101 (17%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK---LEHEEGAPCTAI-------- 137
I Y + L QG + + + + ALK+ + LE + +
Sbjct: 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86
Query: 138 -----REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 173
E+ ++ ++++ +T II + +++EY+E
Sbjct: 87 YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEN 127
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-39
Identities = 69/299 (23%), Positives = 123/299 (41%), Gaps = 69/299 (23%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI-------KLEHEEGAPCTAIREVSLLRELR-HANIV 243
+G + V + R T + A+K + E E RE +LR++ H +I+
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 244 TLHDIIHTEKCLTLVFE----------------YLEKDLKRYMDDCSNILSMNNVKLFLF 287
TL D + + LVF+ EK+ + M
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIM----------------R 207
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYR 347
LL +++ H+ I+HRDLKP+N+L+++ +++L+DFG + P + T Y
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELCGTPGYL 266
Query: 348 PPDVLLGSTE-----YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401
P++L S + Y +D+ G I + +G P F LR+I
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--------- 317
Query: 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
++ + +F +P + S S DL+ + L D + R++A A++HP+F
Sbjct: 318 -MEGQYQF-SSPEWDDRS-----------STVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 30/175 (17%), Positives = 56/175 (32%), Gaps = 13/175 (7%)
Query: 9 ENPKIGSEEE--LEEVQDNLSKPVEVVKVRQRPKRSSEDINKRLSLPADLHLPESFLAKT 66
+ K E E++ + E + R R + L A
Sbjct: 11 VDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTE 70
Query: 67 NIIDAPLTRSSRRQSLSEIGFGRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI- 124
N+ + + + +G+G + V + R T + A+K +
Sbjct: 71 NLYFQSMGPEDELPDWAAAK--EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIME 128
Query: 125 ------KLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLE 172
E E RE +LR++ H +I+TL D + + LVF+ +
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 66/289 (22%), Positives = 110/289 (38%), Gaps = 59/289 (20%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIH 250
+G+++ K + ++ A+K I E +E++ L+ H NIV LH++ H
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVKIISKRMEANT----QKEITALKLCEGHPNIVKLHEVFH 76
Query: 251 TEKCLTLVFEYL----------------EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLA 294
+ LV E L E + M +L+ ++
Sbjct: 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM----------------RKLVSAVS 120
Query: 295 YCHSRRILHRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDV 351
+ H ++HRDLKP+NLL N+ E+K+ DFG AR K + TL Y P++
Sbjct: 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPEL 180
Query: 352 LLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE-LKSKLEF 409
L Y S D+ +G I + M SG+ F I+ + K F
Sbjct: 181 LNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM----KKIKKGDFSF 235
Query: 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
+ + S +A DL+Q L D +R+ + +
Sbjct: 236 -EGEAWKNVS-----------QEAKDLIQGLLTVDPNKRLKMSGLRYNE 272
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 22/83 (26%), Positives = 38/83 (45%), Gaps = 5/83 (6%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HA 149
+ K LG+G+++ K + ++ A+K I E +E++ L+ H
Sbjct: 11 DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT----QKEITALKLCEGHP 66
Query: 150 NIVTLHDIIHTEKCLTLVFEYLE 172
NIV LH++ H + LV E L
Sbjct: 67 NIVKLHEVFHDQLHTFLVMELLN 89
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 74/294 (25%), Positives = 111/294 (37%), Gaps = 56/294 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI----REVSLLRELRHANIVT 244
G V R T VA+K I K E+ +L++L H I+
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 245 LHDIIHTEKCLTLVFEYLE--------KDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAY 295
+ + E +V E +E KR C +Q+L + Y
Sbjct: 80 IKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF---------YQMLLAVQY 129
Query: 296 CHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL 352
H I+HRDLKP+N+L++ + E +K+ DFG ++ T T Y P+VL
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLCGTPTYLAPEVL 188
Query: 353 LGSTE--YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDEL-RLICSILGPPPDELKSKLE 408
+ Y+ ++D +G I SG P F + L I K
Sbjct: 189 VSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----------TSGKYN 238
Query: 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462
F I V+ S+ ALDLV+K L+ D K R + A+RHP+
Sbjct: 239 F-IPEVWAEVSE-----------KALDLVKKLLVVDPKARFTTEEALRHPWLQD 280
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 9/91 (9%)
Query: 90 IESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI----REVS 141
+ + + K LG G V R T VA+K I K E+
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 142 LLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172
+L++L H I+ + + E +V E +E
Sbjct: 68 ILKKLNHPCIIKIKNFFDAED-YYIVLELME 97
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-38
Identities = 62/314 (19%), Positives = 127/314 (40%), Gaps = 23/314 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V + + T VA+K+ + E E+ ++++L H N+V+ ++
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDG 83
Query: 252 EKCLT------LVFEYLEK-DLKRYMDDCSNILSMN--NVKLFLFQLLRGLAYCHSRRIL 302
+ L L EY E DL++Y++ N + ++ L + L Y H RI+
Sbjct: 84 LQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRII 143
Query: 303 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
HRDLKP+N+++ +R K+ D G A+ + + + V TL Y P++L +Y+
Sbjct: 144 HRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFVGTLQYLAPELLEQ-KKYT 201
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLI--CSILGPPPDELKSKLEFCITPVYP 416
++D G + E +G F + + + V P
Sbjct: 202 VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLP 261
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSI 476
+ + L + +++ +Q LM+ +QR + F +L + + +
Sbjct: 262 TPNHLSGILAGKLE----RWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLS--V 315
Query: 477 FSLPHIKLTSNPTD 490
++ ++ + P
Sbjct: 316 MNMVSGRVHTYPVT 329
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 3e-12
Identities = 23/108 (21%), Positives = 47/108 (43%), Gaps = 7/108 (6%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 148
+ ++LG G + V + + T VA+K+ + E E+ ++++L H
Sbjct: 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH 71
Query: 149 ANIVTLHDIIHTEKCLT------LVFEYLEK-DLKRYMDDCSNILSMN 189
N+V+ ++ + L L EY E DL++Y++ N +
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 47/280 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G++ V + K + T A+K+++LE + E+ L IV L+ +
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVRE 121
Query: 252 EKCLTLVFEYLE-----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ + E LE + +K+ L + +L Q L GL Y H+RRILH D+
Sbjct: 122 GPWVNIFMELLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 307 KPQNLLINERG-ELKLADFG----LARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYST 360
K N+L++ G L DFG L + + + T + P+V++G
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK-PCDA 235
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
+D+ C+ M +G P + L I SE
Sbjct: 236 KVDIWSSCCMMLHMLNGCH--PWTQYF-RGPLC----------------LKI----ASEP 272
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P +Q+ L + R SA R
Sbjct: 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 17/83 (20%), Positives = 35/83 (42%), Gaps = 6/83 (7%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
+ ++G+G++ V + K + T A+K+++LE + E+ L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSP 110
Query: 150 NIVTLHDIIHTEKCLTLVFEYLE 172
IV L+ + + + E LE
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLE 133
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 71/308 (23%), Positives = 116/308 (37%), Gaps = 58/308 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELR-HANIVTLHD 247
+G +A V + +T A+K I REV +L + + H N++ L +
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRS----RVFREVEMLYQCQGHRNVLELIE 78
Query: 248 IIHTEKCLTLVFEYLE--------KDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHS 298
E LVFE + + + + S ++ + L + H+
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---------DVASALDFLHN 129
Query: 299 RRILHRDLKPQNLLINERGE---LKLADFGLAR-------AKSVPTKTFSNEVVTLWYRP 348
+ I HRDLKP+N+L + +K+ DF L + T + Y
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 349 PDVLLGSTE----YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403
P+V+ +E Y D+ +G I + + SG P F G D + L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249
Query: 404 -----KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
+ K EF + S A DL+ K L+ DAKQR+SAA ++HP
Sbjct: 250 FESIQEGKYEFP-DKDWAHIS-----------CAAKDLISKLLVRDAKQRLSAAQVLQHP 297
Query: 459 YFNSLGPQ 466
+ P+
Sbjct: 298 WVQGCAPE 305
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 25/91 (27%), Positives = 40/91 (43%), Gaps = 10/91 (10%)
Query: 88 GRIESYFKLDK--LGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSL 142
GR E ++L + LG+G +A V + +T A+K I REV +
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS----RVFREVEM 63
Query: 143 LRELR-HANIVTLHDIIHTEKCLTLVFEYLE 172
L + + H N++ L + E LVFE +
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-37
Identities = 57/301 (18%), Positives = 100/301 (33%), Gaps = 58/301 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC-TAIREVSLLREL-RHANIVTLHDII 249
G + +VFK RL + A+K K A+REV L +H+++V
Sbjct: 21 SGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW 80
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNI---LSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
+ + + EY L + + I +K L Q+ RGL Y HS ++H D
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMD 140
Query: 306 LKPQNLLINERGEL-------------------KLADFGLARAKSVPTKTFSNEVVTLWY 346
+KP N+ I+ K+ D G S P + +
Sbjct: 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-QVE---EGDSRF 196
Query: 347 RPPDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405
+VL + + D+ + + PL D+ I G P
Sbjct: 197 LANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHEIRQ--GRLPR---- 247
Query: 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
P+ + + +L++ + D ++R SA ++H S
Sbjct: 248 -------------------IPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASR 288
Query: 466 Q 466
+
Sbjct: 289 K 289
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 40/323 (12%), Positives = 94/323 (29%), Gaps = 80/323 (24%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-----IREVSLLRELRHANIVTLH 246
+ + + T + + + + LLR +++ +H
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 247 DIIHTEKCLT------------------------LVFEYLEKDLKRYMDDCSNILSMN-- 280
L ++ ++ +L+ + + + S +
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 281 ---NVKLFLF-QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 336
+ +L L Q++R LA H ++H L+P ++++++RG + L F V
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL----VRDGA 258
Query: 337 FSNEVVTLWYRPPDVL----------LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTI 385
V+ + PP++ T + S D +G + + +
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
Query: 386 EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445
I + + + L++ FL Y
Sbjct: 319 LGGSEWIFR------------------------------SCKNIPQPVRALLEGFLRYPK 348
Query: 446 KQRISAANAMRHPYFNSLGPQVH 468
+ R+ AM P + L ++
Sbjct: 349 EDRLLPLQAMETPEYEQLRTELS 371
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 38/321 (11%), Positives = 88/321 (27%), Gaps = 79/321 (24%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-----IREVSLLRELRHANIVTLH 246
+ + + T + + + + LLR +++ +H
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 247 DIIHTEKCLT------------------------LVFEYLEKDLKRYMDDCSNILSMNN- 281
L ++ ++ +L+ + + + S +
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 282 ----VKLFLF-QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 336
+L L Q++R LA H ++H L+P ++++++RG + L F +
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS 267
Query: 337 FSNEVVTLWYRPPDVL---------LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIE 386
PP+ T + + D +G + +
Sbjct: 268 PIGRGFA----PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 387 DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAK 446
I P ++ L++ FL Y +
Sbjct: 324 GGSEWIFRSCKNIPQPVR------------------------------ALLEGFLRYPKE 353
Query: 447 QRISAANAMRHPYFNSLGPQV 467
R+ AM P + L ++
Sbjct: 354 DRLLPLQAMETPEYEQLRTEL 374
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 40/279 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIH 250
KGTY V+ G+ +A+KEI + + E++L + L+H NIV
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 251 TEKCLTLVFEYLEKD-LKRYMDDCSNILSMNN--VKLFLFQLLRGLAYCHSRRILHRDLK 307
+ + E + L + L N + + Q+L GL Y H +I+HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 308 PQNLLINER-GELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTE-YSTSIDM 364
N+LIN G LK++DFG ++ + + TL Y P+++ Y + D+
Sbjct: 150 GDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADI 208
Query: 365 -GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL---GPPPDELKSKLEFCITPVYPSESK 420
+GC EM++G+P P + + + + P
Sbjct: 209 WSLGCTIIEMATGKP--PFYELGEPQAAMFKVGMFKVHPE-------------------- 246
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
PE M ++A + K D +R A + + +
Sbjct: 247 ----IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 19/79 (24%), Positives = 33/79 (41%), Gaps = 3/79 (3%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVT 153
LG+GTY V+ G+ +A+KEI + + E++L + L+H NIV
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS--QPLHEEIALHKHLKHKNIVQ 83
Query: 154 LHDIIHTEKCLTLVFEYLE 172
+ + E +
Sbjct: 84 YLGSFSENGFIKIFMEQVP 102
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 65/287 (22%), Positives = 108/287 (37%), Gaps = 56/287 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLL-RELRHANIVTLHDI-- 248
G V + R T ALK + + A +EV + +IV + D+
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDSPK------ARQEVDHHWQASGGPHIVCILDVYE 92
Query: 249 --IHTEKCLTLVFEYL----------EKDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAY 295
H ++CL ++ E + E+ + + + + I+ + + +
Sbjct: 93 NMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR---------DIGTAIQF 143
Query: 296 CHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL 352
HS I HRD+KP+NLL + + LKL DFG AK T +Y P+VL
Sbjct: 144 LHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF--AKETTQNALQTPCYTPYYVAPEVL 201
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCI 411
+Y S DM +G I + + G P F +T + + + + F
Sbjct: 202 GP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI------RLGQYGF-P 253
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
P + S DA L++ L D +R++ M HP
Sbjct: 254 NPEWSEVS-----------EDAKQLIRLLLKTDPTERLTITQFMNHP 289
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 13/92 (14%)
Query: 88 GRIESYFKLDK--LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLL-R 144
+ ++L K LG G V + R T ALK + + A +EV +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK------ARQEVDHHWQ 77
Query: 145 ELRHANIVTLHDI----IHTEKCLTLVFEYLE 172
+IV + D+ H ++CL ++ E +E
Sbjct: 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECME 109
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-35
Identities = 65/285 (22%), Positives = 115/285 (40%), Gaps = 46/285 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G+Y V + T A+K + KL +E+ LLR LRH N++ L D+
Sbjct: 15 EGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDV 74
Query: 249 IH--TEKCLTLVFEYLEKDLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
++ ++ + +V EY ++ +D + + QL+ GL Y HS+ I+H+D
Sbjct: 75 LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKD 134
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLW-----YRPPDVLLGSTEYS- 359
+KP NLL+ G LK++ G+A +++ ++PP++ G +S
Sbjct: 135 IKPGNLLLTTGGTLKISALGVA---EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSG 191
Query: 360 TSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYP 416
+D GV + +++G F G I I K + I
Sbjct: 192 FKVDIWSAGV--TLYNITTGLYPFEGDNIYKLFENIG------------KGSYAI----- 232
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
P DL++ L Y+ +R S +H +F
Sbjct: 233 ---------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 5/87 (5%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRE 145
I Y D LG+G+Y V + T A+K + KL +E+ LLR
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 146 LRHANIVTLHDIIH--TEKCLTLVFEY 170
LRH N++ L D+++ ++ + +V EY
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEY 89
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 66/304 (21%), Positives = 118/304 (38%), Gaps = 53/304 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTA--IREVSLLRELRHA--NIVT 244
G + +V+ G + VA+K + ++ P EV LL+++ ++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 245 LHDIIHTEKCLTLVFEYLE--KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
L D L+ E E +DL ++ + L + F +Q+L + +CH+ +L
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEAVRHCHNCGVL 171
Query: 303 HRDLKPQNLLIN-ERGELKLADFGL-ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
HRD+K +N+LI+ RGELKL DFG A K F T Y PP+ + +
Sbjct: 172 HRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDG---TRVYSPPEWIRYHRYHGR 228
Query: 361 SID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417
S +G+ + ++M G F E + + ++ ++ F
Sbjct: 229 SAAVWSLGI--LLYDMVCGDIPF-----EHDEEI-----------IRGQVFF-------- 262
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS-LGPQVHELSDTQSI 476
+++ S+ L++ L R + HP+ L PQ S+
Sbjct: 263 --------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSL 314
Query: 477 FSLP 480
P
Sbjct: 315 SPGP 318
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 20/127 (15%), Positives = 42/127 (33%), Gaps = 7/127 (5%)
Query: 51 SLPADLHLPESFLAKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKG 110
S H + + + + + + + + Y LG G + +V+ G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 111 KSRLTDNLVALKEI---KLEHEEGAPCTA--IREVSLLRELRHA--NIVTLHDIIHTEKC 163
+ VA+K + ++ P EV LL+++ ++ L D
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122
Query: 164 LTLVFEY 170
L+ E
Sbjct: 123 FVLILER 129
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 6e-34
Identities = 64/285 (22%), Positives = 123/285 (43%), Gaps = 50/285 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR-EVSLLRELRHANIVTLH---- 246
+G++ TV+KG T VA E++ + + E +L+ L+H NIV +
Sbjct: 36 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 95
Query: 247 DIIHTEKCLTLVFEY-----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR- 300
+ +KC+ LV E L+ LKR+ ++ + ++ + Q+L+GL + H+R
Sbjct: 96 STVKGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 301 -ILHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTE 357
I+HRDLK N+ I G +K+ D GLA K +F+ V+ T + P++ +
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM--YEEK 205
Query: 358 YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVY 415
Y S+D+ G EM++ P S ++ ++ + G P
Sbjct: 206 YDESVDVYAFGMCMLEMATSEY--PYSECQNAAQIYRRVTSGVKPASF------------ 251
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ + ++++ + + +R S + + H +F
Sbjct: 252 ----------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-34
Identities = 74/320 (23%), Positives = 118/320 (36%), Gaps = 64/320 (20%)
Query: 192 KGTYATVFKGKSRLTDNLVALK-----EIKLEHEEGAPCTAIREVSLLRELR----HANI 242
KG + TVF G VA+K + T EV+LL ++ H +
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 243 VTLHDIIHTEKCLTLVFEYLEK--DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
+ L D T++ LV E DL Y+ + L + F Q++ + +CHSR
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGPSRCFFGQVVAAIQHCHSRG 159
Query: 301 ILHRDLKPQNLLIN-ERGELKLADFGL-ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY 358
++HRD+K +N+LI+ RG KL DFG A P F T Y PP+ + +
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDG---TRVYSPPEWISRHQYH 216
Query: 359 STSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
+ +G+ + ++M G F E + + L+++L F
Sbjct: 217 ALPATVWSLGI--LLYDMVCGDIPF-----ERDQEI-----------LEAELHF------ 252
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQS 475
P + D L+++ L R S + P+ + V
Sbjct: 253 ----------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDV-------- 294
Query: 476 IFSLPHIKLTSNPTDGGLLP 495
L K P LLP
Sbjct: 295 --PLNPSKGGPAPLAWSLLP 312
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 23/94 (24%), Positives = 34/94 (36%), Gaps = 9/94 (9%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALK-----EIKLEHEEGAPCTAIREVSLL 143
Y LG+G + TVF G VA+K + T EV+LL
Sbjct: 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALL 88
Query: 144 RELR----HANIVTLHDIIHTEKCLTLVFEYLEK 173
++ H ++ L D T++ LV E
Sbjct: 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLP 122
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 57/288 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDI-- 248
G V + ++ T ALK ++ + REV L + +IV + D+
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVRIVDVYE 125
Query: 249 --IHTEKCLTLVFEYL----------EKDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAY 295
KCL +V E L ++ + + + S I+ + + Y
Sbjct: 126 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------KSIGEAIQY 176
Query: 296 CHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL 352
HS I HRD+KP+NLL + LKL DFG A+ + + + T +Y P+V
Sbjct: 177 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEV- 234
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIED-ELRLICSILGPPPDELKSKLEFC 410
LG +Y S DM +G I + + G P F + + I + EF
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------RMGQYEF- 286
Query: 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
P + S+ + L++ L + QR++ M HP
Sbjct: 287 PNPEWSEVSE-----------EVKMLIRNLLKTEPTQRMTITEFMNHP 323
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 26/116 (22%), Positives = 43/116 (37%), Gaps = 13/116 (11%)
Query: 64 AKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDK--LGQGTYATVFKGKSRLTDNLVAL 121
A+ +S +I I +K+ LG G V + ++ T AL
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 122 KEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDI----IHTEKCLTLVFEYLE 172
K ++ + REV L + +IV + D+ KCL +V E L+
Sbjct: 93 KMLQDCPKAR------REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-33
Identities = 70/277 (25%), Positives = 120/277 (43%), Gaps = 39/277 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG +A V + LT VA+K I +L REV +++ L H NIV L ++
Sbjct: 25 KGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF--REVRIMKILNHPNIVKLFEV 82
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
I TEK L L+ EY ++ Y+ + + Q++ + YCH +RI+HRDLK
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID---M 364
+NLL++ +K+ADFG + + Y P++ G +D +
Sbjct: 142 AENLLLDADMNIKIADFGFS-NEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSL 200
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
GV I + + SG F G ++ EL+ ++ +
Sbjct: 201 GV--ILYTLVSGSLPFDGQNLK---------------ELRERVLRGKYRI---------- 233
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
P M +D +L+++FL+ + +R + M+ + N
Sbjct: 234 -PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN 269
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 5/85 (5%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAIREVSLLRE 145
I +Y L +G+G +A V + LT VA+K I +L REV +++
Sbjct: 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF--REVRIMKI 70
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEY 170
L H NIV L ++I TEK L L+ EY
Sbjct: 71 LNHPNIVKLFEVIETEKTLYLIMEY 95
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 73/304 (24%), Positives = 124/304 (40%), Gaps = 63/304 (20%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI-------------------- 228
KG+Y V + + A+K + KL + G P
Sbjct: 23 KGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQ 82
Query: 229 --REVSLLRELRHANIVTLHDIIH--TEKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNV 282
+E+++L++L H N+V L +++ E L +VFE + + + M+ + LS +
Sbjct: 83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQA 139
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV 342
+ + L++G+ Y H ++I+HRD+KP NLL+ E G +K+ADFG++ SN V
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 343 TLWYRPPDVLLGST-EYS-TSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397
T + P+ L + +S ++D MGV + G+ F I I
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGV--TLYCFVFGQCPFMDERIMCLHSKI----- 252
Query: 398 PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
LEF P P + D DL+ + L + + RI H
Sbjct: 253 -----KSQALEF---PDQPDIA-----------EDLKDLITRMLDKNPESRIVVPEIKLH 293
Query: 458 PYFN 461
P+
Sbjct: 294 PWVT 297
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 24/112 (21%), Positives = 48/112 (42%), Gaps = 27/112 (24%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEI---KLEHEEGAPCTAI-------- 137
++ Y D++G+G+Y V + + A+K + KL + G P
Sbjct: 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 138 --------------REVSLLRELRHANIVTLHDIIH--TEKCLTLVFEYLEK 173
+E+++L++L H N+V L +++ E L +VFE + +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-33
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA------IREVSLLRELRHANIVTL 245
KG + V KG+ ++VA+K + L EG REV ++ L H NIV L
Sbjct: 29 KGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL 88
Query: 246 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR--IL 302
+ ++H + V E++ DL + D ++ + + + + G+ Y ++ I+
Sbjct: 89 YGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIV 146
Query: 303 HRDLKPQNLLINERGE-----LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE 357
HRDL+ N+ + E K+ADFGL++ + S + + P+ + E
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS---VHSVSGLLGNFQWMAPETIGAEEE 203
Query: 358 -YSTSIDMGV---GCIFHEMSSGRPLFPG 382
Y+ D I + + +G F
Sbjct: 204 SYTEKAD--TYSFAMILYTILTGEGPFDE 230
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 26/99 (26%), Positives = 47/99 (47%), Gaps = 9/99 (9%)
Query: 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA------IREVSLLRELRHAN 150
++G+G + V KG+ ++VA+K + L EG REV ++ L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSM 188
IV L+ ++H +V E++ DL + D ++ +
Sbjct: 85 IVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKW 121
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 54/287 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G Y V +R+T+ VA+K + ++ P +E+ + + L H N+V +
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 252 EKCLTLV---------FEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
L F+ +E D+ + + + F QL+ G+ Y H I
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLW-----YRPPDVLLGSTE 357
HRD+KP+NLL++ER LK++DFGLA +V ++ Y P++L
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLA---TVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 358 YSTSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
++ +D G+ + M +G + D+ C + + + P
Sbjct: 185 HAEPVDVWSCGI--VLTAMLAGELPW------DQPSDSCQEY-----SDWKEKKTYLNP- 230
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
+++DS L L+ K L+ + RI+ + + ++N
Sbjct: 231 -----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 9e-12
Identities = 20/81 (24%), Positives = 37/81 (45%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
+E + + LG+G Y V +R+T+ VA+K + ++ P +E+ + + L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 150 NIVTLHDIIHTEKCLTLVFEY 170
N+V + L EY
Sbjct: 66 NVVKFYGHRREGNIQYLFLEY 86
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 66/279 (23%), Positives = 108/279 (38%), Gaps = 42/279 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-------EEGAPCTAIREVSLLRELRHANIVT 244
G + V+ + + V +K IK E E+ E+++L + HANI+
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 245 LHDIIHTEKCLTLVFEYLEK--DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
+ DI + LV E DL ++D L QL+ + Y + I+
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRLKDII 152
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
HRD+K +N++I E +KL DFG A A K F T+ Y P+VL+G+ +
Sbjct: 153 HRDIKDENIVIAEDFTIKLIDFGSA-AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPEL 211
Query: 363 DMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
+M S G L+ L+ P EL+ +E I P
Sbjct: 212 EM--------WSLGVTLYT---------LVFEEN--PFCELEETVEAAIHP--------- 243
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
P + + + LV L ++R + + P+
Sbjct: 244 ---PYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVT 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 23/104 (22%), Positives = 42/104 (40%), Gaps = 7/104 (6%)
Query: 74 TRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH----- 128
++ + L+ + Y + LG G + V+ + + V +K IK E
Sbjct: 7 PKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC 66
Query: 129 --EEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170
E+ E+++L + HANI+ + DI + LV E
Sbjct: 67 WIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-32
Identities = 64/295 (21%), Positives = 116/295 (39%), Gaps = 57/295 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIH 250
+G +A V++ + + ALK + EE I+EV +++L H NIV
Sbjct: 38 EGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNIVQFCSAAS 96
Query: 251 TEKCLT--------LVFEYLEKDLKRYMDDCS--NILSMNNVKLFLFQLLRGLAYCHSRR 300
K + L+ E + L ++ LS + V +Q R + + H ++
Sbjct: 97 IGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK 156
Query: 301 --ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSN------------EVVTLWY 346
I+HRDLK +NLL++ +G +KL DFG A S + T Y
Sbjct: 157 PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMY 216
Query: 347 RPPDV--LLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403
R P++ L + D+ +GCI + + + F ED +L I+
Sbjct: 217 RTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-----EDGAKL--RIV------- 262
Query: 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
++ I P + ++ + L++ L + ++R+S A +
Sbjct: 263 --NGKYSI-PPHDTQY-----------TVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 4/82 (4%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANI 151
L +G +A V++ + + ALK + EE I+EV +++L H NI
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHPNI 88
Query: 152 VTLHD--IIHTEKCLTLVFEYL 171
V I E+ T E+L
Sbjct: 89 VQFCSAASIGKEESDTGQAEFL 110
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 52/282 (18%), Positives = 108/282 (38%), Gaps = 37/282 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRELRHANIVTLHDIIH 250
+G Y +V K + + ++A+K I+ +E + ++ ++R IV + +
Sbjct: 32 RGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91
Query: 251 TEKCLTLVFEY----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRD 305
E + E +K K +++ + ++ L + +I+HRD
Sbjct: 92 REGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRD 151
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE---YSTSI 362
+KP N+L++ G +KL DFG++ + V + + + Y P+ + S Y
Sbjct: 152 IKPSNILLDRSGNIKLCDFGIS-GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRS 210
Query: 363 D---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPSE 418
D +G+ E+++GR FP + ++ G PP
Sbjct: 211 DVWSLGITLY--ELATGR--FPYPKWNSVFDQLTQVVKGDPP------------------ 248
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+L + ++ V L D +R ++HP+
Sbjct: 249 -QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI 289
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 62/295 (21%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G+++TV + T A+K ++ H E P RE ++ L H V L+
Sbjct: 40 EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLDHPFFVKLYFT 98
Query: 249 IHTEKCLTLVFEYLE--------KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
++ L Y + + + + + C+ + + +++ L Y H +
Sbjct: 99 FQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT--------RFYTAEIVSALEYLHGKG 150
Query: 301 ILHRDLKPQNLLINERGELKLADFGLAR-----AKSVPTKTFSNEVVTLWYRPPDVLLGS 355
I+HRDLKP+N+L+NE +++ DFG A+ +K +F V T Y P++L
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF---VGTAQYVSPELLTEK 207
Query: 356 TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
S D+ +GCI +++ +G P F +E + I +K + +F
Sbjct: 208 -SACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKI-------IKLEYDF----- 251
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI------SAANAMRHPYFNSL 463
PE+ A DLV+K L+ DA +R+ HP+F S+
Sbjct: 252 -----------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 22/83 (26%), Positives = 36/83 (43%), Gaps = 5/83 (6%)
Query: 94 FKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAIREVSLLRELRHA 149
FK K LG+G+++TV + T A+K ++ H E P RE ++ L H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV-TRERDVMSRLDHP 90
Query: 150 NIVTLHDIIHTEKCLTLVFEYLE 172
V L+ ++ L Y +
Sbjct: 91 FFVKLYFTFQDDEKLYFGLSYAK 113
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 62/287 (21%), Positives = 117/287 (40%), Gaps = 54/287 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G Y V +R+T+ VA+K + ++ P +E+ + + L H N+V +
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 76
Query: 252 EKCLTLV---------FEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
L F+ +E D+ + + + F QL+ G+ Y H I
Sbjct: 77 GNIQYLFLEYCSGGELFDRIEPDIG---------MPEPDAQRFFHQLMAGVVYLHGIGIT 127
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLW-----YRPPDVLLGSTE 357
HRD+KP+NLL++ER LK++DFGLA +V ++ Y P++L
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLA---TVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 358 YSTSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
++ +D G+ + M +G + D+ C + + + P
Sbjct: 185 HAEPVDVWSCGI--VLTAMLAGELPW------DQPSDSCQEY-----SDWKEKKTYLNP- 230
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
+++DS L L+ K L+ + RI+ + + ++N
Sbjct: 231 -----------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 21/82 (25%), Positives = 38/82 (46%), Gaps = 2/82 (2%)
Query: 90 IESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 148
+E + L + LG+G Y V +R+T+ VA+K + ++ P +E+ + + L H
Sbjct: 6 VEDW-DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 149 ANIVTLHDIIHTEKCLTLVFEY 170
N+V + L EY
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEY 86
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V+K K++ T L A K I+ + EE I E+ +L H IV L +
Sbjct: 29 DGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPYIVKLLGAYYH 87
Query: 252 EKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L ++ E+ + M + L+ +++ Q+L L + HS+RI+HRDLK
Sbjct: 88 DGKLWIMIEFCPGGAVDAI---MLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLK 144
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGST----EYSTSI 362
N+L+ G+++LADFG++ AK++ T + + T ++ P+V++ T Y
Sbjct: 145 AGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKA 203
Query: 363 D---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSI-LGPPPDELKSKLEFCITPVYPSE 418
D +G+ I EM+ P P + +R++ I PP
Sbjct: 204 DIWSLGITLI--EMAQIEP--PHHELN-PMRVLLKIAKSDPP------------------ 240
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
LL P + + D ++ L + + R SAA + HP+ +S+
Sbjct: 241 ---TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 23/82 (28%), Positives = 39/82 (47%), Gaps = 1/82 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + + +LG G + V+K K++ T L A K I+ + EE I E+ +L H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE-DYIVEIEILATCDHPY 77
Query: 151 IVTLHDIIHTEKCLTLVFEYLE 172
IV L + + L ++ E+
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCP 99
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 85/360 (23%), Positives = 146/360 (40%), Gaps = 100/360 (27%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN--------IVT 244
G ++TV+ VA+K +K TA+ E+ LL+ +R+++ +V
Sbjct: 48 GHFSTVWLSWDIQGKKFVAMKVVKSAEHYTE--TALDEIRLLKSVRNSDPNDPNREMVVQ 105
Query: 245 LHDI--------IHTEKCLTLVFEYLEKDLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAY 295
L D H C+ VFE L L +++ + L + VK + Q+L+GL Y
Sbjct: 106 LLDDFKISGVNGTHI--CM--VFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDY 161
Query: 296 CHSR-RILHRDLKPQNLLIN---------------------------------------- 314
H++ RI+H D+KP+N+L++
Sbjct: 162 LHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221
Query: 315 ---------ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
E+ ++K+AD G A K F+ ++ T YR +VL+GS Y+T D+
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNAC---WVHKHFTEDIQTRQYRSLEVLIGS-GYNTPADIW 277
Query: 365 GVGCIFHEMSSGRPLFPG------STIEDELRLICSILGPPPDELKSKLEFC-------- 410
C+ E+++G LF + ED + LI +LG P +L ++
Sbjct: 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337
Query: 411 ----ITPVYPSESKLQLLAPEQMDSD----ALDLVQKFLMYDAKQRISAANAMRHPYFNS 462
IT + P L+ + + D + L ++R +AA +RHP+ NS
Sbjct: 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 196 ATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIHTEK 253
+TV+ + + + VA+K I + E REV +L H NIV++ D+ +
Sbjct: 25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD 84
Query: 254 CLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
C LV EY+E L Y++ LS++ F Q+L G+ + H RI+HRD+KPQN+L
Sbjct: 85 CYYLVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143
Query: 313 INERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTE------YSTSIDMG 365
I+ LK+ DFG+A+A S + T +N V+ T+ Y P+ G YS
Sbjct: 144 IDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYS------ 197
Query: 366 VGCIFHEMSSGRPLFPGST 384
+G + +EM G P F G T
Sbjct: 198 IGIVLYEMLVGEPPFNGET 216
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 3/89 (3%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVT 153
+DKLG G +TV+ + + + VA+K I + E REV +L H NIV+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 154 LHDIIHTEKCLTLVFEYLE-KDLKRYMDD 181
+ D+ + C LV EY+E L Y++
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIES 104
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 52/200 (26%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
G++ TV + + +D VA+K + + +REV++++ LRH NIV +
Sbjct: 47 AGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 251 TEKCLTLVFEYLEK-DLKRYM--DDCSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRD 305
L++V EYL + L R + L + + +G+ Y H+R I+HR+
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG 365
LK NLL++++ +K+ DFGL+R K+ + + T + P+VL + D
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSD-- 221
Query: 366 V---GCIFHEMSSGRPLFPG 382
V G I E+++ + +
Sbjct: 222 VYSFGVILWELATLQQPWGN 241
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 26/108 (24%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSL 142
+I + + +K+G G++ TV + + +D VA+K + + +REV++
Sbjct: 33 DIPWCDLN---IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAI 87
Query: 143 LRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMN 189
++ LRH NIV + L++V EYL + L R + ++
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLD 135
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 4e-31
Identities = 68/301 (22%), Positives = 114/301 (37%), Gaps = 47/301 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G VFK + + ++A K I LE + IRE+ +L E IV + ++
Sbjct: 43 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLF--------LFQLLRGLAYCHS-RRIL 302
+ +++ E+ MD S + +++GL Y +I+
Sbjct: 103 DGEISICMEH--------MDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154
Query: 303 HRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
HRD+KP N+L+N RGE+KL DFG++ S+ +F V T Y P+ L G+ YS
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSF---VGTRSYMSPERLQGTH-YSV 209
Query: 361 SID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417
D MG+ + EM+ GR P ++ + + E + P+
Sbjct: 210 QSDIWSMGLSLV--EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 418 ESKLQ------------------LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
+ L + D V K L+ + +R M H +
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 460 F 460
Sbjct: 328 I 328
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 20/84 (23%), Positives = 42/84 (50%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 148
+ + + K+ +LG G VFK + + ++A K I LE + IRE+ +L E
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 90
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLE 172
IV + +++ +++ E+++
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMD 114
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 60/282 (21%), Positives = 115/282 (40%), Gaps = 38/282 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ V + T + A+K + + +E+ +++ L H +V L
Sbjct: 25 KGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV-FKELQIMQGLEHPFLVNLWYS 83
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
E+ + +V + L DL RY + VKLF+ +L+ L Y ++RI+HRD+K
Sbjct: 84 FQDEEDMFMVVDLLLGGDL-RYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMK 142
Query: 308 PQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLL--GSTEYSTSID 363
P N+L++E G + + DF +A + T + T Y P++ YS ++D
Sbjct: 143 PDNILLDEHGHVHITDFNIAAMLPRETQITTMAG---TKPYMAPEMFSSRKGAGYSFAVD 199
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
+G +E+ GR + + ++ + + + +
Sbjct: 200 WWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF-------ETTVVTY------------- 239
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANA-MRHPYFNSL 463
P + + L++K L + QR S + PY N +
Sbjct: 240 ---PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-31
Identities = 72/284 (25%), Positives = 129/284 (45%), Gaps = 45/284 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+Y +V+K + T +VA+K++ +E + I+E+S++++ ++V +
Sbjct: 39 EGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFK 95
Query: 252 EKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
L +V EY D+ + + L+ + + L L+GL Y H R +HRD+K
Sbjct: 96 NTDLWIVMEYCGAGSVSDI---IRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSID--- 363
N+L+N G KLADFG+A + T N V+ T ++ P+V+ Y+ D
Sbjct: 153 AGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWS 210
Query: 364 MGVGCIFHEMSSGRPLFPGSTIE--DELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
+G+ I EM+ G+P P + I + +I + PPP
Sbjct: 211 LGITAI--EMAEGKP--PYADIHPMRAIFMIPT--NPPP--------------------- 243
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
PE + D V++ L+ +QR +A ++HP+ S
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 7e-12
Identities = 22/82 (26%), Positives = 45/82 (54%), Gaps = 3/82 (3%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + L+KLG+G+Y +V+K + T +VA+K++ +E + I+E+S++++ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPH 85
Query: 151 IVTLHDIIHTEKCLTLVFEYLE 172
+V + L +V EY
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCG 107
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 8e-31
Identities = 56/284 (19%), Positives = 114/284 (40%), Gaps = 45/284 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRELRHANIVTLHDIIH 250
+G Y V K + + ++A+K I+ + ++ +R + VT + +
Sbjct: 17 RGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76
Query: 251 TEKCLTLVFEY----LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRD 305
E + + E L+K K+ + D + + + +++ L + HS ++HRD
Sbjct: 77 REGDVWICMELMDTSLDKFYKQ-VIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRD 135
Query: 306 LKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTE---YST 360
+KP N+LIN G++K+ DFG++ V Y P+ + YS
Sbjct: 136 VKPSNVLINALGQVKMCDFGISGYLVDDVAKDID---AGCKPYMAPERINPELNQKGYSV 192
Query: 361 SID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYP 416
D +G+ I E++ R FP + + + ++ P P
Sbjct: 193 KSDIWSLGITMI--ELAILR--FPYDSWGTPFQQLKQVVEEPSPQ--------------- 233
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
L ++ ++ +D + L ++K+R + M+HP+F
Sbjct: 234 -------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-31
Identities = 61/288 (21%), Positives = 97/288 (33%), Gaps = 78/288 (27%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDI-- 248
G V + ++ T ALK ++ + REV L + +IV + D+
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQCPHIVRIVDVYE 81
Query: 249 --IHTEKCLTLVFEYL----------EKDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAY 295
KCL +V E L ++ + + + S I+ + + Y
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM---------KSIGEAIQY 132
Query: 296 CHSRRILHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL 352
HS I HRD+KP+NLL + LKL DFG A +
Sbjct: 133 LHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------------KETT 171
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPG-STIEDELRLICSILGPPPDELKSKLEFC 410
Y S DM +G I + + G P F + + I + EF
Sbjct: 172 GEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI-------RMGQYEF- 221
Query: 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
P + S + L++ L + QR++ M HP
Sbjct: 222 PNPEWSEVS-----------EEVKMLIRNLLKTEPTQRMTITEFMNHP 258
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 12/89 (13%)
Query: 90 IESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-R 147
I+ Y + LG G V + ++ T ALK ++ + REV L +
Sbjct: 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR------REVELHWRASQ 69
Query: 148 HANIVTLHDI----IHTEKCLTLVFEYLE 172
+IV + D+ KCL +V E L+
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLD 98
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 35/275 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
+G++ V T VALK I + + RE+S L+ LRH +I+ L+D+I
Sbjct: 19 EGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI 78
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
T + +V EY +L Y+ + ++ + + F Q++ + YCH +I+HRDLKP+
Sbjct: 79 TTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPE 137
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID---MGV 366
NLL+++ +K+ADFGL+ + Y P+V+ G +D G+
Sbjct: 138 NLLLDDNLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGI 196
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
+ + M GR F I + + + + + + P
Sbjct: 197 --VLYVMLVGRLPFDDEFIPNLFKKV------------NSCVYVM--------------P 228
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
+ + A L+++ ++ D QRI+ R P+FN
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 27/85 (31%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 89 RIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRE 145
I Y + + LG+G++ V T VALK I + + RE+S L+
Sbjct: 7 HIGPY-IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEY 170
LRH +I+ L+D+I T + +V EY
Sbjct: 66 LRHPHIIKLYDVITTPTDIVMVIEY 90
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 65/283 (22%), Positives = 110/283 (38%), Gaps = 41/283 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G++ V+ + +VA+K++ ++ I+EV L++LRH N +
Sbjct: 64 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 123
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E LV EY ++ L + L+GLAY HS ++HRD+K
Sbjct: 124 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 183
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE--YSTSID---M 364
N+L++E G +KL DFG A + P +F V T ++ P+V+L E Y +D +
Sbjct: 184 NILLSEPGLVKLGDFGSA-SIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSL 239
Query: 365 GVGCIFHEMSSGRPLFPGSTIE--DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
G+ CI E++ +P P + L I P
Sbjct: 240 GITCI--ELAERKP--PLFNMNAMSALYHIAQ--NESPA--------------------- 272
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
L + V L + R ++ ++H + P
Sbjct: 273 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 27/142 (19%), Positives = 51/142 (35%), Gaps = 9/142 (6%)
Query: 55 DLHLPESFLAKTNIIDAPLTRSSRRQSLSEIGFGRIES-------YFKLDKLGQGTYATV 107
D +P + P+ R SL + + + L ++G G++ V
Sbjct: 11 DYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAV 70
Query: 108 FKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIHTEKCLT 165
+ + +VA+K++ ++ I+EV L++LRH N + E
Sbjct: 71 YFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 130
Query: 166 LVFEYLEKDLKRYMDDCSNILS 187
LV EY ++ L
Sbjct: 131 LVMEYCLGSASDLLEVHKKPLQ 152
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 73/290 (25%), Positives = 126/290 (43%), Gaps = 44/290 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG++ VFKG T +VA+K I LE E +E+++L + + +
Sbjct: 32 KGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91
Query: 252 EKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L ++ EYL DL L + L ++L+GL Y HS + +HRD+K
Sbjct: 92 DTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSID--- 363
N+L++E GE+KLADFG+A + T+ N V T ++ P+V+ S Y + D
Sbjct: 147 AANVLLSEHGEVKLADFGVA-GQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWS 204
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
+G+ I E++ G P P S + ++++ I P L+
Sbjct: 205 LGITAI--ELARGEP--PHSEL-HPMKVLFLIPKNNPPTLEGNY---------------- 243
Query: 424 LAPEQMDSDAL-DLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSD 472
S L + V+ L + R +A ++H + + L++
Sbjct: 244 -------SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTE 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 24/82 (29%), Positives = 42/82 (51%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + KL+K+G+G++ VFKG T +VA+K I LE E +E+++L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 151 IVTLHDIIHTEKCLTLVFEYLE 172
+ + + L ++ EYL
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLG 103
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 67/284 (23%), Positives = 118/284 (41%), Gaps = 45/284 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G TV+ T VA++++ L+ + I E+ ++RE ++ NIV D
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDSYLV 88
Query: 252 EKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
L +V EYL D+ + + + L+ L + HS +++HRD+K
Sbjct: 89 GDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSID--- 363
N+L+ G +KL DFG A+ P ++ + +V T ++ P+V+ Y +D
Sbjct: 144 SDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWS 201
Query: 364 MGVGCIFHEMSSGRPLFPGSTIE--DELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
+G+ I EM G P P L LI + P
Sbjct: 202 LGIMAI--EMIEGEP--PYLNENPLRALYLIAT--NGTP--------------------- 234
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+L PE++ + D + + L D ++R SA ++H + P
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 24/82 (29%), Positives = 41/82 (50%), Gaps = 1/82 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ Y + +K+GQG TV+ T VA++++ L+ + I E+ ++RE ++ N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPN 78
Query: 151 IVTLHDIIHTEKCLTLVFEYLE 172
IV D L +V EYL
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLA 100
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 63/201 (31%), Positives = 90/201 (44%), Gaps = 23/201 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V K K R D VA+K+I+ E E A I E+ L + H NIV L+
Sbjct: 18 RGAFGVVCKAKWRAKD--VAIKQIESESERKA---FIVELRQLSRVNHPNIVKLYGA--C 70
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNI--LSMNNVKLFLFQLLRGLAYCHSRR---ILHRD 305
+ LV EY E L + + + + + Q +G+AY HS + ++HRD
Sbjct: 71 LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 306 LKPQNLLINERGE-LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
LKP NLL+ G LK+ DFG A +N + + P+V GS YS D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGS-NYSEKCD- 185
Query: 365 GV---GCIFHEMSSGRPLFPG 382
V G I E+ + R F
Sbjct: 186 -VFSWGIILWEVITRRKPFDE 205
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 33/110 (30%), Positives = 47/110 (42%), Gaps = 11/110 (10%)
Query: 81 SLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREV 140
SL I + IE + +G+G + V K K R D VA+K+I+ E E A I E+
Sbjct: 1 SLHMIDYKEIE---VEEVVGRGAFGVVCKAKWRAKD--VAIKQIESESERKA---FIVEL 52
Query: 141 SLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMN 189
L + H NIV L+ + LV EY E L + +
Sbjct: 53 RQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYT 100
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 64/286 (22%), Positives = 113/286 (39%), Gaps = 36/286 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G A V VA+K I LE + + ++E+ + + H NIV+ +
Sbjct: 25 SGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV 84
Query: 252 EKCLTLVFEYLE--------KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
+ L LV + L K + + S +L + + L ++L GL Y H +H
Sbjct: 85 KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 144
Query: 304 RDLKPQNLLINERGELKLADFG----LARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEY 358
RD+K N+L+ E G +++ADFG LA + V T + P+V+ Y
Sbjct: 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY 204
Query: 359 STSIDM---GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
D+ G+ I E+++G P ++++ L P L++
Sbjct: 205 DFKADIWSFGITAI--ELATGAA--PYHKY-PPMKVLMLTLQNDPPSLETG-----VQDK 254
Query: 416 PSESKLQLLAPEQMDSDAL-DLVQKFLMYDAKQRISAANAMRHPYF 460
K + ++ L D ++R +AA +RH +F
Sbjct: 255 EMLKKY---------GKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 55/286 (19%), Positives = 108/286 (37%), Gaps = 50/286 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRELRHANIVTLHDIIH 250
GT V+K + R T +++A+K+++ + + ++ +L+ IV
Sbjct: 35 SGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI 94
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLF--------LFQLLRGLAYCHSRR-I 301
T + + E M C+ L +++ L Y + +
Sbjct: 95 TNTDVFIAMEL--------MGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGV 146
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE---- 357
+HRD+KP N+L++ERG++KL DFG++ + V K Y P+ +
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGIS-GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 358 YSTSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPV 414
Y D +G+ + E+++G+ FP + + ++ +L P L + F
Sbjct: 206 YDIRADVWSLGISLV--ELATGQ--FPYKNCKTDFEVLTKVLQEEPPLLPGHMGF----- 256
Query: 415 YPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
S D V+ L D ++R + H +
Sbjct: 257 ----SG-----------DFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 65/281 (23%), Positives = 109/281 (38%), Gaps = 46/281 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
GT+ V G+ +LT + VA+K + + RE+ L+ RH +I+ L+ +I
Sbjct: 21 VGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI 80
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
T +V EY+ +L Y+ + + Q+L + YCH ++HRDLKP
Sbjct: 81 STPTDFFMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKP 139
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLW-----YRPPDVLLGSTEYSTSID 363
+N+L++ K+ADFGL+ S E + Y P+V+ G +D
Sbjct: 140 ENVLLDAHMNAKIADFGLSNMMS------DGEFLRTSCGSPNYAAPEVISGRLYAGPEVD 193
Query: 364 ---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
GV I + + G F + + I F I
Sbjct: 194 IWSCGV--ILYALLCGTLPFDDEHVPTLFKKI------------RGGVFYI--------- 230
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
PE ++ L+ L D +R + + H +F
Sbjct: 231 -----PEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 6e-10
Identities = 26/85 (30%), Positives = 41/85 (48%), Gaps = 4/85 (4%)
Query: 89 RIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRE 145
+I Y L LG GT+ V G+ +LT + VA+K + + RE+ L+
Sbjct: 9 KIGHY-VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEY 170
RH +I+ L+ +I T +V EY
Sbjct: 68 FRHPHIIKLYQVISTPTDFFMVMEY 92
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 61/284 (21%), Positives = 123/284 (43%), Gaps = 45/284 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G+ V + + + VA+K + L ++ EV ++R+ +H N+V ++
Sbjct: 55 EGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQHFNVVEMYKSYLV 113
Query: 252 EKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L ++ E+L+ D+ L+ + +L+ LAY H++ ++HRD+K
Sbjct: 114 GEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSID--- 363
++L+ G +KL+DFG A+ +V T ++ P+V+ S Y+T +D
Sbjct: 169 SDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVISRS-LYATEVDIWS 226
Query: 364 MGVGCIFHEMSSGRPLFPGSTIE--DELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
+G+ I EM G P P + ++ + PPP
Sbjct: 227 LGIMVI--EMVDGEP--PYFSDSPVQAMKRLRD--SPPP--------------------- 259
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+L ++ D +++ L+ D ++R +A + HP+ G
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 17/82 (20%), Positives = 39/82 (47%), Gaps = 1/82 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
K+G+G+ V + + + VA+K + L ++ EV ++R+ +H N
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQHFN 103
Query: 151 IVTLHDIIHTEKCLTLVFEYLE 172
+V ++ + L ++ E+L+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQ 125
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 56/200 (28%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
G++ TV+KGK VA+K + + A EV +LR+ RH NI+
Sbjct: 34 SGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89
Query: 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
T L +V ++ E L ++ M + Q RG+ Y H++ I+HRDLK
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSN 149
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYR--PPDVLLG--STEYSTSIDMG 365
N+ ++E +K+ DFGLA KS + + E ++ P+V+ S YS D
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD-- 207
Query: 366 V---GCIFHEMSSGRPLFPG 382
V G + +E+ +G+ +
Sbjct: 208 VYAFGIVLYELMTGQLPYSN 227
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 25/98 (25%), Positives = 42/98 (42%), Gaps = 6/98 (6%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTL 154
++G G++ TV+KGK VA+K + + A EV +LR+ RH NI+
Sbjct: 29 GQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 155 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNV 191
T L +V ++ E L ++ M +
Sbjct: 86 MGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKL 122
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 46/297 (15%), Positives = 98/297 (32%), Gaps = 39/297 (13%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G +A V++ ++ LK K + + + L+ + +
Sbjct: 75 EGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF-YIGTQLMERLKPSMQHMFMKFY 133
Query: 247 DIIHTEKCLTLVFEYLEKD-----LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
+ LV E + Y + ++ V F ++L + H I
Sbjct: 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEI 193
Query: 302 LHRDLKPQNLLINER-----------GELKLADFGLARAKSV--PTKTFSNEVVTLWYRP 348
+H D+KP N ++ L L D G + + F+ + T ++
Sbjct: 194 IHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQC 253
Query: 349 PDVLLGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407
++L ++ ID GV + M G + + E + P ++ ++
Sbjct: 254 VEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNE-GGECKPEGLFRRLPHLDMWNEF 311
Query: 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA-NAMRHPYFNSL 463
+ L P+ +LDL+++ L +Q + A+R+ L
Sbjct: 312 -----------FHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLL 357
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 61/355 (17%), Positives = 113/355 (31%), Gaps = 47/355 (13%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIHT 251
TV + + T V ++ I LE T + E+ + + H NIV
Sbjct: 38 EDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97
Query: 252 EKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L +V ++ KDL + ++ + L +L+ L Y H +HR +K
Sbjct: 98 DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVK 155
Query: 308 PQNLLINERGELKLADFGLA--------RAKSVPTKTFSNEVVTLWYRPPDVLL-GSTEY 358
++LI+ G++ L+ R + V + V L + P+VL Y
Sbjct: 156 ASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS-VKVLPWLSPEVLQQNLQGY 214
Query: 359 STSIDM---GVGCIFHEMSSGRP----------LF----------PGSTIEDELRLICSI 395
D+ G+ E+++G L ++ L S
Sbjct: 215 DAKSDIYSVGITAC--ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSP 272
Query: 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455
+ S TP + V++ L + R SA+ +
Sbjct: 273 SRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332
Query: 456 RHPYFNSLGPQVHE-----LSDTQSIFSLPHIKLTSNPTDGGLLPFYGQKSEKRW 505
H +F + + E L I + + + GL+ + W
Sbjct: 333 NHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEELEVDDW 387
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 3/85 (3%)
Query: 91 ESYFKLDKLGQG--TYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELR 147
Y L +G+G TV + + T V ++ I LE T + E+ + +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLE 172
H NIV + L +V ++
Sbjct: 85 HPNIVPYRATFIADNELWVVTSFMA 109
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 17/200 (8%)
Query: 196 ATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIHTEK 253
V++ + + + +VALK + RE L+ ++V +HD +
Sbjct: 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107
Query: 254 CLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
L + + DL + L+ + Q+ L H+ HRD+KP+N+L
Sbjct: 108 QLYVDMRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166
Query: 313 INERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTE------YSTSIDMG 365
++ L DFG+A A + T V TL+Y P+ S Y+
Sbjct: 167 VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYA------ 220
Query: 366 VGCIFHEMSSGRPLFPGSTI 385
+ C+ +E +G P + G +
Sbjct: 221 LTCVLYECLTGSPPYQGDQL 240
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 6/119 (5%)
Query: 66 TNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK 125
+ ++ +S FG Y +G+G V++ + + + +VALK +
Sbjct: 12 SGLVPRGSHMDGTAESREGTQFGP---YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS 68
Query: 126 LEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDD 181
RE L+ ++V +HD + L + + DL +
Sbjct: 69 ETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR 127
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 2/138 (1%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG + K R T ++ +KE+ EE T ++EV ++R L H N++ +++
Sbjct: 20 KGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+K L + EY++ L+ + + + F + G+AY HS I+HRDL N
Sbjct: 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138
Query: 311 LLINERGELKLADFGLAR 328
L+ E + +ADFGLAR
Sbjct: 139 CLVRENKNVVVADFGLAR 156
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 22/92 (23%), Positives = 44/92 (47%), Gaps = 2/92 (2%)
Query: 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 157
LG+G + K R T ++ +KE+ EE T ++EV ++R L H N++ +
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE-TQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 158 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSM 188
++ +K L + EY++ L+ + +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW 107
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA---IREVSLLRELRHANIVTLHDI 248
G + V++ + VA+K + + +E T +E L L+H NI+ L +
Sbjct: 17 IGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR---ILHR 304
E L LV E+ L R + + + + + Q+ RG+ Y H I+HR
Sbjct: 75 CLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 305 DLKPQNLLINERGE--------LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST 356
DLK N+LI ++ E LK+ DFGLAR TK + + P+V+ S
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM--SAAGAYAWMAPEVIRASM 190
Query: 357 EYSTSIDM---GVGCIFHEMSSGRPLFPG 382
+S D+ GV + E+ +G F G
Sbjct: 191 -FSKGSDVWSYGV--LLWELLTGEVPFRG 216
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 23/102 (22%), Positives = 40/102 (39%), Gaps = 14/102 (13%)
Query: 82 LSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA---IR 138
+E+ +G G + V++ + VA+K + + +E T +
Sbjct: 6 FAELTLEE--------IIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQ 55
Query: 139 EVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179
E L L+H NI+ L + E L LV E+ L R +
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 97
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 54/243 (22%), Positives = 98/243 (40%), Gaps = 30/243 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
KG + V+ G+ VA++ I +E + A REV R+ RH N+V
Sbjct: 43 KGRFGQVYHGRWH---GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM 99
Query: 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ L ++ + L + D +L +N + ++++G+ Y H++ ILH+DLK +
Sbjct: 100 SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSK 159
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTL---WYR----------PPDVLLGST 356
N+ + G++ + DFGL V + + + W PD
Sbjct: 160 NVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKL 218
Query: 357 EYSTSIDMGV---GCIFHEMSSGRPLFPGSTIEDELRLICSILGPP------PDELKSKL 407
+S D V G I++E+ + F E + + + + P E+ L
Sbjct: 219 PFSKHSD--VFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDIL 276
Query: 408 EFC 410
FC
Sbjct: 277 LFC 279
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 31/135 (22%), Positives = 55/135 (40%), Gaps = 10/135 (7%)
Query: 59 PESFLAKTNIIDAPLTRSSRRQSLS--EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTD 116
PE L+ + P S L +I F ++E + +G+G + V+ G+
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLE---IGELIGKGRFGQVYHGRWH--- 55
Query: 117 NLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-D 174
VA++ I +E + A REV R+ RH N+V + L ++ +
Sbjct: 56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115
Query: 175 LKRYMDDCSNILSMN 189
L + D +L +N
Sbjct: 116 LYSVVRDAKIVLDVN 130
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 56/289 (19%)
Query: 192 KGTYATVFKGKSRLTDNLVALKE------IKLEHEEGAPCTAIREVSLLRELRHANIVTL 245
G++ V +SR A+K ++L+ E T E +L + H I+ +
Sbjct: 16 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE---HT-NDERLMLSIVTHPFIIRM 71
Query: 246 HDIIHTEKCLTLVFEYLE-----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
+ + ++ +Y+E L++ S K + ++ L Y HS+
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
I++RDLKP+N+L+++ G +K+ DFG A+ T T T Y P+V+ Y+
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG---TPDYIAPEVVSTK-PYNK 182
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
SID G + +EM +G F + ++ I L ++L F
Sbjct: 183 SIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKI-------LNAELRF---------- 222
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P + D DL+ + + D QR+ + HP+F +
Sbjct: 223 ------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 41.0 bits (97), Expect = 6e-04
Identities = 18/86 (20%), Positives = 38/86 (44%), Gaps = 11/86 (12%)
Query: 94 FKLDK-LGQGTYATVFKGKSRLTDNLVALKE------IKLEHEEGAPCTAIREVSLLREL 146
F++ + LG G++ V +SR A+K ++L+ E T E +L +
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE---HT-NDERLMLSIV 63
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLE 172
H I+ + + + ++ +Y+E
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIE 89
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-28
Identities = 64/276 (23%), Positives = 110/276 (39%), Gaps = 36/276 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
GT+ V GK LT + VA+K + + RE+ L+ RH +I+ L+ +I
Sbjct: 26 VGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI 85
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
T + +V EY+ +L Y+ L + Q+L G+ YCH ++HRDLKP
Sbjct: 86 STPSDIFMVMEYVSGGELFDYICKNGR-LDEKESRRLFQQILSGVDYCHRHMVVHRDLKP 144
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID---MG 365
+N+L++ K+ADFGL+ + + Y P+V+ G +D G
Sbjct: 145 ENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSG 203
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425
V I + + G F + + I F
Sbjct: 204 V--ILYALLCGTLPFDDDHVPTLFKKI------------CDGIFYT-------------- 235
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
P+ ++ + L++ L D +R + + H +F
Sbjct: 236 PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 28/103 (27%), Positives = 46/103 (44%), Gaps = 9/103 (8%)
Query: 71 APLTRSSRRQSLSEIGFGRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEH- 128
P+ + +IG ++ L LG GT+ V GK LT + VA+K + +
Sbjct: 1 GPMAEKQKHDGRVKIG------HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI 54
Query: 129 -EEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170
RE+ L+ RH +I+ L+ +I T + +V EY
Sbjct: 55 RSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 61/288 (21%), Positives = 118/288 (40%), Gaps = 54/288 (18%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK---------LEHEEGAPCTAIREVSLLRELRHANI 242
G++ V K + + N A+K + +EH + E +L+ + +
Sbjct: 51 TGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH-------TLNEKRILQAVNFPFL 103
Query: 243 VTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
V L L +V EY+ ++ ++ S + + + Q++ Y HS +
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
++RDLKP+NLLI+++G +++ DFG A+ T T T P+++L Y+ +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEALAPEIILSK-GYNKA 218
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
+D +G + +EM++G P F + +++ I + K+ F
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKI-------VSGKVRF----------- 257
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P SD DL++ L D +R + H +F +
Sbjct: 258 -----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 8e-28
Identities = 65/286 (22%), Positives = 115/286 (40%), Gaps = 42/286 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG + V + R T + A K+++ + +G + E +L ++ +V+L
Sbjct: 194 KGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSRFVVSLAYA 252
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
T+ L LV + DLK ++ + ++ GL H RI++RDL
Sbjct: 253 YETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDL 312
Query: 307 KPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID- 363
KP+N+L+++ G ++++D GLA + K V T+ Y P+V+ Y+ S D
Sbjct: 313 KPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGYMAPEVVKN-ERYTFSPDW 368
Query: 364 MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL-KSKLEFCITPVYPSESKLQ 422
+GC+ +EM +G+ F + +E+ + E
Sbjct: 369 WALGCLLYEMIAGQSPFQQ---RKKKIKR--------EEVERLVKEV------------P 405
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
E+ A L + L D +R+ SA HP F L
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 42/205 (20%), Positives = 79/205 (38%), Gaps = 28/205 (13%)
Query: 196 ATVFKGK-SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 254
++ + V LK + + A A+ E L E+ H +IV + + +
Sbjct: 94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153
Query: 255 LT-----LVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+V EY+ + LKR L + +L ++L L+Y HS +++ DLKP
Sbjct: 154 HGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSIGLVYNDLKP 210
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTE-----YSTSI 362
+N+++ E LKL D G + T ++ P+++ Y+
Sbjct: 211 ENIMLTEEQ-LKLIDLGAVSR-----INSFGYLYGTPGFQAPEIVRTGPTVATDIYT--- 261
Query: 363 DMGVGCIFHEMSSGRPLFPGSTIED 387
VG ++ P G ++
Sbjct: 262 ---VGRTLAALTLDLPTRNGRYVDG 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 18/93 (19%), Positives = 33/93 (35%), Gaps = 7/93 (7%)
Query: 96 LDKLGQGTYATVFKGK-SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 154
+ G ++ + V LK + + A A+ E L E+ H +IV +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 155 HDIIHTEKCLT-----LVFEYLE-KDLKRYMDD 181
+ + +V EY+ + LKR
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ 177
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 76/278 (27%), Positives = 113/278 (40%), Gaps = 36/278 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + + +LT LVA+K I E RE+ R LRH NIV ++I T
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
L ++ EY +L + C+ S + + F QLL G++YCHS +I HRDLK +
Sbjct: 88 PTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLE 145
Query: 310 NLLI--NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID---M 364
N L+ + LK+ DFG + SV + V T Y P+VLL D
Sbjct: 146 NTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC 204
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELR-LICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
GV + M G F + R I IL +++ I P +
Sbjct: 205 GV--TLYVMLVGAYPFEDPEEPRDYRKTIQRIL---------SVKYSI----PDDI---- 245
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
++ + L+ + + D RIS H +F
Sbjct: 246 ----RISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 25/82 (30%), Positives = 37/82 (45%), Gaps = 2/82 (2%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 148
+ Y + +G G + + +LT LVA+K I E RE+ R LRH
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRH 75
Query: 149 ANIVTLHDIIHTEKCLTLVFEY 170
NIV ++I T L ++ EY
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEY 97
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 66/292 (22%), Positives = 122/292 (41%), Gaps = 51/292 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G + VF + + T L A K++ + +G + E +L ++ IV+L
Sbjct: 195 RGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGA-MVEKKILAKVHSRFIVSLAYA 253
Query: 249 IHTEKCLTLVFEYLEK-DLK---RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
T+ L LV + D++ +D+ + + Q++ GL + H R I++R
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYR 313
Query: 305 DLKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
DLKP+N+L+++ G ++++D GLA A TK + T + P++LLG EY S
Sbjct: 314 DLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY---AGTPGFMAPELLLG-EEYDFS 369
Query: 362 ID-MGVGCIFHEMSSGRPLFPG---STIEDEL-RLICSILGPPPDELKSKLEFCITPVYP 416
+D +G +EM + R F EL + + L+ + +
Sbjct: 370 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV----------LEQAVTY------- 412
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P++ + D + L D ++R+ S HP F +
Sbjct: 413 ---------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 47/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KGT+ V + + T A+K ++ + +E A T + E +L+ RH + L
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA-HT-VTESRVLQNTRHPFLTALKY 72
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
T L V EY +L ++ + + + + +++ L Y HSR +++RD+
Sbjct: 73 AFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 307 KPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
K +NL++++ G +K+ DFGL + + KTF T Y P+VL +Y ++D
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCG---TPEYLAPEVLED-NDYGRAVD 187
Query: 364 -MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
G+G + +EM GR F +D RL I L ++ F
Sbjct: 188 WWGLGVVMYEMMCGRLPFYN---QDHERLFELI-------LMEEIRF------------- 224
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P + +A L+ L D KQR+ A M H +F S+
Sbjct: 225 ---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-27
Identities = 60/287 (20%), Positives = 116/287 (40%), Gaps = 44/287 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH---EEGAPCTAI-REV-SLLRELRHANIVTLH 246
+G + V+ + T + A+K + + ++G R + SL+ IV +
Sbjct: 199 RGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 258
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
HT L+ + + + DL ++ + S +++ + +++ GL + H+R +++RD
Sbjct: 259 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRD 317
Query: 306 LKPQNLLINERGELKLADFGLARAKSVP---TKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
LKP N+L++E G ++++D GL A V T Y P+VL Y +S
Sbjct: 318 LKPANILLDEHGHVRISDLGL--ACDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDSSA 372
Query: 363 D-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D +GC+ ++ G F +D+ + L +E
Sbjct: 373 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-------LTMAVEL------------ 413
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P+ + L++ L D +R+ A P+F SL
Sbjct: 414 ----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 56/208 (26%), Positives = 84/208 (40%), Gaps = 29/208 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL----HD 247
KG + V++GK R + VA+K E E+ LRH NI+ +
Sbjct: 52 KGRFGEVWRGKWRGEE--VAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADNK 107
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR------ 300
T L LV +Y E L Y+ +++ + GLA+ H
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 301 --ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF----SNEVVTLWYRPPDVLLG 354
I HRDLK +N+L+ + G +AD GLA T T ++ V T Y P+VL
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 355 ST-----EYSTSIDM-GVGCIFHEMSSG 376
S E D+ +G +F E++
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARR 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 24/89 (26%), Positives = 37/89 (41%), Gaps = 9/89 (10%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL- 154
+ +G+G + V++GK R + VA+K E E+ LRH NI+
Sbjct: 47 QESIGKGRFGEVWRGKWRGEE--VAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 102
Query: 155 ---HDIIHTEKCLTLVFEYLEK-DLKRYM 179
+ T L LV +Y E L Y+
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL 131
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 69/293 (23%), Positives = 121/293 (41%), Gaps = 50/293 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD--- 247
GTY V+KG+ T L A+K + + +E +E+++L++ H NI T +
Sbjct: 34 NGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE--EIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 248 ---IIHTEKCLTLVFEYLE----KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR 300
+ L LV E+ DL + N L + ++LRGL++ H +
Sbjct: 92 KKNPPGMDDQLWLVMEFCGAGSVTDL--IKNTKGNTLKEEWIAYICREILRGLSHLHQHK 149
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYS 359
++HRD+K QN+L+ E E+KL DFG++ A+ T N + T ++ P+V+
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVS-AQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 360 TSID-------MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412
+ D +G+ I EM+ G P P + +R + I P LK
Sbjct: 209 ATYDFKSDLWSLGITAI--EMAEGAP--PLCDM-HPMRALFLIPRNPAPRLK-------- 255
Query: 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
++ ++ L+ + QR + M+HP+
Sbjct: 256 -------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 73/287 (25%), Positives = 124/287 (43%), Gaps = 48/287 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KGT+ V K + T A+K +K + +E A T + E +L+ RH + L
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA-HT-LTENRVLQNSRHPFLTALKY 215
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR-ILHRD 305
T L V EY +L ++ + S + + + +++ L Y HS + +++RD
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 306 LKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
LK +NL++++ G +K+ DFGL + KTF T Y P+VL +Y ++
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG---TPEYLAPEVLED-NDYGRAV 330
Query: 363 D-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D G+G + +EM GR F +D +L I L ++ F
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYN---QDHEKLFELI-------LMEEIRF------------ 368
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANA-----MRHPYFNSL 463
P + +A L+ L D KQR+ + M+H +F +
Sbjct: 369 ----PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/288 (22%), Positives = 105/288 (36%), Gaps = 40/288 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G ++ V K + T + A+K + L+ E + C E +L I LH
Sbjct: 71 RGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVS-CF-REERDVLVNGDRRWITQLHF 128
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
E L LV EY DL + + + +L +++ + H +HRD+
Sbjct: 129 AFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLG------STEYS 359
KP N+L++ G ++LADFG S V T Y P++L + Y
Sbjct: 189 KPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYG 248
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
D +G +EM G+ F + I+ K L P+
Sbjct: 249 PECDWWALGVFAYEMFYGQTPFYA---DSTAETYGKIV-----HYKEHLSL---PLVDEG 297
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA---MRHPYFNSL 463
+ +A D +Q+ L + R+ A HP+F L
Sbjct: 298 ----------VPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 60/285 (21%), Positives = 104/285 (36%), Gaps = 61/285 (21%)
Query: 196 ATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIHTEK 253
+ V + VA+K ++ + RE L H IV ++D E
Sbjct: 26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 85
Query: 254 CLT----LVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+V EY++ L+ + ++ + + L + H I+HRD+KP
Sbjct: 86 PAGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144
Query: 309 QNLLINERGELKLADFGLARA--KSVPTKTFSNEVV-TLWYRPPDVLLGSTE------YS 359
N++I+ +K+ DFG+ARA S + T + V+ T Y P+ G + YS
Sbjct: 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS 204
Query: 360 TSIDMGVGCIFHEMSSGRPLFPGST--------IEDELRLICSILGPPPDELKSKLEFCI 411
+GC+ +E+ +G P F G + + ++ PP L
Sbjct: 205 ------LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--------IPPSARHEGL---- 246
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456
+D +V K L + + R A MR
Sbjct: 247 --------------SADLD----AVVLKALAKNPENRYQTAAEMR 273
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 3e-26
Identities = 64/286 (22%), Positives = 118/286 (41%), Gaps = 46/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG++ V + + TD L A+K +K ++ ++ + V L + + LH
Sbjct: 351 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQLHS 409
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
T L V EY+ DL ++ + + ++ GL + S+ I++RDL
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDL 468
Query: 307 KPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
K N++++ G +K+ADFG+ + V TKTF T Y P+++ Y S+D
Sbjct: 469 KLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG---TPDYIAPEIIAY-QPYGKSVD 524
Query: 364 M-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
G + +EM +G+ F G EDE L SI ++ + +
Sbjct: 525 WWAFGVLLYEMLAGQAPFEG---EDEDELFQSI-------MEHNVAY------------- 561
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANA-----MRHPYFNSL 463
P+ M +A+ + + + +R+ H +F +
Sbjct: 562 ---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 72/283 (25%), Positives = 129/283 (45%), Gaps = 44/283 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAI-REVSLLRELRHANIVTLH 246
KG++ VF + + T+ A+K +K L ++ CT + + V L H + +
Sbjct: 27 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE-CTMVEKRV-LSLAWEHPFLTHMF 84
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
T++ L V EYL DL ++ C + ++ + +++ GL + HS+ I++RD
Sbjct: 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRD 143
Query: 306 LKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
LK N+L+++ G +K+ADFG+ + T TF T Y P++LLG +Y+ S+
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCG---TPDYIAPEILLG-QKYNHSV 199
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D G + +EM G+ F G +DE L SI +
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHG---QDEEELFHSI-------RMDNPFY------------ 237
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANA-MRHPYFNSL 463
P ++ +A DL+ K + + ++R+ +HP F +
Sbjct: 238 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 64/289 (22%), Positives = 113/289 (39%), Gaps = 44/289 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V K + D + A+K + L+ E A C E +L I TLH
Sbjct: 84 RGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA-CF-REERDVLVNGDSKWITTLHY 141
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ L LV +Y DL + + L + +L +++ + H +HRD+
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDI 201
Query: 307 KPQNLLINERGELKLADFGLA----RAKSVPTKTFSNEVVTLWYRPPDVLL----GSTEY 358
KP N+L++ G ++LADFG +V + V T Y P++L G Y
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA---VGTPDYISPEILQAMEGGKGRY 258
Query: 359 STSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS 417
D +G +EM G F E + I+ K + +F P +
Sbjct: 259 GPECDWWSLGVCMYEMLYGETPFYA---ESLVETYGKIM-----NHKERFQF---PTQVT 307
Query: 418 ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA---MRHPYFNSL 463
+ + +A DL+++ + + R+ +HP+F+ +
Sbjct: 308 D----------VSENAKDLIRRLIC-SREHRLGQNGIEDFKKHPFFSGI 345
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-26
Identities = 32/203 (15%), Positives = 74/203 (36%), Gaps = 21/203 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
+ ++KG+ + N + +K +K+ E LR H N++ +
Sbjct: 20 ENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77
Query: 251 TEKC--LTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRR--ILHR 304
+ TL+ ++ L + + +N + + F + RG+A+ H+ I
Sbjct: 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRH 137
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG--STEYSTSI 362
L ++++I+E +++ + + P + + + P+ L S
Sbjct: 138 ALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-----APAWVAPEALQKKPEDTNRRSA 192
Query: 363 DM---GVGCIFHEMSSGRPLFPG 382
DM V + E+ + F
Sbjct: 193 DMWSFAV--LLWELVTREVPFAD 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 15/86 (17%), Positives = 32/86 (37%), Gaps = 6/86 (6%)
Query: 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHD 156
KL + ++KG+ + N + +K +K+ E LR H N++ +
Sbjct: 17 KLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 157 IIHTEKC--LTLVFEYLEK-DLKRYM 179
+ TL+ ++ L +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL 100
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 66/287 (22%), Positives = 122/287 (42%), Gaps = 48/287 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAI-REVSLLRELRHANIVTLH 246
KG++ V + + TD L A+K +K ++ ++ CT + + V L + + LH
Sbjct: 30 KGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVE-CTMVEKRV-LALPGKPPFLTQLH 87
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
T L V EY+ DL ++ + + ++ GL + S+ I++RD
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146
Query: 306 LKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
LK N++++ G +K+ADFG+ + V TKTF T Y P+++ Y S+
Sbjct: 147 LKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG---TPDYIAPEIIAY-QPYGKSV 202
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D G + +EM +G+ F G EDE L SI ++ + +
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEG---EDEDELFQSI-------MEHNVAY------------ 240
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P+ M +A+ + + + +R+ + H +F +
Sbjct: 241 ----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 55/208 (26%), Positives = 80/208 (38%), Gaps = 29/208 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL----HD 247
KG Y V+ GK R VA+K E E+ +RH NI+
Sbjct: 47 KGRYGEVWMGKWRGEK--VAVKVFFTTEEASW--FRETEIYQTVLMRHENILGFIAADIK 102
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR------ 300
+ L L+ +Y E L Y+ S L ++ + + GL + H+
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160
Query: 301 --ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF----SNEVVTLWYRPPDVLLG 354
I HRDLK +N+L+ + G +AD GLA T + V T Y PP+VL
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220
Query: 355 ST-----EYSTSIDM-GVGCIFHEMSSG 376
S + DM G I E++
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARR 248
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 5e-06
Identities = 22/89 (24%), Positives = 35/89 (39%), Gaps = 9/89 (10%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL- 154
+ ++G+G Y V+ GK R VA+K E E+ +RH NI+
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEK--VAVKVFFTTEEASW--FRETEIYQTVLMRHENILGFI 97
Query: 155 ---HDIIHTEKCLTLVFEYLEK-DLKRYM 179
+ L L+ +Y E L Y+
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYL 126
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 77/297 (25%), Positives = 129/297 (43%), Gaps = 65/297 (21%)
Query: 192 KGTYATVF---KGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVT 244
KG Y VF K T + A+K +K + + + T E ++L E++H IV
Sbjct: 27 KGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFIVD 85
Query: 245 LHDIIHTEKCLTLVFEY---------LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAY 295
L T L L+ EY LE++ I + +L ++ L +
Sbjct: 86 LIYAFQTGGKLYLILEYLSGGELFMQLERE---------GIFMEDTACFYLAEISMALGH 136
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVL 352
H + I++RDLKP+N+++N +G +KL DFGL + T TF T+ Y P++L
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCG---TIEYMAPEIL 193
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCI 411
+ + ++ ++D +G + ++M +G P F G E+ + I I LK KL
Sbjct: 194 MR-SGHNRAVDWWSLGALMYDMLTGAPPFTG---ENRKKTIDKI-------LKCKLNL-- 240
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSL 463
P + +A DL++K L +A R+ A HP+F +
Sbjct: 241 --------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 52/208 (25%), Positives = 82/208 (39%), Gaps = 29/208 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL----HD 247
KG Y V++G + + VA+K E+ E+ LRH NI+
Sbjct: 18 KGRYGEVWRGSWQGEN--VAVKIFSSRDEKSW--FRETELYNTVMLRHENILGFIASDMT 73
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR------ 300
H+ L L+ Y E L Y+ L + + + GLA+ H
Sbjct: 74 SRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 301 --ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTF----SNEVVTLWYRPPDVLLG 354
I HRDLK +N+L+ + G+ +AD GLA S T + V T Y P+VL
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 355 ST-----EYSTSIDM-GVGCIFHEMSSG 376
+ + +D+ G + E++
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARR 219
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 9/89 (10%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL- 154
L+ +G+G Y V++G + + VA+K E+ E+ LRH NI+
Sbjct: 13 LECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDEKSW--FRETELYNTVMLRHENILGFI 68
Query: 155 ---HDIIHTEKCLTLVFEYLEK-DLKRYM 179
H+ L L+ Y E L Y+
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL 97
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 65/288 (22%), Positives = 119/288 (41%), Gaps = 49/288 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAI-REVSLLRELRHANIVTLH 246
KG++ V + + T +L A+K +K L+ ++ CT + + L H + L
Sbjct: 33 KGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVE-CTMTEKRI-LSLARNHPFLTQLF 90
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
T L V E++ DL ++ + + +++ L + H + I++RD
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRD 149
Query: 306 LKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
LK N+L++ G KLADFG+ + V T TF T Y P++L Y ++
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCG---TPDYIAPEILQE-MLYGPAV 205
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D +G + +EM G F E+E L +I L ++ +
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEA---ENEDDLFEAI-------LNDEVVY------------ 243
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANA------MRHPYFNSL 463
P + DA +++ F+ + R+ + +RHP+F +
Sbjct: 244 ----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 72/293 (24%), Positives = 119/293 (40%), Gaps = 50/293 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G+YA V + + TD + A+K +K + E+ + V + H +V LH
Sbjct: 19 RGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGLHS 77
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
TE L V EY+ DL +M L + + + ++ L Y H R I++RDL
Sbjct: 78 CFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDL 136
Query: 307 KPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
K N+L++ G +KL D+G+ + T TF T Y P++L G +Y S+D
Sbjct: 137 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG---TPNYIAPEILRG-EDYGFSVD 192
Query: 364 M-GVGCIFHEMSSGRPLFPGSTI------EDELRLICSILGPPPDELKSKLEFCITPVYP 416
+G + EM +GR F E L I L+ ++
Sbjct: 193 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LEKQIRI------- 238
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA------MRHPYFNSL 463
P + A +++ FL D K+R+ HP+F ++
Sbjct: 239 ---------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 65/286 (22%), Positives = 118/286 (41%), Gaps = 47/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAI-REVSLLRELRHANIVTLH 246
KG++ V + + + A+K ++ L+ +E R V LL+ ++H +V LH
Sbjct: 48 KGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK-HIMSERNV-LLKNVKHPFLVGLH 105
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
T L V +Y+ +L ++ + + ++ L Y HS I++RD
Sbjct: 106 FSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRD 164
Query: 306 LKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
LKP+N+L++ +G + L DFGL + + T TF T Y P+VL Y ++
Sbjct: 165 LKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCG---TPEYLAPEVLHK-QPYDRTV 220
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D +G + +EM G P F + + +I L L+
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYS---RNTAEMYDNI-------LNKPLQL------------ 258
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANA----MRHPYFNSL 463
+ + A L++ L D +R+ A + H +F+ +
Sbjct: 259 ----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 50/293 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G+YA V + + TD + A++ +K + E+ + V + H +V LH
Sbjct: 62 RGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGLHS 120
Query: 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
TE L V EY+ DL +M L + + + ++ L Y H R I++RDL
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDL 179
Query: 307 KPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
K N+L++ G +KL D+G+ + T TF T Y P++L G +Y S+D
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG---TPNYIAPEILRG-EDYGFSVD 235
Query: 364 M-GVGCIFHEMSSGRPLFPGSTI------EDELRLICSILGPPPDELKSKLEFCITPVYP 416
+G + EM +GR F E L I L+ ++
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------LEKQIRI------- 281
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA------MRHPYFNSL 463
P + A +++ FL D K+R+ HP+F ++
Sbjct: 282 ---------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 32/222 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL------ 245
+G + V+K + VA+K ++ ++ EV L ++H NI+
Sbjct: 34 RGRFGCVWKAQLLNEY--VAVKIFPIQDKQSW--QNEYEVYSLPGMKHENILQFIGAEKR 89
Query: 246 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR----- 299
+ + L + + EK L ++ +N++S N + + RGLAY H
Sbjct: 90 GTSVDVDLWL--ITAFHEKGSLSDFLK--ANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 300 -----RILHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTFSNEVV-TLWYRPPDVL 352
I HRD+K +N+L+ +ADFGLA + ++ V T Y P+VL
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 353 LGS----TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDEL 389
G+ + IDM +G + E++S G E L
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 16/84 (19%), Positives = 33/84 (39%), Gaps = 12/84 (14%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL- 154
L+ +G + V+K + VA+K ++ ++ EV L ++H NI+
Sbjct: 29 LEVKARGRFGCVWKAQLLNEY--VAVKIFPIQDKQSW--QNEYEVYSLPGMKHENILQFI 84
Query: 155 -----HDIIHTEKCLTLVFEYLEK 173
+ + L+ + EK
Sbjct: 85 GAEKRGTSVDVDLW--LITAFHEK 106
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 72/297 (24%), Positives = 122/297 (41%), Gaps = 67/297 (22%)
Query: 192 KGTYATVF---KGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVT 244
+G++ VF K L A+K +K + R++ L E+ H IV
Sbjct: 34 QGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-VRTKMERDI--LVEVNHPFIVK 90
Query: 245 LHDIIHTEKCLTLVFEY---------LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAY 295
LH TE L L+ ++ L K++ + +VK +L +L L +
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---------FTEEDVKFYLAELALALDH 141
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVL 352
HS I++RDLKP+N+L++E G +KL DFGL++ +F T+ Y P+V+
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG---TVEYMAPEVV 198
Query: 353 LGSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCI 411
++ S D G + EM +G F G +D + I LK+KL
Sbjct: 199 NRR-GHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKETMTMI-------LKAKLGM-- 245
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA-----MRHPYFNSL 463
P+ + +A L++ + R+ A RH +F+++
Sbjct: 246 --------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 1e-22
Identities = 25/211 (11%), Positives = 53/211 (25%), Gaps = 33/211 (15%)
Query: 193 GTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIH 250
++ D VAL + + + L + + + D++H
Sbjct: 42 VPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101
Query: 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
T +V E++ L+ D S + L H + P
Sbjct: 102 TRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPS 158
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCI 369
+ ++ G++ LA + D+ +G
Sbjct: 159 RVRVSIDGDVVLAYPATMPDANPQD---------------DI------RG------IGAS 191
Query: 370 FHEMSSGRPLFPGSTIEDELRLICSILGPPP 400
+ + R P + + L P
Sbjct: 192 LYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 18/114 (15%), Positives = 35/114 (30%), Gaps = 6/114 (5%)
Query: 71 APLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE 130
+ + + I GR Y L G ++ D VAL + +
Sbjct: 14 SAPPDDVQLVPGARIANGR---YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVL 70
Query: 131 GAPCTA--IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDD 181
+ L + + + D++HT +V E++ L+ D
Sbjct: 71 PDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT 124
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 65/290 (22%), Positives = 114/290 (39%), Gaps = 50/290 (17%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V + + T + A+K + ++ + A E ++ +V L
Sbjct: 79 RGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA-FF-WEERDIMAFANSPWVVQLFY 136
Query: 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
++ L +V EY+ DL M + + + + +++ L HS +HRD+
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMS--NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194
Query: 307 KPQNLLINERGELKLADFGLA----RAKSVPTKTFSNEVVTLWYRPPDVLL---GSTEYS 359
KP N+L+++ G LKLADFG + V T V T Y P+VL G Y
Sbjct: 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA---VGTPDYISPEVLKSQGGDGYYG 251
Query: 360 TSID---MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYP 416
D +GV ++ EM G F + + I+ K+ L F P
Sbjct: 252 RECDWWSVGV-FLY-EMLVGDTPFYA---DSLVGTYSKIM-----NHKNSLTF------P 295
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA---MRHPYFNSL 463
++ + +A +L+ FL D + R+ RH +F +
Sbjct: 296 DDNDIS--------KEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKND 336
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 40/145 (27%), Positives = 70/145 (48%), Gaps = 7/145 (4%)
Query: 192 KGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V + + VA+K +K E +E+ +LR L H NIV
Sbjct: 31 EGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKG 90
Query: 248 IIHTEKC--LTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
I + + L+ E+L LK Y+ N +++ + Q+ +G+ Y SR+ +HR
Sbjct: 91 ICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHR 150
Query: 305 DLKPQNLLINERGELKLADFGLARA 329
DL +N+L+ ++K+ DFGL +A
Sbjct: 151 DLAARNVLVESEHQVKIGDFGLTKA 175
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 8/108 (7%)
Query: 91 ESYFKL-DKLGQGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRE 145
+ + K LG+G + V + + VA+K +K E +E+ +LR
Sbjct: 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 79
Query: 146 LRHANIVTLHDIIHTEKC--LTLVFEYLEK-DLKRYMDDCSNILSMNN 190
L H NIV I + + L+ E+L LK Y+ N +++
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 54/242 (22%), Positives = 88/242 (36%), Gaps = 41/242 (16%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL------ 245
+G Y V+KG VA+K + + + + + + H NI
Sbjct: 23 RGRYGAVYKGSLDERP--VAVKVFSFANRQNF--INEKNIYRVPLMEHDNIARFIVGDER 78
Query: 246 -HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS----- 298
E L V EY L +Y+ + + + RGLAY H+
Sbjct: 79 VTADGRMEYLL--VMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 299 ----RRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV--------TLWY 346
I HRDL +N+L+ G ++DFGL+ + E T+ Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 347 RPPDVLLGS------TEYSTSIDM-GVGCIFHEMSSG-RPLFPGSTIEDELRLICSILGP 398
P+VL G+ +DM +G I+ E+ LFPG ++ + + +G
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254
Query: 399 PP 400
P
Sbjct: 255 HP 256
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 17/83 (20%), Positives = 27/83 (32%), Gaps = 13/83 (15%)
Query: 98 KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL--- 154
+G+G Y V+KG VA+K + + + + + + H NI
Sbjct: 20 LIGRGRYGAVYKGSLDERP--VAVKVFSFANRQNF--INEKNIYRVPLMEHDNIARFIVG 75
Query: 155 ----HDIIHTEKCLTLVFEYLEK 173
E LV EY
Sbjct: 76 DERVTADGRMEYL--LVMEYYPN 96
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 67/301 (22%), Positives = 124/301 (41%), Gaps = 65/301 (21%)
Query: 192 KGTYATVF---KGKSRLTDNLVALKEIK----LEHEEGAPCTAIREVSLLRELRHAN-IV 243
G Y VF K T L A+K +K ++ + T E +L +R + +V
Sbjct: 64 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQSPFLV 122
Query: 244 TLHDIIHTEKCLTLVFEY---------LEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLA 294
TLH TE L L+ +Y L + + + V++++ +++ L
Sbjct: 123 TLHYAFQTETKLHLILDYINGGELFTHLSQ---------RERFTEHEVQIYVGEIVLALE 173
Query: 295 YCHSRRILHRDLKPQNLLINERGELKLADFGLA----RAKSVPTKTFSNEVVTLWYRPPD 350
+ H I++RD+K +N+L++ G + L DFGL+ ++ F T+ Y PD
Sbjct: 174 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG---TIEYMAPD 230
Query: 351 VLLGSTE-YSTSIDM-GVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPPDELKSKL 407
++ G + ++D +G + +E+ +G F + + I LKS+
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------LKSEP 283
Query: 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA-----MRHPYFNS 462
+ P++M + A DL+Q+ LM D K+R+ H +F
Sbjct: 284 PY----------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
Query: 463 L 463
+
Sbjct: 328 I 328
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 36/138 (26%), Positives = 69/138 (50%), Gaps = 1/138 (0%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + VF G+ R + LVA+K + ++E +L++ H NIV L +
Sbjct: 124 RGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ 183
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
++ + +V E ++ D ++ L + + + G+ Y S+ +HRDL +N
Sbjct: 184 KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN 243
Query: 311 LLINERGELKLADFGLAR 328
L+ E+ LK++DFG++R
Sbjct: 244 CLVTEKNVLKISDFGMSR 261
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 20/84 (23%), Positives = 42/84 (50%), Gaps = 1/84 (1%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
+++G+G + VF G+ R + LVA+K + ++E +L++ H NIV L
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRY 178
+ ++ + +V E ++ D +
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTF 202
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 92.6 bits (229), Expect = 9e-21
Identities = 48/293 (16%), Positives = 98/293 (33%), Gaps = 62/293 (21%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E + +K+G+G + VF+ VA+K I +E + + +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQT--IADHTPVAIKIIAIEGPDLVNGSHQKTF---------- 67
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLV 210
+ I E ++ L ++ + + S++ V+G+Y
Sbjct: 68 -----EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSY--------------- 107
Query: 211 ALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYM 270
P ++ + + + + L FE+ DL++
Sbjct: 108 -------------PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR 154
Query: 271 DDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFGLARA 329
+ S+ K L QL LA + R HRDL N+L+ + KL ++
Sbjct: 155 T---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKS 211
Query: 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG 382
++P+ +V + Y + ++ +F ++S LF G
Sbjct: 212 STIPSCGL--QVSIIDY-----------TLSRLERDGIVVFCDVSMDEDLFTG 251
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 2e-20
Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 192 KGTYATVFKGK-SRLTDN---LVALKEIKLEHEEGAPCTA---IREVSLLRELRHANIVT 244
KG + +V + L DN +VA+K+++ RE+ +L+ L+H NIV
Sbjct: 20 KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 245 LHDII--HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
+ + L L+ EYL L+ Y+ + + + Q+ +G+ Y ++R
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 135
Query: 302 LHRDLKPQNLLINERGELKLADFGLARA 329
+HRDL +N+L+ +K+ DFGL +
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKV 163
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 15/111 (13%)
Query: 91 ESYFKL-DKLGQGTYATVFKGK-SRLTDN---LVALKEIKLEHEEGAPCTA---IREVSL 142
E + K +LG+G + +V + L DN +VA+K+++ RE+ +
Sbjct: 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEI 64
Query: 143 LRELRHANIVTLHDII--HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNN 190
L+ L+H NIV + + L L+ EYL L+ Y+ +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 115
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 39/148 (26%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 192 KGTYATVFKGK-SRLTDN---LVALKEIKLEHEEGAPCTA---IREVSLLRELRHANIVT 244
KG + +V + L DN +VA+K+++ RE+ +L+ L+H NIV
Sbjct: 51 KGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 245 LHDII--HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
+ + L L+ EYL L+ Y+ + + + Q+ +G+ Y ++R
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY 166
Query: 302 LHRDLKPQNLLINERGELKLADFGLARA 329
+HRDL +N+L+ +K+ DFGL +
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKV 194
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 27/111 (24%), Positives = 48/111 (43%), Gaps = 15/111 (13%)
Query: 91 ESYFKL-DKLGQGTYATVFKGK-SRLTDN---LVALKEIKLEHEEGAPCTA---IREVSL 142
E + K +LG+G + +V + L DN +VA+K+++ RE+ +
Sbjct: 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ----HSTEEHLRDFEREIEI 95
Query: 143 LRELRHANIVTLHDII--HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNN 190
L+ L+H NIV + + L L+ EYL L+ Y+ +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK 146
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 8e-20
Identities = 40/145 (27%), Positives = 72/145 (49%), Gaps = 9/145 (6%)
Query: 192 KGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+G + V T++ +VA+K +K + +E+ +LR L H +I+
Sbjct: 41 EGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKG 100
Query: 248 II--HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
L LV EY+ L+ Y+ + + + + LF Q+ G+AY H++ +HR
Sbjct: 101 CCEDAGAASLQLVMEYVPLGSLRDYLP--RHSIGLAQLLLFAQQICEGMAYLHAQHYIHR 158
Query: 305 DLKPQNLLINERGELKLADFGLARA 329
DL +N+L++ +K+ DFGLA+A
Sbjct: 159 DLAARNVLLDNDRLVKIGDFGLAKA 183
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 8/96 (8%)
Query: 91 ESYFKL-DKLGQGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRE 145
+ Y K LG+G + V T++ +VA+K +K + +E+ +LR
Sbjct: 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT 89
Query: 146 LRHANIVTLHDII--HTEKCLTLVFEYLEK-DLKRY 178
L H +I+ L LV EY+ L+ Y
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY 125
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 33/142 (23%), Positives = 66/142 (46%), Gaps = 6/142 (4%)
Query: 193 GTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + TV+KG VA+KE++ A + E ++ + + ++ L I
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L+ + + L Y+ + + + + + Q+ +G+ Y RR++HRDL
Sbjct: 86 C-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 308 PQNLLINERGELKLADFGLARA 329
+N+L+ +K+ DFGLA+
Sbjct: 145 ARNVLVKTPQHVKITDFGLAKL 166
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 22/94 (23%), Positives = 39/94 (41%), Gaps = 7/94 (7%)
Query: 91 ESYFKLDK-LGQGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRE 145
E+ FK K LG G + TV+KG VA+KE++ A + E ++
Sbjct: 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
+ + ++ L I + L+ + + L Y
Sbjct: 74 VDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDY 106
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G + V G D VA+K I+ EGA I E ++ +L H +V L+ +
Sbjct: 18 SGQFGLVHLGYWLNKDK-VAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+ + LV E++E L Y+ + + + + G+AY ++HRDL
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAA 132
Query: 309 QNLLINERGELKLADFGLAR 328
+N L+ E +K++DFG+ R
Sbjct: 133 RNCLVGENQVIKVSDFGMTR 152
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 24/86 (27%), Positives = 40/86 (46%), Gaps = 8/86 (9%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVT 153
+ ++G G + V G D VA+K I+ EGA I E ++ +L H +V
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-VAIKTIR----EGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRY 178
L+ + + + LV E++E L Y
Sbjct: 68 LYGVCLEQAPICLVTEFMEHGCLSDY 93
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 39/140 (27%), Positives = 70/140 (50%), Gaps = 4/140 (2%)
Query: 193 GTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
G + +V +G R+ VA+K +K E+ +RE ++ +L + IV L +
Sbjct: 21 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79
Query: 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ L LV E L +++ + ++NV L Q+ G+ Y + +HRDL +
Sbjct: 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAAR 139
Query: 310 NLLINERGELKLADFGLARA 329
N+L+ R K++DFGL++A
Sbjct: 140 NVLLVNRHYAKISDFGLSKA 159
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 22/84 (26%), Positives = 39/84 (46%), Gaps = 4/84 (4%)
Query: 98 KLGQGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
+LG G + +V +G R+ VA+K +K E+ +RE ++ +L + IV L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRY 178
+ + L LV E L ++
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKF 99
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 44/145 (30%), Positives = 74/145 (51%), Gaps = 8/145 (5%)
Query: 192 KGTYATVFKGK-SRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
KG + +V + L DN LVA+K+++ + RE+ +L+ L IV
Sbjct: 33 KGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-QQRDFQREIQILKALHSDFIVKYRG 91
Query: 248 IIHT--EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ + + L LV EYL L+ ++ L + + L+ Q+ +G+ Y SRR +HR
Sbjct: 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHR 151
Query: 305 DLKPQNLLINERGELKLADFGLARA 329
DL +N+L+ +K+ADFGLA+
Sbjct: 152 DLAARNILVESEAHVKIADFGLAKL 176
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 27/108 (25%), Positives = 48/108 (44%), Gaps = 9/108 (8%)
Query: 91 ESYFKL-DKLGQGTYATVFKGK-SRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRE 145
E + K +LG+G + +V + L DN LVA+K+++ + RE+ +L+
Sbjct: 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPD-QQRDFQREIQILKA 80
Query: 146 LRHANIVTLHDIIHT--EKCLTLVFEYLEK-DLKRYMDDCSNILSMNN 190
L IV + + + L LV EYL L+ ++ L +
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASR 128
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 3e-19
Identities = 38/141 (26%), Positives = 70/141 (49%), Gaps = 4/141 (2%)
Query: 192 KGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + +V +G R+ VA+K +K E+ +RE ++ +L + IV L +
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+ L LV E L +++ + ++NV L Q+ G+ Y + +HR+L
Sbjct: 406 -QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAA 464
Query: 309 QNLLINERGELKLADFGLARA 329
+N+L+ R K++DFGL++A
Sbjct: 465 RNVLLVNRHYAKISDFGLSKA 485
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 24/97 (24%), Positives = 45/97 (46%), Gaps = 4/97 (4%)
Query: 98 KLGQGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
+LG G + +V +G R+ VA+K +K E+ +RE ++ +L + IV L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNV 191
+ + L LV E L +++ + ++NV
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV 438
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 40/140 (28%), Positives = 72/140 (51%), Gaps = 5/140 (3%)
Query: 193 GTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V +G +N VA+K K + ++E +R+ H +IV L +I
Sbjct: 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
TE + ++ E +L+ ++ L + ++ L+ +QL LAY S+R +HRD+
Sbjct: 86 -TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 144
Query: 309 QNLLINERGELKLADFGLAR 328
+N+L++ +KL DFGL+R
Sbjct: 145 RNVLVSSNDCVKLGDFGLSR 164
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 20/87 (22%), Positives = 39/87 (44%), Gaps = 5/87 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+G+G + V +G +N VA+K K + ++E +R+ H +IV
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRY 178
L +I TE + ++ E +L+ +
Sbjct: 80 KLIGVI-TENPVWIIMELCTLGELRSF 105
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 7/144 (4%)
Query: 192 KGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLH 246
G++ V +G+ VA+K +K + IREV+ + L H N++ L+
Sbjct: 28 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 87
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
++ + +V E L + + + + Q+ G+ Y S+R +HRD
Sbjct: 88 GVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 146
Query: 306 LKPQNLLINERGELKLADFGLARA 329
L +NLL+ R +K+ DFGL RA
Sbjct: 147 LAARNLLLATRDLVKIGDFGLMRA 170
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 22/95 (23%), Positives = 40/95 (42%), Gaps = 8/95 (8%)
Query: 91 ESYFKLDK-LGQGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTA--IREVSLLR 144
E +L + LG G++ V +G+ VA+K +K + IREV+ +
Sbjct: 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76
Query: 145 ELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
L H N++ L+ ++ + +V E L
Sbjct: 77 SLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDR 110
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 5/141 (3%)
Query: 193 GTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V++G VA+K K + + E +++ L H +IV L II
Sbjct: 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII 82
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E+ ++ E +L Y++ N L + + L+ Q+ + +AY S +HRD+
Sbjct: 83 -EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAV 141
Query: 309 QNLLINERGELKLADFGLARA 329
+N+L+ +KL DFGL+R
Sbjct: 142 RNILVASPECVKLGDFGLSRY 162
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 21/87 (24%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
LG+G + V++G VA+K K + + E +++ L H +IV
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRY 178
L II E+ ++ E +L Y
Sbjct: 77 KLIGII-EEEPTWIIMELYPYGELGHY 102
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 34/142 (23%), Positives = 62/142 (43%), Gaps = 6/142 (4%)
Query: 193 GTYATVFKGKSRLTDNL----VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + TV KG V +K I+ + + + + L HA+IV L +
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGL 83
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
L LV +YL L ++ L + + Q+ +G+ Y ++HR+L
Sbjct: 84 C-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLA 142
Query: 308 PQNLLINERGELKLADFGLARA 329
+N+L+ ++++ADFG+A
Sbjct: 143 ARNVLLKSPSQVQVADFGVADL 164
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 91 ESYFKLDK-LGQGTYATVFKGKSRLTDNL----VALKEIKLEHEEGAPCTAIREVSLLRE 145
E+ + K LG G + TV KG V +K I+ + + + +
Sbjct: 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 71
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
L HA+IV L + L LV +YL L +
Sbjct: 72 LDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDH 104
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 37/141 (26%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G Y V++G + VA+K +K E ++E ++++E++H N+V L +
Sbjct: 23 GGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
E ++ E++ +L Y+ +C+ +S + Q+ + Y + +HRDL
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 138
Query: 308 PQNLLINERGELKLADFGLAR 328
+N L+ E +K+ADFGL+R
Sbjct: 139 ARNCLVGENHLVKVADFGLSR 159
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 22/86 (25%), Positives = 42/86 (48%), Gaps = 7/86 (8%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVT 153
KLG G Y V++G + VA+K +K E ++E ++++E++H N+V
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQ 73
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRY 178
L + E ++ E++ +L Y
Sbjct: 74 LLGVCTREPPFYIITEFMTYGNLLDY 99
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 33/142 (23%), Positives = 66/142 (46%), Gaps = 6/142 (4%)
Query: 193 GTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + TV+KG VA+KE++ A + E ++ + + ++ L I
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 85
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ L+ + + L Y+ + + + + + Q+ +G+ Y RR++HRDL
Sbjct: 86 C-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 144
Query: 308 PQNLLINERGELKLADFGLARA 329
+N+L+ +K+ DFGLA+
Sbjct: 145 ARNVLVKTPQHVKITDFGLAKL 166
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 6/89 (6%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
K+ LG G + TV+KG VA+KE++ A + E ++ + + +
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 78
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
+ L I + L+ + + L Y
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDY 106
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 4/141 (2%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G V G+ R+ VA+K +K + E + E S++ + H NI+ L +
Sbjct: 59 SGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ + +V EY+E L ++ ++ + L + G+ Y +HRDL
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178
Query: 308 PQNLLINERGELKLADFGLAR 328
+N+L++ K++DFGL+R
Sbjct: 179 ARNVLVDSNLVCKVSDFGLSR 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 21/87 (24%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+G G V G+ R+ VA+K +K + E + E S++ + H NI+
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRY 178
L ++ + +V EY+E L +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTF 140
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 39/140 (27%), Positives = 69/140 (49%), Gaps = 8/140 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G + V GK R VA+K IK EG+ I E ++ L H +V L+ +
Sbjct: 34 TGQFGVVKYGKWR-GQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
++ + ++ EY+ L Y+ + + + + + Y S++ LHRDL
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148
Query: 309 QNLLINERGELKLADFGLAR 328
+N L+N++G +K++DFGL+R
Sbjct: 149 RNCLVNDQGVVKVSDFGLSR 168
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 25/86 (29%), Positives = 40/86 (46%), Gaps = 8/86 (9%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVT 153
L +LG G + V GK R VA+K IK EG+ I E ++ L H +V
Sbjct: 29 LKELGTGQFGVVKYGKWR-GQYDVAIKMIK----EGSMSEDEFIEEAKVMMNLSHEKLVQ 83
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRY 178
L+ + ++ + ++ EY+ L Y
Sbjct: 84 LYGVCTKQRPIFIITEYMANGCLLNY 109
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 36/140 (25%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G + V GK + VA+K IK EG+ +E + +L H +V + +
Sbjct: 18 SGQFGVVKLGKWK-GQYDVAVKMIK----EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E + +V EY+ L Y+ L + + + + G+A+ S + +HRDL
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAA 132
Query: 309 QNLLINERGELKLADFGLAR 328
+N L++ +K++DFG+ R
Sbjct: 133 RNCLVDRDLCVKVSDFGMTR 152
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 8/86 (9%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVT 153
L +LG G + V GK + VA+K IK EG+ +E + +L H +V
Sbjct: 13 LKELGSGQFGVVKLGKWK-GQYDVAVKMIK----EGSMSEDEFFQEAQTMMKLSHPKLVK 67
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRY 178
+ + E + +V EY+ L Y
Sbjct: 68 FYGVCSKEYPIYIVTEYISNGCLLNY 93
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 36/142 (25%), Positives = 77/142 (54%), Gaps = 5/142 (3%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G + V+ G D A+K + + G + E ++++ H N+++L I
Sbjct: 35 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94
Query: 249 I-HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+E +V Y++ DL+ ++ + ++ ++ ++ F Q+ +G+ Y S++ +HRDL
Sbjct: 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDL 154
Query: 307 KPQNLLINERGELKLADFGLAR 328
+N +++E+ +K+ADFGLAR
Sbjct: 155 AARNCMLDEKFTVKVADFGLAR 176
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 18/98 (18%), Positives = 46/98 (46%), Gaps = 5/98 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+ +G+G + V+ G D A+K + + G + E ++++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 153 TLHDII-HTEKCLTLVFEYLEK-DLKRYMDDCSNILSM 188
+L I +E +V Y++ DL+ ++ + ++ ++
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 127
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 5/141 (3%)
Query: 193 GTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V +G +N VA+K K + ++E +R+ H +IV L +I
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
TE + ++ E +L+ ++ L + ++ L+ +QL LAY S+R +HRD+
Sbjct: 461 -TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 519
Query: 309 QNLLINERGELKLADFGLARA 329
+N+L++ +KL DFGL+R
Sbjct: 520 RNVLVSSNDCVKLGDFGLSRY 540
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 5e-06
Identities = 20/87 (22%), Positives = 39/87 (44%), Gaps = 5/87 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+G+G + V +G +N VA+K K + ++E +R+ H +IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRY 178
L +I TE + ++ E +L+ +
Sbjct: 455 KLIGVI-TENPVWIIMELCTLGELRSF 480
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 38/141 (26%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 193 GTYATVFKG--KSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDII 249
G + TV KG + + VA+K +K E + A + E +++++L + IV + I
Sbjct: 28 GNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC 87
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
+ LV E E L +Y+ + + N+ + Q+ G+ Y +HRDL
Sbjct: 88 -EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 145
Query: 309 QNLLINERGELKLADFGLARA 329
+N+L+ + K++DFGL++A
Sbjct: 146 RNVLLVTQHYAKISDFGLSKA 166
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 6e-06
Identities = 24/92 (26%), Positives = 44/92 (47%), Gaps = 5/92 (5%)
Query: 98 KLGQGTYATVFKG--KSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTL 154
+LG G + TV KG + + VA+K +K E + A + E +++++L + IV +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 155 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNI 185
I + LV E E L +Y+ ++
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQNRHV 114
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 43/172 (25%), Positives = 78/172 (45%), Gaps = 12/172 (6%)
Query: 169 EYLEKDLKRYMDDC-----SNILSMNNV--KGTYATVFKGKSRLTDN---LVALKEIKLE 218
L+ L + D + + V KG + V+ G+ A+K +
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 219 HEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL-VFEYLEK-DLKRYMDDCSNI 276
E +RE L+R L H N++ L I+ + L + Y+ DL +++
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 277 LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
++ ++ F Q+ RG+ Y ++ +HRDL +N +++E +K+ADFGLAR
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 20/96 (20%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 98 KLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 154
+G+G + V+ G+ A+K + E +RE L+R L H N++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 155 HDIIHTEKCLTL-VFEYLEK-DLKRYMDDCSNILSM 188
I+ + L + Y+ DL +++ ++
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV 123
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 7e-18
Identities = 47/209 (22%), Positives = 92/209 (44%), Gaps = 14/209 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G Y V++G + VA+K +K E ++E ++++E++H N+V L +
Sbjct: 230 GGQYGEVYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
E ++ E++ +L Y+ +C+ +S + Q+ + Y + +HR+L
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345
Query: 308 PQNLLINERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
+N L+ E +K+ADFGL+R T + W P + ++S D+
Sbjct: 346 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVW 403
Query: 365 GVGCIFHE-MSSGRPLFPGSTIEDELRLI 392
G + E + G +PG + L+
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELL 432
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 29/135 (21%), Positives = 51/135 (37%), Gaps = 15/135 (11%)
Query: 47 NKRLSLPADLHLPESFLAKTNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYAT 106
L LH P K I ++I KLG G Y
Sbjct: 184 TVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--------KLGGGQYGE 235
Query: 107 VFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDIIHTEKCL 164
V++G + VA+K +K E ++E ++++E++H N+V L + E
Sbjct: 236 VYEGVWKKYSLTVAVKTLK----EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291
Query: 165 TLVFEYLEK-DLKRY 178
++ E++ +L Y
Sbjct: 292 YIITEFMTYGNLLDY 306
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 35/142 (24%), Positives = 77/142 (54%), Gaps = 5/142 (3%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G + V+ G D A+K + + G + E ++++ H N+++L I
Sbjct: 99 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 158
Query: 249 I-HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+E +V Y++ DL+ ++ + ++ ++ ++ F Q+ +G+ + S++ +HRDL
Sbjct: 159 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 218
Query: 307 KPQNLLINERGELKLADFGLAR 328
+N +++E+ +K+ADFGLAR
Sbjct: 219 AARNCMLDEKFTVKVADFGLAR 240
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 18/98 (18%), Positives = 46/98 (46%), Gaps = 5/98 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+ +G+G + V+ G D A+K + + G + E ++++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 153 TLHDII-HTEKCLTLVFEYLEK-DLKRYMDDCSNILSM 188
+L I +E +V Y++ DL+ ++ + ++ ++
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 191
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
KG + V G R VA+K IK A A + E S++ +LRH+N+V L +I
Sbjct: 31 KGEFGDVMLGDYRGNK--VAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 251 TEK-CLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
EK L +V EY+ K L Y+ ++L + + F + + Y +HRDL
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 308 PQNLLINERGELKLADFGLAR 328
+N+L++E K++DFGL +
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTK 165
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 9/86 (10%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTL 154
L +G+G + V G R VA+K IK A A + E S++ +LRH+N+V L
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNK--VAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQL 79
Query: 155 HDIIHTEK-CLTLVFEYLEK-DLKRY 178
+I EK L +V EY+ K L Y
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDY 105
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 38/143 (26%), Positives = 63/143 (44%), Gaps = 9/143 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA-NIVTLHDIIH 250
G + + GK+ T+ VA IKLE + E ++L I ++
Sbjct: 19 CGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGP 75
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
K +V E L L+ D C S+ V + QL+ + Y HS+ +++RD+KP+N
Sbjct: 76 CGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPEN 135
Query: 311 LLI-----NERGELKLADFGLAR 328
LI + + + DF LA+
Sbjct: 136 FLIGRPGNKTQQVIHIIDFALAK 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 26/113 (23%), Positives = 44/113 (38%), Gaps = 8/113 (7%)
Query: 81 SLSEIGFGRIESYFKLD-KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIRE 139
S+ + + F++ K+G G + + GK+ T+ VA IKLE + E
Sbjct: 1 SMGVL---MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVA---IKLEPMKSRAPQLHLE 54
Query: 140 VSLLRELRHA-NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV 191
++L I ++ K +V E L L+ D C S+ V
Sbjct: 55 YRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTV 107
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 37/141 (26%), Positives = 70/141 (49%), Gaps = 5/141 (3%)
Query: 193 GTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + V+KG + + VA+K +K + E + E ++ + H NI+ L +
Sbjct: 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGV 114
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
I K + ++ EY+E L +++ + S+ + L + G+ Y + +HRDL
Sbjct: 115 ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174
Query: 308 PQNLLINERGELKLADFGLAR 328
+N+L+N K++DFGL+R
Sbjct: 175 ARNILVNSNLVCKVSDFGLSR 195
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 21/88 (23%), Positives = 41/88 (46%), Gaps = 5/88 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 151
+G G + V+KG + + VA+K +K + E + E ++ + H NI
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 152 VTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
+ L +I K + ++ EY+E L ++
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKF 136
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 38/140 (27%), Positives = 67/140 (47%), Gaps = 4/140 (2%)
Query: 193 GTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V G+ +L VA+K +K+ + E + E S++ + H NI+ L ++
Sbjct: 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV 115
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
K + +V EY+E L ++ ++ + L + G+ Y +HRDL
Sbjct: 116 TKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175
Query: 309 QNLLINERGELKLADFGLAR 328
+N+LIN K++DFGL R
Sbjct: 176 RNILINSNLVCKVSDFGLGR 195
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 5/92 (5%)
Query: 92 SYFKLDK-LGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELR 147
+ +DK +G G + V G+ +L VA+K +K+ + E + E S++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
H NI+ L ++ K + +V EY+E L +
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 41/246 (16%), Positives = 81/246 (32%), Gaps = 54/246 (21%)
Query: 193 GTYATVFKGKSRLTDNL-------VALKEIKLEHEEGAPCTA---IREVSLLRELRHANI 242
GT+ +FKG R + V LK + + + S++ +L H ++
Sbjct: 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLD----KAHRNYSESFFEAASMMSKLSHKHL 74
Query: 243 VTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
V + + LV E+++ L Y+ N +++ QL + + +
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL 134
Query: 302 LHRDLKPQNLLINERGEL--------KLADFGLARA------KSVPTKTFSNEVVTLWYR 347
+H ++ +N+L+ + KL+D G++ W
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP---------WV- 184
Query: 348 PPDVLLGSTEYSTSIDM---GVGCIFHEMSSGRPLFPGST-------IEDELRLICSILG 397
PP+ + + + D G ++ S G ED +L
Sbjct: 185 PPECIENPKNLNLATDKWSFGT-TLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA---- 239
Query: 398 PPPDEL 403
P EL
Sbjct: 240 PKAAEL 245
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 22/104 (21%), Positives = 43/104 (41%), Gaps = 15/104 (14%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNL-------VALKEIKLEHEEGAPCTA---IREVSLLRE 145
+ LGQGT+ +FKG R + V LK + + + S++ +
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD----KAHRNYSESFFEAASMMSK 68
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSM 188
L H ++V + + LV E+++ L Y+ N +++
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINI 112
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V+ G T VA+K +K P ++E ++++LRH +V L+ ++ +
Sbjct: 194 QGCFGEVWMGTWNGTTR-VAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV-S 249
Query: 252 EKCLTLVFEYLEK-DLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E+ + +V EY+ K L ++ + L + + Q+ G+AY +HRDL+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309
Query: 310 NLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
N+L+ E K+ADFGLAR + T + W P L G ++ D+
Sbjct: 310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSF 367
Query: 367 GCIFHE-MSSGRPLFPGSTIEDELRLI 392
G + E + GR +PG + L +
Sbjct: 368 GILLTELTTKGRVPYPGMVNREVLDQV 394
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
KLGQG + V+ G T VA+K +K P ++E ++++LRH +V L+
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLY 245
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRY 178
++ +E+ + +V EY+ K L +
Sbjct: 246 AVV-SEEPIYIVTEYMSKGSLLDF 268
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 45/141 (31%), Positives = 71/141 (50%), Gaps = 10/141 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTLHDIIH 250
KG + V G N VA+K IK A A + E S++ +LRH+N+V L +I
Sbjct: 203 KGEFGDVMLGD--YRGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 251 TEK-CLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
EK L +V EY+ K L Y+ ++L + + F + + Y +HRDL
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 308 PQNLLINERGELKLADFGLAR 328
+N+L++E K++DFGL +
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTK 337
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 34/114 (29%), Positives = 48/114 (42%), Gaps = 13/114 (11%)
Query: 72 PLTRSSRRQSLSEIGFGRIE---SYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLE 127
P + E KL +G+G + V G N VA+K IK
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIK-- 225
Query: 128 HEEGAPCTA-IREVSLLRELRHANIVTLHDIIHTEK-CLTLVFEYLEK-DLKRY 178
A A + E S++ +LRH+N+V L +I EK L +V EY+ K L Y
Sbjct: 226 --NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 40/141 (28%), Positives = 77/141 (54%), Gaps = 10/141 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVTLHDII 249
G + V+ G VA+K +K +G+ + E +L+++L+H +V L+ ++
Sbjct: 23 AGQFGEVWMGYYN-GHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T++ + ++ EY+E L ++ S L++N + Q+ G+A+ R +HRDL+
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136
Query: 308 PQNLLINERGELKLADFGLAR 328
N+L+++ K+ADFGLAR
Sbjct: 137 AANILVSDTLSCKIADFGLAR 157
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 21/86 (24%), Positives = 47/86 (54%), Gaps = 9/86 (10%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTA--IREVSLLRELRHANIVT 153
+++LG G + V+ G VA+K +K +G+ + E +L+++L+H +V
Sbjct: 18 VERLGAGQFGEVWMGYYN-GHTKVAVKSLK----QGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRY 178
L+ ++ T++ + ++ EY+E L +
Sbjct: 73 LYAVV-TQEPIYIITEYMENGSLVDF 97
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 3e-16
Identities = 54/207 (26%), Positives = 96/207 (46%), Gaps = 12/207 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V+ G T VA+K +K P ++E ++++LRH +V L+ ++ +
Sbjct: 277 QGCFGEVWMGTWNGTTR-VAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV-S 332
Query: 252 EKCLTLVFEYLEK-DLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E+ + +V EY+ K L ++ + L + + Q+ G+AY +HRDL+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392
Query: 310 NLLINERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
N+L+ E K+ADFGLAR + T + W P L G ++ D+
Sbjct: 393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSF 450
Query: 367 GCIFHE-MSSGRPLFPGSTIEDELRLI 392
G + E + GR +PG + L +
Sbjct: 451 GILLTELTTKGRVPYPGMVNREVLDQV 477
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 25/84 (29%), Positives = 45/84 (53%), Gaps = 5/84 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
KLGQG + V+ G T VA+K +K P ++E ++++LRH +V L+
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLY 328
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRY 178
++ +E+ + +V EY+ K L +
Sbjct: 329 AVV-SEEPIYIVTEYMSKGSLLDF 351
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 31/152 (20%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G++ V++G ++ VA+K + + E S+++E ++V L
Sbjct: 35 QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRY---------MDDCSNILSMNNVKLFLFQLLRGLAYC 296
++ + ++ E + + DLK Y + S++ + ++ G+AY
Sbjct: 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 154
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLAR 328
++ + +HRDL +N ++ E +K+ DFG+ R
Sbjct: 155 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 19/89 (21%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+LGQG++ V++G ++ VA+K + + E S+++E +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
+V L ++ + ++ E + + DLK Y
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 36/141 (25%), Positives = 61/141 (43%), Gaps = 7/141 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA-NIVTLHDIIH 250
G++ ++ G VA IKLE + E + + ++ I T+
Sbjct: 19 SGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA 75
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+V E L L+ + CS S+ V L Q++ + Y HS+ +HRD+KP N
Sbjct: 76 EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135
Query: 311 LLI---NERGELKLADFGLAR 328
L+ + + + DFGLA+
Sbjct: 136 FLMGLGKKGNLVYIIDFGLAK 156
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 5/105 (4%)
Query: 89 RIESYFKLD-KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR 147
R+ + ++L K+G G++ ++ G VA IKLE + E + + ++
Sbjct: 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHIESKIYKMMQ 62
Query: 148 HA-NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV 191
I T+ +V E L L+ + CS S+ V
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTV 107
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 16/153 (10%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTL-- 245
KG + +V + + + D VA+K +K + + +RE + ++E H ++ L
Sbjct: 33 KGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG 92
Query: 246 ----HDIIHTEKCLTLVFEYLEK-DLKRYM-----DDCSNILSMNNVKLFLFQLLRGLAY 295
++ +++ DL ++ + L + + F+ + G+ Y
Sbjct: 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
SR +HRDL +N ++ E + +ADFGL+R
Sbjct: 153 LSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 16/94 (17%), Positives = 38/94 (40%), Gaps = 11/94 (11%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTA-IREVSLLRELRHANI 151
LG+G + +V + + + D VA+K +K + + +RE + ++E H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 152 VTL------HDIIHTEKCLTLVFEYLEK-DLKRY 178
L ++ +++ DL +
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 36/139 (25%), Positives = 70/139 (50%), Gaps = 6/139 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V+ VA+K +K + E ++++ L+H +V LH ++ T
Sbjct: 198 AGQFGEVWMATYNKHTK-VAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAVV-T 253
Query: 252 EKCLTLVFEYLEK-DLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
++ + ++ E++ K L ++ D + + + F Q+ G+A+ R +HRDL+
Sbjct: 254 KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313
Query: 310 NLLINERGELKLADFGLAR 328
N+L++ K+ADFGLAR
Sbjct: 314 NILVSASLVCKIADFGLAR 332
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 19/84 (22%), Positives = 40/84 (47%), Gaps = 5/84 (5%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
KLG G + V+ VA+K +K + E ++++ L+H +V LH
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLH 249
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRY 178
++ T++ + ++ E++ K L +
Sbjct: 250 AVV-TKEPIYIITEFMAKGSLLDF 272
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 31/152 (20%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 192 KGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTA-IREVSLLRELRHANIVTL-- 245
+G + +V +G + D VA+K +KL++ + E + +++ H N++ L
Sbjct: 44 EGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103
Query: 246 ---HDIIHTEKCLTLVFEYLEK-DLKRY-----MDDCSNILSMNNVKLFLFQLLRGLAYC 296
++ +++ DL Y ++ + + + F+ + G+ Y
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLAR 328
+R LHRDL +N ++ + + +ADFGL++
Sbjct: 164 SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 18/93 (19%), Positives = 39/93 (41%), Gaps = 10/93 (10%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTA-IREVSLLRELRHANI 151
LG+G + +V +G + D VA+K +KL++ + E + +++ H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 152 VTL-----HDIIHTEKCLTLVFEYLEK-DLKRY 178
+ L ++ +++ DL Y
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTY 131
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 5e-15
Identities = 33/143 (23%), Positives = 58/143 (40%), Gaps = 9/143 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA-NIVTLHDIIH 250
+G++ +F+G + L + VA IK E E + L I ++
Sbjct: 20 EGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
LV + L L+ +D C S+ V + Q+L + H + +++RD+KP N
Sbjct: 77 EGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDN 136
Query: 311 LLINERGELK-----LADFGLAR 328
LI + DFG+ +
Sbjct: 137 FLIGRPNSKNANMIYVVDFGMVK 159
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 22/105 (20%), Positives = 42/105 (40%), Gaps = 5/105 (4%)
Query: 89 RIESYFKLD-KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR 147
+ ++K+ ++G+G++ +F+G + L + VA IK E E + L
Sbjct: 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 148 HA-NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV 191
I ++ LV + L L+ +D C S+ V
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTV 108
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 33/152 (21%), Positives = 60/152 (39%), Gaps = 15/152 (9%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
G + V++G+ N VA+K + E + E ++ + H NIV
Sbjct: 40 HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 99
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSN------ILSMNNVKLFLFQLLRGLAYCHSR 299
+ ++ E + DLK ++ + L+M ++ + G Y
Sbjct: 100 GVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 159
Query: 300 RILHRDLKPQNLLINERGE---LKLADFGLAR 328
+HRD+ +N L+ G K+ DFG+AR
Sbjct: 160 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 6/89 (6%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ LG G + V++G+ N VA+K + E + E ++ + H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
IV + ++ E + DLK +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSF 123
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 7/141 (4%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA-NIVTLHDIIH 250
G++ ++ G + T+ VA IKLE+ + + E + R L+ I +
Sbjct: 17 SGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV 73
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
LV + L L+ + CS LS+ V + Q++ + + HS+ LHRD+KP N
Sbjct: 74 EGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133
Query: 311 LLI---NERGELKLADFGLAR 328
L+ ++ + DFGLA+
Sbjct: 134 FLMGLGRRANQVYIIDFGLAK 154
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 5/105 (4%)
Query: 89 RIESYFKLD-KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR 147
R+ + F+L K+G G++ ++ G + T+ VA IKLE+ + + E + R L+
Sbjct: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLLYESKIYRILQ 60
Query: 148 HA-NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV 191
I + LV + L L+ + CS LS+ V
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTV 105
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 33/152 (21%), Positives = 61/152 (40%), Gaps = 15/152 (9%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
G + V++G+ N VA+K + E + E ++ + H NIV
Sbjct: 81 HGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCI 140
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCS------NILSMNNVKLFLFQLLRGLAYCHSR 299
+ ++ E + DLK ++ + + L+M ++ + G Y
Sbjct: 141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200
Query: 300 RILHRDLKPQNLLINERGE---LKLADFGLAR 328
+HRD+ +N L+ G K+ DFG+AR
Sbjct: 201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 6/89 (6%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ LG G + V++G+ N VA+K + E + E ++ + H N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
IV + ++ E + DLK +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSF 164
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 22/158 (13%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G + VF + LVA+K +K + A RE LL L+H +IV +
Sbjct: 25 EGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIVKFY 83
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRY--------MDDCSNILSMNNVKLFLFQLL------- 290
+ L +VFEY++ DL ++ M +L L Q+L
Sbjct: 84 GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143
Query: 291 RGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
G+ Y S+ +HRDL +N L+ +K+ DFG++R
Sbjct: 144 SGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 26/87 (29%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 98 KLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+LG+G + VF + LVA+K +K + A RE LL L+H +IV
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELLTNLQHEHIV 80
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRY 178
+ + L +VFEY++ DL ++
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKF 107
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 193 GTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
+ V+KG VA+K +K + E E L L+H N+V L
Sbjct: 20 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLG 79
Query: 248 IIHTEKCLTLVFEYLEK-DLKRY---------------MDDCSNILSMNNVKLFLFQLLR 291
++ ++ L+++F Y DL + + L + + Q+
Sbjct: 80 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 139
Query: 292 GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
G+ Y S ++H+DL +N+L+ ++ +K++D GL R
Sbjct: 140 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 7e-06
Identities = 22/89 (24%), Positives = 41/89 (46%), Gaps = 6/89 (6%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+++LG+ + V+KG VA+K +K + E E L L+H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
+V L ++ ++ L+++F Y DL +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEF 102
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 22/157 (14%)
Query: 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDII 249
V+ T + K + +T VA+K +K + E+ +L L H NIV L
Sbjct: 40 VEATAYGLIKSDAAMT---VAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96
Query: 250 HTEKCLTLVFEYLEK-DLKRY-----------------MDDCSNILSMNNVKLFLFQLLR 291
++ EY DL + M+D L + ++ F +Q+ +
Sbjct: 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAK 156
Query: 292 GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
G+A+ S+ +HRDL +N+L+ K+ DFGLAR
Sbjct: 157 GMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 20/90 (22%), Positives = 31/90 (34%), Gaps = 7/90 (7%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLREL-RHA 149
LG G + V + + VA+K +K + E+ +L L H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
NIV L ++ EY DL +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNF 117
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 30/161 (18%)
Query: 192 KGTYATVFKGKSRLTDN-LVALKEIKLEHEEGAPCTAIR----EVSLLRELRHANIVTLH 246
G + V+KG L D VALK E +G I E+ L RH ++V+L
Sbjct: 49 HGVFGKVYKG--VLRDGAKVALKRRTPESSQG-----IEEFETEIETLSFCRHPHLVSLI 101
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYM---DDCSNILSMNNVKLFLFQLL-------RGLAY 295
+ L+++Y+E +LKR++ D + +S Q L RGL Y
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE-------QRLEICIGAARGLHY 154
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 336
H+R I+HRD+K N+L++E K+ DFG+++ + +T
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 7e-14
Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 19/156 (12%)
Query: 192 KGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDI 248
+G + V K + + A+K +K + E+ +L +L H NI+ L
Sbjct: 35 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94
Query: 249 IHTEKCLTLVFEYLEK-DLKRY---------------MDDCSNILSMNNVKLFLFQLLRG 292
L L EY +L + + ++ LS + F + RG
Sbjct: 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 154
Query: 293 LAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
+ Y ++ +HRDL +N+L+ E K+ADFGL+R
Sbjct: 155 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 20/86 (23%), Positives = 34/86 (39%), Gaps = 4/86 (4%)
Query: 97 DKLGQGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVT 153
D +G+G + V K + + A+K +K + E+ +L +L H NI+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 154 LHDIIHTEKCLTLVFEYLEK-DLKRY 178
L L L EY +L +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDF 116
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 43/157 (27%), Positives = 67/157 (42%), Gaps = 21/157 (13%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G + VF + LVA+K +K E E A RE LL L+H +IV
Sbjct: 51 EGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFF 109
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRY--------------MDDCSNILSMNNVKLFLFQLLR 291
+ + L +VFEY+ DL R+ D L + + Q+
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169
Query: 292 GLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
G+ Y +HRDL +N L+ + +K+ DFG++R
Sbjct: 170 GMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 98 KLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
+LG+G + VF + LVA+K +K E E A RE LL L+H +IV
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIV 106
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRY 178
+ + L +VFEY+ DL R+
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRF 133
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 37/153 (24%), Positives = 66/153 (43%), Gaps = 18/153 (11%)
Query: 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDII 249
V+ T + K + L VA+K +K + E+ ++ L +H NIV L
Sbjct: 63 VEATAFGLGKEDAVLK---VAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119
Query: 250 HTEKCLTLVFEYLEK-DLKRY-------------MDDCSNILSMNNVKLFLFQLLRGLAY 295
+ ++ EY DL + ++ S ++ F Q+ +G+A+
Sbjct: 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAF 179
Query: 296 CHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
S+ +HRD+ +N+L+ K+ DFGLAR
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 36/162 (22%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
VK T + T VA+K +K + E ++L+++ H +++ L+
Sbjct: 40 VKATAFHLKGRAGYTT---VAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96
Query: 251 TEKCLTLVFEYLEK-DLKRY-----------------------MDDCSNILSMNNVKLFL 286
+ L L+ EY + L+ + L+M ++ F
Sbjct: 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFA 156
Query: 287 FQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
+Q+ +G+ Y +++HRDL +N+L+ E ++K++DFGL+R
Sbjct: 157 WQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 5e-05
Identities = 18/89 (20%), Positives = 38/89 (42%), Gaps = 6/89 (6%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
LG+G + V K + VA+K +K + E ++L+++ H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
++ L+ + L L+ EY + L+ +
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 40/160 (25%)
Query: 192 KGTYATVFKGKSRLTDN-LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G + V+KG RL D LVA+K +K E +G EV ++ H N++ L
Sbjct: 40 RGGFGKVYKG--RLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLL-------------------R 291
T LV+ Y+ +V L + R
Sbjct: 98 TPTERLLVYPYMAN---------------GSVASCLRERPESQPPLDWPKRQRIALGSAR 142
Query: 292 GLAYCH---SRRILHRDLKPQNLLINERGELKLADFGLAR 328
GLAY H +I+HRD+K N+L++E E + DFGLA+
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 3/76 (3%)
Query: 98 KLGQGTYATVFKGKSRLTDN-LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 156
LG+G + V+KG RL D LVA+K +K E +G EV ++ H N++ L
Sbjct: 37 ILGRGGFGKVYKG--RLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 157 IIHTEKCLTLVFEYLE 172
T LV+ Y+
Sbjct: 95 FCMTPTERLLVYPYMA 110
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 36/193 (18%), Positives = 66/193 (34%), Gaps = 30/193 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + ++ A +K+E++E P E+ + + + +
Sbjct: 47 SGGFGLIYLAFPTNKPEKDARHVVKVEYQENGP--LFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 252 EKCLT-------------------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRG 292
L +V E L DL++ + + V ++L
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFKKSTVLQLGIRMLDV 163
Query: 293 LAYCHSRRILHRDLKPQNLLINERGELK--LADFGLARAKSVPTKTFSNEVVTLWYRPPD 350
L Y H +H D+K NLL+ + + LAD+GL+ + P P
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY-RYCPNGNH----KQYQENPRK 218
Query: 351 VLLGSTEYSTSID 363
G+ E+ TS+D
Sbjct: 219 GHNGTIEF-TSLD 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 192 KGTYATVFKGKSRLTDN-------LVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIV 243
+G + V ++ D VA+K +K + E + E+ +++ + +H NI+
Sbjct: 45 EGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 104
Query: 244 TLHDIIHTEKCLTLVFEYLEK-DLKRY---------------MDDCSNILSMNNVKLFLF 287
L + L ++ EY K +L+ Y ++ ++ +
Sbjct: 105 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
QL RG+ Y S++ +HRDL +N+L+ E +K+ADFGLAR
Sbjct: 165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 9e-04
Identities = 21/92 (22%), Positives = 41/92 (44%), Gaps = 9/92 (9%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-------LVALKEIKLEHEEGAPCTAIREVSLLREL-R 147
LG+G + V ++ D VA+K +K + E + E+ +++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
H NI+ L + L ++ EY K +L+ Y
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 38/160 (23%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 192 KGTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTL 245
+G + V + T VA+K +K + E+ +L + H N+V L
Sbjct: 37 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96
Query: 246 HDI-IHTEKCLTLVFEYLEK-DLKRY---------------MDDCSNILSMNNVKLFLFQ 288
L ++ E+ + +L Y D + L++ ++ + FQ
Sbjct: 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 156
Query: 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
+ +G+ + SR+ +HRDL +N+L++E+ +K+ DFGLAR
Sbjct: 157 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 36/198 (18%), Positives = 73/198 (36%), Gaps = 27/198 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKE-----IKLEHEEG------------APCTAIREVSLL 234
+ +++ T + + +KL+ ++G A + + L
Sbjct: 52 RDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKL 111
Query: 235 RELRHANIVTLHDI-IHTEKCLTLVFEYLEKDLKRYMDDCSN-ILSMNNVKLFLFQLLRG 292
I T +H +K LV L + L+ +D +LS +V +LL
Sbjct: 112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDA 171
Query: 293 LAYCHSRRILHRDLKPQNLLI--NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPD 350
L + H +H ++ +N+ + ++ ++ LA +G A + P+ V
Sbjct: 172 LEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF-RYCPSGKH----VAYVEGSRS 226
Query: 351 VLLGSTEYSTSIDMGVGC 368
G E+ S+D+ GC
Sbjct: 227 PHEGDLEF-ISMDLHKGC 243
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 8e-13
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 18/155 (11%)
Query: 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDII 249
V + K K VA+K +K + E I E+ +++ + +H NI+ L
Sbjct: 86 VLAEAIGLDKDKPNRV-TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144
Query: 250 HTEKCLTLVFEYLEK-DLKRY---------------MDDCSNILSMNNVKLFLFQLLRGL 293
+ L ++ EY K +L+ Y + LS ++ +Q+ RG+
Sbjct: 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGM 204
Query: 294 AYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
Y S++ +HRDL +N+L+ E +K+ADFGLAR
Sbjct: 205 EYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 28/109 (25%), Positives = 46/109 (42%), Gaps = 8/109 (7%)
Query: 257 LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER 316
++ + DL++ + + S V ++L L Y H +H D+K NLL+N +
Sbjct: 129 MIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK 188
Query: 317 GELK--LADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
+ L D+GLA + P P G+ E+ TSID
Sbjct: 189 NPDQVYLVDYGLAY-RYCPEGVH----KAYAADPKRCHDGTIEF-TSID 231
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 32/165 (19%)
Query: 192 KGTYATVFKGKSRLTDN-------LVALKEIKLEHEEGAPCTA----IREVSLLREL-RH 239
+G + V ++ D VA+K +K + A + E+ +++ + +H
Sbjct: 91 EGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK----DDATEKDLSDLVSEMEMMKMIGKH 146
Query: 240 ANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY--------MDDCSNILSMNNVKLFLFQLL 290
NI+ L + L ++ EY K +L+ Y M+ +I + ++ L+
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 291 -------RGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
RG+ Y S++ +HRDL +N+L+ E +K+ADFGLAR
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 53/244 (21%), Positives = 96/244 (39%), Gaps = 35/244 (14%)
Query: 94 FKLDK-LGQGTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL- 146
KL K LG+G + V + T VA+K +K + E+ +L +
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83
Query: 147 RHANIVTLHDI-IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSR 204
H N+V L L ++ E+ + +L Y+ N KG K
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 205 LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 264
+ + + + + + E EK L+ V E
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVE---------------------EKSLSDVEEE--- 179
Query: 265 DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324
+ D + L++ ++ + FQ+ +G+ + SR+ +HRDL +N+L++E+ +K+ DF
Sbjct: 180 --EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 237
Query: 325 GLAR 328
GLAR
Sbjct: 238 GLAR 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 27/162 (16%)
Query: 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDII 249
+ T + K + VA+K +K + + + E+ ++ +L H NIV L
Sbjct: 62 MNATAYGISKTGVSIQ---VAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118
Query: 250 HTEKCLTLVFEYLEK-DLKRY----------------------MDDCSNILSMNNVKLFL 286
+ L+FEY DL Y ++ N+L+ ++ F
Sbjct: 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFA 178
Query: 287 FQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
+Q+ +G+ + + +HRDL +N+L+ +K+ DFGLAR
Sbjct: 179 YQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 220
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 29/166 (17%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G + VF+ ++ +VA+K +K E RE +L+ E + NIV L
Sbjct: 57 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL 116
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRY-----------------------MDDCSNILSMNNV 282
+ K + L+FEY+ DL + LS
Sbjct: 117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 176
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328
Q+ G+AY R+ +HRDL +N L+ E +K+ADFGL+R
Sbjct: 177 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 6/89 (6%)
Query: 96 LDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ +G+G + VF+ ++ +VA+K +K E RE +L+ E + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178
IV L + K + L+FEY+ DL +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 9e-12
Identities = 40/192 (20%), Positives = 72/192 (37%), Gaps = 57/192 (29%)
Query: 197 TVFKGKSRLTDNLVALKEIKLE--------HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
V+KG + + VA+K++ ++ +E+ ++ + +H N+V L
Sbjct: 46 VVYKG--YVNNTTVAVKKLAAMVDITTEELKQQ-----FDQEIKVMAKCQHENLVELLGF 98
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLL------------------ 290
L LV+ Y+ ++ L L
Sbjct: 99 SSDGDDLCLVYVYMPN---------------GSLLDRLSCLDGTPPLSWHMRCKIAQGAA 143
Query: 291 RGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKT-FSNEVV-TLWYRP 348
G+ + H +HRD+K N+L++E K++DFGLARA +T ++ +V T Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203
Query: 349 PDVLLGSTEYST 360
P E
Sbjct: 204 P-------EALR 208
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 7e-04
Identities = 21/106 (19%), Positives = 43/106 (40%), Gaps = 20/106 (18%)
Query: 81 SLSEI-----GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLE-------- 127
S E+ F +K+G+G + V+KG + + VA+K++
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG--YVNNTTVAVKKLAAMVDITTEEL 73
Query: 128 HEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 173
++ +E+ ++ + +H N+V L L LV+ Y+
Sbjct: 74 KQQ-----FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPN 114
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 1e-11
Identities = 82/526 (15%), Positives = 151/526 (28%), Gaps = 127/526 (24%)
Query: 1 MEQLSVVHENPKIGSEEELEEVQDNLSKPVEVVKVRQRPKRSSEDINKRLSLPADLHL-P 59
M + P E +D L +V R + R +L L L P
Sbjct: 95 MSPIKTEQRQPS-MMTRMYIEQRDRLYNDNQVFAKYNVS-RLQPYLKLRQAL---LELRP 149
Query: 60 ESFLA--------KTNIIDAPLTRSSRRQSLSE-----IGFGRIESYFKLDKLGQGTYAT 106
+ KT + + S + Q + + S + ++ Q
Sbjct: 150 AKNVLIDGVLGSGKT-WVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 107 VFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN--IVTLHDIIHTE--- 161
+ + +D+ IKL +R LL+ + N +V L ++ + +
Sbjct: 209 IDPNWTSRSDHS---SNIKLRIHSIQ--AELRR--LLKSKPYENCLLV-LLNVQNAKAWN 260
Query: 162 ----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTD----NLVA-- 211
C L+ R ++ T+ ++ LT +L+
Sbjct: 261 AFNLSCKILL-------TTR---FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKY 310
Query: 212 --LKEIKLEHE--EGAP--CTAIREVSLLRE-------LRHANIVTLHDIIHTEKCLTLV 258
+ L E P + I E +R+ +H N L II E L
Sbjct: 311 LDCRPQDLPREVLTTNPRRLSIIAE--SIRDGLATWDNWKHVNCDKLTTII--ESSL--- 363
Query: 259 FEYLE-KDLKRYMDDCSNILSMN-NVKLFLFQLL----------RGLAYCHSRRILHRDL 306
LE + ++ D S + + ++ L L+ + H ++ +
Sbjct: 364 -NVLEPAEYRKMFDRLS-VFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQP 421
Query: 307 KPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366
K + I L+L + K +V Y P +D
Sbjct: 422 KESTISIPSI-YLEL------KVKLENEYALHRSIVD-HYNIPKTFDSDDLIPPYLD--- 470
Query: 367 GCIF-----H----EMSSGRPLFPG-----STIEDELRLICSILGPPPD------ELKSK 406
+ H E LF +E ++R + +LK
Sbjct: 471 QYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530
Query: 407 LEFCITPVYPSESKLQ------LLAPEQ--MDSDALDLVQKFLMYD 444
+ I P +L L E+ + S DL++ LM +
Sbjct: 531 KPY-ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAE 575
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 5e-09
Identities = 77/501 (15%), Positives = 160/501 (31%), Gaps = 123/501 (24%)
Query: 8 HENPKIGSEEELEEVQDNLSKPVEVVKVRQRPKR--SSEDINKRLSLPADLH----LPES 61
++ I L +D + V+ PK S E+I+ + + L +
Sbjct: 16 YQYKDI-----LSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWT 70
Query: 62 FLAK-TNIIDAPLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVF-KGKSRLTDNLV 119
L+K ++ + + + I + + S K ++ ++ + + RL ++
Sbjct: 71 LLSKQEEMVQKFV------EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQ 124
Query: 120 ALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK-CLTLVFEYLEKDLKRY 178
+ + + P +R+ L ELR A V + ++ + K + L L ++
Sbjct: 125 VFAKYNVSRLQ--PYLKLRQA--LLELRPAKNVLIDGVLGSGKTWVALDV-CLSYKVQCK 179
Query: 179 MDDCSNI--LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE 236
MD I L++ N + TV + +L + + +H +R S+ E
Sbjct: 180 MDF--KIFWLNLKNCN-SPETVLEMLQKLLYQIDPNWTSRSDHSSNIK---LRIHSIQAE 233
Query: 237 LRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYC 296
LR L + E CL LV + + N F C
Sbjct: 234 LRR----LLKSKPY-ENCL-LV-----------LLNVQN---AKAWNAFNLS-------C 266
Query: 297 HSRRIL--HRDLKPQNLLINE-RGELKLADF--GLARAKSVPTKTFSNEVVTLWYRPPDV 351
+IL R + + L + L L T ++ +
Sbjct: 267 ---KILLTTRFKQVTDFLSAATTTHISLDHHSMTL-------TPDEVKSLLLKY------ 310
Query: 352 LLGSTEYSTSIDMGVGCIFHEMSSGRPLFP---GSTIEDELRLICSILGPPPDELKSKLE 408
+D + E+ + P +I D L + D+L + +E
Sbjct: 311 ----------LDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 409 FCITPVYPSESK-------------------LQLLAPEQMDSDALDLVQKFLMYDAKQRI 449
+ + P+E + L L+ + + SD + +V K +
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL------HKY 414
Query: 450 SAANAMRHPYFNSLGPQVHEL 470
S + P +++ + +
Sbjct: 415 SLVE--KQPKESTIS--IPSI 431
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 3e-04
Identities = 49/337 (14%), Positives = 108/337 (32%), Gaps = 77/337 (22%)
Query: 3 QLSVVHENPKIGSEEELEEVQDNLSKPVEVVKVRQRPKRSSEDINKRLSLPADLHLPESF 62
+S+ H + + + +E++ + L K ++ + + P R N P L S
Sbjct: 288 HISLDHHSMTL-TPDEVKSL---LLKYLDC-RPQDLP-REVLTTN-----P--RRL--SI 332
Query: 63 LAKTNIIDAPLT----RSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDN- 117
+A+ +I D T + L+ I IES L+ L Y +F S +
Sbjct: 333 IAE-SIRDGLATWDNWKHVNCDKLTTI----IES--SLNVLEPAEYRKMFDRLSVFPPSA 385
Query: 118 ------LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171
L + ++ + + + SL+ + + +++ I K L
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 172 EKDL-KRYM---DDCSNILSMNNVKGTYATVFKG----KSRLTDNLVALKEI-------- 215
+ + Y S+ L + Y G + + + +
Sbjct: 446 HRSIVDHYNIPKTFDSDDLIPPYLDQ-YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLE 504
Query: 216 -KLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDC 273
K+ H+ A + ++ L++L+ + + +D +E L +
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDND---------PKYERLVNAILD----- 550
Query: 274 SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
FL ++ L +L L ++
Sbjct: 551 -----------FLPKIEENLICSKYTDLLRIALMAED 576
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.77 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.7 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 98.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.49 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.39 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 98.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.19 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 98.18 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 98.15 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.14 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.09 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 98.08 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.03 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 97.98 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 97.97 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 97.92 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 97.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 97.91 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 97.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 97.87 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 97.8 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.78 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 97.77 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 97.77 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 97.75 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 97.75 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 97.71 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 97.69 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 97.69 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 97.68 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 97.67 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 97.66 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 97.65 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 97.64 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 97.63 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 97.61 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 97.57 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 97.52 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 97.51 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 97.5 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 97.49 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 97.49 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 97.46 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 97.43 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 97.43 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 97.42 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 97.34 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 97.33 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 97.28 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.27 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.24 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 97.23 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.19 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.17 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 96.99 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 96.97 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 96.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 96.83 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 96.78 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.71 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.55 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 96.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.45 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 96.33 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 96.27 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.22 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.14 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 96.14 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 96.06 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 96.06 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 96.06 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 96.03 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 95.99 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.96 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 95.92 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 95.91 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 95.91 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 95.89 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 95.89 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 95.88 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 95.87 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 95.86 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 95.85 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 95.83 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 95.82 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 95.81 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 95.78 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 95.77 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 95.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 95.74 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 95.69 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 95.67 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 95.66 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 95.65 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 95.63 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 95.62 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.6 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 95.6 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 95.59 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 95.59 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 95.56 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 95.52 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 95.52 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 95.51 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 95.47 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 95.45 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 95.45 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 95.44 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 95.43 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 95.42 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 95.41 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 95.41 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 95.4 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 95.38 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 95.35 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 95.34 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.33 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 95.31 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 95.3 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 95.29 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 95.28 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 95.27 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 95.26 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 95.25 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 95.25 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 95.23 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 95.21 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 95.14 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 95.14 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 95.12 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 95.12 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 95.11 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 95.11 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 95.1 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 95.1 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 95.1 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 95.08 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 95.07 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 95.07 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 95.03 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 95.02 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 95.02 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 94.98 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 94.94 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 94.93 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 94.9 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 94.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 94.87 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 94.87 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 94.87 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 94.85 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 94.82 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 94.82 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 94.8 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 94.77 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 94.75 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 94.74 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 94.74 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 94.73 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 94.72 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 94.71 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 94.68 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 94.66 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 94.66 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 94.65 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 94.64 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 94.64 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 94.62 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 94.61 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 94.6 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 94.59 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 94.57 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 94.5 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 94.48 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 94.46 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 94.45 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 94.44 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 94.41 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 94.41 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 94.39 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 94.39 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 94.39 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 94.35 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 94.35 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 94.32 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 94.28 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 94.28 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 94.27 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 94.2 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 94.2 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 94.2 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 94.17 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 94.14 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 94.09 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 94.09 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 94.08 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 94.08 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 94.08 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 94.08 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 94.06 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 94.05 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 94.03 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 94.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 93.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 93.94 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 93.9 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 93.87 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 93.85 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 93.85 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 93.83 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 93.82 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 93.79 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 93.73 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 93.67 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 93.63 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 93.61 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 93.59 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 93.53 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 93.46 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.37 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 93.35 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 93.33 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 93.33 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 93.25 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 93.23 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 93.2 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 93.18 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 93.11 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 93.11 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 93.04 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 93.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 92.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 92.93 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 92.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 92.92 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 92.9 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 92.64 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-65 Score=507.35 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=230.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~------------------------------------ 72 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK------------------------------------ 72 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCC------------------------------------
Confidence 34578999999999999999999999999999999997542110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+|++++|||||++++
T Consensus 73 -----------------------------------------------------~~~~~~~~~E~~il~~l~HpnIv~l~~ 99 (311)
T 4aw0_A 73 -----------------------------------------------------ENKVPYVTRERDVMSRLDHPFFVKLYF 99 (311)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 111235778999999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+|++++++|||||||+ |+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 100 ~~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGl 178 (311)
T 4aw0_A 100 TFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178 (311)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCC
Confidence 9999999999999998 5999999875 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC--CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVP--TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+..... .......+||+.|||||++.+..++.++|+||+||++|||++|++||.+.+..+.+..|....
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-------- 250 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE-------- 250 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence 9876432 233456799999999999999889899999999999999999999999999888888875421
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHH------HHcCCCCCCCCCCcc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAAN------AMRHPYFNSLGPQVH 468 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e------~l~Hp~f~~~~~~~~ 468 (516)
..+|..++++++|||.+||+.||++|||++| +++||||++++|...
T Consensus 251 ------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 251 ------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 2245578999999999999999999999987 589999999887644
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-64 Score=505.73 Aligned_cols=258 Identities=22% Similarity=0.379 Sum_probs=224.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.+.|+++++||+|+||+||+|+++.+|+.||||++.......
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-------------------------------------- 114 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-------------------------------------- 114 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--------------------------------------
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--------------------------------------
Confidence 356999999999999999999999999999999986542211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+|+.++|||||+++++|
T Consensus 115 ------------------------------------------------------~~~~~~Ei~il~~l~HpnIV~l~~~~ 140 (346)
T 4fih_A 115 ------------------------------------------------------RELLFNEVVIMRDYQHENVVEMYNSY 140 (346)
T ss_dssp ------------------------------------------------------GGGGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 12456788888888888899999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+++.+|||||||+ |+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+
T Consensus 141 ~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 141 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCce
Confidence 99999999999999 488888765 459999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
............+||+.|||||++.+..|+.++|+|||||++|||++|++||.+.+..+.+..|.....+.
T Consensus 219 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------- 289 (346)
T 4fih_A 219 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR--------- 289 (346)
T ss_dssp ECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC---------
T ss_pred ecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---------
Confidence 87665556677899999999999999899999999999999999999999999999888887776532111
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...+..++++++|||.+||++||++|||++|+|+||||+...
T Consensus 290 --------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 290 --------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp --------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 111236789999999999999999999999999999998654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-64 Score=493.18 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=209.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~------------------------------------- 53 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAK------------------------------------- 53 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------------------------------------
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCC-------------------------------------
Confidence 5688999999999999999999999999999999997542211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+|+.++|||||+++++
T Consensus 54 ----------------------------------------------------~~~~~~~~~Ei~il~~l~HpnIv~~~~~ 81 (275)
T 3hyh_A 54 ----------------------------------------------------SDMQGRIEREISYLRLLRHPHIIKLYDV 81 (275)
T ss_dssp ------------------------------------------------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence 1112357789999999999999999999
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+++++.+|||||||+|+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 82 ~~~~~~~~ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~ 160 (275)
T 3hyh_A 82 IKSKDEIIMVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSN 160 (275)
T ss_dssp EECSSEEEEEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred EEECCEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCe
Confidence 9999999999999999999999875 469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
..... ......+||+.|||||++.+..++ .++|+||+||++|||+||++||.+.+..+.+..+....
T Consensus 161 ~~~~~-~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~----------- 228 (275)
T 3hyh_A 161 IMTDG-NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV----------- 228 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred ecCCC-CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-----------
Confidence 65432 334557899999999999988775 57899999999999999999999988887777765421
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
...|..+|+++++||.+||+.||++|||++|+++||||+.
T Consensus 229 ---------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 ---------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred ---------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 1234578999999999999999999999999999999964
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-64 Score=508.94 Aligned_cols=263 Identities=23% Similarity=0.396 Sum_probs=222.2
Q ss_pred ccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 85 IGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 85 ~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
+-|..+++|+++++||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 18 ~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~--------------------------------- 64 (350)
T 4b9d_A 18 LYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS--------------------------------- 64 (350)
T ss_dssp CBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH---------------------------------
T ss_pred cCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH---------------------------------
Confidence 34567899999999999999999999999999999999997542111
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
.....+.+|+.+|++|+|||||+
T Consensus 65 ---------------------------------------------------------~~~~~~~~E~~il~~l~HpnIV~ 87 (350)
T 4b9d_A 65 ---------------------------------------------------------KEREESRREVAVLANMKHPNIVQ 87 (350)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHHHCCCCCCCc
Confidence 01225678999999999999999
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
++++|++++.+|||||||+ |+|.+++...+ ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+
T Consensus 88 ~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp EEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEEC
T ss_pred EEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEc
Confidence 9999999999999999998 59999997644 458999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|||+|+............+||+.|||||++.+..++.++|+|||||+||||+||++||.+.+..+.+..|.....+
T Consensus 168 DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~---- 243 (350)
T 4b9d_A 168 DFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP---- 243 (350)
T ss_dssp STTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC----
T ss_pred ccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC----
Confidence 9999987653333344568999999999999998999999999999999999999999999988888877653211
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..+..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 244 ---------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 244 ---------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ---------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 123478999999999999999999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-64 Score=497.76 Aligned_cols=269 Identities=26% Similarity=0.372 Sum_probs=223.0
Q ss_pred cccEeeeeeeccccceEEEEEEEc---CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSR---LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~---~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.++|++++.||+|+||+||+|++. .+++.||||++.+......
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~---------------------------------- 68 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR---------------------------------- 68 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE----------------------------------
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH----------------------------------
Confidence 367999999999999999999985 3678999999865321100
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
....+.+|+.+|++++|||||+++
T Consensus 69 --------------------------------------------------------~~~~~~~E~~il~~l~HpnIv~l~ 92 (304)
T 3ubd_A 69 --------------------------------------------------------DRVRTKMERDILVEVNHPFIVKLH 92 (304)
T ss_dssp --------------------------------------------------------ECC------CCCCCCCCTTEECEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHCCCCCCCeEE
Confidence 011456788899999999999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++|++++.+|||||||+ |+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 93 ~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFG 171 (304)
T 3ubd_A 93 YAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171 (304)
T ss_dssp EEEEETTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSE
T ss_pred EEEEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccc
Confidence 99999999999999999 5899998765 469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+............+||+.|||||++.+..++.++|+||+||++|||+||++||.+.+..+.+..|....
T Consensus 172 la~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--------- 242 (304)
T 3ubd_A 172 LSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--------- 242 (304)
T ss_dssp EEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred cceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC---------
Confidence 99876545555567799999999999999999999999999999999999999999999888888875421
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQS 475 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~ 475 (516)
..+|..+|+++++||.+||+.||++||| ++|+++||||+++++.........+
T Consensus 243 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~p 300 (304)
T 3ubd_A 243 -----------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHP 300 (304)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred -----------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCCc
Confidence 1234578999999999999999999998 5799999999998765444344333
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=507.39 Aligned_cols=258 Identities=22% Similarity=0.379 Sum_probs=225.3
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.+.|+++++||+|+||+||+|+++.+|+.||||++.......
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-------------------------------------- 191 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-------------------------------------- 191 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--------------------------------------
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--------------------------------------
Confidence 356999999999999999999999999999999986532111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+|+.++|||||+++++|
T Consensus 192 ------------------------------------------------------~~~~~~Ei~il~~l~HpnIV~l~~~~ 217 (423)
T 4fie_A 192 ------------------------------------------------------RELLFNEVVIMRDYQHENVVEMYNSY 217 (423)
T ss_dssp ------------------------------------------------------GGGHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCCCceEEEE
Confidence 12466788888888899999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+++.+|||||||+ |+|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+
T Consensus 218 ~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 218 LVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccce
Confidence 99999999999999 588888765 359999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
............+||+.|||||++.+..|+.++|+|||||++|||++|++||.+.+..+.+..|.....+.
T Consensus 296 ~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------- 366 (423)
T 4fie_A 296 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR--------- 366 (423)
T ss_dssp ECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---------
T ss_pred ECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---------
Confidence 87665566677899999999999999999999999999999999999999999999888887775532111
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...+..++++++|||.+||+.||++|||++|+|+||||+...
T Consensus 367 --------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 367 --------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp --------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 112347899999999999999999999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=507.55 Aligned_cols=288 Identities=34% Similarity=0.602 Sum_probs=224.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
.-++|+++++||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|+.|+|||||++++++....
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 126 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV----- 126 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS-----
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc-----
Confidence 336799999999999999999999999999999999654321 11223444555555555555444444332211
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
T Consensus 127 -------------------------------------------------------------------------------- 126 (398)
T 4b99_A 127 -------------------------------------------------------------------------------- 126 (398)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.|.+.+++|||||||+|+|.+++... +.+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||+|
T Consensus 127 ~~~~~~~~~ivmE~~~g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 127 PYGEFKSVYVVLDLMESDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred ccccCCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeeccee
Confidence 01234578999999999999998764 56999999999999999999999999999999999999999999999999999
Q ss_pred cccCCC----CccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVP----TKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
+..... .......+||++|||||++.+..+ +.++|+||+||++|||++|++||.+.+..+++..|....|.|+..
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 865322 233456799999999999988654 567799999999999999999999999999999999999999987
Q ss_pred hhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 403 LKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 403 ~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.+...... ..+.... ..+...+| .++++++|||.+||++||.+||||+|+|+||||+...
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQP-VPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCC-CCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HhhhhhhhhhhhhhhcCCCcCC-CCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 65432111 1111111 12233333 6899999999999999999999999999999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=471.19 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=205.1
Q ss_pred ccE-eeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESY-FKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y-~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++| .+.++||+|+||+||+|+++.+++.||||++........
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~------------------------------------- 67 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS------------------------------------- 67 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH-------------------------------------
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH-------------------------------------
Confidence 455 666789999999999999999999999999875422110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+|++++|||||+++++|
T Consensus 68 -----------------------------------------------------~~~~~~~E~~il~~l~HpnIV~~~~~~ 94 (290)
T 3fpq_A 68 -----------------------------------------------------ERQRFKEEAEMLKGLQHPNIVRFYDSW 94 (290)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 012456777777777777777777777
Q ss_pred ee----CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEcc-CCCEEE
Q psy12305 250 HT----EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINE-RGELKL 321 (516)
Q Consensus 250 ~~----~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~-~~~vkL 321 (516)
.+ +.++|||||||+ |+|.+++.+. ..+++..++.++.||+.||+|||++| |+||||||+|||++. +|.+||
T Consensus 95 ~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl 173 (290)
T 3fpq_A 95 ESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKI 173 (290)
T ss_dssp EEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEE
T ss_pred eeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEE
Confidence 64 456899999999 5899998764 46999999999999999999999998 999999999999984 799999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+|||+|+.... ......+||+.|||||++.+ .++.++|+|||||++|||+||++||.+.+....+...... +..|.
T Consensus 174 ~DFGla~~~~~--~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~-~~~~~ 249 (290)
T 3fpq_A 174 GDLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA 249 (290)
T ss_dssp CCTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG
T ss_pred EeCcCCEeCCC--CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHc-CCCCC
Confidence 99999986432 33445789999999999876 5889999999999999999999999876554443332211 11111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..+...++++++||.+||+.||++|||++|+|+||||+.
T Consensus 250 ----------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 250 ----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ----------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 122367889999999999999999999999999999974
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-61 Score=480.83 Aligned_cols=254 Identities=24% Similarity=0.304 Sum_probs=213.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.++.|++.++||+|+||+||+|+++.+|+.||||+++...
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~---------------------------------------- 95 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---------------------------------------- 95 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----------------------------------------
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----------------------------------------
Confidence 4567999999999999999999999999999999986421
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+|+.+|+.++|||||+++++
T Consensus 96 ---------------------------------------------------------~~~~E~~il~~l~HpnIV~l~~~ 118 (336)
T 4g3f_A 96 ---------------------------------------------------------FRVEELVACAGLSSPRIVPLYGA 118 (336)
T ss_dssp ---------------------------------------------------------CCTHHHHTTTTCCCTTBCCEEEE
T ss_pred ---------------------------------------------------------hHHHHHHHHHhCCCCCCCcEEEE
Confidence 11257777888888888888899
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-CEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-ELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkL~DFGl 326 (516)
|.+++.+|||||||+ |+|.+++.+. +.+++..++.|+.||+.||+|||++|||||||||+|||++.+| .+||+|||+
T Consensus 119 ~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 119 VREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 999999999999999 5999998765 4699999999999999999999999999999999999999988 699999999
Q ss_pred ccccCCCCc-----cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 327 ARAKSVPTK-----TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 327 a~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|+....... .....+||+.|||||++.+..++.++|+|||||++|||+||++||.+.+..+.+..|... .++
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~- 274 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP- 274 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG-
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC-
Confidence 987643221 223458999999999999999999999999999999999999999987766666666442 111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH-------------HcCCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA-------------MRHPYFNSL 463 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~-------------l~Hp~f~~~ 463 (516)
....|..+++++.+||.+||++||.+|||+.|+ |+|||+...
T Consensus 275 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 275 --------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp --------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred --------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 012345889999999999999999999999997 579998764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-60 Score=469.77 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=200.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|++++.||+|+||+||+|+++.+|+.||||+++........+.+.+|+.+|++|+|||||+++++|...+....+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~- 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ- 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc-
Confidence 5789999999999999999999999999999999987654444457889999999999999999988775443111111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
..
T Consensus 83 ------------------------------------------------------------------------------~~ 84 (299)
T 4g31_A 83 ------------------------------------------------------------------------------PS 84 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------------cc
Confidence 11
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
..+.++|||||||+ |+|.+++..... ..++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 23346899999998 589998876432 245567899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc------------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Q psy12305 327 ARAKSVPTK------------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS 394 (516)
Q Consensus 327 a~~~~~~~~------------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~ 394 (516)
|+....... .....+||+.|||||++.+..++.++|+|||||++|||++ ||.+. .+....+..
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~ 239 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTD 239 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHH
Confidence 987543221 1234689999999999999999999999999999999996 77543 233333322
Q ss_pred hcC-CCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 395 ILG-PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 395 ~~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
... ..|..+ ...++.+.+||.+||+.||.+|||++|+++||||+++.+
T Consensus 240 ~~~~~~p~~~-----------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 240 VRNLKFPPLF-----------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp HHTTCCCHHH-----------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred HhcCCCCCCC-----------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 221 111111 134567899999999999999999999999999988754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=474.98 Aligned_cols=276 Identities=26% Similarity=0.431 Sum_probs=214.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcC---CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRL---TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~---~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
++|++.++||+|+||+||+|+++. +++.||||++.....
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-------------------------------------- 62 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-------------------------------------- 62 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--------------------------------------
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--------------------------------------
Confidence 569999999999999999999863 578899998753211
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
...+.+|+.+|+.+ +|||||+++
T Consensus 63 --------------------------------------------------------~~~~~~E~~~l~~~~~h~nIv~l~ 86 (361)
T 4f9c_A 63 --------------------------------------------------------PIRIAAELQCLTVAGGQDNVMGVK 86 (361)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHTCSBTTBCCCS
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHhcCCCCCceEE
Confidence 12456788888877 688899999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCEEEeee
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GELKLADF 324 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~DF 324 (516)
++|.+++++|||||||+ |+|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+||
T Consensus 87 ~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DF 162 (361)
T 4f9c_A 87 YCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDF 162 (361)
T ss_dssp EEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence 99999999999999998 58888874 49999999999999999999999999999999999999877 89999999
Q ss_pred ccccccCCCC----------------------------ccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHc
Q psy12305 325 GLARAKSVPT----------------------------KTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSS 375 (516)
Q Consensus 325 Gla~~~~~~~----------------------------~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~ellt 375 (516)
|+|+...... ......+||++|||||++.+.. ++.++|+||+||++|||++
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~ 242 (361)
T 4f9c_A 163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS 242 (361)
T ss_dssp TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence 9997543211 1234468999999999998865 5667799999999999999
Q ss_pred CCCCC-CCCCHHHHHHHHHHhcCCCChhhhhhcc----cc--cCCC-------------------CCC---chhhhhcCC
Q psy12305 376 GRPLF-PGSTIEDELRLICSILGPPPDELKSKLE----FC--ITPV-------------------YPS---ESKLQLLAP 426 (516)
Q Consensus 376 G~~pF-~~~~~~~~~~~i~~~~~~~p~~~~~~~~----~~--~~~~-------------------~~~---~~~~~~~~p 426 (516)
|++|| .+.+..+++..|...+|+++...+.... .+ ..|. ... .........
T Consensus 243 G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (361)
T 4f9c_A 243 GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGW 322 (361)
T ss_dssp TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------C
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccc
Confidence 99998 4677888999999998875433221100 00 0000 000 000011122
Q ss_pred CCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 427 ~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..++++++|||.+||++||++||||+|+|+||||++++
T Consensus 323 ~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 323 NEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp TTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred ccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 46889999999999999999999999999999998763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=497.51 Aligned_cols=279 Identities=22% Similarity=0.334 Sum_probs=224.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|+++.+|+.||||++.+........
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~--------------------------------- 232 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG--------------------------------- 232 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC---------------------------------
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhh---------------------------------
Confidence 56899999999999999999999999999999999997642110000
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.........++.+++.++|||||++++
T Consensus 233 -----------------------------------------------------~~~~~~E~~~l~ll~~~~HP~IV~l~~ 259 (689)
T 3v5w_A 233 -----------------------------------------------------ETLALNERIMLSLVSTGDCPFIVCMSY 259 (689)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHHSSSCCTTBCCEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhhCCCCCEeEEEE
Confidence 000001223466777889999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+|++++++|||||||+ |+|..++.+. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+
T Consensus 260 ~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGl 338 (689)
T 3v5w_A 260 AFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL 338 (689)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccce
Confidence 9999999999999999 5999998775 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
|+..... .....|||+.|||||++.+ ..++.++|+|||||++|||++|.+||.+.+..+....+....
T Consensus 339 A~~~~~~--~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~--------- 407 (689)
T 3v5w_A 339 ACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL--------- 407 (689)
T ss_dssp CEECSSC--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---------
T ss_pred eeecCCC--CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---------
Confidence 9876532 3345799999999999975 467788899999999999999999998643322221111111
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQSIFS 478 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~~~~ 478 (516)
.....+|..+|+++++||.+||+.||.+|++ ++|+++||||++++|.........++|.
T Consensus 408 --------------~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~ 471 (689)
T 3v5w_A 408 --------------TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471 (689)
T ss_dssp --------------HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCC
T ss_pred --------------CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCcc
Confidence 1122345688999999999999999999998 7999999999999877665555555553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=491.48 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=228.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.......
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~------------------------------------- 197 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD------------------------------------- 197 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-------------------------------------
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh-------------------------------------
Confidence 4688999999999999999999999999999999986532110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+|+.++|||||+++++
T Consensus 198 -------------------------------------------------------~~~~~~Ei~il~~l~hpnIv~l~~~ 222 (573)
T 3uto_A 198 -------------------------------------------------------KETVRKEIQTMSVLRHPTLVNLHDA 222 (573)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 1246678899999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC--CCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER--GELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~vkL~DFG 325 (516)
|+++..+|||||||+ |+|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 223 ~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeecc
Confidence 999999999999998 59999998766789999999999999999999999999999999999999864 899999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+.... .......+||+.|||||++.+..++.++|+||+||++|||++|.+||.+.+..+.+..|......++...
T Consensus 303 ~a~~~~~-~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-- 379 (573)
T 3uto_A 303 LTAHLDP-KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA-- 379 (573)
T ss_dssp SCEECCT-TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGG--
T ss_pred ceeEccC-CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCccc--
Confidence 9987653 3334556899999999999999998899999999999999999999999999988888866443333221
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
+..++++++|||.+||++||.+|||++|+|+||||+...+
T Consensus 380 --------------------~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 380 --------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp --------------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred --------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 1368999999999999999999999999999999987544
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-56 Score=447.93 Aligned_cols=268 Identities=21% Similarity=0.331 Sum_probs=212.0
Q ss_pred CCccccccccccccccccccccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHh
Q psy12305 71 APLTRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRE 145 (516)
Q Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~ 145 (516)
.|+....+..++.++. +++++++++||+|+||+||+|++. .+++.||||+++.....
T Consensus 9 ~p~~~~~~~~~~~ei~---~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--------------- 70 (308)
T 4gt4_A 9 MPLINQHKQAKLKEIS---LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--------------- 70 (308)
T ss_dssp ----------CCCBCC---GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---------------
T ss_pred ccccCccccCCcccCC---HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh---------------
Confidence 3444444444444443 456899999999999999999864 35678899887543211
Q ss_pred cCCCCeeecccccccceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChh
Q psy12305 146 LRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC 225 (516)
Q Consensus 146 l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~ 225 (516)
....
T Consensus 71 ----------------------------------------------------------------------------~~~~ 74 (308)
T 4gt4_A 71 ----------------------------------------------------------------------------PLRE 74 (308)
T ss_dssp -----------------------------------------------------------------------------CHH
T ss_pred ----------------------------------------------------------------------------HHHH
Confidence 1123
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhc---------------CCCCCHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC---------------SNILSMNNVKLFLFQL 289 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~---------------~~~l~~~~~~~i~~qi 289 (516)
.+.+|+.+|++++|||||++++++.+++.+|||||||+ |+|.+++... ...+++..+..++.||
T Consensus 75 ~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 154 (308)
T 4gt4_A 75 EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 154 (308)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHH
Confidence 56778888888888888888888888888999999999 6999999653 2458999999999999
Q ss_pred HHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHH
Q psy12305 290 LRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVG 367 (516)
Q Consensus 290 ~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlG 367 (516)
+.||+|||+++||||||||+|||++.++.+||+|||+|+...... ......+||+.|||||++.+..++.++|+||||
T Consensus 155 a~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfG 234 (308)
T 4gt4_A 155 AAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234 (308)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHH
Confidence 999999999999999999999999999999999999998654322 233456899999999999998999999999999
Q ss_pred HHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcC
Q psy12305 368 CIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAK 446 (516)
Q Consensus 368 vil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~ 446 (516)
|+||||+| |..||.+.+..+.+..+.... ....|+.+++++.+|+.+||+.||+
T Consensus 235 vvl~El~t~g~~Pf~~~~~~~~~~~i~~~~-------------------------~~~~p~~~~~~~~~li~~C~~~dP~ 289 (308)
T 4gt4_A 235 VVLWEVFSYGLQPYCGYSNQDVVEMIRNRQ-------------------------VLPCPDDCPAWVYALMIECWNEFPS 289 (308)
T ss_dssp HHHHHHHTTTCCTTTTCCHHHHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------------CCCCcccchHHHHHHHHHHcCCChh
Confidence 99999998 899999998887777664321 1123558899999999999999999
Q ss_pred CCCCHHHHHcC
Q psy12305 447 QRISAANAMRH 457 (516)
Q Consensus 447 ~R~ta~e~l~H 457 (516)
+|||+.|++++
T Consensus 290 ~RPs~~ei~~~ 300 (308)
T 4gt4_A 290 RRPRFKDIHSR 300 (308)
T ss_dssp GSCCHHHHHHH
T ss_pred HCcCHHHHHHH
Confidence 99999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-57 Score=449.04 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=211.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|.+.++||+|+||+||+|++.. +|+.||||+++....
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----------------------------------- 56 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD----------------------------------- 56 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH-----------------------------------
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh-----------------------------------
Confidence 3679999999999999999999753 577899998753211
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
.....+.+|+.+|++++|||||+
T Consensus 57 ---------------------------------------------------------~~~~~f~~E~~il~~l~HpnIV~ 79 (299)
T 4asz_A 57 ---------------------------------------------------------NARKDFHREAELLTNLQHEHIVK 79 (299)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHHhCCCCCCcc
Confidence 01125677888888888888889
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCE
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NI 311 (516)
+++++.+++.+|||||||+ |+|.+++...+ ..+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 80 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NI 159 (299)
T 4asz_A 80 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNC 159 (299)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhE
Confidence 9999988899999999999 69999997642 4699999999999999999999999999999999999
Q ss_pred EEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHH
Q psy12305 312 LINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDE 388 (516)
Q Consensus 312 Ll~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~ 388 (516)
|++.++.+||+|||+|+....... .....+||+.|||||++.+..++.++|+|||||+||||+| |+.||.+.+..+.
T Consensus 160 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 239 (299)
T 4asz_A 160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239 (299)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999986543222 2234578999999999999899999999999999999999 8999999888887
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
+..+.... ....|..+++++.+||.+||+.||++|||++++ |+|++++
T Consensus 240 ~~~i~~~~-------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 240 IECITQGR-------------------------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp HHHHHHTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred HHHHHcCC-------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 77765421 112355789999999999999999999999999 5566543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=451.18 Aligned_cols=251 Identities=22% Similarity=0.344 Sum_probs=204.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|.+.++||+|+||+||+|+++. +++.||||+++....
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~----------------------------------- 84 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE----------------------------------- 84 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSH-----------------------------------
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCH-----------------------------------
Confidence 4679999999999999999998753 678899998853211
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
.....+.+|+.+|++++|||||+
T Consensus 85 ---------------------------------------------------------~~~~~f~~E~~il~~l~HpnIV~ 107 (329)
T 4aoj_A 85 ---------------------------------------------------------SARQDFQREAELLTMLQHQHIVR 107 (329)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCc
Confidence 01125677888888888888888
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCC
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS--------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~ 309 (516)
+++++.+++.+|||||||+ |+|.+++.... .++++..+..|+.||+.||+|||+++||||||||+
T Consensus 108 l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~ 187 (329)
T 4aoj_A 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATR 187 (329)
T ss_dssp EEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHh
Confidence 8999988889999999999 69999987642 45899999999999999999999999999999999
Q ss_pred CEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHH
Q psy12305 310 NLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIE 386 (516)
Q Consensus 310 NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~ 386 (516)
|||++.++.+||+|||+|+...... ......+||+.|||||++.+..++.++|+|||||+||||+| |+.||.+.+..
T Consensus 188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~ 267 (329)
T 4aoj_A 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT 267 (329)
T ss_dssp GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654322 22344679999999999999999999999999999999999 89999998888
Q ss_pred HHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 387 DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 387 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+.+..+.... +...|..+++++.+||.+||+.||++|||++|++++
T Consensus 268 ~~~~~i~~g~-------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 268 EAIDCITQGR-------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHTC-------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHcCC-------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 7777665421 122455789999999999999999999999999764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=446.38 Aligned_cols=213 Identities=21% Similarity=0.284 Sum_probs=169.7
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|++++|||||++++++.. +.+|||||||+ |+|.+++......+++..+..|+.||+.||+|||+++||||
T Consensus 78 ~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHR 156 (307)
T 3omv_A 78 AFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHR 156 (307)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCS
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 56678888888888888888887654 56899999999 69999998877789999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCC--CccccCCcccccccchhhccCC---CCCCceeeehHHHHHHHHHcCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVP--TKTFSNEVVTLWYRPPDVLLGS---TEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~APE~l~~~---~~~~~~d~~SlGvil~elltG~~p 379 (516)
||||+|||++.++.+||+|||+|+..... .......+||+.|||||++.+. +++.++|+|||||+||||+||+.|
T Consensus 157 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P 236 (307)
T 3omv_A 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236 (307)
T ss_dssp CCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999865432 2234556899999999999643 467789999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH-----
Q psy12305 380 FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA----- 454 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~----- 454 (516)
|.+.+....+..+......+|. ....+..+++++.+||.+||+.||++|||+.|+
T Consensus 237 f~~~~~~~~~~~~~~~~~~~p~--------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 237 YSHINNRDQIIFMVGRGYASPD--------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp TTTCCCHHHHHHHHHTTCCCCC--------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHH
T ss_pred CCCCChHHHHHHHHhcCCCCCC--------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 9987666555544332111110 011234788999999999999999999999976
Q ss_pred -HcCCC
Q psy12305 455 -MRHPY 459 (516)
Q Consensus 455 -l~Hp~ 459 (516)
|+||+
T Consensus 297 ~l~~~l 302 (307)
T 3omv_A 297 LLQHSL 302 (307)
T ss_dssp HHHTTC
T ss_pred HHhccC
Confidence 46665
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-55 Score=441.82 Aligned_cols=311 Identities=66% Similarity=1.081 Sum_probs=247.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|+++++||+|+||+||+|++..+|+.||||++..........
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~----------------------------------- 45 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC----------------------------------- 45 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CC-----------------------------------
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccch-----------------------------------
Confidence 478999999999999999999999999999999986543222111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.+.+|+.+++.++||||+++++++
T Consensus 46 --------------------------------------------------------~~~~E~~~l~~l~h~~iv~~~~~~ 69 (324)
T 3mtl_A 46 --------------------------------------------------------TAIREVSLLKDLKHANIVTLHDII 69 (324)
T ss_dssp --------------------------------------------------------CCCCCHHHHSCCCCTTBCCEEEEE
T ss_pred --------------------------------------------------------hHHHHHHHHHhcCCCCCCeeeeEE
Confidence 223477778888888888888888
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+++..++||||++++|.+++...+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 70 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 149 (324)
T 3mtl_A 70 HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA 149 (324)
T ss_dssp ECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEEC
T ss_pred eeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCccccc
Confidence 88899999999999999999998888899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
...........+||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+..+.+..+...++.|+.+.|....
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (324)
T 3mtl_A 150 KSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 229 (324)
T ss_dssp C------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence 6655555566788999999999877 456778899999999999999999999999999999999999998876654321
Q ss_pred c----c--cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcccCCCCCCCCCCCcc
Q psy12305 409 F----C--ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHI 482 (516)
Q Consensus 409 ~----~--~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~~~~~~~~~~~~~~ 482 (516)
. . ..+.... ... ...+..+++++.+||.+||++||.+|||++|+|+||||.++.......+++.+.+....+
T Consensus 230 ~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~ 307 (324)
T 3mtl_A 230 SNEEFKTYNYPKYRA-EAL-LSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEI 307 (324)
T ss_dssp GCHHHHHTCCCCCCC-CCH-HHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTC
T ss_pred cchhhcccccccccc-hhh-hhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHH
Confidence 1 0 1111111 111 112236889999999999999999999999999999999999999999999999999988
Q ss_pred cccCCCCCCCC
Q psy12305 483 KLTSNPTDGGL 493 (516)
Q Consensus 483 ~~~~~~~~~~~ 493 (516)
+.++.+.+++.
T Consensus 308 ~~q~~~~~~~~ 318 (324)
T 3mtl_A 308 QLQKEASLRSA 318 (324)
T ss_dssp CCCC-------
T ss_pred Hhhhhhhhhhh
Confidence 88887776553
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=447.27 Aligned_cols=208 Identities=22% Similarity=0.398 Sum_probs=175.3
Q ss_pred hHHHHHHHHHhccc-cceeeEeeeEee-CceeeEeeehhh-chHHHHHHhc---------------CCCCCHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRH-ANIVTLHDIIHT-EKCLTLVFEYLE-KDLKRYMDDC---------------SNILSMNNVKLFLF 287 (516)
Q Consensus 226 ~~~~Ei~il~~l~H-pnIv~l~~~~~~-~~~~~lV~E~~~-g~L~~~l~~~---------------~~~l~~~~~~~i~~ 287 (516)
.+.+|+.+|++++| ||||+++++|.. ++.+|||||||+ |+|.+++... ...+++..+..++.
T Consensus 113 ~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 192 (353)
T 4ase_A 113 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 192 (353)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHH
Confidence 56788888888865 899999999866 467999999999 6999999753 23489999999999
Q ss_pred HHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeeh
Q psy12305 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMG 365 (516)
Q Consensus 288 qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~S 365 (516)
||+.||+|||+++||||||||+|||++.++.+||+|||+|+....... .....+||+.|||||++.+..++.++|+||
T Consensus 193 qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS 272 (353)
T 4ase_A 193 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 272 (353)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEee
Confidence 999999999999999999999999999999999999999987543322 234567899999999999999999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccC
Q psy12305 366 VGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYD 444 (516)
Q Consensus 366 lGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~d 444 (516)
|||+||||+| |++||.+.+..+.+..+... ..+...|+.+++++.+||.+||+.|
T Consensus 273 ~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~------------------------g~~~~~p~~~~~~~~~li~~c~~~d 328 (353)
T 4ase_A 273 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKE------------------------GTRMRAPDYTTPEMYQTMLDCWHGE 328 (353)
T ss_dssp HHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH------------------------TCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred hHHHHHHHHhCCCCCCCCCCHHHHHHHHHHc------------------------CCCCCCCccCCHHHHHHHHHHcCcC
Confidence 9999999998 99999986654444333221 1122345678999999999999999
Q ss_pred cCCCCCHHHHHcC
Q psy12305 445 AKQRISAANAMRH 457 (516)
Q Consensus 445 P~~R~ta~e~l~H 457 (516)
|++|||+.|+++|
T Consensus 329 P~~RPt~~eil~~ 341 (353)
T 4ase_A 329 PSQRPTFSELVEH 341 (353)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhHCcCHHHHHHH
Confidence 9999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-54 Score=425.01 Aligned_cols=285 Identities=49% Similarity=0.888 Sum_probs=238.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|+++++||+|+||+||+|++..+|+.||||++.......
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------- 42 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------------------------------------- 42 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--------------------------------------
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcC--------------------------------------
Confidence 468999999999999999999999999999999987543211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.++++++||||+++++++
T Consensus 43 ----------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 70 (292)
T 3o0g_A 43 ----------------------------------------------------GVPSSALREICLLKELKHKNIVRLHDVL 70 (292)
T ss_dssp ----------------------------------------------------THHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------CcchHHHHHHHHHhcCCCCCEeeEEeEE
Confidence 1122566788888889999999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+++.+|+||||+++++..++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 71 ~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~ 150 (292)
T 3o0g_A 71 HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 99999999999999999999988778899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPL-FPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~p-F~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
...........+||+.|+|||++.+.. ++.++|+||+||++|+|++|..| |.+.+..+.+..+....+.++.+.|...
T Consensus 151 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (292)
T 3o0g_A 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred cCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhh
Confidence 765656666778999999999998766 67888999999999999987655 7788888999999999999887766443
Q ss_pred cc----ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 408 EF----CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 408 ~~----~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.. ...+.++...... .....+++++.+||.+||+.||++|||++|+++||||++..+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 231 TKLPDYKPYPMYPATTSLV-NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred cccccccccccccCCcchh-hcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 22 1222222211121 223368899999999999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=430.76 Aligned_cols=288 Identities=50% Similarity=0.865 Sum_probs=236.6
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
+.+..++|+++++||+|+||+||+|++. +|+.||||++.......
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---------------------------------- 60 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDE---------------------------------- 60 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC----------------------------------------
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccc----------------------------------
Confidence 3467789999999999999999999995 69999999986432111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.....+.+|+.+++.++||||+++
T Consensus 61 --------------------------------------------------------~~~~~~~~E~~~l~~l~hp~iv~~ 84 (311)
T 3niz_A 61 --------------------------------------------------------GIPSTAIREISLLKELHHPNIVSL 84 (311)
T ss_dssp --------------------------------------------------------CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred --------------------------------------------------------hhhHHHHHHHHHHHHcCCCCEeee
Confidence 112256678888889999999999
Q ss_pred eeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 246 HDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++++.++.++|+||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 85 IDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCc
Confidence 99999999999999999999999998877789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+|+............+||+.|+|||++.+ ..++.++|+||+||++|+|++|++||.+.+..+.+..+....+.++...+
T Consensus 165 ~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 165 LARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp TCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred CceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 99877655555666788999999999876 45677889999999999999999999999988999999998888776544
Q ss_pred hhcccc------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 405 SKLEFC------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~~~~------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
...... ....... ..+.... ..+++++.+||.+||++||.+|||++|+++||||+++.++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEK-KPWSSII-PGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCC-CCHHHHS-TTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred hhhhccchhhhcccccccC-CcHHHhC-cccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 322110 1111111 1122222 3678999999999999999999999999999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-53 Score=423.25 Aligned_cols=286 Identities=51% Similarity=0.844 Sum_probs=222.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++..+|+.||||++........
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------ 46 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT------------------------------------ 46 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCS------------------------------------
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccccc------------------------------------
Confidence 34679999999999999999999999999999999865432221
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||++++++
T Consensus 47 -------------------------------------------------------~~~~~~E~~~l~~l~hp~iv~~~~~ 71 (317)
T 2pmi_A 47 -------------------------------------------------------PSTAIREISLMKELKHENIVRLYDV 71 (317)
T ss_dssp -------------------------------------------------------CHHHHHHHHHHTTCCBTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhcCCCCcceEEEE
Confidence 1245678888888888888888888
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCS-----NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+.+++.+|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 72 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 72 IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp ECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECc
Confidence 88888999999999999999887542 4589999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
||+++............+||+.|+|||++.+. .++.++|+|||||++|||++|++||.+.+..+.+..+....+.++..
T Consensus 152 fg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 231 (317)
T 2pmi_A 152 FGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231 (317)
T ss_dssp CSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTT
T ss_pred CccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 99998766555555667889999999999764 56788899999999999999999999999999999999999998877
Q ss_pred hhhhccccc--CC------CCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 403 LKSKLEFCI--TP------VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 403 ~~~~~~~~~--~~------~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.|....... .+ ............+..+++++.+||.+||+.||++|||++|+++||||+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 665432110 00 0000111222334578899999999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=415.61 Aligned_cols=281 Identities=49% Similarity=0.811 Sum_probs=227.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|++++.||+|+||+||+|++ .+|+.||||++.......
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-------------------------------------- 41 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-------------------------------------- 41 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG--------------------------------------
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc--------------------------------------
Confidence 46899999999999999999999 689999999986532111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 42 ----------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 69 (288)
T 1ob3_A 42 ----------------------------------------------------GIPSTTIREISILKELKHSNIVKLYDVI 69 (288)
T ss_dssp ----------------------------------------------------CCCHHHHHHHHGGGGCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------ccchhHHHHHHHHHhcCCCCEeeeeeEE
Confidence 1122566788888888899999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+++.+|+||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 70 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 149 (288)
T 1ob3_A 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA 149 (288)
T ss_dssp ECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccc
Confidence 99999999999999999999988777899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
...........+||+.|+|||++.+. .++.++|+|||||++|||++|.+||.+.+..+.+..+....+.++...+....
T Consensus 150 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 65444445566889999999999764 46788899999999999999999999999999999999888887765543321
Q ss_pred cc-c----CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 409 FC-I----TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 409 ~~-~----~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.. . .+.... ..+ ......+++++.+||.+||+.||++|||++|+++||||++.
T Consensus 230 ~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 230 ELPKYDPNFTVYEP-LPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp GSTTCCTTCCCCCC-CCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccccccccC-ccH-HHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 11 0 000000 011 12234689999999999999999999999999999999763
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-53 Score=432.54 Aligned_cols=272 Identities=21% Similarity=0.326 Sum_probs=223.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~------------------------------------ 63 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQ------------------------------------ 63 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcc------------------------------------
Confidence 45688999999999999999999999999999999987532100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
........+|..+++.+ +||||++++
T Consensus 64 -----------------------------------------------------~~~~~~~~~E~~il~~~~~hp~Iv~l~ 90 (353)
T 3txo_A 64 -----------------------------------------------------DDDVECTMTEKRILSLARNHPFLTQLF 90 (353)
T ss_dssp -----------------------------------------------------HTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHHHhccCCCceeeEE
Confidence 01122456788888887 699999999
Q ss_pred eeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++.+.+.+|+|||||+| +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 91 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG 169 (353)
T 3txo_A 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEcccc
Confidence 999999999999999985 888888765 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+.+..|....
T Consensus 170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------- 240 (353)
T 3txo_A 170 MCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------- 240 (353)
T ss_dssp TCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------
Confidence 99865544455566789999999999988888889999999999999999999999999888887775421
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH------HHHHcCCCCCCCCCCcccCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA------ANAMRHPYFNSLGPQVHELSDTQS 475 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta------~e~l~Hp~f~~~~~~~~~~~~~~~ 475 (516)
..+|..+++++.+||.+||+.||.+||++ +++++||||+.+.+.........+
T Consensus 241 -----------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~ 299 (353)
T 3txo_A 241 -----------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEP 299 (353)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred -----------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCC
Confidence 22345789999999999999999999998 899999999988765443333333
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=425.61 Aligned_cols=264 Identities=25% Similarity=0.374 Sum_probs=226.6
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 45 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA------------------------------------- 45 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-------------------------------------
Confidence 4678999999999999999999999999999999986532100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+|+.++||||++++++
T Consensus 46 ----------------------------------------------------~~~~~~~~~E~~~l~~l~hp~iv~l~~~ 73 (337)
T 1o6l_A 46 ----------------------------------------------------KDEVAHTVTESRVLQNTRHPFLTALKYA 73 (337)
T ss_dssp ----------------------------------------------------TTCHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ----------------------------------------------------hhHHHHHHHHHHHHHhCCCCcCcceEEE
Confidence 1112256678888999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+.+.+|+||||++| +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 74 ~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a 152 (337)
T 1o6l_A 74 FQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccch
Confidence 9999999999999985 888887764 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+.......+...
T Consensus 153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~------------ 220 (337)
T 1o6l_A 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------ 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred hhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 86544445556678999999999999888889999999999999999999999998877776666431
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcc
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~ 468 (516)
...+|..+++++.+||.+||+.||.+|| +++++++||||..+.+...
T Consensus 221 --------------~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~ 272 (337)
T 1o6l_A 221 --------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred --------------CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 1123457899999999999999999999 9999999999998775543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=442.93 Aligned_cols=287 Identities=33% Similarity=0.560 Sum_probs=210.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...++|++++.||+|+||+||+|+++.+|+.||||++...... ...+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~-------------------------------- 97 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCK-------------------------------- 97 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHH--------------------------------
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHH--------------------------------
Confidence 3447899999999999999999999999999999998653211 1111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.+.+|+.+|+.++||||++++
T Consensus 98 -----------------------------------------------------------~~~~E~~~l~~l~h~niv~l~ 118 (458)
T 3rp9_A 98 -----------------------------------------------------------RILREIAILNRLNHDHVVKVL 118 (458)
T ss_dssp -----------------------------------------------------------HHHHHHHHHHHCCCTTBCCEE
T ss_pred -----------------------------------------------------------HHHHHHHHHHhCCCCCCCceE
Confidence 344555555555666666666
Q ss_pred eeEe-----eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 247 DIIH-----TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 247 ~~~~-----~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
+++. ....+|+||||++++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 119 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp EECCCSCTTTCCCEEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEE
T ss_pred EEEecCCcccCceEEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEee
Confidence 6553 23568999999999999988764 56999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCC---------------------------ccccCCcccccccchhhcc-CCCCCCceeeehHHHHHHHH
Q psy12305 322 ADFGLARAKSVPT---------------------------KTFSNEVVTLWYRPPDVLL-GSTEYSTSIDMGVGCIFHEM 373 (516)
Q Consensus 322 ~DFGla~~~~~~~---------------------------~~~~~~~gt~~y~APE~l~-~~~~~~~~d~~SlGvil~el 373 (516)
+|||+|+...... ......+||++|+|||++. +..++.++|+|||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 9999998754221 1234568899999999864 45577888999999999999
Q ss_pred Hc-----------CCCCCCCCC--------------------HHHHHHHHHHhcCCCChhhhhhcccc-------cCCCC
Q psy12305 374 SS-----------GRPLFPGST--------------------IEDELRLICSILGPPPDELKSKLEFC-------ITPVY 415 (516)
Q Consensus 374 lt-----------G~~pF~~~~--------------------~~~~~~~i~~~~~~~p~~~~~~~~~~-------~~~~~ 415 (516)
++ |+++|++.+ ..+++..|...+|.|+.+.+...... ..+..
T Consensus 278 ltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 357 (458)
T 3rp9_A 278 LNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKR 357 (458)
T ss_dssp HTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCC
T ss_pred HHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCC
Confidence 99 888888765 36788899999999998766433211 11111
Q ss_pred CCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcc
Q psy12305 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 416 ~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~ 468 (516)
.. ..+...+| ..++++.+||.+||++||.+|||++|+|+||||+.+.....
T Consensus 358 ~~-~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~ 408 (458)
T 3rp9_A 358 EG-TDLAERFP-ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408 (458)
T ss_dssp CC-CCGGGGST-TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGG
T ss_pred CC-CCHHHHCC-CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCcc
Confidence 11 12222333 67999999999999999999999999999999998865543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=420.01 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=222.2
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|++..+|+.||||++.......
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~------------------------------------ 55 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP------------------------------------ 55 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH------------------------------------
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH------------------------------------
Confidence 46788999999999999999999999999999999986542110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.+|+.++||||+++++
T Consensus 56 ------------------------------------------------------~~~~~~~~E~~~l~~l~hpnIv~l~~ 81 (328)
T 3fe3_A 56 ------------------------------------------------------TSLQKLFREVRIMKILNHPNIVKLFE 81 (328)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 01124667888999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+++.+|+||||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 82 VIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred EEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 9999999999999997 5898888765 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
|+..... ......+||+.|+|||++.+..++ .++|+||+||++|+|++|+.||.+.+..+....+....
T Consensus 161 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--------- 230 (328)
T 3fe3_A 161 SNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK--------- 230 (328)
T ss_dssp CGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------
Confidence 9866533 334567899999999999887766 57899999999999999999999988877776664321
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...|..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 231 -----------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 231 -----------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred -----------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 123446889999999999999999999999999999998643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-52 Score=430.16 Aligned_cols=274 Identities=26% Similarity=0.379 Sum_probs=225.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|+++++||+|+||+||+|+++.+++.||||++++......
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~----------------------------------- 93 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDD----------------------------------- 93 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-------------------------------------
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCH-----------------------------------
Confidence 356889999999999999999999999999999999976432110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
.....+.+|..++.++ +||||++++
T Consensus 94 ------------------------------------------------------~~~~~~~~E~~il~~~~~hp~Iv~l~ 119 (396)
T 4dc2_A 94 ------------------------------------------------------EDIDWVQTEKHVFEQASNHPFLVGLH 119 (396)
T ss_dssp --------------------------------------------------------CCHHHHHHHHHHHHTTCTTBCCEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhcCCCCCcCeeE
Confidence 0112456788888777 899999999
Q ss_pred eeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++|.++..+|+||||++| +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 120 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG 198 (396)
T 4dc2_A 120 SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198 (396)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecc
Confidence 999999999999999985 888888764 469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH---------HHHHHHHHHhc
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI---------EDELRLICSIL 396 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~---------~~~~~~i~~~~ 396 (516)
+|+............+||+.|+|||++.+..++.++|+|||||++|||++|++||.+... ......+..
T Consensus 199 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-- 276 (396)
T 4dc2_A 199 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-- 276 (396)
T ss_dssp TCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--
T ss_pred eeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--
Confidence 998655455556678999999999999998888999999999999999999999964321 112222211
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH------HHHHcCCCCCCCCCCcccC
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA------ANAMRHPYFNSLGPQVHEL 470 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta------~e~l~Hp~f~~~~~~~~~~ 470 (516)
.....|..+++++.+||.+||+.||.+||++ +|+++||||+.++|.....
T Consensus 277 ------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~ 332 (396)
T 4dc2_A 277 ------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQ 332 (396)
T ss_dssp ------------------------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHT
T ss_pred ------------------------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHc
Confidence 1223456789999999999999999999985 7999999999987655444
Q ss_pred CCCCCCC
Q psy12305 471 SDTQSIF 477 (516)
Q Consensus 471 ~~~~~~~ 477 (516)
....++|
T Consensus 333 ~~~~pp~ 339 (396)
T 4dc2_A 333 KQVVPPF 339 (396)
T ss_dssp TCSCCSC
T ss_pred CCCCCCC
Confidence 4433333
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=421.25 Aligned_cols=266 Identities=28% Similarity=0.399 Sum_probs=226.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|+++.+|+.||||++.........
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~------------------------------------ 54 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR------------------------------------ 54 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS------------------------------------
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc------------------------------------
Confidence 35699999999999999999999999999999999765322110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.......+.+|+.+|++++||||+++++++
T Consensus 55 --------------------------------------------------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 84 (361)
T 2yab_A 55 --------------------------------------------------RGVCREEIEREVSILRQVLHPNIITLHDVY 84 (361)
T ss_dssp --------------------------------------------------SSBCHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred --------------------------------------------------chhHHHHHHHHHHHHHhCCCcCCCcEEEEE
Confidence 001123577899999999999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC----CEEEeee
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG----ELKLADF 324 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkL~DF 324 (516)
.+...+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 85 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 85 ENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 99999999999997 6898888664 4699999999999999999999999999999999999998877 7999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+++..... ......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+.+..|.......+...+
T Consensus 164 G~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 164 GLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp SSCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred CCceEcCCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 999876532 3345568999999999999888889999999999999999999999999888888877655444333322
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
..+++++++||.+||..||.+|||++|+++||||+...+
T Consensus 243 ----------------------~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 243 ----------------------SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred ----------------------cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 267899999999999999999999999999999987653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=441.29 Aligned_cols=283 Identities=32% Similarity=0.516 Sum_probs=218.8
Q ss_pred ccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 85 IGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 85 ~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..+...++|+++++||+|+||+||+|++..+|+.||||++...... ...+.+.
T Consensus 56 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~-------------------------- 109 (464)
T 3ttj_A 56 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-------------------------- 109 (464)
T ss_dssp CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHH--------------------------
T ss_pred cceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHH--------------------------
Confidence 3445678999999999999999999999999999999999754211 1122334
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccccee
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 243 (516)
+|+.+|+.++||||+
T Consensus 110 -----------------------------------------------------------------~E~~~l~~l~hpnIv 124 (464)
T 3ttj_A 110 -----------------------------------------------------------------RELVLMKCVNHKNII 124 (464)
T ss_dssp -----------------------------------------------------------------HHHHHHHHCCCTTBC
T ss_pred -----------------------------------------------------------------HHHHHHHhCCCCCCC
Confidence 455555555555555
Q ss_pred eEeeeEeeC------ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC
Q psy12305 244 TLHDIIHTE------KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317 (516)
Q Consensus 244 ~l~~~~~~~------~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 317 (516)
++++++... ..+|+||||+++++.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 125 ~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~ 201 (464)
T 3ttj_A 125 SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC 201 (464)
T ss_dssp CCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred cEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC
Confidence 555555432 45799999999998888753 499999999999999999999999999999999999999999
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~ 397 (516)
.+||+|||+|+.... .......+||++|+|||++.+..++.++|+||+||++|||++|++||.+.+..+++..|...+|
T Consensus 202 ~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg 280 (464)
T 3ttj_A 202 TLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 280 (464)
T ss_dssp CEEECCCCCC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred CEEEEEEEeeeecCC-CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999999999987543 2334556899999999999998899999999999999999999999999999999999999999
Q ss_pred CCChhhhhhcccc------cCCCCCCchhhhhcCCCC-----------CCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 398 PPPDELKSKLEFC------ITPVYPSESKLQLLAPEQ-----------MDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 398 ~~p~~~~~~~~~~------~~~~~~~~~~~~~~~p~~-----------~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.|+.+.+...... ..+.+.. ..+...+|.. .+++++|||.+||++||++|||++|+|+||||
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~ 359 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAG-LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCC-CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred CCCHHHHHHcchhhhhHhhcccccCC-CChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence 9988776443210 1111111 1111112211 15679999999999999999999999999999
Q ss_pred CCC
Q psy12305 461 NSL 463 (516)
Q Consensus 461 ~~~ 463 (516)
+..
T Consensus 360 ~~~ 362 (464)
T 3ttj_A 360 NVW 362 (464)
T ss_dssp GGG
T ss_pred hhc
Confidence 853
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=428.90 Aligned_cols=286 Identities=32% Similarity=0.586 Sum_probs=219.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|++..+|+.||||++.......
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~------------------------------------ 49 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNS------------------------------------ 49 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCH------------------------------------
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccCh------------------------------------
Confidence 45678999999999999999999999999999999985431110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 246 (516)
.......+|+.+++.+. ||||++++
T Consensus 50 ------------------------------------------------------~~~~~~~~E~~~l~~l~~h~niv~l~ 75 (388)
T 3oz6_A 50 ------------------------------------------------------TDAQRTFREIMILTELSGHENIVNLL 75 (388)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhccCCCCCCeee
Confidence 00124557778888886 88888888
Q ss_pred eeEeeCc--eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 247 DIIHTEK--CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 247 ~~~~~~~--~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+++..++ .+|+|||||+++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 76 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DF 153 (388)
T 3oz6_A 76 NVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADF 153 (388)
T ss_dssp EEEECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCC
Confidence 8886543 7899999999999998876 46999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCC---------------------CccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCC
Q psy12305 325 GLARAKSVP---------------------TKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPG 382 (516)
Q Consensus 325 Gla~~~~~~---------------------~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~ 382 (516)
|+|+..... .......+||++|+|||++.+ ..++.++|+||+||++|||++|++||++
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 999864321 122344689999999999987 4567788999999999999999999999
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccc----------------cCC---CCCC--chhhhhcCCCCCCHHHHHHHHHcc
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFC----------------ITP---VYPS--ESKLQLLAPEQMDSDALDLVQKFL 441 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~----------------~~~---~~~~--~~~~~~~~p~~~s~~~~dLl~~~L 441 (516)
.+..+++..|...++.|+.+.+...... ... .++. ........+..+++++.+||.+||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 9999999999999999987655322100 000 0000 000112233478899999999999
Q ss_pred ccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 442 MYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 442 ~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
++||++|||++|+|+||||+....
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred ccCcccCCCHHHHhCCHHHHHhcC
Confidence 999999999999999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=424.43 Aligned_cols=265 Identities=24% Similarity=0.400 Sum_probs=225.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|+++.+|+.||||+++......
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 57 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM------------------------------------ 57 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH------------------------------------
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhh------------------------------------
Confidence 35688999999999999999999999999999999987542100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
........+|..++..+ +||||++++
T Consensus 58 -----------------------------------------------------~~~~~~~~~E~~il~~~~~hp~iv~l~ 84 (345)
T 1xjd_A 58 -----------------------------------------------------DDDVECTMVEKRVLSLAWEHPFLTHMF 84 (345)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred -----------------------------------------------------hhhHHHHHHHHHHHHhcCCCCCCCcEE
Confidence 01122456778888776 899999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++++...+|+||||++ |+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 85 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG 163 (345)
T 1xjd_A 85 CTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163 (345)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeECh
Confidence 99999999999999998 5898888764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+.+..|....
T Consensus 164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------- 234 (345)
T 1xjd_A 164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------- 234 (345)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred hhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------
Confidence 99865444444566789999999999999888899999999999999999999999988887777664321
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH-HHHcCCCCCCCCCCcc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA-NAMRHPYFNSLGPQVH 468 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~-e~l~Hp~f~~~~~~~~ 468 (516)
...|..+++++.+||.+||+.||.+|||+. ++++||||+.+.+...
T Consensus 235 -----------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l 281 (345)
T 1xjd_A 235 -----------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281 (345)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred -----------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence 123457899999999999999999999998 9999999998875543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=419.96 Aligned_cols=286 Identities=47% Similarity=0.788 Sum_probs=226.6
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|+++++||+|+||+||+|++..+|+.||||++.......
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 74 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE------------------------------------ 74 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------------------------------------
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccccc------------------------------------
Confidence 46688999999999999999999999999999999986542211
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.+++.++||||+++++
T Consensus 75 ------------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 100 (329)
T 3gbz_A 75 ------------------------------------------------------GVPGTAIREVSLLKELQHRNIIELKS 100 (329)
T ss_dssp -----------------------------------------------------------CHHHHHHGGGCCCTTBCCEEE
T ss_pred ------------------------------------------------------ccchhHHHHHHHHHHcCCCCcceEEE
Confidence 01124567888888889999999999
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc-----cCCCEEEe
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-----ERGELKLA 322 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~-----~~~~vkL~ 322 (516)
++.++..+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 101 ~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 101 VIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEETTEEEEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEecCCEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence 999999999999999999999998754 599999999999999999999999999999999999994 44569999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|||+|+............+||+.|+|||++.+.. +..++|+|||||++|||++|.+||.+.+..+.+..+....+.|+.
T Consensus 180 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 180 DFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259 (329)
T ss_dssp CTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCT
T ss_pred cCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCch
Confidence 9999987665555556678899999999998754 678889999999999999999999999999999999999888877
Q ss_pred hhhhhcccc-----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 402 ELKSKLEFC-----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 402 ~~~~~~~~~-----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
..+...... ..+.... .......+..+++++.+||.+||++||.+|||++|+|+||||++..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRG-KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCC-CCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhhhhhhcc-ccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 655432211 1111111 12222233347899999999999999999999999999999998654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=411.38 Aligned_cols=285 Identities=37% Similarity=0.629 Sum_probs=225.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++..+|+.||||++.........
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------- 51 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGG----------------------------------- 51 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTS-----------------------------------
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccc-----------------------------------
Confidence 346899999999999999999999999999999998754321110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc---ccceeeE
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR---HANIVTL 245 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l 245 (516)
........+|+.+++.++ ||||+++
T Consensus 52 ----------------------------------------------------~~~~~~~~~e~~~l~~l~~~~h~niv~~ 79 (308)
T 3g33_A 52 ----------------------------------------------------GGLPISTVREVALLRRLEAFEHPNVVRL 79 (308)
T ss_dssp ----------------------------------------------------SCCCHHHHHHHHHHHHHHHHCCTTBCCE
T ss_pred ----------------------------------------------------cccchhHHHHHHHHHHHhhcCCCCeEEe
Confidence 011123445665555553 8888888
Q ss_pred eeeEeeCc-----eeeEeeehhhchHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCE
Q psy12305 246 HDIIHTEK-----CLTLVFEYLEKDLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGEL 319 (516)
Q Consensus 246 ~~~~~~~~-----~~~lV~E~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~v 319 (516)
++++.... .+++||||++++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 80 MDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp EEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCE
T ss_pred eeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE
Confidence 88877654 5899999999999999987543 49999999999999999999999999999999999999999999
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
||+|||+|+..... ......+||+.|+|||++.+..++.++|+|||||++|+|++|++||.+.+..+.+..+....+.+
T Consensus 160 kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (308)
T 3g33_A 160 KLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLP 238 (308)
T ss_dssp EECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEeeCccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999999865432 33345688999999999999889999999999999999999999999999999999999999988
Q ss_pred Chhhhhhcccc---cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 400 PDELKSKLEFC---ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 400 p~~~~~~~~~~---~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
+...|...... ..+.... ...... ...+++++.+||.+||++||++|||++|+|+||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 239 PEDDWPRDVSLPRGAFPPRGP-RPVQSV-VPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp CTTTSCSSCSSCGGGSCCCCC-CCHHHH-SCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred ChhhccchhhccccccCCCCC-CcHHHh-CccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 87655322110 0110000 111122 23688999999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=421.53 Aligned_cols=285 Identities=34% Similarity=0.580 Sum_probs=220.8
Q ss_pred cccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccce
Q psy12305 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEK 162 (516)
Q Consensus 84 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 162 (516)
...+...++|++++.||+|+||+||+|++..+|+.||||++...... ...+
T Consensus 18 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~---------------------------- 69 (367)
T 1cm8_A 18 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---------------------------- 69 (367)
T ss_dssp SSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHH----------------------------
T ss_pred CceeeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHH----------------------------
Confidence 33445567899999999999999999999999999999998653211 1112
Q ss_pred eeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccce
Q psy12305 163 CLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 242 (516)
Q Consensus 163 ~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI 242 (516)
.+.+|+.+|+.++||||
T Consensus 70 ---------------------------------------------------------------~~~~E~~~l~~l~hpnI 86 (367)
T 1cm8_A 70 ---------------------------------------------------------------RAYRELRLLKHMRHENV 86 (367)
T ss_dssp ---------------------------------------------------------------HHHHHHHHHHHCCBTTB
T ss_pred ---------------------------------------------------------------HHHHHHHHHHhCCCcCC
Confidence 33445555555555555
Q ss_pred eeEeeeEeeC------ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC
Q psy12305 243 VTLHDIIHTE------KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER 316 (516)
Q Consensus 243 v~l~~~~~~~------~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~ 316 (516)
+++++++... ..+|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 87 v~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~ 164 (367)
T 1cm8_A 87 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 164 (367)
T ss_dssp CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT
T ss_pred CCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCC
Confidence 5555555443 34699999998899988876 459999999999999999999999999999999999999999
Q ss_pred CCEEEeeeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHh
Q psy12305 317 GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395 (516)
Q Consensus 317 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~ 395 (516)
+.+||+|||+|+.... .....+||++|+|||++.+ ..++.++|+||+||++|||++|++||.+.+..+++..|...
T Consensus 165 ~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 241 (367)
T 1cm8_A 165 CELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV 241 (367)
T ss_dssp CCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred CCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999999987543 2345688999999999987 56788899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.|.|+.+++...... ..+.... ..+.... ...++++.+||.+||++||.+|||++++|+||||+.....
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMKGLPELEK-KDFASIL-TNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCC-CCGGGTC-TTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred cCCCCHHHHHHhhhHHHHHHHHhCCCCCC-CCHHHHC-CCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 999998876543211 1111111 1222222 3678999999999999999999999999999999886543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=410.53 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=222.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++..+|+.||||++.......
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 60 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK------------------------------------- 60 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-------------------------------------
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-------------------------------------
Confidence 4567999999999999999999999999999999886532211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||++++++
T Consensus 61 -------------------------------------------------------~~~~~~E~~~l~~l~hp~iv~~~~~ 85 (297)
T 3fxz_A 61 -------------------------------------------------------KELIINEILVMRENKNPNIVNYLDS 85 (297)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHhcCCCCCCCeEeEE
Confidence 1246678888888889999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..++..|+||||++ ++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 86 ~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 86 YLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999997 5888888764 5999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+............+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+.......+.....+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--------- 234 (297)
T 3fxz_A 164 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP--------- 234 (297)
T ss_dssp EECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC---------
T ss_pred eecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 87765555556678999999999999988999999999999999999999999988877766655432211
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
....|..+++.+.+||.+||+.||++|||++|+++||||+...
T Consensus 235 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 235 --------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp --------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred --------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 1112346789999999999999999999999999999998653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=427.10 Aligned_cols=276 Identities=22% Similarity=0.282 Sum_probs=228.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~------------------------------------- 109 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK------------------------------------- 109 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhh-------------------------------------
Confidence 4578999999999999999999999999999999986532100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+++.++||||++++++
T Consensus 110 ----------------------------------------------------~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 110 ----------------------------------------------------RSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp ----------------------------------------------------TCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ----------------------------------------------------hHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 0111246678888888899999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
|.++.++|+|||||+ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEecccee
Confidence 999999999999997 589888865 35999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCC----CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGST----EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~----~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
+....... .....+||+.|+|||++.+.. ++.++|+|||||++|||++|.+||.+.+..+....|.....
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----- 290 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN----- 290 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH-----
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc-----
Confidence 87654332 234678999999999998755 56788999999999999999999999988888877754210
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCCcccCCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQVHELSDTQSIF 477 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~~~~~~~~~~~~ 477 (516)
......+..+++++++||.+||+.+|.+ |++++|+++||||+.+.+.........+++
T Consensus 291 -----------------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~~~~~~p~ 350 (410)
T 3v8s_A 291 -----------------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPV 350 (410)
T ss_dssp -----------------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTGGGSCCSC
T ss_pred -----------------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhhcccCCCC
Confidence 0011112368999999999999999998 999999999999999887765555544443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=421.83 Aligned_cols=273 Identities=21% Similarity=0.309 Sum_probs=228.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~------------------------------------ 60 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------------------------------------ 60 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHH------------------------------------
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhc------------------------------------
Confidence 35688999999999999999999999999999999987542100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
......+.+|..+|..+ +||||++++
T Consensus 61 -----------------------------------------------------~~~~~~~~~E~~~l~~~~~hp~iv~l~ 87 (353)
T 2i0e_A 61 -----------------------------------------------------DDDVECTMVEKRVLALPGKPPFLTQLH 87 (353)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred -----------------------------------------------------chHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence 01122456788888877 799999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++++.+.+|+||||++ |+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 88 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG 166 (353)
T 2i0e_A 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 166 (353)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCC
Confidence 99999999999999998 4898888765 359999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+............+||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+..+.+..|...
T Consensus 167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------- 236 (353)
T 2i0e_A 167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH---------- 236 (353)
T ss_dssp TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----------
T ss_pred cccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC----------
Confidence 9986544444556678999999999999888889999999999999999999999998888777777542
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQSI 476 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~~ 476 (516)
...+|..+++++.+||.+||+.||.+||+ ++++++||||+.+.|.........++
T Consensus 237 ----------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p 296 (353)
T 2i0e_A 237 ----------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPP 296 (353)
T ss_dssp ----------------CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCS
T ss_pred ----------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCC
Confidence 11234578999999999999999999994 69999999999887654443333333
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-51 Score=412.31 Aligned_cols=270 Identities=22% Similarity=0.320 Sum_probs=228.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------------------------------------- 46 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------------------------------------- 46 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhh-------------------------------------
Confidence 4678999999999999999999999999999999986532100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+++.++||||++++++
T Consensus 47 ----------------------------------------------------~~~~~~~~~E~~~l~~l~hp~Iv~~~~~ 74 (318)
T 1fot_A 47 ----------------------------------------------------LKQVEHTNDERLMLSIVTHPFIIRMWGT 74 (318)
T ss_dssp ----------------------------------------------------TTCHHHHHHHHHHHHSCCBTTBCCEEEE
T ss_pred ----------------------------------------------------hhHHHHHHHHHHHHhhCCCCCCceEeEE
Confidence 0112245678889999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+...+|+||||++| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 75 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a 153 (318)
T 1fot_A 75 FQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153 (318)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcc
Confidence 9999999999999984 898888764 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+.... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+.+..+....
T Consensus 154 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~----------- 219 (318)
T 1fot_A 154 KYVPD---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------- 219 (318)
T ss_dssp EECSS---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred eecCC---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 86542 2335689999999999999888899999999999999999999999988877777665421
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcccCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHELSDTQSIF 477 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~~~~ 477 (516)
..+|..+++++.+||.+||+.||.+|| +++++++||||+.+.+..........++
T Consensus 220 ---------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~p~ 279 (318)
T 1fot_A 220 ---------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 279 (318)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSC
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCCCCCCC
Confidence 123457889999999999999999999 8999999999998876544433333333
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=418.24 Aligned_cols=265 Identities=26% Similarity=0.384 Sum_probs=220.2
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++++.||+|+||+||+|+++.+|+.||||++.+......
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~----------------------------------- 50 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDD----------------------------------- 50 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSH-----------------------------------
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcch-----------------------------------
Confidence 356789999999999999999999999999999999875432110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
.....+.+|+.+++++ +||||++++
T Consensus 51 ------------------------------------------------------~~~~~~~~E~~~l~~~~~hp~iv~l~ 76 (345)
T 3a8x_A 51 ------------------------------------------------------EDIDWVQTEKHVFEQASNHPFLVGLH 76 (345)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhcCCCCccCeEE
Confidence 0112456788888887 899999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++.++..+|+||||++ ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 77 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG 155 (345)
T 3a8x_A 77 SCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155 (345)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGG
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecc
Confidence 99999999999999998 5888888764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC---------HHHHHHHHHHhc
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST---------IEDELRLICSIL 396 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~---------~~~~~~~i~~~~ 396 (516)
+|+............+||+.|+|||++.+..++.++|+|||||++|||++|++||.... .......+..
T Consensus 156 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-- 233 (345)
T 3a8x_A 156 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-- 233 (345)
T ss_dssp GCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--
T ss_pred ccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--
Confidence 99865444445566789999999999999888899999999999999999999997521 1122222211
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH------HHHHcCCCCCCCCCCcc
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA------ANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta------~e~l~Hp~f~~~~~~~~ 468 (516)
.....|..+++++.+||.+||+.||.+|||+ +++++||||+.+.+...
T Consensus 234 ------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~ 287 (345)
T 3a8x_A 234 ------------------------KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287 (345)
T ss_dssp ------------------------CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred ------------------------CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHH
Confidence 1122455789999999999999999999995 89999999998876543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=428.28 Aligned_cols=286 Identities=30% Similarity=0.549 Sum_probs=221.6
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...++|++++.||+|+||+||+|++..+|+.||||++...... ...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~--------------------------------- 69 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC--------------------------------- 69 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHH---------------------------------
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHH---------------------------------
Confidence 4457899999999999999999999999999999998643211 111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
..+.+|+.+|+.++||||++++
T Consensus 70 ----------------------------------------------------------~~~~~E~~~l~~l~h~nIv~l~ 91 (432)
T 3n9x_A 70 ----------------------------------------------------------KRILREITILNRLKSDYIIRLY 91 (432)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHCCCTTBCCEE
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHcCCCCcceEE
Confidence 1345566666666666666666
Q ss_pred eeEeeC-----ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 247 DIIHTE-----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 247 ~~~~~~-----~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
+++... ..+|+||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 92 DLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp EECCCSCTTTCCCEEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEecCCCCcCCeEEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEE
Confidence 666554 568999999999999998763 56999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCC----------------------ccccCCcccccccchhhcc-CCCCCCceeeehHHHHHHHHHc---
Q psy12305 322 ADFGLARAKSVPT----------------------KTFSNEVVTLWYRPPDVLL-GSTEYSTSIDMGVGCIFHEMSS--- 375 (516)
Q Consensus 322 ~DFGla~~~~~~~----------------------~~~~~~~gt~~y~APE~l~-~~~~~~~~d~~SlGvil~ellt--- 375 (516)
+|||+|+...... ......+||++|+|||++. +..++.++|+||+||++|||++
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 9999998754322 1235678999999999864 4557778899999999999998
Q ss_pred --------CCCCCCCCC-----------------HHHHHHHHHHhcCCCChhhhhhcccc-------cCCCCCCchhhhh
Q psy12305 376 --------GRPLFPGST-----------------IEDELRLICSILGPPPDELKSKLEFC-------ITPVYPSESKLQL 423 (516)
Q Consensus 376 --------G~~pF~~~~-----------------~~~~~~~i~~~~~~~p~~~~~~~~~~-------~~~~~~~~~~~~~ 423 (516)
|.++|++.+ ..+++..|...+|.|+.+.+...... ..+.... ..+..
T Consensus 251 p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 329 (432)
T 3n9x_A 251 SHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP-INLKQ 329 (432)
T ss_dssp TTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC-CCHHH
T ss_pred ccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC-CCHHH
Confidence 566676654 46788999999999998765432210 1111111 12222
Q ss_pred cCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCc
Q psy12305 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 424 ~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~ 467 (516)
..| .+++++.+||.+||++||.+|||++|+|+||||+++.+..
T Consensus 330 ~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 330 KYP-SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HST-TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HCC-CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 233 6899999999999999999999999999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=406.85 Aligned_cols=286 Identities=32% Similarity=0.588 Sum_probs=224.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|+++++||+|+||+||+|++..+|+.||||++.......
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------- 43 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDP-------------------------------------- 43 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-H--------------------------------------
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccch--------------------------------------
Confidence 578999999999999999999999999999999885432110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.++++++||||+++++++
T Consensus 44 ----------------------------------------------------~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 71 (311)
T 4agu_A 44 ----------------------------------------------------VIKKIALREIRMLKQLKHPNLVNLLEVF 71 (311)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhCCCCCccchhhee
Confidence 0112456788999999999999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
...+..++||||++++++..+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 151 (311)
T 4agu_A 72 RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARL 151 (311)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence 99999999999999765555555566799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
...........+||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+.+..+....+....+..+........
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 152 LTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp CC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred ccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence 6655555556688999999999976 456788899999999999999999999999999999998888887665443211
Q ss_pred c---c---cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 409 F---C---ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 409 ~---~---~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
. . ..+............+ .+++++.+||.+||+.||.+|||++|+++||||+++.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFP-NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCT-TCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cccccccCcCCCccccchhhhhcc-cccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 1 1 1111111112222233 688999999999999999999999999999999987544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=415.46 Aligned_cols=287 Identities=38% Similarity=0.666 Sum_probs=231.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+|+.||||++........
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------------ 51 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA------------------------------------ 51 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------------------------------
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchh------------------------------------
Confidence 45789999999999999999999999999999999865321110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.......+.+|+.+++.++||||++++++
T Consensus 52 ---------------------------------------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (346)
T 1ua2_A 52 ---------------------------------------------------KDGINRTALREIKLLQELSHPNIIGLLDA 80 (346)
T ss_dssp -------------------------------------------------------CTHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ---------------------------------------------------hhhhhHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 00112256788999999999999999999
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+......++||||++++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 81 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 81 FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp ECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 99999999999999999999998877789999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
............+||+.|+|||++.+.. +..++|+|||||++|||++|.+||.+.+..+.+..+....+.++.+.|...
T Consensus 161 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred eccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 7665555556678999999999997654 566789999999999999999999999999999999998888877655432
Q ss_pred cc----ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 408 EF----CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 408 ~~----~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.. ......+. ...... ...+++++.+||.+||+.||.+|||++|+++||||++..
T Consensus 241 ~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 241 CSLPDYVTFKSFPG-IPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TSSTTCCCCCCCCC-CCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCcccccccccCC-CChHHh-hccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 11 00111110 011111 236789999999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=422.02 Aligned_cols=266 Identities=22% Similarity=0.322 Sum_probs=221.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|+++.+++.||||++.+.......
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~---------------------------------- 80 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKK---------------------------------- 80 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------------------------------
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhH----------------------------------
Confidence 4568899999999999999999999999999999999765321110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHH-HHhccccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSL-LRELRHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~ 246 (516)
....+.+|..+ ++.++||||++++
T Consensus 81 -------------------------------------------------------~~~~~~~e~~~ll~~~~hp~Iv~l~ 105 (373)
T 2r5t_A 81 -------------------------------------------------------EEKHIMSERNVLLKNVKHPFLVGLH 105 (373)
T ss_dssp -----------------------------------------------------------------CCBCCCCCTTBCCEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCCEE
Confidence 00122344444 4667899999999
Q ss_pred eeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++.+.+.+|+||||++| +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 106 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG 184 (373)
T 2r5t_A 106 FSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFG 184 (373)
T ss_dssp EEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCc
Confidence 999999999999999985 888888764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+....|...
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------- 254 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK---------- 254 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----------
T ss_pred cccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----------
Confidence 9987554444556678999999999999988888999999999999999999999998888777777542
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH----HHHHcCCCCCCCCCCccc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA----ANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta----~e~l~Hp~f~~~~~~~~~ 469 (516)
....|..+++++.+||.+||+.||.+||++ +++++||||+.++|....
T Consensus 255 ----------------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~ 306 (373)
T 2r5t_A 255 ----------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLI 306 (373)
T ss_dssp ----------------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHH
T ss_pred ----------------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHH
Confidence 112344789999999999999999999986 699999999988765443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=427.26 Aligned_cols=267 Identities=21% Similarity=0.293 Sum_probs=225.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~------------------------------------- 114 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLK------------------------------------- 114 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH-------------------------------------
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhh-------------------------------------
Confidence 3478999999999999999999999999999999986532100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.++..++||||++++++
T Consensus 115 ----------------------------------------------------~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 142 (437)
T 4aw2_A 115 ----------------------------------------------------RAETACFREERDVLVNGDSKWITTLHYA 142 (437)
T ss_dssp ----------------------------------------------------TTTTCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 0111246678888888899999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
|.+++.+|||||||+ |+|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 143 ~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp EECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 999999999999997 6999999876678999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+....... .....+||+.|+|||++. +..++.++|+|||||++|||++|++||.+.+..+.+..|.....
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---- 298 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE---- 298 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH----
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc----
Confidence 76543332 334468999999999997 45677889999999999999999999999988888877754211
Q ss_pred hhhhhcccccCCCCCCchhhhhcCC---CCCCHHHHHHHHHccccCcCC--CCCHHHHHcCCCCCCCCCCcc
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAP---EQMDSDALDLVQKFLMYDAKQ--RISAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p---~~~s~~~~dLl~~~L~~dP~~--R~ta~e~l~Hp~f~~~~~~~~ 468 (516)
...+| ..+++++++||.+||+.+|++ |++++|+++||||++++|...
T Consensus 299 --------------------~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 299 --------------------RFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp --------------------HCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred --------------------cccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 11112 258999999999999999998 999999999999998876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-51 Score=423.69 Aligned_cols=287 Identities=29% Similarity=0.488 Sum_probs=223.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
..+|++++.||+|+||+||+|++..+|+.||||++..... ...+|+++|+.|+|||||++++++...+.
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~------ 121 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGE------ 121 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEET------
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCC------
Confidence 4569999999999999999999999999999999864321 23356666666666666655544321110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.
T Consensus 122 -------------------------------------------------------------------------------~ 122 (420)
T 1j1b_A 122 -------------------------------------------------------------------------------K 122 (420)
T ss_dssp -------------------------------------------------------------------------------T
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred eeCceeeEeeehhhchHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMD---DCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~DFG 325 (516)
.+..++++||||+++++.+.+. .....+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 123 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 123 KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp TTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccch
Confidence 0123478999999988776655 345679999999999999999999999999999999999999965 568999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+|+...... .....+||+.|+|||++.+. .+..++|+|||||++|||++|++||.+.+..+++..+...+|.|+.+.+
T Consensus 203 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 203 SAKQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCEECCTTC-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred hhhhcccCC-CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 998754332 23456889999999999775 5778889999999999999999999999999999999999999987766
Q ss_pred hhcccc----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcc
Q psy12305 405 SKLEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 405 ~~~~~~----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~ 468 (516)
...... ..+.... ..+...++..+++++.+||.+||++||.+|||+.|+++||||+.+.....
T Consensus 282 ~~~~~~~~~~~~p~~~~-~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNV 348 (420)
T ss_dssp HHHCSCCCCCCCCCCCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTC
T ss_pred HhhChhhhhhccCccCC-CCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccc
Confidence 433211 1121111 22333455678999999999999999999999999999999987754433
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=418.53 Aligned_cols=315 Identities=28% Similarity=0.449 Sum_probs=234.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++|||||++++++...+.......
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 3579999999999999999999999999999999865422 34589999999999999999998755431000000
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
... . ......... ..+. .....+.-..
T Consensus 81 ~~~---------------------------------~----~~~~~~~~~---------------~~~~-~~~~~~~~~~ 107 (383)
T 3eb0_A 81 QPP---------------------------------D----DHNKLGGKN---------------NGVN-NHHKSVIVNP 107 (383)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc---------------------------------c----ccccccccc---------------cccc-cccccccccC
Confidence 000 0 000000000 0000 0000011112
Q ss_pred eeCceeeEeeehhhchHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc-cCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-ERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkL~DFG 325 (516)
....++++||||++++|.+.+.. .+..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg 187 (383)
T 3eb0_A 108 SQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFG 187 (383)
T ss_dssp --CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCT
T ss_pred CCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECC
Confidence 34567899999999987776653 456799999999999999999999999999999999999998 68899999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+|+..... ......+||+.|+|||++.+.. ++.++|+||+||++|||++|++||.+.+..+.+..+...+|.|+.+.+
T Consensus 188 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~ 266 (383)
T 3eb0_A 188 SAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQM 266 (383)
T ss_dssp TCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred CCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 99865433 2334567899999999988754 677889999999999999999999999999999999999999988765
Q ss_pred hhcccc----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~~~----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...... ..+.... ..+....|...++++.+||.+||++||.+|||+.|+|+||||+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 267 IRMNPHYTEVRFPTLKA-KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHCTTC--CCCCCCCC-CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHH
T ss_pred HHhCcccccccCCccCc-ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHH
Confidence 433211 1222222 3455566778999999999999999999999999999999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=413.52 Aligned_cols=294 Identities=38% Similarity=0.612 Sum_probs=223.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
+.+++|+++++||+|+||+||+|++..+|+.||||++...... .....+.+|+.+|+.++|||||++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--- 90 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS--- 90 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc---
Confidence 5678999999999999999999999999999999998654332 222244455555555555555555443322110
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 91 -------------------------------------------------------------------------------- 90 (351)
T 3mi9_A 91 -------------------------------------------------------------------------------- 90 (351)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.+....+.+|+||||+++++...+......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp ------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 00011456899999999999999988777899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----CccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 327 ARAKSVP----TKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 327 a~~~~~~----~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|+..... .......+||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+..+....+.++.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 9865422 2233456789999999998764 4678899999999999999999999999999999999999998887
Q ss_pred hhhhhcccc-cC---CCCCC--chhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 402 ELKSKLEFC-IT---PVYPS--ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 402 ~~~~~~~~~-~~---~~~~~--~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
+.+...... .. ..... ............++++.+||.+||++||.+|||++|+|+||||++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 766443211 00 00000 00000000001367899999999999999999999999999998643
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=426.33 Aligned_cols=286 Identities=27% Similarity=0.445 Sum_probs=232.3
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.++|.+
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~~~~------------------- 154 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQD------------------- 154 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHTTC-------------------
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc--hHHHHHHHHHHHHHHhhcc-------------------
Confidence 4679999999999999999999999999999999865321 1124455655555554432
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
..+|+||+++++++
T Consensus 155 ------------------------------------------------------------------~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 155 ------------------------------------------------------------------KDNTMNVIHMLENF 168 (429)
T ss_dssp ------------------------------------------------------------------TTSCSCBCCEEEEE
T ss_pred ------------------------------------------------------------------ccCCcCEEEEEeec
Confidence 12688999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC--EEEeeecc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE--LKLADFGL 326 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--vkL~DFGl 326 (516)
....++|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+
T Consensus 169 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 169 TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 9999999999999999999988754 45999999999999999999999999999999999999999987 99999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+.... .....+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+.+..+...++.|+.+++..
T Consensus 249 a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~ 325 (429)
T 3kvw_A 249 SCYEHQ---RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDA 325 (429)
T ss_dssp CEETTC---CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred ceecCC---cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHh
Confidence 976542 23346889999999999998899999999999999999999999999999999999999999999887643
Q ss_pred cccc-------cCCCC--------------------------CCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHH
Q psy12305 407 LEFC-------ITPVY--------------------------PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAAN 453 (516)
Q Consensus 407 ~~~~-------~~~~~--------------------------~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e 453 (516)
.... ..+.+ +....+....+...++++.+||.+||++||++|||++|
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e 405 (429)
T 3kvw_A 326 SKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405 (429)
T ss_dssp BTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred hhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHH
Confidence 2110 00000 00111222333456889999999999999999999999
Q ss_pred HHcCCCCCCCCC
Q psy12305 454 AMRHPYFNSLGP 465 (516)
Q Consensus 454 ~l~Hp~f~~~~~ 465 (516)
+|+||||+...+
T Consensus 406 ~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 406 ALRHPWLRRRLP 417 (429)
T ss_dssp HHTSTTTC----
T ss_pred HhCChhhccCCC
Confidence 999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=416.73 Aligned_cols=283 Identities=32% Similarity=0.545 Sum_probs=222.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
....+|++.+.||+|+||+||+|++..+++ ||+|++..... ...+|+.+|+.++||||
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~ni---------------- 94 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNV---------------- 94 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTB----------------
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCc----------------
Confidence 345679999999999999999999976665 99998754321 12245555555555554
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+++++
T Consensus 95 ---------------------------------------------------------------------------v~l~~ 99 (394)
T 4e7w_A 95 ---------------------------------------------------------------------------VDLKA 99 (394)
T ss_dssp ---------------------------------------------------------------------------CCEEE
T ss_pred ---------------------------------------------------------------------------ceEEE
Confidence 45554
Q ss_pred eEee------CceeeEeeehhhchHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc-cCC
Q psy12305 248 IIHT------EKCLTLVFEYLEKDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-ERG 317 (516)
Q Consensus 248 ~~~~------~~~~~lV~E~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~-~~~ 317 (516)
++.. ..++|+||||+++++...+.. ....+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~ 179 (394)
T 4e7w_A 100 FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179 (394)
T ss_dssp EEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT
T ss_pred EEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC
Confidence 4432 234889999999877665543 356799999999999999999999999999999999999999 789
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~ 396 (516)
.+||+|||+|+...... .....+||+.|+|||++.+.. ++.++|+||+||++|||++|++||.+.+..+++..+...+
T Consensus 180 ~~kL~DFG~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 180 VLKLIDFGSAKILIAGE-PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp EEEECCCTTCEECCTTC-CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cEEEeeCCCcccccCCC-CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999998764332 334567899999999997754 6778899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcccc----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCccc
Q psy12305 397 GPPPDELKSKLEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 397 ~~~p~~~~~~~~~~----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~~ 469 (516)
|.|+.+.+...... ..+.... ..+...++..+++++.+||.+||++||.+|||+.|+++||||+.+......
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRP-HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCC-CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCC
T ss_pred CCCCHHHHHhhChhhhhhccccccC-CcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccccc
Confidence 99998765432211 1222221 233444556789999999999999999999999999999999987655443
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=414.35 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=226.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|+++.+|+.||||++.......
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------------------------------------ 81 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK------------------------------------ 81 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhcc------------------------------------
Confidence 56789999999999999999999999999999999986532100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+|+.++||||+++++
T Consensus 82 -----------------------------------------------------~~~~~~~~~E~~~l~~l~hp~iv~~~~ 108 (350)
T 1rdq_E 82 -----------------------------------------------------LKQIEHTLNEKRILQAVNFPFLVKLEF 108 (350)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 011235677888999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.++..+|+||||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 109 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~ 187 (350)
T 1rdq_E 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEccccc
Confidence 9999999999999997 5898888765 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+..... ....+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+....+....
T Consensus 188 a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 254 (350)
T 1rdq_E 188 AKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------- 254 (350)
T ss_dssp CEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ceeccCC---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence 9875432 345689999999999999888899999999999999999999999988877777765421
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~ 468 (516)
...|..+++++.+||.+||+.||.+||+ ++++++||||..+.+...
T Consensus 255 ----------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~ 305 (350)
T 1rdq_E 255 ----------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred ----------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence 1234578999999999999999999998 999999999998776443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=412.87 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=223.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+|+.||+|.+.....
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---------------------------------------- 43 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---------------------------------------- 43 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----------------------------------------
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----------------------------------------
Confidence 4689999999999999999999999999999998853211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+++.++||||+++++++
T Consensus 44 -----------------------------------------------------~~~~~~~E~~~l~~l~hpnIv~~~~~~ 70 (321)
T 1tki_A 44 -----------------------------------------------------DQVLVKKEISILNIARHRNILHLHESF 70 (321)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHHSCCTTBCCEEEEE
T ss_pred -----------------------------------------------------cHHHHHHHHHHHHhCCCCCCCeEeEEE
Confidence 011456788888888999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc--CCCEEEeeecc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE--RGELKLADFGL 326 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkL~DFGl 326 (516)
.+.+.+|+|||||+| +|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 71 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp EETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred ecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCC
Confidence 999999999999985 899999876667999999999999999999999999999999999999987 78999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
++..... ......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+.+..+......++...+
T Consensus 151 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-- 227 (321)
T 1tki_A 151 ARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-- 227 (321)
T ss_dssp CEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH--
T ss_pred CeECCCC-CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh--
Confidence 9876532 2334567899999999999888888999999999999999999999999888888777665444433221
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
..+++++.+||.+||..||.+|||++|+|+||||+..
T Consensus 228 --------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 228 --------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp --------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred --------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 2678999999999999999999999999999999754
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=412.97 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=183.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|.+.++||+|+||+||+|++ +|+.||||++...... .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~---------------------------------- 42 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SW---------------------------------- 42 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HH----------------------------------
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hH----------------------------------
Confidence 4689999999999999999987 5899999998643211 11
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....|+..+.+++|||||++++++.
T Consensus 43 -------------------------------------------------------~~e~Ei~~~~~l~HpNIv~l~g~~~ 67 (303)
T 3hmm_A 43 -------------------------------------------------------FREAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp -------------------------------------------------------HHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHhcCCCCCCCcEEEEEE
Confidence 1223555556667777777777776
Q ss_pred eCc----eeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--------CcEeeecCCCCEEEccCC
Q psy12305 251 TEK----CLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR--------RILHRDLKPQNLLINERG 317 (516)
Q Consensus 251 ~~~----~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~ivHrDlKp~NILl~~~~ 317 (516)
.++ .+|||||||+ |+|.+++... .++++.+..++.|++.||+|||++ +|+||||||+|||++.++
T Consensus 68 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~ 145 (303)
T 3hmm_A 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred ecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence 543 5899999999 6999999763 589999999999999999999987 999999999999999999
Q ss_pred CEEEeeeccccccCCCCc----cccCCcccccccchhhccCCC------CCCceeeehHHHHHHHHHcCCCCCCCCCH--
Q psy12305 318 ELKLADFGLARAKSVPTK----TFSNEVVTLWYRPPDVLLGST------EYSTSIDMGVGCIFHEMSSGRPLFPGSTI-- 385 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~APE~l~~~~------~~~~~d~~SlGvil~elltG~~pF~~~~~-- 385 (516)
.+||+|||+|+....... .....+||+.|||||++.+.. ++.++|+|||||+||||+||.+||.....
T Consensus 146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~ 225 (303)
T 3hmm_A 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence 999999999987654332 223458999999999997642 45578999999999999999887743221
Q ss_pred ------------HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHH
Q psy12305 386 ------------EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAAN 453 (516)
Q Consensus 386 ------------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e 453 (516)
.+.+..... .....|..+. ...+...+..+.+|+.+||+.||++|||+.|
T Consensus 226 ~p~~~~~~~~~~~~~~~~~~~-------------~~~~rp~~p~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 287 (303)
T 3hmm_A 226 LPYYDLVPSDPSVEEMRKVVC-------------EQKLRPNIPN-----RWQSCEALRVMAKIMRECWYANGAARLTALR 287 (303)
T ss_dssp CTTTTTSCSSCCHHHHHHHHT-------------TSCCCCCCCG-----GGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred ccchhcccccchHHHHHHHHh-------------cccCCCCCCc-----cccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence 111111100 0000111110 0001123356889999999999999999999
Q ss_pred HHcC
Q psy12305 454 AMRH 457 (516)
Q Consensus 454 ~l~H 457 (516)
+++.
T Consensus 288 i~~~ 291 (303)
T 3hmm_A 288 IKKT 291 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=417.48 Aligned_cols=260 Identities=28% Similarity=0.439 Sum_probs=216.7
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
-..+++|.+.+.||+|+||+||+|++..+|+.||||++.......
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~----------------------------------- 49 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKK----------------------------------- 49 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH-----------------------------------
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccc-----------------------------------
Confidence 356789999999999999999999999999999999986532110
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
......+.+|+.+++.++||||++++
T Consensus 50 ------------------------------------------------------~~~~~~~~~E~~~l~~l~hpnIv~l~ 75 (336)
T 3h4j_B 50 ------------------------------------------------------SDMHMRVEREISYLKLLRHPHIIKLY 75 (336)
T ss_dssp ------------------------------------------------------TTCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ------------------------------------------------------hhHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 01122567888889999999999999
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+++.++..+++||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~~~~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~ 154 (336)
T 3h4j_B 76 DVITTPTDIVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL 154 (336)
T ss_dssp EEEECSSEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred EEEEeCCEEEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEecc
Confidence 999999999999999999999998765 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
|..... .......+||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+....... .
T Consensus 155 s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~ 218 (336)
T 3h4j_B 155 SNIMTD-GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------K 218 (336)
T ss_dssp TBTTTT-SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------C
T ss_pred ceeccC-CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------H
Confidence 976543 333455689999999999988776 45789999999999999999999764322110 0
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.. .......|..+++++.+||.+||+.||.+|||++|+++||||+.-
T Consensus 219 ~i-----------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 219 KV-----------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp CC-----------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HH-----------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 00 111223456789999999999999999999999999999999753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=408.43 Aligned_cols=265 Identities=27% Similarity=0.406 Sum_probs=215.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEc---CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSR---LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~---~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..++|++++.||+|+||+||+|++. .+|+.||||++........
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~--------------------------------- 61 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN--------------------------------- 61 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------------------------------
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhh---------------------------------
Confidence 4578999999999999999999985 5899999999865321100
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
......+.+|+.+|+.++||||+++
T Consensus 62 -------------------------------------------------------~~~~~~~~~E~~~l~~l~hp~iv~~ 86 (327)
T 3a62_A 62 -------------------------------------------------------AKDTAHTKAERNILEEVKHPFIVDL 86 (327)
T ss_dssp ----------------------------------------------------------------HHHHHHHCCCTTBCCE
T ss_pred -------------------------------------------------------hhHHHHHHHHHHHHHhCCCCCccce
Confidence 0011135578899999999999999
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++++..++.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+||
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df 165 (327)
T 3a62_A 87 IYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDF 165 (327)
T ss_dssp EEEEECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCC
T ss_pred eEEEEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeC
Confidence 999999999999999998 5888888764 45899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+++............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+..+....
T Consensus 166 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-------- 237 (327)
T 3a62_A 166 GLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK-------- 237 (327)
T ss_dssp SCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC--------
T ss_pred CcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC--------
Confidence 999765444444456689999999999998888889999999999999999999999988877777665421
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~ 468 (516)
...|..+++++.+||.+||+.||.+|| +++++++||||+.+.+...
T Consensus 238 ------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~ 288 (327)
T 3a62_A 238 ------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEEL 288 (327)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHH
T ss_pred ------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHH
Confidence 123447889999999999999999999 8999999999998765443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=410.55 Aligned_cols=293 Identities=31% Similarity=0.565 Sum_probs=230.3
Q ss_pred cccccccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccc
Q psy12305 80 QSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 159 (516)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 159 (516)
...+.+-+..+++|++++.||+|+||+||+|++..+|+.||||++.......
T Consensus 14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------------------- 65 (331)
T 4aaa_A 14 LGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK---------------------------- 65 (331)
T ss_dssp -----CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH----------------------------
T ss_pred cccchhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch----------------------------
Confidence 3445677889999999999999999999999999999999999885432110
Q ss_pred cceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc
Q psy12305 160 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 239 (516)
Q Consensus 160 ~~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H 239 (516)
.....+.+|+.+++.++|
T Consensus 66 --------------------------------------------------------------~~~~~~~~E~~~l~~l~h 83 (331)
T 4aaa_A 66 --------------------------------------------------------------MVKKIAMREIKLLKQLRH 83 (331)
T ss_dssp --------------------------------------------------------------HHHHHHHHHHHHHHHCCC
T ss_pred --------------------------------------------------------------HHHHHHHHHHHHHhhCCC
Confidence 001245678889999999
Q ss_pred cceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCE
Q psy12305 240 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGEL 319 (516)
Q Consensus 240 pnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~v 319 (516)
|||+++++++...+..|+||||++++++..+......+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 84 ~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~ 163 (331)
T 4aaa_A 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVV 163 (331)
T ss_dssp TTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE
T ss_pred CCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcE
Confidence 99999999999999999999999987766666656679999999999999999999999999999999999999999999
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
||+|||+++............+||+.|+|||++.+. .+..++|+|||||++|+|++|++||.+.+..+.+..+....+.
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (331)
T 4aaa_A 164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN 243 (331)
T ss_dssp EECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 999999998765555555567889999999999875 5677889999999999999999999999999999998888888
Q ss_pred CChhhhhhccc------ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 399 PPDELKSKLEF------CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 399 ~p~~~~~~~~~------~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.+......... ...+............+ .+++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 244 LIPRHQELFNKNPVFAGVRLPEIKEREPLERRYP-KLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp CCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHST-TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred CChhhhhHhhhccccccccCccccccchhhhccc-chhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 76654322111 11111111112222222 678999999999999999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=416.41 Aligned_cols=274 Identities=20% Similarity=0.320 Sum_probs=223.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++++.||+|+||+||+|++..+|+.||||++.......
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~------------------------------------ 55 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVE------------------------------------ 55 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhccc------------------------------------
Confidence 35688999999999999999999999999999999986532100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+|+.++||||+++++
T Consensus 56 -----------------------------------------------------~~~~~~~~~E~~il~~l~hp~Iv~l~~ 82 (384)
T 4fr4_A 56 -----------------------------------------------------RNEVRNVFKELQIMQGLEHPFLVNLWY 82 (384)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 111235678889999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+|.+...+|+||||+. |+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 83 SFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNI 161 (384)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccce
Confidence 9999999999999997 588887765 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccC---CCCCCceeeehHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHhcCCCC
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLG---STEYSTSIDMGVGCIFHEMSSGRPLFPGSTI---EDELRLICSILGPPP 400 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~d~~SlGvil~elltG~~pF~~~~~---~~~~~~i~~~~~~~p 400 (516)
|+.... .......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+... ......+..
T Consensus 162 a~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~------ 234 (384)
T 4fr4_A 162 AAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET------ 234 (384)
T ss_dssp CEECCT-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH------
T ss_pred eeeccC-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh------
Confidence 987643 334456789999999999864 3467788999999999999999999975432 222222211
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-HHHHHcCCCCCCCCCCcccCCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-AANAMRHPYFNSLGPQVHELSDTQSIFS 478 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-a~e~l~Hp~f~~~~~~~~~~~~~~~~~~ 478 (516)
.....|..+++++.+||.+||+.||.+||+ ++++++||||+.+.+.........+.|.
T Consensus 235 --------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~~~~~~~p~~~ 293 (384)
T 4fr4_A 235 --------------------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFI 293 (384)
T ss_dssp --------------------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHHHTTCSCCCCC
T ss_pred --------------------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHHHhCCCCCCCC
Confidence 112234578999999999999999999998 8999999999998776554444444443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=420.91 Aligned_cols=269 Identities=23% Similarity=0.287 Sum_probs=223.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~------------------------------------- 101 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLK------------------------------------- 101 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhh-------------------------------------
Confidence 4578999999999999999999999999999999986532100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|..++..++||||++++++
T Consensus 102 ----------------------------------------------------~~~~~~~~~E~~il~~~~hp~Iv~l~~~ 129 (412)
T 2vd5_A 102 ----------------------------------------------------RGEVSCFREERDVLVNGDRRWITQLHFA 129 (412)
T ss_dssp ----------------------------------------------------HGGGCCHHHHHHHHHHSCTTTBCCEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence 0011245678888888999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
|++++++|+||||++ |+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 130 ~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhh
Confidence 999999999999997 6999999887678999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhcc-------CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLL-------GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~-------~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
+....... .....+||+.|+|||++. +..++.++|+|||||++|||++|++||.+.+..+.+..|.......
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 87654332 233468999999999997 3467788899999999999999999999998888777775421000
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCC---CCHHHHHcCCCCCCCCCCcc
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR---ISAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R---~ta~e~l~Hp~f~~~~~~~~ 468 (516)
..| ..+..+++++++||.+||+ +|.+| ++++|+++||||+++.|...
T Consensus 290 -----------~~p----------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l 339 (412)
T 2vd5_A 290 -----------SLP----------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL 339 (412)
T ss_dssp -----------CCC--------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred -----------CCC----------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence 000 0123789999999999999 99998 49999999999999877644
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=423.75 Aligned_cols=260 Identities=27% Similarity=0.351 Sum_probs=221.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||+||+|+++.+|+.||+|++.......
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-------------------------------------- 51 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-------------------------------------- 51 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH--------------------------------------
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH--------------------------------------
Confidence 467999999999999999999999999999999986532110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 52 ----------------------------------------------------~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 52 ----------------------------------------------------RDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 0112567899999999999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc---cCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN---ERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~---~~~~vkL~DFG 325 (516)
.+++..|+|||||.| +|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG 158 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFG 158 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence 999999999999985 888888765 4599999999999999999999999999999999999998 45789999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+............+||+.|+|||++.+..++.++|+||+||++|+|++|.+||.+.+..+.+..+.......+..
T Consensus 159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 235 (444)
T 3soa_A 159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP--- 235 (444)
T ss_dssp SCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred eeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc---
Confidence 99877655555566789999999999998889999999999999999999999999998888887776543322211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....+++++.+||.+||+.||.+|||++|+|+||||+.
T Consensus 236 -------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 236 -------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp -------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred -------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 11267899999999999999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=413.22 Aligned_cols=276 Identities=25% Similarity=0.390 Sum_probs=223.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|+++++||+|+||+||+|++..+|+.||||++..... ..
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~------------------------------------ 75 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKK--YT------------------------------------ 75 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHH--HH------------------------------------
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchh--hh------------------------------------
Confidence 4789999999999999999999999999999999863211 01
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-----ccceee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-----HANIVT 244 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-----HpnIv~ 244 (516)
.....|+.+++.+. ||||++
T Consensus 76 -------------------------------------------------------~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 76 -------------------------------------------------------RSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred -------------------------------------------------------hhhHHHHHHHHHhcccCCCCCCeec
Confidence 12334555666554 999999
Q ss_pred EeeeEeeCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc--------
Q psy12305 245 LHDIIHTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-------- 315 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-------- 315 (516)
+++++...+..|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred ccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 999999999999999999889999998754 45999999999999999999999999999999999999975
Q ss_pred -----------------CCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCC
Q psy12305 316 -----------------RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRP 378 (516)
Q Consensus 316 -----------------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~ 378 (516)
++.+||+|||+|+.... .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 257 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCC
Confidence 78999999999986443 2345678999999999999889999999999999999999999
Q ss_pred CCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCC--------------------CCCCHHHHHHHH
Q psy12305 379 LFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP--------------------EQMDSDALDLVQ 438 (516)
Q Consensus 379 pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p--------------------~~~s~~~~dLl~ 438 (516)
||.+.+..+.+..+....+++|..+...........+..........| ...++.+.+||.
T Consensus 258 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp SCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 999999999999999999998877653221100000000000000001 123578889999
Q ss_pred HccccCcCCCCCHHHHHcCCCCC
Q psy12305 439 KFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 439 ~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
+||++||.+|||++|+|+||||+
T Consensus 338 ~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999995
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=404.60 Aligned_cols=265 Identities=27% Similarity=0.400 Sum_probs=224.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|.+.+.||+|+||+||+|++..+|+.||||++.........
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~------------------------------------ 53 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR------------------------------------ 53 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS------------------------------------
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc------------------------------------
Confidence 35699999999999999999999999999999998764322110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.......+.+|+.+|+.++||||+++++++
T Consensus 54 --------------------------------------------------~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 83 (326)
T 2y0a_A 54 --------------------------------------------------RGVSREDIEREVSILKEIQHPNVITLHEVY 83 (326)
T ss_dssp --------------------------------------------------SSBCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred --------------------------------------------------chhhHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 001123577899999999999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC----CEEEeee
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG----ELKLADF 324 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkL~DF 324 (516)
.++...++||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 84 ENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 99999999999997 5898888653 5699999999999999999999999999999999999999887 7999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+++..... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.......+...+
T Consensus 163 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 163 GLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp TTCEECCTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCeECCCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 999876432 2344568999999999999888889999999999999999999999998888877777654433332221
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..+++.+.+||.+||+.||.+|||++++++||||+...
T Consensus 242 ----------------------~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 242 ----------------------SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp ----------------------TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred ----------------------ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 26789999999999999999999999999999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=416.44 Aligned_cols=293 Identities=33% Similarity=0.536 Sum_probs=209.6
Q ss_pred ccccccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccc
Q psy12305 81 SLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 159 (516)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 159 (516)
.+....+...++|++++.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++.
T Consensus 19 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 98 (367)
T 2fst_X 19 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 98 (367)
T ss_dssp EETTEEEEEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEC
T ss_pred eecCcccCCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3344445566889999999999999999999999999999999865321 111223445555555555555555444432
Q ss_pred cceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc
Q psy12305 160 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 239 (516)
Q Consensus 160 ~~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H 239 (516)
....
T Consensus 99 ~~~~---------------------------------------------------------------------------- 102 (367)
T 2fst_X 99 PARS---------------------------------------------------------------------------- 102 (367)
T ss_dssp SCSS----------------------------------------------------------------------------
T ss_pred cCCc----------------------------------------------------------------------------
Confidence 2110
Q ss_pred cceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCE
Q psy12305 240 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGEL 319 (516)
Q Consensus 240 pnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~v 319 (516)
+.....+|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 103 ---------~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 103 ---------LEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp ---------GGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred ---------cccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCE
Confidence 011245899999999888888765 469999999999999999999999999999999999999999999
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
||+|||+|+.... .....+||++|+|||++.+ ..++.++|+||+||++|||++|++||.+.+..+++..|....|.
T Consensus 172 kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 248 (367)
T 2fst_X 172 KILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 248 (367)
T ss_dssp EECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred EEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999999986542 2345688999999999987 56778889999999999999999999999999999999999999
Q ss_pred CChhhhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 399 PPDELKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 399 ~p~~~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
|+.+.+...... ..+..+. ..+...++ ..++++.+||.+||++||.+|||++|+|+||||+....
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPK-MNFANVFI-GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCC-CCHHHHTT-TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCC-CCHHHHCC-CCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 998776543210 1111111 12222233 67899999999999999999999999999999987643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=429.58 Aligned_cols=273 Identities=26% Similarity=0.351 Sum_probs=221.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|++..+|+.||||++........
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------ 189 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAK------------------------------------ 189 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC--------------------------------------
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhh------------------------------------
Confidence 45789999999999999999999999999999999875321110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+++.++||||++++++
T Consensus 190 -----------------------------------------------------~~~~~~~~e~~~l~~l~h~~iv~l~~~ 216 (446)
T 4ejn_A 190 -----------------------------------------------------DEVAHTLTENRVLQNSRHPFLTALKYS 216 (446)
T ss_dssp ----------------------------------------------------------------CCCCCSCTTSCCEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhCCCCeEeeEEEE
Confidence 001134567888888899999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+.+.+.+|+||||+++ +|..++... ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 217 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~ 295 (446)
T 4ejn_A 217 FQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL 295 (446)
T ss_dssp EEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCC
T ss_pred EeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCC
Confidence 9999999999999985 888877664 469999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+............+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+....
T Consensus 296 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------- 365 (446)
T 4ejn_A 296 CKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------- 365 (446)
T ss_dssp CCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred ceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC----------
Confidence 9875545555566789999999999999889999999999999999999999999988877776664321
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcccCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHELSDTQSIF 477 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~~~~ 477 (516)
..+|..+++++.+||.+||++||.+|| |++|+++||||+++.++........+++
T Consensus 366 ----------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~~~~~~pp~ 425 (446)
T 4ejn_A 366 ----------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPF 425 (446)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSC
T ss_pred ----------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHHhhCcCCCCc
Confidence 123457889999999999999999999 9999999999999876544433333333
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=411.14 Aligned_cols=264 Identities=25% Similarity=0.350 Sum_probs=217.3
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|++.+.||+|+||+||+|+++.+|+.||||++........
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------------------------- 65 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSS------------------------------------- 65 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTS-------------------------------------
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhcccc-------------------------------------
Confidence 4679999999999999999999999999999999865321110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.......+.+|+.+++.++||||+++++++
T Consensus 66 --------------------------------------------------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 95 (351)
T 3c0i_A 66 --------------------------------------------------PGLSTEDLKREASICHMLKHPHIVELLETY 95 (351)
T ss_dssp --------------------------------------------------SSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred --------------------------------------------------ccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 001123567889999999999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC---EEEe
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE---LKLA 322 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkL~ 322 (516)
.+++.+|+|||||+ ++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~ 175 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEe
Confidence 99999999999999 5887777543 345899999999999999999999999999999999999987655 9999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|||+++............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.. .+....+.......+..
T Consensus 176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~ 254 (351)
T 3c0i_A 176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPR 254 (351)
T ss_dssp CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHH
T ss_pred cCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcc
Confidence 99999876654444556789999999999998888999999999999999999999998753 34444444322222111
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
. ...+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 255 ~----------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 255 Q----------------------WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp H----------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred c----------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1 12678999999999999999999999999999999764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=410.98 Aligned_cols=281 Identities=36% Similarity=0.579 Sum_probs=220.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.-++|++++.||+|+||+||+|++..+++.||||++...........+.+
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------------------ 74 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR------------------------------ 74 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHH------------------------------
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHH------------------------------
Confidence 34689999999999999999999999999999999864332222223444
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
|+.+|++++||||++++++
T Consensus 75 -------------------------------------------------------------E~~~l~~l~h~niv~~~~~ 93 (364)
T 3qyz_A 75 -------------------------------------------------------------EIKILLRFRHENIIGINDI 93 (364)
T ss_dssp -------------------------------------------------------------HHHHHHHCCCTTBCCCCEE
T ss_pred -------------------------------------------------------------HHHHHHhcCCCCCccceeE
Confidence 4455555555555555555
Q ss_pred EeeC-----ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 249 IHTE-----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 249 ~~~~-----~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+... ...|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 94 ~~~~~~~~~~~~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~D 171 (364)
T 3qyz_A 94 IRAPTIEQMKDVYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICD 171 (364)
T ss_dssp ECCSSTTTCCCEEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EecCCccccceEEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEe
Confidence 4432 35899999999999998876 3599999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCc---cccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 324 FGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 324 FGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
||+|+....... .....+||+.|+|||++.+.. ++.++|+|||||++|+|++|++||.+.+..+.+..+...++.|
T Consensus 172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 251 (364)
T 3qyz_A 172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251 (364)
T ss_dssp CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSC
T ss_pred CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999986543221 234558999999999876544 6778899999999999999999999999999999999999999
Q ss_pred Chhhhhhccc------c-cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 400 PDELKSKLEF------C-ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 400 p~~~~~~~~~------~-~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
+.+.+..... . ..+.. ....+.... ..+++++.+||.+||++||.+|||++|+|+||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPHK-NKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCCC-CCCCHHHHC-TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CHHHHHHhhhhhHHHHHHhcCCc-cCCCHHHhC-CCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 8876543211 0 11111 111122222 36789999999999999999999999999999998763
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=442.04 Aligned_cols=273 Identities=21% Similarity=0.320 Sum_probs=231.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~------------------------------------- 381 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ------------------------------------- 381 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEecccccc-------------------------------------
Confidence 5688999999999999999999999999999999987532100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
......+..|..+|..+ +||||+++++
T Consensus 382 ----------------------------------------------------~~~~~~~~~E~~~l~~~~~~~~i~~l~~ 409 (674)
T 3pfq_A 382 ----------------------------------------------------DDDVECTMVEKRVLALPGKPPFLTQLHS 409 (674)
T ss_dssp ----------------------------------------------------TTTTHHHHHHHHHHTCTTCCTTBCCEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 01122456677777776 6889999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++++.+.+||||||++ |+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+
T Consensus 410 ~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGl 488 (674)
T 3pfq_A 410 CFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488 (674)
T ss_dssp ECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred EEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecce
Confidence 9999999999999998 5888888765 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+............+||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+..+.+..|...
T Consensus 489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----------- 557 (674)
T 3pfq_A 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH----------- 557 (674)
T ss_dssp CEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-----------
T ss_pred eeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 987554455566779999999999999988999999999999999999999999999888888777532
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH-----HHHHcCCCCCCCCCCcccCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA-----ANAMRHPYFNSLGPQVHELSDTQSIF 477 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta-----~e~l~Hp~f~~~~~~~~~~~~~~~~~ 477 (516)
...+|..+++++.+||.+||+.||.+||++ +|+++||||+.++|.........++|
T Consensus 558 ---------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~ 618 (674)
T 3pfq_A 558 ---------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPY 618 (674)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSC
T ss_pred ---------------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCC
Confidence 123455789999999999999999999997 99999999999887655544444444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=413.07 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=220.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+|+.||+|++......
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~-------------------------------------- 90 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-------------------------------------- 90 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--------------------------------------
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchh--------------------------------------
Confidence 347799999999999999999999999999999998643210
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+|+.++||||++++++
T Consensus 91 ------------------------------------------------------~~~~~~~E~~il~~l~hpnIv~~~~~ 116 (387)
T 1kob_A 91 ------------------------------------------------------DKYTVKNEISIMNQLHHPKLINLHDA 116 (387)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred ------------------------------------------------------hHHHHHHHHHHHHhCCCcCCCeEEEE
Confidence 01145678888889999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc--CCCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE--RGELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkL~DFG 325 (516)
+.++..+|+||||++ ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 117 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecc
Confidence 999999999999998 5899988776667999999999999999999999999999999999999974 4779999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+..... ......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+.+..+.......+.
T Consensus 197 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~---- 271 (387)
T 1kob_A 197 LATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE---- 271 (387)
T ss_dssp TCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS----
T ss_pred cceecCCC-cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----
Confidence 99876532 2233457899999999999888888999999999999999999999998887777766543211111
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 272 ------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 ------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp ------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 11236789999999999999999999999999999998653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=408.76 Aligned_cols=259 Identities=28% Similarity=0.368 Sum_probs=219.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|+++.+|+.||||++.......
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-------------------------------------- 69 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------------------------------------- 69 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH--------------------------------------
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH--------------------------------------
Confidence 467999999999999999999999999999999986532110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 70 ----------------------------------------------------~~~~~~~~E~~il~~l~hpnIv~~~~~~ 97 (362)
T 2bdw_A 70 ----------------------------------------------------RDFQKLEREARICRKLQHPNIVRLHDSI 97 (362)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 0012466789999999999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC---CEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG---ELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkL~DFG 325 (516)
.+++..|+||||+.| +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 98 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence 999999999999985 888888764 4699999999999999999999999999999999999998654 59999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+++.... .......+||+.|+|||++.+..++.++|+|||||++|+|++|.+||.+.+..+....+.......|...+
T Consensus 177 ~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~- 254 (362)
T 2bdw_A 177 LAIEVND-SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW- 254 (362)
T ss_dssp TCBCCTT-CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG-
T ss_pred cceEecC-CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc-
Confidence 9986653 23344568999999999999888899999999999999999999999998887777777654332221111
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..+++++.+||.+||+.||++|||++++|+||||..
T Consensus 255 ---------------------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 255 ---------------------DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp ---------------------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred ---------------------cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 257899999999999999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=414.90 Aligned_cols=287 Identities=27% Similarity=0.406 Sum_probs=225.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|+++++||+|+||+||+|++..+|+.||||++..... ....+.+|+.+|+.++|++..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~--------------- 96 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEH--YTETALDEIRLLKSVRNSDPN--------------- 96 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHSCTT---------------
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCc--chHHHHHHHHHHHHHhhcCCC---------------
Confidence 344789999999999999999999999999999999864321 122455666666666544310
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
..+||||+++++
T Consensus 97 --------------------------------------------------------------------~~~~~~iv~~~~ 108 (397)
T 1wak_A 97 --------------------------------------------------------------------DPNREMVVQLLD 108 (397)
T ss_dssp --------------------------------------------------------------------CGGGGGBCCEEE
T ss_pred --------------------------------------------------------------------CCCcceeeeeec
Confidence 014888999999
Q ss_pred eEe----eCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCC----
Q psy12305 248 IIH----TEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERG---- 317 (516)
Q Consensus 248 ~~~----~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~---- 317 (516)
++. +..++|+||||+++++.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 109 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp EEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHH
T ss_pred ceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhh
Confidence 887 566899999999999888887654 5699999999999999999999998 999999999999998775
Q ss_pred ---------------------------------------------CEEEeeeccccccCCCCccccCCcccccccchhhc
Q psy12305 318 ---------------------------------------------ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL 352 (516)
Q Consensus 318 ---------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l 352 (516)
.+||+|||+|+.... .....+||+.|+|||++
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHHHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCCCCcccCChhh
Confidence 799999999987543 23456889999999999
Q ss_pred cCCCCCCceeeehHHHHHHHHHcCCCCCCCCC------HHHHHHHHHHhcCCCChhhhhhccccc--CCC---------C
Q psy12305 353 LGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST------IEDELRLICSILGPPPDELKSKLEFCI--TPV---------Y 415 (516)
Q Consensus 353 ~~~~~~~~~d~~SlGvil~elltG~~pF~~~~------~~~~~~~i~~~~~~~p~~~~~~~~~~~--~~~---------~ 415 (516)
.+..++.++|+|||||++|||++|+.||.+.+ ..+.+..+...+|.+|..++....+.. ... .
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99889999999999999999999999998654 567788889999999887653322110 000 0
Q ss_pred CCch-----hhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 416 PSES-----KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 416 ~~~~-----~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.... ......+...++++.+||.+||++||++|||++|+|+||||++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0000 0001112234567899999999999999999999999999974
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=412.35 Aligned_cols=282 Identities=32% Similarity=0.521 Sum_probs=213.6
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.+..+++|++++.||+|+||+||+|++..+|+.||||++...... ....
T Consensus 20 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~------------------------------ 69 (371)
T 2xrw_A 20 TFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK------------------------------ 69 (371)
T ss_dssp EEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHH------------------------------
T ss_pred ccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHH------------------------------
Confidence 345678999999999999999999999999999999998753211 1111
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
.+.+|+.+++.++||||++
T Consensus 70 -------------------------------------------------------------~~~~E~~~l~~l~hpniv~ 88 (371)
T 2xrw_A 70 -------------------------------------------------------------RAYRELVLMKCVNHKNIIG 88 (371)
T ss_dssp -------------------------------------------------------------HHHHHHHHHHHCCCTTBCC
T ss_pred -------------------------------------------------------------HHHHHHHHHHhcCCCCccc
Confidence 3445666666666666666
Q ss_pred EeeeEeeCc------eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC
Q psy12305 245 LHDIIHTEK------CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE 318 (516)
Q Consensus 245 l~~~~~~~~------~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 318 (516)
+++++.... .+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~ 165 (371)
T 2xrw_A 89 LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 165 (371)
T ss_dssp EEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC
T ss_pred eEEeeccccccccccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC
Confidence 666665443 6899999999999988853 4899999999999999999999999999999999999999999
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
+||+|||+|+..... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+..+....+.
T Consensus 166 ~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 166 LKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 244 (371)
T ss_dssp EEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCC
T ss_pred EEEEEeecccccccc-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999999765422 2334568899999999999988899999999999999999999999999999999999999999
Q ss_pred CChhhhhhcccc------cCCCCCCchhhhh-----cCCCC------CCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 399 PPDELKSKLEFC------ITPVYPSESKLQL-----LAPEQ------MDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 399 ~p~~~~~~~~~~------~~~~~~~~~~~~~-----~~p~~------~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
|+.+++...... ..+.+... .+.. ..|.. .++++++||.+||+.||.+|||++|+|+||||+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~ 323 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGY-SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN 323 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCC-CHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCcccccc-chhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence 887766433211 11111110 0111 11111 256899999999999999999999999999997
Q ss_pred CC
Q psy12305 462 SL 463 (516)
Q Consensus 462 ~~ 463 (516)
..
T Consensus 324 ~~ 325 (371)
T 2xrw_A 324 VW 325 (371)
T ss_dssp TT
T ss_pred hh
Confidence 53
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=403.52 Aligned_cols=286 Identities=31% Similarity=0.467 Sum_probs=212.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++.+.||+|+||+||+|++..+|+.||||++..... ......+|
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~---------------------------- 69 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR--FRNRELQI---------------------------- 69 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT--CCCHHHHH----------------------------
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc--ccHHHHHH----------------------------
Confidence 567889999999999999999999999999999998854321 11233344
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+..++.++||||+++++
T Consensus 70 ---------------------------------------------------------------~~~l~~l~h~niv~~~~ 86 (360)
T 3e3p_A 70 ---------------------------------------------------------------MQDLAVLHHPNIVQLQS 86 (360)
T ss_dssp ---------------------------------------------------------------HHHHHHHCCTTBCCEEE
T ss_pred ---------------------------------------------------------------HHHHHhcCCCCcccHHH
Confidence 44444445555555555
Q ss_pred eEeeC-------ceeeEeeehhhchHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHh--hCCcEeeecCCCCEEEcc
Q psy12305 248 IIHTE-------KCLTLVFEYLEKDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCH--SRRILHRDLKPQNLLINE 315 (516)
Q Consensus 248 ~~~~~-------~~~~lV~E~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH--~~~ivHrDlKp~NILl~~ 315 (516)
++... .++++||||+++++...+.. ....+++..++.++.||+.||.||| ++||+||||||+|||++.
T Consensus 87 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~ 166 (360)
T 3e3p_A 87 YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE 166 (360)
T ss_dssp EEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET
T ss_pred hhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC
Confidence 55332 23789999999987766553 4566899999999999999999999 999999999999999997
Q ss_pred -CCCEEEeeeccccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 316 -RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 316 -~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
++.+||+|||+|+..... ......+||+.|+|||++.+.. ++.++|+|||||++|+|++|++||.+.+..+.+..+.
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 245 (360)
T 3e3p_A 167 ADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIV 245 (360)
T ss_dssp TTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHH
Confidence 899999999999876533 2334567899999999987655 6788899999999999999999999999999999999
Q ss_pred HhcCCCChhhhhhcccccCC----CCC--CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCc
Q psy12305 394 SILGPPPDELKSKLEFCITP----VYP--SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~----~~~--~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~ 467 (516)
...+.++.+.+......... ... .........+...++++.+||.+||++||.+|||+.|+|+||||++.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 99999998877543211100 000 001111112234678999999999999999999999999999999875443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-50 Score=410.46 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=199.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++++.||+|+||+||+|++..+|+.||||++......
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------------------------------------- 59 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI------------------------------------- 59 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-------------------------------------
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-------------------------------------
Confidence 3457899999999999999999999999999999998643211
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+.+|+.+++.++||||+++++
T Consensus 60 --------------------------------------------------------~~~~~~E~~~l~~l~hpniv~~~~ 83 (361)
T 3uc3_A 60 --------------------------------------------------------DENVQREIINHRSLRHPNIVRFKE 83 (361)
T ss_dssp --------------------------------------------------------CHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred --------------------------------------------------------cHHHHHHHHHHHhCCCCCCCcEEE
Confidence 124567888888888888889999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC--EEEeee
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE--LKLADF 324 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~--vkL~DF 324 (516)
++.+...+|+||||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Df 162 (361)
T 3uc3_A 84 VILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDF 162 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCC
T ss_pred EEeeCCEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeec
Confidence 9999999999999997 5888888764 45999999999999999999999999999999999999987765 999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCc-eeeehHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHhcCCC
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST-SIDMGVGCIFHEMSSGRPLFPGSTIE----DELRLICSILGPP 399 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-~d~~SlGvil~elltG~~pF~~~~~~----~~~~~i~~~~~~~ 399 (516)
|+|+..... ......+||+.|+|||++.+..++.. +|+|||||++|+|++|+.||.+.... ..+..+.....
T Consensus 163 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~-- 239 (361)
T 3uc3_A 163 GYSKSSVLH-SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY-- 239 (361)
T ss_dssp CCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC--
T ss_pred Ccccccccc-CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC--
Confidence 999754322 23344579999999999988877766 79999999999999999999875432 22222221110
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....+..+++++.+||.+||+.||.+|||++|+++||||..
T Consensus 240 ----------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 240 ----------------------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp ----------------------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred ----------------------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 01112257899999999999999999999999999999954
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=425.06 Aligned_cols=275 Identities=21% Similarity=0.318 Sum_probs=226.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~------------------------------------ 225 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKK------------------------------------ 225 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhh------------------------------------
Confidence 35578999999999999999999999999999999986532110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+|+.++||||+++++
T Consensus 226 -----------------------------------------------------~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 252 (543)
T 3c4z_A 226 -----------------------------------------------------RKGYQGAMVEKKILAKVHSRFIVSLAY 252 (543)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred -----------------------------------------------------hHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 011235677888899999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
++.+...+|+||||++ |+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 253 ~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~D 332 (543)
T 3c4z_A 253 AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISD 332 (543)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEee
Confidence 9999999999999998 5888888764 34699999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHhcCCC
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST----IEDELRLICSILGPP 399 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~----~~~~~~~i~~~~~~~ 399 (516)
||+|+............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+.+ ..+....+...
T Consensus 333 FGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~---- 408 (543)
T 3c4z_A 333 LGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ---- 408 (543)
T ss_dssp CTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC----
T ss_pred cceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc----
Confidence 9999876544444455689999999999999888999999999999999999999998753 23333333221
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQ 474 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~ 474 (516)
....|..+++++.+||.+||+.||.+||+ ++++++||||+.+.+.........
T Consensus 409 ----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~ 466 (543)
T 3c4z_A 409 ----------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLT 466 (543)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ----------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCC
Confidence 11234578999999999999999999996 589999999999876554443434
Q ss_pred CCC
Q psy12305 475 SIF 477 (516)
Q Consensus 475 ~~~ 477 (516)
+++
T Consensus 467 pp~ 469 (543)
T 3c4z_A 467 PPF 469 (543)
T ss_dssp CSC
T ss_pred CCC
Confidence 433
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=397.92 Aligned_cols=282 Identities=23% Similarity=0.320 Sum_probs=212.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++.+.||+|+||+||+|++..+|+.||||++......... .+.+. ....
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~-~~~~~------~~~~------------------ 64 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQA-GFPRR------PPPR------------------ 64 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC----------------------------------------
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhc-ccccc------cccc------------------
Confidence 4568899999999999999999999999999999999765321110 00000 0000
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......... .........+.+|+.+|+.++||||+++++
T Consensus 65 --------------------------------------~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 103 (298)
T 2zv2_A 65 --------------------------------------GTRPAPGGC---IQPRGPIEQVYQEIAILKKLDHPNVVKLVE 103 (298)
T ss_dssp ---------------------------------------------------------CHHHHHHHHHHTCCCTTBCCEEE
T ss_pred --------------------------------------ccccccccc---ccccchHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 000000000 001122346889999999999999999999
Q ss_pred eEee--CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 248 IIHT--EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 248 ~~~~--~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++.+ ...+|+||||+++ +|.+++. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 181 (298)
T 2zv2_A 104 VLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF 181 (298)
T ss_dssp EEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecC
Confidence 9986 5689999999985 5555432 346999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCC---CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE---YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~---~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|+++............+||+.|+|||++.+... ..++|+|||||++|+|++|..||.+.........+.......
T Consensus 182 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 259 (298)
T 2zv2_A 182 GVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF-- 259 (298)
T ss_dssp TTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--
T ss_pred CCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhcccCCC--
Confidence 999876554444556789999999999876542 456799999999999999999999877666555543321111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
..+..+++++.+||.+||+.||++|||++|+++||||+
T Consensus 260 ----------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 260 ----------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp ----------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ----------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 11236889999999999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=403.71 Aligned_cols=291 Identities=28% Similarity=0.472 Sum_probs=223.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++. +|+.||||++............
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~--------------------------------- 66 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNI--------------------------------- 66 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEG---------------------------------
T ss_pred ccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhh---------------------------------
Confidence 467999999999999999999985 4999999998654332211000
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.........+.+|+.++++++||||+++++++
T Consensus 67 ------------------------------------------------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 67 ------------------------------------------------LSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp ------------------------------------------------GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred ------------------------------------------------hhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 00011123567889999999999999999988
Q ss_pred ee-----CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 250 HT-----EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 250 ~~-----~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
.. ...+|+||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 43 3478999999999999999887778999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
|+++..... ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+....+.|+.+.
T Consensus 179 g~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 257 (362)
T 3pg1_A 179 NLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257 (362)
T ss_dssp TC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred Ccccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHH
Confidence 999754422 23344578999999999877 5677889999999999999999999999999999999999999887654
Q ss_pred hhhcc------cc--cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 404 KSKLE------FC--ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 404 ~~~~~------~~--~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
..... +. .....+. ..+... +...++.+.+||.+||+.||.+|||++|+++||||+++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 258 VVMFSSPSARDYLRNSLSNVPA-RAWTAV-VPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp HHHTSCHHHHHHTTTCCCCCCC-CCHHHH-STTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhhccchhhhHHHHhhcccCCh-hhHHhh-CCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 32111 00 0001111 112222 2367899999999999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=406.78 Aligned_cols=286 Identities=29% Similarity=0.429 Sum_probs=224.6
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcC-CCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 166 (516)
...++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+|+.++..++ |+|+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~--------------- 113 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKA--FLNQAQIEVRLLELMNKHDTE--------------- 113 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHCSSG---------------
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHH--HHHHHHHHHHHHHHHHhcccc---------------
Confidence 456889999999999999999999999999999999864321 1123444555555442 3332
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.|++|++++
T Consensus 114 -----------------------------------------------------------------------~~~~iv~~~ 122 (382)
T 2vx3_A 114 -----------------------------------------------------------------------MKYYIVHLK 122 (382)
T ss_dssp -----------------------------------------------------------------------GGGGBCCEE
T ss_pred -----------------------------------------------------------------------cceeEEEee
Confidence 245699999
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh--hCCcEeeecCCCCEEEc--cCCCEEE
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCH--SRRILHRDLKPQNLLIN--ERGELKL 321 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~~ivHrDlKp~NILl~--~~~~vkL 321 (516)
+++...+.+|+||||++++|.+++.... ..+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||
T Consensus 123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999999999999999998754 56999999999999999999999 57999999999999995 4778999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+|||+|+.... .....+||+.|+|||++.+..++.++|+|||||++|||++|++||.+.+..+.+..+....+.||.
T Consensus 203 ~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 203 VDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp CCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EeccCceeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99999987643 234568899999999999988899999999999999999999999999999999999999999988
Q ss_pred hhhhhccc-----ccCCC--------------CCC--chhhhhcC-----------C--CC----CCHHHHHHHHHcccc
Q psy12305 402 ELKSKLEF-----CITPV--------------YPS--ESKLQLLA-----------P--EQ----MDSDALDLVQKFLMY 443 (516)
Q Consensus 402 ~~~~~~~~-----~~~~~--------------~~~--~~~~~~~~-----------p--~~----~s~~~~dLl~~~L~~ 443 (516)
.++..... ...+. +.. ...+.... . .. .++++.+||.+||++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 76543210 00000 000 00000000 0 00 014789999999999
Q ss_pred CcCCCCCHHHHHcCCCCCCCC
Q psy12305 444 DAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 444 dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
||++|||++|+|+||||+...
T Consensus 360 dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 360 DPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp CTTTSCCHHHHTTSGGGCC--
T ss_pred ChhhCCCHHHHhcCcccccCC
Confidence 999999999999999998653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=405.31 Aligned_cols=281 Identities=33% Similarity=0.566 Sum_probs=220.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccC-CcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEG-APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..-++|.+.+.||+|+||+||+|++..+|+.||||++....... ...
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-------------------------------- 86 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-------------------------------- 86 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHH--------------------------------
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHH--------------------------------
Confidence 34478999999999999999999999999999999986532211 111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.+.+|+.+++.++||||++++
T Consensus 87 -----------------------------------------------------------~~~~E~~~l~~l~h~niv~~~ 107 (371)
T 4exu_A 87 -----------------------------------------------------------RAYRELLLLKHMQHENVIGLL 107 (371)
T ss_dssp -----------------------------------------------------------HHHHHHHHHHHCCCTTBCCCS
T ss_pred -----------------------------------------------------------HHHHHHHHHHhcCCCCchhhh
Confidence 344555555555666666666
Q ss_pred eeEeeCce------eeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEE
Q psy12305 247 DIIHTEKC------LTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELK 320 (516)
Q Consensus 247 ~~~~~~~~------~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vk 320 (516)
+++..... .|+||||++++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 108 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~k 184 (371)
T 4exu_A 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELK 184 (371)
T ss_dssp EEECSCSSSTTCCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEE
T ss_pred hheeccCCcccceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEE
Confidence 66555443 49999999999888774 3499999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 321 LADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 321 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
|+|||+|+.... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+..+.+..+....+.+
T Consensus 185 L~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 185 ILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp ECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999999976542 2344578999999999987 567788999999999999999999999999999999999999999
Q ss_pred Chhhhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCc
Q psy12305 400 PDELKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 400 p~~~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~ 467 (516)
+.++....... ..+..+. ..+... +..+++++.+||.+||++||++|||++|+|+||||+......
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPR-KDFTQL-FPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCC-CCHHHH-STTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcc-hhHHHh-ccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence 88776543211 0111111 111122 236789999999999999999999999999999999765443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=394.10 Aligned_cols=267 Identities=27% Similarity=0.391 Sum_probs=225.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+|+.||||++.........
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------- 54 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR----------------------------------- 54 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCS-----------------------------------
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccc-----------------------------------
Confidence 346799999999999999999999999999999998764322110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.......+.+|+.++++++||||++++++
T Consensus 55 ---------------------------------------------------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 83 (321)
T 2a2a_A 55 ---------------------------------------------------RGVSREEIEREVSILRQVLHHNVITLHDV 83 (321)
T ss_dssp ---------------------------------------------------SSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ---------------------------------------------------cchhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence 00112357789999999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC----CEEEee
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG----ELKLAD 323 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkL~D 323 (516)
+.++...++||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 84 YENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 999999999999997 5898888764 4689999999999999999999999999999999999999888 799999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
||+++..... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+..+.......+...
T Consensus 163 fg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (321)
T 2a2a_A 163 FGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241 (321)
T ss_dssp CTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred CccceecCcc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhh
Confidence 9999876532 233456789999999999988888999999999999999999999999888887777765443333222
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
+..+++.+.+||.+||..||++|||++++++||||+....
T Consensus 242 ----------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~ 281 (321)
T 2a2a_A 242 ----------------------FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281 (321)
T ss_dssp ----------------------HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred ----------------------hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence 1267889999999999999999999999999999987653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=426.07 Aligned_cols=267 Identities=24% Similarity=0.358 Sum_probs=221.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++++.||+|+||.||+|+++.+|+.||||++.+.....
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~------------------------------------ 224 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK------------------------------------ 224 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhh------------------------------------
Confidence 34578999999999999999999999999999999986532100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+|+.++||||+++++
T Consensus 225 -----------------------------------------------------~~~~~~~~~E~~iL~~l~hp~Iv~l~~ 251 (576)
T 2acx_A 225 -----------------------------------------------------RKGEAMALNEKQILEKVNSRFVVSLAY 251 (576)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred -----------------------------------------------------hHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence 011225667888999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++.+.+.+|+||||++ |+|..++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 252 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFG 331 (576)
T 2acx_A 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLG 331 (576)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecc
Confidence 9999999999999997 58888887644 349999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHhcCCCCh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI----EDELRLICSILGPPPD 401 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~----~~~~~~i~~~~~~~p~ 401 (516)
+|+..... ......+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+... ......+..
T Consensus 332 la~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~------- 403 (576)
T 2acx_A 332 LAVHVPEG-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------- 403 (576)
T ss_dssp TCEECCTT-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-------
T ss_pred cceecccC-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-------
Confidence 99876432 233456899999999999998888999999999999999999999987532 222222321
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcccC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHEL 470 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~~ 470 (516)
.....|..+++++.+||.+||+.||.+|| |++|+++||||+.+++.....
T Consensus 404 -------------------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~ 458 (576)
T 2acx_A 404 -------------------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGA 458 (576)
T ss_dssp -------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHT
T ss_pred -------------------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhc
Confidence 11123457899999999999999999999 899999999999887654433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=396.20 Aligned_cols=255 Identities=24% Similarity=0.287 Sum_probs=206.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++..+|+.||||++........
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------------ 98 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK------------------------------------ 98 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH------------------------------------
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH------------------------------------
Confidence 34779999999999999999999999999999998754321100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
.......|+..+..+ +||||+++++
T Consensus 99 ------------------------------------------------------~~~~~~~e~~~~~~~~~h~~iv~l~~ 124 (311)
T 3p1a_A 99 ------------------------------------------------------DRARKLAEVGSHEKVGQHPCCVRLEQ 124 (311)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhcCCCcEEEEEE
Confidence 011234455555444 8999999999
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
++.+++.+|+||||++++|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 125 AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceee
Confidence 99999999999999999999999888888999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+..... .......||+.|+|||++.+ .++.++|+|||||++|||++|..||.+... ...+.. +..+.
T Consensus 205 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~--~~~~~------ 271 (311)
T 3p1a_A 205 VELGTA-GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ--GYLPP------ 271 (311)
T ss_dssp EECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT--TCCCH------
T ss_pred eecccC-CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc--cCCCc------
Confidence 765432 23344578999999999887 678899999999999999999777755322 222211 11111
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..+..+++++.+||.+||+.||++|||++|+++||||+.
T Consensus 272 ----------------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 ----------------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp ----------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ----------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 112367899999999999999999999999999999974
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=414.93 Aligned_cols=239 Identities=36% Similarity=0.589 Sum_probs=176.5
Q ss_pred HHHHHHHHHhccccceeeEeeeEe--eCceeeEeeehhhchHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHH
Q psy12305 227 AIREVSLLRELRHANIVTLHDIIH--TEKCLTLVFEYLEKDLKRYMDDCS--------NILSMNNVKLFLFQLLRGLAYC 296 (516)
Q Consensus 227 ~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~E~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~yL 296 (516)
+.+|+.+|+.++||||+++++++. .+..+|+||||++++|.+++.... ..+++..++.++.||+.||+||
T Consensus 65 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 144 (405)
T 3rgf_A 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144 (405)
T ss_dssp HHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 445666666666666666666663 356799999999999988876321 2499999999999999999999
Q ss_pred hhCCcEeeecCCCCEEE----ccCCCEEEeeeccccccCCCC---ccccCCcccccccchhhccCCC-CCCceeeehHHH
Q psy12305 297 HSRRILHRDLKPQNLLI----NERGELKLADFGLARAKSVPT---KTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGC 368 (516)
Q Consensus 297 H~~~ivHrDlKp~NILl----~~~~~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGv 368 (516)
|++||+||||||+|||+ +.++.+||+|||+|+...... ......+||+.|+|||++.+.. +..++|+|||||
T Consensus 145 H~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~ 224 (405)
T 3rgf_A 145 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGC 224 (405)
T ss_dssp HHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHH
T ss_pred HhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHH
Confidence 99999999999999999 677899999999998754322 2334568899999999998754 667789999999
Q ss_pred HHHHHHcCCCCCCCCCH---------HHHHHHHHHhcCCCChhhhhhccccc----------CCCCCC--chhhhhcCCC
Q psy12305 369 IFHEMSSGRPLFPGSTI---------EDELRLICSILGPPPDELKSKLEFCI----------TPVYPS--ESKLQLLAPE 427 (516)
Q Consensus 369 il~elltG~~pF~~~~~---------~~~~~~i~~~~~~~p~~~~~~~~~~~----------~~~~~~--~~~~~~~~p~ 427 (516)
++|||++|.+||.+... .+++..+...+|.|+...|....... ...+.. ..........
T Consensus 225 il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (405)
T 3rgf_A 225 IFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKV 304 (405)
T ss_dssp HHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTC
T ss_pred HHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCC
Confidence 99999999999987654 47888999999999877664332110 000000 0001111122
Q ss_pred CCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 428 ~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
..++++.+||.+||++||.+|||++|+|+||||.....
T Consensus 305 ~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPL 342 (405)
T ss_dssp CTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSC
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCC
Confidence 44788999999999999999999999999999987543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=407.98 Aligned_cols=257 Identities=28% Similarity=0.363 Sum_probs=212.4
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|...+.||+|+||+||+|++..+|+.||||++......
T Consensus 90 ~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~----------------------------------------- 128 (373)
T 2x4f_A 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK----------------------------------------- 128 (373)
T ss_dssp EEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHH-----------------------------------------
T ss_pred eeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc-----------------------------------------
Confidence 345578899999999999999999999999998653210
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+|++++||||+++++++..
T Consensus 129 ---------------------------------------------------~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 157 (373)
T 2x4f_A 129 ---------------------------------------------------DKEEVKNEISVMNQLDHANLIQLYDAFES 157 (373)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ---------------------------------------------------cHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 01246678888888899999999999999
Q ss_pred CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE--ccCCCEEEeeecccc
Q psy12305 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI--NERGELKLADFGLAR 328 (516)
Q Consensus 252 ~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl--~~~~~vkL~DFGla~ 328 (516)
.+.+++||||++ ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 158 ~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~ 237 (373)
T 2x4f_A 158 KNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237 (373)
T ss_dssp SSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCce
Confidence 999999999998 58888887766679999999999999999999999999999999999999 566789999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
..... ......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+.+..+......++...
T Consensus 238 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~----- 311 (373)
T 2x4f_A 238 RYKPR-EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEE----- 311 (373)
T ss_dssp ECCTT-CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGG-----
T ss_pred ecCCc-cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhh-----
Confidence 76533 233455799999999999888888899999999999999999999999988888877765433222111
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 312 -----------------~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 312 -----------------FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -----------------GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -----------------hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 12678999999999999999999999999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=398.19 Aligned_cols=262 Identities=24% Similarity=0.345 Sum_probs=210.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|++..+|+.||||++........
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----------------------------------- 48 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC----------------------------------- 48 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------------------------------------
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccch-----------------------------------
Confidence 457899999999999999999999999999999999864322111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+.+|+.+++.++||||+++++
T Consensus 49 --------------------------------------------------------~~~~~~E~~~l~~l~hpnIv~~~~ 72 (323)
T 3tki_A 49 --------------------------------------------------------PENIKKEICINKMLNHENVVKFYG 72 (323)
T ss_dssp ----------------------------------------------------------CHHHHHHHHHHCCCTTBCCEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhCCCCCCCeEEE
Confidence 124567888888888888999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+++..|+|||||++ +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 73 ~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 73 HRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEecCCeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999985 78777754 34599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC--ccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 327 ARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 327 a~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
++...... ......+||+.|+|||++.+..+ ..++|+|||||++|+|++|+.||.+................
T Consensus 152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~----- 226 (323)
T 3tki_A 152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT----- 226 (323)
T ss_dssp CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT-----
T ss_pred cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc-----
Confidence 97653222 23345689999999999988766 44689999999999999999999875543222111111000
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.......+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 227 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 227 ------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp ------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 0001135789999999999999999999999999999998643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=400.12 Aligned_cols=286 Identities=31% Similarity=0.581 Sum_probs=218.3
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
.+...++|++.+.||+|+||+||+|++..+|+.||||++...........+.+
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~--------------------------- 58 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR--------------------------- 58 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHH---------------------------
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHH---------------------------
Confidence 34556789999999999999999999999999999999864322222223344
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
|+.+++.++||||+++
T Consensus 59 ----------------------------------------------------------------E~~~l~~l~h~~iv~~ 74 (353)
T 2b9h_A 59 ----------------------------------------------------------------EIKILKHFKHENIITI 74 (353)
T ss_dssp ----------------------------------------------------------------HHHHHHHCCCTTBCCE
T ss_pred ----------------------------------------------------------------HHHHHHhCcCCCcCCe
Confidence 4455555555555555
Q ss_pred eeeEee-----CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEE
Q psy12305 246 HDIIHT-----EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELK 320 (516)
Q Consensus 246 ~~~~~~-----~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vk 320 (516)
++++.. ....|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 75 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~k 152 (353)
T 2b9h_A 75 FNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLK 152 (353)
T ss_dssp EEECCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEE
T ss_pred eeeecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEE
Confidence 554433 256899999999999998876 4599999999999999999999999999999999999999999999
Q ss_pred EeeeccccccCCCCc----------cccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHH
Q psy12305 321 LADFGLARAKSVPTK----------TFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDEL 389 (516)
Q Consensus 321 L~DFGla~~~~~~~~----------~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~ 389 (516)
|+|||+|+....... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+.+
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 232 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999999986542211 1233578999999998765 55677889999999999999999999999999999
Q ss_pred HHHHHhcCCCChhhh-hhc------cc-ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 390 RLICSILGPPPDELK-SKL------EF-CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 390 ~~i~~~~~~~p~~~~-~~~------~~-~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
..+....+.|+.... ... ++ ...+.++. ....... ..+++++.+||.+||+.||++|||++++++||||+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPA-APLEKMF-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ 310 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCC-CCHHHHS-TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCC-cchhhhc-ccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence 999988888763211 100 00 01111111 1111222 37899999999999999999999999999999998
Q ss_pred CCCCC
Q psy12305 462 SLGPQ 466 (516)
Q Consensus 462 ~~~~~ 466 (516)
.....
T Consensus 311 ~~~~~ 315 (353)
T 2b9h_A 311 TYHDP 315 (353)
T ss_dssp TTCCT
T ss_pred ccCCc
Confidence 76543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=389.07 Aligned_cols=261 Identities=28% Similarity=0.452 Sum_probs=195.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++.+.||+|+||+||+|++..+|+.||||++.......
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------------------------------------ 51 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYK------------------------------------ 51 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhh------------------------------------
Confidence 35688999999999999999999999999999999986432100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+++.++||||+++++
T Consensus 52 -----------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 78 (278)
T 3cok_A 52 -----------------------------------------------------AGMVQRVQNEVKIHCQLKHPSILELYN 78 (278)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHTTBCCTTBCCEEE
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHHHhCCCCCeEeEEE
Confidence 111235678888999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+.+..++||||++ ++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~ 158 (278)
T 3cok_A 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGL 158 (278)
T ss_dssp EEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTT
T ss_pred EEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecc
Confidence 9999999999999997 589999887767899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+.............+||+.|+|||++.+..+..++|+|||||++|+|++|+.||...+..+.+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 225 (278)
T 3cok_A 159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------- 225 (278)
T ss_dssp CEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC-------------
T ss_pred eeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh-------------
Confidence 9876544444445678999999999988888889999999999999999999998755433222110
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
......|..++.++.+||.+||+.||++|||++++++||||...
T Consensus 226 -------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 226 -------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp -------------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred -------------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 00112345688999999999999999999999999999999753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=405.30 Aligned_cols=289 Identities=19% Similarity=0.199 Sum_probs=214.4
Q ss_pred cccccEeeeeeeccc--cceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 88 GRIESYFKLDKLGQG--TYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G--~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
...++|+++++||+| +||+||+|++..+|+.||||++.......
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~---------------------------------- 67 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN---------------------------------- 67 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH----------------------------------
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh----------------------------------
Confidence 566789999999999 99999999999999999999987542111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.....+.+|+.+++.++||||+++
T Consensus 68 --------------------------------------------------------~~~~~~~~E~~~l~~l~h~niv~~ 91 (389)
T 3gni_B 68 --------------------------------------------------------EMVTFLQGELHVSKLFNHPNIVPY 91 (389)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 011256679999999999999999
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
++++.+++.+|+|||||+ ++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~d 171 (389)
T 3gni_B 92 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSG 171 (389)
T ss_dssp EEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECC
T ss_pred eEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcc
Confidence 999999999999999998 5888888764 35699999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCC-------ccccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Q psy12305 324 FGLARAKSVPT-------KTFSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS 394 (516)
Q Consensus 324 FGla~~~~~~~-------~~~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~ 394 (516)
||++....... ......+||+.|+|||++.+ ..++.++|+|||||++|||++|++||.+.+..+.+..+..
T Consensus 172 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 251 (389)
T 3gni_B 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251 (389)
T ss_dssp GGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred cccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 99986532111 12233478999999999987 5678899999999999999999999988665554443322
Q ss_pred hcC--------CCChhhhhhccc------------ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q psy12305 395 ILG--------PPPDELKSKLEF------------CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 395 ~~~--------~~p~~~~~~~~~------------~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
... .+..++...... ...+............+..+++++.+||.+||++||.+|||++|+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el 331 (389)
T 3gni_B 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331 (389)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 110 000100000000 000000000111122345788999999999999999999999999
Q ss_pred HcCCCCCCCCCC
Q psy12305 455 MRHPYFNSLGPQ 466 (516)
Q Consensus 455 l~Hp~f~~~~~~ 466 (516)
|+||||+.+...
T Consensus 332 l~hp~f~~~~~~ 343 (389)
T 3gni_B 332 LNHSFFKQIKRR 343 (389)
T ss_dssp TTSGGGGGC---
T ss_pred hcCHHHHHHhhc
Confidence 999999887543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=403.05 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=211.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++++.||+|+||+||+|+++.+|+.||||++.....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------------------------------------- 60 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------------------------------------- 60 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--------------------------------------
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--------------------------------------
Confidence 445789999999999999999999999999999999864321
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~ 246 (516)
...+|+.++.++ +||||++++
T Consensus 61 ----------------------------------------------------------~~~~E~~~l~~~~~hp~iv~~~ 82 (342)
T 2qr7_A 61 ----------------------------------------------------------DPTEEIEILLRYGQHPNIITLK 82 (342)
T ss_dssp ----------------------------------------------------------CCHHHHHHHHHHTTSTTBCCEE
T ss_pred ----------------------------------------------------------ChHHHHHHHHHhcCCCCcCeEE
Confidence 123466666666 688888999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC----CCEEE
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER----GELKL 321 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~----~~vkL 321 (516)
+++.++..+|+|||||+ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 83 DVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEE
Confidence 99999999999999998 5888888764 469999999999999999999999999999999999998543 35999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHhcCC
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG---STIEDELRLICSILGP 398 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~---~~~~~~~~~i~~~~~~ 398 (516)
+|||+|+............+||+.|+|||++.+..++.++|+|||||++|||++|.+||.+ .+..+.+..+....-.
T Consensus 162 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 241 (342)
T 2qr7_A 162 CDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241 (342)
T ss_dssp CCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred EECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence 9999998765554555667899999999999887778889999999999999999999986 3444444444332111
Q ss_pred CChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 399 PPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 399 ~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.+ ...+..+++++.+||.+||..||++|||++++++||||..
T Consensus 242 ~~----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 242 LS----------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CC----------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred cC----------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 11 0112368999999999999999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=390.73 Aligned_cols=285 Identities=40% Similarity=0.643 Sum_probs=224.6
Q ss_pred ccEeeeeeeccccceEEEEEEEc-CCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSR-LTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~-~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
++|++++.||+|+||+||+|++. .+|+.||||++...... .....+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------------------------- 59 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI------------------------------- 59 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHH-------------------------------
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhh-------------------------------
Confidence 67999999999999999999995 67899999998754321 1122333
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc---cccceeeE
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL---RHANIVTL 245 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l 245 (516)
+|+.+++.+ +||||+++
T Consensus 60 ------------------------------------------------------------~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 60 ------------------------------------------------------------REVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHHTCCTTBCCE
T ss_pred ------------------------------------------------------------HHHHHHHhhhccCCCCeEee
Confidence 444444443 56666666
Q ss_pred eeeEe-----eCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCE
Q psy12305 246 HDIIH-----TEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGEL 319 (516)
Q Consensus 246 ~~~~~-----~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~v 319 (516)
++++. .....++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~ 159 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI 159 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCE
Confidence 66665 456789999999999999988754 459999999999999999999999999999999999999999999
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
||+|||+++..... .......||+.|+|||++.+..+..++|+|||||++|+|++|++||.+.+..+.+..+....+.+
T Consensus 160 kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 160 KLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp EECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEecCcccccccCC-CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999999765422 23345678999999999998888899999999999999999999999999999999999888887
Q ss_pred ChhhhhhcccccCCCC-CCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCc
Q psy12305 400 PDELKSKLEFCITPVY-PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQV 467 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~-~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~ 467 (516)
+...|..........+ ..........+..+++.+.+||.+||..||.+|||++++++||||+.+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~ 307 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK 307 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhh
Confidence 7655432110000000 0000111223347899999999999999999999999999999999876543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=392.66 Aligned_cols=256 Identities=22% Similarity=0.359 Sum_probs=215.9
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
.|...++||+|+||+||+|++..+|+.||||++......
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~----------------------------------------- 84 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ----------------------------------------- 84 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----------------------------------------
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh-----------------------------------------
Confidence 488889999999999999999999999999998643211
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
....+.+|+.+++.++||||+++++++..
T Consensus 85 ---------------------------------------------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (321)
T 2c30_A 85 ---------------------------------------------------RRELLFNEVVIMRDYQHFNVVEMYKSYLV 113 (321)
T ss_dssp ---------------------------------------------------SHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhCCCCCcceEEEEEEE
Confidence 11245678888888888888899999999
Q ss_pred CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 252 ~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
.+..++||||+++ +|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 114 ~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 191 (321)
T 2c30_A 114 GEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 191 (321)
T ss_dssp TTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeec
Confidence 9999999999985 78777754 45999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC 410 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~ 410 (516)
..........+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+.+..+.....+.
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------- 260 (321)
T 2c30_A 192 SKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK----------- 260 (321)
T ss_dssp CSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCC-----------
T ss_pred ccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCC-----------
Confidence 554444556789999999999998888899999999999999999999999888777666554321110
Q ss_pred cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 411 ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 411 ~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...+..+++++.+||.+||+.||++|||++++++||||....
T Consensus 261 ------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 261 ------------LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp ------------CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred ------------cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 001125688999999999999999999999999999997643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=398.75 Aligned_cols=313 Identities=23% Similarity=0.289 Sum_probs=212.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.........+.+.+|+.+|++++|||||+++++|...+...+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 45789999999999999999999999999999999987665555568899999999999999999999886554211111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
+.....+....... .+. ........ ...+..+......+.+.....
T Consensus 84 ~~~~~~~~~~~~~~--~~~-----------------------------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 129 (332)
T 3qd2_B 84 EMDEIWLKDESTDW--PLS-----------------------------SPSPMDAP---SVKIRRMDPFSTKNTVGQLQP 129 (332)
T ss_dssp HHHC----------------------------------------------------------------------------
T ss_pred hhhhhhhccccccc--ccc-----------------------------CCCccccc---ccceeeccccCcccccccccC
Confidence 11000000000000 000 00000000 000000111122233333333
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
.....++++|||||++ +|.+++..... ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 130 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG 209 (332)
T 3qd2_B 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 209 (332)
T ss_dssp --CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecC
Confidence 4455679999999985 88888876432 25566789999999999999999999999999999999999999999999
Q ss_pred cccccCCCC------------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 326 LARAKSVPT------------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 326 la~~~~~~~------------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
+++...... ......+||+.|+|||++.+..++.++|+|||||++|||++|..|+. +....+.
T Consensus 210 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~ 284 (332)
T 3qd2_B 210 LVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIIT 284 (332)
T ss_dssp TCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHH
T ss_pred cccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHH
Confidence 998765432 22344579999999999999888999999999999999999877652 1111221
Q ss_pred Hhc-CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 394 SIL-GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 394 ~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
... +..|... ...++++.+||.+||+.||.+|||++|+++||||+++
T Consensus 285 ~~~~~~~~~~~-----------------------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 285 DVRNLKFPLLF-----------------------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp HHHTTCCCHHH-----------------------HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred HhhccCCCccc-----------------------ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 111 1111110 1346788999999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=398.79 Aligned_cols=259 Identities=27% Similarity=0.341 Sum_probs=201.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+++.||||++......
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------------------------------- 92 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--------------------------------------- 92 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------------------------------
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhH---------------------------------------
Confidence 36699999999999999999999999999999998643110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
..+.+|+.++++++||||+++++++
T Consensus 93 -------------------------------------------------------~~~~~E~~~l~~l~h~niv~~~~~~ 117 (349)
T 2w4o_A 93 -------------------------------------------------------KIVRTEIGVLLRLSHPNIIKLKEIF 117 (349)
T ss_dssp -------------------------------------------------------------CHHHHHCCCTTBCCEEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHhCCCCCCcceeeeE
Confidence 1344678888888888888999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc---CCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE---RGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkL~DFG 325 (516)
.+....++||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 118 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg 196 (349)
T 2w4o_A 118 ETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFG 196 (349)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC
T ss_pred ecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCc
Confidence 99899999999998 5888888764 45999999999999999999999999999999999999975 8899999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIED-ELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~-~~~~i~~~~~~~p~~~~ 404 (516)
+++..... ......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+....+ .+..+.......+.
T Consensus 197 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~--- 272 (349)
T 2w4o_A 197 LSKIVEHQ-VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFIS--- 272 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCT---
T ss_pred cccccCcc-cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCC---
Confidence 99865432 22345678999999999999888999999999999999999999998765544 33444322111110
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.....++.++.+||.+||+.||++|||++|+++||||......
T Consensus 273 -------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 273 -------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp -------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred -------------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 1123678999999999999999999999999999999875443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=400.64 Aligned_cols=259 Identities=23% Similarity=0.328 Sum_probs=218.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.+.|.+++.||+|+||+||+|++..+|+.||||++........
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~------------------------------------- 95 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN------------------------------------- 95 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHH-------------------------------------
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccch-------------------------------------
Confidence 3569999999999999999999999999999999865321100
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 96 ----------------------------------------------------~~~~~~~~E~~~l~~l~hpniv~~~~~~ 123 (348)
T 1u5q_A 96 ----------------------------------------------------EKWQDIIKEVRFLQKLRHPNTIQYRGCY 123 (348)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 0112566788899999999999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
..++..|+||||+.|++.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 124 ~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 203 (348)
T 1u5q_A 124 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203 (348)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred EECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence 99999999999999999999887777899999999999999999999999999999999999999999999999999976
Q ss_pred cCCCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
... ....+||+.|+|||++. +..++.++|+|||||++|||++|.+||.+.+..+.+..+.....+
T Consensus 204 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-------- 271 (348)
T 1u5q_A 204 MAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------- 271 (348)
T ss_dssp SSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--------
T ss_pred cCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--------
Confidence 542 23457899999999985 456778899999999999999999999988777666555432111
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
...+..+++.+.+||.+||+.||++|||++++++||||....+
T Consensus 272 ----------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~ 314 (348)
T 1u5q_A 272 ----------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 314 (348)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred ----------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence 1122367899999999999999999999999999999976543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=386.21 Aligned_cols=259 Identities=27% Similarity=0.460 Sum_probs=218.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++.+.||+|+||+||+|++..+++.||||++.......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------ 49 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------------------------------------ 49 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccch------------------------------------
Confidence 35688999999999999999999999999999999986432100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+++.++||||+++++
T Consensus 50 -----------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T 3fdn_A 50 -----------------------------------------------------AGVEHQLRREVEIQSHLRHPNILRLYG 76 (279)
T ss_dssp -----------------------------------------------------HTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHHHcCCCCCCcchhh
Confidence 011235678899999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+....++||||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~ 155 (279)
T 3fdn_A 77 YFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 155 (279)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCE
T ss_pred eEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccc
Confidence 9999999999999999 5888888765 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+..... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+....
T Consensus 156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 223 (279)
T 3fdn_A 156 SVHAPS--SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------- 223 (279)
T ss_dssp ESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC----------
T ss_pred cccCCc--ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC----------
Confidence 865432 22344578999999999998888889999999999999999999999988777776664322
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...|..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 224 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 224 ----------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ----------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ----------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 223456889999999999999999999999999999997643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.28 Aligned_cols=263 Identities=27% Similarity=0.357 Sum_probs=220.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+|+.||||++.......
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-------------------------------------- 46 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-------------------------------------- 46 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH--------------------------------------
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH--------------------------------------
Confidence 467999999999999999999999999999999986542110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.++++++||||+++++++
T Consensus 47 ----------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 74 (284)
T 3kk8_A 47 ----------------------------------------------------RDFQKLEREARICRKLQHPNIVRLHDSI 74 (284)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 0012456788899999999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC---EEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE---LKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkL~DFG 325 (516)
..+...++||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 75 ~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg 153 (284)
T 3kk8_A 75 QEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFG 153 (284)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence 999999999999985 888887765 45999999999999999999999999999999999999987665 9999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
++...... .......||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.+.......+.......+..
T Consensus 154 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--- 229 (284)
T 3kk8_A 154 LAIEVNDS-EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP--- 229 (284)
T ss_dssp TCEECCSS-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred eeEEcccC-ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch---
Confidence 99765533 23345678999999999999888899999999999999999999999988877777665533222211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
....+++++.+||.+||+.||++|||++|+++||||......
T Consensus 230 -------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 230 -------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp -------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred -------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 113678999999999999999999999999999999875443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=392.50 Aligned_cols=281 Identities=29% Similarity=0.520 Sum_probs=215.4
Q ss_pred ccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 85 IGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 85 ~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
+.++..++|++++.||+|+||+||+|++..+|+.||||++....
T Consensus 30 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------------------------------ 73 (330)
T 3nsz_A 30 VEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------------------------------------ 73 (330)
T ss_dssp CCCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------------------------------------
T ss_pred hcccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------------------------------------
Confidence 45567789999999999999999999999999999999885321
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-cccee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIV 243 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv 243 (516)
...+.+|+.+++.++ ||||+
T Consensus 74 -----------------------------------------------------------~~~~~~E~~~l~~l~~~~~i~ 94 (330)
T 3nsz_A 74 -----------------------------------------------------------KKKIKREIKILENLRGGPNII 94 (330)
T ss_dssp -----------------------------------------------------------HHHHHHHHHHHHHHTTSTTBC
T ss_pred -----------------------------------------------------------hHHHHHHHHHHHHcCCCCCEE
Confidence 114556777777775 77777
Q ss_pred eEeeeEee--CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-CE
Q psy12305 244 TLHDIIHT--EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-EL 319 (516)
Q Consensus 244 ~l~~~~~~--~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~v 319 (516)
++++++.. ....++||||+++ +|.+++.. +++..++.++.||+.||+|||++||+||||||+|||++.++ .+
T Consensus 95 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~ 170 (330)
T 3nsz_A 95 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKL 170 (330)
T ss_dssp CEEEEEECTTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEE
T ss_pred EeeeeeccCCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEE
Confidence 88887776 5678999999995 67666643 89999999999999999999999999999999999999777 89
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHhcC
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFP-GSTIEDELRLICSILG 397 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~-~~~~~~~~~~i~~~~~ 397 (516)
||+|||+|+..... ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +....+.+..+...++
T Consensus 171 kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 171 RLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp EECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 99999999865432 33455688999999999987 557778899999999999999999984 5666677777776666
Q ss_pred CCChh-hhhhcccccCC----------CCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 398 PPPDE-LKSKLEFCITP----------VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 398 ~~p~~-~~~~~~~~~~~----------~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.++.. ..........+ ............+..+++++.+||.+||++||.+|||++|+|+||||+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred CchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 43211 11110000000 0000001111122247899999999999999999999999999999998754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=397.69 Aligned_cols=256 Identities=24% Similarity=0.351 Sum_probs=190.7
Q ss_pred cccEeee---eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 90 IESYFKL---DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 90 ~~~y~~~---~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.++|++. +.||+|+||+||+|++..+|+.||||++....
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------------------------------------- 48 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM-------------------------------------- 48 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG--------------------------------------
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh--------------------------------------
Confidence 4567776 78999999999999999999999999985421
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeE
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTL 245 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l 245 (516)
.....+|+.+++.+. ||||+++
T Consensus 49 ---------------------------------------------------------~~~~~~e~~~l~~l~~h~niv~~ 71 (325)
T 3kn6_A 49 ---------------------------------------------------------EANTQKEITALKLCEGHPNIVKL 71 (325)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHHHTTTCTTBCCE
T ss_pred ---------------------------------------------------------hhhHHHHHHHHHHhcCCCCeeEE
Confidence 113456788888886 8999999
Q ss_pred eeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC---CEEE
Q psy12305 246 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG---ELKL 321 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkL 321 (516)
++++.++...|+||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||
T Consensus 72 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl 150 (325)
T 3kn6_A 72 HEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKI 150 (325)
T ss_dssp EEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEE
T ss_pred EEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEE
Confidence 9999999999999999985 898888764 5699999999999999999999999999999999999998766 7999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHH
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI-------EDELRLICS 394 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~-------~~~~~~i~~ 394 (516)
+|||+++............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+. .+.+..+..
T Consensus 151 ~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~ 230 (325)
T 3kn6_A 151 IDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK 230 (325)
T ss_dssp CCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred eccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence 9999998766555555667889999999999988888899999999999999999999986433 233333322
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....++.+.+ ..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 231 ~~~~~~~~~~----------------------~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 231 GDFSFEGEAW----------------------KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp TCCCCCSHHH----------------------HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCCCCCcccc----------------------cCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 1111111111 2578999999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=406.17 Aligned_cols=257 Identities=25% Similarity=0.326 Sum_probs=195.8
Q ss_pred cccccEeee-eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~-~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|.+. +.||+|+||+||+|+++.+|+.||||++... ..+.+|+.++.
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~---------------------- 109 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHW---------------------- 109 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHH----------------------
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHH----------------------
Confidence 456789888 7899999999999999999999999998532 13334444432
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
+..+||||++++
T Consensus 110 --------------------------------------------------------------------~~~~hp~iv~l~ 121 (400)
T 1nxk_A 110 --------------------------------------------------------------------RASQCPHIVRIV 121 (400)
T ss_dssp --------------------------------------------------------------------HHTTSTTBCCEE
T ss_pred --------------------------------------------------------------------HhcCCCCcceEe
Confidence 223566666666
Q ss_pred eeEee----CceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc---CC
Q psy12305 247 DIIHT----EKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE---RG 317 (516)
Q Consensus 247 ~~~~~----~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---~~ 317 (516)
++|.. ..++|||||||+ |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++
T Consensus 122 ~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~ 201 (400)
T 1nxk_A 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201 (400)
T ss_dssp EEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC
T ss_pred EEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc
Confidence 66654 567999999998 59999998653 46999999999999999999999999999999999999998 78
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHH----HHHHHH
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIED----ELRLIC 393 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~----~~~~i~ 393 (516)
.+||+|||+|+.... .......+||+.|+|||++.+..++.++|+|||||++|||++|..||.+..... ....+.
T Consensus 202 ~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 202 ILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp CEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred cEEEEecccccccCC-CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 899999999986543 223456688999999999988888999999999999999999999998754321 122222
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
......+ ......+++++.+||.+||+.||++|||++++++||||...
T Consensus 281 ~~~~~~~----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 281 MGQYEFP----------------------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HTCCCCC----------------------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCcccCC----------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1110000 00113678999999999999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=396.04 Aligned_cols=287 Identities=25% Similarity=0.403 Sum_probs=227.3
Q ss_pred ccccEeeeeeeccccceEEEEEEE-cCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKS-RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~-~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..++|++++.||+|+||+||+|++ ..+|+.||||++..... ....+.+|+.+++.++|+|+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~--------------- 74 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDR--YCEAARSEIQVLEHLNTTDPN--------------- 74 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHH--HHHHHHHHHHHHHHHHHHCTT---------------
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCc--hhHHHHHHHHHHHHhhhcCCC---------------
Confidence 346899999999999999999998 56889999999864321 112344555555555444321
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.|++|+++++
T Consensus 75 ----------------------------------------------------------------------~~~~i~~~~~ 84 (339)
T 1z57_A 75 ----------------------------------------------------------------------STFRCVQMLE 84 (339)
T ss_dssp ----------------------------------------------------------------------CTTCBCCEEE
T ss_pred ----------------------------------------------------------------------CceeeEeeec
Confidence 3456999999
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-----------
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE----------- 315 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~----------- 315 (516)
++...+++|+||||++++|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 85 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 85 WFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred ccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999999999889999998754 36899999999999999999999999999999999999987
Q ss_pred --------CCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHH
Q psy12305 316 --------RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIED 387 (516)
Q Consensus 316 --------~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~ 387 (516)
++.+||+|||+++.... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 241 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred ccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence 66899999999976442 2344578999999999999888999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCChhhhhhccccc--------CCCCCCc----------hhhhhcCCCCCCHHHHHHHHHccccCcCCCC
Q psy12305 388 ELRLICSILGPPPDELKSKLEFCI--------TPVYPSE----------SKLQLLAPEQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 388 ~~~~i~~~~~~~p~~~~~~~~~~~--------~~~~~~~----------~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
.+..+....+++|..++....... .+..... .......+...++++.+||.+||+.||.+||
T Consensus 242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 321 (339)
T 1z57_A 242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI 321 (339)
T ss_dssp HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence 999999999999887754322110 0000000 0000111223457899999999999999999
Q ss_pred CHHHHHcCCCCCCCCC
Q psy12305 450 SAANAMRHPYFNSLGP 465 (516)
Q Consensus 450 ta~e~l~Hp~f~~~~~ 465 (516)
|++|+++||||+.+..
T Consensus 322 t~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 322 TLREALKHPFFDLLKK 337 (339)
T ss_dssp CHHHHTTSGGGGGGGC
T ss_pred CHHHHhcCHHHHHHhc
Confidence 9999999999987643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=382.16 Aligned_cols=256 Identities=25% Similarity=0.351 Sum_probs=218.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..++..||+|++......
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~--------------------------------------- 48 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE--------------------------------------- 48 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---------------------------------------
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---------------------------------------
Confidence 36699999999999999999999999999999988653211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+++.++||||+++++++
T Consensus 49 -----------------------------------------------------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (277)
T 3f3z_A 49 -----------------------------------------------------DVDRFKQEIEIMKSLDHPNIIRLYETF 75 (277)
T ss_dssp -----------------------------------------------------CHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred -----------------------------------------------------hHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 122566788888888899999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE---ccCCCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI---NERGELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkL~DFG 325 (516)
.++...|+||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 76 EDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred ecCCeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 999999999999985 888887764 459999999999999999999999999999999999999 788999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
++...... .......||+.|+|||++.+. ++.++|+|||||++|+|++|..||.+.+..+....+......+|...+
T Consensus 155 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 231 (277)
T 3f3z_A 155 LAARFKPG-KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW- 231 (277)
T ss_dssp TCEECCTT-SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH-
T ss_pred cceeccCc-cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh-
Confidence 99765432 334456789999999998764 788999999999999999999999998888877777665444443222
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 232 ---------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 232 ---------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp ---------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred ---------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 157899999999999999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-49 Score=413.58 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=220.8
Q ss_pred ccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...+++|.+.+.||+|+||+||+|++..+|+.||||++.......
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~----------------------------------- 56 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRS----------------------------------- 56 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHH-----------------------------------
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccC-----------------------------------
Confidence 356788999999999999999999999999999999986532110
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
......+.+|+.+++.++||||++++
T Consensus 57 ------------------------------------------------------~~~~~~~~~Ei~~l~~l~HpnIv~l~ 82 (476)
T 2y94_A 57 ------------------------------------------------------LDVVGKIRREIQNLKLFRHPHIIKLY 82 (476)
T ss_dssp ------------------------------------------------------TTTHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 01122567888889999999999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++.+...+|+||||++ ++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG 161 (476)
T 2y94_A 83 QVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFG 161 (476)
T ss_dssp EEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEecc
Confidence 99999999999999997 5898888654 469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+++..... ......+||+.|+|||++.+..+ ..++|+|||||++|+|++|..||.+.+.......+....
T Consensus 162 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 232 (476)
T 2y94_A 162 LSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-------- 232 (476)
T ss_dssp SCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC--------
T ss_pred chhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC--------
Confidence 99876432 33455689999999999988766 457899999999999999999999888777766664321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...|..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 233 ------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 12344688999999999999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=415.18 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=217.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|+++.+|+.||||++.......
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------- 62 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------------------------------------- 62 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-------------------------------------
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-------------------------------------
Confidence 3467999999999999999999999999999999986532211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+|++++||||++++++
T Consensus 63 -----------------------------------------------------~~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 63 -----------------------------------------------------KDTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp -----------------------------------------------------SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -----------------------------------------------------hHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 112356788888888899999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc---cCCCEEEeee
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN---ERGELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~---~~~~vkL~DF 324 (516)
+.+...+|+|||||. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 168 (486)
T 3mwu_A 90 LEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (486)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred EEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEEC
Confidence 999999999999998 4888888765 4599999999999999999999999999999999999995 4567999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+|+..... ......+||+.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 169 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 244 (486)
T 3mwu_A 169 GLSTCFQQN-TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP-- 244 (486)
T ss_dssp SCTTTBCCC-----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG--
T ss_pred CcCeECCCC-CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--
Confidence 999765432 33455689999999999876 47788999999999999999999999998888877776533222111
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
....+++++++||.+||+.||.+|||+.++|+||||+....
T Consensus 245 --------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 245 --------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp --------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred --------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 11257899999999999999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=412.08 Aligned_cols=274 Identities=26% Similarity=0.376 Sum_probs=222.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|+++.+++.||||++......... ...
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~--~~~------------------------------ 81 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR--YSD------------------------------ 81 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC------------------------------------------
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhccccc--ccc------------------------------
Confidence 457799999999999999999999999999999999764321100 000
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...........+.+|+.+|++++||||++++++
T Consensus 82 -----------------------------------------------~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 82 -----------------------------------------------DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp -----------------------------------------------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred -----------------------------------------------cchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 000011233467899999999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC---CEEEeee
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG---ELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkL~DF 324 (516)
+.++..+|+|||||+| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999985 888888765 4599999999999999999999999999999999999998876 6999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+|+..... ......+||+.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+..+.+..+......++...|
T Consensus 194 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 271 (504)
T 3q5i_A 194 GLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271 (504)
T ss_dssp TTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred CCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 999876533 33455689999999999875 5888999999999999999999999999988888777654333222211
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
..+++++++||.+||++||.+|||++|+|+||||+.....
T Consensus 272 ----------------------~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 272 ----------------------KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred ----------------------CCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 2678999999999999999999999999999999865433
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=412.09 Aligned_cols=259 Identities=28% Similarity=0.433 Sum_probs=214.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|+++++||+|+||+||+|+++.+++.||||++.......
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-------------------------------------- 77 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-------------------------------------- 77 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------------------------------------------
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc--------------------------------------
Confidence 356999999999999999999999999999999987542111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+++.++||||+++++++
T Consensus 78 ----------------------------------------------------~~~~~~~~E~~~l~~l~hpniv~~~~~~ 105 (494)
T 3lij_A 78 ----------------------------------------------------SSNSKLLEEVAVLKLLDHPNIMKLYDFF 105 (494)
T ss_dssp ----------------------------------------------------CTTHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------hHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 1122567788888888999999999999
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC---CCEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER---GELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkL~DFG 325 (516)
.+...+|+|||||.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.. +.+||+|||
T Consensus 106 ~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG 184 (494)
T 3lij_A 106 EDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFG 184 (494)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECC
Confidence 999999999999984 888888765 459999999999999999999999999999999999999764 459999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+..... ......+||+.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+..+.+..+......++...
T Consensus 185 ~a~~~~~~-~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-- 260 (494)
T 3lij_A 185 LSAVFENQ-KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPE-- 260 (494)
T ss_dssp TCEECBTT-BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGG--
T ss_pred CCeECCCC-ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchh--
Confidence 99876533 33455689999999999865 588899999999999999999999999998888877765443322211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 261 --------------------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 261 --------------------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp --------------------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred --------------------cccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 12678999999999999999999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=387.23 Aligned_cols=267 Identities=25% Similarity=0.350 Sum_probs=215.4
Q ss_pred cccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 84 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
...+...++|++++.||+|+||+||+|++..+|+.||+|++......
T Consensus 12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--------------------------------- 58 (302)
T 2j7t_A 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--------------------------------- 58 (302)
T ss_dssp BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C---------------------------------
T ss_pred ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH---------------------------------
Confidence 34456678899999999999999999999999999999988543211
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccccee
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 243 (516)
....+.+|+.+++.++||||+
T Consensus 59 -----------------------------------------------------------~~~~~~~e~~~l~~l~h~~i~ 79 (302)
T 2j7t_A 59 -----------------------------------------------------------ELEDYIVEIEILATCDHPYIV 79 (302)
T ss_dssp -----------------------------------------------------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred -----------------------------------------------------------HHHHHHHHHHHHhcCCCCCEe
Confidence 122566788888888888888
Q ss_pred eEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 244 TLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 244 ~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
++++++..++..++||||+++ +|..++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 80 KLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp CEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred eeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEE
Confidence 889988888899999999985 7888887767779999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~ 397 (516)
|||++..............||+.|+|||++. +..++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus 160 Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (302)
T 2j7t_A 160 DFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239 (302)
T ss_dssp CCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred ECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCC
Confidence 9999864322222233457899999999983 55677889999999999999999999998877666555543211
Q ss_pred CCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 398 PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 398 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
+ ....+..++.++.+||.+||..||.+|||++++++||||++...
T Consensus 240 ~-----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 240 P-----------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp C-----------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred c-----------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 1 01123367889999999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=396.95 Aligned_cols=270 Identities=23% Similarity=0.337 Sum_probs=215.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+++.||||++........
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------- 67 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQI------------------------------------- 67 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC--------------------------------------
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhccc-------------------------------------
Confidence 4679999999999999999999999999999999875421110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.......+.+|+.+++.++||||+++++++
T Consensus 68 --------------------------------------------------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 97 (345)
T 3hko_A 68 --------------------------------------------------NPKDVERIKTEVRLMKKLHHPNIARLYEVY 97 (345)
T ss_dssp ----------------------------------------------------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred --------------------------------------------------CHHHHHHHHHHHHHHHhCCCCCcceeehhh
Confidence 011123567899999999999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHH
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC---------------------------------------SNILSMNNVKLFLFQL 289 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi 289 (516)
.+++..|+|||||+ ++|.+++... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 99999999999997 5888877421 1124677889999999
Q ss_pred HHHHHHHhhCCcEeeecCCCCEEEccCC--CEEEeeeccccccCCCC----ccccCCcccccccchhhccC--CCCCCce
Q psy12305 290 LRGLAYCHSRRILHRDLKPQNLLINERG--ELKLADFGLARAKSVPT----KTFSNEVVTLWYRPPDVLLG--STEYSTS 361 (516)
Q Consensus 290 ~~aL~yLH~~~ivHrDlKp~NILl~~~~--~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~APE~l~~--~~~~~~~ 361 (516)
+.||+|||++||+||||||+|||++.++ .+||+|||+|+...... .......||+.|+|||++.+ ..++.++
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 9999999999999999999999998776 89999999998643221 12345678999999999975 5677889
Q ss_pred eeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHcc
Q psy12305 362 IDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFL 441 (516)
Q Consensus 362 d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L 441 (516)
|+|||||++|||++|+.||.+.+..+....+.......+.. ....+++++.+||.+||
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~li~~~l 315 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP----------------------NYNVLSPLARDLLSNLL 315 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG----------------------GGGGSCHHHHHHHHHHS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc----------------------ccccCCHHHHHHHHHHc
Confidence 99999999999999999999988887777765532221110 01247899999999999
Q ss_pred ccCcCCCCCHHHHHcCCCCCCCCCCcc
Q psy12305 442 MYDAKQRISAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 442 ~~dP~~R~ta~e~l~Hp~f~~~~~~~~ 468 (516)
+.||.+|||+.++++||||+...+...
T Consensus 316 ~~~p~~Rps~~~~l~hp~~~~~~~~~~ 342 (345)
T 3hko_A 316 NRNVDERFDAMRALQHPWISQFSDKIY 342 (345)
T ss_dssp CSCTTTSCCHHHHHHSHHHHTTSSCSS
T ss_pred CCChhHCCCHHHHhcChhhccChHhhE
Confidence 999999999999999999998765543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=391.33 Aligned_cols=266 Identities=22% Similarity=0.321 Sum_probs=218.1
Q ss_pred cccEeee-eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 90 IESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 90 ~~~y~~~-~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
-++|.+. +.||+|+||+||+|++..+|+.||||++.......
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------- 69 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ------------------------------------- 69 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-------------------------------------
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-------------------------------------
Confidence 3568888 89999999999999999999999999986532111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
.....+.+|+.+++.+ .||||+++++
T Consensus 70 -----------------------------------------------------~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 70 -----------------------------------------------------DCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp -----------------------------------------------------ECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 1122566788888888 4699999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc---CCCEEEe
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE---RGELKLA 322 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkL~ 322 (516)
++.+...+|+||||+.+ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999985 787776543 356999999999999999999999999999999999999988 7899999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|||+++..... ......+||+.|+|||++.+..+..++|+|||||++|+|++|..||.+.+..+....+.......+..
T Consensus 177 Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 177 DFGMSRKIGHA-CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp CGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred eCccccccCCc-cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 99999876432 22344678999999999998888899999999999999999999999988888777776544333221
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCCcc
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVH 468 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~~~ 468 (516)
.+..+++.+.+||.+||+.||.+|||++++++||||+...+...
T Consensus 256 ----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 256 ----------------------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp ----------------------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred ----------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 12367899999999999999999999999999999998765543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=387.70 Aligned_cols=261 Identities=26% Similarity=0.343 Sum_probs=202.3
Q ss_pred cccEeee-eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 90 IESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 90 ~~~y~~~-~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+.|++. +.||+|+||+||+|++..+|+.||||++.....
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------------------------------------- 51 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--------------------------------------- 51 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---------------------------------------
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---------------------------------------
Confidence 3569986 789999999999999999999999999864321
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
.....+.+|+.++.++ +||||+++++
T Consensus 52 -----------------------------------------------------~~~~~~~~E~~~l~~~~~h~~i~~~~~ 78 (316)
T 2ac3_A 52 -----------------------------------------------------HIRSRVFREVEMLYQCQGHRNVLELIE 78 (316)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHHHhcCCCCeeeEEE
Confidence 1122566788888774 6889999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC---EEEee
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE---LKLAD 323 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkL~D 323 (516)
++.+++.+|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 79 FFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred EEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEE
Confidence 9999999999999998 6898888765 45999999999999999999999999999999999999998776 99999
Q ss_pred eccccccCCCC-------ccccCCcccccccchhhccC-----CCCCCceeeehHHHHHHHHHcCCCCCCCCCH------
Q psy12305 324 FGLARAKSVPT-------KTFSNEVVTLWYRPPDVLLG-----STEYSTSIDMGVGCIFHEMSSGRPLFPGSTI------ 385 (516)
Q Consensus 324 FGla~~~~~~~-------~~~~~~~gt~~y~APE~l~~-----~~~~~~~d~~SlGvil~elltG~~pF~~~~~------ 385 (516)
||+++...... ......+||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+...
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 237 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237 (316)
T ss_dssp TTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC-
T ss_pred ccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccc
Confidence 99987643211 12234568999999999865 4567889999999999999999999987542
Q ss_pred ---------HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 386 ---------EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 386 ---------~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
......+.......|... ...+++++.+||.+||+.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~i~~~~~~~~~~~----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 238 RGEACPACQNMLFESIQEGKYEFPDKD----------------------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp ---CCHHHHHHHHHHHHHCCCCCCHHH----------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccchhHHHHHHHHHhccCcccCchh----------------------cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 112222322111111110 1257899999999999999999999999999
Q ss_pred CCCCCCCCC
Q psy12305 457 HPYFNSLGP 465 (516)
Q Consensus 457 Hp~f~~~~~ 465 (516)
||||+...+
T Consensus 296 hp~~~~~~~ 304 (316)
T 2ac3_A 296 HPWVQGCAP 304 (316)
T ss_dssp STTCC----
T ss_pred ChhhcCCCC
Confidence 999987643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=396.18 Aligned_cols=279 Identities=33% Similarity=0.559 Sum_probs=215.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..++|.+.+.||+|+||+||+|++..+|+.||||++...... .....+.+
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~----------------------------- 72 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR----------------------------- 72 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHH-----------------------------
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHH-----------------------------
Confidence 346799999999999999999999999999999998653221 11123344
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
|+.+++.++||||+++++
T Consensus 73 --------------------------------------------------------------E~~~l~~l~h~~iv~~~~ 90 (353)
T 3coi_A 73 --------------------------------------------------------------ELLLLKHMQHENVIGLLD 90 (353)
T ss_dssp --------------------------------------------------------------HHHHHHHCCCTTBCCCSE
T ss_pred --------------------------------------------------------------HHHHHHhcCCCCcccHhh
Confidence 455555555555555555
Q ss_pred eEeeCc------eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 248 IIHTEK------CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 248 ~~~~~~------~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
++.... ..|+||||++++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 91 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl 167 (353)
T 3coi_A 91 VFTPASSLRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKI 167 (353)
T ss_dssp EECSCSSGGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEE
T ss_pred eEecccccccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEE
Confidence 554433 359999999998877664 34999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
+|||+++.... .....+||+.|+|||++.+ ..+..++|+|||||++|+|++|..||.+.+..+.+..+....|.++
T Consensus 168 ~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 244 (353)
T 3coi_A 168 LDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 244 (353)
T ss_dssp CSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred eecccccCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999976542 2334578999999999887 5677888999999999999999999999999999999999999998
Q ss_pred hhhhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 401 DELKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 401 ~~~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.+++...... ..+..+. ..+.. .+..+++++.+||.+||+.||++|||++++++||||+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPR-KDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSS-CCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCC-ccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 8776443211 0011000 11111 123678999999999999999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=393.51 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=222.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|.+.+.||+|+||+||+|++..+++.||+|++........
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~----------------------------------- 82 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP----------------------------------- 82 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----------------------------------
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCH-----------------------------------
Confidence 455789999999999999999999999999999999865421110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.+++.++||||+++++
T Consensus 83 ------------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 108 (335)
T 2owb_A 83 ------------------------------------------------------HQREKMSMEISIHRSLAHQHVVGFHG 108 (335)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 01225667899999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+.+..|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 187 (335)
T 2owb_A 109 FFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187 (335)
T ss_dssp EEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccC
Confidence 9999999999999999 5888877654 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
++............+||+.|+|||++.+..+..++|+|||||++|+|++|+.||.+....+....+...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 256 (335)
T 2owb_A 188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------- 256 (335)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-----------
T ss_pred ceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-----------
Confidence 987654444455668899999999999888888999999999999999999999988776665555331
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....|..+++++.+||.+||+.||++|||++|+++||||.+.
T Consensus 257 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 257 ---------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ---------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 112344788999999999999999999999999999999764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=380.89 Aligned_cols=266 Identities=28% Similarity=0.418 Sum_probs=219.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|++..+|+.||||.+.........
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~------------------------------------- 47 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR------------------------------------- 47 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS-------------------------------------
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc-------------------------------------
Confidence 5799999999999999999999999999999998764322110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.......+.+|+.++++++||||+++++++.
T Consensus 48 -------------------------------------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (283)
T 3bhy_A 48 -------------------------------------------------RGVSREEIEREVNILREIRHPNIITLHDIFE 78 (283)
T ss_dssp -------------------------------------------------SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred -------------------------------------------------cchHHHHHHHHHHHHHhCCCCCeeehhheec
Confidence 0011235778999999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC----CEEEeeec
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG----ELKLADFG 325 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkL~DFG 325 (516)
+....++||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 79 NKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred CCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 9999999999997 6898888764 4599999999999999999999999999999999999998877 89999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
++...... .......||+.|+|||++.+..+..++|+|||||++|+|++|..||.+.+..+.+..+.......+...
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 234 (283)
T 3bhy_A 158 IAHKIEAG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEY-- 234 (283)
T ss_dssp TCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHH--
T ss_pred cceeccCC-CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchh--
Confidence 99865432 223445789999999999888888899999999999999999999999888777766654333222211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
+..+++.+.+||.+||..||++|||++++++||||+.+...
T Consensus 235 --------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 235 --------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp --------------------HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred --------------------cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 12678899999999999999999999999999999876433
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=391.54 Aligned_cols=299 Identities=32% Similarity=0.531 Sum_probs=222.5
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
++...++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-- 82 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVFEILGPSGS-- 82 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC--
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh-HHHHHHHHHHHHHHhcCCCCeeEEEEecccccc--
Confidence 34455789999999999999999999999999999999875432 223467788888888888888888877644321
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.+...
T Consensus 83 ---------------------------------------------------------------------------~~~~~ 87 (320)
T 2i6l_A 83 ---------------------------------------------------------------------------QLTDD 87 (320)
T ss_dssp ---------------------------------------------------------------------------BCCC-
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01111
Q ss_pred eeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc-cCCCEEEeee
Q psy12305 246 HDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-ERGELKLADF 324 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkL~DF 324 (516)
.+.+......|+||||++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 223345567899999999999998864 4699999999999999999999999999999999999997 5679999999
Q ss_pred ccccccCCC---CccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 325 GLARAKSVP---TKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 325 Gla~~~~~~---~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
|+++..... ........+|+.|+|||++.+ ..+..++|+|||||++|||++|+.||.+.+..+.+..+....+.+.
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 999865422 122334467999999999876 5567778999999999999999999999998888888888776666
Q ss_pred hhhhhhccccc-----CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 401 DELKSKLEFCI-----TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 401 ~~~~~~~~~~~-----~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.+.+....... ............ .+..+++++.+||.+||+.||++|||++++++||||+....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 246 EEDRQELLSVIPVYIRNDMTEPHKPLTQ-LLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHHHTTSCHHHHHHTTSCCCCHHH-HSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred hhhhhhhhhcCcccccccccCCCCChhH-hcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 54432211000 000000011111 12368999999999999999999999999999999987643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-48 Score=380.94 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=207.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.+.++||+|+||+||+|++..+|+.||||++.......
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~------------------------------------- 62 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV------------------------------------- 62 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCS-------------------------------------
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccch-------------------------------------
Confidence 3367999999999999999999999999999999986543211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+++.++||||++++++
T Consensus 63 ------------------------------------------------------~~~~~~~E~~~l~~l~hp~iv~~~~~ 88 (285)
T 3is5_A 63 ------------------------------------------------------PMEQIEAEIEVLKSLDHPNIIKIFEV 88 (285)
T ss_dssp ------------------------------------------------------CHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ------------------------------------------------------hHHHHHHHHHHHHhCCCchHHhHHHh
Confidence 12256678888888888888899999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE---ccCCCEEE
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI---NERGELKL 321 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkL 321 (516)
+.+....|+||||+++ +|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl 168 (285)
T 3is5_A 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKI 168 (285)
T ss_dssp EECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEE
T ss_pred eecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEE
Confidence 9998999999999985 888887543 4679999999999999999999999999999999999999 45678999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+|||+++..... ......+||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+.+..+....+.......+
T Consensus 169 ~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~- 245 (285)
T 3is5_A 169 IDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA- 245 (285)
T ss_dssp CCCCCCCC-----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC-
T ss_pred EeeecceecCCc-ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccc-
Confidence 999999765432 23345678999999999864 577889999999999999999999998877665554432111100
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
.....+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 246 ----------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 246 ----------------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp ----------------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ----------------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 011247899999999999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=394.44 Aligned_cols=291 Identities=26% Similarity=0.410 Sum_probs=226.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCC-cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTD-NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g-~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..++|++++.||+|+||+||+|++..++ +.||||++..... ....+.+|+.+++.++|+|..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~--------------- 79 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGK--YREAARLEINVLKKIKEKDKE--------------- 79 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHHCTT---------------
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccccc--chhHHHHHHHHHHHHhhcCCC---------------
Confidence 3478999999999999999999998877 6899999864321 111333444444444333311
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.|++++.+++
T Consensus 80 ----------------------------------------------------------------------~~~~~~~~~~ 89 (355)
T 2eu9_A 80 ----------------------------------------------------------------------NKFLCVLMSD 89 (355)
T ss_dssp ----------------------------------------------------------------------SCSCBCCEEE
T ss_pred ----------------------------------------------------------------------CceeEEEeee
Confidence 2334889999
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE-------------
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI------------- 313 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl------------- 313 (516)
++...++.|+||||+++++.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 90 WFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 999999999999999999998887654 569999999999999999999999999999999999999
Q ss_pred ------ccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHH
Q psy12305 314 ------NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIED 387 (516)
Q Consensus 314 ------~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~ 387 (516)
+.++.+||+|||+++.... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+..+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 6678999999999976442 2344678999999999998888999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCChhhhhhccccc--------CCCCCCc----------hhhhhcCCCCCCHHHHHHHHHccccCcCCCC
Q psy12305 388 ELRLICSILGPPPDELKSKLEFCI--------TPVYPSE----------SKLQLLAPEQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 388 ~~~~i~~~~~~~p~~~~~~~~~~~--------~~~~~~~----------~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
.+..+....+++|..++....... .+..... ...........++++.+||.+||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 999999999999987764322110 0000000 0000011112346889999999999999999
Q ss_pred CHHHHHcCCCCCCCCCCccc
Q psy12305 450 SAANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 450 ta~e~l~Hp~f~~~~~~~~~ 469 (516)
|++|+++||||+.+.+....
T Consensus 327 t~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 327 TLAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp CHHHHTTSGGGGGCCHHHHC
T ss_pred CHHHHhcChhhcCCChhhcc
Confidence 99999999999987655443
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=413.15 Aligned_cols=262 Identities=28% Similarity=0.400 Sum_probs=220.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+|+.||||++.......
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~------------------------------------- 66 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ------------------------------------- 66 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-------------------------------------
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-------------------------------------
Confidence 3467999999999999999999999999999999986542211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.++++++||||++++++
T Consensus 67 ----------------------------------------------------~~~~~~~~~E~~~l~~l~hpniv~~~~~ 94 (484)
T 3nyv_A 67 ----------------------------------------------------KTDKESLLREVQLLKQLDHPNIMKLYEF 94 (484)
T ss_dssp ----------------------------------------------------SSCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ----------------------------------------------------chHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 1112356788889999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE---ccCCCEEEeee
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI---NERGELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkL~DF 324 (516)
+.+...+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 95 FEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 999999999999998 5888888764 469999999999999999999999999999999999999 56789999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+|+..... ......+||+.|+|||++.+ .++.++|+||+||++|+|++|.+||.+.+..+.+..+......++..
T Consensus 174 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~-- 249 (484)
T 3nyv_A 174 GLSTHFEAS-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP-- 249 (484)
T ss_dssp THHHHBCCC-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG--
T ss_pred eeeEEcccc-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc--
Confidence 999876533 23344579999999999977 57889999999999999999999999998888887776533222111
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.+..+++++++||.+||++||.+|||++|+|+||||+...
T Consensus 250 --------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 250 --------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp --------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred --------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 1125789999999999999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=380.61 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=219.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++.+.||+|+||+||+|++..+++.||||++.......
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 54 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEK------------------------------------ 54 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHH------------------------------------
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccch------------------------------------
Confidence 35678999999999999999999999999999999986532110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+++.++||||+++++
T Consensus 55 -----------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 81 (284)
T 2vgo_A 55 -----------------------------------------------------EGVEHQLRREIEIQSHLRHPNILRMYN 81 (284)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhcCCCCCEeeEEE
Confidence 111235677888888899999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+++..|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 82 YFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW 160 (284)
T ss_dssp EEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccc
Confidence 9999999999999998 58988887654 599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+...... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------- 227 (284)
T 2vgo_A 161 SVHAPSL--RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227 (284)
T ss_dssp CEECSSS--CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred cccCccc--ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc-----------
Confidence 8765422 234457899999999999888889999999999999999999999988777666555321
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....|..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 228 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 228 ---------------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred ---------------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 112344788999999999999999999999999999999754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=382.60 Aligned_cols=260 Identities=25% Similarity=0.339 Sum_probs=221.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|.+.+.||+|+||+||+|++..+++.||+|++........
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~----------------------------------- 56 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKP----------------------------------- 56 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSH-----------------------------------
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCH-----------------------------------
Confidence 455789999999999999999999999999999999865421110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.+++.++||||+++++
T Consensus 57 ------------------------------------------------------~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (294)
T 2rku_A 57 ------------------------------------------------------HQREKMSMEISIHRSLAHQHVVGFHG 82 (294)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhCCCCCEeeeee
Confidence 01125667899999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+++..++||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 161 (294)
T 2rku_A 83 FFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161 (294)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccC
Confidence 9999999999999999 5788777654 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
++.............||+.|+|||++.+..+..++|+|||||++|+|++|..||.+....+....+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------- 230 (294)
T 2rku_A 162 ATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN----------- 230 (294)
T ss_dssp CEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-----------
T ss_pred ceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-----------
Confidence 987654444455567899999999998888888999999999999999999999988776665554321
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....|..+++.+.+||.+||+.||++|||++++++||||.+.
T Consensus 231 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 231 ---------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ---------------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 112344788999999999999999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=384.23 Aligned_cols=259 Identities=19% Similarity=0.290 Sum_probs=198.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+|+.||||++........
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------------------------ 48 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE------------------------------------ 48 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHH------------------------------------
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHH------------------------------------
Confidence 34789999999999999999999999999999999864321100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......++...++.++||||++++++
T Consensus 49 ------------------------------------------------------~~~~~~~~~~~~~~~~h~~iv~~~~~ 74 (290)
T 3fme_A 49 ------------------------------------------------------QKRLLMDLDISMRTVDCPFTVTFYGA 74 (290)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCCCeEEEEeee
Confidence 01123344555778899999999999
Q ss_pred EeeCceeeEeeehhhchHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEeee
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+.+++..++||||++++|.+++.. .+..+++..++.++.||+.||+|||++ ||+||||||+|||++.++.+||+||
T Consensus 75 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Df 154 (290)
T 3fme_A 75 LFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDF 154 (290)
T ss_dssp EECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC
T ss_pred eeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeec
Confidence 999999999999999988777654 456799999999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhc----cCCCCCCceeeehHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHhcCCC
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVL----LGSTEYSTSIDMGVGCIFHEMSSGRPLFPG-STIEDELRLICSILGPP 399 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~d~~SlGvil~elltG~~pF~~-~~~~~~~~~i~~~~~~~ 399 (516)
|+++...... ......||+.|+|||++ .+..++.++|+||+||++|+|++|..||.. ......+..+.....
T Consensus 155 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 231 (290)
T 3fme_A 155 GISGYLVDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-- 231 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC--
T ss_pred CCcccccccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC--
Confidence 9997654322 23334789999999996 455567788999999999999999999986 333333333322111
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....+..+++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 232 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 232 ----------------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp ----------------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred ----------------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 01112367899999999999999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=392.15 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=211.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+|+.||||++.........
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~----------------------------------- 66 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC----------------------------------- 66 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTS-----------------------------------
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccc-----------------------------------
Confidence 457899999999999999999999999999999999764321110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.........+.+|+.+|+.++||||++++++
T Consensus 67 -------------------------------------------------~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~ 97 (335)
T 3dls_A 67 -------------------------------------------------WIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97 (335)
T ss_dssp -------------------------------------------------EEEETTTEEEEHHHHHHTTCCCTTBCCEEEE
T ss_pred -------------------------------------------------ccchHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 0000111234578999999999999999999
Q ss_pred EeeCceeeEeeehhh-c-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-K-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+.+.+.+++||||+. | +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 98 FENQGFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EECSSEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EeeCCEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999999986 4 888888764 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
++..... ......+||+.|+|||++.+..+ ..++|+|||||++|+|++|..||......
T Consensus 177 a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------- 236 (335)
T 3dls_A 177 AAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------- 236 (335)
T ss_dssp CEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------------
T ss_pred ceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------------
Confidence 9876533 23344678999999999988776 45679999999999999999999652110
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.......|..+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 237 -------------~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 -------------VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp -------------TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred -------------HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 011112344688999999999999999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=388.19 Aligned_cols=264 Identities=26% Similarity=0.393 Sum_probs=218.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|.+.+.||+|+||.||+|++..+|+.||||++......... ...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~-~~~-------------------------------- 139 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSP-EQL-------------------------------- 139 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCH-HHH--------------------------------
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCH-HHH--------------------------------
Confidence 46799999999999999999999999999999998764322110 000
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDI 248 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 248 (516)
......+.+|+.+++++ +||||++++++
T Consensus 140 ---------------------------------------------------~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 140 ---------------------------------------------------EEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 00112567899999998 79999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+......|+||||++| +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS 247 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcc
Confidence 9999999999999985 888888764 45999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccC------CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLG------STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
...... ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+....+..+......++.
T Consensus 248 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 326 (365)
T 2y7j_A 248 CHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326 (365)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCH
T ss_pred cccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 876533 33445689999999999863 24677899999999999999999999988877777666553332222
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
..+ ...++++.+||.+||+.||++|||++++++||||+
T Consensus 327 ~~~----------------------~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 327 PEW----------------------DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHH----------------------SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred ccc----------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 111 26788999999999999999999999999999996
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=383.11 Aligned_cols=260 Identities=25% Similarity=0.399 Sum_probs=212.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++++.||+|+||+||+|++..+|+.||||++.... .
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~----------------------------------- 67 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---D----------------------------------- 67 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---C-----------------------------------
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---H-----------------------------------
Confidence 34567999999999999999999999999999999886421 0
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+.+|+.+++.++||||+++++
T Consensus 68 --------------------------------------------------------~~~~~~e~~~l~~l~h~~i~~~~~ 91 (314)
T 3com_A 68 --------------------------------------------------------LQEIIKEISIMQQCDSPHVVKYYG 91 (314)
T ss_dssp --------------------------------------------------------CHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhCCCCCCccEEE
Confidence 124567788888888888888888
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++...+..|+||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp EEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 88888899999999985 89988876677899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+..............||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+..... +
T Consensus 172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------ 243 (314)
T 3com_A 172 AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPP--P------ 243 (314)
T ss_dssp CEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C------
T ss_pred chhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCC--c------
Confidence 98765444444556789999999999988888999999999999999999999988776655444322110 0
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
....+..+++++.+||.+||..||.+|||++++++||||+...
T Consensus 244 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 244 ---------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp ---------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ---------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 0112335688999999999999999999999999999998653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=382.38 Aligned_cols=259 Identities=27% Similarity=0.379 Sum_probs=216.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.+.+.||+|+||+||+|++..+|+.||||++.......
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 49 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR------------------------------------- 49 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-----------------------------------------
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc-------------------------------------
Confidence 3467999999999999999999999999999999986432110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||++++++
T Consensus 50 -------------------------------------------------------~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (304)
T 2jam_A 50 -------------------------------------------------------DSSLENEIAVLKKIKHENIVTLEDI 74 (304)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -------------------------------------------------------hHHHHHHHHHHHhCCCCCeeehhhh
Confidence 1145678888888888899999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE---ccCCCEEEeee
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI---NERGELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkL~DF 324 (516)
+.+....|+||||++ ++|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 75 YESTTHYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred cccCCEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccC
Confidence 999999999999998 5888888764 459999999999999999999999999999999999999 77899999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+++.... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.......+
T Consensus 154 g~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~---- 227 (304)
T 2jam_A 154 GLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFE---- 227 (304)
T ss_dssp STTCCCCC--BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCC----
T ss_pred CcceecCC--CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----
Confidence 99875432 223345689999999999988888899999999999999999999999888777766654322211
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
...+..+++++.+||.+||..||.+|||++++++||||+...
T Consensus 228 ------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 228 ------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp ------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 112246789999999999999999999999999999997643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=374.74 Aligned_cols=271 Identities=26% Similarity=0.355 Sum_probs=221.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
+..++|++.+.||+|+||+||+|++..+|+.||||++.......... .+.
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~---~~~--------------------------- 63 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSA---EEV--------------------------- 63 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCH---HHH---------------------------
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCH---HHH---------------------------
Confidence 45688999999999999999999999999999999997653221110 000
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEe
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLH 246 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~ 246 (516)
......+.+|+.+++++. ||||++++
T Consensus 64 -----------------------------------------------------~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 64 -----------------------------------------------------QELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 001125678999999995 99999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++..+...++||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 99999999999999998 5898888764 459999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhcc------CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLL------GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
++...... .......||+.|+|||++. ...+..++|+|||||++|+|++|..||.+.+.......+.......
T Consensus 170 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (298)
T 1phk_A 170 FSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF 248 (298)
T ss_dssp TCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred chhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence 99775432 2334567899999999985 3456778899999999999999999999888777666665432221
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
+.. ....+++++.+||.+||+.||.+|||++++++||||++...
T Consensus 249 ~~~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 249 GSP----------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp CTT----------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred Ccc----------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 110 01257889999999999999999999999999999987643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=391.11 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=203.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++ .+++.||||++.......
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------------------------------- 48 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN--------------------------------------- 48 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCH---------------------------------------
T ss_pred CEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccch---------------------------------------
Confidence 5699999999999999999998 468999999986532110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc--cceeeEeee
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH--ANIVTLHDI 248 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~ 248 (516)
.....+.+|+.+|+.++| |||++++++
T Consensus 49 ---------------------------------------------------~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 49 ---------------------------------------------------QTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 001245678888888876 899999999
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+.++..+|+|||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ ++.+||+|||+|+
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~ 155 (343)
T 3dbq_A 78 EITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 155 (343)
T ss_dssp EECSSEEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred EeeCCEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence 9999999999998888999999874 5699999999999999999999999999999999999996 6889999999998
Q ss_pred ccCCCCc--cccCCcccccccchhhccC-----------CCCCCceeeehHHHHHHHHHcCCCCCCCCCHH-HHHHHHHH
Q psy12305 329 AKSVPTK--TFSNEVVTLWYRPPDVLLG-----------STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE-DELRLICS 394 (516)
Q Consensus 329 ~~~~~~~--~~~~~~gt~~y~APE~l~~-----------~~~~~~~d~~SlGvil~elltG~~pF~~~~~~-~~~~~i~~ 394 (516)
....... .....+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+.... ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 235 (343)
T 3dbq_A 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 235 (343)
T ss_dssp CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhc
Confidence 6543322 2335679999999999864 55677889999999999999999999864332 22222211
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.......|...+.++.+||.+||+.||.+|||++|+++||||+...
T Consensus 236 ------------------------~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 236 ------------------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp ------------------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ------------------------CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 1112233456678999999999999999999999999999997543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=393.48 Aligned_cols=267 Identities=25% Similarity=0.351 Sum_probs=212.6
Q ss_pred cccccEeeeeeeccccceEEEEEEEc---CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSR---LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~---~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
..+++|++++.||+|+||+||+|++. .+|+.||||++.......
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------- 97 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ--------------------------------- 97 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEE---------------------------------
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhh---------------------------------
Confidence 35688999999999999999999985 489999999986432100
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-ccccee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIV 243 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 243 (516)
.......+.+|+.+|+.+ +||||+
T Consensus 98 -------------------------------------------------------~~~~~~~~~~E~~~l~~l~~h~~iv 122 (355)
T 1vzo_A 98 -------------------------------------------------------KAKTTEHTRTERQVLEHIRQSPFLV 122 (355)
T ss_dssp -------------------------------------------------------EESSGGGCCCHHHHHHHHHTCTTBC
T ss_pred -------------------------------------------------------hhhHHHHHHHHHHHHHHccCCCcee
Confidence 001112344688888888 599999
Q ss_pred eEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 244 TLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 244 ~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
++++++..+..+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 123 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~ 201 (355)
T 1vzo_A 123 TLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLT 201 (355)
T ss_dssp CEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEES
T ss_pred EEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEe
Confidence 99999999999999999998 4898888765 459999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCC-ccccCCcccccccchhhccCC--CCCCceeeehHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHh
Q psy12305 323 DFGLARAKSVPT-KTFSNEVVTLWYRPPDVLLGS--TEYSTSIDMGVGCIFHEMSSGRPLFPGSTI----EDELRLICSI 395 (516)
Q Consensus 323 DFGla~~~~~~~-~~~~~~~gt~~y~APE~l~~~--~~~~~~d~~SlGvil~elltG~~pF~~~~~----~~~~~~i~~~ 395 (516)
|||+++...... ......+||+.|+|||++.+. .++.++|+|||||++|||++|+.||..... ......+..
T Consensus 202 DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~- 280 (355)
T 1vzo_A 202 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK- 280 (355)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH-
T ss_pred eCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc-
Confidence 999998653222 223345789999999999863 356788999999999999999999975432 222222211
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCccc
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~ 469 (516)
.....|..+++.+.+||.+||..||.+|| |++++++||||..+.+....
T Consensus 281 -------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~ 334 (355)
T 1vzo_A 281 -------------------------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLA 334 (355)
T ss_dssp -------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred -------------------------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhh
Confidence 11123457889999999999999999999 99999999999987654443
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=403.01 Aligned_cols=286 Identities=16% Similarity=0.120 Sum_probs=197.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc--cCCcchhHHHHHHHHhc--CCCCeeecccccccceeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLREL--RHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~--~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~~~~ 165 (516)
..+|.+.+.||+|+||+||+|++..+|+.||||++..... ......+.+|+.+++.| +|||||+++..+.......
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999987543 22233556775555555 5999887654332110000
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
. .. .+|++.++
T Consensus 141 ---~-----------------------------------------------~~-------------------~~~~~~~~ 151 (371)
T 3q60_A 141 ---A-----------------------------------------------VQ-------------------SQPPFAQL 151 (371)
T ss_dssp ---E-----------------------------------------------ET-------------------TSCSSSBC
T ss_pred ---e-----------------------------------------------cC-------------------CCCCeeec
Confidence 0 00 01111111
Q ss_pred eeeEe--eCceeeEeeehhhchHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC
Q psy12305 246 HDIIH--TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV------KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317 (516)
Q Consensus 246 ~~~~~--~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~------~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 317 (516)
.+... ....+|||||||+++|.+++...+..+++... ..++.||+.||+|||++||+||||||+|||++.+|
T Consensus 152 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 231 (371)
T 3q60_A 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG 231 (371)
T ss_dssp SCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS
T ss_pred cCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC
Confidence 11111 12458999999999999999876555655555 57779999999999999999999999999999999
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHh
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~ 395 (516)
.+||+|||+|+..... .....||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+......
T Consensus 232 ~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------- 301 (371)
T 3q60_A 232 RLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK------- 301 (371)
T ss_dssp CEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCT-------
T ss_pred CEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccc-------
Confidence 9999999999865422 114466899999999987 6778899999999999999999999987542100
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..+...... ...........+..+++++.+||.+||+.||++|||++++++||||+.+.
T Consensus 302 ------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 302 ------GSWKRPSLR----VPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp ------TCCCBCCTT----SCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred ------cchhhhhhh----hccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 000000000 00001111222347899999999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=380.86 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=212.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|++.+.||+|+||.||+|++..+++.||||++........
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~------------------------------------- 46 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRI------------------------------------- 46 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHS-------------------------------------
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEecccccccc-------------------------------------
Confidence 5789999999999999999999999999999999865421100
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
......+.+|+.+++.++||||+++++++
T Consensus 47 ---------------------------------------------------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (305)
T 2wtk_C 47 ---------------------------------------------------PNGEANVKKEIQLLRRLRHKNVIQLVDVL 75 (305)
T ss_dssp ---------------------------------------------------TTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ---------------------------------------------------chhHHHHHHHHHHHHhcCCCCeeEEEEEE
Confidence 01122566788888888888888888887
Q ss_pred --eeCceeeEeeehhhchHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 250 --HTEKCLTLVFEYLEKDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 250 --~~~~~~~lV~E~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.+....|+||||+++++.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 76 YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp ECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccc
Confidence 345679999999998888877653 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC--CccccCCcccccccchhhccCCCC--CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 327 ARAKSVP--TKTFSNEVVTLWYRPPDVLLGSTE--YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 327 a~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~--~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
+...... ........||+.|+|||++.+... ..++|+|||||++|+|++|..||.+.+..+....+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~------- 228 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG------- 228 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-------
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-------
Confidence 9865422 222345578999999999876433 45789999999999999999999988777666555331
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
....|..+++++.+||.+||..||.+|||++++++||||+...+
T Consensus 229 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 229 -------------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp -------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred -------------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 11234478899999999999999999999999999999987544
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=395.41 Aligned_cols=257 Identities=27% Similarity=0.396 Sum_probs=204.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|++++.||+|+||+||+|++.. ++.||||++.......
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~--------------------------------------- 95 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADN--------------------------------------- 95 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCH---------------------------------------
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccH---------------------------------------
Confidence 459999999999999999999864 9999999986542110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc--ccceeeEeee
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR--HANIVTLHDI 248 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~ 248 (516)
.....+.+|+.+|+.++ ||||++++++
T Consensus 96 ---------------------------------------------------~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~ 124 (390)
T 2zmd_A 96 ---------------------------------------------------QTLDSYRNEIAYLNKLQQHSDKIIRLYDY 124 (390)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHcccCCCeEEEEEEE
Confidence 01124667888888885 4899999999
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+..++.+|+|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+|+
T Consensus 125 ~~~~~~~~lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~ 202 (390)
T 2zmd_A 125 EITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 202 (390)
T ss_dssp EECSSEEEEEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred EecCCEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccc
Confidence 99999999999987789999988754 689999999999999999999999999999999999995 6899999999998
Q ss_pred ccCCCCc--cccCCcccccccchhhccC-----------CCCCCceeeehHHHHHHHHHcCCCCCCCCCH-HHHHHHHHH
Q psy12305 329 AKSVPTK--TFSNEVVTLWYRPPDVLLG-----------STEYSTSIDMGVGCIFHEMSSGRPLFPGSTI-EDELRLICS 394 (516)
Q Consensus 329 ~~~~~~~--~~~~~~gt~~y~APE~l~~-----------~~~~~~~d~~SlGvil~elltG~~pF~~~~~-~~~~~~i~~ 394 (516)
....... .....+||+.|+|||++.+ ..++.++|+|||||++|||++|.+||.+... ...+..+..
T Consensus 203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 6543222 2345689999999999875 3567788999999999999999999987533 233333221
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
. ......|...+.++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 283 ---~---------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 283 ---P---------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp ---T---------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ---c---------------------cccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 0 111223445678999999999999999999999999999997543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=392.84 Aligned_cols=290 Identities=26% Similarity=0.390 Sum_probs=226.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+|+.++++++|++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~~~~~~---------------- 79 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTK---------------- 79 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSH----------------
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc--chhhhhHHHHHHHHhhcccccc----------------
Confidence 4679999999999999999999999999999999875322 1235667777777776554211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.||||+++++++
T Consensus 80 ----------------------------------------------------------------~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 80 ----------------------------------------------------------------EDSMGANHILKLLDHF 95 (373)
T ss_dssp ----------------------------------------------------------------HHHHHHTTBCCCCEEE
T ss_pred ----------------------------------------------------------------hhccccchHHHHHHHh
Confidence 1233689999999998
Q ss_pred eeCc----eeeEeeehhhchHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEcc------CC
Q psy12305 250 HTEK----CLTLVFEYLEKDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINE------RG 317 (516)
Q Consensus 250 ~~~~----~~~lV~E~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~------~~ 317 (516)
.... ++++||||++++|.+++.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++. .+
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~ 175 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175 (373)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred hccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence 8654 899999999889999988743 4599999999999999999999998 9999999999999953 34
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC------HHHHHHH
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST------IEDELRL 391 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~------~~~~~~~ 391 (516)
.+||+|||+|+.... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+ ..+.+..
T Consensus 176 ~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 252 (373)
T 1q8y_A 176 QIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 252 (373)
T ss_dssp EEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eEEEcccccccccCC---CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHH
Confidence 799999999986543 2344578999999999999888999999999999999999999998654 5667888
Q ss_pred HHHhcCCCChhhhhhcccc-----cCCC---------CCCc--hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 392 ICSILGPPPDELKSKLEFC-----ITPV---------YPSE--SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 392 i~~~~~~~p~~~~~~~~~~-----~~~~---------~~~~--~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
+...+|.+|..++....+. .... .+.. .......+...++++.+||.+||+.||++|||++|++
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 332 (373)
T 1q8y_A 253 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 332 (373)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHh
Confidence 8889999988765432211 0000 0000 0111123335567899999999999999999999999
Q ss_pred cCCCCCCCC
Q psy12305 456 RHPYFNSLG 464 (516)
Q Consensus 456 ~Hp~f~~~~ 464 (516)
+||||+...
T Consensus 333 ~hp~f~~~~ 341 (373)
T 1q8y_A 333 NHPWLKDTL 341 (373)
T ss_dssp TCGGGTTCT
T ss_pred hChhhhccc
Confidence 999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=401.41 Aligned_cols=265 Identities=26% Similarity=0.368 Sum_probs=198.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|.+.+.||+|+||+||+|++..+++.||||++..........
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~----------------------------------- 178 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA----------------------------------- 178 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-------------------------------------
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhccccc-----------------------------------
Confidence 477999999999999999999999999999999997653211100
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
........+.+|+.+|++++||||+++++++
T Consensus 179 -------------------------------------------------~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~ 209 (419)
T 3i6u_A 179 -------------------------------------------------READPALNVETEIEILKKLNHPCIIKIKNFF 209 (419)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred -------------------------------------------------ccchhHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 0000112456788888888888888888887
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC---CEEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG---ELKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~---~vkL~DFG 325 (516)
.. ...|+||||+++ +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 210 ~~-~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 210 DA-EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ES-SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ec-CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 54 447899999984 77777654 35699999999999999999999999999999999999997654 59999999
Q ss_pred cccccCCCCccccCCcccccccchhhccC---CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHhcCCCCh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLG---STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE-LRLICSILGPPPD 401 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~-~~~i~~~~~~~p~ 401 (516)
+|+..... ......+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+...... ...+.......+.
T Consensus 288 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~ 366 (419)
T 3i6u_A 288 HSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366 (419)
T ss_dssp TTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCH
T ss_pred cceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCc
Confidence 99876432 23345689999999999864 4456688999999999999999999986543222 2222221111111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
+. ...+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 367 ~~----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 367 EV----------------------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HH----------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred hh----------------------hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 11 12678999999999999999999999999999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=381.99 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=200.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+|+.||||++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~---------------------------------- 65 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEE---------------------------------- 65 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTH----------------------------------
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHH----------------------------------
Confidence 45779999999999999999999999999999999864321 112
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
.+.+|+.+++++ +||||+++++
T Consensus 66 ---------------------------------------------------------~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 66 ---------------------------------------------------------EIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHHCCSTTBCCEEE
T ss_pred ---------------------------------------------------------HHHHHHHHHHhccCCCCeeeeee
Confidence 344555555555 4666666666
Q ss_pred eEee------CceeeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCE
Q psy12305 248 IIHT------EKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGEL 319 (516)
Q Consensus 248 ~~~~------~~~~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~v 319 (516)
++.. ...+|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCE
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCE
Confidence 6654 4578999999985 9999887643 569999999999999999999999999999999999999999999
Q ss_pred EEeeeccccccCCCCccccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Q psy12305 320 KLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS 394 (516)
Q Consensus 320 kL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~ 394 (516)
||+|||++..............||+.|+|||++. +..+..++|+|||||++|+|++|..||.+......+..+..
T Consensus 169 kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 248 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 248 (326)
T ss_dssp EECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred EEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc
Confidence 9999999987554333344567899999999987 45677889999999999999999999988776665554432
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
... ....+..+++.+.+||.+||..||.+|||++++++||||+...
T Consensus 249 ~~~------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 249 NPA------------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp SCC------------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred Ccc------------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 110 0112336789999999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=375.80 Aligned_cols=258 Identities=26% Similarity=0.348 Sum_probs=218.1
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..-+.|++++.||+|+||+||+|++..+|+.||||++.......
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 62 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED------------------------------------ 62 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST------------------------------------
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH------------------------------------
Confidence 44567999999999999999999999999999999986543211
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
....+.+|+.+++.++||||+++++
T Consensus 63 -------------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~ 87 (303)
T 3a7i_A 63 -------------------------------------------------------EIEDIQQEITVLSQCDSPYVTKYYG 87 (303)
T ss_dssp -------------------------------------------------------THHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 1225667888888888888889999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..+...|+||||+++ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 88 SYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGV 165 (303)
T ss_dssp EEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeeccc
Confidence 99888999999999985 88888764 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+..............||+.|+|||++.+..++.++|+|||||++|+|++|..||...........+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 235 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---------- 235 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------
T ss_pred ceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC----------
Confidence 9876544444455678999999999998888899999999999999999999998877666555443211
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
....+..++..+.+||.+||..||.+|||++++++||||...
T Consensus 236 ---------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 236 ---------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp ---------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred ---------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 011234778999999999999999999999999999999653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=405.44 Aligned_cols=268 Identities=15% Similarity=0.186 Sum_probs=196.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc--cCCcchhHHHH---HHHHhcCCCCeeeccccccccee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREV---SLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+ .+|++++|||||++++.+....
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~- 149 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF- 149 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS-
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh-
Confidence 34779999999999999999999999999999999976432 22234566777 3444456777777765442211
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccccee
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 243 (516)
-.+. .++-.
T Consensus 150 -------------------------------------------------~~~~----------------------~~~~~ 158 (377)
T 3byv_A 150 -------------------------------------------------DLVK----------------------DPQKK 158 (377)
T ss_dssp -------------------------------------------------EEEE----------------------CTTSC
T ss_pred -------------------------------------------------hhhh----------------------ccCCc
Confidence 0000 00001
Q ss_pred eEeeeEeeCc-----eeeEeeehhhchHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCE
Q psy12305 244 TLHDIIHTEK-----CLTLVFEYLEKDLKRYMDDCSNILS-------MNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311 (516)
Q Consensus 244 ~l~~~~~~~~-----~~~lV~E~~~g~L~~~l~~~~~~l~-------~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NI 311 (516)
.+...+.+++ ..|+||||++|+|.+++...+. ++ +..+..++.||+.||+|||++||+||||||+||
T Consensus 159 ~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NI 237 (377)
T 3byv_A 159 KMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDI 237 (377)
T ss_dssp SEEEC------CEEESEEEEEECCSEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred cccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 1111222222 3789999999999999986432 44 477888999999999999999999999999999
Q ss_pred EEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCC-----------CCCCceeeehHHHHHHHHHcCCCCC
Q psy12305 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-----------TEYSTSIDMGVGCIFHEMSSGRPLF 380 (516)
Q Consensus 312 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~d~~SlGvil~elltG~~pF 380 (516)
|++.++.+||+|||+|+... ......+| +.|+|||++.+. .++.++|+|||||++|||++|+.||
T Consensus 238 ll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf 313 (377)
T 3byv_A 238 VLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313 (377)
T ss_dssp EECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC
T ss_pred EEcCCCCEEEEechhheecC---CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999998643 23345577 999999999887 7888999999999999999999999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
.+.+....... ....+..+++++.+||.+||+.||++|||+.++++||||
T Consensus 314 ~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f 363 (377)
T 3byv_A 314 TKDAALGGSEW------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363 (377)
T ss_dssp ------CCSGG------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHH
T ss_pred cccccccchhh------------------------------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHH
Confidence 76443211110 011124788999999999999999999999999999999
Q ss_pred CCC
Q psy12305 461 NSL 463 (516)
Q Consensus 461 ~~~ 463 (516)
+.+
T Consensus 364 ~~~ 366 (377)
T 3byv_A 364 EQL 366 (377)
T ss_dssp HHH
T ss_pred HHH
Confidence 765
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=373.75 Aligned_cols=253 Identities=22% Similarity=0.300 Sum_probs=203.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+|+.||||++........
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------ 52 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV------------------------------------ 52 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH------------------------------------
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH------------------------------------
Confidence 34779999999999999999999999999999999875422110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 247 (516)
....+.+|+..+..+ +||||+++++
T Consensus 53 ------------------------------------------------------~~~~~~~e~~~~~~l~~h~~iv~~~~ 78 (289)
T 1x8b_A 53 ------------------------------------------------------DEQNALREVYAHAVLGQHSHVVRYFS 78 (289)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHSCSCTTBCCEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhCCCCCeeeeee
Confidence 112456788888888 8999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-------
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER------- 316 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~------- 316 (516)
++.+++..++||||+++ +|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp EEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------
T ss_pred eeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccc
Confidence 99999999999999985 999888764 2569999999999999999999999999999999999999844
Q ss_pred ------------CCEEEeeeccccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 317 ------------GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 317 ------------~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
..+||+|||++...... ....||+.|+|||++.+.. +..++|+|||||++|+|++|.+||...
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred cccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 47999999999876432 2346899999999998763 336889999999999999999887554
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.. ...+... .....|..+++++.+||.+||+.||++|||++++++||||.+.
T Consensus 235 ~~---~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 235 DQ---WHEIRQG-------------------------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp HH---HHHHHTT-------------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred hH---HHHHHcC-------------------------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 22 2222110 0112344789999999999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=387.46 Aligned_cols=275 Identities=21% Similarity=0.248 Sum_probs=204.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|++.+.||+|+||+||+|++..+|+.||||++.........
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------ 51 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV------------------------------------ 51 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCH------------------------------------
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchH------------------------------------
Confidence 36799999999999999999999999999999998754322222
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
..+.+|+.+++.++||||+++++++
T Consensus 52 -------------------------------------------------------~~~~~E~~~l~~l~h~~iv~~~~~~ 76 (319)
T 4euu_A 52 -------------------------------------------------------DVQMREFEVLKKLNHKNIVKLFAIE 76 (319)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHhcCCCCcceEEEEe
Confidence 2345667777777777777777777
Q ss_pred eeCc--eeeEeeehhh-chHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE----ccCCCEE
Q psy12305 250 HTEK--CLTLVFEYLE-KDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI----NERGELK 320 (516)
Q Consensus 250 ~~~~--~~~lV~E~~~-g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl----~~~~~vk 320 (516)
.... ..|+||||++ ++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (319)
T 4euu_A 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (319)
T ss_dssp ECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEE
T ss_pred ecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEE
Confidence 6544 7899999998 589988876433 39999999999999999999999999999999999999 7778899
Q ss_pred EeeeccccccCCCCccccCCcccccccchhhcc--------CCCCCCceeeehHHHHHHHHHcCCCCCCCCC----HHHH
Q psy12305 321 LADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL--------GSTEYSTSIDMGVGCIFHEMSSGRPLFPGST----IEDE 388 (516)
Q Consensus 321 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~~d~~SlGvil~elltG~~pF~~~~----~~~~ 388 (516)
|+|||+|+...... .....+||+.|+|||++. +..++.++|+|||||++|||++|..||.... ..+.
T Consensus 157 L~Dfg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 157 LTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp ECCCTTCEECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred EccCCCceecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 99999998765432 334567899999999986 4677889999999999999999999996432 2333
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCC--CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYP--SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
+..+.. ..|...+............ .........+..+++.+.+||.+||+.||++|||++|+|+||=
T Consensus 236 ~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 236 MYKIIT---GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHH---HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHHhc---CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 333332 2222222111110000000 0000011112245568899999999999999999999999973
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=373.58 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=209.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++.+.||+|+||.||+|++..+|+.||||++.......
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------ 51 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRS------------------------------------ 51 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccc------------------------------------
Confidence 45688999999999999999999999999999999986532100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+++.++||||+++++
T Consensus 52 -----------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 78 (276)
T 2h6d_A 52 -----------------------------------------------------LDVVGKIKREIQNLKLFRHPHIIKLYQ 78 (276)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred -----------------------------------------------------hhHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence 111235677888889999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++......|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~ 157 (276)
T 2h6d_A 79 VISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL 157 (276)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCG
T ss_pred EEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccc
Confidence 9999999999999998 5899888765 4589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+...... .......||+.|+|||++.+..+. .++|+|||||++|+|++|..||.+.........+....
T Consensus 158 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 227 (276)
T 2h6d_A 158 SNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV--------- 227 (276)
T ss_dssp GGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------
T ss_pred ccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc---------
Confidence 9765432 223445789999999999876653 67899999999999999999999887766665553311
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...|..++.++.+||.+||+.||.+|||++++++||||+..
T Consensus 228 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 -----------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp -----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred -----------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 11244678999999999999999999999999999999754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=386.62 Aligned_cols=263 Identities=23% Similarity=0.295 Sum_probs=207.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+|+.||||++........
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------------------------ 53 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDP------------------------------------ 53 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSH------------------------------------
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCH------------------------------------
Confidence 34679999999999999999999999999999999875422110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.++++++||||++++++
T Consensus 54 -----------------------------------------------------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 80 (311)
T 3ork_A 54 -----------------------------------------------------SFYLRFRREAQNAAALNHPAIVAVYDT 80 (311)
T ss_dssp -----------------------------------------------------HHHHHHHHHHTTCCCCCCTTBCCEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHcCCCCCcceEEEe
Confidence 001145567777777777888888877
Q ss_pred EeeCc----eeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 249 IHTEK----CLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 249 ~~~~~----~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+.... ..|+||||++ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~D 159 (311)
T 3ork_A 81 GEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMD 159 (311)
T ss_dssp EEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECC
T ss_pred eeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEee
Confidence 76554 3499999997 5888888764 4699999999999999999999999999999999999999999999999
Q ss_pred eccccccCCCC---ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 324 FGLARAKSVPT---KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 324 FGla~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
||+++...... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+......++
T Consensus 160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 3ork_A 160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 239 (311)
T ss_dssp CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCH
T ss_pred ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCc
Confidence 99997654322 122345789999999999998888899999999999999999999999887776665544322222
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.. .+..+++++.+||.+||+.||.+||++.+++.|+|++..
T Consensus 240 ~~----------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 SA----------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HH----------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cc----------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 11 123688999999999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=377.48 Aligned_cols=259 Identities=23% Similarity=0.343 Sum_probs=204.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++ +|+.||||++.......
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~------------------------------------- 75 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHA------------------------------------- 75 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSH-------------------------------------
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCH-------------------------------------
Confidence 346799999999999999999987 58899999986432110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.++++++||||++++++
T Consensus 76 -----------------------------------------------------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 76 -----------------------------------------------------ERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 011246678888999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccCCCEEEee
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+.+...+++||||+++ +|.+++..... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 9999999999999985 89888876432 3899999999999999999999999 99999999999999999999999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
||+++............+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.....
T Consensus 183 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------ 256 (309)
T 3p86_A 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------ 256 (309)
T ss_dssp CC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC------
T ss_pred CCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Confidence 99998655443444556889999999999998888999999999999999999999998877766555532111
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc--CCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR--HPYFNSL 463 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~--Hp~f~~~ 463 (516)
....|..+++++.+||.+||+.||.+|||++++++ ++++.+.
T Consensus 257 ------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 257 ------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 12234578999999999999999999999999987 5666543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=372.27 Aligned_cols=260 Identities=28% Similarity=0.377 Sum_probs=212.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+|+.||+|++.......
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------------- 46 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE------------------------------------- 46 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-------------------------------------
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-------------------------------------
Confidence 5678999999999999999999999999999999986542110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.++++++||||++++++
T Consensus 47 -----------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (279)
T 2w5a_A 47 -----------------------------------------------------AEKQMLVSEVNLLRELKHPNIVRYYDR 73 (279)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 011245677888888888888888887
Q ss_pred Ee--eCceeeEeeehhhc-hHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCC-----cEeeecCCCCEEEccCC
Q psy12305 249 IH--TEKCLTLVFEYLEK-DLKRYMDDC---SNILSMNNVKLFLFQLLRGLAYCHSRR-----ILHRDLKPQNLLINERG 317 (516)
Q Consensus 249 ~~--~~~~~~lV~E~~~g-~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~-----ivHrDlKp~NILl~~~~ 317 (516)
+. ....+|+||||+++ +|.+++... ...+++..+..++.||+.||+|||++| |+||||||+|||++.++
T Consensus 74 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS
T ss_pred EecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC
Confidence 64 35689999999984 898888753 345999999999999999999999999 99999999999999999
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~ 397 (516)
.+||+|||+++.............||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+....+.....
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 233 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233 (279)
T ss_dssp CEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred CEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc
Confidence 99999999998765433333345789999999999988888889999999999999999999998877666555543211
Q ss_pred CCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 398 PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 398 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...|..+++++.+||.+||+.||.+|||++++++|+|+..-
T Consensus 234 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 234 -------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp -------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred -------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 11234678999999999999999999999999999999753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=377.01 Aligned_cols=269 Identities=24% Similarity=0.335 Sum_probs=201.5
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||+||+|++..+|+.||||++..... ....+.+|+.++++++||||+++++++....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------- 75 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE--KLSTILSEVMLLASLNHQYVVRYYAAWLERR------- 75 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHH--HHHHHHHHHHHHTTCCCTTBCCEEEEEEECC-------
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHH--HHHHHHHHHHHHHhcCchHHHHHHHHHHhhc-------
Confidence 4679999999999999999999999999999999965322 2236678888888888888888777653321
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
+++...+..
T Consensus 76 -----------------------------------------------------------------------~~~~~~~~~ 84 (303)
T 1zy4_A 76 -----------------------------------------------------------------------NFVKPMTAV 84 (303)
T ss_dssp -----------------------------------------------------------------------CCCC-----
T ss_pred -----------------------------------------------------------------------chhhhhccc
Confidence 222333344
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
......|+||||++ ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 164 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCS
T ss_pred ccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchh
Confidence 45677999999998 59999998766678899999999999999999999999999999999999999999999999997
Q ss_pred ccCCC--------------CccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHH
Q psy12305 329 AKSVP--------------TKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLI 392 (516)
Q Consensus 329 ~~~~~--------------~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i 392 (516)
..... ........||+.|+|||++.+. .+..++|+|||||++|+|++ ||... ...+....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~ 241 (303)
T 1zy4_A 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKL 241 (303)
T ss_dssp CTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred hcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhc
Confidence 65321 1223445789999999999764 57788999999999999998 55432 222222233
Q ss_pred HHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 393 CSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.......| ...+...++.+.+||.+||+.||.+|||++++++||||...
T Consensus 242 ~~~~~~~~----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 242 RSVSIEFP----------------------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HSTTCCCC----------------------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred cccccccC----------------------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 22111111 11234667889999999999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=370.64 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=203.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
..|.+.+.||+|+||+||+|++..++..||+|++.......
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~--------------------------------------- 66 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK--------------------------------------- 66 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH---------------------------------------
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH---------------------------------------
Confidence 34899999999999999999999999999999986532111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+++.++||||+++++++.
T Consensus 67 ---------------------------------------------------~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 95 (290)
T 1t4h_A 67 ---------------------------------------------------SERQRFKEEAEMLKGLQHPNIVRFYDSWE 95 (290)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence 01124556777777777777777777765
Q ss_pred e----CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEc-cCCCEEEe
Q psy12305 251 T----EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLIN-ERGELKLA 322 (516)
Q Consensus 251 ~----~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~-~~~~vkL~ 322 (516)
. ...+++||||+++ +|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~ 174 (290)
T 1t4h_A 96 STVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 174 (290)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred cccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEe
Confidence 4 4568999999974 898888764 45999999999999999999999999 99999999999997 78999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|||++...... ......||+.|+|||++.+ .++.++|+|||||++|+|++|..||.+............. +..+
T Consensus 175 Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~-- 248 (290)
T 1t4h_A 175 DLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKP-- 248 (290)
T ss_dssp CTTGGGGCCTT--SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCC--
T ss_pred eCCCccccccc--ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhc-cCCc--
Confidence 99999754432 2334578999999998875 5788999999999999999999999875544433322211 1111
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
...+...++++.+||.+||+.||.+|||++++++||||++
T Consensus 249 --------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 249 --------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp --------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred --------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 1122356789999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=372.98 Aligned_cols=264 Identities=28% Similarity=0.381 Sum_probs=211.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..-++|++++.||+|+||+||+|++..+++.||||++........
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------- 52 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKE----------------------------------- 52 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCH-----------------------------------
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccH-----------------------------------
Confidence 344679999999999999999999999999999999865322110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.++++++||||+++++
T Consensus 53 ------------------------------------------------------~~~~~~~~e~~~l~~l~hp~iv~~~~ 78 (294)
T 4eqm_A 53 ------------------------------------------------------ETLKRFEREVHNSSQLSHQNIVSMID 78 (294)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHTTCCBTTBCCEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhcCCCCCCceEEE
Confidence 01125678999999999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..++..|+||||++| +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 157 (294)
T 4eqm_A 79 VDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157 (294)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999999999985 898888765 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
++...... ......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+........ ..+
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~----- 230 (294)
T 4eqm_A 158 AKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVP----- 230 (294)
T ss_dssp STTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CCC-----
T ss_pred ccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cCC-----
Confidence 98654332 2233457899999999999988888999999999999999999999988776654443321 111
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
......+..+++.+.++|.+||+.||.+||+..+.+.+.|..-
T Consensus 231 --------------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 231 --------------NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp --------------CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred --------------CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 1111233478899999999999999999997777777777543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=378.91 Aligned_cols=265 Identities=27% Similarity=0.375 Sum_probs=206.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+|+.||||++.........
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------------ 52 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGS------------------------------------ 52 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-------------------------------------------
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcc------------------------------------
Confidence 46799999999999999999999999999999998653211000
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.........+.+|+.+++.++||||+++++++
T Consensus 53 ------------------------------------------------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 53 ------------------------------------------------AREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp --------------------------------------------------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ------------------------------------------------cccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 00011122567899999999999999999998
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC---EEEeeec
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE---LKLADFG 325 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~---vkL~DFG 325 (516)
..+. .|+||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred cCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 7665 8999999984 888887653 56999999999999999999999999999999999999987665 9999999
Q ss_pred cccccCCCCccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHhcCCCCh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIED-ELRLICSILGPPPD 401 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~-~~~~i~~~~~~~p~ 401 (516)
+++..... ......+||+.|+|||++. +..+..++|+|||||++|+|++|..||.+..... ....+.........
T Consensus 163 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T 2ycf_A 163 HSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241 (322)
T ss_dssp TCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCH
T ss_pred cceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCc
Confidence 99865422 2223456899999999974 4556778999999999999999999997654322 22223221111111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
+. +..+++++.+||.+||..||++|||++++++||||+..
T Consensus 242 ~~----------------------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 242 EV----------------------WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp HH----------------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred hh----------------------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 11 12678999999999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=385.00 Aligned_cols=270 Identities=14% Similarity=0.146 Sum_probs=216.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCC-----CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLT-----DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~-----g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|++.+.||+|+||+||+|++..+ ++.||||++.... ..+.+|++++.++.|++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~~~~~~~~~-------------- 94 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-----GPLFTELKFYQRAAKPE-------------- 94 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-----HHHHHHHHHHHHHCCHH--------------
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-----hhHHHHHHHHHhhhhhH--------------
Confidence 35799999999999999999999765 5889999987543 26789999999887654
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
...|+..++.++||||++
T Consensus 95 --------------------------------------------------------------~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 95 --------------------------------------------------------------QIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp --------------------------------------------------------------HHHHHHHHTTCSCCCSCC
T ss_pred --------------------------------------------------------------HHHHHHHHhhccCCCCCe
Confidence 346888899999999999
Q ss_pred EeeeEeeC----ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc--cCCC
Q psy12305 245 LHDIIHTE----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN--ERGE 318 (516)
Q Consensus 245 l~~~~~~~----~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~ 318 (516)
+++++... .+.||||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 99998765 56899999997799999988777899999999999999999999999999999999999999 8899
Q ss_pred EEEeeeccccccCCCC-------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHH
Q psy12305 319 LKLADFGLARAKSVPT-------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRL 391 (516)
Q Consensus 319 vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~ 391 (516)
+||+|||+|+...... ......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.........
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~ 272 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVR 272 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHH
Confidence 9999999997653221 112345699999999999998888899999999999999999999986432222222
Q ss_pred -HHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 392 -ICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 392 -i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..........++. .....+..+++++.+||..||..||.+|||++++++
T Consensus 273 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 273 DSKIRYRENIASLM----------------DKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHCHHHHH----------------HHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhhhhHHHHH----------------HHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1111111111110 111122477899999999999999999999998874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=369.04 Aligned_cols=261 Identities=28% Similarity=0.430 Sum_probs=214.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++..+++.||||++.......
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~------------------------------------- 62 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN------------------------------------- 62 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-------------------------------------
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-------------------------------------
Confidence 3467999999999999999999999999999999986543211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.++++++||||++++++
T Consensus 63 -----------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (287)
T 2wei_A 63 -----------------------------------------------------KDTSTILREVELLKKLDHPNIMKLFEI 89 (287)
T ss_dssp -----------------------------------------------------SCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhccCCCccEEEEE
Confidence 112356678888888888888999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC---CCEEEeee
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER---GELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~~vkL~DF 324 (516)
+......++||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 90 LEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEecc
Confidence 998899999999998 58888877643 59999999999999999999999999999999999999764 46999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|++...... .......||+.|+|||++.+. +..++|+|||||++|+|++|..||.+.+..+....+......++.
T Consensus 169 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 243 (287)
T 2wei_A 169 GLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL--- 243 (287)
T ss_dssp TGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCS---
T ss_pred CcceeecCC-CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc---
Confidence 999765432 233445689999999998764 788899999999999999999999998877766666442211110
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....+++++.+||.+||..||.+|||++++++||||+...
T Consensus 244 -------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 244 -------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp -------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred -------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 01136789999999999999999999999999999997653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=370.23 Aligned_cols=259 Identities=23% Similarity=0.348 Sum_probs=204.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|.....||+|+||+||+|++..+++.||||.+......
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---------------------------------------- 61 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR---------------------------------------- 61 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----------------------------------------
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH----------------------------------------
Confidence 4455666999999999999999999999999988643210
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+.+++.++||||+++++++.
T Consensus 62 ----------------------------------------------------~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 89 (295)
T 2clq_A 62 ----------------------------------------------------YSQPLHEEIALHKHLKHKNIVQYLGSFS 89 (295)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhCCCCCEeeEeeEEE
Confidence 1125667888888888889999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-CCCEEEeeecc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-RGELKLADFGL 326 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-~~~vkL~DFGl 326 (516)
..+..++||||++ ++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGT 169 (295)
T ss_dssp ETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTT
T ss_pred eCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccc
Confidence 9999999999997 588888876533 4668889999999999999999999999999999999987 89999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCC--CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGST--EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++.............||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.................
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 242 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK------- 242 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC-------
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc-------
Confidence 987654333344567899999999987643 56788999999999999999999976433222111111100
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....|..+++++.+||.+||+.||++|||++++++||||+...
T Consensus 243 ----------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 243 ----------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp ----------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred ----------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 11123457889999999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=367.72 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=210.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++.+.||+|+||+||+|++..+|+.||||++.......
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------------------------------------- 47 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD------------------------------------- 47 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTT-------------------------------------
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchh-------------------------------------
Confidence 5678999999999999999999999999999999986532211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+++.++||||++++++
T Consensus 48 ------------------------------------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~ 73 (276)
T 2yex_A 48 ------------------------------------------------------CPENIKKEICINKMLNHENVVKFYGH 73 (276)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ------------------------------------------------------hhHHHHHHHHHHHhcCCCCceeeeeE
Confidence 11256678888888899999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++..|+||||+++ +|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 74 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 152 (276)
T 2yex_A 74 RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152 (276)
T ss_dssp EEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEcCCEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCc
Confidence 9999999999999985 88777754 345999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC--ccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHhcCCCChhh
Q psy12305 328 RAKSVPT--KTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIED-ELRLICSILGPPPDEL 403 (516)
Q Consensus 328 ~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~-~~~~i~~~~~~~p~~~ 403 (516)
....... ......+||+.|+|||++.+..+ ..++|+|||||++|+|++|..||.+..... .+..+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 226 (276)
T 2yex_A 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT------ 226 (276)
T ss_dssp EECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCT------
T ss_pred cccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccc------
Confidence 7653222 22345678999999999987665 456899999999999999999998754432 2222211000
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.......+++++.+||.+||+.||.+|||++++++||||+..
T Consensus 227 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 227 ------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp ------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------------------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 000112578899999999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=378.81 Aligned_cols=257 Identities=20% Similarity=0.294 Sum_probs=202.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-..++|++++.||+|+||+||+|++..+|+.||+|+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~va------------------------------------------- 48 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVA------------------------------------------- 48 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEE-------------------------------------------
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEE-------------------------------------------
Confidence 4557799999999999999999999888887655432
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+|.++..........+.+|+.++++++||||+++++
T Consensus 49 --------------------------------------------iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 49 --------------------------------------------IKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp --------------------------------------------EEEC-------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred --------------------------------------------EeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 222222222223346778999999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..+. .++|+||+. |+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred EEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 998765 678888888 699999988778899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 327 ARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 327 a~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
|+....... ......||+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+....
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------- 236 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 236 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC-------
Confidence 987643332 2233456889999999998888889999999999999999 999998877655444443211
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....+..++.++.+|+.+||+.||.+|||+.++++|
T Consensus 237 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 ------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ------------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ------------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 112244678999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=376.19 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=209.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.+.+.||+|+||+||+|++..+|+.||+|++.....
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~--------------------------------------- 48 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE--------------------------------------- 48 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH---------------------------------------
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH---------------------------------------
Confidence 45789999999999999999999999999999998743211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.....+.+|+.+++.++||||++++++
T Consensus 49 -----------------------------------------------------~~~~~~~~E~~~l~~l~hp~iv~~~~~ 75 (310)
T 3s95_A 49 -----------------------------------------------------ETQRTFLKEVKVMRCLEHPNVLKFIGV 75 (310)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHhCCCcCcccEEEE
Confidence 011256788888999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.++...++||||+++ +|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccc
Confidence 9999999999999985 999999887778999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcc--------------ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 328 RAKSVPTKT--------------FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 328 ~~~~~~~~~--------------~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
+........ ....+||+.|+|||++.+..++.++|+|||||++|||++|..||.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~---- 231 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD---- 231 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT----
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH----
Confidence 865432211 12457999999999999988899999999999999999999999753211000
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
. ............|..+++++.+||.+||+.||++|||++++++ |+..
T Consensus 232 ---------~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 232 ---------F----------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp ---------S----------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred ---------H----------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 0 0000011223345578899999999999999999999999986 4443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=384.40 Aligned_cols=285 Identities=22% Similarity=0.319 Sum_probs=215.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-..++|++++.||+|+||+||+|++..+|+.||+|++.......
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~------------------------------------ 73 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA------------------------------------ 73 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHH------------------------------------
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHH------------------------------------
Confidence 44578999999999999999999999999999999986532110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
....+.+|+.+++.++||||+++++
T Consensus 74 -------------------------------------------------------~~~~~~~E~~~l~~l~h~~iv~~~~ 98 (360)
T 3eqc_A 74 -------------------------------------------------------IRNQIIRELQVLHECNSPYIVGFYG 98 (360)
T ss_dssp -------------------------------------------------------HHHHHHHHHGGGGGCCCTTBCCEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHHCCCCCEEEEeE
Confidence 1125678888899999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++..++..|+||||+++ +|.+++...+ .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 177 (360)
T 3eqc_A 99 AFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFG 177 (360)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECC
Confidence 99999999999999985 8988887653 599999999999999999999986 99999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc-CCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~-~~~p~~~~ 404 (516)
+++..... .....+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.... +.++....
T Consensus 178 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3eqc_A 178 VSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255 (360)
T ss_dssp CCHHHHHH--C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------
T ss_pred CCcccccc--cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCC
Confidence 99754321 2234578999999999998888889999999999999999999999877665443332111 11110000
Q ss_pred hhc---------ccccCCCCCCc--------hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 405 SKL---------EFCITPVYPSE--------SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~---------~~~~~~~~~~~--------~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
... .....+..... .......+..++.++.+||.+||++||.+|||++|+++||||+...+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred CcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 000 00000000000 000111223578899999999999999999999999999999875443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=379.12 Aligned_cols=206 Identities=20% Similarity=0.263 Sum_probs=170.7
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++. +...++||||+. ++|.+++......+++..+..++.||+.||+|||++||+||
T Consensus 61 ~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 139 (325)
T 3kex_A 61 AVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHR 139 (325)
T ss_dssp SCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 4457888888888999999999886 456899999998 69999998766679999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
||||+|||++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus 140 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp CCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 9999999999999999999999987643322 2344567889999999988888889999999999999999 999999
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+....+....+... .....|..++.++.+||.+||..||.+|||+.++++|
T Consensus 220 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 220 GLRLAEVPDLLEKG-------------------------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TSCTTHHHHHHHTT-------------------------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ccCHHHHHHHHHcC-------------------------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 87666555444321 1122344677889999999999999999999999986
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=382.67 Aligned_cols=207 Identities=22% Similarity=0.402 Sum_probs=174.7
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.+|+.+ +||||+++++++..++.+|+||||+++ +|.+++.... ..+++..+..++.|
T Consensus 132 ~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 211 (370)
T 2psq_A 132 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 211 (370)
T ss_dssp HHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHH
Confidence 567788888888 799999999999999999999999985 9999988653 34889999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||+|||++||+||||||+|||++.++.+||+|||+|+....... ......+|+.|+|||++.+..++.++|+|||
T Consensus 212 i~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl 291 (370)
T 2psq_A 212 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291 (370)
T ss_dssp HHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHH
Confidence 99999999999999999999999999999999999999986543222 2233466889999999999888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|||++ |..||.+....+....+.... ....|..+++++.+||.+||+.||
T Consensus 292 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dP 346 (370)
T 2psq_A 292 GVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-------------------------RMDKPANCTNELYMMMRDCWHAVP 346 (370)
T ss_dssp HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-------------------------CCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC-------------------------CCCCCCCCCHHHHHHHHHHcCCCh
Confidence 999999999 999999877666555443211 112345788999999999999999
Q ss_pred CCCCCHHHHHcC
Q psy12305 446 KQRISAANAMRH 457 (516)
Q Consensus 446 ~~R~ta~e~l~H 457 (516)
.+|||+.|++++
T Consensus 347 ~~Rpt~~ell~~ 358 (370)
T 2psq_A 347 SQRPTFKQLVED 358 (370)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=365.39 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=209.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||+||+|++. +++.||||++......
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------------------------------------- 48 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--------------------------------------- 48 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---------------------------------------
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---------------------------------------
Confidence 467999999999999999999986 5788999988643211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.++++++||||+++++++
T Consensus 49 ------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~~~~~ 74 (269)
T 4hcu_A 49 ------------------------------------------------------EEDFIEEAEVMMKLSHPKLVQLYGVC 74 (269)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 12466788888888888888889998
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.++...|+||||+++ +|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 75 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred ecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccc
Confidence 888899999999984 8999998777789999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
...... .......+|+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~---------- 224 (269)
T 4hcu_A 155 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 224 (269)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred cccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc----------
Confidence 654221 12234456888999999988888889999999999999999 999999988877766664321
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|...++++.+||.+||+.||.+|||++++++|
T Consensus 225 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 ---------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 122344678999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=374.77 Aligned_cols=250 Identities=21% Similarity=0.297 Sum_probs=203.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|++..+|+.||||++......
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------------------------------------- 48 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---------------------------------------- 48 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----------------------------------------
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----------------------------------------
Confidence 6799999999999999999999999999999987643211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 249 (516)
..+.+|+.+++.+ +||||+++++++
T Consensus 49 ------------------------------------------------------~~~~~E~~~l~~l~~h~~i~~~~~~~ 74 (330)
T 2izr_A 49 ------------------------------------------------------PQLHLEYRFYKQLGSGDGIPQVYYFG 74 (330)
T ss_dssp ------------------------------------------------------CCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence 1355677777777 788888888888
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC-----EEEeee
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE-----LKLADF 324 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~-----vkL~DF 324 (516)
..+...++||||++++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+||
T Consensus 75 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 75 PCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred ecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 888999999999988999999887778999999999999999999999999999999999999998887 999999
Q ss_pred ccccccCCCCc-------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC---HHHHHHHHHH
Q psy12305 325 GLARAKSVPTK-------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST---IEDELRLICS 394 (516)
Q Consensus 325 Gla~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~---~~~~~~~i~~ 394 (516)
|+|+....... .....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+ ..+.+..+..
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 99986543322 1245689999999999999888889999999999999999999998743 3333444432
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+.+. .....+ ++.+||.+||..||.+||+++++++
T Consensus 235 ~~~~~~~~~---------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEV---------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHH---------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHH---------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 211111110 011334 8999999999999999999988765
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=382.46 Aligned_cols=291 Identities=18% Similarity=0.307 Sum_probs=218.4
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++.+.||+|+||+||+|++ +|+.||||++...........
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~-------------------------------- 73 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDF-------------------------------- 73 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEE--------------------------------
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhh--------------------------------
Confidence 4568899999999999999999998 899999999976432211000
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
........ ........+.+|+.+++.++||||+++++
T Consensus 74 -----------------------------------~~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 74 -----------------------------------TKSNNDKI--------SIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp -----------------------------------CCCSSSSC--------CEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred -----------------------------------ccccchhh--------hHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 00000000 00011246788999999999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCC
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRY------MDDC-SNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGE 318 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~------l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~ 318 (516)
++.+.+..|+||||+++ +|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||++.++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~ 190 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR 190 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc
Confidence 99999999999999996 88776 4432 4679999999999999999999999 99999999999999999999
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCC-CCCC-ceeeehHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHh
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYS-TSIDMGVGCIFHEMSSGRPLFPGSTI-EDELRLICSI 395 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~-~~d~~SlGvil~elltG~~pF~~~~~-~~~~~~i~~~ 395 (516)
+||+|||++...... ......||+.|+|||++.+. .+.. ++|+|||||++|+|++|..||.+.+. .+....+...
T Consensus 191 ~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~ 268 (348)
T 2pml_X 191 VKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268 (348)
T ss_dssp EEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC
T ss_pred EEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc
Confidence 999999999875432 34456789999999999876 4445 78999999999999999999988766 5555555332
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
....|...... ..+.. .......+..+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 269 ~~~~~~~~~~~----~~~~~---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~ 330 (348)
T 2pml_X 269 NIEYPLDRNHF----LYPLT---NKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN 330 (348)
T ss_dssp CCCCCCSSSSS----TTTTC---C--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CcCCccchhhh----hcccc---ccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence 22222110000 00000 0001112247889999999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=384.56 Aligned_cols=310 Identities=20% Similarity=0.292 Sum_probs=201.2
Q ss_pred ccccEeeeeeeccccceEEEEEE-----EcCCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccce
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEK 162 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 162 (516)
..++|++.+.||+|+||+||+|+ +..+++.||||++.........+.+.+|+.+|+++ +|||||++++++...+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 34679999999999999999999 55677999999997654333334577788888777 6777777777766543
Q ss_pred e-eeeeeehhhh-hhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccc
Q psy12305 163 C-LTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 240 (516)
Q Consensus 163 ~-~~lv~Ey~~~-~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hp 240 (516)
. .+++|||+++ +|.+++........... .....+.........
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~ 144 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYK-----------------------------------TKGARFRQGKDYVGA 144 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccc-----------------------------------cccchhhcccccccc
Confidence 3 6677777754 55555543321100000 000000000000000
Q ss_pred ceeeEeeeEee--CceeeEeeehhhc-hHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCE
Q psy12305 241 NIVTLHDIIHT--EKCLTLVFEYLEK-DLKRYMD------DCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311 (516)
Q Consensus 241 nIv~l~~~~~~--~~~~~lV~E~~~g-~L~~~l~------~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NI 311 (516)
.-+.+..-... .....-...+... .+..... .....+++..++.++.||+.||.|||++||+||||||+||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NI 224 (359)
T 3vhe_A 145 IPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 224 (359)
T ss_dssp ---------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 00000000000 0000000001110 0000000 0123389999999999999999999999999999999999
Q ss_pred EEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHH
Q psy12305 312 LINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDE 388 (516)
Q Consensus 312 Ll~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~ 388 (516)
|++.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|+|||||++|||++ |..||.+....+.
T Consensus 225 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 304 (359)
T 3vhe_A 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304 (359)
T ss_dssp EECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred EEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH
Confidence 99999999999999998653322 23344577999999999988888889999999999999998 9999988765444
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+....... .....|..+++++.+||.+||+.||.+|||++++++|
T Consensus 305 ~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 305 FCRRLKEG------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHT------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcC------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 43333211 1122345788999999999999999999999999876
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=384.89 Aligned_cols=259 Identities=18% Similarity=0.271 Sum_probs=211.0
Q ss_pred ccccccEeeeeeeccccceEEEEEEE-----cCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccc
Q psy12305 87 FGRIESYFKLDKLGQGTYATVFKGKS-----RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 161 (516)
Q Consensus 87 ~~~~~~y~~~~~LG~G~fG~Vyka~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 161 (516)
....++|++++.||+|+||+||+|++ ..+++.||||++......
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------------------------------- 115 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE------------------------------- 115 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH-------------------------------
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh-------------------------------
Confidence 34457899999999999999999994 456778899887532111
Q ss_pred eeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc
Q psy12305 162 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 241 (516)
Q Consensus 162 ~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn 241 (516)
.....+.+|+.++++++|||
T Consensus 116 ------------------------------------------------------------~~~~~~~~E~~~l~~l~hpn 135 (367)
T 3l9p_A 116 ------------------------------------------------------------QDELDFLMEALIISKFNHQN 135 (367)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHHHHHHCCCTT
T ss_pred ------------------------------------------------------------hhHHHHHHHHHHHHhCCCCC
Confidence 11124667888888888888
Q ss_pred eeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc
Q psy12305 242 IVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN 314 (516)
Q Consensus 242 Iv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 314 (516)
|+++++++......|+|||||+ |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 136 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 215 (367)
T 3l9p_A 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 215 (367)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred CCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEe
Confidence 8999999988889999999997 59999988654 3589999999999999999999999999999999999999
Q ss_pred cCC---CEEEeeeccccccCCC--CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHH
Q psy12305 315 ERG---ELKLADFGLARAKSVP--TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDE 388 (516)
Q Consensus 315 ~~~---~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~ 388 (516)
.+| .+||+|||+|+..... ........||+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+.
T Consensus 216 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~ 295 (367)
T 3l9p_A 216 CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 295 (367)
T ss_dssp CSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred cCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 655 5999999999754221 122334567999999999988888889999999999999998 9999999888777
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
+..+..... ...+..+++.+.+||.+||+.||.+|||++++++|.|+.
T Consensus 296 ~~~i~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 296 LEFVTSGGR-------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHHHTTCC-------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHcCCC-------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 666643211 122447889999999999999999999999999998874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=374.16 Aligned_cols=269 Identities=23% Similarity=0.299 Sum_probs=193.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++..+|+.||||++........
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------- 56 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS------------------------------------- 56 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC--------------------------------------------
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchh-------------------------------------
Confidence 4679999999999999999999988999999998754321111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.++++++||||+++++++
T Consensus 57 ------------------------------------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 57 ------------------------------------------------------MDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ---------------------------------------------------------------CCCCCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 11345678888888999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDD-------CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
...+..++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 99999999999997 588888764 2456999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCC-----ccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHh
Q psy12305 322 ADFGLARAKSVPT-----KTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395 (516)
Q Consensus 322 ~DFGla~~~~~~~-----~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~ 395 (516)
+|||++....... .......||+.|+|||++.+ ..+..++|+|||||++|+|++|..||.+.............
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 9999997654221 12234578999999999865 45678899999999999999999999886655544333221
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.++. . .. ..........+++++.+||.+||+.||.+|||++++++||||+....
T Consensus 243 --~~~~-~------------~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 243 --DPPS-L------------ET-GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp --SCCC-T------------TC------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred --CCCc-c------------cc-ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 1110 0 00 00111223467899999999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=361.39 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=209.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++. ++..||||++......
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------------------------------------- 46 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS-------------------------------------- 46 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--------------------------------------
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--------------------------------------
Confidence 3467999999999999999999885 6778999988643211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.++++++||||++++++
T Consensus 47 -------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~~~~ 71 (268)
T 3sxs_A 47 -------------------------------------------------------EDEFFQEAQTMMKLSHPKLVKFYGV 71 (268)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 1245678888888888888888888
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.++...++||||++ ++|.+++...+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 72 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred EccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccc
Confidence 888889999999998 5799999887777999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+....... ......+|+.|+|||++.+..++.++|+||+||++|+|++ |..||.+.+..+....+....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------- 222 (268)
T 3sxs_A 152 RYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH--------- 222 (268)
T ss_dssp EECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---------
T ss_pred eecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC---------
Confidence 86543322 2233456788999999988888899999999999999999 999999888777665553321
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|...++++.+||.+||+.||.+|||+.++++|
T Consensus 223 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 ----------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ----------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112234678899999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=373.95 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=209.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++.+.||+|+||+||+|++..+|+.||||++.........
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------- 85 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG---------------------------------- 85 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEE----------------------------------
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhh----------------------------------
Confidence 3456799999999999999999999999999999999765322100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc--ccceeeE
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR--HANIVTL 245 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l 245 (516)
.......+.+|+.++++++ ||||+++
T Consensus 86 ----------------------------------------------------~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 86 ----------------------------------------------------ELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ----------------------------------------------------ECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred ----------------------------------------------------hhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 0001113446888888885 5999999
Q ss_pred eeeEeeCceeeEeeehhh--chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc-cCCCEEEe
Q psy12305 246 HDIIHTEKCLTLVFEYLE--KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-ERGELKLA 322 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~--g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkL~ 322 (516)
++++..++..++|||++. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEEC
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999999999997 6899888764 4699999999999999999999999999999999999999 78999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCC-CceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEY-STSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|||+++..... ......||+.|+|||++.+..++ .++|+|||||++|||++|+.||..... +..
T Consensus 193 Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~------- 257 (320)
T 3a99_A 193 DFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIR------- 257 (320)
T ss_dssp CCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HHH-------
T ss_pred eCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------hhc-------
Confidence 99999876432 33456789999999999876664 556999999999999999999965321 110
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....+..+++++.+||.+||+.||++|||++++++||||++..
T Consensus 258 -------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 258 -------------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -------------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -------------------ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 01123347889999999999999999999999999999998753
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=375.90 Aligned_cols=268 Identities=15% Similarity=0.135 Sum_probs=213.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcC---CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRL---TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~---~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
-++|++.+.||+|+||+||+|++.. ++..||||++.... ....+|+.++.++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-----~~~~~e~~~~~~~~~~----------------- 93 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-----GPLFSELKFYQRVAKK----------------- 93 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC------CHHHHHHHHHHHHCCH-----------------
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCC-----cchHHHHHHHHHHhhh-----------------
Confidence 3679999999999999999999987 78999999987542 2567888888876543
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.+.+|+.+++.++||||++++
T Consensus 94 -----------------------------------------------------------~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 94 -----------------------------------------------------------DCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp -----------------------------------------------------------HHHHHHHHHHTCSCCCCCCEE
T ss_pred -----------------------------------------------------------HHHHHHHhhccccccCcceee
Confidence 356799999999999999999
Q ss_pred eeEee----CceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC--CEE
Q psy12305 247 DIIHT----EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG--ELK 320 (516)
Q Consensus 247 ~~~~~----~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~--~vk 320 (516)
+++.. ....|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 99988 78899999999779999887654 699999999999999999999999999999999999999887 999
Q ss_pred EeeeccccccCCCC-------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCC--CCHHHHHHH
Q psy12305 321 LADFGLARAKSVPT-------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG--STIEDELRL 391 (516)
Q Consensus 321 L~DFGla~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~--~~~~~~~~~ 391 (516)
|+|||+|+...... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+ .........
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999997653211 122455789999999999998888899999999999999999999965 333333333
Q ss_pred HHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 392 ICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 392 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
........|..+.. ...+..+++++.+||.+||..||++|||++++++
T Consensus 274 ~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 274 KTNLLDELPQSVLK-----------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHTTTHHHHH-----------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHhhcccccHHHHh-----------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 33333333322211 1122368899999999999999999999999875
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=373.06 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=209.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcE---EEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNL---VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~---vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..++|++.+.||+|+||+||+|++..+|+. ||||++......
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~----------------------------------- 91 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE----------------------------------- 91 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH-----------------------------------
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH-----------------------------------
Confidence 457799999999999999999999876654 999988643111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.....+.+|+.+++.++||||+++
T Consensus 92 --------------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~ 115 (325)
T 3kul_A 92 --------------------------------------------------------RQRRDFLSEASIMGQFDHPNIIRL 115 (325)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHhCCCCCCCcE
Confidence 111256778888999999999999
Q ss_pred eeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 246 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++++.+++..|+||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 116 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Df 195 (325)
T 3kul_A 116 EGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDF 195 (325)
T ss_dssp EEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCC
Confidence 9999999999999999985 999999877778999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 325 GLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 325 Gla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
|+++....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+....
T Consensus 196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~---- 271 (325)
T 3kul_A 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---- 271 (325)
T ss_dssp SSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC----
T ss_pred CcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC----
Confidence 99987543322 2223345788999999988888889999999999999999 999999988877766664321
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..+++++.+||.+||..||.+|||+.++++
T Consensus 272 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 ---------------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11234478899999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=373.77 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=203.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-..++|++++.||+|+||+||+|++..+++.||+|+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~i------------------------------------------ 49 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI------------------------------------------ 49 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEE------------------------------------------
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEE------------------------------------------
Confidence 34577999999999999999999999999887666432
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
|.+...........+.+|+.+++.++||||+++++
T Consensus 50 ---------------------------------------------K~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 84 (327)
T 3lzb_A 50 ---------------------------------------------KELREATSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp ---------------------------------------------EEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCE
T ss_pred ---------------------------------------------EeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEE
Confidence 33222222333446778999999999999999999
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..+. .++|+||+. ++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~ 163 (327)
T 3lzb_A 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC
T ss_pred EEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcc
Confidence 998765 778888887 699999988778899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 327 ARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 327 a~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
|+....... ......||+.|+|||++.+..++.++|+|||||++|||++ |..||.+....+....+....
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~------- 236 (327)
T 3lzb_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------- 236 (327)
T ss_dssp ----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-------
T ss_pred eeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC-------
Confidence 987543322 2233456889999999998888889999999999999999 999999877665554443211
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..++.++.+||.+||..||.+|||+.++++
T Consensus 237 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 237 ------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp ------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11224467899999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=373.96 Aligned_cols=263 Identities=20% Similarity=0.279 Sum_probs=184.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCc---EEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~---~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
..++|++.+.||+|+||+||+|++..++. .||||++...... ...
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~------------------------------- 69 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI------------------------------- 69 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHH-------------------------------
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHH-------------------------------
Confidence 34679999999999999999999887775 8999988654211 111
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
..+.+|+.++++++||||++
T Consensus 70 ------------------------------------------------------------~~~~~E~~~l~~l~h~~iv~ 89 (323)
T 3qup_A 70 ------------------------------------------------------------EEFLREAACMKEFDHPHVAK 89 (323)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHTTCCCTTBCC
T ss_pred ------------------------------------------------------------HHHHHHHHHHHHCCCCceeh
Confidence 23445666666666666666
Q ss_pred EeeeEeeCce------eeEeeehhhc-hHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEE
Q psy12305 245 LHDIIHTEKC------LTLVFEYLEK-DLKRYMDDCS-----NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312 (516)
Q Consensus 245 l~~~~~~~~~------~~lV~E~~~g-~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NIL 312 (516)
+++++..... .++||||+.+ +|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIl 169 (323)
T 3qup_A 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169 (323)
T ss_dssp CCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred hhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEE
Confidence 6666655443 3899999985 8888886432 25899999999999999999999999999999999999
Q ss_pred EccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHH
Q psy12305 313 INERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDEL 389 (516)
Q Consensus 313 l~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~ 389 (516)
++.++.+||+|||+|+....... ......+|+.|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+..+..
T Consensus 170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~ 249 (323)
T 3qup_A 170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249 (323)
T ss_dssp ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence 99999999999999976543221 2223456789999999988888889999999999999999 99999987776665
Q ss_pred HHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-------HHHHHcCCCCCC
Q psy12305 390 RLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-------AANAMRHPYFNS 462 (516)
Q Consensus 390 ~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-------a~e~l~Hp~f~~ 462 (516)
..+.... ....+..+++++.+||.+||+.||.+||| ++++++|||+.+
T Consensus 250 ~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 250 NYLIGGN-------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp HHHHTTC-------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred HHHhcCC-------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 5553211 11224478899999999999999999999 778889999987
Q ss_pred CCCCc
Q psy12305 463 LGPQV 467 (516)
Q Consensus 463 ~~~~~ 467 (516)
..+..
T Consensus 305 ~~~~p 309 (323)
T 3qup_A 305 TSQDP 309 (323)
T ss_dssp -----
T ss_pred CCCCC
Confidence 65443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=362.51 Aligned_cols=252 Identities=18% Similarity=0.207 Sum_probs=205.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|++.+.||+|+||+||+|++..+|+.||||++......
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--------------------------------------- 49 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--------------------------------------- 49 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---------------------------------------
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc---------------------------------------
Confidence 46799999999999999999999999999999987543211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDI 248 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 248 (516)
..+.+|+.+++.+ +|+||++++++
T Consensus 50 -------------------------------------------------------~~~~~e~~~~~~l~~~~~i~~~~~~ 74 (298)
T 1csn_A 50 -------------------------------------------------------PQLRDEYRTYKLLAGCTGIPNVYYF 74 (298)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTTTCTTCCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHhcCCCCCeEEee
Confidence 1345677777777 67888888888
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC-----EEEee
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE-----LKLAD 323 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~-----vkL~D 323 (516)
+..+...++||||++++|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|
T Consensus 75 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 75 GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred cCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 8888999999999988999999887777999999999999999999999999999999999999987776 99999
Q ss_pred eccccccCCCCc-------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC---CHHHHHHHHH
Q psy12305 324 FGLARAKSVPTK-------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS---TIEDELRLIC 393 (516)
Q Consensus 324 FGla~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~---~~~~~~~~i~ 393 (516)
||+|+....... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+. .....+..+.
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 999987543322 234567899999999999888888999999999999999999999874 3334444433
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....++. . .....+++++.+||.+||+.||++|||++++++
T Consensus 235 ~~~~~~~~--------------------~-~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 235 EKKQSTPL--------------------R-ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHSCH--------------------H-HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCccH--------------------H-HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 22111111 0 012367899999999999999999999998864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=382.45 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=207.6
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+|+.||||.+........
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------------------------ 155 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL------------------------------------ 155 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHH------------------------------------
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHH------------------------------------
Confidence 34689999999999999999999999999999998864321110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+|++++||||++++++
T Consensus 156 -------------------------------------------------------~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 156 -------------------------------------------------------KAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp -------------------------------------------------------HTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 1134567778888888888888888
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+..+..+|+||||++ ++|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 888888999999998 6999999877777999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccc--cCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVPTKTF--SNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+......... ....+|+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~--------- 331 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG--------- 331 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTT---------
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------
Confidence 8643221111 12245788999999988888889999999999999998 99999988776655444321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....|..+++++.+||.+||+.||++|||++++++
T Consensus 332 ----------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 ----------------GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 112234578899999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=363.18 Aligned_cols=250 Identities=23% Similarity=0.321 Sum_probs=206.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++. +++.||||++......
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-------------------------------------- 62 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-------------------------------------- 62 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--------------------------------------
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--------------------------------------
Confidence 3467999999999999999999885 6788999998643211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||++++++
T Consensus 63 -------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 63 -------------------------------------------------------EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 1245678888888888888888999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++..++||||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence 988889999999997 5899999876677999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+...... .......+|+.|+|||++.+..++.++|+||+||++|+|++ |+.||.+.+..+....+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--------- 238 (283)
T 3gen_A 168 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL--------- 238 (283)
T ss_dssp GGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC---------
T ss_pred ccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc---------
Confidence 7654221 12233456888999999988888889999999999999998 999999888777766664322
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|...++.+.+||.+||+.||.+|||++++++|
T Consensus 239 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 239 ----------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 122344678999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=369.47 Aligned_cols=263 Identities=19% Similarity=0.286 Sum_probs=196.3
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++++.||+|+||+||+|++..+|+.||||++.........
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---------------------------------- 67 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEEN---------------------------------- 67 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHH----------------------------------
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHH----------------------------------
Confidence 4578899999999999999999999999999999998654211100
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+..+..+++.++||||+++++
T Consensus 68 --------------------------------------------------------~~~~~~~~~~~~~~~h~~i~~~~~ 91 (318)
T 2dyl_A 68 --------------------------------------------------------KRILMDLDVVLKSHDCPYIVQCFG 91 (318)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhcCCCceeeEEE
Confidence 012234455677889999999999
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..++..|+||||+++.+..........+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 171 (318)
T 2dyl_A 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI 171 (318)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCC
Confidence 9999999999999997666666665567799999999999999999999995 999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHhcCCCC
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGS-TIEDELRLICSILGPPP 400 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~-~~~~~~~~i~~~~~~~p 400 (516)
+...... .......||+.|+|||++. +..+..++|+|||||++|+|++|+.||... ...+.+..+.... ++
T Consensus 172 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~ 248 (318)
T 2dyl_A 172 SGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP 248 (318)
T ss_dssp C---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC
T ss_pred chhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC
Confidence 9765432 2233457899999999984 445677899999999999999999999873 4444444443211 10
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
. ......+++++.+||.+||..||.+|||++++++||||+...
T Consensus 249 -------------~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 249 -------------L--------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -------------C--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -------------C--------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 0 001125789999999999999999999999999999997643
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=365.54 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=194.6
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCC---CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~---g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..++|++.+.||+|+||+||+|++..+ +..||||++........
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~--------------------------------- 59 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--------------------------------- 59 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH---------------------------------
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHH---------------------------------
Confidence 346799999999999999999998754 45799998764321111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
...+.+|+.++++++||||+++
T Consensus 60 ----------------------------------------------------------~~~~~~e~~~l~~l~h~~iv~~ 81 (281)
T 1mp8_A 60 ----------------------------------------------------------REKFLQEALTMRQFDHPHIVKL 81 (281)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHhCCCCccceE
Confidence 1245667777777888888888
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++++. ++..|+||||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 82 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 160 (281)
T 1mp8_A 82 IGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF 160 (281)
T ss_dssp EEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-
T ss_pred EEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcc
Confidence 88774 456899999999 4999999877667999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 325 GLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 325 Gla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|+++....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |.+||.+.+..+....+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~------ 234 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------ 234 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------
T ss_pred ccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC------
Confidence 99986543222 2233456789999999988888888999999999999997 999999877766655553211
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....+..+++++.+||.+||..||++|||+.+++++
T Consensus 235 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 235 -------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112344788999999999999999999999998863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=376.53 Aligned_cols=268 Identities=14% Similarity=0.100 Sum_probs=213.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCC--------CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccc
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLT--------DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 161 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~--------g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 161 (516)
-++|++.+.||+|+||+||+|++..+ ++.||||++... ..+.+|+.++++++|||||++++.+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~--- 111 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKL--- 111 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHH---
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhh---
Confidence 36899999999999999999999874 899999998754 3789999999999999998765432
Q ss_pred eeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc
Q psy12305 162 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 241 (516)
Q Consensus 162 ~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn 241 (516)
....+++
T Consensus 112 -------------------------------------------------------------------------~~~~~~~ 118 (352)
T 2jii_A 112 -------------------------------------------------------------------------YSTPLLA 118 (352)
T ss_dssp -------------------------------------------------------------------------TTCTTCS
T ss_pred -------------------------------------------------------------------------ccCCccC
Confidence 2335678
Q ss_pred eeeEeeeEee-CceeeEeeehhhchHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC--
Q psy12305 242 IVTLHDIIHT-EKCLTLVFEYLEKDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-- 317 (516)
Q Consensus 242 Iv~l~~~~~~-~~~~~lV~E~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-- 317 (516)
++++++++.. +...|+||||++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 119 i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~ 198 (352)
T 2jii_A 119 IPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS 198 (352)
T ss_dssp CCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEE
T ss_pred ccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCc
Confidence 8889998876 7789999999987999999875 35699999999999999999999999999999999999999998
Q ss_pred CEEEeeeccccccCCCCc-------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC--HHHH
Q psy12305 318 ELKLADFGLARAKSVPTK-------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST--IEDE 388 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~--~~~~ 388 (516)
.+||+|||+|+....... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.. ....
T Consensus 199 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 278 (352)
T 2jii_A 199 QVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278 (352)
T ss_dssp EEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHH
Confidence 899999999976542211 2234578999999999998888889999999999999999999998753 3333
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..........++.-. ........+++++.+||.+||+.||.+|||++++++
T Consensus 279 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 279 MKQKQKFVDKPGPFV-----------------GPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HHHHHHHHHSCCCEE-----------------CTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHhccCChhhhh-----------------hhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 333322221111000 000011256899999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=374.39 Aligned_cols=260 Identities=23% Similarity=0.320 Sum_probs=178.8
Q ss_pred cccccEeeee-eeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLD-KLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~-~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...++|++++ .||+|+||+||+|+++.+|+.||||++.... ...+|+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~-------------------------- 72 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEV-------------------------- 72 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHH--------------------------
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHH--------------------------
Confidence 4557899976 5999999999999999999999999985421 111221
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
...++.++||||++++
T Consensus 73 ----------------------------------------------------------------~~~~~~~~h~~i~~~~ 88 (336)
T 3fhr_A 73 ----------------------------------------------------------------DHHWQASGGPHIVCIL 88 (336)
T ss_dssp ----------------------------------------------------------------HHHHHHTTSTTBCCEE
T ss_pred ----------------------------------------------------------------HHHHHhcCCCChHHHH
Confidence 2234455677777777
Q ss_pred eeEee----CceeeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC---C
Q psy12305 247 DIIHT----EKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER---G 317 (516)
Q Consensus 247 ~~~~~----~~~~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~---~ 317 (516)
+++.. +..+++||||+++ +|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+ +
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTC
T ss_pred HHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCc
Confidence 77765 4568999999985 9999998754 469999999999999999999999999999999999999864 5
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~ 397 (516)
.+||+|||+++.... ......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+.....
T Consensus 169 ~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246 (336)
T ss_dssp CEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-----------------
T ss_pred eEEEeccccceeccc--cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhh
Confidence 599999999976542 233456789999999999888888889999999999999999999977554332111111000
Q ss_pred CCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 398 PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 398 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
... ..........+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 247 -----------~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 247 -----------LGQ-------YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ----------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred -----------ccc-------cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 000 000111123678999999999999999999999999999999753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=386.35 Aligned_cols=215 Identities=29% Similarity=0.363 Sum_probs=165.3
Q ss_pred HHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeec
Q psy12305 228 IREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306 (516)
Q Consensus 228 ~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl 306 (516)
.+|+.+|+.+ +||||+++++++.+....|+|||||+++|.+++......+.+..+..++.||+.||+|||++||+||||
T Consensus 65 ~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 144 (432)
T 3p23_A 65 DREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDL 144 (432)
T ss_dssp HHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCC
Confidence 4677778777 688888888889999999999999999999999887766777788899999999999999999999999
Q ss_pred CCCCEEEccC-----CCEEEeeeccccccCCCC---ccccCCcccccccchhhccC---CCCCCceeeehHHHHHHHHHc
Q psy12305 307 KPQNLLINER-----GELKLADFGLARAKSVPT---KTFSNEVVTLWYRPPDVLLG---STEYSTSIDMGVGCIFHEMSS 375 (516)
Q Consensus 307 Kp~NILl~~~-----~~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~APE~l~~---~~~~~~~d~~SlGvil~ellt 375 (516)
||+|||++.+ ..+||+|||+|+...... ......+||+.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 145 Kp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt 224 (432)
T 3p23_A 145 KPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224 (432)
T ss_dssp STTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHT
T ss_pred CHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHc
Confidence 9999999532 358899999998764332 22344679999999999974 445568899999999999999
Q ss_pred -CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q psy12305 376 -GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 376 -G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
|..||........ ..+ .+..... ....+...+..+.+||.+||+.||.+|||++++
T Consensus 225 ~g~~pf~~~~~~~~-~~~---~~~~~~~-------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ev 281 (432)
T 3p23_A 225 EGSHPFGKSLQRQA-NIL---LGACSLD-------------------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281 (432)
T ss_dssp TSCBTTBSTTTHHH-HHH---TTCCCCT-------------------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCcchhhHHHH-HHH---hccCCcc-------------------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHH
Confidence 9999966543322 111 1111000 000111335668999999999999999999999
Q ss_pred HcCCCCCCCCC
Q psy12305 455 MRHPYFNSLGP 465 (516)
Q Consensus 455 l~Hp~f~~~~~ 465 (516)
++||||.+..+
T Consensus 282 l~hp~f~~~~~ 292 (432)
T 3p23_A 282 LKHPFFWSLEK 292 (432)
T ss_dssp HTSTTTCCHHH
T ss_pred HhCccccChHH
Confidence 99999987543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=376.47 Aligned_cols=207 Identities=24% Similarity=0.410 Sum_probs=179.2
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++.+ +||||+++++++..++..|+||||+++ +|.+++.... ..+++..++.++.|
T Consensus 120 ~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 199 (382)
T 3tt0_A 120 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 199 (382)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHH
Confidence 577899999999 999999999999999999999999985 9999998754 35999999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||+|||++||+||||||+|||++.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|+|||
T Consensus 200 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diwsl 279 (382)
T 3tt0_A 200 VARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF 279 (382)
T ss_dssp HHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred HHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHH
Confidence 9999999999999999999999999999999999999998654322 22334567899999999999888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|+|++ |..||.+.+..+....+.... ....|..+++++.+||.+||+.||
T Consensus 280 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dP 334 (382)
T 3tt0_A 280 GVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-------------------------RMDKPSNCTNELYMMMRDCWHAVP 334 (382)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-------------------------CCCCCSSCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-------------------------CCCCCccCCHHHHHHHHHHcCCCh
Confidence 999999999 999999988777665554321 112345788999999999999999
Q ss_pred CCCCCHHHHHcC
Q psy12305 446 KQRISAANAMRH 457 (516)
Q Consensus 446 ~~R~ta~e~l~H 457 (516)
++|||+++++++
T Consensus 335 ~~Rps~~ell~~ 346 (382)
T 3tt0_A 335 SQRPTFKQLVED 346 (382)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=386.07 Aligned_cols=265 Identities=24% Similarity=0.320 Sum_probs=194.3
Q ss_pred ccccccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccc
Q psy12305 81 SLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 160 (516)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 160 (516)
+++++....-+.|.+.+.||+|+||+||.+. ..+|+.||||++.....
T Consensus 5 ~~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~------------------------------- 52 (434)
T 2rio_A 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC------------------------------- 52 (434)
T ss_dssp ---CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGH-------------------------------
T ss_pred cccchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHH-------------------------------
Confidence 3445555555668888999999999998754 46899999998754210
Q ss_pred ceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cc
Q psy12305 161 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RH 239 (516)
Q Consensus 161 ~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~H 239 (516)
..+.+|+.+|+++ +|
T Consensus 53 ----------------------------------------------------------------~~~~~E~~~l~~l~~H 68 (434)
T 2rio_A 53 ----------------------------------------------------------------DIALMEIKLLTESDDH 68 (434)
T ss_dssp ----------------------------------------------------------------HHHHHHHHHHHHHTTS
T ss_pred ----------------------------------------------------------------HHHHHHHHHHHhccCC
Confidence 1345677777765 78
Q ss_pred cceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE
Q psy12305 240 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNI------LSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI 313 (516)
Q Consensus 240 pnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~------l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl 313 (516)
|||+++++++.++..+|+|||||+|+|.+++...... .++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 69 pnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl 148 (434)
T 2rio_A 69 PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148 (434)
T ss_dssp TTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred CCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEE
Confidence 8888888889889999999999999999999764321 1334567899999999999999999999999999999
Q ss_pred ccC-------------CCEEEeeeccccccCCCCc----cccCCcccccccchhhccC-------CCCCCceeeehHHHH
Q psy12305 314 NER-------------GELKLADFGLARAKSVPTK----TFSNEVVTLWYRPPDVLLG-------STEYSTSIDMGVGCI 369 (516)
Q Consensus 314 ~~~-------------~~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~APE~l~~-------~~~~~~~d~~SlGvi 369 (516)
+.+ +.+||+|||+|+....... .....+||+.|+|||++.+ ..++.++|+|||||+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~i 228 (434)
T 2rio_A 149 STSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228 (434)
T ss_dssp ECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHH
T ss_pred ecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHH
Confidence 754 4799999999987653322 2234579999999999976 557788999999999
Q ss_pred HHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCC
Q psy12305 370 FHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQR 448 (516)
Q Consensus 370 l~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R 448 (516)
+|||++ |..||.+..... ..+.......+ ......+..+++++.+||.+||+.||.+|
T Consensus 229 l~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (434)
T 2rio_A 229 FYYILSKGKHPFGDKYSRE--SNIIRGIFSLD-------------------EMKCLHDRSLIAEATDLISQMIDHDPLKR 287 (434)
T ss_dssp HHHHHTTSCCTTCSTTTHH--HHHHHTCCCCC-------------------CCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHhCCCCCCCCchhhH--HHHhcCCCCcc-------------------cccccccccchHHHHHHHHHHhhCChhhC
Confidence 999999 999997654433 22222111100 00001112345789999999999999999
Q ss_pred CCHHHHHcCCCCCC
Q psy12305 449 ISAANAMRHPYFNS 462 (516)
Q Consensus 449 ~ta~e~l~Hp~f~~ 462 (516)
||+.++++||||.+
T Consensus 288 ps~~eil~hp~f~~ 301 (434)
T 2rio_A 288 PTAMKVLRHPLFWP 301 (434)
T ss_dssp CCHHHHHTSGGGSC
T ss_pred CCHHHHHhCCccCC
Confidence 99999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=366.00 Aligned_cols=258 Identities=27% Similarity=0.396 Sum_probs=201.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|++. +|+.||||++.......
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------------------------------- 67 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADN--------------------------------------- 67 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCH---------------------------------------
T ss_pred ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccc---------------------------------------
Confidence 56999999999999999999985 58999999986532110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc--ccceeeEeee
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR--HANIVTLHDI 248 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~ 248 (516)
.....+.+|+.++++++ ||||++++++
T Consensus 68 ---------------------------------------------------~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 68 ---------------------------------------------------QTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred ---------------------------------------------------cchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 01124567888888886 4899999999
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+..+...|+|||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++
T Consensus 97 ~~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 97 EITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp EECSSEEEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred eecCCEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence 9999999999998888999999875 4689999999999999999999999999999999999996 5899999999997
Q ss_pred ccCCCCc--cccCCcccccccchhhccC-----------CCCCCceeeehHHHHHHHHHcCCCCCCCCCHH-HHHHHHHH
Q psy12305 329 AKSVPTK--TFSNEVVTLWYRPPDVLLG-----------STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE-DELRLICS 394 (516)
Q Consensus 329 ~~~~~~~--~~~~~~gt~~y~APE~l~~-----------~~~~~~~d~~SlGvil~elltG~~pF~~~~~~-~~~~~i~~ 394 (516)
....... .....+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...... ..+..+..
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 254 (313)
T 3cek_A 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 254 (313)
T ss_dssp C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence 6543222 2234578999999999875 35667889999999999999999999765332 22222211
Q ss_pred hcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 395 ILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 395 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.......|...+.++.+||.+||..||.+|||++++++||||+....
T Consensus 255 ------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 255 ------------------------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp ------------------------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred ------------------------cccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 01112234466889999999999999999999999999999976543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=370.44 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=205.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..++|.+.+.||+|+||+||+|++. .+++.||||++.......
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------- 90 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS-------------------------------- 90 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------------------------------
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHH--------------------------------
Confidence 3478999999999999999999974 355678888876432111
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccce
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANI 242 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnI 242 (516)
....+.+|+.+++++ +||||
T Consensus 91 -----------------------------------------------------------~~~~~~~E~~~l~~l~~hp~i 111 (344)
T 1rjb_A 91 -----------------------------------------------------------EREALMSELKMMTQLGSHENI 111 (344)
T ss_dssp ------------------------------------------------------------CHHHHHHHHHHHHHCCCTTB
T ss_pred -----------------------------------------------------------HHHHHHHHHHHHHhhcCCCCe
Confidence 123566788888888 78888
Q ss_pred eeEeeeEeeCceeeEeeehhh-chHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHhhC
Q psy12305 243 VTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSN----------------------ILSMNNVKLFLFQLLRGLAYCHSR 299 (516)
Q Consensus 243 v~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~----------------------~l~~~~~~~i~~qi~~aL~yLH~~ 299 (516)
+++++++...+..++||||++ ++|.+++..... .+++..+..++.||+.||+|||++
T Consensus 112 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 191 (344)
T 1rjb_A 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK 191 (344)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 888888888889999999998 599999986543 378999999999999999999999
Q ss_pred CcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-C
Q psy12305 300 RILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-G 376 (516)
Q Consensus 300 ~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G 376 (516)
||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|+| |
T Consensus 192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999976543222 2234467889999999988888889999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 377 RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 377 ~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..||.+......+..+.... .....|..+++++.+||.+||..||.+|||+.++++
T Consensus 272 ~~p~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 272 VNPYPGIPVDANFYKLIQNG------------------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp CCSSTTCCCSHHHHHHHHTT------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCCcHHHHHHHHhcC------------------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99998876544444333211 111234467899999999999999999999999998
Q ss_pred CCC
Q psy12305 457 HPY 459 (516)
Q Consensus 457 Hp~ 459 (516)
|-.
T Consensus 328 ~l~ 330 (344)
T 1rjb_A 328 FLG 330 (344)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=372.97 Aligned_cols=264 Identities=18% Similarity=0.300 Sum_probs=188.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.+++.||+|+||+||+|++..+|+.||||++........
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~------------------------------------ 63 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE------------------------------------ 63 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH------------------------------------
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH------------------------------------
Confidence 45789999999999999999999999999999999865321110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHH-HHHhccccceeeEee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRELRHANIVTLHD 247 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~ 247 (516)
...+..|+. +++.++||||+++++
T Consensus 64 -------------------------------------------------------~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 64 -------------------------------------------------------QKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHcCCCCcEeeeee
Confidence 112334444 667778999999999
Q ss_pred eEeeCceeeEeeehhhchHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcEeeecCCCCEEEccCCCEEEe
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDD----CSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~-~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
++..++..++||||++++|.+++.. ....+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~ 168 (327)
T 3aln_A 89 ALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLC 168 (327)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEEC
T ss_pred EEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEc
Confidence 9999999999999999988777753 246799999999999999999999998 99999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhc----cCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVL----LGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
|||+++..... .......||+.|+|||++ .+..++.++|+|||||++|+|++|..||.+..... ..+......
T Consensus 169 Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~ 245 (327)
T 3aln_A 169 DFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQLTQVVKG 245 (327)
T ss_dssp CCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCS
T ss_pred cCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHHHHHhcC
Confidence 99999765432 223344789999999998 45567788999999999999999999998643211 111000000
Q ss_pred CChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 399 PPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 399 ~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..+ ......+..+++++.+||.+||+.||++|||+.++++||||....
T Consensus 246 ------------~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 246 ------------DPP------QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp ------------CCC------CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ------------CCC------CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 000 011111236789999999999999999999999999999997643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=367.49 Aligned_cols=256 Identities=26% Similarity=0.370 Sum_probs=199.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+|+.||||++.........
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~----------------------------------- 73 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWS----------------------------------- 73 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------------------------------------
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccc-----------------------------------
Confidence 346799999999999999999999999999999998654321100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc----cccceee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL----RHANIVT 244 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l----~HpnIv~ 244 (516)
.......+.+|+.++.++ +||||++
T Consensus 74 ---------------------------------------------------~~~~~~~~~~e~~~l~~l~~~~~h~~i~~ 102 (312)
T 2iwi_A 74 ---------------------------------------------------PLSDSVTCPLEVALLWKVGAGGGHPGVIR 102 (312)
T ss_dssp --------------------------------------------------------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred ---------------------------------------------------cchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence 000011344678888887 7999999
Q ss_pred EeeeEeeCceeeEeeeh-hh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc-cCCCEEE
Q psy12305 245 LHDIIHTEKCLTLVFEY-LE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN-ERGELKL 321 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~-~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~-~~~~vkL 321 (516)
+++++...+..++|||+ +. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||
T Consensus 103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 103 LLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp EEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence 99999988999999999 55 6899988764 4599999999999999999999999999999999999999 7899999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCC-ceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS-TSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
+|||+++..... ......||+.|+|||++.+..++. ++|+|||||++|+|++|+.||.+.. .+..
T Consensus 182 ~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~------ 247 (312)
T 2iwi_A 182 IDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILE------ 247 (312)
T ss_dssp CCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH------
T ss_pred EEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhh------
Confidence 999999876532 334567899999999987766654 7899999999999999999997531 1111
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.....+..+++++.+||.+||+.||++|||++|+++||||+....
T Consensus 248 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 248 --------------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp --------------------TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred --------------------hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 111234578899999999999999999999999999999986543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=363.81 Aligned_cols=264 Identities=21% Similarity=0.328 Sum_probs=196.9
Q ss_pred ccccEeeeeeeccccceEEEEEE----EcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~----~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
..++|+++++||+|+||+||+|+ +..+|+.||||++......
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------- 53 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---------------------------------- 53 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHH----------------------------------
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHH----------------------------------
Confidence 44679999999999999999999 5668899999988643211
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
....+.+|+.++++++||||++
T Consensus 54 ----------------------------------------------------------~~~~~~~E~~~l~~l~h~~iv~ 75 (295)
T 3ugc_A 54 ----------------------------------------------------------HLRDFEREIEILKSLQHDNIVK 75 (295)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHTCCCTTBCC
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHHhCCCCCEee
Confidence 0114556777777777777777
Q ss_pred EeeeEee--CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 245 LHDIIHT--EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 245 l~~~~~~--~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
+++++.. ...+++||||++ ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 76 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl 155 (295)
T 3ugc_A 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 155 (295)
T ss_dssp EEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEE
T ss_pred EEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEE
Confidence 7777644 346899999997 5999999887777999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 322 ADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 322 ~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
+|||+++....... ......+|+.|+|||++.+..++.++|+|||||++|||++|..||...... . ....+.
T Consensus 156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~---~~~~~~ 230 (295)
T 3ugc_A 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--F---MRMIGN 230 (295)
T ss_dssp CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--H---HHHHCT
T ss_pred ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--H---HhhhcC
Confidence 99999986543221 223345688899999999888888999999999999999999998653211 1 111111
Q ss_pred CChhhh---hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 399 PPDELK---SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 399 ~p~~~~---~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+.... ....... .......|..+++++.+||.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 231 DKQGQMIVFHLIELLK-------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TCCTHHHHHHHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccchhHHHHHHHHh-------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111000 0000000 11122335578999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=355.02 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=195.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++. |+.||||++........
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~------------------------------------ 46 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDI------------------------------------ 46 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC--------------------------------------------
T ss_pred chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccH------------------------------------
Confidence 3567999999999999999999974 89999998865322110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+++.++||||++++++
T Consensus 47 ----------------------------------------------------~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (271)
T 3dtc_A 47 ----------------------------------------------------SQTIENVRQEAKLFAMLKHPNIIALRGV 74 (271)
T ss_dssp ------------------------------------------------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 1112356788999999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---cEeeecCCCCEEEcc--------C
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR---ILHRDLKPQNLLINE--------R 316 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---ivHrDlKp~NILl~~--------~ 316 (516)
+..++..++||||++ ++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++. +
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~ 152 (271)
T 3dtc_A 75 CLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN 152 (271)
T ss_dssp ECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred EecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence 999999999999998 57777774 346999999999999999999999999 999999999999986 6
Q ss_pred CCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc
Q psy12305 317 GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396 (516)
Q Consensus 317 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~ 396 (516)
+.+||+|||+++...... .....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.......+...
T Consensus 153 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 229 (271)
T 3dtc_A 153 KILKITDFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN- 229 (271)
T ss_dssp CCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTS-
T ss_pred cceEEccCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcC-
Confidence 789999999997654322 23457899999999998888888899999999999999999999987766555444321
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
......+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus 230 -----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 -----------------------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -----------------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 11122345788999999999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=357.77 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=203.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+++.||||++..........
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------------------------------- 62 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE---------------------------------- 62 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHH----------------------------------
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchh----------------------------------
Confidence 3467999999999999999999999999999999986543222100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
.......+.+|+.++++++||||++++++
T Consensus 63 ---------------------------------------------------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (287)
T 4f0f_A 63 ---------------------------------------------------MIEKFQEFQREVFIMSNLNHPNIVKLYGL 91 (287)
T ss_dssp ---------------------------------------------------HHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence 00111356778888888888889999888
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccCCC-----EE
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINERGE-----LK 320 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~-----vk 320 (516)
+.+.. ++||||++ ++|.+++......+++..+..++.|++.||+|||++| |+||||||+|||++.++. +|
T Consensus 92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 87655 69999998 6999999887778999999999999999999999999 999999999999988776 99
Q ss_pred EeeeccccccCCCCccccCCcccccccchhhcc--CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHhc
Q psy12305 321 LADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL--GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDE--LRLICSIL 396 (516)
Q Consensus 321 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~--~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~--~~~i~~~~ 396 (516)
|+|||+++.... ......||+.|+|||++. +..++.++|+|||||++|+|++|+.||.+.+.... ...+.. .
T Consensus 170 l~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~ 245 (287)
T 4f0f_A 170 VADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-E 245 (287)
T ss_dssp ECCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-S
T ss_pred eCCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-c
Confidence 999999975432 334567899999999984 34456788999999999999999999986543332 222211 1
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
......+..+++++.+||.+||+.||.+|||++++++
T Consensus 246 -----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 246 -----------------------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp -----------------------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1112234578899999999999999999999999975
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=363.84 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=207.0
Q ss_pred ccccEeeeeeeccccceEEEEEEE-----cCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKS-----RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~-----~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..++|++.+.||+|+||+||+|++ ..+++.||||++.......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------------------- 68 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT-------------------------------- 68 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHH--------------------------------
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHH--------------------------------
Confidence 346799999999999999999985 3467889999876432111
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccce
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANI 242 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnI 242 (516)
....+.+|+.+++++ +||||
T Consensus 69 -----------------------------------------------------------~~~~~~~E~~~l~~l~~h~~i 89 (313)
T 1t46_A 69 -----------------------------------------------------------EREALMSELKVLSYLGNHMNI 89 (313)
T ss_dssp -----------------------------------------------------------HHHHHHHHHHHHHHHCCCTTB
T ss_pred -----------------------------------------------------------HHHHHHHHHHHHhhcccCCCe
Confidence 112566788888888 88899
Q ss_pred eeEeeeEeeCceeeEeeehhh-chHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 243 VTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSN-----------------ILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 243 v~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~-----------------~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
+++++++..++..++||||++ ++|.+++..... .+++..++.++.||+.||.|||++||+||
T Consensus 90 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 169 (313)
T 1t46_A 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHR 169 (313)
T ss_dssp CCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred eeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 999999988899999999998 499999886543 48999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFP 381 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~ 381 (516)
||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.
T Consensus 170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 249 (313)
T 1t46_A 170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (313)
T ss_dssp CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986553322 2234467889999999988888889999999999999999 999998
Q ss_pred CCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 382 GSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 382 ~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+.........+.... .....+..+++++.+||.+||..||.+|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 250 GMPVDSKFYKMIKEG------------------------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TCCSSHHHHHHHHHT------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHhccC------------------------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 866544444433211 1112344788999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=368.86 Aligned_cols=272 Identities=18% Similarity=0.273 Sum_probs=213.3
Q ss_pred cccccccccccccccccccEeeeeeeccccceEEEEEE-----EcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCC
Q psy12305 74 TRSSRRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH 148 (516)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~-----~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h 148 (516)
++.+...+++++..-..++|++++.||+|+||+||+|+ +..+++.||||++......
T Consensus 13 ~~~~~sss~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------------------ 74 (327)
T 2yfx_A 13 CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE------------------ 74 (327)
T ss_dssp EETTEEECGGGSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH------------------
T ss_pred cccCCccchhhcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch------------------
Confidence 34444455555555666889999999999999999999 4567788999987532111
Q ss_pred CCeeecccccccceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHH
Q psy12305 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI 228 (516)
Q Consensus 149 ~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~ 228 (516)
.....+.
T Consensus 75 -------------------------------------------------------------------------~~~~~~~ 81 (327)
T 2yfx_A 75 -------------------------------------------------------------------------QDELDFL 81 (327)
T ss_dssp -------------------------------------------------------------------------HHHHHHH
T ss_pred -------------------------------------------------------------------------hhHHHHH
Confidence 1112466
Q ss_pred HHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCCc
Q psy12305 229 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS------NILSMNNVKLFLFQLLRGLAYCHSRRI 301 (516)
Q Consensus 229 ~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~i 301 (516)
+|+.+++.++||||+++++++......|+||||++ ++|.+++.... ..+++..+..++.||+.||.|||++||
T Consensus 82 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 161 (327)
T 2yfx_A 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHF 161 (327)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCe
Confidence 78888888888899999999988889999999996 69999998754 348999999999999999999999999
Q ss_pred EeeecCCCCEEEccC---CCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-
Q psy12305 302 LHRDLKPQNLLINER---GELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS- 375 (516)
Q Consensus 302 vHrDlKp~NILl~~~---~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt- 375 (516)
+||||||+|||++.+ ..+||+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 999999999999844 469999999997543222 12233467899999999988888889999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 376 GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 376 G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
|..||.+....+....+.... ....+..+++.+.+||.+||+.||.+|||+++++
T Consensus 242 g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 296 (327)
T 2yfx_A 242 GYMPYPSKSNQEVLEFVTSGG-------------------------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296 (327)
T ss_dssp SCCSSTTCCHHHHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCCcCHHHHHHHHhcCC-------------------------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 999999887776665554321 1112347889999999999999999999999999
Q ss_pred cCCCCC
Q psy12305 456 RHPYFN 461 (516)
Q Consensus 456 ~Hp~f~ 461 (516)
+|.|+.
T Consensus 297 ~~l~~~ 302 (327)
T 2yfx_A 297 ERIEYC 302 (327)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=360.03 Aligned_cols=262 Identities=25% Similarity=0.403 Sum_probs=199.2
Q ss_pred cccccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccc
Q psy12305 82 LSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 161 (516)
Q Consensus 82 ~~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 161 (516)
.++.+...+++|++.+.||+|+||+||+|++..+|+.||||++........
T Consensus 23 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------- 73 (310)
T 2wqm_A 23 RPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA----------------------------- 73 (310)
T ss_dssp CGGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCH-----------------------------
T ss_pred CCCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCH-----------------------------
Confidence 355667888999999999999999999999999999999999865321110
Q ss_pred eeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc
Q psy12305 162 KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 241 (516)
Q Consensus 162 ~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn 241 (516)
.....+.+|+.+++.++|||
T Consensus 74 ------------------------------------------------------------~~~~~~~~E~~~l~~l~h~~ 93 (310)
T 2wqm_A 74 ------------------------------------------------------------KARADCIKEIDLLKQLNHPN 93 (310)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHHHHHTCCCTT
T ss_pred ------------------------------------------------------------HHHHHHHHHHHHHHhCCCCC
Confidence 01125667889999999999
Q ss_pred eeeEeeeEeeCceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC
Q psy12305 242 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG 317 (516)
Q Consensus 242 Iv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~ 317 (516)
|+++++++..++..++||||+++ +|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 94 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~ 173 (310)
T 2wqm_A 94 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG 173 (310)
T ss_dssp BCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS
T ss_pred EeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC
Confidence 99999999999999999999985 88887764 356699999999999999999999999999999999999999999
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHh
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI--EDELRLICSI 395 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~--~~~~~~i~~~ 395 (516)
.+||+|||+++.............||+.|+|||++.+..+..++|+|||||++|+|++|..||.+... ......+...
T Consensus 174 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 253 (310)
T 2wqm_A 174 VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC 253 (310)
T ss_dssp CEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTT
T ss_pred CEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcc
Confidence 99999999998765444444456789999999999988888899999999999999999999976432 2222222110
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
. .....+..+++++.+||.+||..||.+|||++++++
T Consensus 254 -~-----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 254 -D-----------------------YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -C-----------------------SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -c-----------------------CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 001112367899999999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=361.58 Aligned_cols=201 Identities=16% Similarity=0.240 Sum_probs=166.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.++++++||||+++++++.+++..++||||++ ++|.+++......+++..+..++.||+.||.|||++||+||
T Consensus 58 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~ 137 (289)
T 4fvq_A 58 SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHG 137 (289)
T ss_dssp HHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECC
Confidence 56788888889999999999999999999999999998 59999998876679999999999999999999999999999
Q ss_pred ecCCCCEEEccCCC--------EEEeeeccccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHc
Q psy12305 305 DLKPQNLLINERGE--------LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSS 375 (516)
Q Consensus 305 DlKp~NILl~~~~~--------vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~ellt 375 (516)
||||+|||++.++. +||+|||++..... .....||+.|+|||++.+ ..++.++|+|||||++|||++
T Consensus 138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred CcCcceEEEecCCcccccccceeeeccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 99999999998887 99999999865432 123457899999999987 567778899999999999999
Q ss_pred C-CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH
Q psy12305 376 G-RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA 454 (516)
Q Consensus 376 G-~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~ 454 (516)
| .+||............ .. ....|...++++.+||.+||+.||.+|||++++
T Consensus 214 g~~~~~~~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 266 (289)
T 4fvq_A 214 GGDKPLSALDSQRKLQFY-ED--------------------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAI 266 (289)
T ss_dssp TTCCTTTTSCHHHHHHHH-HT--------------------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCccccchHHHHHHh-hc--------------------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 5 5555555444333222 11 111233567889999999999999999999999
Q ss_pred HcC
Q psy12305 455 MRH 457 (516)
Q Consensus 455 l~H 457 (516)
++|
T Consensus 267 l~~ 269 (289)
T 4fvq_A 267 IRD 269 (289)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=363.97 Aligned_cols=252 Identities=20% Similarity=0.349 Sum_probs=206.5
Q ss_pred cccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|.+.+.||+|+||.||+|++. .+++.||||++......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------- 67 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP---------------------------------- 67 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCH----------------------------------
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCH----------------------------------
Confidence 467999999999999999999984 45578899887543211
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
.....+.+|+.+++.++||||++
T Consensus 68 ---------------------------------------------------------~~~~~~~~E~~~l~~l~hp~iv~ 90 (314)
T 2ivs_A 68 ---------------------------------------------------------SELRDLLSEFNVLKQVNHPHVIK 90 (314)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHhhCCCCceee
Confidence 11124667888888888999999
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCC
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-----------------------NILSMNNVKLFLFQLLRGLAYCHSRR 300 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ 300 (516)
+++++..++..++||||++ ++|.+++.... ..+++..++.++.||+.||+|||++|
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 170 (314)
T 2ivs_A 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK 170 (314)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999988899999999998 69999987643 23889999999999999999999999
Q ss_pred cEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CC
Q psy12305 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GR 377 (516)
Q Consensus 301 ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~ 377 (516)
|+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |.
T Consensus 171 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 250 (314)
T 2ivs_A 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 250 (314)
T ss_dssp EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986543322 2233456889999999988888889999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 378 PLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 378 ~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.||.+.........+.... ....+..+++++.+||.+||+.||.+|||+++++++
T Consensus 251 ~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 251 NPYPGIPPERLFNLLKTGH-------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CSSTTCCGGGHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHhhcCC-------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999877665554443211 112344788999999999999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=353.40 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=208.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++. +++.||||++......
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--------------------------------------- 46 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--------------------------------------- 46 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---------------------------------------
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---------------------------------------
Confidence 467999999999999999999986 6788999988643211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+++.++||||+++++++
T Consensus 47 ------------------------------------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~ 72 (267)
T 3t9t_A 47 ------------------------------------------------------EEDFIEEAEVMMKLSHPKLVQLYGVC 72 (267)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 12456788888888888888888888
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+++..++||||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++
T Consensus 73 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 152 (267)
T 3t9t_A 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR 152 (267)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGG
T ss_pred ccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccc
Confidence 88889999999998 58999998877779999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
...... .......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~---------- 222 (267)
T 3t9t_A 153 FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 222 (267)
T ss_dssp GBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred ccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC----------
Confidence 653221 12233456889999999988788888999999999999999 899999888777666554321
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|...++++.+||.+||+.||.+|||+++++++
T Consensus 223 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 223 ---------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112244678999999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=368.73 Aligned_cols=252 Identities=25% Similarity=0.360 Sum_probs=208.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..++|++++.||+|+||+||+|++. .+++.||||++......
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------------- 91 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--------------------------------- 91 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH---------------------------------
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCH---------------------------------
Confidence 3477999999999999999999997 34588999987543210
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccccee
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 243 (516)
.....+.+|+.+++.++||||+
T Consensus 92 ----------------------------------------------------------~~~~~~~~E~~~l~~l~hp~iv 113 (343)
T 1luf_A 92 ----------------------------------------------------------DMQADFQREAALMAEFDNPNIV 113 (343)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHHTCCCTTBC
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHHHhCCCCCEE
Confidence 1122567888999999999999
Q ss_pred eEeeeEeeCceeeEeeehhhc-hHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhC
Q psy12305 244 TLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS-----------------------NILSMNNVKLFLFQLLRGLAYCHSR 299 (516)
Q Consensus 244 ~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~ 299 (516)
++++++.+++..|+||||+++ +|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~ 193 (343)
T 1luf_A 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193 (343)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 999999999999999999985 9999987642 5699999999999999999999999
Q ss_pred CcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-C
Q psy12305 300 RILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-G 376 (516)
Q Consensus 300 ~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G 376 (516)
||+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|||++ |
T Consensus 194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 99999999999999999999999999997653221 22234567999999999988888889999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 377 RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 377 ~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..||.+.+..+....+.... ....|..+++++.+||.+||+.||.+|||+.++++
T Consensus 274 ~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 274 LQPYYGMAHEEVIYYVRDGN-------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CCTTTTSCHHHHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCCCCChHHHHHHHhCCC-------------------------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999888776665553211 11234578899999999999999999999999975
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=358.38 Aligned_cols=254 Identities=18% Similarity=0.207 Sum_probs=194.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..-++|++.+.||+|+||+||+|++..+|+.||||++...... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~-------------------------------- 50 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQ-------------------------------- 50 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CC--------------------------------
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hH--------------------------------
Confidence 3447899999999999999999999999999999986543221 12
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+.+|+.+++.++|++++..+.
T Consensus 51 -----------------------------------------------------------~~~e~~~l~~l~~~~~i~~~~ 71 (296)
T 4hgt_A 51 -----------------------------------------------------------LHIESKIYKMMQGGVGIPTIR 71 (296)
T ss_dssp -----------------------------------------------------------HHHHHHHHHHHTTSTTCCCEE
T ss_pred -----------------------------------------------------------HHHHHHHHHHhcCCCCCCeee
Confidence 344555556665555444333
Q ss_pred -eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE---ccCCCEEEee
Q psy12305 248 -IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI---NERGELKLAD 323 (516)
Q Consensus 248 -~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkL~D 323 (516)
++......++||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 72 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 72 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred eecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEec
Confidence 345667889999999889999998777789999999999999999999999999999999999999 7889999999
Q ss_pred eccccccCCCCc-------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHH---HHHHHHH
Q psy12305 324 FGLARAKSVPTK-------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE---DELRLIC 393 (516)
Q Consensus 324 FGla~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~---~~~~~i~ 393 (516)
||+|+....... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.. ..+..+.
T Consensus 152 fg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 999987543322 223557899999999999988888999999999999999999999864322 1222221
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
......+. ......+++++.+||.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 232 EKKMSTPI---------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSCH---------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccccchh---------------------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11101110 0111367899999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=365.23 Aligned_cols=260 Identities=20% Similarity=0.340 Sum_probs=211.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..++|++.+.||+|+||+||+|++. .+++.||||.+......
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--------------------------------- 69 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--------------------------------- 69 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH---------------------------------
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH---------------------------------
Confidence 3467999999999999999999986 35677888877532110
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccccee
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 243 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv 243 (516)
.....+.+|+.+++.++||||+
T Consensus 70 ----------------------------------------------------------~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 70 ----------------------------------------------------------RERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHGGGCCCTTBC
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHHHhcCCCCEe
Confidence 1112466788888888999999
Q ss_pred eEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE
Q psy12305 244 TLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI 313 (516)
Q Consensus 244 ~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl 313 (516)
++++++.+.+..++||||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 99999988899999999998 58988887532 457899999999999999999999999999999999999
Q ss_pred ccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHH
Q psy12305 314 NERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELR 390 (516)
Q Consensus 314 ~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~ 390 (516)
+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+...
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 999999999999997653222 12234467899999999988888889999999999999999 899999887776665
Q ss_pred HHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC------CCCCCCC
Q psy12305 391 LICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH------PYFNSLG 464 (516)
Q Consensus 391 ~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H------p~f~~~~ 464 (516)
.+.... ....+..+++++.+||.+||..||.+|||+.++++| |||+.+.
T Consensus 252 ~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~ 306 (322)
T 1p4o_A 252 FVMEGG-------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 306 (322)
T ss_dssp HHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred HHHcCC-------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCcccc
Confidence 553211 011234788999999999999999999999999976 6665543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=353.60 Aligned_cols=248 Identities=15% Similarity=0.185 Sum_probs=204.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++.+.||+|+||+||+|++. |+.||||++.......
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~------------------------------------ 48 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST------------------------------------ 48 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH------------------------------------
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH------------------------------------
Confidence 35678999999999999999999984 8899999986542111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.++++++||||+++++
T Consensus 49 ------------------------------------------------------~~~~~~~~E~~~l~~l~h~~iv~~~~ 74 (271)
T 3kmu_A 49 ------------------------------------------------------RKSRDFNEECPRLRIFSHPNVLPVLG 74 (271)
T ss_dssp ------------------------------------------------------HHHHHHHHHGGGGCCCSCTTEECEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHhcCCCchhheEE
Confidence 00124567788888888888888888
Q ss_pred eEeeC--ceeeEeeehhh-chHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccCCCEEE
Q psy12305 248 IIHTE--KCLTLVFEYLE-KDLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 248 ~~~~~--~~~~lV~E~~~-g~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~~vkL 321 (516)
++.+. ...++||||++ ++|.+++..... .+++..+..++.||+.||+|||++| |+||||||+|||++.++.++|
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l 154 (271)
T 3kmu_A 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARI 154 (271)
T ss_dssp EECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEE
T ss_pred EEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeE
Confidence 88776 78899999998 599999987543 5899999999999999999999999 999999999999999999999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCC---ceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS---TSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~---~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
+|||++.... .....||+.|+|||++.+..... ++|+|||||++|||++|+.||.+.+..+....+....
T Consensus 155 ~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-- 227 (271)
T 3kmu_A 155 SMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG-- 227 (271)
T ss_dssp EGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSC--
T ss_pred Eeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcC--
Confidence 9999875432 23357899999999998765555 5899999999999999999999887776655554321
Q ss_pred CChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 399 PPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 399 ~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....|..+++++.+||.+||+.||.+|||++++++
T Consensus 228 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 228 ----------------------LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ----------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 112234578999999999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=355.34 Aligned_cols=254 Identities=18% Similarity=0.206 Sum_probs=197.7
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
...++|++.+.||+|+||+||+|++..+|+.||||++..... ...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~------------------------------ 52 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLH------------------------------ 52 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS---CCHHH------------------------------
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc---hhHHH------------------------------
Confidence 345789999999999999999999999999999998765321 11344
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+|+.+++.++|++++..+.
T Consensus 53 -------------------------------------------------------------~e~~~l~~l~~~~~i~~~~ 71 (296)
T 3uzp_A 53 -------------------------------------------------------------IESKIYKMMQGGVGIPTIR 71 (296)
T ss_dssp -------------------------------------------------------------HHHHHHHHHTTSTTCCCEE
T ss_pred -------------------------------------------------------------HHHHHHHHhhcCCCCCccc
Confidence 4555555555444333333
Q ss_pred -eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE---ccCCCEEEee
Q psy12305 248 -IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI---NERGELKLAD 323 (516)
Q Consensus 248 -~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkL~D 323 (516)
++......++||||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 72 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~D 151 (296)
T 3uzp_A 72 WCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECC
T ss_pred cccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEee
Confidence 335667789999999889999998777789999999999999999999999999999999999999 4889999999
Q ss_pred eccccccCCCCc-------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH---HHHHHHHH
Q psy12305 324 FGLARAKSVPTK-------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI---EDELRLIC 393 (516)
Q Consensus 324 FGla~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~---~~~~~~i~ 393 (516)
||+++....... ......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+... ...+..+.
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 152 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp CTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 999987553322 12456789999999999998888899999999999999999999986432 22222222
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....++. ...+..+++++.+||.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~---------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 232 EKKMSTPI---------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHSCH---------------------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccccCCch---------------------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 21111110 0112367899999999999999999999998875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=370.42 Aligned_cols=266 Identities=23% Similarity=0.268 Sum_probs=193.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++. ++.||||++.......
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~------------------------------------- 62 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS------------------------------------- 62 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHH-------------------------------------
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHH-------------------------------------
Confidence 4477999999999999999999875 8999999986432110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+|+.++++++||||++++++
T Consensus 63 --------------------------------------------------------~~~~~E~~~l~~l~hpniv~~~~~ 86 (322)
T 3soc_A 63 --------------------------------------------------------WQNEYEVYSLPGMKHENILQFIGA 86 (322)
T ss_dssp --------------------------------------------------------HHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHhcCCCCCchhhcce
Confidence 123346666777777777777777
Q ss_pred EeeCc----eeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC----------CcEeeecCCCCEEE
Q psy12305 249 IHTEK----CLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR----------RILHRDLKPQNLLI 313 (516)
Q Consensus 249 ~~~~~----~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~ivHrDlKp~NILl 313 (516)
+.... .+|+||||+++ +|.+++... .+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill 164 (322)
T 3soc_A 87 EKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL 164 (322)
T ss_dssp EEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE
T ss_pred eccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE
Confidence 76643 47999999985 999998763 499999999999999999999999 99999999999999
Q ss_pred ccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCC-----CCCCceeeehHHHHHHHHHcCCCCCCCCCHH
Q psy12305 314 NERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGS-----TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE 386 (516)
Q Consensus 314 ~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~-----~~~~~~d~~SlGvil~elltG~~pF~~~~~~ 386 (516)
+.++.+||+|||+|+....... .....+||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+....
T Consensus 165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~ 244 (322)
T 3soc_A 165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244 (322)
T ss_dssp CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence 9999999999999976543322 23346789999999999874 3344669999999999999999999875432
Q ss_pred HHHHHHHHhcCCCChhhhhh-c-ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 387 DELRLICSILGPPPDELKSK-L-EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 387 ~~~~~i~~~~~~~p~~~~~~-~-~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
............+....... . .....+..+. ...+...++++.+||.+||+.||++|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD-----YWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCG-----GGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hccchhhhhccCCchhhhhhhhhcccCCCCccc-----cccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 21111111122222111110 0 0000111000 0011123456999999999999999999999975
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=385.05 Aligned_cols=265 Identities=18% Similarity=0.185 Sum_probs=207.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-------CCcchhHHHHHHHHhcC---------CCCee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-------GAPCTAIREVSLLRELR---------HANIV 152 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-------~~~~~~~~E~~~l~~l~---------h~niv 152 (516)
..++|+++++||+|+||+||+|++ +|+.||||++...... .....+.+|+.+|++|+ |||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 357799999999999999999998 7899999999876422 22257889999999986 99999
Q ss_pred ecccccccceeeeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHH
Q psy12305 153 TLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS 232 (516)
Q Consensus 153 ~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~ 232 (516)
++++++...+
T Consensus 96 ~l~~~~~~~~---------------------------------------------------------------------- 105 (336)
T 2vuw_A 96 GLNSVHCVQG---------------------------------------------------------------------- 105 (336)
T ss_dssp CEEEEEEEES----------------------------------------------------------------------
T ss_pred hhcceeEecC----------------------------------------------------------------------
Confidence 9887542211
Q ss_pred HHHhccccceeeEeeeEee-------------CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-
Q psy12305 233 LLRELRHANIVTLHDIIHT-------------EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH- 297 (516)
Q Consensus 233 il~~l~HpnIv~l~~~~~~-------------~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH- 297 (516)
..||||++++++|.+ +..+|||||||++ ++++.+.+ ..+++..++.++.||+.||+|||
T Consensus 106 ----~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~ 179 (336)
T 2vuw_A 106 ----SYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAVAEA 179 (336)
T ss_dssp ----SCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ----CCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHH
Confidence 259999999999886 7899999999974 56666543 56899999999999999999999
Q ss_pred hCCcEeeecCCCCEEEccCC--------------------CEEEeeeccccccCCCCccccCCcccccccchhhccCCCC
Q psy12305 298 SRRILHRDLKPQNLLINERG--------------------ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE 357 (516)
Q Consensus 298 ~~~ivHrDlKp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 357 (516)
++||+||||||+|||++.++ .+||+|||+|+..... ..+||+.|+|||++.+..
T Consensus 180 ~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-----~~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-----IVVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----EEECCCCTTCSGGGCCCS-
T ss_pred hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----cEEEeecccChhhhcCCC-
Confidence 99999999999999999987 8999999999876432 347899999999998766
Q ss_pred CCceeeehHHHH-HHHHHcCCCCCCCCCH-HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHH
Q psy12305 358 YSTSIDMGVGCI-FHEMSSGRPLFPGSTI-EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALD 435 (516)
Q Consensus 358 ~~~~d~~SlGvi-l~elltG~~pF~~~~~-~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~d 435 (516)
+.++|+||+|++ .+++++|..||.+... ......+........ .. ....+..+++++++
T Consensus 254 ~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------~~-----~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKT--------------KC-----NTPAMKQIKRKIQE 314 (336)
T ss_dssp SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSS--------------CC-----CSHHHHHHHHHHHH
T ss_pred ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCc--------------cc-----chhhhhhcCHHHHH
Confidence 778999998776 8889999999954211 111122221110000 00 00011246789999
Q ss_pred HHHHccccCcCCCCCHHHHH-cCCCCC
Q psy12305 436 LVQKFLMYDAKQRISAANAM-RHPYFN 461 (516)
Q Consensus 436 Ll~~~L~~dP~~R~ta~e~l-~Hp~f~ 461 (516)
||.+||++| ||+|+| +||||+
T Consensus 315 li~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred HHHHHhccC-----CHHHHHhcCCCcC
Confidence 999999987 999999 999995
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=358.32 Aligned_cols=264 Identities=23% Similarity=0.393 Sum_probs=201.7
Q ss_pred cccEeeeeeeccccceEEEEEE----EcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~----~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
.++|+++++||+|+||+||+|+ +..+|+.||||++........
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------- 66 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--------------------------------- 66 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CC---------------------------------
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchh---------------------------------
Confidence 3559999999999999999999 567899999999865432221
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
...+.+|+.+++.++||||+++
T Consensus 67 ----------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 67 ----------------------------------------------------------IADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHTCCCTTBCCE
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHhCCCCCeeee
Confidence 1245567777777777777777
Q ss_pred eeeEeeC--ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 246 HDIIHTE--KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 246 ~~~~~~~--~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
++++... ..+++||||+++ +|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEEC
Confidence 7777665 668999999985 9999997777789999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 323 DFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 323 DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
|||+++....... ......||..|+|||++.+..++.++|+|||||++|+|++|..|+... ...+....++.
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~~~~~ 243 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP-----MALFLKMIGPT 243 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH-----HHHHHHHHCSC
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch-----hhHHhhccCCc
Confidence 9999987654332 234456788999999998888888899999999999999999987432 11222222222
Q ss_pred Chhhhh--hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 400 PDELKS--KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 400 p~~~~~--~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...... ...... .......|..+++++.+||.+||+.||.+|||++++++
T Consensus 244 ~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 244 HGQMTVTRLVNTLK-------EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp CGGGHHHHHHHHHH-------TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred ccccCHHHHHHHHh-------ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 221110 000000 11122245578999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=358.77 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=209.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++..+++.||||++.....
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------------------- 51 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------------------------------- 51 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---------------------------------------
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---------------------------------------
Confidence 45679999999999999999999999999999998854211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+++.++||||++++++
T Consensus 52 ------------------------------------------------------~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 52 ------------------------------------------------------EVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 11245678888888888888889999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+.++...|+||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 988889999999999 69999987643 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+........ ......+|+.|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+.......+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~--------- 228 (288)
T 3kfa_A 158 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------- 228 (288)
T ss_dssp GGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT---------
T ss_pred ceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc---------
Confidence 987553332 2334456889999999988888889999999999999999 99999887766555444321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....|..+++++.+||.+||..||.+|||++++++
T Consensus 229 ----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 229 ----------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 112234578899999999999999999999999875
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=374.40 Aligned_cols=251 Identities=21% Similarity=0.300 Sum_probs=196.8
Q ss_pred cccEeeeeeeccccceEEEEEEEc---CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSR---LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~---~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.++|.+.+.||+|+||+||+|++. .++..||||+++......
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------- 88 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK----------------------------------- 88 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHH-----------------------------------
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHH-----------------------------------
Confidence 467999999999999999999987 456779999886432110
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
....+.+|+.++++++||||++++
T Consensus 89 --------------------------------------------------------~~~~~~~E~~~l~~l~h~niv~~~ 112 (373)
T 2qol_A 89 --------------------------------------------------------QRRDFLGEASIMGQFDHPNIIRLE 112 (373)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHhCCCCCCCeEE
Confidence 112566788888888888899999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++......++||||++ ++|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 192 (373)
T 2qol_A 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFG 192 (373)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCc
Confidence 99988889999999997 69999998877789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 326 LARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 326 la~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+++....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |+.||.+.+..+....+....
T Consensus 193 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~----- 267 (373)
T 2qol_A 193 LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY----- 267 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE-----
T ss_pred cccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence 9987543221 1122245778999999988888889999999999999998 999999888776665553321
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..++.++.+||.+||+.||.+|||++++++
T Consensus 268 --------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 --------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp --------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 11223467899999999999999999999999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=356.91 Aligned_cols=254 Identities=22% Similarity=0.302 Sum_probs=206.4
Q ss_pred ccccEeeee-eeccccceEEEEEEEc--CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLD-KLGQGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~-~LG~G~fG~Vyka~~~--~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..++|.+++ .||+|+||+||+|.++ .+++.||||++........
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------- 53 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD--------------------------------- 53 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHH---------------------------------
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhH---------------------------------
Confidence 346688887 9999999999999864 4678899999865321111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
...+.+|+.+++.++||||+++
T Consensus 54 ----------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~ 75 (287)
T 1u59_A 54 ----------------------------------------------------------TEEMMREAQIMHQLDNPYIVRL 75 (287)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCE
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHhCCCCCEeEE
Confidence 1245677778888888888888
Q ss_pred eeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 246 HDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++++ ..+..++||||+++ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 76 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp EEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCC
T ss_pred EEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcc
Confidence 8888 44568999999985 899998877777999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 325 GLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 325 Gla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
|+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++ |+.||.+.+..+....+....
T Consensus 155 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~---- 230 (287)
T 1u59_A 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---- 230 (287)
T ss_dssp TTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC----
T ss_pred cceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC----
Confidence 99987643322 1233456899999999988788889999999999999998 999999877766655553211
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
....|..+++++.+||.+||..||.+|||+.++++|.+
T Consensus 231 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 231 ---------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred ---------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11234578999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=357.02 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=200.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCC---CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~---g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..++|.+.+.||+|+||+||+|++..+ +..||||.+........
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------- 56 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN--------------------------------- 56 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHH---------------------------------
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchH---------------------------------
Confidence 346799999999999999999997643 45699999865421111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
...+.+|+.+++.++||||+++
T Consensus 57 ----------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~ 78 (281)
T 3cc6_A 57 ----------------------------------------------------------KEKFMSEAVIMKNLDHPHIVKL 78 (281)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHHCCTTBCCE
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHhCCCCCcceE
Confidence 1245667777777778888888
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++++.+ +..|+||||++ ++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 79 ~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 79 IGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp EEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCC
T ss_pred EEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCcc
Confidence 887764 34689999998 5899999887777999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 325 GLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 325 Gla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|+++....... ......+|+.|+|||++.+..++.++|+|||||++|+|++ |+.||......+....+....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~------ 231 (281)
T 3cc6_A 158 GLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD------ 231 (281)
T ss_dssp CGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC------
T ss_pred CCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC------
Confidence 99986543221 2233456889999999988888888999999999999998 999998766665555443321
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....+..+++.+.+||.+||..||++|||+.+++++
T Consensus 232 -------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 232 -------------------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp -------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 112234678999999999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=385.99 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=208.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.++||+|+||+||+|++..++..||||++.....
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--------------------------------------- 258 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--------------------------------------- 258 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---------------------------------------
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---------------------------------------
Confidence 34679999999999999999999998899999998864321
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+|++++||||++++++
T Consensus 259 ------------------------------------------------------~~~~~~~E~~~l~~l~hpniv~l~~~ 284 (495)
T 1opk_A 259 ------------------------------------------------------EVEEFLKEAAVMKEIKHPNLVQLLGV 284 (495)
T ss_dssp ------------------------------------------------------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ------------------------------------------------------chHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 11246677888888888888888888
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+..+..+||||||++ |+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 285 ~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 364 (495)
T 1opk_A 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL 364 (495)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC
T ss_pred EecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc
Confidence 888888999999998 69999998643 5689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+..
T Consensus 365 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------- 434 (495)
T 1opk_A 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---------- 434 (495)
T ss_dssp EECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----------
T ss_pred ceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc----------
Confidence 987543322 2233456789999999988888889999999999999999 9999998776655544422
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
......|..+++++.+||.+||+.||.+|||+.++++
T Consensus 435 ---------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 ---------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 1122345578999999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.23 Aligned_cols=272 Identities=22% Similarity=0.258 Sum_probs=199.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|++.+.||+|+||+||+|++..+|+.||||++.........
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~------------------------------------ 51 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPV------------------------------------ 51 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCH------------------------------------
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchH------------------------------------
Confidence 36799999999999999999999999999999998654322221
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
..+.+|+.++++++||||+++++++
T Consensus 52 -------------------------------------------------------~~~~~E~~~l~~l~hpnIv~~~~~~ 76 (396)
T 4eut_A 52 -------------------------------------------------------DVQMREFEVLKKLNHKNIVKLFAIE 76 (396)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHhcCCCCCCeEEEee
Confidence 2345677777777777777777777
Q ss_pred eeCc--eeeEeeehhh-chHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE----ccCCCEE
Q psy12305 250 HTEK--CLTLVFEYLE-KDLKRYMDDCS--NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI----NERGELK 320 (516)
Q Consensus 250 ~~~~--~~~lV~E~~~-g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl----~~~~~vk 320 (516)
.... ..|+|||||+ ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 77 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 156 (396)
T 4eut_A 77 EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYK 156 (396)
T ss_dssp ECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEE
T ss_pred ccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEE
Confidence 6544 7899999998 58988887643 239999999999999999999999999999999999999 7778899
Q ss_pred EeeeccccccCCCCccccCCcccccccchhhccC--------CCCCCceeeehHHHHHHHHHcCCCCCCCC----CHHHH
Q psy12305 321 LADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLG--------STEYSTSIDMGVGCIFHEMSSGRPLFPGS----TIEDE 388 (516)
Q Consensus 321 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~d~~SlGvil~elltG~~pF~~~----~~~~~ 388 (516)
|+|||+|+..... ......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||.+. ...+.
T Consensus 157 L~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 157 LTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp ECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred EecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 9999999875432 23345679999999999864 34566889999999999999999999642 22333
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCC--CchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYP--SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+..+.. +.|+ ..+............ .........+..+++.+.+||.+||++||++|||++++++
T Consensus 236 ~~~~~~--~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 236 MYKIIT--GKPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHH--SCCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHHhc--CCCc-ccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 333332 3332 222111110000000 0000001112234567899999999999999999998753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=362.39 Aligned_cols=207 Identities=22% Similarity=0.402 Sum_probs=174.8
Q ss_pred hHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcC---------------CCCCHHHHHHHHHH
Q psy12305 226 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS---------------NILSMNNVKLFLFQ 288 (516)
Q Consensus 226 ~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~---------------~~l~~~~~~~i~~q 288 (516)
.+.+|+.+++.+ +||||+++++++..++.+|+||||+++ +|.+++.... ..+++..+..++.|
T Consensus 86 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~q 165 (334)
T 2pvf_A 86 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQ 165 (334)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHH
Confidence 566788888888 899999999999999999999999985 9999987653 24899999999999
Q ss_pred HHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehH
Q psy12305 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGV 366 (516)
Q Consensus 289 i~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~Sl 366 (516)
|+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|+|||
T Consensus 166 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 245 (334)
T 2pvf_A 166 LARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 245 (334)
T ss_dssp HHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHH
T ss_pred HHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHH
Confidence 99999999999999999999999999999999999999986543321 2233456889999999988888889999999
Q ss_pred HHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCc
Q psy12305 367 GCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDA 445 (516)
Q Consensus 367 Gvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP 445 (516)
||++|+|++ |..||.+....+....+.... ....+..+++++.+||.+||..||
T Consensus 246 G~il~ellt~g~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp 300 (334)
T 2pvf_A 246 GVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-------------------------RMDKPANCTNELYMMMRDCWHAVP 300 (334)
T ss_dssp HHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred HHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-------------------------CCCCCccCCHHHHHHHHHHccCCh
Confidence 999999999 999999888776665554321 112234788999999999999999
Q ss_pred CCCCCHHHHHcC
Q psy12305 446 KQRISAANAMRH 457 (516)
Q Consensus 446 ~~R~ta~e~l~H 457 (516)
.+|||+++++++
T Consensus 301 ~~Rps~~ell~~ 312 (334)
T 2pvf_A 301 SQRPTFKQLVED 312 (334)
T ss_dssp GGSCCHHHHHHH
T ss_pred hhCcCHHHHHHH
Confidence 999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=364.21 Aligned_cols=253 Identities=22% Similarity=0.355 Sum_probs=200.0
Q ss_pred cccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|++.+.||+|+||+||+|++. .+++.||||++.........
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~------------------------------- 74 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH------------------------------- 74 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHH-------------------------------
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHH-------------------------------
Confidence 477999999999999999999853 57789999998654221111
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-ccccee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIV 243 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 243 (516)
..+.+|+.+++++ +||||+
T Consensus 75 ------------------------------------------------------------~~~~~E~~~l~~l~~hp~iv 94 (316)
T 2xir_A 75 ------------------------------------------------------------RALMSELKILIHIGHHLNVV 94 (316)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHHHHCCCTTBC
T ss_pred ------------------------------------------------------------HHHHHHHHHHHhcccCCCee
Confidence 1345677777777 567777
Q ss_pred eEeeeEeeCc-eeeEeeehhh-chHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHhhCCcEeeec
Q psy12305 244 TLHDIIHTEK-CLTLVFEYLE-KDLKRYMDDCSNI---------------LSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306 (516)
Q Consensus 244 ~l~~~~~~~~-~~~lV~E~~~-g~L~~~l~~~~~~---------------l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl 306 (516)
++++++...+ .+++||||++ ++|.+++...... +++..+..++.||+.||.|||++||+||||
T Consensus 95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~di 174 (316)
T 2xir_A 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 174 (316)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccC
Confidence 7777776543 5889999998 4888888765432 889999999999999999999999999999
Q ss_pred CCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCC
Q psy12305 307 KPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGS 383 (516)
Q Consensus 307 Kp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~ 383 (516)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999976543222 2234567899999999988888889999999999999998 99999876
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
...+.+....... .....|..+++++.+||.+||+.||.+|||++++++|
T Consensus 255 ~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 255 KIDEEFCRRLKEG------------------------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CCSHHHHHHHHHT------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHHhccC------------------------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5444333322211 1112344678999999999999999999999999976
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=362.65 Aligned_cols=253 Identities=23% Similarity=0.302 Sum_probs=206.5
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEE--EEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLV--ALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~v--AvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
-..++|++.+.||+|+||+||+|++..+|..+ |||.+.......
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~---------------------------------- 67 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---------------------------------- 67 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------------------------------------
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchH----------------------------------
Confidence 44578999999999999999999999888865 888875422111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceee
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVT 244 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 244 (516)
....+.+|+.+++++ +||||++
T Consensus 68 ---------------------------------------------------------~~~~~~~E~~~l~~l~~hp~iv~ 90 (327)
T 1fvr_A 68 ---------------------------------------------------------DHRDFAGELEVLCKLGHHPNIIN 90 (327)
T ss_dssp -----------------------------------------------------------CHHHHHHHHHTTCCCCTTBCC
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHHhccCCCchhh
Confidence 112567788888888 8999999
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCC
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp 308 (516)
+++++.+++..|+||||++ ++|.+++.... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 170 (327)
T 1fvr_A 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAA 170 (327)
T ss_dssp EEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred hceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCcc
Confidence 9999999999999999997 59999887643 4699999999999999999999999999999999
Q ss_pred CCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHH
Q psy12305 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIED 387 (516)
Q Consensus 309 ~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~ 387 (516)
+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+
T Consensus 171 ~NIl~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 171 RNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp GGEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ceEEEcCCCeEEEcccCcCccccccc-cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH
Confidence 99999999999999999997533211 1223456889999999988888889999999999999998 999999887766
Q ss_pred HHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 388 ELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 388 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....+... .....+..+++++.+||.+||..||.+|||++++++|
T Consensus 250 ~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 250 LYEKLPQG-------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHGGGT-------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcC-------------------------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 55444221 1112344778999999999999999999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=366.70 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=206.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCc-----EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|.+.+.||+|+||+||+|++..+++ .||||.+.....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------------------------------- 89 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH----------------------------------- 89 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCC-----------------------------------
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccC-----------------------------------
Confidence 4779999999999999999999987664 688887754211
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-ccccee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIV 243 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv 243 (516)
......+.+|+.+++.+ +||||+
T Consensus 90 --------------------------------------------------------~~~~~~~~~E~~~l~~l~~h~~iv 113 (333)
T 2i1m_A 90 --------------------------------------------------------ADEKEALMSELKIMSHLGQHENIV 113 (333)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred --------------------------------------------------------hHHHHHHHHHHHHHHhhcCCCCee
Confidence 11123567899999999 899999
Q ss_pred eEeeeEeeCceeeEeeehhh-chHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCC
Q psy12305 244 TLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC-------------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309 (516)
Q Consensus 244 ~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~-------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~ 309 (516)
++++++..++.+|+||||++ ++|.+++... ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 114 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 193 (333)
T 2i1m_A 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAAR 193 (333)
T ss_dssp CEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccc
Confidence 99999999999999999998 4999888753 345899999999999999999999999999999999
Q ss_pred CEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHH
Q psy12305 310 NLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIE 386 (516)
Q Consensus 310 NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~ 386 (516)
|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|||++ |..||.+....
T Consensus 194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 99999999999999999986543222 2234567889999999988888889999999999999999 99999886655
Q ss_pred HHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 387 DELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 387 ~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
..+..+.... .....|...++++.+||.+||+.||.+|||++++++
T Consensus 274 ~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 274 SKFYKLVKDG------------------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHHT------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcC------------------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 4444433211 111224467899999999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=376.61 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=198.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++. |+.||||+++... ..
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~----------------------------------- 230 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TA----------------------------------- 230 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TS-----------------------------------
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HH-----------------------------------
Confidence 4578999999999999999999874 7899999886432 11
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
..+.+|+.+|++++||||++++++
T Consensus 231 --------------------------------------------------------~~~~~E~~~l~~l~h~niv~~~~~ 254 (450)
T 1k9a_A 231 --------------------------------------------------------QAFLAEASVMTQLRHSNLVQLLGV 254 (450)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHhccCCCEEEEEEE
Confidence 145566666667777777777777
Q ss_pred EeeCc-eeeEeeehhh-chHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 249 IHTEK-CLTLVFEYLE-KDLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 249 ~~~~~-~~~lV~E~~~-g~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+.... .+|+||||++ |+|.+++...+. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 255 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG 334 (450)
T 1k9a_A 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 334 (450)
T ss_dssp EECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCC
Confidence 65544 7899999998 599999987654 37999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+++..... .....+|+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+...
T Consensus 335 ~a~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~--------- 402 (450)
T 1k9a_A 335 LTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------- 402 (450)
T ss_dssp TCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT---------
T ss_pred Cccccccc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---------
Confidence 99854322 222356889999999998888899999999999999998 99999987666555544321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....|..+++++.+||.+||..||.+|||+.++++
T Consensus 403 ----------------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 403 ----------------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 122345578999999999999999999999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=355.77 Aligned_cols=262 Identities=21% Similarity=0.320 Sum_probs=207.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||.||+|++..+|+.||||++.... ..+.+|+.++++++||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 78 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDY------ 78 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEecccc------
Confidence 367999999999999999999999999999999997543 367789999999999999988876532110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
++.........
T Consensus 79 ---------------------------------------------------------------------~~~~~~~~~~~ 89 (284)
T 2a19_B 79 ---------------------------------------------------------------------DPETSSKNSSR 89 (284)
T ss_dssp ---------------------------------------------------------------------C---------C
T ss_pred ---------------------------------------------------------------------Ccccccccccc
Confidence 00000001112
Q ss_pred eeCceeeEeeehhhc-hHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLEK-DLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.....+++||||+++ +|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 169 (284)
T 2a19_B 90 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169 (284)
T ss_dssp CEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred cCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhh
Confidence 234568999999995 999998754 356999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+...... ......||+.|+|||++.+..+..++|+|||||++|+|++|..||... ......+.
T Consensus 170 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~-------------- 232 (284)
T 2a19_B 170 TSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR-------------- 232 (284)
T ss_dssp EESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH--------------
T ss_pred eeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh--------------
Confidence 8765332 334457899999999999888889999999999999999999887421 11111110
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....+..+++++.+||.+||..||.+|||+.++++|.|.-.
T Consensus 233 --------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 --------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------------TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 01123467889999999999999999999999999988643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=364.17 Aligned_cols=249 Identities=23% Similarity=0.308 Sum_probs=177.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|++.++||+|+||+||+|++..+|+.||||++...... ....
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~----------------------------------- 71 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEE-KNRA----------------------------------- 71 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHH-HHHH-----------------------------------
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchH-HHHH-----------------------------------
Confidence 4799999999999999999999999999999988543211 1113
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~ 249 (516)
+.+|+.+++++. ||||+++++++
T Consensus 72 --------------------------------------------------------~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 72 --------------------------------------------------------IIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHhccCCChhhccccc
Confidence 344555555553 55555555555
Q ss_pred --------eeCceeeEeeehhhchHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEccCC
Q psy12305 250 --------HTEKCLTLVFEYLEKDLKRYMDD--CSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLINERG 317 (516)
Q Consensus 250 --------~~~~~~~lV~E~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~~~~ 317 (516)
.....+++||||++|+|.+++.. ....+++..++.++.||+.||.|||++| |+||||||+|||++.++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~ 175 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG 175 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS
T ss_pred cccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC
Confidence 23456899999999999998865 3456999999999999999999999999 99999999999999999
Q ss_pred CEEEeeeccccccCCCCc------------cccCCcccccccchhhc---cCCCCCCceeeehHHHHHHHHHcCCCCCCC
Q psy12305 318 ELKLADFGLARAKSVPTK------------TFSNEVVTLWYRPPDVL---LGSTEYSTSIDMGVGCIFHEMSSGRPLFPG 382 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~------------~~~~~~gt~~y~APE~l---~~~~~~~~~d~~SlGvil~elltG~~pF~~ 382 (516)
.+||+|||+++....... .....+||+.|+|||++ .+..+..++|+|||||++|+|++|..||.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 999999999986543221 11144689999999998 455667789999999999999999999976
Q ss_pred CCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCC
Q psy12305 383 STIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459 (516)
Q Consensus 383 ~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~ 459 (516)
......... ......+...+..+.+||.+||+.||.+|||++|+++|-+
T Consensus 256 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 256 GAKLRIVNG----------------------------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp --------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hhHHHhhcC----------------------------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 433221110 1111123356788999999999999999999999998754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=378.02 Aligned_cols=254 Identities=20% Similarity=0.329 Sum_probs=204.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|.+.+.||+|+||+||+|++. ++..||||+++.... .
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~------------------------------------ 226 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--S------------------------------------ 226 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--C------------------------------------
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--c------------------------------------
Confidence 3467999999999999999999985 577899999864321 1
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+|++++||||++++++
T Consensus 227 -------------------------------------------------------~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 227 -------------------------------------------------------VEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 1245567777777777777777777
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+. ...+|+||||+. |+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 65 556899999998 59999987542 3589999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |+.||.+.+..+....+....
T Consensus 331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------- 402 (454)
T 1qcf_A 331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY-------- 402 (454)
T ss_dssp GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC--------
T ss_pred ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 987542211 1223346789999999988888889999999999999999 999999988877766664321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc--CCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR--HPYFNS 462 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~--Hp~f~~ 462 (516)
....|..+++++.+||.+||..||++|||++++++ ..++..
T Consensus 403 -----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 403 -----------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11234578899999999999999999999999875 444443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=356.50 Aligned_cols=256 Identities=19% Similarity=0.263 Sum_probs=197.2
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++.+.||+|+||+||+|++..+++.||||++........
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------- 75 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDP----------------------------------- 75 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSH-----------------------------------
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCH-----------------------------------
Confidence 456889999999999999999999999999999999865321110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
.....+.+|+.+++.++||||+++++
T Consensus 76 ------------------------------------------------------~~~~~~~~e~~~l~~l~hp~iv~~~~ 101 (309)
T 2h34_A 76 ------------------------------------------------------VFRTRMQREARTAGRLQEPHVVPIHD 101 (309)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 01125667889999999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++..++..|+||||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~ 180 (309)
T 2h34_A 102 FGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGI 180 (309)
T ss_dssp EEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC
T ss_pred EEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCcc
Confidence 99999999999999985 898888764 4599999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 327 ARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 327 a~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+....... .......||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.........+ .....+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~------ 253 (309)
T 2h34_A 181 ASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPR------ 253 (309)
T ss_dssp ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCC------
T ss_pred CccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCC------
Confidence 97654322 2234557899999999999888888999999999999999999999886654322222 211111
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-CHHHHHc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-SAANAMR 456 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-ta~e~l~ 456 (516)
....+..+++++.+||.+||+.||++|| |++++++
T Consensus 254 ----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 254 ----------------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ----------------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----------------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 1112347889999999999999999999 7877764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=365.47 Aligned_cols=264 Identities=22% Similarity=0.298 Sum_probs=201.7
Q ss_pred ccccEeeeeeeccccceEEEEEE----EcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~----~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
..++|++++.||+|+||+||+|+ +..+++.||||++.......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------------------------- 67 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--------------------------------- 67 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHH---------------------------------
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHH---------------------------------
Confidence 44679999999999999999999 56688999999886432110
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
...+.+|+.++++++||||++
T Consensus 68 -----------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~ 88 (327)
T 3lxl_A 68 -----------------------------------------------------------QRDFQREIQILKALHSDFIVK 88 (327)
T ss_dssp -----------------------------------------------------------HHHHHHHHHHHHTCCCTTBCC
T ss_pred -----------------------------------------------------------HHHHHHHHHHHHhcCCCceeE
Confidence 124566777777778888888
Q ss_pred EeeeEe--eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 245 LHDIIH--TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 245 l~~~~~--~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
+++++. ....+|+||||++ ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl 168 (327)
T 3lxl_A 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKI 168 (327)
T ss_dssp EEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred EEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEE
Confidence 877765 4567899999997 5899999876667999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 322 ADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 322 ~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||......... .......
T Consensus 169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~ 246 (327)
T 3lxl_A 169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERD 246 (327)
T ss_dssp CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----
T ss_pred cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hcccccc
Confidence 99999987643322 223446788999999998888888999999999999999999999754322111 0000000
Q ss_pred CC--hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 399 PP--DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 399 ~p--~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+ ........ .......+..+++++.+||.+||+.||.+|||++++++
T Consensus 247 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 247 VPALSRLLELLE----------EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp CCHHHHHHHHHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHhh----------cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 00001000 11122234578999999999999999999999999964
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=356.12 Aligned_cols=206 Identities=22% Similarity=0.352 Sum_probs=165.8
Q ss_pred hHHHHHHHHHhccccceeeEeeeE-eeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDII-HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.++++++||||+++++++ ..++..++||||+++ +|.+++......+++..+..++.||+.||+|||++||+|
T Consensus 72 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 151 (298)
T 3f66_A 72 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVH 151 (298)
T ss_dssp HHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 455677777777777777777764 445678999999985 999999877777999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCC----ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPT----KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRP 378 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~ 378 (516)
|||||+|||++.++.+||+|||+|+...... .......||+.|+|||++.+..++.++|+|||||++|+|++ |.+
T Consensus 152 ~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 231 (298)
T 3f66_A 152 RDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231 (298)
T ss_dssp SCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999997653221 12334467889999999988888889999999999999999 677
Q ss_pred CCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 379 LFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 379 pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
||.+.+..+....+.... ....|..+++++.+||.+||..||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 232 PYPDVNTFDITVYLLQGR-------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp SSTTSCTTTHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccCCHHHHHHHHhcCC-------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 887766555544443211 11234467899999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=353.40 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=198.3
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCc---EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~---~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.|.+.++||+|+||+||+|++..+++ .||||.+........
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~------------------------------------ 65 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQ------------------------------------ 65 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHH------------------------------------
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHH------------------------------------
Confidence 48888999999999999999876655 799999864322111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+++.++||||++++++
T Consensus 66 -------------------------------------------------------~~~~~~E~~~l~~l~h~~iv~~~~~ 90 (298)
T 3pls_A 66 -------------------------------------------------------VEAFLREGLLMRGLNHPNVLALIGI 90 (298)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 1245567777777777777777777
Q ss_pred EeeCcee-eEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCL-TLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~-~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+.+.+.. ++||||+. ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 91 ~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~ 170 (298)
T 3pls_A 91 MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGL 170 (298)
T ss_dssp ECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTS
T ss_pred EecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCC
Confidence 7665544 89999997 699999988777899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCC----CccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 327 ARAKSVP----TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 327 a~~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
++..... ........+|+.|+|||++.+..++.++|+|||||++|+|++ |.+||...+..+....+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~----- 245 (298)
T 3pls_A 171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR----- 245 (298)
T ss_dssp SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-----
T ss_pred cccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-----
Confidence 9754321 122334567899999999998888889999999999999999 556666665555444443211
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..+++++.+||.+||+.||.+|||++++++
T Consensus 246 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 --------------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp --------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11234467899999999999999999999999875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=360.09 Aligned_cols=207 Identities=21% Similarity=0.321 Sum_probs=171.4
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+++.++||||+++++++...+..++||||+++ +|.+++......+++..+..++.||+.||.|||++||+||
T Consensus 92 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 171 (333)
T 1mqb_A 92 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR 171 (333)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 567889999999999999999999999999999999985 9999998877789999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |..||
T Consensus 172 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 251 (333)
T 1mqb_A 172 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251 (333)
T ss_dssp CCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999986543221 1223345789999999988888889999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.+.+..+....+.... ....+..+++++.+||.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 252 WELSNHEVMKAINDGF-------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp TTCCHHHHHHHHHTTC-------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCCHHHHHHHHHCCC-------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9887776666554321 111234678999999999999999999999998864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=371.95 Aligned_cols=207 Identities=21% Similarity=0.337 Sum_probs=158.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEe-eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIH-TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.++++++||||+++++++. .++..++||||+++ +|.+++......+++..+..++.||+.||+|||++||+|
T Consensus 136 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 215 (373)
T 3c1x_A 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 215 (373)
T ss_dssp HHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 4556666666667777777777643 44578999999984 999999877777999999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCc----cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTK----TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRP 378 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~ 378 (516)
|||||+|||++.++.+||+|||+|+....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |.+
T Consensus 216 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~ 295 (373)
T 3c1x_A 216 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295 (373)
T ss_dssp SCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCC
Confidence 99999999999999999999999986532211 1233456889999999988888889999999999999999 788
Q ss_pred CCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 379 LFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 379 pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
||.+.+..+....+... .....|..+++.+.+||.+||..||++|||+++++++
T Consensus 296 p~~~~~~~~~~~~~~~~-------------------------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 296 PYPDVNTFDITVYLLQG-------------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp SCTTSCSSCHHHHHHTT-------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcC-------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99876554444433221 1112345788999999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=352.93 Aligned_cols=210 Identities=23% Similarity=0.327 Sum_probs=158.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.++++++||||++++++. .....++||||++ ++|.+++......+++..+..++.||+.||.|||++||+||
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~ 144 (289)
T 3og7_A 66 AFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144 (289)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 456788888888888888888854 5566899999998 58999987777789999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCC--CccccCCcccccccchhhcc---CCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVP--TKTFSNEVVTLWYRPPDVLL---GSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~APE~l~---~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
||||+|||++.++.+||+|||+++..... ........||+.|+|||++. +..++.++|+|||||++|+|++|+.|
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (289)
T 3og7_A 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224 (289)
T ss_dssp CCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999764421 22334457899999999986 45566688999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 380 FPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
|.+....+.+..+......++. ....+..+++++.+||.+||+.||.+|||++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 225 YSNINNRDQIIEMVGRGSLSPD--------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TSSCCCHHHHHHHHHHTSCCCC--------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHhcccccCcc--------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9886655555444332111110 00112367899999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=375.05 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=202.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.++||+|+||+||+|++.. +..||||+++.... .
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~------------------------------------ 222 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--S------------------------------------ 222 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--C------------------------------------
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--C------------------------------------
Confidence 34679999999999999999999864 56799998864321 1
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+|++++||||++++++
T Consensus 223 -------------------------------------------------------~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 223 -------------------------------------------------------PEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 1245566777777777777777777
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+.. +.+|+||||++ |+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 655 56899999998 5999998753 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |+.||.+.+..+.+..+....
T Consensus 327 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------- 398 (452)
T 1fmk_A 327 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------- 398 (452)
T ss_dssp TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred ceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 986543221 2223456789999999988888889999999999999999 999999988777666553321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc--CCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR--HPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~--Hp~f~~~~~~ 466 (516)
....|..+++++.+||.+||+.||++|||++++++ ..+|.+..++
T Consensus 399 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 399 -----------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 12234578899999999999999999999999986 5777665443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=388.40 Aligned_cols=209 Identities=22% Similarity=0.311 Sum_probs=168.2
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|++++||||+++++++.. +.+|+|||||+ |+|.+++......+++..+..++.||+.||+|||++||+||
T Consensus 382 ~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHr 460 (613)
T 2ozo_A 382 EMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460 (613)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcC
Confidence 45566777777777777777777765 45899999998 58999998777779999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcc---ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKT---FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.+||+|||+|+........ .....+|+.|+|||++.+..++.++|+|||||++|||++ |+.||
T Consensus 461 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 540 (613)
T 2ozo_A 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540 (613)
T ss_dssp CCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999875432221 122345689999999988888899999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH---cC
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM---RH 457 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l---~H 457 (516)
.+.+..+....+... .....|..+++++.+||.+||..||++|||+++++ ++
T Consensus 541 ~~~~~~~~~~~i~~~-------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 541 KKMKGPEVMAFIEQG-------------------------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTCCSHHHHHHHHTT-------------------------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHcC-------------------------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 998877766655431 11224557899999999999999999999999874 44
Q ss_pred CCC
Q psy12305 458 PYF 460 (516)
Q Consensus 458 p~f 460 (516)
.|+
T Consensus 596 ~~~ 598 (613)
T 2ozo_A 596 CYY 598 (613)
T ss_dssp HHH
T ss_pred HHH
Confidence 444
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=354.08 Aligned_cols=253 Identities=25% Similarity=0.329 Sum_probs=186.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++++.||+|+||+||+|++ +|+.||||++.... ...+.+|.+++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~----------------------- 56 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNT----------------------- 56 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHH-----------------------
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHH-----------------------
Confidence 357899999999999999999987 68999999985432 1122333333332
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
..++||||++++++
T Consensus 57 ------------------------------------------------------------------~~l~h~niv~~~~~ 70 (301)
T 3q4u_A 57 ------------------------------------------------------------------VMLRHENILGFIAS 70 (301)
T ss_dssp ------------------------------------------------------------------TCCCCTTBCCEEEE
T ss_pred ------------------------------------------------------------------hhccCcCeeeEEEe
Confidence 11456666666665
Q ss_pred Eee----CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--------hCCcEeeecCCCCEEEcc
Q psy12305 249 IHT----EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH--------SRRILHRDLKPQNLLINE 315 (516)
Q Consensus 249 ~~~----~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~ivHrDlKp~NILl~~ 315 (516)
+.. ...+|+||||++ ++|.+++.. ..+++..+..++.||+.||+||| ++||+||||||+|||++.
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~ 148 (301)
T 3q4u_A 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK 148 (301)
T ss_dssp EEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred eccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcC
Confidence 433 356899999998 499998854 46999999999999999999999 999999999999999999
Q ss_pred CCCEEEeeeccccccCCCCcc----ccCCcccccccchhhccCCC------CCCceeeehHHHHHHHHHcC---------
Q psy12305 316 RGELKLADFGLARAKSVPTKT----FSNEVVTLWYRPPDVLLGST------EYSTSIDMGVGCIFHEMSSG--------- 376 (516)
Q Consensus 316 ~~~vkL~DFGla~~~~~~~~~----~~~~~gt~~y~APE~l~~~~------~~~~~d~~SlGvil~elltG--------- 376 (516)
++.+||+|||+|+........ ....+||+.|+|||++.+.. ++.++|+|||||++|||++|
T Consensus 149 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~ 228 (301)
T 3q4u_A 149 NGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228 (301)
T ss_dssp TSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccc
Confidence 999999999999765433221 23447899999999998763 33578999999999999999
Q ss_pred -CCCCCCCC----HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCH
Q psy12305 377 -RPLFPGST----IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISA 451 (516)
Q Consensus 377 -~~pF~~~~----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta 451 (516)
..||.... ....+.......+..+ ..+ ....+...++++.+||.+||+.||.+|||+
T Consensus 229 ~~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 290 (301)
T 3q4u_A 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRP-------------NIP-----NRWFSDPTLTSLAKLMKECWYQNPSARLTA 290 (301)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCC-------------CCC-----GGGGGSHHHHHHHHHHHHHCCSSGGGSCCH
T ss_pred ccccccccCCCCcchhhhhHHHhccCCCC-------------CCC-----hhhccCccHHHHHHHHHHHhhcChhhCCCH
Confidence 88886532 1222222221111110 000 001112345789999999999999999999
Q ss_pred HHHHc
Q psy12305 452 ANAMR 456 (516)
Q Consensus 452 ~e~l~ 456 (516)
+++++
T Consensus 291 ~~i~~ 295 (301)
T 3q4u_A 291 LRIKK 295 (301)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=347.55 Aligned_cols=247 Identities=22% Similarity=0.359 Sum_probs=200.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||+||+|++. +++.||||.+..... .
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~------------------------------------- 51 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--S------------------------------------- 51 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--C-------------------------------------
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--c-------------------------------------
Confidence 467999999999999999999975 677899998864321 1
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+++.++||||+++++++
T Consensus 52 ------------------------------------------------------~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (279)
T 1qpc_A 52 ------------------------------------------------------PDAFLAEANLMKQLQHQRLVRLYAVV 77 (279)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 12455677777777777777777776
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
. .+..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 5 345889999997 58988886532 25999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--------- 227 (279)
T 1qpc_A 157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------- 227 (279)
T ss_dssp EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc---------
Confidence 87653322 2233456889999999988778888999999999999999 999999888776665553211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..+++++.+||.+||..||++|||++++++
T Consensus 228 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 ----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11234478899999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=371.74 Aligned_cols=263 Identities=17% Similarity=0.223 Sum_probs=205.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|+++++||+|+||+||+|++..+|+.||||++...... ..+
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~--------------------------------- 49 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQL--------------------------------- 49 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCH---------------------------------
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHH---------------------------------
Confidence 46799999999999999999999999999999987653221 123
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc-cceeeEeee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH-ANIVTLHDI 248 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~ 248 (516)
.+|+.+++.++| ++|..+..+
T Consensus 50 ----------------------------------------------------------~~E~~il~~L~~~~~i~~i~~~ 71 (483)
T 3sv0_A 50 ----------------------------------------------------------LYESKIYRILQGGTGIPNVRWF 71 (483)
T ss_dssp ----------------------------------------------------------HHHHHHHHHTTTSTTCCCEEEE
T ss_pred ----------------------------------------------------------HHHHHHHHHhcCCCCCCeEEEE
Confidence 445555555544 344445555
Q ss_pred EeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEE---ccCCCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLI---NERGELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl---~~~~~vkL~DFG 325 (516)
+......+|||||+.++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 72 ~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFG 151 (483)
T 3sv0_A 72 GVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (483)
T ss_dssp EEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCT
T ss_pred EeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCC
Confidence 66777889999999889999998777789999999999999999999999999999999999999 688999999999
Q ss_pred cccccCCCCc-------cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHh
Q psy12305 326 LARAKSVPTK-------TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI---EDELRLICSI 395 (516)
Q Consensus 326 la~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~---~~~~~~i~~~ 395 (516)
+|+....... .....+||+.|+|||++.+..+..++|+|||||+||||++|+.||.+... .+.+..+...
T Consensus 152 la~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (483)
T 3sv0_A 152 LAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (483)
T ss_dssp TCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH
T ss_pred cceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc
Confidence 9987553322 12356789999999999998888899999999999999999999987443 3333333221
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH----------cCCCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM----------RHPYFNSLGP 465 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l----------~Hp~f~~~~~ 465 (516)
....+ ....+..+++++.+||.+||..||++||++++++ .++|+..+.|
T Consensus 232 ~~~~~---------------------~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW 290 (483)
T 3sv0_A 232 KVATS---------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDW 290 (483)
T ss_dssp HHHSC---------------------HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHH
T ss_pred ccccc---------------------HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCc
Confidence 10000 0011136789999999999999999999998765 3788766554
Q ss_pred Cc
Q psy12305 466 QV 467 (516)
Q Consensus 466 ~~ 467 (516)
..
T Consensus 291 ~~ 292 (483)
T 3sv0_A 291 TI 292 (483)
T ss_dssp HH
T ss_pred hh
Confidence 43
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=364.03 Aligned_cols=268 Identities=22% Similarity=0.263 Sum_probs=201.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++. +|+.||||++......
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------------------------------------- 77 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ-------------------------------------- 77 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS--------------------------------------
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH--------------------------------------
Confidence 4578999999999999999999974 7899999987543110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+++.++||||++++++
T Consensus 78 ------------------------------------------------------~~~~~~~E~~~l~~l~h~~iv~~~~~ 103 (321)
T 2qkw_B 78 ------------------------------------------------------GIEEFETEIETLSFCRHPHLVSLIGF 103 (321)
T ss_dssp ------------------------------------------------------HHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 11245678888888888888888888
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCS---NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
+..++..++||||++ ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCC
T ss_pred EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeec
Confidence 888889999999998 58888776533 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 325 GLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 325 Gla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|+++...... .......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+....+....+... ..
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~-----~~ 258 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA-----VE 258 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHT-----HH
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHh-----hh
Confidence 9997643222 2233456899999999998888899999999999999999999999764332211110000 00
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp 458 (516)
....... ..... .......+...+..+.+|+.+||+.||++|||+.++++|-
T Consensus 259 ~~~~~~~--~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 259 SHNNGQL--EQIVD--PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHTTTCC--CSSSS--SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccccccH--HHhcC--hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 0000000 00000 0011111223456789999999999999999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=354.62 Aligned_cols=252 Identities=18% Similarity=0.286 Sum_probs=188.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcC---CCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRL---TDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~---~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
.++|.+.+.||+|+||+||+|++.. +++.||||++...... ....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~------------------------------- 81 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIE------------------------------- 81 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHH-------------------------------
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHH-------------------------------
Confidence 3679999999999999999998876 4568999988654221 1111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.+.+|+.++++++||||+++
T Consensus 82 ------------------------------------------------------------~~~~e~~~l~~l~h~~iv~~ 101 (313)
T 3brb_A 82 ------------------------------------------------------------EFLSEAACMKDFSHPNVIRL 101 (313)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHTCCCTTBCCC
T ss_pred ------------------------------------------------------------HHHHHHHHHhcCCCCCeeee
Confidence 34455555666666666666
Q ss_pred eeeEeeCc-----eeeEeeehhh-chHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc
Q psy12305 246 HDIIHTEK-----CLTLVFEYLE-KDLKRYMDD-----CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN 314 (516)
Q Consensus 246 ~~~~~~~~-----~~~lV~E~~~-g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 314 (516)
++++.... ..++||||++ ++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~ 181 (313)
T 3brb_A 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR 181 (313)
T ss_dssp CEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEEC
T ss_pred eEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 66555433 4699999999 488888853 235699999999999999999999999999999999999999
Q ss_pred cCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q psy12305 315 ERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRL 391 (516)
Q Consensus 315 ~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~ 391 (516)
.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|+|||||++|+|++ |.+||.+....+....
T Consensus 182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 261 (313)
T 3brb_A 182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDY 261 (313)
T ss_dssp TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH
Confidence 99999999999997654322 12233456889999999998888889999999999999999 9999988776665554
Q ss_pred HHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 392 ICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 392 i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+.... ....+..+++++.+||.+||..||.+|||+.++++|
T Consensus 262 ~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 262 LLHGH-------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHTTC-------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHcCC-------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 43211 112234788999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.98 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=201.1
Q ss_pred ccccEeeee-eeccccceEEEEEEE--cCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLD-KLGQGTYATVFKGKS--RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~-~LG~G~fG~Vyka~~--~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
..++|.+.+ .||+|+||+||+|.+ ..+++.||||++.......
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------- 59 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP---------------------------------- 59 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----C----------------------------------
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCH----------------------------------
Confidence 346799998 999999999999954 5567899999886432111
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.....+.+|+.+++.++||||+++
T Consensus 60 --------------------------------------------------------~~~~~~~~e~~~l~~l~h~~i~~~ 83 (291)
T 1xbb_A 60 --------------------------------------------------------ALKDELLAEANVMQQLDNPYIVRM 83 (291)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHhCCCCCEEEE
Confidence 011256678888888888888888
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
++++ ..+..++||||++ ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 84 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Df 161 (291)
T 1xbb_A 84 IGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDF 161 (291)
T ss_dssp EEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred EEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccC
Confidence 8888 5567899999998 5898888764 45999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcc---ccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 325 GLARAKSVPTKT---FSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 325 Gla~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
|+++........ .....+|+.|+|||++.+..++.++|+|||||++|+|++ |..||.+.+..+....+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~---- 237 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE---- 237 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC----
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----
Confidence 999876433221 222345789999999988778888999999999999999 999999887766555543211
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....|..+++++.+||.+||+.||.+|||+.++++
T Consensus 238 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 ---------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11234478899999999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=351.55 Aligned_cols=206 Identities=24% Similarity=0.318 Sum_probs=171.5
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.++++++||||+++++++..+. .++||||+. ++|.+++......+++..+..++.||+.||.|||++||+||
T Consensus 67 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 145 (291)
T 1u46_A 67 DFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 145 (291)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 5667888888888888888888887665 889999998 59999998776779999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|+|||||++|+|++ |..||
T Consensus 146 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 225 (291)
T 1u46_A 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225 (291)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999999987643322 1233456889999999988778888999999999999999 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+.+..+....+...... ...+..+++++.+||.+||..||.+|||+.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 226 IGLNGSQILHKIDKEGER------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTCCHHHHHHHHHTSCCC------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHccCCC------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 998877766655432111 1123478899999999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=374.82 Aligned_cols=272 Identities=15% Similarity=0.144 Sum_probs=200.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc--cCCcchhHHHHHHHHhcCC-CCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLRELRH-ANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 165 (516)
...+|...+.||+|+||+||+|++..+|+.||||++..... ....+.+.+|+.+++.++| +|+......+..-.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~--- 152 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF--- 152 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC---
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc---
Confidence 34569999999999999999999999999999999874433 2335578899999999987 55433322210000
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeE
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTL 245 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 245 (516)
.. . .+..++...+
T Consensus 153 -~~--------------------------------------------~----------------------~~~~~~~~~~ 165 (413)
T 3dzo_A 153 -PF--------------------------------------------D----------------------LVKDPQKKKM 165 (413)
T ss_dssp -CC--------------------------------------------E----------------------EEECCC----
T ss_pred -ch--------------------------------------------h----------------------hcccCCCCcc
Confidence 00 0 0011111112
Q ss_pred eeeEee-----CceeeEeeehhhchHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc
Q psy12305 246 HDIIHT-----EKCLTLVFEYLEKDLKRYMDD------CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN 314 (516)
Q Consensus 246 ~~~~~~-----~~~~~lV~E~~~g~L~~~l~~------~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~ 314 (516)
..++.. ....+++|+++.++|.+++.. .+..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~ 245 (413)
T 3dzo_A 166 IRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 245 (413)
T ss_dssp -----------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred ccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEe
Confidence 221111 234788999999988888742 234577888999999999999999999999999999999999
Q ss_pred cCCCEEEeeeccccccCCCCccccCCcccccccchhhc----------cCCCCCCceeeehHHHHHHHHHcCCCCCCCCC
Q psy12305 315 ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL----------LGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST 384 (516)
Q Consensus 315 ~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~~~d~~SlGvil~elltG~~pF~~~~ 384 (516)
.++.+||+|||+|+..... ....+| +.|+|||++ .+..++.++|+|||||++|||++|+.||.+.+
T Consensus 246 ~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~ 321 (413)
T 3dzo_A 246 QRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDA 321 (413)
T ss_dssp TTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTG
T ss_pred cCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 9999999999998765432 445677 999999999 55556778999999999999999999997754
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
..+.... .......+++++.+||.+||+.||++|||+.++++||||+.+.
T Consensus 322 ~~~~~~~------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 322 ALGGSEW------------------------------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp GGSCSGG------------------------------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred hhhhHHH------------------------------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 3211100 0111126789999999999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=355.80 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=189.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||+||+|++..+|+.||||++...... ...
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~----------------------------------- 71 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQ-DRE----------------------------------- 71 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHH-HHH-----------------------------------
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHH-HHH-----------------------------------
Confidence 46799999999999999999999999999999988653211 111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.+.+|+.+++.++||||+++++++
T Consensus 72 --------------------------------------------------------~~~~E~~~l~~l~h~~iv~~~~~~ 95 (317)
T 2buj_A 72 --------------------------------------------------------EAQREADMHRLFNHPNILRLVAYC 95 (317)
T ss_dssp --------------------------------------------------------HHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred --------------------------------------------------------HHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344566666666666666666665
Q ss_pred e----eCceeeEeeehhhc-hHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 250 H----TEKCLTLVFEYLEK-DLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 250 ~----~~~~~~lV~E~~~g-~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
. .....|+||||+.+ +|.+++.. .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl 175 (317)
T 2buj_A 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVL 175 (317)
T ss_dssp EEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEE
T ss_pred EeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEE
Confidence 4 23468999999995 88888876 3567999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCCc---------cccCCcccccccchhhccCCC---CCCceeeehHHHHHHHHHcCCCCCCCCCH--HH
Q psy12305 322 ADFGLARAKSVPTK---------TFSNEVVTLWYRPPDVLLGST---EYSTSIDMGVGCIFHEMSSGRPLFPGSTI--ED 387 (516)
Q Consensus 322 ~DFGla~~~~~~~~---------~~~~~~gt~~y~APE~l~~~~---~~~~~d~~SlGvil~elltG~~pF~~~~~--~~ 387 (516)
+|||+++....... ......||+.|+|||++.+.. +..++|+|||||++|+|++|+.||..... ..
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 99999875432111 112335699999999987654 57789999999999999999999953110 00
Q ss_pred HHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 388 ELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 388 ~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....+.. ......+..+++++.+||.+||+.||.+|||++++++|
T Consensus 256 ~~~~~~~-------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 256 VALAVQN-------------------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHHHHHC-------------------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHhhc-------------------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0011100 01111223678999999999999999999999999976
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=359.43 Aligned_cols=271 Identities=21% Similarity=0.284 Sum_probs=201.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++ .+|+.||||++.........
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~----------------------------------- 71 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGE----------------------------------- 71 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CC-----------------------------------
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHH-----------------------------------
Confidence 346799999999999999999986 47899999998654322211
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
..+.+|+.+++.++||||++++++
T Consensus 72 --------------------------------------------------------~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 72 --------------------------------------------------------LQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp --------------------------------------------------------CHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHhccCCCccceEEE
Confidence 145667777777788888888888
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CcEeeecCCCCEEEccCCCEEE
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCS---NILSMNNVKLFLFQLLRGLAYCHSR---RILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---~ivHrDlKp~NILl~~~~~vkL 321 (516)
+.++...++||||+++ +|.+++.... ..+++..+..++.||+.||+|||++ ||+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 8888889999999985 8988887643 3499999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHHh
Q psy12305 322 ADFGLARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGST-----IEDELRLICSI 395 (516)
Q Consensus 322 ~DFGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~-----~~~~~~~i~~~ 395 (516)
+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..||.... .......+...
T Consensus 176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99999987543322 2344568999999999988888889999999999999999999995210 00000000000
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.... ...... ........+...+.++.+|+.+||+.||.+|||+.++++|-.-..+
T Consensus 256 ~~~~-----------~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEK-----------KLEALV-DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSC-----------CSTTSS-CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhch-----------hhhhhc-ChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 0000 000000 0011111122345779999999999999999999999988765443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=347.01 Aligned_cols=244 Identities=24% Similarity=0.380 Sum_probs=190.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++ +|+.||||.+.... ..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~----------------------------------- 58 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TA----------------------------------- 58 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----------------------------------------
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HH-----------------------------------
Confidence 457899999999999999999987 48899999875321 11
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
..+.+|+.++++++||||++++++
T Consensus 59 --------------------------------------------------------~~~~~E~~~l~~l~h~~iv~~~~~ 82 (278)
T 1byg_A 59 --------------------------------------------------------QAFLAEASVMTQLRHSNLVQLLGV 82 (278)
T ss_dssp --------------------------------------------------------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHhCCCCCEeeEEEE
Confidence 145566677777777777777776
Q ss_pred Eee-CceeeEeeehhhc-hHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 249 IHT-EKCLTLVFEYLEK-DLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 249 ~~~-~~~~~lV~E~~~g-~L~~~l~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+.. .+..++||||+++ +|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg 162 (278)
T 1byg_A 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 162 (278)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecc
Confidence 543 3478999999985 99998876432 38999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+++..... .....+|+.|+|||++.+..++.++|+|||||++|+|++ |..||...+..+....+...
T Consensus 163 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~--------- 230 (278)
T 1byg_A 163 LTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------- 230 (278)
T ss_dssp C---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------
T ss_pred cccccccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC---------
Confidence 98765432 223356889999999988888889999999999999998 99999887665554443211
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.....+..+++.+.+||.+||..||.+|||+.++++
T Consensus 231 ----------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 ----------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ----------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 112234578899999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=378.10 Aligned_cols=258 Identities=24% Similarity=0.354 Sum_probs=207.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.++||+|+||+||+|++.. +..||||+++.... .
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~------------------------------------ 305 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--S------------------------------------ 305 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--C------------------------------------
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--C------------------------------------
Confidence 34679999999999999999999864 56799999865321 1
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+|++++||||++++++
T Consensus 306 -------------------------------------------------------~~~~~~E~~~l~~l~hpniv~~~~~ 330 (535)
T 2h8h_A 306 -------------------------------------------------------PEAFLQEAQVMKKLRHEKLVQLYAV 330 (535)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 1245566777777777777777777
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
+.. ..+||||||+. |+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 655 56899999998 5999998753 35699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
++...... .......+|..|+|||++.+..++.++|+|||||+||||++ |+.||.+....+.+..+....
T Consensus 410 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~-------- 481 (535)
T 2h8h_A 410 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------- 481 (535)
T ss_dssp TTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC--------
T ss_pred ceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 98654221 11223456789999999988888889999999999999999 999999988777666553221
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc--CCCCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR--HPYFNSLGPQ 466 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~--Hp~f~~~~~~ 466 (516)
....|..+++++.+||.+||..||++|||++++++ ..+|....++
T Consensus 482 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~~ 528 (535)
T 2h8h_A 482 -----------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 528 (535)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSCS
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCcc
Confidence 12234578899999999999999999999999986 3677665443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=348.36 Aligned_cols=242 Identities=26% Similarity=0.336 Sum_probs=184.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++. ++.||||++.... ..
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~----------------------------------- 45 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES---ER----------------------------------- 45 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT---HH-----------------------------------
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh---HH-----------------------------------
Confidence 4567999999999999999999974 7899999875321 11
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
..+.+|+.++++++||||++++++
T Consensus 46 --------------------------------------------------------~~~~~E~~~l~~l~hp~iv~~~~~ 69 (307)
T 2eva_A 46 --------------------------------------------------------KAFIVELRQLSRVNHPNIVKLYGA 69 (307)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHCCCTTBCCEEEB
T ss_pred --------------------------------------------------------HHHHHHHHHHhcCCCCCcCeEEEE
Confidence 134556666666666666666666
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhh---CCcEeeecCCCCEEEccCCC-EEE
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHS---RRILHRDLKPQNLLINERGE-LKL 321 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~---~~ivHrDlKp~NILl~~~~~-vkL 321 (516)
+.+ ..|+||||++ ++|.+++..... .+++..+..++.||+.||+|||+ +||+||||||+|||++.++. +||
T Consensus 70 ~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl 147 (307)
T 2eva_A 70 CLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKI 147 (307)
T ss_dssp CTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEE
T ss_pred EcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEE
Confidence 553 3789999998 589998876542 47889999999999999999999 89999999999999998887 799
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHhcCCC
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIE--DELRLICSILGPP 399 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~--~~~~~i~~~~~~~ 399 (516)
+|||++...... .....||+.|+|||++.+..++.++|+|||||++|||++|+.||...... .....+.. +.
T Consensus 148 ~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~- 221 (307)
T 2eva_A 148 CDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN--GT- 221 (307)
T ss_dssp CCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT--TC-
T ss_pred cccccccccccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc--CC-
Confidence 999999764322 23346899999999999888889999999999999999999999754322 11111111 11
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+..+++.+.+||.+||+.||.+|||++++++
T Consensus 222 ----------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 222 ----------------------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp ----------------------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11123467899999999999999999999999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=390.75 Aligned_cols=282 Identities=21% Similarity=0.265 Sum_probs=196.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|++.+.||+|+||+||+|++..+|+.||||++...........+.+|+.
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~-------------------------- 64 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQ-------------------------- 64 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHH--------------------------
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHH--------------------------
Confidence 345789999999999999999999999999999999865422222223444444
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+++.++||||+++++
T Consensus 65 -----------------------------------------------------------------iL~~L~HpnIV~l~~ 79 (676)
T 3qa8_A 65 -----------------------------------------------------------------IMKKLNHPNVVSARE 79 (676)
T ss_dssp -----------------------------------------------------------------HHHHCCBTTBCCEEE
T ss_pred -----------------------------------------------------------------HHHhCCCCCCCceee
Confidence 444555555555544
Q ss_pred eEee------CceeeEeeehhh-chHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCC
Q psy12305 248 IIHT------EKCLTLVFEYLE-KDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGE 318 (516)
Q Consensus 248 ~~~~------~~~~~lV~E~~~-g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~ 318 (516)
++.. ++..|+|||||+ ++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 80 v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~ 159 (676)
T 3qa8_A 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159 (676)
T ss_dssp CCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSS
T ss_pred eecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCC
Confidence 4433 567899999997 599998876442 5999999999999999999999999999999999999997765
Q ss_pred ---EEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHh
Q psy12305 319 ---LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSI 395 (516)
Q Consensus 319 ---vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~ 395 (516)
+||+|||+++..... ......+||+.|+|||++.+..++.++|+||+||++|+|++|..||.+.............
T Consensus 160 ~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~ 238 (676)
T 3qa8_A 160 RLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238 (676)
T ss_dssp SCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-
T ss_pred ceeEEEcccccccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhc
Confidence 999999999876533 2334568899999999999888899999999999999999999999875433221110000
Q ss_pred cCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 396 LGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 396 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.................+..........+..+++.+.+||.+||.+||.+|||++++++||||+.+
T Consensus 239 --~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 239 --KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp -------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred --ccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 000000000000000000000001111222466889999999999999999999999999999753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=361.44 Aligned_cols=243 Identities=16% Similarity=0.162 Sum_probs=190.8
Q ss_pred cccEeeeeeeccccceEEEEE-----EEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKG-----KSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka-----~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
-++|.+.+.||+|+||+||+| .+..+++.||||++.... .
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~------------------------------- 108 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----P------------------------------- 108 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----H-------------------------------
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----h-------------------------------
Confidence 367999999999999999999 466788899999875421 1
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc---ccc
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR---HAN 241 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~---Hpn 241 (516)
..+.+|+.+++.++ |+|
T Consensus 109 ------------------------------------------------------------~~~~~e~~~~~~l~~~~~~~ 128 (365)
T 3e7e_A 109 ------------------------------------------------------------WEFYIGTQLMERLKPSMQHM 128 (365)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHHHSCGGGGGG
T ss_pred ------------------------------------------------------------hHHHHHHHHHHHhhhhhhhh
Confidence 13344555555554 899
Q ss_pred eeeEeeeEeeCceeeEeeehhh-chHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-
Q psy12305 242 IVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDD----CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE- 315 (516)
Q Consensus 242 Iv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~- 315 (516)
|+++++++..++..|+|||||+ |+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 129 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~ 208 (365)
T 3e7e_A 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208 (365)
T ss_dssp BCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGG
T ss_pred hhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEeccc
Confidence 9999999999999999999998 689998875 3456999999999999999999999999999999999999998
Q ss_pred ----------CCCEEEeeeccccccC--CCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC
Q psy12305 316 ----------RGELKLADFGLARAKS--VPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS 383 (516)
Q Consensus 316 ----------~~~vkL~DFGla~~~~--~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~ 383 (516)
++.+||+|||+|+... .........+||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 209 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp GTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred ccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 8999999999997543 2233455678999999999999988899999999999999999999999643
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.... ...... ......++.+.+++.+||+.+|.+|++..+.+.+
T Consensus 289 ~~~~---------------------~~~~~~---------~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 289 EGGE---------------------CKPEGL---------FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp ETTE---------------------EEECSC---------CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CCCc---------------------eeechh---------ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 2100 000000 0011235678999999999999999765554443
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=349.31 Aligned_cols=239 Identities=25% Similarity=0.347 Sum_probs=182.1
Q ss_pred cccccEeee-eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~-~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|.++ +.||+|+||+||+|++..+|+.||||++... ..+
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~------------------------------ 57 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKA------------------------------ 57 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHH------------------------------
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHH------------------------------
Confidence 456789998 7799999999999999999999999988532 123
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHH-HhccccceeeE
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLL-RELRHANIVTL 245 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l 245 (516)
.+|+.++ +.++||||+++
T Consensus 58 -------------------------------------------------------------~~e~~~~~~~~~h~~i~~~ 76 (299)
T 3m2w_A 58 -------------------------------------------------------------RREVELHWRASQCPHIVRI 76 (299)
T ss_dssp -------------------------------------------------------------HHHHHHHHHHTTSTTBCCE
T ss_pred -------------------------------------------------------------HHHHHHHHHhccCCCchhH
Confidence 3455554 33466677777
Q ss_pred eeeEee----CceeeEeeehhhc-hHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc---C
Q psy12305 246 HDIIHT----EKCLTLVFEYLEK-DLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE---R 316 (516)
Q Consensus 246 ~~~~~~----~~~~~lV~E~~~g-~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---~ 316 (516)
++++.. +..+|+||||+++ +|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 156 (299)
T 3m2w_A 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 156 (299)
T ss_dssp EEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTT
T ss_pred HhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCC
Confidence 776665 6779999999985 9999998754 46999999999999999999999999999999999999998 7
Q ss_pred CCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc
Q psy12305 317 GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396 (516)
Q Consensus 317 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~ 396 (516)
+.+||+|||+|.... +..++.++|+|||||++|||++|..||.+.........+..
T Consensus 157 ~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-- 212 (299)
T 3m2w_A 157 AILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-- 212 (299)
T ss_dssp CCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC--
T ss_pred CcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH--
Confidence 889999999986432 12355678999999999999999999977543321100000
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.. ..... .........+++++.+||.+||+.||.+|||++|+++||||...
T Consensus 213 ---------~~---~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 213 ---------RI---RMGQY----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp ---------SS---CTTCC----SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred ---------HH---hhccc----cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 00 00000 00000113678999999999999999999999999999999764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=351.92 Aligned_cols=217 Identities=22% Similarity=0.342 Sum_probs=168.9
Q ss_pred hHHHHHHHHHhccccceeeEeeeEee--CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+++.++||||+++++++.+ ...+++||||+++ +|.+++... .+++..+..++.||+.||.|||++||+
T Consensus 79 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~iv 156 (318)
T 3lxp_A 79 GWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYI 156 (318)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 56789999999999999999999987 4688999999984 898888764 499999999999999999999999999
Q ss_pred eeecCCCCEEEccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 303 HrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 157 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p 236 (318)
T 3lxp_A 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDS 236 (318)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCG
T ss_pred CCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCc
Confidence 999999999999999999999999987654322 22344678899999999888888889999999999999999999
Q ss_pred CCCCCHHHHHHHHHHhcCCCChhhh--hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 380 FPGSTIEDELRLICSILGPPPDELK--SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 380 F~~~~~~~~~~~i~~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
|....... . ...+....... ....... .......+..+++++.+||.+||+.||.+|||++++++
T Consensus 237 ~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 237 SQSPPTKF--L---ELIGIAQGQMTVLRLTELLE-------RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp GGSHHHHH--H---HHHCSCCHHHHHHHHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccchhh--h---hhhcccccchhHHHHHHHHh-------cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 97532211 0 00011100000 0000000 11122334578899999999999999999999999984
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=350.58 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=187.6
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|++. |+.||||++..... .
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~----~---------------------------------- 74 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE----A---------------------------------- 74 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH----H----------------------------------
T ss_pred cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc----c----------------------------------
Confidence 3478999999999999999999974 89999998854311 1
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHh--ccccceeeEe
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE--LRHANIVTLH 246 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~ 246 (516)
...+|..++.. ++||||++++
T Consensus 75 ---------------------------------------------------------~~~~e~~~~~~~~~~h~~i~~~~ 97 (337)
T 3mdy_A 75 ---------------------------------------------------------SWFRETEIYQTVLMRHENILGFI 97 (337)
T ss_dssp ---------------------------------------------------------HHHHHHHHHTSTTCCCTTBCCEE
T ss_pred ---------------------------------------------------------hhhhHHHHHHHHhhcCCCeeeEE
Confidence 12233333333 3777888888
Q ss_pred eeEeeC----ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC--------CcEeeecCCCCEEE
Q psy12305 247 DIIHTE----KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR--------RILHRDLKPQNLLI 313 (516)
Q Consensus 247 ~~~~~~----~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~ivHrDlKp~NILl 313 (516)
+++... ..+|+||||+++ +|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||+
T Consensus 98 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill 175 (337)
T 3mdy_A 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175 (337)
T ss_dssp EEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE
T ss_pred EEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE
Confidence 777766 679999999985 999998764 599999999999999999999998 99999999999999
Q ss_pred ccCCCEEEeeeccccccCCCCcc----ccCCcccccccchhhccCCCCCCc------eeeehHHHHHHHHHcC-------
Q psy12305 314 NERGELKLADFGLARAKSVPTKT----FSNEVVTLWYRPPDVLLGSTEYST------SIDMGVGCIFHEMSSG------- 376 (516)
Q Consensus 314 ~~~~~vkL~DFGla~~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~------~d~~SlGvil~elltG------- 376 (516)
+.++.+||+|||+|+........ ....+||+.|+|||++.+...... +|+|||||++|||++|
T Consensus 176 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~ 255 (337)
T 3mdy_A 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIV 255 (337)
T ss_dssp CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccc
Confidence 99999999999999765433221 234579999999999988766655 8999999999999999
Q ss_pred ---CCCCCCCC----HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC
Q psy12305 377 ---RPLFPGST----IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI 449 (516)
Q Consensus 377 ---~~pF~~~~----~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ 449 (516)
..||.... .............. .+..+ ....+..+++++.+||.+||+.||.+||
T Consensus 256 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rp 317 (337)
T 3mdy_A 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKL-------------RPSFP-----NRWSSDECLRQMGKLMTECWAHNPASRL 317 (337)
T ss_dssp CCCCCTTTTTSCSSCCHHHHHHHHTTSCC-------------CCCCC-----GGGGGSHHHHHHHHHHHHHSCSSGGGSC
T ss_pred ccccccHhhhcCCCCchhhhHHHHhhhcc-------------Ccccc-----ccchhhHHHHHHHHHHHHhhhhChhhCC
Confidence 66665421 11112111111000 00000 0011124567799999999999999999
Q ss_pred CHHHHHcC
Q psy12305 450 SAANAMRH 457 (516)
Q Consensus 450 ta~e~l~H 457 (516)
|++++++|
T Consensus 318 s~~ell~~ 325 (337)
T 3mdy_A 318 TALRVKKT 325 (337)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=379.51 Aligned_cols=204 Identities=21% Similarity=0.295 Sum_probs=167.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|++++|||||++++++.. +..++|||||+ |+|.+++... ..+++..++.++.||+.||+|||++||+||
T Consensus 416 ~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~iiHr 493 (635)
T 4fl3_A 416 ELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHR 493 (635)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeCC
Confidence 56677778888888888888887764 45789999998 5898888654 569999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.+||+|||+|+....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |+.||
T Consensus 494 DLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 573 (635)
T 4fl3_A 494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573 (635)
T ss_dssp CCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987643322 2233356789999999988888889999999999999998 99999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+.+..+....+.... ....|..+++++.+||.+||..||++|||++++++
T Consensus 574 ~~~~~~~~~~~i~~~~-------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 574 RGMKGSEVTAMLEKGE-------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TTCCHHHHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCC-------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 9988877666654321 12234578999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=350.05 Aligned_cols=220 Identities=21% Similarity=0.230 Sum_probs=168.7
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCCcE
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDC--SNILSMNNVKLFLFQLLRGLAYCHSRRIL 302 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~iv 302 (516)
.+.+|+.+++.++||||+++++++.+.+..++||||++ ++|.+++... ...+++..+..++.||+.||.|||++||+
T Consensus 76 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 155 (307)
T 2nru_A 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155 (307)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence 56788888999999999999999999999999999997 5898888743 34699999999999999999999999999
Q ss_pred eeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCC
Q psy12305 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLF 380 (516)
Q Consensus 303 HrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF 380 (516)
||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+ .++.++|+|||||++|+|++|.+||
T Consensus 156 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999999986543222 2334578999999999876 4778899999999999999999999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
.+......+..+..........+..... +. ....+...++.+.+|+.+||..||.+|||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 235 DEHREPQLLLDIKEEIEDEEKTIEDYID----KK-------MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CTTBSSSBTTHHHHHHHTTSCCHHHHSC----SS-------CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ccCcchHHHHHHHHHhhhhhhhhhhhcc----cc-------ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8754333222222211111100100000 00 000112345678999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=359.51 Aligned_cols=274 Identities=23% Similarity=0.312 Sum_probs=186.2
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
-.+++|++++.||+|+||+||+|++ +|+.||||++..... ..+..|.
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~--------------------------- 56 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEK--------------------------- 56 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHH---------------------------
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHH---------------------------
Confidence 3567899999999999999999976 689999999864321 1122222
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
|+..+..++||||+++++
T Consensus 57 --------------------------------------------------------------~~~~~~~~~h~~i~~~~~ 74 (336)
T 3g2f_A 57 --------------------------------------------------------------NIYRVPLMEHDNIARFIV 74 (336)
T ss_dssp --------------------------------------------------------------HHHTSTTCCCTTBCCEEE
T ss_pred --------------------------------------------------------------HHHHHHhccCcchhhhee
Confidence 222233355666666655
Q ss_pred eEe-----eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---------CcEeeecCCCCEE
Q psy12305 248 IIH-----TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR---------RILHRDLKPQNLL 312 (516)
Q Consensus 248 ~~~-----~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~ivHrDlKp~NIL 312 (516)
.+. ....+|+|||||+ |+|.+++.... .++..+..++.||+.||+|||++ ||+||||||+|||
T Consensus 75 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil 152 (336)
T 3g2f_A 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152 (336)
T ss_dssp EEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred cccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence 332 2346789999997 59999987643 58899999999999999999999 9999999999999
Q ss_pred EccCCCEEEeeeccccccCCC--------CccccCCcccccccchhhccC-------CCCCCceeeehHHHHHHHHHcCC
Q psy12305 313 INERGELKLADFGLARAKSVP--------TKTFSNEVVTLWYRPPDVLLG-------STEYSTSIDMGVGCIFHEMSSGR 377 (516)
Q Consensus 313 l~~~~~vkL~DFGla~~~~~~--------~~~~~~~~gt~~y~APE~l~~-------~~~~~~~d~~SlGvil~elltG~ 377 (516)
++.++.+||+|||+|+..... .......+||+.|+|||++.+ ..++.++|+|||||++|||++|.
T Consensus 153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~ 232 (336)
T 3g2f_A 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232 (336)
T ss_dssp ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence 999999999999999765422 122234578999999999987 33445789999999999999996
Q ss_pred CCC-CCCCHHHHHHHHHHhcCC-CChhhhhhc-c-cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHH
Q psy12305 378 PLF-PGSTIEDELRLICSILGP-PPDELKSKL-E-FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAAN 453 (516)
Q Consensus 378 ~pF-~~~~~~~~~~~i~~~~~~-~p~~~~~~~-~-~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e 453 (516)
.|| ++....+....+....+. +..+..... . ....+..+. ........++++.+||.+||+.||++|||++|
T Consensus 233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----ccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 555 433221111111111111 111111000 0 000111100 00001123457999999999999999999999
Q ss_pred H------HcCCCCCC
Q psy12305 454 A------MRHPYFNS 462 (516)
Q Consensus 454 ~------l~Hp~f~~ 462 (516)
+ +.++|-++
T Consensus 309 ~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 309 AEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHHHCCCC-
T ss_pred HHHHHHHHHHHHHhc
Confidence 9 45788654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.96 Aligned_cols=264 Identities=21% Similarity=0.331 Sum_probs=198.4
Q ss_pred ccccEeeeeeeccccceEEEEEE----EcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGK----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~----~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
..++|++++.||+|+||.||+|+ +..+|+.||||++......
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------------------- 84 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE---------------------------------- 84 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSH----------------------------------
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHH----------------------------------
Confidence 44679999999999999999999 4568899999988643110
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
....+.+|+.+++.++||||++
T Consensus 85 ----------------------------------------------------------~~~~~~~E~~~l~~l~h~~iv~ 106 (326)
T 2w1i_A 85 ----------------------------------------------------------HLRDFEREIEILKSLQHDNIVK 106 (326)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHTCCCTTBCC
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHHhCCCCCeee
Confidence 0124556777777777777777
Q ss_pred EeeeEeeC--ceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 245 LHDIIHTE--KCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 245 l~~~~~~~--~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
+++++... ..+++||||++ ++|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 107 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL 186 (326)
T 2w1i_A 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKI 186 (326)
T ss_dssp EEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEE
T ss_pred EEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEE
Confidence 77776543 37899999998 4999999887777999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCC
Q psy12305 322 ADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGP 398 (516)
Q Consensus 322 ~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~ 398 (516)
+|||+++....... ......+|..|+|||++.+..++.++|+|||||++|||++|..||.... .. +....+.
T Consensus 187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~--~~---~~~~~~~ 261 (326)
T 2w1i_A 187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP--AE---FMRMIGN 261 (326)
T ss_dssp CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH--HH---HHHHHCT
T ss_pred ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH--HH---HHHhhcc
Confidence 99999987653322 1223456888999999988878888999999999999999999986421 11 1111121
Q ss_pred CCh-hhh-h-hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 399 PPD-ELK-S-KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 399 ~p~-~~~-~-~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+. ... . ...... .......|..+++++.+||.+||+.||++|||+.++++
T Consensus 262 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 262 DKQGQMIVFHLIELLK-------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp TCCTHHHHHHHHHHHH-------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccchhhhHHHHHHHhh-------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 000 0 000000 00112234578899999999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.52 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=196.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.+.||+|+||+||+|++. ..||||++........
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~---~~~avk~~~~~~~~~~------------------------------------ 71 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWH---GEVAIRLIDIERDNED------------------------------------ 71 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEES---SSEEEEECCCCSCCCC------------------------------------
T ss_pred CHHHeEEeeEeccCCceEEEEEEEc---CeEEEEEeecCCCCHH------------------------------------
Confidence 4577999999999999999999985 3599999865432111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.++++++||||++++++
T Consensus 72 ------------------------------------------------------~~~~~~~e~~~l~~l~h~~iv~~~~~ 97 (319)
T 2y4i_B 72 ------------------------------------------------------QLKAFKREVMAYRQTRHENVVLFMGA 97 (319)
T ss_dssp ------------------------------------------------------CCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence 01123356667777788888888888
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+...+++||||++ ++|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++ ++.+||+|||++
T Consensus 98 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred EecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCc
Confidence 888888999999998 589999887666799999999999999999999999999999999999998 789999999998
Q ss_pred cccCC-----CCccccCCcccccccchhhccC---------CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q psy12305 328 RAKSV-----PTKTFSNEVVTLWYRPPDVLLG---------STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLIC 393 (516)
Q Consensus 328 ~~~~~-----~~~~~~~~~gt~~y~APE~l~~---------~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~ 393 (516)
+.... .........||+.|+|||++.+ ..++.++|+|||||++|||++|..||.+.........+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 256 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG 256 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHH
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc
Confidence 75431 1122334568999999999875 235667899999999999999999999888776665553
Q ss_pred HhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 394 SILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 394 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....+ ...+..++.++.+||.+||..||.+|||++++++
T Consensus 257 ~~~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 257 TGMKP------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TTCCC------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred cCCCC------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 32111 0112257789999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=381.03 Aligned_cols=250 Identities=24% Similarity=0.299 Sum_probs=202.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCC---CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLT---DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~---g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.++|++.+.||+|+||+||+|++..+ +..||||++........
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------- 434 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV---------------------------------- 434 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHH----------------------------------
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHH----------------------------------
Confidence 46799999999999999999998754 46799998764321111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
...+.+|+.++++++||||++++
T Consensus 435 ---------------------------------------------------------~~~~~~E~~~l~~l~HpnIv~l~ 457 (656)
T 2j0j_A 435 ---------------------------------------------------------REKFLQEALTMRQFDHPHIVKLI 457 (656)
T ss_dssp ---------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ---------------------------------------------------------HHHHHHHHHHHHhCCCCCCCeEE
Confidence 12456777777888888888888
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++. ++..|+||||++ |+|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 458 ~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 458 GVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp EEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred EEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecC
Confidence 8774 456899999998 69999998776679999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 326 LARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 326 la~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
+|+....... ......+|+.|+|||++.+..++.++|+|||||++|||++ |.+||.+....+.+..+....
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~------- 609 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE------- 609 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-------
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-------
Confidence 9986543222 2223456789999999988888889999999999999997 999999988877766664321
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
....|..+++++.+||.+||..||.+|||+.++++
T Consensus 610 ------------------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 610 ------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11234578899999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=344.07 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=189.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|++ +|+.||||++.... ..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~----------------------------------- 79 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ER----------------------------------- 79 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG----HH-----------------------------------
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh----HH-----------------------------------
Confidence 46799999999999999999997 58999999885321 11
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHh--ccccceeeEee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRE--LRHANIVTLHD 247 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~--l~HpnIv~l~~ 247 (516)
.+.+|+.++.. ++||||+++++
T Consensus 80 --------------------------------------------------------~~~~e~~~~~~~~l~h~ni~~~~~ 103 (342)
T 1b6c_B 80 --------------------------------------------------------SWFREAEIYQTVMLRHENILGFIA 103 (342)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHSCCCCTTBCCEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHhhcCCCcEEEEEe
Confidence 23445555555 56777777777
Q ss_pred eEeeCc----eeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--------hCCcEeeecCCCCEEEc
Q psy12305 248 IIHTEK----CLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH--------SRRILHRDLKPQNLLIN 314 (516)
Q Consensus 248 ~~~~~~----~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~ivHrDlKp~NILl~ 314 (516)
++.... .+|+||||+++ +|.+++... .+++..+..++.||+.||.||| ++||+||||||+|||++
T Consensus 104 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181 (342)
T ss_dssp EEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEEC
T ss_pred eecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEEC
Confidence 776654 78999999995 999998763 5999999999999999999999 89999999999999999
Q ss_pred cCCCEEEeeeccccccCCCCc----cccCCcccccccchhhccCCCCC------CceeeehHHHHHHHHHcC--------
Q psy12305 315 ERGELKLADFGLARAKSVPTK----TFSNEVVTLWYRPPDVLLGSTEY------STSIDMGVGCIFHEMSSG-------- 376 (516)
Q Consensus 315 ~~~~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~------~~~d~~SlGvil~elltG-------- 376 (516)
.++.+||+|||+++....... ......||+.|+|||++.+.... .++|+|||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 999999999999976554332 23455789999999999775322 468999999999999999
Q ss_pred --CCCCCCCCH----HHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC
Q psy12305 377 --RPLFPGSTI----EDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS 450 (516)
Q Consensus 377 --~~pF~~~~~----~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t 450 (516)
..||..... .+.+......... .+..+. .......++.+.+||.+||+.||++|||
T Consensus 262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps 323 (342)
T 1b6c_B 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKL-------------RPNIPN-----RWQSCEALRVMAKIMRECWYANGAARLT 323 (342)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCC-------------CCCCCG-----GGGTSHHHHHHHHHHHHHCCSSGGGSCC
T ss_pred ccccCccccCcCcccHHHHHHHHHHHHh-------------CCCCcc-----cccchhHHHHHHHHHHHHhccChhhCCC
Confidence 778865321 1222211110000 000000 0011134467899999999999999999
Q ss_pred HHHHHcC
Q psy12305 451 AANAMRH 457 (516)
Q Consensus 451 a~e~l~H 457 (516)
++++++|
T Consensus 324 ~~~i~~~ 330 (342)
T 1b6c_B 324 ALRIKKT 330 (342)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=328.63 Aligned_cols=226 Identities=15% Similarity=0.097 Sum_probs=177.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|++..+|+.||||++........
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~-------------------------------------- 72 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPD-------------------------------------- 72 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCH--------------------------------------
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCH--------------------------------------
Confidence 679999999999999999999999999999999865422110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.++++++||||+++++++.
T Consensus 73 ---------------------------------------------------~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 73 ---------------------------------------------------DVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 01125677888888999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.++..|+||||++ ++|.+++.. + .....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~---- 174 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA---- 174 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----
T ss_pred ECCcEEEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----
Confidence 9999999999998 588888854 2 4566788899999999999999999999999999999999999998554
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-hcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICS-ILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~-~~~~~p~~~~~~~~ 408 (516)
|++| ++.++|+|||||++|||++|+.||.+.+..+.+..... ..+.
T Consensus 175 ----------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~---------- 221 (286)
T 3uqc_A 175 ----------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ---------- 221 (286)
T ss_dssp ----------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSC----------
T ss_pred ----------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccC----------
Confidence 3332 56788999999999999999999987543211100000 0000
Q ss_pred cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 409 FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 409 ~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.......+..+++++.+||.+||+.||.+| |++++++
T Consensus 222 ----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 222 ----------PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ----------BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ----------CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 000011223788999999999999999999 9999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=371.88 Aligned_cols=239 Identities=22% Similarity=0.313 Sum_probs=188.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcC-CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRL-TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~-~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++|++.+.||+|+||+||+|++.. +|+.||||++........
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~------------------------------------- 122 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEA------------------------------------- 122 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHH-------------------------------------
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHH-------------------------------------
Confidence 789999999999999999999976 789999998754321111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.++++++||||+++++++
T Consensus 123 ------------------------------------------------------~~~~~~E~~~l~~l~hp~iv~~~~~~ 148 (681)
T 2pzi_A 123 ------------------------------------------------------QAMAMAERQFLAEVVHPSIVQIFNFV 148 (681)
T ss_dssp ------------------------------------------------------HHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence 11445677777777777777777777
Q ss_pred eeCce-----eeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 250 HTEKC-----LTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 250 ~~~~~-----~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
...+. .||||||++| +|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|
T Consensus 149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp EEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECC
T ss_pred eecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEe
Confidence 76554 7999999985 77665543 69999999999999999999999999999999999999875 899999
Q ss_pred eccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 324 FGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 324 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
||+++..... ...+||+.|+|||++.+. ++.++|+|||||++|+|++|.+||.+.... +.+.
T Consensus 225 FG~a~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~--- 286 (681)
T 2pzi_A 225 LGAVSRINSF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPE--- 286 (681)
T ss_dssp CTTCEETTCC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCT---
T ss_pred cccchhcccC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc----------cccc---
Confidence 9999875432 445789999999998765 477889999999999999999998652110 0000
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
. ... ...++.+.+||.+||+.||.+||++.+++.|+|+.
T Consensus 287 -------------~-~~~-----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 287 -------------D-DPV-----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp -------------T-CHH-----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------c-ccc-----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 0 000 02357899999999999999999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.54 Aligned_cols=199 Identities=14% Similarity=0.080 Sum_probs=138.8
Q ss_pred eeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh
Q psy12305 94 FKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 173 (516)
Q Consensus 94 ~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 173 (516)
.....++.|++|.+..++..-.|+.||+|++.+.........-.+
T Consensus 237 ~w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~----------------------------------- 281 (569)
T 4azs_A 237 HWQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEES----------------------------------- 281 (569)
T ss_dssp EEECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHH-----------------------------------
T ss_pred hhhhccccCCcccccccccccccceeEEEEEecccccccchhhhh-----------------------------------
Confidence 445678999999999999888999999999876533221111111
Q ss_pred hhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeEeeC
Q psy12305 174 DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTE 252 (516)
Q Consensus 174 ~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 252 (516)
+.....+.+|+++|+++ .|+||++++++++++
T Consensus 282 -----------------------------------------------~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~ 314 (569)
T 4azs_A 282 -----------------------------------------------QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA 314 (569)
T ss_dssp -----------------------------------------------HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS
T ss_pred -----------------------------------------------HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC
Confidence 11223678899999999 799999999999999
Q ss_pred ceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccC
Q psy12305 253 KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKS 331 (516)
Q Consensus 253 ~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~ 331 (516)
..+|||||||+| +|.+.+... +++++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+...
T Consensus 315 ~~~yLVMEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 315 QSGWLVMEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp SEEEEEEECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred CEEEEEEecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 999999999996 888888764 456654 589999999999999999999999999999999999999999998876
Q ss_pred CCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 332 VPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 332 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
.........+||+.|||||++.+. +...+|+||+|+++++|.++..+
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 555556667999999999999874 55678889999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-28 Score=263.88 Aligned_cols=144 Identities=15% Similarity=0.158 Sum_probs=119.5
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|++++||||+++..++...+..||||||++ ++|.+++.. +..++.||+.||+|||++||+||
T Consensus 385 ~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHr 455 (540)
T 3en9_A 385 RTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHN 455 (540)
T ss_dssp HHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECT
T ss_pred HHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccC
Confidence 56789999999999999966666667778899999998 689888765 56899999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCcc-------ccCCcccccccchhhccC--CCCCCceeeehHHHHHHHHHc
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKT-------FSNEVVTLWYRPPDVLLG--STEYSTSIDMGVGCIFHEMSS 375 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~-------~~~~~gt~~y~APE~l~~--~~~~~~~d~~SlGvil~ellt 375 (516)
||||+|||++. .+||+|||+|+........ ....+||+.|||||++.+ ..|....|.||..+-..+...
T Consensus 456 DiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 456 DLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp TCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred CCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 99999999998 9999999999876532211 134688999999999976 445566788898888888887
Q ss_pred CCCCC
Q psy12305 376 GRPLF 380 (516)
Q Consensus 376 G~~pF 380 (516)
++.+|
T Consensus 534 ~r~rY 538 (540)
T 3en9_A 534 RRARY 538 (540)
T ss_dssp TCSCC
T ss_pred hcccc
Confidence 77665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-25 Score=216.93 Aligned_cols=102 Identities=21% Similarity=0.254 Sum_probs=82.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|+.++ | +++.+++.. +..|+||||++| +|.+ + ....+..++.||+.||.|||++||+||
T Consensus 150 ~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l-------~~~~~~~i~~qi~~~l~~lH~~giiHr 217 (282)
T 1zar_A 150 SARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-V-------RVENPDEVLDMILEEVAKFYHRGIVHG 217 (282)
T ss_dssp HHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-C-------CCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-c-------chhhHHHHHHHHHHHHHHHHHCCCEeC
Confidence 5677888888888 4 556665543 567999999985 7765 3 223466799999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhcc
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL 353 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~ 353 (516)
||||+|||++ ++.+||+|||+|+. +..|+|||.+.
T Consensus 218 Dlkp~NILl~-~~~vkl~DFG~a~~-------------~~~~~a~e~l~ 252 (282)
T 1zar_A 218 DLSQYNVLVS-EEGIWIIDFPQSVE-------------VGEEGWREILE 252 (282)
T ss_dssp CCSTTSEEEE-TTEEEECCCTTCEE-------------TTSTTHHHHHH
T ss_pred CCCHHHEEEE-CCcEEEEECCCCeE-------------CCCCCHHHHHH
Confidence 9999999999 99999999999863 44678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.7e-23 Score=197.92 Aligned_cols=95 Identities=16% Similarity=0.202 Sum_probs=76.1
Q ss_pred hHHHHHHHHHhccccce--eeEeeeEeeCceeeEeeehhhc------hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh
Q psy12305 226 TAIREVSLLRELRHANI--VTLHDIIHTEKCLTLVFEYLEK------DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH 297 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnI--v~l~~~~~~~~~~~lV~E~~~g------~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH 297 (516)
.+.+|+.+|..+.|++| +.+++. ...+|||||+++ .|.+.... .++..+..++.||+.||.|||
T Consensus 116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHH
Confidence 56789999999988864 333332 367899999953 55554332 345678899999999999999
Q ss_pred -hCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 298 -SRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 298 -~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
++||+||||||+|||++. .++|+|||+|...
T Consensus 188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999999999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-19 Score=184.12 Aligned_cols=93 Identities=16% Similarity=0.253 Sum_probs=67.1
Q ss_pred HHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeec
Q psy12305 228 IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306 (516)
Q Consensus 228 ~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl 306 (516)
.+|...|.++.++++....-+.. ...+|||||++| .|.+. .....+..++.||+.||.|||++|||||||
T Consensus 161 ~kE~~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 161 IKEFAFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 45666777775554432221111 224799999997 44321 223456788999999999999999999999
Q ss_pred CCCCEEEccCC----------CEEEeeeccccc
Q psy12305 307 KPQNLLINERG----------ELKLADFGLARA 329 (516)
Q Consensus 307 Kp~NILl~~~~----------~vkL~DFGla~~ 329 (516)
||.|||++.+| .+.|+||+-+-.
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999998877 389999997654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=4.5e-12 Score=122.42 Aligned_cols=96 Identities=13% Similarity=0.107 Sum_probs=72.0
Q ss_pred HHHHHHHHHhcc-ccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh------
Q psy12305 227 AIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS------ 298 (516)
Q Consensus 227 ~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~------ 298 (516)
+.+|+.+++.+. +..+.++++++...+..|+||||++| ++.+.+ .+......++.+++.+|..||+
T Consensus 56 ~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~ 129 (263)
T 3tm0_A 56 VEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDC 129 (263)
T ss_dssp HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTC
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccC
Confidence 445666666553 45566777778788889999999997 554432 1223345788999999999998
Q ss_pred -----------------------------------------------------CCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 299 -----------------------------------------------------RRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 299 -----------------------------------------------------~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
..++|+|++|.|||++.++.+.|+||+
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe 209 (263)
T 3tm0_A 130 PYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLG 209 (263)
T ss_dssp SCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCT
T ss_pred CCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEch
Confidence 458999999999999875556799999
Q ss_pred ccc
Q psy12305 326 LAR 328 (516)
Q Consensus 326 la~ 328 (516)
.+.
T Consensus 210 ~a~ 212 (263)
T 3tm0_A 210 RSG 212 (263)
T ss_dssp TCE
T ss_pred hcc
Confidence 764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=9.7e-11 Score=112.40 Aligned_cols=28 Identities=18% Similarity=0.210 Sum_probs=24.8
Q ss_pred cEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 301 ILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 301 ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
++|+|++|.|||++.++.+.|+|||.|.
T Consensus 186 l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 186 VTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred EECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876667799999874
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.3e-09 Score=110.28 Aligned_cols=136 Identities=15% Similarity=0.161 Sum_probs=98.6
Q ss_pred cccceeeEEEEEEEecCCceEEEEEee--cccccCChhhHHHHHHHHHhcc--ccceeeEeeeEeeC---ceeeEeeehh
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELR--HANIVTLHDIIHTE---KCLTLVFEYL 262 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~--~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~~lV~E~~ 262 (516)
.+.|.++.||+.... +..+++|... ..........+.+|+.+++.+. +..+++++.++.+. +..|+||||+
T Consensus 46 l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 46 FKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp CCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred cCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 356888899988754 4678888776 3332223346788999999997 45578888888776 4589999999
Q ss_pred hchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q psy12305 263 EKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-------------------------------------------- 298 (516)
Q Consensus 263 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-------------------------------------------- 298 (516)
+|..... ..-..++......++.+++.+|..||+
T Consensus 124 ~G~~l~~--~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (359)
T 3dxp_A 124 SGRVLWD--QSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLM 201 (359)
T ss_dssp CCBCCCC--TTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHH
T ss_pred CCeecCC--CccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHH
Confidence 9732210 111236778888899999999999997
Q ss_pred --------------CCcEeeecCCCCEEEccCCC--EEEeeeccccc
Q psy12305 299 --------------RRILHRDLKPQNLLINERGE--LKLADFGLARA 329 (516)
Q Consensus 299 --------------~~ivHrDlKp~NILl~~~~~--vkL~DFGla~~ 329 (516)
.+++|+|++|.|||++.++. +.|+||+.|..
T Consensus 202 ~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 202 DWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997753 68999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.5e-09 Score=107.07 Aligned_cols=74 Identities=26% Similarity=0.321 Sum_probs=57.0
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeeeh
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 261 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 261 (516)
...|+|+||+||+|+++.+++.||||.++..........+.+|+.+|++++|||||+++++|.+.+....+.+.
T Consensus 11 ~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp EEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred eEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45789999999999999999999999998766555556788999999999999999999999887766555443
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.70 E-value=7e-09 Score=102.31 Aligned_cols=179 Identities=16% Similarity=0.101 Sum_probs=110.7
Q ss_pred cccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccc--eeeEeeeEeeCc---eeeEeeehhh
Q psy12305 190 NVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHAN--IVTLHDIIHTEK---CLTLVFEYLE 263 (516)
Q Consensus 190 ~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~Hpn--Iv~l~~~~~~~~---~~~lV~E~~~ 263 (516)
...|....||+.. ..+++|..... .....+.+|+.+|+.+ .+.. +.+.+....... ..|+|||+++
T Consensus 28 ~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 28 SGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp EEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred cCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3567788888863 46888875433 2234678899999988 3433 344444443333 4589999999
Q ss_pred c-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--------------------------------------------
Q psy12305 264 K-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-------------------------------------------- 298 (516)
Q Consensus 264 g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-------------------------------------------- 298 (516)
| .+..... ..++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 7 3332222 136777777888888888888885
Q ss_pred --------------CCcEeeecCCCCEEEcc--CCCEEEeeeccccccCCCCccccCCcccccccchhhc---cCCCC--
Q psy12305 299 --------------RRILHRDLKPQNLLINE--RGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL---LGSTE-- 357 (516)
Q Consensus 299 --------------~~ivHrDlKp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l---~~~~~-- 357 (516)
..++|+|++|.||+++. .+.+.|+||+.+.... +............-..|+.. .....
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~-~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD-PDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC-TTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC-hHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 23799999999999998 4567899999986532 11111000000000122211 11000
Q ss_pred ---------CCceeeehHHHHHHHHHcCCCCC
Q psy12305 358 ---------YSTSIDMGVGCIFHEMSSGRPLF 380 (516)
Q Consensus 358 ---------~~~~d~~SlGvil~elltG~~pF 380 (516)
.-..+.|++|.++|.+.+|..+|
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01134469999999999998876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.57 E-value=3.1e-08 Score=101.49 Aligned_cols=66 Identities=27% Similarity=0.466 Sum_probs=55.9
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccc-cCChhhHHHHHHHHHhccccceeeEeeeEeeCc
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 253 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 253 (516)
..+|+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|+.++|||||++++++....
T Consensus 60 ~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 126 (398)
T 4b99_A 60 ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV 126 (398)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred EEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence 457899999999999999999999999975532 223456789999999999999999999987654
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.39 E-value=1.6e-07 Score=92.69 Aligned_cols=34 Identities=35% Similarity=0.404 Sum_probs=26.4
Q ss_pred cccccccccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 182 CSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 182 ~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
....+...+|+|+||+||+|+++. .||||+++..
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~ 69 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVV 69 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEec
Confidence 344466678999999999998653 5999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.35 E-value=4.5e-07 Score=89.76 Aligned_cols=66 Identities=29% Similarity=0.387 Sum_probs=57.5
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCc
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 253 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 253 (516)
...|+|+||.||+|+++.+++.||+|+++..........+.+|+.+|++++||||+++++++.+..
T Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 77 (332)
T 3qd2_B 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP 77 (332)
T ss_dssp EEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred eEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence 346899999999999999999999999987666666678899999999999999999999987654
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=8.5e-06 Score=78.33 Aligned_cols=124 Identities=19% Similarity=0.131 Sum_probs=87.4
Q ss_pred eEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhc
Q psy12305 196 ATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 273 (516)
Q Consensus 196 g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~ 273 (516)
+.||+......+..+.+|.-... ....+.+|...|+.+. +--+.+++.++.+++..++|||+++| .+.+....
T Consensus 39 ~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~- 113 (272)
T 4gkh_A 39 ATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE- 113 (272)
T ss_dssp CEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHH-
T ss_pred CeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccC-
Confidence 47898887777888999986543 2335778999999884 32366788888888999999999987 44333221
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhC------------------------------------------------------
Q psy12305 274 SNILSMNNVKLFLFQLLRGLAYCHSR------------------------------------------------------ 299 (516)
Q Consensus 274 ~~~l~~~~~~~i~~qi~~aL~yLH~~------------------------------------------------------ 299 (516)
.......+..++...|.-||+.
T Consensus 114 ----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 189 (272)
T 4gkh_A 114 ----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPF 189 (272)
T ss_dssp ----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCC
T ss_pred ----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccc
Confidence 1122233445555555555521
Q ss_pred ----CcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 300 ----RILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 300 ----~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 190 ~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 190 SPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 27899999999999877767799999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=4.3e-07 Score=91.37 Aligned_cols=94 Identities=20% Similarity=0.279 Sum_probs=78.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCC-----cEEEEEEeecccccCCcchhHHHHHHHHhcCC-CCeeecccccccc-e
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTD-----NLVALKEIKLEHEEGAPCTAIREVSLLRELRH-ANIVTLHDIIHTE-K 162 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g-----~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-~ 162 (516)
.++|++.++||+|+||+||+|++..++ +.||||++.........+.+.+|+.+|++++| ||||+++++|..+ +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 378999999999999999999987543 68999999876554445578999999999965 9999999998664 5
Q ss_pred eeeeeeehhhh-hhhccccccc
Q psy12305 163 CLTLVFEYLEK-DLKRYMDDCS 183 (516)
Q Consensus 163 ~~~lv~Ey~~~-~L~~~l~~~s 183 (516)
..++|||||++ +|.+++....
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~ 164 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKR 164 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTG
T ss_pred EEEEEEEcCCCCCHHHHHHhcc
Confidence 68999999986 9999887643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.15 E-value=2.6e-06 Score=84.07 Aligned_cols=32 Identities=34% Similarity=0.426 Sum_probs=27.9
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeec
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~ 217 (516)
+....|+|+||+||+|.+..+++.||+|+++.
T Consensus 13 ~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~ 44 (319)
T 4euu_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNN 44 (319)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECG
T ss_pred EEEEecCCCCeEEEEEEECCCCcEEEEEEecc
Confidence 34456899999999999999999999999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=8.1e-06 Score=80.40 Aligned_cols=128 Identities=20% Similarity=0.148 Sum_probs=82.4
Q ss_pred ccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccc---ceeeEeeeEe-eCceeeEeeehhhc-h
Q psy12305 191 VKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA---NIVTLHDIIH-TEKCLTLVFEYLEK-D 265 (516)
Q Consensus 191 ~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~g-~ 265 (516)
..|....||+. +..+++|.-... .....+.+|..+|+.+.+. .+.+.+.+.. ..+..++||||++| .
T Consensus 28 ~~G~~n~v~~v-----g~~~VlR~~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~ 99 (306)
T 3tdw_A 28 GEGFRNYAILV-----NGDWVFRFPKSQ---QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI 99 (306)
T ss_dssp EECSSEEEEEE-----TTTEEEEEESSH---HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred CCCcceeEEEE-----CCEEEEEecCCc---hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence 45666788887 567788874321 1234678999999999652 3556666654 44567899999997 3
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-----------------------------------------------
Q psy12305 266 LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS----------------------------------------------- 298 (516)
Q Consensus 266 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~----------------------------------------------- 298 (516)
+..... ..++......++.|+...|..||+
T Consensus 100 l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~ 176 (306)
T 3tdw_A 100 LGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF 176 (306)
T ss_dssp CHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred Cchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence 332111 113344444444444444444442
Q ss_pred -------------CCcEeeecCCCCEEEcc---CCCE-EEeeeccccc
Q psy12305 299 -------------RRILHRDLKPQNLLINE---RGEL-KLADFGLARA 329 (516)
Q Consensus 299 -------------~~ivHrDlKp~NILl~~---~~~v-kL~DFGla~~ 329 (516)
..++|+|++|.|||++. ++.+ .|+||+.+..
T Consensus 177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 24699999999999987 4564 8999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=4.1e-06 Score=85.55 Aligned_cols=32 Identities=34% Similarity=0.426 Sum_probs=27.9
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeec
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~ 217 (516)
+....|+|+||+||+|.+..+++.||+|+++.
T Consensus 13 i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~ 44 (396)
T 4eut_A 13 LSDILGQGATANVFRGRHKKTGDLFAIKVFNN 44 (396)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEECG
T ss_pred EEEEEEcCCCeEEEEEEECCCCcEEEEEEecc
Confidence 34456899999999999999999999999864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=2.8e-05 Score=79.31 Aligned_cols=74 Identities=16% Similarity=0.018 Sum_probs=47.8
Q ss_pred ccccceeeEEEEEEEecCCceEEEEEeecccc------cCChhhHHHHHHHHHhccc--c-ceeeEeeeEeeCceeeEee
Q psy12305 189 NNVKGTYATVFKGKSRLTDNLVALKEIKLEHE------EGAPCTAIREVSLLRELRH--A-NIVTLHDIIHTEKCLTLVF 259 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~------~~~~~~~~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~lV~ 259 (516)
..+.|..+.||++....++..+++|....... .....+...|..+|+.+.. | .+.+++.+ +....++||
T Consensus 37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvm 114 (397)
T 2olc_A 37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 114 (397)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEE
Confidence 35678899999998776778899998653211 1233456789999988843 3 34455543 345578999
Q ss_pred ehhhc
Q psy12305 260 EYLEK 264 (516)
Q Consensus 260 E~~~g 264 (516)
|++++
T Consensus 115 E~l~g 119 (397)
T 2olc_A 115 EDLSH 119 (397)
T ss_dssp CCCTT
T ss_pred EeCCC
Confidence 99975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=97.98 E-value=4.4e-06 Score=84.24 Aligned_cols=31 Identities=26% Similarity=0.243 Sum_probs=27.4
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeec
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~ 217 (516)
....|+|+||.||+|.+..++..||+|.+..
T Consensus 32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~ 62 (364)
T 3qyz_A 32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISP 62 (364)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC
T ss_pred EEEeecCCCeEEEEEEECCCCeEEEEEEecc
Confidence 3456899999999999999999999999874
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.97 E-value=4.4e-06 Score=87.04 Aligned_cols=33 Identities=24% Similarity=0.316 Sum_probs=20.1
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
+....|+|+||+||+|.++.+++.||||.+...
T Consensus 57 ~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~ 89 (458)
T 3rp9_A 57 IRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV 89 (458)
T ss_dssp ECCC-------CEEEEEECC--CEEEEEEECST
T ss_pred EeeEeeecCCeEEEEEEECCCCcEEEEEEechh
Confidence 345578999999999999999999999998643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=1e-05 Score=78.91 Aligned_cols=31 Identities=26% Similarity=0.247 Sum_probs=25.5
Q ss_pred cccccceeeEEEEEE----EecCCceEEEEEeecc
Q psy12305 188 MNNVKGTYATVFKGK----SRLTDNLVALKEIKLE 218 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~----~~~~~~~vAiK~i~~~ 218 (516)
...|+|+||.||+|+ +..+++.||+|.++..
T Consensus 27 ~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~ 61 (302)
T 4e5w_A 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE 61 (302)
T ss_dssp EEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--
T ss_pred hccCCCCceEEEEEEEccccCccCeEEEEEEeccc
Confidence 456899999999999 6778999999998743
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=6.7e-06 Score=82.17 Aligned_cols=31 Identities=26% Similarity=0.343 Sum_probs=27.4
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeec
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~ 217 (516)
....|+|+||.||+|.+..+++.||+|.++.
T Consensus 16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~ 46 (353)
T 2b9h_A 16 KSLLGEGAYGVVCSATHKPTGEIVAIKKIEP 46 (353)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECC
T ss_pred eeEEcCCCCeEEEEEEECCCCcEEEEEeecc
Confidence 3456899999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=5.3e-06 Score=81.89 Aligned_cols=89 Identities=26% Similarity=0.379 Sum_probs=73.5
Q ss_pred EeeeeeeccccceEEEEEEE----cCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccc--ceeeee
Q psy12305 93 YFKLDKLGQGTYATVFKGKS----RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT--EKCLTL 166 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~----~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 166 (516)
|+++++||+|+||+||+|+. ..+|+.||||++...........+.+|+.+|++++||||+++++++.. ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 59999999999999977754 458899999999876444444578999999999999999999999976 356899
Q ss_pred eeehhhh-hhhccccc
Q psy12305 167 VFEYLEK-DLKRYMDD 181 (516)
Q Consensus 167 v~Ey~~~-~L~~~l~~ 181 (516)
+|||++. +|.+++..
T Consensus 113 v~e~~~~~~L~~~l~~ 128 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR 128 (318)
T ss_dssp EECCCTTCBHHHHGGG
T ss_pred EEecccCCcHHHHHhh
Confidence 9999976 88777754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=97.90 E-value=9.1e-06 Score=83.71 Aligned_cols=34 Identities=24% Similarity=0.126 Sum_probs=29.9
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeeccc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEH 219 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~ 219 (516)
+....|+|+||+||+|.+..+++.||+|++....
T Consensus 139 ~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~ 172 (419)
T 3i6u_A 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRK 172 (419)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG
T ss_pred EEeEEeeCCCeEEEEEEECCCCcEEEEEEEEech
Confidence 4456789999999999999999999999998654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=5.6e-05 Score=74.98 Aligned_cols=31 Identities=19% Similarity=0.311 Sum_probs=27.9
Q ss_pred CCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 299 RRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 299 ~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+++|+|++|.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=7.5e-06 Score=82.03 Aligned_cols=90 Identities=20% Similarity=0.285 Sum_probs=74.5
Q ss_pred ccccccccceeeEEEEEE-----EecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeEeeeEeeCc-eeeE
Q psy12305 185 ILSMNNVKGTYATVFKGK-----SRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEK-CLTL 257 (516)
Q Consensus 185 ~l~~~~~~G~~g~V~~~~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~-~~~l 257 (516)
.+....|+|+||.||+|. +..+++.||+|.++..........+.+|+.+++++ +||||+++++++...+ .+++
T Consensus 25 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~i 104 (359)
T 3vhe_A 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMV 104 (359)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEE
T ss_pred eeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEE
Confidence 345567899999999999 55667899999998655444455788999999999 7999999999988755 5999
Q ss_pred eeehhh-chHHHHHHhcC
Q psy12305 258 VFEYLE-KDLKRYMDDCS 274 (516)
Q Consensus 258 V~E~~~-g~L~~~l~~~~ 274 (516)
|||||+ |+|.+++....
T Consensus 105 v~e~~~~g~L~~~l~~~~ 122 (359)
T 3vhe_A 105 IVEFCKFGNLSTYLRSKR 122 (359)
T ss_dssp EEECCTTEEHHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcc
Confidence 999998 59999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=97.80 E-value=1.7e-05 Score=77.03 Aligned_cols=71 Identities=21% Similarity=0.267 Sum_probs=56.8
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeee
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 260 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 260 (516)
...++|+||.||+|++..+++.||+|.++... .....+.+|+.+++.++||||+++++++.+...+.-.++
T Consensus 12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 12 AVLGQGAFGQVVKARNALDSRYYAIKKIRHTE--EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEEEEEH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred heeccCCcEEEEEEEEcCCCeEEEEEEEeccH--HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 44678999999999999999999999996532 223467899999999999999999999987765444433
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=3.3e-05 Score=77.50 Aligned_cols=74 Identities=9% Similarity=0.075 Sum_probs=49.0
Q ss_pred ccceeeEEEEEEEe--c----CCceEEEEEeecccc--cCChhhHHHHHHHHHhccc---cceeeEeeeEeeC---ceee
Q psy12305 191 VKGTYATVFKGKSR--L----TDNLVALKEIKLEHE--EGAPCTAIREVSLLRELRH---ANIVTLHDIIHTE---KCLT 256 (516)
Q Consensus 191 ~~G~~g~V~~~~~~--~----~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~~---~~~~ 256 (516)
..|....+|+.... . ++..+++|....... ......+.+|+.+++.+.. -.+.+++.+..+. +..+
T Consensus 30 ~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~ 109 (357)
T 3ats_A 30 STGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPF 109 (357)
T ss_dssp TTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCE
T ss_pred CCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCce
Confidence 45777888987643 1 256788887654321 1112467889999998853 2467778777655 3568
Q ss_pred Eeeehhhc
Q psy12305 257 LVFEYLEK 264 (516)
Q Consensus 257 lV~E~~~g 264 (516)
+||||++|
T Consensus 110 ~v~e~l~G 117 (357)
T 3ats_A 110 FLMDYVEG 117 (357)
T ss_dssp EEEECCCC
T ss_pred EEEEecCC
Confidence 99999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.77 E-value=1.5e-05 Score=77.39 Aligned_cols=30 Identities=20% Similarity=0.244 Sum_probs=24.5
Q ss_pred cccccceeeEEEEEEEecCCc---eEEEEEeec
Q psy12305 188 MNNVKGTYATVFKGKSRLTDN---LVALKEIKL 217 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~---~vAiK~i~~ 217 (516)
...|+|+||+||+|.+..++. .||+|.+..
T Consensus 27 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~ 59 (298)
T 3pls_A 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR 59 (298)
T ss_dssp EEEEEETTEEEEEEEEECSSSCEEEEEEEEETT
T ss_pred ceeccCCCceEEEEEEecCCCceeeeeeeeccc
Confidence 457899999999999876655 799998853
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.77 E-value=2.1e-05 Score=76.16 Aligned_cols=30 Identities=27% Similarity=0.235 Sum_probs=24.5
Q ss_pred ccccceeeEEEEEEEe--cCCceEEEEEeecc
Q psy12305 189 NNVKGTYATVFKGKSR--LTDNLVALKEIKLE 218 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~--~~~~~vAiK~i~~~ 218 (516)
..|+|+||.||+|.+. .++..||+|.++..
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~ 48 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG 48 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSS
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCc
Confidence 5789999999999864 56788999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.75 E-value=2.2e-05 Score=84.91 Aligned_cols=30 Identities=27% Similarity=0.289 Sum_probs=24.9
Q ss_pred ccccceeeEEEEEEEec--CCceEEEEEeecc
Q psy12305 189 NNVKGTYATVFKGKSRL--TDNLVALKEIKLE 218 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~--~~~~vAiK~i~~~ 218 (516)
..|+|+||.||+|.++. ++..||||+++..
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~ 374 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG 374 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCC
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC
Confidence 46999999999998764 5567999999754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.75 E-value=1.9e-05 Score=77.34 Aligned_cols=65 Identities=29% Similarity=0.372 Sum_probs=49.9
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCc
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 253 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 253 (516)
...++|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 81 (320)
T 2i6l_A 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSG 81 (320)
T ss_dssp EECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTS
T ss_pred EEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccc
Confidence 44688999999999999999999999987543 223346789999999999999999999987654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=97.71 E-value=3.9e-05 Score=73.84 Aligned_cols=60 Identities=30% Similarity=0.360 Sum_probs=52.2
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
...++|+||.||+|.+..+++.||+|.++... ..+.+|+.+++.++||||+++++++...
T Consensus 17 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (284)
T 2a19_B 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGF 76 (284)
T ss_dssp EEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred eeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence 34678999999999999999999999997543 3677999999999999999999988653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=1.3e-05 Score=80.26 Aligned_cols=47 Identities=30% Similarity=0.535 Sum_probs=43.3
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++|+|||||++++++..++..|+|||||++ +|.+++..
T Consensus 69 ~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~ 116 (350)
T 4b9d_A 69 ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINA 116 (350)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHH
Confidence 688999999999999999999999999999999999986 88888753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=2.5e-05 Score=75.41 Aligned_cols=32 Identities=25% Similarity=0.191 Sum_probs=25.0
Q ss_pred cccccccceeeEEEEEEEecC---CceEEEEEeec
Q psy12305 186 LSMNNVKGTYATVFKGKSRLT---DNLVALKEIKL 217 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~---~~~vAiK~i~~ 217 (516)
+....|+|+||.||+|.+..+ +..||+|.++.
T Consensus 19 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~ 53 (281)
T 1mp8_A 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN 53 (281)
T ss_dssp EEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT
T ss_pred EEeEeeecCCeeEEEEEEecCCCCceEEEEEeccc
Confidence 445578999999999998764 45699998763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=97.68 E-value=1.3e-05 Score=78.89 Aligned_cols=48 Identities=25% Similarity=0.458 Sum_probs=44.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++|+|||||+++++|..++..++||||+++ +|.+++...
T Consensus 75 ~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~ 123 (308)
T 4gt4_A 75 EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMR 123 (308)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhh
Confidence 689999999999999999999999999999999999986 898888543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=97.67 E-value=1.3e-05 Score=77.51 Aligned_cols=47 Identities=36% Similarity=0.600 Sum_probs=43.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|++|+|||||++++++..++..++||||++++|.+++..
T Consensus 59 ~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~ 105 (275)
T 3hyh_A 59 RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQ 105 (275)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHH
Confidence 68899999999999999999999999999999999998888877654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=1.5e-05 Score=78.30 Aligned_cols=48 Identities=31% Similarity=0.558 Sum_probs=44.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+++|++|+|||||+++++|..++..++||||+++ +|.+++...
T Consensus 61 ~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~ 109 (299)
T 4asz_A 61 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAH 109 (299)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc
Confidence 689999999999999999999999999999999999986 898888654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=97.65 E-value=1.2e-05 Score=79.12 Aligned_cols=47 Identities=21% Similarity=0.356 Sum_probs=43.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+++|++|+|||||++++++..++..|+||||+++ +|.+++..
T Consensus 78 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~ 125 (311)
T 4aw0_A 78 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK 125 (311)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH
Confidence 789999999999999999999999999999999999986 88888754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=3.6e-05 Score=74.23 Aligned_cols=33 Identities=24% Similarity=0.229 Sum_probs=25.0
Q ss_pred cccccccceeeEEEEEEEecC---CceEEEEEeecc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLT---DNLVALKEIKLE 218 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~---~~~vAiK~i~~~ 218 (516)
+....++|+||+||+|.+... +..||+|.++..
T Consensus 16 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~ 51 (281)
T 3cc6_A 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD 51 (281)
T ss_dssp EEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT
T ss_pred EEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc
Confidence 345568999999999997653 446999998643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=97.63 E-value=3e-05 Score=75.98 Aligned_cols=34 Identities=24% Similarity=0.247 Sum_probs=26.9
Q ss_pred ccccccccceeeEEEEEEE-----ecCCceEEEEEeecc
Q psy12305 185 ILSMNNVKGTYATVFKGKS-----RLTDNLVALKEIKLE 218 (516)
Q Consensus 185 ~l~~~~~~G~~g~V~~~~~-----~~~~~~vAiK~i~~~ 218 (516)
.+....|+|+||+||+|.+ ..+++.||+|.++..
T Consensus 30 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~ 68 (316)
T 2xir_A 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 68 (316)
T ss_dssp EEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT
T ss_pred eeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC
Confidence 3455678999999999985 356789999998743
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.61 E-value=1.8e-05 Score=78.80 Aligned_cols=48 Identities=33% Similarity=0.587 Sum_probs=44.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+++|++|+|||||+++++|..++..++||||+++ +|.+++...
T Consensus 89 ~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~ 137 (329)
T 4aoj_A 89 DFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137 (329)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTS
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhc
Confidence 689999999999999999999999999999999999986 888888654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.57 E-value=3.1e-05 Score=76.91 Aligned_cols=92 Identities=23% Similarity=0.444 Sum_probs=77.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCC----cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTD----NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g----~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
.++|.+.+.||+|+||+||+|++..++ ..||||++...........+.+|+.++++++||||+++++++...+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 356999999999999999999987654 3599999976544334447889999999999999999999999999999
Q ss_pred eeeehhhh-hhhccccc
Q psy12305 166 LVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 166 lv~Ey~~~-~L~~~l~~ 181 (516)
++|||+++ +|.+++..
T Consensus 123 lv~e~~~~~~L~~~l~~ 139 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE 139 (333)
T ss_dssp EEEECCTTEEHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHh
Confidence 99999986 88777754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=97.52 E-value=4.6e-05 Score=74.04 Aligned_cols=31 Identities=16% Similarity=0.190 Sum_probs=22.9
Q ss_pred ccccccceeeEEEEEEEecC---CceEEEEEeec
Q psy12305 187 SMNNVKGTYATVFKGKSRLT---DNLVALKEIKL 217 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~---~~~vAiK~i~~ 217 (516)
....|+|+||+||+|.+..+ ...||+|.++.
T Consensus 30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~ 63 (298)
T 3f66_A 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63 (298)
T ss_dssp EEEEEEETTEEEEEEEEC-----CEEEEEEEETT
T ss_pred cceeeecCCceEEEEEEecCCCceeEEEEEeccc
Confidence 34578999999999997544 34689998864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.51 E-value=3.1e-05 Score=78.57 Aligned_cols=93 Identities=23% Similarity=0.357 Sum_probs=80.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCC-------CcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccc
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLT-------DNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTE 161 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 161 (516)
.++|.+.++||+|+||+||+|++..+ +..||||++...........+.+|+.+++++ +|||||++++++..+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 36799999999999999999998643 3579999998765444445788999999999 999999999999999
Q ss_pred eeeeeeeehhhh-hhhcccccc
Q psy12305 162 KCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 162 ~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+..+++|||+++ +|.+++...
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~ 169 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQAR 169 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHT
T ss_pred CceEEEEEecCCCcHHHHHHHh
Confidence 999999999976 888887654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=97.50 E-value=3.2e-05 Score=75.45 Aligned_cols=47 Identities=34% Similarity=0.583 Sum_probs=40.8
Q ss_pred hhHHHHHHHHhcCCCCeeeccccccc----ceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHT----EKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+++|++|+|||||+++++|.. ++..++||||+++ +|.+++..
T Consensus 71 ~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~ 122 (290)
T 3fpq_A 71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122 (290)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh
Confidence 68899999999999999999999854 4668999999986 88887754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00011 Score=72.98 Aligned_cols=64 Identities=19% Similarity=0.257 Sum_probs=51.8
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeecccc-------cCChhhHHHHHHHHHhcc---------ccceeeEeeeE
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE-------EGAPCTAIREVSLLRELR---------HANIVTLHDII 249 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~il~~l~---------HpnIv~l~~~~ 249 (516)
+....|+|+||+||+|++ +++.||+|+++.... ......+.+|+.+|+.++ ||||+++.+++
T Consensus 24 ~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~ 101 (336)
T 2vuw_A 24 RCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVH 101 (336)
T ss_dssp TCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEE
T ss_pred heeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhccee
Confidence 345578999999999998 789999999986642 222357889999999986 99999999986
Q ss_pred ee
Q psy12305 250 HT 251 (516)
Q Consensus 250 ~~ 251 (516)
..
T Consensus 102 ~~ 103 (336)
T 2vuw_A 102 CV 103 (336)
T ss_dssp EE
T ss_pred Ee
Confidence 53
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=3.2e-05 Score=77.23 Aligned_cols=45 Identities=27% Similarity=0.437 Sum_probs=40.8
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+|++|+|||||+++++|..++..|+|||||++ +|.+++.
T Consensus 118 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~ 163 (346)
T 4fih_A 118 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 163 (346)
T ss_dssp GHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 46899999999999999999999999999999999986 7776664
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=4.6e-05 Score=75.37 Aligned_cols=48 Identities=23% Similarity=0.351 Sum_probs=43.7
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|+.+ +||||+++++++..++..+++|||+++ +|.+++...
T Consensus 95 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 144 (333)
T 2i1m_A 95 ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRK 144 (333)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHh
Confidence 688999999999 899999999999999999999999976 888887654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.43 E-value=4.9e-05 Score=76.96 Aligned_cols=30 Identities=20% Similarity=0.233 Sum_probs=23.8
Q ss_pred cccccceeeEEEEEEEecCC---ceEEEEEeec
Q psy12305 188 MNNVKGTYATVFKGKSRLTD---NLVALKEIKL 217 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~---~~vAiK~i~~ 217 (516)
...|+|+||+||+|....++ ..||+|.++.
T Consensus 95 ~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~ 127 (373)
T 3c1x_A 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 127 (373)
T ss_dssp EEEECCSSSEEEEEEEEETTTEEEEEEEEECCS
T ss_pred cEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC
Confidence 45789999999999987543 4689998864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=2.1e-05 Score=85.29 Aligned_cols=33 Identities=21% Similarity=0.229 Sum_probs=28.7
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
+....|.|+||+||+|.+..+++.||+|.++..
T Consensus 18 i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~ 50 (676)
T 3qa8_A 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE 50 (676)
T ss_dssp CCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc
Confidence 345578999999999999999999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.42 E-value=4.6e-05 Score=78.17 Aligned_cols=45 Identities=27% Similarity=0.437 Sum_probs=40.7
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+|++|+|||||+++++|..++..|+|||||++ +|.+++.
T Consensus 195 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~ 240 (423)
T 4fie_A 195 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 240 (423)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHh
Confidence 56899999999999999999999999999999999986 7776664
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=3.6e-05 Score=76.58 Aligned_cols=44 Identities=20% Similarity=0.307 Sum_probs=40.4
Q ss_pred HHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+.+|++|+|||||++++++..++..|+||||+++ +|.+++..
T Consensus 99 ~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~ 143 (336)
T 4g3f_A 99 EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ 143 (336)
T ss_dssp HHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH
T ss_pred HHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH
Confidence 499999999999999999999999999999999986 88888754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=97.28 E-value=2.2e-05 Score=77.08 Aligned_cols=47 Identities=32% Similarity=0.428 Sum_probs=37.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+++|++|+|||||++++++..++..|+||||+++ +|.+++..
T Consensus 72 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~ 119 (304)
T 3ubd_A 72 RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK 119 (304)
T ss_dssp ------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh
Confidence 467899999999999999999999999999999999986 88777754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0016 Score=66.86 Aligned_cols=78 Identities=8% Similarity=-0.003 Sum_probs=46.0
Q ss_pred hhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCcc--cccccchhhccCCCCCC--ceeee-hHHHHHH
Q psy12305 297 HSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV--TLWYRPPDVLLGSTEYS--TSIDM-GVGCIFH 371 (516)
Q Consensus 297 H~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~--~~d~~-SlGvil~ 371 (516)
+...++|+|++|.|||++.++ ++|+||+.+.... +........+ ...|.+|+......... ..++. +....+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~-p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP-MGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC-HHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc-hHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 457899999999999998776 9999999886532 1111111111 23466766543211100 11222 6677777
Q ss_pred HHHcC
Q psy12305 372 EMSSG 376 (516)
Q Consensus 372 elltG 376 (516)
+++++
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0011 Score=60.87 Aligned_cols=97 Identities=13% Similarity=0.054 Sum_probs=63.7
Q ss_pred hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh-hCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCccccCCccc
Q psy12305 265 DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCH-SRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVT 343 (516)
Q Consensus 265 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt 343 (516)
+|.+.+...+.++++++++.++.|.+.+|.-+- ...-..+=+-|..|++..+|.|.+.+ +.+. ...
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~ 100 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE 100 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence 688899988999999999999999999987762 11111233456889999999987764 2110 112
Q ss_pred ccccchhhccCCCCCCceeeehHHHHHHHHHc
Q psy12305 344 LWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS 375 (516)
Q Consensus 344 ~~y~APE~l~~~~~~~~~d~~SlGvil~ellt 375 (516)
..+.|||... .....+..++|||+++|..+-
T Consensus 101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred cCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 3567888753 223455667799999998885
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00019 Score=78.31 Aligned_cols=32 Identities=25% Similarity=0.200 Sum_probs=24.8
Q ss_pred cccccccceeeEEEEEEEecC---CceEEEEEeec
Q psy12305 186 LSMNNVKGTYATVFKGKSRLT---DNLVALKEIKL 217 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~---~~~vAiK~i~~ 217 (516)
+....|+|+||+||+|.+..+ +..||+|.++.
T Consensus 394 i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~ 428 (656)
T 2j0j_A 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN 428 (656)
T ss_dssp EEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS
T ss_pred EeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc
Confidence 345578999999999998764 45688888753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00015 Score=73.05 Aligned_cols=61 Identities=13% Similarity=-0.047 Sum_probs=38.0
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeecccc--cCChhhHHHHHHHHHhc--cccceeeEee
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLREL--RHANIVTLHD 247 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l--~HpnIv~l~~ 247 (516)
....|+|+||+||+|.+..+++.||+|+++.... ......+.+|+.+++.+ +||||++++.
T Consensus 67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~ 131 (371)
T 3q60_A 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRR 131 (371)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------
T ss_pred eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhce
Confidence 3456899999999999999999999999987542 22334566775555544 6999888653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0012 Score=64.27 Aligned_cols=29 Identities=17% Similarity=0.225 Sum_probs=25.1
Q ss_pred CcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 300 RILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 300 ~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.++|+|+.|.||+ ..++.+.|+||..|..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5677899999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.17 E-value=0.0029 Score=61.11 Aligned_cols=77 Identities=10% Similarity=0.015 Sum_probs=51.1
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
..-+..+|.|..+.||+.+. .+|+.|.||+-.... ......+.+|...|+.|.--.-|..-.+... +..+++||+++
T Consensus 17 v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-~~~~lv~e~l~ 93 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW-DDRTLAMEWVD 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-ETTEEEEECCC
T ss_pred eEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec-cCceEEEEeec
Confidence 56688999999999999986 578999999765432 2223357799999999843221222222111 33477888765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00043 Score=68.37 Aligned_cols=87 Identities=17% Similarity=0.164 Sum_probs=55.6
Q ss_pred eeeeeeccccceEEE-EEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh
Q psy12305 94 FKLDKLGQGTYATVF-KGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE 172 (516)
Q Consensus 94 ~~~~~LG~G~fG~Vy-ka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~ 172 (516)
..+..=|.|.=-.+. +.....-...||+|.+...........+.+|+.+|++++|||||++++++..+. .++++||+.
T Consensus 21 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~ 99 (327)
T 3poz_A 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99 (327)
T ss_dssp EEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCT
T ss_pred eEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecC
Confidence 334444444333332 333334466899999987655556668999999999999999999999998765 678888886
Q ss_pred h-hhhccccc
Q psy12305 173 K-DLKRYMDD 181 (516)
Q Consensus 173 ~-~L~~~l~~ 181 (516)
. ++.+++..
T Consensus 100 ~g~L~~~l~~ 109 (327)
T 3poz_A 100 FGCLLDYVRE 109 (327)
T ss_dssp TCBHHHHHHH
T ss_pred CCcHHHHHHh
Confidence 5 77666644
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.00014 Score=72.64 Aligned_cols=62 Identities=10% Similarity=0.075 Sum_probs=49.5
Q ss_pred cccccccceeeEEEEEEEecC--------CceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLT--------DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 253 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 253 (516)
+....|+|+||.||+|.+..+ ++.||+|.+... ..+.+|+.++++++||||+++++.+....
T Consensus 46 ~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 46 LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp EEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred EEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 344568999999999999884 889999998754 36889999999999999999887765543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00053 Score=67.57 Aligned_cols=93 Identities=26% Similarity=0.283 Sum_probs=77.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcE----EEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNL----VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~----vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
..++|++++.||+|+||+||+|++..+|+. ||+|.+...........+.+|+.++++++|||||++++++. ++..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence 446799999999999999999999888876 77777765554555568899999999999999999999886 5568
Q ss_pred eeeeehhhh-hhhcccccc
Q psy12305 165 TLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 165 ~lv~Ey~~~-~L~~~l~~~ 182 (516)
+++|||+.+ +|.+++...
T Consensus 90 ~~v~e~~~~~~L~~~l~~~ 108 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQH 108 (325)
T ss_dssp EEEEECCTTCBSHHHHHSS
T ss_pred EEEEEeCCCCCHHHHHHHc
Confidence 899999975 777766543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=96.83 E-value=6.5e-05 Score=80.46 Aligned_cols=51 Identities=14% Similarity=0.025 Sum_probs=45.3
Q ss_pred CcchhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 132 APCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 132 ~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
..+.+.+|+++|+++ .|+||+++++++..++..|+||||+++ +|.+++...
T Consensus 284 ~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~ 336 (569)
T 4azs_A 284 NKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAG 336 (569)
T ss_dssp HHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhC
Confidence 344789999999999 799999999999999999999999987 888887553
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.00051 Score=73.53 Aligned_cols=46 Identities=24% Similarity=0.557 Sum_probs=41.1
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.+|+.|+|||||+++++|..++..+++|||+++ +|.+++..
T Consensus 201 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~ 247 (573)
T 3uto_A 201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 247 (573)
T ss_dssp HHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH
Confidence 45899999999999999999999999999999999986 77776643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0035 Score=61.53 Aligned_cols=73 Identities=19% Similarity=0.106 Sum_probs=56.6
Q ss_pred eeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcC---CCCeeecccccccceeeeeeeehh
Q psy12305 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR---HANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 95 ~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
-++.|+.|.+..||+... +++.+.||+-... ....+.+|...|+.|. ...+.+++.+....+..+++||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 457899999999999975 5678889987543 2346789999999884 245667777776677889999998
Q ss_pred hh
Q psy12305 172 EK 173 (516)
Q Consensus 172 ~~ 173 (516)
++
T Consensus 114 ~G 115 (312)
T 3jr1_A 114 NK 115 (312)
T ss_dssp CC
T ss_pred cC
Confidence 75
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0095 Score=58.45 Aligned_cols=47 Identities=13% Similarity=0.047 Sum_probs=33.4
Q ss_pred eeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcC
Q psy12305 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR 147 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~ 147 (516)
..|+ |.-..||++.. .+|+.+.+|+..... .....+..|..++..|.
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~--~~~~~~~~E~~~~~~L~ 78 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLV 78 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHH
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC--CCHHHHHHHHHHHHHHH
Confidence 4566 88899998865 356679999986331 12336678999998884
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0012 Score=65.06 Aligned_cols=65 Identities=18% Similarity=0.252 Sum_probs=52.8
Q ss_pred CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 116 DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 116 g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
...||+|.+...........+.+|+.+|++++||||+++++++..+. .++++||+.. ++.+++..
T Consensus 44 ~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~ 109 (327)
T 3lzb_A 44 KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE 109 (327)
T ss_dssp CEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH
T ss_pred EEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh
Confidence 45699999987666666678999999999999999999999998765 6778888765 77666644
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0054 Score=60.09 Aligned_cols=133 Identities=15% Similarity=0.082 Sum_probs=72.5
Q ss_pred cceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc--eeeEeee------EeeCceeeEeeehhh
Q psy12305 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN--IVTLHDI------IHTEKCLTLVFEYLE 263 (516)
Q Consensus 192 ~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~lV~E~~~ 263 (516)
.|....+|+.... +..+++|...... ....+..|+.+++.|.... +.+++.. ....+..+++|+|++
T Consensus 32 ~G~~n~~~~v~~~--~g~~vlk~~~~~~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~ 106 (322)
T 2ppq_A 32 EGVENSNFLLHTT--KDPLILTLYEKRV---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 106 (322)
T ss_dssp C---EEEEEEEES--SCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCcccceEEEEeC--CccEEEEEeCCCC---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence 4666788887643 3367888876521 2335667888888875322 2333321 123456789999987
Q ss_pred chH---------------HHHHHhcCCCC--------CHHHHHH---------------HHHHHHHHHHHHhh-------
Q psy12305 264 KDL---------------KRYMDDCSNIL--------SMNNVKL---------------FLFQLLRGLAYCHS------- 298 (516)
Q Consensus 264 g~L---------------~~~l~~~~~~l--------~~~~~~~---------------i~~qi~~aL~yLH~------- 298 (516)
|.. +..+......+ ....-.. +...+...++++..
T Consensus 107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~ 186 (322)
T 2ppq_A 107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 186 (322)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence 521 11111111001 1000000 00113344555552
Q ss_pred CCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 299 RRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 299 ~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3699999999999998776568999998753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.00071 Score=66.29 Aligned_cols=44 Identities=30% Similarity=0.373 Sum_probs=37.4
Q ss_pred HHHHHHHhcCCCCeeecccccccce----eeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEK----CLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+..+.+|+|||||++++++..++ ..++||||+++ +|.+++..
T Consensus 46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 94 (303)
T 3hmm_A 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 94 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh
Confidence 4888889999999999999997654 47999999985 88888754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=96.27 E-value=0.0017 Score=63.46 Aligned_cols=47 Identities=68% Similarity=1.149 Sum_probs=42.8
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++++.+++..
T Consensus 65 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~ 111 (311)
T 3niz_A 65 TAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE 111 (311)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHT
T ss_pred HHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHh
Confidence 67899999999999999999999999999999999999887777654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.012 Score=59.44 Aligned_cols=72 Identities=11% Similarity=0.065 Sum_probs=42.1
Q ss_pred eeeeccccceEEEEEEEcC-------CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCe-eecccccccceeeeee
Q psy12305 96 LDKLGQGTYATVFKGKSRL-------TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI-VTLHDIIHTEKCLTLV 167 (516)
Q Consensus 96 ~~~LG~G~fG~Vyka~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv 167 (516)
++.|.-|-...+|++.... +++.|.+|+-... ........+|..+++.|..-++ -++++.+.. .++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 4577778889999988642 3578888875321 2223356799999998843333 345555443 288
Q ss_pred eehhhh
Q psy12305 168 FEYLEK 173 (516)
Q Consensus 168 ~Ey~~~ 173 (516)
|||+++
T Consensus 129 ~e~i~G 134 (379)
T 3feg_A 129 EQYIPS 134 (379)
T ss_dssp EECCSE
T ss_pred EEEecC
Confidence 888875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.013 Score=57.82 Aligned_cols=33 Identities=30% Similarity=0.401 Sum_probs=28.0
Q ss_pred hCCcEeeecCCCCEEEccC----CCEEEeeecccccc
Q psy12305 298 SRRILHRDLKPQNLLINER----GELKLADFGLARAK 330 (516)
Q Consensus 298 ~~~ivHrDlKp~NILl~~~----~~vkL~DFGla~~~ 330 (516)
...++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999874 67999999988643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.14 E-value=0.029 Score=57.51 Aligned_cols=72 Identities=15% Similarity=0.182 Sum_probs=48.4
Q ss_pred eeeeeccccceEEEEEEEcC-------CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCe-eecccccccceeeee
Q psy12305 95 KLDKLGQGTYATVFKGKSRL-------TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI-VTLHDIIHTEKCLTL 166 (516)
Q Consensus 95 ~~~~LG~G~fG~Vyka~~~~-------~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~l 166 (516)
.++.|+.|....||++.... +++.|.+|+-... .....+.+|..+++.|...++ .++++.+.. .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 46788999999999998642 2578888887321 111467789999998854444 355554432 27
Q ss_pred eeehhhh
Q psy12305 167 VFEYLEK 173 (516)
Q Consensus 167 v~Ey~~~ 173 (516)
++||+++
T Consensus 150 v~e~l~G 156 (429)
T 1nw1_A 150 LEEYIPS 156 (429)
T ss_dssp EECCCCE
T ss_pred EEEEeCC
Confidence 7888764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=96.14 E-value=0.0016 Score=63.84 Aligned_cols=46 Identities=65% Similarity=1.073 Sum_probs=41.6
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
+.+|+.+|++++|||||++++++..++..+++|||++++|.+++..
T Consensus 50 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~ 95 (317)
T 2pmi_A 50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS 95 (317)
T ss_dssp HHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHH
T ss_pred HHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHh
Confidence 3589999999999999999999999999999999999888877654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0022 Score=63.19 Aligned_cols=47 Identities=23% Similarity=0.533 Sum_probs=42.8
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 96 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 143 (325)
T 3kul_A 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT 143 (325)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh
Confidence 688999999999999999999999999999999999976 88877754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0021 Score=64.05 Aligned_cols=48 Identities=29% Similarity=0.413 Sum_probs=42.0
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
...+.+|+.+|+.++|||||++++++..++..+++|||+++ +|..++.
T Consensus 70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 118 (351)
T 3c0i_A 70 TEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIV 118 (351)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHH
Confidence 34789999999999999999999999999999999999985 6655543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=96.06 E-value=0.0018 Score=62.36 Aligned_cols=48 Identities=60% Similarity=0.985 Sum_probs=43.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~ 182 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++++.+++...
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~ 93 (288)
T 1ob3_A 46 TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC 93 (288)
T ss_dssp HHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS
T ss_pred hHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhc
Confidence 678999999999999999999999999999999999998887777554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0061 Score=58.84 Aligned_cols=32 Identities=19% Similarity=0.035 Sum_probs=27.1
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
+....|.|+||.||+|.+ .+++.||+|.++..
T Consensus 94 ~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~ 125 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVG 125 (282)
T ss_dssp EEEEEEECSSEEEEEEEE-TTTEEEEEEEECC-
T ss_pred ecCEeccCCCceEEEEEe-CCCCEEEEEEEECC
Confidence 345678999999999999 88999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.0027 Score=62.69 Aligned_cols=48 Identities=27% Similarity=0.400 Sum_probs=42.9
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
...+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++.
T Consensus 72 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 120 (345)
T 3hko_A 72 VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120 (345)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEE
T ss_pred HHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHH
Confidence 44789999999999999999999999999999999999965 7777764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.96 E-value=0.016 Score=58.09 Aligned_cols=67 Identities=13% Similarity=0.121 Sum_probs=39.3
Q ss_pred cceeeEEEEEEEec--------CCceEEEEEeecccccCChhhHHHHHHHHHhccccc-eeeEeeeEeeCceeeEeeehh
Q psy12305 192 KGTYATVFKGKSRL--------TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN-IVTLHDIIHTEKCLTLVFEYL 262 (516)
Q Consensus 192 ~G~~g~V~~~~~~~--------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~ 262 (516)
.|....+|+..... .+..+++|+....... ......|..+++.+...+ +.++++.+. -++||||+
T Consensus 43 ~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~e~i 116 (369)
T 3c5i_A 43 SGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIEEWL 116 (369)
T ss_dssp ---CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEECC
T ss_pred CcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEEEEe
Confidence 46667888887543 1367888876543211 112467888888885444 346665442 36889988
Q ss_pred hc
Q psy12305 263 EK 264 (516)
Q Consensus 263 ~g 264 (516)
+|
T Consensus 117 ~G 118 (369)
T 3c5i_A 117 YG 118 (369)
T ss_dssp CS
T ss_pred cC
Confidence 75
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=95.92 E-value=0.0024 Score=63.72 Aligned_cols=46 Identities=28% Similarity=0.422 Sum_probs=41.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~ 180 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+.+++.+++.
T Consensus 100 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~ 145 (348)
T 1u5q_A 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE 145 (348)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHH
Confidence 6889999999999999999999999999999999999887766654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=95.91 E-value=0.003 Score=63.63 Aligned_cols=48 Identities=25% Similarity=0.533 Sum_probs=43.2
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++...
T Consensus 92 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~ 140 (373)
T 2qol_A 92 DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH 140 (373)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhC
Confidence 688999999999999999999999999999999999965 888887543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.91 E-value=0.0032 Score=62.04 Aligned_cols=49 Identities=29% Similarity=0.577 Sum_probs=43.4
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
...+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 107 (326)
T 2y0a_A 58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE 107 (326)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh
Confidence 44788999999999999999999999999999999999965 88777643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0034 Score=62.06 Aligned_cols=47 Identities=38% Similarity=0.640 Sum_probs=41.8
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++||||+++++++..++..+++|||+++ ++.+++..
T Consensus 60 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 107 (328)
T 3fe3_A 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA 107 (328)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH
Confidence 678999999999999999999999999999999999975 77666643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=95.89 E-value=0.0025 Score=61.50 Aligned_cols=47 Identities=57% Similarity=1.052 Sum_probs=42.2
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++++..++..
T Consensus 47 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~ 93 (292)
T 3o0g_A 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS 93 (292)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHh
Confidence 67899999999999999999999999999999999999877666543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=95.88 E-value=0.0028 Score=63.59 Aligned_cols=45 Identities=13% Similarity=0.271 Sum_probs=39.7
Q ss_pred hHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+++|+.+ +|||||+++++|..++..++||||+++ +|.+++.
T Consensus 66 ~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~ 112 (361)
T 4f9c_A 66 IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN 112 (361)
T ss_dssp HHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT
T ss_pred HHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc
Confidence 35899999998 799999999999999999999999975 7777664
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.87 E-value=0.0036 Score=62.08 Aligned_cols=49 Identities=41% Similarity=0.687 Sum_probs=44.0
Q ss_pred chhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhcccccc
Q psy12305 134 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDC 182 (516)
Q Consensus 134 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~ 182 (516)
..+.+|+.+|+.++|||||++++++..++..+++|||+++++..++...
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~ 105 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN 105 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhc
Confidence 4788999999999999999999999999999999999998877776543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=95.86 E-value=0.0029 Score=63.44 Aligned_cols=49 Identities=33% Similarity=0.553 Sum_probs=43.3
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
...+.+|+.+|+.++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 108 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ 108 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh
Confidence 34788999999999999999999999999999999999964 77777643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0054 Score=62.65 Aligned_cols=52 Identities=15% Similarity=0.002 Sum_probs=42.4
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccc--cCChhhHHHHHHHHHhccc
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE--EGAPCTAIREVSLLRELRH 239 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~H 239 (516)
...|+|+||+||+|.+..+++.||||+++.... ......+.+|+.+++.+.|
T Consensus 84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~ 137 (413)
T 3dzo_A 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRG 137 (413)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTT
T ss_pred cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhcc
Confidence 347899999999999999999999999884432 2335678899999999977
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.0036 Score=61.17 Aligned_cols=47 Identities=34% Similarity=0.605 Sum_probs=42.7
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++...+..+++|||+++ +|.+++..
T Consensus 80 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 127 (309)
T 3p86_A 80 EFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK 127 (309)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhh
Confidence 688999999999999999999999999999999999976 78777754
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0027 Score=63.02 Aligned_cols=47 Identities=36% Similarity=0.581 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++++.+++..
T Consensus 55 ~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~ 101 (336)
T 3h4j_B 55 RVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE 101 (336)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHH
Confidence 68899999999999999999999999999999999998887776643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.81 E-value=0.0031 Score=62.18 Aligned_cols=48 Identities=31% Similarity=0.533 Sum_probs=44.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++++||||+++++++..++..+++|||+++ +|.+++...
T Consensus 96 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 144 (343)
T 1luf_A 96 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 144 (343)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHh
Confidence 688999999999999999999999999999999999986 888888664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=95.78 E-value=0.0037 Score=62.87 Aligned_cols=94 Identities=21% Similarity=0.343 Sum_probs=80.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEc-------CCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeeccccccc
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSR-------LTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHT 160 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 160 (516)
..++|++.+.||+|+||+||+|++. .++..||||++...........+.+|+.+|+.+ +|||||++++++..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3478999999999999999999975 345679999998765444455789999999999 89999999999999
Q ss_pred ceeeeeeeehhhh-hhhcccccc
Q psy12305 161 EKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 161 ~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
++..+++|||+++ +|.+++...
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~ 181 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRAR 181 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHT
T ss_pred CCCEEEEEEcCCCCCHHHHHHhh
Confidence 9999999999987 888887654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=95.77 E-value=0.0039 Score=62.50 Aligned_cols=46 Identities=37% Similarity=0.507 Sum_probs=41.2
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|++|+|||||++++++..++..+++|||+++ +|.+++.
T Consensus 74 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 120 (362)
T 2bdw_A 74 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120 (362)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 678999999999999999999999999999999999976 6766554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=95.77 E-value=0.0024 Score=62.96 Aligned_cols=48 Identities=60% Similarity=0.961 Sum_probs=42.7
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~ 182 (516)
.+.+|+.+|++++|||||++++++..++..+++|||++++|.+++...
T Consensus 79 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~ 126 (329)
T 3gbz_A 79 TAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN 126 (329)
T ss_dssp -CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHC
T ss_pred hHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhhc
Confidence 567999999999999999999999999999999999998888777543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=95.74 E-value=0.0077 Score=57.23 Aligned_cols=32 Identities=22% Similarity=0.219 Sum_probs=27.3
Q ss_pred ccccccceeeEEEEEEEecCCce--EEEEEeecc
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNL--VALKEIKLE 218 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~--vAiK~i~~~ 218 (516)
....|+|+||.||+|.+..+|+. ||||+++..
T Consensus 52 ~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~ 85 (258)
T 1zth_A 52 GGVISTGKEANVFYADGVFDGKPVAMAVKIYRIE 85 (258)
T ss_dssp EEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC
T ss_pred CCEEeecceEEEEEEEEcCCCcEeeEEEEEEECC
Confidence 34578999999999999889999 999997643
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=95.69 E-value=0.0042 Score=62.68 Aligned_cols=47 Identities=17% Similarity=0.207 Sum_probs=42.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 72 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 119 (389)
T 3gni_B 72 FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICT 119 (389)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhh
Confidence 678899999999999999999999999999999999985 77776643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=95.67 E-value=0.0064 Score=59.75 Aligned_cols=46 Identities=20% Similarity=0.291 Sum_probs=40.8
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.+++.++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 52 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 98 (323)
T 3tki_A 52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98 (323)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh
Confidence 45899999999999999999999999999999999976 77777653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0036 Score=60.58 Aligned_cols=47 Identities=36% Similarity=0.613 Sum_probs=42.7
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 57 ~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 104 (294)
T 4eqm_A 57 RFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES 104 (294)
T ss_dssp HHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh
Confidence 688999999999999999999999999999999999976 88777654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=95.65 E-value=0.0041 Score=60.35 Aligned_cols=49 Identities=18% Similarity=0.450 Sum_probs=44.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS 183 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~s 183 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++....
T Consensus 72 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 121 (314)
T 2ivs_A 72 DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121 (314)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTT
T ss_pred HHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHh
Confidence 688999999999999999999999999999999999984 8888876543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=95.63 E-value=0.0055 Score=61.60 Aligned_cols=53 Identities=25% Similarity=0.296 Sum_probs=43.2
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 241 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn 241 (516)
....|+|+||+||+|++..+++.||+|+++... .....+.+|+.+++.++|++
T Consensus 42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~E~~~l~~l~~~~ 94 (397)
T 1wak_A 42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE--HYTETALDEIRLLKSVRNSD 94 (397)
T ss_dssp EEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHSC
T ss_pred EEEeeecCCeeEEEEEecCCCeEEEEEEEecCC--cchHHHHHHHHHHHHHhhcC
Confidence 345689999999999999999999999997432 22346789999999997655
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.62 E-value=0.0045 Score=62.13 Aligned_cols=48 Identities=19% Similarity=0.320 Sum_probs=43.2
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++...
T Consensus 120 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 168 (367)
T 3l9p_A 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 168 (367)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhh
Confidence 678999999999999999999999999999999999966 888887654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.60 E-value=0.11 Score=53.61 Aligned_cols=73 Identities=12% Similarity=0.104 Sum_probs=47.2
Q ss_pred eeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCee-ecccccccceeeeeeeehhhh
Q psy12305 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV-TLHDIIHTEKCLTLVFEYLEK 173 (516)
Q Consensus 95 ~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~Ey~~~ 173 (516)
.++.|+.|-...||++....+++.|.+|+..... .......+|..+|+.|...+++ ++++.+. + ..++||+++
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DEIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCC
Confidence 4678999999999999875435788888764321 1111236999999999755554 5666552 2 248888764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.60 E-value=0.0049 Score=60.58 Aligned_cols=47 Identities=28% Similarity=0.539 Sum_probs=42.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++...+..+++|||+++ +|.+++..
T Consensus 47 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 94 (321)
T 1tki_A 47 LVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94 (321)
T ss_dssp HHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS
T ss_pred HHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh
Confidence 477999999999999999999999999999999999976 77777654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=95.59 E-value=0.0063 Score=59.89 Aligned_cols=47 Identities=30% Similarity=0.392 Sum_probs=38.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++ +|..++..
T Consensus 67 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 114 (327)
T 3a62_A 67 HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER 114 (327)
T ss_dssp ----HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh
Confidence 677999999999999999999999999999999999975 77666643
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=95.56 E-value=0.0044 Score=59.85 Aligned_cols=46 Identities=17% Similarity=0.319 Sum_probs=41.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.++++++|||||++++++..++..+++|||+++ +|.++++
T Consensus 77 ~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 123 (286)
T 3uqc_A 77 ETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD 123 (286)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT
T ss_pred HHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh
Confidence 688999999999999999999999999999999999975 7777764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.52 E-value=0.0046 Score=60.12 Aligned_cols=47 Identities=26% Similarity=0.541 Sum_probs=43.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 53 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 100 (310)
T 3s95_A 53 TFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS 100 (310)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh
Confidence 688999999999999999999999999999999999976 88877754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=95.52 E-value=0.0054 Score=58.80 Aligned_cols=93 Identities=26% Similarity=0.361 Sum_probs=80.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCC-------cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccc
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTD-------NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 161 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 161 (516)
..++|.+.+.||+|+||+||+|++..++ ..||+|++..... ...+.+.+|+.+|++++|||||++++++..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 3467999999999999999999998877 4699999976433 3334789999999999999999999999999
Q ss_pred eeeeeeeehhhh-hhhcccccc
Q psy12305 162 KCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 162 ~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+..+++|||+++ +|.+++...
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~ 106 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN 106 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT
T ss_pred CCCEEEEECCCCCCHHHHHHhC
Confidence 999999999985 888887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=95.51 E-value=0.0062 Score=57.81 Aligned_cols=46 Identities=28% Similarity=0.512 Sum_probs=41.2
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 52 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 98 (269)
T 4hcu_A 52 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 98 (269)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh
Confidence 56899999999999999999999999999999999976 77777644
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=95.45 E-value=0.0061 Score=62.26 Aligned_cols=46 Identities=22% Similarity=0.301 Sum_probs=41.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|+.++|||||++++++..++..++||||+++ +|..++.
T Consensus 115 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~ 161 (410)
T 3v8s_A 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS 161 (410)
T ss_dssp THHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 688999999999999999999999999999999999965 7776664
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=95.45 E-value=0.013 Score=63.45 Aligned_cols=60 Identities=13% Similarity=0.138 Sum_probs=47.3
Q ss_pred ccccccccceeeEEEEEEEecCCceEEEEEeeccc--ccCChhhHHHHHHHHHhccccceee
Q psy12305 185 ILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 185 ~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
.+...+|+|+||+||+|+++.+|+.||||++++.. .........+|..++..+.+-+-..
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~ 253 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTT
T ss_pred EEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCC
Confidence 34566899999999999999999999999998764 4555566777888888777755443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.44 E-value=0.0053 Score=63.44 Aligned_cols=46 Identities=35% Similarity=0.462 Sum_probs=41.2
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++ +|.+.+.
T Consensus 56 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~ 102 (444)
T 3soa_A 56 KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV 102 (444)
T ss_dssp HHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHH
T ss_pred HHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHH
Confidence 678999999999999999999999999999999999976 6665553
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=95.43 E-value=0.0063 Score=57.69 Aligned_cols=49 Identities=29% Similarity=0.428 Sum_probs=40.8
Q ss_pred CcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 132 APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 132 ~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
..+.+.+|+.+++.++||||+++++++..++..+++|||+++ ++.+++.
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 98 (271)
T 3dtc_A 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS 98 (271)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh
Confidence 344789999999999999999999999999999999999975 6666653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.0055 Score=62.03 Aligned_cols=47 Identities=21% Similarity=0.388 Sum_probs=42.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+.+ +|..++..
T Consensus 61 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 108 (384)
T 4fr4_A 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ 108 (384)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh
Confidence 788999999999999999999999999999999999976 77666643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=95.41 E-value=0.006 Score=59.08 Aligned_cols=45 Identities=31% Similarity=0.412 Sum_probs=40.0
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+|+.++|||||++++++..++..+++|||+++ +|.+++.
T Consensus 64 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 109 (297)
T 3fxz_A 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT 109 (297)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHh
Confidence 46899999999999999999999999999999999965 7777664
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=95.41 E-value=0.0045 Score=59.66 Aligned_cols=48 Identities=65% Similarity=0.987 Sum_probs=43.3
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~ 182 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++++.+++...
T Consensus 48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~ 95 (299)
T 2r3i_A 48 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS 95 (299)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT
T ss_pred HHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEEcccCCHHHHHHhh
Confidence 678999999999999999999999999999999999998887776543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.0061 Score=63.93 Aligned_cols=48 Identities=33% Similarity=0.485 Sum_probs=42.3
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
...+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++.
T Consensus 90 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 138 (504)
T 3q5i_A 90 HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII 138 (504)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH
Confidence 44788999999999999999999999999999999999976 6666553
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=95.38 E-value=0.0097 Score=61.06 Aligned_cols=60 Identities=25% Similarity=0.322 Sum_probs=45.7
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcccc---ceeeEeeeE
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA---NIVTLHDII 249 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~ 249 (516)
...|+|+||+||+|.+..+++.||+|+++... .....+.+|+.+++.++|. +...+..++
T Consensus 103 ~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~ 165 (429)
T 3kvw_A 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHML 165 (429)
T ss_dssp EEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEE
T ss_pred EEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEE
Confidence 45689999999999999999999999997542 2234567899999998765 555444443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=95.35 E-value=0.0064 Score=59.65 Aligned_cols=48 Identities=19% Similarity=0.317 Sum_probs=43.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++...
T Consensus 79 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 127 (327)
T 2yfx_A 79 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127 (327)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHT
T ss_pred HHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhh
Confidence 678999999999999999999999999999999999964 888887654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=95.34 E-value=0.0035 Score=59.37 Aligned_cols=48 Identities=17% Similarity=0.236 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccc--eeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTE--KCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.++++++||||+++++++... +..+++|||+++ +|.+++...
T Consensus 53 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 103 (271)
T 3kmu_A 53 DFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG 103 (271)
T ss_dssp HHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC
T ss_pred HHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc
Confidence 688999999999999999999999876 778999999986 888887653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.31 E-value=0.0061 Score=61.35 Aligned_cols=46 Identities=28% Similarity=0.504 Sum_probs=41.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|++|+|||||++++++...+..+++|||+++ +|.+++.
T Consensus 132 ~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~ 178 (373)
T 2x4f_A 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRII 178 (373)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHH
Confidence 578999999999999999999999999999999999975 6666554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=95.30 E-value=0.0068 Score=58.18 Aligned_cols=46 Identities=22% Similarity=0.383 Sum_probs=41.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|++++||||+++++++...+..+++|||+++ +|.+++.
T Consensus 66 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 112 (285)
T 3is5_A 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIV 112 (285)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHH
T ss_pred HHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHH
Confidence 578999999999999999999999999999999999976 6666653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=95.29 E-value=0.0072 Score=57.71 Aligned_cols=49 Identities=37% Similarity=0.646 Sum_probs=43.2
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh-hhhhccccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDD 181 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~-~~L~~~l~~ 181 (516)
.+.+.+|+.+|++++||||+++++++..++..+++|||++ .+|.+++..
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 101 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE 101 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh
Confidence 4478999999999999999999999999999999999996 477777643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=95.28 E-value=0.0094 Score=56.57 Aligned_cols=47 Identities=19% Similarity=0.288 Sum_probs=42.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+++.++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 98 (276)
T 2yex_A 51 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98 (276)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT
T ss_pred HHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh
Confidence 578999999999999999999999999999999999976 77777653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=95.27 E-value=0.0069 Score=60.99 Aligned_cols=57 Identities=28% Similarity=0.282 Sum_probs=44.8
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeE
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTL 245 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l 245 (516)
....|+|+||+||+|.+..+++.||+|+++... .....+.+|+.+++.++ |+++...
T Consensus 59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~ 116 (382)
T 2vx3_A 59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK--AFLNQAQIEVRLLELMNKHDTEMKY 116 (382)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHCSSGGGG
T ss_pred EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH--HHHHHHHHHHHHHHHHHhcccccce
Confidence 345789999999999999999999999997432 12345678999999996 7776643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=95.26 E-value=0.0073 Score=62.96 Aligned_cols=47 Identities=30% Similarity=0.502 Sum_probs=42.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 62 ~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 109 (476)
T 2y94_A 62 KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK 109 (476)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh
Confidence 688999999999999999999999999999999999965 78777653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.25 E-value=0.0075 Score=57.46 Aligned_cols=47 Identities=23% Similarity=0.478 Sum_probs=42.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 57 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 104 (278)
T 3cok_A 57 RVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN 104 (278)
T ss_dssp HHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh
Confidence 688999999999999999999999999999999999975 77776654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=95.25 E-value=0.0068 Score=59.32 Aligned_cols=49 Identities=31% Similarity=0.539 Sum_probs=43.4
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
...+.+|+.+|++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 108 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ 108 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh
Confidence 34788999999999999999999999999999999999965 78777653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=95.23 E-value=0.0069 Score=63.45 Aligned_cols=47 Identities=21% Similarity=0.526 Sum_probs=42.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 262 ~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~ 309 (495)
T 1opk_A 262 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 309 (495)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHh
Confidence 688999999999999999999999999999999999985 88887754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=95.21 E-value=0.02 Score=55.97 Aligned_cols=48 Identities=25% Similarity=0.399 Sum_probs=43.4
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|+++ +||||+++++++..++..+++|||+++ +|.+++...
T Consensus 71 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 120 (327)
T 1fvr_A 71 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 120 (327)
T ss_dssp HHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTT
T ss_pred HHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhc
Confidence 578999999999 999999999999999999999999976 888887654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.14 E-value=0.0064 Score=59.71 Aligned_cols=47 Identities=15% Similarity=0.322 Sum_probs=42.3
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++...+..+++|||+++ +|..++..
T Consensus 52 ~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 99 (318)
T 1fot_A 52 HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK 99 (318)
T ss_dssp HHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred HHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH
Confidence 678999999999999999999999999999999999976 77777653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=95.14 E-value=0.0085 Score=57.98 Aligned_cols=86 Identities=23% Similarity=0.379 Sum_probs=72.5
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc---cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE---EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
|...+.||+|+||+||+|++ +++.||||++..... ....+.+.+|+.++++++||||+++++++..++..+++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 55568999999999999986 689999999976432 2223468899999999999999999999999999999999
Q ss_pred hhhh-hhhcccc
Q psy12305 170 YLEK-DLKRYMD 180 (516)
Q Consensus 170 y~~~-~L~~~l~ 180 (516)
|+++ +|.+++.
T Consensus 111 ~~~~~~L~~~l~ 122 (307)
T 2nru_A 111 YMPNGSLLDRLS 122 (307)
T ss_dssp CCTTCBHHHHHH
T ss_pred ecCCCcHHHHHH
Confidence 9965 7776664
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=95.12 E-value=0.0089 Score=56.60 Aligned_cols=46 Identities=22% Similarity=0.381 Sum_probs=41.0
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.++++++||||+++++++..++..+++|||+++ ++.+++..
T Consensus 50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 96 (268)
T 3sxs_A 50 FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS 96 (268)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH
Confidence 56899999999999999999999999999999999975 67777654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=95.12 E-value=0.0082 Score=58.17 Aligned_cols=49 Identities=24% Similarity=0.287 Sum_probs=44.0
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS 183 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~s 183 (516)
.+.+|+.+|+++ +||||+++++++..++..+++|||+++ +|.+++....
T Consensus 72 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 122 (313)
T 1t46_A 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKR 122 (313)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTT
T ss_pred HHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcc
Confidence 688999999999 999999999999999999999999976 8888876543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=95.11 E-value=0.0086 Score=59.36 Aligned_cols=46 Identities=24% Similarity=0.364 Sum_probs=41.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|+.++||||+++++++...+..+++|||+++ +|..++.
T Consensus 51 ~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~ 97 (337)
T 1o6l_A 51 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97 (337)
T ss_dssp HHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred HHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHH
Confidence 678999999999999999999999999999999999976 6766654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=95.11 E-value=0.0081 Score=59.88 Aligned_cols=47 Identities=17% Similarity=0.298 Sum_probs=42.3
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++ +|..++..
T Consensus 87 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 134 (350)
T 1rdq_E 87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR 134 (350)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH
Confidence 788999999999999999999999999999999999975 77777654
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=95.10 E-value=0.0082 Score=61.64 Aligned_cols=45 Identities=31% Similarity=0.577 Sum_probs=39.4
Q ss_pred HHHHHHHHhcCCCCeeecccccccc-----eeeeeeeehhhhhhhccccc
Q psy12305 137 IREVSLLRELRHANIVTLHDIIHTE-----KCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 137 ~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+|+.+|++++|||||++++++... ...+++|||++++|.+++..
T Consensus 73 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~ 122 (432)
T 3n9x_A 73 LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT 122 (432)
T ss_dssp HHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHS
T ss_pred HHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhc
Confidence 3799999999999999999998776 56899999999888887754
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.10 E-value=0.0094 Score=60.34 Aligned_cols=47 Identities=26% Similarity=0.523 Sum_probs=41.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..+...+++|||+++ +|.+++..
T Consensus 94 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 141 (387)
T 1kob_A 94 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 141 (387)
T ss_dssp HHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC
T ss_pred HHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh
Confidence 577999999999999999999999999999999999975 77776654
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=95.10 E-value=0.0092 Score=59.35 Aligned_cols=48 Identities=35% Similarity=0.531 Sum_probs=40.7
Q ss_pred chhHHHHHHHHhcCCCCeeecccccc-----cceeeeeeeehhhhhhhccccc
Q psy12305 134 CTAIREVSLLRELRHANIVTLHDIIH-----TEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 134 ~~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
+.+.+|+.+|++++||||+++++++. .....+++|||+++++.+++..
T Consensus 74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~ 126 (362)
T 3pg1_A 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHD 126 (362)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHC
T ss_pred HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHh
Confidence 47899999999999999999999983 3446899999999887777654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=95.08 E-value=0.0083 Score=59.18 Aligned_cols=49 Identities=29% Similarity=0.443 Sum_probs=44.4
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCS 183 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~s 183 (516)
.+.+|+.+|+++ +||||+++++++..++..+++|||+++ +|.+++....
T Consensus 94 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 144 (344)
T 1rjb_A 94 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144 (344)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT
T ss_pred HHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcc
Confidence 688999999999 999999999999999999999999976 8888886654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=95.07 E-value=0.0079 Score=62.91 Aligned_cols=45 Identities=29% Similarity=0.442 Sum_probs=40.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l 179 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++ +|.+++
T Consensus 82 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~ 127 (494)
T 3lij_A 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI 127 (494)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHH
Confidence 688999999999999999999999999999999999976 665544
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=95.07 E-value=0.0076 Score=58.81 Aligned_cols=48 Identities=21% Similarity=0.452 Sum_probs=43.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++++||||+++++++..++..+++|||+++ +|.+++...
T Consensus 74 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 122 (322)
T 1p4o_A 74 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 122 (322)
T ss_dssp HHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHh
Confidence 578999999999999999999999999999999999976 888887654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=95.03 E-value=0.0091 Score=58.36 Aligned_cols=47 Identities=26% Similarity=0.437 Sum_probs=42.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 81 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 128 (321)
T 2qkw_B 81 EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYG 128 (321)
T ss_dssp HHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSS
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhc
Confidence 578999999999999999999999999999999999975 88777654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=95.02 E-value=0.011 Score=56.57 Aligned_cols=46 Identities=22% Similarity=0.456 Sum_probs=41.1
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 66 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 112 (283)
T 3gen_A 66 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 112 (283)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC
T ss_pred HHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH
Confidence 56899999999999999999999999999999999965 77777654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=95.02 E-value=0.011 Score=61.03 Aligned_cols=47 Identities=26% Similarity=0.276 Sum_probs=42.8
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|..++|||||+++++|..++..++||||+++ +|..++..
T Consensus 120 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~ 167 (437)
T 4aw2_A 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK 167 (437)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH
Confidence 688999999999999999999999999999999999965 88877755
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=94.98 E-value=0.0098 Score=58.64 Aligned_cols=46 Identities=22% Similarity=0.374 Sum_probs=41.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+++.++||||+++++++..++..+++|||+++ +|.+++.
T Consensus 87 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 133 (335)
T 2owb_A 87 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 133 (335)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHh
Confidence 678999999999999999999999999999999999985 6666553
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=94.94 E-value=0.011 Score=56.90 Aligned_cols=46 Identities=22% Similarity=0.374 Sum_probs=40.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+++.++||||+++++++..++..+++|||+++ ++.+++.
T Consensus 61 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 107 (294)
T 2rku_A 61 KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 107 (294)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHH
Confidence 678999999999999999999999999999999999985 6666553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=94.93 E-value=0.0099 Score=58.47 Aligned_cols=93 Identities=22% Similarity=0.354 Sum_probs=78.9
Q ss_pred cccEeeeeeeccccceEEEEEEEc-------CCCcEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccc
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSR-------LTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTE 161 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~-------~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 161 (516)
.++|++.+.||+|+||+||+|++. .+++.||||++...........+.+|+.+|+++ +||||+++++++..+
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999986 467889999998654444445788999999999 999999999999999
Q ss_pred eeeeeeeehhhh-hhhcccccc
Q psy12305 162 KCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 162 ~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+..+++|||+++ +|.+++...
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~ 135 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRAR 135 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTT
T ss_pred CceEEEEECCCCCcHHHHHHHh
Confidence 999999999976 888887654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=94.90 E-value=0.011 Score=59.20 Aligned_cols=45 Identities=33% Similarity=0.512 Sum_probs=39.8
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+++.++|||||++++++..++..+++|||+++ +|..++.
T Consensus 63 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 108 (361)
T 3uc3_A 63 VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERIC 108 (361)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHH
Confidence 35899999999999999999999999999999999965 7766654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=94.90 E-value=0.011 Score=57.78 Aligned_cols=56 Identities=18% Similarity=0.135 Sum_probs=44.6
Q ss_pred ccccccceeeEEEEEEE-ecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 187 SMNNVKGTYATVFKGKS-RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~-~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
....|+|+||+||+|.+ ..+++.||+|+++... .....+.+|+.+++.++|+++..
T Consensus 19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~ 75 (339)
T 1z57_A 19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD--RYCEAARSEIQVLEHLNTTDPNS 75 (339)
T ss_dssp EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH--HHHHHHHHHHHHHHHHHHHCTTC
T ss_pred EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC--chhHHHHHHHHHHHHhhhcCCCC
Confidence 34568999999999998 5688999999997432 22346788999999999988764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=94.87 E-value=0.011 Score=61.78 Aligned_cols=45 Identities=33% Similarity=0.507 Sum_probs=40.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l 179 (516)
.+.+|+.+|++++|||||++++++...+..+++|||+.+ +|.+.+
T Consensus 67 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 112 (486)
T 3mwu_A 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI 112 (486)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred HHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHH
Confidence 688999999999999999999999999999999999975 665554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.01 Score=60.19 Aligned_cols=88 Identities=36% Similarity=0.609 Sum_probs=68.6
Q ss_pred ccEeee-eeeccccceEEEEEEEc--CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccc--ccceeee
Q psy12305 91 ESYFKL-DKLGQGTYATVFKGKSR--LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII--HTEKCLT 165 (516)
Q Consensus 91 ~~y~~~-~~LG~G~fG~Vyka~~~--~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~ 165 (516)
+.|++. ++||+|+||+||+|+++ .+++.||||++... .....+.+|+.+|++|+|||||++++++ ..+...+
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT---GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS---SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC---CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 458874 48999999999999976 47899999999643 2334788999999999999999999999 4567799
Q ss_pred eeeehhhhhhhccccc
Q psy12305 166 LVFEYLEKDLKRYMDD 181 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~ 181 (516)
++|||+++++..++..
T Consensus 97 lv~e~~~~~l~~~~~~ 112 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKF 112 (405)
T ss_dssp EEEECCSEEHHHHHHH
T ss_pred EEEeCCCCCHHHHHHH
Confidence 9999999887776643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=94.87 E-value=0.011 Score=55.86 Aligned_cols=46 Identities=26% Similarity=0.446 Sum_probs=41.2
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 50 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 96 (267)
T 3t9t_A 50 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT 96 (267)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh
Confidence 56899999999999999999999999999999999975 78777754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=94.85 E-value=0.011 Score=56.54 Aligned_cols=47 Identities=26% Similarity=0.506 Sum_probs=42.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+++.++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 60 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 107 (284)
T 2vgo_A 60 QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK 107 (284)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh
Confidence 688999999999999999999999999999999999975 77766643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=94.82 E-value=0.0069 Score=60.28 Aligned_cols=47 Identities=19% Similarity=0.349 Sum_probs=42.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 77 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 124 (360)
T 3eqc_A 77 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124 (360)
T ss_dssp HHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH
Confidence 678999999999999999999999999999999999976 88777754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=94.82 E-value=0.011 Score=56.04 Aligned_cols=47 Identities=30% Similarity=0.499 Sum_probs=42.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+++.++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 57 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 104 (276)
T 2h6d_A 57 KIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK 104 (276)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc
Confidence 678999999999999999999999999999999999975 77777643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=94.80 E-value=0.011 Score=61.41 Aligned_cols=39 Identities=26% Similarity=0.508 Sum_probs=31.8
Q ss_pred HHHHhcCCCCeeecccccccce------eeeeeeehhhhhhhccc
Q psy12305 141 SLLRELRHANIVTLHDIIHTEK------CLTLVFEYLEKDLKRYM 179 (516)
Q Consensus 141 ~~l~~l~h~niv~l~~~~~~~~------~~~lv~Ey~~~~L~~~l 179 (516)
.+|+.++|||||++++++...+ ..++||||+++++.+.+
T Consensus 113 ~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~ 157 (464)
T 3ttj_A 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI 157 (464)
T ss_dssp HHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHH
T ss_pred HHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHH
Confidence 4678899999999999986653 46999999988766554
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=94.77 E-value=0.012 Score=56.04 Aligned_cols=48 Identities=21% Similarity=0.305 Sum_probs=43.1
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.++..+ +||||+++++++..++..+++|||+++ +|.+++...
T Consensus 56 ~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 105 (289)
T 1x8b_A 56 NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN 105 (289)
T ss_dssp HHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhh
Confidence 678999999999 999999999999999999999999976 888887543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=94.75 E-value=0.013 Score=55.66 Aligned_cols=47 Identities=45% Similarity=0.614 Sum_probs=40.7
Q ss_pred hhHHHHHHHHhcCCCCeeecccccc--cceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIH--TEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.++++++||||+++++++. .++..+++|||+++ +|.+++..
T Consensus 51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 100 (279)
T 2w5a_A 51 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100 (279)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHh
Confidence 6889999999999999999999874 45678999999976 88887754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.74 E-value=0.0091 Score=57.66 Aligned_cols=49 Identities=29% Similarity=0.577 Sum_probs=39.2
Q ss_pred cchhHHHHHHHHhcCCCCeeeccccc--ccceeeeeeeehhhhhhhccccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDII--HTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
...+.+|+.++++++||||+++++++ ...+..+++|||++.++.+++..
T Consensus 50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~ 100 (305)
T 2wtk_C 50 EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDS 100 (305)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHh
Confidence 34789999999999999999999998 44567899999998876665543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=94.74 E-value=0.01 Score=61.84 Aligned_cols=46 Identities=30% Similarity=0.408 Sum_probs=40.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|++++|||||++++++...+..+++|||+.+ +|.+++.
T Consensus 72 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 118 (484)
T 3nyv_A 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 118 (484)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 788999999999999999999999999999999999975 6655553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.73 E-value=0.016 Score=55.90 Aligned_cols=46 Identities=26% Similarity=0.509 Sum_probs=38.5
Q ss_pred cchhHHHHHHHHhcCCCCeeeccccccc--ceeeeeeeehhhh-hhhcc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLEK-DLKRY 178 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~Ey~~~-~L~~~ 178 (516)
.+.+.+|+.+|++++||||+++++++.. ++..+++|||+++ ++.++
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 128 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV 128 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCS
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHH
Confidence 4578999999999999999999999876 5678999999975 55443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.72 E-value=0.012 Score=60.22 Aligned_cols=47 Identities=28% Similarity=0.273 Sum_probs=42.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|..++|||||++++++..++..+++|||+++ +|..++..
T Consensus 107 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~ 154 (412)
T 2vd5_A 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK 154 (412)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh
Confidence 688999999999999999999999999999999999965 88877754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=94.71 E-value=0.013 Score=55.78 Aligned_cols=46 Identities=22% Similarity=0.346 Sum_probs=40.7
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ ++.+++.
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 98 (277)
T 3f3z_A 52 RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVV 98 (277)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHH
Confidence 578999999999999999999999999999999999975 6665553
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=94.68 E-value=0.012 Score=56.20 Aligned_cols=47 Identities=30% Similarity=0.446 Sum_probs=41.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.++++++||||+++++++...+..+++|||++. ++.+++..
T Consensus 55 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~ 102 (279)
T 3fdn_A 55 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 102 (279)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh
Confidence 688999999999999999999999999999999999985 66666543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=94.66 E-value=0.0098 Score=58.15 Aligned_cols=44 Identities=20% Similarity=0.376 Sum_probs=39.6
Q ss_pred HHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+.+++.++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 76 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 120 (326)
T 3uim_A 76 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120 (326)
T ss_dssp HHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHC
T ss_pred HHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHh
Confidence 689999999999999999999999999999999976 77777654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=94.66 E-value=0.01 Score=59.43 Aligned_cols=44 Identities=32% Similarity=0.653 Sum_probs=37.5
Q ss_pred HHHHHHHhcCCCCeeecccccccce------eeeeeeehhhhhhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEK------CLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~Ey~~~~L~~~l~~ 181 (516)
+|+.+|+.++|||||++++++..++ ..+++|||+..+|.+++..
T Consensus 73 ~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~ 122 (367)
T 1cm8_A 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122 (367)
T ss_dssp HHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH
T ss_pred HHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc
Confidence 6999999999999999999987763 3599999998788777643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=94.65 E-value=0.011 Score=57.31 Aligned_cols=47 Identities=28% Similarity=0.543 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 78 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 125 (310)
T 2wqm_A 78 DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKH 125 (310)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHH
Confidence 688999999999999999999999999999999999986 77777654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=94.64 E-value=0.014 Score=55.72 Aligned_cols=47 Identities=21% Similarity=0.526 Sum_probs=42.3
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+++.++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 55 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 102 (288)
T 3kfa_A 55 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 102 (288)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHh
Confidence 578999999999999999999999999999999999984 88777754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=94.64 E-value=0.014 Score=58.50 Aligned_cols=42 Identities=26% Similarity=0.522 Sum_probs=36.5
Q ss_pred HHHHHHHhcCCCCeeecccccccce------eeeeeeehhhhhhhccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEK------CLTLVFEYLEKDLKRYM 179 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~------~~~lv~Ey~~~~L~~~l 179 (516)
+|+.+|+.++|||||++++++...+ ..+++|||+++++.+++
T Consensus 73 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~ 120 (371)
T 2xrw_A 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI 120 (371)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHH
T ss_pred HHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHH
Confidence 6899999999999999999987654 68999999998776665
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=94.62 E-value=0.0098 Score=57.84 Aligned_cols=47 Identities=19% Similarity=0.290 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 80 ~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 127 (309)
T 2h34_A 80 RMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR 127 (309)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh
Confidence 688999999999999999999999999999999999986 88777654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=94.61 E-value=0.011 Score=60.75 Aligned_cols=45 Identities=22% Similarity=0.330 Sum_probs=40.5
Q ss_pred HHHHHHHhc-CCCCeeecccccccceeeeeeeehhhhhhhcccccc
Q psy12305 138 REVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDC 182 (516)
Q Consensus 138 ~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~ 182 (516)
+|+.+|+++ +|||||++++++..++..+++|||++++|.+++...
T Consensus 57 ~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~ 102 (434)
T 2rio_A 57 MEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESK 102 (434)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC
T ss_pred HHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhcc
Confidence 699999987 899999999999999999999999998888887654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=94.60 E-value=0.014 Score=55.59 Aligned_cols=45 Identities=38% Similarity=0.539 Sum_probs=39.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l 179 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ ++..++
T Consensus 51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~ 96 (284)
T 3kk8_A 51 KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI 96 (284)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred HHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHH
Confidence 678999999999999999999999999999999999975 555544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=94.59 E-value=0.016 Score=57.14 Aligned_cols=47 Identities=15% Similarity=0.392 Sum_probs=42.7
Q ss_pred chhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 134 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 134 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
..+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++.
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 135 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE 135 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESS
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHH
Confidence 4788999999999999999999999999999999999987 8877743
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.013 Score=56.74 Aligned_cols=44 Identities=36% Similarity=0.719 Sum_probs=39.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRY 178 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~ 178 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ .+..+
T Consensus 48 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 92 (311)
T 4agu_A 48 IALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHEL 92 (311)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred HHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHH
Confidence 678999999999999999999999999999999999987 44444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=94.50 E-value=0.012 Score=57.62 Aligned_cols=46 Identities=22% Similarity=0.372 Sum_probs=40.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|++++|||||++++++..++..+++|||+++ +|.+++.
T Consensus 88 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 134 (321)
T 2c30_A 88 LLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS 134 (321)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHT
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHH
Confidence 578999999999999999999999999999999999976 6666654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=94.48 E-value=0.016 Score=55.74 Aligned_cols=48 Identities=33% Similarity=0.655 Sum_probs=42.3
Q ss_pred chhHHHHHHHHhcC-CCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 134 CTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 134 ~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
..+.+|+.+|+++. ||||+++++++..++..+++|||+++ +|.+++..
T Consensus 68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 117 (298)
T 1phk_A 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117 (298)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc
Confidence 47789999999995 99999999999999999999999975 77777653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=94.46 E-value=0.0058 Score=58.90 Aligned_cols=45 Identities=20% Similarity=0.325 Sum_probs=35.6
Q ss_pred HHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 137 IREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 137 ~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+|+.++++++||||+++++++..++..+++|||+++ +|.+++..
T Consensus 61 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 106 (303)
T 2vwi_A 61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKH 106 (303)
T ss_dssp -----CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHH
Confidence 4688999999999999999999999999999999965 77777653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.45 E-value=0.013 Score=57.98 Aligned_cols=49 Identities=29% Similarity=0.453 Sum_probs=42.0
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh--hhhccccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK--DLKRYMDD 181 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~--~L~~~l~~ 181 (516)
...+.+|+.+|++++|||||++++++..++..+++|||+.. ++..++..
T Consensus 73 ~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~ 123 (335)
T 3dls_A 73 LGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR 123 (335)
T ss_dssp TEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh
Confidence 34778999999999999999999999999999999998854 66666543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=94.44 E-value=0.015 Score=57.69 Aligned_cols=47 Identities=30% Similarity=0.378 Sum_probs=41.4
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|.++ +|||||++++++..++..+++|||+++ +|..++..
T Consensus 55 ~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 103 (345)
T 3a8x_A 55 WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR 103 (345)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence 678999999998 899999999999999999999999975 77666643
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=94.41 E-value=0.036 Score=55.12 Aligned_cols=79 Identities=10% Similarity=0.151 Sum_probs=55.4
Q ss_pred EeeeeeeccccceEEEEEEEcCCCcEEEEEEee--cccccCCcchhHHHHHHHHhcC--CCCeeecccccccc---eeee
Q psy12305 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK--LEHEEGAPCTAIREVSLLRELR--HANIVTLHDIIHTE---KCLT 165 (516)
Q Consensus 93 y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~ 165 (516)
...++.|+.|.++.||++... +..+++|+.. ..........+.+|+.+|+.|. +.++.+++.++... +..+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 345788999999999999863 5688898876 4332223347889999999996 45577888777665 5589
Q ss_pred eeeehhhh
Q psy12305 166 LVFEYLEK 173 (516)
Q Consensus 166 lv~Ey~~~ 173 (516)
++|||+++
T Consensus 118 ~vme~v~G 125 (359)
T 3dxp_A 118 YIMEFVSG 125 (359)
T ss_dssp EEEECCCC
T ss_pred EEEEecCC
Confidence 99999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=94.41 E-value=0.017 Score=55.73 Aligned_cols=46 Identities=13% Similarity=0.233 Sum_probs=41.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+++.++||||+++++++..++..+++|||+++ ++.+++.
T Consensus 66 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 112 (303)
T 3a7i_A 66 DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE 112 (303)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHT
T ss_pred HHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHh
Confidence 578999999999999999999999999999999999976 7776664
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=94.39 E-value=0.016 Score=57.30 Aligned_cols=21 Identities=29% Similarity=0.616 Sum_probs=15.5
Q ss_pred ceeeeeeeehhhhhhhccccc
Q psy12305 161 EKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 161 ~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+..+++|||+++++...+..
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~ 116 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSN 116 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHC
T ss_pred CceEEEEEeccCCCHHHHHhh
Confidence 567899999999877666544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.39 E-value=0.02 Score=56.66 Aligned_cols=39 Identities=28% Similarity=0.651 Sum_probs=32.0
Q ss_pred HHHhcCCCCeeeccccccccee------eeeeeehhhhhhhcccc
Q psy12305 142 LLRELRHANIVTLHDIIHTEKC------LTLVFEYLEKDLKRYMD 180 (516)
Q Consensus 142 ~l~~l~h~niv~l~~~~~~~~~------~~lv~Ey~~~~L~~~l~ 180 (516)
+|+.++||||+++++++...+. .+++|||+++++.+++.
T Consensus 76 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 120 (353)
T 3coi_A 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 120 (353)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT
T ss_pred HHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc
Confidence 3677899999999999987654 49999999987777653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=94.39 E-value=0.017 Score=58.05 Aligned_cols=36 Identities=28% Similarity=0.442 Sum_probs=30.3
Q ss_pred cccccccccccceeeEEEEEEEecCCceEEEEEeec
Q psy12305 182 CSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217 (516)
Q Consensus 182 ~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~ 217 (516)
....+....|+|+||.||+|.++.++..||+|.++.
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~ 149 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE 149 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCT
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccc
Confidence 334455668999999999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=94.35 E-value=0.015 Score=61.94 Aligned_cols=47 Identities=26% Similarity=0.339 Sum_probs=42.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.++|||||++++++..++..++||||+++ +|..++..
T Consensus 230 ~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~ 277 (576)
T 2acx_A 230 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYH 277 (576)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHS
T ss_pred HHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHh
Confidence 678999999999999999999999999999999999975 77766643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=94.35 E-value=0.02 Score=55.81 Aligned_cols=46 Identities=22% Similarity=0.417 Sum_probs=38.8
Q ss_pred chhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 134 CTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 134 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
..+.+|+.+|++++||||+++++++..+. .+++|||+++ +|.+++.
T Consensus 60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~ 106 (322)
T 2ycf_A 60 LNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVV 106 (322)
T ss_dssp -CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHS
T ss_pred hhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHh
Confidence 36889999999999999999999987665 8999999976 7766654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=94.32 E-value=0.016 Score=59.82 Aligned_cols=45 Identities=40% Similarity=0.621 Sum_probs=38.7
Q ss_pred HHHHHHHhcCCCCeeecccccccce-eeeeeeehhhh-hhhcccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEK-CLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+|+.+|++++|||||++++++.... ..+++|||+++ +|.+++...
T Consensus 235 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~ 281 (450)
T 1k9a_A 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281 (450)
T ss_dssp HHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH
T ss_pred HHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc
Confidence 6999999999999999999976654 78999999976 888887643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=94.28 E-value=0.016 Score=56.82 Aligned_cols=41 Identities=39% Similarity=0.744 Sum_probs=37.8
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhh
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDL 175 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L 175 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++.+
T Consensus 70 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 110 (331)
T 4aaa_A 70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTI 110 (331)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred HHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcch
Confidence 67899999999999999999999999999999999998743
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=94.28 E-value=0.018 Score=55.49 Aligned_cols=46 Identities=22% Similarity=0.240 Sum_probs=39.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|+.++||||+++++++..++..+++|||+++ ++..++.
T Consensus 62 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 108 (302)
T 2j7t_A 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIML 108 (302)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHH
T ss_pred HHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHH
Confidence 578999999999999999999999999999999999976 6665554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=94.27 E-value=0.018 Score=55.11 Aligned_cols=46 Identities=33% Similarity=0.469 Sum_probs=40.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.++++++||||+++++++...+..++++||+++ ++.+++.
T Consensus 67 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 113 (287)
T 2wei_A 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113 (287)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred HHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHH
Confidence 688999999999999999999999999999999999965 6655543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.20 E-value=0.013 Score=58.18 Aligned_cols=44 Identities=30% Similarity=0.495 Sum_probs=37.3
Q ss_pred HHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+.+|++++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 97 ~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 141 (349)
T 2w4o_A 97 TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE 141 (349)
T ss_dssp --CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT
T ss_pred HHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh
Confidence 588999999999999999999999999999999975 77666543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=94.20 E-value=0.02 Score=57.34 Aligned_cols=43 Identities=33% Similarity=0.668 Sum_probs=37.4
Q ss_pred HHHHHHHhcCCCCeeecccccccceee------eeeeehhhhhhhcccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKCL------TLVFEYLEKDLKRYMD 180 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~~------~lv~Ey~~~~L~~~l~ 180 (516)
+|+.+++.++||||+++++++...+.. +++|||+.+++.+++.
T Consensus 90 ~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~ 138 (371)
T 4exu_A 90 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG 138 (371)
T ss_dssp HHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT
T ss_pred HHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh
Confidence 589999999999999999999877665 9999999987776653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.20 E-value=0.014 Score=57.12 Aligned_cols=31 Identities=74% Similarity=0.976 Sum_probs=26.9
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
...|+|+||+||+|.+..+++.||+|.++..
T Consensus 8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~ 38 (324)
T 3mtl_A 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLE 38 (324)
T ss_dssp EEEEECSSEEEEEEEETTTCCEEEEEEECC-
T ss_pred EEEcCCCCEEEEEEEECCCCcEEEEEEEecc
Confidence 3467899999999999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=94.17 E-value=0.019 Score=60.86 Aligned_cols=47 Identities=23% Similarity=0.304 Sum_probs=42.2
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++...+..+++|||+++ +|..++..
T Consensus 231 ~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~ 278 (543)
T 3c4z_A 231 GAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYN 278 (543)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT
T ss_pred HHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHH
Confidence 788999999999999999999999999999999999985 77766543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=94.14 E-value=0.015 Score=56.01 Aligned_cols=48 Identities=31% Similarity=0.590 Sum_probs=40.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccc--eeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTE--KCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++++||||+++++++... ...+++|||+++ +|.+++...
T Consensus 57 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 107 (295)
T 3ugc_A 57 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 107 (295)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc
Confidence 578999999999999999999998654 448999999966 888877543
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.09 E-value=0.017 Score=55.41 Aligned_cols=47 Identities=19% Similarity=0.329 Sum_probs=41.8
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+++.++|||||++++++...+..+++|||+++ +|..++..
T Consensus 65 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 112 (295)
T 2clq_A 65 PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS 112 (295)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHh
Confidence 578999999999999999999999999999999999964 77777654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=94.09 E-value=0.019 Score=55.00 Aligned_cols=47 Identities=34% Similarity=0.583 Sum_probs=40.0
Q ss_pred hhHHHHHHHHhcCCCCeeeccccccc----ceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHT----EKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++.. ....+++|||+++ +|.+++..
T Consensus 71 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 122 (290)
T 1t4h_A 71 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122 (290)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH
Confidence 68899999999999999999998754 4668999999976 88777754
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.019 Score=55.89 Aligned_cols=44 Identities=16% Similarity=0.455 Sum_probs=36.1
Q ss_pred HHHHHHHhcCCCCeeecccccccceee------eeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKCL------TLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~~------~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+.++++++||||+++++++...... +++|||+++ +|..++..
T Consensus 74 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~ 124 (323)
T 3qup_A 74 REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA 124 (323)
T ss_dssp HHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHh
Confidence 799999999999999999999876654 899999987 77777643
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=94.08 E-value=0.0068 Score=59.00 Aligned_cols=47 Identities=26% Similarity=0.314 Sum_probs=39.5
Q ss_pred hhHHHHHHHHhcCCCCeeeccccccccee----eeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKC----LTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.++++++|||||++++++..... .+++|||+++ +|.+++..
T Consensus 58 ~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 109 (311)
T 3ork_A 58 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT 109 (311)
T ss_dssp HHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh
Confidence 67899999999999999999999876654 4999999975 77777643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=94.08 E-value=0.018 Score=55.24 Aligned_cols=46 Identities=24% Similarity=0.434 Sum_probs=40.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+++.++||||+++++++ ..+..+++|||+++ +|.+++..
T Consensus 64 ~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~ 110 (291)
T 1xbb_A 64 ELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ 110 (291)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh
Confidence 688999999999999999999998 55678999999975 77777654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=94.08 E-value=0.021 Score=56.11 Aligned_cols=45 Identities=31% Similarity=0.502 Sum_probs=39.5
Q ss_pred HHHHHHHHhcC-CCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 137 IREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 137 ~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+|+.++..+. |||||++++++..+...+++|||+++ +|.+++..
T Consensus 53 ~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 99 (325)
T 3kn6_A 53 QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK 99 (325)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh
Confidence 47999999996 99999999999999999999999976 77776643
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=94.06 E-value=0.02 Score=59.03 Aligned_cols=45 Identities=24% Similarity=0.554 Sum_probs=39.5
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.+|++++|||||++++++.. +..+++|||+++ +|.+++..
T Consensus 226 ~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~ 271 (452)
T 1fmk_A 226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG 271 (452)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSH
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHh
Confidence 5789999999999999999999876 668999999976 88888754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=94.05 E-value=0.021 Score=55.14 Aligned_cols=45 Identities=29% Similarity=0.457 Sum_probs=39.5
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.++++++||||+++++++...+..+++|||+++ +|.+++.
T Consensus 53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 98 (304)
T 2jam_A 53 LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL 98 (304)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred HHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHH
Confidence 35899999999999999999999999999999999975 7766653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.03 E-value=0.022 Score=56.79 Aligned_cols=47 Identities=21% Similarity=0.285 Sum_probs=41.5
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|+.+ +|||||++++++..++..+++|||+++ +|..++..
T Consensus 69 ~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 117 (353)
T 3txo_A 69 CTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK 117 (353)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence 678999999998 799999999999999999999999976 77666643
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=94.00 E-value=0.019 Score=57.75 Aligned_cols=47 Identities=36% Similarity=0.678 Sum_probs=40.2
Q ss_pred hhHHHHHHHHhcC-CCCeeecccccccce--eeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELR-HANIVTLHDIIHTEK--CLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|+++. |||||++++++..++ ..+++|||+++++..++..
T Consensus 54 ~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~ 103 (388)
T 3oz6_A 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA 103 (388)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH
T ss_pred HHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc
Confidence 6789999999997 999999999987544 6899999999888777643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=93.97 E-value=0.021 Score=60.41 Aligned_cols=45 Identities=24% Similarity=0.554 Sum_probs=39.5
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.+|++|+|||||++++++.. +..+++|||+++ +|.+++..
T Consensus 309 ~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~ 354 (535)
T 2h8h_A 309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG 354 (535)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSH
T ss_pred HHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhh
Confidence 5789999999999999999999876 668999999976 88888754
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=93.94 E-value=0.025 Score=57.45 Aligned_cols=47 Identities=30% Similarity=0.378 Sum_probs=41.2
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|..+|.++ +|||||++++++..++..++||||+++ +|..++..
T Consensus 98 ~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~ 146 (396)
T 4dc2_A 98 WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR 146 (396)
T ss_dssp HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH
Confidence 678999999987 899999999999999999999999976 77666543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=93.90 E-value=0.024 Score=56.32 Aligned_cols=47 Identities=23% Similarity=0.323 Sum_probs=41.5
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
...+|..+|..+ +|||||++++++..++..+++|||+++ +|..++..
T Consensus 63 ~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 111 (345)
T 1xjd_A 63 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS 111 (345)
T ss_dssp HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH
Confidence 678999999987 999999999999999999999999976 77777654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.87 E-value=0.026 Score=55.78 Aligned_cols=48 Identities=19% Similarity=0.110 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhcCCCCeeeccccccc----ceeeeeeeehhhhhhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHT----EKCLTLVFEYLEKDLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~Ey~~~~L~~~l~~~ 182 (516)
.+.+|+.+++.++||||+++++++.. +...+++|||+..+|.+++...
T Consensus 94 ~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~ 145 (345)
T 2v62_A 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQN 145 (345)
T ss_dssp HHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGG
T ss_pred HHHHHHHhhccccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhc
Confidence 67899999999999999999999877 7889999999977888887654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=93.85 E-value=0.025 Score=54.90 Aligned_cols=47 Identities=26% Similarity=0.427 Sum_probs=41.3
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|.++ +||||+++++++..++..+++|||+++ +|.+++..
T Consensus 56 ~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 104 (316)
T 2ac3_A 56 RVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK 104 (316)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc
Confidence 678999999995 799999999999999999999999974 77777643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=93.85 E-value=0.019 Score=59.21 Aligned_cols=45 Identities=20% Similarity=0.558 Sum_probs=39.2
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.+|++++|||||++++++. .+..+++|||+++ +|.+++..
T Consensus 230 ~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~ 275 (454)
T 1qcf_A 230 FLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS 275 (454)
T ss_dssp HHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHS
T ss_pred HHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHh
Confidence 578999999999999999999986 5678999999976 88888754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=93.83 E-value=0.023 Score=61.41 Aligned_cols=87 Identities=26% Similarity=0.371 Sum_probs=70.1
Q ss_pred Eeee-eeeccccceEEEEEEE--cCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 93 YFKL-DKLGQGTYATVFKGKS--RLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 93 y~~~-~~LG~G~fG~Vyka~~--~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
+.+. ++||+|+||+||+|.+ ..+++.||||+++..... ...+.+.+|+.+|++|+|||||++++++.. +..+++|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~ 448 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVM 448 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEE
Confidence 4443 4899999999999955 456789999999865432 234578999999999999999999999864 4578999
Q ss_pred ehhhh-hhhcccc
Q psy12305 169 EYLEK-DLKRYMD 180 (516)
Q Consensus 169 Ey~~~-~L~~~l~ 180 (516)
||+++ +|.+++.
T Consensus 449 E~~~~g~L~~~l~ 461 (635)
T 4fl3_A 449 EMAELGPLNKYLQ 461 (635)
T ss_dssp ECCTTEEHHHHHH
T ss_pred EccCCCCHHHHHh
Confidence 99976 7777764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.82 E-value=0.023 Score=55.09 Aligned_cols=42 Identities=31% Similarity=0.389 Sum_probs=36.3
Q ss_pred HHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+.+|++++|||||++++++.. ..+++|||+++ +|.+++..
T Consensus 50 ~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~ 92 (307)
T 2eva_A 50 VELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHG 92 (307)
T ss_dssp HHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHC
T ss_pred HHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhc
Confidence 69999999999999999998874 47999999976 88777754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=93.79 E-value=0.027 Score=56.44 Aligned_cols=22 Identities=18% Similarity=0.188 Sum_probs=13.5
Q ss_pred ccceeeeeeeehhhhhhhcccc
Q psy12305 159 HTEKCLTLVFEYLEKDLKRYMD 180 (516)
Q Consensus 159 ~~~~~~~lv~Ey~~~~L~~~l~ 180 (516)
......++++|++..+|.+++.
T Consensus 104 ~~~~~~~lv~e~~~~~L~~~~~ 125 (367)
T 2fst_X 104 EEFNDVYLVTHLMGADLNNIVK 125 (367)
T ss_dssp GGCCCCEEEEECCCEECC----
T ss_pred ccCCeEEEEecccCCCHHHHHh
Confidence 3445578999999877766654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=93.73 E-value=0.024 Score=56.19 Aligned_cols=43 Identities=28% Similarity=0.447 Sum_probs=37.2
Q ss_pred HHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 138 REVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 138 ~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+|+.+|.++ +|||||++++++..++..+++|||+++ +|.+++.
T Consensus 64 ~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~ 108 (342)
T 2qr7_A 64 EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL 108 (342)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred HHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHH
Confidence 488888888 899999999999999999999999975 6666554
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.67 E-value=0.026 Score=54.68 Aligned_cols=45 Identities=18% Similarity=0.324 Sum_probs=40.3
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+|+.++||||+++++++..++..+++|||+++ +|.+++.
T Consensus 71 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 116 (314)
T 3com_A 71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR 116 (314)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHH
T ss_pred HHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHH
Confidence 46899999999999999999999999999999999976 7777764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=93.63 E-value=0.029 Score=53.61 Aligned_cols=92 Identities=26% Similarity=0.334 Sum_probs=66.9
Q ss_pred ccccEeeeeeeccccceEEEEEEEcC-CCc--EEEEEEeecccc--cCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRL-TDN--LVALKEIKLEHE--EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~-~g~--~vAvK~i~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
..++|++++.||+|+||+||+|++.. +++ .||||++..... ....+.+.+|+.++++++||||+++++++..+.
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence 34679999999999999999999754 333 699999976532 223447889999999999999999999988765
Q ss_pred eeeeeehhhh-hhhccccc
Q psy12305 164 LTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 164 ~~lv~Ey~~~-~L~~~l~~ 181 (516)
.++++||++. ++.+++..
T Consensus 95 ~~~v~e~~~~~~L~~~l~~ 113 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRK 113 (291)
T ss_dssp CEEEEECCTTCBHHHHHHH
T ss_pred ceeeEecccCCCHHHHHHh
Confidence 8899999975 77776654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.61 E-value=0.011 Score=57.47 Aligned_cols=48 Identities=23% Similarity=0.286 Sum_probs=41.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.++++++||||+++++++..++..+++|||+++ +|.+++...
T Consensus 75 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~ 123 (319)
T 2y4i_B 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA 123 (319)
T ss_dssp CCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSS
T ss_pred HHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhc
Confidence 456799999999999999999999999999999999974 888777543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=93.59 E-value=0.024 Score=55.55 Aligned_cols=45 Identities=22% Similarity=0.268 Sum_probs=40.7
Q ss_pred HHHHHHHhc-CCCCeeecccccccceeeeeeeehhhhhhhcccccc
Q psy12305 138 REVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDC 182 (516)
Q Consensus 138 ~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~~ 182 (516)
+|+.++++| +||||+++++++..++..+++|||+..+|.+++...
T Consensus 53 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~ 98 (330)
T 2izr_A 53 LEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLC 98 (330)
T ss_dssp HHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHT
T ss_pred HHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHc
Confidence 699999999 999999999999999999999999977888887653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=93.53 E-value=0.029 Score=53.59 Aligned_cols=46 Identities=30% Similarity=0.423 Sum_probs=38.6
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+.+|+.++++++||||+++++++.... +++|||++. ++.+++.
T Consensus 67 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~ 113 (287)
T 4f0f_A 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLL 113 (287)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHh
Confidence 347899999999999999999999987665 799999974 7765553
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=93.46 E-value=0.048 Score=53.18 Aligned_cols=34 Identities=18% Similarity=0.218 Sum_probs=29.4
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeecccc
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE 220 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~ 220 (516)
....|+|+||.||+|.+..+++.||+|.++....
T Consensus 48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~ 81 (320)
T 3a99_A 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRI 81 (320)
T ss_dssp EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGC
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccc
Confidence 4457899999999999999999999999986543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.37 E-value=0.43 Score=48.65 Aligned_cols=73 Identities=12% Similarity=0.114 Sum_probs=46.5
Q ss_pred eeeeeccccceEEEEEEEcCC-------CcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCee-ecccccccceeeee
Q psy12305 95 KLDKLGQGTYATVFKGKSRLT-------DNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV-TLHDIIHTEKCLTL 166 (516)
Q Consensus 95 ~~~~LG~G~fG~Vyka~~~~~-------g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~l 166 (516)
.++.|.-|--..+|++..... ++.|.+++-.... .......+|..+++.|..-+|+ ++++.+. -+.
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t--~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV--GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc--chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888999999987521 5788888854322 2222456899999988533332 4443221 367
Q ss_pred eeehhhh
Q psy12305 167 VFEYLEK 173 (516)
Q Consensus 167 v~Ey~~~ 173 (516)
++||+++
T Consensus 148 I~efI~G 154 (424)
T 3mes_A 148 IEEFIDG 154 (424)
T ss_dssp EEECCCS
T ss_pred EEEEeCC
Confidence 8888875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=93.35 E-value=0.034 Score=53.87 Aligned_cols=43 Identities=16% Similarity=0.431 Sum_probs=34.9
Q ss_pred HHHHHHHhcCCCCeeeccccccccee-----eeeeeehhhh-hhhcccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKC-----LTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~Ey~~~-~L~~~l~ 180 (516)
+|+.++++++||||+++++++...+. .+++|||++. +|..++.
T Consensus 85 ~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 133 (313)
T 3brb_A 85 SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLL 133 (313)
T ss_dssp HHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHH
T ss_pred HHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHH
Confidence 58999999999999999999877543 5999999986 7777763
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=93.33 E-value=0.022 Score=60.34 Aligned_cols=86 Identities=17% Similarity=0.147 Sum_probs=59.7
Q ss_pred eeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccC-------CcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 94 FKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEG-------APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 94 ~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
...+.||+|+||+||+|+ ..++.+|+|+........ ..+.+.+|+++|++++|||||++..++..++..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 456799999999999994 468999999875432211 12347899999999999999966555556667799
Q ss_pred eeehhh-hhhhccccc
Q psy12305 167 VFEYLE-KDLKRYMDD 181 (516)
Q Consensus 167 v~Ey~~-~~L~~~l~~ 181 (516)
+|||++ .+|.+++..
T Consensus 417 VmE~~~ggsL~~~l~~ 432 (540)
T 3en9_A 417 MMSYINGKLAKDVIED 432 (540)
T ss_dssp EEECCCSEEHHHHSTT
T ss_pred EEECCCCCCHHHHHHH
Confidence 999997 588888765
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=93.33 E-value=0.032 Score=55.67 Aligned_cols=47 Identities=32% Similarity=0.555 Sum_probs=41.9
Q ss_pred chhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 134 CTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 134 ~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
..+.+|+.+++++ +||||+++++++...+..+++|||+++ +|.+++.
T Consensus 144 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~ 192 (365)
T 2y7j_A 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLT 192 (365)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHH
Confidence 3678999999999 899999999999999999999999986 7777664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=93.25 E-value=0.041 Score=52.20 Aligned_cols=45 Identities=22% Similarity=0.541 Sum_probs=38.3
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.+|++++||||+++++++.. +..+++|||+++ +|.+++..
T Consensus 55 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~ 100 (279)
T 1qpc_A 55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT 100 (279)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTS
T ss_pred HHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhc
Confidence 5689999999999999999998864 458999999965 88887754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=93.23 E-value=0.035 Score=55.72 Aligned_cols=47 Identities=23% Similarity=0.408 Sum_probs=34.2
Q ss_pred hhHHHHHH-HHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSL-LRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|..+ ++.++|||||++++++...+..+++|||+++ +|..++..
T Consensus 84 ~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 132 (373)
T 2r5t_A 84 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR 132 (373)
T ss_dssp -------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh
Confidence 34566666 4678999999999999999999999999976 77666643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=93.20 E-value=0.021 Score=62.23 Aligned_cols=45 Identities=29% Similarity=0.437 Sum_probs=35.3
Q ss_pred hHHHHHHHHhcCCCCeeeccccccccee-----eeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKC-----LTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+|++++|||||++++++...+. .++||||+++ +|.+++.
T Consensus 126 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~ 176 (681)
T 2pzi_A 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG 176 (681)
T ss_dssp HHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----
T ss_pred HHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh
Confidence 3579999999999999999999987655 6999999975 6655543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=93.18 E-value=0.027 Score=55.97 Aligned_cols=48 Identities=25% Similarity=0.391 Sum_probs=41.9
Q ss_pred chhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 134 CTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 134 ~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
..+.+|+.+|+++ +||||+++++++..++..+++|||+++ +|.+++..
T Consensus 103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 152 (355)
T 1vzo_A 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ 152 (355)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH
T ss_pred HHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH
Confidence 3677899999999 699999999999999999999999976 77777643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=93.11 E-value=0.095 Score=52.81 Aligned_cols=77 Identities=18% Similarity=0.124 Sum_probs=50.2
Q ss_pred eeeeeccccceEEEEEEEcCCCcEEEEEEeecccc------cCCcchhHHHHHHHHhcCC--CCee-ecccccccceeee
Q psy12305 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE------EGAPCTAIREVSLLRELRH--ANIV-TLHDIIHTEKCLT 165 (516)
Q Consensus 95 ~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~------~~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~ 165 (516)
.++.||.|.++.||++.+..+++.|+||....... ........+|.++|+.+.. |..| +++.+ ..+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999998766678999998653211 1223466889999998843 3333 44433 233468
Q ss_pred eeeehhhh
Q psy12305 166 LVFEYLEK 173 (516)
Q Consensus 166 lv~Ey~~~ 173 (516)
++||++++
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=93.11 E-value=0.02 Score=55.93 Aligned_cols=44 Identities=25% Similarity=0.345 Sum_probs=37.3
Q ss_pred HHHHHHHhcCCCCeeecccccccce----eeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEK----CLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+.+|++++|||||++++++..+. ..+++|||+++ +|.+++..
T Consensus 67 ~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 115 (322)
T 3soc_A 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA 115 (322)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh
Confidence 4899999999999999999987754 36999999976 88887754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=93.04 E-value=0.013 Score=60.32 Aligned_cols=46 Identities=24% Similarity=0.340 Sum_probs=34.8
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|+.++|||||++++++...+..++||||+++ +|..++.
T Consensus 194 ~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~ 240 (446)
T 4ejn_A 194 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLS 240 (446)
T ss_dssp -------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHH
T ss_pred HHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHH
Confidence 567899999999999999999999999999999999976 6665553
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=93.00 E-value=0.042 Score=53.64 Aligned_cols=46 Identities=28% Similarity=0.476 Sum_probs=38.6
Q ss_pred hHHHHHHHHhcCCCCeeecccccc--cceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIH--TEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+.+|++++||||+++++++. .....+++|||+++ +|.+++..
T Consensus 71 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 119 (327)
T 3lxl_A 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR 119 (327)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh
Confidence 458999999999999999999876 45668899999965 78777754
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=92.95 E-value=0.038 Score=52.96 Aligned_cols=87 Identities=26% Similarity=0.353 Sum_probs=70.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
++|++.++||+|+||+||+|++. ..||||++..... ....+.+.+|+.+|++++||||+++++++ ..+..+++||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 56999999999999999999864 4699999976543 22334688999999999999999999965 4556899999
Q ss_pred hhhh-hhhccccc
Q psy12305 170 YLEK-DLKRYMDD 181 (516)
Q Consensus 170 y~~~-~L~~~l~~ 181 (516)
|+++ +|.+++..
T Consensus 100 ~~~~~~L~~~l~~ 112 (289)
T 3og7_A 100 WCEGSSLYHHLHA 112 (289)
T ss_dssp CCCEEEHHHHHTT
T ss_pred ecCCCcHHHHHhh
Confidence 9975 67666643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.93 E-value=0.043 Score=53.20 Aligned_cols=44 Identities=20% Similarity=0.333 Sum_probs=37.5
Q ss_pred HHHHHHHhcCCCCeeecccccc----cceeeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIH----TEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+.+++.++||||+++++++. .....+++|||++. +|.+++..
T Consensus 75 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 123 (317)
T 2buj_A 75 READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIER 123 (317)
T ss_dssp HHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHH
Confidence 5899999999999999999986 34578999999987 88777654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.92 E-value=0.041 Score=53.77 Aligned_cols=48 Identities=31% Similarity=0.564 Sum_probs=40.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccce--eeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEK--CLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++++||||+++++++...+ ..+++|||+++ +|.+++...
T Consensus 88 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 138 (326)
T 2w1i_A 88 DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH 138 (326)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc
Confidence 5789999999999999999999887654 68999999976 888877543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=92.92 E-value=0.04 Score=53.60 Aligned_cols=47 Identities=36% Similarity=0.617 Sum_probs=39.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccc-----cceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIH-----TEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~-----~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.....+..+..++||||+++++++. .....+++|||+++++.+++..
T Consensus 60 ~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~ 111 (326)
T 1blx_A 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 111 (326)
T ss_dssp HHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH
T ss_pred HHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHh
Confidence 5567777888889999999999987 5677999999999888877654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.90 E-value=0.038 Score=54.49 Aligned_cols=47 Identities=23% Similarity=0.392 Sum_probs=42.1
Q ss_pred hhHHHHHHHHhcCC--CCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELRH--ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|++++| |||+++++++..++..+++||+...+|.+++..
T Consensus 53 ~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~ 101 (343)
T 3dbq_A 53 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK 101 (343)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHH
T ss_pred HHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHh
Confidence 68899999999976 999999999999999999999888788877754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=92.64 E-value=0.045 Score=55.23 Aligned_cols=47 Identities=23% Similarity=0.382 Sum_probs=41.6
Q ss_pred hhHHHHHHHHhcC--CCCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELR--HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|++|+ |||||++++++..++..+++||+...+|.+++..
T Consensus 100 ~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~ 148 (390)
T 2zmd_A 100 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK 148 (390)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHH
T ss_pred HHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHh
Confidence 6889999999996 5999999999999999999999877788877754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 516 | ||||
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-67 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-17 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-67 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-20 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-66 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-19 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-65 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-21 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-64 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-17 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-63 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-15 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-62 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-19 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-61 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-21 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-17 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-60 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-20 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-59 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-16 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-18 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-57 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-18 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-57 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-12 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-18 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-56 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-16 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-18 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-55 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-20 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-19 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-53 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-14 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-53 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-15 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-15 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-51 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-18 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-15 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-50 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-49 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-14 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-15 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-48 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-13 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-14 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-13 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-44 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-13 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-15 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-12 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-17 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-11 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-14 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-41 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-15 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-14 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-40 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-14 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-11 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-40 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-14 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-14 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-13 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 9e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-12 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-38 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-14 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-38 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-37 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-14 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-13 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-35 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-13 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-11 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-10 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-13 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-12 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-31 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-05 |
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 2e-67
Identities = 147/281 (52%), Positives = 202/281 (71%), Gaps = 8/281 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY TVFK K+R T +VALK ++L+ +EG P +A+RE+ LL+EL+H NIV LHD++H
Sbjct: 12 EGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH 71
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
++K LTLVFE+ ++DLK+Y D C+ L VK FLFQLL+GL +CHSR +LHRDLKPQN
Sbjct: 72 SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQN 131
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
LLIN GELKLA+FGLARA +P + +S EVVTLWYRPPDVL G+ YSTSIDM GCI
Sbjct: 132 LLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI 191
Query: 370 FHEMSSG-RPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYPSESKLQLL 424
F E+++ RPLFPG+ ++D+L+ I +LG P +E + ++ P+YP+ + L +
Sbjct: 192 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV 251
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
P+ +++ DL+Q L + QRISA A++HPYF+ P
Sbjct: 252 VPK-LNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.0 bits (196), Expect = 3e-17
Identities = 58/130 (44%), Positives = 88/130 (67%), Gaps = 1/130 (0%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHA 149
+ Y KL+K+G+GTY TVFK K+R T +VALK ++L+ +EG P +A+RE+ LL+EL+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNL 209
NIV LHD++H++K LTLVFE+ ++DLK+Y D C+ L VK + KG
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 210 VALKEIKLEH 219
V +++K ++
Sbjct: 122 VLHRDLKPQN 131
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (552), Expect = 2e-67
Identities = 106/280 (37%), Positives = 165/280 (58%), Gaps = 9/280 (3%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH----EEGAPCTAIREVSLLRELRHANIVTLHD 247
+G +ATV+K + + T+ +VA+K+IKL H ++G TA+RE+ LL+EL H NI+ L D
Sbjct: 8 EGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLD 67
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ ++LVF+++E DL+ + D S +L+ +++K ++ L+GL Y H ILHRDLK
Sbjct: 68 AFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLK 127
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
P NLL++E G LKLADFGLA++ P + ++++VVT WYR P++L G+ Y +DM V
Sbjct: 128 PNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAV 187
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFCITPVYPSESKLQL 423
GCI E+ P PG + D+L I LG P +E L +T L
Sbjct: 188 GCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHH 247
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ D LDL+Q +++ RI+A A++ YF++
Sbjct: 248 IFSA-AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.5 bits (221), Expect = 2e-20
Identities = 45/129 (34%), Positives = 80/129 (62%), Gaps = 4/129 (3%)
Query: 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH----EEGAPCTAIREVSLLRELRHAN 150
KLD LG+G +ATV+K + + T+ +VA+K+IKL H ++G TA+RE+ LL+EL H N
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLV 210
I+ L D + ++LVF+++E DL+ + D S +L+ +++K +G L + +
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWI 121
Query: 211 ALKEIKLEH 219
+++K +
Sbjct: 122 LHRDLKPNN 130
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 215 bits (547), Expect = 1e-66
Identities = 138/274 (50%), Positives = 182/274 (66%), Gaps = 6/274 (2%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY V+K ++ ALK+I+LE E EG P T IRE+S+L+EL+H+NIV L+D+IH
Sbjct: 12 EGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH 70
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
T+K L LVFE+L++DLK+ +D C L K FL QLL G+AYCH RR+LHRDLKPQN
Sbjct: 71 TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
LLIN GELK+ADFGLARA +P + +++E+VTLWYR PDVL+GS +YST+ID+ VGCI
Sbjct: 131 LLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI 190
Query: 370 FHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL---KSKLEFCITPVYPSESKLQLLAP 426
F EM +G PLFPG + D+L I ILG P + ++L E
Sbjct: 191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFL 250
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ +D +DL+ K L D QRI+A A+ H YF
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 86.1 bits (212), Expect = 2e-19
Identities = 55/127 (43%), Positives = 81/127 (63%), Gaps = 2/127 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHA 149
E Y L+K+G+GTY V+K ++ ALK+I+LE E EG P T IRE+S+L+EL+H+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNL 209
NIV L+D+IHT+K L LVFE+L++DLK+ +D C L K + G + D
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 210 VALKEIK 216
V +++K
Sbjct: 121 VLHRDLK 127
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 2e-65
Identities = 141/299 (47%), Positives = 193/299 (64%), Gaps = 18/299 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GTY V+K +++LT +VALK+I+L+ E EG P TAIRE+SLL+EL H NIV L D+IH
Sbjct: 12 EGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 251 TEKCLTLVFEYLEKDLKRYMD-DCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
TE L LVFE+L +DLK++MD + + +K +LFQLL+GLA+CHS R+LHRDLKPQ
Sbjct: 72 TENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQ 131
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
NLLIN G +KLADFGLARA VP +T+++EVVTLWYR P++LLG YST++D+ +GC
Sbjct: 132 NLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC 191
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC--ITPVYPSESKLQLL-A 425
IF EM + R LFPG + D+L I LG P + + + P +P ++
Sbjct: 192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKV 251
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIKL 484
+D D L+ + L YD +RISA A+ HP+F + V PH++L
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV------------PHLRL 298
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 4e-21
Identities = 56/133 (42%), Positives = 90/133 (67%), Gaps = 2/133 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRH 148
+E++ K++K+G+GTY V+K +++LT +VALK+I+L+ E EG P TAIRE+SLL+EL H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMD-DCSNILSMNNVKGTYATVFKGKSRLTD 207
NIV L D+IHTE L LVFE+L +DLK++MD + + +K + +G +
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 208 NLVALKEIKLEHE 220
+ V +++K ++
Sbjct: 121 HRVLHRDLKPQNL 133
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-64
Identities = 110/291 (37%), Positives = 158/291 (54%), Gaps = 20/291 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+GT+ VFK + R T VALK++ +E+E EG P TA+RE+ +L+ L+H N+V L +I
Sbjct: 20 QGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICR 79
Query: 251 T--------EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
T + + LVF++ E DL + + +++ +K + LL GL Y H +IL
Sbjct: 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKIL 139
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNE----VVTLWYRPPDVLLGSTEY 358
HRD+K N+LI G LKLADFGLARA S+ + N VVTLWYRPP++LLG +Y
Sbjct: 140 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 199
Query: 359 STSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL------EFCI 411
ID+ G GCI EM + P+ G+T + +L LI + G E+ + E
Sbjct: 200 GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 259
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462
L D ALDL+ K L+ D QRI + +A+ H +F S
Sbjct: 260 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 2e-17
Identities = 44/139 (31%), Positives = 75/139 (53%), Gaps = 9/139 (6%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELR 147
+ Y KL K+GQGT+ VFK + R T VALK++ +E+E EG P TA+RE+ +L+ L+
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK 67
Query: 148 HANIVTLHDIIHT--------EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVF 199
H N+V L +I T + + LVF++ E DL + + +++ +K +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 127
Query: 200 KGKSRLTDNLVALKEIKLE 218
G + N + +++K
Sbjct: 128 NGLYYIHRNKILHRDMKAA 146
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-63
Identities = 70/289 (24%), Positives = 119/289 (41%), Gaps = 23/289 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G VFK + + ++A K I LE + IRE+ +L E IV + ++
Sbjct: 16 AGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 75
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR-RILHRDLKPQN 310
+ +++ E+++ + + + + +++GL Y + +I+HRD+KP N
Sbjct: 76 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCI 369
+L+N RGE+KL DFG++ + ++ V T Y P+ L G+ YS D+ +G
Sbjct: 136 ILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLS 192
Query: 370 FHEMSSGRPLFPGSTI-EDELRLICSILG------PPPDELKSKLEFCITPVYPSESKLQ 422
EM+ GR P E EL C + G P P L P + +
Sbjct: 193 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFE 252
Query: 423 L-----------LAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
L L + D V K L+ + +R M H +
Sbjct: 253 LLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 9e-63
Identities = 96/316 (30%), Positives = 162/316 (51%), Gaps = 25/316 (7%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G++ V++ K + LVA+K++ + RE+ ++R+L H NIV L ++
Sbjct: 30 NGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYS 84
Query: 252 ------EKCLTLVFEYLEKDLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCHSRRIL 302
E L LV +Y+ + + R S L + VKL+++QL R LAY HS I
Sbjct: 85 SGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGIC 144
Query: 303 HRDLKPQNLLINERGE-LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
HRD+KPQNLL++ LKL DFG A+ + V + + + + +YR P+++ G+T+Y++S
Sbjct: 145 HRDIKPQNLLLDPDTAVLKLCDFGSAK-QLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 362 IDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE----LKSKLEFCITPVYP 416
ID+ GC+ E+ G+P+FPG + D+L I +LG P E + P
Sbjct: 204 IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK 263
Query: 417 SESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELS---DT 473
+ ++ P + +A+ L + L Y R++ A H +F+ L +L DT
Sbjct: 264 AHPWTKVFRP-RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDT 322
Query: 474 QSIFSLPHIKLTSNPT 489
++F+ +L+SNP
Sbjct: 323 PALFNFTTQELSSNPP 338
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 2e-15
Identities = 32/137 (23%), Positives = 62/137 (45%), Gaps = 14/137 (10%)
Query: 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 151
SY +G G++ V++ K + LVA+K++ + RE+ ++R+L H NI
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNI 75
Query: 152 VTLHDIIHT------EKCLTLVFEYLEKDLKRYMDDCSN---ILSMNNVKGTYATVFKGK 202
V L ++ E L LV +Y+ + + R S L + VK +F+
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 203 SRLTDNLVALKEIKLEH 219
+ + + ++IK ++
Sbjct: 136 AYIHSFGICHRDIKPQN 152
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 8e-62
Identities = 64/276 (23%), Positives = 114/276 (41%), Gaps = 30/276 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V+K +++ T L A K I + EE + E+ +L H NIV L D +
Sbjct: 22 DGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASCDHPNIVKLLDAFYY 80
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
E L ++ E+ + M + L+ + +++ Q L L Y H +I+HRDLK N
Sbjct: 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGN 140
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST----EYSTSIDM-G 365
+L G++KLADFG++ + + + + T ++ P+V++ T Y D+
Sbjct: 141 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS 200
Query: 366 VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425
+G EM+ P L I P +
Sbjct: 201 LGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ----------------------- 237
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
P + S+ D ++K L + R + + ++HP+
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.7 bits (209), Expect = 8e-19
Identities = 29/129 (22%), Positives = 57/129 (44%), Gaps = 2/129 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ + + +LG G + V+K +++ T L A K I + EE + E+ +L H N
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-YMVEIDILASCDHPN 70
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNL 209
IV L D + E L ++ E+ + M + L+ + ++ + L DN
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 130
Query: 210 VALKEIKLE 218
+ +++K
Sbjct: 131 IIHRDLKAG 139
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-61
Identities = 59/273 (21%), Positives = 110/273 (40%), Gaps = 26/273 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G Y V +R+T+ VA+K + ++ P +E+ + + L H N+V +
Sbjct: 15 EGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE 74
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
L EY + + + + F QL+ G+ Y H I HRD+KP+NL
Sbjct: 75 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134
Query: 312 LINERGELKLADFGLARAKSV--PTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
L++ER LK++DFGLA + + TL Y P++L ++ +D+ G
Sbjct: 135 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGI 194
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ M +G + + + + ++
Sbjct: 195 VLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-----------------------WKK 231
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461
+DS L L+ K L+ + RI+ + + ++N
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.8 bits (225), Expect = 4e-21
Identities = 25/130 (19%), Positives = 52/130 (40%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
+E + + LG+G Y V +R+T+ VA+K + ++ P +E+ + + L H
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 150 NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNL 209
N+V + L EY + + + + + + G L
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 210 VALKEIKLEH 219
+ ++IK E+
Sbjct: 124 ITHRDIKPEN 133
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 4e-61
Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 32/274 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
KG + V+ + + + ++ALK + + G REV + LRH NI+ L+
Sbjct: 16 KGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF 75
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
H + L+ EY + ++ +L L+YCHS+R++HRD+KP+
Sbjct: 76 HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 135
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
NLL+ GELK+ADFG + P+ + TL Y PP+++ G + +D+ +G
Sbjct: 136 NLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGV 192
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ +E G+P F +T ++ + I + PD
Sbjct: 193 LCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--------------------------F 226
Query: 429 MDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462
+ A DL+ + L ++ QR + HP+ +
Sbjct: 227 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.0 bits (197), Expect = 2e-17
Identities = 27/131 (20%), Positives = 48/131 (36%), Gaps = 2/131 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELR 147
+E + LG+G + V+ + + + ++ALK + + G REV + LR
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTD 207
H NI+ L+ H + L+ EY + + S
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 208 NLVALKEIKLE 218
V ++IK E
Sbjct: 125 KRVIHRDIKPE 135
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 199 bits (507), Expect = 5e-60
Identities = 68/291 (23%), Positives = 116/291 (39%), Gaps = 29/291 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V + R T N A K + HE T +E+ + LRH +V LHD
Sbjct: 36 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHPTLVNLHDAFED 94
Query: 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + +++E++ +L + D N +S + ++ Q+ +GL + H +H DLKP+N
Sbjct: 95 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN 154
Query: 311 LLIN--ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
++ ELKL DFGL P ++ T + P+V G DM VG
Sbjct: 155 IMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVG 212
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ + + SG F G ++ LR + S D
Sbjct: 213 VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA----------------------FS 250
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFS 478
+ D D ++K L+ D R++ A+ HP+ + S ++
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYT 301
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 89.7 bits (222), Expect = 3e-20
Identities = 32/131 (24%), Positives = 59/131 (45%), Gaps = 2/131 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
++ Y ++LG G + V + R T N A K + HE T +E+ + LRH
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKE-TVRKEIQTMSVLRHP 83
Query: 150 NIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDN 208
+V LHD + + +++E++ +L + D N +S + V KG + +N
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 209 LVALKEIKLEH 219
++K E+
Sbjct: 144 NYVHLDLKPEN 154
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 4e-59
Identities = 102/286 (35%), Positives = 143/286 (50%), Gaps = 16/286 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G Y V + VA+K+I + +RE+ +L RH NI+ ++DII
Sbjct: 18 EGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRA 77
Query: 252 E-----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
K + LV + DL + + + LS +++ FL+Q+LRGL Y HS +LHRDL
Sbjct: 78 PTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHSANVLHRDL 135
Query: 307 KPQNLLINERGELKLADFGLARA---KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
KP NLL+N +LK+ DFGLAR T + V T WYR P+++L S Y+ SID
Sbjct: 136 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 195
Query: 364 MG-VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
+ VGCI EM S RP+FPG D+L I ILG P E + + Y +
Sbjct: 196 IWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 255
Query: 423 LLAP-----EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
P DS ALDL+ K L ++ +RI A+ HPY
Sbjct: 256 NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 2e-16
Identities = 30/132 (22%), Positives = 57/132 (43%), Gaps = 7/132 (5%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
Y L +G+G Y V + VA+K+I + +RE+ +L RH NI+
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 153 TLHDIIHTE-----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTD 207
++DII K + LV + DL + + + LS +++ + +G +
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIHS 127
Query: 208 NLVALKEIKLEH 219
V +++K +
Sbjct: 128 ANVLHRDLKPSN 139
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-58
Identities = 62/275 (22%), Positives = 110/275 (40%), Gaps = 27/275 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G TV+ T VA++++ L+ + I E+ ++RE ++ NIV D
Sbjct: 30 QGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPNIVNYLDSYLV 88
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
L +V EYL + + + + L+ L + HS +++HRD+K N+
Sbjct: 89 GDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147
Query: 312 LINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGCIF 370
L+ G +KL DFG + S V T ++ P+V+ Y +D+ +G +
Sbjct: 148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMA 206
Query: 371 HEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMD 430
EM G P + L LI + P PE++
Sbjct: 207 IEMIEGEPPYLNENPLRALYLIATNGTPELQN-----------------------PEKLS 243
Query: 431 SDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465
+ D + + L D ++R SA ++H + P
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.3 bits (203), Expect = 5e-18
Identities = 24/89 (26%), Positives = 42/89 (47%), Gaps = 1/89 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ Y + +K+GQG TV+ T VA++++ L+ + I E+ ++RE ++ N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE-LIINEILVMRENKNPN 78
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179
IV D L +V EYL +
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 192 bits (488), Expect = 3e-57
Identities = 54/294 (18%), Positives = 112/294 (38%), Gaps = 29/294 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V + + T + K I + T E+S++ +L H ++ LHD
Sbjct: 39 SGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKNEISIMNQLHHPKLINLHDAFED 97
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + L+ E+L +L + +S V ++ Q GL + H I+H D+KP+N
Sbjct: 98 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157
Query: 311 LLI--NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
++ + +K+ DFGLA K P + T + P+++ DM +G
Sbjct: 158 IMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIG 215
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ + + SG F G + L+ + ++
Sbjct: 216 VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA----------------------FS 253
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPH 481
+ +A D ++ L + ++R++ +A+ HP+ + + +
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 84.0 bits (207), Expect = 3e-18
Identities = 25/111 (22%), Positives = 48/111 (43%), Gaps = 3/111 (2%)
Query: 84 EIGFGRIESYFK-LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSL 142
E+ G + Y+ L++LG G + V + + T + K I + T E+S+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK-YTVKNEISI 79
Query: 143 LRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVK 192
+ +L H ++ LHD + + L+ E+L +L + +S V
Sbjct: 80 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 130
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-57
Identities = 118/285 (41%), Positives = 165/285 (57%), Gaps = 15/285 (5%)
Query: 192 KGTYATVFKGKSRLTDN-LVALKEIKLEH-EEGAPCTAIREVSLLREL---RHANIVTLH 246
+G Y VFK + VALK ++++ EEG P + IREV++LR L H N+V L
Sbjct: 17 EGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF 76
Query: 247 DIIHT-----EKCLTLVFEYLEKDLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRR 300
D+ E LTLVFE++++DL Y+D + +K +FQLLRGL + HS R
Sbjct: 77 DVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR 136
Query: 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
++HRDLKPQN+L+ G++KLADFGLAR S S VVTLWYR P+VLL S Y+T
Sbjct: 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV-VVTLWYRAPEVLLQS-SYAT 194
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
+D+ VGCIF EM +PLF GS+ D+L I ++G P +E + + S+S
Sbjct: 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 254
Query: 420 KLQLLA-PEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
+ +D DL+ K L ++ +RISA +A+ HPYF L
Sbjct: 255 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.9 bits (157), Expect = 4e-12
Identities = 38/105 (36%), Positives = 58/105 (55%), Gaps = 10/105 (9%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDN-LVALKEIKLEH-EEGAPCTAIREVSLLREL- 146
+ Y + ++G+G Y VFK + VALK ++++ EEG P + IREV++LR L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 147 --RHANIVTLHDIIHT-----EKCLTLVFEYLEKDLKRYMDDCSN 184
H N+V L D+ E LTLVFE++++DL Y+D
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE 110
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 188 bits (479), Expect = 2e-56
Identities = 62/292 (21%), Positives = 107/292 (36%), Gaps = 33/292 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC--TAIREVSLLRELRHANIVTLHDII 249
G++ V+ + +VA+K++ ++ I+EV L++LRH N +
Sbjct: 25 HGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY 84
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E LV EY ++ L + L+GLAY HS ++HRD+K
Sbjct: 85 LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAG 144
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE--YSTSIDMG-V 366
N+L++E G +KL DFG A + P +F V T ++ P+V+L E Y +D+ +
Sbjct: 145 NILLSEPGLVKLGDFGSASIMA-PANSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSL 200
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G E++ +P L I P
Sbjct: 201 GITCIELAERKPPLFNMNAMSALYHIAQNESPALQ------------------------S 236
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFS 478
+ V L + R ++ ++H + P + Q
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKD 288
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.4 bits (203), Expect = 6e-18
Identities = 24/131 (18%), Positives = 53/131 (40%), Gaps = 2/131 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC--TAIREVSLLRELRH 148
+ + L ++G G++ V+ + +VA+K++ ++ I+EV L++LRH
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 149 ANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDN 208
N + E LV EY ++ L + +G + L +
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 209 LVALKEIKLEH 219
+ +++K +
Sbjct: 135 NMIHRDVKAGN 145
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-56
Identities = 103/307 (33%), Positives = 154/307 (50%), Gaps = 18/307 (5%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
G Y V T VA+K++ + E A RE+ LL+ +RH N++ L D+
Sbjct: 28 SGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFT 87
Query: 251 TEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
++ L LV ++ DL + M L + ++ ++Q+L+GL Y H+ I+HR
Sbjct: 88 PDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHR 145
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
DLKP NL +NE ELK+ DFGLAR + VVT WYR P+V+L Y+ ++D+
Sbjct: 146 DLKPGNLAVNEDCELKILDFGLARQADSEMTGY---VVTRWYRAPEVILNWMRYTQTVDI 202
Query: 365 G-VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPS-----E 418
VGCI EM +G+ LF GS D+L+ I + G PP E +L+ Y E
Sbjct: 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFS 478
K A++L++K L+ DA+QR++A A+ HPYF SL E + S
Sbjct: 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDS 322
Query: 479 LPHIKLT 485
+ T
Sbjct: 323 FDDVDRT 329
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.6 bits (190), Expect = 4e-16
Identities = 33/148 (22%), Positives = 63/148 (42%), Gaps = 9/148 (6%)
Query: 79 RQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAI 137
RQ +++ + Y L +G G Y V T VA+K++ + E A
Sbjct: 6 RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY 65
Query: 138 REVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNV 191
RE+ LL+ +RH N++ L D+ ++ L LV ++ DL + M L + +
Sbjct: 66 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRI 123
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH 219
+ + KG + + +++K +
Sbjct: 124 QFLVYQMLKGLRYIHAAGIIHRDLKPGN 151
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-55
Identities = 61/296 (20%), Positives = 126/296 (42%), Gaps = 34/296 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V + + K +K++ + +E+S+L RH NI+ LH+ +
Sbjct: 15 RGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFES 72
Query: 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ L ++FE++ D+ ++ + L+ + ++ Q+ L + HS I H D++P+N
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN 132
Query: 311 LLI--NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
++ +K+ +FG AR +Y P + ST+ DM +G
Sbjct: 133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE--VHQHDVVSTATDMWSLG 190
Query: 368 CIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ + + SG F T + + I + +E +
Sbjct: 191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----------------------FK 228
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLPHIK 483
++ +A+D V + L+ + K R++A+ A++HP+ Q E T+ I +L H +
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLK----QKIERVSTKVIRTLKHRR 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.6 bits (206), Expect = 2e-18
Identities = 26/129 (20%), Positives = 57/129 (44%), Gaps = 3/129 (2%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E Y + LG+G + V + + K +K++ + +E+S+L RH N
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRN 62
Query: 151 IVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNL 209
I+ LH+ + + L ++FE++ D+ ++ + L+ + V + L +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122
Query: 210 VALKEIKLE 218
+ +I+ E
Sbjct: 123 IGHFDIRPE 131
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (471), Expect = 3e-55
Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 30/274 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G ++ V + + T LVA+K I + EG + E+++L +++H NIV L DI +
Sbjct: 19 TGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES 78
Query: 252 EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
L L+ + + +L + + + + +FQ+L + Y H I+HRDLKP+N
Sbjct: 79 GGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPEN 137
Query: 311 LLI---NERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
LL +E ++ ++DFGL++ + P S T Y P+VL YS ++D +
Sbjct: 138 LLYYSLDEDSKIMISDFGLSKMED-PGSVLSTACGTPGYVAPEVLAQK-PYSKAVDCWSI 195
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G I + + G P F I
Sbjct: 196 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPY----------------------W 233
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ + A D ++ + D ++R + A++HP+
Sbjct: 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 89.7 bits (222), Expect = 2e-20
Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 1/90 (1%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ Y D LG G ++ V + + T LVA+K I + EG + E+++L +++H N
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 68
Query: 151 IVTLHDIIHTEKCLTLVFEYLE-KDLKRYM 179
IV L DI + L L+ + + +L +
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFDRI 98
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-55
Identities = 67/283 (23%), Positives = 118/283 (41%), Gaps = 38/283 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
+G+++TV + T A+K ++ H +E RE ++ L H V L+
Sbjct: 18 EGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF 77
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
++ L Y + + + +++ L Y H + I+HRDLKP+
Sbjct: 78 QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPE 137
Query: 310 NLLINERGELKLADFGLARAKSVPTKT--FSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
N+L+NE +++ DFG A+ S +K ++ V T Y P++L S D+ +
Sbjct: 138 NILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWAL 196
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
GCI +++ +G P F + I +K + +F P
Sbjct: 197 GCIIYQLVAGLPPFRAGNEYLIFQKI----------IKLEYDF----------------P 230
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANA------MRHPYFNSL 463
E+ A DLV+K L+ DA +R+ HP+F S+
Sbjct: 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.5 bits (211), Expect = 4e-19
Identities = 24/132 (18%), Positives = 46/132 (34%), Gaps = 2/132 (1%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLREL 146
R E + LG+G+++TV + T A+K ++ H +E RE ++ L
Sbjct: 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL 65
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLT 206
H V L+ ++ L Y + + A + L
Sbjct: 66 DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLH 125
Query: 207 DNLVALKEIKLE 218
+ +++K E
Sbjct: 126 GKGIIHRDLKPE 137
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-53
Identities = 69/281 (24%), Positives = 111/281 (39%), Gaps = 39/281 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
G+Y K + + ++ KE+ E + EV+LLREL+H NIV +D I
Sbjct: 14 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73
Query: 251 --TEKCLTLVFEYLEK-DLKRYMDDCSN---ILSMNNVKLFLFQLLRGLAYCHSR----- 299
T L +V EY E DL + + L V + QL L CH R
Sbjct: 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 133
Query: 300 RILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
+LHRDLKP N+ ++ + +KL DFGLAR + T V T +Y P+ + Y+
Sbjct: 134 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM-SYN 192
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSE 418
D+ +GC+ +E+ + P F + ++ I
Sbjct: 193 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI------------------ 234
Query: 419 SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPY 459
P + + +++ + L R S + +P
Sbjct: 235 -------PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 179 bits (454), Expect = 4e-53
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 40/285 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKL--------EHEEGAPCTAIREVSLLRELR-HANI 242
+G + V + + T A+K I + E + ++EV +LR++ H NI
Sbjct: 13 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 72
Query: 243 VTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRI 301
+ L D T LVF+ ++K +L Y+ + LS + + LL + H I
Sbjct: 73 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLEVICALHKLNI 131
Query: 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTE---- 357
+HRDLKP+N+L+++ +KL DFG + P + T Y P+++ S
Sbjct: 132 VHRDLKPENILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHP 190
Query: 358 -YSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVY 415
Y +DM G I + + +G P F LR+I S
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE------------ 238
Query: 416 PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ DLV +FL+ ++R +A A+ HP+F
Sbjct: 239 ----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 70.9 bits (173), Expect = 3e-14
Identities = 32/139 (23%), Positives = 61/139 (43%), Gaps = 11/139 (7%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKL--------EHEEGAPCTAIREVSL 142
E+Y + LG+G + V + + T A+K I + E + ++EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 143 LRELR-HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFK 200
LR++ H NI+ L D T LVF+ ++K +L Y+ + LS + + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-LSEKETRKIMRALLE 121
Query: 201 GKSRLTDNLVALKEIKLEH 219
L + +++K E+
Sbjct: 122 VICALHKLNIVHRDLKPEN 140
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 180 bits (458), Expect = 4e-53
Identities = 82/290 (28%), Positives = 145/290 (50%), Gaps = 27/290 (9%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDIIH 250
+G Y+ VF+ + + V +K +K ++ RE+ +L LR NI+TL DI+
Sbjct: 45 RGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLADIVK 100
Query: 251 --TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ LVFE++ D K+ L+ +++ +++++L+ L YCHS I+HRD+K
Sbjct: 101 DPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVK 156
Query: 308 PQNLLINERG-ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-G 365
P N++I+ +L+L D+GLA P + ++ V + +++ P++L+ Y S+DM
Sbjct: 157 PHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWS 215
Query: 366 VGCIFHEMSSGR-PLFPGSTIEDELRLICSILGPP-PDELKSKLEFCITPVYPS------ 417
+GC+ M + P F G D+L I +LG + K + P +
Sbjct: 216 LGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHS 275
Query: 418 ----ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
E + + +ALD + K L YD + R++A AM HPYF ++
Sbjct: 276 RKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 73.3 bits (179), Expect = 8e-15
Identities = 29/100 (29%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLL 143
+ +G + Y + KLG+G Y+ VF+ + + V +K +K ++ RE+ +L
Sbjct: 28 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK----KIKREIKIL 83
Query: 144 RELR-HANIVTLHDIIH--TEKCLTLVFEYLE-KDLKRYM 179
LR NI+TL DI+ + LVFE++ D K+
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 1e-52
Identities = 93/285 (32%), Positives = 144/285 (50%), Gaps = 18/285 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC-TAIREVSLLRELRHANIVTLHDIIH 250
G Y +V T VA+K++ + RE+ LL+ ++H N++ L D+
Sbjct: 28 SGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 87
Query: 251 TEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+ L LV + DL + L+ ++V+ ++Q+LRGL Y HS I+HR
Sbjct: 88 PARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHR 145
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
DLKP NL +NE ELK+ DFGLAR + T WYR P+++L Y+ ++D+
Sbjct: 146 DLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA---TRWYRAPEIMLNWMHYNQTVDI 202
Query: 365 -GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL----KSKLEFCITPVYPSES 419
VGCI E+ +GR LFPG+ D+L+LI ++G P EL S+
Sbjct: 203 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 262
Query: 420 KLQLL-APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
K+ + A+DL++K L+ D+ +RI+AA A+ H YF
Sbjct: 263 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 4e-15
Identities = 31/148 (20%), Positives = 62/148 (41%), Gaps = 9/148 (6%)
Query: 79 RQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPC-TAI 137
RQ L++ + E Y L +G G Y +V T VA+K++ +
Sbjct: 6 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY 65
Query: 138 REVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNV 191
RE+ LL+ ++H N++ L D+ + L LV + DL + L+ ++V
Sbjct: 66 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHV 123
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH 219
+ + +G + + +++K +
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSN 151
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-51
Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 34/285 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH----EEGAPCTAI-REVSLLRELRHANIVTLH 246
G +A V K + + T A K IK G I REVS+L+E++H N++TLH
Sbjct: 20 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 79
Query: 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
++ + + L+ E + L+ FL Q+L G+ Y HS +I H DL
Sbjct: 80 EVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDL 139
Query: 307 KPQNLLINERGE----LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
KP+N+++ +R +K+ DFGLA F N T + P+++
Sbjct: 140 KPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIVNYE-PLGLEA 197
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
DM +G I + + SG F G T ++ L + ++ DE
Sbjct: 198 DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY------------------ 239
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466
+ A D +++ L+ D K+R++ ++++HP+ Q
Sbjct: 240 ----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 3e-18
Identities = 33/136 (24%), Positives = 59/136 (43%), Gaps = 6/136 (4%)
Query: 90 IESYFKL-DKLGQGTYATVFKGKSRLTDNLVALKEIKLEH----EEGAPCTAI-REVSLL 143
++ Y+ ++LG G +A V K + + T A K IK G I REVS+L
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 144 RELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKS 203
+E++H N++TLH++ + + L+ E + L+ + G
Sbjct: 68 KEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 204 RLTDNLVALKEIKLEH 219
L +A ++K E+
Sbjct: 128 YLHSLQIAHFDLKPEN 143
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 7e-50
Identities = 66/278 (23%), Positives = 125/278 (44%), Gaps = 34/278 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
KG++ VF + + T+ A+K +K + ++ CT + + L H + +
Sbjct: 12 KGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCT 71
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
T++ L V EYL DL ++ C + ++ + +++ GL + HS+ I++RDLK
Sbjct: 72 FQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 130
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
N+L+++ G +K+ADFG+ + + + T Y P++LLG +Y+ S+D
Sbjct: 131 LDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSF 189
Query: 367 GCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
G + +EM G+ F G E+ I P P
Sbjct: 190 GVLLYEMLIGQSPFHGQDEEELFHSIRM--DNPF------------------------YP 223
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMR-HPYFNSL 463
++ +A DL+ K + + ++R+ +R HP F +
Sbjct: 224 RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 3e-15
Identities = 24/100 (24%), Positives = 44/100 (44%), Gaps = 4/100 (4%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLE---HEEGAPCTAIREVSLLREL 146
IE + LG+G++ VF + + T+ A+K +K + ++ CT + + L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNI 185
H + + T++ L V EYL DL ++ C
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF 100
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 8e-50
Identities = 58/279 (20%), Positives = 115/279 (41%), Gaps = 38/279 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIH 250
+G++ TV+KG T VA E++ + E +L+ L+H NIV +D
Sbjct: 19 RGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 78
Query: 251 T----EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSR--RILHR 304
+ +KC+ LV E + + ++ + ++ + Q+L+GL + H+R I+HR
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138
Query: 305 DLKPQNLLIN-ERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSI 362
DLK N+ I G +K+ D GLA K +F+ V+ T + P++ +Y S+
Sbjct: 139 DLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMYEE--KYDESV 193
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D+ G EM++ + ++ + P
Sbjct: 194 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF------------------- 234
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460
+ + ++++ + + +R S + + H +F
Sbjct: 235 ----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (435), Expect = 1e-49
Identities = 87/310 (28%), Positives = 138/310 (44%), Gaps = 27/310 (8%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIH 250
G V + D VA+K++ + + A RE+ L++ + H NI++L ++
Sbjct: 27 SGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 251 TEKCLT------LVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
+K L LV E ++ +L + + + L+Q+L G+ + HS I+HR
Sbjct: 87 PQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGIIHR 143
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM 364
DLKP N+++ LK+ DFGLAR + + VVT +YR P+V+LG
Sbjct: 144 DLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT------PVYPSE 418
VGCI EM + LFPG D+ + LG P E KL+ + P Y
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
Query: 419 SKLQLL----------APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVH 468
+ +L + S A DL+ K L+ D +RIS +A++HPY N
Sbjct: 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAE 322
Query: 469 ELSDTQSIFS 478
+ I+
Sbjct: 323 VEAPPPQIYD 332
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.5 bits (174), Expect = 4e-14
Identities = 24/113 (21%), Positives = 50/113 (44%), Gaps = 7/113 (6%)
Query: 79 RQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAI 137
+ + F ++ Y L +G G V + D VA+K++ + + A
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 64
Query: 138 REVSLLRELRHANIVTLHDIIHTEKCLT------LVFEYLEKDLKRYMDDCSN 184
RE+ L++ + H NI++L ++ +K L LV E ++ +L + + +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD 117
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (435), Expect = 2e-49
Identities = 61/296 (20%), Positives = 116/296 (39%), Gaps = 43/296 (14%)
Query: 186 LSMNNV-------KGTYATVFKGKSRLTDNLVALKEIK-----LEHEEGAPCTAIREVSL 233
L+MN+ +G + V+ + T + A+K + ++ E +SL
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 234 LRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGL 293
+ IV + HT L+ + + + Y + S +++ + +++ GL
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120
Query: 294 AYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLL 353
+ H+R +++RDLKP N+L++E G ++++D GLA S S T Y P+VL
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG--THGYMAPEVLQ 178
Query: 354 GSTEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCIT 412
Y +S D +GC+ ++ G F +D+ + L +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---------- 228
Query: 413 PVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSL 463
P+ + L++ L D +R+ A P+F SL
Sbjct: 229 -------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 74.8 bits (183), Expect = 4e-15
Identities = 20/135 (14%), Positives = 50/135 (37%), Gaps = 5/135 (3%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIK-----LEHEEGAPCTAIREVSLLR 144
+ + +G+G + V+ + T + A+K + ++ E +SL+
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 145 ELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSR 204
IV + HT L+ + + + Y + S +++ A + G
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 205 LTDNLVALKEIKLEH 219
+ + V +++K +
Sbjct: 123 MHNRFVVYRDLKPAN 137
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (430), Expect = 3e-49
Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 38/277 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
G++ V +SR A+K +K E E +L + H I+ +
Sbjct: 14 TGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF 73
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
+ + ++ +Y+E + S K + ++ L Y HS+ I++RDLKP+
Sbjct: 74 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPE 133
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG-VGC 368
N+L+++ G +K+ DFG A+ T T T Y P+V+ Y+ SID G
Sbjct: 134 NILLDKNGHIKITDFGFAKYVPDVTYTL---CGTPDYIAPEVVSTK-PYNKSIDWWSFGI 189
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ +EM +G F S I L ++L F P
Sbjct: 190 LIYEMLAGYTPFYDSNTMKTYEKI----------LNAELRF----------------PPF 223
Query: 429 MDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYF 460
+ D DL+ + + D QR+ + HP+F
Sbjct: 224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 74.7 bits (183), Expect = 2e-15
Identities = 24/132 (18%), Positives = 48/132 (36%), Gaps = 2/132 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELR 147
++ + L LG G++ V +SR A+K +K E E +L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTD 207
H I+ + + + ++ +Y+E + S K A V L
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 208 NLVALKEIKLEH 219
+ +++K E+
Sbjct: 123 KDIIYRDLKPEN 134
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-48
Identities = 67/280 (23%), Positives = 114/280 (40%), Gaps = 35/280 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
KGT+ V + + T A+K ++ E + + E +L+ RH + L
Sbjct: 15 KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 74
Query: 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
T L V EY + + + + + +++ L Y HSR +++RD+K +
Sbjct: 75 QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLE 134
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID-MGVGC 368
NL++++ G +K+ DFGL + T T Y P+VL + +Y ++D G+G
Sbjct: 135 NLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGV 193
Query: 369 IFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQ 428
+ +EM GR F E LI L ++ F P
Sbjct: 194 VMYEMMCGRLPFYNQDHERLFELI----------LMEEIRF----------------PRT 227
Query: 429 MDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSL 463
+ +A L+ L D KQR+ A M H +F S+
Sbjct: 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.3 bits (166), Expect = 4e-13
Identities = 27/131 (20%), Positives = 48/131 (36%), Gaps = 2/131 (1%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELR 147
+ + L LG+GT+ V + + T A+K ++ E + + E +L+ R
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTD 207
H + L T L V EY + + + + A + L
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 208 NLVALKEIKLE 218
V ++IKLE
Sbjct: 124 RDVVYRDIKLE 134
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-47
Identities = 60/273 (21%), Positives = 105/273 (38%), Gaps = 31/273 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSLLRELRHANIVTLHDIIH 250
G++ TV+KGK VA+K + + A EV +LR+ RH NI+
Sbjct: 18 SGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-S 73
Query: 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
T L +V ++ E L ++ M + Q +G+ Y H++ I+HRDLK
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133
Query: 310 NLLINERGELKLADFGLARAKSV--PTKTFSNEVVTLWYRPPDVLLG--STEYSTSIDM- 364
N+ ++E +K+ DFGLA KS + F ++ + P+V+ YS D+
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 365 GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
G + +E+ +G+ + D++ + PD K
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK-------------------- 233
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
L+ + L +R +
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.9 bits (176), Expect = 1e-14
Identities = 32/138 (23%), Positives = 56/138 (40%), Gaps = 9/138 (6%)
Query: 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAI-REVSL 142
EI G+I ++G G++ TV+KGK VA+K + + A EV +
Sbjct: 4 EIPDGQIT---VGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 143 LRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKG 201
LR+ RH NI+ T L +V ++ E L ++ M + +G
Sbjct: 58 LRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 202 KSRLTDNLVALKEIKLEH 219
L + +++K +
Sbjct: 117 MDYLHAKSIIHRDLKSNN 134
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-47
Identities = 64/297 (21%), Positives = 110/297 (37%), Gaps = 37/297 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRELRHANIVTLHDIIH 250
G V + ++ T ALK ++ + A REV R + +IV + D+
Sbjct: 22 LGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQCPHIVRIVDVYE 75
Query: 251 T----EKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKLFLFQLLRGLAYCHSRRILHR 304
KCL +V E L+ +L + D + + + + + Y HS I HR
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHR 135
Query: 305 DLKPQNLLIN---ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTS 361
D+KP+NLL LKL DFG A+ + + + T +Y P+VL +Y S
Sbjct: 136 DVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEVLGP-EKYDKS 193
Query: 362 IDMG-VGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
DM +G I + + G P F + + + + E +
Sbjct: 194 CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE------------- 240
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIF 477
++ + L++ L + QR++ M HP+ T +
Sbjct: 241 -----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVL 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 5e-13
Identities = 30/137 (21%), Positives = 55/137 (40%), Gaps = 14/137 (10%)
Query: 90 IESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVS-LLRELR 147
I+ Y + LG G V + ++ T ALK ++ + A REV R +
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK------ARREVELHWRASQ 63
Query: 148 HANIVTLHDIIHT----EKCLTLVFEYLEK-DLKRYMDDCSNI-LSMNNVKGTYATVFKG 201
+IV + D+ KCL +V E L+ +L + D + + ++ +
Sbjct: 64 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 202 KSRLTDNLVALKEIKLE 218
L +A +++K E
Sbjct: 124 IQYLHSINIAHRDVKPE 140
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 158 bits (401), Expect = 1e-44
Identities = 61/306 (19%), Positives = 113/306 (36%), Gaps = 45/306 (14%)
Query: 172 EKDLKRYMDDCSNILSMNNV-------KGTYATVFKGKSRLTDNLVALKEIKLEH--EEG 222
E LK++ N ++ G++ V K + + N A+K + + +
Sbjct: 24 EDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLK 83
Query: 223 APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNV 282
+ E +L+ + +V L L +V EY+ S +
Sbjct: 84 QIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA 143
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVV 342
+ + Q++ Y HS +++RDLKP+NLLI+++G +++ DFG A+ T T
Sbjct: 144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP- 202
Query: 343 TLWYRPPDVLLGSTEYSTSID-MGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401
P+++L Y+ ++D +G + +EM++G P F I S P
Sbjct: 203 --EALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259
Query: 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMR 456
SD DL++ L D +R +
Sbjct: 260 HF--------------------------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
Query: 457 HPYFNS 462
H +F +
Sbjct: 294 HKWFAT 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.5 bits (164), Expect = 7e-13
Identities = 21/143 (14%), Positives = 51/143 (35%), Gaps = 2/143 (1%)
Query: 78 RRQSLSEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCT 135
++ +++ + ++ LG G++ V K + + N A+K + + +
Sbjct: 28 KKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEH 87
Query: 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTY 195
+ E +L+ + +V L L +V EY+ S + +
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147
Query: 196 ATVFKGKSRLTDNLVALKEIKLE 218
A + L + +++K E
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPE 170
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-43
Identities = 55/281 (19%), Positives = 106/281 (37%), Gaps = 38/281 (13%)
Query: 192 KGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + +V +G R+ VA+K +K E+ +RE ++ +L + IV L +
Sbjct: 19 CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 78
Query: 250 HTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E + LV E L +++ + ++NV L Q+ G+ Y + +HRDL
Sbjct: 79 QAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 137
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVV---TLWYRPPDVLLGSTEYSTSIDM- 364
+N+L+ R K++DFGL++A ++ L + P+ + ++S+ D+
Sbjct: 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVW 196
Query: 365 GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
G E S G+ + + + I
Sbjct: 197 SYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC----------------------- 233
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAA---NAMRHPYFN 461
P + + L+ +Y + R MR Y++
Sbjct: 234 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.0 bits (181), Expect = 3e-15
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 4/124 (3%)
Query: 98 KLGQGTYATVFKGKSRLTDN--LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
+LG G + +V +G R+ VA+K +K E+ +RE ++ +L + IV L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 156 DIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKE 214
+ E + LV E L +++ + ++NV V G L + ++
Sbjct: 76 GVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 134
Query: 215 IKLE 218
+
Sbjct: 135 LAAR 138
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-43
Identities = 55/282 (19%), Positives = 104/282 (36%), Gaps = 44/282 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH-----EEGAPCTAIREVSLLRELR--HANIVT 244
G + +V+ G + VA+K ++ + E EV LL+++ + ++
Sbjct: 14 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 73
Query: 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303
L D L+ E E L + F +Q+L + +CH+ +LH
Sbjct: 74 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLH 133
Query: 304 RDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
RD+K +N+LI+ RGELKL DFG + +++ T Y PP+ + + S
Sbjct: 134 RDIKDENILIDLNRGELKLIDFGSG--ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
+ +G + ++M G F +
Sbjct: 192 AVWSLGILLYDMVCGDIPFEHDE--------------------------------EIIRG 219
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463
Q+ +++ S+ L++ L R + HP+ +
Sbjct: 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.3 bits (156), Expect = 4e-12
Identities = 19/94 (20%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH-----EEGAPCTAIREVSLLRELR 147
Y LG G + +V+ G + VA+K ++ + E EV LL+++
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 148 --HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179
+ ++ L D L+ E E +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 99
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 152 bits (386), Expect = 3e-43
Identities = 57/277 (20%), Positives = 100/277 (36%), Gaps = 33/277 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249
G + V + VA+K ++ + + RE L H IV ++D
Sbjct: 17 FGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTG 76
Query: 250 HTE----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
E +V EY++ R + ++ + + L + H I+HRD
Sbjct: 77 EAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRD 136
Query: 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNE---VVTLWYRPPDVLLGSTEYSTSI 362
+KP N++I+ +K+ DFG+ARA + + + + T Y P+ G
Sbjct: 137 VKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARS 195
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D+ +GC+ +E+ +G P F G + PP
Sbjct: 196 DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR------------------ 237
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458
E + +D +V K L + + R A MR
Sbjct: 238 ----HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 79.0 bits (194), Expect = 5e-17
Identities = 23/135 (17%), Positives = 47/135 (34%), Gaps = 6/135 (4%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRH 148
+ Y + LG G + V + VA+K ++ + + RE L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 149 ANIVTLHDIIHTE----KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSR 204
IV ++D E +V EY++ R + ++ A + +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 205 LTDNLVALKEIKLEH 219
N + +++K +
Sbjct: 127 SHQNGIIHRDVKPAN 141
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-42
Identities = 62/282 (21%), Positives = 109/282 (38%), Gaps = 37/282 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G + V+ G T VA+K +K P ++E ++++LRH +V L+ ++
Sbjct: 27 QGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 252 EKCLTLVFEYLEKD--LKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E +V EY+ K L + L + + Q+ G+AY +HRDL+
Sbjct: 84 EPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 142
Query: 310 NLLINERGELKLADFGLAR-AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
N+L+ E K+ADFGLAR + + + P+ L ++ D+ G
Sbjct: 143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFG 201
Query: 368 CIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
+ E+ + GR +PG + L + P P
Sbjct: 202 ILLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------------------CP 236
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAAN--AMRHPYFNSLGPQ 466
+ DL+ + + ++R + A YF S PQ
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.8 bits (152), Expect = 2e-11
Identities = 26/89 (29%), Positives = 42/89 (47%), Gaps = 4/89 (4%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
ES KLGQG + V+ G T VA+K +K P ++E ++++LRH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEK 73
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179
+V L+ ++ E +V EY+ K
Sbjct: 74 LVQLYAVVSEEPIY-IVTEYMSKGSLLDF 101
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-42
Identities = 63/271 (23%), Positives = 108/271 (39%), Gaps = 39/271 (14%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG + V G N VA+K IK + A + E S++ +LRH+N+V L +I
Sbjct: 17 KGEFGDVMLG--DYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 252 EK-CLTLVFEYLEK-DLKRYMDDCSN-ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
EK L +V EY+ K L Y+ +L + + F + + Y +HRDL
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 131
Query: 309 QNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
+N+L++E K++DFGL + S T + + + P+ L ++ST D+ G
Sbjct: 132 RNVLVSEDNVAKVSDFGLTKEASSTQDTG---KLPVKWTAPEALREK-KFSTKSDVWSFG 187
Query: 368 CIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
+ E+ S GR +P ++D + + P
Sbjct: 188 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA-------------------------P 222
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
+ ++++ DA R S
Sbjct: 223 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.0 bits (171), Expect = 4e-14
Identities = 30/92 (32%), Positives = 47/92 (51%), Gaps = 7/92 (7%)
Query: 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHA 149
++ L +G+G + V G N VA+K IK + A + E S++ +LRH+
Sbjct: 6 MKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHS 60
Query: 150 NIVTLHDIIHTEK-CLTLVFEYLEK-DLKRYM 179
N+V L +I EK L +V EY+ K L Y+
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 92
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 60/328 (18%), Positives = 115/328 (35%), Gaps = 63/328 (19%)
Query: 169 EYLEKDLKRYMDDCSNILSMNNV-------KGTYATVFKGKSRLTDNL-----VALKEIK 216
EY D + Y D N+ G + V + VA+K +K
Sbjct: 17 EYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK 76
Query: 217 LEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM---- 270
+ + + E+ ++ +L H NIV L + L+FEY DL Y+
Sbjct: 77 EKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 136
Query: 271 ------------------DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLL 312
++ N+L+ ++ F +Q+ +G+ + + +HRDL +N+L
Sbjct: 137 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196
Query: 313 INERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIF 370
+ +K+ DFGLAR N + + + P+ L S G +
Sbjct: 197 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 256
Query: 371 HEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQM 429
E+ S G +PG ++ + ++ ++ P
Sbjct: 257 WEIFSLGVNPYPGIPVDANFYKLI------------------------QNGFKMDQPFYA 292
Query: 430 DSDALDLVQKFLMYDAKQRISAANAMRH 457
+ ++Q +D+++R S N
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 4e-41
Identities = 56/272 (20%), Positives = 103/272 (37%), Gaps = 32/272 (11%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G + V +G +N VA+K K + ++E +R+ H +IV L +
Sbjct: 17 EGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 76
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
I TE + ++ E +L+ ++ L + ++ L+ +QL LAY S+R +HRD+
Sbjct: 77 I-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135
Query: 308 PQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GV 366
+N+L++ +KL DFGL+R T +++ + ++++ D+
Sbjct: 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 195
Query: 367 GCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLA 425
G E+ G F G D + I + P
Sbjct: 196 GVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------------------------- 230
Query: 426 PEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
P L+ K YD +R
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 4e-15
Identities = 24/133 (18%), Positives = 52/133 (39%), Gaps = 5/133 (3%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELR 147
E +G+G + V +G +N VA+K K + ++E +R+
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLT 206
H +IV L +I TE + ++ E +L+ ++ L + ++ + + L
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 207 DNLVALKEIKLEH 219
++I +
Sbjct: 126 SKRFVHRDIAARN 138
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-41
Identities = 54/270 (20%), Positives = 103/270 (38%), Gaps = 33/270 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V GK R VA+K IK I E ++ L H +V L+ +
Sbjct: 14 TGQFGVVKYGKWR-GQYDVAIKMIKEGSMSED--EFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
++ + ++ EY+ L Y+ + + + + + Y S++ LHRDL +N
Sbjct: 71 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN 130
Query: 311 LLINERGELKLADFGLAR-AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVGC 368
L+N++G +K++DFGL+R + + + PP+VL+ S ++S+ D+ G
Sbjct: 131 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGV 189
Query: 369 IFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ E+ S G+ + T + I L P
Sbjct: 190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------------------------PH 224
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRH 457
++ A +R + + +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.3 bits (174), Expect = 1e-14
Identities = 25/130 (19%), Positives = 49/130 (37%), Gaps = 4/130 (3%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ L +LG G + V GK R VA+K IK I E ++ L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSED--EFIEEAKVMMNLSHEK 60
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNL 209
+V L+ + ++ + ++ EY+ L Y+ + + + V + L
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 210 VALKEIKLEH 219
+++ +
Sbjct: 121 FLHRDLAARN 130
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-40
Identities = 52/278 (18%), Positives = 115/278 (41%), Gaps = 37/278 (13%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V+ G VA+K +K +P + E +L+++L+H +V L+ ++ T
Sbjct: 23 AGQFGEVWMGYYN-GHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T 78
Query: 252 EKCLTLVFEYLEKDLKRYM--DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
++ + ++ EY+E L++N + Q+ G+A+ R +HRDL+
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138
Query: 310 NLLINERGELKLADFGLAR-AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM-GVG 367
N+L+++ K+ADFGLAR + + + P+ + ++ D+ G
Sbjct: 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFTIKSDVWSFG 197
Query: 368 CIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAP 426
+ E+ + GR +PG T + ++ + E +++ P
Sbjct: 198 ILLTEIVTHGRIPYPGMTNPEVIQNL-------------------------ERGYRMVRP 232
Query: 427 EQMDSDALDLVQKFLMYDAKQRISAAN--AMRHPYFNS 462
+ + L++ + R + ++ +F +
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.1 bits (171), Expect = 5e-14
Identities = 21/89 (23%), Positives = 46/89 (51%), Gaps = 4/89 (4%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
E+ +++LG G + V+ G VA+K +K +P + E +L+++L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLK--QGSMSPDAFLAEANLMKQLQHQR 69
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179
+V L+ ++ T++ + ++ EY+E
Sbjct: 70 LVRLYAVV-TQEPIYIITEYMENGSLVDF 97
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-40
Identities = 63/314 (20%), Positives = 122/314 (38%), Gaps = 41/314 (13%)
Query: 192 KGTYATVFKGK---SRLTDNLVALKEIK---LEHEEGAPCTAIREVSLLRELRHA-NIVT 244
G Y VF + T L A+K +K + + E +L +R + +VT
Sbjct: 34 TGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVT 93
Query: 245 LHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304
LH TE L L+ +Y+ + + V++++ +++ L + H I++R
Sbjct: 94 LHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYR 153
Query: 305 DLKPQNLLINERGELKLADFGLARAKSVP--TKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
D+K +N+L++ G + L DFGL++ + + + P V G + + ++
Sbjct: 154 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV 213
Query: 363 DM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
D +G + +E+ +G F ++ I +
Sbjct: 214 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY------------------ 255
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQSI 476
P++M + A DL+Q+ LM D K+R+ A H +F + +
Sbjct: 256 ----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 311
Query: 477 FSLPHIKLTSNPTD 490
F P I+ + D
Sbjct: 312 F-KPVIR---DELD 321
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.6 bits (146), Expect = 9e-11
Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 7/137 (5%)
Query: 90 IESYFKLDKLGQGTYATVFKGK---SRLTDNLVALKEIK---LEHEEGAPCTAIREVSLL 143
IE++ L LG G Y VF + T L A+K +K + + E +L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 144 RELRHA-NIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGK 202
+R + +VTLH TE L L+ +Y+ + + V+ +
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 203 SRLTDNLVALKEIKLEH 219
L + ++IKLE+
Sbjct: 143 EHLHKLGIIYRDIKLEN 159
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 3e-40
Identities = 52/270 (19%), Positives = 100/270 (37%), Gaps = 33/270 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G + V G L + VA+K I+ I E ++ +L H +V L+ +
Sbjct: 15 SGQFGLVHLGY-WLNKDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 252 EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+ + LVFE++E L Y+ + + + + G+AY ++HRDL +N
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 131
Query: 311 LLINERGELKLADFGLARAKSVPTKTFSNEVV-TLWYRPPDVLLGSTEYSTSIDM-GVGC 368
L+ E +K++DFG+ R T S + + P+V S YS+ D+ G
Sbjct: 132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGV 190
Query: 369 IFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ E+ S G+ + + + + I + P
Sbjct: 191 LMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------------------PR 225
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMRH 457
+ ++ + R + + +R
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.6 bits (175), Expect = 1e-14
Identities = 27/130 (20%), Positives = 55/130 (42%), Gaps = 4/130 (3%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
+ ++G G + V G L + VA+K I+ I E ++ +L H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEE--DFIEEAEVMMKLSHPK 61
Query: 151 IVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNL 209
+V L+ + + + LVFE++E L Y+ + + + G V +G + L +
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 210 VALKEIKLEH 219
V +++ +
Sbjct: 122 VIHRDLAARN 131
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 4e-40
Identities = 54/290 (18%), Positives = 106/290 (36%), Gaps = 46/290 (15%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + V G +L VA+K +K + E + E S++ + H N++ L +
Sbjct: 36 AGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV 95
Query: 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
+ + ++ E++E L ++ ++ + L + G+ Y +HRDL
Sbjct: 96 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLA 155
Query: 308 PQNLLINERGELKLADFGLAR-----AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
+N+L+N K++DFGL+R + + + + P+ + +++++
Sbjct: 156 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR-KFTSAS 214
Query: 363 DM-GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
D+ G + E+ S G + T +D + I PP
Sbjct: 215 DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-------------------- 254
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAA-------NAMRHPYFNSL 463
P S L+ D R +R+P NSL
Sbjct: 255 -----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP--NSL 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 70.2 bits (171), Expect = 6e-14
Identities = 24/133 (18%), Positives = 56/133 (42%), Gaps = 5/133 (3%)
Query: 92 SYFKLDK-LGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELR 147
S K+++ +G G + V G +L VA+K +K + E + E S++ +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLT 206
H N++ L ++ + ++ E++E L ++ ++ + G + G L
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 207 DNLVALKEIKLEH 219
D +++ +
Sbjct: 146 DMNYVHRDLAARN 158
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 5e-40
Identities = 54/283 (19%), Positives = 109/283 (38%), Gaps = 38/283 (13%)
Query: 192 KGTYATVFKGKSRL--TDNLVALKEIKLE-HEEGAPCTAIREVSLLRELRHANIVTLHDI 248
G + TV KG ++ VA+K +K E ++ + E +++++L + IV + I
Sbjct: 17 SGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 76
Query: 249 IHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKP 308
E + LV E E + + N+ + Q+ G+ Y +HRDL
Sbjct: 77 CEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 135
Query: 309 QNLLINERGELKLADFGLARAKSVP---TKTFSNEVVTLWYRPPDVLLGSTEYSTSIDM- 364
+N+L+ + K++DFGL++A K ++ + + P+ + ++S+ D+
Sbjct: 136 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVW 194
Query: 365 GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQL 423
G + E S G+ + G + ++
Sbjct: 195 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC----------------------- 231
Query: 424 LAPEQMDSDALDLVQKFLMYDAKQRISAA---NAMRHPYFNSL 463
P + DL+ YD + R A +R+ Y++ +
Sbjct: 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.8 bits (165), Expect = 3e-13
Identities = 27/134 (20%), Positives = 54/134 (40%), Gaps = 6/134 (4%)
Query: 91 ESYFKLD--KLGQGTYATVFKGKSRL--TDNLVALKEIKLE-HEEGAPCTAIREVSLLRE 145
L+ +LG G + TV KG ++ VA+K +K E ++ + E +++++
Sbjct: 5 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQ 64
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRL 205
L + IV + I E + LV E E + + N+ V G L
Sbjct: 65 LDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 123
Query: 206 TDNLVALKEIKLEH 219
++ +++ +
Sbjct: 124 EESNFVHRDLAARN 137
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 5e-39
Identities = 54/271 (19%), Positives = 99/271 (36%), Gaps = 35/271 (12%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLH 246
G++ V +G+ VA+K +K + + A IREV+ + L H N++ L+
Sbjct: 18 DGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLY 77
Query: 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305
++ + +V E L + + + + Q+ G+ Y S+R +HRD
Sbjct: 78 GVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 136
Query: 306 LKPQNLLINERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
L +NLL+ R +K+ DFGL RA ++ + L + +S + D
Sbjct: 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASD 196
Query: 364 M-GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKL 421
G EM + G+ + G L I P
Sbjct: 197 TWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR-------------------- 236
Query: 422 QLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452
PE D +++ + + + R +
Sbjct: 237 ----PEDCPQDIYNVMVQCWAHKPEDRPTFV 263
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.4 bits (169), Expect = 9e-14
Identities = 26/134 (19%), Positives = 52/134 (38%), Gaps = 7/134 (5%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEH--EEGAPCTAIREVSLLRE 145
+ L+KLG G++ V +G+ VA+K +K + + A IREV+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKGTYATVFKGKSR 204
L H N++ L+ ++ + +V E L + + + V +G
Sbjct: 68 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 205 LTDNLVALKEIKLE 218
L +++
Sbjct: 127 LESKRFIHRDLAAR 140
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-38
Identities = 52/296 (17%), Positives = 98/296 (33%), Gaps = 32/296 (10%)
Query: 192 KGTYATVFKGKSRLTDNL----VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
G + TV+KG VA+KE++ A + E ++ + + ++ L
Sbjct: 19 SGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG 78
Query: 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307
I T + L Y+ + + + + + Q+ +G+ Y RR++HRDL
Sbjct: 79 ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLA 138
Query: 308 PQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG 365
+N+L+ +K+ DFGLA+ V + + + +L S
Sbjct: 139 ARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWS 198
Query: 366 VGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLL 424
G E+ + G + G + ++ P
Sbjct: 199 YGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ------------------------ 234
Query: 425 APEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQVHELSDTQSIFSLP 480
P D ++ K M DA R + + PQ + + LP
Sbjct: 235 -PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 289
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 2e-12
Identities = 23/134 (17%), Positives = 50/134 (37%), Gaps = 4/134 (2%)
Query: 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNL----VALKEIKLEHEEGAPCTAIREVSLLR 144
+ + K+ LG G + TV+KG VA+KE++ A + E ++
Sbjct: 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 145 ELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSR 204
+ + ++ L I T + L Y+ + + + + + KG +
Sbjct: 67 SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 205 LTDNLVALKEIKLE 218
L D + +++
Sbjct: 127 LEDRRLVHRDLAAR 140
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (353), Expect = 2e-38
Identities = 52/269 (19%), Positives = 98/269 (36%), Gaps = 31/269 (11%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G Y V++G + VA+K +K + E ++E ++++E++H N+V L +
Sbjct: 27 GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFLKEAAVMKEIKHPNLVQLLGVCTR 84
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSN--ILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309
E ++ E++ N +S + Q+ + Y + +HRDL +
Sbjct: 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144
Query: 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYST-SIDMGVGC 368
N L+ E +K+ADFGL+R + T T L ++S S G
Sbjct: 145 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204
Query: 369 IFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPE 427
+ E+ + G +PG + L+ PE
Sbjct: 205 LLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------------------PE 239
Query: 428 QMDSDALDLVQKFLMYDAKQRISAANAMR 456
+L++ ++ R S A +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 71.3 bits (174), Expect = 2e-14
Identities = 21/94 (22%), Positives = 41/94 (43%), Gaps = 2/94 (2%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150
KLG G Y V++G + VA+K +K + E ++E ++++E++H N
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE--EFLKEAAVMKEIKHPN 74
Query: 151 IVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSN 184
+V L + E ++ E++ N
Sbjct: 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 108
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 142 bits (357), Expect = 2e-38
Identities = 72/333 (21%), Positives = 129/333 (38%), Gaps = 51/333 (15%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
G ++TV+ K + + VA+K ++ + + A E+ LL+ + A+ +
Sbjct: 23 WGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80
Query: 252 E--KCLTLVFEYLEKDLKRYMDDC--------------SNILSMNNVKLFLFQLLRGLAY 295
K L + M + + VK QLL GL Y
Sbjct: 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDY 140
Query: 296 CHSRR-ILHRDLKPQNLLINERG------ELKLADFGLARAKSVPTKTFSNEVVTLWYRP 348
H R I+H D+KP+N+L+ ++K+AD G A + ++N + T YR
Sbjct: 141 MHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYTNSIQTREYRS 197
Query: 349 PDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPG------STIEDELRLICSILGPPPDE 402
P+VLLG+ + C+ E+ +G LF + +D + I +LG P
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSY 257
Query: 403 L-----KSKLEFCITPVYPSESKLQ-----------LLAPEQMDSDALDLVQKFLMYDAK 446
L ++ F + + SKL+ + + D + L D +
Sbjct: 258 LLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317
Query: 447 QRISAANAMRHPYF-NSLGPQVHELSDTQSIFS 478
+R A + HP+ ++LG + + D + S
Sbjct: 318 KRADAGGLVNHPWLKDTLGMEEIRVPDRELYGS 350
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 139 bits (352), Expect = 2e-38
Identities = 49/286 (17%), Positives = 94/286 (32%), Gaps = 37/286 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN-IVTLHDIIH 250
G++ ++ G VA+K ++ + E + + ++ I T+
Sbjct: 17 SGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGIPTIRWCGA 73
Query: 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQN 310
+V E L L+ + CS S+ V L Q++ + Y HS+ +HRD+KP N
Sbjct: 74 EGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133
Query: 311 LLINERG---ELKLADFGLARA-------KSVPTKTFSNEVVTLWYRPPDVLLGSTEYST 360
L+ + + DFGLA+ + +P + N T Y + LG E S
Sbjct: 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG-IEQSR 192
Query: 361 SIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSES 419
D+ +G + + G + G + + I L
Sbjct: 193 RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL------------ 240
Query: 420 KLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA---NAMRHPYFNS 462
+ S+ + + + R+ +
Sbjct: 241 ------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.6 bits (172), Expect = 4e-14
Identities = 20/128 (15%), Positives = 45/128 (35%), Gaps = 4/128 (3%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN-I 151
Y K+G G++ ++ G VA+K ++ + E + + ++ I
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ---LHIESKIYKMMQGGVGI 65
Query: 152 VTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVA 211
T+ +V E L L+ + CS S+ V + +
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 212 LKEIKLEH 219
+++K ++
Sbjct: 126 HRDVKPDN 133
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 4e-38
Identities = 53/292 (18%), Positives = 104/292 (35%), Gaps = 51/292 (17%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTL 245
G + V + + VA+K +K + E+ +L L H NIV L
Sbjct: 33 AGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNL 92
Query: 246 HDIIHTEKCLTLVFEYLEK-DLKRYM-----------------DDCSNILSMNNVKLFLF 287
++ EY DL ++ +D L + ++ F +
Sbjct: 93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLW 345
Q+ +G+A+ S+ +HRDL +N+L+ K+ DFGLAR N + +
Sbjct: 153 QVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212
Query: 346 YRPPDVLLGSTEYSTSIDMGVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELK 404
+ P+ + S G E+ S G +PG ++ + +
Sbjct: 213 WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI----------- 261
Query: 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456
+ ++L+PE ++ D+++ D +R + ++
Sbjct: 262 -------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-37
Identities = 52/274 (18%), Positives = 104/274 (37%), Gaps = 34/274 (12%)
Query: 192 KGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247
G + V+KG + + VA+K +K + E + E ++ + H NI+ L
Sbjct: 17 AGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEG 76
Query: 248 IIHTEKCLTLVFEYLEKDLK-RYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+I K + ++ EY+E +++ + S+ + L + G+ Y + +HRDL
Sbjct: 77 VISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 136
Query: 307 KPQNLLINERGELKLADFGLAR---AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSID 363
+N+L+N K++DFGL+R T T S + + + P+ + S S
Sbjct: 137 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDV 196
Query: 364 MGVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQ 422
G + E+ + G + + + ++ I P
Sbjct: 197 WSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---------------------- 234
Query: 423 LLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456
P S L+ + + +R A+ +
Sbjct: 235 ---PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.9 bits (170), Expect = 6e-14
Identities = 26/134 (19%), Positives = 56/134 (41%), Gaps = 6/134 (4%)
Query: 92 SYFKLDK-LGQGTYATVFKGKSRLTDN----LVALKEIKLEHEEGAPCTAIREVSLLREL 146
S K +G G + V+KG + + VA+K +K + E + E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 147 RHANIVTLHDIIHTEKCLTLVFEYLEKDLK-RYMDDCSNILSMNNVKGTYATVFKGKSRL 205
H NI+ L +I K + ++ EY+E +++ + S+ + G + G L
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 206 TDNLVALKEIKLEH 219
+ +++ +
Sbjct: 127 ANMNYVHRDLAARN 140
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 3e-37
Identities = 65/298 (21%), Positives = 111/298 (37%), Gaps = 59/298 (19%)
Query: 192 KGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G + VF+ ++ +VA+K +K E RE +L+ E + NIV L
Sbjct: 23 EGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL 82
Query: 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSN-----------------------ILSMNNV 282
+ K + L+FEY+ DL ++ S LS
Sbjct: 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 142
Query: 283 KLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNE 340
Q+ G+AY R+ +HRDL +N L+ E +K+ADFGL+R + K N+
Sbjct: 143 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGND 202
Query: 341 VVTLWYRPPDVLLGSTEYSTSIDM-GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGP 398
+ + + PP+ + Y+T D+ G + E+ S G + G E+ + + G
Sbjct: 203 AIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD--GN 259
Query: 399 PPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456
PE + +L++ R S + R
Sbjct: 260 ILA-----------------------CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 136 bits (344), Expect = 4e-37
Identities = 50/251 (19%), Positives = 89/251 (35%), Gaps = 17/251 (6%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
+G++ +F+G + L + VA+K + R LL I ++
Sbjct: 15 EGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG--IPNVYYFGQE 72
Query: 252 EKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNL 311
LV + L L+ +D C S+ V + Q+L + H + +++RD+KP N
Sbjct: 73 GLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132
Query: 312 LINE-----RGELKLADFGLAR-------AKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS 359
LI + + DFG+ + + +P + N T Y + LG E S
Sbjct: 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGR-EQS 191
Query: 360 TSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSIL-GPPPDELKSKLEFCITPVYPS 417
D+ +G +F G + G + I L+ Y
Sbjct: 192 RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKY 251
Query: 418 ESKLQLLAPEQ 428
+ LA +
Sbjct: 252 MHYARNLAFDA 262
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 67.1 bits (163), Expect = 7e-13
Identities = 23/127 (18%), Positives = 48/127 (37%), Gaps = 2/127 (1%)
Query: 93 YFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIV 152
Y ++G+G++ +F+G + L + VA+K + R LL I
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG--IP 64
Query: 153 TLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVAL 212
++ LV + L L+ +D C S+ V + + + +
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 213 KEIKLEH 219
++IK ++
Sbjct: 125 RDIKPDN 131
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 7e-35
Identities = 52/277 (18%), Positives = 116/277 (41%), Gaps = 37/277 (13%)
Query: 192 KGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248
+G + V+ G D A+K + + G + E ++++ H N+++L I
Sbjct: 37 RGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 96
Query: 249 -IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306
+ +E +V Y++ DL+ ++ + ++ ++ ++ F Q+ +G+ + S++ +HRDL
Sbjct: 97 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 156
Query: 307 KPQNLLINERGELKLADFGLARAKSVP----TKTFSNEVVTLWYRPPDVLLGSTEYSTSI 362
+N +++E+ +K+ADFGLAR + + + + + L +++T
Sbjct: 157 AARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ-KFTTKS 215
Query: 363 DM-GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESK 420
D+ G + E+ + G P +P D +
Sbjct: 216 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-------------------------QG 250
Query: 421 LQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
+LL PE +++ K A+ R S + +
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.7 bits (167), Expect = 2e-13
Identities = 26/141 (18%), Positives = 63/141 (44%), Gaps = 6/141 (4%)
Query: 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREV 140
IG + +F + +G+G + V+ G D A+K + + G + E
Sbjct: 21 VIGPSSLIVHFN-EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79
Query: 141 SLLRELRHANIVTLHDI-IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKGTYATV 198
++++ H N+++L I + +E +V Y++ DL+ ++ + ++ ++ ++ G V
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 199 FKGKSRLTDNLVALKEIKLEH 219
KG L +++ +
Sbjct: 140 AKGMKFLASKKFVHRDLAARN 160
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-34
Identities = 56/286 (19%), Positives = 101/286 (35%), Gaps = 46/286 (16%)
Query: 192 KGTYATVFKGKSRLTDNL--VALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDI 248
+G + V K + + A+K +K + E+ +L +L H NI+ L
Sbjct: 20 EGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79
Query: 249 IHTEKCLTLVFEYLEK-DLKRYM---------------DDCSNILSMNNVKLFLFQLLRG 292
L L EY +L ++ + ++ LS + F + RG
Sbjct: 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARG 139
Query: 293 LAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVL 352
+ Y ++ +HRDL +N+L+ E K+ADFGL+R + V K + + + + L
Sbjct: 140 MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG-RLPVRWMAIESL 198
Query: 353 LGSTEYSTSIDMGVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCI 411
S + S G + E+ S G + G T + +
Sbjct: 199 NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK----------- 247
Query: 412 TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
P D + DL+++ +R S A +
Sbjct: 248 --------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.4 bits (148), Expect = 5e-11
Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 4/88 (4%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNL--VALKEIKLEHEEGAPCTAIREVSLLREL-RHANIV 152
D +G+G + V K + + A+K +K + E+ +L +L H NI+
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 153 TLHDIIHTEKCLTLVFEYLEK-DLKRYM 179
L L L EY +L ++
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFL 102
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-34
Identities = 62/289 (21%), Positives = 105/289 (36%), Gaps = 35/289 (12%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251
KG + V++GK VA+K E E+ LRH NI+ +
Sbjct: 13 KGRFGEVWRGK--WRGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFIAADNK 68
Query: 252 E----KCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-------- 298
+ L LV +Y E L Y++ +++ + GLA+ H
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 299 RRILHRDLKPQNLLINERGELKLADFGLARAKSVPTKTFS----NEVVTLWYRPPDVLLG 354
I HRDLK +N+L+ + G +AD GLA T T + V T Y P+VL
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 355 S-----TEYSTSIDM-GVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL-KSKL 407
S E D+ +G +F E++ + P +E+ K
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456
E + P P+ + + ++++ + R++A +
Sbjct: 247 EQKLRPNIPNRWQ-----SCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 5e-10
Identities = 22/90 (24%), Positives = 36/90 (40%), Gaps = 9/90 (10%)
Query: 96 LDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 155
+ +G+G + V++GK VA+K E E+ LRH NI+
Sbjct: 8 QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSW--FREAEIYQTVMLRHENILGFI 63
Query: 156 DIIHTE----KCLTLVFEYLEK-DLKRYMD 180
+ + L LV +Y E L Y++
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN 93
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-33
Identities = 50/293 (17%), Positives = 112/293 (38%), Gaps = 49/293 (16%)
Query: 192 KGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246
+G++ V++G ++ + VA+K + + E S+++E ++V L
Sbjct: 30 QGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 89
Query: 247 DIIHTEKCLTLVFEYLEK-DLKRYMDDC---------SNILSMNNVKLFLFQLLRGLAYC 296
++ + ++ E + + DLK Y+ S++ + ++ G+AY
Sbjct: 90 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149
Query: 297 HSRRILHRDLKPQNLLINERGELKLADFGLARA--KSVPTKTFSNEVVTLWYRPPDVLLG 354
++ + +HRDL +N ++ E +K+ DFG+ R ++ + ++ + + P+ L
Sbjct: 150 NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 209
Query: 355 STEYSTSIDMGVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITP 413
+ S G + E+ + + G + E LR + G D+
Sbjct: 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--GGLLDK----------- 256
Query: 414 VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR------HPYF 460
P+ +L++ Y+ K R S + P F
Sbjct: 257 ------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 4e-13
Identities = 22/109 (20%), Positives = 48/109 (44%), Gaps = 6/109 (5%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRE 145
E +LGQG++ V++G ++ + VA+K + + E S+++E
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 146 LRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKG 193
++V L ++ + ++ E + + DLK Y+ ++ N V
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 128
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 8e-33
Identities = 58/294 (19%), Positives = 113/294 (38%), Gaps = 54/294 (18%)
Query: 192 KGTYATVFKGKSRLTDN-------LVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIV 243
+G + V ++ D VA+K +K + E I E+ +++ + +H NI+
Sbjct: 23 EGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNII 82
Query: 244 TLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC---------------SNILSMNNVKLFLF 287
L + L ++ EY K +L+ Y+ LS ++ +
Sbjct: 83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142
Query: 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR--AKSVPTKTFSNEVVTLW 345
Q+ RG+ Y S++ +HRDL +N+L+ E +K+ADFGLAR K +N + +
Sbjct: 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202
Query: 346 YRPPDVLLGSTEYSTSIDM-GVGCIFHEM-SSGRPLFPGSTIEDELRLICSILGPPPDEL 403
+ P+ L Y+ D+ G + E+ + G +PG +E+ +L+
Sbjct: 203 WMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--- 258
Query: 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
P ++ +++ QR + +
Sbjct: 259 ----------------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (154), Expect = 8e-12
Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 9/101 (8%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDN-------LVALKEIKLEHEEGAPCTAIREVSLL 143
+ LG+G + V ++ D VA+K +K + E I E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 144 REL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182
+ + +H NI+ L + L ++ EY K +L+ Y+
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR 113
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-31
Identities = 54/292 (18%), Positives = 108/292 (36%), Gaps = 50/292 (17%)
Query: 192 KGTYATVFKGKSRLTDNL-----VALKEIKLEHEEGAPCTAIREVS-LLRELRHANIVTL 245
+G + V + + D VA+K +K + E+ L+ H N+V L
Sbjct: 23 RGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82
Query: 246 HDII-HTEKCLTLVFEYLEK-DLKRYM---------------DDCSNILSMNNVKLFLFQ 288
L ++ E+ + +L Y+ D + L++ ++ + FQ
Sbjct: 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 142
Query: 289 LLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTFSNEVV-TLWY 346
+ +G+ + SR+ +HRDL +N+L++E+ +K+ DFGLAR P + L +
Sbjct: 143 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 202
Query: 347 RPPDVLLGSTEYSTSIDMGVGCIFHEMSSG-RPLFPGSTIEDELRLICSILGPPPDELKS 405
P+ + S G + E+ S +PG I++E
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------------ 250
Query: 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457
+ ++ AP+ + + + QR + + + H
Sbjct: 251 ------------KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.0 bits (121), Expect = 1e-07
Identities = 20/102 (19%), Positives = 37/102 (36%), Gaps = 8/102 (7%)
Query: 91 ESYFKLDKLGQGTYATVFKGKSRLTDNL-----VALKEIKLEHEEGAPCTAIREVS-LLR 144
+ LG+G + V + + D VA+K +K + E+ L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 145 ELRHANIVTLHDII-HTEKCLTLVFEYLEK-DLKRYMDDCSN 184
H N+V L L ++ E+ + +L Y+ N
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 114
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 3e-18
Identities = 26/169 (15%), Positives = 49/169 (28%), Gaps = 18/169 (10%)
Query: 192 KGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR---------EVSLLRELRHANI 242
+G + VF S +K K+ H R +
Sbjct: 10 EGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRAL 68
Query: 243 VTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRIL 302
L + K + +L + + N L +L +A + R I+
Sbjct: 69 QKLQGL-AVPKVYAWEGNAVLMEL--IDAKELYRVRVENPDEVLDMILEEVAKFYHRGIV 125
Query: 303 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTF----SNEVVTLWYR 347
H DL N+L++E G + + DF + + ++
Sbjct: 126 HGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 41.3 bits (96), Expect = 9e-05
Identities = 13/132 (9%), Positives = 32/132 (24%), Gaps = 13/132 (9%)
Query: 97 DKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIR---------EVSLLRELR 147
+G+G + VF S +K K+ H R
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 148 HANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTD 207
+ L + K + +L + + N + + ++
Sbjct: 65 FRALQKLQG-LAVPKVYAWEGNAVLMEL--IDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 208 NLVALKEIKLEH 219
+ ++ +
Sbjct: 122 RGIVHGDLSQYN 133
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 516 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 98.59 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 98.58 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 98.53 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 98.51 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 98.46 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 98.4 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 98.37 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 98.35 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.3 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 98.27 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 98.27 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 98.2 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 98.17 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.17 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 98.1 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 97.87 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 97.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.81 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 97.69 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 97.47 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 97.42 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.41 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 97.37 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 97.33 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 97.24 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 97.23 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 97.2 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 97.18 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 97.15 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 97.15 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 97.15 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 97.13 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 97.11 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 97.1 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 97.08 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 97.07 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 97.03 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 97.02 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 97.02 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 97.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 96.85 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 96.84 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 96.83 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 96.81 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 96.81 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 96.67 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 96.58 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 96.58 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 96.56 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 96.45 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.44 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 96.4 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 96.36 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 96.2 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 96.17 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 96.13 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 96.01 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 95.98 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 95.73 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 95.64 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 95.07 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 94.72 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.61 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 94.58 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 94.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.5 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 94.46 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 94.08 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 93.65 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-62 Score=473.53 Aligned_cols=256 Identities=27% Similarity=0.478 Sum_probs=222.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~------------------------------------- 46 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEK------------------------------------- 46 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccC-------------------------------------
Confidence 3688999999999999999999999999999999986532110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+|+.++|||||+++++
T Consensus 47 ----------------------------------------------------~~~~~~~~~E~~il~~l~hpnIv~~~~~ 74 (263)
T d2j4za1 47 ----------------------------------------------------AGVEHQLRREVEIQSHLRHPNILRLYGY 74 (263)
T ss_dssp ----------------------------------------------------TTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ----------------------------------------------------hHHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence 1122356788999999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++.+|+|||||+ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 75 ~~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a 153 (263)
T d2j4za1 75 FHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 153 (263)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSC
T ss_pred EEECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeeccccee
Confidence 999999999999999 5888888764 45999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+..... .....+||+.|||||++.+..++.++|+|||||++|||++|++||.+.+..+.+..+...
T Consensus 154 ~~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------------ 219 (263)
T d2j4za1 154 VHAPSS--RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 219 (263)
T ss_dssp SCCCCC--CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT------------
T ss_pred eecCCC--cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC------------
Confidence 765432 334568999999999999988899999999999999999999999998888877776432
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....|+.+++++++||.+||+.||++|||++|+|+||||++
T Consensus 220 --------------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 220 --------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred --------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 12235578999999999999999999999999999999964
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-61 Score=476.92 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=221.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|+++.+|+.||||++.......
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--------------------------------------- 60 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--------------------------------------- 60 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---------------------------------------
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---------------------------------------
Confidence 46999999999999999999999999999999986542211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.+|++++|||||+++++|.
T Consensus 61 -----------------------------------------------------~~~~~~E~~il~~l~HpnIv~~~~~~~ 87 (293)
T d1yhwa1 61 -----------------------------------------------------KELIINEILVMRENKNPNIVNYLDSYL 87 (293)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEeEEEE
Confidence 125677888888889999999999999
Q ss_pred eCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++++|||||||+| +|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 88 ~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~ 165 (293)
T d1yhwa1 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 165 (293)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhhee
Confidence 99999999999995 78777655 4599999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhccc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEF 409 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ 409 (516)
...........+||+.|+|||++.+..++.++|+||+||++|+|++|++||.+.+..+.+..+.....+
T Consensus 166 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~----------- 234 (293)
T d1yhwa1 166 ITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP----------- 234 (293)
T ss_dssp CCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-----------
T ss_pred eccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence 765555566778999999999999988999999999999999999999999998887777766543211
Q ss_pred ccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 410 CITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 410 ~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....|..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 235 ------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 235 ------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 11223468899999999999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-60 Score=479.28 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=228.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~------------------------------------- 45 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIA------------------------------------- 45 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccC-------------------------------------
Confidence 4688999999999999999999999999999999997542100
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+|+.++||||++++++
T Consensus 46 ----------------------------------------------------~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 73 (337)
T d1o6la_ 46 ----------------------------------------------------KDEVAHTVTESRVLQNTRHPFLTALKYA 73 (337)
T ss_dssp ----------------------------------------------------TTCHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHhCCCCCEEEEEee
Confidence 1112356788889999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
|++++.+|+|||||+ |+|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 74 ~~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a 152 (337)
T d1o6la_ 74 FQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152 (337)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccc
Confidence 999999999999999 5888887764 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+............+||+.|+|||++.+..++.++|+||+||++|||++|++||.+.+..+.+..+...
T Consensus 153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~------------ 220 (337)
T d1o6la_ 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------ 220 (337)
T ss_dssp BCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred cccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC------------
Confidence 87665555666789999999999999999999999999999999999999999999988877776442
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQ 466 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~ 466 (516)
...+|..+|++++|||.+||++||.+|++ ++|+++||||+.+.+.
T Consensus 221 --------------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 221 --------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred --------------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 12345678999999999999999999994 9999999999887543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-61 Score=473.22 Aligned_cols=258 Identities=25% Similarity=0.365 Sum_probs=218.8
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-+.|+++++||+|+||+||+|+++.+|+.||||++.......
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------------------------------------- 52 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-------------------------------------- 52 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG--------------------------------------
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH--------------------------------------
Confidence 356999999999999999999999999999999986532111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+|++++|||||++++++
T Consensus 53 ------------------------------------------------------~~~~~~E~~il~~l~HpnIv~l~~~~ 78 (288)
T d2jfla1 53 ------------------------------------------------------LEDYMVEIDILASCDHPNIVKLLDAF 78 (288)
T ss_dssp ------------------------------------------------------GGGTHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 12456788888888888888999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+++.+|||||||+ |+|.+++.+..+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 79 ~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 79 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhh
Confidence 99999999999998 58888887777789999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCccccCCcccccccchhhcc-----CCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLL-----GSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
............+||+.|+|||++. +..++.++|+|||||++|||+||++||.+.+..+.+..+..... +
T Consensus 159 ~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~--~--- 233 (288)
T d2jfla1 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP--P--- 233 (288)
T ss_dssp ECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCC--C---
T ss_pred ccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--C---
Confidence 6543333345678999999999984 44567889999999999999999999999888777776654211 1
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
....|..+++++++||.+||+.||++|||++|+|+||||+.
T Consensus 234 ------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 234 ------------------TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp ------------------CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ------------------CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 11123467899999999999999999999999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-60 Score=471.64 Aligned_cols=282 Identities=38% Similarity=0.663 Sum_probs=231.8
Q ss_pred eeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh
Q psy12305 94 FKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 173 (516)
Q Consensus 94 ~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 173 (516)
+.+++||+|+||+||+|+++.+|+.||||+++.......
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~----------------------------------------- 39 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEA----------------------------------------- 39 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC-------------------------------------------------
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhh-----------------------------------------
Confidence 468999999999999999999999999999865432110
Q ss_pred hhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCc
Q psy12305 174 DLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 253 (516)
Q Consensus 174 ~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 253 (516)
.......+.+|+.+|++++|||||++++++.+++
T Consensus 40 ----------------------------------------------~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~ 73 (299)
T d1ua2a_ 40 ----------------------------------------------KDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 73 (299)
T ss_dssp --------------------------------------------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred ----------------------------------------------hHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC
Confidence 0111236778999999999999999999999999
Q ss_pred eeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCC
Q psy12305 254 CLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVP 333 (516)
Q Consensus 254 ~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~ 333 (516)
++|||||||.+++...+...+..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 74 ~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 74 NISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred ceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC
Confidence 99999999998888888777778999999999999999999999999999999999999999999999999999877665
Q ss_pred CccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccc--
Q psy12305 334 TKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLEFC-- 410 (516)
Q Consensus 334 ~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~-- 410 (516)
.......+||+.|+|||++.+.. ++.++|+||+||++|||++|.+||.+.+..+++..|...+|+|+.+.+......
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 55566678999999999987654 567889999999999999999999999999999999999999887655322111
Q ss_pred --cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 411 --ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 411 --~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.....+. ....... ..+++++.|||.+||++||++||||+|+|+||||++..
T Consensus 234 ~~~~~~~~~-~~~~~~~-~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 234 YVTFKSFPG-IPLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCC-CCHHHHC-TTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hhhhccCCC-CChHHhc-ccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 1111111 1122222 26789999999999999999999999999999998653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-60 Score=470.27 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=223.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------------------------------------- 48 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIK-------------------------------------- 48 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH--------------------------------------
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccC--------------------------------------
Confidence 367999999999999999999999999999999987532110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
......+.+|+.+|++++||||++++++|
T Consensus 49 ---------------------------------------------------~~~~~~~~~E~~il~~l~HpnIv~l~~~~ 77 (288)
T d1uu3a_ 49 ---------------------------------------------------ENKVPYVTRERDVMSRLDHPFFVKLYFTF 77 (288)
T ss_dssp ---------------------------------------------------TTCHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHHcCCCCeeEEEEEE
Confidence 11123567889999999999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+++.+|||||||+ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+
T Consensus 78 ~~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~ 156 (288)
T d1uu3a_ 78 QDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156 (288)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccce
Confidence 99999999999999 5888887765 469999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
...... ......+||+.|+|||++.+..++.++|+||+||++|||++|++||.+.+..+.+..|...
T Consensus 157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~----------- 225 (288)
T d1uu3a_ 157 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL----------- 225 (288)
T ss_dssp ECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT-----------
T ss_pred ecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC-----------
Confidence 765332 2334568999999999999988899999999999999999999999998888877776432
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHH------HHcCCCCCCCCCCcc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAAN------AMRHPYFNSLGPQVH 468 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e------~l~Hp~f~~~~~~~~ 468 (516)
...+|..+++++++||.+||+.||++|||++| +++||||+++.+...
T Consensus 226 ---------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l 278 (288)
T d1uu3a_ 226 ---------------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278 (288)
T ss_dssp ---------------CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred ---------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence 12245578999999999999999999999987 589999999876543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-61 Score=467.87 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=212.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++........
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~------------------------------------ 46 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDC------------------------------------ 46 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-----------------------------------------
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchH------------------------------------
Confidence 46889999999999999999999999999999999865422111
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+|++++|||||+++++
T Consensus 47 -------------------------------------------------------~~~~~~Ei~~l~~l~HpnIv~~~~~ 71 (271)
T d1nvra_ 47 -------------------------------------------------------PENIKKEICINKMLNHENVVKFYGH 71 (271)
T ss_dssp ---------------------------------------------------------CHHHHHHHHHTCCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEeee
Confidence 1246678888888888888999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++.+|||||||+ |+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 72 ~~~~~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a 150 (271)
T d1nvra_ 72 RREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 150 (271)
T ss_dssp EEETTEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred eccCceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhh
Confidence 999999999999998 588888765 346999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC--ccccCCcccccccchhhccCCCCCC-ceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYS-TSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~-~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+...... ......+||+.|||||++.+..+++ ++|+||+||++|||++|++||.+.................
T Consensus 151 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~----- 225 (271)
T d1nvra_ 151 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY----- 225 (271)
T ss_dssp EECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-----
T ss_pred eeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-----
Confidence 8754322 2345578999999999998887764 5799999999999999999998755433332222111100
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
...+..+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 226 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0112367899999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-60 Score=471.06 Aligned_cols=270 Identities=22% Similarity=0.316 Sum_probs=228.3
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||+++......
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~------------------------------------- 44 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR------------------------------------- 44 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH-------------------------------------
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccC-------------------------------------
Confidence 3678999999999999999999999999999999987532110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
......+.+|+.+|+.++|||||+++++
T Consensus 45 ----------------------------------------------------~~~~~~~~~E~~il~~l~HpnIv~~~~~ 72 (316)
T d1fota_ 45 ----------------------------------------------------LKQVEHTNDERLMLSIVTHPFIIRMWGT 72 (316)
T ss_dssp ----------------------------------------------------TTCHHHHHHHHHHHHSCCBTTBCCEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHHhccCcChhheeee
Confidence 1112356789999999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++.+|+|||||+| ++..++. ....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 73 ~~~~~~~~ivmE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a 151 (316)
T d1fota_ 73 FQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 151 (316)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EeeCCeeeeEeeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccc
Confidence 9999999999999996 5555554 4566899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+..... ....+||+.|||||++.+..++.++|+||+||++|||++|+.||.+.+..+.+..+....
T Consensus 152 ~~~~~~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~----------- 217 (316)
T d1fota_ 152 KYVPDV---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE----------- 217 (316)
T ss_dssp EECSSC---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred eEeccc---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC-----------
Confidence 876432 345689999999999999889999999999999999999999999998888877775421
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcccCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHELSDTQSIF 477 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~~~~ 477 (516)
...|..+++++.+||.+||++||.+|+ |++++++||||+++.+........+.++
T Consensus 218 ---------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~ 277 (316)
T d1fota_ 218 ---------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPY 277 (316)
T ss_dssp ---------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSC
T ss_pred ---------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCCCcCC
Confidence 123457899999999999999999996 9999999999999876544333333333
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.9e-60 Score=477.22 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=226.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++......
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-------------------------------------- 65 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-------------------------------------- 65 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH--------------------------------------
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh--------------------------------------
Confidence 468999999999999999999999999999999998643210
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+|++++|||||+++++
T Consensus 66 ------------------------------------------------------~~~~~~~E~~il~~l~HpnIv~~~~~ 91 (350)
T d1koaa2 66 ------------------------------------------------------DKETVRKEIQTMSVLRHPTLVNLHDA 91 (350)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred ------------------------------------------------------hHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 01246678899999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc--CCCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE--RGELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~--~~~vkL~DFG 325 (516)
+.+++.+|||||||+ |+|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||
T Consensus 92 ~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 92 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecc
Confidence 999999999999998 5999999776677999999999999999999999999999999999999964 5789999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+..... ......+||+.|||||++.+..++.++|+|||||++|||++|++||.+.+..+.+..|......++...
T Consensus 172 ~a~~~~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~-- 248 (350)
T d1koaa2 172 LTAHLDPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA-- 248 (350)
T ss_dssp TCEECCTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGG--
T ss_pred hheecccc-cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc--
Confidence 99876533 333456889999999999998888899999999999999999999999998888888876544333211
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
+..+++++++||.+||++||++|||++|+|+||||+....
T Consensus 249 --------------------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 249 --------------------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp --------------------GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred --------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 1267899999999999999999999999999999987654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-60 Score=462.71 Aligned_cols=257 Identities=28% Similarity=0.384 Sum_probs=205.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
+.++|++++.||+|+||+||+|+++.+|+.||||++........
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~------------------------------------ 45 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA------------------------------------ 45 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHH------------------------------------
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHH------------------------------------
Confidence 45789999999999999999999999999999999875432110
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+|++++|||||+++++
T Consensus 46 ------------------------------------------------------~~~~~~~E~~il~~l~HpnIv~~~~~ 71 (269)
T d2java1 46 ------------------------------------------------------EKQMLVSEVNLLRELKHPNIVRYYDR 71 (269)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHTTSCCCTTBCCEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence 01245677888888888888888887
Q ss_pred Eee--CceeeEeeehhh-chHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC-----cEeeecCCCCEEEccCC
Q psy12305 249 IHT--EKCLTLVFEYLE-KDLKRYMDD---CSNILSMNNVKLFLFQLLRGLAYCHSRR-----ILHRDLKPQNLLINERG 317 (516)
Q Consensus 249 ~~~--~~~~~lV~E~~~-g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~-----ivHrDlKp~NILl~~~~ 317 (516)
+.+ ++.+|||||||+ |+|.+++.+ .+..+++..++.++.||+.||+|||++| |+||||||+|||++.++
T Consensus 72 ~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~ 151 (269)
T d2java1 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151 (269)
T ss_dssp EEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS
T ss_pred EEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC
Confidence 754 456899999998 589888764 3467999999999999999999999876 99999999999999999
Q ss_pred CEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcC
Q psy12305 318 ELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILG 397 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~ 397 (516)
.+||+|||+|+............+||+.|||||++.+..++.++|+|||||++|||+||++||.+.+..+....+....-
T Consensus 152 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~ 231 (269)
T d2java1 152 NVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 231 (269)
T ss_dssp CEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred cEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999999998876555555667899999999999998888999999999999999999999999888877776654210
Q ss_pred CCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 398 PPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 398 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
...|..+++++.+||.+||+.||.+|||++|+++|||+
T Consensus 232 -------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 -------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 11344789999999999999999999999999999995
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=464.27 Aligned_cols=285 Identities=48% Similarity=0.832 Sum_probs=236.7
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|+++++||+|+||+||+|+++.+|+.||||+++......
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-------------------------------------- 42 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-------------------------------------- 42 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------------------------------------------
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh--------------------------------------
Confidence 478999999999999999999999999999999986532111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+|++++|||||+++++|
T Consensus 43 ----------------------------------------------------~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~ 70 (298)
T d1gz8a_ 43 ----------------------------------------------------GVPSTAIREISLLKELNHPNIVKLLDVI 70 (298)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhCCCCcEEEecccc
Confidence 1123567888889999999999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDD-CSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
.+++++|+|||||.+++..++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 71 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~ 150 (298)
T d1gz8a_ 71 HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 150 (298)
T ss_dssp EETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHH
T ss_pred ccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcce
Confidence 99999999999999887777654 45679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 329 AKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 329 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
............+||+.|+|||++....+ ..++|+||+||++|+|++|+.||.+.+..+.+..+....+.+++..+...
T Consensus 151 ~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 151 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp HHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred eccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 87766666677789999999999877665 56789999999999999999999999999999999999998887665433
Q ss_pred ccc-----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 408 EFC-----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 408 ~~~-----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
... ..+.... .......+ .+++++.|||.+||++||++|||++|+|+||||+++...
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~-~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWAR-QDFSKVVP-PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp GGSTTCCTTSCCCCC-CCHHHHST-TCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred ccccccccccccccc-cchhhhcc-CCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 211 1111111 11112222 678999999999999999999999999999999987544
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-59 Score=461.74 Aligned_cols=266 Identities=27% Similarity=0.407 Sum_probs=225.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|+++.+|+.||||++.+.......
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~------------------------------------- 52 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR------------------------------------- 52 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS-------------------------------------
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh-------------------------------------
Confidence 4599999999999999999999999999999999765322211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.......+.+|+.+|++++|||||+++++|.
T Consensus 53 -------------------------------------------------~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 53 -------------------------------------------------RGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp -------------------------------------------------SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred -------------------------------------------------hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 0112236778999999999999999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC----CEEEeeec
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG----ELKLADFG 325 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~----~vkL~DFG 325 (516)
+++++|||||||+ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred ECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence 9999999999999 5898888765 4699999999999999999999999999999999999998876 49999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+..... ......+||+.|+|||++.+..++.++|+||+||++|||++|+.||.+.+..+.+..+......++...
T Consensus 163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-- 239 (293)
T d1jksa_ 163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY-- 239 (293)
T ss_dssp TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH--
T ss_pred hhhhcCCC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh--
Confidence 99876533 334456889999999999998899999999999999999999999999998888888765443333222
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
+..+|+++++||.+||+.||++|||++|+|+||||+...++
T Consensus 240 --------------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 240 --------------------FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp --------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred --------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 23678999999999999999999999999999999875443
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-60 Score=478.11 Aligned_cols=260 Identities=21% Similarity=0.330 Sum_probs=225.5
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|+++++||+|+||+||+|+++.+|+.||||++......
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-------------------------------------- 68 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-------------------------------------- 68 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH--------------------------------------
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh--------------------------------------
Confidence 346799999999999999999999999999999998653210
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
....+.+|+.+|++++|||||+++++
T Consensus 69 ------------------------------------------------------~~~~~~~Ei~il~~l~HpnIv~~~~~ 94 (352)
T d1koba_ 69 ------------------------------------------------------DKYTVKNEISIMNQLHHPKLINLHDA 94 (352)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHTTCCSTTBCCEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 01245678999999999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc--cCCCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN--ERGELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~--~~~~vkL~DFG 325 (516)
|.+++++|||||||+ |+|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus 95 ~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 95 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecc
Confidence 999999999999999 588888877777899999999999999999999999999999999999998 57899999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+|+..... ......+||+.|+|||++.+..++.++|+|||||++|||+||++||.+.+..+.+..|......++..
T Consensus 175 la~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~--- 250 (352)
T d1koba_ 175 LATKLNPD-EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED--- 250 (352)
T ss_dssp TCEECCTT-SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSS---
T ss_pred cceecCCC-CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc---
Confidence 99876533 33445678999999999999999999999999999999999999999999888888886644333321
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.+..+++++.+||.+||++||.+|||++|+|+||||+..
T Consensus 251 -------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 251 -------------------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 123789999999999999999999999999999999864
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3e-59 Score=464.51 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=205.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+.|++.+.||+|+||+||+|+++.+|+.||||++.........
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------------------------------------- 51 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE------------------------------------- 51 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC--------------------------------------------
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHH-------------------------------------
Confidence 5599999999999999999999999999999998754321111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
..+.+|+.+|+.++|||||++++++.
T Consensus 52 ------------------------------------------------------~~~~~Ei~il~~l~HpnIv~l~~~~~ 77 (307)
T d1a06a_ 52 ------------------------------------------------------GSMENEIAVLHKIKHPNIVALDDIYE 77 (307)
T ss_dssp ---------------------------------------------------------CHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 13457888888888889999999999
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEc---cCCCEEEeeecc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLIN---ERGELKLADFGL 326 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~---~~~~vkL~DFGl 326 (516)
+++.+|||||||+ |+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+. .++.+||+|||+
T Consensus 78 ~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~ 156 (307)
T d1a06a_ 78 SGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156 (307)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred ECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccce
Confidence 9999999999998 5999998764 5699999999999999999999999999999999999995 478999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+..... ......+||+.|||||++.+..++.++|+||+||++|||++|++||.+.+..+....+......++
T Consensus 157 a~~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~------ 229 (307)
T d1a06a_ 157 SKMEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD------ 229 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC------
T ss_pred eEEccCC-CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC------
Confidence 9865432 334456899999999999999899999999999999999999999999888887777755322211
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+..+|+++.+||.+||++||++|||++|+++||||+..
T Consensus 230 ----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 230 ----------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp ----------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred ----------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11234789999999999999999999999999999999753
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-59 Score=466.18 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=216.4
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
..|+++++||+|+||+||+|+++.+|+.||||++........
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------------------------------------- 56 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSN-------------------------------------- 56 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHH--------------------------------------
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCH--------------------------------------
Confidence 349999999999999999999999999999999875422110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+|++++|||||++++++.
T Consensus 57 ---------------------------------------------------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~ 85 (309)
T d1u5ra_ 57 ---------------------------------------------------EKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85 (309)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHCCCCCEeeEEEEEE
Confidence 01125678899999999999999999999
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
+++.+|+|||||.++++..+....+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~ 165 (309)
T d1u5ra_ 86 REHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (309)
T ss_dssp ETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred ECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence 99999999999997665655555677999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCccccCCcccccccchhhccC---CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 331 SVPTKTFSNEVVTLWYRPPDVLLG---STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 331 ~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
.. ....+||+.|||||++.+ ..++.++|+|||||++|||++|..||.+.+..+.+..+.....+
T Consensus 166 ~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~--------- 232 (309)
T d1u5ra_ 166 AP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP--------- 232 (309)
T ss_dssp SS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC---------
T ss_pred CC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 42 234689999999999864 34678899999999999999999999998887777766542211
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...+..+++++.+||.+||+.||.+|||++|+|+||||..-
T Consensus 233 ---------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 233 ---------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp ---------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred ---------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 11223678999999999999999999999999999999753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-59 Score=469.76 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=226.9
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
..+++|+++++||+|+||+||+|+++.+|+.||||++.+.....
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~------------------------------------ 81 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVK------------------------------------ 81 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHH------------------------------------
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccC------------------------------------
Confidence 45789999999999999999999999999999999986532110
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
......+.+|+.+|+.++|||||++++
T Consensus 82 -----------------------------------------------------~~~~~~~~~E~~il~~l~hpnIv~~~~ 108 (350)
T d1rdqe_ 82 -----------------------------------------------------LKQIEHTLNEKRILQAVNFPFLVKLEF 108 (350)
T ss_dssp -----------------------------------------------------TTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHHHHcCCCcEeeccc
Confidence 011235678889999999999999999
Q ss_pred eEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+...+++||||+.+ +|..++... +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+
T Consensus 109 ~~~~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 109 SFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ccccccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeecee
Confidence 99999999999999994 788887665 4699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 327 ARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 327 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
|+..... ....+||+.|||||++.+..++.++|+|||||++|||+||++||.+.+....+..|....
T Consensus 188 a~~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~---------- 254 (350)
T d1rdqe_ 188 AKRVKGR---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK---------- 254 (350)
T ss_dssp CEECSSC---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred eeecccc---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCC----------
Confidence 9876532 345689999999999999999999999999999999999999999998888877775422
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCccc
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHE 469 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~ 469 (516)
...|..+++++.+||++||++||.+|+ |++++++||||+++.+....
T Consensus 255 ----------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~ 306 (350)
T d1rdqe_ 255 ----------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIY 306 (350)
T ss_dssp ----------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHH
T ss_pred ----------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHH
Confidence 123457899999999999999999995 99999999999988765443
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-58 Score=457.46 Aligned_cols=286 Identities=39% Similarity=0.631 Sum_probs=223.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCC-CcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLT-DNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~-g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
++|+++++||+|+||+||+|++..+ ++.||||+++..... .....+.+|+.+|+.|
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l---------------------- 64 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL---------------------- 64 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHH----------------------
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHH----------------------
Confidence 6799999999999999999999765 678999999775432 2222444555554443
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
+.++||||++++++
T Consensus 65 ------------------------------------------------------------------~~~~HpnIv~~~~~ 78 (305)
T d1blxa_ 65 ------------------------------------------------------------------ETFEHPNVVRLFDV 78 (305)
T ss_dssp ------------------------------------------------------------------HHTCCTTBCCEEEE
T ss_pred ------------------------------------------------------------------hhcCCCCcceeeee
Confidence 11245555555555
Q ss_pred Ee-----eCceeeEeeehhhchHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEe
Q psy12305 249 IH-----TEKCLTLVFEYLEKDLKRYM-DDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLA 322 (516)
Q Consensus 249 ~~-----~~~~~~lV~E~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~ 322 (516)
|. ...+++++||||++++..+. ......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 79 CTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp EEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeec
Confidence 53 23468999999997665544 3445679999999999999999999999999999999999999999999999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|||+++.... .......+||+.|+|||++.+..++.++|+||+||++|||++|++||.+.+..+.+..+....+.++..
T Consensus 159 dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 159 DFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred chhhhhhhcc-cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence 9999976543 234456789999999999999999999999999999999999999999999999999999999998876
Q ss_pred hhhhccccc-CCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 403 LKSKLEFCI-TPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 403 ~~~~~~~~~-~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.+....... ..............+..++++++|||.+||++||++||||+|+|+||||+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 553221110 000000011122234578999999999999999999999999999999998743
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-59 Score=470.58 Aligned_cols=281 Identities=24% Similarity=0.349 Sum_probs=212.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
-++|+++++||+|+||+||+|+++.+|+.||||+++......
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~-------------------------------------- 46 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPA-------------------------------------- 46 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTT--------------------------------------
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHH--------------------------------------
Confidence 467999999999999999999999999999999987542111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+|++++|||||+++++|
T Consensus 47 -----------------------------------------------------~~~~~~~Ei~il~~l~HpnIv~l~~~~ 73 (322)
T d1s9ja_ 47 -----------------------------------------------------IRNQIIRELQVLHECNSPYIVGFYGAF 73 (322)
T ss_dssp -----------------------------------------------------HHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 122567888888999999999999999
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.+++++|||||||+ |+|.+++.+. +.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|
T Consensus 74 ~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 74 YSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp ECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 99999999999999 4888888765 459999999999999999999997 59999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHhcCCCChhhhh-
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIED-ELRLICSILGPPPDELKS- 405 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~-~~~~i~~~~~~~p~~~~~- 405 (516)
+.... ......+||++|||||++.+..++.++|+||+||++|||++|+.||.+.+..+ ....+....+.+......
T Consensus 153 ~~~~~--~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 153 GQLID--SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHHH--HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred cccCC--CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 86542 22345689999999999999999999999999999999999999998765433 222233333322211000
Q ss_pred ---hc-----ccccCCCCCCchh---h-----hhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 406 ---KL-----EFCITPVYPSESK---L-----QLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 406 ---~~-----~~~~~~~~~~~~~---~-----~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.. .....+....... . ........+.+++|||.+||++||.+||||+|+|+||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00 0000000000000 0 0011124688999999999999999999999999999997644
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=462.95 Aligned_cols=261 Identities=24% Similarity=0.422 Sum_probs=224.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|+++++||+|+||+||+|+++.+|+.||||++++.....
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~-------------------------------------- 42 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLM-------------------------------------- 42 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHH--------------------------------------
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccC--------------------------------------
Confidence 578999999999999999999999999999999997542110
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHH-hccccceeeEeee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLR-ELRHANIVTLHDI 248 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~ 248 (516)
......+.+|..++. .++|||||+++++
T Consensus 43 ---------------------------------------------------~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~ 71 (320)
T d1xjda_ 43 ---------------------------------------------------DDDVECTMVEKRVLSLAWEHPFLTHMFCT 71 (320)
T ss_dssp ---------------------------------------------------TTCHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred ---------------------------------------------------hHHHHHHHHHHHHHHHhCCCCcEEEEEEE
Confidence 011123455666554 6799999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++.+|||||||+ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 72 ~~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a 150 (320)
T d1xjda_ 72 FQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 150 (320)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchh
Confidence 999999999999999 5888888764 45999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
+............+||+.|+|||++.+..++.++|+||+||++|||++|+.||.+.+..+.+..+...
T Consensus 151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~------------ 218 (320)
T d1xjda_ 151 KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD------------ 218 (320)
T ss_dssp BCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC------------
T ss_pred hhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence 87665555666678999999999999999999999999999999999999999999988877777431
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH-HHHcCCCCCCCCCC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA-NAMRHPYFNSLGPQ 466 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~-e~l~Hp~f~~~~~~ 466 (516)
....|..+++++.+||.+||+.||++|||+. ++++||||+.+.+.
T Consensus 219 --------------~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 219 --------------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred --------------CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 1123457899999999999999999999996 89999999987543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-58 Score=451.81 Aligned_cols=282 Identities=49% Similarity=0.813 Sum_probs=229.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|+++++||+|+||+||+|+++ +|+.||||++.......
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~-------------------------------------- 41 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDE-------------------------------------- 41 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGG--------------------------------------
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcCh--------------------------------------
Confidence 478999999999999999999995 88999999986543211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+|++++|||||++++++
T Consensus 42 ----------------------------------------------------~~~~~~~~E~~il~~l~hpnIv~~~~~~ 69 (286)
T d1ob3a_ 42 ----------------------------------------------------GIPSTTIREISILKELKHSNIVKLYDVI 69 (286)
T ss_dssp ----------------------------------------------------CCCHHHHHHHHGGGGCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhCCCCcEEeeeeec
Confidence 1123567788888888888888999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+++..|++|||+.+++...+....+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..
T Consensus 70 ~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~ 149 (286)
T d1ob3a_ 70 HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA 149 (286)
T ss_dssp ECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred ccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEeccccccee
Confidence 99999999999999988888888778899999999999999999999999999999999999999999999999999988
Q ss_pred cCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSKLE 408 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 408 (516)
...+.......+||+.|+|||.+.+.. ++.++|+||+||++|||++|++||.+.+..+++..+....+.++...+....
T Consensus 150 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp HCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred cccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 765555555667899999999997654 4678899999999999999999999999999999999999988766554322
Q ss_pred ccc--CCCC-CCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 409 FCI--TPVY-PSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 409 ~~~--~~~~-~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
... .... ..........+..+++++.|||.+||++||++||||+|+|+||||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 110 0000 00011122234578999999999999999999999999999999973
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-58 Score=446.66 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=202.2
Q ss_pred cE-eeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 92 SY-FKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 92 ~y-~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
+| ++.++||+|+||+||+|+++.+++.||||++........
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~-------------------------------------- 50 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKS-------------------------------------- 50 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHH--------------------------------------
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHH--------------------------------------
Confidence 44 566789999999999999999999999999875432110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
....+.+|+++|++++|||||++++++.
T Consensus 51 ----------------------------------------------------~~~~~~~E~~il~~l~HpnIv~~~~~~~ 78 (270)
T d1t4ha_ 51 ----------------------------------------------------ERQRFKEEAEMLKGLQHPNIVRFYDSWE 78 (270)
T ss_dssp ----------------------------------------------------HHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHhCCCCCeeeEEEEEe
Confidence 0124556777777777777777777765
Q ss_pred e----CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC--cEeeecCCCCEEEc-cCCCEEEe
Q psy12305 251 T----EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRR--ILHRDLKPQNLLIN-ERGELKLA 322 (516)
Q Consensus 251 ~----~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--ivHrDlKp~NILl~-~~~~vkL~ 322 (516)
+ +..+|||||||+ |+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+
T Consensus 79 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 79 STVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred eccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEe
Confidence 4 456899999998 5888888764 46999999999999999999999998 99999999999996 47899999
Q ss_pred eeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHhcCCCCh
Q psy12305 323 DFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDEL-RLICSILGPPPD 401 (516)
Q Consensus 323 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~-~~i~~~~~~~p~ 401 (516)
|||+|+.... ......+||+.|||||++.+ .++.++|+|||||++|||++|+.||.+......+ ..+.. +.+|.
T Consensus 158 DFGla~~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~--~~~~~ 232 (270)
T d1t4ha_ 158 DLGLATLKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS--GVKPA 232 (270)
T ss_dssp CTTGGGGCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT--TCCCG
T ss_pred ecCcceeccC--CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc--CCCCc
Confidence 9999986442 23345689999999999876 5889999999999999999999999876544433 33322 11111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFN 461 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~ 461 (516)
..+...++++.+||.+||++||++|||++|+|+||||+
T Consensus 233 ----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 233 ----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ----------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 11236788999999999999999999999999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.6e-57 Score=443.89 Aligned_cols=266 Identities=26% Similarity=0.362 Sum_probs=223.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+......... +.
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~---~~----------------------------- 49 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAE---EV----------------------------- 49 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHH---HH-----------------------------
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHH---HH-----------------------------
Confidence 3689999999999999999999999999999999987643322110 00
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccceeeEeee
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANIVTLHDI 248 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~ 248 (516)
......+.+|+.+|++++ ||||++++++
T Consensus 50 ---------------------------------------------------~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 78 (277)
T d1phka_ 50 ---------------------------------------------------QELREATLKEVDILRKVSGHPNIIQLKDT 78 (277)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHHHhcCCCCeEEEEee
Confidence 011225778999999997 9999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.+++++|||||||+ |+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 79 ~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 79 YETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 999999999999998 59999997654 6999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccC------CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLG------STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~------~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
+..... ......+||+.|+|||++.+ ..++.++|+||+||++|||++|+.||.+.+..+....+....-.++.
T Consensus 158 ~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (277)
T d1phka_ 158 CQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236 (277)
T ss_dssp EECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred eEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 876543 33455789999999999853 23567789999999999999999999999988887777653222111
Q ss_pred hhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 402 ELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..+..+|+++++||.+||+.||++|||++|+|+||||+.
T Consensus 237 ----------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 237 ----------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ----------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ----------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 112268899999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-58 Score=460.35 Aligned_cols=258 Identities=22% Similarity=0.383 Sum_probs=225.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
-.++|++++.||+|+||+||+|+++.+|+.||||+++.....
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-------------------------------------- 44 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-------------------------------------- 44 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--------------------------------------
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--------------------------------------
Confidence 357899999999999999999999999999999998653210
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
...+.+|+.+|+.++|||||+++++
T Consensus 45 -------------------------------------------------------~~~~~~Ei~il~~l~HpnIv~~~~~ 69 (321)
T d1tkia_ 45 -------------------------------------------------------QVLVKKEISILNIARHRNILHLHES 69 (321)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHSCCTTBCCEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 1145678889999999999999999
Q ss_pred EeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC--CCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER--GELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~--~~vkL~DFG 325 (516)
|++++++|||||||+| +|.+++...+..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 70 ~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccc
Confidence 9999999999999994 8999998777679999999999999999999999999999999999999854 479999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+++..... ......+||+.|+|||++.+..++.++|+||+||++|+|++|.+||.+.+..+.+..|......++...+
T Consensus 150 ~~~~~~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~- 227 (321)
T d1tkia_ 150 QARQLKPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF- 227 (321)
T ss_dssp TCEECCTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-
T ss_pred hhhccccC-CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc-
Confidence 99876433 2334567899999999999988999999999999999999999999999999888888765544443322
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
..+++++++||.+||++||.+|||++|+++||||+.
T Consensus 228 ---------------------~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 228 ---------------------KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp ---------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ---------------------cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 267899999999999999999999999999999964
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.9e-58 Score=467.93 Aligned_cols=273 Identities=22% Similarity=0.347 Sum_probs=220.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc--CCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE--GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~------------------------------ 51 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLA------------------------------ 51 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHH------------------------------
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHH------------------------------
Confidence 468899999999999999999999999999999998653211 000000
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
....+|+.+++.++|||||+++
T Consensus 52 ----------------------------------------------------------~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 52 ----------------------------------------------------------LNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHSSSCCTTBCCEE
T ss_pred ----------------------------------------------------------HHHHHHHHHHhcCCCCcEEEEE
Confidence 0223456777888899999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
++|.+++.+|||||||+ |+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 74 ~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFG 152 (364)
T d1omwa3 74 YAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 152 (364)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCT
T ss_pred EEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeec
Confidence 99999999999999999 5898888764 468999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccC-CCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLG-STEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+|+..... .....+||+.|+|||++.+ ..++.++|+|||||++|||+||+.||.+.+..+....+......
T Consensus 153 la~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------ 224 (364)
T d1omwa3 153 LACDFSKK--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM------ 224 (364)
T ss_dssp TCEECSSS--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC------
T ss_pred eeeecCCC--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC------
Confidence 99876532 3345689999999999975 45678889999999999999999999876544333322221111
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCC-----HHHHHcCCCCCCCCCCcccCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRIS-----AANAMRHPYFNSLGPQVHELSDTQS 475 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~t-----a~e~l~Hp~f~~~~~~~~~~~~~~~ 475 (516)
....|..+++++++||.+||+.||.+||| |+|+++||||+++++.........+
T Consensus 225 -----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~ 283 (364)
T d1omwa3 225 -----------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 283 (364)
T ss_dssp -----------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCc
Confidence 12234578999999999999999999999 7999999999998765444444333
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-57 Score=456.89 Aligned_cols=283 Identities=30% Similarity=0.505 Sum_probs=222.8
Q ss_pred cEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehh
Q psy12305 92 SYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYL 171 (516)
Q Consensus 92 ~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~ 171 (516)
+|..+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|++|+|||||+++++|....
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~--------- 86 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSG--------- 86 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC----------
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecC---------
Confidence 59999999999999999999999999999999865421 2335666666666666655555432211
Q ss_pred hhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEee
Q psy12305 172 EKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHT 251 (516)
Q Consensus 172 ~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 251 (516)
...+
T Consensus 87 ----------------------------------------------------------------------------~~~~ 90 (350)
T d1q5ka_ 87 ----------------------------------------------------------------------------EKKD 90 (350)
T ss_dssp -----------------------------------------------------------------------------CCS
T ss_pred ----------------------------------------------------------------------------ccCC
Confidence 0012
Q ss_pred CceeeEeeehhhchHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-CEEEeeeccc
Q psy12305 252 EKCLTLVFEYLEKDLKRYMD---DCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-ELKLADFGLA 327 (516)
Q Consensus 252 ~~~~~lV~E~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~vkL~DFGla 327 (516)
..++|||||||++++...+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccch
Confidence 34689999999987665554 3456799999999999999999999999999999999999999875 8999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
+..... ......+||+.|+|||++.+. .++.++|+||+||++|||++|++||.+.+..+++..+...+|.++.+.+..
T Consensus 171 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 171 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp EECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred hhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 876533 334556899999999998764 567888999999999999999999999999999999999999999887754
Q ss_pred cccc----cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCCC
Q psy12305 407 LEFC----ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGPQ 466 (516)
Q Consensus 407 ~~~~----~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~~ 466 (516)
.... ..+.... ..+........++++.|||.+||++||++||||+|+|+||||+.+...
T Consensus 250 ~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKA-HPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HCC---CCCCCCCCC-CCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hccchhhcccccccc-CchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 3222 1121111 112223344789999999999999999999999999999999876443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-57 Score=450.13 Aligned_cols=292 Identities=38% Similarity=0.612 Sum_probs=224.0
Q ss_pred cccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccc-cCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..+++|+++++||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|++++||||+++++++.....
T Consensus 7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~--- 83 (318)
T d3blha1 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS--- 83 (318)
T ss_dssp CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc---
Confidence 347899999999999999999999999999999999976543 3334456777777777777777777665533220
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
T Consensus 84 -------------------------------------------------------------------------------- 83 (318)
T d3blha1 84 -------------------------------------------------------------------------------- 83 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 247 DIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
.+...+.++|+|||||++++..........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 84 PYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred cccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 01123456899999999888887777778899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCC----ccccCCcccccccchhhccCC-CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCCh
Q psy12305 327 ARAKSVPT----KTFSNEVVTLWYRPPDVLLGS-TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPD 401 (516)
Q Consensus 327 a~~~~~~~----~~~~~~~gt~~y~APE~l~~~-~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~ 401 (516)
|+...... ......+||+.|+|||++.+. .++.++|+||+||++|||++|++||.+.+..+.+..+....+.++.
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 97654222 223445799999999999865 4667889999999999999999999999999999999999998887
Q ss_pred hhhhhccccc-CC-----CCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 402 ELKSKLEFCI-TP-----VYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 402 ~~~~~~~~~~-~~-----~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
+.+....... .. ............+...+++++|||.+||++||++||||+|+|+||||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 6654322110 00 0000000000001134788999999999999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-57 Score=456.17 Aligned_cols=279 Identities=35% Similarity=0.579 Sum_probs=215.8
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
.-++|+++++||+|+||+||+|+++.+|+.||||+++..... ...+.+.+|+++|+.+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l--------------------- 74 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM--------------------- 74 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC---------------------
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc---------------------
Confidence 457899999999999999999999999999999999754221 1122344455555444
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
+|||||++++
T Consensus 75 ----------------------------------------------------------------------~hpniv~l~~ 84 (346)
T d1cm8a_ 75 ----------------------------------------------------------------------RHENVIGLLD 84 (346)
T ss_dssp ----------------------------------------------------------------------CBTTBCCCSE
T ss_pred ----------------------------------------------------------------------CCCCeeEEEE
Confidence 4555555555
Q ss_pred eEeeC------ceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEE
Q psy12305 248 IIHTE------KCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKL 321 (516)
Q Consensus 248 ~~~~~------~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL 321 (516)
+|... .++|+|||||+.+|...... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 85 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl 162 (346)
T d1cm8a_ 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKI 162 (346)
T ss_dssp EECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred EeccCccccccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccccccc
Confidence 54433 25799999998888777654 45999999999999999999999999999999999999999999999
Q ss_pred eeeccccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 322 ADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 322 ~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
+|||+|+.... .....+||+.|+|||++.+.. +..++|+||+||++|+|++|++||.+.+..+.+..+....+.+|
T Consensus 163 ~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 163 LDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp CCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCc
Confidence 99999987643 335568999999999998754 46788999999999999999999999999999999999999999
Q ss_pred hhhhhhcccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 401 DELKSKLEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 401 ~~~~~~~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
.+.+...... ..+.... ..+.. ....+++++.|||.+||++||.+||||+|+|+||||+.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEK-KDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCC-CCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHhhhcchhhhhhhccCCcccc-cchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 8876543211 1111111 11111 22478999999999999999999999999999999998753
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-56 Score=436.75 Aligned_cols=285 Identities=49% Similarity=0.892 Sum_probs=235.9
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
+++|+++++||+|+||+||+|+++.+|+.||||+++......
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~-------------------------------------- 42 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-------------------------------------- 42 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSST--------------------------------------
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCCh--------------------------------------
Confidence 468999999999999999999999999999999996543211
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
.....+.+|+.+|+.++||||+++++++
T Consensus 43 ----------------------------------------------------~~~~~~~~E~~il~~l~h~niv~~~~~~ 70 (292)
T d1unla_ 43 ----------------------------------------------------GVPSSALREICLLKELKHKNIVRLHDVL 70 (292)
T ss_dssp ----------------------------------------------------THHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ----------------------------------------------------HHHHHHHHHHHHHHhcCcCCEEeecccc
Confidence 1123567888889899999999999999
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.+....++|+|++.++.+..+....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+.
T Consensus 71 ~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~ 150 (292)
T d1unla_ 71 HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA 150 (292)
T ss_dssp ECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhc
Confidence 99999999999999866666666677899999999999999999999999999999999999999999999999999998
Q ss_pred cCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 330 KSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPL-FPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 330 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~p-F~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
............+++.|+|||++.+.. ++.++|+||+||++|||++|+.| |.+.+..+.+..+....+.++...+...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 151 FGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTG
T ss_pred ccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhh
Confidence 776666666667899999999988765 46778999999999999999877 5677888889999998888876655332
Q ss_pred c----cccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 408 E----FCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 408 ~----~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
. ....+.... .......+..+++++.|||.+||++||.+||||+|+|+||||++..+
T Consensus 231 ~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 231 TKLPDYKPYPMYPA-TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp GGSTTCCCCCCCCT-TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred hhcccccccccccc-cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 2 111222222 11222233478899999999999999999999999999999987643
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-57 Score=439.84 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=208.1
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|+++.+|+.||||++.........
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~------------------------------------- 46 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG------------------------------------- 46 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEE-------------------------------------
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchh-------------------------------------
Confidence 5799999999999999999999999999999999764321110
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc--ccceeeEeee
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR--HANIVTLHDI 248 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~--HpnIv~l~~~ 248 (516)
.......+.+|+.+|++++ |||||+++++
T Consensus 47 -------------------------------------------------~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~ 77 (273)
T d1xwsa_ 47 -------------------------------------------------ELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77 (273)
T ss_dssp -------------------------------------------------ECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred -------------------------------------------------hhhHHHHHHHHHHHHHHhccCCCCccEEEEE
Confidence 0000113457888888886 8999999999
Q ss_pred EeeCceeeEeeehhhc--hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccC-CCEEEeeec
Q psy12305 249 IHTEKCLTLVFEYLEK--DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINER-GELKLADFG 325 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~g--~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~-~~vkL~DFG 325 (516)
+.+++..|+||||+.+ ++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 78 ~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 78 FERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccc
Confidence 9999999999999973 677777654 469999999999999999999999999999999999999854 799999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCC-ceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYS-TSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~-~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+|+.... ......+||+.|+|||++.+..+++ ++|+||+||++|||++|+.||.+.+ .+..
T Consensus 157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~---------- 218 (273)
T d1xwsa_ 157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR---------- 218 (273)
T ss_dssp TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH----------
T ss_pred cceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhh----------
Confidence 9986543 3345678999999999998777654 4699999999999999999997632 1111
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
.....+..+|+++++||.+||++||++|||++|+++||||++.
T Consensus 219 ----------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 219 ----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ----------------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ----------------cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1122345789999999999999999999999999999999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-56 Score=450.44 Aligned_cols=259 Identities=24% Similarity=0.336 Sum_probs=202.2
Q ss_pred cccccEeeeee-eccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 88 GRIESYFKLDK-LGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 88 ~~~~~y~~~~~-LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.-+++|.++++ ||+|+||+||+|+++.+|+.||||+++.. ..
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~------------------------------- 50 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PK------------------------------- 50 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HH-------------------------------
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HH-------------------------------
Confidence 34688999865 99999999999999999999999998532 12
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeE
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTL 245 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 245 (516)
+.+|+.++.++ +|||||++
T Consensus 51 ------------------------------------------------------------~~~E~~~~~~~~~hpnIv~l 70 (335)
T d2ozaa1 51 ------------------------------------------------------------ARREVELHWRASQCPHIVRI 70 (335)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHHTTSTTBCCE
T ss_pred ------------------------------------------------------------HHHHHHHHHHhcCCCCCCeE
Confidence 33455554333 56666777
Q ss_pred eeeEee----CceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc---C
Q psy12305 246 HDIIHT----EKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE---R 316 (516)
Q Consensus 246 ~~~~~~----~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---~ 316 (516)
+++|++ +.++|||||||+ |+|.+++.+.+ ..+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 71 ~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~ 150 (335)
T d2ozaa1 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPN 150 (335)
T ss_dssp EEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTT
T ss_pred EEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccc
Confidence 776654 467999999998 59999998754 56999999999999999999999999999999999999986 4
Q ss_pred CCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhc
Q psy12305 317 GELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSIL 396 (516)
Q Consensus 317 ~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~ 396 (516)
+.+||+|||+|+..... ......+||+.|||||++.+..++.++|+|||||++|+|+||++||.+.+.......+....
T Consensus 151 ~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i 229 (335)
T d2ozaa1 151 AILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229 (335)
T ss_dssp CCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred ccccccccceeeeccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence 67999999999876543 33455689999999999998888899999999999999999999998765444333332211
Q ss_pred CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCC
Q psy12305 397 GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNS 462 (516)
Q Consensus 397 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~ 462 (516)
... . ..++. .....+|+++.+||.+||++||++|||++|+++||||..
T Consensus 230 ~~~-----------~-~~~~~------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 230 RMG-----------Q-YEFPN------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CSC-----------S-SSCCT------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred hcC-----------C-CCCCC------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 000 0 00000 001257899999999999999999999999999999964
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-55 Score=442.75 Aligned_cols=284 Identities=36% Similarity=0.576 Sum_probs=213.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|+++.+|+.||||++.........+.+.+|+.+|+.|+|||||++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~-------- 79 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT-------- 79 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS--------
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc--------
Confidence 569999999999999999999999999999999975443332334455555555555555555544432211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
+.
T Consensus 80 ------------------------------------------------------------------------------~~ 81 (345)
T d1pmea_ 80 ------------------------------------------------------------------------------IE 81 (345)
T ss_dssp ------------------------------------------------------------------------------TT
T ss_pred ------------------------------------------------------------------------------cc
Confidence 01
Q ss_pred eCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccccc
Q psy12305 251 TEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAK 330 (516)
Q Consensus 251 ~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~ 330 (516)
...++|++|++++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 82 QMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp TCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 12346788887778999998753 5999999999999999999999999999999999999999999999999999765
Q ss_pred CCCC---ccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 331 SVPT---KTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 331 ~~~~---~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
.... ......+||+.|+|||++.... +..++|+||+||++|||++|++||.+.+..+....+....+.++.+....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 4321 2235567999999999986544 45677999999999999999999999999999888888888877654321
Q ss_pred ccc------c-cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 LEF------C-ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~~~------~-~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
... . ..+... ...+....+ .+++++++||.+||++||.+||||+|+|+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKN-KVPWNRLFP-NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCCHHHHHHHHTSCCCC-CCCHHHHCT-TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhcccccCCccC-CCCHHHhCC-CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 110 0 111111 111222233 6789999999999999999999999999999998653
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=445.06 Aligned_cols=288 Identities=32% Similarity=0.507 Sum_probs=212.1
Q ss_pred cccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 86 GFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 86 ~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.|.-+++|+++++||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|++++|||||+++++|...+
T Consensus 12 ~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~-- 89 (355)
T d2b1pa1 12 TFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK-- 89 (355)
T ss_dssp EEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC--
T ss_pred ceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc--
Confidence 344568899999999999999999999999999999999764321 11123445555555555555554444432221
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
T Consensus 90 -------------------------------------------------------------------------------- 89 (355)
T d2b1pa1 90 -------------------------------------------------------------------------------- 89 (355)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred EeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeee
Q psy12305 245 LHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADF 324 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DF 324 (516)
.+.+..++|+|||||.+++++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++||
T Consensus 90 ---~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df 163 (355)
T d2b1pa1 90 ---TLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_dssp ---STTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC
T ss_pred ---ccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeech
Confidence 001346789999999998887764 45899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 325 GLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 325 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+++..... ......+||+.|+|||++.+..++.++|+||+||++|||++|++||.+.+.......+....+.++.+.+
T Consensus 164 ~~~~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 164 GLARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp CC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred hhhhccccc-cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence 999876543 3344567899999999999998999999999999999999999999999999999999998888887766
Q ss_pred hhcccc------cCCCCCCchhhhhcCC-----------CCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCC
Q psy12305 405 SKLEFC------ITPVYPSESKLQLLAP-----------EQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSL 463 (516)
Q Consensus 405 ~~~~~~------~~~~~~~~~~~~~~~p-----------~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~ 463 (516)
...... ..+.... ......++ ...++++.|||++||.+||++||||+|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAG-LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCC-CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHhhhhHHHHhhcCccccc-cccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 432211 1111110 00110111 1236789999999999999999999999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=431.84 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=208.2
Q ss_pred ccEeeee-eeccccceEEEEEEEcC--CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 91 ESYFKLD-KLGQGTYATVFKGKSRL--TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 91 ~~y~~~~-~LG~G~fG~Vyka~~~~--~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
++|.+.+ +||+|+||+||+|.++. ++..||||+++.......
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~----------------------------------- 52 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD----------------------------------- 52 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHH-----------------------------------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHH-----------------------------------
Confidence 5688888 49999999999998765 345799999865422111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+.+|+.+|++++|||||++++
T Consensus 53 --------------------------------------------------------~~~~~~E~~il~~l~HpnIv~l~g 76 (285)
T d1u59a_ 53 --------------------------------------------------------TEEMMREAQIMHQLDNPYIVRLIG 76 (285)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEee
Confidence 124566777777777777778888
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++.+ +.+|||||||+ |+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGl 155 (285)
T d1u59a_ 77 VCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL 155 (285)
T ss_dssp EEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTT
T ss_pred eecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchh
Confidence 7764 45789999999 589998877777899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 327 ARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 327 a~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
|+....... .....+||+.|+|||++.+..++.++|+|||||++|||+| |+.||.+.+..+....+....
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~------ 229 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK------ 229 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC------
T ss_pred hhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC------
Confidence 987653322 2234568999999999998888999999999999999998 999999888777666664311
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH---HcCCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA---MRHPYFN 461 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~---l~Hp~f~ 461 (516)
+...|+.+++++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 230 -------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 -------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp -------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122455889999999999999999999999887 6788874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1e-54 Score=436.66 Aligned_cols=282 Identities=28% Similarity=0.493 Sum_probs=215.4
Q ss_pred cccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeeccccccccee
Q psy12305 84 EIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 163 (516)
Q Consensus 84 ~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 163 (516)
.+.++..++|+++++||+|+||+||+|+++.+|+.||||+++... .
T Consensus 28 ~~~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~------------------------------ 73 (328)
T d3bqca1 28 VVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----K------------------------------ 73 (328)
T ss_dssp CCCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----H------------------------------
T ss_pred ccCCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----H------------------------------
Confidence 445567789999999999999999999999999999999985421 1
Q ss_pred eeeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhcc-ccce
Q psy12305 164 LTLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELR-HANI 242 (516)
Q Consensus 164 ~~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnI 242 (516)
..+.+|+.+|++++ ||||
T Consensus 74 -------------------------------------------------------------~~~~~Ei~il~~l~~hpnI 92 (328)
T d3bqca1 74 -------------------------------------------------------------KKIKREIKILENLRGGPNI 92 (328)
T ss_dssp -------------------------------------------------------------HHHHHHHHHHHHHTTSTTB
T ss_pred -------------------------------------------------------------HHHHHHHHHHHhccCCCCC
Confidence 13456666676664 7777
Q ss_pred eeEeeeEee--CceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCC-C
Q psy12305 243 VTLHDIIHT--EKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERG-E 318 (516)
Q Consensus 243 v~l~~~~~~--~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~-~ 318 (516)
++++++|.. ..++++|||||++ +|... .+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 93 v~~~~~~~~~~~~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~ 168 (328)
T d3bqca1 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK 168 (328)
T ss_dssp CCEEEEEECTTTCSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE
T ss_pred cEEEEEEEecCCCceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCe
Confidence 777777764 3568999999995 55433 34599999999999999999999999999999999999998765 5
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCCC-CCCceeeehHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHhc
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGST-EYSTSIDMGVGCIFHEMSSGRPLFPG-STIEDELRLICSIL 396 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~d~~SlGvil~elltG~~pF~~-~~~~~~~~~i~~~~ 396 (516)
+||+|||+|+..... ......+||+.|+|||++.+.. ++.++|+||+||++|||++|..||.. .+..++...+...+
T Consensus 169 vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~ 247 (328)
T d3bqca1 169 LRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL 247 (328)
T ss_dssp EEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred eeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence 999999999876533 3445668899999999988755 56778999999999999999999965 45666777777777
Q ss_pred CCCChhhh-hhccc------c-cCCCCCC---chhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCCC
Q psy12305 397 GPPPDELK-SKLEF------C-ITPVYPS---ESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLGP 465 (516)
Q Consensus 397 ~~~p~~~~-~~~~~------~-~~~~~~~---~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~~ 465 (516)
|.+....+ ..... . ..+.... ...........++++++|||++||++||++||||+|+|+||||+++.+
T Consensus 248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 76533222 11110 0 0000000 011111122357899999999999999999999999999999998754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-55 Score=423.53 Aligned_cols=248 Identities=20% Similarity=0.316 Sum_probs=199.9
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|+++ +++.||||+++.....
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---------------------------------------- 43 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---------------------------------------- 43 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----------------------------------------
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----------------------------------------
Confidence 57999999999999999999985 6788999998643211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.++++++|||||++++++.
T Consensus 44 -----------------------------------------------------~~~~~~E~~~l~~l~HpnIv~~~g~~~ 70 (263)
T d1sm2a_ 44 -----------------------------------------------------EEDFIEEAEVMMKLSHPKLVQLYGVCL 70 (263)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhcCCCCcccccceec
Confidence 124667777888888888888888888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
.++.+|+|||||+ |+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.
T Consensus 71 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred cCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchhee
Confidence 8888999999998 689999888777899999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 330 KSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 330 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
...... ......||+.|+|||++.+..++.++|+|||||++|||+| |.+||...+..+.+..+....
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~----------- 219 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF----------- 219 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC-----------
T ss_pred ccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC-----------
Confidence 643322 2334578999999999999999999999999999999999 577787777777666664421
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|..+++++.+||.+||+.||++|||++|+++|
T Consensus 220 --------------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 --------------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 122345778999999999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.5e-55 Score=429.33 Aligned_cols=249 Identities=22% Similarity=0.354 Sum_probs=206.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.++||+|+||+||+|+++.+|+.||||+++.+..
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------------------------------------- 55 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---------------------------------------- 55 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----------------------------------------
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----------------------------------------
Confidence 3679999999999999999999999999999998864321
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+|++++|||||++++++
T Consensus 56 -----------------------------------------------------~~~~~~~E~~il~~l~HpnIv~~~~~~ 82 (287)
T d1opja_ 56 -----------------------------------------------------EVEEFLKEAAVMKEIKHPNLVQLLGVC 82 (287)
T ss_dssp -----------------------------------------------------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred -----------------------------------------------------hHHHHHHHHHHHHhCCCCCEecCCccE
Confidence 112466788888888888888888888
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.+++.+|||||||+ |+|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a 162 (287)
T d1opja_ 83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 162 (287)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccce
Confidence 88889999999999 6888888754 456999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC-CCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL-FPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p-F~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+....... ......||+.|+|||++.+..++.++|+|||||++|||++|..| |.+.+.......+..
T Consensus 163 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~----------- 231 (287)
T d1opja_ 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 231 (287)
T ss_dssp TTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----------
T ss_pred eecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhc-----------
Confidence 87654332 23444679999999999988899999999999999999996555 555555444433322
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
......|..+++++.+||.+||+.||++|||++|+++
T Consensus 232 --------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 232 --------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1122345578999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-54 Score=429.06 Aligned_cols=252 Identities=21% Similarity=0.302 Sum_probs=201.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCc---EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDN---LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~---~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
.++|++.+.||+|+||+||+|+++.+|+ .||||.+......
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~------------------------------------ 68 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE------------------------------------ 68 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH------------------------------------
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH------------------------------------
Confidence 4679999999999999999999987765 5788876532211
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
.....+.+|+.+|++++|||||+++
T Consensus 69 -------------------------------------------------------~~~~~~~~E~~~l~~l~HpnIv~l~ 93 (299)
T d1jpaa_ 69 -------------------------------------------------------KQRRDFLSEASIMGQFDHPNVIHLE 93 (299)
T ss_dssp -------------------------------------------------------HHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHHHHhCCCCCCccEE
Confidence 1122567899999999999999999
Q ss_pred eeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 247 DIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 247 ~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+++..++.+|+|||||+ |+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 94 g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 173 (299)
T d1jpaa_ 94 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG 173 (299)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred EEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcc
Confidence 99999999999999999 58888888777789999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCc-----cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 326 LARAKSVPTK-----TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 326 la~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
+|+....... ......||+.|||||++.+..++.++|+|||||++|||+| |++||.+.+..+.+..+....
T Consensus 174 la~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~--- 250 (299)
T d1jpaa_ 174 LSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY--- 250 (299)
T ss_dssp ----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC---
T ss_pred cceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC---
Confidence 9987543221 1122457999999999998888899999999999999998 899999988877776664321
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|..+++++.+||.+||+.||++|||+.|++++
T Consensus 251 ----------------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 ----------------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 122345788999999999999999999999998764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=425.43 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=199.4
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.++||+|+||+||+|++. ..||||+++.......
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~------------------------------------- 46 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQ------------------------------------- 46 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTT-------------------------------------
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHH-------------------------------------
Confidence 366999999999999999999853 4699999865432111
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....+.+|+.+|++++|||||++++++
T Consensus 47 -----------------------------------------------------~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 47 -----------------------------------------------------QLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred -----------------------------------------------------HHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 112456677777777777777777765
Q ss_pred eeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
. ++.++||||||+ |+|.+++...+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp C-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred e-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence 4 456899999999 69999998877789999999999999999999999999999999999999999999999999998
Q ss_pred ccCCC--CccccCCcccccccchhhccCC---CCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhh
Q psy12305 329 AKSVP--TKTFSNEVVTLWYRPPDVLLGS---TEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDEL 403 (516)
Q Consensus 329 ~~~~~--~~~~~~~~gt~~y~APE~l~~~---~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~ 403 (516)
..... .......+||+.|||||++.+. .++.++|+|||||++|||+||+.||.+.+....+..+......+|.
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~-- 230 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD-- 230 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--
Confidence 75432 2234456899999999998643 3567889999999999999999999987766655544432221111
Q ss_pred hhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 404 KSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....+..+++++.+||.+||+.||++|||++|+++|
T Consensus 231 ------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 ------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 012234788999999999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-54 Score=434.70 Aligned_cols=252 Identities=23% Similarity=0.359 Sum_probs=208.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCc-----EEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDN-----LVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~-----~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
++|++.++||+|+||+||+|+++.+++ .||||.+......
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~----------------------------------- 81 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS----------------------------------- 81 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------------------------------------
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCH-----------------------------------
Confidence 679999999999999999999986654 5788776543211
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceee
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVT 244 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 244 (516)
.....+.+|+.+|.++ +|||||+
T Consensus 82 --------------------------------------------------------~~~~~~~~E~~~l~~l~~HpnIv~ 105 (325)
T d1rjba_ 82 --------------------------------------------------------SEREALMSELKMMTQLGSHENIVN 105 (325)
T ss_dssp ----------------------------------------------------------CHHHHHHHHHHHHHCCCTTBCC
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHHhcCCCcEeE
Confidence 1223567888888888 8999999
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHhhCCc
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS----------------------NILSMNNVKLFLFQLLRGLAYCHSRRI 301 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~i 301 (516)
+++++.+.+.+|+|||||+ |+|.+++.... ..+++..++.++.||+.||+|||++||
T Consensus 106 l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~I 185 (325)
T d1rjba_ 106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 185 (325)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred EEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 9999999999999999998 59999987643 348899999999999999999999999
Q ss_pred EeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCC
Q psy12305 302 LHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRP 378 (516)
Q Consensus 302 vHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~ 378 (516)
+||||||+|||++.++.+||+|||+|+....... .....+||+.|||||++.+..++.++|+|||||++|||+| |.+
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 9999999999999999999999999986543332 2345578999999999998888999999999999999998 899
Q ss_pred CCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 379 LFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 379 pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
||.+.+..+.+..+... ..+...|..+++++.+||.+||+.||++|||++|+++|
T Consensus 266 Pf~~~~~~~~~~~~~~~------------------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 266 PYPGIPVDANFYKLIQN------------------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SSTTCCCSHHHHHHHHT------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHhc------------------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99987666665555432 11223456789999999999999999999999999876
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-54 Score=418.35 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=212.7
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|+++ +++.||||+++.....
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~---------------------------------------- 42 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---------------------------------------- 42 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----------------------------------------
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----------------------------------------
Confidence 67999999999999999999985 7889999998753211
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
...+.+|+.++++++||||+++++++.
T Consensus 43 -----------------------------------------------------~~~~~~Ev~~~~~l~HpnIv~~~g~~~ 69 (258)
T d1k2pa_ 43 -----------------------------------------------------EDEFIEEAKVMMNLSHEKLVQLYGVCT 69 (258)
T ss_dssp -----------------------------------------------------HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred -----------------------------------------------------HHHHHHHHHHHHhcCCCceeeEEEEEe
Confidence 124667788888888888888888888
Q ss_pred eCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARA 329 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~ 329 (516)
+++.+++||||++ |++..++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 70 ~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 70 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp CSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred eCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhhee
Confidence 8889999999998 688888887777899999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhc
Q psy12305 330 KSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKL 407 (516)
Q Consensus 330 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~ 407 (516)
...... ......||+.|+|||++.+..++.++|+|||||++|||+| |+.||.+.+..+....+....
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~----------- 218 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL----------- 218 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred ccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 543322 3344678999999999998888999999999999999998 899999998888777665422
Q ss_pred ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 408 EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 408 ~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+...|...++++.+||.+||+.||++|||++++++|
T Consensus 219 --------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 --------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 223455788999999999999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=434.55 Aligned_cols=284 Identities=34% Similarity=0.554 Sum_probs=214.0
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
.-++|+++++||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+|++|+|||||++++++....
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~----- 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR----- 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS-----
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc-----
Confidence 347899999999999999999999999999999999754321 11223445555555555555555544432211
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
T Consensus 91 -------------------------------------------------------------------------------- 90 (348)
T d2gfsa1 91 -------------------------------------------------------------------------------- 90 (348)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred eEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 248 IIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.+.+....++++++++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred ccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchh
Confidence 0012234566666666799988854 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCccccCCcccccccchhhccCCCC-CCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 328 RAKSVPTKTFSNEVVTLWYRPPDVLLGSTE-YSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 328 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
.... .......||+.|+|||++.+..+ +.++|+||+||++|+|++|++||.+.+.......+....+.++.+....
T Consensus 169 ~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 169 RHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp -CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 7643 33455688999999999877654 5678999999999999999999999999999999999999888776532
Q ss_pred cccc-------cCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCCCCCC
Q psy12305 407 LEFC-------ITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYFNSLG 464 (516)
Q Consensus 407 ~~~~-------~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f~~~~ 464 (516)
.... ..+..+. ..+.... ..++++++|||.+||++||.+||||+|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPK-MNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CCCHHHHHHHTTSCCCCC-CCHHHHS-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccchhhhhhhhhcccCCC-cchhhhc-CCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 2110 1111111 1111122 36889999999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=424.41 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=204.0
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|+++ +++.||||+++.... ..
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~------------------------------------- 52 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SP------------------------------------- 52 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CH-------------------------------------
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CH-------------------------------------
Confidence 67999999999999999999985 678899999864321 11
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
..+.+|+.+|++++|||||++++++.
T Consensus 53 ------------------------------------------------------~~~~~E~~~l~~l~HpnIv~~~g~~~ 78 (272)
T d1qpca_ 53 ------------------------------------------------------DAFLAEANLMKQLQHQRLVRLYAVVT 78 (272)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ------------------------------------------------------HHHHHHHHHHHhCCCCCEeEEEeeec
Confidence 14556666666667777777777654
Q ss_pred eCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 251 TEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 251 ~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
+ +.+|+|||||+ |+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+
T Consensus 79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~ 157 (272)
T d1qpca_ 79 Q-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR 157 (272)
T ss_dssp S-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred c-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceE
Confidence 3 45789999999 5787766543 2359999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHhcCCCChhhhhh
Q psy12305 329 AKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSG-RPLFPGSTIEDELRLICSILGPPPDELKSK 406 (516)
Q Consensus 329 ~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG-~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~ 406 (516)
...... .......||+.|+|||++.+..++.++|+|||||++|||+|| .+||...+..+.+..+...
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~----------- 226 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG----------- 226 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-----------
T ss_pred EccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-----------
Confidence 765332 233445789999999999888888999999999999999994 6667777776666655321
Q ss_pred cccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc--CCCCCC
Q psy12305 407 LEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR--HPYFNS 462 (516)
Q Consensus 407 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~--Hp~f~~ 462 (516)
.....|..+++++.+||.+||+.||++|||++++++ |+||++
T Consensus 227 --------------~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 227 --------------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp --------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 122345578999999999999999999999999998 888864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.7e-54 Score=423.16 Aligned_cols=258 Identities=23% Similarity=0.307 Sum_probs=201.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++++.||+|+||+||+|+++.+|+.||||+++.......
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------------------------------- 48 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDP-------------------------------------- 48 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCH--------------------------------------
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCH--------------------------------------
Confidence 569999999999999999999999999999999975432111
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
.....+.+|+.+|+.++||||+++++++.
T Consensus 49 ---------------------------------------------------~~~~~~~~E~~~l~~~~hpniv~~~~~~~ 77 (277)
T d1o6ya_ 49 ---------------------------------------------------SFYLRFRREAQNAAALNHPAIVAVYDTGE 77 (277)
T ss_dssp ---------------------------------------------------HHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ---------------------------------------------------HHHHHHHHHHHHHHhcCCCCCCcccceee
Confidence 01124567777777777777777777776
Q ss_pred eCc----eeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 251 TEK----CLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 251 ~~~----~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
..+ .+|||||||+| +|..++... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCT
T ss_pred eccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhh
Confidence 543 48999999995 777777654 469999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC---ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCChh
Q psy12305 326 LARAKSVPT---KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPPDE 402 (516)
Q Consensus 326 la~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p~~ 402 (516)
.+....... ......+||+.|+|||++.+..++.++|+||+||++|||+||++||.+.+..+.+..+......++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~- 235 (277)
T d1o6ya_ 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS- 235 (277)
T ss_dssp TCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGG-
T ss_pred hhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCc-
Confidence 987643322 2344568999999999999988889999999999999999999999998888877766553322221
Q ss_pred hhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCCCC
Q psy12305 403 LKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHPYF 460 (516)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp~f 460 (516)
..+..+|+++.+||.+||++||.+||+..+.+.|+|.
T Consensus 236 ---------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 236 ---------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp ---------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ---------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 1224789999999999999999999954444556664
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=425.96 Aligned_cols=257 Identities=21% Similarity=0.299 Sum_probs=202.4
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
+-++|+++++||+|+||+||+|++..+|+.+|+|+
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~v--------------------------------------------- 41 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV--------------------------------------------- 41 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEE---------------------------------------------
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEE---------------------------------------------
Confidence 33679999999999999999999988887544432
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
|+|.++..........+.+|+.+|++++|||||+++++
T Consensus 42 ------------------------------------------avK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 79 (317)
T d1xkka_ 42 ------------------------------------------AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGI 79 (317)
T ss_dssp ------------------------------------------EEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ------------------------------------------EEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 22222222222334467788888888999999999999
Q ss_pred EeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 249 IHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 249 ~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
+.++. .+++|||+. ++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 80 ~~~~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla 158 (317)
T d1xkka_ 80 CLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 158 (317)
T ss_dssp EESSS-EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred EecCC-eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccc
Confidence 88765 556666666 7899999888888999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 328 RAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 328 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+....... ......||+.|+|||++.++.++.++|+|||||++|||+| |.+||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~-------- 230 (317)
T d1xkka_ 159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-------- 230 (317)
T ss_dssp HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC--------
T ss_pred eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 87654332 2234468999999999999888899999999999999998 899998877766555553321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcCC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRHP 458 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~Hp 458 (516)
+...|..+++++.+||.+||+.||.+|||+.|+++|-
T Consensus 231 -----------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 231 -----------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp -----------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -----------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 1223457889999999999999999999999999883
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-54 Score=427.73 Aligned_cols=275 Identities=25% Similarity=0.352 Sum_probs=218.2
Q ss_pred ccccEeeeeeeccccceEEEEEEEc---CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSR---LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~---~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
.+++|+++++||+|+||+||+|++. .+|+.||||++++......
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~--------------------------------- 68 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK--------------------------------- 68 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE---------------------------------
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccc---------------------------------
Confidence 4688999999999999999999974 4689999999865421100
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc-cceee
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH-ANIVT 244 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~ 244 (516)
......+.+|+.+|++++| |||++
T Consensus 69 -------------------------------------------------------~~~~~~~~~E~~il~~l~h~pnIv~ 93 (322)
T d1vzoa_ 69 -------------------------------------------------------AKTTEHTRTERQVLEHIRQSPFLVT 93 (322)
T ss_dssp -------------------------------------------------------ESSGGGCCCHHHHHHHHHTCTTBCC
T ss_pred -------------------------------------------------------hHHHHHHHHHHHHHHhccCCCeEEE
Confidence 1112245578888888876 78999
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEee
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLAD 323 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~D 323 (516)
+++++.+...+++||||+. |+|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 94 ~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~D 172 (322)
T d1vzoa_ 94 LHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTD 172 (322)
T ss_dssp EEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESC
T ss_pred eeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEee
Confidence 9999999999999999999 58888887654 578999999999999999999999999999999999999999999999
Q ss_pred eccccccCCC-CccccCCcccccccchhhccCCC--CCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCCC
Q psy12305 324 FGLARAKSVP-TKTFSNEVVTLWYRPPDVLLGST--EYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPPP 400 (516)
Q Consensus 324 FGla~~~~~~-~~~~~~~~gt~~y~APE~l~~~~--~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~p 400 (516)
||+|+..... ........||+.|+|||.+.+.. ++.++|+||+||+||||++|+.||.+.+..+....+....
T Consensus 173 FG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~---- 248 (322)
T d1vzoa_ 173 FGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---- 248 (322)
T ss_dssp SSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH----
T ss_pred ccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----
Confidence 9999865432 22344567899999999997643 4567899999999999999999998865544444443321
Q ss_pred hhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCC-----CHHHHHcCCCCCCCCCCcccCCCCC
Q psy12305 401 DELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRI-----SAANAMRHPYFNSLGPQVHELSDTQ 474 (516)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~-----ta~e~l~Hp~f~~~~~~~~~~~~~~ 474 (516)
.......|..+++++.+||.+||++||++|| ||+|+++||||+.+.+.........
T Consensus 249 ------------------~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 249 ------------------LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309 (322)
T ss_dssp ------------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred ------------------ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCCCC
Confidence 0111223457899999999999999999999 5899999999998765444333333
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=416.56 Aligned_cols=209 Identities=22% Similarity=0.332 Sum_probs=173.4
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|++++|||||++++++.++ ..|||||||+ |+|.+++... ..+++..+..++.||+.||+|||++||+||
T Consensus 54 ~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~iiHr 131 (277)
T d1xbba_ 54 ELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHR 131 (277)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCCcccC
Confidence 566788888888888888888888654 5789999998 5888887764 569999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|+|||||++|||+| |++||
T Consensus 132 DlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf 211 (277)
T d1xbba_ 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211 (277)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCC
Confidence 9999999999999999999999987543322 2234578999999999998888899999999999999998 89999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHH---HcC
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANA---MRH 457 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~---l~H 457 (516)
.+.+..+....+... .....|..+++++.+||.+||+.||++|||++++ |+|
T Consensus 212 ~~~~~~~~~~~i~~~-------------------------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 212 RGMKGSEVTAMLEKG-------------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TTCCHHHHHHHHHTT-------------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHcC-------------------------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 998877766655431 1122345789999999999999999999999998 567
Q ss_pred CCCC
Q psy12305 458 PYFN 461 (516)
Q Consensus 458 p~f~ 461 (516)
+|+.
T Consensus 267 ~~~~ 270 (277)
T d1xbba_ 267 YYYD 270 (277)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 7664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=417.65 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=196.6
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCC---cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTD---NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLV 167 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g---~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 167 (516)
++|++.+.||+|+||+||+|++..++ ..||||.++.......
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~----------------------------------- 51 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----------------------------------- 51 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHH-----------------------------------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHH-----------------------------------
Confidence 57999999999999999999987654 4688988754322111
Q ss_pred eehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEee
Q psy12305 168 FEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHD 247 (516)
Q Consensus 168 ~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~ 247 (516)
...+.+|+.+|++++|||||++++
T Consensus 52 --------------------------------------------------------~~~~~~E~~~l~~l~HpnIv~l~~ 75 (273)
T d1mp8a_ 52 --------------------------------------------------------REKFLQEALTMRQFDHPHIVKLIG 75 (273)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHhCCCCCEeeEEE
Confidence 124667777888888888888888
Q ss_pred eEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeecc
Q psy12305 248 IIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGL 326 (516)
Q Consensus 248 ~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGl 326 (516)
++. ++.+|+|||||+ |++..++......+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~ 154 (273)
T d1mp8a_ 76 VIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 154 (273)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchh
Confidence 775 467899999999 588888877777899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCc-cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 327 ARAKSVPTK-TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 327 a~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
|+....... ......||+.|+|||++.+..++.++|+|||||++|||+| |.+||.+.+..+.+..+....
T Consensus 155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-------- 226 (273)
T d1mp8a_ 155 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------- 226 (273)
T ss_dssp ----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC--------
T ss_pred heeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------
Confidence 987543322 2334567999999999998888899999999999999998 899999888777766664321
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
....|..+++++.+||.+||+.||++|||++|+++|
T Consensus 227 -----------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 -----------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 112355789999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=412.30 Aligned_cols=256 Identities=24% Similarity=0.348 Sum_probs=202.2
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 169 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~E 169 (516)
.++|++.++||+|+||+||+|+++.+ +.||||+++.... .
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~--~------------------------------------- 55 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--S------------------------------------- 55 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS--C-------------------------------------
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC--C-------------------------------------
Confidence 47899999999999999999999654 6799999864321 1
Q ss_pred hhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 170 YLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 170 y~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
...+.+|+.+|++++|||||++++++
T Consensus 56 ------------------------------------------------------~~~~~~E~~~l~~l~h~nIv~~~g~~ 81 (285)
T d1fmka3 56 ------------------------------------------------------PEAFLQEAQVMKKLRHEKLVQLYAVV 81 (285)
T ss_dssp ------------------------------------------------------HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ------------------------------------------------------HHHHHHHHHHHHhcccCCEeEEEEEE
Confidence 12456677777777777777777777
Q ss_pred eeCceeeEeeehhh-chHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccc
Q psy12305 250 HTEKCLTLVFEYLE-KDLKRYMDDC-SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLA 327 (516)
Q Consensus 250 ~~~~~~~lV~E~~~-g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla 327 (516)
.+ +.+++|||||+ |+|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 82 ~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 82 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred ec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchh
Confidence 44 45789999999 5677776543 356999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCC-ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHhcCCCChhhhh
Q psy12305 328 RAKSVPT-KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSG-RPLFPGSTIEDELRLICSILGPPPDELKS 405 (516)
Q Consensus 328 ~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG-~~pF~~~~~~~~~~~i~~~~~~~p~~~~~ 405 (516)
+...... .......||+.|+|||++.+..++.++|+|||||++|||++| .+||.+....+.+..+....
T Consensus 161 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~--------- 231 (285)
T d1fmka3 161 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------- 231 (285)
T ss_dssp C--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred hhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---------
Confidence 8654222 233446789999999999988899999999999999999995 66667777776666664321
Q ss_pred hcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc--CCCCCCCCC
Q psy12305 406 KLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR--HPYFNSLGP 465 (516)
Q Consensus 406 ~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~--Hp~f~~~~~ 465 (516)
....+..+++++.+||.+||+.||++|||++++++ |+||++..+
T Consensus 232 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 232 ----------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ----------------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 12234578999999999999999999999999988 999987543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=408.89 Aligned_cols=206 Identities=20% Similarity=0.309 Sum_probs=168.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhc-hHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|++++|||||++++++.+.+..++|||||.+ ++...+......+++..+..++.||+.||+|||+++|+||
T Consensus 55 ~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHr 134 (283)
T d1mqba_ 55 DFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR 134 (283)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccC
Confidence 567889999999999999999999999999999999995 6777777777789999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcC-CCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSG-RPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG-~~pF 380 (516)
||||+|||++.++.+||+|||+|+....... ......||+.|||||++.+..++.++|+|||||++|||++| .+||
T Consensus 135 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp CCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 9999999999999999999999987543221 22345679999999999999999999999999999999995 5556
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.+.+..+.+..+... .+...|..++.++.+||.+||+.||++|||+.|+++
T Consensus 215 ~~~~~~~~~~~i~~~-------------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 215 WELSNHEVMKAINDG-------------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TTCCHHHHHHHHHTT-------------------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccCCHHHHHHHHhcc-------------------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 666666555555321 122234578899999999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=414.46 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=189.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
++|++.++||+|+||+||+|+++. +++.||||+++.........
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~------------------------------- 61 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR------------------------------- 61 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHH-------------------------------
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHH-------------------------------
Confidence 679999999999999999999865 44789999986543222222
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceee
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVT 244 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 244 (516)
.+.+|..++.++ +|+||+.
T Consensus 62 ------------------------------------------------------------~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 62 ------------------------------------------------------------ALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp ------------------------------------------------------------HHHHHHHHHHHHCCCTTBCC
T ss_pred ------------------------------------------------------------HHHHHHHHHHhhcCCCeEEE
Confidence 334455555544 4666666
Q ss_pred EeeeEee-CceeeEeeehhh-chHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecC
Q psy12305 245 LHDIIHT-EKCLTLVFEYLE-KDLKRYMDDC---------------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLK 307 (516)
Q Consensus 245 l~~~~~~-~~~~~lV~E~~~-g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlK 307 (516)
+++++.. +..+++|||||+ |+|.+++... ...+++..++.++.||+.||+|||++||+|||||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 6666544 346788899988 5888887643 2358999999999999999999999999999999
Q ss_pred CCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcC-CCCCCCCC
Q psy12305 308 PQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSG-RPLFPGST 384 (516)
Q Consensus 308 p~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG-~~pF~~~~ 384 (516)
|+|||++.++.+||+|||+|+....... .....+||+.|+|||++.+..++.++|+|||||++|||+|| .+||.+..
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986543322 33456799999999999998889999999999999999996 67888766
Q ss_pred HHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 385 IEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 385 ~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
..+.+..+... ......|+.+++++.+||.+||+.||++|||++|+++|
T Consensus 242 ~~~~~~~~~~~------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 242 IDEEFCRRLKE------------------------GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CSHHHHHHHHH------------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhc------------------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 55544443321 11223455789999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-52 Score=405.63 Aligned_cols=205 Identities=24% Similarity=0.317 Sum_probs=173.6
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHR 304 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHr 304 (516)
.+.+|+.+|++++||||+++++++.+ +.+++|||||+ |++.+++....+.+++..++.++.||+.||.|||++||+||
T Consensus 57 ~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHr 135 (273)
T d1u46a_ 57 DFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHR 135 (273)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeee
Confidence 56788888888888899999998865 46789999998 68888887777779999999999999999999999999999
Q ss_pred ecCCCCEEEccCCCEEEeeeccccccCCCCc---cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCC
Q psy12305 305 DLKPQNLLINERGELKLADFGLARAKSVPTK---TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLF 380 (516)
Q Consensus 305 DlKp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF 380 (516)
||||+|||++.++.+||+|||+|+....... ......||+.|+|||++.+..++.++|+|||||++|||+| |.+||
T Consensus 136 Dikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf 215 (273)
T d1u46a_ 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215 (273)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred eecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987643322 2233457889999999999888888999999999999998 89999
Q ss_pred CCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHH
Q psy12305 381 PGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAM 455 (516)
Q Consensus 381 ~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l 455 (516)
.+.+..+.+..+.... .....|..+++++.+||.+||..||++|||+++++
T Consensus 216 ~~~~~~~~~~~i~~~~------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 216 IGLNGSQILHKIDKEG------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp TTCCHHHHHHHHHTSC------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCcCHHHHHHHHHhCC------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999888877775421 11223457899999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.3e-51 Score=404.41 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=206.0
Q ss_pred cccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|+++++||+|+||+||+|+++. +++.||||++.......
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~--------------------------------- 58 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--------------------------------- 58 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHH---------------------------------
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChH---------------------------------
Confidence 5679999999999999999999763 55789999876432111
Q ss_pred eeeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceee
Q psy12305 165 TLVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVT 244 (516)
Q Consensus 165 ~lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 244 (516)
....+.+|+.+|++++||||++
T Consensus 59 ----------------------------------------------------------~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 59 ----------------------------------------------------------MQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp ----------------------------------------------------------HHHHHHHHHHHHHTCCCTTBCC
T ss_pred ----------------------------------------------------------HHHHHHHHHHHHHhcCCCCccc
Confidence 1225677888888888888888
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHhhCC
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-----------------------NILSMNNVKLFLFQLLRGLAYCHSRR 300 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~aL~yLH~~~ 300 (516)
+++++...+..++||||++ |+|.+++.... ..+++..+..++.||+.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 8888888889999999998 68888886432 24889999999999999999999999
Q ss_pred cEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcC-C
Q psy12305 301 ILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSG-R 377 (516)
Q Consensus 301 ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG-~ 377 (516)
|+||||||+|||++.++.+||+|||+|+...... ......+||+.|+|||++.+..++.++|+|||||++|||++| .
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 9999999999999999999999999998653322 223456789999999999998899999999999999999998 4
Q ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 378 PLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 378 ~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+||.+.+..+.+..+.... ....|..+++++.+||.+||+.||++|||+.|+++
T Consensus 241 ~p~~~~~~~e~~~~v~~~~-------------------------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVRDGN-------------------------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CTTTTSCHHHHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCC-------------------------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7899888887777664321 11235578999999999999999999999999964
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=405.26 Aligned_cols=252 Identities=23% Similarity=0.294 Sum_probs=206.1
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcE--EEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNL--VALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~--vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
..++|++.++||+|+||+||+|+++.+|.. ||||++.......
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------- 52 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD----------------------------------- 52 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------------------------------------
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChH-----------------------------------
Confidence 447899999999999999999999988875 6667664322111
Q ss_pred eeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceeeE
Q psy12305 167 VFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTL 245 (516)
Q Consensus 167 v~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l 245 (516)
....+.+|+.+|+++ +|||||++
T Consensus 53 --------------------------------------------------------~~~~~~~E~~~l~~l~~HpnIv~~ 76 (309)
T d1fvra_ 53 --------------------------------------------------------DHRDFAGELEVLCKLGHHPNIINL 76 (309)
T ss_dssp ----------------------------------------------------------CHHHHHHHHHTTCCCCTTBCCE
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHhccCCCCEeeE
Confidence 122567788888887 68899999
Q ss_pred eeeEeeCceeeEeeehhh-chHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCC
Q psy12305 246 HDIIHTEKCLTLVFEYLE-KDLKRYMDDC---------------SNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQ 309 (516)
Q Consensus 246 ~~~~~~~~~~~lV~E~~~-g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~ 309 (516)
++++.+++.+|+|||||+ |+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+
T Consensus 77 ~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~ 156 (309)
T d1fvra_ 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 156 (309)
T ss_dssp EEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccc
Confidence 999999999999999999 6899988643 356999999999999999999999999999999999
Q ss_pred CEEEccCCCEEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcC-CCCCCCCCHHHH
Q psy12305 310 NLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSG-RPLFPGSTIEDE 388 (516)
Q Consensus 310 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG-~~pF~~~~~~~~ 388 (516)
|||++.++.+||+|||+|+...... ......||+.|+|||.+.+..++.++|+|||||++|||++| .+||.+.+..+.
T Consensus 157 NIL~~~~~~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 157 NILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp GEEECGGGCEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred eEEEcCCCceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 9999999999999999997654322 22345689999999999988888899999999999999996 567888887776
Q ss_pred HHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 389 LRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 389 ~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
+..+... .+...|..+++++.+||.+||+.||++|||++|+++|
T Consensus 236 ~~~i~~~-------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 236 YEKLPQG-------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHGGGT-------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhc-------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 6555321 1122345789999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=395.91 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=193.7
Q ss_pred ccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeee
Q psy12305 89 RIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVF 168 (516)
Q Consensus 89 ~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 168 (516)
..++|++.++||+|+||.||+|++ .|..||||+++.+. ..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~---~~----------------------------------- 44 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TA----------------------------------- 44 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----------------------------------------
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH---HH-----------------------------------
Confidence 356799999999999999999998 47899999985421 11
Q ss_pred ehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeee
Q psy12305 169 EYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDI 248 (516)
Q Consensus 169 Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~ 248 (516)
..+.+|+.+|++++||||++++++
T Consensus 45 --------------------------------------------------------~~~~~E~~~l~~l~HpnIv~~~g~ 68 (262)
T d1byga_ 45 --------------------------------------------------------QAFLAEASVMTQLRHSNLVQLLGV 68 (262)
T ss_dssp --------------------------------------------------------HHHHHTHHHHTTCCCTTBCCEEEE
T ss_pred --------------------------------------------------------HHHHHHHHHHHhCCCCCEeeEEEE
Confidence 145566777777777777777776
Q ss_pred Ee-eCceeeEeeehhh-chHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeec
Q psy12305 249 IH-TEKCLTLVFEYLE-KDLKRYMDDCS-NILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFG 325 (516)
Q Consensus 249 ~~-~~~~~~lV~E~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFG 325 (516)
+. ..+.+|+||||++ |+|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||
T Consensus 69 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg 148 (262)
T d1byga_ 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFG 148 (262)
T ss_dssp ECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred EEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccc
Confidence 64 3456899999998 68999886543 358999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhh
Q psy12305 326 LARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELK 404 (516)
Q Consensus 326 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~ 404 (516)
+++..... .....+|+.|+|||++.+..++.++|+|||||++|||+| |++||.+.+..+....+..
T Consensus 149 ~s~~~~~~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~---------- 215 (262)
T d1byga_ 149 LTKEASST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---------- 215 (262)
T ss_dssp C---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT----------
T ss_pred cceecCCC---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence 99865432 233467999999999988888899999999999999998 7999988777666655532
Q ss_pred hhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 405 SKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
..+...|..+++++.+||.+||..||.+|||+.+++++
T Consensus 216 ---------------~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 ---------------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 12223456788999999999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=401.22 Aligned_cols=212 Identities=20% Similarity=0.327 Sum_probs=179.3
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHH
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------NILSMNNVKLFLFQLLRGLAY 295 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~aL~y 295 (516)
.+.+|+.++++++|||||++++++..++..++|||||+ |+|.+++.... ..+++..+..++.|++.||.|
T Consensus 69 ~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~ 148 (308)
T d1p4oa_ 69 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 148 (308)
T ss_dssp HHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 56788888888888889999999988889999999998 68888776432 347889999999999999999
Q ss_pred HhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCCc--cccCCcccccccchhhccCCCCCCceeeehHHHHHHHH
Q psy12305 296 CHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEM 373 (516)
Q Consensus 296 LH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~el 373 (516)
||+++|+||||||+|||++.++++||+|||+|+....... .....+||+.|+|||.+.+..++.++|+|||||++|||
T Consensus 149 LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El 228 (308)
T d1p4oa_ 149 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 228 (308)
T ss_dssp HHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred HhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHH
Confidence 9999999999999999999999999999999986543222 23445789999999999998888899999999999999
Q ss_pred HcC-CCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH
Q psy12305 374 SSG-RPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA 452 (516)
Q Consensus 374 ltG-~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~ 452 (516)
+|| .+||.+.+..+.+..+.+.. ....|..+++.+.+||.+||+.||++|||++
T Consensus 229 ~t~~~~p~~~~~~~~~~~~i~~~~-------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ 283 (308)
T d1p4oa_ 229 ATLAEQPYQGLSNEQVLRFVMEGG-------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFL 283 (308)
T ss_dssp HHTSCCTTTTSCHHHHHHHHHTTC-------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHhCC-------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence 998 68899888888777664321 1223457889999999999999999999999
Q ss_pred HHHc------CCCCCC
Q psy12305 453 NAMR------HPYFNS 462 (516)
Q Consensus 453 e~l~------Hp~f~~ 462 (516)
++++ +|+|+.
T Consensus 284 ~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 284 EIISSIKEEMEPGFRE 299 (308)
T ss_dssp HHHHHHGGGSCTTHHH
T ss_pred HHHHHHHHhcCCCCcC
Confidence 9987 777754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=397.53 Aligned_cols=207 Identities=23% Similarity=0.402 Sum_probs=177.7
Q ss_pred hhHHHHHHHHHhc-cccceeeEeeeEeeCceeeEeeehhh-chHHHHHHhcC---------------CCCCHHHHHHHHH
Q psy12305 225 CTAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS---------------NILSMNNVKLFLF 287 (516)
Q Consensus 225 ~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~---------------~~l~~~~~~~i~~ 287 (516)
..+.+|...+.++ +|||||++++++.+++.+++|||||+ |+|.+++.... ..+++..++.++.
T Consensus 63 ~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 142 (299)
T d1fgka_ 63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142 (299)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHH
Confidence 3567788888888 79999999999999999999999999 68999886543 3589999999999
Q ss_pred HHHHHHHHHhhCCcEeeecCCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeeh
Q psy12305 288 QLLRGLAYCHSRRILHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMG 365 (516)
Q Consensus 288 qi~~aL~yLH~~~ivHrDlKp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~S 365 (516)
||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|+||
T Consensus 143 qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS 222 (299)
T d1fgka_ 143 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 222 (299)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHH
Confidence 99999999999999999999999999999999999999998764332 2234457899999999999888999999999
Q ss_pred HHHHHHHHHc-CCCCCCCCCHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccC
Q psy12305 366 VGCIFHEMSS-GRPLFPGSTIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYD 444 (516)
Q Consensus 366 lGvil~ellt-G~~pF~~~~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~d 444 (516)
|||++|||++ |.+||.+.+..+....+... .....|..+++++.+||.+||++|
T Consensus 223 ~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-------------------------~~~~~p~~~~~~l~~li~~cl~~d 277 (299)
T d1fgka_ 223 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-------------------------HRMDKPSNCTNELYMMMRDCWHAV 277 (299)
T ss_dssp HHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-------------------------CCCCCCSSCCHHHHHHHHHHTCSS
T ss_pred hHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-------------------------CCCCCCccchHHHHHHHHHHccCC
Confidence 9999999998 79999988877665555321 112235578999999999999999
Q ss_pred cCCCCCHHHHHc
Q psy12305 445 AKQRISAANAMR 456 (516)
Q Consensus 445 P~~R~ta~e~l~ 456 (516)
|.+|||+.|+++
T Consensus 278 P~~Rps~~eil~ 289 (299)
T d1fgka_ 278 PSQRPTFKQLVE 289 (299)
T ss_dssp GGGSCCHHHHHH
T ss_pred HhHCcCHHHHHH
Confidence 999999999986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=396.38 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=209.0
Q ss_pred ccEeeeeeeccccceEEEEEEEc-----CCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSR-----LTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLT 165 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 165 (516)
++|++.++||+|+||.||+|+++ .+++.||||+++.....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~----------------------------------- 67 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL----------------------------------- 67 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH-----------------------------------
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH-----------------------------------
Confidence 78999999999999999999874 35677888887643211
Q ss_pred eeeehhhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhc-cccceee
Q psy12305 166 LVFEYLEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVT 244 (516)
Q Consensus 166 lv~Ey~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~ 244 (516)
.....+.+|+.+++.+ +|||||+
T Consensus 68 --------------------------------------------------------~~~~~~~~E~~~~~~l~~HpnIv~ 91 (311)
T d1t46a_ 68 --------------------------------------------------------TEREALMSELKVLSYLGNHMNIVN 91 (311)
T ss_dssp --------------------------------------------------------HHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred --------------------------------------------------------HHHHHHHHHHHHHHhccCCCCEEE
Confidence 1122567889999998 6999999
Q ss_pred EeeeEeeCceeeEeeehhh-chHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHhhCCcEeeec
Q psy12305 245 LHDIIHTEKCLTLVFEYLE-KDLKRYMDDCS-----------------NILSMNNVKLFLFQLLRGLAYCHSRRILHRDL 306 (516)
Q Consensus 245 l~~~~~~~~~~~lV~E~~~-g~L~~~l~~~~-----------------~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDl 306 (516)
+++++.++..+|+|||||+ |+|..++.... ..+++..+..++.||+.||+|||+++|+||||
T Consensus 92 ~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDL 171 (311)
T d1t46a_ 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (311)
T ss_dssp EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 9999999999999999998 58888886532 25899999999999999999999999999999
Q ss_pred CCCCEEEccCCCEEEeeeccccccCCCC--ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHc-CCCCCCCC
Q psy12305 307 KPQNLLINERGELKLADFGLARAKSVPT--KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSS-GRPLFPGS 383 (516)
Q Consensus 307 Kp~NILl~~~~~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~ellt-G~~pF~~~ 383 (516)
||+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|+|||||++|||+| |.+||.+.
T Consensus 172 Kp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998765332 23345688999999999998888999999999999999998 77778777
Q ss_pred CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 384 TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 384 ~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
+..+.+..+... ......|..+++++.+||.+||++||++|||++++++
T Consensus 252 ~~~~~~~~~i~~------------------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVDSKFYKMIKE------------------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSSHHHHHHHHH------------------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHhc------------------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 666666555432 1222345578899999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=396.53 Aligned_cols=207 Identities=20% Similarity=0.275 Sum_probs=164.1
Q ss_pred hHHHHHHHHHhccccceeeEeeeEee-CceeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEe
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHT-EKCLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILH 303 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivH 303 (516)
.+.+|+.+|++++||||+++++++.. ++..++|||||+ ++|.+++......+++..+..++.|++.||.|||+++|+|
T Consensus 74 ~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiH 153 (311)
T d1r0pa_ 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVH 153 (311)
T ss_dssp HHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCccc
Confidence 45566666666666777777776544 457899999999 5788888877777889999999999999999999999999
Q ss_pred eecCCCCEEEccCCCEEEeeeccccccCCCCc----cccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCC
Q psy12305 304 RDLKPQNLLINERGELKLADFGLARAKSVPTK----TFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPL 379 (516)
Q Consensus 304 rDlKp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~p 379 (516)
|||||+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|+|||||++|||+||..|
T Consensus 154 rDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p 233 (311)
T d1r0pa_ 154 RDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233 (311)
T ss_dssp SCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCC
Confidence 99999999999999999999999986543221 22335689999999999888889999999999999999997777
Q ss_pred CCCC-CHHHHHHHHHHhcCCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHcC
Q psy12305 380 FPGS-TIEDELRLICSILGPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMRH 457 (516)
Q Consensus 380 F~~~-~~~~~~~~i~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~H 457 (516)
|... +..+....+... .+...|..+++++.+||.+||+.||++|||+.|+++|
T Consensus 234 ~~~~~~~~~~~~~i~~g-------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 234 PYPDVNTFDITVYLLQG-------------------------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp SCC------CHHHHHTT-------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcC-------------------------CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 7653 332333333211 1223455788999999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-49 Score=404.69 Aligned_cols=288 Identities=25% Similarity=0.362 Sum_probs=223.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|+++++||+|+||+||+|+++.+|+.||||++++.... ...+.+|+++|+.++|+|++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~--~~~~~~Ei~~l~~l~~~~~~~~---------------- 74 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY--TEAAEDEIKLLQRVNDADNTKE---------------- 74 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH--HHHHHHHHHHHHHHHHTCCSHH----------------
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccc--hHHHHHHHHHHHHhcchhhhhh----------------
Confidence 3599999999999999999999999999999999765322 2367899999999999997632
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
..+.|+||+++++++.
T Consensus 75 ----------------------------------------------------------------~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 75 ----------------------------------------------------------------DSMGANHILKLLDHFN 90 (362)
T ss_dssp ----------------------------------------------------------------HHHHHTTBCCCCEEEE
T ss_pred ----------------------------------------------------------------hhcCcCceEEEEEEee
Confidence 3346999999999886
Q ss_pred eC--ceeeEeeehhh--chHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCcEeeecCCCCEEEccCCC------
Q psy12305 251 TE--KCLTLVFEYLE--KDLKR-YMDDCSNILSMNNVKLFLFQLLRGLAYCHS-RRILHRDLKPQNLLINERGE------ 318 (516)
Q Consensus 251 ~~--~~~~lV~E~~~--g~L~~-~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~ivHrDlKp~NILl~~~~~------ 318 (516)
.. ...+++|+++. ++... ........+++..++.++.||+.||+|||+ +||+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence 54 45566666554 33333 333445679999999999999999999997 89999999999999987654
Q ss_pred EEEeeeccccccCCCCccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCC------CHHHHHHHH
Q psy12305 319 LKLADFGLARAKSVPTKTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGS------TIEDELRLI 392 (516)
Q Consensus 319 vkL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~------~~~~~~~~i 392 (516)
+||+|||.|..... .....+||+.|+|||++.+..++.++|+||+||++++|++|+.||.+. ...+.+..+
T Consensus 171 ~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~ 247 (362)
T d1q8ya_ 171 IKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247 (362)
T ss_dssp EEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred eeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHH
Confidence 99999999976543 334568999999999999988999999999999999999999999753 345567778
Q ss_pred HHhcCCCChhhhhhcccc-----------cCCCC---CCc--hhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 393 CSILGPPPDELKSKLEFC-----------ITPVY---PSE--SKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 393 ~~~~~~~p~~~~~~~~~~-----------~~~~~---~~~--~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
...+|.+|.+.+....+. ..... +.. .......+...++++.|||.+||++||.+||||+|+|+
T Consensus 248 ~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred HHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 888999888776432211 00000 000 01112222345678999999999999999999999999
Q ss_pred CCCCCCC
Q psy12305 457 HPYFNSL 463 (516)
Q Consensus 457 Hp~f~~~ 463 (516)
||||++.
T Consensus 328 Hp~f~~~ 334 (362)
T d1q8ya_ 328 HPWLKDT 334 (362)
T ss_dssp CGGGTTC
T ss_pred CcccCCC
Confidence 9999854
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.5e-49 Score=390.19 Aligned_cols=259 Identities=19% Similarity=0.230 Sum_probs=198.5
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~--------------------------------- 50 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLH--------------------------------- 50 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHH---------------------------------
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHH---------------------------------
Confidence 4699999999999999999999999999999987653221 1333
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc-eeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN-IVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~ 249 (516)
+|+.+++.++|+| |+.+.+++
T Consensus 51 ----------------------------------------------------------~E~~i~~~l~~~~~i~~~~~~~ 72 (299)
T d1ckia_ 51 ----------------------------------------------------------IESKIYKMMQGGVGIPTIRWCG 72 (299)
T ss_dssp ----------------------------------------------------------HHHHHHHHSTTSTTCCCEEEEE
T ss_pred ----------------------------------------------------------HHHHHHHHccCCCcccEEEEEE
Confidence 4555555554443 34445556
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc---CCCEEEeeecc
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE---RGELKLADFGL 326 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~---~~~vkL~DFGl 326 (516)
.+++..++||||+++++...+......+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+
T Consensus 73 ~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~ 152 (299)
T d1ckia_ 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 152 (299)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSS
T ss_pred ecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCc
Confidence 677889999999999998888887888999999999999999999999999999999999999864 45799999999
Q ss_pred ccccCCCC-------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCHHHHHHHHHHhcCCC
Q psy12305 327 ARAKSVPT-------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTIEDELRLICSILGPP 399 (516)
Q Consensus 327 a~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~~~~~~~i~~~~~~~ 399 (516)
|+...... ......+||+.|||||++.+..++.++|+|||||++|||++|+.||.+....+....+.......
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ckia_ 153 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 232 (299)
T ss_dssp CEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH
T ss_pred ceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc
Confidence 98754322 12345689999999999999888999999999999999999999998766554443332211000
Q ss_pred ChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHH---HHHcCCCCC
Q psy12305 400 PDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAA---NAMRHPYFN 461 (516)
Q Consensus 400 p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~---e~l~Hp~f~ 461 (516)
. .......+..+++++.+||.+||+.||++||+++ ++|+|+|.+
T Consensus 233 -------~-----------~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 233 -------M-----------STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -------H-----------HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------C-----------CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 0 0000111237889999999999999999999987 457787753
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.9e-48 Score=381.45 Aligned_cols=250 Identities=18% Similarity=0.225 Sum_probs=201.8
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
++|++.++||+|+||+||+|++..+|+.||||++...... .
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~------------------------------------ 45 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---P------------------------------------ 45 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---C------------------------------------
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---H------------------------------------
Confidence 5799999999999999999999999999999987543211 1
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccc-cceeeEeeeE
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH-ANIVTLHDII 249 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~ 249 (516)
.+.+|+++++.+.| +||+.+++++
T Consensus 46 -------------------------------------------------------~~~~e~~~~~~l~~~~~i~~~~~~~ 70 (293)
T d1csna_ 46 -------------------------------------------------------QLRDEYRTYKLLAGCTGIPNVYYFG 70 (293)
T ss_dssp -------------------------------------------------------CHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred -------------------------------------------------------HHHHHHHHHHHhcCCCCCCEEEEEe
Confidence 34456666666654 7788888888
Q ss_pred eeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeeecCCCCEEEcc-----CCCEEEeee
Q psy12305 250 HTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRDLKPQNLLINE-----RGELKLADF 324 (516)
Q Consensus 250 ~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrDlKp~NILl~~-----~~~vkL~DF 324 (516)
..+...|+||||++++|..++...+..+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+||
T Consensus 71 ~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 71 QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp EETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred ecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEccc
Confidence 889999999999999999999888888999999999999999999999999999999999999974 578999999
Q ss_pred ccccccCCCC-------ccccCCcccccccchhhccCCCCCCceeeehHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH
Q psy12305 325 GLARAKSVPT-------KTFSNEVVTLWYRPPDVLLGSTEYSTSIDMGVGCIFHEMSSGRPLFPGSTI---EDELRLICS 394 (516)
Q Consensus 325 Gla~~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~d~~SlGvil~elltG~~pF~~~~~---~~~~~~i~~ 394 (516)
|+|+...... ......+||+.|||||++.+..++.++|+|||||++|||+||..||.+... ......+..
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 9998754321 123456899999999999998888899999999999999999999986433 233333322
Q ss_pred hc-CCCChhhhhhcccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 395 IL-GPPPDELKSKLEFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 395 ~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.. ..++.+ .+..+++++.+++..|+..+|++||+++.+.+
T Consensus 231 ~~~~~~~~~----------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 231 KKQSTPLRE----------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHSCHHH----------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCCChHH----------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11 111111 12367899999999999999999999876643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=380.10 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=182.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeeh
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEY 170 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey 170 (516)
.+|.+.++||+|+||+||+|++ +|+.||||++..... ..+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~-------------------------------- 44 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFR-------------------------------- 44 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHH--------------------------------
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHH--------------------------------
Confidence 4699999999999999999986 689999998854321 11112
Q ss_pred hhhhhhccccccccccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEe
Q psy12305 171 LEKDLKRYMDDCSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIH 250 (516)
Q Consensus 171 ~~~~L~~~l~~~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 250 (516)
..|+..+.+++|||||++++++.
T Consensus 45 ---------------------------------------------------------e~ei~~~~~~~HpnIv~~~~~~~ 67 (303)
T d1vjya_ 45 ---------------------------------------------------------EAEIYQTVMLRHENILGFIAADN 67 (303)
T ss_dssp ---------------------------------------------------------HHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ---------------------------------------------------------HHHHHHHhhCCCCcCcceEEEEE
Confidence 23444445566777777777765
Q ss_pred eCc----eeeEeeehhh-chHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh--------CCcEeeecCCCCEEEccCC
Q psy12305 251 TEK----CLTLVFEYLE-KDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHS--------RRILHRDLKPQNLLINERG 317 (516)
Q Consensus 251 ~~~----~~~lV~E~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~~ivHrDlKp~NILl~~~~ 317 (516)
+++ .+|+|||||+ |+|..++.+. .+++..+..++.|++.||+|||+ +||+||||||+|||++.++
T Consensus 68 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~ 145 (303)
T d1vjya_ 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145 (303)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred eCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC
Confidence 443 5899999998 5999999764 58999999999999999999996 5999999999999999999
Q ss_pred CEEEeeeccccccCCCCc----cccCCcccccccchhhccCCC------CCCceeeehHHHHHHHHHcCCCCCCCCCHHH
Q psy12305 318 ELKLADFGLARAKSVPTK----TFSNEVVTLWYRPPDVLLGST------EYSTSIDMGVGCIFHEMSSGRPLFPGSTIED 387 (516)
Q Consensus 318 ~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~APE~l~~~~------~~~~~d~~SlGvil~elltG~~pF~~~~~~~ 387 (516)
.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|+|||||+||||+||.+||.......
T Consensus 146 ~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~ 225 (303)
T d1vjya_ 146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225 (303)
T ss_dssp CEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred CeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc
Confidence 999999999987643322 234568999999999987643 3457899999999999999998874322110
Q ss_pred HHHHHHHhcCCCCh-hhhhhc-ccccCCCCCCchhhhhcCCCCCCHHHHHHHHHccccCcCCCCCHHHHHc
Q psy12305 388 ELRLICSILGPPPD-ELKSKL-EFCITPVYPSESKLQLLAPEQMDSDALDLVQKFLMYDAKQRISAANAMR 456 (516)
Q Consensus 388 ~~~~i~~~~~~~p~-~~~~~~-~~~~~~~~~~~~~~~~~~p~~~s~~~~dLl~~~L~~dP~~R~ta~e~l~ 456 (516)
.... ......+.. ...... .....|..+. ...+......+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 226 LPYY-DLVPSDPSVEEMRKVVCEQKLRPNIPN-----RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp CTTT-TTSCSSCCHHHHHHHHTTSCCCCCCCG-----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred cchh-hcccccchHHHHHHHHhccccCCCCCc-----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 0000 000000000 000000 0000010000 0001122346889999999999999999999976
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=4.2e-25 Score=202.45 Aligned_cols=122 Identities=16% Similarity=0.086 Sum_probs=90.5
Q ss_pred hHHHHHHHHHhccccceeeEeeeEeeCceeeEeeehhhchHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCcEeee
Q psy12305 226 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDDCSNILSMNNVKLFLFQLLRGLAYCHSRRILHRD 305 (516)
Q Consensus 226 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~ivHrD 305 (516)
...+|...+.++.|++++..+++.. .+++|||+++... ..++...+..++.|++.||.|||++||+|||
T Consensus 60 ~~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrD 128 (191)
T d1zara2 60 SARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGD 128 (191)
T ss_dssp HHHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHHHccCCCcceEEEecC----CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEcc
Confidence 4567899999999999998876532 3799999996422 1256677889999999999999999999999
Q ss_pred cCCCCEEEccCCCEEEeeeccccccCCCCccccCCcccccccch------hhccCCCCCCceeeehHHH
Q psy12305 306 LKPQNLLINERGELKLADFGLARAKSVPTKTFSNEVVTLWYRPP------DVLLGSTEYSTSIDMGVGC 368 (516)
Q Consensus 306 lKp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~gt~~y~AP------E~l~~~~~~~~~d~~SlGv 368 (516)
|||+|||++++ .++|+|||+|.....+.. ..|... +.+ ...+...+|+||+.-
T Consensus 129 iKP~NILv~~~-~~~liDFG~a~~~~~~~~--------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 129 LSQYNVLVSEE-GIWIIDFPQSVEVGEEGW--------REILERDVRNIITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp CSTTSEEEETT-EEEECCCTTCEETTSTTH--------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHH
T ss_pred CChhheeeeCC-CEEEEECCCcccCCCCCc--------HHHHHHHHHHHHHHH-cCCCCCcccHHHHHH
Confidence 99999999865 599999999976542221 111111 112 245677888888643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=1.7e-08 Score=96.33 Aligned_cols=29 Identities=28% Similarity=0.305 Sum_probs=22.9
Q ss_pred ccccceeeEEEEEEEecC--CceEEEEEeec
Q psy12305 189 NNVKGTYATVFKGKSRLT--DNLVALKEIKL 217 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~--~~~vAiK~i~~ 217 (516)
.+|+|+||+||+|.++.+ +..||||.++.
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~ 46 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ 46 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECS
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEECh
Confidence 379999999999987654 45799999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=7.6e-09 Score=101.71 Aligned_cols=47 Identities=28% Similarity=0.244 Sum_probs=30.2
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccc-cCChhhHHHHHHHH
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLL 234 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il 234 (516)
..+|+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|
T Consensus 24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il 71 (346)
T d1cm8a_ 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71 (346)
T ss_dssp EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHH
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHH
Confidence 457899999999999999999999999975432 22234566777663
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=4e-08 Score=95.13 Aligned_cols=74 Identities=36% Similarity=0.530 Sum_probs=54.5
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeeccc-ccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeEeee
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEH-EEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFE 260 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 260 (516)
....|+|+||+||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++......+...+
T Consensus 15 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 15 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 345789999999999999999999999987654 34455678899999999999999999999988776665544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.51 E-value=2e-08 Score=98.56 Aligned_cols=70 Identities=24% Similarity=0.338 Sum_probs=56.8
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeCceeeE
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 257 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 257 (516)
...|+|+||+||+|.++.+|+.||||+++..........+.+|+.+|++++||||+++++++........
T Consensus 14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4578999999999999999999999999865544455678899999999999999999999977664433
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.46 E-value=4.8e-08 Score=96.18 Aligned_cols=67 Identities=22% Similarity=0.310 Sum_probs=55.1
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccc-cCChhhHHHHHHHHHhccccceeeEeeeEeeCce
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEKC 254 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 254 (516)
...|+|+||+||+|.++.+|+.||||+++.... ......+.+|+.+|++++|||||+++++|.....
T Consensus 23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 457899999999999999999999999986543 2334467899999999999999999999987654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=7.5e-08 Score=91.14 Aligned_cols=33 Identities=24% Similarity=0.191 Sum_probs=24.8
Q ss_pred cccccccccceeeEEEEEEEecCC---ceEEEEEee
Q psy12305 184 NILSMNNVKGTYATVFKGKSRLTD---NLVALKEIK 216 (516)
Q Consensus 184 ~~l~~~~~~G~~g~V~~~~~~~~~---~~vAiK~i~ 216 (516)
..+....|+|+||+||+|.+..++ ..||||.++
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~ 44 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK 44 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECT
T ss_pred eEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEec
Confidence 344566899999999999987654 468888775
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=6.5e-08 Score=94.81 Aligned_cols=66 Identities=23% Similarity=0.315 Sum_probs=55.8
Q ss_pred cccccceeeEEEEEEEecCCceEEEEEeecccc-cCChhhHHHHHHHHHhccccceeeEeeeEeeCc
Q psy12305 188 MNNVKGTYATVFKGKSRLTDNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLHDIIHTEK 253 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 253 (516)
...|+|+||+||+|+++.+|+.||||+++.... ......+.+|+.+|++++|||||++++++....
T Consensus 24 ~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp EECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred EEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 457899999999999999999999999986542 223346789999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.35 E-value=1.3e-07 Score=90.78 Aligned_cols=47 Identities=17% Similarity=0.511 Sum_probs=42.4
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++|+|||||++++++..++..+++|||+++ +|..++..
T Consensus 73 ~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~ 120 (299)
T d1jpaa_ 73 DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ 120 (299)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc
Confidence 688999999999999999999999999999999999986 67666544
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=2.1e-07 Score=88.13 Aligned_cols=33 Identities=27% Similarity=0.364 Sum_probs=25.2
Q ss_pred cccccccccccceeeEEEEEEEecCCceEEEEEeec
Q psy12305 182 CSNILSMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217 (516)
Q Consensus 182 ~s~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~ 217 (516)
....+....|+|+||+||+|+.+ ..||||+++.
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~ 40 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNV 40 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCC
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEc
Confidence 33445566899999999999754 3599999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=2.7e-07 Score=87.66 Aligned_cols=89 Identities=24% Similarity=0.459 Sum_probs=74.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCC----cEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeee
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTD----NLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTL 166 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g----~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 166 (516)
+.|++.+.||+|+||+||+|+++.++ ..||||++...........+.+|+.+|++|+|||||++++++..++..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 46999999999999999999988665 47999999765554445578999999999999999999999999999999
Q ss_pred eeehhhh-hhhccc
Q psy12305 167 VFEYLEK-DLKRYM 179 (516)
Q Consensus 167 v~Ey~~~-~L~~~l 179 (516)
+|||+.. .+..++
T Consensus 87 v~e~~~~~~l~~~~ 100 (283)
T d1mqba_ 87 ITEYMENGALDKFL 100 (283)
T ss_dssp EEECCTTEEHHHHH
T ss_pred EEEecccCcchhhh
Confidence 9999986 343433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=4.1e-07 Score=87.16 Aligned_cols=59 Identities=32% Similarity=0.525 Sum_probs=44.9
Q ss_pred cccccceeeEEEEEEEecC-CceEEEEEeecccc-cCChhhHHHHHHHHHhccccceeeEe
Q psy12305 188 MNNVKGTYATVFKGKSRLT-DNLVALKEIKLEHE-EGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~-~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
...|+|+||+||+|++..+ ++.||||+++.... ......+.+|+.+|+.|...+-..+.
T Consensus 13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv 73 (305)
T d1blxa_ 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73 (305)
T ss_dssp EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBC
T ss_pred EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcc
Confidence 4578999999999999766 67899999987643 33455678999999998776544333
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=1.5e-07 Score=90.78 Aligned_cols=48 Identities=25% Similarity=0.294 Sum_probs=42.6
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+++++ +|||||++++++..++..+++|||+++ ++..++...
T Consensus 72 ~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~ 121 (311)
T d1t46a_ 72 ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRK 121 (311)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHT
T ss_pred HHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhc
Confidence 688999999999 799999999999999999999999986 777776543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.17 E-value=3.6e-07 Score=88.03 Aligned_cols=30 Identities=20% Similarity=0.233 Sum_probs=23.2
Q ss_pred cccccceeeEEEEEEEecCC---ceEEEEEeec
Q psy12305 188 MNNVKGTYATVFKGKSRLTD---NLVALKEIKL 217 (516)
Q Consensus 188 ~~~~~G~~g~V~~~~~~~~~---~~vAiK~i~~ 217 (516)
...|+|+||+||+|++..++ ..||||.++.
T Consensus 33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~ 65 (311)
T d1r0pa_ 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65 (311)
T ss_dssp EEEEEETTEEEEEEEECC----CEEEEEEEECC
T ss_pred eEEeecCCeEEEEEEEECCCCEEEEEEEEEECc
Confidence 34799999999999986653 3699999864
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.17 E-value=7.8e-06 Score=75.84 Aligned_cols=28 Identities=21% Similarity=0.375 Sum_probs=24.4
Q ss_pred cEeeecCCCCEEEccCCCEEEeeecccc
Q psy12305 301 ILHRDLKPQNLLINERGELKLADFGLAR 328 (516)
Q Consensus 301 ivHrDlKp~NILl~~~~~vkL~DFGla~ 328 (516)
++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred EEEeeccCcceeecCCceEEEeechhcc
Confidence 7899999999999876666799999774
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.10 E-value=6.3e-07 Score=86.83 Aligned_cols=50 Identities=28% Similarity=0.440 Sum_probs=44.8
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDCSN 184 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~s~ 184 (516)
.+.+|+.+|+++ +|||||++++++...+..+++|||+++ +|.+++.....
T Consensus 86 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~ 137 (325)
T d1rjba_ 86 ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKRE 137 (325)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT
T ss_pred HHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccC
Confidence 688999999998 899999999999999999999999986 88888865543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=4.4e-06 Score=80.40 Aligned_cols=68 Identities=18% Similarity=0.243 Sum_probs=49.2
Q ss_pred cCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhh-hhhhccccc
Q psy12305 113 RLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLE-KDLKRYMDD 181 (516)
Q Consensus 113 ~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~-~~L~~~l~~ 181 (516)
......||||+++........+.+.+|+.+|++++|||||+++++|..++ .++++||+. +++.+++..
T Consensus 35 ~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~v~e~~~~~~l~~~~~~ 103 (317)
T d1xkka_ 35 EKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE 103 (317)
T ss_dssp --CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH
T ss_pred CEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeEEEEeccCCcccccccc
Confidence 34567899999987666666678999999999999999999999998765 456666665 466655443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.85 E-value=1.6e-06 Score=82.78 Aligned_cols=93 Identities=24% Similarity=0.384 Sum_probs=75.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCCC-------cEEEEEEeecccccCCcchhHHHHHHHHhc-CCCCeeecccccccc
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLTD-------NLVALKEIKLEHEEGAPCTAIREVSLLREL-RHANIVTLHDIIHTE 161 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~g-------~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 161 (516)
.++|++.+.||+|+||.||+|++..++ ..||||+++.+........+.+|+..+.++ +|||||+++++|..+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 368999999999999999999987655 379999998766555556889999999998 899999999999999
Q ss_pred eeeeeeeehhhh-hhhcccccc
Q psy12305 162 KCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 162 ~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+..+++|||+++ ++..++...
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~ 113 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQAR 113 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTT
T ss_pred CeEEEEEEccCCCcHHHHHHhh
Confidence 999999999986 787777544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.81 E-value=3.7e-05 Score=75.97 Aligned_cols=30 Identities=20% Similarity=0.345 Sum_probs=22.4
Q ss_pred eeeeeccccceEEEEEEEcCCCcEEEEEEe
Q psy12305 95 KLDKLGQGTYATVFKGKSRLTDNLVALKEI 124 (516)
Q Consensus 95 ~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i 124 (516)
..+.||.|....||++.+..+|+.|.||.-
T Consensus 30 ~~~eig~G~~N~vfrV~~~~~~~svivKqa 59 (392)
T d2pula1 30 TCQEIGDGNLNYVFHIYDQEHDRALIIKQA 59 (392)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEE
T ss_pred eEEEeCCCceEeEEEEEeCCCCeEEEEecC
Confidence 356789999999999998777889999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.69 E-value=1.1e-05 Score=76.66 Aligned_cols=35 Identities=20% Similarity=0.129 Sum_probs=26.2
Q ss_pred ccccccccccceeeEEEEEEEecC-----CceEEEEEeec
Q psy12305 183 SNILSMNNVKGTYATVFKGKSRLT-----DNLVALKEIKL 217 (516)
Q Consensus 183 s~~l~~~~~~G~~g~V~~~~~~~~-----~~~vAiK~i~~ 217 (516)
...+...+|+|+||+||+|.+..+ ++.||+|.++.
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~ 53 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE 53 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC--
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcc
Confidence 344556689999999999997654 46899999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.47 E-value=2.4e-05 Score=76.20 Aligned_cols=61 Identities=23% Similarity=0.253 Sum_probs=50.3
Q ss_pred cccccccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEe
Q psy12305 184 NILSMNNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLH 246 (516)
Q Consensus 184 ~~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 246 (516)
..+....|+|+||+||+|+++.+|+.||||+++.... ....+.+|+.+++.++|+|++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~ 75 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKED 75 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHH
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhh
Confidence 3445667899999999999999999999999975532 234678899999999999998653
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.42 E-value=2.3e-05 Score=74.22 Aligned_cols=50 Identities=28% Similarity=0.573 Sum_probs=44.5
Q ss_pred CcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 132 APCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 132 ~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
..+.+.+|+.+|++|+|||||++++++..++..+++|||+++ +|.+++..
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~ 106 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE 106 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc
Confidence 345789999999999999999999999999999999999985 88777654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.41 E-value=0.00017 Score=65.99 Aligned_cols=65 Identities=15% Similarity=0.045 Sum_probs=46.0
Q ss_pred eeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccc--eeeEeeeEeeCceeeEeeehhhc
Q psy12305 195 YATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN--IVTLHDIIHTEKCLTLVFEYLEK 264 (516)
Q Consensus 195 ~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~g 264 (516)
-+.||+... .++..+.+|.-... ....+..|...|+.+.... +.+++.+..+++..++||++++|
T Consensus 24 ~~~v~r~~~-~~~~~~vlK~~~~~----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 24 DAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp SCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred CCeEEEEEe-CCCCEEEEEeCCcc----CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 467888764 34556777865433 2335778999988885433 56778888888889999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.37 E-value=1.8e-05 Score=76.19 Aligned_cols=47 Identities=19% Similarity=0.349 Sum_probs=42.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||+++++|..++..++||||+++ +|..++..
T Consensus 50 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~ 97 (322)
T d1s9ja_ 50 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 97 (322)
T ss_dssp HHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh
Confidence 678999999999999999999999999999999999986 88777754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.33 E-value=3.7e-05 Score=71.61 Aligned_cols=47 Identities=30% Similarity=0.446 Sum_probs=42.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+++|++++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 52 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~ 99 (263)
T d2j4za1 52 QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK 99 (263)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh
Confidence 688999999999999999999999999999999999986 77777643
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.24 E-value=4.4e-05 Score=72.08 Aligned_cols=46 Identities=26% Similarity=0.354 Sum_probs=40.7
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+|+++|++|+|||||++++++..++..+++|||+++ +|..++..
T Consensus 56 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~ 102 (288)
T d2jfla1 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE 102 (288)
T ss_dssp THHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh
Confidence 46899999999999999999999999999999999986 77666543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.23 E-value=5.2e-05 Score=71.58 Aligned_cols=47 Identities=21% Similarity=0.356 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+++|++++|||||++++++..++..+++|||+++ +|.+++..
T Consensus 54 ~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~ 101 (288)
T d1uu3a_ 54 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK 101 (288)
T ss_dssp HHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc
Confidence 788999999999999999999999999999999999986 77776543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.20 E-value=5.4e-05 Score=71.01 Aligned_cols=84 Identities=27% Similarity=0.431 Sum_probs=66.3
Q ss_pred eeeccccceEEEEEEEcC--CCcEEEEEEeeccccc-CCcchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh
Q psy12305 97 DKLGQGTYATVFKGKSRL--TDNLVALKEIKLEHEE-GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK 173 (516)
Q Consensus 97 ~~LG~G~fG~Vyka~~~~--~g~~vAvK~i~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~ 173 (516)
++||+|+||+||+|.++. +++.||||+++..... ...+.+.+|+++|++++|||||+++++|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998754 5678999999764332 223478999999999999999999999865 457899999986
Q ss_pred -hhhccccc
Q psy12305 174 -DLKRYMDD 181 (516)
Q Consensus 174 -~L~~~l~~ 181 (516)
+|.+++..
T Consensus 92 g~L~~~l~~ 100 (277)
T d1xbba_ 92 GPLNKYLQQ 100 (277)
T ss_dssp EEHHHHHHH
T ss_pred CcHHHHHhh
Confidence 77777654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.18 E-value=7.1e-05 Score=69.54 Aligned_cols=47 Identities=28% Similarity=0.485 Sum_probs=41.7
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+.+|+.+|++++|||||++++++..++..+++|||++. +|.+++...
T Consensus 47 ~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~ 94 (263)
T d1sm2a_ 47 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ 94 (263)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTT
T ss_pred HHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcc
Confidence 57899999999999999999999999999999999976 777766443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.15 E-value=4.8e-05 Score=72.59 Aligned_cols=41 Identities=32% Similarity=0.430 Sum_probs=38.2
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhh
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDL 175 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L 175 (516)
.+.+|+++|++|+|||||++++++..++..+++|||+.++.
T Consensus 61 ~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 101 (309)
T d1u5ra_ 61 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101 (309)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred HHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCc
Confidence 68899999999999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.15 E-value=5.5e-05 Score=70.65 Aligned_cols=47 Identities=34% Similarity=0.583 Sum_probs=40.1
Q ss_pred hhHHHHHHHHhcCCCCeeeccccccc----ceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHT----EKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+++|++++|||||++++++.. +...+++|||+++ +|.+++..
T Consensus 54 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~ 105 (270)
T d1t4ha_ 54 RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 105 (270)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc
Confidence 68899999999999999999999854 4568999999986 77777654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.15 E-value=7.2e-05 Score=71.72 Aligned_cols=47 Identities=28% Similarity=0.549 Sum_probs=42.0
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
+.+|+++|+.++|||||++++++..++..|+||||+++ +|.+++...
T Consensus 48 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~ 95 (321)
T d1tkia_ 48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS 95 (321)
T ss_dssp HHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS
T ss_pred HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhc
Confidence 45899999999999999999999999999999999986 888777543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.13 E-value=8.7e-05 Score=70.22 Aligned_cols=47 Identities=40% Similarity=0.685 Sum_probs=41.6
Q ss_pred cchhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccc
Q psy12305 133 PCTAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l 179 (516)
...+.+|+.+|++++|||||++++++..++..++||||+.+.+...+
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~ 90 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVII 90 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhh
Confidence 44799999999999999999999999999999999999987554443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.11 E-value=8e-05 Score=70.92 Aligned_cols=48 Identities=25% Similarity=0.399 Sum_probs=43.3
Q ss_pred hhHHHHHHHHhc-CCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLREL-RHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+++|+++ +|||||++++++..++..++||||+++ +|.+++...
T Consensus 56 ~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~ 105 (309)
T d1fvra_ 56 DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 105 (309)
T ss_dssp HHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTT
T ss_pred HHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhc
Confidence 689999999999 799999999999999999999999986 888887543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.10 E-value=8.4e-05 Score=70.26 Aligned_cols=44 Identities=32% Similarity=0.421 Sum_probs=39.7
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYM 179 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l 179 (516)
+.+|+.+|++++|||||++++++..++..+++|||+++ +|..++
T Consensus 64 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~ 108 (293)
T d1yhwa1 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108 (293)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred HHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHh
Confidence 57899999999999999999999999999999999986 666554
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.08 E-value=6.6e-05 Score=70.08 Aligned_cols=47 Identities=43% Similarity=0.596 Sum_probs=39.4
Q ss_pred hhHHHHHHHHhcCCCCeeeccccccc--ceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHT--EKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+++|++++|||||++++++.. ++..+++|||+++ +|.+++..
T Consensus 49 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~ 98 (269)
T d2java1 49 MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98 (269)
T ss_dssp HHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHh
Confidence 68899999999999999999998854 4568999999986 88877754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.07 E-value=9.6e-05 Score=69.60 Aligned_cols=47 Identities=21% Similarity=0.526 Sum_probs=42.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||+++++|..++..+++|||+++ ++..++..
T Consensus 59 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~ 106 (287)
T d1opja_ 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106 (287)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhh
Confidence 588999999999999999999999999999999999986 77666643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=97.03 E-value=0.00012 Score=71.17 Aligned_cols=47 Identities=26% Similarity=0.523 Sum_probs=41.6
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++|+|||||+++++|..++..+++|||+++ +|.+++..
T Consensus 72 ~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~ 119 (352)
T d1koba_ 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA 119 (352)
T ss_dssp HHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh
Confidence 577999999999999999999999999999999999985 77665543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=97.02 E-value=0.00011 Score=71.23 Aligned_cols=47 Identities=26% Similarity=0.563 Sum_probs=42.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++|+|||||++++++..++..+++|||+++ +|.+++..
T Consensus 69 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~ 116 (350)
T d1koaa2 69 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD 116 (350)
T ss_dssp HHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC
T ss_pred HHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh
Confidence 578999999999999999999999999999999999986 88777644
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=97.02 E-value=0.00011 Score=68.79 Aligned_cols=48 Identities=33% Similarity=0.655 Sum_probs=43.4
Q ss_pred chhHHHHHHHHhcC-CCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 134 CTAIREVSLLRELR-HANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 134 ~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+.+.+|+.+|++|+ |||||++++++..++..+++|||+++ +|.+++..
T Consensus 54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~ 103 (277)
T d1phka_ 54 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 103 (277)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh
Confidence 47889999999997 99999999999999999999999986 88888753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.00 E-value=0.00022 Score=66.50 Aligned_cols=31 Identities=26% Similarity=0.357 Sum_probs=27.8
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeec
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKL 217 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~ 217 (516)
....|+|+||+||+|+++.+++.||+|+++.
T Consensus 10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~ 40 (271)
T d1nvra_ 10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM 40 (271)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEEC
T ss_pred EEEEecCcCeEEEEEEECCCCCEEEEEEEeh
Confidence 3457899999999999999999999999974
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.85 E-value=0.00017 Score=69.58 Aligned_cols=47 Identities=23% Similarity=0.354 Sum_probs=42.3
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++..++..++||||+++ +|..++..
T Consensus 51 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~ 98 (337)
T d1o6la_ 51 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR 98 (337)
T ss_dssp HHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH
T ss_pred HHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc
Confidence 688999999999999999999999999999999999986 67666543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.84 E-value=0.00022 Score=65.94 Aligned_cols=45 Identities=22% Similarity=0.446 Sum_probs=39.8
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+|++++|||||++++++..++..+++|||++. ++..++.
T Consensus 46 ~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~ 91 (258)
T d1k2pa_ 46 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR 91 (258)
T ss_dssp HHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHH
T ss_pred HHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhh
Confidence 57899999999999999999999999999999999975 6666643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.83 E-value=0.00016 Score=68.41 Aligned_cols=45 Identities=67% Similarity=1.020 Sum_probs=40.9
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYM 179 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l 179 (516)
.+.+|+++|++++|||||++++++..++..+++|||+.+++..++
T Consensus 47 ~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~ 91 (298)
T d1gz8a_ 47 TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM 91 (298)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHH
T ss_pred HHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhh
Confidence 788999999999999999999999999999999999987655544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.81 E-value=0.00024 Score=67.47 Aligned_cols=32 Identities=25% Similarity=0.277 Sum_probs=28.0
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
....|+|+||+||+|+++.+++.||+|++...
T Consensus 14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~ 45 (307)
T d1a06a_ 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKK 45 (307)
T ss_dssp EEESBSGGGGGEEEEEETTTCCEEEEEEEEC-
T ss_pred EEEEeeccCeEEEEEEECCCCCEEEEEEEchH
Confidence 44578999999999999999999999999754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=96.81 E-value=0.00017 Score=68.87 Aligned_cols=46 Identities=15% Similarity=0.325 Sum_probs=40.7
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|+.++|||||++++++..++..+++|||+++ ++..++.
T Consensus 50 ~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~ 96 (316)
T d1fota_ 50 HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96 (316)
T ss_dssp HHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred HHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccc
Confidence 788999999999999999999999999999999999986 4444443
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.67 E-value=0.00022 Score=66.14 Aligned_cols=44 Identities=36% Similarity=0.601 Sum_probs=36.9
Q ss_pred HHHHHHHhcCCCCeeeccccccc-ceeeeeeeehhhh-hhhccccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHT-EKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
+|+++|++++|||||++++++.. ++..++||||+++ +|.+++..
T Consensus 49 ~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~ 94 (262)
T d1byga_ 49 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94 (262)
T ss_dssp HTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHH
T ss_pred HHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHh
Confidence 79999999999999999998855 4668999999976 78887754
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.58 E-value=0.00079 Score=63.26 Aligned_cols=33 Identities=18% Similarity=0.266 Sum_probs=28.7
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
+...+|+|+||+||+|++..+++.||||++...
T Consensus 11 l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~ 43 (299)
T d1ckia_ 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK 43 (299)
T ss_dssp EEEEEEECSSSEEEEEEETTTTEEEEEEEEESC
T ss_pred EeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh
Confidence 445678999999999999999999999988753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.58 E-value=0.00044 Score=64.27 Aligned_cols=42 Identities=24% Similarity=0.575 Sum_probs=35.5
Q ss_pred HHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 138 REVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 138 ~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+|+.+|++++|||||++++++.. +..+++|||+++ +|.+++.
T Consensus 57 ~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~ 99 (272)
T d1qpca_ 57 AEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLK 99 (272)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTT
T ss_pred HHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHh
Confidence 79999999999999999998754 567999999986 6666553
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.56 E-value=0.00039 Score=64.75 Aligned_cols=90 Identities=27% Similarity=0.320 Sum_probs=64.1
Q ss_pred cccEeeeeeeccccceEEEEEEEcCC-C--cEEEEEEeeccccc--CCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRLT-D--NLVALKEIKLEHEE--GAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~~-g--~~vAvK~i~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
-++|++++.||+|+||+||+|++..+ + ..||||++...... ...+.+.+|+.+|++++|||||++++++.. +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 36799999999999999999987543 3 36899999765432 223478999999999999999999999965 467
Q ss_pred eeeeehhhh-hhhcccc
Q psy12305 165 TLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 165 ~lv~Ey~~~-~L~~~l~ 180 (516)
+++|||++. ++.+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~ 102 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLR 102 (273)
T ss_dssp EEEEECCTTCBHHHHHH
T ss_pred heeeeeecCcchhhhhh
Confidence 899999986 5554443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=96.45 E-value=0.0011 Score=64.37 Aligned_cols=63 Identities=13% Similarity=0.122 Sum_probs=49.6
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEeeccc--ccCChhhHHHHHHHHHhccccceeeEeeeE
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIKLEH--EEGAPCTAIREVSLLRELRHANIVTLHDII 249 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~ 249 (516)
....|+|+||+||+|+++.+|+.||||++.... .......+.+|...++.+++.+-..+..++
T Consensus 9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~ 73 (364)
T d1omwa3 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMS 73 (364)
T ss_dssp EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEE
T ss_pred eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEE
Confidence 345789999999999999999999999997553 344566678899999988887665554443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.44 E-value=0.0029 Score=60.13 Aligned_cols=43 Identities=12% Similarity=0.068 Sum_probs=31.1
Q ss_pred eEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCC
Q psy12305 105 ATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHAN 150 (516)
Q Consensus 105 G~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~n 150 (516)
=.||+++. .+|..|++|+-+... .....+..|...|..|....
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~g 78 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDE 78 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTT
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCC--CCHHHHHHHHHHHHHHHhcC
Confidence 48999987 478889999876432 22346788999999885433
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=96.40 E-value=0.00045 Score=64.30 Aligned_cols=46 Identities=26% Similarity=0.333 Sum_probs=38.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccce----eeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEK----CLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+.+|+.++|||||++++++...+ ..|+||||+++ +|..++.
T Consensus 53 ~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~ 103 (277)
T d1o6ya_ 53 RFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH 103 (277)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhc
Confidence 6889999999999999999999987643 48899999986 6655543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.36 E-value=0.00056 Score=64.77 Aligned_cols=93 Identities=22% Similarity=0.393 Sum_probs=79.6
Q ss_pred cccEeeeeeeccccceEEEEEEEcC-----CCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCeeecccccccceee
Q psy12305 90 IESYFKLDKLGQGTYATVFKGKSRL-----TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTEKCL 164 (516)
Q Consensus 90 ~~~y~~~~~LG~G~fG~Vyka~~~~-----~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 164 (516)
.++|++.++||+|+||+||+|++.. ++..||||+++..........+.+|+.+|++++|||||++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4789999999999999999999853 45789999998655444445789999999999999999999999999999
Q ss_pred eeeeehhhh-hhhcccccc
Q psy12305 165 TLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 165 ~lv~Ey~~~-~L~~~l~~~ 182 (516)
+++|||+++ ++..++...
T Consensus 99 ~lv~e~~~~g~l~~~~~~~ 117 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSL 117 (308)
T ss_dssp EEEEECCTTCBHHHHHHHH
T ss_pred eEEEeecCCCCHHHHHHhc
Confidence 999999976 777776544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=96.20 E-value=0.00066 Score=63.38 Aligned_cols=47 Identities=60% Similarity=0.924 Sum_probs=41.7
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhhccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLKRYMDD 181 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~~~l~~ 181 (516)
.+.+|+.+|++++|||||++++++..++..++++||+...+...+..
T Consensus 46 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~ 92 (286)
T d1ob3a_ 46 TTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV 92 (286)
T ss_dssp HHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHT
T ss_pred HHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHh
Confidence 78899999999999999999999999999999999998765555443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.17 E-value=0.00088 Score=62.67 Aligned_cols=44 Identities=27% Similarity=0.594 Sum_probs=36.7
Q ss_pred hHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 136 AIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 136 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
+.+|+.+|++++|||||++++++. ++..+++|||+++ ++..++.
T Consensus 59 ~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~ 103 (285)
T d1fmka3 59 FLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK 103 (285)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHS
T ss_pred HHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhh
Confidence 568999999999999999999985 4568999999986 5555543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.13 E-value=0.00098 Score=63.42 Aligned_cols=48 Identities=25% Similarity=0.419 Sum_probs=41.5
Q ss_pred hhHHHHHHHH-hcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLR-ELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.++. .++|||||++++++..++..|+||||+++ +|..++...
T Consensus 48 ~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~ 97 (320)
T d1xjda_ 48 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC 97 (320)
T ss_dssp HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc
Confidence 6778888776 68999999999999999999999999986 887777543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.01 E-value=0.0012 Score=61.99 Aligned_cols=48 Identities=31% Similarity=0.533 Sum_probs=43.0
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
.+.+|+.+|++++||||++++++|...+..+++|||++. +|.+++...
T Consensus 62 ~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~ 110 (301)
T d1lufa_ 62 DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSM 110 (301)
T ss_dssp HHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHT
T ss_pred HHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhc
Confidence 678999999999999999999999999999999999975 777776543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.98 E-value=0.0012 Score=63.67 Aligned_cols=46 Identities=17% Similarity=0.307 Sum_probs=41.1
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhh-hhhcccc
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEK-DLKRYMD 180 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~-~L~~~l~ 180 (516)
.+.+|+++|+.++|||||++++++......+++|||+.+ ++..++.
T Consensus 87 ~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~ 133 (350)
T d1rdqe_ 87 HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133 (350)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred HHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHh
Confidence 688999999999999999999999999999999999976 5655553
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.73 E-value=0.0018 Score=61.50 Aligned_cols=92 Identities=21% Similarity=0.299 Sum_probs=59.3
Q ss_pred ccccccccccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCC-CCeeecccccccc
Q psy12305 83 SEIGFGRIESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRH-ANIVTLHDIIHTE 161 (516)
Q Consensus 83 ~~~~~~~~~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~ 161 (516)
..+|.|..+.=-....+....-|.+|-.+- +..+.+..+ ....+.+.+|+++|++++| ||||++++++...
T Consensus 30 ~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~------i~~~~~~~~--~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKV------LKKATIVQK--AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp EEEEETTTEEEEEEEECSSTTTTCEEEEEE------ESEEEEEEE--ESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred EEEecCCCeEEEEEEECccCCCCcEEEEEE------EehHHhccc--hHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 445556555422222223333466665532 112222221 2234478899999999976 8999999999999
Q ss_pred eeeeeeeehhhh-hhhcccccc
Q psy12305 162 KCLTLVFEYLEK-DLKRYMDDC 182 (516)
Q Consensus 162 ~~~~lv~Ey~~~-~L~~~l~~~ 182 (516)
...+++|||+.+ +|..++...
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~ 123 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR 123 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH
T ss_pred CceeeeeecccccHHHHHHHhc
Confidence 999999999975 777776544
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.64 E-value=0.0017 Score=62.18 Aligned_cols=43 Identities=33% Similarity=0.531 Sum_probs=35.6
Q ss_pred HHHHHHhc-CCCCeeeccccccc----ceeeeeeeehhhh-hhhccccc
Q psy12305 139 EVSLLREL-RHANIVTLHDIIHT----EKCLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 139 E~~~l~~l-~h~niv~l~~~~~~----~~~~~lv~Ey~~~-~L~~~l~~ 181 (516)
|+.++.++ +|||||+++++|.. +...|++||||++ +|.+++..
T Consensus 54 E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~ 102 (335)
T d2ozaa1 54 EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD 102 (335)
T ss_dssp HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHS
T ss_pred HHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHh
Confidence 78887665 89999999999864 5668999999975 88888754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.07 E-value=0.0037 Score=57.75 Aligned_cols=41 Identities=22% Similarity=0.329 Sum_probs=36.9
Q ss_pred cchhHHHHHHHHhcC--CCCeeecccccccceeeeeeeehhhh
Q psy12305 133 PCTAIREVSLLRELR--HANIVTLHDIIHTEKCLTLVFEYLEK 173 (516)
Q Consensus 133 ~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~Ey~~~ 173 (516)
...+.+|+.+|++++ |||||++++++..++..+++|||+..
T Consensus 51 ~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~ 93 (273)
T d1xwsa_ 51 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEP 93 (273)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSS
T ss_pred HHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccC
Confidence 346789999999996 99999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.72 E-value=0.0073 Score=57.78 Aligned_cols=59 Identities=27% Similarity=0.425 Sum_probs=51.3
Q ss_pred ccccceeeEEEEEEEecCCceEEEEEeecccccCChhhHHHHHHHHHhccccceeeEeeeEeeC
Q psy12305 189 NNVKGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANIVTLHDIIHTE 252 (516)
Q Consensus 189 ~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 252 (516)
..|+|+||+||+|+++.+|+.||||+++.... ...+|+.+|++++||||++++++|...
T Consensus 27 ~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~ 85 (350)
T d1q5ka_ 27 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSS 85 (350)
T ss_dssp EEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred EEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEec
Confidence 47899999999999999999999999976532 234799999999999999999998654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.61 E-value=0.034 Score=51.81 Aligned_cols=56 Identities=13% Similarity=0.083 Sum_probs=34.3
Q ss_pred ccEeeeeeeccccceEEEEEEEcCCCcEEEEEEeecccccCCcchhHHHHHHHHhcCCCCe
Q psy12305 91 ESYFKLDKLGQGTYATVFKGKSRLTDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI 151 (516)
Q Consensus 91 ~~y~~~~~LG~G~fG~Vyka~~~~~g~~vAvK~i~~~~~~~~~~~~~~E~~~l~~l~h~ni 151 (516)
++..-.+.|..|-=-+.|+.... .| .|.+|+..... ....+..|+++|..|...++
T Consensus 18 g~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~---~~~~l~~~~~~l~~L~~~g~ 73 (316)
T d2ppqa1 18 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV---EKNDLPFFLGLMQHLAAKGL 73 (316)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC------CCHHHHHHHHHHHHHHTTC
T ss_pred CCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCC---CHHHHHHHHHHHHhhhhccc
Confidence 33455567778888899998863 34 58899875431 23466778889988854443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=94.58 E-value=0.0086 Score=56.59 Aligned_cols=32 Identities=25% Similarity=0.341 Sum_probs=28.2
Q ss_pred ccccccccceeeEEEEEEEecCCceEEEEEee
Q psy12305 185 ILSMNNVKGTYATVFKGKSRLTDNLVALKEIK 216 (516)
Q Consensus 185 ~l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~ 216 (516)
.+....|+|+||+||+|+++.+++.||||+++
T Consensus 38 ~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~ 69 (328)
T d3bqca1 38 QLVRKLGRGKYSEVFEAINITNNEKVVVKILK 69 (328)
T ss_dssp EEEEEEEECSSEEEEEEEETTTTEEEEEEEEC
T ss_pred EEEEEEecCcCeEEEEEEECCCCCEEEEEEEC
Confidence 34456789999999999999999999999984
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.54 E-value=0.0061 Score=56.44 Aligned_cols=42 Identities=60% Similarity=1.040 Sum_probs=38.5
Q ss_pred hhHHHHHHHHhcCCCCeeecccccccceeeeeeeehhhhhhh
Q psy12305 135 TAIREVSLLRELRHANIVTLHDIIHTEKCLTLVFEYLEKDLK 176 (516)
Q Consensus 135 ~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~Ey~~~~L~ 176 (516)
.+.+|+.+|+.++|||||++++++......+++++++.+...
T Consensus 47 ~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l 88 (292)
T d1unla_ 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88 (292)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHH
T ss_pred HHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccc
Confidence 688999999999999999999999999999999999987443
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.50 E-value=0.068 Score=51.54 Aligned_cols=66 Identities=17% Similarity=0.146 Sum_probs=40.3
Q ss_pred cceeeEEEEEEEec-------CCceEEEEEeecccccCChhhHHHHHHHHHhccccce-eeEeeeEeeCceeeEeeehhh
Q psy12305 192 KGTYATVFKGKSRL-------TDNLVALKEIKLEHEEGAPCTAIREVSLLRELRHANI-VTLHDIIHTEKCLTLVFEYLE 263 (516)
Q Consensus 192 ~G~~g~V~~~~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 263 (516)
.|-.-.+|+..... ....|.+++... ........+|..+++.+.-.++ .++++++.+ .+|+||++
T Consensus 52 GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~ 124 (395)
T d1nw1a_ 52 GGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIP 124 (395)
T ss_dssp CCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCC
T ss_pred CccccceEEEEeCCCCccccCCCCcEEEEecCC---cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEec
Confidence 45556788876543 234566665431 1222345689999998854444 577777653 57888876
Q ss_pred c
Q psy12305 264 K 264 (516)
Q Consensus 264 g 264 (516)
|
T Consensus 125 g 125 (395)
T d1nw1a_ 125 S 125 (395)
T ss_dssp E
T ss_pred c
Confidence 5
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.46 E-value=0.0039 Score=58.55 Aligned_cols=41 Identities=29% Similarity=0.351 Sum_probs=33.0
Q ss_pred HHHHhcCCCCeeecccccccce----eeeeeeehhhh-hhhccccc
Q psy12305 141 SLLRELRHANIVTLHDIIHTEK----CLTLVFEYLEK-DLKRYMDD 181 (516)
Q Consensus 141 ~~l~~l~h~niv~l~~~~~~~~----~~~lv~Ey~~~-~L~~~l~~ 181 (516)
..++.++|||||++++++..++ ..+++|||++. +|..++..
T Consensus 49 ~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~ 94 (303)
T d1vjya_ 49 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR 94 (303)
T ss_dssp HTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH
T ss_pred HHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc
Confidence 3456689999999999987654 47899999976 88888754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=94.08 E-value=0.012 Score=54.76 Aligned_cols=30 Identities=23% Similarity=0.389 Sum_probs=26.9
Q ss_pred ccccccceeeEEEEEEEecCCceEEEEEee
Q psy12305 187 SMNNVKGTYATVFKGKSRLTDNLVALKEIK 216 (516)
Q Consensus 187 ~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~ 216 (516)
...+|+|+||+||+|++..+++.||||+++
T Consensus 10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~ 39 (293)
T d1csna_ 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP 39 (293)
T ss_dssp EEEEEECSSCEEEEEEETTTTEEEEEEEEE
T ss_pred EEEEecCCCeEEEEEEECCCCCEEEEEEEc
Confidence 445789999999999999999999999875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=93.65 E-value=0.018 Score=49.63 Aligned_cols=32 Identities=19% Similarity=0.068 Sum_probs=26.3
Q ss_pred cccccccceeeEEEEEEEecCCceEEEEEeecc
Q psy12305 186 LSMNNVKGTYATVFKGKSRLTDNLVALKEIKLE 218 (516)
Q Consensus 186 l~~~~~~G~~g~V~~~~~~~~~~~vAiK~i~~~ 218 (516)
++..+|+|+||+||+|.+. +|+.||||+++..
T Consensus 4 vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~ 35 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVG 35 (191)
T ss_dssp EEEEEEECSSEEEEEEEET-TTEEEEEEEECC-
T ss_pred hCCEeeeCcceEEEEEECC-CCCEEEEEEEecc
Confidence 4556789999999999885 7899999988643
|